{"title": "PDF", "author": "PDF", "url": "http://anales.ranf.com/2014/vol2/HTML/files/assets/common/downloads/An.%20Real.%20Acad.%20Farm.%20vol%2079%20n.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "ANALES  DE LA  REAL ACADEMIA NACIONAL DE FARMACIA \t\r \u00a0\n\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0REAL\t\r \u00a0ACADEMIA\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0NACIONAL\t\r \u00a0DE\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0FARMACIA\t\r \u00a0\t\r \u00a0\nwww.analesranf.com\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0ISSN\t\r \u00a01697-\u00ad\u20104271\t\r \u00a0\t\r \u00a0\nVolumen\t\r \u00a080\t\r \u00a0|\t\r \u00a0N\u00famero\t\r \u00a02\t\r \u00a0|\t\r \u00a0Abril-\u00ad\u2010Junio\t\r \u00a02014\t\r \u00a0|\t\r \u00a0P\u00e1ginas\t\r \u00a0239-\u00ad\u2010452\t\r \u00a0\nIns%tuto\t\r \u00a0De\t\r \u00a0Espa\u00f1a\t\r \u00a0\nPublicaci\u00f3n\t\r \u00a0cien5\ufb01ca\t\r \u00a0electr\u00f3nica\t\r \u00a0trimestral\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Madrid,\t\r \u00a0Spain\t\r \u00a0\nMinisterio\t\r \u00a0de\t\r \u00a0Educaci\u00f3n\t\r \u00a0Cultura\t\r \u00a0y\t\r \u00a0Deporte\t\r \u00a0\t\r \u00a0\t\r \u00a0EQUIPO\t\r \u00a0EDITORIAL-\u00ad\u2010EDITORIAL\t\r \u00a0BOARD\t\r \u00a0\t\r \u00a0Director-\u00ad\u2010Journal\t\r \u00a0Manager\t\r \u00a0Antonio\t\r \u00a0L.\t\r \u00a0Doadrio\t\r \u00a0Editor\t\r \u00a0Jefe-\u00ad\u2010Editor\t\r \u00a0in\t\r \u00a0chief\t\r \u00a0Antonio\t\r \u00a0L.\t\r \u00a0Doadrio\t\r \u00a0\t\r \u00a0Editor\t\r \u00a0Cient\u00edfico-\u00ad\u2010Editor\t\r \u00a0executive\t\r \u00a0Jos\u00e9\t\r \u00a0Miguel\t\r \u00a0Ortiz\t\r \u00a0Mel\u00f3n\t\r \u00a0Editores\t\r \u00a0asociados-\u00ad\u2010Associate\t\r \u00a0editors\t\r \u00a0Antonio\t\r \u00a0L.\t\r \u00a0Doadrio.\t\r \u00a0Editor\t\r \u00a0on\t\r \u00a0line\t\r \u00a0Ana\t\r \u00a0M\u00aa\t\r \u00a0Pascual-\u00ad\u2010Leone\t\r \u00a0Pascual.\t\r \u00a0Editora\t\r \u00a0adjunta\t\r \u00a0Antonio\t\r \u00a0J.\t\r \u00a0Salinas.\t\r \u00a0Editor\t\r \u00a0de\t\r \u00a0estilo\t\r \u00a0Benito\t\r \u00a0del\t\r \u00a0Castillo.\t\r \u00a0Editor\t\r \u00a0para\t\r \u00a0asuntos\t\r \u00a0Iberoamericanos\t\r \u00a0Jes\u00fas\t\r \u00a0Pintor\t\r \u00a0Just.\t\r \u00a0Editor\t\r \u00a0para\t\r \u00a0relaciones\t\r \u00a0internacionales\t\r \u00a0\t\r \u00a0Consejo\t\r \u00a0editorial-\u00ad\u2010Editorial\t\r \u00a0Advisory\t\r \u00a0Board\t\r \u00a0Manuel\t\r \u00a0Dom\u00ednguez\t\r \u00a0Carmona,\t\r \u00a0Eugenio\t\r \u00a0Sell\u00e9s\t\r \u00a0Florez,\t\r \u00a0Mar\u00eda\t\r \u00a0Del\t\r \u00a0Carmen\t\r \u00a0Avenda\u00f1o\t\r \u00a0L\u00f3pez,\t\r \u00a0\u00c1ngel\t\r \u00a0Mar\u00eda\t\r \u00a0Villar\t\r \u00a0Del\t\r \u00a0Fresno,\t\r \u00a0Juan\t\r \u00a0Tamargo\t\r \u00a0Men\u00e9ndez,\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0Ozonas,\t\r \u00a0Julio\t\r \u00a0Rodr\u00edguez\t\r \u00a0Villanueva,\t\r \u00a0Manuel\t\r \u00a0Ortega\t\r \u00a0Mata,\t\r \u00a0Salvador\t\r \u00a0Rivas\t\r \u00a0Mart\u00ednez,\t\r \u00a0Alberto\t\r \u00a0Gir\u00e1ldez\t\r \u00a0D\u00e1vila,\t\r \u00a0Guillermo\t\r \u00a0Gim\u00e9nez\t\r \u00a0Gallego\t\r \u00a0\t\r \u00a0Comit\u00e9\t\r \u00a0cient\u00edfico\t\r \u00a0internacional-\u00ad\u2010Editorial\t\r \u00a0International\t\r \u00a0Board\t\r \u00a0Aquiles\t\r \u00a0Arencibia\t\r \u00a0Orrego\t\r \u00a0(Chile),\t\r \u00a0Bernard\t\r \u00a0Portha\t\r \u00a0(France),\t\r \u00a0Herbert\t\r \u00a0Zimmermann\t\r \u00a0(Germany),\t\r \u00a0Geoffrey\t\r \u00a0Burnstock\t\r \u00a0(United\t\r \u00a0Kingdom),\t\r \u00a0Vicenzo\t\r \u00a0Tortorella\t\r \u00a0(Italy),\t\r \u00a0Fernando\t\r \u00a0Quevedo\t\r \u00a0Ganoza\t\r \u00a0(Per\u00fa),\t\r \u00a0Adolfo\t\r \u00a0P\u00e9rez\t\r \u00a0Miravete\t\r \u00a0(M\u00e9xico),\t\r \u00a0Kazurhiro\t\r \u00a0Imai\t\r \u00a0(Japan),\t\r \u00a0Carl-\u00ad\u2010G\u00f6ran\t\r \u00a0Ed\u00e9n\t\r \u00a0(Sweden),\t\r \u00a0Lucette\t\r \u00a0Bardet\t\r \u00a0(France),\t\r \u00a0Joaquim\t\r \u00a0Alexandre\t\r \u00a0Ribeiro\t\r \u00a0(Portugal)\t\r \u00a0\t\r \u00a0e-\u00ad\u2010mail\t\r \u00a0:\t\r \u00a0edicion@ranf.com\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia.\t\r \u00a0\t\r \u00a0Farmacia\t\r \u00a011,\t\r \u00a028004\t\r \u00a0Madrid.\t\r \u00a0Spain\t\r \u00a0Tel\u00e9fonos-\u00ad\u2010Phones:\t\r \u00a0+34915310307-\u00ad\u2010+34915223147.\t\r \u00a0Fax:\t\r \u00a0+34915310306\t\r \u00a0Web:\t\r \u00a0http://www.ranf.com\t\r \u00a0\t\r \u00a0\t\r \u00a0CONTENIDO\t\r \u00a0DEL\t\r \u00a0N\u00daMERO\t\r \u00a0NOTICIAS\t\r \u00a0CIENT\u00cdFICAS:\t\r \u00a0AN\u00c1LISIS\t\r \u00a0\t\r \u00a0\u201cUnited\t\r \u00a0 States\t\r \u00a0 to\t\r \u00a0 approve\t\r \u00a0 potent\t\r \u00a0 oral\t\r \u00a0 drugs\t\r \u00a0 for\t\r \u00a0 hepatitis\t\r \u00a0 C.\t\r \u00a0 Improved\t\r \u00a0 treatments\t\r \u00a0 offer\t\r \u00a0 hope\t\r \u00a0 for\t\r \u00a0eradication\t\r \u00a0of\t\r \u00a0viral\t\r \u00a0liver\t\r \u00a0infection\u201d.\t\r \u00a0M.\t\r \u00a0Carmen\t\r \u00a0Avenda\u00f1o\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0242\t\r \u00a0REVISIONES\t\r \u00a0\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines:\t\r \u00a0contribution\t\r \u00a0of\t\r \u00a0Spanish\t\r \u00a0researchers\t\r \u00a0250\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos:\t\r \u00a0conceptos\t\r \u00a0generales\t\r \u00a0265\t\r \u00a0Marlene\t\r \u00a0Marcelina\t\r \u00a0Saucedo-\u00ad\u2010Balderas,\t\r \u00a0Oscar\t\r \u00a0Z\u00fa\u00f1iga-\u00ad\u2010Lemus,\t\r \u00a0David\t\r \u00a0Orteg\u00f3n-\u00ad\u2010\t\r \u00a0Reyna,\t\r \u00a0Juan\t\r \u00a0Saulo\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Gonz\u00e1lez\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0que\t\r \u00a0sufren\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0a\t\r \u00a0medicamentos.\t\r \u00a0Identificaci\u00f3n\t\r \u00a0y\t\r \u00a0caracterizaci\u00f3n\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0miner\u00eda\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0274\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\t\r \u00a0en\t\r \u00a0las\t\r \u00a0complicaciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0322\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0Liliana\t\r \u00a0Perdomo,\t\r \u00a0\u00d3scar\t\r \u00a0Escribano,\t\r \u00a0Manuel\t\r \u00a0Benito\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\t\r \u00a0pathway\t\r \u00a0in\t\r \u00a0heart\t\r \u00a0development:\t\r \u00a0beyond\t\r \u00a0neuromodulatory\t\r \u00a0actions\t\r \u00a0347\t\r \u00a0Catalina\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0Patricia\t\r \u00a0V\u00e1zquez\t\r \u00a0and\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0ART\u00cdCULOS\t\r \u00a0\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\t\r \u00a0aislados\t\r \u00a0del\t\r \u00a0g\u00e9nero\t\r \u00a0Sideritis\t\r \u00a0362\t\r \u00a0Elena\t\r \u00a0M\u00aa\t\r \u00a0Gonz\u00e1lez\t\r \u00a0Burgos,\t\r \u00a0Ma\t\r \u00a0Emilia\t\r \u00a0Carretero\t\r \u00a0Accame,\t\r \u00a0Ma\t\r \u00a0Pilar\t\r \u00a0G\u00f3mez-\u00ad\u2010\t\r \u00a0Serranillos\t\r \u00a0Cuadrado\t\r \u00a0\t\r \u00a0\t\r \u00a0Detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\t\r \u00a0mediante\t\r \u00a0un\t\r \u00a0sensor\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0377\t\r \u00a0Marta\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez,\t\r \u00a0Gloria\t\r \u00a0Frutos\t\r \u00a0Cabanillas,\t\r \u00a0M.\t\r \u00a0Jes\u00fas\t\r \u00a0Lobo\t\r \u00a0Casta\u00f1\u00f3n,\t\r \u00a0Beatriz\t\r \u00a0L\u00f3pez-\u00ad\u2010Ruiz\t\r \u00a0SESIONES\t\r \u00a0CIENT\u00cdFICAS\t\r \u00a0\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0conmemorativa\t\r \u00a0del\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0y\t\r \u00a0en\t\r \u00a0Qu\u00edmica\t\r \u00a0393\t\r \u00a0Juan\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A,\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0433\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0Ribera\t\r \u00a0INFORMACI\u00d3N\t\r \u00a0CIENT\u00cdFICA\t\r \u00a0\t\r \u00a0Informaci\u00f3n\t\r \u00a0acad\u00e9mica\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0a\t\r \u00a0junio\t\r \u00a0de\t\r \u00a02014\t\r \u00a0444\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\t\r \u00a0242\t\r \u00a0\t\r \u00a0\t\r \u00a0M\u00aa\t\r \u00a0del\t\r \u00a0Carmen\t\r \u00a0Avenda\u00f1o\t\r \u00a0L\u00f3pez\t\r \u00a0Catedr\u00e1tica\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a0Org\u00e1nica\t\r \u00a0Acad\u00e9mica\t\r \u00a0de\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\u201cUnited\t\r \u00a0States\t\r \u00a0 to\t\r \u00a0 approve\t\r \u00a0 potent\t\r \u00a0 oral\t\r \u00a0 drugs\t\r \u00a0 for\t\r \u00a0 hepatitis\t\r \u00a0 C.\t\r \u00a0 Improved\t\r \u00a0treatments\t\r \u00a0offer\t\r \u00a0hope\t\r \u00a0for\t\r \u00a0eradication\t\r \u00a0of\t\r \u00a0viral\t\r \u00a0liver\t\r \u00a0infection\u201d\t\r \u00a0Nature\t\r \u00a0News\t\r \u00a02013\t\r \u00a0doi:10.1038/nature.2013.14059\t\r \u00a0La\t\r \u00a0FDA\t\r \u00a0aprob\u00f3\t\r \u00a0el\t\r \u00a06\t\r \u00a0de\t\r \u00a0diciembre\t\r \u00a0de\t\r \u00a02013\t\r \u00a0el\t\r \u00a0f\u00e1rmaco\t\r \u00a0sofosbuvir\t\r \u00a0(Sovaldi\u00ae)\t\r \u00a0y\t\r \u00a0la\t\r \u00a0 EMA\t\r \u00a0 lo\t\r \u00a0 hizo\t\r \u00a0 el\t\r \u00a0 17\t\r \u00a0 de\t\r \u00a0 enero\t\r \u00a0 de\t\r \u00a0 2014.\t\r \u00a0Su\t\r \u00a0 precio\t\r \u00a0 ha\t\r \u00a0 generado\t\r \u00a0 una\t\r \u00a0 enorme\t\r \u00a0controversia\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0opinan\t\r \u00a0que\t\r \u00a0es\t\r \u00a0inabordable\t\r \u00a0y\t\r \u00a0los\t\r \u00a0que\t\r \u00a0lo\t\r \u00a0justifican\t\r \u00a0por\t\r \u00a0las\t\r \u00a0ventajas\t\r \u00a0que\t\r \u00a0supone\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0tratamientos\t\r \u00a0anteriores.\t\r \u00a0Sofosbuvir\t\r \u00a0forma\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0un\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0nuevos\t\r \u00a0f\u00e1rmacos\t\r \u00a0contra\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0(HCV),\t\r \u00a0desarrollados\t\r \u00a0por\t\r \u00a0distintas\t\r \u00a0compa\u00f1\u00edas\t\r \u00a0que\t\r \u00a0quieren\t\r \u00a0conseguir\t\r \u00a0una\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0este\t\r \u00a0jugoso\t\r \u00a0mercado.\t\r \u00a0COMENTARIOS\t\r \u00a0SOBRE\t\r \u00a0LA\t\r \u00a0HEPATITIS\t\r \u00a0C,\t\r \u00a0PREVENCI\u00d3N\t\r \u00a0Y\t\r \u00a0TRATAMIENTO\t\r \u00a0Uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0mayores\t\r \u00a0problemas\t\r \u00a0inherentes\t\r \u00a0al\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0transfusiones\t\r \u00a0de\t\r \u00a0sangre\t\r \u00a0es\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0agentes\t\r \u00a0infecciosos\t\r \u00a0que\t\r \u00a0no\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0detectados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0sangre\t\r \u00a0de\t\r \u00a0los\t\r \u00a0donantes.\t\r \u00a0Entre\t\r \u00a0ellos\t\r \u00a0podr\u00edan\t\r \u00a0encontrarse\t\r \u00a0los\t\r \u00a0virus\t\r \u00a0HCV\t\r \u00a0y\t\r \u00a0HIV,\t\r \u00a0causantes\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0 C\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 SIDA\t\r \u00a0 respectivamente.\t\r \u00a0Tras\t\r \u00a0 conocerse\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 1970\t\r \u00a0 que\t\r \u00a0exist\u00eda\t\r \u00a0un\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0hepatitis\t\r \u00a0diferente\t\r \u00a0a\t\r \u00a0las\t\r \u00a0entonces\t\r \u00a0conocidas\t\r \u00a0(A\t\r \u00a0y\t\r \u00a0B),\t\r \u00a0tuvieron\t\r \u00a0que\t\r \u00a0transcurrir\t\r \u00a0casi\t\r \u00a020\t\r \u00a0a\u00f1os\t\r \u00a0para\t\r \u00a0que\t\r \u00a0en\t\r \u00a01989\t\r \u00a0se\t\r \u00a0identificara\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0y\t\r \u00a0se\t\r \u00a0desarrollara\t\r \u00a0un\t\r \u00a0test\t\r \u00a0diagn\u00f3stico\t\r \u00a0(1).\t\r \u00a0Los\t\r \u00a0test\t\r \u00a0diagn\u00f3sticos,\t\r \u00a0generalizados\t\r \u00a0en\t\r \u00a0USA\t\r \u00a0en\t\r \u00a0 1992, redujeron\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 contagiarse\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 virus\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 hepatitis\t\r \u00a0 C\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a030%\t\r \u00a0en\t\r \u00a01970\t\r \u00a0a\t\r \u00a0pr\u00e1cticamente\t\r \u00a0un\t\r \u00a00%\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02000.\t\r \u00a0Mientras\t\r \u00a0tanto,\t\r \u00a0como\t\r \u00a0hasta\t\r \u00a0finales\t\r \u00a0de\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a080\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0HCV\t\r \u00a0no\t\r \u00a0se\t\r \u00a0analizaba\t\r \u00a0en\t\r \u00a0las\t\r \u00a0donaciones\t\r \u00a0de\t\r \u00a0sangre,\t\r \u00a0muchas\t\r \u00a0 personas\t\r \u00a0 se\t\r \u00a0 infectaron\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 transfusiones\t\r \u00a0 o\t\r \u00a0 compartiendo\t\r \u00a0agujas\t\r \u00a0 inyectables.\t\r \u00a0Hay\t\r \u00a0 dos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 hepatitis\t\r \u00a0 C:\t\r \u00a0 la\t\r \u00a0 aguda\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 cr\u00f3nica.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0primera,\t\r \u00a0el\t\r \u00a0cuerpo\t\r \u00a0es\t\r \u00a0capaz\t\r \u00a0de\t\r \u00a0liberarse\t\r \u00a0del\t\r \u00a0virus\t\r \u00a0por\t\r \u00a0s\u00ed\t\r \u00a0solo,\t\r \u00a0pero\t\r \u00a0de\t\r \u00a0un\t\r \u00a075\t\r \u00a0a\t\r \u00a0un\t\r \u00a085%\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 infectados\t\r \u00a0 puede\t\r \u00a0 desarrollar\t\r \u00a0 hepatitis\t\r \u00a0 cr\u00f3nica\t\r \u00a0 y\t\r \u00a0 graves\t\r \u00a0problemas\t\r \u00a0hep\u00e1ticos.\t\r \u00a0Seg\u00fan\t\r \u00a0la\t\r \u00a0OMS,\t\r \u00a0del\t\r \u00a060\t\r \u00a0al\t\r \u00a080%\t\r \u00a0de\t\r \u00a0las\t\r \u00a0personas\t\r \u00a0con\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0cr\u00f3nica\t\r \u00a0 no\t\r \u00a0 tienen\t\r \u00a0 s\u00edntomas,\t\r \u00a0 pero\t\r \u00a0 cuando\t\r \u00a0estos\t\r \u00a0 aparecen,\t\r \u00a0 el\t\r \u00a0 h\u00edgado\t\r \u00a0 ya\t\r \u00a0 ha\t\r \u00a0comenzado\t\r \u00a0 a\t\r \u00a0 da\u00f1arse\t\r \u00a0 por\t\r \u00a0 cirrosis\t\r \u00a0 o,\t\r \u00a0en\t\r \u00a0 casos\t\r \u00a0 muy\t\r \u00a0 avanzados,\t\r \u00a0 por\t\r \u00a0 carcinoma\t\r \u00a0NOTICIAS\t\r \u00a0CIENT\u00cdFICAS:\t\r \u00a0AN\u00c1LISIS\t\r \u00a0\nNOTICIAS\t\r \u00a0CIENT\u00cdFICAS\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0243\t\r \u00a0hep\u00e1tico.\t\r \u00a0Todav\u00eda\t\r \u00a0no\t\r \u00a0existe\t\r \u00a0ninguna\t\r \u00a0vacuna\t\r \u00a0que\t\r \u00a0sea\t\r \u00a0preventiva\t\r \u00a0contra\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0y,\t\r \u00a0aunque\t\r \u00a0 es\t\r \u00a0 posible\t\r \u00a0 generar\t\r \u00a0 respuestas\t\r \u00a0 inmunes\t\r \u00a0 celulares\t\r \u00a0 amplias\t\r \u00a0 que\t\r \u00a0 duren\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0menos\t\r \u00a0un\t\r \u00a0a\u00f1o,\t\r \u00a0parecen\t\r \u00a0necesitarse\t\r \u00a0muchos\t\r \u00a0m\u00e1s\t\r \u00a0esfuerzos\t\r \u00a0para\t\r \u00a0conseguir\t\r \u00a0el\t\r \u00a0\u00e9xito\t\r \u00a0en\t\r \u00a0este\t\r \u00a0campo.\t\r \u00a0La\t\r \u00a0 hepatitis\t\r \u00a0 C\t\r \u00a0es\t\r \u00a0 la\t\r \u00a0 causa\t\r \u00a0 m\u00e1s\t\r \u00a0 importante\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0trasplantes\t\r \u00a0de\t\r \u00a0 h\u00edgado,\t\r \u00a0aunque\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0antiviral\t\r \u00a0ha\t\r \u00a0de\t\r \u00a0continuarse\t\r \u00a0despu\u00e9s\t\r \u00a0del\t\r \u00a0trasplante\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0que,\t\r \u00a0 incluso\t\r \u00a0 los\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 orales\t\r \u00a0 m\u00e1s\t\r \u00a0 activos,\t\r \u00a0 son\t\r \u00a0 incapaces\t\r \u00a0 de\t\r \u00a0 estimular\t\r \u00a0 una\t\r \u00a0respuesta\t\r \u00a0inmune\t\r \u00a0duradera,\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0un\t\r \u00a0paciente\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0reinfectado.\t\r \u00a0Por\t\r \u00a0otra\t\r \u00a0parte,\t\r \u00a0 dado\t\r \u00a0 que\t\r \u00a0 este\t\r \u00a0 virus\t\r \u00a0 progresa\t\r \u00a0 muy\t\r \u00a0 lentamente,\t\r \u00a0 es\t\r \u00a0 posible\t\r \u00a0 encontrar\t\r \u00a0 las\t\r \u00a0complicaciones\t\r \u00a0hep\u00e1ticas\t\r \u00a0graves\t\r \u00a0que\t\r \u00a0hemos\t\r \u00a0mencionado\t\r \u00a0transcurridos\t\r \u00a020,\t\r \u00a030\t\r \u00a0o\t\r \u00a040\t\r \u00a0a\u00f1os\t\r \u00a0desde\t\r \u00a0su\t\r \u00a0infecci\u00f3n.\t\r \u00a0El\t\r \u00a0pron\u00f3stico\t\r \u00a0y\t\r \u00a0la\t\r \u00a0expectativa\t\r \u00a0de\t\r \u00a0vida\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0pacientes\t\r \u00a0depende\t\r \u00a0 del\t\r \u00a0 da\u00f1o\t\r \u00a0 hep\u00e1tico\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 respuesta\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 tratamientos. El\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0enfermos\t\r \u00a0 contagiados\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0virus\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 hepatitis\t\r \u00a0 C\t\r \u00a0 (HCV)\t\r \u00a0 supone\t\r \u00a0un\t\r \u00a0 3% de\t\r \u00a0 la\t\r \u00a0poblaci\u00f3n\t\r \u00a0mundial,\t\r \u00a0unos\t\r \u00a0170\t\r \u00a0millones\t\r \u00a0de\t\r \u00a0personas,\t\r \u00a0de\t\r \u00a0las\t\r \u00a0que\t\r \u00a09\t\r \u00a0millones\t\r \u00a0residen\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 Uni\u00f3n\t\r \u00a0 Europea.\t\r \u00a0 Estos\t\r \u00a0 enfermos\t\r \u00a0se\t\r \u00a0 han\t\r \u00a0 tratado\t\r \u00a0 durante\t\r \u00a0 d\u00e9cadas\t\r \u00a0 con\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0f\u00e1rmacos.\t\r \u00a0En\t\r \u00a0una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0m\u00e1s\t\r \u00a0utilizadas\t\r \u00a0se\t\r \u00a0combina\t\r \u00a0el\t\r \u00a0interfer\u00f3n\t\r \u00a0\u03b1,\t\r \u00a0 un\t\r \u00a0 activante\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 inmune\t\r \u00a0 que\t\r \u00a0 tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 usa\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0leucemia\t\r \u00a0 mieloide\t\r \u00a0 cr\u00f3nica\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 administra\t\r \u00a0 como\t\r \u00a0 inyectable,\t\r \u00a0 con\t\r \u00a0 ribavirina\t\r \u00a0administrada\t\r \u00a0por\t\r \u00a0v\u00eda\t\r \u00a0oral.\t\r \u00a0La\t\r \u00a0ribavirina\t\r \u00a0(Virazol\u00ae)\t\r \u00a0es\t\r \u00a0un\t\r \u00a0an\u00e1logo\t\r \u00a0de\t\r \u00a0un\t\r \u00a0nucle\u00f3sido\t\r \u00a0de\t\r \u00a0purina\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0la\t\r \u00a0base\t\r \u00a0nitrogenada\t\r \u00a0es\t\r \u00a0triazolcarboxamida.\t\r \u00a0Es\t\r \u00a0un\t\r \u00a0antiviral\t\r \u00a0de\t\r \u00a0amplio\t\r \u00a0espectro\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C,\t\r \u00a0ejerce\t\r \u00a0su\t\r \u00a0efecto\t\r \u00a0antiviral\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0diversos\t\r \u00a0mecanismos,\t\r \u00a0entre\t\r \u00a0ellos\t\r \u00a0produciendo\t\r \u00a0en\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0una\t\r \u00a0mutag\u00e9nesis\t\r \u00a0letal\t\r \u00a0(3).\t\r \u00a0En\t\r \u00a0esta\t\r \u00a0combinaci\u00f3n,\t\r \u00a0el\t\r \u00a0interfer\u00f3n\t\r \u00a0\u03b1\t\r \u00a0puede\t\r \u00a0reemplazarse\t\r \u00a0por\t\r \u00a0peginterfer\u00f3n\t\r \u00a0\u03b1\t\r \u00a0(PEG-\u00ad\u2010intron),\t\r \u00a0que\t\r \u00a0se\t\r \u00a0administra\t\r \u00a0por\t\r \u00a0v\u00eda\t\r \u00a0subcut\u00e1nea\t\r \u00a0en\t\r \u00a0el\t\r \u00a0abdomen\t\r \u00a0o\t\r \u00a0en\t\r \u00a0el\t\r \u00a0muslo.\t\r \u00a0Estas\t\r \u00a0combinaciones\t\r \u00a0pretenden\t\r \u00a0estimular\t\r \u00a0el\t\r \u00a0sistema\t\r \u00a0inmune\t\r \u00a0y,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0vez,\t\r \u00a0matar\t\r \u00a0el\t\r \u00a0virus.\t\r \u00a0NNNONH2OHOOHOHRibavirina (Virazol\u00ae)\t\r \u00a0\t\r \u00a0El\t\r \u00a0\u00e9xito\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tratamientos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0cr\u00f3nica\t\r \u00a0dependen\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez\t\r \u00a0del\t\r \u00a0genotipo\t\r \u00a0del\t\r \u00a0virus\t\r \u00a0infectante.\t\r \u00a0En\t\r \u00a0USA,\t\r \u00a0un\t\r \u00a075%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0pacientes\t\r \u00a0infectados\t\r \u00a0tienen\t\r \u00a0el\t\r \u00a0genotipo\t\r \u00a01\t\r \u00a0(el\t\r \u00a0m\u00e1s\t\r \u00a0dif\u00edcil\t\r \u00a0de\t\r \u00a0curar),\t\r \u00a0entre\t\r \u00a0un\t\r \u00a020\t\r \u00a0y\t\r \u00a0un\t\r \u00a025%\t\r \u00a0tienen\t\r \u00a0el\t\r \u00a0genotipo\t\r \u00a02\t\r \u00a0o\t\r \u00a0el\t\r \u00a03,\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 peque\u00f1o\t\r \u00a0 porcentaje\t\r \u00a0 posee\t\r \u00a0 los\t\r \u00a0 genotipos\t\r \u00a0 4,\t\r \u00a0 5\t\r \u00a0o\t\r \u00a06.\t\r \u00a0 Los\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0genotipos\t\r \u00a0 2\t\r \u00a0 \u00f3\t\r \u00a0 3\t\r \u00a0 tienen\t\r \u00a0 m\u00e1s\t\r \u00a0 posibilidades\t\r \u00a0 de\t\r \u00a0 curarse\t\r \u00a0 totalmente\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 del\t\r \u00a0genotipo\t\r \u00a01\t\r \u00a0y,\t\r \u00a0adem\u00e1s,\t\r \u00a0sus\t\r \u00a0tratamientos\t\r \u00a0son\t\r \u00a0m\u00e1s\t\r \u00a0cortos.\t\r \u00a0\t\r \u00a0\t\r \u00a0M.\t\r \u00a0C.\t\r \u00a0Avenda\u00f1o\t\r \u00a0L\u00f3pez\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0244\t\r \u00a0LA\t\r \u00a0CARRERA\t\r \u00a0PARA\t\r \u00a0ENCONTRAR\t\r \u00a0NUEVOS\t\r \u00a0TRATAMIENTOS\t\r \u00a0ANTI\t\r \u00a0HCV\t\r \u00a0En\t\r \u00a0 breve,\t\r \u00a0 los\t\r \u00a0 importantes\t\r \u00a0 efectos\t\r \u00a0 secundarios\t\r \u00a0 que\t\r \u00a0 produce\t\r \u00a0 el\t\r \u00a0 interfer\u00f3n\t\r \u00a0podr\u00edan\t\r \u00a0eliminarse\t\r \u00a0con\t\r \u00a0la\t\r \u00a0reciente\t\r \u00a0o\t\r \u00a0inminente\t\r \u00a0aprobaci\u00f3n\t\r \u00a0de\t\r \u00a0f\u00e1rmacos\t\r \u00a0antivirales\t\r \u00a0orales,\t\r \u00a0 muy\t\r \u00a0 eficaces,\t\r \u00a0 que\t\r \u00a0 interfieren\t\r \u00a0 la\t\r \u00a0 replicaci\u00f3n\t\r \u00a0 del\t\r \u00a0 virus\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0 capacidad\t\r \u00a0 para\t\r \u00a0fabricar\t\r \u00a0 sus\t\r \u00a0 propias\t\r \u00a0 prote\u00ednas.\t\r \u00a0 Seg\u00fan\t\r \u00a0 los\t\r \u00a0 expertos,\t\r \u00a0 la\t\r \u00a0 erradicaci\u00f3n\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0enfermedad\t\r \u00a0en\t\r \u00a0el\t\r \u00a0mundo\t\r \u00a0es\t\r \u00a0ahora\t\r \u00a0al\t\r \u00a0menos\t\r \u00a0en\t\r \u00a0teor\u00eda\t\r \u00a0un\t\r \u00a0objetivo\t\r \u00a0realista,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0este\t\r \u00a0 virus\t\r \u00a0 no\t\r \u00a0 tiene\t\r \u00a0 ning\u00fan\t\r \u00a0 reservorio\t\r \u00a0 animal,\t\r \u00a0 la\t\r \u00a0 enfermedad\t\r \u00a0se\t\r \u00a0 desarrolla\t\r \u00a0 muy\t\r \u00a0lentamente,\t\r \u00a0y\t\r \u00a0las\t\r \u00a0personas\t\r \u00a0no\t\r \u00a0se\t\r \u00a0contagian\t\r \u00a0f\u00e1cilmente\t\r \u00a0si\t\r \u00a0no\t\r \u00a0es\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sangre\t\r \u00a0u\t\r \u00a0otros\t\r \u00a0fluidos\t\r \u00a0corporales\t\r \u00a0contaminados.\t\r \u00a0La\t\r \u00a0FDA\t\r \u00a0aprob\u00f3\t\r \u00a0el\t\r \u00a06\t\r \u00a0de\t\r \u00a0diciembre\t\r \u00a0de\t\r \u00a02013\t\r \u00a0el\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sofosbuvir\t\r \u00a0 (Sovaldi\u00ae)\t\r \u00a0 en\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 con\t\r \u00a0 ribavirina\t\r \u00a0 (RBV)\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0tratamiento\t\r \u00a0oral\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0producida\t\r \u00a0por\t\r \u00a0los\t\r \u00a0genotipos\t\r \u00a02\t\r \u00a0y\t\r \u00a03,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0para\t\r \u00a0 los\t\r \u00a0 genotipos\t\r \u00a0 1\t\r \u00a0 y\t\r \u00a0 4\t\r \u00a0 se\t\r \u00a0 requiere\t\r \u00a0 un\t\r \u00a0 tratamiento\t\r \u00a0 triple\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 adici\u00f3n\t\r \u00a0 de\t\r \u00a0interfer\u00f3n\t\r \u00a0 pegilado.\t\r \u00a0 La\t\r \u00a0 EMA\t\r \u00a0 lo\t\r \u00a0 hizo\t\r \u00a0 el\t\r \u00a0 17\t\r \u00a0 de\t\r \u00a0 enero\t\r \u00a0 de\t\r \u00a0 2014.\t\r \u00a0Sofosbuvir,\t\r \u00a0descubierto\t\r \u00a0por\t\r \u00a0la\t\r \u00a0empresa\t\r \u00a0Pharmasset\t\r \u00a0pero\t\r \u00a0desarrollado\t\r \u00a0por\t\r \u00a0Gilead\t\r \u00a0Sciences,\t\r \u00a0es\t\r \u00a0en\t\r \u00a0realidad\t\r \u00a0 un\t\r \u00a0 prof\u00e1rmaco\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 metaboliza\t\r \u00a0 originando\t\r \u00a0 el\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 activo\t\r \u00a0 2'-\u00ad\u2010desoxi-\u00ad\u20102'-\u00ad\u2010\u03b1-\u00ad\u2010fluoro-\u00ad\u2010\u03b2-\u00ad\u2010C-\u00ad\u2010metiluridina-\u00ad\u20105'-\u00ad\u2010trifosfato,\t\r \u00a0 un\t\r \u00a0 antimetabolito\t\r \u00a0 que\t\r \u00a0 inhibe\t\r \u00a0 la\t\r \u00a0polimerasa\t\r \u00a0de\t\r \u00a0ARN\t\r \u00a0denominada\t\r \u00a0NS5B,\t\r \u00a0que\t\r \u00a0es\t\r \u00a0la\t\r \u00a0enzima\t\r \u00a0que\t\r \u00a0utiliza\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0HCV\t\r \u00a0para\t\r \u00a0la\t\r \u00a0s\u00edntesis\t\r \u00a0de\t\r \u00a0su\t\r \u00a0ARN.\t\r \u00a0Ya\t\r \u00a0se\t\r \u00a0conoc\u00edan\t\r \u00a0varios\t\r \u00a0an\u00e1logos\t\r \u00a0de\t\r \u00a0nucle\u00f3sidos\t\r \u00a0activos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0(la\t\r \u00a0propia\t\r \u00a0ribavirina),\t\r \u00a0pero\t\r \u00a0su\t\r \u00a0potencia\t\r \u00a0era\t\r \u00a0muy\t\r \u00a0baja\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0la\t\r \u00a0 incorporaci\u00f3n\t\r \u00a0 del\t\r \u00a0 primer\t\r \u00a0 grupo\t\r \u00a0 fosfato,\t\r \u00a0necesaria\t\r \u00a0 para\t\r \u00a0 originar\t\r \u00a0 despu\u00e9s\t\r \u00a0 el\t\r \u00a0nucle\u00f3tido\t\r \u00a0trifosfato,\t\r \u00a0es\t\r \u00a0lenta.\t\r \u00a0En\t\r \u00a0sofosbuvir\t\r \u00a0este\t\r \u00a0grupo\t\r \u00a0ya\t\r \u00a0est\u00e1\t\r \u00a0presente,\t\r \u00a0aunque\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0 modificado\t\r \u00a0 para\t\r \u00a0 optimizar\t\r \u00a0 su\t\r \u00a0 farmacocin\u00e9tica\t\r \u00a0 enmascarando\t\r \u00a0 las\t\r \u00a0 dos\t\r \u00a0 cargas\t\r \u00a0negativas\t\r \u00a0 del\t\r \u00a0 grupo\t\r \u00a0 fosfato\t\r \u00a0 a\t\r \u00a0 fin\t\r \u00a0 de\t\r \u00a0 facilitar\t\r \u00a0 su\t\r \u00a0 entrada\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 infectadas\t\r \u00a0(Figura\t\r \u00a01).\t\r \u00a0\t\r \u00a0\nH3CFOHNNHOOOPOHNOOOCH3CH3H3C\nSofosbuvir (Sovaldi\u00ae)H3CFOHNNHOOHOAn\u00e1logo de nucle\u00f3sidoNucle\u00f3sido cinasa(lenta)H3CFOHNNHOOONucle\u00f3sido monofosfatoPOOO\nEnzimascelulares(r\u00e1pida)Nucle\u00f3tido y nucle\u00f3sidodifosfato cinasasH3CFOHNNHOOONucle\u00f3sido trifosfatoactivoPOOO(r\u00e1pida)POOOPOOO\n Figura\t\r \u00a0 1.-\u00ad\u2010\t\r \u00a0Biotransformaci\u00f3n\t\r \u00a0 del\t\r \u00a0 prof\u00e1rmaco\t\r \u00a0 sofosbuvir\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 nucle\u00f3sido\t\r \u00a0 monofosfato\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0siguiente\t\r \u00a0difosforilaci\u00f3n\t\r \u00a0al\t\r \u00a0nucle\u00f3sido\t\r \u00a0trifosfato\t\r \u00a0activo.\t\r \u00a0NOTICIAS\t\r \u00a0CIENT\u00cdFICAS\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0245\t\r \u00a0Los\t\r \u00a0tratamientos\t\r \u00a0que\t\r \u00a0incluyen\t\r \u00a0sofosbuvir\t\r \u00a0son\t\r \u00a0aproximadamente\t\r \u00a0una\t\r \u00a0mitad\t\r \u00a0m\u00e1s\t\r \u00a0cortos\t\r \u00a0que\t\r \u00a0los\t\r \u00a0utilizados\t\r \u00a0anteriormente,\t\r \u00a0pero\t\r \u00a0su\t\r \u00a0principal\t\r \u00a0ventaja\t\r \u00a0es\t\r \u00a0que\t\r \u00a0en\t\r \u00a0los\t\r \u00a0genotipos\t\r \u00a02\t\r \u00a0y\t\r \u00a03\t\r \u00a0del\t\r \u00a0virus\t\r \u00a0puede\t\r \u00a0omitirse\t\r \u00a0el\t\r \u00a0interfer\u00f3n\t\r \u00a0y,\t\r \u00a0por\t\r \u00a0tanto,\t\r \u00a0sus\t\r \u00a0efectos\t\r \u00a0secundarios.\t\r \u00a0 En\t\r \u00a0 estos\t\r \u00a0 reg\u00edmenes\t\r \u00a0 libres\t\r \u00a0 de\t\r \u00a0 interfer\u00f3n,\t\r \u00a0 la\t\r \u00a0 neutropenia,\t\r \u00a0 fatiga,\t\r \u00a0n\u00e1useas,\t\r \u00a0 dolor\t\r \u00a0 de\t\r \u00a0 cabeza,\t\r \u00a0 prurito\t\r \u00a0 e\t\r \u00a0 irritabilidad\t\r \u00a0 se\t\r \u00a0 ven\t\r \u00a0 muy\t\r \u00a0 reducidos\t\r \u00a0 o\t\r \u00a0 est\u00e1n\t\r \u00a0pr\u00e1cticamente\t\r \u00a0ausentes.\t\r \u00a0Otra\t\r \u00a0ventaja\t\r \u00a0es\t\r \u00a0que\t\r \u00a0los\t\r \u00a0nucle\u00f3tidos\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ARN\t\r \u00a0polimerasa\t\r \u00a0parecen\t\r \u00a0 poco\t\r \u00a0 proclives\t\r \u00a0 a\t\r \u00a0 desarrollar\t\r \u00a0 resistencias,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0otras\t\r \u00a0enzimas\t\r \u00a0v\u00edricas,\t\r \u00a0como\t\r \u00a0por\t\r \u00a0ejemplo\t\r \u00a0la\t\r \u00a0proteasa,\t\r \u00a0las\t\r \u00a0desarrollan\t\r \u00a0r\u00e1pidamente,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0justifica\t\r \u00a0en\t\r \u00a0gran\t\r \u00a0parte\t\r \u00a0su\t\r \u00a0fracaso\t\r \u00a0en\t\r \u00a0cl\u00ednica.\t\r \u00a0Aunque\t\r \u00a0no\t\r \u00a0puede\t\r \u00a0descartarse\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 desarrollen\t\r \u00a0 nuevos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 virus\t\r \u00a0 resistentes\t\r \u00a0 a\t\r \u00a0 estos\t\r \u00a0 nuevos\t\r \u00a0tratamientos,\t\r \u00a0parece\t\r \u00a0que\t\r \u00a0esta\t\r \u00a0posibilidad\t\r \u00a0no\t\r \u00a0es\t\r \u00a0f\u00e1cil,\t\r \u00a0debido\t\r \u00a0fundamentalmente\t\r \u00a0a\t\r \u00a0su\t\r \u00a0 extremada\t\r \u00a0 potencia.\t\r \u00a0Pharmasset\t\r \u00a0 ya\t\r \u00a0 ten\u00eda\t\r \u00a0 varios\t\r \u00a0 compuestos\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 tipo\t\r \u00a0 en\t\r \u00a0desarrollo,\t\r \u00a0 como\t\r \u00a0 mericitabina\t\r \u00a0 (RG7128)\t\r \u00a0 (4),\t\r \u00a0 un\t\r \u00a0 an\u00e1logo\t\r \u00a0 del\t\r \u00a0 nucle\u00f3sido\t\r \u00a0 citidina\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0en\t\r \u00a0estudios\t\r \u00a0cl\u00ednicos\t\r \u00a0de\t\r \u00a0fase\t\r \u00a0II\t\r \u00a0y\t\r \u00a0se\t\r \u00a0desarrolla\t\r \u00a0en\t\r \u00a0conjunci\u00f3n\t\r \u00a0con\t\r \u00a0Roche.\t\r \u00a0\nNNOOH2NFH3COOOCH3CH3Mericitabina (RG7128)OH3CCH3\t\r \u00a0Desafortunadamente,\t\r \u00a0 sofosbuvir\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 sustrato\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 glicoprote\u00edna\t\r \u00a0 de\t\r \u00a0transporte\t\r \u00a0 P\t\r \u00a0 (Pgp),\t\r \u00a0por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 inducen\t\r \u00a0 podr\u00edan\t\r \u00a0 afectar\t\r \u00a0 su\t\r \u00a0absorci\u00f3n\t\r \u00a0 intestinal.\t\r \u00a0Sin\t\r \u00a0 embargo,\t\r \u00a0 el\t\r \u00a0 mayor\t\r \u00a0 problema\t\r \u00a0 para\t\r \u00a0 usar\t\r \u00a0 sofosbuvir\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0precio\t\r \u00a0del\t\r \u00a0tratamiento,\t\r \u00a0que\t\r \u00a0se\t\r \u00a0cifra\t\r \u00a0entre\t\r \u00a084.000\t\r \u00a0$\t\r \u00a0(1.000\t\r \u00a0$/d\u00eda)\t\r \u00a0para\t\r \u00a0su\t\r \u00a0uso\t\r \u00a0en\t\r \u00a0los\t\r \u00a0genotipos\t\r \u00a01\t\r \u00a0y\t\r \u00a02\t\r \u00a0y\t\r \u00a0168.000\t\r \u00a0$\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0del\t\r \u00a0genotipo\t\r \u00a03,\t\r \u00a0que\t\r \u00a0requiere\t\r \u00a024\t\r \u00a0semanas.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 Reino\t\r \u00a0 Unido\t\r \u00a0 su\t\r \u00a0 precio\t\r \u00a0 se\t\r \u00a0 calcula\t\r \u00a0 en\t\r \u00a0 35.000\t\r \u00a0 \u00a3.\t\r \u00a0 Este\t\r \u00a0 precio\t\r \u00a0 ha\t\r \u00a0generado\t\r \u00a0una\t\r \u00a0enorme\t\r \u00a0controversia\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0opinan\t\r \u00a0que\t\r \u00a0es\t\r \u00a0inabordable\t\r \u00a0y\t\r \u00a0los\t\r \u00a0que\t\r \u00a0piensan\t\r \u00a0que\t\r \u00a0est\u00e1\t\r \u00a0justificado\t\r \u00a0por\t\r \u00a0las\t\r \u00a0ventajas\t\r \u00a0que\t\r \u00a0supone\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0tratamientos\t\r \u00a0anteriores.\t\r \u00a0La\t\r \u00a0organizaci\u00f3n\t\r \u00a0\u201cDoctors\t\r \u00a0of\t\r \u00a0the\t\r \u00a0World\u201d\t\r \u00a0lo\t\r \u00a0ha\t\r \u00a0criticado\t\r \u00a0duramente\t\r \u00a0(5),\t\r \u00a0y\t\r \u00a0es\t\r \u00a0que,\t\r \u00a0a\t\r \u00a0diferencia\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0ocurrido\t\r \u00a0con\t\r \u00a0los\t\r \u00a0tratamientos\t\r \u00a0anti-\u00ad\u2010HIV\t\r \u00a0que\t\r \u00a0duran\t\r \u00a0toda\t\r \u00a0la\t\r \u00a0vida\t\r \u00a0de\t\r \u00a0los\t\r \u00a0pacientes,\t\r \u00a0estos\t\r \u00a0tratamientos\t\r \u00a0pueden\t\r \u00a0durar\t\r \u00a0s\u00f3lo\t\r \u00a012\t\r \u00a0semanas\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 empresas\t\r \u00a0 farmac\u00e9uticas\t\r \u00a0 no\t\r \u00a0 tienen\t\r \u00a0 ning\u00fan\t\r \u00a0 incentivo\t\r \u00a0 para\t\r \u00a0 bajar\t\r \u00a0 los\t\r \u00a0precios.\t\r \u00a0\t\r \u00a0Sofosbuvir\t\r \u00a0forma\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0un\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0nuevos\t\r \u00a0f\u00e1rmacos\t\r \u00a0anti\t\r \u00a0HCV\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a0actualmente\t\r \u00a0 hay\t\r \u00a0 unos\t\r \u00a0 60\t\r \u00a0 compuestos\t\r \u00a0 en\t\r \u00a0 desarrollo\t\r \u00a0 precl\u00ednico\t\r \u00a0 o\t\r \u00a0 cl\u00ednico,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0compa\u00f1\u00edas\t\r \u00a0quieren\t\r \u00a0conseguir\t\r \u00a0una\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0este\t\r \u00a0jugoso\t\r \u00a0mercado. Entre\t\r \u00a0ellos\t\r \u00a0 se\t\r \u00a0 encuentran\t\r \u00a0 los\t\r \u00a0 inhibidores\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 proteasa\t\r \u00a0 NS3/4A\t\r \u00a0 (esencial\t\r \u00a0 para\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0virus\t\r \u00a0produzca\t\r \u00a0sus\t\r \u00a0propias\t\r \u00a0prote\u00ednas)\t\r \u00a0boceprevir\t\r \u00a0(Victrelis\u00ae)\t\r \u00a0(6)\t\r \u00a0desarrollado\t\r \u00a0por\t\r \u00a0M.\t\r \u00a0C.\t\r \u00a0Avenda\u00f1o\t\r \u00a0L\u00f3pez\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0246\t\r \u00a0Shering-\u00ad\u2010Plough\t\r \u00a0y\t\r \u00a0luego\t\r \u00a0por\t\r \u00a0Merck\t\r \u00a0y\t\r \u00a0aprobado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0FDA\t\r \u00a0el\t\r \u00a013\t\r \u00a0de\t\r \u00a0Mayo\t\r \u00a0de\t\r \u00a02011,\t\r \u00a0telaprevir\t\r \u00a0 (Telavic\u00ae)\t\r \u00a0 (7)\t\r \u00a0 desarrollado\t\r \u00a0 por\t\r \u00a0 Vertex\t\r \u00a0 y\t\r \u00a0 Jonson&Johnson\t\r \u00a0 y\t\r \u00a0 aprobado\t\r \u00a0por\t\r \u00a0 la\t\r \u00a0 FDA\t\r \u00a0 el\t\r \u00a0 23\t\r \u00a0 de\t\r \u00a0 mayo\t\r \u00a0 de\t\r \u00a0 2011,\t\r \u00a0 y\t\r \u00a0simeprevir\t\r \u00a0 (Olysio\u00ae)\t\r \u00a0 (8),\t\r \u00a0 desarrollado\t\r \u00a0 por\t\r \u00a0Janssen\t\r \u00a0y\t\r \u00a0aprobado\t\r \u00a0tambi\u00e9n\t\r \u00a0por\t\r \u00a0la\t\r \u00a0FDA\t\r \u00a0el\t\r \u00a022\t\r \u00a0de\t\r \u00a0noviembre\t\r \u00a0de\t\r \u00a02013.\t\r \u00a0Los\t\r \u00a0tres\t\r \u00a0est\u00e1n\t\r \u00a0indicados\t\r \u00a0para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0del\t\r \u00a0 genotipo\t\r \u00a0 1\t\r \u00a0 del\t\r \u00a0 virus\t\r \u00a0 HCV\t\r \u00a0combinados\t\r \u00a0 con\t\r \u00a0interfer\u00f3n\t\r \u00a0pegilado\t\r \u00a0y\t\r \u00a0ribavirina.  HNHNOH3CH3CCH3OH3CCH3CH3NH3CCH3HNOOHNOBoceprevir (Victrelis\u00ae)NHHNOONNOH3CCH3CH3NHNOOHNOCH3Telaprevir (Telavic\u00ae)\nNCH3OONHONHOSOO\nNSNCH3H3CCH3OCH3Simeprevir (Olysio\u00ae)\t\r \u00a0La\t\r \u00a0 firma\t\r \u00a0 Bristol-\u00ad\u2010Myers-\u00ad\u2010Squibb\t\r \u00a0 descubri\u00f3\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2010\t\r \u00a0 una\t\r \u00a0 prote\u00edna\t\r \u00a0 del\t\r \u00a0virus\t\r \u00a0HCV\t\r \u00a0llamada\t\r \u00a0NS5A\t\r \u00a0que,\t\r \u00a0aunque\t\r \u00a0no\t\r \u00a0es\t\r \u00a0una\t\r \u00a0enzima,\t\r \u00a0es\t\r \u00a0esencial\t\r \u00a0para\t\r \u00a0la\t\r \u00a0uni\u00f3n\t\r \u00a0de\t\r \u00a0 las\t\r \u00a0 part\u00edculas\t\r \u00a0 virales\t\r \u00a0 infecciosas\t\r \u00a0 y\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 amplificaci\u00f3n\t\r \u00a0 del\t\r \u00a0 RNA1\t\r \u00a0 v\u00edrico\t\r \u00a0 (9).\t\r \u00a0Daclatasvir\t\r \u00a0 (10)\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0inhibidor\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0prote\u00edna\t\r \u00a0desarrollado\t\r \u00a0 por\t\r \u00a0 Bristol-\u00ad\u2010Myers\t\r \u00a0Squibb\t\r \u00a0 cuya\t\r \u00a0 aprobaci\u00f3n\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 solicitado\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0Agencia\t\r \u00a0 Europea\t\r \u00a0 del\t\r \u00a0 Medicamento\t\r \u00a0(EMA).\t\r \u00a0 Esta\t\r \u00a0 solicitud\t\r \u00a0 busca\t\r \u00a0 la\t\r \u00a0 aprobaci\u00f3n\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 en\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 con\t\r \u00a0otros\t\r \u00a0agentes,\t\r \u00a0incluido\t\r \u00a0sofosbuvir.\t\r \u00a0Asunaprevir\t\r \u00a0es\t\r \u00a0un\t\r \u00a0inhibidor\t\r \u00a0de\t\r \u00a0la\t\r \u00a0proteasa\t\r \u00a0NS3\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0en\t\r \u00a0ensayos\t\r \u00a0cl\u00ednicos\t\r \u00a0de\t\r \u00a0fase\t\r \u00a0III\t\r \u00a0y\t\r \u00a0est\u00e1\t\r \u00a0siendo\t\r \u00a0desarrollado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0empresa\t\r \u00a0(11). Otra\t\r \u00a0estrategia\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0tratar\t\r \u00a0de\t\r \u00a0parar\t\r \u00a0la\t\r \u00a0expansi\u00f3n\t\r \u00a0del\t\r \u00a0virus\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 interior\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 paciente\t\r \u00a0 impidiendo\t\r \u00a0 su\t\r \u00a0 entrada\t\r \u00a0 en\t\r \u00a0 otras\t\r \u00a0 c\u00e9lulas.\t\r \u00a0 Cuando\t\r \u00a0 un\t\r \u00a0equipo\t\r \u00a0de\t\r \u00a0vir\u00f3logos\t\r \u00a0demostr\u00f3\t\r \u00a0en\t\r \u00a02011\t\r \u00a0que\t\r \u00a0este\t\r \u00a0virus\t\r \u00a0requiere\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0 receptora\t\r \u00a0 denominada\t\r \u00a0 factor\t\r \u00a0 de\t\r \u00a0 crecimiento\t\r \u00a0 epid\u00e9rmico\t\r \u00a0 (EGFR)\t\r \u00a0 para\t\r \u00a0penetrar\t\r \u00a0en\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0humanas\t\r \u00a0(12),\t\r \u00a0se\t\r \u00a0plante\u00f3\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0cl\u00ednico\t\r \u00a0de\t\r \u00a0inhibidores\t\r \u00a0EGFR\t\r \u00a0 que\t\r \u00a0 ya\t\r \u00a0 estaban\t\r \u00a0 comercializados\t\r \u00a0 como\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 antic\u00e1ncer,\t\r \u00a0 como\t\r \u00a0 erlotinib\t\r \u00a0(Tarceva\u00ae).\t\r \u00a0Otro\t\r \u00a0mecanismo\t\r \u00a0de\t\r \u00a0entrada\t\r \u00a0de\t\r \u00a0HCV\t\r \u00a0en\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0humanas\t\r \u00a0implica\t\r \u00a0a\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0 de\t\r \u00a0 transmembrana\t\r \u00a0 denominada\t\r \u00a0scavenger\t\r \u00a0receptor\t\r \u00a0 B1\t\r \u00a0 (SRB1),\t\r \u00a0 que\t\r \u00a0funciona\t\r \u00a0como\t\r \u00a0un\t\r \u00a0receptor\t\r \u00a0de\t\r \u00a0lipoprote\u00ednas\t\r \u00a0de\t\r \u00a0alta\t\r \u00a0densidad\t\r \u00a0facilitando\t\r \u00a0su\t\r \u00a0entrada\t\r \u00a0NOTICIAS\t\r \u00a0CIENT\u00cdFICAS\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0247\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 h\u00edgado.\t\r \u00a0 El\t\r \u00a0 compuesto\t\r \u00a0 ITX-\u00ad\u20105061\t\r \u00a0 inhibe\t\r \u00a0 este\t\r \u00a0 mecanismo.\t\r \u00a0 Desarrollado\t\r \u00a0 por\t\r \u00a0iTherX\t\r \u00a0Pharmaceuticals,\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0en\t\r \u00a0ensayos\t\r \u00a0cl\u00ednicos\t\r \u00a0fase\t\r \u00a0II.\t\r \u00a0\nH3COOH3CCH3ONNHNNHNNOH3CCH3HNOOCH3NHDaclatasvir (BMS-790052)H3COHNNH3CCH3OH3CCH3CH3OONOCH3ClONHOHNSOO\nAsunaprevirONO\nOOHNCH3CH3CH3H3COHNSOOCH3ITX-5061 Un\t\r \u00a0nuevo\t\r \u00a0r\u00e9gimen\t\r \u00a0antiviral\t\r \u00a0oral,\t\r \u00a0desarrollado\t\r \u00a0por\t\r \u00a0AbbVie\t\r \u00a0(una\t\r \u00a0subdivisi\u00f3n\t\r \u00a0de\t\r \u00a0 Abbott) en\t\r \u00a0 colaboraci\u00f3n\t\r \u00a0 con\t\r \u00a0 Enanta,\t\r \u00a0 est\u00e1\t\r \u00a0formado\t\r \u00a0 por\t\r \u00a0 una\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 del\t\r \u00a0inhibidor\t\r \u00a0 de\t\r \u00a0 proteasa\t\r \u00a0 ritonavir\t\r \u00a0 (ABT-\u00ad\u2010450/r),\t\r \u00a0 el\t\r \u00a0 inhibidor\t\r \u00a0 de\t\r \u00a0 NS5A\t\r \u00a0 ombitasvir\t\r \u00a0(ABT-\u00ad\u2010267)\t\r \u00a0y\t\r \u00a0el\t\r \u00a0inhibidor\t\r \u00a0de\t\r \u00a0polimerasa\t\r \u00a0no\t\r \u00a0nucle\u00f3sido\t\r \u00a0dasabuvir\t\r \u00a0(ABT-\u00ad\u2010333).\t\r \u00a0\t\r \u00a0\nNHNHNSOOCH3OOH3CH3CCH3OCH3Dasabuvir (ABT-333)Inhibidor de polimerasano-nucle\u00f3sidoNHNONHNOOCH3OH3CCH3HNONOHNOH3COH3CCH3CH3H3CH3C\nOmbitasvir (ABT-267)Inhibidor de la prote\u00ednaHCV NS5ANSH3CH3CNNHHNOCH3OH3CCH3OOHOSNRitonavir (Norvir\u00ae) (ABT-450r)Inhibidor de proteasa\n\t\r \u00a0M.\t\r \u00a0C.\t\r \u00a0Avenda\u00f1o\t\r \u00a0L\u00f3pez\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0248\t\r \u00a0Este\t\r \u00a0 r\u00e9gimen\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 calificado\t\r \u00a0 de\t\r \u00a0 revolucionario\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 del\t\r \u00a0HCV\t\r \u00a0del\t\r \u00a0genotipo\t\r \u00a01\t\r \u00a0ya\t\r \u00a0que,\t\r \u00a0seg\u00fan\t\r \u00a0un\t\r \u00a0ensayo\t\r \u00a0cl\u00ednico\t\r \u00a0de\t\r \u00a0fase\t\r \u00a0III\t\r \u00a0con\t\r \u00a0700\t\r \u00a0enfermos\t\r \u00a0de\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0sin\t\r \u00a0cirrosis\t\r \u00a0y\t\r \u00a0sin\t\r \u00a0tratamiento\t\r \u00a0previo,\t\r \u00a0ha\t\r \u00a0logrado\t\r \u00a0curar\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0patolog\u00eda\t\r \u00a0al\t\r \u00a096%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0pacientes\t\r \u00a0(13).\t\r \u00a0Doce\t\r \u00a0semanas\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0esta\t\r \u00a0combinaci\u00f3n,\t\r \u00a0sin\t\r \u00a0 ribavirina,\t\r \u00a0 produjo\t\r \u00a0 una\t\r \u00a0 respuesta\t\r \u00a0 antiviral\t\r \u00a0 sostenida\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0genotipo\t\r \u00a0HCV1b,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0de\t\r \u00a0los\t\r \u00a0pacientes\t\r \u00a0con\t\r \u00a0genotipo\t\r \u00a0HCV1a\t\r \u00a0fue\t\r \u00a0mejor\t\r \u00a0incluyendo\t\r \u00a0ribavirina.\t\r \u00a0AbbVie\t\r \u00a0conf\u00eda\t\r \u00a0en\t\r \u00a0su\t\r \u00a0pronta\t\r \u00a0aprobaci\u00f3n.\t\r \u00a0CONCLUSI\u00d3N\t\r \u00a0En\t\r \u00a0los\t\r \u00a0nuevos\t\r \u00a0tratamientos\t\r \u00a0anti\t\r \u00a0HCV\t\r \u00a0se\t\r \u00a0est\u00e1\t\r \u00a0siguiendo\t\r \u00a0el\t\r \u00a0camino\t\r \u00a0del\t\r \u00a0SIDA:\t\r \u00a0a\u00f1adir\t\r \u00a0complejidad\t\r \u00a0a\t\r \u00a0los\t\r \u00a0c\u00f3cteles\t\r \u00a0antivirales.\t\r \u00a0De\t\r \u00a0esta\t\r \u00a0forma,\t\r \u00a0es\t\r \u00a0normal\t\r \u00a0esperar\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0eficacia,\t\r \u00a0pero\t\r \u00a0tambi\u00e9n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0secundarios.\t\r \u00a0Los\t\r \u00a0especialistas\t\r \u00a0advierten\t\r \u00a0 que\t\r \u00a0 hay\t\r \u00a0 que\t\r \u00a0 andar\t\r \u00a0 con\t\r \u00a0 cautela,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 otro\t\r \u00a0 inhibidor\t\r \u00a0 de\t\r \u00a0 proteasa\t\r \u00a0estudiado\t\r \u00a0previamente\t\r \u00a0por\t\r \u00a0Boehringer\t\r \u00a0Ingelheim,\t\r \u00a0fue\t\r \u00a0demasiado\t\r \u00a0t\u00f3xico,\t\r \u00a0y\t\r \u00a0varios\t\r \u00a0HCV\t\r \u00a0 inhibidores\t\r \u00a0 de\t\r \u00a0 polimerasa\t\r \u00a0 mostraron\t\r \u00a0 efectos\t\r \u00a0secundarios\t\r \u00a0inaceptables\t\r \u00a0 que\t\r \u00a0impidieron\t\r \u00a0 su\t\r \u00a0 posterior\t\r \u00a0 desarrollo.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 como\t\r \u00a0 ya\t\r \u00a0 hemos\t\r \u00a0 mencionado,\t\r \u00a0 los\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0proteasa\t\r \u00a0son\t\r \u00a0muy\t\r \u00a0proclives\t\r \u00a0a\t\r \u00a0desarrollar\t\r \u00a0resistencias.\t\r \u00a0Son\t\r \u00a0muchos\t\r \u00a0los\t\r \u00a0 que\t\r \u00a0 creen\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 esta\t\r \u00a0 carrera\t\r \u00a0 por\t\r \u00a0 conseguir\t\r \u00a0 el\t\r \u00a0 \u00e9xito,\t\r \u00a0 los\t\r \u00a0 nucle\u00f3sidos\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0polimerasa\t\r \u00a0(que\t\r \u00a0impiden\t\r \u00a0que\t\r \u00a0el\t\r \u00a0virus\t\r \u00a0copie\t\r \u00a0su\t\r \u00a0genoma),\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a0sofosbuvir\t\r \u00a0es\t\r \u00a0 el\t\r \u00a0 primero\t\r \u00a0 en\t\r \u00a0 ser\t\r \u00a0 aprobado,\t\r \u00a0 ser\u00e1n\t\r \u00a0 ingredientes\t\r \u00a0 indispensables\t\r \u00a0 en\t\r \u00a0cualquier\t\r \u00a0c\u00f3ctel\t\r \u00a0anti-\u00ad\u2010HCV.\t\r \u00a0\t\r \u00a0REFERENCIAS\t\r \u00a01. \t\r \u00a0a)\t\r \u00a0Choo,\t\r \u00a0Q.\t\r \u00a0L.;\t\r \u00a0Kuo,\t\r \u00a0G.;\t\r \u00a0Weiner,\t\r \u00a0A.\t\r \u00a0J.;\t\r \u00a0Overby,\t\r \u00a0L.\t\r \u00a0R.;\t\r \u00a0Bradley,\t\r \u00a0D.\t\r \u00a0W.;\t\r \u00a0Houghton,\t\r \u00a0M.;\t\r \u00a0(1989)\t\r \u00a0\"Isolation\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 cDNA\t\r \u00a0 clone\t\r \u00a0 derived\t\r \u00a0 from\t\r \u00a0 a\t\r \u00a0 blood-\u00ad\u2010borne\t\r \u00a0 non-\u00ad\u2010A,\t\r \u00a0 non-\u00ad\u2010B\t\r \u00a0 viral\t\r \u00a0 hepatitis\t\r \u00a0genome\",\t\r \u00a0Science,\t\r \u00a0244,\t\r \u00a0359-\u00ad\u2010362.\t\r \u00a0b)\t\r \u00a0Kuo,\t\r \u00a0G.;\t\r \u00a0Choo,\t\r \u00a0Q.\t\r \u00a0L.;\t\r \u00a0Alter,\t\r \u00a0H.\t\r \u00a0J.;\t\r \u00a0Gitnick,\t\r \u00a0G.\t\r \u00a0L.;\t\r \u00a0Redeker,\t\r \u00a0A.\t\r \u00a0G.;\t\r \u00a0Purcell,\t\r \u00a0R.\t\r \u00a0H.;\t\r \u00a0Miyamura,\t\r \u00a0T.;\t\r \u00a0Dienstag,\t\r \u00a0J.\t\r \u00a0L.;\t\r \u00a0Alter,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0Stevens,\t\r \u00a0C.\t\r \u00a0E.;\t\r \u00a0et\t\r \u00a0al.;\t\r \u00a0(1989)\t\r \u00a0\"An\t\r \u00a0assay\t\r \u00a0for\t\r \u00a0 circulating\t\r \u00a0 antibodies\t\r \u00a0 to\t\r \u00a0 a\t\r \u00a0 major\t\r \u00a0 etiologic\t\r \u00a0 virus\t\r \u00a0 of\t\r \u00a0 human\t\r \u00a0 non-\u00ad\u2010A,\t\r \u00a0 non-\u00ad\u2010B\t\r \u00a0hepatitis\",\t\r \u00a0Science,\t\r \u00a0244,\t\r \u00a0362-\u00ad\u2010364.\t\r \u00a02. \t\r \u00a0U.S.\t\r \u00a0 Department\t\r \u00a0 of\t\r \u00a0 Health\t\r \u00a0 &\t\r \u00a0 Human\t\r \u00a0 Services\t\r \u00a0 (2012)\t\r \u00a0\u201cTreating\t\r \u00a0 Chronic\t\r \u00a0 Hepatitis\t\r \u00a0 C:\t\r \u00a0 A\t\r \u00a0Review\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 Research\t\r \u00a0 for\t\r \u00a0 Adults\u201d,\t\r \u00a0 Retrieved\t\r \u00a0 November\t\r \u00a0 11,\t\r \u00a0 2013,\t\r \u00a0 from\t\r \u00a0http://effectivehealthcare.ahrq.gov/search-\u00ad\u2010for-\u00ad\u2010guides-\u00ad\u2010reviews-\u00ad\u2010and-\u00ad\u2010reports.\t\r \u00a03.\t\r \u00a0Ortega-\u00ad\u2010Prieto,\t\r \u00a0A.\t\r \u00a0M.;\t\r \u00a0Sheldon,\t\r \u00a0J.;\t\r \u00a0Grande-\u00ad\u2010P\u00e9rez,\t\r \u00a0A.;\t\r \u00a0Tejero,\t\r \u00a0H.;\t\r \u00a0Gregori,\t\r \u00a0J.;\t\r \u00a0Quer,\t\r \u00a0J.;\t\r \u00a0Esteban,\t\r \u00a0J.\t\r \u00a0I.;\t\r \u00a0 Domingo,\t\r \u00a0 E.;\t\r \u00a0 Perales,\t\r \u00a0 C.;\t\r \u00a0 (2013)\t\r \u00a0 \u201cExtinction\t\r \u00a0 of\t\r \u00a0 Hepatitis\t\r \u00a0 C\t\r \u00a0 Virus\t\r \u00a0 by\t\r \u00a0 Ribavirin\t\r \u00a0 in\t\r \u00a0Hepatoma\t\r \u00a0 Cells\t\r \u00a0Involves\t\r \u00a0 Lethal\t\r \u00a0 Mutagenesis\u201d,\t\r \u00a0PLoS\t\r \u00a0 ONE\t\r \u00a08,\t\r \u00a0 e71039.\t\r \u00a0doi:10.1371/journal.pone.0071039.\t\r \u00a04.\t\r \u00a0Guedj,\t\r \u00a0J.;\t\r \u00a0Dari,\t\r \u00a0H.;\t\r \u00a0Shudo,\t\r \u00a0E.;\t\r \u00a0Smith,\t\r \u00a0P.;\t\r \u00a0Perelson,\t\r \u00a0A.\t\r \u00a0S.;\t\r \u00a0(2012)\t\r \u00a0\u201cHepatitis\t\r \u00a0C\t\r \u00a0viral\t\r \u00a0kinetics\t\r \u00a0with\t\r \u00a0the\t\r \u00a0nucleoside\t\r \u00a0polymerase\t\r \u00a0inhibitor\t\r \u00a0mericitabine\t\r \u00a0(RG7128)\u201d,\t\r \u00a0Hepatology,\t\r \u00a055,\t\r \u00a01030-\u00ad\u20101037.\t\r \u00a05.\t\r \u00a0Waldman,\t\r \u00a0R.\t\r \u00a0(Doctors\t\r \u00a0of\t\r \u00a0the\t\r \u00a0World);\t\r \u00a0(2013)\t\r \u00a0\"Gilead\u2019s\t\r \u00a0HCV\t\r \u00a0drug\t\r \u00a0sofosbuvir\t\r \u00a0approved\t\r \u00a0by\t\r \u00a0the\t\r \u00a0FDA\t\r \u00a0but\t\r \u00a0accessible\t\r \u00a0for\t\r \u00a0how\t\r \u00a0many?\"\t\r \u00a0Press\t\r \u00a0Release,\t\r \u00a0December\t\r \u00a09.\t\r \u00a06.\t\r \u00a0Njoroge,\t\r \u00a0 F.\t\r \u00a0 G.;\t\r \u00a0 Chen,\t\r \u00a0 K.\t\r \u00a0 X.;\t\r \u00a0 Shih,\t\r \u00a0 N.\t\r \u00a0 Y.;\t\r \u00a0 Piwinski,\t\r \u00a0 J.\t\r \u00a0 J.;\t\r \u00a0 (2008)\t\r \u00a0 \"Challenges\t\r \u00a0 in\t\r \u00a0 modern\t\r \u00a0 drug\t\r \u00a0discovery:\t\r \u00a0 a\t\r \u00a0 case\t\r \u00a0 study\t\r \u00a0 of\t\r \u00a0 boceprevir,\t\r \u00a0 an\t\r \u00a0 HCV\t\r \u00a0 protease\t\r \u00a0 inhibitor\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 treatment\t\r \u00a0 of\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0virus\t\r \u00a0infection\"\t\r \u00a0Acc.\t\r \u00a0Chem.\t\r \u00a0Res.\t\r \u00a041,\t\r \u00a050-\u00ad\u201059.\t\r \u00a07.\t\r \u00a0Lin,\t\r \u00a0C.;\t\r \u00a0Kwong,\t\r \u00a0A.\t\r \u00a0D.;\t\r \u00a0Perni,\t\r \u00a0R.\t\r \u00a0B.;\t\r \u00a0(2006)\t\r \u00a0\"Discovery\t\r \u00a0and\t\r \u00a0development\t\r \u00a0of\t\r \u00a0VX-\u00ad\u2010950,\t\r \u00a0a\t\r \u00a0novel,\t\r \u00a0covalent,\t\r \u00a0 and\t\r \u00a0 reversible\t\r \u00a0 inhibitor\t\r \u00a0 of\t\r \u00a0 hepatitis\t\r \u00a0 C\t\r \u00a0 virus\t\r \u00a0 NS3/4A\t\r \u00a0 serine\t\r \u00a0 protease\"\t\r \u00a0Infect.\t\r \u00a0Disord.\t\r \u00a0Drug\t\r \u00a0Targets\t\r \u00a06,\t\r \u00a03-\u00ad\u201016.\t\r \u00a0\t\r \u00a0NOTICIAS\t\r \u00a0CIENT\u00cdFICAS\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0249\t\r \u00a08.\t\r \u00a0 Lin,\t\r \u00a0 T.\t\r \u00a0 I;\t\r \u00a0 Lenz,\t\r \u00a0 O;\t\r \u00a0 Fanning,\t\r \u00a0 G;\t\r \u00a0 Verbinnen,\t\r \u00a0 T;\t\r \u00a0 Delouvroy,\t\r \u00a0 F;\t\r \u00a0 Scholliers,\t\r \u00a0 A;\t\r \u00a0 Vermeiren,\t\r \u00a0 K;\t\r \u00a0Rosenquist,\t\r \u00a0A;\t\r \u00a0Edlund,\t\r \u00a0M;\t\r \u00a0Samuelsson,\t\r \u00a0B.;\t\r \u00a0Vrang,\t\r \u00a0L.;\t\r \u00a0De\t\r \u00a0Kock,\t\r \u00a0H.;\t\r \u00a0Wigerinck,\t\r \u00a0P.;\t\r \u00a0Raboisson,\t\r \u00a0P.;\t\r \u00a0 Simmen,\t\r \u00a0 K.\t\r \u00a0 (2009)\t\r \u00a0\"In\t\r \u00a0 vitro\t\r \u00a0 activity\t\r \u00a0 and\t\r \u00a0 preclinical\t\r \u00a0 profile\t\r \u00a0 of\t\r \u00a0 TMC435350,\t\r \u00a0 a\t\r \u00a0 potent\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0virus\t\r \u00a0protease\t\r \u00a0inhibitor\"\t\r \u00a0Antimicrob.\t\r \u00a0Agents\t\r \u00a0and\t\r \u00a0Chemother.,\t\r \u00a053,\t\r \u00a01377-\u00ad\u20101385.\t\r \u00a09.\t\r \u00a0Gao,\t\r \u00a0M.;\t\r \u00a0Nettles,\t\r \u00a0R.\t\r \u00a0E.;\t\r \u00a0Belema,\t\r \u00a0M.;\t\r \u00a0Zinder,\t\r \u00a0L.\t\r \u00a0B.;\t\r \u00a0Nguyen,\t\r \u00a0V.\t\r \u00a0N.;\t\r \u00a0Fridell,\t\r \u00a0R.\t\r \u00a0A.;\t\r \u00a0Serrano-\u00ad\u2010Wu,\t\r \u00a0M.\t\r \u00a0H.;\t\r \u00a0 Langley,\t\r \u00a0 D.\t\r \u00a0 R.;\t\r \u00a0 Sun,\t\r \u00a0 J.\t\r \u00a0 H.;\t\r \u00a0 O'Boyle,\t\r \u00a0 D.\t\r \u00a0 R.;\t\r \u00a0 Lemm,\t\r \u00a0 J.\t\r \u00a0 A.;\t\r \u00a0 Wang,\t\r \u00a0 C.;\t\r \u00a0 Knipe,\t\r \u00a0 J.\t\r \u00a0 O.;\t\r \u00a0 Chien,\t\r \u00a0 C.;\t\r \u00a0Colonno,\t\r \u00a0 R.\t\r \u00a0 J.;\t\r \u00a0 Grasela,\t\r \u00a0 D.\t\r \u00a0 M.;\t\r \u00a0 Meanwell,\t\r \u00a0 N.\t\r \u00a0 A.;\t\r \u00a0 Hamann,\t\r \u00a0 L.\t\r \u00a0 G.\t\r \u00a0 (2010)\t\r \u00a0 \u201cChemical\t\r \u00a0 genetics\t\r \u00a0strategy\t\r \u00a0 identifies\t\r \u00a0 an\t\r \u00a0 HCV\t\r \u00a0 NS5A\t\r \u00a0 inhibitor\t\r \u00a0 with\t\r \u00a0 a\t\r \u00a0 potent\t\r \u00a0 clinical\t\r \u00a0 effect\u201d\t\r \u00a0Nature,\t\r \u00a0 465,\t\r \u00a0 96-\u00ad\u2010100.\t\r \u00a010.\t\r \u00a0Lok,\t\r \u00a0A.\t\r \u00a0S.;\t\r \u00a0Gardiner,\t\r \u00a0D.\t\r \u00a0F.;\t\r \u00a0Lawitz,\t\r \u00a0E.;\t\r \u00a0Martorell,\t\r \u00a0C.;\t\r \u00a0Everson,\t\r \u00a0G.\t\r \u00a0T.;\t\r \u00a0Ghalib,\t\r \u00a0R.;\t\r \u00a0Reindollar,\t\r \u00a0R.;\t\r \u00a0Rustgi,\t\r \u00a0V.;\t\r \u00a0McPhee,\t\r \u00a0F.;\t\r \u00a0Wind-\u00ad\u2010Rotolo,\t\r \u00a0M.;\t\r \u00a0Persson,\t\r \u00a0A.;\t\r \u00a0Zhu,\t\r \u00a0K.;\t\r \u00a0Dimitrova,\t\r \u00a0D.\t\r \u00a0I.;\t\r \u00a0Eley,\t\r \u00a0T.;\t\r \u00a0Guo,\t\r \u00a0T.;\t\r \u00a0 Grasela,\t\r \u00a0 D.\t\r \u00a0 N.;\t\r \u00a0 Pasquinelli,\t\r \u00a0 C.;\t\r \u00a0 (2012)\t\r \u00a0 \u201cPreliminary\t\r \u00a0 Study\t\r \u00a0 of\t\r \u00a0 Two\t\r \u00a0 Antiviral\t\r \u00a0 Agents\t\r \u00a0 for\t\r \u00a0Hepatitis\t\r \u00a0C\t\r \u00a0Genotype\t\r \u00a01\u201d,\t\r \u00a0New\t\r \u00a0Engl.\t\r \u00a0J.\t\r \u00a0Med.\t\r \u00a0366,\t\r \u00a0216-\u00ad\u2010224.\t\r \u00a011.\t\r \u00a0Lupberger,\t\r \u00a0J.;\t\r \u00a0Zeisel,\t\r \u00a0M.\t\r \u00a0B.;\t\r \u00a0Xiao,\t\r \u00a0F.;\t\r \u00a0Thumann,\t\r \u00a0Ch.;\t\r \u00a0Fofana,\t\r \u00a0I.;\t\r \u00a0Zona,\t\r \u00a0L.;\t\r \u00a0Davis,\t\r \u00a0Ch.;\t\r \u00a0Mee,\t\r \u00a0Ch.\t\r \u00a0J.;\t\r \u00a0Turek,\t\r \u00a0M.;\t\r \u00a0Gorke,\t\r \u00a0S.;\t\r \u00a0Royer,\t\r \u00a0C.;\t\r \u00a0Fischer,\t\r \u00a0B.;\t\r \u00a0Zahid,\t\r \u00a0M.\t\r \u00a0N.;\t\r \u00a0Lavillette,\t\r \u00a0D.;\t\r \u00a0Fresquet,\t\r \u00a0J.;\t\r \u00a0Cosset,\t\r \u00a0F.-\u00ad\u2010L.;\t\r \u00a0Rothenberg,\t\r \u00a0S.\t\r \u00a0M.;\t\r \u00a0Pietschmann,\t\r \u00a0T.;\t\r \u00a0Patel,\t\r \u00a0A.\t\r \u00a0H.;\t\r \u00a0Pessaux,\t\r \u00a0P.;\t\r \u00a0Doffo\u00ebl,\t\r \u00a0M.;\t\r \u00a0Raffelsberger,\t\r \u00a0W.;\t\r \u00a0Poch,\t\r \u00a0O.;\t\r \u00a0McKeating,\t\r \u00a0J.\t\r \u00a0A.;\t\r \u00a0Brino,\t\r \u00a0L.;\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0(2011)\t\r \u00a0\u201cEGFR\t\r \u00a0and\t\r \u00a0EphA2\t\r \u00a0are\t\r \u00a0host\t\r \u00a0factors\t\r \u00a0for\t\r \u00a0hepatitis\t\r \u00a0C\t\r \u00a0virus\t\r \u00a0entry\t\r \u00a0and\t\r \u00a0possible\t\r \u00a0targets\t\r \u00a0for\t\r \u00a0antiviral\t\r \u00a0therapy\u201d\t\r \u00a0Nature\t\r \u00a0Medicine,\t\r \u00a017,\t\r \u00a0589-\u00ad\u2010595.\t\r \u00a012.\t\r \u00a0Sulkowski,\t\r \u00a0M.\t\r \u00a0S.;\t\r \u00a0Kang,\t\r \u00a0M.;\t\r \u00a0Matining,\t\r \u00a0R.;\t\r \u00a0Wyles,\t\r \u00a0D.;\t\r \u00a0Johnson,\t\r \u00a0V.\t\r \u00a0A.;\t\r \u00a0Morse,\t\r \u00a0G.\t\r \u00a0D.;\t\r \u00a0Amorosa,\t\r \u00a0V.;\t\r \u00a0Bhattacharya,\t\r \u00a0D.;\t\r \u00a0Coughlin,\t\r \u00a0K.;\t\r \u00a0Wong-\u00ad\u2010Staal,\t\r \u00a0F.;\t\r \u00a0Glesby,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0(2014)\t\r \u00a0\u201cSafety\t\r \u00a0and\t\r \u00a0Antiviral\t\r \u00a0Activity\t\r \u00a0of\t\r \u00a0the\t\r \u00a0HCV\t\r \u00a0Entry\t\r \u00a0Inhibitor\t\r \u00a0ITX5061\t\r \u00a0in\t\r \u00a0Treatment-\u00ad\u2010Naive\t\r \u00a0HCV-\u00ad\u2010Infected\t\r \u00a0 Adults:\t\r \u00a0 A\t\r \u00a0Randomized,\t\r \u00a0Double-\u00ad\u2010Blind,\t\r \u00a0Phase\t\r \u00a01b\t\r \u00a0Study\u201d,\t\r \u00a0J.\t\r \u00a0Infect.\t\r \u00a0Dis.\t\r \u00a0209,\t\r \u00a0658-\u00ad\u2010667.\t\r \u00a013.\t\r \u00a0Ferenci,\t\r \u00a0P.;\t\r \u00a0Bernstein,\t\r \u00a0D.;\t\r \u00a0Lalezari,\t\r \u00a0J.;\t\r \u00a0Cohen,\t\r \u00a0D.;\t\r \u00a0Luo,\t\r \u00a0Y.;\t\r \u00a0Cooper,\t\r \u00a0C.;\t\r \u00a0Tam,\t\r \u00a0E.;\t\r \u00a0Marinho,\t\r \u00a0R.\t\r \u00a0T.;\t\r \u00a0Tsai,\t\r \u00a0N.;\t\r \u00a0Nyberg,\t\r \u00a0A.;\t\r \u00a0Box,\t\r \u00a0T.\t\r \u00a0D.;\t\r \u00a0Younes,\t\r \u00a0Z.;\t\r \u00a0Enayati,\t\r \u00a0P.;\t\r \u00a0Green,\t\r \u00a0S.;\t\r \u00a0Baruch,\t\r \u00a0Y.;\t\r \u00a0Bhandari,\t\r \u00a0B.\t\r \u00a0R.;\t\r \u00a0Caruntu,\t\r \u00a0 F.\t\r \u00a0 A.;\t\r \u00a0 Sepe,\t\r \u00a0 T.;\t\r \u00a0 Chulanov,\t\r \u00a0 V.;\t\r \u00a0 Janczewska,\t\r \u00a0 E.;\t\r \u00a0 Rizzardini,\t\r \u00a0 G.;\t\r \u00a0 Gervain,\t\r \u00a0 J.;\t\r \u00a0 Planas,\t\r \u00a0Planas;\t\r \u00a0Moreno,\t\r \u00a0Ch.;\t\r \u00a0Hassanein,\t\r \u00a0T.;\t\r \u00a0Xie,\t\r \u00a0W.;\t\r \u00a0King,\t\r \u00a0M.;\t\r \u00a0Podsadecki,\t\r \u00a0T.;\t\r \u00a0Reddy,\t\r \u00a0K.\t\r \u00a0R.;\t\r \u00a0(2014)\t\r \u00a0\u201cABT-\u00ad\u2010450/r\u2013Ombitasvir\t\r \u00a0 and\t\r \u00a0 Dasabuvir\t\r \u00a0 with\t\r \u00a0 or\t\r \u00a0 without\t\r \u00a0 Ribavirin\t\r \u00a0 for\t\r \u00a0 HCV\u201d,\t\r \u00a0New\t\r \u00a0 Eng.\t\r \u00a0 J.\t\r \u00a0Med.\t\r \u00a0DOI:\t\r \u00a010.1056/NEJMoa1402338.\t\r \u00a0  \t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0250\t\r \u00a0\t\r \u00a0\t\r \u00a0Development\t\r \u00a0 of\t\r \u00a0 anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines:\t\r \u00a0 contribution\t\r \u00a0 of\t\r \u00a0Spanish\t\r \u00a0researchers\t\r \u00a0Carlos\t\r \u00a0Alonso*1,\t\r \u00a0Manuel\t\r \u00a0Soto1\t\r \u00a01Centro\t\r \u00a0de\t\r \u00a0Biolog\u00eda\t\r \u00a0Molecular\t\r \u00a0Severo\t\r \u00a0Ochoa\t\r \u00a0(CSIC-\u00ad\u2010UAM),\t\r \u00a0Nicol\u00e1s\t\r \u00a0Cabrera,\t\r \u00a01,\t\r \u00a0Universidad\t\r \u00a0Aut\u00f3noma\t\r \u00a0de\t\r \u00a0Madrid,\t\r \u00a028049,\t\r \u00a0Madrid,\t\r \u00a0Spain\t\r \u00a0*e-\u00ad\u2010mail:\t\r \u00a0calonso@cbm.uam.es\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0250-\u00ad\u2010264\t\r \u00a0\t\r \u00a0ABSTRACT\t\r \u00a0Several\t\r \u00a0Leishmania\t\r \u00a0antigens\t\r \u00a0 have\t\r \u00a0 been\t\r \u00a0 characterized\t\r \u00a0 and\t\r \u00a0 assayed,\t\r \u00a0 as\t\r \u00a0recombinant\t\r \u00a0 products,\t\r \u00a0 in\t\r \u00a0 vaccination\t\r \u00a0 trials\t\r \u00a0 using\t\r \u00a0 different\t\r \u00a0 experimental\t\r \u00a0 models\t\r \u00a0of\t\r \u00a0leishmaniasis.\t\r \u00a0\t\r \u00a0Vaccination\t\r \u00a0strategies\t\r \u00a0have\t\r \u00a0been\t\r \u00a0developed\t\r \u00a0to\t\r \u00a0induce\t\r \u00a0adequate\t\r \u00a0cellular\t\r \u00a0responses\t\r \u00a0against\t\r \u00a0a\t\r \u00a0great\t\r \u00a0number\t\r \u00a0of\t\r \u00a0antigenic\t\r \u00a0proteins.\t\r \u00a0Spanish\t\r \u00a0groups,\t\r \u00a0working\t\r \u00a0 alone\t\r \u00a0 or,\t\r \u00a0 in\t\r \u00a0 many\t\r \u00a0 cases,\t\r \u00a0 in\t\r \u00a0 collaborative\t\r \u00a0 research\t\r \u00a0 projects\t\r \u00a0 have\t\r \u00a0contributed\t\r \u00a0to\t\r \u00a0gather\t\r \u00a0and\t\r \u00a0get\t\r \u00a0an\t\r \u00a0important\t\r \u00a0level\t\r \u00a0of\t\r \u00a0information\t\r \u00a0about\t\r \u00a0families\t\r \u00a0of\t\r \u00a0antigenic\t\r \u00a0 protein\t\r \u00a0 properties\t\r \u00a0 and\t\r \u00a0 procedures\t\r \u00a0 for\t\r \u00a0 immune\t\r \u00a0 intervention.\t\r \u00a0 Some\t\r \u00a0 of\t\r \u00a0these\t\r \u00a0topics\t\r \u00a0are\t\r \u00a0included\t\r \u00a0in\t\r \u00a0the\t\r \u00a0present\t\r \u00a0review.\t\r \u00a0Keywords:\t\r \u00a0Anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines;\t\r \u00a0antigenic\t\r \u00a0proteins;\t\r \u00a0experimental\t\r \u00a0models.\t\r \u00a0RESUMEN\t\r \u00a0Desarrollo\t\r \u00a0de\t\r \u00a0vacunas\t\r \u00a0contra\t\r \u00a0Leishmania:\t\r \u00a0contribuci\u00f3n\t\r \u00a0de\t\r \u00a0investigadores\t\r \u00a0espa\u00f1oles\t\r \u00a0Varios\t\r \u00a0 ant\u00edgenos\t\r \u00a0 de\t\r \u00a0Leishmania\t\r \u00a0han\t\r \u00a0 sido\t\r \u00a0 caracterizados\t\r \u00a0 y\t\r \u00a0 probados,\t\r \u00a0 como\t\r \u00a0productos\t\r \u00a0 recombinantes,\t\r \u00a0 en\t\r \u00a0 ensayos\t\r \u00a0 de\t\r \u00a0 vacunaci\u00f3n\t\r \u00a0 empleando\t\r \u00a0 diferentes\t\r \u00a0modelos\t\r \u00a0 experimentales\t\r \u00a0 de\t\r \u00a0 leishmaniosis\t\r \u00a0 con\t\r \u00a0 objeto\t\r \u00a0 de\t\r \u00a0 inducir\t\r \u00a0 respuestas\t\r \u00a0celulares\t\r \u00a0adecuadas,\t\r \u00a0ademas,\t\r \u00a0de\t\r \u00a0protecci\u00f3n\t\r \u00a0contra\t\r \u00a0la\t\r \u00a0infecci\u00f3n.\t\r \u00a0Diferentes\t\r \u00a0grupos\t\r \u00a0de\t\r \u00a0investigaci\u00f3n\t\r \u00a0espa\u00f1oles,\t\r \u00a0trabajando\t\r \u00a0solos\t\r \u00a0o,\t\r \u00a0en\t\r \u00a0muchos\t\r \u00a0casos,\t\r \u00a0en\t\r \u00a0proyectos\t\r \u00a0de\t\r \u00a0investigaci\u00f3n\t\r \u00a0 cooperativos,\t\r \u00a0 han\t\r \u00a0 contribuido\t\r \u00a0 a\t\r \u00a0 reunir\t\r \u00a0 un\t\r \u00a0 importante\t\r \u00a0 nivel\t\r \u00a0 de\t\r \u00a0conocimiento\t\r \u00a0sobre\t\r \u00a0diferentes\t\r \u00a0familias\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0antig\u00e9nicas\t\r \u00a0y\t\r \u00a0procedimientos\t\r \u00a0de\t\r \u00a0intervenci\u00f3n\t\r \u00a0 inmunitaria.\t\r \u00a0 Algunos\t\r \u00a0 de\t\r \u00a0 estos\t\r \u00a0 temas\t\r \u00a0 se\t\r \u00a0 discuten\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 presente\t\r \u00a0revisi\u00f3n.\t\r \u00a0Palabras\t\r \u00a0 clave:\t\r \u00a0Vacunas\t\r \u00a0 contra\t\r \u00a0Leishmania;\t\r \u00a0 Prote\u00ednas\t\r \u00a0 antig\u00e9nicas;\t\r \u00a0 Modelos\t\r \u00a0experimentales.\t\r \u00a0REVISI\u00d3N\t\r \u00a0\nDevelopment\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0251\t\r \u00a0\t\r \u00a01.\t\r \u00a0INTRODUCTION\t\r \u00a0Parasites\t\r \u00a0 from\t\r \u00a0 genus\t\r \u00a0Leishmania\t\r \u00a0have\t\r \u00a0 a\t\r \u00a0 digenetic\t\r \u00a0 life\t\r \u00a0 cycle\t\r \u00a0 in\t\r \u00a0 which\t\r \u00a0parasite\t\r \u00a0 multiply\t\r \u00a0 as\t\r \u00a0 extracellular\t\r \u00a0 promastigotes\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 mid-\u00ad\u2010gut\t\r \u00a0 of\t\r \u00a0 their\t\r \u00a0 insect\t\r \u00a0vectors\t\r \u00a0(sand-\u00ad\u2010flies\t\r \u00a0from\t\r \u00a0genus\t\r \u00a0Phlebotomus\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Old\t\r \u00a0World\t\r \u00a0and\t\r \u00a0Lutzomyia\t\r \u00a0in\t\r \u00a0the\t\r \u00a0New\t\r \u00a0 World).\t\r \u00a0 Parasites\t\r \u00a0 are\t\r \u00a0 transmitted\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0 vertebrate\t\r \u00a0 host\t\r \u00a0 during\t\r \u00a0 blood\t\r \u00a0 meal\t\r \u00a0and\t\r \u00a0after\t\r \u00a0infecting\t\r \u00a0macrophages\t\r \u00a0they\t\r \u00a0are\t\r \u00a0transformed\t\r \u00a0in\t\r \u00a0the\t\r \u00a0amastigote\t\r \u00a0forms\t\r \u00a0that\t\r \u00a0replicate\t\r \u00a0 in\t\r \u00a0 vacuoles\t\r \u00a0 of\t\r \u00a0 lysosomal\t\r \u00a0 origin.\t\r \u00a0 Infection\t\r \u00a0 of\t\r \u00a0 different\t\r \u00a0 vertebrate\t\r \u00a0 hosts\t\r \u00a0with\t\r \u00a0several\t\r \u00a0species\t\r \u00a0from\t\r \u00a0genus\t\r \u00a0Leishmania\t\r \u00a0can\t\r \u00a0cause\t\r \u00a0a\t\r \u00a0complex\t\r \u00a0group\t\r \u00a0of\t\r \u00a0diseases\t\r \u00a0globally\t\r \u00a0termed\t\r \u00a0as\t\r \u00a0leishmaniasis.\t\r \u00a0In\t\r \u00a0humans,\t\r \u00a0depending\t\r \u00a0on\t\r \u00a0the\t\r \u00a0infectious\t\r \u00a0species\t\r \u00a0and\t\r \u00a0 the\t\r \u00a0 host\t\r \u00a0 immune\t\r \u00a0 state,\t\r \u00a0 the\t\r \u00a0 disease\t\r \u00a0 ranges\t\r \u00a0 in\t\r \u00a0 severity\t\r \u00a0 from\t\r \u00a0 cutaneous\t\r \u00a0 (CL;\t\r \u00a0caused\t\r \u00a0 by\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0in\t\r \u00a0 the\t\r \u00a0 Old\t\r \u00a0 World\t\r \u00a0 and\t\r \u00a0Leishmania\t\r \u00a0 mexicana,\t\r \u00a0Leishmania\t\r \u00a0amazonensis\t\r \u00a0and\t\r \u00a0Leishmania\t\r \u00a0braziliensis,\t\r \u00a0between\t\r \u00a0other\t\r \u00a0species\t\r \u00a0in\t\r \u00a0the\t\r \u00a0New\t\r \u00a0World),\t\r \u00a0diffuse\t\r \u00a0cutaneous\t\r \u00a0(DCL,\t\r \u00a0caused\t\r \u00a0by\t\r \u00a0Leishmania\t\r \u00a0 aethiopica\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Old\t\r \u00a0World\t\r \u00a0and\t\r \u00a0L.\t\r \u00a0mexicana\t\r \u00a0in\t\r \u00a0the\t\r \u00a0New\t\r \u00a0World)\t\r \u00a0to\t\r \u00a0mucocutaneous\t\r \u00a0(MCL,\t\r \u00a0caused\t\r \u00a0mainly\t\r \u00a0by\t\r \u00a0L.\t\r \u00a0 braziliensis)\t\r \u00a0and\t\r \u00a0visceral\t\r \u00a0leishmaniasis\t\r \u00a0(VL,\t\r \u00a0caused\t\r \u00a0by\t\r \u00a0Leishmania\t\r \u00a0 donovani\t\r \u00a0and\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Old\t\r \u00a0World\t\r \u00a0and\t\r \u00a0by\t\r \u00a0Leishmania\t\r \u00a0chagasi\t\r \u00a0(genetically\t\r \u00a0identical\t\r \u00a0to\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0(1))\t\r \u00a0in\t\r \u00a0the\t\r \u00a0New\t\r \u00a0World\t\r \u00a0(2).\t\r \u00a0These\t\r \u00a0infections\t\r \u00a0are\t\r \u00a0endemic\t\r \u00a0in\t\r \u00a0several\t\r \u00a0 tropical\t\r \u00a0 and\t\r \u00a0 subtropical\t\r \u00a0 countries\t\r \u00a0 around\t\r \u00a0 the\t\r \u00a0 world\t\r \u00a0(3)\t\r \u00a0and\t\r \u00a0 are\t\r \u00a0responsible\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 second-\u00ad\u2010highest\t\r \u00a0 number\t\r \u00a0 of\t\r \u00a0 deaths\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0 a\t\r \u00a0 parasite\t\r \u00a0 infection\t\r \u00a0after\t\r \u00a0 malaria\t\r \u00a0(4).\t\r \u00a0 Canine\t\r \u00a0 viscerocutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0 (VCL)\t\r \u00a0 is\t\r \u00a0 an\t\r \u00a0 important\t\r \u00a0emerging\t\r \u00a0zoonosis\t\r \u00a0in\t\r \u00a0Mediterranean\t\r \u00a0countries,\t\r \u00a0Middle\t\r \u00a0East\t\r \u00a0and\t\r \u00a0Latin\t\r \u00a0America\t\r \u00a0(5).\t\r \u00a0This\t\r \u00a0severe\t\r \u00a0form\t\r \u00a0of\t\r \u00a0the\t\r \u00a0disease\t\r \u00a0is\t\r \u00a0caused\t\r \u00a0by\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0and\t\r \u00a0by\t\r \u00a0L.\t\r \u00a0chagasi\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Old\t\r \u00a0World\t\r \u00a0and\t\r \u00a0in\t\r \u00a0the\t\r \u00a0New\t\r \u00a0World,\t\r \u00a0respectively.\t\r \u00a0Wild\t\r \u00a0canids\t\r \u00a0and\t\r \u00a0domestic\t\r \u00a0dogs\t\r \u00a0act\t\r \u00a0as\t\r \u00a0parasite\t\r \u00a0 reservoirs,\t\r \u00a0 playing\t\r \u00a0 a\t\r \u00a0 central\t\r \u00a0 role\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 transmission\t\r \u00a0 to\t\r \u00a0 humans\t\r \u00a0(Reviewed\t\r \u00a0in\t\r \u00a0(6).\t\r \u00a0Different\t\r \u00a0spectra\t\r \u00a0of\t\r \u00a0human\t\r \u00a0and\t\r \u00a0canine\t\r \u00a0disease\t\r \u00a0can\t\r \u00a0be\t\r \u00a0developed\t\r \u00a0after\t\r \u00a0 infection,\t\r \u00a0 from\t\r \u00a0 subclinical\t\r \u00a0 infection\t\r \u00a0 to\t\r \u00a0 disseminated\t\r \u00a0 infection\t\r \u00a0(2,\t\r \u00a07).\t\r \u00a0 The\t\r \u00a0outcome\t\r \u00a0of\t\r \u00a0infection\t\r \u00a0is\t\r \u00a0determined\t\r \u00a0by\t\r \u00a0the\t\r \u00a0interactions\t\r \u00a0between\t\r \u00a0the\t\r \u00a0host\t\r \u00a0immune\t\r \u00a0system\t\r \u00a0 and\t\r \u00a0 different\t\r \u00a0 parasite\t\r \u00a0 species.\t\r \u00a0 Generally,\t\r \u00a0 for\t\r \u00a0 all\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0 leishmaniasis,\t\r \u00a0except\t\r \u00a0 MCL,\t\r \u00a0 protective\t\r \u00a0 immunity\t\r \u00a0 is\t\r \u00a0 associated\t\r \u00a0 with\t\r \u00a0 a\t\r \u00a0 classical\t\r \u00a0 cell\t\r \u00a0 mediated\t\r \u00a0immune\t\r \u00a0response\t\r \u00a0that\t\r \u00a0induces\t\r \u00a0macrophage\t\r \u00a0activation\t\r \u00a0by\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0derived\t\r \u00a0cytokines,\t\r \u00a0while\t\r \u00a0non-\u00ad\u2010healing\t\r \u00a0disease\t\r \u00a0is\t\r \u00a0associated\t\r \u00a0with\t\r \u00a0the\t\r \u00a0generation\t\r \u00a0of\t\r \u00a0humoral\t\r \u00a0responses\t\r \u00a0(6-\u00ad\u20108).\t\r \u00a0In\t\r \u00a0MCL\t\r \u00a0patients\t\r \u00a0an\t\r \u00a0exacerbated\t\r \u00a0and\t\r \u00a0non-\u00ad\u2010controlled\t\r \u00a0inflammatory\t\r \u00a0response\t\r \u00a0seems\t\r \u00a0to\t\r \u00a0be\t\r \u00a0responsible\t\r \u00a0for\t\r \u00a0the\t\r \u00a0pathogenesis\t\r \u00a0(9).\t\r \u00a0\t\r \u00a0The\t\r \u00a0 fact\t\r \u00a0 that\t\r \u00a0 patients\t\r \u00a0 recovered\t\r \u00a0 from\t\r \u00a0 disease\t\r \u00a0 are\t\r \u00a0 resistant\t\r \u00a0 to\t\r \u00a0 reinfection\t\r \u00a0has\t\r \u00a0 been\t\r \u00a0 taken\t\r \u00a0 as\t\r \u00a0 an\t\r \u00a0 indication\t\r \u00a0 that\t\r \u00a0 a\t\r \u00a0 vaccine\t\r \u00a0 is\t\r \u00a0 feasible.\t\r \u00a0 Different\t\r \u00a0 research\t\r \u00a0strategies\t\r \u00a0have\t\r \u00a0been\t\r \u00a0employed\t\r \u00a0for\t\r \u00a0the\t\r \u00a0generation\t\r \u00a0of\t\r \u00a0vaccines\t\r \u00a0against\t\r \u00a0Leishmania\t\r \u00a0although\t\r \u00a0there\t\r \u00a0is\t\r \u00a0no\t\r \u00a0vaccine\t\r \u00a0against\t\r \u00a0this\t\r \u00a0parasite\t\r \u00a0in\t\r \u00a0humans.\t\r \u00a0In\t\r \u00a0this\t\r \u00a0context,\t\r \u00a0some\t\r \u00a0vaccines\t\r \u00a0are\t\r \u00a0now\t\r \u00a0at\t\r \u00a0the\t\r \u00a0research\t\r \u00a0phase\t\r \u00a0and\t\r \u00a0one\t\r \u00a0of\t\r \u00a0them,\t\r \u00a0namely\t\r \u00a0Leish-\u00ad\u2010110f\t\r \u00a0and\t\r \u00a0that\t\r \u00a0 is\t\r \u00a0 based\t\r \u00a0 on\t\r \u00a0 a\t\r \u00a0 three\t\r \u00a0 antigen\t\r \u00a0 fusion\t\r \u00a0 recombinant\t\r \u00a0 protein\t\r \u00a0(10)\t\r \u00a0is\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0development\t\r \u00a0 phase\t\r \u00a0(11).\t\r \u00a0 Regarding\t\r \u00a0 prophylaxis\t\r \u00a0 in\t\r \u00a0 dogs,\t\r \u00a0 there\t\r \u00a0 are\t\r \u00a0 three\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n252\t\r \u00a0\t\r \u00a0commercial\t\r \u00a0vaccines\t\r \u00a0against\t\r \u00a0canine\t\r \u00a0leishmaniasis:\t\r \u00a0Leishmune\t\r \u00a0(based\t\r \u00a0on\t\r \u00a0Parasite\t\r \u00a0Fucose-\u00ad\u2010Manose-\u00ad\u2010Ligand)\t\r \u00a0(12),\t\r \u00a0Leishtec,\t\r \u00a0based\t\r \u00a0on\t\r \u00a0a\t\r \u00a0recombinant\t\r \u00a0amastigote\t\r \u00a0antigen\t\r \u00a0namely\t\r \u00a0 A2\t\r \u00a0 protein\t\r \u00a0(13)\t\r \u00a0and\t\r \u00a0 CaniLeish,\t\r \u00a0 composed\t\r \u00a0 on\t\r \u00a0 promastigotes\t\r \u00a0 secreted-\u00ad\u2010excreted\t\r \u00a0factors\t\r \u00a0(14,\t\r \u00a015).\t\r \u00a0In\t\r \u00a0spite\t\r \u00a0of\t\r \u00a0the\t\r \u00a0existence\t\r \u00a0of\t\r \u00a0these\t\r \u00a0products,\t\r \u00a0the\t\r \u00a0search\t\r \u00a0of\t\r \u00a0molecules\t\r \u00a0 for\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0vaccines\t\r \u00a0 continues,\t\r \u00a0 looking\t\r \u00a0 for\t\r \u00a0improving\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 different\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0 leishmaniasis.\t\r \u00a0There\t\r \u00a0 are\t\r \u00a0 recent\t\r \u00a0review\t\r \u00a0 articles\t\r \u00a0 covering\t\r \u00a0 the\t\r \u00a0 progress\t\r \u00a0 made\t\r \u00a0 towards\t\r \u00a0 the\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0vaccines,\t\r \u00a0including\t\r \u00a0some\t\r \u00a0of\t\r \u00a0the\t\r \u00a0most\t\r \u00a0studied\t\r \u00a0parasite\t\r \u00a0proteins\t\r \u00a0together\t\r \u00a0with\t\r \u00a0the\t\r \u00a0effect\t\r \u00a0of\t\r \u00a0various\t\r \u00a0adjuvants\t\r \u00a0employed\t\r \u00a0in\t\r \u00a0experimental\t\r \u00a0vaccination\t\r \u00a0trials\t\r \u00a0(4,\t\r \u00a011,\t\r \u00a016-\u00ad\u201022).\t\r \u00a0 There\t\r \u00a0 is\t\r \u00a0 general\t\r \u00a0 consensus\t\r \u00a0 indicating\t\r \u00a0 that\t\r \u00a0 the\t\r \u00a0 establishment\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0protective\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0response\t\r \u00a0may\t\r \u00a0require\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0parasite\t\r \u00a0specific\t\r \u00a0long-\u00ad\u2010lasting\t\r \u00a0memory\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0that\t\r \u00a0will\t\r \u00a0expand\t\r \u00a0as\t\r \u00a0effector\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0for\t\r \u00a0the\t\r \u00a0production\t\r \u00a0of\t\r \u00a0 IFN-\u00ad\u2010gamma\t\r \u00a0 dependent\t\r \u00a0 responses\t\r \u00a0 specific\t\r \u00a0 for\t\r \u00a0 parasite\t\r \u00a0 antigens\t\r \u00a0 in\t\r \u00a0 order\t\r \u00a0 to\t\r \u00a0activate\t\r \u00a0the\t\r \u00a0leishmanicidal\t\r \u00a0capacities\t\r \u00a0of\t\r \u00a0infected\t\r \u00a0macrophages.\t\r \u00a0In\t\r \u00a0this\t\r \u00a0way,\t\r \u00a0most\t\r \u00a0of\t\r \u00a0the\t\r \u00a0 recent\t\r \u00a0 research\t\r \u00a0 is\t\r \u00a0 focused\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0 identification\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0molecules\t\r \u00a0that\t\r \u00a0 interacts\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 host\t\r \u00a0 immune\t\r \u00a0 system\t\r \u00a0 and\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0 analysis\t\r \u00a0 of\t\r \u00a0 their\t\r \u00a0prophylactic\t\r \u00a0 properties\t\r \u00a0 when\t\r \u00a0 immunized\t\r \u00a0 in\t\r \u00a0 experimental\t\r \u00a0 models\t\r \u00a0 of\t\r \u00a0 infection\t\r \u00a0 as\t\r \u00a0second\t\r \u00a0generation\t\r \u00a0vaccines\t\r \u00a0(based\t\r \u00a0on\t\r \u00a0parasite\t\r \u00a0fractions\t\r \u00a0or\t\r \u00a0recombinant\t\r \u00a0proteins)\t\r \u00a0or\t\r \u00a0third\t\r \u00a0generation\t\r \u00a0vaccines\t\r \u00a0(mainly\t\r \u00a0DNA-\u00ad\u2010based\t\r \u00a0vaccines).\t\r \u00a0In\t\r \u00a0this\t\r \u00a0work\t\r \u00a0we\t\r \u00a0make\t\r \u00a0a\t\r \u00a0review\t\r \u00a0 of\t\r \u00a0 these\t\r \u00a0 studies\t\r \u00a0 performed\t\r \u00a0 with\t\r \u00a0 different\t\r \u00a0 parasite\t\r \u00a0 proteins,\t\r \u00a0immunodominant\t\r \u00a0 antigens\t\r \u00a0 during\t\r \u00a0 infection,\t\r \u00a0 focusing\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0 results\t\r \u00a0 obtained\t\r \u00a0taking\t\r \u00a0into\t\r \u00a0consideration\t\r \u00a0the\t\r \u00a0implication\t\r \u00a0of\t\r \u00a0different\t\r \u00a0Spanish\t\r \u00a0researchers,\t\r \u00a0alone\t\r \u00a0or\t\r \u00a0in\t\r \u00a0collaborative\t\r \u00a0work,\t\r \u00a0in\t\r \u00a0order\t\r \u00a0to\t\r \u00a0show\t\r \u00a0the\t\r \u00a0important\t\r \u00a0efforts\t\r \u00a0made\t\r \u00a0in\t\r \u00a0our\t\r \u00a0country\t\r \u00a0during\t\r \u00a0the\t\r \u00a0last\t\r \u00a0years,\t\r \u00a0helping\t\r \u00a0to\t\r \u00a0mitigate\t\r \u00a0the\t\r \u00a0effects\t\r \u00a0of\t\r \u00a0this\t\r \u00a0emerging\t\r \u00a0disease.\t\r \u00a0\t\r \u00a02.\t\r \u00a0LEISHMANIA\t\r \u00a0SURFACE\t\r \u00a0ANTIGENS\t\r \u00a0A\t\r \u00a0 number\t\r \u00a0 of\t\r \u00a0 surface\t\r \u00a0 glycoproteins\t\r \u00a0 are\t\r \u00a0 present\t\r \u00a0 in\t\r \u00a0 promastigote\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0parasites.\t\r \u00a0The\t\r \u00a0Leishmania\t\r \u00a0proteinase\t\r \u00a0GP63,\t\r \u00a0one\t\r \u00a0of\t\r \u00a0the\t\r \u00a0most\t\r \u00a0abundant\t\r \u00a0surface-\u00ad\u2010exposed\t\r \u00a0proteins\t\r \u00a0on\t\r \u00a0parasite\t\r \u00a0promastigotes\t\r \u00a0(23,\t\r \u00a024)\t\r \u00a0has\t\r \u00a0been\t\r \u00a0described\t\r \u00a0as\t\r \u00a0an\t\r \u00a0 immunogenic\t\r \u00a0 protein\t\r \u00a0 during\t\r \u00a0 human\t\r \u00a0 VL\t\r \u00a0(25).\t\r \u00a0 The\t\r \u00a0 GP63\t\r \u00a0 is\t\r \u00a0 also\t\r \u00a0 an\t\r \u00a0 antigenic\t\r \u00a0molecule\t\r \u00a0in\t\r \u00a0canine\t\r \u00a0VL,\t\r \u00a0as\t\r \u00a0described\t\r \u00a0by\t\r \u00a0(26).\t\r \u00a0Using\t\r \u00a0a\t\r \u00a0recombinant\t\r \u00a0version\t\r \u00a0of\t\r \u00a0the\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0GP63\t\r \u00a0 (LiGP63)\t\r \u00a0 as\t\r \u00a0 well\t\r \u00a0 as\t\r \u00a0 some\t\r \u00a0 synthetic\t\r \u00a0 peptides\t\r \u00a0 derived\t\r \u00a0 from\t\r \u00a0 its\t\r \u00a0aminoacid\t\r \u00a0sequence,\t\r \u00a0Dr.\t\r \u00a0Alonso\u2019s\t\r \u00a0laboratory\t\r \u00a0(Centro\t\r \u00a0de\t\r \u00a0Biolog\u00eda\t\r \u00a0Molecular\t\r \u00a0Severo\t\r \u00a0Ochoa,\t\r \u00a0 CSIC-\u00ad\u2010UAM)\t\r \u00a0 was\t\r \u00a0 able\t\r \u00a0 to\t\r \u00a0 demonstrate\t\r \u00a0 that\t\r \u00a0 LiGP63\t\r \u00a0 was\t\r \u00a0 recognized\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0100%\t\r \u00a0of\t\r \u00a0the\t\r \u00a0sera\t\r \u00a0from\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0infected\t\r \u00a0dogs\t\r \u00a0and\t\r \u00a0that\t\r \u00a0the\t\r \u00a0C-\u00ad\u2010terminal\t\r \u00a0domain\t\r \u00a0was\t\r \u00a0the\t\r \u00a0most\t\r \u00a0antigenic\t\r \u00a0region\t\r \u00a0of\t\r \u00a0the\t\r \u00a0protein.\t\r \u00a0On\t\r \u00a0the\t\r \u00a0basis\t\r \u00a0of\t\r \u00a0its\t\r \u00a0surface\t\r \u00a0localization\t\r \u00a0and\t\r \u00a0 its\t\r \u00a0 antigenicity,\t\r \u00a0 second\t\r \u00a0 generation\t\r \u00a0 vaccines\t\r \u00a0 related\t\r \u00a0 with\t\r \u00a0 GP63\t\r \u00a0 and\t\r \u00a0 its\t\r \u00a0immunodominant\t\r \u00a0 epitopes\t\r \u00a0 have\t\r \u00a0 been\t\r \u00a0 extensively\t\r \u00a0 studied\t\r \u00a0 as\t\r \u00a0 vaccine\t\r \u00a0 candidates\t\r \u00a0using\t\r \u00a0murine\t\r \u00a0models\t\r \u00a0of\t\r \u00a0infection\t\r \u00a0(Revised\t\r \u00a0in\t\r \u00a0(27)).\t\r \u00a0Of\t\r \u00a0special\t\r \u00a0interest\t\r \u00a0is\t\r \u00a0the\t\r \u00a0work\t\r \u00a0published\t\r \u00a0 by\t\r \u00a0 Cote-\u00ad\u2010Sierra\t\r \u00a0 and\t\r \u00a0 coworkers\t\r \u00a0(28)\t\r \u00a0with\t\r \u00a0 the\t\r \u00a0 collaboration\t\r \u00a0 of\t\r \u00a0 Dr..\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0253\t\r \u00a0\t\r \u00a0Segovia\u2019s\t\r \u00a0group\t\r \u00a0(Facultad\t\r \u00a0de\t\r \u00a0Medicina,\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Murcia).\t\r \u00a0In\t\r \u00a0this\t\r \u00a0work\t\r \u00a0they\t\r \u00a0used\t\r \u00a0 a\t\r \u00a0 recombinant\t\r \u00a0 version\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 C-\u00ad\u2010terminal\t\r \u00a0 domain\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 GP63\t\r \u00a0 fused\t\r \u00a0 to\t\r \u00a0 an\t\r \u00a0immunostimulatory\t\r \u00a0 molecule.\t\r \u00a0 The\t\r \u00a0 main\t\r \u00a0 objective\t\r \u00a0 was\t\r \u00a0 to\t\r \u00a0 improve\t\r \u00a0 protection\t\r \u00a0derived\t\r \u00a0 from\t\r \u00a0 this\t\r \u00a0 region\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 GP63,\t\r \u00a0 which\t\r \u00a0 contains\t\r \u00a0 the\t\r \u00a0 host-\u00ad\u2010protective\t\r \u00a0 T\t\r \u00a0 cell\t\r \u00a0epitopes\t\r \u00a0(29),\t\r \u00a0 by\t\r \u00a0 its\t\r \u00a0 fusion\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 lipoprotein\t\r \u00a0 OprI\t\r \u00a0 from\t\r \u00a0Pseudomonas\t\r \u00a0aeruginosa,\t\r \u00a0 an\t\r \u00a0 inductor\t\r \u00a0 of\t\r \u00a0 IL-\u00ad\u201012.\t\r \u00a0 The\t\r \u00a0 authors\t\r \u00a0 demonstrated\t\r \u00a0 that\t\r \u00a0 the\t\r \u00a0 fusion\t\r \u00a0lipoprotein\t\r \u00a0 was\t\r \u00a0 able\t\r \u00a0 to\t\r \u00a0 induce\t\r \u00a0 \t\r \u00a0 GP63\t\r \u00a0 specific\t\r \u00a0 Th1\t\r \u00a0 and\t\r \u00a0 TNF-\u00ad\u2010alpha\t\r \u00a0 mediated\t\r \u00a0responses\t\r \u00a0 correlated\t\r \u00a0 to\t\r \u00a0 robust\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 murine\t\r \u00a0 CL\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0L.\t\r \u00a0 major\t\r \u00a0infection\t\r \u00a0in\t\r \u00a0the\t\r \u00a0susceptible\t\r \u00a0BALB/c\t\r \u00a0mice\t\r \u00a0(28).\t\r \u00a0\t\r \u00a0An\t\r \u00a0additional\t\r \u00a0promastigote\t\r \u00a0surface\t\r \u00a0glycoprotein,\t\r \u00a0namely\t\r \u00a0GP46,\t\r \u00a0M2\t\r \u00a0or\t\r \u00a0PSA\t\r \u00a0has\t\r \u00a0been\t\r \u00a0described\t\r \u00a0in\t\r \u00a0different\t\r \u00a0Leishmania\t\r \u00a0species\t\r \u00a0(30,\t\r \u00a031).\t\r \u00a0 This\t\r \u00a0 protein\t\r \u00a0 possesses\t\r \u00a0 a\t\r \u00a0 central\t\r \u00a0 core\t\r \u00a0 composed\t\r \u00a0 by\t\r \u00a0 different\t\r \u00a0repeats\t\r \u00a0 of\t\r \u00a0 leucine\t\r \u00a0 rich\t\r \u00a0 regions\t\r \u00a0 described\t\r \u00a0 as\t\r \u00a0 most\t\r \u00a0 immunodominant\t\r \u00a0 region\t\r \u00a0recognized\t\r \u00a0by\t\r \u00a0human\t\r \u00a0and\t\r \u00a0canine\t\r \u00a0VL\t\r \u00a0patients\t\r \u00a0(31).\t\r \u00a0\t\r \u00a0\t\r \u00a0Another\t\r \u00a0 abundant\t\r \u00a0 component\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 promastigote\t\r \u00a0 surface\t\r \u00a0 is\t\r \u00a0 the\t\r \u00a0Kinetoplastid\t\r \u00a0 Membrane\t\r \u00a0 Protein\t\r \u00a0 11\t\r \u00a0 (KMP-\u00ad\u201011)\t\r \u00a0 a\t\r \u00a0 dominant\t\r \u00a0 surface\t\r \u00a0 membrane\t\r \u00a0protein\t\r \u00a0 associated\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 promastigote\t\r \u00a0 lipophosphoglycan\t\r \u00a0 (LPG).\t\r \u00a0 Dr.\t\r \u00a0 Alonso\u2019s\t\r \u00a0research\t\r \u00a0group\t\r \u00a0in\t\r \u00a0collaboration\t\r \u00a0with\t\r \u00a0different\t\r \u00a0laboratories\t\r \u00a0has\t\r \u00a0been\t\r \u00a0implicated\t\r \u00a0in\t\r \u00a0the\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0genes\t\r \u00a0encoding\t\r \u00a0the\t\r \u00a0\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0from\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0(32)\t\r \u00a0and\t\r \u00a0L.\t\r \u00a0panamensis\t\r \u00a0(33)\t\r \u00a0as\t\r \u00a0 well\t\r \u00a0 as\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 study\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 antigenicity\t\r \u00a0 of\t\r \u00a0 this\t\r \u00a0 protein.\t\r \u00a0 The\t\r \u00a0immunogenicity\t\r \u00a0of\t\r \u00a0the\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0has\t\r \u00a0been\t\r \u00a0demonstrated\t\r \u00a0in\t\r \u00a0different\t\r \u00a0hosts.\t\r \u00a0Thus,\t\r \u00a0the\t\r \u00a0sera\t\r \u00a0 from\t\r \u00a0 human\t\r \u00a0 patients\t\r \u00a0 suffering\t\r \u00a0 from\t\r \u00a0 active\t\r \u00a0 VL\t\r \u00a0 but\t\r \u00a0 not\t\r \u00a0 individuals\t\r \u00a0 with\t\r \u00a0subclinical\t\r \u00a0L.\t\r \u00a0 chagasi\t\r \u00a0infections,\t\r \u00a0 react\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 recombinant\t\r \u00a0L.\t\r \u00a0 infantum\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0protein\t\r \u00a0(34).\t\r \u00a0 In\t\r \u00a0 addition,\t\r \u00a0 patients\t\r \u00a0 suffering\t\r \u00a0 from\t\r \u00a0 MCL\t\r \u00a0 or\t\r \u00a0 CL\t\r \u00a0 showed\t\r \u00a0 a\t\r \u00a0 KMP-\u00ad\u201011\t\r \u00a0specific\t\r \u00a0 production\t\r \u00a0 of\t\r \u00a0 IL-\u00ad\u201010\t\r \u00a0(35).\t\r \u00a0 Finally,\t\r \u00a0 anti-\u00ad\u2010KMP-\u00ad\u201011\t\r \u00a0 antibodies\t\r \u00a0 were\t\r \u00a0 found\t\r \u00a0 in\t\r \u00a0the\t\r \u00a0sera\t\r \u00a0from\t\r \u00a0VL\t\r \u00a0dogs\t\r \u00a0infected\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0 infantum\t\r \u00a0(32,\t\r \u00a036).\t\r \u00a0Vaccines\t\r \u00a0based\t\r \u00a0on\t\r \u00a0this\t\r \u00a0protein\t\r \u00a0 have\t\r \u00a0 shown\t\r \u00a0 to\t\r \u00a0 be\t\r \u00a0 protective\t\r \u00a0 in\t\r \u00a0 different\t\r \u00a0 animal\t\r \u00a0 models.\t\r \u00a0 The\t\r \u00a0 protective\t\r \u00a0capacity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 KMP-\u00ad\u201011\t\r \u00a0 described\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0 hamster\t\r \u00a0 model\t\r \u00a0 of\t\r \u00a0 VL\t\r \u00a0 infected\t\r \u00a0 by\t\r \u00a0 both\t\r \u00a0pentavalent\t\r \u00a0antimonial\t\r \u00a0sensitive\t\r \u00a0and\t\r \u00a0resistant\t\r \u00a0virulent\t\r \u00a0L.\t\r \u00a0donovani\t\r \u00a0strains\t\r \u00a0(37)\t\r \u00a0has\t\r \u00a0been\t\r \u00a0 recently\t\r \u00a0 reinforced\t\r \u00a0 after\t\r \u00a0 demonstration\t\r \u00a0 that\t\r \u00a0 a\t\r \u00a0 DNA\t\r \u00a0 vaccine\t\r \u00a0 based\t\r \u00a0 on\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0was\t\r \u00a0able\t\r \u00a0to\t\r \u00a0protect\t\r \u00a0hamster\t\r \u00a0from\t\r \u00a0infection\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0chagasi\t\r \u00a0(38)\t\r \u00a0and\t\r \u00a0a\t\r \u00a0vaccine\t\r \u00a0composition\t\r \u00a0formed\t\r \u00a0by\t\r \u00a0the\t\r \u00a0recombinant\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0loaded\t\r \u00a0in\t\r \u00a0poly(lactic-\u00ad\u2010co-\u00ad\u2010glycolic\t\r \u00a0acid)\t\r \u00a0nanoparticles\t\r \u00a0was\t\r \u00a0able\t\r \u00a0to\t\r \u00a0protect\t\r \u00a0mice\t\r \u00a0from\t\r \u00a0CL\t\r \u00a0due\t\r \u00a0to\t\r \u00a0L.\t\r \u00a0 braziliensis\t\r \u00a0infection\t\r \u00a0(39).\t\r \u00a0 Moreover,\t\r \u00a0 this\t\r \u00a0 last\t\r \u00a0 formulation\t\r \u00a0 stimulates\t\r \u00a0macrophages\t\r \u00a0 for\t\r \u00a0 secreting\t\r \u00a0 pro-\u00ad\u2010inflammatory\t\r \u00a0 cytokines\t\r \u00a0 and\t\r \u00a0 chemokines\t\r \u00a0 and\t\r \u00a0 for\t\r \u00a0synthesis\t\r \u00a0of\t\r \u00a0superoxide\t\r \u00a0resulting\t\r \u00a0in\t\r \u00a0intracellular\t\r \u00a0L.\t\r \u00a0braziliensis\t\r \u00a0killing\t\r \u00a0(40).\t\r \u00a0The\t\r \u00a0 antigenic\t\r \u00a0 nature\t\r \u00a0 of\t\r \u00a0 two\t\r \u00a0 different\t\r \u00a0 amastigote\t\r \u00a0 specific\t\r \u00a0 membrane\t\r \u00a0components\t\r \u00a0 has\t\r \u00a0 been\t\r \u00a0 studied\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 implication\t\r \u00a0 of\t\r \u00a0 different\t\r \u00a0 Spanish\t\r \u00a0researchers.\t\r \u00a0P8\t\r \u00a0antigen,\t\r \u00a0a\t\r \u00a0Leishmania\t\r \u00a0pifanoi\t\r \u00a0amastigote\t\r \u00a0specific\t\r \u00a0proteoglycolipid\t\r \u00a0complex,\t\r \u00a0biochemically\t\r \u00a0characterized\t\r \u00a0by\t\r \u00a0Dr.\t\r \u00a0Colmenares\t\r \u00a0in\t\r \u00a0Dr..\t\r \u00a0MacMahon-\u00ad\u2010Pratt\u2019s\t\r \u00a0laboratory\t\r \u00a0(41),\t\r \u00a0 was\t\r \u00a0 able\t\r \u00a0 to\t\r \u00a0 stimulate\t\r \u00a0 the\t\r \u00a0 innate\t\r \u00a0 immune\t\r \u00a0 response\t\r \u00a0 of\t\r \u00a0 murine\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n254\t\r \u00a0\t\r \u00a0macrophages\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0 TLR4\t\r \u00a0 dependent\t\r \u00a0 manner\t\r \u00a0(42)\t\r \u00a0and\t\r \u00a0 also\t\r \u00a0 was\t\r \u00a0 up-\u00ad\u2010regulating\t\r \u00a0 the\t\r \u00a0expression\t\r \u00a0 of\t\r \u00a0 IFN-\u00ad\u2010gamma\t\r \u00a0 and\t\r \u00a0 TNF-\u00ad\u2010alpha\t\r \u00a0 in\t\r \u00a0 asymptomatic\t\r \u00a0L.\t\r \u00a0 infantum\t\r \u00a0infected\t\r \u00a0dogs\t\r \u00a0(43).\t\r \u00a0 \t\r \u00a0 The\t\r \u00a0 induction\t\r \u00a0 of\t\r \u00a0 CD4+\t\r \u00a0and\t\r \u00a0 CD8+\t\r \u00a0mediated\t\r \u00a0 responses\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0immunization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 P8\t\r \u00a0 complex\t\r \u00a0 combined\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0Propionibacterium\t\r \u00a0 acnes\t\r \u00a0adjuvant\t\r \u00a0in\t\r \u00a0C57BL/6\t\r \u00a0mice\t\r \u00a0resulted\t\r \u00a0in\t\r \u00a0protection\t\r \u00a0against\t\r \u00a0L.\t\r \u00a0amazonensis\t\r \u00a0infection\t\r \u00a0(44).\t\r \u00a0HASPB1,\t\r \u00a0an\t\r \u00a0hydrophilic\t\r \u00a0acylated\t\r \u00a0surface\t\r \u00a0protein,\t\r \u00a0is\t\r \u00a0another\t\r \u00a0component\t\r \u00a0of\t\r \u00a0the\t\r \u00a0amastigote\t\r \u00a0membranes\t\r \u00a0(45,\t\r \u00a046).\t\r \u00a0This\t\r \u00a0protein\t\r \u00a0is\t\r \u00a0able\t\r \u00a0to\t\r \u00a0elicit\t\r \u00a0humoral\t\r \u00a0responses\t\r \u00a0in\t\r \u00a0humans\t\r \u00a0 infected\t\r \u00a0 by\t\r \u00a0L.\t\r \u00a0 donovani\t\r \u00a0(47).\t\r \u00a0 In\t\r \u00a0 a\t\r \u00a0 canine\t\r \u00a0 vaccine\t\r \u00a0 trial\t\r \u00a0 made\t\r \u00a0 in\t\r \u00a0 Madrid\t\r \u00a0(Instituto\t\r \u00a0 de\t\r \u00a0 Salud\t\r \u00a0 Carlos\t\r \u00a0 III)\t\r \u00a0 it\t\r \u00a0 was\t\r \u00a0 shown\t\r \u00a0 that\t\r \u00a0 HASPB1\t\r \u00a0 was\t\r \u00a0 able\t\r \u00a0 to\t\r \u00a0 induce\t\r \u00a0protection\t\r \u00a0 against\t\r \u00a0 experimental\t\r \u00a0 infection\t\r \u00a0 with\t\r \u00a0L.\t\r \u00a0 infantum\t\r \u00a0in\t\r \u00a0 dogs\t\r \u00a0 when\t\r \u00a0administered\t\r \u00a0in\t\r \u00a0combination\t\r \u00a0with\t\r \u00a0a\t\r \u00a0mineral\t\r \u00a0oil\t\r \u00a0based\t\r \u00a0adjuvant\t\r \u00a0(Montanide\t\r \u00a0\u2122ISA\t\r \u00a0720).\t\r \u00a0\t\r \u00a0Globally,\t\r \u00a0 most\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 surface\t\r \u00a0 components\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0 are\t\r \u00a0 antigenic\t\r \u00a0during\t\r \u00a0 infection\t\r \u00a0 in\t\r \u00a0 different\t\r \u00a0 hosts.\t\r \u00a0 Different\t\r \u00a0 vaccination\t\r \u00a0 trials\t\r \u00a0 were\t\r \u00a0 performed\t\r \u00a0employing\t\r \u00a0purified\t\r \u00a0fractions\t\r \u00a0(in\t\r \u00a0some\t\r \u00a0cases)\t\r \u00a0and\t\r \u00a0mostly\t\r \u00a0recombinant\t\r \u00a0versions\t\r \u00a0of\t\r \u00a0the\t\r \u00a0 antigens,\t\r \u00a0 combined\t\r \u00a0with\t\r \u00a0 adjuvants\t\r \u00a0 that\t\r \u00a0 stimulate\t\r \u00a0 cellular\t\r \u00a0 responses.\t\r \u00a0Depending\t\r \u00a0on\t\r \u00a0the\t\r \u00a0model,\t\r \u00a0the\t\r \u00a0vaccination\t\r \u00a0studies\t\r \u00a0resulted\t\r \u00a0in\t\r \u00a0different\t\r \u00a0degrees\t\r \u00a0of\t\r \u00a0protection,\t\r \u00a0 The\t\r \u00a0 different\t\r \u00a0 degrees\t\r \u00a0 of\t\r \u00a0 protection\t\r \u00a0 was\t\r \u00a0 usually\t\r \u00a0 correlated\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0induction\t\r \u00a0 of\t\r \u00a0 cellular\t\r \u00a0 responses.\t\r \u00a0 These\t\r \u00a0 results\t\r \u00a0 can\t\r \u00a0 be\t\r \u00a0 taken\t\r \u00a0 as\t\r \u00a0 an\t\r \u00a0 indication\t\r \u00a0 that\t\r \u00a0surface\t\r \u00a0 proteins\t\r \u00a0 should\t\r \u00a0 be\t\r \u00a0 taken\t\r \u00a0 into\t\r \u00a0 account\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0 anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines.\t\r \u00a0 However,\t\r \u00a0 and\t\r \u00a0 at\t\r \u00a0 is\t\r \u00a0 indicated\t\r \u00a0 below,\t\r \u00a0 proteins\t\r \u00a0 with\t\r \u00a0intracellular\t\r \u00a0locations\t\r \u00a0are\t\r \u00a0also\t\r \u00a0interacting\t\r \u00a0with\t\r \u00a0the\t\r \u00a0host\t\r \u00a0immune\t\r \u00a0system.\t\r \u00a03.\t\r \u00a0LEISHMANIA\t\r \u00a0INTRACELLULAR\t\r \u00a0ANTIGENIC\t\r \u00a0PROTEINS\t\r \u00a0Many\t\r \u00a0intracellular\t\r \u00a0parasite\t\r \u00a0proteins\t\r \u00a0interact\t\r \u00a0with\t\r \u00a0the\t\r \u00a0host\t\r \u00a0immune\t\r \u00a0system\t\r \u00a0after\t\r \u00a0Leishmania\t\r \u00a0infection.\t\r \u00a0Most\t\r \u00a0of\t\r \u00a0them\t\r \u00a0are\t\r \u00a0members\t\r \u00a0of\t\r \u00a0conserved\t\r \u00a0housekeeping\t\r \u00a0proteins\t\r \u00a0like\t\r \u00a0intracellular\t\r \u00a0receptors,\t\r \u00a0heat\t\r \u00a0shock\t\r \u00a0proteins,\t\r \u00a0ribosomal\t\r \u00a0proteins\t\r \u00a0and\t\r \u00a0histones\t\r \u00a0(48).\t\r \u00a0 In\t\r \u00a0 spite\t\r \u00a0 of\t\r \u00a0 their\t\r \u00a0 conserved\t\r \u00a0 nature,\t\r \u00a0 the\t\r \u00a0 humoral\t\r \u00a0 and\t\r \u00a0 cellular\t\r \u00a0responses\t\r \u00a0 against\t\r \u00a0 them\t\r \u00a0 are\t\r \u00a0 specifically\t\r \u00a0 directed\t\r \u00a0 against\t\r \u00a0the\t\r \u00a0 parasite\t\r \u00a0 antigens\t\r \u00a0without\t\r \u00a0showing\t\r \u00a0cross-\u00ad\u2010reactivity\t\r \u00a0with\t\r \u00a0the\t\r \u00a0host\t\r \u00a0counterparts.\t\r \u00a0The\t\r \u00a0specificity\t\r \u00a0of\t\r \u00a0the\t\r \u00a0response\t\r \u00a0 is\t\r \u00a0 based\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0 location\t\r \u00a0 of\t\r \u00a0 their\t\r \u00a0 antigenic\t\r \u00a0 determinants\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 most\t\r \u00a0divergent\t\r \u00a0 regions\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0 proteins\t\r \u00a0(48,\t\r \u00a049).\t\r \u00a0 Different\t\r \u00a0 Spanish\t\r \u00a0 scientists\t\r \u00a0have\t\r \u00a0been\t\r \u00a0implicated\t\r \u00a0in\t\r \u00a0the\t\r \u00a0search\t\r \u00a0for\t\r \u00a0this\t\r \u00a0type\t\r \u00a0of\t\r \u00a0related\t\r \u00a0proteins.\t\r \u00a0Some\t\r \u00a0of\t\r \u00a0their\t\r \u00a0results\t\r \u00a0are\t\r \u00a0highlighted\t\r \u00a0below.\t\r \u00a0\t\r \u00a03.1.\t\r \u00a0Leishmania\t\r \u00a0and\t\r \u00a0its\t\r \u00a0antigenic\t\r \u00a0histones\t\r \u00a0Leishmania\t\r \u00a0histones,\t\r \u00a0in\t\r \u00a0spite\t\r \u00a0of\t\r \u00a0their\t\r \u00a0nuclear\t\r \u00a0location\t\r \u00a0and\t\r \u00a0their\t\r \u00a0high\t\r \u00a0degree\t\r \u00a0of\t\r \u00a0 conservation\t\r \u00a0 throughout\t\r \u00a0 eukaryotic\t\r \u00a0 organisms,\t\r \u00a0 have\t\r \u00a0 been\t\r \u00a0 described\t\r \u00a0 as\t\r \u00a0immunodominant\t\r \u00a0antigens\t\r \u00a0during\t\r \u00a0Leishmania\t\r \u00a0infection\t\r \u00a0(48).\t\r \u00a0\t\r \u00a0The\t\r \u00a0characterization\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0255\t\r \u00a0\t\r \u00a0of\t\r \u00a0the\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0histone\t\r \u00a0H2A\t\r \u00a0was\t\r \u00a0made\t\r \u00a0using\t\r \u00a0sera\t\r \u00a0from\t\r \u00a0infected\t\r \u00a0dogs\t\r \u00a0that\t\r \u00a0were\t\r \u00a0recognizing\t\r \u00a0this\t\r \u00a0basic\t\r \u00a0protein\t\r \u00a0(50).\t\r \u00a0The\t\r \u00a0rest\t\r \u00a0of\t\r \u00a0the\t\r \u00a0nucleosome\t\r \u00a0forming\t\r \u00a0histones\t\r \u00a0(H3,\t\r \u00a0H2B\t\r \u00a0and\t\r \u00a0H4)\t\r \u00a0was\t\r \u00a0described\t\r \u00a0as\t\r \u00a0antigens\t\r \u00a0in\t\r \u00a0serologic\t\r \u00a0assays\t\r \u00a0employing\t\r \u00a0canine\t\r \u00a0VCL\t\r \u00a0sera\t\r \u00a0(51,\t\r \u00a052).\t\r \u00a0Antigenicity\t\r \u00a0is\t\r \u00a0not\t\r \u00a0only\t\r \u00a0related\t\r \u00a0to\t\r \u00a0the\t\r \u00a0VL\t\r \u00a0canine\t\r \u00a0infection,\t\r \u00a0since\t\r \u00a0the\t\r \u00a0 four\t\r \u00a0 core\t\r \u00a0 histones\t\r \u00a0 were\t\r \u00a0 also\t\r \u00a0 recognized\t\r \u00a0 by\t\r \u00a0 sera\t\r \u00a0 from\t\r \u00a0 CL\t\r \u00a0 and\t\r \u00a0 MCL\t\r \u00a0 human\t\r \u00a0patients,\t\r \u00a0being\t\r \u00a0the\t\r \u00a0H2A\t\r \u00a0the\t\r \u00a0most\t\r \u00a0antigenic\t\r \u00a0core\t\r \u00a0histone\t\r \u00a0(53).\t\r \u00a0This\t\r \u00a0protein\t\r \u00a0is\t\r \u00a0also\t\r \u00a0recognized\t\r \u00a0by\t\r \u00a0sera\t\r \u00a0from\t\r \u00a0VL\t\r \u00a0patients\t\r \u00a0infected\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0chagasi\t\r \u00a0(34).\t\r \u00a0The\t\r \u00a0antigenicity\t\r \u00a0of\t\r \u00a0 the\t\r \u00a0 H1\t\r \u00a0 linker\t\r \u00a0 histone\t\r \u00a0 in\t\r \u00a0 patients\t\r \u00a0 infected\t\r \u00a0 by\t\r \u00a0L.\t\r \u00a0 braziliensis\t\r \u00a0has\t\r \u00a0 been\t\r \u00a0demonstrated\t\r \u00a0 by\t\r \u00a0 Dr.\t\r \u00a0 Valladares\t\r \u00a0 research\t\r \u00a0 group\t\r \u00a0 (Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia,\t\r \u00a0Universidad\t\r \u00a0 de\t\r \u00a0 La\t\r \u00a0 Laguna)\t\r \u00a0(54,\t\r \u00a055).\t\r \u00a0 Remarkably,\t\r \u00a0 the\t\r \u00a0 anti-\u00ad\u2010histone\t\r \u00a0 humoral\t\r \u00a0response\t\r \u00a0elicited\t\r \u00a0during\t\r \u00a0infection\t\r \u00a0is\t\r \u00a0specific\t\r \u00a0for\t\r \u00a0the\t\r \u00a0parasite\t\r \u00a0antigens\t\r \u00a0and\t\r \u00a0does\t\r \u00a0not\t\r \u00a0show\t\r \u00a0 cross-\u00ad\u2010reactivity\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 host\t\r \u00a0 histone,\t\r \u00a0 since\t\r \u00a0 B\t\r \u00a0cell\t\r \u00a0 epitopes\t\r \u00a0 are\t\r \u00a0 mainly\t\r \u00a0located\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 most\t\r \u00a0 divergent\t\r \u00a0 regions\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0 histones\t\r \u00a0(52,\t\r \u00a055-\u00ad\u201057).\t\r \u00a0 The\t\r \u00a0presence\t\r \u00a0of\t\r \u00a0IFN-\u00ad\u2010gamma\t\r \u00a0mediated\t\r \u00a0specific\t\r \u00a0T\t\r \u00a0cell\t\r \u00a0responses\t\r \u00a0has\t\r \u00a0been\t\r \u00a0demonstrated\t\r \u00a0for\t\r \u00a0the\t\r \u00a0H2B\t\r \u00a0protein\t\r \u00a0in\t\r \u00a0human\t\r \u00a0patients\t\r \u00a0of\t\r \u00a0\t\r \u00a0CL\t\r \u00a0and\t\r \u00a0\t\r \u00a0VL\t\r \u00a0(49,\t\r \u00a058)\t\r \u00a0and\t\r \u00a0for\t\r \u00a0H2A\t\r \u00a0and\t\r \u00a0H3\t\r \u00a0in\t\r \u00a0CL\t\r \u00a0patients\t\r \u00a0(59).\t\r \u00a0The\t\r \u00a0 prophylactic\t\r \u00a0 value\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0histones\t\r \u00a0 was\t\r \u00a0 evaluated\t\r \u00a0 in\t\r \u00a0different\t\r \u00a0 experimental\t\r \u00a0 models\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 implication\t\r \u00a0 of\t\r \u00a0 different\t\r \u00a0 Spanish\t\r \u00a0researchers.\t\r \u00a0Induction\t\r \u00a0of\t\r \u00a0Th1\t\r \u00a0responses\t\r \u00a0against\t\r \u00a0the\t\r \u00a0four\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0nucleosomal\t\r \u00a0histones\t\r \u00a0 were\t\r \u00a0 able\t\r \u00a0 to\t\r \u00a0 protect\t\r \u00a0 BALB/c\t\r \u00a0 mice\t\r \u00a0 against\t\r \u00a0 a\t\r \u00a0 virulent\t\r \u00a0 challenge\t\r \u00a0 with\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0(60,\t\r \u00a061),\t\r \u00a0L.\t\r \u00a0braziliensis\t\r \u00a0(62)\t\r \u00a0and\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0(63).\t\r \u00a0Beside\t\r \u00a0data\t\r \u00a0reporting\t\r \u00a0the\t\r \u00a0protective\t\r \u00a0capacities\t\r \u00a0of\t\r \u00a0the\t\r \u00a0H1\t\r \u00a0histone\t\r \u00a0in\t\r \u00a0murine\t\r \u00a0(64)\t\r \u00a0and\t\r \u00a0monkey\t\r \u00a0(65)\t\r \u00a0models,\t\r \u00a0a\t\r \u00a0vaccine\t\r \u00a0based\t\r \u00a0on\t\r \u00a0this\t\r \u00a0protein\t\r \u00a0was\t\r \u00a0tested\t\r \u00a0with\t\r \u00a0success\t\r \u00a0(62.5%\t\r \u00a0\t\r \u00a0of\t\r \u00a0infected\t\r \u00a0animals\t\r \u00a0without\t\r \u00a0clinical\t\r \u00a0symptoms)\t\r \u00a0in\t\r \u00a0a\t\r \u00a0vaccine\t\r \u00a0trial\t\r \u00a0against\t\r \u00a0experimental\t\r \u00a0canine\t\r \u00a0VL\t\r \u00a0(66).\t\r \u00a0\t\r \u00a0Taking\t\r \u00a0 into\t\r \u00a0 account\t\r \u00a0 the\t\r \u00a0 high\t\r \u00a0 degree\t\r \u00a0 of\t\r \u00a0 immunogenicity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0histones\t\r \u00a0 and\t\r \u00a0 their\t\r \u00a0 value\t\r \u00a0 as\t\r \u00a0 immuno-\u00ad\u2010prophylactic\t\r \u00a0 molecules\t\r \u00a0 tools\t\r \u00a0 against\t\r \u00a0leishmaniasis\t\r \u00a0 in\t\r \u00a0 different\t\r \u00a0 experimental\t\r \u00a0 models,\t\r \u00a0 parasite\t\r \u00a0 histones\t\r \u00a0 emerge\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0powerful\t\r \u00a0tool\t\r \u00a0against\t\r \u00a0Leishmania\t\r \u00a0infection.\t\r \u00a0In\t\r \u00a0this\t\r \u00a0sense\t\r \u00a0and\t\r \u00a0as\t\r \u00a0it\t\r \u00a0is\t\r \u00a0indicated\t\r \u00a0in\t\r \u00a0section\t\r \u00a0 4,\t\r \u00a0 different\t\r \u00a0 combination\t\r \u00a0 molecules\t\r \u00a0 designed\t\r \u00a0 as\t\r \u00a0 anti-\u00ad\u2010Leishmania\t\r \u00a0 vaccines\t\r \u00a0include\t\r \u00a0Leishmania\t\r \u00a0histone-\u00ad\u2010genes\t\r \u00a0or\t\r \u00a0proteins.\t\r \u00a0\t\r \u00a03.2.\t\r \u00a0Leishmania\t\r \u00a0ribosomes\t\r \u00a0as\t\r \u00a0vaccines\t\r \u00a0Leishmania\t\r \u00a0ribosomes\t\r \u00a0have\t\r \u00a0emerged\t\r \u00a0as\t\r \u00a0immunodominant\t\r \u00a0particles\t\r \u00a0during\t\r \u00a0parasite\t\r \u00a0 infection.\t\r \u00a0 Many\t\r \u00a0 ribosomal\t\r \u00a0 proteins\t\r \u00a0 are\t\r \u00a0 recognized\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 sera\t\r \u00a0 from\t\r \u00a0 VL\t\r \u00a0dogs\t\r \u00a0(67-\u00ad\u201070)\t\r \u00a0or\t\r \u00a0are\t\r \u00a0antigenic\t\r \u00a0in\t\r \u00a0human\t\r \u00a0MCL\t\r \u00a0and\t\r \u00a0VL\t\r \u00a0patients\t\r \u00a0(68,\t\r \u00a071).\t\r \u00a0Leishmania\t\r \u00a0acidic\t\r \u00a0 ribosomal\t\r \u00a0 P\t\r \u00a0 proteins\t\r \u00a0 (namely\t\r \u00a0 P0,\t\r \u00a0 P2a\t\r \u00a0 and\t\r \u00a0 P2b)\t\r \u00a0 are\t\r \u00a0 good\t\r \u00a0 examples\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0intracellular\t\r \u00a0 antigens.\t\r \u00a0 Strong\t\r \u00a0 humoral\t\r \u00a0 responses\t\r \u00a0 are\t\r \u00a0 elicited\t\r \u00a0 against\t\r \u00a0them\t\r \u00a0 during\t\r \u00a0 infection\t\r \u00a0 (mainly\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 VL\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0 human\t\r \u00a0 and\t\r \u00a0 canine\t\r \u00a0 disease).\t\r \u00a0Interestingly,\t\r \u00a0anti-\u00ad\u2010P\t\r \u00a0antibodies\t\r \u00a0are\t\r \u00a0specifically\t\r \u00a0directed\t\r \u00a0against\t\r \u00a0parasite\t\r \u00a0P\t\r \u00a0proteins\t\r \u00a0without\t\r \u00a0cross-\u00ad\u2010reactivity\t\r \u00a0with\t\r \u00a0the\t\r \u00a0host\t\r \u00a0orthologs\t\r \u00a0(reviewed\t\r \u00a0in\t\r \u00a0(48))\t\r \u00a0although\t\r \u00a0these\t\r \u00a0proteins\t\r \u00a0are\t\r \u00a0antigenic\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0autoimmune\t\r \u00a0diseases\t\r \u00a0(72).\t\r \u00a0The\t\r \u00a0location\t\r \u00a0of\t\r \u00a0B\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n256\t\r \u00a0\t\r \u00a0cell\t\r \u00a0epitopes\t\r \u00a0in\t\r \u00a0the\t\r \u00a0most\t\r \u00a0variable\t\r \u00a0region\t\r \u00a0of\t\r \u00a0the\t\r \u00a0P2a,\t\r \u00a0P2b\t\r \u00a0and\t\r \u00a0P0\t\r \u00a0proteins\t\r \u00a0explains\t\r \u00a0the\t\r \u00a0 observed\t\r \u00a0 specificity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 response\t\r \u00a0(69,\t\r \u00a070).\t\r \u00a0 The\t\r \u00a0 P0\t\r \u00a0 protein\t\r \u00a0 has\t\r \u00a0 been\t\r \u00a0employed\t\r \u00a0 in\t\r \u00a0 different\t\r \u00a0 vaccination\t\r \u00a0 assays\t\r \u00a0 in\t\r \u00a0 murine\t\r \u00a0 models\t\r \u00a0 of\t\r \u00a0 CL\t\r \u00a0 employing\t\r \u00a0susceptible\t\r \u00a0 (BALB/c)\t\r \u00a0 and\t\r \u00a0 resistant\t\r \u00a0 (C57BL/6)\t\r \u00a0 mice.\t\r \u00a0BALB/c\t\r \u00a0 mice\t\r \u00a0 immunization\t\r \u00a0with\t\r \u00a0a\t\r \u00a0parasite\t\r \u00a0P0-\u00ad\u2010based\t\r \u00a0DNA\t\r \u00a0vaccine\t\r \u00a0or\t\r \u00a0with\t\r \u00a0the\t\r \u00a0rP0\t\r \u00a0protein\t\r \u00a0combined\t\r \u00a0with\t\r \u00a0Th1\t\r \u00a0inducing\t\r \u00a0oligonucleotides\t\r \u00a0induced\t\r \u00a0partial\t\r \u00a0protection\t\r \u00a0after\t\r \u00a0challenge\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0major.\t\r \u00a0Immunized\t\r \u00a0animals\t\r \u00a0showed\t\r \u00a0a\t\r \u00a0delay\t\r \u00a0in\t\r \u00a0the\t\r \u00a0development\t\r \u00a0of\t\r \u00a0cutaneous\t\r \u00a0lesions\t\r \u00a0but\t\r \u00a0mice\t\r \u00a0ultimately\t\r \u00a0developed\t\r \u00a0a\t\r \u00a0non-\u00ad\u2010healing\t\r \u00a0form\t\r \u00a0of\t\r \u00a0the\t\r \u00a0disease\t\r \u00a0(73,\t\r \u00a074).\t\r \u00a0On\t\r \u00a0the\t\r \u00a0other\t\r \u00a0hand,\t\r \u00a0the\t\r \u00a0Th1\t\r \u00a0responses\t\r \u00a0induced\t\r \u00a0by\t\r \u00a0vaccination\t\r \u00a0conferred\t\r \u00a0protection\t\r \u00a0against\t\r \u00a0CL\t\r \u00a0in\t\r \u00a0C57BL/6\t\r \u00a0mice\t\r \u00a0(74).\t\r \u00a0Since\t\r \u00a0the\t\r \u00a0administration\t\r \u00a0of\t\r \u00a0some\t\r \u00a0other\t\r \u00a0ribosomal\t\r \u00a0constituents\t\r \u00a0using\t\r \u00a0 immunization\t\r \u00a0 procedures\t\r \u00a0 inducing\t\r \u00a0 Th1\t\r \u00a0 responses\t\r \u00a0 was\t\r \u00a0 related\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0generation\t\r \u00a0 of\t\r \u00a0 protective\t\r \u00a0 responses\t\r \u00a0(75,\t\r \u00a076),\t\r \u00a0 vaccines\t\r \u00a0 based\t\r \u00a0 on\t\r \u00a0 total\t\r \u00a0 ribosome\t\r \u00a0extract\t\r \u00a0(LRP)\t\r \u00a0were\t\r \u00a0analyzed.\t\r \u00a0In\t\r \u00a0addition,\t\r \u00a0a\t\r \u00a0cDNA\t\r \u00a0clone\t\r \u00a0encoding\t\r \u00a0the\t\r \u00a0L.\t\r \u00a0braziliensis\t\r \u00a0ribosomal\t\r \u00a0protein\t\r \u00a0S4\t\r \u00a0was\t\r \u00a0recognized\t\r \u00a0by\t\r \u00a0a\t\r \u00a0T-\u00ad\u2010cell\t\r \u00a0clone\t\r \u00a0derived\t\r \u00a0from\t\r \u00a0a\t\r \u00a0resistant\t\r \u00a0VL\t\r \u00a0human\t\r \u00a0donor\t\r \u00a0with\t\r \u00a0a\t\r \u00a0positive\t\r \u00a0DTH\t\r \u00a0skin\t\r \u00a0test\t\r \u00a0(49),\t\r \u00a0indicating\t\r \u00a0that\t\r \u00a0the\t\r \u00a0recognition\t\r \u00a0of\t\r \u00a0some\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0 ribosomal\t\r \u00a0 proteins\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 host\t\r \u00a0 immune\t\r \u00a0 system\t\r \u00a0 is\t\r \u00a0 not\t\r \u00a0necessarily\t\r \u00a0 related\t\r \u00a0 to\t\r \u00a0 disease\t\r \u00a0 progression.\t\r \u00a0 Administration\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 LRP\t\r \u00a0 combined\t\r \u00a0with\t\r \u00a0Th1\t\r \u00a0inducing\t\r \u00a0adjuvants\t\r \u00a0prompted\t\r \u00a0a\t\r \u00a0ribosome-\u00ad\u2010specific\t\r \u00a0Th1\t\r \u00a0response\t\r \u00a0in\t\r \u00a0mice,\t\r \u00a0correlated\t\r \u00a0 with\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 the\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0 leishmaniasis\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0infective\t\r \u00a0challenges\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0(77),\t\r \u00a0L.\t\r \u00a0amazonensis\t\r \u00a0or\t\r \u00a0L.\t\r \u00a0chagasi\t\r \u00a0(78)\t\r \u00a0parasites.\t\r \u00a0The\t\r \u00a0 robust\t\r \u00a0 protection\t\r \u00a0 observed\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 susceptible\t\r \u00a0 model\t\r \u00a0 BALB/c-\u00ad\u2010L.\t\r \u00a0 major\t\r \u00a0(detected\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 absence\t\r \u00a0 of\t\r \u00a0 cutaneous\t\r \u00a0 lesions\t\r \u00a0 for\t\r \u00a0 long\t\r \u00a0 periods\t\r \u00a0 of\t\r \u00a0 time)\t\r \u00a0 was\t\r \u00a0accompanied\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 capacity\t\r \u00a0 to\t\r \u00a0 resist\t\r \u00a0 a\t\r \u00a0 secondary\t\r \u00a0 infection\t\r \u00a0(79).\t\r \u00a0Two\t\r \u00a0 new\t\r \u00a0antigenic\t\r \u00a0ribosomal\t\r \u00a0molecules\t\r \u00a0obtained\t\r \u00a0as\t\r \u00a0recombinant\t\r \u00a0proteins\t\r \u00a0by\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0the\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0encoding\t\r \u00a0LmL3\t\r \u00a0and\t\r \u00a0LmL5\t\r \u00a0genes\t\r \u00a0have\t\r \u00a0shown\t\r \u00a0immuno-\u00ad\u2010prophylactic\t\r \u00a0properties\t\r \u00a0against\t\r \u00a0infection\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0and\t\r \u00a0L.\t\r \u00a0braziliensis\t\r \u00a0in\t\r \u00a0BALB/c\t\r \u00a0mice.\t\r \u00a03.3.\t\r \u00a0Leishmania\t\r \u00a0homolog\t\r \u00a0of\t\r \u00a0mammalian\t\r \u00a0receptor\t\r \u00a0for\t\r \u00a0activated\t\r \u00a0C\t\r \u00a0kinase\t\r \u00a0(LACK)\t\r \u00a0LACK\t\r \u00a0 protein\t\r \u00a0 is\t\r \u00a0 one\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 most\t\r \u00a0 studied\t\r \u00a0 Leishmania\t\r \u00a0 antigens.\t\r \u00a0 This\t\r \u00a0intracellular\t\r \u00a0protein\t\r \u00a0is\t\r \u00a0a\t\r \u00a0member\t\r \u00a0of\t\r \u00a0the\t\r \u00a0tryptophan-\u00ad\u2010aspartic\t\r \u00a0acid\t\r \u00a0repeat\t\r \u00a0family\t\r \u00a0of\t\r \u00a0proteins\t\r \u00a0and\t\r \u00a0it\t\r \u00a0has\t\r \u00a0been\t\r \u00a0implicated\t\r \u00a0in\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0early\t\r \u00a0IL-\u00ad\u20104\t\r \u00a0responses\t\r \u00a0after\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0infection\t\r \u00a0(80).\t\r \u00a0In\t\r \u00a0this\t\r \u00a0sense,\t\r \u00a0BALB/c\t\r \u00a0rendered\t\r \u00a0tolerant\t\r \u00a0to\t\r \u00a0LACK,\t\r \u00a0as\t\r \u00a0a\t\r \u00a0result\t\r \u00a0of\t\r \u00a0transgenic\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0this\t\r \u00a0molecule\t\r \u00a0in\t\r \u00a0the\t\r \u00a0thymus,\t\r \u00a0were\t\r \u00a0resistant\t\r \u00a0to\t\r \u00a0infection\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0and\t\r \u00a0develop\t\r \u00a0a\t\r \u00a0Th1\t\r \u00a0response\t\r \u00a0after\t\r \u00a0infection\t\r \u00a0(81).\t\r \u00a0Several\t\r \u00a0vaccination\t\r \u00a0protocols\t\r \u00a0 were\t\r \u00a0 tested\t\r \u00a0 in\t\r \u00a0 collaboration\t\r \u00a0 between\t\r \u00a0 Dr.\t\r \u00a0 Esteban\t\r \u00a0 (Centro\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0Biotecnolog\u00eda)\t\r \u00a0 and\t\r \u00a0 Dr.\t\r \u00a0 Larraga\t\r \u00a0 (Centro\t\r \u00a0 de\t\r \u00a0 Investigaciones\t\r \u00a0 Biol\u00f3gicas)\t\r \u00a0 research\t\r \u00a0groups\t\r \u00a0using\t\r \u00a0different\t\r \u00a0LACK\t\r \u00a0preparations,\t\r \u00a0based\t\r \u00a0on\t\r \u00a0the\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0LACK\t\r \u00a0protein,\t\r \u00a0that\t\r \u00a0was\t\r \u00a0characterized\t\r \u00a0in\t\r \u00a0Dr.\t\r \u00a0Larraga\u2019s\t\r \u00a0research\t\r \u00a0group\t\r \u00a0(82).\t\r \u00a0The\t\r \u00a0main\t\r \u00a0strategy\t\r \u00a0was\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0robust\t\r \u00a0cellular\t\r \u00a0responses\t\r \u00a0against\t\r \u00a0LACK\t\r \u00a0by\t\r \u00a0the\t\r \u00a0use\t\r \u00a0of\t\r \u00a0Th1\t\r \u00a0inducing\t\r \u00a0procedures\t\r \u00a0(mainly\t\r \u00a0DNA\t\r \u00a0vaccines\t\r \u00a0(83-\u00ad\u201085))\t\r \u00a0alone\t\r \u00a0or\t\r \u00a0combined\t\r \u00a0with\t\r \u00a0recombinant\t\r \u00a0Vaccinia\t\r \u00a0virus\t\r \u00a0expressing\t\r \u00a0LACK\t\r \u00a0using\t\r \u00a0a\t\r \u00a0prime-\u00ad\u2010boost\t\r \u00a0strategy\t\r \u00a0(86-\u00ad\u201094).\t\r \u00a0Using\t\r \u00a0these\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0257\t\r \u00a0\t\r \u00a0strategies\t\r \u00a0involving\t\r \u00a0the\t\r \u00a0LACK\t\r \u00a0molecule\t\r \u00a0of\t\r \u00a0L.\t\r \u00a0infantum,\t\r \u00a0cross-\u00ad\u2010protective\t\r \u00a0responses\t\r \u00a0were\t\r \u00a0found\t\r \u00a0in\t\r \u00a0murine\t\r \u00a0models\t\r \u00a0of\t\r \u00a0CL\t\r \u00a0due\t\r \u00a0to\t\r \u00a0L.\t\r \u00a0major\t\r \u00a0(83,\t\r \u00a087,\t\r \u00a088,\t\r \u00a090,\t\r \u00a093,\t\r \u00a094)\t\r \u00a0or\t\r \u00a0L.\t\r \u00a0amazonensis\t\r \u00a0(84)\t\r \u00a0infections.\t\r \u00a0 The\t\r \u00a0 L.\t\r \u00a0 infantum\t\r \u00a0 LACK\t\r \u00a0 based\t\r \u00a0 vaccines\t\r \u00a0 also\t\r \u00a0 protect\t\r \u00a0mice\t\r \u00a0 against\t\r \u00a0 murine\t\r \u00a0 VL\t\r \u00a0 disease\t\r \u00a0 caused\t\r \u00a0 by\t\r \u00a0 L.\t\r \u00a0 infantum/L.\t\r \u00a0 chagasi\t\r \u00a0(85,\t\r \u00a086,\t\r \u00a091).\t\r \u00a0Recent\t\r \u00a0studies\t\r \u00a0have\t\r \u00a0correlated\t\r \u00a0the\t\r \u00a0observed\t\r \u00a0protection\t\r \u00a0to\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0effector\t\r \u00a0memory\t\r \u00a0CD4+\t\r \u00a0and\t\r \u00a0CD8+\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0expressing\t\r \u00a0IFN-\u00ad\u2010gamma\t\r \u00a0and\t\r \u00a0TNF-\u00ad\u2010alpha\t\r \u00a0in\t\r \u00a0response\t\r \u00a0to\t\r \u00a0 the\t\r \u00a0 LACK\t\r \u00a0 antigen\t\r \u00a0(92).\t\r \u00a0 These\t\r \u00a0 vaccination\t\r \u00a0 trials\t\r \u00a0 were\t\r \u00a0 extended\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0experimental\t\r \u00a0 model\t\r \u00a0 of\t\r \u00a0 canine\t\r \u00a0 leishmaniasis\t\r \u00a0(89,\t\r \u00a095).\t\r \u00a0 Prime-\u00ad\u2010boost\t\r \u00a0 vaccination\t\r \u00a0resulted\t\r \u00a0in\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0Th1-\u00ad\u2010like\t\r \u00a0specific\t\r \u00a0for\t\r \u00a0the\t\r \u00a0LACK\t\r \u00a0antigen,\t\r \u00a0correlated\t\r \u00a0with\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0protective\t\r \u00a0responses\t\r \u00a0in\t\r \u00a0the\t\r \u00a0vaccinated\t\r \u00a0groups:\t\r \u00a0lower\t\r \u00a0parasite\t\r \u00a0load\t\r \u00a0and\t\r \u00a0humoral\t\r \u00a0responses\t\r \u00a0against\t\r \u00a0parasite\t\r \u00a0proteins,\t\r \u00a0as\t\r \u00a0well\t\r \u00a0as\t\r \u00a0less\t\r \u00a0external\t\r \u00a0clinical\t\r \u00a0symptoms\t\r \u00a0(89).\t\r \u00a04.\t\r \u00a0CONCLUDING\t\r \u00a0REMARKS\t\r \u00a0Different\t\r \u00a0 candidates\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0vaccines\t\r \u00a0 have\t\r \u00a0emerged\t\r \u00a0from\t\r \u00a0the\t\r \u00a0studies\t\r \u00a0described\t\r \u00a0in\t\r \u00a0this\t\r \u00a0review.\t\r \u00a0As\t\r \u00a0a\t\r \u00a0brief\t\r \u00a0summary,\t\r \u00a0vaccines\t\r \u00a0against\t\r \u00a0Leishmania\t\r \u00a0may\t\r \u00a0depend\t\r \u00a0on\t\r \u00a0the\t\r \u00a0selection\t\r \u00a0of\t\r \u00a0the\t\r \u00a0adequate\t\r \u00a0parasite\t\r \u00a0proteins\t\r \u00a0but\t\r \u00a0 also\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0 immunization\t\r \u00a0 strategies\t\r \u00a0 inducing\t\r \u00a0 memory\t\r \u00a0 T\t\r \u00a0cellular\t\r \u00a0responses\t\r \u00a0able\t\r \u00a0to\t\r \u00a0mount\t\r \u00a0a\t\r \u00a0fast\t\r \u00a0but\t\r \u00a0controlled\t\r \u00a0Th1\t\r \u00a0response\t\r \u00a0when\t\r \u00a0parasite\t\r \u00a0is\t\r \u00a0 inoculated\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 insect\t\r \u00a0 vector.\t\r \u00a0 Combination\t\r \u00a0 of\t\r \u00a0 parasite\t\r \u00a0 surface\t\r \u00a0 exposed\t\r \u00a0structures\t\r \u00a0and\t\r \u00a0intracellular\t\r \u00a0antigens\t\r \u00a0emerge\t\r \u00a0as\t\r \u00a0an\t\r \u00a0interesting\t\r \u00a0poly-\u00ad\u2010epitope\t\r \u00a0based\t\r \u00a0strategy\t\r \u00a0 that\t\r \u00a0 should\t\r \u00a0 control\t\r \u00a0 de\t\r \u00a0 replication\t\r \u00a0 of\t\r \u00a0 different\t\r \u00a0Leishmania\t\r \u00a0species.\t\r \u00a0Different\t\r \u00a0poly-\u00ad\u2010antigenic\t\r \u00a0fusion\t\r \u00a0molecules\t\r \u00a0have\t\r \u00a0been\t\r \u00a0designed\t\r \u00a0for\t\r \u00a0development\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0vaccines\t\r \u00a0(10,\t\r \u00a096).\t\r \u00a0Among\t\r \u00a0them,\t\r \u00a0the\t\r \u00a0Q\t\r \u00a0protein\t\r \u00a0developed\t\r \u00a0and\t\r \u00a0tested\t\r \u00a0in\t\r \u00a0collaboration\t\r \u00a0 between\t\r \u00a0 different\t\r \u00a0 Spanish\t\r \u00a0 groups,\t\r \u00a0 is\t\r \u00a0 formed\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 fusion\t\r \u00a0 of\t\r \u00a0 two\t\r \u00a0antigenic\t\r \u00a0regions\t\r \u00a0of\t\r \u00a0the\t\r \u00a0H2A\t\r \u00a0beside\t\r \u00a0the\t\r \u00a0antigenic\t\r \u00a0domains\t\r \u00a0of\t\r \u00a0the\t\r \u00a0three\t\r \u00a0P\t\r \u00a0ribosomal\t\r \u00a0antigens\t\r \u00a0(P2a,\t\r \u00a0P2b\t\r \u00a0and\t\r \u00a0P0).\t\r \u00a0This\t\r \u00a0protein\t\r \u00a0was\t\r \u00a0able\t\r \u00a0to\t\r \u00a0confer\t\r \u00a0protection\t\r \u00a0to\t\r \u00a0mice\t\r \u00a0(97)\t\r \u00a0and\t\r \u00a0dogs\t\r \u00a0(98)\t\r \u00a0when\t\r \u00a0combined\t\r \u00a0with\t\r \u00a0BCG\t\r \u00a0as\t\r \u00a0adjuvant.\t\r \u00a0In\t\r \u00a0addition,\t\r \u00a0the\t\r \u00a0Q-\u00ad\u2010protein\t\r \u00a0was\t\r \u00a0able\t\r \u00a0to\t\r \u00a0induce\t\r \u00a0protection\t\r \u00a0when\t\r \u00a0administered\t\r \u00a0in\t\r \u00a0dogs\t\r \u00a0\t\r \u00a0without\t\r \u00a0any\t\r \u00a0adjuvant\t\r \u00a0(99).\t\r \u00a0This\t\r \u00a0 protection\t\r \u00a0 was\t\r \u00a0 demonstrated\t\r \u00a0 by\t\r \u00a0 Dr.\t\r \u00a0 Gomez-\u00ad\u2010Nieto\t\r \u00a0 group\t\r \u00a0 using\t\r \u00a0 a\t\r \u00a0 model\t\r \u00a0 of\t\r \u00a0experimental\t\r \u00a0 infection\t\r \u00a0 that\t\r \u00a0 reproduced\t\r \u00a0 \t\r \u00a0 the\t\r \u00a0 course\t\r \u00a0 of\t\r \u00a0 canine\t\r \u00a0 natural\t\r \u00a0 infection\t\r \u00a0(100).\t\r \u00a0\t\r \u00a0Some\t\r \u00a0authors\t\r \u00a0have\t\r \u00a0pointed\t\r \u00a0out\t\r \u00a0that\t\r \u00a0the\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0such\t\r \u00a0complex\t\r \u00a0immune\t\r \u00a0responses\t\r \u00a0as\t\r \u00a0well\t\r \u00a0as\t\r \u00a0the\t\r \u00a0maintenance\t\r \u00a0of\t\r \u00a0the\t\r \u00a0effector\t\r \u00a0memory\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0would\t\r \u00a0require\t\r \u00a0parasite\t\r \u00a0 chronicity\t\r \u00a0 (reviewed\t\r \u00a0 in\t\r \u00a0(101,\t\r \u00a0102)).\t\r \u00a0 In\t\r \u00a0 this\t\r \u00a0 sense,\t\r \u00a0 a\t\r \u00a0 mutant\t\r \u00a0L.\t\r \u00a0 infantum\t\r \u00a0parasite\t\r \u00a0strain\t\r \u00a0with\t\r \u00a0a\t\r \u00a0limited\t\r \u00a0capacity\t\r \u00a0of\t\r \u00a0multiplication\t\r \u00a0within\t\r \u00a0the\t\r \u00a0vertebrate\t\r \u00a0host\t\r \u00a0by\t\r \u00a0the\t\r \u00a0deletion\t\r \u00a0of\t\r \u00a0part\t\r \u00a0of\t\r \u00a0the\t\r \u00a0hsp70\t\r \u00a0genes\t\r \u00a0has\t\r \u00a0been\t\r \u00a0constructed\t\r \u00a0in\t\r \u00a0Dr.\t\r \u00a0Requena\u2019s\t\r \u00a0laboratory\t\r \u00a0(CBMSO,\t\r \u00a0UAM-\u00ad\u2010CSIC).\t\r \u00a0As\t\r \u00a0the\t\r \u00a0authors\t\r \u00a0point\t\r \u00a0out\t\r \u00a0this\t\r \u00a0mutant\t\r \u00a0strain\t\r \u00a0may\t\r \u00a0emerge\t\r \u00a0 as\t\r \u00a0 an\t\r \u00a0 interesting\t\r \u00a0 alternative\t\r \u00a0 to\t\r \u00a0 antigen-\u00ad\u2010based\t\r \u00a0 formulations\t\r \u00a0 for\t\r \u00a0 creating\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\t\r \u00a0(103,\t\r \u00a0104)\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n258\t\r \u00a0\t\r \u00a0ACKNOWLEDGEMENTS\t\r \u00a0This\t\r \u00a0review\t\r \u00a0gathers\t\r \u00a0data\t\r \u00a0from\t\r \u00a0already\t\r \u00a0published\t\r \u00a0paper.\t\r \u00a0It\t\r \u00a0was\t\r \u00a0supported\t\r \u00a0by\t\r \u00a0grants\t\r \u00a0 from\t\r \u00a0 Ministerio\t\r \u00a0 de\t\r \u00a0 Ciencia\t\r \u00a0 e\t\r \u00a0 Innovaci\u00f3n\t\r \u00a0 FIS\t\r \u00a0 PI11/00095\t\r \u00a0 and\t\r \u00a0 from\t\r \u00a0 the\t\r \u00a0Instituto\t\r \u00a0de\t\r \u00a0Salud\t\r \u00a0Carlos\t\r \u00a0III\t\r \u00a0within\t\r \u00a0the\t\r \u00a0Network\t\r \u00a0of\t\r \u00a0Tropical\t\r \u00a0Diseases\t\r \u00a0Research\t\r \u00a0(VI\t\r \u00a0P\t\r \u00a0I+D+I\t\r \u00a02008-\u00ad\u20102011,\t\r \u00a0ISCIII\t\r \u00a0-\u00ad\u2010Subdirecci\u00f3n\t\r \u00a0General\t\r \u00a0de\t\r \u00a0Redes\t\r \u00a0y\t\r \u00a0Centros\t\r \u00a0de\t\r \u00a0Investigaci\u00f3n\t\r \u00a0Cooperativa\t\r \u00a0 (RD12/0018/0009)).\t\r \u00a0 Funding\t\r \u00a0 from\t\r \u00a0 Laboratorios\t\r \u00a0 Leti\t\r \u00a0 and\t\r \u00a0 an\t\r \u00a0institutional\t\r \u00a0grant\t\r \u00a0from\t\r \u00a0Fundaci\u00f3n\t\r \u00a0Ram\u00f3n\t\r \u00a0Areces\t\r \u00a0are\t\r \u00a0also\t\r \u00a0acknowledged.\t\r \u00a0\t\r \u00a0REFERENCES\t\r \u00a01\t\r \u00a0Mauricio,\t\r \u00a0 I.\t\r \u00a0 L.;\t\r \u00a0 Stothard,\t\r \u00a0 J.\t\r \u00a0 R.;\t\r \u00a0 Miles,\t\r \u00a0 M.\t\r \u00a0 A.\t\r \u00a0 The\t\r \u00a0 strange\t\r \u00a0 case\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0chagasi.\t\r \u00a0Parasitology\t\r \u00a0Today\t\r \u00a016,\t\r \u00a0188-\u00ad\u2010189\t\r \u00a0(2000).\t\r \u00a02\t\r \u00a0Murray,\t\r \u00a0H.\t\r \u00a0W.;\t\r \u00a0Berman,\t\r \u00a0J.\t\r \u00a0D.;\t\r \u00a0Davies,\t\r \u00a0C.\t\r \u00a0R.;\t\r \u00a0Saravia,\t\r \u00a0N.\t\r \u00a0G.\t\r \u00a0Advances\t\r \u00a0in\t\r \u00a0Leishmaniasis.\t\r \u00a0Lancet\t\r \u00a0366,\t\r \u00a01561-\u00ad\u20101577\t\r \u00a0(2005).\t\r \u00a03\t\r \u00a0Herwaldt,\t\r \u00a0B.\t\r \u00a0L.\t\r \u00a0Leishmaniasis.\t\r \u00a0Lancet\t\r \u00a0354,\t\r \u00a01191-\u00ad\u20101199\t\r \u00a0(1999).\t\r \u00a04\t\r \u00a0Mutiso,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Macharia,\t\r \u00a0 J.\t\r \u00a0 C.;\t\r \u00a0 Kiio,\t\r \u00a0 M.\t\r \u00a0 N.;\t\r \u00a0 Ichagichu,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Rikoi,\t\r \u00a0 H.;\t\r \u00a0 Gicheru,\t\r \u00a0 M.\t\r \u00a0 M.\t\r \u00a0Development\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0vaccines:\t\r \u00a0 predicting\t\r \u00a0 the\t\r \u00a0 future\t\r \u00a0 from\t\r \u00a0 past\t\r \u00a0 and\t\r \u00a0 present\t\r \u00a0experience.\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Biomedical\t\r \u00a0Research\t\r \u00a027,\t\r \u00a085-\u00ad\u2010102\t\r \u00a0(2013).\t\r \u00a05\t\r \u00a0Gramiccia,\t\r \u00a0M.;\t\r \u00a0Gradoni,\t\r \u00a0L.\t\r \u00a0The\t\r \u00a0current\t\r \u00a0status\t\r \u00a0of\t\r \u00a0zoonotic\t\r \u00a0leishmaniases\t\r \u00a0and\t\r \u00a0approaches\t\r \u00a0to\t\r \u00a0disease\t\r \u00a0control.\t\r \u00a0International\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Parasitology\t\r \u00a035,\t\r \u00a01169-\u00ad\u20101180\t\r \u00a0(2005).\t\r \u00a06\t\r \u00a0Reis,\t\r \u00a0 A.\t\r \u00a0 B.;\t\r \u00a0 Giunchetti,\t\r \u00a0 R.\t\r \u00a0 C.;\t\r \u00a0 Carrillo,\t\r \u00a0 E.;\t\r \u00a0 Martins-\u00ad\u2010Filho,\t\r \u00a0 O.\t\r \u00a0 A.;\t\r \u00a0 Moreno,\t\r \u00a0 J.\t\r \u00a0 Immunity\t\r \u00a0 to\t\r \u00a0Leishmania\t\r \u00a0and\t\r \u00a0 the\t\r \u00a0 rational\t\r \u00a0 search\t\r \u00a0 for\t\r \u00a0 vaccines\t\r \u00a0 against\t\r \u00a0 canine\t\r \u00a0 leishmaniasis.\t\r \u00a0 Trends\t\r \u00a0 in\t\r \u00a0Parasitology\t\r \u00a026,\t\r \u00a0341-\u00ad\u2010349\t\r \u00a0(2010).\t\r \u00a07\t\r \u00a0Baneth,\t\r \u00a0G.;\t\r \u00a0Koutinas,\t\r \u00a0A.\t\r \u00a0F.;\t\r \u00a0Solano-\u00ad\u2010Gallego,\t\r \u00a0L.;\t\r \u00a0Bourdeau,\t\r \u00a0P.;\t\r \u00a0Ferrer,\t\r \u00a0L.\t\r \u00a0Canine\t\r \u00a0leishmaniosis:\t\r \u00a0new\t\r \u00a0concepts\t\r \u00a0and\t\r \u00a0insights\t\r \u00a0on\t\r \u00a0an\t\r \u00a0expanding\t\r \u00a0zoonosis:\t\r \u00a0part\t\r \u00a0one.\t\r \u00a0Trends\t\r \u00a0in\t\r \u00a0Parasitology\t\r \u00a024,\t\r \u00a0324-\u00ad\u2010330\t\r \u00a0(2008).\t\r \u00a08\t\r \u00a0Murray,\t\r \u00a0H.\t\r \u00a0W.\t\r \u00a0Endogenous\t\r \u00a0interleukin-\u00ad\u201012\t\r \u00a0regulates\t\r \u00a0acquired\t\r \u00a0resistance\t\r \u00a0in\t\r \u00a0experimental\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0The\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Infectious\t\r \u00a0Diseases\t\r \u00a0175,\t\r \u00a01477-\u00ad\u20101479\t\r \u00a0(1997).\t\r \u00a09\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.;\t\r \u00a0Brodskyn,\t\r \u00a0C.\t\r \u00a0I.\t\r \u00a0The\t\r \u00a0immunobiology\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0braziliensis\t\r \u00a0infection.\t\r \u00a0Frontiers\t\r \u00a0in\t\r \u00a0Immunology\t\r \u00a03,\t\r \u00a0145\t\r \u00a0(2012).\t\r \u00a010\t\r \u00a0Bertholet,\t\r \u00a0S.;\t\r \u00a0Goto,\t\r \u00a0Y.;\t\r \u00a0Carter,\t\r \u00a0L.;\t\r \u00a0Bhatia,\t\r \u00a0A.;\t\r \u00a0Howard,\t\r \u00a0R.\t\r \u00a0F.;\t\r \u00a0Carter,\t\r \u00a0D.;\t\r \u00a0Coler,\t\r \u00a0R.\t\r \u00a0N.;\t\r \u00a0Vedvick,\t\r \u00a0T.\t\r \u00a0S.;\t\r \u00a0 Reed,\t\r \u00a0 S.\t\r \u00a0 G.\t\r \u00a0 Optimized\t\r \u00a0 subunit\t\r \u00a0 vaccine\t\r \u00a0 protects\t\r \u00a0 against\t\r \u00a0 experimental\t\r \u00a0 leishmaniasis.\t\r \u00a0Vaccine\t\r \u00a027,\t\r \u00a07036-\u00ad\u20107045\t\r \u00a0(2009).\t\r \u00a011\t\r \u00a0Beaumier,\t\r \u00a0 C.\t\r \u00a0 M.;\t\r \u00a0 Gillespie,\t\r \u00a0 P.\t\r \u00a0 M.;\t\r \u00a0 Hotez,\t\r \u00a0 P.\t\r \u00a0 J.;\t\r \u00a0Bottazzi,\t\r \u00a0 M.\t\r \u00a0 E.\t\r \u00a0 New\t\r \u00a0 vaccines\t\r \u00a0 for\t\r \u00a0 neglected\t\r \u00a0parasitic\t\r \u00a0diseases\t\r \u00a0and\t\r \u00a0dengue.\t\r \u00a0Translational\t\r \u00a0Research\t\r \u00a0162,\t\r \u00a0144-\u00ad\u2010155\t\r \u00a0(2013).\t\r \u00a012\t\r \u00a0Dantas-\u00ad\u2010Torres,\t\r \u00a0F.\t\r \u00a0Leishmune\t\r \u00a0vaccine:\t\r \u00a0the\t\r \u00a0newest\t\r \u00a0tool\t\r \u00a0for\t\r \u00a0prevention\t\r \u00a0and\t\r \u00a0control\t\r \u00a0of\t\r \u00a0canine\t\r \u00a0visceral\t\r \u00a0 leishmaniosis\t\r \u00a0 and\t\r \u00a0 its\t\r \u00a0 potential\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0transmission-\u00ad\u2010blocking\t\r \u00a0 vaccine.\t\r \u00a0 Veterinary\t\r \u00a0Parasitology\t\r \u00a0141,\t\r \u00a01-\u00ad\u20108\t\r \u00a0(2006).\t\r \u00a013\t\r \u00a0Fernandes,\t\r \u00a0 A.\t\r \u00a0 P.;\t\r \u00a0 Coelho,\t\r \u00a0 E.\t\r \u00a0 A.;\t\r \u00a0 Machado-\u00ad\u2010Coelho,\t\r \u00a0 G.\t\r \u00a0 L.;\t\r \u00a0 Grimaldi,\t\r \u00a0 G.,\t\r \u00a0 Jr.;\t\r \u00a0 Gazzinelli,\t\r \u00a0 R.\t\r \u00a0 T.\t\r \u00a0Making\t\r \u00a0 an\t\r \u00a0 anti-\u00ad\u2010amastigote\t\r \u00a0 vaccine\t\r \u00a0 for\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis:\t\r \u00a0 rational,\t\r \u00a0 update\t\r \u00a0 and\t\r \u00a0perspectives.\t\r \u00a0Current\t\r \u00a0Opinion\t\r \u00a0in\t\r \u00a0Microbiology\t\r \u00a015,\t\r \u00a0476-\u00ad\u2010485\t\r \u00a0(2012).\t\r \u00a014\t\r \u00a0Bongiorno,\t\r \u00a0 G.;\t\r \u00a0 Paparcone,\t\r \u00a0 R.;\t\r \u00a0 Manzillo,\t\r \u00a0 V.\t\r \u00a0 F.;\t\r \u00a0 Oliva,\t\r \u00a0 G.;\t\r \u00a0 Cuisinier,\t\r \u00a0 A.\t\r \u00a0 M.;\t\r \u00a0 Gradoni,\t\r \u00a0 L.\t\r \u00a0Vaccination\t\r \u00a0 with\t\r \u00a0 LiESP/QA-\u00ad\u201021\t\r \u00a0 (CaniLeish)\t\r \u00a0 reduces\t\r \u00a0 the\t\r \u00a0 intensity\t\r \u00a0 of\t\r \u00a0 infection\t\r \u00a0 in\t\r \u00a0Phlebotomus\t\r \u00a0 perniciosus\t\r \u00a0fed\t\r \u00a0 on\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0infected\t\r \u00a0 dogs-\u00ad\u2010A\t\r \u00a0 preliminary\t\r \u00a0xenodiagnosis\t\r \u00a0study.\t\r \u00a0Veterinary\t\r \u00a0Parasitology\t\r \u00a097\t\r \u00a0691-\u00ad\u2010695\t\r \u00a0(2013).\t\r \u00a015\t\r \u00a0Moreno,\t\r \u00a0 J.;\t\r \u00a0 Vouldoukis,\t\r \u00a0 I.;\t\r \u00a0 Martin,\t\r \u00a0 V.;\t\r \u00a0 McGahie,\t\r \u00a0 D.;\t\r \u00a0 Cuisinier,\t\r \u00a0 A.\t\r \u00a0 M.;\t\r \u00a0 Gueguen,\t\r \u00a0 S.\t\r \u00a0 Use\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0LiESP/QA-\u00ad\u201021\t\r \u00a0vaccine\t\r \u00a0(CaniLeish)\t\r \u00a0stimulates\t\r \u00a0an\t\r \u00a0appropriate\t\r \u00a0Th1-\u00ad\u2010dominated\t\r \u00a0cell-\u00ad\u2010mediated\t\r \u00a0immune\t\r \u00a0response\t\r \u00a0in\t\r \u00a0dogs.\t\r \u00a0PLoS\t\r \u00a0Neglected\t\r \u00a0Tropical\t\r \u00a0Diseases\t\r \u00a06,\t\r \u00a0e1683\t\r \u00a0(2012)\t\r \u00a016\t\r \u00a0Melby,\t\r \u00a0 P.\t\r \u00a0 C.;\t\r \u00a0 Yang,\t\r \u00a0 Y.\t\r \u00a0 Z.;\t\r \u00a0 Cheng,\t\r \u00a0 J.;\t\r \u00a0 Zhao,\t\r \u00a0 W.\t\r \u00a0 Regional\t\r \u00a0 differences\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 cellular\t\r \u00a0 immune\t\r \u00a0response\t\r \u00a0 to\t\r \u00a0 experimental\t\r \u00a0 cutaneous\t\r \u00a0 or\t\r \u00a0 visceral\t\r \u00a0 infection\t\r \u00a0 with\t\r \u00a0Leishmania\t\r \u00a0 donovani.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a066,\t\r \u00a018-\u00ad\u201027\t\r \u00a0(1998).\t\r \u00a017\t\r \u00a0de\t\r \u00a0 Oliveira,\t\r \u00a0 C.\t\r \u00a0 I.;\t\r \u00a0 Nascimento,\t\r \u00a0 I.\t\r \u00a0 P.;\t\r \u00a0 Barral,\t\r \u00a0 A.;\t\r \u00a0 Soto,\t\r \u00a0 M.;\t\r \u00a0 Barral-\u00ad\u2010Netto,\t\r \u00a0 M.\t\r \u00a0 Challenges\t\r \u00a0 and\t\r \u00a0perspectives\t\r \u00a0in\t\r \u00a0vaccination\t\r \u00a0against\t\r \u00a0leishmaniasis.\t\r \u00a0Parasitology\t\r \u00a0International\t\r \u00a058,\t\r \u00a0319-\u00ad\u2010324\t\r \u00a0(2009).\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0259\t\r \u00a0\t\r \u00a018\t\r \u00a0Duthie,\t\r \u00a0 M.\t\r \u00a0 S.;\t\r \u00a0 Raman,\t\r \u00a0 V.\t\r \u00a0 S.;\t\r \u00a0 Piazza,\t\r \u00a0 F.\t\r \u00a0 M.;\t\r \u00a0 Reed,\t\r \u00a0 S.\t\r \u00a0 G.\t\r \u00a0 The\t\r \u00a0 development\t\r \u00a0 and\t\r \u00a0 clinical\t\r \u00a0evaluation\t\r \u00a0of\t\r \u00a0second-\u00ad\u2010generation\t\r \u00a0leishmaniasis\t\r \u00a0vaccines.\t\r \u00a0Vaccine\t\r \u00a030,\t\r \u00a0134-\u00ad\u2010141\t\r \u00a0(2012).\t\r \u00a019\t\r \u00a0Singh,\t\r \u00a0 B.;\t\r \u00a0 Sundar,\t\r \u00a0 S.\t\r \u00a0 Leishmaniasis:\t\r \u00a0 Vaccine\t\r \u00a0 candidates\t\r \u00a0 and\t\r \u00a0 perspectives.\t\r \u00a0 Vaccine\t\r \u00a030,\t\r \u00a03834-\u00ad\u20103842\t\r \u00a0(2012).\t\r \u00a020\t\r \u00a0Raman,\t\r \u00a0V.\t\r \u00a0S.;\t\r \u00a0Duthie,\t\r \u00a0M.\t\r \u00a0S.;\t\r \u00a0Fox,\t\r \u00a0C.\t\r \u00a0B.;\t\r \u00a0Matlashewski,\t\r \u00a0G.;\t\r \u00a0Reed,\t\r \u00a0S.\t\r \u00a0G.\t\r \u00a0Adjuvants\t\r \u00a0for\t\r \u00a0Leishmania\t\r \u00a0vaccines:\t\r \u00a0from\t\r \u00a0models\t\r \u00a0to\t\r \u00a0clinical\t\r \u00a0application.\t\r \u00a0Frontiers\t\r \u00a0in\t\r \u00a0Immunology\t\r \u00a03,\t\r \u00a0144\t\r \u00a0(2012).\t\r \u00a021\t\r \u00a0Kedzierski,\t\r \u00a0L.\t\r \u00a0Leishmaniasis.\t\r \u00a0Human\t\r \u00a0Vaccines\t\r \u00a07,\t\r \u00a01204-\u00ad\u20101214\t\r \u00a0(2011).\t\r \u00a022\t\r \u00a0Okwor,\t\r \u00a0 I.;\t\r \u00a0 Mou,\t\r \u00a0 Z.;\t\r \u00a0 Liu,\t\r \u00a0 D.;\t\r \u00a0 Uzonna,\t\r \u00a0 J.\t\r \u00a0 Protective\t\r \u00a0 immunity\t\r \u00a0 and\t\r \u00a0 vaccination\t\r \u00a0 against\t\r \u00a0cutaneous\t\r \u00a0leishmaniasis.\t\r \u00a0Frontiers\t\r \u00a0in\t\r \u00a0Immunology\t\r \u00a03,\t\r \u00a0128\t\r \u00a0(2012).\t\r \u00a023\t\r \u00a0McConville,\t\r \u00a0 M.\t\r \u00a0 J.;\t\r \u00a0 Blackwell,\t\r \u00a0 J.\t\r \u00a0 M.\t\r \u00a0 Developmental\t\r \u00a0 changes\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 glycosylated\t\r \u00a0phosphatidylinositols\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0 donovani.\t\r \u00a0 Characterization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 promastigote\t\r \u00a0 and\t\r \u00a0amastigote\t\r \u00a0glycolipids.\t\r \u00a0Jornal\t\r \u00a0of\t\r \u00a0Biological\t\r \u00a0Chemistry\t\r \u00a0266,\t\r \u00a015170-\u00ad\u201015179\t\r \u00a0(1991).\t\r \u00a024\t\r \u00a0Pimenta,\t\r \u00a0P.\t\r \u00a0 F.;\t\r \u00a0 Saraiva,\t\r \u00a0 E.\t\r \u00a0 M.;\t\r \u00a0 Sacks,\t\r \u00a0 D.\t\r \u00a0 L.\t\r \u00a0 The\t\r \u00a0 comparative\t\r \u00a0 fine\t\r \u00a0 structure\t\r \u00a0 and\t\r \u00a0 surface\t\r \u00a0glycoconjugate\t\r \u00a0 expression\t\r \u00a0 of\t\r \u00a0 three\t\r \u00a0 life\t\r \u00a0 stages\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0 major.\t\r \u00a0 Experimental\t\r \u00a0Parasitology\t\r \u00a072,\t\r \u00a0191-\u00ad\u2010204\t\r \u00a0(1991).\t\r \u00a025\t\r \u00a0Shreffler,\t\r \u00a0W.\t\r \u00a0G.;\t\r \u00a0Burns,\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0Jr.;\t\r \u00a0Badaro,\t\r \u00a0R.;\t\r \u00a0Ghalib,\t\r \u00a0H.\t\r \u00a0W.;\t\r \u00a0Button,\t\r \u00a0L.\t\r \u00a0L.;\t\r \u00a0McMaster,\t\r \u00a0W.\t\r \u00a0R.;\t\r \u00a0Reed,\t\r \u00a0S.\t\r \u00a0G.\t\r \u00a0Antibody\t\r \u00a0responses\t\r \u00a0of\t\r \u00a0visceral\t\r \u00a0leishmaniasis\t\r \u00a0patients\t\r \u00a0to\t\r \u00a0gp63,\t\r \u00a0a\t\r \u00a0major\t\r \u00a0surface\t\r \u00a0glycoprotein\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0species.\t\r \u00a0 The\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0 Infectious\t\r \u00a0 Diseases\t\r \u00a0167,\t\r \u00a0 426-\u00ad\u2010430\t\r \u00a0(1993).\t\r \u00a026\t\r \u00a0Morales,\t\r \u00a0G.;\t\r \u00a0Carrillo,\t\r \u00a0G.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Gomez,\t\r \u00a0L.\t\r \u00a0C.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Mapping\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 antigenic\t\r \u00a0 determinants\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0gp63\t\r \u00a0 protein\t\r \u00a0recognized\t\r \u00a0by\t\r \u00a0antibodies\t\r \u00a0elicited\t\r \u00a0during\t\r \u00a0canine\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Parasitology\t\r \u00a0114,\t\r \u00a0507-\u00ad\u2010516\t\r \u00a0(1997).\t\r \u00a027\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Ramirez,\t\r \u00a0L.;\t\r \u00a0Pineda,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Gonzalez,\t\r \u00a0V.\t\r \u00a0M.;\t\r \u00a0Entringer,\t\r \u00a0P.\t\r \u00a0F.;\t\r \u00a0Indiani\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.;\t\r \u00a0Nascimento,\t\r \u00a0I.\t\r \u00a0P.;\t\r \u00a0Souza,\t\r \u00a0A.\t\r \u00a0P.;\t\r \u00a0Corvo,\t\r \u00a0L.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Brodskyn,\t\r \u00a0C.;\t\r \u00a0Barral,\t\r \u00a0A.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Iborra,\t\r \u00a0S.\t\r \u00a0Searching\t\r \u00a0genes\t\r \u00a0encoding\t\r \u00a0Leishmania\t\r \u00a0antigens\t\r \u00a0for\t\r \u00a0diagnosis\t\r \u00a0and\t\r \u00a0protection.\t\r \u00a0Scholarly\t\r \u00a0Research\t\r \u00a0Exchange\t\r \u00a02009,\t\r \u00a0ID\t\r \u00a0173039\t\r \u00a0(2009).\t\r \u00a028\t\r \u00a0Cote-\u00ad\u2010Sierra,\t\r \u00a0J.;\t\r \u00a0Bredan,\t\r \u00a0A.;\t\r \u00a0Toldos,\t\r \u00a0C.\t\r \u00a0M.;\t\r \u00a0Stijlemans,\t\r \u00a0B.;\t\r \u00a0Brys,\t\r \u00a0L.;\t\r \u00a0Cornelis,\t\r \u00a0P.;\t\r \u00a0Segovia,\t\r \u00a0M.;\t\r \u00a0de\t\r \u00a0Baetselier,\t\r \u00a0 P.;\t\r \u00a0 Revets,\t\r \u00a0 H.\t\r \u00a0 Bacterial\t\r \u00a0 lipoprotein-\u00ad\u2010based\t\r \u00a0 vaccines\t\r \u00a0 induce\t\r \u00a0 tumor\t\r \u00a0 necrosis\t\r \u00a0factor-\u00ad\u2010dependent\t\r \u00a0 type\t\r \u00a0 1\t\r \u00a0 protective\t\r \u00a0 immunity\t\r \u00a0 against\t\r \u00a0Leishmania\t\r \u00a0 major.\t\r \u00a0 Infection\t\r \u00a0 and\t\r \u00a0Immunity\t\r \u00a070,\t\r \u00a0240-\u00ad\u2010248\t\r \u00a0(2002).\t\r \u00a029\t\r \u00a0Yang,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Rogers,\t\r \u00a0M.\t\r \u00a0V.;\t\r \u00a0Liew,\t\r \u00a0F.\t\r \u00a0Y.\t\r \u00a0Identification\t\r \u00a0and\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0host-\u00ad\u2010protective\t\r \u00a0T-\u00ad\u2010cell\t\r \u00a0 epitopes\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 major\t\r \u00a0 surface\t\r \u00a0 glycoprotein\t\r \u00a0 (gp63)\t\r \u00a0 from\t\r \u00a0Leishmania\t\r \u00a0 major.\t\r \u00a0Immunology\t\r \u00a072,\t\r \u00a03-\u00ad\u20109\t\r \u00a0(1991).\t\r \u00a030\t\r \u00a0Rivas,\t\r \u00a0 L.;\t\r \u00a0 Kahl,\t\r \u00a0 L.;\t\r \u00a0 Manson,\t\r \u00a0 K.;\t\r \u00a0 McMahon-\u00ad\u2010Pratt,\t\r \u00a0 D.\t\r \u00a0 Biochemical\t\r \u00a0 characterization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0protective\t\r \u00a0membrane\t\r \u00a0glycoprotein\t\r \u00a0GP46/M-\u00ad\u20102\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0amazonensis.\t\r \u00a0Molecular\t\r \u00a0and\t\r \u00a0Biochemical\t\r \u00a0Parasitology\t\r \u00a047,\t\r \u00a0235-\u00ad\u2010243\t\r \u00a0(1991).\t\r \u00a031\t\r \u00a0Boceta,\t\r \u00a0 C.;\t\r \u00a0 Alonso,\t\r \u00a0 C.;\t\r \u00a0 Jimenez-\u00ad\u2010Ruiz,\t\r \u00a0 A.\t\r \u00a0 Leucine\t\r \u00a0 rich\t\r \u00a0 repeats\t\r \u00a0 are\t\r \u00a0 the\t\r \u00a0 main\t\r \u00a0 epitopes\t\r \u00a0 in\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0PSA\t\r \u00a0 during\t\r \u00a0 canine\t\r \u00a0 and\t\r \u00a0 human\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis.\t\r \u00a0 Parasite\t\r \u00a0Immunology\t\r \u00a022,\t\r \u00a055-\u00ad\u201062\t\r \u00a0(2000).\t\r \u00a032\t\r \u00a0Berberich,\t\r \u00a0C.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Cloning\t\r \u00a0of\t\r \u00a0genes\t\r \u00a0and\t\r \u00a0expression\t\r \u00a0and\t\r \u00a0antigenicity\t\r \u00a0analysis\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0protein.\t\r \u00a0Experimental\t\r \u00a0Parasitology\t\r \u00a085,\t\r \u00a0105-\u00ad\u2010108\t\r \u00a0(1997).\t\r \u00a033\t\r \u00a0Ramirez,\t\r \u00a0J.\t\r \u00a0R.;\t\r \u00a0Berberich,\t\r \u00a0C.;\t\r \u00a0Jaramillo,\t\r \u00a0A.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Velez,\t\r \u00a0I.\t\r \u00a0V.\t\r \u00a0Molecular\t\r \u00a0and\t\r \u00a0antigenic\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0(Viannia)\t\r \u00a0panamensis\t\r \u00a0kinetoplastid\t\r \u00a0membrane\t\r \u00a0protein-\u00ad\u201011.\t\r \u00a0Memorias\t\r \u00a0do\t\r \u00a0Instituto\t\r \u00a0Oswaldo\t\r \u00a0Cruz.\t\r \u00a093,\t\r \u00a0247-\u00ad\u2010254\t\r \u00a0(1998).\t\r \u00a034\t\r \u00a0Passos,\t\r \u00a0 S.;\t\r \u00a0 Carvalho,\t\r \u00a0 L.\t\r \u00a0 P.;\t\r \u00a0 Orge,\t\r \u00a0 G.;\t\r \u00a0 Jeronimo,\t\r \u00a0 S.\t\r \u00a0 M.;\t\r \u00a0 Bezerra,\t\r \u00a0 G.;\t\r \u00a0 Soto,\t\r \u00a0M.;\t\r \u00a0 Alonso,\t\r \u00a0 C.;\t\r \u00a0Carvalho,\t\r \u00a0 E.\t\r \u00a0 M.\t\r \u00a0 Recombinant\t\r \u00a0Leishmania\t\r \u00a0antigens\t\r \u00a0 for\t\r \u00a0 serodiagnosis\t\r \u00a0 of\t\r \u00a0 visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Clinical\t\r \u00a0and\t\r \u00a0Diagnostic\t\r \u00a0Laboratory\t\r \u00a0Immunolology\t\r \u00a012,\t\r \u00a01164-\u00ad\u20101167\t\r \u00a0(2005).\t\r \u00a035\t\r \u00a0Carvalho,\t\r \u00a0L.\t\r \u00a0P.;\t\r \u00a0Passos,\t\r \u00a0S.;\t\r \u00a0Dutra,\t\r \u00a0W.\t\r \u00a0O.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Gollob,\t\r \u00a0K.\t\r \u00a0J.;\t\r \u00a0Carvalho,\t\r \u00a0E.\t\r \u00a0M.;\t\r \u00a0Ribeiro\t\r \u00a0de\t\r \u00a0Jesus,\t\r \u00a0A.\t\r \u00a0Effect\t\r \u00a0of\t\r \u00a0LACK\t\r \u00a0and\t\r \u00a0KMP11\t\r \u00a0on\t\r \u00a0IFN-\u00ad\u2010gamma\t\r \u00a0production\t\r \u00a0by\t\r \u00a0peripheral\t\r \u00a0blood\t\r \u00a0 mononuclear\t\r \u00a0 cells\t\r \u00a0 from\t\r \u00a0 cutaneous\t\r \u00a0 and\t\r \u00a0 mucosal\t\r \u00a0 leishmaniasis\t\r \u00a0 patients.\t\r \u00a0Scandinavian\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Immunology\t\r \u00a061,\t\r \u00a0337-\u00ad\u2010342\t\r \u00a0(2005).\t\r \u00a036\t\r \u00a0Carrillo,\t\r \u00a0E.;\t\r \u00a0Crusat,\t\r \u00a0M.;\t\r \u00a0Nieto,\t\r \u00a0J.;\t\r \u00a0Chicharro,\t\r \u00a0C.;\t\r \u00a0Thomas\t\r \u00a0M,\t\r \u00a0C.;\t\r \u00a0Martinez,\t\r \u00a0E.;\t\r \u00a0Valladares,\t\r \u00a0B.;\t\r \u00a0Ca\u00f1avate,\t\r \u00a0C.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Lopez,\t\r \u00a0M.\t\r \u00a0C.;\t\r \u00a0Alvar,\t\r \u00a0J.;\t\r \u00a0Moreno,\t\r \u00a0J.\t\r \u00a0Immunogenicity\t\r \u00a0of\t\r \u00a0HSP-\u00ad\u201070,\t\r \u00a0KMP-\u00ad\u201011\t\r \u00a0 and\t\r \u00a0 PFR-\u00ad\u20102\t\r \u00a0 leishmanial\t\r \u00a0 antigens\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 experimental\t\r \u00a0 model\t\r \u00a0 of\t\r \u00a0 canine\t\r \u00a0 visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine\t\r \u00a026,\t\r \u00a01902-\u00ad\u20101911\t\r \u00a0(2008).\t\r \u00a037\t\r \u00a0Basu,\t\r \u00a0 R.;\t\r \u00a0 Bhaumik,\t\r \u00a0 S.;\t\r \u00a0 Basu,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Naskar,\t\r \u00a0 K.;\t\r \u00a0 De,\t\r \u00a0 T.;\t\r \u00a0 Roy,\t\r \u00a0 S.\t\r \u00a0 Kinetoplastid\t\r \u00a0 membrane\t\r \u00a0protein-\u00ad\u201011\t\r \u00a0 DNA\t\r \u00a0 vaccination\t\r \u00a0 induces\t\r \u00a0 complete\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 both\t\r \u00a0 pentavalent\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n260\t\r \u00a0\t\r \u00a0antimonial-\u00ad\u2010sensitive\t\r \u00a0 and\t\r \u00a0-\u00ad\u2010resistant\t\r \u00a0 strains\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0 donovani\t\r \u00a0that\t\r \u00a0 correlates\t\r \u00a0 with\t\r \u00a0inducible\t\r \u00a0nitric\t\r \u00a0oxide\t\r \u00a0synthase\t\r \u00a0activity\t\r \u00a0and\t\r \u00a0IL-\u00ad\u20104\t\r \u00a0generation:\t\r \u00a0evidence\t\r \u00a0for\t\r \u00a0mixed\t\r \u00a0Th1-\u00ad\u2010\t\r \u00a0and\t\r \u00a0Th2-\u00ad\u2010like\t\r \u00a0 responses\t\r \u00a0 in\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis.\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0 Immunology\t\r \u00a0174,\t\r \u00a0 7160-\u00ad\u20107171\t\r \u00a0(2005).\t\r \u00a038\t\r \u00a0da\t\r \u00a0Silva,\t\r \u00a0R.\t\r \u00a0A.;\t\r \u00a0Tavares,\t\r \u00a0N.\t\r \u00a0M.;\t\r \u00a0Costa,\t\r \u00a0D.;\t\r \u00a0Pitombo,\t\r \u00a0M.;\t\r \u00a0Barbosa,\t\r \u00a0L.;\t\r \u00a0Fukutani,\t\r \u00a0K.;\t\r \u00a0Miranda,\t\r \u00a0J.\t\r \u00a0C.;\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.;\t\r \u00a0Valenzuela,\t\r \u00a0J.\t\r \u00a0G.;\t\r \u00a0Barral,\t\r \u00a0A.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Brodskyn,\t\r \u00a0C.\t\r \u00a0DNA\t\r \u00a0vaccination\t\r \u00a0 with\t\r \u00a0 KMP11\t\r \u00a0 and\t\r \u00a0 Lutzomyia\t\r \u00a0 longipalpis\t\r \u00a0 salivary\t\r \u00a0 protein\t\r \u00a0 protects\t\r \u00a0 hamsters\t\r \u00a0against\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Acta\t\r \u00a0Tropica\t\r \u00a0120,\t\r \u00a0185-\u00ad\u2010190\t\r \u00a0(2011).\t\r \u00a039\t\r \u00a0Santos,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Carneiro,\t\r \u00a0M.\t\r \u00a0W.;\t\r \u00a0de\t\r \u00a0Moura,\t\r \u00a0T.\t\r \u00a0R.;\t\r \u00a0Fukutani,\t\r \u00a0K.;\t\r \u00a0Clarencio,\t\r \u00a0J.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Espuelas,\t\r \u00a0S.;\t\r \u00a0 Brodskyn,\t\r \u00a0 C.;\t\r \u00a0 Barral,\t\r \u00a0 A.;\t\r \u00a0 Barral-\u00ad\u2010Netto,\t\r \u00a0 M.;\t\r \u00a0 de\t\r \u00a0 Oliveira,\t\r \u00a0 C.\t\r \u00a0 I.\t\r \u00a0 Towards\t\r \u00a0 development\t\r \u00a0 of\t\r \u00a0novel\t\r \u00a0 immunization\t\r \u00a0 strategies\t\r \u00a0 against\t\r \u00a0 leishmaniasis\t\r \u00a0 using\t\r \u00a0 PLGA\t\r \u00a0 nanoparticles\t\r \u00a0 loaded\t\r \u00a0with\t\r \u00a0kinetoplastid\t\r \u00a0membrane\t\r \u00a0protein-\u00ad\u201011.\t\r \u00a0International\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Nanomedicine\t\r \u00a07,\t\r \u00a02115-\u00ad\u20102127\t\r \u00a0(2012).\t\r \u00a040\t\r \u00a0Santos,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Carneiro,\t\r \u00a0M.\t\r \u00a0W.;\t\r \u00a0de\t\r \u00a0Moura,\t\r \u00a0T.\t\r \u00a0R.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Luz,\t\r \u00a0N.\t\r \u00a0F.;\t\r \u00a0Prates,\t\r \u00a0D.\t\r \u00a0B.;\t\r \u00a0Irache,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Brodskyn,\t\r \u00a0C.;\t\r \u00a0Barral,\t\r \u00a0A.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Espuelas,\t\r \u00a0S.;\t\r \u00a0Borges,\t\r \u00a0V.\t\r \u00a0M.;\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.\t\r \u00a0PLGA\t\r \u00a0nanoparticles\t\r \u00a0 loaded\t\r \u00a0 with\t\r \u00a0 KMP-\u00ad\u201011\t\r \u00a0 stimulate\t\r \u00a0 innate\t\r \u00a0 immunity\t\r \u00a0 and\t\r \u00a0 induce\t\r \u00a0 the\t\r \u00a0 killing\t\r \u00a0 of\t\r \u00a0Leishmania.\t\r \u00a0Nanomedicine\t\r \u00a09,\t\r \u00a0985-\u00ad\u2010995\t\r \u00a0(2013).\t\r \u00a041\t\r \u00a0Colmenares,\t\r \u00a0 M.;\t\r \u00a0 Tiemeyer,\t\r \u00a0 M.;\t\r \u00a0 Kima,\t\r \u00a0 P.;\t\r \u00a0 McMahon-\u00ad\u2010Pratt,\t\r \u00a0 D.\t\r \u00a0 Biochemical\t\r \u00a0 and\t\r \u00a0 biological\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0the\t\r \u00a0protective\t\r \u00a0Leishmania\t\r \u00a0pifanoi\t\r \u00a0amastigote\t\r \u00a0antigen\t\r \u00a0P-\u00ad\u20108.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a069,\t\r \u00a06776-\u00ad\u20106784\t\r \u00a0(2001).\t\r \u00a042\t\r \u00a0Whitaker,\t\r \u00a0 S.\t\r \u00a0 M.;\t\r \u00a0 Colmenares,\t\r \u00a0 M.;\t\r \u00a0 Pestana,\t\r \u00a0K.\t\r \u00a0 G.;\t\r \u00a0 McMahon-\u00ad\u2010Pratt,\t\r \u00a0 D.\t\r \u00a0Leishmania\t\r \u00a0 pifanoi\t\r \u00a0proteoglycolipid\t\r \u00a0 complex\t\r \u00a0 P8\t\r \u00a0 induces\t\r \u00a0 macrophage\t\r \u00a0 cytokine\t\r \u00a0 production\t\r \u00a0 through\t\r \u00a0 Toll-\u00ad\u2010like\t\r \u00a0receptor\t\r \u00a04.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a076,\t\r \u00a02149-\u00ad\u20102156\t\r \u00a0(2008).\t\r \u00a043\t\r \u00a0Carrillo,\t\r \u00a0 E.;\t\r \u00a0 Ahmed,\t\r \u00a0 S.;\t\r \u00a0 Goldsmith-\u00ad\u2010Pestana,\t\r \u00a0 K.;\t\r \u00a0 Nieto,\t\r \u00a0 J.;\t\r \u00a0 Osorio,\t\r \u00a0Y.;\t\r \u00a0 Travi,\t\r \u00a0 B.;\t\r \u00a0 Moreno,\t\r \u00a0 J.;\t\r \u00a0McMahon-\u00ad\u2010Pratt,\t\r \u00a0 D.\t\r \u00a0 Immunogenicity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 P-\u00ad\u20108\t\r \u00a0 amastigote\t\r \u00a0 antigen\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 experimental\t\r \u00a0model\t\r \u00a0of\t\r \u00a0canine\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine\t\r \u00a025,\t\r \u00a01534-\u00ad\u20101543\t\r \u00a0(2007).\t\r \u00a044\t\r \u00a0Colmenares,\t\r \u00a0M.;\t\r \u00a0Kima,\t\r \u00a0P.\t\r \u00a0E.;\t\r \u00a0Samoff,\t\r \u00a0E.;\t\r \u00a0Soong,\t\r \u00a0L.;\t\r \u00a0McMahon-\u00ad\u2010Pratt,\t\r \u00a0D.\t\r \u00a0Perforin\t\r \u00a0and\t\r \u00a0gamma\t\r \u00a0interferon\t\r \u00a0 are\t\r \u00a0 critical\t\r \u00a0 CD8+\t\r \u00a0 T-\u00ad\u2010cell-\u00ad\u2010mediated\t\r \u00a0 responses\t\r \u00a0 in\t\r \u00a0 vaccine-\u00ad\u2010induced\t\r \u00a0 immunity\t\r \u00a0against\t\r \u00a0Leishmania\t\r \u00a0amazonensis\t\r \u00a0infection.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity.\t\r \u00a071,\t\r \u00a03172-\u00ad\u20103182\t\r \u00a0(2003).\t\r \u00a045\t\r \u00a0McKean,\t\r \u00a0P.\t\r \u00a0G.;\t\r \u00a0Delahay,\t\r \u00a0R.;\t\r \u00a0Pimenta,\t\r \u00a0P.\t\r \u00a0F.;\t\r \u00a0Smith,\t\r \u00a0D.\t\r \u00a0F.\t\r \u00a0Characterisation\t\r \u00a0of\t\r \u00a0a\t\r \u00a0second\t\r \u00a0protein\t\r \u00a0encoded\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 differentially\t\r \u00a0 regulated\t\r \u00a0 LmcDNA16\t\r \u00a0 gene\t\r \u00a0 family\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0 major.\t\r \u00a0Molecular\t\r \u00a0and\t\r \u00a0Biochemical\t\r \u00a0Parasitology\t\r \u00a085,\t\r \u00a0221-\u00ad\u2010231(1997).\t\r \u00a046\t\r \u00a0Flinn,\t\r \u00a0 H.\t\r \u00a0 M.;\t\r \u00a0 Rangarajan,\t\r \u00a0 D.;\t\r \u00a0 Smith,\t\r \u00a0 D.\t\r \u00a0 F.\t\r \u00a0 Expression\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 hydrophilic\t\r \u00a0 surface\t\r \u00a0 protein\t\r \u00a0 in\t\r \u00a0infective\t\r \u00a0stages\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0major.\t\r \u00a0Molecular\t\r \u00a0and\t\r \u00a0Biochemical\t\r \u00a0Parasitology.\t\r \u00a065,\t\r \u00a0259-\u00ad\u2010270\t\r \u00a0(1994).\t\r \u00a047\t\r \u00a0Jensen,\t\r \u00a0 A.\t\r \u00a0 T.;\t\r \u00a0 Gasim,\t\r \u00a0 S.;\t\r \u00a0 Moller,\t\r \u00a0 T.;\t\r \u00a0 Ismail,\t\r \u00a0 A.;\t\r \u00a0 Gaafar,\t\r \u00a0 A.;\t\r \u00a0 Kemp,\t\r \u00a0 M.;\t\r \u00a0 el\t\r \u00a0 Hassan,\t\r \u00a0 A.\t\r \u00a0 M.;\t\r \u00a0Kharazmi,\t\r \u00a0 A.;\t\r \u00a0 Alce,\t\r \u00a0 T.\t\r \u00a0 M.;\t\r \u00a0 Smith,\t\r \u00a0 D.\t\r \u00a0 F.;\t\r \u00a0 Theander,\t\r \u00a0 T.\t\r \u00a0 G.\t\r \u00a0 Serodiagnosis\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0donovani\t\r \u00a0infections:\t\r \u00a0 assessment\t\r \u00a0 of\t\r \u00a0 enzyme-\u00ad\u2010linked\t\r \u00a0 immunosorbent\t\r \u00a0 assays\t\r \u00a0 using\t\r \u00a0recombinant\t\r \u00a0L.\t\r \u00a0donovani\t\r \u00a0gene\t\r \u00a0B\t\r \u00a0protein\t\r \u00a0(GBP)\t\r \u00a0and\t\r \u00a0a\t\r \u00a0peptide\t\r \u00a0sequence\t\r \u00a0of\t\r \u00a0L.\t\r \u00a0donovani\t\r \u00a0GBP.\t\r \u00a0Transactions\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Royal\t\r \u00a0Society\t\r \u00a0of\t\r \u00a0Tropical\t\r \u00a0Medicine\t\r \u00a0and\t\r \u00a0Hygiene.\t\r \u00a093,\t\r \u00a0157-\u00ad\u2010160\t\r \u00a0(1999).\t\r \u00a048\t\r \u00a0Requena,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Alonso,\t\r \u00a0 C.;\t\r \u00a0 Soto,\t\r \u00a0 M.\t\r \u00a0 Evolutionarily\t\r \u00a0 conserved\t\r \u00a0 proteins\t\r \u00a0 as\t\r \u00a0 prominent\t\r \u00a0immunogens\t\r \u00a0during\t\r \u00a0Leishmania\t\r \u00a0infections.\t\r \u00a0Parasitology\t\r \u00a0Today\t\r \u00a016,\t\r \u00a0246-\u00ad\u2010250\t\r \u00a0(2000).\t\r \u00a049\t\r \u00a0Probst,\t\r \u00a0 P.;\t\r \u00a0 Stromberg,\t\r \u00a0 E.;\t\r \u00a0 Ghalib,\t\r \u00a0 H.\t\r \u00a0 W.;\t\r \u00a0 Mozel,\t\r \u00a0 M.;\t\r \u00a0 Badaro,\t\r \u00a0 R.;\t\r \u00a0 Reed,\t\r \u00a0 S.\t\r \u00a0 G.;\t\r \u00a0 Webb,\t\r \u00a0 J.\t\r \u00a0 R.\t\r \u00a0Identification\t\r \u00a0and\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0T\t\r \u00a0cell-\u00ad\u2010stimulating\t\r \u00a0antigens\t\r \u00a0from\t\r \u00a0Leishmania\t\r \u00a0by\t\r \u00a0CD4\t\r \u00a0T\t\r \u00a0cell\t\r \u00a0expression\t\r \u00a0cloning.\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0\t\r \u00a0Immunology\t\r \u00a0166,\t\r \u00a0498-\u00ad\u2010505\t\r \u00a0(2001).\t\r \u00a050\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Gomez,\t\r \u00a0L.\t\r \u00a0C.;\t\r \u00a0Navarrete,\t\r \u00a0I.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Molecular\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0a\t\r \u00a0Leishmania\t\r \u00a0 donovani\t\r \u00a0 infantum\t\r \u00a0antigen\t\r \u00a0 identified\t\r \u00a0 as\t\r \u00a0 histone\t\r \u00a0 H2A.\t\r \u00a0 European\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0Biochemistry\t\r \u00a0205,\t\r \u00a0211-\u00ad\u2010216\t\r \u00a0(1992).\t\r \u00a051\t\r \u00a0Soto,\t\r \u00a0 M.;\t\r \u00a0 Requena,\t\r \u00a0J.\t\r \u00a0 M.;\t\r \u00a0 Morales,\t\r \u00a0 G.;\t\r \u00a0 Alonso,\t\r \u00a0 C.\t\r \u00a0 The\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0histone\t\r \u00a0 H3\t\r \u00a0possesses\t\r \u00a0 an\t\r \u00a0 extremely\t\r \u00a0 divergent\t\r \u00a0 N-\u00ad\u2010terminal\t\r \u00a0 domain.\t\r \u00a0 Biochimica\t\r \u00a0 et\t\r \u00a0 Biophysica\t\r \u00a0 Acta.\t\r \u00a01219,\t\r \u00a0533-\u00ad\u2010535\t\r \u00a0(1994).\t\r \u00a052\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Quijada,\t\r \u00a0L.;\t\r \u00a0Perez,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0Nieto,\t\r \u00a0C.\t\r \u00a0G.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0Alonso,\t\r \u00a0 C.\t\r \u00a0 Antigenicity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0histones\t\r \u00a0 H2B\t\r \u00a0 and\t\r \u00a0 H4\t\r \u00a0 during\t\r \u00a0 canine\t\r \u00a0viscerocutaneous\t\r \u00a0 leishmaniasis.\t\r \u00a0 Clinical\t\r \u00a0 and\t\r \u00a0 Experimental\t\r \u00a0 Immunology\t\r \u00a0115,\t\r \u00a0 342-\u00ad\u2010349\t\r \u00a0(1999).\t\r \u00a053\t\r \u00a0Souza,\t\r \u00a0A.\t\r \u00a0P.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Costa,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Boaventura,\t\r \u00a0V.\t\r \u00a0S.;\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.;\t\r \u00a0Cristal,\t\r \u00a0J.\t\r \u00a0R.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Barral,\t\r \u00a0A.\t\r \u00a0Towards\t\r \u00a0a\t\r \u00a0more\t\r \u00a0precise\t\r \u00a0serological\t\r \u00a0diagnosis\t\r \u00a0of\t\r \u00a0human\t\r \u00a0tegumentary\t\r \u00a0leishmaniasis\t\r \u00a0using\t\r \u00a0Leishmania\t\r \u00a0recombinant\t\r \u00a0proteins.\t\r \u00a0PLoS\t\r \u00a0One\t\r \u00a08,\t\r \u00a0e66110\t\r \u00a0(2013).\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0261\t\r \u00a0\t\r \u00a054\t\r \u00a0Carmelo,\t\r \u00a0 E.;\t\r \u00a0 Zurita,\t\r \u00a0 A.\t\r \u00a0 I.;\t\r \u00a0 Martinez,\t\r \u00a0 E.;\t\r \u00a0 Valladares,\t\r \u00a0 B.\t\r \u00a0 The\t\r \u00a0 sera\t\r \u00a0 from\t\r \u00a0 individuals\t\r \u00a0 suffering\t\r \u00a0from\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0Leishmania\t\r \u00a0 brazilensis\t\r \u00a0present\t\r \u00a0 antibodies\t\r \u00a0 against\t\r \u00a0parasitic\t\r \u00a0 conserved\t\r \u00a0 proteins,\t\r \u00a0 but\t\r \u00a0 not\t\r \u00a0 their\t\r \u00a0 human\t\r \u00a0 counterparts.\t\r \u00a0 Parasite\t\r \u00a013,\t\r \u00a0 231-\u00ad\u2010236\t\r \u00a0(2006).\t\r \u00a055\t\r \u00a0Carmelo,\t\r \u00a0 E.;\t\r \u00a0 Martinez,\t\r \u00a0 E.;\t\r \u00a0 Gonzalez,\t\r \u00a0 A.\t\r \u00a0 C.;\t\r \u00a0 Pinero,\t\r \u00a0 J.\t\r \u00a0 E.;\t\r \u00a0 Patarroyo,\t\r \u00a0 M.\t\r \u00a0 E.;\t\r \u00a0 Del\t\r \u00a0 Castillo,\t\r \u00a0 A.;\t\r \u00a0Valladares,\t\r \u00a0 B.\t\r \u00a0 Antigenicity\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0 braziliensis\t\r \u00a0histone\t\r \u00a0 H1\t\r \u00a0 during\t\r \u00a0 cutaneous\t\r \u00a0leishmaniasis:\t\r \u00a0localization\t\r \u00a0of\t\r \u00a0antigenic\t\r \u00a0determinants.\t\r \u00a0Clinical\t\r \u00a0and\t\r \u00a0Diagnostic\t\r \u00a0\t\r \u00a0Laboratory\t\r \u00a0\t\r \u00a0Immunology\t\r \u00a09,\t\r \u00a0808-\u00ad\u2010811(2002).\t\r \u00a056\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Quijada,\t\r \u00a0L.;\t\r \u00a0Garcia,\t\r \u00a0M.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Mapping\t\r \u00a0of\t\r \u00a0the\t\r \u00a0linear\t\r \u00a0antigenic\t\r \u00a0determinants\t\r \u00a0from\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0histone\t\r \u00a0H2A\t\r \u00a0recognized\t\r \u00a0 by\t\r \u00a0 sera\t\r \u00a0 from\t\r \u00a0 dogs\t\r \u00a0 with\t\r \u00a0 leishmaniasis.\t\r \u00a0 Immunology\t\r \u00a0Letters\t\r \u00a048,\t\r \u00a0 209-\u00ad\u2010214\t\r \u00a0(1995).\t\r \u00a057\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Quijada,\t\r \u00a0L.;\t\r \u00a0Gomez,\t\r \u00a0L.\t\r \u00a0C.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Characterization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 antigenic\t\r \u00a0 determinants\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0histone\t\r \u00a0 H3\t\r \u00a0recognized\t\r \u00a0 by\t\r \u00a0 antibodies\t\r \u00a0 elicited\t\r \u00a0 during\t\r \u00a0 canine\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis.\t\r \u00a0 Clinical\t\r \u00a0 and\t\r \u00a0\t\r \u00a0Experimental\t\r \u00a0Immunology\t\r \u00a0106,\t\r \u00a0454-\u00ad\u2010461(1996).\t\r \u00a058\t\r \u00a0Meddeb-\u00ad\u2010Garnaoui,\t\r \u00a0A.;\t\r \u00a0Toumi,\t\r \u00a0A.;\t\r \u00a0Ghelis,\t\r \u00a0H.;\t\r \u00a0Mahjoub,\t\r \u00a0M.;\t\r \u00a0Louzir,\t\r \u00a0H.;\t\r \u00a0Chenik,\t\r \u00a0M.\t\r \u00a0Cellular\t\r \u00a0and\t\r \u00a0humoral\t\r \u00a0responses\t\r \u00a0induced\t\r \u00a0by\t\r \u00a0Leishmania\t\r \u00a0histone\t\r \u00a0H2B\t\r \u00a0and\t\r \u00a0its\t\r \u00a0divergent\t\r \u00a0and\t\r \u00a0conserved\t\r \u00a0parts\t\r \u00a0 in\t\r \u00a0 cutaneous\t\r \u00a0 and\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis\t\r \u00a0 patients,\t\r \u00a0 respectively.\t\r \u00a0 Vaccine\t\r \u00a028,\t\r \u00a0 1881-\u00ad\u20101886\t\r \u00a0(2010).\t\r \u00a059\t\r \u00a0de\t\r \u00a0Carvalho,\t\r \u00a0L.\t\r \u00a0P.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Jeronimo,\t\r \u00a0S.;\t\r \u00a0Dondji,\t\r \u00a0B.;\t\r \u00a0Bacellar,\t\r \u00a0O.;\t\r \u00a0Luz,\t\r \u00a0V.;\t\r \u00a0Orge,\t\r \u00a0G.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Jesus,\t\r \u00a0 A.\t\r \u00a0 R.;\t\r \u00a0 Carvalho,\t\r \u00a0 E.\t\r \u00a0 M.\t\r \u00a0 Characterization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 immune\t\r \u00a0 response\t\r \u00a0 to\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0recombinant\t\r \u00a0antigens.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a05,\t\r \u00a07-\u00ad\u201012\t\r \u00a0(2003).\t\r \u00a060\t\r \u00a0Iborra,\t\r \u00a0S.;\t\r \u00a0Soto;\t\r \u00a0M.;\t\r \u00a0Carrion,\t\r \u00a0J.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0Vaccination\t\r \u00a0with\t\r \u00a0a\t\r \u00a0plasmid\t\r \u00a0DNA\t\r \u00a0cocktail\t\r \u00a0 encoding\t\r \u00a0 the\t\r \u00a0 nucleosomal\t\r \u00a0 histones\t\r \u00a0 of\t\r \u00a0Leishmania\t\r \u00a0confers\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0murine\t\r \u00a0cutaneous\t\r \u00a0leishmaniosis.\t\r \u00a0Vaccine\t\r \u00a022,\t\r \u00a03865-\u00ad\u20103876\t\r \u00a0(2004).\t\r \u00a061\t\r \u00a0Carrion,\t\r \u00a0J.;\t\r \u00a0Nieto,\t\r \u00a0A.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Adoptive\t\r \u00a0transfer\t\r \u00a0of\t\r \u00a0dendritic\t\r \u00a0cells\t\r \u00a0pulsed\t\r \u00a0with\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0nucleosomal\t\r \u00a0 histones\t\r \u00a0 confers\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 cutaneous\t\r \u00a0leishmaniosis\t\r \u00a0in\t\r \u00a0BALB/c\t\r \u00a0mice.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a09,\t\r \u00a0735-\u00ad\u2010743\t\r \u00a0(2007).\t\r \u00a062\t\r \u00a0Carneiro,\t\r \u00a0 M.\t\r \u00a0 W.;\t\r \u00a0 Santos,\t\r \u00a0 D.\t\r \u00a0 M.;\t\r \u00a0 Fukutani,\t\r \u00a0 K.\t\r \u00a0 F.;\t\r \u00a0 Clarencio,\t\r \u00a0 J.;\t\r \u00a0 Miranda,\t\r \u00a0 J.\t\r \u00a0 C.;\t\r \u00a0 Brodskyn,\t\r \u00a0 C.;\t\r \u00a0Barral,\t\r \u00a0A.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.\t\r \u00a0Vaccination\t\r \u00a0with\t\r \u00a0L.\t\r \u00a0infantum\t\r \u00a0chagasi\t\r \u00a0nucleosomal\t\r \u00a0 histones\t\r \u00a0 confers\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 new\t\r \u00a0 world\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0caused\t\r \u00a0by\t\r \u00a0Leishmania\t\r \u00a0braziliensis.\t\r \u00a0PLoS\t\r \u00a0One.\t\r \u00a07,\t\r \u00a0e52296\t\r \u00a0(2012).\t\r \u00a063\t\r \u00a0Carrion,\t\r \u00a0J.;\t\r \u00a0Folgueira,\t\r \u00a0C.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Immunization\t\r \u00a0strategies\t\r \u00a0against\t\r \u00a0visceral\t\r \u00a0leishmaniosis\t\r \u00a0with\t\r \u00a0the\t\r \u00a0nucleosomal\t\r \u00a0histones\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0encoded\t\r \u00a0in\t\r \u00a0DNA\t\r \u00a0vaccine\t\r \u00a0or\t\r \u00a0pulsed\t\r \u00a0in\t\r \u00a0dendritic\t\r \u00a0cells.\t\r \u00a0Vaccine\t\r \u00a026,\t\r \u00a02537-\u00ad\u201044\t\r \u00a0(2008).\t\r \u00a064\t\r \u00a0Solioz,\t\r \u00a0 N.;\t\r \u00a0 Blum-\u00ad\u2010Tirouvanziam,\t\r \u00a0 U.;\t\r \u00a0 Jacquet,\t\r \u00a0 R.;\t\r \u00a0 Rafati,\t\r \u00a0 S.;\t\r \u00a0 Corradin,\t\r \u00a0 G.;\t\r \u00a0 Mauel,\t\r \u00a0 J.;\t\r \u00a0 Fasel,\t\r \u00a0 N.\t\r \u00a0The\t\r \u00a0 protective\t\r \u00a0 capacities\t\r \u00a0 of\t\r \u00a0 histone\t\r \u00a0 H1\t\r \u00a0 against\t\r \u00a0 experimental\t\r \u00a0 murine\t\r \u00a0 cutaneous\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine.\t\r \u00a018,\t\r \u00a0850-\u00ad\u2010859\t\r \u00a0(1999).\t\r \u00a065\t\r \u00a0Masina,\t\r \u00a0 S.;\t\r \u00a0 Gicheru,\t\r \u00a0 M.\t\r \u00a0 M.;\t\r \u00a0 Demotz,\t\r \u00a0 S.\t\r \u00a0 O.;\t\r \u00a0 Fasel,\t\r \u00a0 N.\t\r \u00a0 J.\t\r \u00a0 Protection\t\r \u00a0 against\t\r \u00a0 cutaneous\t\r \u00a0leishmaniasis\t\r \u00a0 in\t\r \u00a0 outbred\t\r \u00a0 vervet\t\r \u00a0 monkeys\t\r \u00a0 using\t\r \u00a0 a\t\r \u00a0 recombinant\t\r \u00a0 histone\t\r \u00a0 H1\t\r \u00a0 antigen.\t\r \u00a0 The\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Infectious\t\r \u00a0Diseases.\t\r \u00a0188,\t\r \u00a01250-\u00ad\u20101257\t\r \u00a0(2003).\t\r \u00a066\t\r \u00a0Moreno,\t\r \u00a0J.;\t\r \u00a0Nieto,\t\r \u00a0J.;\t\r \u00a0Masina,\t\r \u00a0S.;\t\r \u00a0Ca\u00f1avate,\t\r \u00a0C.;\t\r \u00a0Cruz,\t\r \u00a0I.;\t\r \u00a0Chicharro,\t\r \u00a0C.;\t\r \u00a0Carrillo,\t\r \u00a0E.;\t\r \u00a0Napp,\t\r \u00a0S.;\t\r \u00a0Reymond,\t\r \u00a0C.;\t\r \u00a0Kaye,\t\r \u00a0P.\t\r \u00a0M.;\t\r \u00a0Smith,\t\r \u00a0D.\t\r \u00a0F.;\t\r \u00a0Fasel,\t\r \u00a0N.;\t\r \u00a0Alvar,\t\r \u00a0J.\t\r \u00a0Immunization\t\r \u00a0with\t\r \u00a0H1,\t\r \u00a0HASPB1\t\r \u00a0and\t\r \u00a0MML\t\r \u00a0Leishmania\t\r \u00a0proteins\t\r \u00a0in\t\r \u00a0a\t\r \u00a0vaccine\t\r \u00a0trial\t\r \u00a0against\t\r \u00a0experimental\t\r \u00a0canine\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine\t\r \u00a025,\t\r \u00a05290-\u00ad\u20105300\t\r \u00a0(2007).\t\r \u00a067\t\r \u00a0Coelho,\t\r \u00a0E.\t\r \u00a0A.;\t\r \u00a0Ramirez,\t\r \u00a0L.;\t\r \u00a0Costa,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Coelho,\t\r \u00a0V.\t\r \u00a0T.;\t\r \u00a0Martins,\t\r \u00a0V.\t\r \u00a0T.;\t\r \u00a0Chavez-\u00ad\u2010Fumagalli,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Oliveira,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Tavares,\t\r \u00a0C.\t\r \u00a0A.;\t\r \u00a0Bonay,\t\r \u00a0P.;\t\r \u00a0Nieto,\t\r \u00a0C.\t\r \u00a0G.;\t\r \u00a0Abanades,\t\r \u00a0D.\t\r \u00a0R.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Soto,\t\r \u00a0M.\t\r \u00a0Specific\t\r \u00a0serodiagnosis\t\r \u00a0of\t\r \u00a0canine\t\r \u00a0visceral\t\r \u00a0leishmaniasis\t\r \u00a0using\t\r \u00a0Leishmania\t\r \u00a0species\t\r \u00a0ribosomal\t\r \u00a0protein\t\r \u00a0extracts.\t\r \u00a0Clinical\t\r \u00a0and\t\r \u00a0Vaccine\t\r \u00a0Immunology\t\r \u00a016,\t\r \u00a01774-\u00ad\u20101780\t\r \u00a0(2009).\t\r \u00a068\t\r \u00a0Ramirez,\t\r \u00a0L.;\t\r \u00a0Santos,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Souza,\t\r \u00a0A.\t\r \u00a0P.;\t\r \u00a0Coelho,\t\r \u00a0E.\t\r \u00a0A.;\t\r \u00a0Barral,\t\r \u00a0A.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Escutia,\t\r \u00a0M.\t\r \u00a0R.;\t\r \u00a0Bonay,\t\r \u00a0P.;\t\r \u00a0de\t\r \u00a0Oliveira,\t\r \u00a0C.\t\r \u00a0I.;\t\r \u00a0Soto,\t\r \u00a0M.\t\r \u00a0Evaluation\t\r \u00a0of\t\r \u00a0immune\t\r \u00a0responses\t\r \u00a0and\t\r \u00a0analysis\t\r \u00a0of\t\r \u00a0the\t\r \u00a0effect\t\r \u00a0of\t\r \u00a0vaccination\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0major\t\r \u00a0recombinant\t\r \u00a0ribosomal\t\r \u00a0proteins\t\r \u00a0L3\t\r \u00a0or\t\r \u00a0L5\t\r \u00a0in\t\r \u00a0two\t\r \u00a0different\t\r \u00a0murine\t\r \u00a0models\t\r \u00a0of\t\r \u00a0cutaneous\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine.\t\r \u00a031,\t\r \u00a01312-\u00ad\u20101319\t\r \u00a0(2013).\t\r \u00a069\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Quijada,\t\r \u00a0L.;\t\r \u00a0Angel,\t\r \u00a0S.\t\r \u00a0O.;\t\r \u00a0Gomez,\t\r \u00a0L.\t\r \u00a0C.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0During\t\r \u00a0active\t\r \u00a0viscerocutaneous\t\r \u00a0leishmaniasis\t\r \u00a0the\t\r \u00a0anti-\u00ad\u2010P2\t\r \u00a0humoral\t\r \u00a0response\t\r \u00a0is\t\r \u00a0specifically\t\r \u00a0 triggered\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 parasite\t\r \u00a0 P\t\r \u00a0 proteins.\t\r \u00a0 Clinical\t\r \u00a0 and\t\r \u00a0 Experimental\t\r \u00a0 Immunology\t\r \u00a0100,\t\r \u00a0246-\u00ad\u2010252\t\r \u00a0(1995).\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n262\t\r \u00a0\t\r \u00a070\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Quijada,\t\r \u00a0L.;\t\r \u00a0Guzman,\t\r \u00a0F.;\t\r \u00a0Patarroyo,\t\r \u00a0M.\t\r \u00a0E.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Identification\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0P0\t\r \u00a0ribosomal\t\r \u00a0protein\t\r \u00a0epitope\t\r \u00a0in\t\r \u00a0canine\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Immunology\t\r \u00a0Letters\t\r \u00a048,\t\r \u00a023-\u00ad\u201028(1995).\t\r \u00a071\t\r \u00a0Soto,\t\r \u00a0 M.;\t\r \u00a0 Requena,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Quijada,\t\r \u00a0 L.;\t\r \u00a0 Alonso,\t\r \u00a0 C.\t\r \u00a0 Specific\t\r \u00a0 serodiagnosis\t\r \u00a0 of\t\r \u00a0 human\t\r \u00a0leishmaniasis\t\r \u00a0 with\t\r \u00a0 recombinant\t\r \u00a0Leishmania\t\r \u00a0P2\t\r \u00a0 acidic\t\r \u00a0ribosomal\t\r \u00a0 proteins.\t\r \u00a0 Clinical\t\r \u00a0 and\t\r \u00a0Diagnostic\t\r \u00a0Laboratory\t\r \u00a0Immunology\t\r \u00a03,\t\r \u00a0387-\u00ad\u2010391\t\r \u00a0(1996).\t\r \u00a072\t\r \u00a0Elkon,\t\r \u00a0 K.;\t\r \u00a0 Skelly,\t\r \u00a0 S.;\t\r \u00a0 Parnassa,\t\r \u00a0 A.;\t\r \u00a0 Moller,\t\r \u00a0 W.;\t\r \u00a0 Danho,\t\r \u00a0 W.;\t\r \u00a0 Weissbach,\t\r \u00a0 H.;\t\r \u00a0 Brot,\t\r \u00a0 N.\t\r \u00a0Identification\t\r \u00a0 and\t\r \u00a0 chemical\t\r \u00a0 synthesis\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 ribosomal\t\r \u00a0 protein\t\r \u00a0 antigenic\t\r \u00a0 determinant\t\r \u00a0 in\t\r \u00a0systemic\t\r \u00a0 lupus\t\r \u00a0 erythematosus.\t\r \u00a0 Proccedings\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 National\t\r \u00a0 Academy\t\r \u00a0 Sciences\t\r \u00a0 U.S.A\t\r \u00a083,\t\r \u00a07419-\u00ad\u20107423\t\r \u00a0(1986).\t\r \u00a073\t\r \u00a0Iborra,\t\r \u00a0 S.;\t\r \u00a0 Soto,\t\r \u00a0 M.;\t\r \u00a0 Carrion,\t\r \u00a0 J.;\t\r \u00a0 Nieto,\t\r \u00a0 A.;\t\r \u00a0 Fernandez,\t\r \u00a0 E.;\t\r \u00a0 Alonso,\t\r \u00a0 C.;\t\r \u00a0 Requena,\t\r \u00a0 J.\t\r \u00a0 M.\t\r \u00a0 The\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0acidic\t\r \u00a0ribosomal\t\r \u00a0protein\t\r \u00a0P0\t\r \u00a0administered\t\r \u00a0as\t\r \u00a0a\t\r \u00a0DNA\t\r \u00a0vaccine\t\r \u00a0confers\t\r \u00a0protective\t\r \u00a0 immunity\t\r \u00a0 to\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0infection\t\r \u00a0 in\t\r \u00a0 BALB/c\t\r \u00a0 mice.\t\r \u00a0 Infection\t\r \u00a0 and\t\r \u00a0Immunity.\t\r \u00a071,\t\r \u00a06562-\u00ad\u20106572\t\r \u00a0(2003).\t\r \u00a074\t\r \u00a0Iborra,\t\r \u00a0 S.;\t\r \u00a0 Carrion,\t\r \u00a0 J.;\t\r \u00a0 Anderson,\t\r \u00a0 C.;\t\r \u00a0 Alonso,\t\r \u00a0 C.;\t\r \u00a0 Sacks,\t\r \u00a0 D;\t\r \u00a0 Soto,\t\r \u00a0 M.\t\r \u00a0 Vaccination\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0acidic\t\r \u00a0ribosomal\t\r \u00a0P0\t\r \u00a0protein\t\r \u00a0plus\t\r \u00a0CpG\t\r \u00a0oligodeoxynucleotides\t\r \u00a0induces\t\r \u00a0protection\t\r \u00a0 against\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0 in\t\r \u00a0 C57BL/6\t\r \u00a0 mice\t\r \u00a0 but\t\r \u00a0 does\t\r \u00a0 not\t\r \u00a0 prevent\t\r \u00a0progressive\t\r \u00a0disease\t\r \u00a0in\t\r \u00a0BALB/c\t\r \u00a0mice.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a073,\t\r \u00a05842-\u00ad\u20105852\t\r \u00a0(2005).\t\r \u00a075\t\r \u00a0Melby,\t\r \u00a0P.\t\r \u00a0C.;\t\r \u00a0Ogden,\t\r \u00a0G.\t\r \u00a0B.;\t\r \u00a0Flores,\t\r \u00a0H.\t\r \u00a0A.;\t\r \u00a0Zhao,\t\r \u00a0W.;\t\r \u00a0Geldmacher,\t\r \u00a0C.;\t\r \u00a0Biediger,\t\r \u00a0N.\t\r \u00a0M.;\t\r \u00a0Ahuja,\t\r \u00a0S.\t\r \u00a0K.;\t\r \u00a0Uranga,\t\r \u00a0J.;\t\r \u00a0Melendez,\t\r \u00a0M.\t\r \u00a0Identification\t\r \u00a0of\t\r \u00a0vaccine\t\r \u00a0candidates\t\r \u00a0for\t\r \u00a0experimental\t\r \u00a0visceral\t\r \u00a0leishmaniasis\t\r \u00a0 by\t\r \u00a0 immunization\t\r \u00a0 with\t\r \u00a0 sequential\t\r \u00a0 fractions\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 cDNA\t\r \u00a0 expression\t\r \u00a0 library.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a068,\t\r \u00a05595-\u00ad\u20105602\t\r \u00a0(2000).\t\r \u00a076\t\r \u00a0Stober,\t\r \u00a0C.\t\r \u00a0B.;\t\r \u00a0Lange,\t\r \u00a0U.\t\r \u00a0G.;\t\r \u00a0Roberts,\t\r \u00a0M.\t\r \u00a0T.;\t\r \u00a0Gilmartin,\t\r \u00a0B.;\t\r \u00a0Francis,\t\r \u00a0R.;\t\r \u00a0Almeida,\t\r \u00a0R.;\t\r \u00a0Peacock,\t\r \u00a0C.\t\r \u00a0S.;\t\r \u00a0McCann,\t\r \u00a0S.;\t\r \u00a0Blackwell,\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0From\t\r \u00a0genome\t\r \u00a0to\t\r \u00a0vaccines\t\r \u00a0for\t\r \u00a0leishmaniasis:\t\r \u00a0screening\t\r \u00a0100\t\r \u00a0novel\t\r \u00a0vaccine\t\r \u00a0candidates\t\r \u00a0against\t\r \u00a0murine\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0infection.\t\r \u00a0 Vaccine.\t\r \u00a024,\t\r \u00a0 2602-\u00ad\u20102616\t\r \u00a0(2006).\t\r \u00a077\t\r \u00a0Iborra,\t\r \u00a0S.;\t\r \u00a0Parody,\t\r \u00a0N.;\t\r \u00a0Abanades,\t\r \u00a0D.\t\r \u00a0R.;\t\r \u00a0Bonay,\t\r \u00a0P.;\t\r \u00a0Prates,\t\r \u00a0D.;\t\r \u00a0Novais,\t\r \u00a0F.\t\r \u00a0O.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Soto,\t\r \u00a0M.\t\r \u00a0Vaccination\t\r \u00a0with\t\r \u00a0the\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0ribosomal\t\r \u00a0 proteins\t\r \u00a0 plus\t\r \u00a0 CpG\t\r \u00a0oligodeoxynucleotides\t\r \u00a0 induces\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 experimental\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0in\t\r \u00a0mice.\t\r \u00a0Microbes\t\r \u00a0Infection\t\r \u00a010,\t\r \u00a01133-\u00ad\u20101141\t\r \u00a0(2008).\t\r \u00a078\t\r \u00a0Chavez-\u00ad\u2010Fumagalli,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Costa,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Oliveira,\t\r \u00a0D.\t\r \u00a0M.;\t\r \u00a0Ramirez,\t\r \u00a0L.;\t\r \u00a0Costa,\t\r \u00a0L.\t\r \u00a0E.;\t\r \u00a0Duarte,\t\r \u00a0M.\t\r \u00a0C.;\t\r \u00a0Martins,\t\r \u00a0V.\t\r \u00a0T.;\t\r \u00a0Oliveira,\t\r \u00a0J.\t\r \u00a0S.;\t\r \u00a0Olortegi,\t\r \u00a0C.\t\r \u00a0C.;\t\r \u00a0Bonay,\t\r \u00a0P.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Tavares,\t\r \u00a0C.\t\r \u00a0A.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Coelho,\t\r \u00a0 E.\t\r \u00a0 A.\t\r \u00a0 Vaccination\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0ribosomal\t\r \u00a0 proteins\t\r \u00a0 induces\t\r \u00a0protection\t\r \u00a0 in\t\r \u00a0 BALB/c\t\r \u00a0 mice\t\r \u00a0 against\t\r \u00a0 Leishmania\t\r \u00a0 chagasi\t\r \u00a0 and\t\r \u00a0Leishmania\t\r \u00a0 amazonensis\t\r \u00a0challenge.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a012,\t\r \u00a0967-\u00ad\u2010977\t\r \u00a0(2010).\t\r \u00a079\t\r \u00a0Ramirez,\t\r \u00a0L.;\t\r \u00a0Iborra,\t\r \u00a0S.;\t\r \u00a0Cortes,\t\r \u00a0J.;\t\r \u00a0Bonay,\t\r \u00a0P.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Barral-\u00ad\u2010Netto,\t\r \u00a0M.;\t\r \u00a0Soto,\t\r \u00a0M.\t\r \u00a0BALB/c\t\r \u00a0mice\t\r \u00a0vaccinated\t\r \u00a0with\t\r \u00a0Leishmania\t\r \u00a0major\t\r \u00a0ribosomal\t\r \u00a0proteins\t\r \u00a0extracts\t\r \u00a0combined\t\r \u00a0with\t\r \u00a0CpG\t\r \u00a0oligodeoxynucleotides\t\r \u00a0 become\t\r \u00a0 resistant\t\r \u00a0 to\t\r \u00a0 disease\t\r \u00a0 caused\t\r \u00a0 by\t\r \u00a0 a\t\r \u00a0 secondary\t\r \u00a0 parasite\t\r \u00a0challenge.\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Biomedicine\t\r \u00a0&\t\r \u00a0Biotechnology\t\r \u00a02010,\t\r \u00a0181690\t\r \u00a0(2010).\t\r \u00a080\t\r \u00a0Launois,\t\r \u00a0P.;\t\r \u00a0Maillard,\t\r \u00a0I.;\t\r \u00a0Pingel,\t\r \u00a0S.;\t\r \u00a0Swihart,\t\r \u00a0K.\t\r \u00a0G.;\t\r \u00a0Xenarios,\t\r \u00a0I.;\t\r \u00a0Acha-\u00ad\u2010Orbea,\t\r \u00a0H.;\t\r \u00a0Diggelmann,\t\r \u00a0H.;\t\r \u00a0Locksley,\t\r \u00a0R.\t\r \u00a0M.;\t\r \u00a0MacDonald,\t\r \u00a0H.\t\r \u00a0R.;\t\r \u00a0Louis,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0IL-\u00ad\u20104\t\r \u00a0rapidly\t\r \u00a0produced\t\r \u00a0by\t\r \u00a0V\t\r \u00a0beta\t\r \u00a04\t\r \u00a0V\t\r \u00a0alpha\t\r \u00a08\t\r \u00a0 CD4+\t\r \u00a0 T\t\r \u00a0 cells\t\r \u00a0 instructs\t\r \u00a0 Th2\t\r \u00a0 development\t\r \u00a0 and\t\r \u00a0 susceptibility\t\r \u00a0 to\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0in\t\r \u00a0BALB/c\t\r \u00a0mice.\t\r \u00a0Immunity\t\r \u00a06,\t\r \u00a0541-\u00ad\u2010549\t\r \u00a0(1997).\t\r \u00a081\t\r \u00a0Julia,\t\r \u00a0V.;\t\r \u00a0Rassoulzadegan,\t\r \u00a0M.;\t\r \u00a0Glaichenhaus,\t\r \u00a0N.\t\r \u00a0Resistance\t\r \u00a0to\t\r \u00a0Leishmania\t\r \u00a0major\t\r \u00a0induced\t\r \u00a0by\t\r \u00a0tolerance\t\r \u00a0to\t\r \u00a0a\t\r \u00a0single\t\r \u00a0antigen.\t\r \u00a0Science\t\r \u00a0274,\t\r \u00a0421-\u00ad\u2010423\t\r \u00a0(1996)\t\r \u00a082\t\r \u00a0Gonzalez-\u00ad\u2010Aseguinolaza,\t\r \u00a0 G.;\t\r \u00a0 Taladriz,\t\r \u00a0 S.;\t\r \u00a0 Marquet,\t\r \u00a0 A.;\t\r \u00a0 Larraga,\t\r \u00a0 V.\t\r \u00a0 Molecular\t\r \u00a0 cloning,\t\r \u00a0 cell\t\r \u00a0localization\t\r \u00a0and\t\r \u00a0binding\t\r \u00a0affinity\t\r \u00a0to\t\r \u00a0DNA\t\r \u00a0replication\t\r \u00a0proteins\t\r \u00a0of\t\r \u00a0the\t\r \u00a0p36/LACK\t\r \u00a0protective\t\r \u00a0antigen\t\r \u00a0 from\t\r \u00a0Leishmania\t\r \u00a0 infantum.\t\r \u00a0 European\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0 Biochemistry\t\r \u00a0259,\t\r \u00a0 909-\u00ad\u2010916\t\r \u00a0(1999).\t\r \u00a083\t\r \u00a0Lopez-\u00ad\u2010Fuertes,\t\r \u00a0 L.;\t\r \u00a0 Perez-\u00ad\u2010Jimenez,\t\r \u00a0 E.;\t\r \u00a0 Vila-\u00ad\u2010Coro,\t\r \u00a0 A.\t\r \u00a0 J.;\t\r \u00a0 Sack,\t\r \u00a0 F.;\t\r \u00a0 Moreno,\t\r \u00a0 S.;\t\r \u00a0 Konig,\t\r \u00a0 S.\t\r \u00a0 A.;\t\r \u00a0Junghans,\t\r \u00a0C.;\t\r \u00a0Wittig,\t\r \u00a0B.;\t\r \u00a0Timon,\t\r \u00a0M.;\t\r \u00a0Esteban,\t\r \u00a0M.\t\r \u00a0DNA\t\r \u00a0vaccination\t\r \u00a0with\t\r \u00a0linear\t\r \u00a0minimalistic\t\r \u00a0(MIDGE)\t\r \u00a0 vectors\t\r \u00a0 confers\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0Leishmania\t\r \u00a0 major\t\r \u00a0infection\t\r \u00a0 in\t\r \u00a0 mice.\t\r \u00a0 Vaccine\t\r \u00a021,\t\r \u00a0247-\u00ad\u2010257\t\r \u00a0(2002).\t\r \u00a084\t\r \u00a0Pinto,\t\r \u00a0E.\t\r \u00a0F.;\t\r \u00a0Pinheiro,\t\r \u00a0R.\t\r \u00a0O.;\t\r \u00a0Rayol,\t\r \u00a0A.;\t\r \u00a0Larraga,\t\r \u00a0V.;\t\r \u00a0Rossi-\u00ad\u2010Bergmann,\t\r \u00a0B.\t\r \u00a0Intranasal\t\r \u00a0vaccination\t\r \u00a0against\t\r \u00a0cutaneous\t\r \u00a0leishmaniasis\t\r \u00a0with\t\r \u00a0a\t\r \u00a0particulated\t\r \u00a0leishmanial\t\r \u00a0antigen\t\r \u00a0or\t\r \u00a0DNA\t\r \u00a0encoding\t\r \u00a0LACK.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a072,\t\r \u00a04521-\u00ad\u20104527\t\r \u00a0(2004).\t\r \u00a085\t\r \u00a0Gomes,\t\r \u00a0 D.\t\r \u00a0 C.;\t\r \u00a0 Pinto,\t\r \u00a0 E.\t\r \u00a0 F.;\t\r \u00a0 de\t\r \u00a0 Melo,\t\r \u00a0 L.\t\r \u00a0 D.;\t\r \u00a0 Lima,\t\r \u00a0 W.\t\r \u00a0 P.;\t\r \u00a0 Larraga,\t\r \u00a0 V.;\t\r \u00a0 Lopes,\t\r \u00a0 U.\t\r \u00a0 G.;\t\r \u00a0 Rossi-\u00ad\u2010Bergmann,\t\r \u00a0 B.\t\r \u00a0 Intranasal\t\r \u00a0 delivery\t\r \u00a0 of\t\r \u00a0 naked\t\r \u00a0 DNA\t\r \u00a0 encoding\t\r \u00a0 the\t\r \u00a0 LACK\t\r \u00a0 antigen\t\r \u00a0 leads\t\r \u00a0 to\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0anti-\u00ad\u2010Leishmania\t\r \u00a0vaccines\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0263\t\r \u00a0\t\r \u00a0protective\t\r \u00a0 immunity\t\r \u00a0 against\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis\t\r \u00a0 in\t\r \u00a0 mice.\t\r \u00a0 Vaccine\t\r \u00a025,\t\r \u00a0 2168-\u00ad\u20102172\t\r \u00a0(2007).\t\r \u00a086\t\r \u00a0Dondji,\t\r \u00a0 B.;\t\r \u00a0 Perez-\u00ad\u2010Jimenez,\t\r \u00a0 E.;\t\r \u00a0 Goldsmith-\u00ad\u2010Pestana,\t\r \u00a0 K.;\t\r \u00a0 Esteban,\t\r \u00a0 M.;\t\r \u00a0 McMahon-\u00ad\u2010Pratt,\t\r \u00a0 D.\t\r \u00a0Heterologous\t\r \u00a0 prime-\u00ad\u2010boost\t\r \u00a0 vaccination\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0 LACK\t\r \u00a0 antigen\t\r \u00a0 protects\t\r \u00a0 against\t\r \u00a0 murine\t\r \u00a0visceral\t\r \u00a0leishmaniasis.\t\r \u00a0Infection\t\r \u00a0and\t\r \u00a0Immunity\t\r \u00a073,\t\r \u00a05286-\u00ad\u20105289\t\r \u00a0(2005).\t\r \u00a087\t\r \u00a0Gonzalo,\t\r \u00a0 R.\t\r \u00a0 M.;\t\r \u00a0 Rodriguez,\t\r \u00a0 J.\t\r \u00a0 R.;\t\r \u00a0 Rodriguez,\t\r \u00a0 D.;\t\r \u00a0 Gonzalez-\u00ad\u2010Aseguinolaza,\t\r \u00a0 G.;\t\r \u00a0 Larraga,\t\r \u00a0 V.;\t\r \u00a0Esteban,\t\r \u00a0 M.\t\r \u00a0 Protective\t\r \u00a0 immune\t\r \u00a0 response\t\r \u00a0 against\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0 by\t\r \u00a0prime/booster\t\r \u00a0 immunization\t\r \u00a0 regimens\t\r \u00a0 with\t\r \u00a0 vaccinia\t\r \u00a0 virus\t\r \u00a0 recombinants\t\r \u00a0 expressing\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0p36/LACK\t\r \u00a0and\t\r \u00a0IL-\u00ad\u201012\t\r \u00a0in\t\r \u00a0combination\t\r \u00a0with\t\r \u00a0purified\t\r \u00a0p36.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a03,\t\r \u00a0701-\u00ad\u2010711\t\r \u00a0(2001).\t\r \u00a088\t\r \u00a0Gonzalo,\t\r \u00a0 R.\t\r \u00a0 M.;\t\r \u00a0 del\t\r \u00a0 Real,\t\r \u00a0 G.;\t\r \u00a0 Rodriguez,\t\r \u00a0 J.\t\r \u00a0 R.;\t\r \u00a0 Rodriguez,\t\r \u00a0 D.;\t\r \u00a0 Heljasvaara,\t\r \u00a0 R.;\t\r \u00a0 Lucas,\t\r \u00a0 P.;\t\r \u00a0Larraga,\t\r \u00a0V.;\t\r \u00a0Esteban,\t\r \u00a0M.\t\r \u00a0A\t\r \u00a0heterologous\t\r \u00a0prime-\u00ad\u2010boost\t\r \u00a0regime\t\r \u00a0using\t\r \u00a0DNA\t\r \u00a0and\t\r \u00a0recombinant\t\r \u00a0vaccinia\t\r \u00a0 virus\t\r \u00a0 expressing\t\r \u00a0 the\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0P36/LACK\t\r \u00a0 antigen\t\r \u00a0 protects\t\r \u00a0 BALB/c\t\r \u00a0mice\t\r \u00a0from\t\r \u00a0cutaneous\t\r \u00a0leishmaniasis.\t\r \u00a0Vaccine\t\r \u00a020,\t\r \u00a01226-\u00ad\u20101231\t\r \u00a0(2002).\t\r \u00a089\t\r \u00a0Ramos,\t\r \u00a0 I.;\t\r \u00a0 Alonso,\t\r \u00a0 A.;\t\r \u00a0 Marcen,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Peris,\t\r \u00a0 A.;\t\r \u00a0 Castillo,\t\r \u00a0 J.\t\r \u00a0 A.;\t\r \u00a0 Colmenares,\t\r \u00a0 M.;\t\r \u00a0 Larraga,\t\r \u00a0 V.\t\r \u00a0Heterologous\t\r \u00a0prime-\u00ad\u2010boost\t\r \u00a0vaccination\t\r \u00a0with\t\r \u00a0a\t\r \u00a0non-\u00ad\u2010replicative\t\r \u00a0vaccinia\t\r \u00a0recombinant\t\r \u00a0vector\t\r \u00a0expressing\t\r \u00a0 LACK\t\r \u00a0 confers\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0 canine\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis\t\r \u00a0 with\t\r \u00a0 a\t\r \u00a0predominant\t\r \u00a0Th1-\u00ad\u2010specific\t\r \u00a0immune\t\r \u00a0response.\t\r \u00a0Vaccine\t\r \u00a026,\t\r \u00a0333-\u00ad\u2010344\t\r \u00a0(2008).\t\r \u00a090\t\r \u00a0Dondji,\t\r \u00a0 B.;\t\r \u00a0 Deak,\t\r \u00a0 E.;\t\r \u00a0 Goldsmith-\u00ad\u2010Pestana,\t\r \u00a0 K.;\t\r \u00a0 Perez-\u00ad\u2010Jimenez,\t\r \u00a0 E.;\t\r \u00a0 Esteban,\t\r \u00a0 M.;\t\r \u00a0 Miyake,\t\r \u00a0 S.;\t\r \u00a0Yamamura,\t\r \u00a0T.;\t\r \u00a0McMahon-\u00ad\u2010Pratt,\t\r \u00a0D.\t\r \u00a0Intradermal\t\r \u00a0NKT\t\r \u00a0cell\t\r \u00a0activation\t\r \u00a0during\t\r \u00a0DNA\t\r \u00a0priming\t\r \u00a0in\t\r \u00a0heterologous\t\r \u00a0 prime-\u00ad\u2010boost\t\r \u00a0 vaccination\t\r \u00a0 enhances\t\r \u00a0 T\t\r \u00a0 cell\t\r \u00a0 responses\t\r \u00a0 and\t\r \u00a0 protection\t\r \u00a0 against\t\r \u00a0Leishmania.\t\r \u00a0European\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Immunology\t\r \u00a038,\t\r \u00a0706-\u00ad\u2010719\t\r \u00a0(2008).\t\r \u00a091\t\r \u00a0Ramos,\t\r \u00a0I.;\t\r \u00a0Alonso,\t\r \u00a0A.;\t\r \u00a0Peris,\t\r \u00a0A.;\t\r \u00a0Marcen,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Abengozar,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Alcolea,\t\r \u00a0P.\t\r \u00a0J.;\t\r \u00a0Castillo,\t\r \u00a0J.\t\r \u00a0A.;\t\r \u00a0Larraga,\t\r \u00a0V.\t\r \u00a0Antibiotic\t\r \u00a0resistance\t\r \u00a0free\t\r \u00a0plasmid\t\r \u00a0DNA\t\r \u00a0expressing\t\r \u00a0LACK\t\r \u00a0protein\t\r \u00a0leads\t\r \u00a0towards\t\r \u00a0a\t\r \u00a0protective\t\r \u00a0Th1\t\r \u00a0response\t\r \u00a0against\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0infection.\t\r \u00a0Vaccine\t\r \u00a027,\t\r \u00a06695-\u00ad\u20106703\t\r \u00a0(2009).\t\r \u00a092\t\r \u00a0Sanchez-\u00ad\u2010Sampedro,\t\r \u00a0 L.;\t\r \u00a0 Gomez,\t\r \u00a0 C.\t\r \u00a0 E.,\t\r \u00a0 Mejias-\u00ad\u2010Perez,\t\r \u00a0 E.;\t\r \u00a0 Sorzano,\t\r \u00a0 C.\t\r \u00a0 O.;\t\r \u00a0 Esteban,\t\r \u00a0 M.\t\r \u00a0 High\t\r \u00a0quality\t\r \u00a0 long-\u00ad\u2010term\t\r \u00a0 CD4+\t\r \u00a0 and\t\r \u00a0 CD8+\t\r \u00a0 effector\t\r \u00a0 memory\t\r \u00a0 populations\t\r \u00a0 stimulated\t\r \u00a0 by\t\r \u00a0 DNA-\u00ad\u2010LACK/MVA-\u00ad\u2010LACK\t\r \u00a0regimen\t\r \u00a0in\t\r \u00a0Leishmania\t\r \u00a0major\t\r \u00a0BALB/c\t\r \u00a0model\t\r \u00a0of\t\r \u00a0infection.\t\r \u00a0PLoS\t\r \u00a0One.\t\r \u00a07,\t\r \u00a0e38859\t\r \u00a0(2012).\t\r \u00a093\t\r \u00a0Perez-\u00ad\u2010Jimenez,\t\r \u00a0 E.;\t\r \u00a0 Kochan,\t\r \u00a0 G.;\t\r \u00a0 Gherardi,\t\r \u00a0 M.\t\r \u00a0 M.;\t\r \u00a0 Esteban,\t\r \u00a0 M.\t\r \u00a0 MVA-\u00ad\u2010LACK\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0 safe\t\r \u00a0 and\t\r \u00a0efficient\t\r \u00a0vector\t\r \u00a0for\t\r \u00a0vaccination\t\r \u00a0against\t\r \u00a0leishmaniasis.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a08,\t\r \u00a0810-\u00ad\u2010822\t\r \u00a0(2006).\t\r \u00a094\t\r \u00a0Tapia,\t\r \u00a0E.;\t\r \u00a0Perez-\u00ad\u2010Jimenez,\t\r \u00a0E.;\t\r \u00a0Lopez-\u00ad\u2010Fuertes,\t\r \u00a0L.;\t\r \u00a0Gonzalo,\t\r \u00a0R.;\t\r \u00a0Gherardi,\t\r \u00a0M.\t\r \u00a0M.;\t\r \u00a0Esteban,\t\r \u00a0M.\t\r \u00a0The\t\r \u00a0combination\t\r \u00a0 of\t\r \u00a0 DNA\t\r \u00a0 vectors\t\r \u00a0 expressing\t\r \u00a0 IL-\u00ad\u201012\t\r \u00a0 +\t\r \u00a0 IL-\u00ad\u201018\t\r \u00a0 elicits\t\r \u00a0 high\t\r \u00a0 protective\t\r \u00a0 immune\t\r \u00a0response\t\r \u00a0 against\t\r \u00a0 cutaneous\t\r \u00a0 leishmaniasis\t\r \u00a0 after\t\r \u00a0 priming\t\r \u00a0 with\t\r \u00a0 DNA-\u00ad\u2010p36/LACK\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0cytokines,\t\r \u00a0followed\t\r \u00a0by\t\r \u00a0a\t\r \u00a0booster\t\r \u00a0with\t\r \u00a0a\t\r \u00a0vaccinia\t\r \u00a0virus\t\r \u00a0recombinant\t\r \u00a0expressing\t\r \u00a0p36/LACK.\t\r \u00a0Microbes\t\r \u00a0and\t\r \u00a0Infection\t\r \u00a05,\t\r \u00a073-\u00ad\u201084\t\r \u00a0(2003).\t\r \u00a095\t\r \u00a0Ramiro,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0Zarate,\t\r \u00a0J.\t\r \u00a0J.;\t\r \u00a0Hanke,\t\r \u00a0T.;\t\r \u00a0Rodriguez,\t\r \u00a0D.;\t\r \u00a0Rodriguez,\t\r \u00a0J.\t\r \u00a0R.;\t\r \u00a0Esteban,\t\r \u00a0M.;\t\r \u00a0Lucientes,\t\r \u00a0J.;\t\r \u00a0 Castillo,\t\r \u00a0 J.\t\r \u00a0 A.;\t\r \u00a0 Larraga,\t\r \u00a0 V.\t\r \u00a0 Protection\t\r \u00a0 in\t\r \u00a0 dogs\t\r \u00a0 against\t\r \u00a0 visceral\t\r \u00a0 leishmaniasis\t\r \u00a0 caused\t\r \u00a0 by\t\r \u00a0Leishmania\t\r \u00a0 infantum\t\r \u00a0is\t\r \u00a0 achieved\t\r \u00a0 by\t\r \u00a0 immunization\t\r \u00a0 with\t\r \u00a0 a\t\r \u00a0 heterologous\t\r \u00a0 prime-\u00ad\u2010boost\t\r \u00a0regime\t\r \u00a0using\t\r \u00a0DNA\t\r \u00a0and\t\r \u00a0vaccinia\t\r \u00a0recombinant\t\r \u00a0vectors\t\r \u00a0expressing\t\r \u00a0LACK.\t\r \u00a0Vaccine\t\r \u00a021,\t\r \u00a02474-\u00ad\u20102484\t\r \u00a0(2003).\t\r \u00a096\t\r \u00a0Dominguez-\u00ad\u2010Bernal,\t\r \u00a0G.;\t\r \u00a0Horcajo,\t\r \u00a0P.;\t\r \u00a0Orden,\t\r \u00a0J.\t\r \u00a0A.;\t\r \u00a0De\t\r \u00a0La\t\r \u00a0Fuente,\t\r \u00a0R.;\t\r \u00a0Herrero-\u00ad\u2010Gil,\t\r \u00a0A.;\t\r \u00a0Ordonez-\u00ad\u2010Gutierrez,\t\r \u00a0 L.;\t\r \u00a0 Carrion,\t\r \u00a0 J.\t\r \u00a0 Mitigating\t\r \u00a0 an\t\r \u00a0 undesirable\t\r \u00a0 immune\t\r \u00a0 response\t\r \u00a0 of\t\r \u00a0 inherent\t\r \u00a0susceptibility\t\r \u00a0to\t\r \u00a0cutaneous\t\r \u00a0leishmaniosis\t\r \u00a0in\t\r \u00a0a\t\r \u00a0mouse\t\r \u00a0model:\t\r \u00a0the\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0pathoantigenic\t\r \u00a0HISA70\t\r \u00a0DNA\t\r \u00a0vaccine.\t\r \u00a0Veterinary\t\r \u00a0Research\t\r \u00a043,\t\r \u00a059\t\r \u00a0(2012).\t\r \u00a097\t\r \u00a0Parody,\t\r \u00a0N.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0Adjuvant\t\r \u00a0guided\t\r \u00a0polarization\t\r \u00a0of\t\r \u00a0the\t\r \u00a0immune\t\r \u00a0humoral\t\r \u00a0 response\t\r \u00a0 against\t\r \u00a0 a\t\r \u00a0 protective\t\r \u00a0 multicomponent\t\r \u00a0 antigenic\t\r \u00a0 protein\t\r \u00a0 (Q)\t\r \u00a0 from\t\r \u00a0Leishmania\t\r \u00a0 infantum.\t\r \u00a0 A\t\r \u00a0 CpG\t\r \u00a0 +\t\r \u00a0 Q\t\r \u00a0 mix\t\r \u00a0 protects\t\r \u00a0 Balb/c\t\r \u00a0 mice\t\r \u00a0 from\t\r \u00a0 infection.\t\r \u00a0 Parasite\t\r \u00a0Immunology\t\r \u00a026,\t\r \u00a0283-\u00ad\u2010293\t\r \u00a0(2004).\t\r \u00a098\t\r \u00a0Molano,\t\r \u00a0 I.;\t\r \u00a0 Alonso,\t\r \u00a0 M.\t\r \u00a0 G.;\t\r \u00a0 Miron,\t\r \u00a0 C.;\t\r \u00a0 Redondo,\t\r \u00a0 E.;\t\r \u00a0 Requena,\t\r \u00a0 J.\t\r \u00a0 M.;\t\r \u00a0 Soto,\t\r \u00a0 M.;\t\r \u00a0 Nieto,\t\r \u00a0 C.\t\r \u00a0 G.;\t\r \u00a0Alonso,\t\r \u00a0C.\t\r \u00a0A\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0multi-\u00ad\u2010component\t\r \u00a0antigenic\t\r \u00a0protein\t\r \u00a0mixed\t\r \u00a0with\t\r \u00a0live\t\r \u00a0BCG\t\r \u00a0confers\t\r \u00a0 protection\t\r \u00a0 to\t\r \u00a0 dogs\t\r \u00a0 experimentally\t\r \u00a0 infected\t\r \u00a0 with\t\r \u00a0L.\t\r \u00a0 infantum.\t\r \u00a0 Veterinary\t\r \u00a0Immunology\t\r \u00a0Immunopathology\t\r \u00a092,\t\r \u00a01-\u00ad\u201013\t\r \u00a0(2003).\t\r \u00a099\t\r \u00a0Carcelen,\t\r \u00a0 J.;\t\r \u00a0 Iniesta,\t\r \u00a0 V.;\t\r \u00a0 Fernandez-\u00ad\u2010Cotrina,\t\r \u00a0 J.;\t\r \u00a0 Serrano,\t\r \u00a0 F.;\t\r \u00a0 Parejo,\t\r \u00a0 J.\t\r \u00a0 C.;\t\r \u00a0 Corraliza,\t\r \u00a0 I.;\t\r \u00a0Gallardo-\u00ad\u2010Soler,\t\r \u00a0A.;\t\r \u00a0Mara\u00f1on,\t\r \u00a0F.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Gomez-\u00ad\u2010Nieto,\t\r \u00a0C.\t\r \u00a0The\t\r \u00a0chimerical\t\r \u00a0multi-\u00ad\u2010component\t\r \u00a0Q\t\r \u00a0protein\t\r \u00a0from\t\r \u00a0Leishmania\t\r \u00a0in\t\r \u00a0the\t\r \u00a0absence\t\r \u00a0of\t\r \u00a0adjuvant\t\r \u00a0protects\t\r \u00a0dogs\t\r \u00a0against\t\r \u00a0an\t\r \u00a0experimental\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0infection.\t\r \u00a0Vaccine.\t\r \u00a027,\t\r \u00a05964-\u00ad\u20105973\t\r \u00a0(2009).\t\r \u00a0Carlos\t\r \u00a0Alonso,\t\r \u00a0Manuel\t\r \u00a0Soto\t\r \u00a0\t\r \u00a0\n264\t\r \u00a0\t\r \u00a0100\t\r \u00a0Fernandez-\u00ad\u2010Cotrina,\t\r \u00a0 J.;\t\r \u00a0 Iniesta,\t\r \u00a0 V.;\t\r \u00a0 Belinchon-\u00ad\u2010Lorenzo,\t\r \u00a0 S.;\t\r \u00a0 Munoz-\u00ad\u2010Madrid,\t\r \u00a0 R.;\t\r \u00a0 Serrano,\t\r \u00a0 F.;\t\r \u00a0Parejo,\t\r \u00a0J.\t\r \u00a0C.;\t\r \u00a0Gomez-\u00ad\u2010Gordo,\t\r \u00a0L.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Alonso,\t\r \u00a0C.;\t\r \u00a0Gomez-\u00ad\u2010Nieto,\t\r \u00a0L.\t\r \u00a0C.\t\r \u00a0Experimental\t\r \u00a0model\t\r \u00a0for\t\r \u00a0 reproduction\t\r \u00a0 of\t\r \u00a0 canine\t\r \u00a0 visceral\t\r \u00a0 leishmaniosis\t\r \u00a0 by\t\r \u00a0Leishmania\t\r \u00a0 infantum.\t\r \u00a0Veterinary\t\r \u00a0Parasitology\t\r \u00a0192,\t\r \u00a0118-\u00ad\u2010128\t\r \u00a0(2013).\t\r \u00a0101\t\r \u00a0Kaye,\t\r \u00a0P.;\t\r \u00a0Scott,\t\r \u00a0P.\t\r \u00a0Leishmaniasis:\t\r \u00a0complexity\t\r \u00a0at\t\r \u00a0the\t\r \u00a0host-\u00ad\u2010pathogen\t\r \u00a0interface.\t\r \u00a0Nature\t\r \u00a0Review\t\r \u00a0Microbiology\t\r \u00a09,\t\r \u00a0604-\u00ad\u2010615\t\r \u00a0(2011).\t\r \u00a0102\t\r \u00a0Beattie,\t\r \u00a0L.;\t\r \u00a0Evans,\t\r \u00a0K.\t\r \u00a0J.;\t\r \u00a0Kaye,\t\r \u00a0P.\t\r \u00a0M.;\t\r \u00a0Smith,\t\r \u00a0D.\t\r \u00a0F.\t\r \u00a0Transgenic\t\r \u00a0Leishmania\t\r \u00a0and\t\r \u00a0the\t\r \u00a0immune\t\r \u00a0response\t\r \u00a0to\t\r \u00a0infection.\t\r \u00a0Parasite\t\r \u00a0Immunology\t\r \u00a030,\t\r \u00a0255-\u00ad\u2010266\t\r \u00a0(2008).\t\r \u00a0103\t\r \u00a0Carrion,\t\r \u00a0J.;\t\r \u00a0Folgueira,\t\r \u00a0C.;\t\r \u00a0Soto,\t\r \u00a0M.;\t\r \u00a0Fresno,\t\r \u00a0M.;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0HSP70-\u00ad\u2010II\t\r \u00a0null\t\r \u00a0mutant\t\r \u00a0as\t\r \u00a0candidate\t\r \u00a0vaccine\t\r \u00a0against\t\r \u00a0leishmaniasis:\t\r \u00a0a\t\r \u00a0preliminary\t\r \u00a0evaluation.\t\r \u00a0Parasites\t\r \u00a0&\t\r \u00a0Vectors\t\r \u00a04,\t\r \u00a0150\t\r \u00a0(2011).\t\r \u00a0104\t\r \u00a0Folgueira,\t\r \u00a0C.;\t\r \u00a0Carrion,\t\r \u00a0J.;\t\r \u00a0Moreno,\t\r \u00a0J.;\t\r \u00a0Saugar,\t\r \u00a0J.\t\r \u00a0M.;\t\r \u00a0Ca\u00f1avate,\t\r \u00a0C;\t\r \u00a0Requena,\t\r \u00a0J.\t\r \u00a0M.\t\r \u00a0Effects\t\r \u00a0of\t\r \u00a0the\t\r \u00a0disruption\t\r \u00a0of\t\r \u00a0the\t\r \u00a0HSP70-\u00ad\u2010II\t\r \u00a0gene\t\r \u00a0on\t\r \u00a0the\t\r \u00a0growth,\t\r \u00a0morphology,\t\r \u00a0and\t\r \u00a0virulence\t\r \u00a0of\t\r \u00a0Leishmania\t\r \u00a0infantum\t\r \u00a0promastigotes.\t\r \u00a0International\t\r \u00a0Microbiology\t\r \u00a011,\t\r \u00a081-\u00ad\u201089\t\r \u00a0(2008).\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0265\t\r \u00a0\t\r \u00a0\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos:\t\r \u00a0conceptos\t\r \u00a0generales\t\r \u00a0Marlene\t\r \u00a0 Marcelina\t\r \u00a0 Saucedo-\u00ad\u2010Balderas1,\t\r \u00a0 Oscar\t\r \u00a0 Z\u00fa\u00f1iga-\u00ad\u2010Lemus1,\t\r \u00a0 David\t\r \u00a0 Orteg\u00f3n-\u00ad\u2010Reyna2,\t\r \u00a0Juan\t\r \u00a0Saulo\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Gonz\u00e1lez1*\t\r \u00a01Instituto\t\r \u00a0de\t\r \u00a0Farmacobiolog\u00eda,\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Ca\u00f1ada,Carretera\t\r \u00a0Teotitl\u00e1n\t\r \u00a0-\u00ad\u2010\t\r \u00a0San\t\r \u00a0Antonio\t\r \u00a0Nanahuatip\u00e1n\t\r \u00a0Km\t\r \u00a01.7\t\r \u00a0s/n.\t\r \u00a0Paraje\t\r \u00a0Titlacuatitla.\t\r \u00a0Teotitl\u00e1n\t\r \u00a0de\t\r \u00a0Flores\t\r \u00a0Mag\u00f3n,\t\r \u00a0Oax.\t\r \u00a0M\u00e9xico,\t\r \u00a0C.P.\t\r \u00a068540.\t\r \u00a02Departamento\t\r \u00a0de\t\r \u00a0Qu\u00edmica,\t\r \u00a0 CINVESTAV-\u00ad\u2010IPN,\t\r \u00a0 Av.\t\r \u00a0 Instituto\t\r \u00a0 Polit\u00e9cnicoNacional\t\r \u00a0 2508,\t\r \u00a0Col.\t\r \u00a0 San\t\r \u00a0 Pedro\t\r \u00a0 Zacatenco,\t\r \u00a0 Apartado\t\r \u00a0postal:\t\r \u00a014-\u00ad\u2010740,07000,\t\r \u00a0C.P.\t\r \u00a007360\t\r \u00a0M\u00e9xico,\t\r \u00a0D.F.,\t\r \u00a0M\u00e9xico\t\r \u00a0e-\u00ad\u2010mail:\t\r \u00a0juan_saulo@unca.edu.mx\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0265-\u00ad\u2010273.\t\r \u00a0RESUMEN\t\r \u00a0Los\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 surgen\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 posibilidad\t\r \u00a0 para\t\r \u00a0 mejorar\t\r \u00a0 las\t\r \u00a0propiedades\t\r \u00a0 biofarmac\u00e9uticas\t\r \u00a0 y\t\r \u00a0 farmacot\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 IFA\t\r \u00a0 (Ingrediente\t\r \u00a0Farmac\u00e9utico\t\r \u00a0 Activo).\t\r \u00a0 Los\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 son\t\r \u00a0 s\u00f3lidos\t\r \u00a0 cristalinos\t\r \u00a0constituidos\t\r \u00a0por\t\r \u00a0un\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0un\t\r \u00a0formador,\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0en\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0celda\t\r \u00a0cristalina.\t\r \u00a0La\t\r \u00a0b\u00fasqueda\t\r \u00a0de\t\r \u00a0nuevos\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0es\t\r \u00a0competencia\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0 supramolecular,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 IFA\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 formador\t\r \u00a0 se\t\r \u00a0 mantienen\t\r \u00a0 juntos\t\r \u00a0mediante\t\r \u00a0interacciones\t\r \u00a0no\t\r \u00a0covalentes.\t\r \u00a0Existen\t\r \u00a0m\u00e9todos\t\r \u00a0en\t\r \u00a0soluci\u00f3n\t\r \u00a0y\t\r \u00a0en\t\r \u00a0s\u00f3lidos\t\r \u00a0para\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 cocristales.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 este\t\r \u00a0 campo\t\r \u00a0 ofrece\t\r \u00a0 una\t\r \u00a0 posibilidad\t\r \u00a0 de\t\r \u00a0desarrollo\t\r \u00a0 intelectual\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0posibilidad\t\r \u00a0 de\t\r \u00a0 patentar\t\r \u00a0 los\t\r \u00a0 productos,\t\r \u00a0considerando\t\r \u00a0 los\t\r \u00a0 par\u00e1metros\t\r \u00a0regulatorios.\t\r \u00a0Este\t\r \u00a0 trabajo\t\r \u00a0 presenta\t\r \u00a0 los\t\r \u00a0 principales\t\r \u00a0conceptos\t\r \u00a0que\t\r \u00a0se\t\r \u00a0consideran\t\r \u00a0para\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0s\u00f3lidos\t\r \u00a0farmac\u00e9uticos.\t\r \u00a0Palabras\t\r \u00a0 clave:\t\r \u00a0Qu\u00edmica\t\r \u00a0 supramolecular;\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos;\t\r \u00a0cocristalizaci\u00f3n.\t\r \u00a0ABSTRACT\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystals:\t\r \u00a0General\t\r \u00a0concepts.\t\r \u00a0Pharmaceutical\t\r \u00a0co-\u00ad\u2010crystals\t\r \u00a0emerge\t\r \u00a0as\t\r \u00a0 a\t\r \u00a0possibility\t\r \u00a0to\t\r \u00a0 improve\t\r \u00a0 the\t\r \u00a0biopharmaceutical\t\r \u00a0properties\t\r \u00a0and\t\r \u00a0pharmacotechnical\t\r \u00a0of\t\r \u00a0an\t\r \u00a0Active\t\r \u00a0Pharmaceutical\t\r \u00a0Ingredient\t\r \u00a0 (API).\t\r \u00a0Theco-\u00ad\u2010crystalsare\t\r \u00a0 crystalline\t\r \u00a0 solids\t\r \u00a0composed\t\r \u00a0 of\t\r \u00a0an\t\r \u00a0 API\t\r \u00a0and\t\r \u00a0a\t\r \u00a0former,\t\r \u00a0which\t\r \u00a0 are\t\r \u00a0 located\t\r \u00a0in\t\r \u00a0the\t\r \u00a0 same\t\r \u00a0 crystal\t\r \u00a0cell.\t\r \u00a0The\t\r \u00a0 search\t\r \u00a0for\t\r \u00a0 new\t\r \u00a0pharmaceutical\t\r \u00a0co-\u00ad\u2010crystals\t\r \u00a0is\t\r \u00a0 the\t\r \u00a0 responsibility\t\r \u00a0of\t\r \u00a0 supramolecular\t\r \u00a0 chemistry,\t\r \u00a0since\t\r \u00a0 the\t\r \u00a0formerand\t\r \u00a0 the\t\r \u00a0 API\t\r \u00a0 are\t\r \u00a0 held\t\r \u00a0 together\t\r \u00a0by\t\r \u00a0 non-\u00ad\u2010covalent\t\r \u00a0interactions.\t\r \u00a0REVISI\u00d3N\t\r \u00a0\nMarlene\t\r \u00a0Marcelina\t\r \u00a0Saucedo-\u00ad\u2010Balderas\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n266\t\r \u00a0\t\r \u00a0Solution\t\r \u00a0and\t\r \u00a0solid\t\r \u00a0state\t\r \u00a0methods\t\r \u00a0are\t\r \u00a0employed\t\r \u00a0for\t\r \u00a0the\t\r \u00a0formation\t\r \u00a0of\t\r \u00a0cocrystals.\t\r \u00a0In\t\r \u00a0addition,\t\r \u00a0 this\t\r \u00a0field\t\r \u00a0offers\t\r \u00a0 a\t\r \u00a0 possibility\t\r \u00a0 of\t\r \u00a0intellectual\t\r \u00a0development\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0the\t\r \u00a0patentability\t\r \u00a0 of\t\r \u00a0products,\t\r \u00a0without\t\r \u00a0 neglecting\t\r \u00a0the\t\r \u00a0 regulatory\t\r \u00a0aspects.\t\r \u00a0This\t\r \u00a0 work\t\r \u00a0presents\t\r \u00a0 the\t\r \u00a0 main\t\r \u00a0concepts\t\r \u00a0 considered\t\r \u00a0for\t\r \u00a0 the\t\r \u00a0 study\t\r \u00a0 of\t\r \u00a0these\t\r \u00a0 pharmaceutical\t\r \u00a0solids.\t\r \u00a0Keywords:\t\r \u00a0Supramolecular\t\r \u00a0chemistry;\t\r \u00a0 active\t\r \u00a0 pharmaceutical\t\r \u00a0 ingredient;\t\r \u00a0cocrystallization.\t\r \u00a01.\t\r \u00a0INTRODUCCI\u00d3N\t\r \u00a0La\t\r \u00a0 qu\u00edmica\t\r \u00a0 supramolecular,\t\r \u00a0 o\t\r \u00a0qu\u00edmica\t\r \u00a0 entre\t\r \u00a0 mol\u00e9culas,\t\r \u00a0 se\t\r \u00a0 encarga\t\r \u00a0 del\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0las\t\r \u00a0interacciones\t\r \u00a0no\t\r \u00a0covalentes\t\r \u00a0presentes\t\r \u00a0entre\t\r \u00a0mol\u00e9culas\t\r \u00a0diferentes\t\r \u00a0o\t\r \u00a0del\t\r \u00a0 mismo\t\r \u00a0 tipo,\t\r \u00a0 ya\t\r \u00a0 sea\t\r \u00a0 en\t\r \u00a0estado\t\r \u00a0 s\u00f3lido\t\r \u00a0 (empaquetamiento\t\r \u00a0 cristalino)\t\r \u00a0 o\t\r \u00a0 en\t\r \u00a0soluci\u00f3n.\t\r \u00a0Estas\t\r \u00a0interacciones\t\r \u00a0se\t\r \u00a0llevan\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0sitios\t\r \u00a0de\t\r \u00a0reconocimiento\t\r \u00a0de\t\r \u00a0las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 (grupos\t\r \u00a0 funcionales)\t\r \u00a0 y\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0 responsables\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diferentes\t\r \u00a0arreglos\t\r \u00a0supramoleculares\t\r \u00a0adoptados\t\r \u00a0(1).\t\r \u00a0El\t\r \u00a0reconocimiento\t\r \u00a0molecular\t\r \u00a0es\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0supramolecular,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0la\t\r \u00a0 construcci\u00f3n\t\r \u00a0 de\t\r \u00a0 cualquier\t\r \u00a0 sistema\t\r \u00a0 supramolecular\t\r \u00a0 \t\r \u00a0 involucra\t\r \u00a0combinaciones\t\r \u00a0moleculares\t\r \u00a0 selectivas.\t\r \u00a0 Las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 que\t\r \u00a0 hacen\t\r \u00a0 el\t\r \u00a0 reconocimiento\t\r \u00a0 se\t\r \u00a0 llaman\t\r \u00a0receptores\t\r \u00a0 (host)\t\r \u00a0 y\t\r \u00a0 aquellas\t\r \u00a0 que\t\r \u00a0son\t\r \u00a0 reconocidas\t\r \u00a0 son\t\r \u00a0 conocidas\t\r \u00a0 como\t\r \u00a0 sustratos\t\r \u00a0(guest),\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 tanto,\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 qu\u00edmica\t\r \u00a0 supramolecular\t\r \u00a0 a\t\r \u00a0 veces\t\r \u00a0 se\t\r \u00a0 le\t\r \u00a0 conoce\t\r \u00a0 como\t\r \u00a0qu\u00edmica\t\r \u00a0de\t\r \u00a0receptor-\u00ad\u2010sustrato\t\r \u00a0(host-\u00ad\u2010guest\t\r \u00a0chemistry)\t\r \u00a0(1).\t\r \u00a0La\t\r \u00a0ingenier\u00eda\t\r \u00a0de\t\r \u00a0cristales\t\r \u00a0se\t\r \u00a0encarga\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aplicaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0conceptos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0 supramolecular\t\r \u00a0 al\t\r \u00a0 estado\t\r \u00a0 s\u00f3lido,\t\r \u00a0 enfatizando\t\r \u00a0 la\t\r \u00a0 idea\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 s\u00f3lidos\t\r \u00a0cristalinos\t\r \u00a0son\t\r \u00a0manifestaciones\t\r \u00a0de\t\r \u00a0autoensambles\t\r \u00a0de\t\r \u00a0mol\u00e9culas.\t\r \u00a0Estas\t\r \u00a0estructuras\t\r \u00a0cristalinas\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0consideradas\t\r \u00a0como\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0eventos\t\r \u00a0moleculares\t\r \u00a0de\t\r \u00a0que\t\r \u00a0involucran\t\r \u00a0un\t\r \u00a0 reconocimiento\t\r \u00a0 molecular\t\r \u00a0 mediante\t\r \u00a0 interacciones\t\r \u00a0 d\u00e9biles\t\r \u00a0 y\t\r \u00a0direccionales.\t\r \u00a0 De\t\r \u00a0 esta\t\r \u00a0 forma,\t\r \u00a0 es\t\r \u00a0 competencia\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 s\u00edntesis\t\r \u00a0 supramolecular\t\r \u00a0 el\t\r \u00a0dise\u00f1o\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 preparaci\u00f3n\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 materiales\t\r \u00a0 cristalinos,\t\r \u00a0 entre\t\r \u00a0 ellos\t\r \u00a0 los\t\r \u00a0cocristales\t\r \u00a0(2).\t\r \u00a0Un\t\r \u00a0 cocristal\t\r \u00a0 puede\t\r \u00a0 ser\t\r \u00a0 definido\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 complejo\t\r \u00a0 cristalino\t\r \u00a0 formado\t\r \u00a0 por\t\r \u00a0dos\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0especies\t\r \u00a0neutras\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0en\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0celda\t\r \u00a0cristalina\t\r \u00a0y\t\r \u00a0que\t\r \u00a0se\t\r \u00a0mantienen\t\r \u00a0 unidas\t\r \u00a0 mediante\t\r \u00a0 interacciones\t\r \u00a0 no\t\r \u00a0 covalentes,\t\r \u00a0 principalmente\t\r \u00a0 por\t\r \u00a0enlaces\t\r \u00a0de\t\r \u00a0hidr\u00f3geno\t\r \u00a0(3).\t\r \u00a02.\t\r \u00a0COCRISTALES\t\r \u00a0FARMAC\u00c9UTICOS\t\r \u00a0La\t\r \u00a0 capacidad\t\r \u00a0 de\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 dentro\t\r \u00a0 del\t\r \u00a0 paciente\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0eficiente,\t\r \u00a0 segura\t\r \u00a0 y\t\r \u00a0 barata\t\r \u00a0 depende\t\r \u00a0 en\t\r \u00a0 gran\t\r \u00a0 medida\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 caracter\u00edsticas\t\r \u00a0fisicoqu\u00edmicas\t\r \u00a0 del\t\r \u00a0 ingrediente\t\r \u00a0 farmac\u00e9utico\t\r \u00a0 activo\t\r \u00a0 (IFA)\t\r \u00a0(4).\t\r \u00a0 La\t\r \u00a0 mayor\u00eda\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0267\t\r \u00a0\t\r \u00a0IFA\u00b4s\t\r \u00a0 son\t\r \u00a0 s\u00f3lidos,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0que\t\r \u00a0 se\t\r \u00a0 requiere\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 encuentren\t\r \u00a0 en\t\r \u00a0 estado\t\r \u00a0 cristalino\t\r \u00a0debido\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 facilidad\t\r \u00a0 de\t\r \u00a0 obtenci\u00f3n\t\r \u00a0 y\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 proceso\t\r \u00a0 de\t\r \u00a0 cristalizaci\u00f3n\t\r \u00a0 ayuda\t\r \u00a0 a\t\r \u00a0eliminar\t\r \u00a0las\t\r \u00a0impurezas\t\r \u00a0presentes.\t\r \u00a0Tradicionalmente\t\r \u00a0los\t\r \u00a0IFA\u00b4s\t\r \u00a0en\t\r \u00a0estado\t\r \u00a0cristalino\t\r \u00a0se\t\r \u00a0presentan\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0sales,\t\r \u00a0solvatos\t\r \u00a0y\t\r \u00a0polimorfos\t\r \u00a0(Figura\t\r \u00a01).\t\r \u00a0\t\r \u00a0Los\t\r \u00a0 polimorfos\t\r \u00a0 son\t\r \u00a0 estructuras\t\r \u00a0 cristalinas\t\r \u00a0 del\t\r \u00a0 mismo\t\r \u00a0 compuesto\t\r \u00a0 que\t\r \u00a0pueden\t\r \u00a0 organizarse\t\r \u00a0 al\t\r \u00a0 menos\t\r \u00a0 de\t\r \u00a0 dos\t\r \u00a0 formas\t\r \u00a0 diferentes;\t\r \u00a0 cada\t\r \u00a0 polimorfo\t\r \u00a0 puede\t\r \u00a0presentar\t\r \u00a0propiedades\t\r \u00a0fisicoqu\u00edmicas\t\r \u00a0diferentes.\t\r \u00a0Los\t\r \u00a0solvatos\t\r \u00a0e\t\r \u00a0hidratos\t\r \u00a0se\t\r \u00a0forman\t\r \u00a0al\t\r \u00a0quedar\t\r \u00a0atrapadas\t\r \u00a0mol\u00e9culas\t\r \u00a0del\t\r \u00a0disolvente\t\r \u00a0o\t\r \u00a0de\t\r \u00a0agua\t\r \u00a0dentro\t\r \u00a0de\t\r \u00a0la\t\r \u00a0red\t\r \u00a0cristalina;\t\r \u00a0esto\t\r \u00a0puede\t\r \u00a0representar\t\r \u00a0un\t\r \u00a0problema\t\r \u00a0si\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0periodo\t\r \u00a0de\t\r \u00a0almacenamiento\t\r \u00a0las\t\r \u00a0mol\u00e9culas\t\r \u00a0de\t\r \u00a0disolvente\t\r \u00a0se\t\r \u00a0liberan\t\r \u00a0de\t\r \u00a0la\t\r \u00a0red\t\r \u00a0cristalina\t\r \u00a0puede\t\r \u00a0afectar\t\r \u00a0la\t\r \u00a0estabilidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0forma\t\r \u00a0farmac\u00e9utica.\t\r \u00a0La\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0sales\t\r \u00a0de\t\r \u00a0los\t\r \u00a0IFA\u00b4s\t\r \u00a0constituye\t\r \u00a0el\t\r \u00a0principal\t\r \u00a0m\u00e9todo\t\r \u00a0 para\t\r \u00a0 mejorar\t\r \u00a0 la\t\r \u00a0 solubilidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 mismos;\t\r \u00a0 esto\t\r \u00a0 se\t\r \u00a0 logra\t\r \u00a0 haciendo\t\r \u00a0reaccionar\t\r \u00a0el\t\r \u00a0IFA\t\r \u00a0con\t\r \u00a0un\t\r \u00a0\u00e1cido\t\r \u00a0o\t\r \u00a0una\t\r \u00a0base,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0da\t\r \u00a0como\t\r \u00a0resulta\t\r \u00a0el\t\r \u00a0IFA\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0ionizada\t\r \u00a0(5).\t\r \u00a0En\t\r \u00a0ocasiones\t\r \u00a0estas\t\r \u00a0sales\t\r \u00a0no\t\r \u00a0tienen\t\r \u00a0las\t\r \u00a0propiedades\t\r \u00a0s\u00f3lidas\t\r \u00a0adecuadas\t\r \u00a0o\t\r \u00a0no\t\r \u00a0pueden\t\r \u00a0formarse\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0ausencia\t\r \u00a0de\t\r \u00a0grupos\t\r \u00a0ionizables\t\r \u00a0en\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0qu\u00edmica\t\r \u00a0del\t\r \u00a0IFA\t\r \u00a0(6).\t\r \u00a0Los\t\r \u00a0problemas\t\r \u00a0con\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0los\t\r \u00a0materiales\t\r \u00a0en\t\r \u00a0estado\t\r \u00a0cristalino\t\r \u00a0son\t\r \u00a0su\t\r \u00a0poca\t\r \u00a0solubilidad\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 existencia\t\r \u00a0 de\t\r \u00a0 m\u00e1s\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0 cristalina\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 IFA\t\r \u00a0(polimorfismo).\t\r \u00a0 Es\t\r \u00a0 aqu\u00ed\t\r \u00a0 donde\t\r \u00a0 la\t\r \u00a0 ingenier\u00eda\t\r \u00a0 de\t\r \u00a0 cristales\t\r \u00a0 ofrece\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0alternativa\t\r \u00a0 de\t\r \u00a0 presentaci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 IFA\u00b4s\t\r \u00a0 en\t\r \u00a0 estado\t\r \u00a0 cristalino:\t\r \u00a0 los\t\r \u00a0 cocristales\t\r \u00a0farmac\u00e9uticos.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Sistemas\t\r \u00a0cristalinos\t\r \u00a0de\t\r \u00a0IFA\u00b4s.\t\r \u00a0Los\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 (Figura\t\r \u00a0 1)\t\r \u00a0 son\t\r \u00a0 materiales\t\r \u00a0 cristalinos\t\r \u00a0constituidos\t\r \u00a0por\t\r \u00a0un\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0uno\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0agentes\t\r \u00a0formadores\t\r \u00a0de\t\r \u00a0cocristales,\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0son\t\r \u00a0s\u00f3lidos\t\r \u00a0a\t\r \u00a0temperatura\t\r \u00a0ambiente\t\r \u00a0(7).\t\r \u00a0\nMarlene\t\r \u00a0Marcelina\t\r \u00a0Saucedo-\u00ad\u2010Balderas\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n268\t\r \u00a0\t\r \u00a0Para\t\r \u00a0 el\t\r \u00a0 dise\u00f1o\t\r \u00a0 de\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 debe\t\r \u00a0 tomarse\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 los\t\r \u00a0grupos\t\r \u00a0 funcionales\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 que\t\r \u00a0 permitan\t\r \u00a0 el\t\r \u00a0 reconocimiento\t\r \u00a0 molecular\t\r \u00a0 por\t\r \u00a0 parte\t\r \u00a0del\t\r \u00a0 agente\t\r \u00a0 cocristalizante.\t\r \u00a0 Para\t\r \u00a0 esto\t\r \u00a0 se\t\r \u00a0 utilizan\t\r \u00a0 diferentes\t\r \u00a0sintones\t\r \u00a0supramoleculares,\t\r \u00a0 que\t\r \u00a0 son\t\r \u00a0 mol\u00e9culas\t\r \u00a0 que\t\r \u00a0 contienen\t\r \u00a0 grupos\t\r \u00a0 funcionales\t\r \u00a0 que\t\r \u00a0se\t\r \u00a0complementan\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 funcionales\t\r \u00a0 del\t\r \u00a0 IFA,\t\r \u00a0 facilitando\t\r \u00a0 el\t\r \u00a0 reconocimiento\t\r \u00a0molecular\t\r \u00a0(2).\t\r \u00a0Los\t\r \u00a0agentes\t\r \u00a0formadores\t\r \u00a0de\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0m\u00e1s\t\r \u00a0comunes\t\r \u00a0son:\t\r \u00a0 \u00e1cidos,\t\r \u00a0 amidas,\t\r \u00a0 carbohidratos,\t\r \u00a0 alcoholes\t\r \u00a0 y\t\r \u00a0 amino\u00e1cidos\t\r \u00a0(8).\t\r \u00a0La\t\r \u00a0 Figura\t\r \u00a0 2\t\r \u00a0\t\r \u00a0muestra\t\r \u00a0algunos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 principales\t\r \u00a0 sintones\t\r \u00a0 supramoleculares\t\r \u00a0 empleados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a02.-\u00ad\u2010\t\r \u00a0Sintones\t\r \u00a0supramoleculares\t\r \u00a0empleados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos.\t\r \u00a0Los\t\r \u00a0 cocristales\t\r \u00a0 representan\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 modificar\t\r \u00a0 las\t\r \u00a0 propiedades\t\r \u00a0biofarmaceuticas\t\r \u00a0 y\t\r \u00a0 farmacot\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 IFA,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 permite\t\r \u00a0 obtener\t\r \u00a0 nuevos\t\r \u00a0s\u00f3lidos\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 con\t\r \u00a0 propiedades\t\r \u00a0distintas\t\r \u00a0 de\t\r \u00a0 solubilidad,\t\r \u00a0 velocidad\t\r \u00a0 de\t\r \u00a0disoluci\u00f3n,\t\r \u00a0estabilidad\t\r \u00a0fisicoqu\u00edmica,\t\r \u00a0higroscopicidad\t\r \u00a0(7).\t\r \u00a03.\t\r \u00a0PREPARACI\u00d3N\t\r \u00a0DE\t\r \u00a0COCRISTALES\t\r \u00a0FARMAC\u00c9UTICOS\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0se\t\r \u00a0preparan\t\r \u00a0principalmente\t\r \u00a0por\t\r \u00a0m\u00e9todos\t\r \u00a0en\t\r \u00a0soluci\u00f3n\t\r \u00a0y\t\r \u00a0por\t\r \u00a0m\u00e9todos\t\r \u00a0en\t\r \u00a0estado\t\r \u00a0s\u00f3lido.\t\r \u00a0Los\t\r \u00a0m\u00e9todos\t\r \u00a0en\t\r \u00a0soluci\u00f3n\t\r \u00a0consisten\t\r \u00a0en\t\r \u00a0mezclar\t\r \u00a0cantidades\t\r \u00a0equimolares\t\r \u00a0del\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0del\t\r \u00a0formador\t\r \u00a0en\t\r \u00a0un\t\r \u00a0disolvente\t\r \u00a0adecuado,con\t\r \u00a0la\t\r \u00a0finalidad\t\r \u00a0de\t\r \u00a0que\t\r \u00a0al\t\r \u00a0evaporarse\t\r \u00a0el\t\r \u00a0disolvente\t\r \u00a0se\t\r \u00a0obtengan\t\r \u00a0los\t\r \u00a0cocristales.\t\r \u00a0Los\t\r \u00a0m\u00e9todos\t\r \u00a0s\u00f3lidos\t\r \u00a0son\t\r \u00a0una\t\r \u00a0aplicaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0s\u00edntesis\t\r \u00a0mecanoqu\u00edmica\t\r \u00a0(8)\t\r \u00a0y\t\r \u00a0consisten\t\r \u00a0en\t\r \u00a0moler\t\r \u00a0en\t\r \u00a0un\t\r \u00a0mortero\t\r \u00a0o\t\r \u00a0en\t\r \u00a0un\t\r \u00a0molino,\t\r \u00a0cantidades\t\r \u00a0equimolares\t\r \u00a0del\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0 del\t\r \u00a0 formador.\t\r \u00a0 Una\t\r \u00a0 modificaci\u00f3n\t\r \u00a0 de\t\r \u00a0esta\t\r \u00a0 t\u00e9cnica\t\r \u00a0 consiste\t\r \u00a0 en\t\r \u00a0 agregar\t\r \u00a0 gotas\t\r \u00a0 de\t\r \u00a0alg\u00fan\t\r \u00a0disolvente\t\r \u00a0al\t\r \u00a0momento\t\r \u00a0de\t\r \u00a0hacer\t\r \u00a0la\t\r \u00a0molienda\t\r \u00a0(9-\u00ad\u201012).\t\r \u00a0Otros\t\r \u00a0m\u00e9todos\t\r \u00a0 reportados\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0son:\t\r \u00a0la\t\r \u00a0adici\u00f3n\t\r \u00a0de\t\r \u00a0antisolventes\t\r \u00a0(13),\t\r \u00a0cocristalizaci\u00f3n\t\r \u00a0asistida\t\r \u00a0por\t\r \u00a0ultrasonido(14),\t\r \u00a0cocristalizaci\u00f3n\t\r \u00a0 con\t\r \u00a0 fluidos\t\r \u00a0 supercr\u00edticos\t\r \u00a0(15)\t\r \u00a0 y\t\r \u00a0 cocristalizaci\u00f3n\t\r \u00a0 por\t\r \u00a0 slurryng\t\r \u00a0 o\t\r \u00a0suspensi\u00f3n\t\r \u00a0(16).\t\r \u00a0\nLos\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0269\t\r \u00a0\t\r \u00a04.\t\r \u00a0CARACTERIZACI\u00d3N\t\r \u00a0DE\t\r \u00a0COCRISTALES\t\r \u00a0FARMAC\u00c9UTICOS\t\r \u00a0La\t\r \u00a0 caracterizaci\u00f3n\t\r \u00a0 estructural\t\r \u00a0 \t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 cocristales\t\r \u00a0 se\t\r \u00a0 realiza\t\r \u00a0 utilizando\t\r \u00a0t\u00e9cnicas\t\r \u00a0 como\t\r \u00a0 espectrofotometr\u00eda\t\r \u00a0 de\t\r \u00a0 infrarrojo\t\r \u00a0 (IR),\t\r \u00a0 difracci\u00f3n\t\r \u00a0 de\t\r \u00a0 rayos\t\r \u00a0 X\t\r \u00a0de\t\r \u00a0monocristal,\t\r \u00a0 difracci\u00f3n\t\r \u00a0 de\t\r \u00a0 rayos\t\r \u00a0 X\t\r \u00a0 de\t\r \u00a0 polvos\t\r \u00a0 y\t\r \u00a0 resonancia\t\r \u00a0 magn\u00e9tica\t\r \u00a0 nuclear.\t\r \u00a0Mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0caracterizaci\u00f3n\t\r \u00a0f\u00edsica\t\r \u00a0se\t\r \u00a0determina\t\r \u00a0el\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0fusi\u00f3n\t\r \u00a0y\t\r \u00a0se\t\r \u00a0utilizan\t\r \u00a0t\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 calorimetr\u00eda\t\r \u00a0 diferencial\t\r \u00a0 de\t\r \u00a0 barrido\t\r \u00a0 DSC\t\r \u00a0 y\t\r \u00a0 an\u00e1lisis\t\r \u00a0 termogravim\u00e9trico\t\r \u00a0(TGA)\t\r \u00a0(17).\t\r \u00a0La\t\r \u00a0espectrofotometr\u00eda\t\r \u00a0de\t\r \u00a0IR\t\r \u00a0y\t\r \u00a0Raman\t\r \u00a0permiten\t\r \u00a0identificar\t\r \u00a0desplazamientos\t\r \u00a0en\t\r \u00a0 las\t\r \u00a0 frecuencias\t\r \u00a0 vibracionales\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 funcionales\t\r \u00a0 involucrados\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0interacciones\t\r \u00a0no\t\r \u00a0covalentes\t\r \u00a0encargadas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0del\t\r \u00a0cocristal\t\r \u00a0(18-\u00ad\u201019).\t\r \u00a0La\t\r \u00a0 difracci\u00f3n\t\r \u00a0 de\t\r \u00a0 rayos\t\r \u00a0 X\t\r \u00a0 de\t\r \u00a0 monocristal\t\r \u00a0 (XRD)\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 t\u00e9cnica\t\r \u00a0 m\u00e1s\t\r \u00a0 utilizada\t\r \u00a0para\t\r \u00a0 conocer\t\r \u00a0 la\t\r \u00a0 estructura\t\r \u00a0 molecular\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 cocristal\t\r \u00a0 farmac\u00e9utico\t\r \u00a0(20-\u00ad\u201022),\t\r \u00a0 sin\t\r \u00a0embargo,\t\r \u00a0 como\t\r \u00a0 no\t\r \u00a0 todos\t\r \u00a0 los\t\r \u00a0 cocristales\t\r \u00a0 forman\t\r \u00a0 monocristales,\t\r \u00a0 se\t\r \u00a0 recurre\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0difracci\u00f3n\t\r \u00a0de\t\r \u00a0rayos\t\r \u00a0X\t\r \u00a0de\t\r \u00a0polvos\t\r \u00a0(PXRD),\t\r \u00a0en\t\r \u00a0la\t\r \u00a0cual,\t\r \u00a0se\t\r \u00a0obtienen\t\r \u00a0los\t\r \u00a0difractogramas\t\r \u00a0del\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0del\t\r \u00a0formador\t\r \u00a0y\t\r \u00a0se\t\r \u00a0comparan\t\r \u00a0con\t\r \u00a0el\t\r \u00a0difractograma\t\r \u00a0del\t\r \u00a0cocristal\t\r \u00a0en\t\r \u00a0busca\t\r \u00a0de\t\r \u00a0nuevas\t\r \u00a0fases\t\r \u00a0cristalinas\t\r \u00a0(23-\u00ad\u201025).\t\r \u00a0La\t\r \u00a0calorimetr\u00eda\t\r \u00a0diferencial\t\r \u00a0de\t\r \u00a0barrido\t\r \u00a0permite\t\r \u00a0obtener\t\r \u00a0informaci\u00f3n\t\r \u00a0acerca\t\r \u00a0de\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0de\t\r \u00a0fusi\u00f3n,\t\r \u00a0obteniendo\t\r \u00a0las\t\r \u00a0temperaturas\t\r \u00a0de\t\r \u00a0transiciones\t\r \u00a0de\t\r \u00a0fase\t\r \u00a0y\t\r \u00a0entalp\u00edas\t\r \u00a0de\t\r \u00a0fusi\u00f3n\t\r \u00a0que\t\r \u00a0presentan\t\r \u00a0los\t\r \u00a0cocristales\t\r \u00a0en\t\r \u00a0comparaci\u00f3n\t\r \u00a0con\t\r \u00a0el\t\r \u00a0formador\t\r \u00a0y\t\r \u00a0el\t\r \u00a0IFA\t\r \u00a0(26-\u00ad\u201027).\t\r \u00a05.\t\r \u00a0PROPIEDADES\t\r \u00a0F\u00cdSICAS\t\r \u00a0DE\t\r \u00a0LOS\t\r \u00a0COCRISTALES\t\r \u00a0FARMAC\u00c9UTICOS\t\r \u00a0Al\t\r \u00a0igual\t\r \u00a0que\t\r \u00a0con\t\r \u00a0cualquier\t\r \u00a0otro\t\r \u00a0polvo\t\r \u00a0farmac\u00e9utico,\t\r \u00a0es\t\r \u00a0necesario\t\r \u00a0estudiar\t\r \u00a0las\t\r \u00a0propiedades\t\r \u00a0 fisicoqu\u00edmicas\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 cocristal\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 finalidad\t\r \u00a0 de\t\r \u00a0 determinar\t\r \u00a0 su\t\r \u00a0posible\t\r \u00a0 uso\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0 aplicaci\u00f3n\t\r \u00a0 comercial\t\r \u00a0 garantizando\t\r \u00a0 la\t\r \u00a0 estabilidad\t\r \u00a0seguridad\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0farmac\u00e9utica.\t\r \u00a0 Estas\t\r \u00a0 propiedades\t\r \u00a0 incluyen\t\r \u00a0 el\t\r \u00a0 punto\t\r \u00a0 de\t\r \u00a0fusi\u00f3n,\t\r \u00a0solubilidad,\t\r \u00a0disoluci\u00f3n\t\r \u00a0y\t\r \u00a0estabilidad\t\r \u00a0(3).\t\r \u00a05.1\t\r \u00a0Punto\t\r \u00a0de\t\r \u00a0fusi\u00f3n\t\r \u00a0El\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0fusi\u00f3n\t\r \u00a0es\t\r \u00a0una\t\r \u00a0propiedad\t\r \u00a0f\u00edsica\t\r \u00a0y\t\r \u00a0fundamental\t\r \u00a0de\t\r \u00a0los\t\r \u00a0s\u00f3lidos\t\r \u00a0que\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0para\t\r \u00a0como\t\r \u00a0indicador\t\r \u00a0de\t\r \u00a0pureza\t\r \u00a0y\t\r \u00a0caracterizaci\u00f3n.\t\r \u00a0Es\t\r \u00a0la\t\r \u00a0temperatura\t\r \u00a0a\t\r \u00a0la\t\r \u00a0cual\t\r \u00a0 se\t\r \u00a0 encuentran\t\r \u00a0 en\t\r \u00a0 equilibrio\t\r \u00a0 la\t\r \u00a0 fase\t\r \u00a0 s\u00f3lida\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 fase\t\r \u00a0 l\u00edquida.\t\r \u00a0 \u00c9sta\t\r \u00a0 puede\t\r \u00a0 ser\t\r \u00a0determinada\t\r \u00a0 utilizando\t\r \u00a0 un\t\r \u00a0 fusi\u00f3metro\t\r \u00a0 o,\t\r \u00a0 preferentemente,\t\r \u00a0 la\t\r \u00a0 calorimetr\u00eda\t\r \u00a0diferencial\t\r \u00a0 de\t\r \u00a0 barrido\t\r \u00a0 (DSC),\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 esta\t\r \u00a0 \u00faltima\t\r \u00a0 aporta\t\r \u00a0 informaci\u00f3n\t\r \u00a0 acerca\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0entalp\u00eda\t\r \u00a0de\t\r \u00a0fusi\u00f3n\t\r \u00a0del\t\r \u00a0s\u00f3lido.\t\r \u00a0Se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 puntos\t\r \u00a0 de\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 cocristal\t\r \u00a0 cambian\t\r \u00a0 con\t\r \u00a0respecto\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 puntos\t\r \u00a0 de\t\r \u00a0 fusi\u00f3n\t\r \u00a0 individuales\t\r \u00a0 del\t\r \u00a0IFA\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 formador,\t\r \u00a0 pudiendo\t\r \u00a0quedar\t\r \u00a0 dentro\t\r \u00a0 del\t\r \u00a0 rango\t\r \u00a0 formado\t\r \u00a0 por\t\r \u00a0 las\t\r \u00a0 temperaturas\t\r \u00a0 de\t\r \u00a0 fusi\u00f3n\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 o\t\r \u00a0 del\t\r \u00a0formador;\t\r \u00a0 o\t\r \u00a0 por\t\r \u00a0 encima\t\r \u00a0 o\t\r \u00a0 por\t\r \u00a0debajo\t\r \u00a0 de\t\r \u00a0 dicho\t\r \u00a0 rango.\t\r \u00a0 Esto\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 arreglos\t\r \u00a0Marlene\t\r \u00a0Marcelina\t\r \u00a0Saucedo-\u00ad\u2010Balderas\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n270\t\r \u00a0\t\r \u00a0moleculares\t\r \u00a0 presentes\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 celda\t\r \u00a0 cristalina\t\r \u00a0 del\t\r \u00a0 cocristal\t\r \u00a0 que\t\r \u00a0 difieren\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0arreglos\t\r \u00a0cristalinos\t\r \u00a0en\t\r \u00a0las\t\r \u00a0formas\t\r \u00a0libres\t\r \u00a0del\t\r \u00a0IFA\t\r \u00a0y\t\r \u00a0del\t\r \u00a0formador\t\r \u00a0(17,\t\r \u00a026-\u00ad\u201027).\t\r \u00a05.2\t\r \u00a0Estabilidad\t\r \u00a0Es\t\r \u00a0 una\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 pruebas\t\r \u00a0 m\u00e1s\t\r \u00a0 importantes\t\r \u00a0 para\t\r \u00a0 evaluar\t\r \u00a0 un\t\r \u00a0 cocristal\t\r \u00a0farmac\u00e9utico.\t\r \u00a0Las\t\r \u00a0pruebas\t\r \u00a0de\t\r \u00a0estabilidad\t\r \u00a0incluyen.\t\r \u00a0Se\t\r \u00a0realizan\t\r \u00a0diferentes\t\r \u00a0pruebas\t\r \u00a0de\t\r \u00a0 estabilidad\t\r \u00a0 dependiendo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 estructura\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0mol\u00e9culas.\t\r \u00a0Se\t\r \u00a0 realizan\t\r \u00a0 pruebas\t\r \u00a0 de\t\r \u00a0 estabilidad\t\r \u00a0 \t\r \u00a0 acelerada\t\r \u00a0 de\t\r \u00a0 temperatura\t\r \u00a0 y\t\r \u00a0 humedad\t\r \u00a0con\t\r \u00a0 la\t\r \u00a0 finalidad\t\r \u00a0 de\t\r \u00a0 identificar\t\r \u00a0 las\t\r \u00a0 mejores\t\r \u00a0 condiciones\t\r \u00a0 de\t\r \u00a0 almacenamiento\t\r \u00a0 del\t\r \u00a0producto(28).\t\r \u00a0 La\t\r \u00a0 cocristalizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 cafe\u00edna\t\r \u00a0 con\t\r \u00a0 \u00e1cidos\t\r \u00a0 dicarbox\u00edlicos\t\r \u00a0 ha\t\r \u00a0permitido\t\r \u00a0solucionar\t\r \u00a0el\t\r \u00a0problema\t\r \u00a0de\t\r \u00a0hidrataci\u00f3n\t\r \u00a0que\t\r \u00a0presenta\t\r \u00a0la\t\r \u00a0cafe\u00edna\t\r \u00a0(29).\t\r \u00a0La\t\r \u00a0estabilidad\t\r \u00a0de\t\r \u00a0disoluci\u00f3n\t\r \u00a0es\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0que\t\r \u00a0tienen\t\r \u00a0los\t\r \u00a0componentes\t\r \u00a0del\t\r \u00a0cocristal\t\r \u00a0de\t\r \u00a0permanecer\t\r \u00a0en\t\r \u00a0soluci\u00f3n\t\r \u00a0y\t\r \u00a0no\t\r \u00a0cristalizar.\t\r \u00a0Esta\t\r \u00a0prueba\t\r \u00a0da\t\r \u00a0indicios\t\r \u00a0acerca\t\r \u00a0de\t\r \u00a0la\t\r \u00a0posible\t\r \u00a0disociaci\u00f3n\t\r \u00a0o\t\r \u00a0precipitaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0componentes\t\r \u00a0del\t\r \u00a0cocristal.\t\r \u00a0En\t\r \u00a0estos\t\r \u00a0estudios\t\r \u00a0 se\t\r \u00a0 simulan\t\r \u00a0 las\t\r \u00a0 condiciones\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 fluidos\t\r \u00a0g\u00e1stricos\t\r \u00a0 o\t\r \u00a0 intestinales\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0finalidad\t\r \u00a0de\t\r \u00a0asegurar\t\r \u00a0la\t\r \u00a0solubilidad\t\r \u00a0y\t\r \u00a0la\t\r \u00a0velocidad\t\r \u00a0de\t\r \u00a0disoluci\u00f3n\t\r \u00a0(30).\t\r \u00a05.3\t\r \u00a0Solubilidad\t\r \u00a0La\t\r \u00a0 b\u00fasqueda\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 mejora\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 solubilidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 IFA\u00b4s\t\r \u00a0(31)\t\r \u00a0 es\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0conducido\t\r \u00a0al\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0caso\t\r \u00a0se\t\r \u00a0eval\u00faa,\t\r \u00a0en\t\r \u00a0diferentes\t\r \u00a0 medios,\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0 disoluci\u00f3n\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0 libre\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0disoluci\u00f3n\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 cocristal.\t\r \u00a0 Se\t\r \u00a0 han\t\r \u00a0 reportado\t\r \u00a0 revisiones\t\r \u00a0 en\t\r \u00a0 donde\t\r \u00a0 se\t\r \u00a0muestran\t\r \u00a0ejemplos\t\r \u00a0acerca\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mejor\u00eda\t\r \u00a0en\t\r \u00a0la\t\r \u00a0solubilidad\t\r \u00a0de\t\r \u00a0un\t\r \u00a0IFA\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0cocristal\t\r \u00a0con\t\r \u00a0respecto\t\r \u00a0al\t\r \u00a0f\u00e1rmaco\t\r \u00a0libre\t\r \u00a0(32-\u00ad\u201033).\t\r \u00a05.4\t\r \u00a0Biodisponibilidad\t\r \u00a0La\t\r \u00a0biodisponibilidad\t\r \u00a0es\t\r \u00a0la\t\r \u00a0cantidad\t\r \u00a0y\t\r \u00a0velocidad\t\r \u00a0con\t\r \u00a0la\t\r \u00a0que\t\r \u00a0un\t\r \u00a0IFA\t\r \u00a0llega\t\r \u00a0a\t\r \u00a0la\t\r \u00a0circulaci\u00f3n\t\r \u00a0 sist\u00e9mica.\t\r \u00a0 Uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 objetivos\t\r \u00a0 principales\t\r \u00a0 del\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 es\t\r \u00a0 que\t\r \u00a0 mediante\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 cocristal,\t\r \u00a0 un\t\r \u00a0 IFA\t\r \u00a0pueda\t\r \u00a0 aumentar\t\r \u00a0 su\t\r \u00a0biodisponibilidad.\t\r \u00a0 Se\t\r \u00a0 llevan\t\r \u00a0 a\t\r \u00a0 cabo\t\r \u00a0 estudios\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0se\t\r \u00a0compara\t\r \u00a0 la\t\r \u00a0 biodisponibilidad\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0 libre\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 del\t\r \u00a0 IFA\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0cocristal.\t\r \u00a0Algunos\t\r \u00a0f\u00e1rmacos\t\r \u00a0cuya\t\r \u00a0biodisponibilidad\t\r \u00a0aumenta\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0cocristal\t\r \u00a0son\t\r \u00a0la\t\r \u00a0quercetina\t\r \u00a0(34),\t\r \u00a0la\t\r \u00a0carbamazepina\t\r \u00a0(35)\t\r \u00a0y\t\r \u00a0la\t\r \u00a0iloperidona\t\r \u00a0(36).\t\r \u00a06.\t\r \u00a0COCRISTALES\t\r \u00a0Y\t\r \u00a0PROPIEDAD\t\r \u00a0INTELECTUAL\t\r \u00a0La\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0ofrece\t\r \u00a0un\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0investigaci\u00f3n\t\r \u00a0floreciente\t\r \u00a0con\t\r \u00a0aplicaci\u00f3n\t\r \u00a0 directa\t\r \u00a0a\t\r \u00a0 la\t\r \u00a0industria\t\r \u00a0 farmac\u00e9utica.\t\r \u00a0Los\t\r \u00a0 cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0son\t\r \u00a0patentables\t\r \u00a0si\t\r \u00a0cumplen\t\r \u00a0con\t\r \u00a0los\t\r \u00a0criterios\t\r \u00a0de\t\r \u00a0novedad,\t\r \u00a0utilidad\t\r \u00a0y\t\r \u00a0no\t\r \u00a0obviedad.\t\r \u00a0Como\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0una\t\r \u00a0amplia\t\r \u00a0cartera\t\r \u00a0de\t\r \u00a0patentes\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0s\u00f3lida,\t\r \u00a0los\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0271\t\r \u00a0\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\t\r \u00a0pueden\t\r \u00a0ofrecer\t\r \u00a0una\t\r \u00a0ventaja\t\r \u00a0comercial\t\r \u00a0distinta\t\r \u00a0respecto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0exclusividad\t\r \u00a0en\t\r \u00a0el\t\r \u00a0mercado\t\r \u00a0(37).\t\r \u00a07.\t\r \u00a0MARCO\t\r \u00a0REGULATORIO\t\r \u00a0La\t\r \u00a0 FDA\t\r \u00a0 clasifica\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 como\t\r \u00a0 \u201ccomplejos\t\r \u00a0moleculares\t\r \u00a0 disociables\t\r \u00a0 IFA-\u00ad\u2010excipiente\u201d,\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 agente\t\r \u00a0 cocristalizante\t\r \u00a0 se\t\r \u00a0considera\t\r \u00a0como\t\r \u00a0un\t\r \u00a0excipiente.\t\r \u00a0Por\t\r \u00a0lo\t\r \u00a0tanto,\t\r \u00a0un\t\r \u00a0IFA\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0procesado\t\r \u00a0con\t\r \u00a0un\t\r \u00a0excipiente\t\r \u00a0 cocristalizante\t\r \u00a0 debe\t\r \u00a0 ser\t\r \u00a0 tratado\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 producto\t\r \u00a0 intermediario\t\r \u00a0farmac\u00e9utico.\t\r \u00a0Para\t\r \u00a0 la\t\r \u00a0 solicitud\t\r \u00a0 de\t\r \u00a0 nuevos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 que\t\r \u00a0 contengan\t\r \u00a0 o\t\r \u00a0 digan\t\r \u00a0 contener\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos,\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0tener\t\r \u00a0evidencia\t\r \u00a0que\t\r \u00a0cumpla\t\r \u00a0dos\t\r \u00a0criterios:\t\r \u00a0-\u00ad\u2010Que\t\r \u00a0 el\t\r \u00a0 IFA\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 excipiente\t\r \u00a0 se\t\r \u00a0 encuentran\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0 neutra\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0interaccionan\t\r \u00a0de\t\r \u00a0manera\t\r \u00a0no\t\r \u00a0i\u00f3nica.\t\r \u00a0-\u00ad\u2010Que\t\r \u00a0la\t\r \u00a0disociaci\u00f3n\t\r \u00a0completa\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0excipiente\t\r \u00a0y\t\r \u00a0el\t\r \u00a0IFA\t\r \u00a0ocurre\t\r \u00a0antes\t\r \u00a0de\t\r \u00a0que\t\r \u00a0este\t\r \u00a0\u00faltimo\t\r \u00a0llegue\t\r \u00a0a\t\r \u00a0su\t\r \u00a0sitio\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0farmacol\u00f3gica.\t\r \u00a0Un\t\r \u00a0cocristal\t\r \u00a0IFA-\u00ad\u2010excipiente\t\r \u00a0que\t\r \u00a0cumple\t\r \u00a0con\t\r \u00a0estas\t\r \u00a0condiciones\t\r \u00a0se\t\r \u00a0considera\t\r \u00a0como\t\r \u00a0un\t\r \u00a0cocristal\t\r \u00a0farmac\u00e9utico\t\r \u00a0y\t\r \u00a0obtiene\t\r \u00a0la\t\r \u00a0clasificaci\u00f3n\t\r \u00a0regulatoria\t\r \u00a0de\t\r \u00a0producto\t\r \u00a0intermedio,\t\r \u00a0 el\t\r \u00a0 cual\t\r \u00a0no\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 nuevo\t\r \u00a0 IFA,\t\r \u00a0 sino\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0intermediario\t\r \u00a0farmac\u00e9utico\t\r \u00a0cocristalino\t\r \u00a0(38).\t\r \u00a08.\t\r \u00a0COCRISTALES\t\r \u00a0FARMAC\u00c9UTICOS\t\r \u00a0DE\t\r \u00a0INTER\u00c9S\t\r \u00a0En\t\r \u00a0 varias\t\r \u00a0 revisiones\t\r \u00a0 se\t\r \u00a0 muestra\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 sistemas\t\r \u00a0 cocristalinos\t\r \u00a0farmac\u00e9uticos\t\r \u00a0 m\u00e1s\t\r \u00a0 estudiados\t\r \u00a0 involucran\t\r \u00a0 los\t\r \u00a0 siguientes\t\r \u00a0 IFA\u00b4s:\t\r \u00a0 acetaminof\u00e9n,\t\r \u00a0acetazolamida,\t\r \u00a0alprazolam,\t\r \u00a0carbamazepina,\t\r \u00a0cafe\u00edna,\t\r \u00a0citosina,\t\r \u00a0ibuprofeno,\t\r \u00a0efavirenz,\t\r \u00a0etenzamida,\t\r \u00a0 fluconazol,\t\r \u00a0 indometacina,\t\r \u00a0isoniazida,\t\r \u00a0 lamotrigina,\t\r \u00a0 lidoca\u00edna,\t\r \u00a0mefloquina,\t\r \u00a0meloxicam,\t\r \u00a0minoxidil,\t\r \u00a0pterostilbeno,\t\r \u00a0nifedipina,\t\r \u00a0piracetam,\t\r \u00a0quinidina,\t\r \u00a0espironolactona,\t\r \u00a0\u00e1cido\t\r \u00a0salic\u00edlico,\t\r \u00a0teofilina\t\r \u00a0(39-\u00ad\u201040).\t\r \u00a09.\t\r \u00a0CONCLUSI\u00d3N\t\r \u00a0La\t\r \u00a0 b\u00fasqueda\t\r \u00a0 de\t\r \u00a0 nuevos\t\r \u00a0cocristales\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 \u00e1rea\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 gran\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0desarrollo,\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0las\t\r \u00a0mejoras\t\r \u00a0en\t\r \u00a0las\t\r \u00a0propiedades\t\r \u00a0de\t\r \u00a0los\t\r \u00a0IFA\u00b4s.\t\r \u00a0Para\t\r \u00a0lograr\t\r \u00a0 esto\t\r \u00a0 se\t\r \u00a0 debe\t\r \u00a0 poner\t\r \u00a0 especial\t\r \u00a0 atenci\u00f3n\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 posibles\t\r \u00a0 interacciones\t\r \u00a0 no\t\r \u00a0covalentes\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 formar\t\r \u00a0 el\t\r \u00a0 IFA\t\r \u00a0 y\t\r \u00a0 elegir\t\r \u00a0 el\t\r \u00a0 sint\u00f3n\t\r \u00a0 supramolecular\t\r \u00a0 adecuado\t\r \u00a0para\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0del\t\r \u00a0cocristal,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0tambi\u00e9n\t\r \u00a0la\t\r \u00a0t\u00e9cnica\t\r \u00a0que\t\r \u00a0se\t\r \u00a0emplear\u00e1\t\r \u00a0para\t\r \u00a0prepararlos.\t\r \u00a0 Todo\t\r \u00a0 esto\t\r \u00a0 permite\t\r \u00a0 obtener\t\r \u00a0 productos\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 novedosos\t\r \u00a0 que\t\r \u00a0son\t\r \u00a0patentables,\t\r \u00a0sin\t\r \u00a0dejar\t\r \u00a0de\t\r \u00a0lado\t\r \u00a0el\t\r \u00a0aspecto\t\r \u00a0regulatorio.\t\r \u00a0Marlene\t\r \u00a0Marcelina\t\r \u00a0Saucedo-\u00ad\u2010Balderas\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n272\t\r \u00a0\t\r \u00a010.\t\r \u00a0AGRADECIMIENTOS\t\r \u00a0Al\t\r \u00a0 Consejo\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 Ciencia\t\r \u00a0 y\t\r \u00a0Tecnolog\u00eda\t\r \u00a0 de\t\r \u00a0 M\u00e9xico\t\r \u00a0 (CONACyT)\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0financiamiento\t\r \u00a0(proyecto\t\r \u00a0179674)\t\r \u00a0otorgado.\t\r \u00a011.\t\r \u00a0REFERENCIAS\t\r \u00a01. Steed,\t\r \u00a0J.\t\r \u00a0W.;\t\r \u00a0Atwood,\t\r \u00a0J.\t\r \u00a0L.;\t\r \u00a0Supramolecular\t\r \u00a0Chemistry;Second\t\r \u00a0Ed;\t\r \u00a0John\t\r \u00a0Wiley\t\r \u00a0&\t\r \u00a0Sons,\t\r \u00a0Ltd.;\t\r \u00a0UK,\t\r \u00a02009;\t\r \u00a0p\t\r \u00a027.\t\r \u00a02. Almarsson,\t\r \u00a0\u00d6.;\t\r \u00a0Zaworotko,\t\r \u00a0M.\t\r \u00a0J.\t\r \u00a0Crystal\t\r \u00a0engineering\t\r \u00a0of\t\r \u00a0the\t\r \u00a0composition\t\r \u00a0of\t\r \u00a0pharmaceutical\t\r \u00a0phases.\t\r \u00a0Do\t\r \u00a0pharmaceutical\t\r \u00a0co-\u00ad\u2010crystals\t\r \u00a0represent\t\r \u00a0a\t\r \u00a0new\t\r \u00a0path\t\r \u00a0to\t\r \u00a0improved\t\r \u00a0medicines?\t\r \u00a0Chem.\t\r \u00a0Comm.7,\t\r \u00a01889-\u00ad\u20101896\t\r \u00a0(2004).\t\r \u00a03. Schultheiss,\t\r \u00a0N.;\t\r \u00a0Newman,\t\r \u00a0A.\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystals\t\r \u00a0and\t\r \u00a0Their\t\r \u00a0Physicochemical\t\r \u00a0Properties.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.9,\t\r \u00a02950-\u00ad\u20102967\t\r \u00a0(2009).\t\r \u00a04. Mirza,\t\r \u00a0S.;\t\r \u00a0Miroshnyk,\t\r \u00a0I.;\t\r \u00a0Hein\u00e4m\u00e4ki,\t\r \u00a0J.;\t\r \u00a0Yliruu,\t\r \u00a0J.\t\r \u00a0Co-\u00ad\u2010crystals:\t\r \u00a0An\t\r \u00a0emerging\t\r \u00a0approach\t\r \u00a0for\t\r \u00a0enhancing\t\r \u00a0properties\t\r \u00a0of\t\r \u00a0pharmaceutical\t\r \u00a0solids.\t\r \u00a0Dosis24,\t\r \u00a090-\u00ad\u201096\t\r \u00a0(2008).\t\r \u00a05. Jones,\t\r \u00a0W.;\t\r \u00a0Motherwell,\t\r \u00a0W.\t\r \u00a0D.\t\r \u00a0S.;\t\r \u00a0Trask,\t\r \u00a0A.\t\r \u00a0V.\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystals:\t\r \u00a0An\t\r \u00a0Emerging\t\r \u00a0Approach\t\r \u00a0to\t\r \u00a0Physical\t\r \u00a0Property\t\r \u00a0Enhancement.\t\r \u00a0MRS\t\r \u00a0Bull.31,\t\r \u00a0875-\u00ad\u2010879\t\r \u00a0(2006).\t\r \u00a06. Sekhon,\t\r \u00a0B.\t\r \u00a0S.\t\r \u00a0Pharmaceutical\t\r \u00a0co-\u00ad\u2010crystals\t\r \u00a0-\u00ad\u2010\t\r \u00a0a\t\r \u00a0review.\t\r \u00a0ARS\t\r \u00a0Pharm.50,\t\r \u00a099-\u00ad\u2010117\t\r \u00a0(2009).\t\r \u00a0\t\r \u00a07. Herrera\t\r \u00a0Ruiz,\t\r \u00a0D.\t\r \u00a0\u00bfQu\u00e9\t\r \u00a0sabe\t\r \u00a0Ud.\t\r \u00a0acerca\t\r \u00a0de\u2026\t\r \u00a0los\t\r \u00a0co-\u00ad\u2010cristales\t\r \u00a0farmac\u00e9uticos?\t\r \u00a0Rev.\t\r \u00a0Mex.\t\r \u00a0Cienc.\t\r \u00a0Farm.41,\t\r \u00a055-\u00ad\u201056\t\r \u00a0(2010).\t\r \u00a08. Delori,\t\r \u00a0A.;\t\r \u00a0Friscic,\t\r \u00a0T.;\t\r \u00a0Jones,\t\r \u00a0W.\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0mechanochemistry\t\r \u00a0and\t\r \u00a0supramolecular\t\r \u00a0design\t\r \u00a0in\t\r \u00a0the\t\r \u00a0development\t\r \u00a0of\t\r \u00a0pharmaceutical\t\r \u00a0materials.CrystEngComm14,\t\r \u00a02350-\u00ad\u20102362\t\r \u00a0(2012).\t\r \u00a09. Prasad,\t\r \u00a0R.\t\r \u00a0V.;\t\r \u00a0Rakesh,\t\r \u00a0M.\t\r \u00a0G.;\t\r \u00a0Jyotsna,\t\r \u00a0R.\t\r \u00a0M.;\t\r \u00a0Mangesh,\t\r \u00a0S.\t\r \u00a0T.;\t\r \u00a0Anita,\t\r \u00a0P.\t\r \u00a0S.;Mayur,\t\r \u00a0P.\t\r \u00a0K.\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystallization:\t\r \u00a0A\t\r \u00a0Review.\t\r \u00a0IJPCS.3,\t\r \u00a0725-\u00ad\u2010736\t\r \u00a0(2012).\t\r \u00a010. Friscic,\t\r \u00a0T.;\t\r \u00a0Jones,\t\r \u00a0W.\t\r \u00a0Recent\t\r \u00a0Advances\t\r \u00a0in\t\r \u00a0Understanding\t\r \u00a0the\t\r \u00a0Mechanism\t\r \u00a0of\t\r \u00a0Cocrystal\t\r \u00a0Formation\t\r \u00a0via\t\r \u00a0Grinding.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.9,\t\r \u00a01621-\u00ad\u20101637\t\r \u00a0(2009).\t\r \u00a011. Weyna,\t\r \u00a0D.\t\r \u00a0R.;\t\r \u00a0Shattock,\t\r \u00a0T.;\t\r \u00a0Vishweshwar,\t\r \u00a0P.;\t\r \u00a0Zaworotko,\t\r \u00a0M.\t\r \u00a0J.\t\r \u00a0Synthesis\t\r \u00a0and\t\r \u00a0Structural\t\r \u00a0Characterization\t\r \u00a0of\t\r \u00a0Cocrystals\t\r \u00a0and\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystals:\t\r \u00a0Mechanochemistryvs\t\r \u00a0Slow\t\r \u00a0Evaporation\t\r \u00a0from\t\r \u00a0Solution.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.9,\t\r \u00a01106-\u00ad\u20101123\t\r \u00a0(2009).\t\r \u00a012. Lin,\t\r \u00a0H.-\u00ad\u2010L.;\t\r \u00a0Wu,\t\r \u00a0T.-\u00ad\u2010K.;\t\r \u00a0Lin,\t\r \u00a0S.-\u00ad\u2010Y.\t\r \u00a0Screening\t\r \u00a0and\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0cocrystal\t\r \u00a0formation\t\r \u00a0of\t\r \u00a0metaxalonewith\t\r \u00a0short-\u00ad\u2010chain\t\r \u00a0dicarboxylic\t\r \u00a0acids\t\r \u00a0induced\t\r \u00a0by\t\r \u00a0solvent-\u00ad\u2010assistedgrinding\t\r \u00a0approach.\t\r \u00a0Thermochim.\t\r \u00a0Acta575,\t\r \u00a0313-\u00ad\u2010321\t\r \u00a0(2014).\t\r \u00a013. Ober,\t\r \u00a0C.\t\r \u00a0A.;\t\r \u00a0Montgomery,\t\r \u00a0S.\t\r \u00a0E.;\t\r \u00a0Gupta,\t\r \u00a0R.\t\r \u00a0B.\t\r \u00a0Formation\t\r \u00a0of\t\r \u00a0itraconazole/L-\u00ad\u2010malic\t\r \u00a0acid\t\r \u00a0cocrystals\t\r \u00a0by\t\r \u00a0gas\t\r \u00a0antisolventcocrystallization.\t\r \u00a0Powder\t\r \u00a0Technol.236,\t\r \u00a0122-\u00ad\u2010131\t\r \u00a0(2013).\t\r \u00a0\t\r \u00a014. Aher,\t\r \u00a0S.;\t\r \u00a0Dhumal,\t\r \u00a0R.;\t\r \u00a0Mahadik,\t\r \u00a0K.;\t\r \u00a0Paradkar,\t\r \u00a0A.;\t\r \u00a0York,\t\r \u00a0P.\t\r \u00a0Ultrasound\t\r \u00a0assisted\t\r \u00a0cocrystallization\t\r \u00a0from\t\r \u00a0solution\t\r \u00a0(USSC)\t\r \u00a0containing\t\r \u00a0a\t\r \u00a0non-\u00ad\u2010congruently\t\r \u00a0soluble\t\r \u00a0cocrystal\t\r \u00a0component\t\r \u00a0pair:\t\r \u00a0Caffeine/maleic\t\r \u00a0acid.\t\r \u00a0Eur.\t\r \u00a0J.\t\r \u00a0of\t\r \u00a0Pharm.\t\r \u00a0Sci.41,\t\r \u00a0597-\u00ad\u2010602\t\r \u00a0(2010).\t\r \u00a0\t\r \u00a015. Padrela,\t\r \u00a0L.;\t\r \u00a0Rodrigues,\t\r \u00a0M.\t\r \u00a0A.;\t\r \u00a0Tiago,\t\r \u00a0J.;\t\r \u00a0Velaga,\t\r \u00a0S.\t\r \u00a0P.;\t\r \u00a0Matos,\t\r \u00a0H.\t\r \u00a0A.;\t\r \u00a0Azevedo,\t\r \u00a0E.\t\r \u00a0G.\t\r \u00a0Tuning\t\r \u00a0physicochemical\t\r \u00a0properties\t\r \u00a0of\t\r \u00a0theophylline\t\r \u00a0bycocrystallization\t\r \u00a0using\t\r \u00a0the\t\r \u00a0supercritical\t\r \u00a0fluid\t\r \u00a0enhancedatomization\t\r \u00a0technique.\t\r \u00a0J.of\t\r \u00a0Supercritical\t\r \u00a0Fluids86,\t\r \u00a0129-\u00ad\u2010136\t\r \u00a0(2014).\t\r \u00a0\t\r \u00a016. Kojima,\t\r \u00a0T.;\t\r \u00a0Tsutsumi,\t\r \u00a0S.;\t\r \u00a0Yamamoto,\t\r \u00a0K.;\t\r \u00a0Ikeda,\t\r \u00a0Y.;\t\r \u00a0Moriwaki,\t\r \u00a0T.\t\r \u00a0High-\u00ad\u2010throughput\t\r \u00a0cocrystal\t\r \u00a0slurry\t\r \u00a0screening\t\r \u00a0by\t\r \u00a0use\t\r \u00a0of\t\r \u00a0in\t\r \u00a0situ\t\r \u00a0Raman\t\r \u00a0microscopy\t\r \u00a0and\t\r \u00a0multi-\u00ad\u2010well\t\r \u00a0plate.\t\r \u00a0Int.\t\r \u00a0J.\t\r \u00a0of\t\r \u00a0Pharm.399,\t\r \u00a052-\u00ad\u201059\t\r \u00a0(2010).\t\r \u00a0\t\r \u00a017. Nanjwade,\t\r \u00a0V.\t\r \u00a0K.;\t\r \u00a0Manvi,\t\r \u00a0F.\t\r \u00a0V.;\t\r \u00a0Shamrez,\t\r \u00a0A.\t\r \u00a0M.;\t\r \u00a0Nanjwade,\t\r \u00a0B.\t\r \u00a0K.;Maste,\t\r \u00a0M.\t\r \u00a0M.\t\r \u00a0(2011).\t\r \u00a0New\t\r \u00a0Trends\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Co-\u00ad\u2010crystallization\t\r \u00a0of\t\r \u00a0Active\t\r \u00a0Pharmaceutical\t\r \u00a0Ingredients.J.\t\r \u00a0of\t\r \u00a0Appl.\t\r \u00a0Pharm.\t\r \u00a0Sci.1,\t\r \u00a01-\u00ad\u20105.\t\r \u00a0\t\r \u00a018. Ali,\t\r \u00a0H.\t\r \u00a0R.\t\r \u00a0H.;\t\r \u00a0Alhalaweh,\t\r \u00a0A.;\t\r \u00a0Mendes,\t\r \u00a0N.\t\r \u00a0F.\t\r \u00a0C.;\t\r \u00a0Ribeiro-\u00ad\u2010Claro,\t\r \u00a0P.;Velaga,\t\r \u00a0S.\t\r \u00a0P.\t\r \u00a0Solid-\u00ad\u2010state\t\r \u00a0vibrational\t\r \u00a0spectroscopic\t\r \u00a0investigation\t\r \u00a0of\t\r \u00a0cocrystals\t\r \u00a0and\t\r \u00a0salt\t\r \u00a0of\t\r \u00a0indomethacin.\t\r \u00a0CrystEngComm.14,\t\r \u00a06665-\u00ad\u20106674\t\r \u00a0(2012).\t\r \u00a0\t\r \u00a019. Castro,\t\r \u00a0R.\t\r \u00a0A.\t\r \u00a0E.;\t\r \u00a0Ribeiro,\t\r \u00a0J.\t\r \u00a0D.\t\r \u00a0B.;\t\r \u00a0Maria,\t\r \u00a0T.\t\r \u00a0M.\t\r \u00a0R.;\t\r \u00a0Silva,\t\r \u00a0M.\t\r \u00a0R.;\t\r \u00a0Yuste-\u00ad\u2010Vivas,\t\r \u00a0C.;\t\r \u00a0Canotilho,\t\r \u00a0J.;\t\r \u00a0Eusebio,\t\r \u00a0M.\t\r \u00a0E.\t\r \u00a0S.\t\r \u00a0Naproxen\t\r \u00a0Cocrystals\t\r \u00a0with\t\r \u00a0Pyridinecarboxamide\t\r \u00a0Isomers.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.11,\t\r \u00a05396-\u00ad\u20105404\t\r \u00a0(2011).\t\r \u00a020. Bathori,\t\r \u00a0N.\t\r \u00a0B.;\t\r \u00a0Lemmerer,\t\r \u00a0A.;\t\r \u00a0Venter,\t\r \u00a0G.\t\r \u00a0A.;\t\r \u00a0Bourne,\t\r \u00a0S.\t\r \u00a0A.;\t\r \u00a0Caira,\t\r \u00a0M.\t\r \u00a0R.\t\r \u00a0Pharmaceutical\t\r \u00a0Co-\u00ad\u2010crystals\t\r \u00a0with\t\r \u00a0Isonicotinamide;Vitamin\t\r \u00a0B3,\t\r \u00a0Clofibric\t\r \u00a0Acid,\t\r \u00a0and\t\r \u00a0Diclofenac-\u00ad\u2010and\t\r \u00a0Two\t\r \u00a0Isonicotinamide\t\r \u00a0Hydrates.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.11,\t\r \u00a075-\u00ad\u201087\t\r \u00a0(2011).\t\r \u00a0Los\t\r \u00a0cocristales\t\r \u00a0farmac\u00e9uticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0273\t\r \u00a0\t\r \u00a021. Leyssens,\t\r \u00a0T.;\t\r \u00a0Springuel,\t\r \u00a0G.;\t\r \u00a0Montis,\t\r \u00a0R.,\t\r \u00a0Candoni,\t\r \u00a0N.;\t\r \u00a0Veesler,\t\r \u00a0S.\t\r \u00a0Importance\t\r \u00a0of\t\r \u00a0Solvent\t\r \u00a0Selection\t\r \u00a0for\t\r \u00a0Stoichiometrically\t\r \u00a0Diverse\t\r \u00a0Cocrystal\t\r \u00a0Systems:\t\r \u00a0Caffeine/Maleic\t\r \u00a0Acid\t\r \u00a01:1\t\r \u00a0and\t\r \u00a02:1\t\r \u00a0Cocrystals.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.\t\r \u00a012,\t\r \u00a01520-\u00ad\u20101530\t\r \u00a0(2012).\t\r \u00a022. Aitipamula,\t\r \u00a0S.;\t\r \u00a0Chowa,\t\r \u00a0P.\t\r \u00a0S.;\t\r \u00a0Tan,\t\r \u00a0R.\t\r \u00a0B.\t\r \u00a0H.\t\r \u00a0(2009).\t\r \u00a0Theophylline\u2013gentisic\t\r \u00a0acid\t\r \u00a0(1/1).ActaCrystallogr.,\t\r \u00a0Sect.\t\r \u00a0E:\t\r \u00a0Struct.\t\r \u00a0Rep.\t\r \u00a0OnlineE65,\t\r \u00a0o2126-\u00ad\u2010o2127.\t\r \u00a023. Karki,\t\r \u00a0S.;\t\r \u00a0Fabian,\t\r \u00a0L.;\t\r \u00a0Friscic,\t\r \u00a0T.;\t\r \u00a0Jones,\t\r \u00a0W.\t\r \u00a0Powder\t\r \u00a0X-\u00ad\u2010ray\t\r \u00a0Diffraction\t\r \u00a0as\t\r \u00a0an\t\r \u00a0Emerging\t\r \u00a0Method\t\r \u00a0to\t\r \u00a0Structurally\t\r \u00a0Characterize\t\r \u00a0Organic\t\r \u00a0Solids.\t\r \u00a0Org.\t\r \u00a0Lett.9,\t\r \u00a03133-\u00ad\u20103136\t\r \u00a0(2007).\t\r \u00a024. Chieng,\t\r \u00a0N.;\t\r \u00a0Hubert,\t\r \u00a0M.;\t\r \u00a0Saville,\t\r \u00a0D.;\t\r \u00a0Rades,\t\r \u00a0T.;\t\r \u00a0Aaltonen,\t\r \u00a0J.\t\r \u00a0Formation\t\r \u00a0Kinetics\t\r \u00a0and\t\r \u00a0Stability\t\r \u00a0of\t\r \u00a0Carbamazepine-\u00ad\u2010NicotinamideCocrystals\t\r \u00a0Prepared\t\r \u00a0by\t\r \u00a0Mechanical\t\r \u00a0Activation.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.9,\t\r \u00a02377-\u00ad\u20102386\t\r \u00a0(2009).\t\r \u00a025. Bucar,\t\r \u00a0D.K.;\t\r \u00a0Henry,\t\r \u00a0R.\t\r \u00a0F.;\t\r \u00a0Lou,\t\r \u00a0X.;\t\r \u00a0Richard\t\r \u00a0W.\t\r \u00a0D;\t\r \u00a0MacGillivray,\t\r \u00a0L.\t\r \u00a0R.;\t\r \u00a0Zhang,\t\r \u00a0G.\t\r \u00a0G.\t\r \u00a0Z.\t\r \u00a0Cocrystals\t\r \u00a0of\t\r \u00a0Caffeine\t\r \u00a0and\t\r \u00a0Hydroxybenzoic\t\r \u00a0Acids\t\r \u00a0Composed\t\r \u00a0of\t\r \u00a0Multiple\t\r \u00a0SupramolecularHeterosynthons:\t\r \u00a0Screening\t\r \u00a0via\t\r \u00a0Solution-\u00ad\u2010Mediated\t\r \u00a0Phase\t\r \u00a0Transformation\t\r \u00a0and\t\r \u00a0Structural\t\r \u00a0Characterization.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.9,\t\r \u00a01932-\u00ad\u20101943\t\r \u00a0(2009).\t\r \u00a026. Lu,\t\r \u00a0E.;\t\r \u00a0Rodr\u00edguez-\u00ad\u2010Hornedo,\t\r \u00a0N.;\t\r \u00a0Suryanarayanan,\t\r \u00a0R.\t\r \u00a0A\t\r \u00a0rapid\t\r \u00a0thermal\t\r \u00a0method\t\r \u00a0for\t\r \u00a0cocrystal\t\r \u00a0screening.CrystEngComm.10,\t\r \u00a0665-\u00ad\u2010668\t\r \u00a0(2008).\t\r \u00a027. Sun,\t\r \u00a0C.\t\r \u00a0C.;\t\r \u00a0Hou,\t\r \u00a0H.\t\r \u00a0Improving\t\r \u00a0Mechanical\t\r \u00a0Properties\t\r \u00a0of\t\r \u00a0Caffeine\t\r \u00a0and\t\r \u00a0Methyl\t\r \u00a0Gallate\t\r \u00a0Crystals\t\r \u00a0by\t\r \u00a0Cocrystallization.\t\r \u00a0Crystal\t\r \u00a0Growth\t\r \u00a0Des.8,\t\r \u00a01575-\u00ad\u20101579\t\r \u00a0(2008).\t\r \u00a028. International\t\r \u00a0Conference\t\r \u00a0on\t\r \u00a0Harmonization\t\r \u00a0(ICH).\t\r \u00a0ICH\t\r \u00a0Harmonized\t\r \u00a0Tripartite\t\r \u00a0Guideline:\t\r \u00a0Stability\t\r \u00a0Testing\t\r \u00a0of\t\r \u00a0New\t\r \u00a0Drugs\t\r \u00a0Substances\t\r \u00a0and\t\r \u00a0Products\t\r \u00a0Q1A(R2)\t\r \u00a0(2003).\t\r \u00a0http://www.ich.org/products/guidelines/quality/quality-\u00ad\u2010single/article/stability-\u00ad\u2010testing-\u00ad\u2010of-\u00ad\u2010new-\u00ad\u2010drug-\u00ad\u2010substances-\u00ad\u2010and-\u00ad\u2010products.html\t\r \u00a029. Trask,\t\r \u00a0A.\t\r \u00a0V.;\t\r \u00a0Motherwell,\t\r \u00a0W.\t\r \u00a0D.\t\r \u00a0S.;\t\r \u00a0Jones,\t\r \u00a0W.\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystallization:\t\r \u00a0Engineering\t\r \u00a0a\t\r \u00a0Remedy\t\r \u00a0for\t\r \u00a0Caffeine\t\r \u00a0Hydration.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.5,\t\r \u00a01013-\u00ad\u20101021\t\r \u00a0(2005).\t\r \u00a030. Tomaszewska,\t\r \u00a0I.;Karki,\t\r \u00a0S.;\t\r \u00a0Shur,\t\r \u00a0J.;\t\r \u00a0Price,\t\r \u00a0R.;\t\r \u00a0Fotaki,\t\r \u00a0N.\t\r \u00a0Pharmaceutical\t\r \u00a0characterisation\t\r \u00a0and\t\r \u00a0evaluation\t\r \u00a0of\t\r \u00a0cocrystals:\t\r \u00a0Importance\t\r \u00a0of\t\r \u00a0in\t\r \u00a0vitro\t\r \u00a0dissolution\t\r \u00a0conditions\t\r \u00a0and\t\r \u00a0type\t\r \u00a0of\t\r \u00a0coformer.\t\r \u00a0Int.\t\r \u00a0J.\t\r \u00a0Pharm.453,\t\r \u00a0380-\u00ad\u2010388\t\r \u00a0(2013).\t\r \u00a031. Mohanachandran,\t\r \u00a0P.\t\r \u00a0S.;\t\r \u00a0Sindhumol,\t\r \u00a0P.\t\r \u00a0G.;\t\r \u00a0Kiran,\t\r \u00a0T.\t\r \u00a0S.\t\r \u00a0Enhancement\t\r \u00a0of\t\r \u00a0solubility\t\r \u00a0and\t\r \u00a0dissolution\t\r \u00a0rate:\t\r \u00a0An\t\r \u00a0overview.\t\r \u00a0Pharm.\t\r \u00a0Globale,\t\r \u00a04,\t\r \u00a01-\u00ad\u201010\t\r \u00a0(2010).\t\r \u00a0\t\r \u00a032. Thakuria,\t\r \u00a0R.;\t\r \u00a0Delori,\t\r \u00a0A.;\t\r \u00a0Jones,\t\r \u00a0W.;\t\r \u00a0Lipert,\t\r \u00a0M.\t\r \u00a0P.;\t\r \u00a0Roy,\t\r \u00a0L.;\t\r \u00a0Rodr\u00edguez-\u00ad\u2010Hornedo,\t\r \u00a0N.\t\r \u00a0Pharmaceutical\t\r \u00a0cocrystals\t\r \u00a0and\t\r \u00a0poorly\t\r \u00a0soluble\t\r \u00a0drugs.\t\r \u00a0Int.\t\r \u00a0J.\t\r \u00a0Pharm.453,\t\r \u00a0101-\u00ad\u2010125\t\r \u00a0(2013).\t\r \u00a033. Elder,\t\r \u00a0D.\t\r \u00a0P.;\t\r \u00a0Holm,\t\r \u00a0R.;\t\r \u00a0Diego,\t\r \u00a0H.\t\r \u00a0L.\t\r \u00a0Use\t\r \u00a0of\t\r \u00a0pharmaceutical\t\r \u00a0salts\t\r \u00a0and\t\r \u00a0cocrystals\t\r \u00a0to\t\r \u00a0address\t\r \u00a0the\t\r \u00a0issue\t\r \u00a0of\t\r \u00a0poor\t\r \u00a0solubility.\t\r \u00a0Int.\t\r \u00a0J.\t\r \u00a0Pharm.,\t\r \u00a0453,\t\r \u00a088-\u00ad\u2010100\t\r \u00a0(2013).\t\r \u00a0\t\r \u00a034. Smith,\t\r \u00a0A.\t\r \u00a0J.;\t\r \u00a0Kavuru,\t\r \u00a0P.;\t\r \u00a0Wojtas,\t\r \u00a0L.;\t\r \u00a0Zaworotko,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0Shytle,\t\r \u00a0R.\t\r \u00a0D.\t\r \u00a0Cocrystals\t\r \u00a0of\t\r \u00a0Quercetin\t\r \u00a0with\t\r \u00a0Improved\t\r \u00a0Solubility\t\r \u00a0and\t\r \u00a0Oral\t\r \u00a0Bioavailability.\t\r \u00a0Mol.\t\r \u00a0Pharm.8,\t\r \u00a01867-\u00ad\u20101876\t\r \u00a0(2011).\t\r \u00a0\t\r \u00a035. Hickey,\t\r \u00a0M.\t\r \u00a0B.;\t\r \u00a0Peterson,\t\r \u00a0M.\t\r \u00a0L.;\t\r \u00a0Scoppettuolo,\t\r \u00a0L.\t\r \u00a0A.;Morrisette,\t\r \u00a0S.\t\r \u00a0L.;\t\r \u00a0Vetter,\t\r \u00a0A.;\t\r \u00a0Guzm\u00e1n,\t\r \u00a0H.,\t\r \u00a0Remenar,\t\r \u00a0J.\t\r \u00a0F.;\t\r \u00a0Zhang,\t\r \u00a0Z.;\t\r \u00a0Tawa,\t\r \u00a0M.\t\r \u00a0D.;\t\r \u00a0Haley,\t\r \u00a0S.;\t\r \u00a0Zaworotko,\t\r \u00a0M.\t\r \u00a0J.;\t\r \u00a0Almarsson,\t\r \u00a0O.\t\r \u00a0Performance\t\r \u00a0comparison\t\r \u00a0of\t\r \u00a0a\t\r \u00a0co-\u00ad\u2010crystal\t\r \u00a0of\t\r \u00a0carbamazepine\t\r \u00a0with\t\r \u00a0marketed\t\r \u00a0product.\t\r \u00a0Eur.\t\r \u00a0J.\t\r \u00a0of\t\r \u00a0Pharm.\t\r \u00a0Biopharm.,67,\t\r \u00a0112-\u00ad\u2010119\t\r \u00a0(2007).\t\r \u00a0\t\r \u00a036. Zhang,\t\r \u00a0T.-\u00ad\u2010T.;\t\r \u00a0Wang,\t\r \u00a0H.-\u00ad\u2010T.;\t\r \u00a0Jia,\t\r \u00a0J.-\u00ad\u2010T.;\t\r \u00a0Cui,\t\r \u00a0X.-\u00ad\u2010Q.;\t\r \u00a0Li,\t\r \u00a0Q.;Zhu,\t\r \u00a0G.-\u00ad\u2010S.\t\r \u00a0Syntheses\t\r \u00a0and\t\r \u00a0pharmacokinetics\t\r \u00a0properties\t\r \u00a0of\t\r \u00a0an\t\r \u00a0iloperidone\t\r \u00a0pharmaceutical\t\r \u00a0cocrystal.\t\r \u00a0Inorg.\t\r \u00a0Chem.\t\r \u00a0Commun.\t\r \u00a039,\t\r \u00a0144-\u00ad\u2010146\t\r \u00a0(2014).\t\r \u00a037. Trask,\t\r \u00a0A.\t\r \u00a0V.\t\r \u00a0An\t\r \u00a0Overview\t\r \u00a0of\t\r \u00a0Pharmaceutical\t\r \u00a0Cocrystals\t\r \u00a0as\t\r \u00a0Intellectual\t\r \u00a0Property.Mol.\t\r \u00a0Pharm.4,\t\r \u00a0301-\u00ad\u2010309\t\r \u00a0(2007).\t\r \u00a038. Center\t\r \u00a0for\t\r \u00a0Drug\t\r \u00a0Evaluation\t\r \u00a0and\t\r \u00a0Research.\t\r \u00a0Regulatory\t\r \u00a0Classification\t\r \u00a0of\t\r \u00a0Pharmaceutical\t\r \u00a0Co-\u00ad\u2010Crystals.\t\r \u00a0United\t\r \u00a0States\t\r \u00a0Food\t\r \u00a0and\t\r \u00a0Drug\t\r \u00a0Administration\t\r \u00a0(2013).\t\r \u00a0http://www.fda.gov/downloads/Drugs/Guidances/UCM281764.pdf\t\r \u00a039. Brittain,\t\r \u00a0H.\t\r \u00a0G.\t\r \u00a0Cocrystal\t\r \u00a0Systems\t\r \u00a0of\t\r \u00a0Pharmaceutical\t\r \u00a0Interest:\t\r \u00a02011.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.12,\t\r \u00a05823-\u00ad\u20105832\t\r \u00a0(2011).\t\r \u00a040. Brittain,\t\r \u00a0H.\t\r \u00a0G.\t\r \u00a0Cocrystal\t\r \u00a0Systems\t\r \u00a0of\t\r \u00a0Pharmaceutical\t\r \u00a0Interest:\t\r \u00a02010.\t\r \u00a0Cryst.\t\r \u00a0Growth\t\r \u00a0Des.12,\t\r \u00a01046-\u00ad\u20101054\t\r \u00a0(2012).\t\r \u00a0274\t\r \u00a0\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0que\t\r \u00a0sufren\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0a\t\r \u00a0 medicamentos.\t\r \u00a0 Identificaci\u00f3n\t\r \u00a0 y\t\r \u00a0 caracterizaci\u00f3n\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0miner\u00eda\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda1*,\t\r \u00a0Ramona\t\r \u00a0Mateos1\t\r \u00a01Departamento\t\r \u00a0 de\t\r \u00a0 Medicina\t\r \u00a0 Preventiva\t\r \u00a0 y\t\r \u00a0 Salud\t\r \u00a0 P\u00fablica.\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia.\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0Salamanca.\t\r \u00a0Campus\t\r \u00a0Miguel\t\r \u00a0de\t\r \u00a0Unamuno\t\r \u00a0s/n.;\t\r \u00a037007\t\r \u00a0Salamanca\t\r \u00a0\t\r \u00a0*e-\u00ad\u2010mail:\t\r \u00a0mabel.j.serrania@gmail.com\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0274-\u00ad\u2010321.\t\r \u00a0\t\r \u00a0Premio\t\r \u00a0CINFA\t\r \u00a0del\t\r \u00a0Concurso\t\r \u00a0Cient\u00edfico\t\r \u00a02013\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0\t\r \u00a0Farmacia\t\r \u00a0RESUMEN\t\r \u00a0El\t\r \u00a0 an\u00e1lisis\t\r \u00a0 estad\u00edstico\t\r \u00a0 tradicional\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 notificaciones\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0 adversas\t\r \u00a0 a\t\r \u00a0medicamentos\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0complejo\t\r \u00a0y\t\r \u00a0escaso.\t\r \u00a0Las\t\r \u00a0t\u00e9cnicas\t\r \u00a0de\t\r \u00a0miner\u00eda\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0\u2013modelo\t\r \u00a0 de\t\r \u00a0 red\t\r \u00a0 de\t\r \u00a0 enlaces,\t\r \u00a0 modelo\t\r \u00a0 de\t\r \u00a0 redes\t\r \u00a0 de\t\r \u00a0 Kohonen-\u00ad\u2010\t\r \u00a0permiten\t\r \u00a0 identificar\t\r \u00a0 perfiles\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 tratados\t\r \u00a0 con\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 que\t\r \u00a0sufren\t\r \u00a0 reacciones\t\r \u00a0 adversas.\t\r \u00a0 Son\t\r \u00a0 perfiles\t\r \u00a0 caracter\u00edsticos\t\r \u00a0 los\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0metabolismo\t\r \u00a0graves\t\r \u00a0no\t\r \u00a0mortales\t\r \u00a0por\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0en\t\r \u00a0Catalu\u00f1a;\t\r \u00a0y\t\r \u00a0los\t\r \u00a0trastornos\t\r \u00a0gastrointestinales\t\r \u00a0no\t\r \u00a0graves\t\r \u00a0por\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0de\t\r \u00a065-\u00ad\u201074\t\r \u00a0a\u00f1os\t\r \u00a0 en\t\r \u00a0 Arag\u00f3n.\t\r \u00a0 Los\t\r \u00a0 pacientes\t\r \u00a0 en\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0 tres\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 agentes\t\r \u00a0 orales\t\r \u00a0presentan\t\r \u00a0mayor\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0sufrir\t\r \u00a0una\t\r \u00a0reacci\u00f3n\t\r \u00a0adversa.\t\r \u00a0Palabras\t\r \u00a0clave:\t\r \u00a0Reacci\u00f3n\t\r \u00a0adversa\t\r \u00a0a\t\r \u00a0medicamento;\t\r \u00a0diabetes;\t\r \u00a0miner\u00eda\t\r \u00a0de\t\r \u00a0datos.\t\r \u00a0ABSTRACT\t\r \u00a0Profiles\t\r \u00a0of\t\r \u00a0diabetic\t\r \u00a0patients\t\r \u00a0who\t\r \u00a0suffer\t\r \u00a0adverse\t\r \u00a0drug\t\r \u00a0reactions.\t\r \u00a0Identification\t\r \u00a0and\t\r \u00a0characterization\t\r \u00a0through\t\r \u00a0data\t\r \u00a0mining.\t\r \u00a0The\t\r \u00a0 traditional\t\r \u00a0 statistical\t\r \u00a0 analysis\t\r \u00a0 of\t\r \u00a0 notifications\t\r \u00a0 of\t\r \u00a0 adverse\t\r \u00a0 drug\t\r \u00a0 reactions\t\r \u00a0 in\t\r \u00a0diabetic\t\r \u00a0 patients\t\r \u00a0 was\t\r \u00a0 complex\t\r \u00a0 and\t\r \u00a0 sparse.\t\r \u00a0 The\t\r \u00a0 data\t\r \u00a0 mining\t\r \u00a0 techniques\t\r \u00a0\u2013web\t\r \u00a0graph\t\r \u00a0 and\t\r \u00a0 Kohonen\t\r \u00a0 networks\t\r \u00a0 model-\u00ad\u2010\t\r \u00a0allow\t\r \u00a0 us\t\r \u00a0 to\t\r \u00a0 identify\t\r \u00a0 drug-\u00ad\u2010treated\t\r \u00a0 diabetic\t\r \u00a0patients\t\r \u00a0who\t\r \u00a0suffer\t\r \u00a0adverse\t\r \u00a0reactions.\t\r \u00a0Nonfatal\t\r \u00a0severe\t\r \u00a0metabolic\t\r \u00a0disorders\t\r \u00a0due\t\r \u00a0to\t\r \u00a0insulin\t\r \u00a0 glargine\t\r \u00a0 in\t\r \u00a0 women\t\r \u00a0 in\t\r \u00a0 Catalonia,\t\r \u00a0 and\t\r \u00a0 non-\u00ad\u2010serious\t\r \u00a0 gastrointestinal\t\r \u00a0metformin\t\r \u00a0 disorders\t\r \u00a0 in\t\r \u00a0 women\t\r \u00a0 between\t\r \u00a0 65\t\r \u00a0 and\t\r \u00a0 74\t\r \u00a0 years\t\r \u00a0 in\t\r \u00a0 Aragon\t\r \u00a0 are\t\r \u00a0 two\t\r \u00a0characteristics\t\r \u00a0 profiles.\t\r \u00a0 Patients\t\r \u00a0 treated\t\r \u00a0 with\t\r \u00a0 three\t\r \u00a0 or\t\r \u00a0 more\t\r \u00a0 oral\t\r \u00a0 agents\t\r \u00a0 are\t\r \u00a0 at\t\r \u00a0increased\t\r \u00a0risk\t\r \u00a0of\t\r \u00a0suffering\t\r \u00a0an\t\r \u00a0adverse\t\r \u00a0reaction.\t\r \u00a0Keywords:\t\r \u00a0Adverse\t\r \u00a0drug\t\r \u00a0reaction,\t\r \u00a0diabetes,\t\r \u00a0data\t\r \u00a0mining.\t\r \u00a0REVISI\u00d3N\t\r \u00a0\nPerfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0275\t\r \u00a0\t\r \u00a01.\t\r \u00a0ANTECEDENTES\t\r \u00a0Las\t\r \u00a0 fuentes\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 en\t\r \u00a0 farmacovigilancia\t\r \u00a0 se\t\r \u00a0 generan\t\r \u00a0 a\t\r \u00a0 partir\t\r \u00a0 de\t\r \u00a0 estudios\t\r \u00a0espec\u00edficos\t\r \u00a0sobre\t\r \u00a0una\t\r \u00a0poblaci\u00f3n\t\r \u00a0expuesta,\t\r \u00a0de\t\r \u00a0las\t\r \u00a0historias\t\r \u00a0cl\u00ednicas\t\r \u00a0o\t\r \u00a0de\t\r \u00a0los\t\r \u00a0sistemas\t\r \u00a0estables\t\r \u00a0de\t\r \u00a0recogida\t\r \u00a0de\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0(RAs).\t\r \u00a0Estos\t\r \u00a0\u00faltimos\t\r \u00a0aglutinan\t\r \u00a0mayor\t\r \u00a0n\u00famero\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0 y\t\r \u00a0 son\t\r \u00a0 de\t\r \u00a0 gran\t\r \u00a0 utilidad\t\r \u00a0 para\t\r \u00a0 estudiar\t\r \u00a0 los\t\r \u00a0 problemas\t\r \u00a0 de\t\r \u00a0seguridad\t\r \u00a0de\t\r \u00a0los\t\r \u00a0medicamentos,\t\r \u00a0siendo\t\r \u00a0el\t\r \u00a0Sistema\t\r \u00a0de\t\r \u00a0Notificaci\u00f3n\t\r \u00a0Espont\u00e1nea\t\r \u00a0de\t\r \u00a0Reacciones\t\r \u00a0Adversas\t\r \u00a0a\t\r \u00a0Medicamentos\t\r \u00a0(RAM)\t\r \u00a0el\t\r \u00a0m\u00e1s\t\r \u00a0extendido\t\r \u00a0internacionalmente\t\r \u00a0(1).\t\r \u00a0 Las\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAM\t\r \u00a0 son\t\r \u00a0 notificadas\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 profesionales\t\r \u00a0 sanitarios\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0Centros\t\r \u00a0Regionales\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0codifican\t\r \u00a0y\t\r \u00a0eval\u00faan\t\r \u00a0(2).\t\r \u00a0A\t\r \u00a0 partir\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 notificaciones\t\r \u00a0 espont\u00e1neas\t\r \u00a0 se\t\r \u00a0 generan\t\r \u00a0 alertas\t\r \u00a0sobre\t\r \u00a0 una\t\r \u00a0posible\t\r \u00a0relaci\u00f3n\t\r \u00a0causal\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0f\u00e1rmaco\t\r \u00a0y\t\r \u00a0la\t\r \u00a0aparici\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0determinado\t\r \u00a0 acontecimiento\t\r \u00a0 adverso,\t\r \u00a0 normalmente\t\r \u00a0 desconocido\t\r \u00a0 o\t\r \u00a0 poco\t\r \u00a0documentado\t\r \u00a0(3).\t\r \u00a0 Estas\t\r \u00a0 alertas\t\r \u00a0 son\t\r \u00a0 el\t\r \u00a0 origen\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 hip\u00f3tesis\t\r \u00a0 sobre\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0pueden\t\r \u00a0realizar\t\r \u00a0estudios\t\r \u00a0de\t\r \u00a0farmacovigilancia\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0ensayos\t\r \u00a0cl\u00ednicos\t\r \u00a0u\t\r \u00a0otros\t\r \u00a0estudios\t\r \u00a0epidemiol\u00f3gicos\t\r \u00a0espec\u00edficos\t\r \u00a0(2,\t\r \u00a04).\t\r \u00a0\t\r \u00a0A\t\r \u00a0pesar\t\r \u00a0de\t\r \u00a0ello,\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0sobre\t\r \u00a0notificaciones\t\r \u00a0espont\u00e1neas\t\r \u00a0son\t\r \u00a0escasos\t\r \u00a0para\t\r \u00a0 algunos\t\r \u00a0 grupos\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 muy\t\r \u00a0 utilizados,\t\r \u00a0 como\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0(5).\t\r \u00a0 Sus\t\r \u00a0 efectos\t\r \u00a0 adversos\t\r \u00a0 conocidos\t\r \u00a0 aparecen\t\r \u00a0 recogidos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0literatura\t\r \u00a0 (ver\t\r \u00a0 Tabla\t\r \u00a0 1),\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 otros\t\r \u00a0 van\t\r \u00a0 apareciendo\t\r \u00a0 por\t\r \u00a0 nuevas\t\r \u00a0inclusiones\t\r \u00a0o\t\r \u00a0combinaciones.\t\r \u00a0\t\r \u00a0Existen\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 conocidas\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 tales\t\r \u00a0como\t\r \u00a0el\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0m\u00e1s\t\r \u00a0numeroso\t\r \u00a0\u2013entre\t\r \u00a070\t\r \u00a0y\t\r \u00a080\t\r \u00a0a\u00f1os-\u00ad\u2010\t\r \u00a0(6),\t\r \u00a0las\t\r \u00a0proporciones\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0mayores\t\r \u00a0de\t\r \u00a080\t\r \u00a0a\u00f1os\t\r \u00a0-\u00ad\u201024,2%-\u00ad\u2010\t\r \u00a0y\t\r \u00a0de\t\r \u00a040\t\r \u00a0o\t\r \u00a0menos\t\r \u00a0a\u00f1os\t\r \u00a0-\u00ad\u20103,5%-\u00ad\u2010\t\r \u00a0(7)\t\r \u00a0o\t\r \u00a0 el\t\r \u00a0 porcentaje\t\r \u00a0 de\t\r \u00a0 mujeres\t\r \u00a0 diab\u00e9ticas\t\r \u00a0-\u00ad\u201052%-\u00ad\u2010\t\r \u00a0(6).\t\r \u00a0A\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 notificaci\u00f3n\t\r \u00a0espont\u00e1nea,\t\r \u00a0 tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 conocen\t\r \u00a0 detalles\t\r \u00a0 sobre\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 que\t\r \u00a0 sufren\t\r \u00a0 RAM,\t\r \u00a0como\t\r \u00a0que\t\r \u00a0las\t\r \u00a0mujeres\t\r \u00a0presentan\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0m\u00e1s\t\r \u00a0RAM\t\r \u00a0que\t\r \u00a0los\t\r \u00a0hombres\t\r \u00a0(57%\t\r \u00a0vs.\t\r \u00a041%)\t\r \u00a0(8),\t\r \u00a0o\t\r \u00a0que\t\r \u00a0Galicia\t\r \u00a0presenta\t\r \u00a0el\t\r \u00a0mayor\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0en\t\r \u00a02005\t\r \u00a0y\t\r \u00a0Cantabria\t\r \u00a0en\t\r \u00a02009\t\r \u00a0(9).\t\r \u00a0En\t\r \u00a0cambio,\t\r \u00a0no\t\r \u00a0se\t\r \u00a0dispone\t\r \u00a0de\t\r \u00a0perfiles\t\r \u00a0definidos\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0que\t\r \u00a0sufren\t\r \u00a0RAM.\t\r \u00a0Para\t\r \u00a0identificar\t\r \u00a0estos\t\r \u00a0perfiles\t\r \u00a0a\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0los\t\r \u00a0registros\t\r \u00a0de\t\r \u00a0sospechas\t\r \u00a0de\t\r \u00a0RAs,\t\r \u00a0los\t\r \u00a0 m\u00e9todos\t\r \u00a0 estad\u00edsticos\t\r \u00a0 tradicionales\t\r \u00a0 no\t\r \u00a0 son\t\r \u00a0 suficientes.\t\r \u00a0 Hay\t\r \u00a0 que\t\r \u00a0 recurrir\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0t\u00e9cnicas\t\r \u00a0 de\t\r \u00a0miner\u00eda\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 (\u2018data\t\r \u00a0 mining\u2019)\t\r \u00a0 para\t\r \u00a0 manejar\t\r \u00a0 de\t\r \u00a0forma\t\r \u00a0 eficiente\t\r \u00a0 el\t\r \u00a0volumen\t\r \u00a0de\t\r \u00a0informaci\u00f3n\t\r \u00a0disponible\t\r \u00a0en\t\r \u00a0cada\t\r \u00a0caso\t\r \u00a0(10).\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n276\t\r \u00a0\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a01a.-\u00ad\u2010\t\r \u00a0Efectos\t\r \u00a0adversos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0f\u00e1rmacos\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0presentes\t\r \u00a0en\t\r \u00a0la\t\r \u00a0terap\u00e9utica\t\r \u00a02000-\u00ad\u20102008.\t\r \u00a0EFECTOS\t\r \u00a0ADVERSOS\t\r \u00a0INS\t\r \u00a0BI\t\r \u00a0SU\t\r \u00a0I-\u00ad\u2010\u03b1G\t\r \u00a0Alteraciones\t\r \u00a0gastrointestinales\t\r \u00a0(n\u00e1useas,\t\r \u00a0v\u00f3mitos,\t\r \u00a0diarrea,\t\r \u00a0dolor\t\r \u00a0abdominal)\t\r \u00a0-\u00ad\u2010\t\r \u00a0x\t\r \u00a0diarrea\t\r \u00a0dosis\t\r \u00a0dependiente,\t\r \u00a0acidez,\t\r \u00a0sabor\t\r \u00a0met\u00e1lico,\t\r \u00a0p\u00e9rdida\t\r \u00a0de\t\r \u00a0apetito\t\r \u00a0x\t\r \u00a0x\t\r \u00a0\t\r \u00a0\t\r \u00a0flatulencia\t\r \u00a0dosis,\t\r \u00a0dieta\t\r \u00a0y\t\r \u00a0tiempo\t\r \u00a0dependientes;\t\r \u00a0tolerancia\t\r \u00a0Hipoglucemia\t\r \u00a0Leve:\t\r \u00a0todas\t\r \u00a0Graves:\t\r \u00a0inhalada>humana\t\r \u00a0r\u00e1pida>an\u00e1logos\t\r \u00a0r\u00e1pida\t\r \u00a0-\u00ad\u2010\t\r \u00a0glibenclamida,\t\r \u00a0clorpropamida>\t\r \u00a0glimepirida>gliclazida\t\r \u00a0terapia\t\r \u00a0combinada\t\r \u00a0SNC\t\r \u00a0\u2026\u2026.-\u00ad\u2010\u2026\u2026.\t\r \u00a0cefaleas\t\r \u00a0x\t\r \u00a0x\t\r \u00a0Aumento\t\r \u00a0de\t\r \u00a0peso\t\r \u00a0NPH\t\r \u00a0>\t\r \u00a0detemir\t\r \u00a0\u2026\u2026.-\u00ad\u2010\u2026\u2026.\t\r \u00a0x\t\r \u00a0\u2026\u2026.-\u00ad\u2010\u2026\u2026.\t\r \u00a0Hepatotoxicidad\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Alteraci\u00f3n\t\r \u00a0pruebas\t\r \u00a0hep\u00e1ticas\t\r \u00a0x\t\r \u00a0Alteraciones\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0inmunol\u00f3gico\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Neumonitis\t\r \u00a0Infecciones\t\r \u00a0urinarias\t\r \u00a0y\t\r \u00a0respiratorias\t\r \u00a0Alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0administraci\u00f3n\t\r \u00a0y\t\r \u00a0reacciones\t\r \u00a0cut\u00e1neas\t\r \u00a0Lipohipertrofia\t\r \u00a0localizada,\t\r \u00a0lipoatrofia.\t\r \u00a0Hipersensibilidad.\t\r \u00a0An\u00e1logos\t\r \u00a0lenta>humana\t\r \u00a0lenta\t\r \u00a0-\u00ad\u2010\t\r \u00a0Rash\t\r \u00a0cut\u00e1neo,\t\r \u00a0p\u00farpura,\t\r \u00a0prurito,\t\r \u00a0dermatitis\t\r \u00a0exfoliativa,\t\r \u00a0eritema\t\r \u00a0nodoso,\t\r \u00a0fotosensibilidad.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Edema\t\r \u00a0(insul\u00ednico)\t\r \u00a0-\u00ad\u2010\t\r \u00a0\u2026\u2026.-\u00ad\u2010\u2026\u2026.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hem\u00e1ticas\t\r \u00a0-\u00ad\u2010\t\r \u00a0Anemia,\t\r \u00a0reducci\u00f3n\t\r \u00a0de\t\r \u00a0absorci\u00f3n\t\r \u00a0de\t\r \u00a0\u00e1cido\t\r \u00a0f\u00f3lico\t\r \u00a0y\t\r \u00a0vit.\t\r \u00a0B12\t\r \u00a0Anemia\t\r \u00a0hemol\u00edtica,\t\r \u00a0agranulocitosis,\t\r \u00a0leucopenia,\t\r \u00a0trombocitopenia\t\r \u00a0-\u00ad\u2010\t\r \u00a0Cardiovasculares\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Musculo-\u00ad\u2010esquel\u00e9ticas\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Visuales\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Pancreatitis\t\r \u00a0aguda\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Espec\u00edficas\t\r \u00a0de\t\r \u00a0grupo\t\r \u00a0I.inhalada:\t\r \u00a0tos\t\r \u00a0irritativa\t\r \u00a0remitente,\t\r \u00a0disminuci\u00f3n\t\r \u00a0progresiva\t\r \u00a0de\t\r \u00a0funci\u00f3n\t\r \u00a0pulmonar,\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0c\u00e1ncer\t\r \u00a0de\t\r \u00a0pulm\u00f3n\t\r \u00a0en\t\r \u00a0fumadores\t\r \u00a0Acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0Colestasis,\t\r \u00a0hipotiroidismo\t\r \u00a0subcl\u00ednico\t\r \u00a0transitorio.\t\r \u00a0\t\r \u00a0Hiponatremia,\t\r \u00a0efecto\t\r \u00a0diur\u00e9tico\t\r \u00a0-\u00ad\u2010\t\r \u00a0Adaptado\t\r \u00a0 de\t\r \u00a0(19-\u00ad\u201026).\t\r \u00a0 INS,\t\r \u00a0 insulina;\t\r \u00a0 BI,\t\r \u00a0 biguanidas;\t\r \u00a0 SU,\t\r \u00a0 sulfonilureas;\t\r \u00a0 I-\u00ad\u2010\u03b1G,\t\r \u00a0 inhibidores\t\r \u00a0 de\t\r \u00a0 \u03b1-\u00ad\u2010glucosidasas.\t\r \u00a0\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0277\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a01b.-\u00ad\u2010\t\r \u00a0Efectos\t\r \u00a0adversos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0f\u00e1rmacos\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0presentes\t\r \u00a0en\t\r \u00a0la\t\r \u00a0terap\u00e9utica\t\r \u00a02000-\u00ad\u20102008\t\r \u00a0(continuaci\u00f3n)\t\r \u00a0EFECTOS\t\r \u00a0ADVERSOS\t\r \u00a0TZD\t\r \u00a0I-\u00ad\u2010DPP4\t\r \u00a0GLIN\t\r \u00a0A-\u00ad\u2010GLP1\t\r \u00a0Alteraciones\t\r \u00a0gastrointestinales\t\r \u00a0(n\u00e1useas,\t\r \u00a0v\u00f3mitos,\t\r \u00a0 diarrea,\t\r \u00a0dolor\t\r \u00a0abdominal)\t\r \u00a0\t\r \u00a0\t\r \u00a0-\u00ad\u2010\t\r \u00a0\t\r \u00a0\t\r \u00a0x\t\r \u00a0x\t\r \u00a0x\t\r \u00a0\t\r \u00a0Hipoglucemia\t\r \u00a0\t\r \u00a0raras\t\r \u00a0ocasiones\t\r \u00a0-\u00ad\u2010\t\r \u00a0repaglinida\t\r \u00a0 >\t\r \u00a0nateglinida\t\r \u00a0-\u00ad\u2010\t\r \u00a0SNC\t\r \u00a0-\u00ad\u2010\t\r \u00a0cefaleas\t\r \u00a0-\u00ad\u2010-\u00ad\u2010-\u00ad\u2010\t\r \u00a0cefaleas\t\r \u00a0Aumento\t\r \u00a0de\t\r \u00a0peso\t\r \u00a0ligero\t\r \u00a0-\u00ad\u2010\t\r \u00a0(con\t\r \u00a0repaglinida)\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hepatotoxicidad\t\r \u00a0x\t\r \u00a0-\u00ad\u2010\t\r \u00a0Alteraci\u00f3n\t\r \u00a0pruebas\t\r \u00a0hep\u00e1ticas\t\r \u00a0-\u00ad\u2010\t\r \u00a0Alteraciones\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0inmunol\u00f3gico\t\r \u00a0\t\r \u00a0Nasofaringitis,\t\r \u00a0rinorrea\t\r \u00a0S\u00edndrome\t\r \u00a0pseudogripal\t\r \u00a0x\t\r \u00a0Alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0 de\t\r \u00a0administraci\u00f3n\t\r \u00a0 y\t\r \u00a0reacciones\t\r \u00a0cut\u00e1neas\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Reacciones\t\r \u00a0 de\t\r \u00a0hipersensibilidad\t\r \u00a0cut\u00e1nea\t\r \u00a0-\u00ad\u2010\t\r \u00a0Edema\t\r \u00a0Retenci\u00f3n\t\r \u00a0hidrosalina\t\r \u00a0x\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hem\u00e1ticas\t\r \u00a0Anemia\t\r \u00a0 dilucional\t\r \u00a0leve\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0-\u00ad\u2010\t\r \u00a0Cardiovasculares\t\r \u00a0Aumento\t\r \u00a0 del\t\r \u00a0riesgo\t\r \u00a0 de\t\r \u00a0insuficiencia\t\r \u00a0cardiaca.\t\r \u00a0Rosiglitazona:\t\r \u00a0aumento\t\r \u00a0del\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0infarto\t\r \u00a0-\u00ad\u2010\t\r \u00a0S\u00edndrome\t\r \u00a0coronario\t\r \u00a0-\u00ad\u2010\t\r \u00a0Musculo-\u00ad\u2010esquel\u00e9ticas\t\r \u00a0Fracturas\t\r \u00a0\u00f3seas\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0Mialgias,\t\r \u00a0artralgias\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Visuales\t\r \u00a0(Pioglitazona:\t\r \u00a0edema\t\r \u00a0 macular\t\r \u00a0diab\u00e9tico)\t\r \u00a0-\u00ad\u2010\t\r \u00a0x\t\r \u00a0-\u00ad\u2010\t\r \u00a0Pancreatitis\t\r \u00a0aguda\t\r \u00a0-\u00ad\u2010\t\r \u00a0x\t\r \u00a0-\u00ad\u2010\t\r \u00a0x\t\r \u00a0Espec\u00edficas\t\r \u00a0 de\t\r \u00a0grupo\t\r \u00a0Hiperlipidemia\t\r \u00a0 e\t\r \u00a0hipotrigliceridemia\t\r \u00a0\t\r \u00a0P\u00e9rdida\t\r \u00a0de\t\r \u00a0peso\t\r \u00a0\t\r \u00a0\t\r \u00a0-\u00ad\u2010\t\r \u00a0\t\r \u00a0Reacci\u00f3n\t\r \u00a0anafil\u00e1ctica\t\r \u00a0Adaptado\t\r \u00a0de\t\r \u00a0(19-\u00ad\u201026).\t\r \u00a0TZD,\t\r \u00a0tiazolidindionas;\t\r \u00a0I-\u00ad\u2010DPP4,\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0la\t\r \u00a0dipeptidilpeptidasa\t\r \u00a04;\t\r \u00a0GLIN,\t\r \u00a0Glinidas;\t\r \u00a0A-\u00ad\u2010GLP1,\t\r \u00a0an\u00e1logos\t\r \u00a0de\t\r \u00a0GLP-\u00ad\u20101.\t\r \u00a0\t\r \u00a0\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n278\t\r \u00a0\t\r \u00a02.\t\r \u00a0OBJETIVO\t\r \u00a0Identificar\t\r \u00a0perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0que\t\r \u00a0sufren\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0a\t\r \u00a0medicamentos.\t\r \u00a03.\t\r \u00a0MATERIAL\t\r \u00a0Y\t\r \u00a0M\u00c9TODO\t\r \u00a03.1.\t\r \u00a0Material\t\r \u00a0Todas\t\r \u00a0 aquellas\t\r \u00a0 notificaciones\t\r \u00a0 espont\u00e1neas\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0adversas\t\r \u00a0 donde\t\r \u00a0 est\u00e1n\t\r \u00a0 registrados\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 antidiab\u00e9ticos\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 periodo\t\r \u00a0 2000-\u00ad\u20102008\t\r \u00a0 en\t\r \u00a0 Espa\u00f1a.\t\r \u00a0 Seg\u00fan\t\r \u00a0 la\t\r \u00a0 clasificaci\u00f3n\t\r \u00a0 Anat\u00f3mica\t\r \u00a0 Terap\u00e9utica\t\r \u00a0 Qu\u00edmica\t\r \u00a0-\u00ad\u2010Anatomical\t\r \u00a0 Therapeutic\t\r \u00a0 Chemical\t\r \u00a0 Classification,\t\r \u00a0 ATC-\u00ad\u2010\t\r \u00a0(11),\t\r \u00a0 los\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0de\t\r \u00a0 referencia\t\r \u00a0 pertenecen\t\r \u00a0 al\t\r \u00a0 Subgrupo\t\r \u00a0 Terap\u00e9utico\t\r \u00a0 A10\t\r \u00a0 \u2018F\u00e1rmacos\t\r \u00a0 usados\t\r \u00a0 en\t\r \u00a0Diabetes\u2019\t\r \u00a0 que\t\r \u00a0 incluye\t\r \u00a0 los\t\r \u00a0 subgrupos\t\r \u00a0 farmacol\u00f3gicos\t\r \u00a0 \u2018A10A\t\r \u00a0 Insulinas\t\r \u00a0 y\t\r \u00a0 an\u00e1logos\u2019\t\r \u00a0(Tabla\t\r \u00a02)\t\r \u00a0y\t\r \u00a0\t\r \u00a0\u2018A10B\t\r \u00a0Agentes\t\r \u00a0hipoglucemiantes\t\r \u00a0orales,\t\r \u00a0excluyendo\t\r \u00a0insulinas\u2019\t\r \u00a0-\u00ad\u2010AHOs-\u00ad\u2010\t\r \u00a0(Tabla\t\r \u00a03).\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a02.-\u00ad\u2010\t\r \u00a0A10A\t\r \u00a0Insulinas\t\r \u00a0y\t\r \u00a0an\u00e1logos.\t\r \u00a0Principios\t\r \u00a0activos\t\r \u00a0y\t\r \u00a0c\u00f3digo\t\r \u00a0ATC.\t\r \u00a0C\u00f3digo\t\r \u00a0ATC\t\r \u00a0Principio\t\r \u00a0activo\t\r \u00a0A10AB01\t\r \u00a0I.\t\r \u00a0regular\t\r \u00a0A10AB04\t\r \u00a0I.\t\r \u00a0lispro\t\r \u00a0A10AB05\t\r \u00a0I.\t\r \u00a0aspart\t\r \u00a0A10AB06\t\r \u00a0I.\t\r \u00a0glulisina\t\r \u00a0A10AC01\t\r \u00a0I.\t\r \u00a0NPH\t\r \u00a0o\t\r \u00a0isof\u00e1nica\t\r \u00a0A10AC01\t\r \u00a0I.\t\r \u00a0zinc\t\r \u00a070%\t\r \u00a0A10AC04\t\r \u00a0I.\t\r \u00a0lispro\t\r \u00a0protamina\t\r \u00a0A10AC30\t\r \u00a0I.\t\r \u00a0bovina+porcina\t\r \u00a0zinc\t\r \u00a070%\t\r \u00a0A10AD01\t\r \u00a0I.\t\r \u00a0regular\t\r \u00a0+\t\r \u00a0NPH\t\r \u00a0A10AD04\t\r \u00a0I.\t\r \u00a0lispro\t\r \u00a0+\t\r \u00a0lispro\t\r \u00a0protamina\t\r \u00a0A10AD05\t\r \u00a0I.\t\r \u00a0aspart\t\r \u00a0+\t\r \u00a0aspart\t\r \u00a0protamina\t\r \u00a0A10AE01\t\r \u00a0I.\t\r \u00a0zinc\t\r \u00a090%\t\r \u00a0A10AE04\t\r \u00a0I.\t\r \u00a0glargina\t\r \u00a0A10AE05\t\r \u00a0I.\t\r \u00a0detemir\t\r \u00a0A10AF01\t\r \u00a0I.\t\r \u00a0inhalada\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0279\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a03.-\u00ad\u2010\t\r \u00a0A10B\t\r \u00a0Agentes\t\r \u00a0hipoglucemiantes,\t\r \u00a0excluyendo\t\r \u00a0insulinas\t\r \u00a0(AHOs).\t\r \u00a0Principios\t\r \u00a0activos\t\r \u00a0y\t\r \u00a0c\u00f3digo\t\r \u00a0ATC.\t\r \u00a0C\u00f3digo\t\r \u00a0ATC\t\r \u00a0Principio\t\r \u00a0activo\t\r \u00a0A10BA02\t\r \u00a0Metformina\t\r \u00a0A10BA03\t\r \u00a0Buformina\t\r \u00a0A10BB01\t\r \u00a0Glibenclamida\t\r \u00a0A10BB02\t\r \u00a0Clorpropamida\t\r \u00a0A10BB03\t\r \u00a0Tolbutamida\t\r \u00a0A10BB07\t\r \u00a0Glipizida\t\r \u00a0A10BB08\t\r \u00a0Gliquidona\t\r \u00a0A10BB09\t\r \u00a0Gliclazida\t\r \u00a0A10BB12\t\r \u00a0Glimepirida\t\r \u00a0A10BB00\t\r \u00a0Glisentida\t\r \u00a0A10BD03\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0rosiglitazona\t\r \u00a0A10BD04\t\r \u00a0Glimepirida\t\r \u00a0y\t\r \u00a0rosiglitazona\t\r \u00a0A10BD05\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0pioglitazona\t\r \u00a0A10BD07\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0sitagliptina\t\r \u00a0A10BD08\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0vildagliptina\t\r \u00a0A10BF01\t\r \u00a0Acarbosa\t\r \u00a0A10BF01\t\r \u00a0Miglitol\t\r \u00a0A10BG02\t\r \u00a0Rosiglitazona\t\r \u00a0A10BG03\t\r \u00a0Pioglitazona\t\r \u00a0A10BH01\t\r \u00a0Sitagliptina\t\r \u00a0A10BH02\t\r \u00a0Vildagliptina\t\r \u00a0A10BX01\t\r \u00a0Goma\t\r \u00a0guar*\t\r \u00a0A10BX02\t\r \u00a0Repaglinida\t\r \u00a0A10BX03\t\r \u00a0Nateglinida\t\r \u00a0A10BX04\t\r \u00a0Exenatida\t\r \u00a0\t\r \u00a0La\t\r \u00a0 base\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 FEDRA\u00ae\t\r \u00a0 2.0\t\r \u00a0 (Farmacovigilancia\t\r \u00a0 Espa\u00f1ola,\t\r \u00a0 Datos\t\r \u00a0 de\t\r \u00a0Reacciones\t\r \u00a0Adversas),\t\r \u00a0perteneciente\t\r \u00a0al\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 del\t\r \u00a0 Medicamento,\t\r \u00a0 contiene\t\r \u00a0 la\t\r \u00a0 informaci\u00f3n\t\r \u00a0 sobre\t\r \u00a0 las\t\r \u00a0 RAs\t\r \u00a0detectadas\t\r \u00a0 y\t\r \u00a0 notificadas\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 profesionales\t\r \u00a0 sanitarios\t\r \u00a0 y\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 laboratorios\t\r \u00a0farmac\u00e9uticos,\t\r \u00a0 tras\t\r \u00a0 el\t\r \u00a0 inicio\t\r \u00a0 de\t\r \u00a0 comercializaci\u00f3n\t\r \u00a0 de\t\r \u00a0 medicamentos\t\r \u00a0 y\t\r \u00a0 productos\t\r \u00a0sanitarios\t\r \u00a0(12).\t\r \u00a0\t\r \u00a0El\t\r \u00a0 material\t\r \u00a0 se\t\r \u00a0 solicit\u00f3\t\r \u00a0 en\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 consulta\t\r \u00a0 abierta,\t\r \u00a0 previo\t\r \u00a0 permiso\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 del\t\r \u00a0Medicamento\t\r \u00a0(13),\t\r \u00a0 y\t\r \u00a0 fue\t\r \u00a0 facilitado\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 Instituto\t\r \u00a0 de\t\r \u00a0Farmacoepidemiolog\u00eda\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Valladolid\t\r \u00a0en\t\r \u00a0archivos\t\r \u00a0Excel.\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n280\t\r \u00a0\t\r \u00a0Para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 informaci\u00f3n\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAM,\t\r \u00a0 hemos\t\r \u00a0respetado\t\r \u00a0los\t\r \u00a0\u2018Criterios\t\r \u00a0para\t\r \u00a0la\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Base\t\r \u00a0de\t\r \u00a0Datos\t\r \u00a0FEDRA\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\u2019\t\r \u00a0-\u00ad\u2010SEFV/1/CT-\u00ad\u2010\t\r \u00a0(14)\t\r \u00a0y\t\r \u00a0las\t\r \u00a0\u2018Normas\t\r \u00a0para\t\r \u00a0la\t\r \u00a0correcta\t\r \u00a0 interpretaci\u00f3n\t\r \u00a0 y\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 datos\t\r \u00a0 del\t\r \u00a0 SEFV\u2019\t\r \u00a0-\u00ad\u2010SEFV/2/CT-\u00ad\u2010\t\r \u00a0(15).\t\r \u00a0 A\t\r \u00a0este\t\r \u00a0 respecto,\t\r \u00a0 hemos\t\r \u00a0 tenido\t\r \u00a0 en\t\r \u00a0 especial\t\r \u00a0 consideraci\u00f3n\t\r \u00a0 que,\t\r \u00a0para\t\r \u00a0 cualquier\t\r \u00a0notificaci\u00f3n,\t\r \u00a0 no\t\r \u00a0 hay\t\r \u00a0 certeza\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 haya\t\r \u00a0 causado\t\r \u00a0 la\t\r \u00a0 RA\t\r \u00a0comunicada.\t\r \u00a0PROCESADO\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0INFORMACI\u00d3N.\t\r \u00a0La\t\r \u00a0fecha\t\r \u00a0de\t\r \u00a0inicio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0(campo\t\r \u00a0obligatorio)\t\r \u00a0es\t\r \u00a0la\t\r \u00a0referencia\t\r \u00a0para\t\r \u00a0la\t\r \u00a0b\u00fasqueda.\t\r \u00a0Cada\t\r \u00a0caso\t\r \u00a0queda\t\r \u00a0identificado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables\t\r \u00a0\u2018n\u00famero\t\r \u00a0de\t\r \u00a0notificaci\u00f3n\u2019,\t\r \u00a0\u2018a\u00f1o\u2019\t\r \u00a0y\t\r \u00a0\u2018Comunidad\t\r \u00a0Aut\u00f3noma\t\r \u00a0(CC.AA.)\u2019\t\r \u00a0(ya\t\r \u00a0que\t\r \u00a0hay\t\r \u00a0casos\t\r \u00a0donde\t\r \u00a0coinciden\t\r \u00a0 los\t\r \u00a0 n\u00fameros\t\r \u00a0 de\t\r \u00a0 notificaci\u00f3n\t\r \u00a0 y\t\r \u00a0 Comunidad).\t\r \u00a0 Las\t\r \u00a0 operaciones\t\r \u00a0 m\u00e1s\t\r \u00a0relevantes\t\r \u00a0realizadas\t\r \u00a0en\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos,\t\r \u00a0a\t\r \u00a0efectos\t\r \u00a0de\t\r \u00a0interpretaci\u00f3n,\t\r \u00a0han\t\r \u00a0sido:\t\r \u00a0i)\t\r \u00a0codificar\t\r \u00a0la\t\r \u00a0variable\t\r \u00a0continua\t\r \u00a0\u2018edad\u2019\t\r \u00a0en\t\r \u00a0grupos\t\r \u00a0acordes\t\r \u00a0con\t\r \u00a0los\t\r \u00a0establecidos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Encuesta\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Salud\t\r \u00a0(ENSE)\t\r \u00a0(16),\t\r \u00a0ii)\t\r \u00a0definir\t\r \u00a0el\t\r \u00a05\u00ba\t\r \u00a0nivel\t\r \u00a0del\t\r \u00a0c\u00f3digo\t\r \u00a0ATC\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0o\t\r \u00a0producto\t\r \u00a0notificado\t\r \u00a0-\u00ad\u20103.929\t\r \u00a0entradas-\u00ad\u2010\t\r \u00a0seg\u00fan\t\r \u00a0la\t\r \u00a0especialidad\t\r \u00a0farmac\u00e9utica\t\r \u00a0registrada,\t\r \u00a0y\t\r \u00a0iii)\t\r \u00a0codificar\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0y\t\r \u00a0las\t\r \u00a0indicaciones\t\r \u00a0terap\u00e9uticas\t\r \u00a0de\t\r \u00a0los\t\r \u00a0 medicamentos\t\r \u00a0 asociados\t\r \u00a0 a\t\r \u00a0 dichas\t\r \u00a0 reacciones\t\r \u00a0 seg\u00fan\t\r \u00a0 la\t\r \u00a0 terminolog\u00eda\t\r \u00a0 del\t\r \u00a0diccionario\t\r \u00a0 MedDRA\t\r \u00a0 (Medical\t\r \u00a0 Dictionary\t\r \u00a0 for\t\r \u00a0 Regulatory\t\r \u00a0 Activities)(17,\t\r \u00a0 18).\t\r \u00a0FEDRA\u00ae\t\r \u00a0 2.0\t\r \u00a0 emplea\t\r \u00a0 la\t\r \u00a0 versi\u00f3n\t\r \u00a0 en\t\r \u00a0 espa\u00f1ol\t\r \u00a0 del\t\r \u00a0 diccionario\t\r \u00a0 MedDRA\t\r \u00a0(5).\t\r \u00a0 Su\t\r \u00a0traducci\u00f3n\t\r \u00a0incluye\t\r \u00a0\u2013manteniendo\t\r \u00a0el\t\r \u00a0orden\t\r \u00a0jer\u00e1rquico-\u00ad\u2010\t\r \u00a0los\t\r \u00a0t\u00e9rminos\t\r \u00a0de\t\r \u00a0bajo\t\r \u00a0nivel\t\r \u00a0(Low\t\r \u00a0 Level\t\r \u00a0 Term,\t\r \u00a0 LltRAM)\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 indicaci\u00f3n\t\r \u00a0 terap\u00e9utica;\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 t\u00e9rminos\t\r \u00a0preferentes\t\r \u00a0(Preferred\t\r \u00a0Term,\t\r \u00a0PtRAM),\t\r \u00a0los\t\r \u00a0t\u00e9rminos\t\r \u00a0de\t\r \u00a0alto\t\r \u00a0nivel\t\r \u00a0(High\t\r \u00a0Level\t\r \u00a0Term,\t\r \u00a0HltRAM),\t\r \u00a0y\t\r \u00a0el\t\r \u00a0\u00f3rgano\t\r \u00a0o\t\r \u00a0sistema\t\r \u00a0correspondiente\t\r \u00a0(System\t\r \u00a0Organ\t\r \u00a0Class,\t\r \u00a0SOC)\t\r \u00a0para\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0adversa\t\r \u00a0(18,\t\r \u00a027).\t\r \u00a0De\t\r \u00a0este\t\r \u00a0modo\t\r \u00a0se\t\r \u00a0codificaron\t\r \u00a0185\t\r \u00a0t\u00e9rminos\t\r \u00a0de\t\r \u00a0bajo\t\r \u00a0nivel,\t\r \u00a0380\t\r \u00a0 t\u00e9rminos\t\r \u00a0 preferentes,\t\r \u00a0 236\t\r \u00a0 t\u00e9rminos\t\r \u00a0 de\t\r \u00a0 alto\t\r \u00a0 nivel\t\r \u00a0 y\t\r \u00a0 25\t\r \u00a0 \u00f3rganos\t\r \u00a0o\t\r \u00a0 sistemas\t\r \u00a0afectados.\t\r \u00a03.1.\t\r \u00a0M\u00e9todo\t\r \u00a0Cada\t\r \u00a0notificaci\u00f3n\t\r \u00a0presenta,\t\r \u00a0al\t\r \u00a0menos,\t\r \u00a0un\t\r \u00a0f\u00e1rmaco\t\r \u00a0antidiab\u00e9tico\t\r \u00a0registrado,\t\r \u00a0pudiendo\t\r \u00a0 acompa\u00f1arse\t\r \u00a0 de\t\r \u00a0 otros\t\r \u00a0 antidiab\u00e9ticos\t\r \u00a0 u\t\r \u00a0 otros\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 diferentes.\t\r \u00a0 Por\t\r \u00a0ello,\t\r \u00a0las\t\r \u00a0notificaciones\t\r \u00a0se\t\r \u00a0pre-\u00ad\u2010clasifican\t\r \u00a0seg\u00fan:\t\r \u00a0i)\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0f\u00e1rmacos\t\r \u00a0registrados\t\r \u00a0por\t\r \u00a0notificaci\u00f3n\t\r \u00a0en\t\r \u00a0\u2018notificaciones\t\r \u00a0con\t\r \u00a0un\t\r \u00a0f\u00e1rmaco\u2019\t\r \u00a0(siempre\t\r \u00a0ser\u00e1\t\r \u00a0un\t\r \u00a0antidiab\u00e9tico)\t\r \u00a0y\t\r \u00a0\u2018notificaciones\t\r \u00a0con\t\r \u00a0varios\t\r \u00a0f\u00e1rmacos\u2019\t\r \u00a0(al\t\r \u00a0menos\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0es\t\r \u00a0antidiab\u00e9tico),\t\r \u00a0y\t\r \u00a0ii)\t\r \u00a0el\t\r \u00a0 subgrupo\t\r \u00a0 farmacol\u00f3gico:\t\r \u00a0 Insulinas,\t\r \u00a0 Agentes\t\r \u00a0 hipoglucemiantes\t\r \u00a0 excluyendo\t\r \u00a0insulinas\t\r \u00a0\u2013AHOs-\u00ad\u2010\t\r \u00a0o\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0Insulinas+AHOs.\t\r \u00a0Se\t\r \u00a0dispone\t\r \u00a0de\t\r \u00a0un\t\r \u00a0total\t\r \u00a0de\t\r \u00a01.253\t\r \u00a0casos,\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0excluyen\t\r \u00a08\t\r \u00a0casos\t\r \u00a0sin\t\r \u00a0grupos\t\r \u00a0farmacol\u00f3gicos\t\r \u00a0definidos.\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 grupo\t\r \u00a0 \u2018AHO/s\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0 antidiab\u00e9ticos\u2019\t\r \u00a0 se\t\r \u00a0 observa\t\r \u00a0 un\t\r \u00a0elevado\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 notificaciones\t\r \u00a0 que\t\r \u00a0 presentan\t\r \u00a0 un\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 no\t\r \u00a0 antidiab\u00e9tico\t\r \u00a0 en\t\r \u00a0primera\t\r \u00a0posici\u00f3n\t\r \u00a0\u2013orden\t\r \u00a0establecido\t\r \u00a0seg\u00fan\t\r \u00a0el\t\r \u00a0grado\t\r \u00a0de\t\r \u00a0sospecha-\u00ad\u2010.\t\r \u00a0Se\t\r \u00a0realiza\t\r \u00a0una\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0281\t\r \u00a0\t\r \u00a0segunda\t\r \u00a0 subdivisi\u00f3n\t\r \u00a0 en\t\r \u00a0 funci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0posici\u00f3n\t\r \u00a0 del\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 antidiab\u00e9tico,\t\r \u00a0resultando\t\r \u00a0las\t\r \u00a0categor\u00edas:\t\r \u00a0\u2018posici\u00f3n\t\r \u00a01\u2019\t\r \u00a0y\t\r \u00a0\u2018otras\t\r \u00a0posiciones\u2019.\t\r \u00a0\t\r \u00a0La\t\r \u00a0 gravedad\t\r \u00a0 (mortal,\t\r \u00a0 grave,\t\r \u00a0 moderada\t\r \u00a0 o\t\r \u00a0 leve)\t\r \u00a0(4)\t\r \u00a0y\t\r \u00a0 la\t\r \u00a0 causalidad\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0notificaciones\t\r \u00a0 (definitiva,\t\r \u00a0 probable,\t\r \u00a0 posible,\t\r \u00a0 condicional,\t\r \u00a0 improbable\t\r \u00a0 o\t\r \u00a0inclasificable)\t\r \u00a0(2,\t\r \u00a0 28)\t\r \u00a0son\t\r \u00a0 examinadas\t\r \u00a0 y\t\r \u00a0 evaluadas\t\r \u00a0 en\t\r \u00a0 cada\t\r \u00a0 Centro\t\r \u00a0 Regional\t\r \u00a0 de\t\r \u00a0Farmacovigilancia.\t\r \u00a0Como\t\r \u00a0 se\t\r \u00a0 indica\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Figura\t\r \u00a0 1,\t\r \u00a0para\t\r \u00a0 cada\t\r \u00a0 uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 definidos\t\r \u00a0 se\t\r \u00a0realiza\t\r \u00a0un\t\r \u00a0estudio\t\r \u00a0consistente\t\r \u00a0en\t\r \u00a0la\t\r \u00a0obtenci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0Gr\u00e1fico\t\r \u00a0de\t\r \u00a0red\t\r \u00a0(An\u00e1lisis\t\r \u00a0de\t\r \u00a0red\t\r \u00a0de\t\r \u00a0 enlaces)\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 An\u00e1lisis\t\r \u00a0 de\t\r \u00a0 perfiles\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 (Modelo\t\r \u00a0 de\t\r \u00a0segmentaci\u00f3n).\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Clasificaci\u00f3n\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0espont\u00e1neas\t\r \u00a0de\t\r \u00a0RAM\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos,\t\r \u00a0seg\u00fan\t\r \u00a0el/los\t\r \u00a0f\u00e1rmaco/s\t\r \u00a0antidiab\u00e9tico/s\t\r \u00a0registrados.\t\r \u00a0*\t\r \u00a0con\t\r \u00a0subgrupo\t\r \u00a0farmacol\u00f3gico\t\r \u00a0definido.\t\r \u00a0(\t\r \u00a0)\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0incluidas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0grupo.\t\r \u00a0\t\r \u00a0AN\u00c1LISIS\t\r \u00a0DE\t\r \u00a0RED\t\r \u00a0DE\t\r \u00a0ENLACES.\t\r \u00a0Ofrece\t\r \u00a0una\t\r \u00a0imagen\t\r \u00a0previa\t\r \u00a0de\t\r \u00a0las\t\r \u00a0situaciones\t\r \u00a0m\u00e1s\t\r \u00a0 frecuentes\t\r \u00a0 y\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 de\t\r \u00a0 cada\t\r \u00a0 grupo\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos.\t\r \u00a0 Este\t\r \u00a0an\u00e1lisis\t\r \u00a0explora\t\r \u00a0la\t\r \u00a0frecuencia\t\r \u00a0de\t\r \u00a0asociaci\u00f3n\t\r \u00a0entre\t\r \u00a0objetos\t\r \u00a0de\t\r \u00a0diferentes\t\r \u00a0tipos.\t\r \u00a0Una\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0aplicaciones\t\r \u00a0m\u00e1s\t\r \u00a0conocidas\t\r \u00a0es\t\r \u00a0la\t\r \u00a0evaluaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0adversos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0medicamentos\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 etapa\t\r \u00a0 de\t\r \u00a0 vigilancia\t\r \u00a0 post-\u00ad\u2010comercializaci\u00f3n,\t\r \u00a0 permitiendo\t\r \u00a0determinar\t\r \u00a0 si\t\r \u00a0 un\t\r \u00a0 efecto\t\r \u00a0 adverso\t\r \u00a0 particular\t\r \u00a0 puede\t\r \u00a0 \u2018enlazarse\u2019\t\r \u00a0 (o\t\r \u00a0 correlacionarse)\t\r \u00a0con\t\r \u00a0uno\t\r \u00a0o\t\r \u00a0con\t\r \u00a0varios\t\r \u00a0medicamentos\t\r \u00a0(29).\t\r \u00a0Se\t\r \u00a0visualiza\t\r \u00a0mediante\t\r \u00a0un\t\r \u00a0resumen\t\r \u00a0gr\u00e1fico\t\r \u00a0de\t\r \u00a0 frecuencias\t\r \u00a0 de\t\r \u00a0 co-\u00ad\u2010ocurrencia\t\r \u00a0 o\t\r \u00a0 Gr\u00e1fico\t\r \u00a0 de\t\r \u00a0 red\t\r \u00a0 entre\t\r \u00a0 valores\t\r \u00a0 de\t\r \u00a0 dos\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0\nMar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n282\t\r \u00a0\t\r \u00a0variables\t\r \u00a0 categ\u00f3ricas,\t\r \u00a0 donde\t\r \u00a0 las\t\r \u00a0 l\u00edneas\t\r \u00a0 m\u00e1s\t\r \u00a0 gruesas\t\r \u00a0 indican\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 t\u00e9rminos\t\r \u00a0enlazados\t\r \u00a0 est\u00e1n\t\r \u00a0 fuertemente\t\r \u00a0 relacionados\t\r \u00a0(30).\t\r \u00a0 Las\t\r \u00a0 variables\t\r \u00a0 incluidas\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0an\u00e1lisis\t\r \u00a0son\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0sospechosos\t\r \u00a0(o\t\r \u00a0sospechosos\t\r \u00a0por\t\r \u00a0interacci\u00f3n)\t\r \u00a0y\t\r \u00a0las\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0(t\u00e9rminos\t\r \u00a0preferentes\t\r \u00a0de\t\r \u00a0RAM\t\r \u00a0-\u00ad\u2010MedDRA-\u00ad\u2010),\t\r \u00a0respetando\t\r \u00a0el\t\r \u00a0orden\t\r \u00a0de\t\r \u00a0notificaci\u00f3n\t\r \u00a0de\t\r \u00a0mayor\t\r \u00a0a\t\r \u00a0menor\t\r \u00a0sospecha\t\r \u00a0y\t\r \u00a0gravedad\t\r \u00a0respectivamente.\t\r \u00a0Las\t\r \u00a0frecuencias\t\r \u00a0de\t\r \u00a0correlaci\u00f3n\t\r \u00a0m\u00e1s\t\r \u00a0altas\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0extraen\t\r \u00a0en\t\r \u00a0tablas\t\r \u00a0(ver\t\r \u00a0Ap\u00e9ndice).\t\r \u00a0En\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0monoterapia\t\r \u00a0exploramos\t\r \u00a0las\t\r \u00a0correlaciones\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0sospechoso\t\r \u00a0-\u00ad\u2010\u2018PRINCIPIO\t\r \u00a0ACTIVO\u2019-\u00ad\u2010\t\r \u00a0y\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0adversa\t\r \u00a0de\t\r \u00a0mayor\t\r \u00a0gravedad\t\r \u00a0-\u00ad\u2010\u2018reacci\u00f3n\t\r \u00a0 adversa\t\r \u00a0 (t\u00e9rmino\t\r \u00a0 Preferente\t\r \u00a0 MedDRA),\t\r \u00a0 posici\u00f3n\t\r \u00a0 1\u2019-\u00ad\u2010.\t\r \u00a0 En\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0politerapia,\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0incidencia\t\r \u00a0de\t\r \u00a0RAM\t\r \u00a0con\t\r \u00a0el\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0los\t\r \u00a0f\u00e1rmacos\t\r \u00a0administrados,\t\r \u00a0se\t\r \u00a0exploran\t\r \u00a0las\t\r \u00a0correlaciones\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0dos\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0m\u00e1s\t\r \u00a0sospechosos\t\r \u00a0-\u00ad\u2010\u2018PRINCIPIO\t\r \u00a0ACTIVO,\t\r \u00a0POSICI\u00d3N\t\r \u00a01\u2019\t\r \u00a0y\t\r \u00a0\u2018PRINCIPIO\t\r \u00a0ACTIVO,\t\r \u00a0POSICI\u00d3N\t\r \u00a02\u2019-\u00ad\u2010\t\r \u00a0y\t\r \u00a0 las\t\r \u00a0 dos\t\r \u00a0 reacciones\t\r \u00a0 adversas\t\r \u00a0 de\t\r \u00a0 mayor\t\r \u00a0 gravedad\t\r \u00a0-\u00ad\u2010\u2018reacci\u00f3n\t\r \u00a0 adversa\t\r \u00a0 (T\u00e9rmino\t\r \u00a0Preferente\t\r \u00a0 MedDRA),\t\r \u00a0 posici\u00f3n\t\r \u00a0 1\u2019\t\r \u00a0 y\t\r \u00a0 \u2018reacci\u00f3n\t\r \u00a0 adversa\t\r \u00a0 (T\u00e9rmino\t\r \u00a0 Preferente\t\r \u00a0MedDRA),\t\r \u00a0posici\u00f3n\t\r \u00a02\u2019-\u00ad\u2010.\t\r \u00a0\t\r \u00a0MODELOS\t\r \u00a0 DE\t\r \u00a0 SEGMENTACI\u00d3N.\t\r \u00a0 Permiten\t\r \u00a0 identificar\t\r \u00a0 registros\t\r \u00a0 similares\t\r \u00a0 y\t\r \u00a0clasificarlos\t\r \u00a0 seg\u00fan\t\r \u00a0 el\t\r \u00a0 grupo\t\r \u00a0 al\t\r \u00a0 que\t\r \u00a0 pertenecen.\t\r \u00a0 Este\t\r \u00a0 procedimiento\t\r \u00a0 se\t\r \u00a0 realiza\t\r \u00a0 sin\t\r \u00a0ning\u00fan\t\r \u00a0 conocimiento\t\r \u00a0 previo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 y\t\r \u00a0 sus\t\r \u00a0 caracter\u00edsticas.\t\r \u00a0 S\u00f3lo\t\r \u00a0 puede\t\r \u00a0aplicarse\t\r \u00a0 en\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 resultado\t\r \u00a0 espec\u00edfico\t\r \u00a0 se\t\r \u00a0 desconoce,\t\r \u00a0 como\t\r \u00a0 ocurre\t\r \u00a0cuando\t\r \u00a0 se\t\r \u00a0 quieren\t\r \u00a0 identificar\t\r \u00a0 nuevos\t\r \u00a0 patrones\t\r \u00a0 o\t\r \u00a0 grupos\t\r \u00a0 de\t\r \u00a0inter\u00e9s\t\r \u00a0(31,\t\r \u00a0 32).\t\r \u00a0 Se\t\r \u00a0basan\t\r \u00a0en\t\r \u00a0la\t\r \u00a0medida\t\r \u00a0de\t\r \u00a0las\t\r \u00a0distancias\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0registros\t\r \u00a0(casos)\t\r \u00a0y\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0grupos.\t\r \u00a0Los\t\r \u00a0 casos\t\r \u00a0 se\t\r \u00a0 asignan\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 de\t\r \u00a0 tal\t\r \u00a0 manera\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 tiende\t\r \u00a0 a\t\r \u00a0 minimizar\t\r \u00a0 la\t\r \u00a0distancia\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 pertenecientes\t\r \u00a0 al\t\r \u00a0 mismo\t\r \u00a0 grupo\t\r \u00a0(31).\t\r \u00a0 Este\t\r \u00a0 tipo\t\r \u00a0de\t\r \u00a0aprendizaje\t\r \u00a0 no\t\r \u00a0 supervisado,\t\r \u00a0 no\t\r \u00a0 dispone\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 referencia\t\r \u00a0 externa\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0juzgar\t\r \u00a0la\t\r \u00a0clasificaci\u00f3n\t\r \u00a0realizada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0modelo,\t\r \u00a0sino\t\r \u00a0que\t\r \u00a0su\t\r \u00a0la\t\r \u00a0validez\t\r \u00a0se\t\r \u00a0determina\t\r \u00a0seg\u00fan\t\r \u00a0 su\t\r \u00a0 capacidad\t\r \u00a0 de\t\r \u00a0 recoger\t\r \u00a0 agrupamientos\t\r \u00a0 interesantes\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 datos\t\r \u00a0 y\t\r \u00a0proporcionar\t\r \u00a0descripciones\t\r \u00a0\u00fatiles\t\r \u00a0de\t\r \u00a0esos\t\r \u00a0grupos\t\r \u00a0(31,\t\r \u00a032).\t\r \u00a0Dentro\t\r \u00a0de\t\r \u00a0este\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0modelos\t\r \u00a0se\t\r \u00a0incluye\t\r \u00a0el\t\r \u00a0modelo\t\r \u00a0de\t\r \u00a0redes\t\r \u00a0de\t\r \u00a0Kohonen.\t\r \u00a0Modelo\t\r \u00a0de\t\r \u00a0redes\t\r \u00a0de\t\r \u00a0Kohonen.\t\r \u00a0Basado\t\r \u00a0en\t\r \u00a0un\t\r \u00a0modelo\t\r \u00a0preliminar\t\r \u00a0denominado\t\r \u00a0mapa\t\r \u00a0 auto-\u00ad\u2010organizado\t\r \u00a0 (Self-\u00ad\u2010Organizing\t\r \u00a0 Map,\t\r \u00a0 SOM)\t\r \u00a0(33),\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 actual\t\r \u00a0 modelo\t\r \u00a0de\t\r \u00a0redes\t\r \u00a0de\t\r \u00a0Kohonen\t\r \u00a0se\t\r \u00a0genera\t\r \u00a0un\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0red\t\r \u00a0neuronal\t\r \u00a0que\t\r \u00a0agrupa\t\r \u00a0los\t\r \u00a0registros\t\r \u00a0de\t\r \u00a0una\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0en\t\r \u00a0diferentes\t\r \u00a0grupos\t\r \u00a0cuya\t\r \u00a0existencia\t\r \u00a0no\t\r \u00a0se\t\r \u00a0conoce\t\r \u00a0al\t\r \u00a0inicio.\t\r \u00a0\t\r \u00a0El\t\r \u00a0mapa\t\r \u00a0de\t\r \u00a0salida\t\r \u00a0es\t\r \u00a0una\t\r \u00a0red\t\r \u00a0o\t\r \u00a0cuadr\u00edcula\t\r \u00a0bidimensional\t\r \u00a0de\t\r \u00a0neuronas,\t\r \u00a0sin\t\r \u00a0conexiones\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0unidades\t\r \u00a0(31,\t\r \u00a032).\t\r \u00a0La\t\r \u00a0 t\u00e9cnica\t\r \u00a0 para\t\r \u00a0 construir\t\r \u00a0 estos\t\r \u00a0 modelos\t\r \u00a0 se\t\r \u00a0 denomina\t\r \u00a0 aprendizaje\t\r \u00a0 o\t\r \u00a0modelado\t\r \u00a0autom\u00e1tico\t\r \u00a0(10),\t\r \u00a0y\t\r \u00a0consiste\t\r \u00a0en\t\r \u00a0una\t\r \u00a0presentaci\u00f3n\t\r \u00a0de\t\r \u00a0cada\t\r \u00a0registro\t\r \u00a0en\t\r \u00a0la\t\r \u00a0capa\t\r \u00a0de\t\r \u00a0entrada\t\r \u00a0y\t\r \u00a0una\t\r \u00a0propagaci\u00f3n\t\r \u00a0competitiva\t\r \u00a0hacia\t\r \u00a0el\t\r \u00a0mapa\t\r \u00a0de\t\r \u00a0salida\t\r \u00a0(Figura\t\r \u00a02).\t\r \u00a0Esto\t\r \u00a0se\t\r \u00a0repite\t\r \u00a0con\t\r \u00a0cada\t\r \u00a0registro\t\r \u00a0y\t\r \u00a0cuando\t\r \u00a0la\t\r \u00a0red\t\r \u00a0est\u00e1\t\r \u00a0completamente\t\r \u00a0\u2018entrenada\u2019,\t\r \u00a0los\t\r \u00a0registros\t\r \u00a0de\t\r \u00a0dentro\t\r \u00a0de\t\r \u00a0un\t\r \u00a0grupo\t\r \u00a0se\t\r \u00a0consideran\t\r \u00a0similares\t\r \u00a0y\t\r \u00a0deben\t\r \u00a0aparecer\t\r \u00a0m\u00e1s\t\r \u00a0cercanos\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 mapa\t\r \u00a0 de\t\r \u00a0 salida,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 registros\t\r \u00a0 entre\t\r \u00a0 grupos\t\r \u00a0 se\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0283\t\r \u00a0\t\r \u00a0consideran\t\r \u00a0 diferentes\t\r \u00a0 y\t\r \u00a0 aparecen\t\r \u00a0 alejados.\t\r \u00a0 Las\t\r \u00a0 agrupaciones\t\r \u00a0 m\u00e1s\t\r \u00a0 fuertes\t\r \u00a0 ser\u00e1n\t\r \u00a0aquellas\t\r \u00a0que\t\r \u00a0resumen\t\r \u00a0muchos\t\r \u00a0registros\t\r \u00a0(31,\t\r \u00a032).\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a0 2.-\u00ad\u2010\t\r \u00a0Estructura\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 modelo\t\r \u00a0 de\t\r \u00a0 red\t\r \u00a0 de\t\r \u00a0 Kohonen.\t\r \u00a0Todas\t\r \u00a0 las\t\r \u00a0 neuronas\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 capa\t\r \u00a0 de\t\r \u00a0entrada\t\r \u00a0 est\u00e1n\t\r \u00a0 conectadas\t\r \u00a0 a\t\r \u00a0 todas\t\r \u00a0 las\t\r \u00a0 neuronas\t\r \u00a0 del\t\r \u00a0 mapa\t\r \u00a0 de\t\r \u00a0 salida.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 figura\t\r \u00a0 mostramos\t\r \u00a0 las\t\r \u00a0conexiones\t\r \u00a0que\t\r \u00a0establecer\u00eda\t\r \u00a0una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0neuronas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0capa\t\r \u00a0de\t\r \u00a0entrada.\t\r \u00a0Adaptado\t\r \u00a0de\t\r \u00a0(31).\t\r \u00a0Para\t\r \u00a0 el\t\r \u00a0 presente\t\r \u00a0 estudio\t\r \u00a0 se\t\r \u00a0 selecciona\t\r \u00a0 un\t\r \u00a0modelo\t\r \u00a0 de\t\r \u00a0 an\u00e1lisis\t\r \u00a0 con\t\r \u00a0 datos\t\r \u00a0particionados\t\r \u00a0y\t\r \u00a0un\t\r \u00a0mapa\t\r \u00a0de\t\r \u00a0salida\t\r \u00a0de\t\r \u00a03x2\t\r \u00a0neuronas,\t\r \u00a0que\t\r \u00a0genera\t\r \u00a0tres\t\r \u00a0perfiles\t\r \u00a0por\t\r \u00a0grupo.\t\r \u00a0La\t\r \u00a0informaci\u00f3n\t\r \u00a0obtenida\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0perfil\t\r \u00a0a\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables\t\r \u00a0de\t\r \u00a0entrada\t\r \u00a0se\t\r \u00a0recoge\t\r \u00a0en\t\r \u00a0una\t\r \u00a0ficha-\u00ad\u2010resumen\t\r \u00a0estructurada\t\r \u00a0(Tabla\t\r \u00a04;\t\r \u00a0ver\t\r \u00a0Ap\u00e9ndice).\t\r \u00a0El\t\r \u00a0procesamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0realizado\t\r \u00a0con\t\r \u00a0Microsoft\t\r \u00a0Office\t\r \u00a0Excel\t\r \u00a0 v2007\t\r \u00a0 e\t\r \u00a0 IBM\t\r \u00a0 PASW\u00ae\t\r \u00a0 Statistics\t\r \u00a0 18,\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 modelado\t\r \u00a0 con\t\r \u00a0 Clementine\u00ae\t\r \u00a0 SPSS\t\r \u00a0v12.0.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a04.-\u00ad\u2010\t\r \u00a0Modelo\t\r \u00a0de\t\r \u00a0ficha-\u00ad\u2010resumen\t\r \u00a0de\t\r \u00a0los\t\r \u00a0perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0que\t\r \u00a0sufren\t\r \u00a0RAM.\t\r \u00a0Se\t\r \u00a0registran\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0con\t\r \u00a0mayor\t\r \u00a0porcentaje\t\r \u00a0atribuible\t\r \u00a0(%)\t\r \u00a0respecto\t\r \u00a0del\t\r \u00a0total\t\r \u00a0notificado\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0variable.\t\r \u00a0PERFIL\t\r \u00a0\t\r \u00a0DATOS\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0NOTIFICACI\u00d3N\t\r \u00a0n\u00ba\t\r \u00a0notificaciones\t\r \u00a0(principio\t\r \u00a0activo)\t\r \u00a0G\u00e9nero:\t\r \u00a0(%)\t\r \u00a0Gravedad:\t\r \u00a0(%)\t\r \u00a0Edad\t\r \u00a0(a\u00f1os):\t\r \u00a0(%)\t\r \u00a0Mortal:\t\r \u00a0(%)\t\r \u00a0\nMar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n284\t\r \u00a0\t\r \u00a0CC.AA.:\t\r \u00a0(%)\t\r \u00a0A\u00f1o:\t\r \u00a0\t\r \u00a0(%)\t\r \u00a0PRINCIPIOS\t\r \u00a0ACTIVOS\t\r \u00a0(PAs)\t\r \u00a0PA*\t\r \u00a0ATC\t\r \u00a01:\t\r \u00a0(%)\t\r \u00a0ATC\t\r \u00a02:\t\r \u00a0(%)\t\r \u00a0ATC\t\r \u00a03:\t\r \u00a0(%)\t\r \u00a0ATC\t\r \u00a04:\t\r \u00a0\t\r \u00a0(%)\t\r \u00a0ATC\t\r \u00a05:\t\r \u00a0\t\r \u00a0(%)\t\r \u00a0Sospecha:\t\r \u00a0(%)\t\r \u00a0Indicaci\u00f3n\t\r \u00a0terap\u00e9utica:\t\r \u00a0(%)\t\r \u00a0REACCIONES\t\r \u00a0ADVERSAS\t\r \u00a0A\t\r \u00a0MEDICAMENTOS\t\r \u00a0(RAMs)\t\r \u00a0RAM*\t\r \u00a0\u00d3rgano\t\r \u00a0(%)\t\r \u00a0HltRAM\t\r \u00a0(%)\t\r \u00a0PtRAM\t\r \u00a0(%)\t\r \u00a0RELACI\u00d3N\t\r \u00a0CAUSAL-\u00ad\u2010\t\r \u00a0Algoritmo\t\r \u00a0de\t\r \u00a0Karch\t\r \u00a0y\t\r \u00a0Lasagna:\t\r \u00a0%\t\r \u00a0*se\t\r \u00a0incluyen\t\r \u00a0tantos\t\r \u00a0apartados\t\r \u00a0de\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0(PA)\t\r \u00a0y\t\r \u00a0reacci\u00f3n\t\r \u00a0adversa\t\r \u00a0a\t\r \u00a0medicamento\t\r \u00a0(RAM)\t\r \u00a0como\t\r \u00a0requiera\t\r \u00a0cada\t\r \u00a0perfil.\t\r \u00a04.\t\r \u00a0RESULTADOS\t\r \u00a0GRUPO\t\r \u00a01:\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0Insulina\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0Perfil\t\r \u00a0 1.1\t\r \u00a0(52\t\r \u00a0 notificaciones):\t\r \u00a0 Mujer\t\r \u00a0 de\t\r \u00a0 m\u00e1s\t\r \u00a0 de\t\r \u00a0 75\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02006\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0considerada\t\r \u00a0no\t\r \u00a0grave\t\r \u00a0y\t\r \u00a0probable.\t\r \u00a0El\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0es\t\r \u00a0insulina\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0detemir,\t\r \u00a0indicada\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0 diabetes,\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 producir,\t\r \u00a0 en\t\r \u00a0 primer\t\r \u00a0 lugar,\t\r \u00a0 trastornos\t\r \u00a0 generales\t\r \u00a0 y\t\r \u00a0alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0administraci\u00f3n\t\r \u00a0y,\t\r \u00a0en\t\r \u00a0segundo\t\r \u00a0lugar,\t\r \u00a0prurito.\t\r \u00a0Perfil\t\r \u00a01.2\t\r \u00a0(1\t\r \u00a0notificaci\u00f3n):\t\r \u00a0caso\t\r \u00a0aislado\t\r \u00a0de\t\r \u00a0un\t\r \u00a0hombre\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0desconocida,\t\r \u00a0procedente\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Islas\t\r \u00a0Baleares,\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02007\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0considerada\t\r \u00a0no\t\r \u00a0grave\t\r \u00a0y\t\r \u00a0 probable.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 es\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 glargina,\t\r \u00a0indicada\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 diabetes,\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0metabolismo\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nutrici\u00f3n.\t\r \u00a0Perfil\t\r \u00a01.3\t\r \u00a0(46\t\r \u00a0notificaciones):\t\r \u00a0mujer\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0no\t\r \u00a0definida\t\r \u00a0de\t\r \u00a0Catalu\u00f1a\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02008\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0considerada\t\r \u00a0grave\t\r \u00a0(aunque\t\r \u00a0no\t\r \u00a0mortal)\t\r \u00a0y\t\r \u00a0posible.\t\r \u00a0El\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0es\t\r \u00a0insulina\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0glargina,\t\r \u00a0indicada\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0diabetes,\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0del\t\r \u00a0metabolismo\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nutrici\u00f3n,\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0 acompa\u00f1arse\t\r \u00a0 de\t\r \u00a0 trastornos\t\r \u00a0 generales\t\r \u00a0 y\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0administraci\u00f3n.\t\r \u00a0En\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0aparecer\t\r \u00a03\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0RAs\t\r \u00a0podr\u00eda\t\r \u00a0notificarse\t\r \u00a0edema,\t\r \u00a0fallo\t\r \u00a0de\t\r \u00a0dispositivo\t\r \u00a0m\u00e9dico,\t\r \u00a0f\u00e1rmaco\t\r \u00a0ineficaz,\t\r \u00a0insuficiencia\t\r \u00a0de\t\r \u00a0v\u00e1lvula\t\r \u00a0tric\u00faspide\t\r \u00a0o\t\r \u00a0fetopat\u00eda\t\r \u00a0diab\u00e9tica.\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0285\t\r \u00a0\t\r \u00a0\t\r \u00a0Gr\u00e1fico\t\r \u00a0 1.-\u00ad\u2010\t\r \u00a0Red\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 con\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 monoterapia.\t\r \u00a0Este\t\r \u00a0 grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a099\t\r \u00a0notificaciones.\t\r \u00a0Se\t\r \u00a0observa\t\r \u00a0un\t\r \u00a0predominio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0insulina\t\r \u00a0aspart\t\r \u00a0+\t\r \u00a0aspart-\u00ad\u2010protamina\t\r \u00a0y\t\r \u00a0la\t\r \u00a0RA\t\r \u00a0hiperglucemia\t\r \u00a0(7\t\r \u00a0casos).\t\r \u00a0Otras\t\r \u00a0relaciones\t\r \u00a0interesantes\t\r \u00a0son\t\r \u00a0detemir\t\r \u00a0con\t\r \u00a0\u2018reacci\u00f3n\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 zona\t\r \u00a0 de\t\r \u00a0 inyecci\u00f3n\u2019,\t\r \u00a0 insulina\t\r \u00a0 isof\u00e1nica\t\r \u00a0 con\t\r \u00a0 \u2018hipoglucemia\u2019\t\r \u00a0 e\t\r \u00a0 insulina\t\r \u00a0 glargina\t\r \u00a0 con\t\r \u00a0\u2018hiperglucemia\u2019\t\r \u00a0(todos\t\r \u00a0ellos\t\r \u00a0con\t\r \u00a05\t\r \u00a0casos\t\r \u00a0cada\t\r \u00a0uno).\t\r \u00a0\t\r \u00a0GRUPO\t\r \u00a02:\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a0 2.1\t\r \u00a0(125\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 de\t\r \u00a0 m\u00e1s\t\r \u00a0 de\t\r \u00a0 75\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2004\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 considerada\t\r \u00a0 grave\t\r \u00a0 (aunque\t\r \u00a0 no\t\r \u00a0 mortal)\t\r \u00a0 y\t\r \u00a0probable.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 biguanida\t\r \u00a0 metformina,\t\r \u00a0 indicada\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0tratamiento\t\r \u00a0 de\t\r \u00a0 diabetes,\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0del\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0nutrici\u00f3n,\t\r \u00a0 trastornos\t\r \u00a0 renales,\t\r \u00a0 e\t\r \u00a0 incluso,\t\r \u00a0 pueden\t\r \u00a0 acompa\u00f1arse\t\r \u00a0 de\t\r \u00a0 trastornos\t\r \u00a0respiratorios.\t\r \u00a0En\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0aparecer\t\r \u00a04\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0RAs\t\r \u00a0podr\u00eda\t\r \u00a0llegar\t\r \u00a0a\t\r \u00a0notificarse\t\r \u00a0aspartato\t\r \u00a0aminotransferasa\t\r \u00a0elevada,\t\r \u00a0diarrea,\t\r \u00a0v\u00f3mitos,\t\r \u00a0alucinaci\u00f3n\t\r \u00a0o\t\r \u00a0alteraci\u00f3n\t\r \u00a0del\t\r \u00a0equilibrio.\t\r \u00a0Perfil\t\r \u00a02.2\t\r \u00a0(13\t\r \u00a0notificaciones):\t\r \u00a0mujer\t\r \u00a0de\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a075\t\r \u00a0a\u00f1os,\t\r \u00a0de\t\r \u00a0Galicia,\t\r \u00a0que\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0 a\u00f1os\t\r \u00a0 2006\t\r \u00a0 y\t\r \u00a0 2007\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 considerada\t\r \u00a0 no\t\r \u00a0 grave\t\r \u00a0 y\t\r \u00a0 posible.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 sulfonilurea\t\r \u00a0 glibenclamida,\t\r \u00a0 indicada\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0diabetes,\t\r \u00a0 que\t\r \u00a0puede\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 nervioso,\t\r \u00a0 trastornos\t\r \u00a0psiqui\u00e1tricos\t\r \u00a0 y\t\r \u00a0 trastornos\t\r \u00a0 respiratorios,\t\r \u00a0 tor\u00e1cicos\t\r \u00a0 y\t\r \u00a0 mediast\u00ednicos.\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0aparecer\t\r \u00a04\t\r \u00a0RAs\t\r \u00a0podr\u00eda\t\r \u00a0notificarse\t\r \u00a0estados\t\r \u00a0disociativos.\t\r \u00a0Perfil\t\r \u00a02.3\t\r \u00a0(388\t\r \u00a0notificaciones):\t\r \u00a0mujer\t\r \u00a0entre\t\r \u00a065\t\r \u00a0y\t\r \u00a074\t\r \u00a0a\u00f1os,\t\r \u00a0de\t\r \u00a0Arag\u00f3n,\t\r \u00a0que\t\r \u00a0en\t\r \u00a02008\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 considerada\t\r \u00a0 no\t\r \u00a0 grave\t\r \u00a0 y\t\r \u00a0 probable.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0biguanida\t\r \u00a0 metformina,\t\r \u00a0 indicada\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 diabetes,\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0gastrointestinales\t\r \u00a0diversos\t\r \u00a0como\t\r \u00a0diarrea.\t\r \u00a0En\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0aparecer\t\r \u00a05\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0RAs\t\r \u00a0podr\u00edan\t\r \u00a0notificarse\t\r \u00a0palpitaciones\t\r \u00a0y\t\r \u00a0v\u00f3mitos.\t\r \u00a0\t\r \u00a0\nMar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n286\t\r \u00a0\t\r \u00a0\t\r \u00a0Gr\u00e1fico\t\r \u00a02.-\u00ad\u2010\t\r \u00a0Red\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0de\t\r \u00a0sospechas\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0con\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0Este\t\r \u00a0grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a0526\t\r \u00a0notificaciones.\t\r \u00a0Se\t\r \u00a0observa\t\r \u00a0una\t\r \u00a0fuerte\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0\u2018Diarrea\u2019\t\r \u00a0(60\t\r \u00a0casos)\t\r \u00a0y\t\r \u00a0\u2018Acidosis\t\r \u00a0l\u00e1ctica\u2019\t\r \u00a0(28\t\r \u00a0casos),\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0\u2018dolor\t\r \u00a0abdominal\u2019,\t\r \u00a0\u2018dispepsia\u2019\t\r \u00a0y\t\r \u00a0\u2018n\u00e1useas\u2019.\t\r \u00a0La\t\r \u00a0\u2018hipoglucemia\u2019\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0con\t\r \u00a0las\t\r \u00a0sulfonilureas\t\r \u00a0glibenclamida\t\r \u00a0(20\t\r \u00a0casos)\t\r \u00a0y\t\r \u00a0glimepirida\t\r \u00a0(9\t\r \u00a0casos).\t\r \u00a0En\t\r \u00a0menor\t\r \u00a0grado,\t\r \u00a0rosiglitazona\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0con\t\r \u00a0\u2018anemia\u2019\t\r \u00a0y\t\r \u00a0acarbosa\t\r \u00a0con\t\r \u00a0\u2018diarrrea\u2019.\t\r \u00a0GRUPO\t\r \u00a0 3:\t\r \u00a0 Notificaciones\t\r \u00a0 con\t\r \u00a0 Insulina/s\t\r \u00a0 y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a03.1\t\r \u00a0(39\t\r \u00a0notificaciones):\t\r \u00a0mujer\t\r \u00a0entre\t\r \u00a025\t\r \u00a0y\t\r \u00a034\t\r \u00a0a\u00f1os,\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Comunidades\t\r \u00a0de\t\r \u00a0Valencia\t\r \u00a0o\t\r \u00a0Madrid,\t\r \u00a0que\t\r \u00a0en\t\r \u00a02008\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0considerada\t\r \u00a0grave\t\r \u00a0(aunque\t\r \u00a0no\t\r \u00a0mortal)\t\r \u00a0y\t\r \u00a0 posible.\t\r \u00a0 Presenta\t\r \u00a0 combinaciones\t\r \u00a0 de\t\r \u00a0 hasta\t\r \u00a0 7\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos,\t\r \u00a0 siendo\t\r \u00a0 el\t\r \u00a0primero\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 glargina\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 siguientes\t\r \u00a0 hasta\t\r \u00a0 cuatro\t\r \u00a0insulinas\t\r \u00a0 diferentes\t\r \u00a0 (r\u00e1pida,\t\r \u00a0 intermedia\t\r \u00a0 o\t\r \u00a0 prolongada)-\u00ad\u2010,\t\r \u00a0 y\t\r \u00a0 puede\t\r \u00a0 producir\t\r \u00a0trastornos\t\r \u00a0 generales\t\r \u00a0 y\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0 administraci\u00f3n.\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0aparecer\t\r \u00a03\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0RAs\t\r \u00a0podr\u00eda\t\r \u00a0notificarse\t\r \u00a0edema\t\r \u00a0de\t\r \u00a0la\t\r \u00a0boca,\t\r \u00a0eritema,\t\r \u00a0hiperglucemia,\t\r \u00a0prurito\t\r \u00a0o\t\r \u00a0hiperhidrosis.\t\r \u00a0\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a03.2\t\r \u00a0(5\t\r \u00a0notificaciones):\t\r \u00a0hombre\t\r \u00a0de\t\r \u00a016\t\r \u00a0a\u00f1os\t\r \u00a0en\t\r \u00a0adelante,\t\r \u00a0de\t\r \u00a0Andaluc\u00eda,\t\r \u00a0Canarias,\t\r \u00a0 Castilla-\u00ad\u2010Le\u00f3n,\t\r \u00a0 Catalu\u00f1a\t\r \u00a0 o\t\r \u00a0 Madrid,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2006\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 grave\t\r \u00a0(aunque\t\r \u00a0 no\t\r \u00a0 mortal)\t\r \u00a0 y\t\r \u00a0 probable.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 es\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0intermedia\t\r \u00a0 \u2018regular\t\r \u00a0 +\t\r \u00a0 isof\u00e1nica\u2019\t\r \u00a0 o\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 detemir\t\r \u00a0-\u00ad\u2010combinada\t\r \u00a0 con\t\r \u00a0 hasta\t\r \u00a0 3\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0 sospechosos\t\r \u00a0 (otra\t\r \u00a0 insulina,\t\r \u00a0 vitaminas\t\r \u00a0 o\t\r \u00a0agentes\t\r \u00a0modificadores\t\r \u00a0de\t\r \u00a0l\u00edpidos)-\u00ad\u2010,\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0piel\t\r \u00a0y\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0 subcut\u00e1neo,\t\r \u00a0 trastornos\t\r \u00a0 generales\t\r \u00a0 y\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0administraci\u00f3n,\t\r \u00a0y\t\r \u00a0trastornos\t\r \u00a0del\t\r \u00a0metabolismo\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nutrici\u00f3n\t\r \u00a0(hiperglucemia).\t\r \u00a0En\t\r \u00a0caso\t\r \u00a0 de\t\r \u00a0 aparecer\t\r \u00a0 3\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 puede\t\r \u00a0 notificarse\t\r \u00a0 eritema\t\r \u00a0 nudoso,\t\r \u00a0 temblor,\t\r \u00a0hiperhidrosis,\t\r \u00a0hipersensibilidad,\t\r \u00a0palidez\t\r \u00a0o\t\r \u00a0prurito.\t\r \u00a0Perfil\t\r \u00a03.3\t\r \u00a0(24\t\r \u00a0notificaciones):\t\r \u00a0hombre\t\r \u00a0o\t\r \u00a0mujer\t\r \u00a0de\t\r \u00a075\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0a\u00f1os,\t\r \u00a0procedente\t\r \u00a0de\t\r \u00a0 Andaluc\u00eda,\t\r \u00a0 Catalu\u00f1a\t\r \u00a0 o\t\r \u00a0 Comunidad\t\r \u00a0 Valenciana;\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2004\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0grave\t\r \u00a0(aunque\t\r \u00a0no\t\r \u00a0mortal)\t\r \u00a0y\t\r \u00a0considerada\t\r \u00a0posible/probable.\t\r \u00a0El\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0\nPerfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0287\t\r \u00a0\t\r \u00a0es\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0glargina\t\r \u00a0-\u00ad\u2010combinada\t\r \u00a0hasta\t\r \u00a0con\t\r \u00a06\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0sospechosos\t\r \u00a0 (una\t\r \u00a0 o\t\r \u00a0 dos\t\r \u00a0 insulinas\t\r \u00a0 adicionales\t\r \u00a0 y\t\r \u00a0 agentes\t\r \u00a0 antitromb\u00f3ticos)-\u00ad\u2010,\t\r \u00a0 que\t\r \u00a0puede\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 nutrici\u00f3n\t\r \u00a0 (hipoglucemia).\t\r \u00a0 En\t\r \u00a0caso\t\r \u00a0 de\t\r \u00a0 aparecer\t\r \u00a0 3\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 puede\t\r \u00a0 darse\t\r \u00a0 efecto\t\r \u00a0 farmacol\u00f3gico\t\r \u00a0 o\t\r \u00a0 respuesta\t\r \u00a0terap\u00e9utica\t\r \u00a0disminuida,\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0anticuerpos\t\r \u00a0a\t\r \u00a0un\t\r \u00a0f\u00e1rmaco,\t\r \u00a0retenci\u00f3n\t\r \u00a0urinaria,\t\r \u00a0lagrimeo\t\r \u00a0aumentado\t\r \u00a0o\t\r \u00a0acaloramiento.\t\r \u00a0\n\t\r \u00a0Gr\u00e1fico\t\r \u00a0 3.-\u00ad\u2010\t\r \u00a0Red\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 con\t\r \u00a0 Insulina/s\t\r \u00a0 y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0Este\t\r \u00a0grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a068\t\r \u00a0notificaciones.\t\r \u00a0Se\t\r \u00a0refleja\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0an\u00e1logo\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0detemir\t\r \u00a0\u2013posici\u00f3n\t\r \u00a01-\u00ad\u2010\t\r \u00a0y\t\r \u00a0el\t\r \u00a0an\u00e1logo\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0r\u00e1pida\t\r \u00a0aspart\t\r \u00a0-\u00ad\u2010posici\u00f3n\t\r \u00a02-\u00ad\u2010\t\r \u00a0(3\t\r \u00a0casos).\t\r \u00a0La\t\r \u00a0 insulina\t\r \u00a0 r\u00e1pida\t\r \u00a0 lispro\t\r \u00a0 aparece\t\r \u00a0 relacionada\t\r \u00a0 en\t\r \u00a0 posici\u00f3n\t\r \u00a0 1\t\r \u00a0 con\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 intermedia\t\r \u00a0isof\u00e1nica\t\r \u00a0 (2\t\r \u00a0 casos);\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 posici\u00f3n\t\r \u00a0 2\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 an\u00e1logo\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 bif\u00e1sica\t\r \u00a0 lispro+lispro\t\r \u00a0 protamina\t\r \u00a0 (2\t\r \u00a0casos).\t\r \u00a0 Existen\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 politerapia\t\r \u00a0 con\t\r \u00a0 antihipertensivos\t\r \u00a0 (irbesart\u00e1n)\t\r \u00a0 y\t\r \u00a0 diur\u00e9ticos\t\r \u00a0(hidroclorotiazida)\t\r \u00a0 donde\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 aparece\t\r \u00a0 en\t\r \u00a0 posiciones\t\r \u00a0 menos\t\r \u00a0 relevantes.\t\r \u00a0 Existe\t\r \u00a0 una\t\r \u00a0correlaci\u00f3n\t\r \u00a0 similar\t\r \u00a0 (2\t\r \u00a0 enlaces)\t\r \u00a0 entre\t\r \u00a0 insulina\t\r \u00a0 isof\u00e1nica\t\r \u00a0 y\t\r \u00a0la\t\r \u00a0 RA\t\r \u00a0 \u2018Hipoglucemia\u2019,\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 entre\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0y\t\r \u00a0la\t\r \u00a0RA\t\r \u00a0\u2018Shock\t\r \u00a0hipogluc\u00e9mico\u2019.\t\r \u00a0No\t\r \u00a0destaca\t\r \u00a0ninguna\t\r \u00a0RA\t\r \u00a0en\t\r \u00a0posici\u00f3n\t\r \u00a02.\t\r \u00a0\t\r \u00a0GRUPO\t\r \u00a0 4:\t\r \u00a0 Notificaciones\t\r \u00a0 con\t\r \u00a0 AHO/s\t\r \u00a0 y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0El\t\r \u00a0primer\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0sospechoso\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0o\t\r \u00a0no\t\r \u00a0un\t\r \u00a0antidiab\u00e9tico\t\r \u00a0oral.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0grupo\t\r \u00a0analizamos\t\r \u00a0los\t\r \u00a0que\t\r \u00a0presentan\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0Perfil\t\r \u00a0 4.1\t\r \u00a0(190\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a0 74\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Galicia,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2006\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 no\t\r \u00a0 grave\t\r \u00a0 y\t\r \u00a0 posible/probable.\t\r \u00a0 Presenta\t\r \u00a0combinaciones\t\r \u00a0 de\t\r \u00a0 hasta\t\r \u00a0 7\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos,\t\r \u00a0 siendo\t\r \u00a0 el\t\r \u00a0 primero\t\r \u00a0 metformina.\t\r \u00a0Los\t\r \u00a0 6\t\r \u00a0 restantes\t\r \u00a0 est\u00e1n\t\r \u00a0 relacionados\t\r \u00a0 con\t\r \u00a0 tratamientos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sangre\t\r \u00a0 y\t\r \u00a0 \u00f3rganos\t\r \u00a0hematopoy\u00e9ticos,\t\r \u00a0 sistema\t\r \u00a0 cardiovascular,\t\r \u00a0 sistema\t\r \u00a0 nervioso\t\r \u00a0 y\t\r \u00a0 preparados\t\r \u00a0hormonales\t\r \u00a0sist\u00e9micos\t\r \u00a0(excluyendo\t\r \u00a0hormonas\t\r \u00a0sexuales\t\r \u00a0e\t\r \u00a0insulinas);\t\r \u00a0e\t\r \u00a0incluso\t\r \u00a0en\t\r \u00a0casos\t\r \u00a0con\t\r \u00a0nueve\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0f\u00e1rmacos\t\r \u00a0administrados\t\r \u00a0se\t\r \u00a0notifican\t\r \u00a0pantoprazol,\t\r \u00a0captopril\t\r \u00a0o\t\r \u00a0glibenclamida\t\r \u00a0(tratamiento\t\r \u00a0de\t\r \u00a0diabetes).\t\r \u00a0Estas\t\r \u00a0combinaciones\t\r \u00a0pueden\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0gastrointestinales,\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0nervioso,\t\r \u00a0generales\t\r \u00a0y\t\r \u00a0alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0\nMar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n288\t\r \u00a0\t\r \u00a0lugar\t\r \u00a0 de\t\r \u00a0 administraci\u00f3n,\t\r \u00a0trastornos\t\r \u00a0musculoesquel\u00e9ticos\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 conjuntivo,\t\r \u00a0renales\t\r \u00a0y\t\r \u00a0urinarios.\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a0 4.2\t\r \u00a0(60\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 entre\t\r \u00a0 55\t\r \u00a0 y\t\r \u00a0 64\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2007\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 grave\t\r \u00a0no\t\r \u00a0 mortal\t\r \u00a0 y\t\r \u00a0 probable.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 biguanida\t\r \u00a0 metformina\t\r \u00a0 combinada\t\r \u00a0 con\t\r \u00a0 hasta\t\r \u00a0 10\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0sospechosos\t\r \u00a0-\u00ad\u2010relacionados\t\r \u00a0con\t\r \u00a0tratamientos\t\r \u00a0del\t\r \u00a0tracto\t\r \u00a0alimentario\t\r \u00a0y\t\r \u00a0metabolismo,\t\r \u00a0sistema\t\r \u00a0cardiovascular\t\r \u00a0y\t\r \u00a0sistema\t\r \u00a0nervioso-\u00ad\u2010.\t\r \u00a0El\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0puede\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0 del\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 nutrici\u00f3n,\t\r \u00a0trastornos\t\r \u00a0gastrointestinales\t\r \u00a0y\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0nervioso.\t\r \u00a0Perfil\t\r \u00a0 4.3\t\r \u00a0(167\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a0 74\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02008\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0no\t\r \u00a0grave\t\r \u00a0y\t\r \u00a0probable.\t\r \u00a0El\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0es\t\r \u00a0 la\t\r \u00a0 biguanida\t\r \u00a0 metformina\t\r \u00a0 combinada\t\r \u00a0 hasta\t\r \u00a0 con\t\r \u00a0 11\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0 sospechosos\t\r \u00a0-\u00ad\u2010relacionados\t\r \u00a0 con\t\r \u00a0 tratamientos\t\r \u00a0 del\t\r \u00a0 tracto\t\r \u00a0 alimentario\t\r \u00a0 y\t\r \u00a0 metabolismo\t\r \u00a0 (incluyendo\t\r \u00a0vitaminas)\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 cardiovascular-\u00ad\u2010.\t\r \u00a0 Se\t\r \u00a0 pueden\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0gastrointestinales,\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 nervioso,\t\r \u00a0generales\t\r \u00a0 y\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0administraci\u00f3n.\t\r \u00a0\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Gr\u00e1fico\t\r \u00a0 4.-\u00ad\u2010\t\r \u00a0Red\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 con\t\r \u00a0 AHO/s\t\r \u00a0 y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0Este\t\r \u00a0grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a0417\t\r \u00a0notificaciones.\t\r \u00a0Se\t\r \u00a0detecta\t\r \u00a0una\t\r \u00a0fuerte\t\r \u00a0 relaci\u00f3n\t\r \u00a0 entre\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0 glibenclamida\t\r \u00a0 (20\t\r \u00a0 casos).\t\r \u00a0 Tambi\u00e9n\t\r \u00a0 existen\t\r \u00a0 enlaces\t\r \u00a0 entre\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0glimepirida\t\r \u00a0(4\t\r \u00a0casos),\t\r \u00a0y\t\r \u00a0entre\t\r \u00a0glibenclamida\t\r \u00a0y\t\r \u00a0el\t\r \u00a0antihipertensivo\t\r \u00a0enalapril\t\r \u00a0(3\t\r \u00a0casos).\t\r \u00a0Se\t\r \u00a0observa\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0tiazolidindionas\t\r \u00a0(rosiglitazona\t\r \u00a0o\t\r \u00a0pioglitazona)\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0segunda\t\r \u00a0posici\u00f3n.\t\r \u00a0La\t\r \u00a0RA\t\r \u00a0\u2018Hipoglucemia\u2019\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0fuertemente\t\r \u00a0con\t\r \u00a0metformina\t\r \u00a0(16\t\r \u00a0casos),\t\r \u00a0glibenclamida\t\r \u00a0(18\t\r \u00a0casos)\t\r \u00a0y\t\r \u00a0glimepirida\t\r \u00a0(6\t\r \u00a0casos)\t\r \u00a0independientemente\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0posiciones.\t\r \u00a0Metformina\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0con\t\r \u00a0\u2018Diarrea\u2019\t\r \u00a0(11\t\r \u00a0casos),\t\r \u00a0\u2018Acidosis\t\r \u00a0l\u00e1ctica\u2019\t\r \u00a0(7\t\r \u00a0casos)\t\r \u00a0y\t\r \u00a0\u2018Acidosis\u2019\t\r \u00a0\u2013no\t\r \u00a0l\u00e1ctica-\u00ad\u2010\t\r \u00a0(3\t\r \u00a0casos).\t\r \u00a0\t\r \u00a0\nPerfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0289\t\r \u00a0\t\r \u00a0GRUPO\t\r \u00a0 5:\t\r \u00a0 Notificaciones\t\r \u00a0 con\t\r \u00a0 AHO/s\t\r \u00a0 y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0Principio\t\r \u00a0activo\t\r \u00a0no\t\r \u00a0antidiab\u00e9tico\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a0 5.1\t\r \u00a0(36\t\r \u00a0 notificaciones):\t\r \u00a0 hombre\t\r \u00a0 o\t\r \u00a0 mujer\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a0 74\t\r \u00a0 a\u00f1os,\t\r \u00a0procedente\t\r \u00a0de\t\r \u00a0Galicia,\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0a\u00f1o\t\r \u00a02003\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0no\t\r \u00a0grave\t\r \u00a0y\t\r \u00a0posible.\t\r \u00a0Presenta\t\r \u00a0combinaciones\t\r \u00a0 de\t\r \u00a0 hasta\t\r \u00a0 8\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos,\t\r \u00a0 siendo\t\r \u00a0 el\t\r \u00a0 primero\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0cardiovascular.\t\r \u00a0 Los\t\r \u00a0 7\t\r \u00a0 restantes\t\r \u00a0 son\t\r \u00a0 antidiab\u00e9ticos\t\r \u00a0 orales\t\r \u00a0 no\t\r \u00a0 especificados.\t\r \u00a0 Estas\t\r \u00a0combinaciones\t\r \u00a0 pueden\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 piel\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 subcut\u00e1neo\t\r \u00a0 y\t\r \u00a0trastornos\t\r \u00a0 gastrointestinales.\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 aparecer\t\r \u00a0 3\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 podr\u00eda\t\r \u00a0 llegar\t\r \u00a0 a\t\r \u00a0notificarse\t\r \u00a0malestar\t\r \u00a0general,\t\r \u00a0diarrea\t\r \u00a0o\t\r \u00a0dispepsia.\t\r \u00a0Perfil\t\r \u00a0 5.2\t\r \u00a0(22\t\r \u00a0 notificaciones):\t\r \u00a0 hombre\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a0 74\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2008\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 grave\t\r \u00a0 (aunque\t\r \u00a0 no\t\r \u00a0 mortal)\t\r \u00a0 y\t\r \u00a0 posible.\t\r \u00a0Presenta\t\r \u00a0 combinaciones\t\r \u00a0 de\t\r \u00a0 hasta\t\r \u00a0 10\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos\t\r \u00a0 (o\t\r \u00a0 sospechosos\t\r \u00a0 por\t\r \u00a0interacci\u00f3n),\t\r \u00a0siendo\t\r \u00a0 el\t\r \u00a0 primero\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 cardiovascular\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 restantes\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0 orales\t\r \u00a0\u2013principalmente-\u00ad\u2010,\t\r \u00a0 anti\u00e1cidos,\t\r \u00a0 bloqueantes\t\r \u00a0 de\t\r \u00a0 canales\t\r \u00a0 de\t\r \u00a0calcio,\t\r \u00a0 modificadores\t\r \u00a0 de\t\r \u00a0 l\u00edpidos,\t\r \u00a0 psicol\u00e9pticos\t\r \u00a0 y\t\r \u00a0 psicoanal\u00e9pticos.\t\r \u00a0 Estas\t\r \u00a0combinaciones\t\r \u00a0pueden\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0del\t\r \u00a0metabolismo\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nutrici\u00f3n,\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sangre\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 linf\u00e1tico,\t\r \u00a0trastornos\t\r \u00a0psiqui\u00e1tricos,\t\r \u00a0 respiratorios,\t\r \u00a0 tor\u00e1cicos\t\r \u00a0 y\t\r \u00a0mediast\u00ednicos.\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 presentarse\t\r \u00a0 3\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 podr\u00eda\t\r \u00a0 notificarse\t\r \u00a0 diarrea,\t\r \u00a0dolor\t\r \u00a0 abdominal,\t\r \u00a0 hipoglucemia,\t\r \u00a0 insuficiencia\t\r \u00a0 renal\t\r \u00a0 aguda,\t\r \u00a0 acaloramiento,\t\r \u00a0taquicardia,\t\r \u00a0nerviosismo,\t\r \u00a0rubefacci\u00f3n\t\r \u00a0y\t\r \u00a0retenci\u00f3n\t\r \u00a0urinaria.\t\r \u00a0Perfil\t\r \u00a0 5.3\t\r \u00a0(35\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 mayor\t\r \u00a0 de\t\r \u00a0 75\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 2005\t\r \u00a0 o\t\r \u00a0 2007\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 grave\t\r \u00a0 (aunque\t\r \u00a0 no\t\r \u00a0 mortal)\t\r \u00a0 y\t\r \u00a0probable.\t\r \u00a0Presenta\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a02\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos,\t\r \u00a0donde\t\r \u00a0el\t\r \u00a0primero\t\r \u00a0es\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0 cardiovascular\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 segundo\t\r \u00a0 un\t\r \u00a0 antidiab\u00e9tico\t\r \u00a0 oral,\t\r \u00a0 administrados\t\r \u00a0concomitantemente\t\r \u00a0con\t\r \u00a0hasta\t\r \u00a010\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0sospechosos.\t\r \u00a0Dichas\t\r \u00a0combinaciones\t\r \u00a0pueden\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 nutrici\u00f3n,\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0presentarse\t\r \u00a03\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0RAs\t\r \u00a0podr\u00eda\t\r \u00a0notificarse\t\r \u00a0anemia,\t\r \u00a0bradifrenia,\t\r \u00a0disnea,\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0f\u00e1rmaco\t\r \u00a0elevados,\t\r \u00a0apetito\t\r \u00a0disminuido,\t\r \u00a0edema\t\r \u00a0de\t\r \u00a0lengua\t\r \u00a0o\t\r \u00a0de\t\r \u00a0cara,\t\r \u00a0peso\t\r \u00a0disminuido\t\r \u00a0y\t\r \u00a0disgeusia.\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n290\t\r \u00a0\t\r \u00a0\t\r \u00a0Gr\u00e1fico\t\r \u00a0 5.\t\r \u00a0 Red\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 con\t\r \u00a0 AHO/s\t\r \u00a0y\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0Principio\t\r \u00a0activo\t\r \u00a0no\t\r \u00a0antidiab\u00e9tico\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0Este\t\r \u00a0grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a093\t\r \u00a0notificaciones.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 Gr\u00e1fico\t\r \u00a0 5,\t\r \u00a0 aparece\t\r \u00a0 una\t\r \u00a0 fuerte\t\r \u00a0 relaci\u00f3n\t\r \u00a0 entre\t\r \u00a0 el\t\r \u00a0 agente\t\r \u00a0 antitromb\u00f3tico\t\r \u00a0acenocumarol\t\r \u00a0y\t\r \u00a0la\t\r \u00a0sulfonilurea\t\r \u00a0glibenclamida\t\r \u00a0(4\t\r \u00a0casos).\t\r \u00a0Destaca\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0como\t\r \u00a0segundo\t\r \u00a0 principio\t\r \u00a0 activo\t\r \u00a0 relacionado\t\r \u00a0 con\t\r \u00a0 diversos\t\r \u00a0 f\u00e1rmacos,\t\r \u00a0 tales\t\r \u00a0 como\t\r \u00a0 antihipertensivos\t\r \u00a0(enalapril\t\r \u00a0-\u00ad\u20103\t\r \u00a0 casos-\u00ad\u2010),\t\r \u00a0 antagonistas\t\r \u00a0 de\t\r \u00a0 angiotensina\t\r \u00a0 2\t\r \u00a0 (valsart\u00e1n\t\r \u00a0-\u00ad\u20102\t\r \u00a0 casos-\u00ad\u2010)\t\r \u00a0 y\t\r \u00a0 medicamentos\t\r \u00a0antidemencia\t\r \u00a0 (rivastigmina\t\r \u00a0-\u00ad\u20102\t\r \u00a0 casos-\u00ad\u2010).\t\r \u00a0 Se\t\r \u00a0 relaciona\t\r \u00a0 la\t\r \u00a0 RA\t\r \u00a0 \u2018Hipoglucemia\u2019\t\r \u00a0 con\t\r \u00a0 gemfibrozilo\t\r \u00a0 en\t\r \u00a0posici\u00f3n\t\r \u00a01\t\r \u00a0(3\t\r \u00a0casos),\t\r \u00a0con\t\r \u00a0glibenclamida\t\r \u00a0en\t\r \u00a0posici\u00f3n\t\r \u00a02\t\r \u00a0(5\t\r \u00a0casos),\t\r \u00a0\t\r \u00a0y\t\r \u00a0con\t\r \u00a0levofloxacino\t\r \u00a0en\t\r \u00a0posici\u00f3n\t\r \u00a02\t\r \u00a0(2\t\r \u00a0casos).\t\r \u00a0Se\t\r \u00a0observa\t\r \u00a0una\t\r \u00a0estructura\t\r \u00a0que\t\r \u00a0relaciona\t\r \u00a0rivastigmina,\t\r \u00a0metformina,\t\r \u00a0\u2018pirexia\u2019\t\r \u00a0y\t\r \u00a0\u2018n\u00e1useas\u2019.\t\r \u00a0Es\t\r \u00a0llamativa\t\r \u00a0 la\t\r \u00a0 RA\t\r \u00a0 \u2018Hepatitis\t\r \u00a0 colest\u00e1sica\u2019\t\r \u00a0 relacionada\t\r \u00a0 con\t\r \u00a0 glibenclamida\t\r \u00a0 o\t\r \u00a0 simvastatina\t\r \u00a0 (2\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0ambos),\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0la\t\r \u00a0\u2018Erupci\u00f3n\t\r \u00a0eritematosa\u2019\t\r \u00a0enlazada\t\r \u00a0exclusivamente\t\r \u00a0con\t\r \u00a0irbesart\u00e1n\t\r \u00a0(2\t\r \u00a0casos).\t\r \u00a0\t\r \u00a0GRUPO\t\r \u00a06:\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0Insulina/s\t\r \u00a0y\t\r \u00a0AHO/s.\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a06.1\t\r \u00a0(15\t\r \u00a0notificaciones):\t\r \u00a0mujer\t\r \u00a0entre\t\r \u00a045\t\r \u00a0y\t\r \u00a064\t\r \u00a0a\u00f1os\t\r \u00a0o\t\r \u00a0mayor\t\r \u00a0de\t\r \u00a075\t\r \u00a0a\u00f1os,\t\r \u00a0procedente\t\r \u00a0 de\t\r \u00a0 Extremadura,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 2008\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 no\t\r \u00a0 grave\t\r \u00a0 y\t\r \u00a0 posible.\t\r \u00a0 El\t\r \u00a0f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 ser\u00eda\t\r \u00a0 la\t\r \u00a0 biguanida\t\r \u00a0 metformina\t\r \u00a0 combinada\t\r \u00a0 con\t\r \u00a0 hasta\t\r \u00a0 13\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0 sospechosos\t\r \u00a0 y\t\r \u00a0 muy\t\r \u00a0 diversos\t\r \u00a0 (insulinas\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 bif\u00e1sica,\t\r \u00a0 enalapril,\t\r \u00a0bloqueantes\t\r \u00a0 de\t\r \u00a0 canales\t\r \u00a0 de\t\r \u00a0 calcio,\t\r \u00a0 \u00e1cido\t\r \u00a0 acetilsalic\u00edlico).\t\r \u00a0 El\t\r \u00a0 \u00fanico\t\r \u00a0 f\u00e1rmaco\t\r \u00a0considerado\t\r \u00a0sospechoso\t\r \u00a0puede\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0piel\t\r \u00a0y\t\r \u00a0tejido\t\r \u00a0subcut\u00e1neo,\t\r \u00a0y\t\r \u00a0a\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0la\t\r \u00a0segunda\t\r \u00a0RA\t\r \u00a0podr\u00eda\t\r \u00a0notificarse\t\r \u00a0edema,\t\r \u00a0estado\t\r \u00a0confusional,\t\r \u00a0insomnio,\t\r \u00a0masa\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n,\t\r \u00a0mialgia\t\r \u00a0y\t\r \u00a0respuesta\t\r \u00a0terap\u00e9utica\t\r \u00a0disminuida.\t\r \u00a0\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a0 6.2\t\r \u00a0(3\t\r \u00a0 notificaciones):\t\r \u00a0 hombre\t\r \u00a0 entre\t\r \u00a0 55\t\r \u00a0 y\t\r \u00a0 64\t\r \u00a0 a\u00f1os,\t\r \u00a0 que\t\r \u00a0 sufre\t\r \u00a0 RA\t\r \u00a0 no\t\r \u00a0grave\t\r \u00a0 y\t\r \u00a0 posible.\t\r \u00a0 El\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 ser\u00eda\t\r \u00a0 la\t\r \u00a0insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0glargina,\t\r \u00a0la\t\r \u00a0biguanida\t\r \u00a0metformina\t\r \u00a0o\t\r \u00a0la\t\r \u00a0glinida\t\r \u00a0repaglinida;\t\r \u00a0y\t\r \u00a0combinado\t\r \u00a0hasta\t\r \u00a0con\t\r \u00a04\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0sospechosos\t\r \u00a0(insulinas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0intermedia,\t\r \u00a0agentes\t\r \u00a0antitromb\u00f3ticos,\t\r \u00a0metformina,\t\r \u00a0 enalapril,\t\r \u00a0 paracetamol,\t\r \u00a0 agentes\t\r \u00a0 urol\u00f3gicos\t\r \u00a0 o\t\r \u00a0 glibenclamida).\t\r \u00a0 El\t\r \u00a0f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 puede\t\r \u00a0 producir\t\r \u00a0 trastornos\t\r \u00a0 gastrointestinales,\t\r \u00a0 trastornos\t\r \u00a0vasculares\t\r \u00a0 o\t\r \u00a0 exploraciones\t\r \u00a0 complementarias\t\r \u00a0 (elevaci\u00f3n\t\r \u00a0 de\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 enzimas\t\r \u00a0hep\u00e1ticos).\t\r \u00a0\nPerfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0291\t\r \u00a0\t\r \u00a0Perfil\t\r \u00a0 6.3\t\r \u00a0(24\t\r \u00a0 notificaciones):\t\r \u00a0 mujer\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a0 74\t\r \u00a0 a\u00f1os,\t\r \u00a0 procedente\t\r \u00a0 de\t\r \u00a0Galicia,\t\r \u00a0que\t\r \u00a0en\t\r \u00a02007\t\r \u00a0o\t\r \u00a02008\t\r \u00a0sufre\t\r \u00a0RA\t\r \u00a0no\t\r \u00a0grave\t\r \u00a0y\t\r \u00a0posible.\t\r \u00a0Presenta\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0hasta\t\r \u00a07\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos\t\r \u00a0siendo\t\r \u00a0el\t\r \u00a0primero\t\r \u00a0insulina\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0glargina,\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 restantes\t\r \u00a0 sospechosos\t\r \u00a0-\u00ad\u2010paracetamol,\t\r \u00a0 tramadol,\t\r \u00a0 ibuprofeno\t\r \u00a0 y\t\r \u00a0diclofenaco-\u00ad\u2010\t\r \u00a0o\t\r \u00a0 sospechosos\t\r \u00a0 por\t\r \u00a0 interacci\u00f3n\t\r \u00a0-\u00ad\u2010metformina,\t\r \u00a0 \u00e1cido\t\r \u00a0 acetilsalic\u00edlico,\t\r \u00a0sulpirida,\t\r \u00a0 glipizida,\t\r \u00a0 atorvastatina,\t\r \u00a0 diazepam-\u00ad\u2010.\t\r \u00a0 Estas\t\r \u00a0 combinaciones\t\r \u00a0 pueden\t\r \u00a0producir\t\r \u00a0trastornos\t\r \u00a0del\t\r \u00a0metabolismo\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nutrici\u00f3n,\t\r \u00a0y\t\r \u00a0a\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0la\t\r \u00a0segunda\t\r \u00a0RA,\t\r \u00a0bloqueo\t\r \u00a0 auriculoventricular,\t\r \u00a0 cefalea,\t\r \u00a0 edema\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 zona\t\r \u00a0 de\t\r \u00a0 inyecci\u00f3n,\t\r \u00a0 error\t\r \u00a0 de\t\r \u00a0medicaci\u00f3n,\t\r \u00a0 hipoglucemia,\t\r \u00a0 insuficiencia\t\r \u00a0 cardiaca,\t\r \u00a0 mareo,\t\r \u00a0 reacci\u00f3n\t\r \u00a0 en\t\r \u00a0la\t\r \u00a0 zona\t\r \u00a0 de\t\r \u00a0inyecci\u00f3n,\t\r \u00a0s\u00edncope\t\r \u00a0o\t\r \u00a0visi\u00f3n\t\r \u00a0borrosa.\t\r \u00a0\n\t\r \u00a0Gr\u00e1fico\t\r \u00a06.-\u00ad\u2010\t\r \u00a0Red\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0de\t\r \u00a0sospechas\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0con\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0Insulina/s\t\r \u00a0y\t\r \u00a0AHO/s.\t\r \u00a0Este\t\r \u00a0grupo\t\r \u00a0consta\t\r \u00a0de\t\r \u00a042\t\r \u00a0notificaciones.\t\r \u00a0La\t\r \u00a0relaci\u00f3n\t\r \u00a0m\u00e1s\t\r \u00a0fuerte\t\r \u00a0es\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0biguanida\t\r \u00a0metformina\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 glinida\t\r \u00a0 repaglinida\t\r \u00a0 (2\t\r \u00a0 casos),\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 se\t\r \u00a0 localiza\t\r \u00a0 en\t\r \u00a0 posiciones\t\r \u00a0inferiores.\t\r \u00a0 Respecto\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 RAs,\t\r \u00a0 se\t\r \u00a0 localizan\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 \u2018Hipoglucemia\u2019\t\r \u00a0 con\t\r \u00a0insulina\t\r \u00a0 glargina\t\r \u00a0 en\t\r \u00a0posici\u00f3n\t\r \u00a0 1\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 en\t\r \u00a0 posici\u00f3n\t\r \u00a0 2\t\r \u00a0 (2\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 ambos).\t\r \u00a0 Con\t\r \u00a0 igual\t\r \u00a0 frecuencia\t\r \u00a0 aparece\t\r \u00a0 la\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0\u2018V\u00e9rtigo\u2019\t\r \u00a0y\t\r \u00a0pioglitazona\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n.\t\r \u00a0No\t\r \u00a0destaca\t\r \u00a0ninguna\t\r \u00a0RA\t\r \u00a0en\t\r \u00a0posici\u00f3n\t\r \u00a02.\t\r \u00a0\t\r \u00a05.\t\r \u00a0DISCUSI\u00d3N\t\r \u00a0Manteniendo\t\r \u00a0 la\t\r \u00a0 clasificaci\u00f3n\t\r \u00a0inicial\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 notificaciones,\t\r \u00a0 analizamos\t\r \u00a0 las\t\r \u00a0caracter\u00edsticas\t\r \u00a0 de\t\r \u00a0 cada\t\r \u00a0 grupo\t\r \u00a0 y\t\r \u00a0 perfil,\t\r \u00a0 con\t\r \u00a0 especial\t\r \u00a0 inter\u00e9s\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 combinaciones\t\r \u00a0f\u00e1rmacos-\u00ad\u2010reacciones\t\r \u00a0adversas.\t\r \u00a0INSULINAS\t\r \u00a0EN\t\r \u00a0MONOTERAPIA\t\r \u00a0An\u00e1logos\t\r \u00a0 de\t\r \u00a0 insulinas\t\r \u00a0 e\t\r \u00a0 hiperglucemia.\t\r \u00a0 La\t\r \u00a0 relaci\u00f3n\t\r \u00a0 que\t\r \u00a0 hemos\t\r \u00a0 observado\t\r \u00a0mayoritariamente\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 que\t\r \u00a0 s\u00f3lo\t\r \u00a0 utilizan\t\r \u00a0 insulina\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 existente\t\r \u00a0 entre\t\r \u00a0aspart+aspart\t\r \u00a0 protamina\t\r \u00a0 e\t\r \u00a0 hiperglucemia.\t\r \u00a0 Seg\u00fan\t\r \u00a0 la\t\r \u00a0 bibliograf\u00eda\t\r \u00a0 existente,\t\r \u00a0 la\t\r \u00a0hiperglucemia\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 contempla\t\r \u00a0 como\t\r \u00a0 RA,\t\r \u00a0 sino\t\r \u00a0 como\t\r \u00a0 efecto\t\r \u00a0 derivado\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0interacci\u00f3n\t\r \u00a0entre\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0f\u00e1rmacos\t\r \u00a0(como\t\r \u00a0clonidina,\t\r \u00a0corticosteroides,\t\r \u00a0diaz\u00f3xido\t\r \u00a0\nMar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n292\t\r \u00a0\t\r \u00a0o\t\r \u00a0fenito\u00edna)\t\r \u00a0(19,\t\r \u00a020,\t\r \u00a026).\t\r \u00a0En\t\r \u00a0nuestra\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos,\t\r \u00a0el\t\r \u00a0\u00fanico\t\r \u00a0caso\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0aparece\t\r \u00a0como\t\r \u00a0sospechoso\t\r \u00a0por\t\r \u00a0interacci\u00f3n\t\r \u00a0es\t\r \u00a0junto\t\r \u00a0a\t\r \u00a0insulina\t\r \u00a0r\u00e1pida\t\r \u00a0aspart.\t\r \u00a0\t\r \u00a0Tambi\u00e9n\t\r \u00a0es\t\r \u00a0conocida\t\r \u00a0la\t\r \u00a0indicaci\u00f3n\t\r \u00a0a\t\r \u00a0modo\t\r \u00a0de\t\r \u00a0precauci\u00f3n,\t\r \u00a0de\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0producirse\t\r \u00a0hiperglucemia\t\r \u00a0matutina,\t\r \u00a0siendo\t\r \u00a0importante\t\r \u00a0distinguir\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0hiperglucemia\t\r \u00a0posibles\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0no\t\r \u00a0es\t\r \u00a0el\t\r \u00a0mismo\t\r \u00a0para\t\r \u00a0todos\t\r \u00a0(34).\t\r \u00a0Debido\t\r \u00a0a\t\r \u00a0ello,\t\r \u00a0habr\u00eda\t\r \u00a0que\t\r \u00a0diferenciar\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0la\t\r \u00a0hiperglucemia\t\r \u00a0matutina\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0al\t\r \u00a0efecto\t\r \u00a0Somogyi\t\r \u00a0y\t\r \u00a0aquellos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0hiperglucemia\t\r \u00a0sin\t\r \u00a0 antecedente\t\r \u00a0 hipogluc\u00e9mico\t\r \u00a0 alguno\t\r \u00a0 conocido\t\r \u00a0 como\t\r \u00a0 fen\u00f3meno\t\r \u00a0 del\t\r \u00a0 alba.\t\r \u00a0 El\t\r \u00a0tratamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 hiperglucemia\t\r \u00a0 de\t\r \u00a0 rebote\t\r \u00a0 consistir\u00eda\t\r \u00a0 en\t\r \u00a0 reducir\t\r \u00a0 las\t\r \u00a0 dosis\t\r \u00a0 de\t\r \u00a0insulina\t\r \u00a0y/o\t\r \u00a0tomar\t\r \u00a0una\t\r \u00a0fuente\t\r \u00a0de\t\r \u00a0carbohidrato\t\r \u00a0antes\t\r \u00a0de\t\r \u00a0acostarse,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a0otro\t\r \u00a0caso\t\r \u00a0deber\u00eda\t\r \u00a0ajustarse\t\r \u00a0la\t\r \u00a0dosis\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0nocturna\t\r \u00a0para\t\r \u00a0favorecer\t\r \u00a0que\t\r \u00a0las\t\r \u00a0necesidades\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 entre\t\r \u00a0 las\t\r \u00a0 4\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 7\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0ma\u00f1ana\t\r \u00a0 queden\t\r \u00a0 cubiertas\t\r \u00a0(34).\t\r \u00a0Creemos\t\r \u00a0 que\t\r \u00a0 este\t\r \u00a0 \u00faltimo\t\r \u00a0 caso\t\r \u00a0 podr\u00eda\t\r \u00a0 ser\t\r \u00a0 m\u00e1s\t\r \u00a0 acertado\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0aspart+aspart\t\r \u00a0 protamina\t\r \u00a0 en\t\r \u00a0 nuestro\t\r \u00a0 estudio,\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 presenta\t\r \u00a0 tambi\u00e9n\t\r \u00a0relaci\u00f3n\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 RA\t\r \u00a0 \u2018Respuesta\t\r \u00a0 terap\u00e9utica\t\r \u00a0 disminuida\u2019.\t\r \u00a0 Ya\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 hecho\t\r \u00a0 de\t\r \u00a0confundir\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 hiperglucemia\t\r \u00a0 matutina\t\r \u00a0 podr\u00eda\t\r \u00a0 resultar\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0hipoglucemia\t\r \u00a0nocturna\t\r \u00a0a\u00fan\t\r \u00a0m\u00e1s\t\r \u00a0grave,\t\r \u00a0ser\u00eda\t\r \u00a0interesante\t\r \u00a0que\t\r \u00a0se\t\r \u00a0diferenciase\t\r \u00a0entre\t\r \u00a0estos\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0hiperglucemia\t\r \u00a0en\t\r \u00a0la\t\r \u00a0codificaci\u00f3n\t\r \u00a0y\t\r \u00a0que\t\r \u00a0se\t\r \u00a0incluyesen\t\r \u00a0como\t\r \u00a0RAs\t\r \u00a0en\t\r \u00a0las\t\r \u00a0fichas\t\r \u00a0t\u00e9cnicas\t\r \u00a0de\t\r \u00a0insulina.\t\r \u00a0Otras\t\r \u00a0 relaciones\t\r \u00a0 mayoritarias\t\r \u00a0 entre\t\r \u00a0 usuarios\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 monoterapia\t\r \u00a0son\t\r \u00a0detemir-\u00ad\u2010reacci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a0y\t\r \u00a0glargina-\u00ad\u2010hiperglucemia.\t\r \u00a0Cada\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0aparece\t\r \u00a0tambi\u00e9n\t\r \u00a0reflejado\t\r \u00a0en\t\r \u00a0perfiles\t\r \u00a0diferentes\t\r \u00a0-\u00ad\u2010perfil\t\r \u00a01.1\t\r \u00a0y\t\r \u00a0perfil\t\r \u00a01.3,\t\r \u00a0respectivamente-\u00ad\u2010,\t\r \u00a0que\t\r \u00a0se\t\r \u00a0caracterizan\t\r \u00a0por\t\r \u00a0ocurrir\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0en\t\r \u00a0la\t\r \u00a0segunda\t\r \u00a0mitad\t\r \u00a0del\t\r \u00a0periodo\t\r \u00a0de\t\r \u00a0estudio\t\r \u00a0y\t\r \u00a0en\t\r \u00a0las\t\r \u00a0que\t\r \u00a0se\t\r \u00a0notifican\t\r \u00a0como\t\r \u00a0sospechosas\t\r \u00a0las\t\r \u00a0insulinas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada.\t\r \u00a0\t\r \u00a0Por\t\r \u00a0su\t\r \u00a0parte,\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0se\t\r \u00a0asocia\t\r \u00a0m\u00e1s\t\r \u00a0en\t\r \u00a0nuestro\t\r \u00a0estudio\t\r \u00a0a\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0hiperglucemia\t\r \u00a0 que\t\r \u00a0 de\t\r \u00a0 hipoglucemia,\t\r \u00a0 coincidiendo\t\r \u00a0 as\u00ed\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0perfil\t\r \u00a0 1.3\t\r \u00a0que\t\r \u00a0 se\t\r \u00a0caracteriza\t\r \u00a0 por\t\r \u00a0 no\t\r \u00a0 presentar\t\r \u00a0 una\t\r \u00a0 edad\t\r \u00a0 mayoritaria\t\r \u00a0 de\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RA\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0adem\u00e1s\t\r \u00a0 esta\t\r \u00a0 \u00faltima\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 grave\t\r \u00a0\u2013aunque\t\r \u00a0 no\t\r \u00a0 mortal-\u00ad\u2010\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 100%\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0casos.\t\r \u00a0\t\r \u00a0Adicionalmente,\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0isof\u00e1nica\t\r \u00a0es\t\r \u00a0la\t\r \u00a0que\t\r \u00a0presenta\t\r \u00a0mayor\t\r \u00a0relaci\u00f3n\t\r \u00a0con\t\r \u00a0hipoglucemia.\t\r \u00a0Seg\u00fan\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0comparan\t\r \u00a0glargina\t\r \u00a0e\t\r \u00a0isof\u00e1nica\t\r \u00a0(35),\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0 glargina\t\r \u00a0 es\t\r \u00a0 igual\t\r \u00a0 de\t\r \u00a0 efectiva\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 isof\u00e1nica\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 control\t\r \u00a0gluc\u00e9mico,\t\r \u00a0 especialmente\t\r \u00a0 en\t\r \u00a0diabetes\t\r \u00a0 tipo\t\r \u00a0 2,\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 asocia\t\r \u00a0 con\t\r \u00a0 menos\t\r \u00a0 episodios\t\r \u00a0nocturnos\t\r \u00a0de\t\r \u00a0hipoglucemia\t\r \u00a0sintom\u00e1tica.\t\r \u00a0\t\r \u00a0Esto\t\r \u00a0apoya\t\r \u00a0que\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0hiperglucemia\t\r \u00a0con\t\r \u00a0insulinas\t\r \u00a0an\u00e1logas\t\r \u00a0se\t\r \u00a0deben\t\r \u00a0m\u00e1s\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 fen\u00f3meno\t\r \u00a0 de\t\r \u00a0 alba\t\r \u00a0 o\t\r \u00a0 a\t\r \u00a0 disminuci\u00f3n\t\r \u00a0 del\t\r \u00a0 nivel\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 que\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0hiperglucemia\t\r \u00a0de\t\r \u00a0rebote.\t\r \u00a0A\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0la\t\r \u00a0aparici\u00f3n\t\r \u00a0del\t\r \u00a0fen\u00f3meno\t\r \u00a0de\t\r \u00a0alba\t\r \u00a0se\t\r \u00a0conoce\t\r \u00a0que\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0293\t\r \u00a0\t\r \u00a0es\t\r \u00a0 menor\t\r \u00a0 si\t\r \u00a0 la\t\r \u00a0 insulinizaci\u00f3n\t\r \u00a0 del\t\r \u00a0 paciente\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 adecuada\t\r \u00a0(36)\t\r \u00a0y\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0frecuente\t\r \u00a0que\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0Somogyi.\t\r \u00a0\t\r \u00a0Estas\t\r \u00a0hiperglucemias\t\r \u00a0de\t\r \u00a0insulinas\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0pueden\t\r \u00a0derivarse\t\r \u00a0de\t\r \u00a0una\t\r \u00a0insulinizaci\u00f3n\t\r \u00a0de\t\r \u00a0 novo\t\r \u00a0o\t\r \u00a0 un\t\r \u00a0 cambio\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 humana\t\r \u00a0 a\t\r \u00a0 an\u00e1logo\t\r \u00a0 realizados\t\r \u00a0inadecuadamente.\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0en\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 realicen\t\r \u00a0 estos\t\r \u00a0 cambios,\t\r \u00a0deber\u00eda\t\r \u00a0considerarse\t\r \u00a0el\t\r \u00a0diagn\u00f3stico\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0fen\u00f3menos\t\r \u00a0recomendando\t\r \u00a0un\t\r \u00a0control\t\r \u00a0de\t\r \u00a0glucemia\t\r \u00a0entre\t\r \u00a0las\t\r \u00a03\t\r \u00a0y\t\r \u00a0las\t\r \u00a05\t\r \u00a0de\t\r \u00a0la\t\r \u00a0madrugada\t\r \u00a0durante\t\r \u00a0varias\t\r \u00a0noches\t\r \u00a0(37).\t\r \u00a0An\u00e1logos\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0y\t\r \u00a0reacci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n.\t\r \u00a0Se\t\r \u00a0podr\u00eda\t\r \u00a0decir\t\r \u00a0que\t\r \u00a0una\t\r \u00a0RA\t\r \u00a0espec\u00edfica\t\r \u00a0del\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0insulinas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0(detemir,\t\r \u00a0glargina)\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0 administraci\u00f3n\t\r \u00a0 (dolor,\t\r \u00a0 enrojecimiento,\t\r \u00a0ronchas,\t\r \u00a0hinchaz\u00f3n,\t\r \u00a0picor)\t\r \u00a0por\t\r \u00a0presentar\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0frecuencia\t\r \u00a0de\t\r \u00a0aparici\u00f3n\t\r \u00a0que\t\r \u00a0con\t\r \u00a0 insulina\t\r \u00a0 isof\u00e1nica,\t\r \u00a0 aunque\t\r \u00a0 es\t\r \u00a0 generalmente\t\r \u00a0 transitoria\t\r \u00a0 y\t\r \u00a0 desaparece\t\r \u00a0 al\t\r \u00a0continuar\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0(38,\t\r \u00a039).\t\r \u00a0Estos\t\r \u00a0datos\t\r \u00a0concuerdan\t\r \u00a0con\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a01.1,\t\r \u00a0que\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0predominantemente\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0y\t\r \u00a0en\t\r \u00a0edades\t\r \u00a0de\t\r \u00a075\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0a\u00f1os.\t\r \u00a0Aunque\t\r \u00a0cualquier\t\r \u00a0terapia\t\r \u00a0insul\u00ednica\t\r \u00a0puede\t\r \u00a0producir\t\r \u00a0reacciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0 inyecci\u00f3n,\t\r \u00a0 la\t\r \u00a0 gran\t\r \u00a0 afinidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 an\u00e1logos\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 tanto\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0alb\u00famina\t\r \u00a0tisular\t\r \u00a0subcut\u00e1nea\t\r \u00a0como\t\r \u00a0por\t\r \u00a0la\t\r \u00a0plasm\u00e1tica,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0la\t\r \u00a0fuerte\t\r \u00a0asociaci\u00f3n\t\r \u00a0de\t\r \u00a0 las\t\r \u00a0 propias\t\r \u00a0 mol\u00e9culas\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0 inyecci\u00f3n\t\r \u00a0 condiciona\t\r \u00a0 sus\t\r \u00a0caracter\u00edsticas\t\r \u00a0de\t\r \u00a0absorci\u00f3n\t\r \u00a0 lenta\t\r \u00a0 y\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0(40,\t\r \u00a0 41);\t\r \u00a0 y\t\r \u00a0 es\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 vez\t\r \u00a0responsable\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0reacciones\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0subcut\u00e1neo.\t\r \u00a0La\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 zona\t\r \u00a0 de\t\r \u00a0 inyecci\u00f3n\t\r \u00a0 puede\t\r \u00a0 ser\t\r \u00a0 sin\u00f3nimo\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0administraci\u00f3n\t\r \u00a0inadecuada,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0las\t\r \u00a0recomendaciones\t\r \u00a0de\t\r \u00a0rotaci\u00f3n\t\r \u00a0del\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a0dentro\t\r \u00a0de\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0zona\t\r \u00a0-\u00ad\u2010dadas\t\r \u00a0espec\u00edficamente\t\r \u00a0para\t\r \u00a0reducir\t\r \u00a0o\t\r \u00a0prevenir\t\r \u00a0estas\t\r \u00a0reacciones-\u00ad\u2010\t\r \u00a0no\t\r \u00a0parecen\t\r \u00a0considerarse\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0casos.\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a01.2\t\r \u00a0consta\t\r \u00a0de\t\r \u00a0un\t\r \u00a0\u00fanico\t\r \u00a0caso\t\r \u00a0aislado\t\r \u00a0que\t\r \u00a0no\t\r \u00a0concuerda\t\r \u00a0con\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0de\t\r \u00a0ning\u00fan\t\r \u00a0otro\t\r \u00a0perfil\t\r \u00a0definido,\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0demuestra\t\r \u00a0la\t\r \u00a0validez\t\r \u00a0del\t\r \u00a0modelo\t\r \u00a0aplicado\t\r \u00a0tanto\t\r \u00a0 para\t\r \u00a0 detectar\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 comunes\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 como\t\r \u00a0 para\t\r \u00a0 detectar\t\r \u00a0casos\t\r \u00a0at\u00edpicos.\t\r \u00a0Dentro\t\r \u00a0 del\t\r \u00a0perfil\t\r \u00a0 1.3\t\r \u00a0se\t\r \u00a0 localiza\t\r \u00a0 el\t\r \u00a0 \u00fanico\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 fetopat\u00eda\t\r \u00a0 diab\u00e9tica\t\r \u00a0presente\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 de\t\r \u00a0 datos.\t\r \u00a0 Esta\t\r \u00a0 RA\t\r \u00a0 es\t\r \u00a0 considerada\t\r \u00a0 como\t\r \u00a0 posible\t\r \u00a0 tras\t\r \u00a0 la\t\r \u00a0administraci\u00f3n\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 detemir.\t\r \u00a0 Existen\t\r \u00a0 estudios\t\r \u00a0 que\t\r \u00a0 demuestran\t\r \u00a0que\t\r \u00a0 en\t\r \u00a0mujeres\t\r \u00a0con\t\r \u00a0diabetes\t\r \u00a0gestacional,\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0an\u00e1logos\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0r\u00e1pida\t\r \u00a0no\t\r \u00a0produce\t\r \u00a0efectos\t\r \u00a0adversos\t\r \u00a0ni\t\r \u00a0en\t\r \u00a0la\t\r \u00a0madre\t\r \u00a0ni\t\r \u00a0en\t\r \u00a0el\t\r \u00a0feto.\t\r \u00a0La\t\r \u00a0insulina\t\r \u00a0prolongada\t\r \u00a0glargina\t\r \u00a0no\t\r \u00a0est\u00e1\t\r \u00a0recomendada\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0embarazo\t\r \u00a0aunque\t\r \u00a0ha\t\r \u00a0demostrado\t\r \u00a0no\t\r \u00a0producir\t\r \u00a0mayor\t\r \u00a0incidencia\t\r \u00a0 de\t\r \u00a0 malformaciones\t\r \u00a0 cong\u00e9nitas\t\r \u00a0 comparada\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 humana,\t\r \u00a0mientras\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 existen\t\r \u00a0 suficientes\t\r \u00a0 datos\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 valoraci\u00f3n\t\r \u00a0 de\t\r \u00a0 detemir\t\r \u00a0(42).\t\r \u00a0 El\t\r \u00a0hecho\t\r \u00a0de\t\r \u00a0que\t\r \u00a0muchas\t\r \u00a0mujeres\t\r \u00a0diab\u00e9ticas\t\r \u00a0que\t\r \u00a0est\u00e9n\t\r \u00a0utilizando\t\r \u00a0an\u00e1logos\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0tengan\t\r \u00a0embarazos\t\r \u00a0no\t\r \u00a0planificados\t\r \u00a0aumentar\u00eda\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0en\t\r \u00a0el\t\r \u00a0embarazo.\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n294\t\r \u00a0\t\r \u00a0AHOS\t\r \u00a0EN\t\r \u00a0MONOTERAPIA\t\r \u00a0Las\t\r \u00a0observaciones\t\r \u00a0mayoritarias\t\r \u00a0van\t\r \u00a0dirigidas\t\r \u00a0a\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0sulfonilureas\t\r \u00a0debido\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 frecuencia\t\r \u00a0 de\t\r \u00a0 aparici\u00f3n.\t\r \u00a0 Destaca\t\r \u00a0 el\t\r \u00a0 uso\t\r \u00a0 de\t\r \u00a0 rosiglitazona\t\r \u00a0 asociada\t\r \u00a0 a\t\r \u00a0anemia.\t\r \u00a0\t\r \u00a0Aunque\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 periodo\t\r \u00a0 de\t\r \u00a0 estudio\t\r \u00a0 el\t\r \u00a0 uso\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 no\t\r \u00a0 supera\t\r \u00a0 al\t\r \u00a0 de\t\r \u00a0sulfonilureas,\t\r \u00a0 algunas\t\r \u00a0 investigaciones\t\r \u00a0 utilizan\t\r \u00a0 este\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 resultados\t\r \u00a0 para\t\r \u00a0justificar\t\r \u00a0 que\t\r \u00a0 metformina,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 d\u00e9cada\t\r \u00a0 posterior\t\r \u00a0 al\t\r \u00a0 estudio\t\r \u00a0 UKPDS,\t\r \u00a0 ha\t\r \u00a0 ejercido\t\r \u00a0m\u00e1s\t\r \u00a0un\t\r \u00a0papel\t\r \u00a0de\t\r \u00a0complemento\t\r \u00a0de\t\r \u00a0las\t\r \u00a0sulfonilureas\t\r \u00a0-\u00ad\u2010o\t\r \u00a0de\t\r \u00a0otras\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0AHOs-\u00ad\u2010,\t\r \u00a0 que\t\r \u00a0 de\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 de\t\r \u00a0 primera\t\r \u00a0 l\u00ednea\t\r \u00a0(43).\t\r \u00a0 Adem\u00e1s\t\r \u00a0 se\t\r \u00a0 a\u00f1ade\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 terapia\t\r \u00a0combinada\t\r \u00a0de\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0est\u00e9\t\r \u00a0tan\t\r \u00a0extendida\t\r \u00a0(m\u00e1s\t\r \u00a0del\t\r \u00a067%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0usuarios\t\r \u00a0 de\t\r \u00a0 AHOs\t\r \u00a0 a\t\r \u00a0 nivel\t\r \u00a0 internacional)\t\r \u00a0 indica\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 adversos\t\r \u00a0 de\t\r \u00a0metformina\t\r \u00a0 no\t\r \u00a0 son\t\r \u00a0 una\t\r \u00a0 gran\t\r \u00a0 barrera\t\r \u00a0 para\t\r \u00a0 su\t\r \u00a0 uso\t\r \u00a0 ni\t\r \u00a0 explican\t\r \u00a0 su\t\r \u00a0 menor\t\r \u00a0 uso\t\r \u00a0 en\t\r \u00a0monoterapia.\t\r \u00a0\t\r \u00a0Esto\t\r \u00a0 contrasta\t\r \u00a0 con\t\r \u00a0 nuestra\t\r \u00a0 observaci\u00f3n\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 mayor\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0notificaciones\t\r \u00a0 de\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 monoterapia\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 (220)\t\r \u00a0 que\t\r \u00a0 con\t\r \u00a0sulfonilureas\t\r \u00a0(91),\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0consideramos\t\r \u00a0que,\t\r \u00a0al\t\r \u00a0menos\t\r \u00a0en\t\r \u00a0Espa\u00f1a,\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0que\t\r \u00a0genera\t\r \u00a0la\t\r \u00a0metformina\t\r \u00a0s\u00ed\t\r \u00a0pueden\t\r \u00a0ejercen\t\r \u00a0limitaciones\t\r \u00a0para\t\r \u00a0su\t\r \u00a0perfil\t\r \u00a0de\t\r \u00a0uso.\t\r \u00a0\t\r \u00a0Metformina\t\r \u00a0 y\t\r \u00a0 acidosis\t\r \u00a0 l\u00e1ctica.\t\r \u00a0La\t\r \u00a0 acidosis\t\r \u00a0 l\u00e1ctica\t\r \u00a0 asociada\t\r \u00a0 a\t\r \u00a0 metformina\t\r \u00a0(MALA\t\r \u00a0en\t\r \u00a0sus\t\r \u00a0siglas\t\r \u00a0en\t\r \u00a0ingl\u00e9s)\t\r \u00a0es\t\r \u00a0una\t\r \u00a0complicaci\u00f3n\t\r \u00a0metab\u00f3lica\t\r \u00a0grave\t\r \u00a0que\t\r \u00a0ocurre\t\r \u00a0habitualmente\t\r \u00a0por\t\r \u00a0acumulaci\u00f3n\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0que\t\r \u00a0alcanzan\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0deshidrataci\u00f3n\t\r \u00a0o\t\r \u00a0que\t\r \u00a0desarrollan\t\r \u00a0fallo\t\r \u00a0renal\t\r \u00a0agudo.\t\r \u00a0Tambi\u00e9n\t\r \u00a0hay\t\r \u00a0casos\t\r \u00a0debidos\t\r \u00a0a\t\r \u00a0exposiciones\t\r \u00a0agudas\t\r \u00a0a\t\r \u00a0este\t\r \u00a0principio\t\r \u00a0activo.\t\r \u00a0Mientras\t\r \u00a0que\t\r \u00a0MALA\t\r \u00a0no\t\r \u00a0es\t\r \u00a0com\u00fan,\t\r \u00a0su\t\r \u00a0morbilidad\t\r \u00a0y\t\r \u00a0mortalidad\t\r \u00a0asociadas\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0elevadas\t\r \u00a0(en\t\r \u00a0el\t\r \u00a050%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0 la\t\r \u00a0 muerte).\t\r \u00a0 Secundariamente\t\r \u00a0 a\t\r \u00a0 esta\t\r \u00a0 reacci\u00f3n,\t\r \u00a0 el\t\r \u00a0 paciente\t\r \u00a0 puede\t\r \u00a0experimentar\t\r \u00a0cambios\t\r \u00a0en\t\r \u00a0su\t\r \u00a0sistema\t\r \u00a0nervioso\t\r \u00a0central,\t\r \u00a0colapso\t\r \u00a0cardiovascular,\t\r \u00a0fallo\t\r \u00a0renal,\t\r \u00a0y\t\r \u00a0muerte\t\r \u00a0en\t\r \u00a0la\t\r \u00a0mitad\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0(44).\t\r \u00a0\t\r \u00a0Varios\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0s\u00edntomas\t\r \u00a0quedan\t\r \u00a0reflejados\t\r \u00a0en\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a02.1,\t\r \u00a0especialmente\t\r \u00a0la\t\r \u00a0 afectaci\u00f3n\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 nervioso\t\r \u00a0 central\t\r \u00a0 (alucinaciones,\t\r \u00a0 alteraciones\t\r \u00a0 del\t\r \u00a0equilibrio)\t\r \u00a0y\t\r \u00a0trastornos\t\r \u00a0renales.\t\r \u00a0Este\t\r \u00a0perfil\t\r \u00a0se\t\r \u00a0da\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0mujeres,\t\r \u00a0en\t\r \u00a0edades\t\r \u00a0de\t\r \u00a075\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0a\u00f1os,\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0es\t\r \u00a0considerada\t\r \u00a0grave\t\r \u00a0en\t\r \u00a0un\t\r \u00a0100%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0y\t\r \u00a0mortal\t\r \u00a0en\t\r \u00a0un\t\r \u00a04,8%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0mismos.\t\r \u00a0Tambi\u00e9n\t\r \u00a0llama\t\r \u00a0la\t\r \u00a0atenci\u00f3n\t\r \u00a0que\t\r \u00a0casi\t\r \u00a0un\t\r \u00a0tercio\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0ocurren\t\r \u00a0en\t\r \u00a0Catalu\u00f1a.\t\r \u00a0Adicionalmente,\t\r \u00a0hemos\t\r \u00a0observado\t\r \u00a0que\t\r \u00a0un\t\r \u00a045%\t\r \u00a0de\t\r \u00a0casos\t\r \u00a0con\t\r \u00a0asociaci\u00f3n\t\r \u00a0metformina-\u00ad\u2010acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0con\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0Los\t\r \u00a0primeros\t\r \u00a0objetivos\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0MALA\t\r \u00a0son\t\r \u00a0el\t\r \u00a0restablecimiento\t\r \u00a0del\t\r \u00a0equilibrio\t\r \u00a0 \u00e1cido-\u00ad\u2010base\t\r \u00a0 y\t\r \u00a0 eliminaci\u00f3n\t\r \u00a0 de\t\r \u00a0 metformina,\t\r \u00a0 mediante\t\r \u00a0 hemodi\u00e1lisis\t\r \u00a0 y\t\r \u00a0terapia\t\r \u00a0 con\t\r \u00a0 bicarbonato.\t\r \u00a0 No\t\r \u00a0 existe\t\r \u00a0 un\t\r \u00a0 ant\u00eddoto\t\r \u00a0 espec\u00edfico\t\r \u00a0(44).\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 Centro\t\r \u00a0Regional\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0de\t\r \u00a0Castilla-\u00ad\u2010la\t\r \u00a0Mancha\t\r \u00a0se\t\r \u00a0hicieron\t\r \u00a0eco\t\r \u00a0de\t\r \u00a0los\t\r \u00a0cinco\t\r \u00a0casos\t\r \u00a0 de\t\r \u00a0 sospechas\t\r \u00a0 de\t\r \u00a0 acidosis\t\r \u00a0 l\u00e1ctica,\t\r \u00a0 dos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 cuales\t\r \u00a0 tuvieron\t\r \u00a0 resultado\t\r \u00a0 de\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0295\t\r \u00a0\t\r \u00a0muerte,\t\r \u00a0situaci\u00f3n\t\r \u00a0que\t\r \u00a0motiv\u00f3\t\r \u00a0una\t\r \u00a0alerta\t\r \u00a0de\t\r \u00a0seguridad\t\r \u00a0en\t\r \u00a0julio\t\r \u00a0de\t\r \u00a02003\t\r \u00a0(45).\t\r \u00a0En\t\r \u00a0el\t\r \u00a0extenso\t\r \u00a0 estudio\t\r \u00a0 UKPDS\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 control\t\r \u00a0 gluc\u00e9mico\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 produjo\t\r \u00a0ning\u00fan\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0muerte\t\r \u00a0por\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica.\t\r \u00a0A\t\r \u00a0esto\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0a\u00f1adir\t\r \u00a0que\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0posibles\t\r \u00a0 motivos\t\r \u00a0 de\t\r \u00a0 desaparici\u00f3n\t\r \u00a0 de\t\r \u00a0 otras\t\r \u00a0 biguanidas\t\r \u00a0 como\t\r \u00a0 fenformina\t\r \u00a0 o\t\r \u00a0buformina\t\r \u00a0es\t\r \u00a0que\t\r \u00a0metformina\t\r \u00a0tiene\t\r \u00a0entre\t\r \u00a010\t\r \u00a0y\t\r \u00a020\t\r \u00a0veces\t\r \u00a0menos\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0producir\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0(46).\t\r \u00a0\t\r \u00a0Respecto\t\r \u00a0a\t\r \u00a0la\t\r \u00a0informaci\u00f3n\t\r \u00a0incluida\t\r \u00a0en\t\r \u00a0las\t\r \u00a0fuentes\t\r \u00a0bibliogr\u00e1ficas\t\r \u00a0al\t\r \u00a0respecto\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0RA,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Cat\u00e1logo\t\r \u00a0de\t\r \u00a0Especialidades\t\r \u00a0Farmac\u00e9uticas,\t\r \u00a0la\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0por\t\r \u00a0metformina\t\r \u00a0 se\t\r \u00a0 encuadra\t\r \u00a0 dentro\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 RAs\t\r \u00a0 hematol\u00f3gicas\t\r \u00a0(47),\t\r \u00a0 en\t\r \u00a0 vez\t\r \u00a0 de\t\r \u00a0 en\t\r \u00a0metab\u00f3licas\t\r \u00a0como\t\r \u00a0corresponder\u00eda\t\r \u00a0seg\u00fan\t\r \u00a0se\t\r \u00a0recoge\t\r \u00a0en\t\r \u00a0el\t\r \u00a0diccionario\t\r \u00a0MedDRA\t\r \u00a0(17).\t\r \u00a0\t\r \u00a0Tambi\u00e9n\t\r \u00a0podr\u00eda\t\r \u00a0ser\t\r \u00a0de\t\r \u00a0utilidad\t\r \u00a0la\t\r \u00a0inclusi\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0\u00edtem\t\r \u00a0en\t\r \u00a0la\t\r \u00a0tarjeta\t\r \u00a0amarilla\t\r \u00a0que\t\r \u00a0 indique\t\r \u00a0 si\t\r \u00a0 el\t\r \u00a0 paciente\t\r \u00a0 consume\t\r \u00a0 o\t\r \u00a0 no\t\r \u00a0 alcohol.\t\r \u00a0 El\t\r \u00a0 consumo\t\r \u00a0 de\t\r \u00a0 alcohol\t\r \u00a0 en\t\r \u00a0pacientes\t\r \u00a0 que\t\r \u00a0 toman\t\r \u00a0 metformina\t\r \u00a0 aumenta\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0 (si\t\r \u00a0 el\t\r \u00a0consumo\t\r \u00a0es\t\r \u00a0agudo)\t\r \u00a0y\t\r \u00a0de\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0(si\t\r \u00a0el\t\r \u00a0consumo\t\r \u00a0es\t\r \u00a0cr\u00f3nico)\t\r \u00a0(19,\t\r \u00a020,\t\r \u00a026).\t\r \u00a0\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0diarrea.\t\r \u00a0Se\t\r \u00a0trata\t\r \u00a0de\t\r \u00a0una\t\r \u00a0RA\t\r \u00a0cuya\t\r \u00a0relaci\u00f3n\t\r \u00a0con\t\r \u00a0metformina\t\r \u00a0es\t\r \u00a0conocida.\t\r \u00a0 Se\t\r \u00a0 sabe\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0 dosis\t\r \u00a0 dependiente\t\r \u00a0 y\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 ello\t\r \u00a0 presenta\t\r \u00a0especificaciones\t\r \u00a0 de\t\r \u00a0 uso\t\r \u00a0 recogidas\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica.\t\r \u00a0 El\t\r \u00a0 comienzo\t\r \u00a0 est\u00e1\t\r \u00a0 indicado\t\r \u00a0con\t\r \u00a0una\t\r \u00a0dosis\t\r \u00a0baja\t\r \u00a0(500-\u00ad\u2010850\t\r \u00a0mg\t\r \u00a0en\t\r \u00a02-\u00ad\u20103\t\r \u00a0tomas\t\r \u00a0diarias)\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0aumentarse\t\r \u00a0tras\t\r \u00a010-\u00ad\u201015\t\r \u00a0 d\u00edas\t\r \u00a0 seg\u00fan\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 glucemia\t\r \u00a0(48).\t\r \u00a0 El\t\r \u00a0 aumento\t\r \u00a0 lento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 dosis\t\r \u00a0 ha\t\r \u00a0demostrado\t\r \u00a0 mejorar\t\r \u00a0 la\t\r \u00a0 tolerancia\t\r \u00a0 gastrointestinal.\t\r \u00a0 En\t\r \u00a0 nuestros\t\r \u00a0 resultados\t\r \u00a0observamos\t\r \u00a0 que\t\r \u00a0 un\t\r \u00a0 44%\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 de\t\r \u00a0 metformina-\u00ad\u2010diarrea\t\r \u00a0 se\t\r \u00a0producen\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0Estas\t\r \u00a0caracter\u00edsticas\t\r \u00a0concuerdan\t\r \u00a0con\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a02.3\t\r \u00a0que\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0mujeres,\t\r \u00a0en\t\r \u00a0edades\t\r \u00a0comprendidas\t\r \u00a0entre\t\r \u00a0los\t\r \u00a065\t\r \u00a0y\t\r \u00a0los\t\r \u00a074\t\r \u00a0a\u00f1os\t\r \u00a0y,\t\r \u00a0llamativamente,\t\r \u00a0casi\t\r \u00a0un\t\r \u00a0cuarto\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0se\t\r \u00a0dan\t\r \u00a0en\t\r \u00a0Arag\u00f3n.\t\r \u00a0\t\r \u00a0Existen\t\r \u00a0 estudios\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 prescripci\u00f3n\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 poblaci\u00f3n\t\r \u00a0 con\t\r \u00a0mayor\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0desarrollar\t\r \u00a0RAs\t\r \u00a0que\t\r \u00a0han\t\r \u00a0demostrado\t\r \u00a0que\t\r \u00a0este\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0se\t\r \u00a0administra\t\r \u00a0 a\t\r \u00a0pacientes\t\r \u00a0en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 estar\u00eda\t\r \u00a0 recomendado\t\r \u00a0(contraindicado\t\r \u00a0con\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0creatinina\t\r \u00a0superiores\t\r \u00a0a\t\r \u00a00,132mMol/l,\t\r \u00a0respecto\t\r \u00a0a\t\r \u00a0su\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica),\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0 como\t\r \u00a0 efecto\t\r \u00a0 adverso\t\r \u00a0 diarrea\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0 requerido\t\r \u00a0disminuci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 dosis\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0(49).\t\r \u00a0 Es\t\r \u00a0 destacable\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 83%\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0intervenciones\t\r \u00a0farmac\u00e9uticas\t\r \u00a0realizadas\t\r \u00a0en\t\r \u00a0este\t\r \u00a0\u00faltimo\t\r \u00a0estudio,\t\r \u00a0que\t\r \u00a0aconsejaban\t\r \u00a0la\t\r \u00a0suspensi\u00f3n\t\r \u00a0 del\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0 metformina,\t\r \u00a0fueron\t\r \u00a0 aceptadas,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0seguimiento\t\r \u00a0farmacoterap\u00e9utico\t\r \u00a0se\t\r \u00a0posiciona\t\r \u00a0como\t\r \u00a0un\t\r \u00a0servicio\t\r \u00a0de\t\r \u00a0gran\t\r \u00a0utilidad\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0casos.\t\r \u00a0\t\r \u00a0Metformina\t\r \u00a0 actualmente\t\r \u00a0 se\t\r \u00a0 indica\t\r \u00a0 como\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 de\t\r \u00a0 primera\t\r \u00a0 l\u00ednea\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0control\t\r \u00a0 gluc\u00e9mico\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 diabetes\t\r \u00a0 tipo\t\r \u00a0 2,\t\r \u00a0 incidiendo\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 potencial\t\r \u00a0aplicaci\u00f3n\t\r \u00a0en\t\r \u00a0dosis\t\r \u00a0elevadas\t\r \u00a0para\t\r \u00a0maximizar\t\r \u00a0el\t\r \u00a0control\t\r \u00a0gluc\u00e9mico\t\r \u00a0sin\t\r \u00a0aumentarse\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0adversos\t\r \u00a0gastrointestinales\t\r \u00a0(50).\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n296\t\r \u00a0\t\r \u00a0Por\t\r \u00a0 \u00faltimo,\t\r \u00a0 cabe\t\r \u00a0 indicar\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 estudiado\t\r \u00a0 que\t\r \u00a0 ambas\t\r \u00a0 condiciones\t\r \u00a0producidas\t\r \u00a0por\t\r \u00a0metformina\t\r \u00a0\u2013diarrea\t\r \u00a0y\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica-\u00ad\u2010\t\r \u00a0pueden\t\r \u00a0estar\t\r \u00a0relacionadas.\t\r \u00a0Una\t\r \u00a0ingesta\t\r \u00a0oral\t\r \u00a0reducida\t\r \u00a0junto\t\r \u00a0a\t\r \u00a0la\t\r \u00a0deshidrataci\u00f3n\t\r \u00a0secundaria\t\r \u00a0debida\t\r \u00a0a\t\r \u00a0la\t\r \u00a0diarrea\t\r \u00a0puede\t\r \u00a0resultar\t\r \u00a0en\t\r \u00a0un\t\r \u00a0fallo\t\r \u00a0renal\t\r \u00a0agudo\t\r \u00a0que\t\r \u00a0precipita\t\r \u00a0la\t\r \u00a0aparici\u00f3n\t\r \u00a0de\t\r \u00a0MALA\t\r \u00a0(51).\t\r \u00a0\t\r \u00a0Sulfonilureas\t\r \u00a0 e\t\r \u00a0 hipoglucemia.\t\r \u00a0Seg\u00fan\t\r \u00a0 nuestros\t\r \u00a0 resultados,\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0hipoglucemia\t\r \u00a0 por\t\r \u00a0 sulfonilureas\t\r \u00a0 en\t\r \u00a0 monoterapia\t\r \u00a0 se\t\r \u00a0 asocian\t\r \u00a0 fundamentalmente\t\r \u00a0 al\t\r \u00a0uso\t\r \u00a0 de\t\r \u00a0 glibenclamida,\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 menor\t\r \u00a0 medida\t\r \u00a0 al\t\r \u00a0 de\t\r \u00a0 glimepirida.\t\r \u00a0 A\t\r \u00a0 pesar\t\r \u00a0 de\t\r \u00a0 ello,\t\r \u00a0 los\t\r \u00a0casos\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0-\u00ad\u2010respecto\t\r \u00a0al\t\r \u00a0total\t\r \u00a0de\t\r \u00a0casos\t\r \u00a0(monoterapia\t\r \u00a0y\t\r \u00a0politerapia)-\u00ad\u2010\t\r \u00a0son\t\r \u00a0inferiores\t\r \u00a0 para\t\r \u00a0 glibenclamida\t\r \u00a0 (34,5%)\t\r \u00a0 que\t\r \u00a0 para\t\r \u00a0 glimepirida\t\r \u00a0 (42,8%);\t\r \u00a0 en\t\r \u00a0 cambio,\t\r \u00a0esta\t\r \u00a0 \u00faltima\t\r \u00a0 parece\t\r \u00a0 ser\t\r \u00a0 m\u00e1s\t\r \u00a0 segura\t\r \u00a0 en\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 combinaciones\t\r \u00a0 con\t\r \u00a0 otros\t\r \u00a0 AHOs\t\r \u00a0 o\t\r \u00a0insulina.\t\r \u00a0Es\t\r \u00a0 conocido\t\r \u00a0 que\t\r \u00a0glibenclamida\t\r \u00a0 tiene\t\r \u00a0 un\t\r \u00a0 mayor\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hipoglucemias\t\r \u00a0 e\t\r \u00a0hiperinsulinemias.\t\r \u00a0 Otras\t\r \u00a0 sulfonilureas\t\r \u00a0 de\t\r \u00a0 segunda\t\r \u00a0 generaci\u00f3n,\t\r \u00a0 como\t\r \u00a0 gliclazida\t\r \u00a0 y\t\r \u00a0glimepirida,\t\r \u00a0 podr\u00edan\t\r \u00a0 ser\t\r \u00a0 m\u00e1s\t\r \u00a0 \u00fatiles\t\r \u00a0 en\t\r \u00a0 ancianos\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 menor\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0hipoglucemias\t\r \u00a0 graves\t\r \u00a0\u2013demostrado\t\r \u00a0 en\t\r \u00a0 comparaciones\t\r \u00a0de\t\r \u00a0 glimepirida\t\r \u00a0 y\t\r \u00a0glibenclamida\t\r \u00a0(52)-\u00ad\u2010;\t\r \u00a0y\t\r \u00a0adem\u00e1s,\t\r \u00a0al\t\r \u00a0ser\t\r \u00a0de\t\r \u00a0toma\t\r \u00a0\u00fanica\t\r \u00a0diaria,\t\r \u00a0puede\t\r \u00a0ayudar\t\r \u00a0a\t\r \u00a0mejorar\t\r \u00a0el\t\r \u00a0 cumplimiento\t\r \u00a0 terap\u00e9utico\t\r \u00a0(6).\t\r \u00a0 En\t\r \u00a0 cambio,\t\r \u00a0 otros\t\r \u00a0 autores\t\r \u00a0 consideran\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0efectos\t\r \u00a0secundarios\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0diferentes\t\r \u00a0sulfonilureas\t\r \u00a0son\t\r \u00a0similares,\t\r \u00a0y\t\r \u00a0que\t\r \u00a0cuanto\t\r \u00a0m\u00e1s\t\r \u00a0larga\t\r \u00a0es\t\r \u00a0la\t\r \u00a0duraci\u00f3n\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0m\u00e1s\t\r \u00a0prolongado\t\r \u00a0ser\u00e1\t\r \u00a0un\t\r \u00a0episodio\t\r \u00a0hipogluc\u00e9mico\t\r \u00a0en\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0producirse,\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0consideran\t\r \u00a0prudente\t\r \u00a0recurrir\t\r \u00a0a\t\r \u00a0sulfonilureas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0 corta\t\r \u00a0-\u00ad\u2010glibenclamida-\u00ad\u2010\t\r \u00a0en\t\r \u00a0 pacientes\t\r \u00a0 ancianos\t\r \u00a0 con\t\r \u00a0 h\u00e1bitos\t\r \u00a0 diet\u00e9ticos\t\r \u00a0irregulares\t\r \u00a0(53).\t\r \u00a0\t\r \u00a0En\t\r \u00a0 nuestro\t\r \u00a0 estudio,\t\r \u00a0 observamos\t\r \u00a0 que\t\r \u00a0 Galicia\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 \u00fanica\t\r \u00a0 Comunidad\t\r \u00a0Aut\u00f3noma\t\r \u00a0 con\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 por\t\r \u00a0 sulfonilureas\t\r \u00a0 que\t\r \u00a0 por\t\r \u00a0 biguanidas\t\r \u00a0 (demostrando\t\r \u00a0 una\t\r \u00a0posible\t\r \u00a0 infrautilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 metformina),\t\r \u00a0 siendo\t\r \u00a0 DAONIL\t\r \u00a0 5mg\t\r \u00a0 30\t\r \u00a0 comprimidos\t\r \u00a0 la\t\r \u00a0especialidad\t\r \u00a0notificada\t\r \u00a0como\t\r \u00a0sospechosa\t\r \u00a0m\u00e1s\t\r \u00a0frecuentemente.\t\r \u00a0Galicia\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0caracteriza\t\r \u00a0 por\t\r \u00a0 ser\t\r \u00a0 la\t\r \u00a0 tercera\t\r \u00a0 Comunidad\t\r \u00a0 en\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 notificaciones\t\r \u00a0 de\t\r \u00a0RAs\t\r \u00a0relacionadas\t\r \u00a0 con\t\r \u00a0 antidiab\u00e9ticos\t\r \u00a0durante\t\r \u00a0 el\t\r \u00a0 periodo\t\r \u00a0 de\t\r \u00a0 estudio\t\r \u00a0 (154\t\r \u00a0 casos),\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 regi\u00f3n\t\r \u00a0 que\t\r \u00a0 sufren\t\r \u00a0 RAs\t\r \u00a0 tienen\t\r \u00a0 entre\t\r \u00a0 65-\u00ad\u201074\t\r \u00a0 a\u00f1os,\t\r \u00a0 la\t\r \u00a0mayor\u00eda\t\r \u00a0 son\t\r \u00a0 mujeres\t\r \u00a0 y\t\r \u00a0 suelen\t\r \u00a0 presentar\t\r \u00a0 hipoglucemias\t\r \u00a0 no\t\r \u00a0 graves.\t\r \u00a0 Nuestros\t\r \u00a0resultados\t\r \u00a0se\t\r \u00a0confirman\t\r \u00a0con\t\r \u00a0estudios\t\r \u00a0realizados\t\r \u00a0en\t\r \u00a0Galicia\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0concluye\t\r \u00a0que\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0m\u00e1s\t\r \u00a0glibenclamida\t\r \u00a0que\t\r \u00a0glimepirida\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0pensionistas\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0no\t\r \u00a0pensionistas\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 su\t\r \u00a0 uso\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 ajusta\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 recomendaciones\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 gu\u00edas\t\r \u00a0terap\u00e9uticas\t\r \u00a0disponibles\t\r \u00a0(6).\t\r \u00a0Estas\t\r \u00a0 mismas\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 diferenciadoras\t\r \u00a0 tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 observan\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0perfil\t\r \u00a02.2,\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0observan\t\r \u00a0reacciones\t\r \u00a0no\t\r \u00a0graves,\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0mujeres,\t\r \u00a0en\t\r \u00a0edades\t\r \u00a0de\t\r \u00a075\t\r \u00a0o\t\r \u00a0m\u00e1s\t\r \u00a0a\u00f1os,\t\r \u00a0durante\t\r \u00a0la\t\r \u00a0segunda\t\r \u00a0mitad\t\r \u00a0del\t\r \u00a0periodo,\t\r \u00a0y\t\r \u00a0-\u00ad\u2010concordando\t\r \u00a0con\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0anteriores-\u00ad\u2010\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mitad\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0ocurren\t\r \u00a0en\t\r \u00a0Galicia.\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0297\t\r \u00a0\t\r \u00a0Tambi\u00e9n\t\r \u00a0 hemos\t\r \u00a0 observado\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Pa\u00eds\t\r \u00a0 Vasco\t\r \u00a0 un\t\r \u00a0 mayor\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 de\t\r \u00a0hipoglucemia,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0vez\t\r \u00a0que\t\r \u00a0una\t\r \u00a0mayor\u00eda\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0producidas\t\r \u00a0por\t\r \u00a0sulfonilureas,\t\r \u00a0pero\t\r \u00a0no\t\r \u00a0 estrictamente\t\r \u00a0 por\t\r \u00a0 glibenclamida.\t\r \u00a0 Esto\t\r \u00a0 \u00faltimo\t\r \u00a0 coincide\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 datos\t\r \u00a0 de\t\r \u00a0descenso\t\r \u00a0de\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0este\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0del\t\r \u00a0periodo,\t\r \u00a0presentes\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0nuestro\t\r \u00a0 estudio\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 otros\t\r \u00a0 consultados\t\r \u00a0(54).\t\r \u00a0 Aun\t\r \u00a0 as\u00ed\t\r \u00a0 estimamos\t\r \u00a0 que\t\r \u00a0glibenclamida\t\r \u00a0podr\u00eda\t\r \u00a0seguir\t\r \u00a0siendo\t\r \u00a0responsable\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0hipoglucemias\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0el\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0sulfonilureas\t\r \u00a0de\t\r \u00a0primera\t\r \u00a0generaci\u00f3n\t\r \u00a0como\t\r \u00a0clorpropamida\t\r \u00a0o\t\r \u00a0tolbutamida,\t\r \u00a0tambi\u00e9n\t\r \u00a0tendentes\t\r \u00a0a\t\r \u00a0producir\t\r \u00a0estos\t\r \u00a0episodios,\t\r \u00a0presentan\t\r \u00a0un\t\r \u00a0uso\t\r \u00a0residual.\t\r \u00a0\t\r \u00a0\t\r \u00a0Respecto\t\r \u00a0 a\t\r \u00a0 glimepirida\t\r \u00a0-\u00ad\u2010incluida\t\r \u00a0 en\t\r \u00a0 1997-\u00ad\u2010,\t\r \u00a0 s\u00f3lo\t\r \u00a0 parece\t\r \u00a0 adoptarse\t\r \u00a0 la\t\r \u00a0evidencia\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0 uso\t\r \u00a0 preferente\t\r \u00a0 en\t\r \u00a0 ancianos\t\r \u00a0 frente\t\r \u00a0 al\t\r \u00a0 uso\t\r \u00a0 de\t\r \u00a0 glibenclamida\t\r \u00a0 por\t\r \u00a0menor\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0-\u00ad\u2010conocida\t\r \u00a0 desde\t\r \u00a0 2001\t\r \u00a0(52)-\u00ad\u2010\t\r \u00a0tras\t\r \u00a0 las\t\r \u00a0recomendaciones\t\r \u00a0del\t\r \u00a0NICE\t\r \u00a0de\t\r \u00a02002\t\r \u00a0(55).\t\r \u00a0Aun\t\r \u00a0as\u00ed,\t\r \u00a0seg\u00fan\t\r \u00a0recogen\t\r \u00a0algunos\t\r \u00a0estudios,\t\r \u00a0en\t\r \u00a0gu\u00edas\t\r \u00a0espa\u00f1olas\t\r \u00a0posteriores\t\r \u00a0a\u00fan\t\r \u00a0se\t\r \u00a0recomienda\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0glibenclamida\t\r \u00a0como\t\r \u00a0f\u00e1rmaco\t\r \u00a0 de\t\r \u00a0 primera\t\r \u00a0 elecci\u00f3n\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 normopeso\t\r \u00a0 con\t\r \u00a0 glucemia\t\r \u00a0 no\t\r \u00a0controlada\t\r \u00a0por\t\r \u00a0medidas\t\r \u00a0no\t\r \u00a0farmacol\u00f3gicas\t\r \u00a0(56).\t\r \u00a0\t\r \u00a0En\t\r \u00a0nuestros\t\r \u00a0resultados\t\r \u00a0no\t\r \u00a0se\t\r \u00a0recoge\t\r \u00a0ning\u00fan\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0RA\t\r \u00a0con\t\r \u00a0gliclazida\t\r \u00a0como\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0cuando\t\r \u00a0su\t\r \u00a0uso\t\r \u00a0medio\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0de\t\r \u00a0un\t\r \u00a09%\t\r \u00a0del\t\r \u00a0total\t\r \u00a0de\t\r \u00a0AHOs.\t\r \u00a0Este\t\r \u00a0hecho\t\r \u00a0viene\t\r \u00a0apoyado\t\r \u00a0por\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0del\t\r \u00a0estudio\t\r \u00a0ADVANCE\t\r \u00a0que\t\r \u00a0revelan\t\r \u00a0que\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0 de\t\r \u00a0 gliclazida\t\r \u00a0 de\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 retardada\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 opci\u00f3n\t\r \u00a0 m\u00e1s\t\r \u00a0 segura\t\r \u00a0 dentro\t\r \u00a0 del\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0sulfonilureas\t\r \u00a0(57,\t\r \u00a058).\t\r \u00a0\t\r \u00a0Rosiglitazona\t\r \u00a0 y\t\r \u00a0 anemia.\t\r \u00a0Aunque\t\r \u00a0 la\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 anemia\t\r \u00a0 suele\t\r \u00a0 ir\t\r \u00a0 m\u00e1s\t\r \u00a0asociada\t\r \u00a0 al\t\r \u00a0 uso\t\r \u00a0 combinado\t\r \u00a0 de\t\r \u00a0 rosiglitazona\t\r \u00a0 y\t\r \u00a0 metformina,\t\r \u00a0 en\t\r \u00a0 nuestro\t\r \u00a0 estudio\t\r \u00a0observamos\t\r \u00a0una\t\r \u00a0frecuencia\t\r \u00a0elevada\t\r \u00a0de\t\r \u00a0casos\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0con\t\r \u00a0rosiglitazona\t\r \u00a0que\t\r \u00a0presentan\t\r \u00a0 anemia.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 el\t\r \u00a0 58%\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 presenta\t\r \u00a0 dicha\t\r \u00a0relaci\u00f3n\t\r \u00a0rosiglitazona-\u00ad\u2010anemia\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0(12\t\r \u00a0casos).\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0 Esta\t\r \u00a0 RA\t\r \u00a0 hematol\u00f3gica\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 frecuente\t\r \u00a0 (1,9%),\t\r \u00a0 con\t\r \u00a0 disminuci\u00f3n\t\r \u00a0 del\t\r \u00a0hematocrito\t\r \u00a0 alrededor\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 3,3%\t\r \u00a0 y\t\r \u00a0 descensos\t\r \u00a0 de\t\r \u00a0 hemoglobina\t\r \u00a0 de\t\r \u00a0 1\t\r \u00a0 g/dL.\t\r \u00a0 Su\t\r \u00a0aparici\u00f3n\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0en\t\r \u00a0los\t\r \u00a0tres\t\r \u00a0primeros\t\r \u00a0meses\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0o\t\r \u00a0al\t\r \u00a0aumentar\t\r \u00a0la\t\r \u00a0dosis\t\r \u00a0 de\t\r \u00a0 rosiglitazona.\t\r \u00a0 Se\t\r \u00a0 suele\t\r \u00a0 asociar\t\r \u00a0 a\t\r \u00a0 hemodiluci\u00f3n\t\r \u00a0(26)\t\r \u00a0y\t\r \u00a0 no\t\r \u00a0 suele\t\r \u00a0 reportar\t\r \u00a0gravedad\t\r \u00a0ni\t\r \u00a0consecuencias\t\r \u00a0cl\u00ednicas\t\r \u00a0(59).\t\r \u00a0Existen\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0asociado\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0 rosiglitazona\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0 reducci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0hemoglobina\t\r \u00a0dosis-\u00ad\u2010dependiente\t\r \u00a0(60).\t\r \u00a0\t\r \u00a0En\t\r \u00a0otros\t\r \u00a0estudios\t\r \u00a0se\t\r \u00a0recalca\t\r \u00a0la\t\r \u00a0asociaci\u00f3n\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0anemia\t\r \u00a0y\t\r \u00a0el\t\r \u00a0aumento\t\r \u00a0del\t\r \u00a0riesgo\t\r \u00a0 de\t\r \u00a0 complicaciones\t\r \u00a0 diab\u00e9ticas\t\r \u00a0-\u00ad\u2010incluyendo\t\r \u00a0 nefropat\u00eda,\t\r \u00a0 retinopat\u00eda,\t\r \u00a0neuropat\u00eda\t\r \u00a0 y\t\r \u00a0 enfermedad\t\r \u00a0 macrovascular-\u00ad\u2010;\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 consideran\t\r \u00a0 que\t\r \u00a0 esta\t\r \u00a0 RA\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0significativa\t\r \u00a0en\t\r \u00a0la\t\r \u00a0determinaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0evoluci\u00f3n\t\r \u00a0tras\t\r \u00a0un\t\r \u00a0fallo\t\r \u00a0cardiaco\t\r \u00a0y\t\r \u00a0del\t\r \u00a0 da\u00f1o\t\r \u00a0 org\u00e1nico\t\r \u00a0 inducido\t\r \u00a0 por\t\r \u00a0 hipoxia\t\r \u00a0 en\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 diabetes.\t\r \u00a0 El\t\r \u00a0 fallo\t\r \u00a0 renal\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0s\u00edntesis\t\r \u00a0de\t\r \u00a0eritropoyetina\t\r \u00a0parece\t\r \u00a0un\t\r \u00a0factor\t\r \u00a0fundamental\t\r \u00a0en\t\r \u00a0su\t\r \u00a0aparici\u00f3n\t\r \u00a0(61).\t\r \u00a0\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n298\t\r \u00a0\t\r \u00a0Para\t\r \u00a0 la\t\r \u00a0 prevenci\u00f3n\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 RA\t\r \u00a0 se\t\r \u00a0 recomienda\t\r \u00a0 un\t\r \u00a0 control\t\r \u00a0 \u00f3ptimo,\t\r \u00a0 tanto\t\r \u00a0metab\u00f3lico\t\r \u00a0 como\t\r \u00a0 de\t\r \u00a0 presi\u00f3n\t\r \u00a0 arterial.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0la\t\r \u00a0 detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 anemia\t\r \u00a0 puede\t\r \u00a0utilizarse\t\r \u00a0 para\t\r \u00a0 identificar\t\r \u00a0 a\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 diabetes\t\r \u00a0 que\t\r \u00a0 tengan\t\r \u00a0 mayor\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0sufrir\t\r \u00a0resultados\t\r \u00a0cl\u00ednicos\t\r \u00a0adversos\t\r \u00a0seg\u00fan\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0consultados\t\r \u00a0(61).\t\r \u00a0INSULINAS\t\r \u00a0EN\t\r \u00a0POLITERAPIA\t\r \u00a0Existe\t\r \u00a0una\t\r \u00a0baja\t\r \u00a0frecuencia\t\r \u00a0de\t\r \u00a0coincidencias\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0m\u00e1s\t\r \u00a0sospechosos.\t\r \u00a0 Esto\t\r \u00a0 se\t\r \u00a0 debe,\t\r \u00a0 en\t\r \u00a0 parte,\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 grupo\t\r \u00a0 de\t\r \u00a0 notificaciones\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0aparece\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 politerapia\t\r \u00a0-\u00ad\u2010bien\t\r \u00a0 con\t\r \u00a0 otro\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 o\t\r \u00a0 bien\t\r \u00a0 con\t\r \u00a0 otros\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos-\u00ad\u2010\t\r \u00a0es\t\r \u00a0el\t\r \u00a0segundo\t\r \u00a0menos\t\r \u00a0numeroso.\t\r \u00a0Aun\t\r \u00a0as\u00ed,\t\r \u00a0destacan\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0 detemir-\u00ad\u2010aspart\t\r \u00a0 y,\t\r \u00a0 en\t\r \u00a0 especial,\t\r \u00a0 la\t\r \u00a0 relaci\u00f3n\t\r \u00a0 glargina-\u00ad\u2010shock\t\r \u00a0 hipogluc\u00e9mico\t\r \u00a0contrastando\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 mayor\t\r \u00a0 frecuencia\t\r \u00a0 de\t\r \u00a0 glargina-\u00ad\u2010hiperglucemia\t\r \u00a0 observada\t\r \u00a0 en\t\r \u00a0monoterapia.\t\r \u00a0Insulinas\t\r \u00a0 r\u00e1pidas\t\r \u00a0 combinadas\t\r \u00a0 con\t\r \u00a0 insulinas\t\r \u00a0 intermedias/prolongadas:\t\r \u00a0hipoglucemias\t\r \u00a0e\t\r \u00a0hiperglucemias.\t\r \u00a0Se\t\r \u00a0observa\t\r \u00a0una\t\r \u00a0relaci\u00f3n\t\r \u00a0de\t\r \u00a0insulinas\t\r \u00a0intermedias\t\r \u00a0o\t\r \u00a0 prolongadas\t\r \u00a0 con\t\r \u00a0 insulinas\t\r \u00a0 r\u00e1pidas,\t\r \u00a0 siempre\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 an\u00e1logo\t\r \u00a0 implicado\t\r \u00a0 en\t\r \u00a0 esa\t\r \u00a0asociaci\u00f3n.\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a03.1\t\r \u00a0ser\u00eda\t\r \u00a0el\t\r \u00a0m\u00e1s\t\r \u00a0ajustado\t\r \u00a0a\t\r \u00a0esta\t\r \u00a0situaci\u00f3n,\t\r \u00a0con\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0como\t\r \u00a0principal\t\r \u00a0an\u00e1logo\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0sospechoso,\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0RAs\t\r \u00a0 en\t\r \u00a0 personas\t\r \u00a0 j\u00f3venes\t\r \u00a0 o\t\r \u00a0 adultas.\t\r \u00a0 Los\t\r \u00a0 otros\t\r \u00a0 dos\t\r \u00a0 perfiles\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 adaptan\t\r \u00a0 a\t\r \u00a0 esta\t\r \u00a0descripci\u00f3n\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 caracterizan\t\r \u00a0 por\t\r \u00a0 presentar\t\r \u00a0 s\u00f3lo\t\r \u00a0 un\t\r \u00a0 principio\t\r \u00a0 activo\t\r \u00a0sospechoso\t\r \u00a0en\t\r \u00a0la\t\r \u00a0mayor\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos.\t\r \u00a0Estas\t\r \u00a0 combinaciones\t\r \u00a0 de\t\r \u00a0 insulinas\t\r \u00a0 r\u00e1pidas-\u00ad\u2010prolongadas\t\r \u00a0 que\t\r \u00a0 destacamos\t\r \u00a0coinciden\t\r \u00a0con\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0de\t\r \u00a0insulinas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0r\u00e1pida\t\r \u00a0y\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0en\t\r \u00a0combinaci\u00f3n\t\r \u00a0con\t\r \u00a0al\t\r \u00a0menos\t\r \u00a0otro\t\r \u00a0principio\t\r \u00a0activo.\t\r \u00a0\t\r \u00a0Tras\t\r \u00a0considerar\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0del\t\r \u00a0gr\u00e1fico\t\r \u00a0de\t\r \u00a0red\t\r \u00a0y\t\r \u00a0de\t\r \u00a0los\t\r \u00a0perfiles\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0en\t\r \u00a0 politerapia,\t\r \u00a0 podemos\t\r \u00a0 concluir\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 segundo\t\r \u00a0 principio\t\r \u00a0 activo\t\r \u00a0 suele\t\r \u00a0 ser,\t\r \u00a0frecuentemente,\t\r \u00a0 otra\t\r \u00a0 insulina.\t\r \u00a0 Creemos\t\r \u00a0 que\t\r \u00a0 esta\t\r \u00a0 mayor\t\r \u00a0 notificaci\u00f3n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0implican\t\r \u00a0insulinas\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0y\t\r \u00a0r\u00e1pida\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0a\t\r \u00a0la\t\r \u00a0implementaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0recomendaciones\t\r \u00a0de\t\r \u00a0su\t\r \u00a0uso\t\r \u00a0combinado\t\r \u00a0en\t\r \u00a0tratamientos\t\r \u00a0intensivos\t\r \u00a0(62,\t\r \u00a063),\t\r \u00a0al\t\r \u00a0haber\t\r \u00a0 demostrado\t\r \u00a0 estos\t\r \u00a0mejoras\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 control\t\r \u00a0 gluc\u00e9mico\t\r \u00a0(64,\t\r \u00a0 65),\t\r \u00a0observ\u00e1ndose\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0con\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a01\t\r \u00a0como\t\r \u00a0con\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0(66,\t\r \u00a067).\t\r \u00a0\t\r \u00a0Este\t\r \u00a0 estricto\t\r \u00a0 control\t\r \u00a0 puede\t\r \u00a0 llevar\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 episodios\t\r \u00a0 de\t\r \u00a0descompensaci\u00f3n\t\r \u00a0 gluc\u00e9mica\t\r \u00a0 con\t\r \u00a0 su\t\r \u00a0 consiguiente\t\r \u00a0 riesgo.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 hemos\t\r \u00a0observado\t\r \u00a0en\t\r \u00a0nuestros\t\r \u00a0resultados\t\r \u00a0que,\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0mortales,\t\r \u00a0los\t\r \u00a0dos\t\r \u00a0\u00fanicos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0 que\t\r \u00a0 estaban\t\r \u00a0 implicadas\t\r \u00a0 insulinas\t\r \u00a0 presentan\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 r\u00e1pida\t\r \u00a0(aspart)\t\r \u00a0 con\t\r \u00a0 insulinas\t\r \u00a0 bif\u00e1sicas\t\r \u00a0 (lispro+lispro\t\r \u00a0 protamina)\t\r \u00a0 y/o\t\r \u00a0 prolongadas\t\r \u00a0(glargina\t\r \u00a0o\t\r \u00a0detemir).\t\r \u00a0En\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0coma\t\r \u00a0diab\u00e9tico\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0otro\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0malformaciones\t\r \u00a0cong\u00e9nitas.\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0299\t\r \u00a0\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0algunos\t\r \u00a0autores\t\r \u00a0han\t\r \u00a0estudiado\t\r \u00a0la\t\r \u00a0tendencia\t\r \u00a0a\t\r \u00a0usar\t\r \u00a0la\t\r \u00a0mezcla\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0aspart\t\r \u00a0con\t\r \u00a0insulina\t\r \u00a0detemir\t\r \u00a0en\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0jeringa\t\r \u00a0como\t\r \u00a0r\u00e9gimen\t\r \u00a0habitual\t\r \u00a0para\t\r \u00a0 minimizar\t\r \u00a0 el\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 inyecciones\t\r \u00a0 diarias\t\r \u00a0-\u00ad\u2010especialmente\t\r \u00a0 en\t\r \u00a0 ni\u00f1os\t\r \u00a0 con\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a01-\u00ad\u2010\t\r \u00a0que\t\r \u00a0va\t\r \u00a0en\t\r \u00a0contra\t\r \u00a0de\t\r \u00a0las\t\r \u00a0advertencias\t\r \u00a0del\t\r \u00a0laboratorio\t\r \u00a0fabricante.\t\r \u00a0Sus\t\r \u00a0resultados\t\r \u00a0 constatan\t\r \u00a0 que\t\r \u00a0 tal\t\r \u00a0 pr\u00e1ctica\t\r \u00a0 produce\t\r \u00a0 un\t\r \u00a0 efecto\t\r \u00a0 adverso\t\r \u00a0debido\t\r \u00a0 al\t\r \u00a0descenso\t\r \u00a0acusado\t\r \u00a0del\t\r \u00a0pico\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0aspart\t\r \u00a0y\t\r \u00a0a\t\r \u00a0la\t\r \u00a0prolongaci\u00f3n\t\r \u00a0de\t\r \u00a0su\t\r \u00a0duraci\u00f3n\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0separada\t\r \u00a0de\t\r \u00a0aspart\t\r \u00a0y\t\r \u00a0detemir\t\r \u00a0(68).\t\r \u00a0\t\r \u00a0Debemos\t\r \u00a0puntualizar\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0nuestro\t\r \u00a0pa\u00eds\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0periodo\t\r \u00a0de\t\r \u00a0estudio,\t\r \u00a0no\t\r \u00a0existen\t\r \u00a0presentaciones\t\r \u00a0en\t\r \u00a0vial\t\r \u00a0para\t\r \u00a0insulina\t\r \u00a0detemir,\t\r \u00a0pero\t\r \u00a0s\u00ed\t\r \u00a0para\t\r \u00a0insulina\t\r \u00a0glargina.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0glargina\t\r \u00a0se\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0no\t\r \u00a0se\t\r \u00a0puede\t\r \u00a0mezclar\t\r \u00a0con\t\r \u00a0otra\t\r \u00a0insulina\t\r \u00a0o\t\r \u00a0diluirse\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 cambiar\t\r \u00a0 su\t\r \u00a0 tiempo/perfil\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 mezcla\t\r \u00a0 puede\t\r \u00a0precipitar\t\r \u00a0(69),\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0en\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0aspart\t\r \u00a0(vial)\t\r \u00a0se\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0s\u00f3lo\t\r \u00a0puede\t\r \u00a0mezclarse\t\r \u00a0con\t\r \u00a0insulina\t\r \u00a0NPH\t\r \u00a0(70).\t\r \u00a0\t\r \u00a0En\t\r \u00a0nuestra\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0no\t\r \u00a0aparece\t\r \u00a0ning\u00fan\t\r \u00a0caso\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0se\t\r \u00a0administre\t\r \u00a0insulina\t\r \u00a0 aspart\t\r \u00a0 e\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 ambas\t\r \u00a0 en\t\r \u00a0 viales\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0que\t\r \u00a0la\t\r \u00a0pr\u00e1ctica\t\r \u00a0comentada\t\r \u00a0no\t\r \u00a0 parece\t\r \u00a0 muy\t\r \u00a0 extendida\t\r \u00a0 en\t\r \u00a0 Espa\u00f1a.\t\r \u00a0 Aun\t\r \u00a0 as\u00ed\t\r \u00a0 deber\u00eda\t\r \u00a0estudiarse\t\r \u00a0si\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0al\t\r \u00a0mismo\t\r \u00a0tiempo\t\r \u00a0y\t\r \u00a0en\t\r \u00a0una\t\r \u00a0zona\t\r \u00a0cercana\t\r \u00a0de\t\r \u00a0ambas\t\r \u00a0insulinas\t\r \u00a0\u2013aunque\t\r \u00a0 no\t\r \u00a0 sea\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 misma\t\r \u00a0 jeringa-\u00ad\u2010\t\r \u00a0puede\t\r \u00a0 alterar\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0farmacodin\u00e1mico\t\r \u00a0de\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0r\u00e1pida\t\r \u00a0pudiendo\t\r \u00a0generar\t\r \u00a0hiperglucemias.\t\r \u00a0As\u00ed\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a03.1,\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0las\t\r \u00a0reacciones\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a0caracter\u00edsticas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 insulinas\t\r \u00a0 prolongadas\t\r \u00a0 se\t\r \u00a0 detecta\t\r \u00a0 hiperglucemia.\t\r \u00a0 Este\t\r \u00a0 perfil\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0caracteriza\t\r \u00a0por\t\r \u00a0presentar\t\r \u00a0casos\t\r \u00a0graves\t\r \u00a0(el\t\r \u00a05,1%\t\r \u00a0son\t\r \u00a0mortales).\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a03.2\t\r \u00a0es\t\r \u00a0poco\t\r \u00a0frecuente,\t\r \u00a0se\t\r \u00a0da\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0hombres\t\r \u00a0-\u00ad\u2010tanto\t\r \u00a0j\u00f3venes\t\r \u00a0como\t\r \u00a0adultos-\u00ad\u2010\t\r \u00a0en\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0insulina\t\r \u00a0regular+isof\u00e1nica\t\r \u00a0o\t\r \u00a0detemir,\t\r \u00a0y\t\r \u00a0se\t\r \u00a0dan\t\r \u00a0casos\t\r \u00a0graves\t\r \u00a0aunque\t\r \u00a0la\t\r \u00a0mayor\u00eda\t\r \u00a0no\t\r \u00a0mortales.\t\r \u00a0Lo\t\r \u00a0llamativo\t\r \u00a0es\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0insulinas,\t\r \u00a0 vitaminas\t\r \u00a0 y\t\r \u00a0 agentes\t\r \u00a0 modificadores\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 l\u00edpidos\t\r \u00a0 como\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0sospechosos.\t\r \u00a0 Respecto\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 dos\t\r \u00a0 \u00faltimos,\t\r \u00a0 no\t\r \u00a0 hemos\t\r \u00a0 encontrado\t\r \u00a0 ninguna\t\r \u00a0interacci\u00f3n\t\r \u00a0 conocida.\t\r \u00a0 Los\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 hiperglucemia\t\r \u00a0 los\t\r \u00a0 consideramos\t\r \u00a0 asociados\t\r \u00a0 al\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0regular+isof\u00e1nica\t\r \u00a0o\t\r \u00a0detemir\t\r \u00a0para\t\r \u00a0cubrir\t\r \u00a0las\t\r \u00a0necesidades\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0durante\t\r \u00a0la\t\r \u00a0noche\t\r \u00a0con\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0producirse\t\r \u00a0hiperglucemias\t\r \u00a0matutinas.\t\r \u00a0Respecto\t\r \u00a0 al\t\r \u00a0perfil\t\r \u00a0 3.3\t\r \u00a0hay\t\r \u00a0 que\t\r \u00a0 destacar\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 produce\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 de\t\r \u00a0mayor\t\r \u00a0 edad\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0que\t\r \u00a0 est\u00e1\t\r \u00a0 implicada\t\r \u00a0 glargina\t\r \u00a0 como\t\r \u00a0 \u00fanico\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso,\t\r \u00a0siendo\t\r \u00a0 la\t\r \u00a0 mitad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 graves\t\r \u00a0 y\t\r \u00a0 mortales.\t\r \u00a0 Es\t\r \u00a0 contradictorio\t\r \u00a0 que\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0f\u00e1rmacos\t\r \u00a0 considerados\t\r \u00a0 no\t\r \u00a0 sospechosos\t\r \u00a0 se\t\r \u00a0 encuentren\t\r \u00a0 otras\t\r \u00a0 insulinas,\t\r \u00a0 cuando\t\r \u00a0 la\t\r \u00a0RA\t\r \u00a0 m\u00e1s\t\r \u00a0 frecuentemente\t\r \u00a0 observada\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 perfil\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 hipoglucemia,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0creemos\t\r \u00a0que\t\r \u00a0deb\u00eda\t\r \u00a0haberse\t\r \u00a0tenido\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0en\t\r \u00a0la\t\r \u00a0notificaci\u00f3n.\t\r \u00a0Esto\t\r \u00a0explicar\u00eda\t\r \u00a0por\t\r \u00a0qu\u00e9\t\r \u00a0en\t\r \u00a0la\t\r \u00a0red\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0destaca\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0glargina-\u00ad\u2010shock\t\r \u00a0hipogluc\u00e9mico,\t\r \u00a0cuando\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0glargina\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0m\u00e1s\t\r \u00a0frecuentemente\t\r \u00a0con\t\r \u00a0hiperglucemia.\t\r \u00a0\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n300\t\r \u00a0\t\r \u00a0En\t\r \u00a0este\t\r \u00a0perfil\t\r \u00a0tambi\u00e9n\t\r \u00a0observamos\t\r \u00a0casos\t\r \u00a0que\t\r \u00a0concuerdan\t\r \u00a0con\t\r \u00a0RAs\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0al\u00e9rgico\t\r \u00a0 inherentes\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 insulina,\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0anticuerpos\t\r \u00a0anti-\u00ad\u2010insulina\t\r \u00a0que\t\r \u00a0producen\t\r \u00a0una\t\r \u00a0disminuci\u00f3n\t\r \u00a0del\t\r \u00a0efecto\t\r \u00a0farmacol\u00f3gico\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0terap\u00e9utica\t\r \u00a0(26,\t\r \u00a069).\t\r \u00a0\t\r \u00a0Combinaciones\t\r \u00a0 de\t\r \u00a0 an\u00e1logos\t\r \u00a0 de\t\r \u00a0 lispro.\t\r \u00a0Son\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 observa\t\r \u00a0asociaci\u00f3n\t\r \u00a0 entre\t\r \u00a0 insulina\t\r \u00a0 lispro\t\r \u00a0 con\t\r \u00a0 insulinas\t\r \u00a0 intermedias\t\r \u00a0 (isof\u00e1nica)\t\r \u00a0 o\t\r \u00a0 bif\u00e1sicas\t\r \u00a0(lispro+lispro\t\r \u00a0 protamina).\t\r \u00a0 Seg\u00fan\t\r \u00a0 su\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica,\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 r\u00e1pida\t\r \u00a0lispro\t\r \u00a0 s\u00f3lo\t\r \u00a0est\u00e1\t\r \u00a0 autorizada\t\r \u00a0 para\t\r \u00a0 su\t\r \u00a0 uso\t\r \u00a0 en\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 con\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0o\t\r \u00a0sulfonilureas\t\r \u00a0(71).\t\r \u00a0Es\t\r \u00a0por\t\r \u00a0ello\t\r \u00a0que\t\r \u00a0pensamos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0existencia\t\r \u00a0de\t\r \u00a0un\t\r \u00a0uso\t\r \u00a0combinado\t\r \u00a0incorrecto\t\r \u00a0con\t\r \u00a0este\t\r \u00a0an\u00e1logo\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0r\u00e1pida.\t\r \u00a0Insulina,\t\r \u00a0 irbesart\u00e1n\t\r \u00a0 e\t\r \u00a0 hidroclorotiazida.\t\r \u00a0Respecto\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 entre\t\r \u00a0irbesart\u00e1n\t\r \u00a0e\t\r \u00a0hidroclorotiazida\t\r \u00a0observada\t\r \u00a0en\t\r \u00a0determinados\t\r \u00a0casos\t\r \u00a0donde\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0 insulina,\t\r \u00a0 hemos\t\r \u00a0 descubierto\t\r \u00a0 que\t\r \u00a0 tal\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 se\t\r \u00a0 debe\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 codificaci\u00f3n\t\r \u00a0imprecisa.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0original,\t\r \u00a0siempre\t\r \u00a0que\t\r \u00a0aparecen\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0irbesart\u00e1n\t\r \u00a0e\t\r \u00a0hidroclorotiazida\t\r \u00a0lo\t\r \u00a0hacen\t\r \u00a0porque\t\r \u00a0el\t\r \u00a0paciente\t\r \u00a0toma\t\r \u00a0una\t\r \u00a0combinaci\u00f3n\t\r \u00a0a\t\r \u00a0dosis\t\r \u00a0fija\t\r \u00a0(c\u00f3digo\t\r \u00a0C02F2),\t\r \u00a0a\t\r \u00a0pesar\t\r \u00a0de\t\r \u00a0ello,\t\r \u00a0se\t\r \u00a0codifican\t\r \u00a0por\t\r \u00a0separado.\t\r \u00a0Al\t\r \u00a0realizar\t\r \u00a0la\t\r \u00a0actualizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 c\u00f3digos\t\r \u00a0 ATC\t\r \u00a0 observamos\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 existe\t\r \u00a0 un\t\r \u00a0 c\u00f3digo\t\r \u00a0 concreto\t\r \u00a0para\t\r \u00a0esta\t\r \u00a0combinaci\u00f3n\t\r \u00a0-\u00ad\u2010en\t\r \u00a0el\t\r \u00a0\u00edndice\t\r \u00a0ATC/DDD\t\r \u00a02011\t\r \u00a0(72,\t\r \u00a073)\t\r \u00a0la\t\r \u00a0\u00fanica\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0nombrar\t\r \u00a0 correctamente\t\r \u00a0 este\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 formulaci\u00f3n\t\r \u00a0 ser\u00eda\t\r \u00a0 asign\u00e1ndole\t\r \u00a0 el\t\r \u00a0 c\u00f3digo\t\r \u00a0 de\t\r \u00a0\u2018Irbesart\u00e1n\t\r \u00a0 y\t\r \u00a0 diur\u00e9ticos\t\r \u00a0 C09DA04\u2019\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 especifica\t\r \u00a0 el\t\r \u00a0 diur\u00e9tico\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0combinaci\u00f3n-\u00ad\u2010.\t\r \u00a0 Es\t\r \u00a0 por\t\r \u00a0 ello\t\r \u00a0 que,\t\r \u00a0 al\t\r \u00a0 igual\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 original,\t\r \u00a0 tambi\u00e9n\t\r \u00a0adjudicamos\t\r \u00a0 un\t\r \u00a0 c\u00f3digo\t\r \u00a0 a\t\r \u00a0 cada\t\r \u00a0 principio\t\r \u00a0 activo\t\r \u00a0 por\t\r \u00a0 separado,\t\r \u00a0 motivo\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0aparecen\t\r \u00a0relacionados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0red\t\r \u00a0de\t\r \u00a0enlaces.\t\r \u00a0Este\t\r \u00a0es\t\r \u00a0un\t\r \u00a0ejemplo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0relevancia\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0 tener\t\r \u00a0 algunos\t\r \u00a0 defectos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 notificaci\u00f3n\t\r \u00a0 a\t\r \u00a0 tener\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 en\t\r \u00a0 estudios\t\r \u00a0posteriores.\t\r \u00a0\t\r \u00a0A\t\r \u00a0 pesar\t\r \u00a0 de\t\r \u00a0 lo\t\r \u00a0 comentado,\t\r \u00a0 y\t\r \u00a0 dado\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 e\t\r \u00a0hidroclorotiazida\t\r \u00a0 (combinada\t\r \u00a0 o\t\r \u00a0 no\t\r \u00a0 con\t\r \u00a0 irbesart\u00e1n)\t\r \u00a0 existe\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 de\t\r \u00a0 datos,\t\r \u00a0queremos\t\r \u00a0hacer\t\r \u00a0hincapi\u00e9\t\r \u00a0en\t\r \u00a0la\t\r \u00a0posible\t\r \u00a0inhibici\u00f3n\t\r \u00a0del\t\r \u00a0efecto\t\r \u00a0hipoglucemiante\t\r \u00a0de\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0 en\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 diur\u00e9ticos\t\r \u00a0 tiaz\u00eddicos,\t\r \u00a0 interacci\u00f3n\t\r \u00a0 ampliamente\t\r \u00a0 conocida\t\r \u00a0(26).\t\r \u00a0 En\t\r \u00a0 nuestros\t\r \u00a0 datos\t\r \u00a0 no\t\r \u00a0 hemos\t\r \u00a0 observado\t\r \u00a0 ninguna\t\r \u00a0 RA\t\r \u00a0 hipergluc\u00e9mica\t\r \u00a0en\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0e\t\r \u00a0hidroclorotiazida.\t\r \u00a0\t\r \u00a0\t\r \u00a0AHOs\t\r \u00a0EN\t\r \u00a0POLITERAPIA\t\r \u00a0Hemos\t\r \u00a0 observado\t\r \u00a0 pocos\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 coincidan\t\r \u00a0 las\t\r \u00a0 asociaciones\t\r \u00a0 de\t\r \u00a0principios\t\r \u00a0 activos\t\r \u00a0 independientemente\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 posici\u00f3n\t\r \u00a0 de\t\r \u00a0 sospecha\t\r \u00a0 que\t\r \u00a0 ocupe\t\r \u00a0 el\t\r \u00a0AHO,\t\r \u00a0es\t\r \u00a0decir,\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0coincidan\t\r \u00a0combinaciones\t\r \u00a0del\t\r \u00a0perfil\t\r \u00a04\t\r \u00a0y\t\r \u00a0del\t\r \u00a0perfil\t\r \u00a05.\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0301\t\r \u00a0\t\r \u00a0El\t\r \u00a0 perfil\t\r \u00a0 4\t\r \u00a0 se\t\r \u00a0 caracteriza\t\r \u00a0 por\t\r \u00a0 presentar\t\r \u00a0AHOs\t\r \u00a0 notificados\t\r \u00a0 en\t\r \u00a0 primera\t\r \u00a0posici\u00f3n\t\r \u00a0de\t\r \u00a0sospecha\t\r \u00a0(seg\u00fan\t\r \u00a0la\t\r \u00a0clasificaci\u00f3n\t\r \u00a0preliminar,\t\r \u00a0ver\t\r \u00a0M\u00e9todo)\t\r \u00a0y\t\r \u00a0donde\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0notificados\t\r \u00a0en\t\r \u00a0segunda\t\r \u00a0posici\u00f3n\t\r \u00a0tambi\u00e9n\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0AHOs\t\r \u00a0en\t\r \u00a0su\t\r \u00a0mayor\u00eda,\t\r \u00a0situ\u00e1ndose\t\r \u00a0por\t\r \u00a0delante\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0Es\t\r \u00a0llamativa\t\r \u00a0la\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 relaci\u00f3n\t\r \u00a0 metformina-\u00ad\u2010hipoglucemia\t\r \u00a0 y\t\r \u00a0 metformina-\u00ad\u2010acidosis,\t\r \u00a0 no\t\r \u00a0observadas\t\r \u00a0 en\t\r \u00a0 monoterapia.\t\r \u00a0 A\t\r \u00a0 continuaci\u00f3n\t\r \u00a0 comentamos\t\r \u00a0estas\t\r \u00a0 y\t\r \u00a0 otras\t\r \u00a0 de\t\r \u00a0las\t\r \u00a0relaciones\t\r \u00a0m\u00e1s\t\r \u00a0relevantes\t\r \u00a0observadas\t\r \u00a0en\t\r \u00a0este\t\r \u00a0perfil\t\r \u00a04:\t\r \u00a0\t\r \u00a0Metformina\t\r \u00a0y\t\r \u00a0sulfonilureas.\t\r \u00a0Se\t\r \u00a0sabe\t\r \u00a0que\t\r \u00a0la\t\r \u00a0acci\u00f3n\t\r \u00a0antihiperglucemiante\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0presenta\t\r \u00a0efecto\t\r \u00a0sin\u00e9rgico\t\r \u00a0con\t\r \u00a0las\t\r \u00a0sulfonilureas,\t\r \u00a0de\t\r \u00a0hecho\t\r \u00a0est\u00e1\t\r \u00a0indicada\t\r \u00a0su\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 en\t\r \u00a0 adultos.\t\r \u00a0 Esta\t\r \u00a0 sinergia\t\r \u00a0 puede\t\r \u00a0 desencadenar\t\r \u00a0 fen\u00f3menos\t\r \u00a0 de\t\r \u00a0hipoglucemia\t\r \u00a0que\t\r \u00a0la\t\r \u00a0metformina\t\r \u00a0por\t\r \u00a0s\u00ed\t\r \u00a0sola\t\r \u00a0no\t\r \u00a0suele\t\r \u00a0producir\t\r \u00a0(26).\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a04.1\t\r \u00a0es\t\r \u00a0el\t\r \u00a0\u00fanico\t\r \u00a0que\t\r \u00a0presenta\t\r \u00a0como\t\r \u00a0sospechoso\t\r \u00a0de\t\r \u00a0RA\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0concomitante\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0sulfonilureas;\t\r \u00a0y\t\r \u00a0se\t\r \u00a0caracteriza\t\r \u00a0por\t\r \u00a0producir\t\r \u00a0casos\t\r \u00a0no\t\r \u00a0graves,\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0mujeres,\t\r \u00a0y\t\r \u00a0en\t\r \u00a0edades\t\r \u00a0entre\t\r \u00a0los\t\r \u00a065\t\r \u00a0y\t\r \u00a074\t\r \u00a0a\u00f1os.\t\r \u00a0Es\t\r \u00a0especialmente\t\r \u00a0interesante\t\r \u00a0el\t\r \u00a0alto\t\r \u00a0porcentaje\t\r \u00a0 de\t\r \u00a0 casos\t\r \u00a0 observados\t\r \u00a0 en\t\r \u00a0 Galicia,\t\r \u00a0 concordando\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 ya\t\r \u00a0 comentado\t\r \u00a0mayor\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0glibenclamida\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0en\t\r \u00a0esta\t\r \u00a0regi\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a02.2.\t\r \u00a0\t\r \u00a0Adicionalmente,\t\r \u00a0hemos\t\r \u00a0observado\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0glibenclamida\t\r \u00a0 (20\t\r \u00a0 registros)\t\r \u00a0 que\t\r \u00a0 entre\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0 glimepirida\t\r \u00a0 (4\t\r \u00a0 registros).\t\r \u00a0Nuestros\t\r \u00a0resultados\t\r \u00a0coinciden\t\r \u00a0tanto\t\r \u00a0con\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0las\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0glimepirida\t\r \u00a0 o\t\r \u00a0 gliclazida\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 presentan\t\r \u00a0 menor\t\r \u00a0 riesgo\t\r \u00a0 (en\t\r \u00a0 concreto,\t\r \u00a0menor\t\r \u00a0 mortalidad)\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 de\t\r \u00a0 glibenclamida\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0(74);\t\r \u00a0como\t\r \u00a0con\t\r \u00a0 otros\t\r \u00a0estudios\t\r \u00a0que\t\r \u00a0 demuestran\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 \t\r \u00a0 de\t\r \u00a0glimepirida+metformina\t\r \u00a0\u2013en\t\r \u00a0 este\t\r \u00a0 caso\t\r \u00a0 a\t\r \u00a0 dosis\t\r \u00a0 fija-\u00ad\u2010es\t\r \u00a0 m\u00e1s\t\r \u00a0 eficaz\t\r \u00a0 que\t\r \u00a0glibenclamida+metformina\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 consecuci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 objetivos\t\r \u00a0 gluc\u00e9micos,\t\r \u00a0 al\t\r \u00a0reducir\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0episodios\t\r \u00a0de\t\r \u00a0hipoglucemia\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0no\t\r \u00a0controlados\t\r \u00a0(75).\t\r \u00a0\t\r \u00a0Estas\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0ampliamente\t\r \u00a0recomendadas\t\r \u00a0(76-\u00ad\u201079)\t\r \u00a0y\t\r \u00a0aplicadas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0antidiab\u00e9tico\t\r \u00a0en\t\r \u00a0Espa\u00f1a\t\r \u00a0(19,\t\r \u00a022,\t\r \u00a0 25),\t\r \u00a0 aunque\t\r \u00a0 en\t\r \u00a0 nuestro\t\r \u00a0 pa\u00eds\t\r \u00a0 s\u00f3lo\t\r \u00a0 se\t\r \u00a0 presentan\t\r \u00a0 en\t\r \u00a0 formulaciones\t\r \u00a0 separadas.\t\r \u00a0Teniendo\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 el\t\r \u00a0 impulso\t\r \u00a0 actual\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 formulaciones\t\r \u00a0 de\t\r \u00a0 combinaciones\t\r \u00a0 a\t\r \u00a0dosis\t\r \u00a0 fijas\t\r \u00a0-\u00ad\u2010debido\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 simplificaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 dosificaci\u00f3n\t\r \u00a0 y\t\r \u00a0 posible\t\r \u00a0 mejora\t\r \u00a0 del\t\r \u00a0cumplimiento\t\r \u00a0terap\u00e9utico-\u00ad\u2010,\t\r \u00a0creemos\t\r \u00a0que\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0metformina+glimepirida\t\r \u00a0podr\u00eda\t\r \u00a0ser\t\r \u00a0una\t\r \u00a0opci\u00f3n\t\r \u00a0terap\u00e9utica\t\r \u00a0interesante.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Seg\u00fan\t\r \u00a0nuestros\t\r \u00a0resultados,\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0correspondientes\t\r \u00a0a\t\r \u00a0terapia\t\r \u00a0combinada\t\r \u00a0de\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0es\t\r \u00a0bajo\t\r \u00a0(117\t\r \u00a0casos)\t\r \u00a0comparado\t\r \u00a0con\t\r \u00a0las\t\r \u00a0notificaciones\t\r \u00a0respectivas\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0f\u00e1rmacos\t\r \u00a0en\t\r \u00a0monoterapia.\t\r \u00a0\t\r \u00a0Esto\t\r \u00a0 contrasta\t\r \u00a0 con\t\r \u00a0 estudios\t\r \u00a0 que\t\r \u00a0 valoran\t\r \u00a0 la\t\r \u00a0 terapia\t\r \u00a0 combinada\t\r \u00a0 de\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0como\t\r \u00a0la\t\r \u00a0m\u00e1s\t\r \u00a0ampliamente\t\r \u00a0utilizada\t\r \u00a0(m\u00e1s\t\r \u00a0del\t\r \u00a067%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0usuarios\t\r \u00a0de\t\r \u00a0AHOs\t\r \u00a0a\t\r \u00a0nivel\t\r \u00a0internacional),\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0una\t\r \u00a0aplicaci\u00f3n\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n302\t\r \u00a0\t\r \u00a0como\t\r \u00a0f\u00e1rmaco\t\r \u00a0suplementario\t\r \u00a0en\t\r \u00a0tratamientos\t\r \u00a0con\t\r \u00a0sulfonilureas\t\r \u00a0u\t\r \u00a0otros\t\r \u00a0AHOs\t\r \u00a0(43),\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0casos,\t\r \u00a0cabr\u00eda\t\r \u00a0esperar\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0proporci\u00f3n\t\r \u00a0de\t\r \u00a0RAs.\t\r \u00a0\t\r \u00a0En\t\r \u00a0el\t\r \u00a084%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0nuestro\t\r \u00a0estudio\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0notifican\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0sulfonilureas,\t\r \u00a0 tambi\u00e9n\t\r \u00a0 aparecen\t\r \u00a0 notificados\t\r \u00a0 otros\t\r \u00a0 principios\t\r \u00a0 activos.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0mortales,\t\r \u00a0hemos\t\r \u00a0observado\t\r \u00a0con\t\r \u00a0mayor\t\r \u00a0frecuencia\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0con\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0con\t\r \u00a0otros\t\r \u00a0AHOs\t\r \u00a0(3\t\r \u00a0casos),\t\r \u00a0que\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dos\t\r \u00a0primeros\t\r \u00a0exclusivamente\t\r \u00a0(1\t\r \u00a0caso).\t\r \u00a0\t\r \u00a0A\t\r \u00a0 prop\u00f3sito\t\r \u00a0 del\t\r \u00a0 \u00fanico\t\r \u00a0 caso\t\r \u00a0 mortal\t\r \u00a0 donde\t\r \u00a0 los\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 implicados\t\r \u00a0 son\t\r \u00a0metformina\t\r \u00a0 y\t\r \u00a0 glibenclamida,\t\r \u00a0 observamos\t\r \u00a0 que\t\r \u00a0 s\u00f3lo\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 sospechoso\t\r \u00a0 al\t\r \u00a0f\u00e1rmaco\t\r \u00a0metformina\t\r \u00a0cuando\t\r \u00a0ninguna\t\r \u00a0de\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0registradas\t\r \u00a0es\t\r \u00a0espec\u00edfica\t\r \u00a0de\t\r \u00a0este\t\r \u00a0principio\t\r \u00a0 activo\t\r \u00a0 (el\t\r \u00a0 caso\t\r \u00a0 presenta\t\r \u00a0 acidosis\t\r \u00a0 metab\u00f3lica,\t\r \u00a0 anuria,\t\r \u00a0 hipoglucemia,\t\r \u00a0hipotensi\u00f3n\t\r \u00a0y\t\r \u00a0malestar\t\r \u00a0general;\t\r \u00a0sin\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica).\t\r \u00a0A\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0ambos\t\r \u00a0tratamientos\t\r \u00a0-\u00ad\u2010metformina\t\r \u00a0 y\t\r \u00a0 glibenclamida-\u00ad\u2010\t\r \u00a0fueron\t\r \u00a0 concomitantes,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0hipoglucemia\t\r \u00a0 generada\t\r \u00a0 podr\u00eda\t\r \u00a0 asociarse\t\r \u00a0 m\u00e1s\t\r \u00a0 al\t\r \u00a0 uso\t\r \u00a0 combinado\t\r \u00a0 que\t\r \u00a0 al\t\r \u00a0 efecto\t\r \u00a0 de\t\r \u00a0metformina\t\r \u00a0 por\t\r \u00a0 s\u00ed\t\r \u00a0 sola\t\r \u00a0(26).\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 creemos\t\r \u00a0 recomendable\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 casos\t\r \u00a0 con\t\r \u00a0desenlace\t\r \u00a0mortal,\t\r \u00a0todos\t\r \u00a0aquellos\t\r \u00a0medicamentos\t\r \u00a0concomitantes\t\r \u00a0con\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0producir\t\r \u00a0 alguna\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 RAs\t\r \u00a0 notificadas,\t\r \u00a0 sean\t\r \u00a0 considerados\t\r \u00a0sospechosos\t\r \u00a0 o,\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0defecto,\t\r \u00a0sospechosos\t\r \u00a0por\t\r \u00a0interacci\u00f3n.\t\r \u00a0En\t\r \u00a0t\u00e9rminos\t\r \u00a0generales,\t\r \u00a0y\t\r \u00a0aun\t\r \u00a0teniendo\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0el\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0hipoglucemia\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0las\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0su\t\r \u00a0efecto\t\r \u00a0sin\u00e9rgico\t\r \u00a0con\t\r \u00a0metformina,\t\r \u00a0creemos\t\r \u00a0que\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0combinado\t\r \u00a0de\t\r \u00a0ambos\t\r \u00a0f\u00e1rmacos\t\r \u00a0ha\t\r \u00a0tenido\t\r \u00a0buenos\t\r \u00a0resultados\t\r \u00a0durante\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a0de\t\r \u00a0estudio\t\r \u00a0en\t\r \u00a0lo\t\r \u00a0referido\t\r \u00a0a\t\r \u00a0seguridad\t\r \u00a0(s\u00f3lo\t\r \u00a019\t\r \u00a0casos\t\r \u00a0donde\t\r \u00a0aparece\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0sulfonilurea\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0sin\t\r \u00a0ning\u00fan\t\r \u00a0otro\t\r \u00a0f\u00e1rmaco).\t\r \u00a0En\t\r \u00a0cambio,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0notificaciones\t\r \u00a0 con\t\r \u00a0 sulfonilureas,\t\r \u00a0 AHOs\t\r \u00a0 y\t\r \u00a0 terceros\t\r \u00a0 principios\t\r \u00a0 activos,\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0sufrir\t\r \u00a0una\t\r \u00a0RA\t\r \u00a0parece\t\r \u00a0estar\t\r \u00a0m\u00e1s\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0dicha\t\r \u00a0combinaci\u00f3n\t\r \u00a0con\t\r \u00a0terceros\t\r \u00a0que\t\r \u00a0a\t\r \u00a0RAs\t\r \u00a0espec\u00edficas\t\r \u00a0de\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos.\t\r \u00a0Por\t\r \u00a0lo\t\r \u00a0tanto,\t\r \u00a0las\t\r \u00a0politerapias\t\r \u00a0de\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0dos\t\r \u00a0 AHOs\t\r \u00a0 parecen\t\r \u00a0 presentan\t\r \u00a0 mayores\t\r \u00a0 riesgos\t\r \u00a0 de\t\r \u00a0 seguridad\t\r \u00a0 en\t\r \u00a0 detrimento\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0potencial\t\r \u00a0efecto\t\r \u00a0sin\u00e9rgico\t\r \u00a0para\t\r \u00a0la\t\r \u00a0consecuci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0buen\t\r \u00a0control\t\r \u00a0gluc\u00e9mico.\t\r \u00a0Metformina\t\r \u00a0 y\t\r \u00a0 acidosis.\t\r \u00a0En\t\r \u00a0 nuestro\t\r \u00a0 estudio,\t\r \u00a0 la\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 acidosis\t\r \u00a0(diferente\t\r \u00a0 de\t\r \u00a0 acidosis\t\r \u00a0 l\u00e1ctica)\t\r \u00a0 como\t\r \u00a0 RA\t\r \u00a0 relacionada\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 en\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0politerapia\t\r \u00a0\u2013cuando\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0 en\t\r \u00a0 monoterapia-\u00ad\u2010,\t\r \u00a0 lleva\t\r \u00a0 a\t\r \u00a0 pensar\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0influencia\t\r \u00a0 del\t\r \u00a0 resto\t\r \u00a0 de\t\r \u00a0 medicaci\u00f3n\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 aparici\u00f3n.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 existen\t\r \u00a0 estudios\t\r \u00a0recientes\t\r \u00a0sobre\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0acidosis\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0metformina\t\r \u00a0debida\t\r \u00a0a\t\r \u00a0RAs\t\r \u00a0con\t\r \u00a0otros\t\r \u00a0f\u00e1rmacos\t\r \u00a0(80).\t\r \u00a0Ser\u00eda\t\r \u00a0interesante\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0casos,\t\r \u00a0se\t\r \u00a0registrase\t\r \u00a0si\t\r \u00a0ha\t\r \u00a0habido\t\r \u00a0RAs\t\r \u00a0previas\t\r \u00a0 y,\t\r \u00a0 si\t\r \u00a0 as\u00ed\t\r \u00a0 fuese,\t\r \u00a0 notificar\t\r \u00a0 los\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 implicados\t\r \u00a0 como\t\r \u00a0 sospechosos\t\r \u00a0 por\t\r \u00a0interacci\u00f3n,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0facilitar\u00eda\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0se\u00f1ales.\t\r \u00a0\t\r \u00a0Glitazonas\t\r \u00a0y\t\r \u00a0metformina.\t\r \u00a0Hemos\t\r \u00a0observado\t\r \u00a0el\t\r \u00a0mismo\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0relaciones\t\r \u00a0entre\t\r \u00a0 rosiglitazona\t\r \u00a0 y\t\r \u00a0 metformina\t\r \u00a0 que\t\r \u00a0entre\t\r \u00a0 pioglitazona\t\r \u00a0 y\t\r \u00a0 metformina\t\r \u00a0en\t\r \u00a0 las\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0303\t\r \u00a0\t\r \u00a0notificaciones\t\r \u00a0donde\t\r \u00a0estos\t\r \u00a0f\u00e1rmacos\t\r \u00a0se\t\r \u00a0consideraban\t\r \u00a0sospechosos\t\r \u00a0y\t\r \u00a0se\t\r \u00a0administran\t\r \u00a0en\t\r \u00a0formulaciones\t\r \u00a0independientes.\t\r \u00a0\t\r \u00a0Tampoco\t\r \u00a0 hemos\t\r \u00a0 observado\t\r \u00a0 diferencias\t\r \u00a0 entre\t\r \u00a0 la\t\r \u00a0 notificaci\u00f3n\t\r \u00a0 de\t\r \u00a0 glitazonas\t\r \u00a0combinadas\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 en\t\r \u00a0 formulaciones\t\r \u00a0 separadas\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 de\t\r \u00a0 glitazonas\t\r \u00a0 sin\t\r \u00a0combinar\t\r \u00a0con\t\r \u00a0metfomina.\t\r \u00a0En\t\r \u00a0 cambio,\t\r \u00a0 considerando\t\r \u00a0 las\t\r \u00a0 notificaciones\t\r \u00a0 con\t\r \u00a0 glitazonas+metformina\t\r \u00a0 a\t\r \u00a0dosis\t\r \u00a0fijas\t\r \u00a0(un\t\r \u00a051%\t\r \u00a0del\t\r \u00a0total\t\r \u00a0de\t\r \u00a0casos\t\r \u00a0con\t\r \u00a0glitazonas),\t\r \u00a0existe\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0frecuencia\t\r \u00a0de\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0con\t\r \u00a0rosiglitazona\t\r \u00a0(94%)\t\r \u00a0que\t\r \u00a0con\t\r \u00a0pioglitazona\t\r \u00a0(6%).\t\r \u00a0\t\r \u00a0Si\t\r \u00a0consideramos\t\r \u00a0tanto\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0por\t\r \u00a0separado\t\r \u00a0como\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0a\t\r \u00a0 dosis\t\r \u00a0 fija,\t\r \u00a0 observamos\t\r \u00a0 mayor\t\r \u00a0 frecuencia\t\r \u00a0 de\t\r \u00a0 notificaci\u00f3n\t\r \u00a0 en\t\r \u00a0 mujeres\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0rosiglitazona\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0(tanto\t\r \u00a0por\t\r \u00a0separado\t\r \u00a0como\t\r \u00a0combinados\t\r \u00a0a\t\r \u00a0dosis\t\r \u00a0 fija),\t\r \u00a0 y\t\r \u00a0 mayor\t\r \u00a0 frecuencia\t\r \u00a0 en\t\r \u00a0 hombres\t\r \u00a0 para\t\r \u00a0 pioglitazona\t\r \u00a0 y\t\r \u00a0 metformina.\t\r \u00a0 Esto\t\r \u00a0\u00faltimo\t\r \u00a0concuerda\t\r \u00a0con\t\r \u00a0algunos\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0los\t\r \u00a0hombres\t\r \u00a0tienen\t\r \u00a0m\u00e1s\t\r \u00a0probabilidad\t\r \u00a0de\t\r \u00a0ser\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0glitazonas\t\r \u00a0que\t\r \u00a0las\t\r \u00a0mujeres\t\r \u00a0(81).\t\r \u00a0\t\r \u00a0Para\t\r \u00a0el\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0combinaciones\t\r \u00a0a\t\r \u00a0dosis\t\r \u00a0fijas\t\r \u00a0de\t\r \u00a0glitazonas,\t\r \u00a0s\u00f3lo\t\r \u00a0se\t\r \u00a0observan\t\r \u00a0ligeras\t\r \u00a0 diferencias\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 seg\u00fan\t\r \u00a0 el\t\r \u00a0 g\u00e9nero\t\r \u00a0 para\t\r \u00a0 los\t\r \u00a0 hombres\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0rosiglitazona+glimepirida.\t\r \u00a0\t\r \u00a0Respecto\t\r \u00a0 al\t\r \u00a0 uso\t\r \u00a0 combinado\t\r \u00a0 de\t\r \u00a0 glitazonas\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 f\u00e1rmacos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos,\t\r \u00a0 observamos\t\r \u00a0 mayor\t\r \u00a0 frecuencia\t\r \u00a0 de\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0 estatinas\t\r \u00a0 entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0toman\t\r \u00a0glitazonas\t\r \u00a0y\t\r \u00a0mayor\t\r \u00a0frecuencia\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0IECAs\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0 toman\t\r \u00a0 AHOs\t\r \u00a0 diferentes\t\r \u00a0 a\t\r \u00a0 glitazonas.\t\r \u00a0 Estos\t\r \u00a0 resultados\t\r \u00a0 difieren\t\r \u00a0 en\t\r \u00a0 parte\t\r \u00a0 con\t\r \u00a0estudios\t\r \u00a0 donde\t\r \u00a0 se\t\r \u00a0 indica\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 en\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0 glitazonas\t\r \u00a0 tienen\t\r \u00a0m\u00e1s\t\r \u00a0probabilidad\t\r \u00a0de\t\r \u00a0estar\t\r \u00a0trat\u00e1ndose\t\r \u00a0con\t\r \u00a0medicamentos\t\r \u00a0cardioprotectores,\t\r \u00a0-\u00ad\u2010tanto\t\r \u00a0estatinas\t\r \u00a0 como\t\r \u00a0 IECAs-\u00ad\u2010\t\r \u00a0que\t\r \u00a0 en\t\r \u00a0 cualquier\t\r \u00a0 otro\t\r \u00a0 grupo\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0AHOs,\t\r \u00a0aunque\t\r \u00a0puntualizan\t\r \u00a0que\t\r \u00a0las\t\r \u00a0diferencias\t\r \u00a0se\t\r \u00a0limitan\t\r \u00a0a\t\r \u00a0f\u00e1rmacos\t\r \u00a0recomendados\t\r \u00a0como\t\r \u00a0 prevenci\u00f3n\t\r \u00a0 primaria\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 mayor\u00eda\t\r \u00a0 de\t\r \u00a0 diab\u00e9ticos,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0prescripci\u00f3n\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0medicamentos\t\r \u00a0cardioprotectores\t\r \u00a0es\t\r \u00a0similar\t\r \u00a0(81).\t\r \u00a0\t\r \u00a0Tambi\u00e9n\t\r \u00a0llama\t\r \u00a0la\t\r \u00a0atenci\u00f3n\t\r \u00a0que\t\r \u00a0en\t\r \u00a0alrededor\t\r \u00a0de\t\r \u00a0un\t\r \u00a075%\t\r \u00a0de\t\r \u00a0las\t\r \u00a0notificaciones\t\r \u00a0en\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 aparecen\t\r \u00a0 combinadas\t\r \u00a0 glitazonas,\t\r \u00a0 estatinas\t\r \u00a0 y/o\t\r \u00a0 IECAs,\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0estaban\t\r \u00a0 siendo\t\r \u00a0 tratados\t\r \u00a0 con\t\r \u00a0 combinaciones\t\r \u00a0 a\t\r \u00a0 dosis\t\r \u00a0 fijas\t\r \u00a0 de\t\r \u00a0 glitazonas\t\r \u00a0 y\t\r \u00a0metformina.\t\r \u00a0Esto\t\r \u00a0nos\t\r \u00a0lleva\t\r \u00a0a\t\r \u00a0plantearnos\t\r \u00a0si\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0combinaciones\t\r \u00a0a\t\r \u00a0dosis\t\r \u00a0fijas\t\r \u00a0favorece\t\r \u00a0 el\t\r \u00a0 aumento\t\r \u00a0 del\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 en\t\r \u00a0 politerapia,\t\r \u00a0 y\t\r \u00a0 si\t\r \u00a0 esto\t\r \u00a0 tiene\t\r \u00a0implicaciones\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 seguridad\t\r \u00a0 del\t\r \u00a0 tratamiento,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 administraci\u00f3n\t\r \u00a0 por\t\r \u00a0separado\t\r \u00a0de\t\r \u00a0una\t\r \u00a0glitazona\t\r \u00a0y\t\r \u00a0metformina\t\r \u00a0parece\t\r \u00a0haber\t\r \u00a0resultado\t\r \u00a0m\u00e1s\t\r \u00a0segura.\t\r \u00a0\t\r \u00a0Metformina\t\r \u00a0 y\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 del\t\r \u00a0 Sistema\t\r \u00a0 Nervioso.\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a0 4.2.\t\r \u00a0se\t\r \u00a0da\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0y\t\r \u00a0en\t\r \u00a0la\t\r \u00a0edad\t\r \u00a0adulta\t\r \u00a0(entre\t\r \u00a0los\t\r \u00a055\t\r \u00a0y\t\r \u00a064\t\r \u00a0a\u00f1os),\t\r \u00a0siendo\t\r \u00a0el\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 metformina.\t\r \u00a0Es\t\r \u00a0 interesante\t\r \u00a0 la\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0 nervioso,\t\r \u00a0 aunque\t\r \u00a0 aparezcan\t\r \u00a0 como\t\r \u00a0 no\t\r \u00a0 sospechosos.\t\r \u00a0 Algunos\t\r \u00a0 de\t\r \u00a0 ellos\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n304\t\r \u00a0\t\r \u00a0pertenecen\t\r \u00a0 al\t\r \u00a0subgrupo\t\r \u00a0 de\t\r \u00a0 ansiol\u00edticos\t\r \u00a0 (N05B)\t\r \u00a0 y\t\r \u00a0 al\t\r \u00a0 de\t\r \u00a0 hipn\u00f3ticos\t\r \u00a0 y\t\r \u00a0 sedantes\t\r \u00a0(N05C).\t\r \u00a0Existen\t\r \u00a0 estudios\t\r \u00a0 donde\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0 ha\t\r \u00a0observado\t\r \u00a0 un\t\r \u00a0 mayor\t\r \u00a0 consumo\t\r \u00a0 de\t\r \u00a0antidepresivos\t\r \u00a0 y\t\r \u00a0 ansiol\u00edticos\t\r \u00a0 en\t\r \u00a0 mujeres\t\r \u00a0 diab\u00e9ticas,\t\r \u00a0situaci\u00f3n\t\r \u00a0que\t\r \u00a0 junto\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0mayor\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 AINEs\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 analg\u00e9sicos,\t\r \u00a0 podr\u00eda\t\r \u00a0 sugerir\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 mujeres\t\r \u00a0diab\u00e9ticas\t\r \u00a0 tienen\t\r \u00a0 peor\t\r \u00a0 calidad\t\r \u00a0 de\t\r \u00a0 vida\t\r \u00a0(6,\t\r \u00a0 82).\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 en\t\r \u00a0 general\t\r \u00a0 las\t\r \u00a0 mujeres\t\r \u00a0declaran\t\r \u00a0tener\t\r \u00a0peor\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0salud\t\r \u00a0que\t\r \u00a0los\t\r \u00a0hombres\t\r \u00a0(83).\t\r \u00a0Metformina\t\r \u00a0 y\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 del\t\r \u00a0 Sistema\t\r \u00a0Cardiovascular.\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a0 4.3\t\r \u00a0se\t\r \u00a0caracteriza\t\r \u00a0por\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0con\t\r \u00a0f\u00e1rmacos\t\r \u00a0no\t\r \u00a0sospechosos.\t\r \u00a0Esta\t\r \u00a0combinaci\u00f3n\t\r \u00a0puede\t\r \u00a0darse\t\r \u00a0con\t\r \u00a0pocos\t\r \u00a0f\u00e1rmacos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0mayor\u00eda\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos,\t\r \u00a0o\t\r \u00a0bien\t\r \u00a0con\t\r \u00a0 muchos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 en\t\r \u00a0 algunos\t\r \u00a0 casos\t\r \u00a0 aislados.\t\r \u00a0 Entre\t\r \u00a0 dichos\t\r \u00a0f\u00e1rmacos\t\r \u00a0 no\t\r \u00a0sospechosos,\t\r \u00a0los\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0cardiovascular\t\r \u00a0se\t\r \u00a0presentan\t\r \u00a0con\t\r \u00a0frecuencia.\t\r \u00a0A\t\r \u00a0pesar\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 politerapia\t\r \u00a0existente\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 perfil,\t\r \u00a0 las\t\r \u00a0 RAs\t\r \u00a0 son\t\r \u00a0 mayoritariamente\t\r \u00a0gastrointestinales,\t\r \u00a0 no\t\r \u00a0 revisten\t\r \u00a0 gravedad\t\r \u00a0 y\t\r \u00a0 no\t\r \u00a0 est\u00e1n\t\r \u00a0 asociadas\t\r \u00a0 con\t\r \u00a0 trastornos\t\r \u00a0 del\t\r \u00a0metabolismo\t\r \u00a0o\t\r \u00a0alteraciones\t\r \u00a0cardiovasculares.\t\r \u00a0Creemos\t\r \u00a0que\t\r \u00a0el\t\r \u00a0hecho\t\r \u00a0de\t\r \u00a0darse\t\r \u00a0este\t\r \u00a0perfil\t\r \u00a0fundamentalmente\t\r \u00a0en\t\r \u00a0mujeres,\t\r \u00a0y\t\r \u00a0entre\t\r \u00a0los\t\r \u00a065\t\r \u00a0y\t\r \u00a074\t\r \u00a0a\u00f1os,\t\r \u00a0puede\t\r \u00a0influir\t\r \u00a0en\t\r \u00a0la\t\r \u00a0reducida\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0cardiovasculares\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0este\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0presenta\t\r \u00a0menores\t\r \u00a0factores\t\r \u00a0de\t\r \u00a0riesgo\t\r \u00a0asociados\t\r \u00a0que\t\r \u00a0los\t\r \u00a0hombres.\t\r \u00a0As\u00ed,\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0se\t\r \u00a0sabe\t\r \u00a0que\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores\t\r \u00a0de\t\r \u00a0riesgo\t\r \u00a0cardiovascular\t\r \u00a0como\t\r \u00a0es\t\r \u00a0el\t\r \u00a0tabaquismo\t\r \u00a0es\t\r \u00a0menor\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0avanzada\t\r \u00a0con\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0(7).\t\r \u00a0\t\r \u00a0Respecto\t\r \u00a0a\t\r \u00a0las\t\r \u00a0diferencias\t\r \u00a0entre\t\r \u00a0g\u00e9neros,\t\r \u00a0seg\u00fan\t\r \u00a0cifras\t\r \u00a0oficiales\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ENS,\t\r \u00a0el\t\r \u00a0sobrepeso\t\r \u00a0y\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0en\t\r \u00a0Espa\u00f1a\t\r \u00a0es\t\r \u00a0mayor\t\r \u00a0en\t\r \u00a0hombres\t\r \u00a0que\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0(83);\t\r \u00a0y\t\r \u00a0tambi\u00e9n\t\r \u00a0 es\t\r \u00a0 conocido\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 se\t\r \u00a0 relaciona\t\r \u00a0 con\t\r \u00a0mayor\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 complicaciones\t\r \u00a0 macrovasculares,\t\r \u00a0 peor\t\r \u00a0 control\t\r \u00a0 metab\u00f3lico\t\r \u00a0 y\t\r \u00a0peor\t\r \u00a0 cumplimiento\t\r \u00a0 del\t\r \u00a0 tratamiento\t\r \u00a0(84).\t\r \u00a0 A\t\r \u00a0 su\t\r \u00a0 vez,\t\r \u00a0 las\t\r \u00a0 mujeres\t\r \u00a0 refieren\t\r \u00a0 m\u00e1s\t\r \u00a0controles\t\r \u00a0 preventivos\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0 factores\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 cardiovascular\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0 la\t\r \u00a0hipertensi\u00f3n\t\r \u00a0arterial\t\r \u00a0o\t\r \u00a0la\t\r \u00a0hipercolesterolemia\t\r \u00a0que\t\r \u00a0los\t\r \u00a0hombres\t\r \u00a0(83).\t\r \u00a0\t\r \u00a0Glibenclamida\t\r \u00a0 y\t\r \u00a0 enalapril.\t\r \u00a0Seg\u00fan\t\r \u00a0 nuestros\t\r \u00a0 resultados,\t\r \u00a0 habr\u00eda\t\r \u00a0 19\t\r \u00a0 casos\t\r \u00a0donde\t\r \u00a0 aparecen\t\r \u00a0 relacionados\t\r \u00a0 glibenclamida\t\r \u00a0 y\t\r \u00a0 enalapril,\t\r \u00a0 con\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0hipoglucemia\t\r \u00a0en\t\r \u00a04\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0-\u00ad\u2010dos\t\r \u00a0casos\t\r \u00a0son\t\r \u00a0graves\t\r \u00a0aunque\t\r \u00a0ninguno\t\r \u00a0es\t\r \u00a0mortal-\u00ad\u2010.\t\r \u00a0En\t\r \u00a0algunas\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 notificaciones\t\r \u00a0de\t\r \u00a0 hipoglucemia\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 enalapril\t\r \u00a0 como\t\r \u00a0f\u00e1rmaco\t\r \u00a0 sospechoso\t\r \u00a0 por\t\r \u00a0 interacci\u00f3n\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 otros\t\r \u00a0 como\t\r \u00a0 no\t\r \u00a0 sospechoso,\t\r \u00a0cuando\t\r \u00a0 se\t\r \u00a0conoce\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 entre\t\r \u00a0 sulfamidas\t\r \u00a0 hipoglucemiantes\t\r \u00a0 e\t\r \u00a0 IECAs\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0paciente\t\r \u00a0 diab\u00e9tico\t\r \u00a0 puede\t\r \u00a0 producir,\t\r \u00a0 excepcionalmente,\t\r \u00a0 hipoglucemia.\t\r \u00a0 Es\t\r \u00a0 una\t\r \u00a0 RA\t\r \u00a0que\t\r \u00a0 tambi\u00e9n\t\r \u00a0 puede\t\r \u00a0 presentarse\t\r \u00a0 con\t\r \u00a0 otros\t\r \u00a0 IECAs\t\r \u00a0-\u00ad\u2010como\t\r \u00a0 captopril-\u00ad\u2010,\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 otros\t\r \u00a0hipoglucemiantes\t\r \u00a0-\u00ad\u2010como\t\r \u00a0 la\t\r \u00a0 sulfonilurea\t\r \u00a0 gliclazida\t\r \u00a0 o\t\r \u00a0 la\t\r \u00a0 propia\t\r \u00a0 insulina\t\r \u00a0(85).\t\r \u00a0Tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 sabe\t\r \u00a0 que\t\r \u00a0 este\t\r \u00a0 fen\u00f3meno\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0 probable\t\r \u00a0 que\t\r \u00a0 ocurra\t\r \u00a0 durante\t\r \u00a0 las\t\r \u00a0primeras\t\r \u00a0 semanas\t\r \u00a0 de\t\r \u00a0 tratamiento\t\r \u00a0 combinado\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 insuficiencia\t\r \u00a0renal\t\r \u00a0(86).\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0305\t\r \u00a0\t\r \u00a0Ser\u00eda\t\r \u00a0recomendable\t\r \u00a0que\t\r \u00a0en\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0glibenclamida\t\r \u00a0(87),\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0indicaci\u00f3n\t\r \u00a0general\t\r \u00a0sobre\t\r \u00a0su\t\r \u00a0interacci\u00f3n\t\r \u00a0con\t\r \u00a0inhibidores\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ECA,\t\r \u00a0se\t\r \u00a0indicara\t\r \u00a0que\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0observado\t\r \u00a0con\t\r \u00a0enalapril\t\r \u00a0y\t\r \u00a0captopril.\t\r \u00a0\t\r \u00a0Glibenclamida\t\r \u00a0y\t\r \u00a0acarbosa.\t\r \u00a0S\u00f3lo\t\r \u00a0hemos\t\r \u00a0encontrado\t\r \u00a0un\t\r \u00a0caso\t\r \u00a0con\t\r \u00a0hipoglucemia\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0estaban\t\r \u00a0implicadas\t\r \u00a0glibenclamida\t\r \u00a0y\t\r \u00a0acarbosa\t\r \u00a0exclusivamente.\t\r \u00a0Aunque\t\r \u00a0la\t\r \u00a0acarbosa\t\r \u00a0 posee\t\r \u00a0 un\t\r \u00a0 efecto\t\r \u00a0 antihiperglucemiante,\t\r \u00a0 sin\t\r \u00a0 ser\t\r \u00a0 hipoglucemiante\t\r \u00a0 por\t\r \u00a0 s\u00ed\t\r \u00a0misma,\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0otros\t\r \u00a0AHOs\t\r \u00a0o\t\r \u00a0insulina\t\r \u00a0pueden\t\r \u00a0producirse\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0shock\t\r \u00a0hipogluc\u00e9mico\t\r \u00a0(85).\t\r \u00a0El\t\r \u00a0conocimiento\t\r \u00a0de\t\r \u00a0dicha\t\r \u00a0interacci\u00f3n\t\r \u00a0es\t\r \u00a0reciente\t\r \u00a0(87,\t\r \u00a088),\t\r \u00a0y\t\r \u00a0puede\t\r \u00a0que\t\r \u00a0esto\t\r \u00a0haya\t\r \u00a0evitado\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0uso\t\r \u00a0combinado\t\r \u00a0de\t\r \u00a0ambos\t\r \u00a0principios\t\r \u00a0activos,\t\r \u00a0 influyendo\t\r \u00a0 positivamente\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0 mejora\t\r \u00a0 del\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0 seguridad.\t\r \u00a0En\t\r \u00a0relaci\u00f3n\t\r \u00a0al\t\r \u00a0 restablecimiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 glucemia\t\r \u00a0en\t\r \u00a0 estos\t\r \u00a0 casos,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0 de\t\r \u00a0glibenclamida\t\r \u00a0se\t\r \u00a0 recomienda\t\r \u00a0 la\t\r \u00a0\u2018toma\t\r \u00a0 de\t\r \u00a0 glucosa\u2019\t\r \u00a0 en\t\r \u00a0 vez\t\r \u00a0 de\t\r \u00a0 \u2018preferiblemente\t\r \u00a0 en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0glucosa\u2019,\t\r \u00a0o\t\r \u00a0bien,\t\r \u00a0se\t\r \u00a0podr\u00eda\t\r \u00a0especificar\t\r \u00a0que\t\r \u00a0debe\t\r \u00a0utilizarse\t\r \u00a0s\u00f3lo\t\r \u00a0glucosa\t\r \u00a0si\t\r \u00a0el\t\r \u00a0paciente\t\r \u00a0usa\t\r \u00a0acarbosa\t\r \u00a0como\t\r \u00a0tratamiento\t\r \u00a0concomitantemente.\t\r \u00a0El\t\r \u00a0PERFIL\t\r \u00a0 5\t\r \u00a0se\t\r \u00a0 caracteriza\t\r \u00a0 por\t\r \u00a0 presentar\t\r \u00a0AHOs\t\r \u00a0 notificados\t\r \u00a0 en\t\r \u00a0 otras\t\r \u00a0posiciones\t\r \u00a0 de\t\r \u00a0 sospecha\t\r \u00a0(segunda\t\r \u00a0 posici\u00f3n\t\r \u00a0 o\t\r \u00a0 siguientes).\t\r \u00a0 Se\t\r \u00a0 observan\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0un\t\r \u00a0n\u00famero\t\r \u00a0elevado\t\r \u00a0de\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos,\t\r \u00a0siendo\t\r \u00a0entre\t\r \u00a0ellos\t\r \u00a0casi\t\r \u00a0 una\t\r \u00a0constante\t\r \u00a0 la\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 cardiovascular\t\r \u00a0combinados\t\r \u00a0 con\t\r \u00a0 diferentes\t\r \u00a0 AHOs.\t\r \u00a0 Como\t\r \u00a0caso\t\r \u00a0 llamativo\t\r \u00a0 destaca\t\r \u00a0 la\t\r \u00a0 relaci\u00f3n\t\r \u00a0metformina-\u00ad\u2010rivastigmina\t\r \u00a0en\t\r \u00a0la\t\r \u00a0que\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0n\u00e1useas\t\r \u00a0y\t\r \u00a0pirexia.\t\r \u00a0\t\r \u00a0Profundizando\t\r \u00a0 m\u00e1s,\t\r \u00a0 el\t\r \u00a0perfil\t\r \u00a0 5.1\t\r \u00a0se\t\r \u00a0 caracteriza\t\r \u00a0 por\t\r \u00a0 presentar\t\r \u00a0-\u00ad\u2010tanto\t\r \u00a0 en\t\r \u00a0hombres\t\r \u00a0como\t\r \u00a0mujeres-\u00ad\u2010\t\r \u00a0trastornos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0piel\t\r \u00a0y\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0subcut\u00e1neo\t\r \u00a0no\t\r \u00a0graves.\t\r \u00a0En\t\r \u00a0cambio,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a05.2,\t\r \u00a0se\t\r \u00a0observan\t\r \u00a0RAs\t\r \u00a0graves\t\r \u00a0que\t\r \u00a0ocurren\t\r \u00a0mayoritariamente\t\r \u00a0en\t\r \u00a0hombres\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 afectan\t\r \u00a0 al\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 nutrici\u00f3n,\t\r \u00a0 al\t\r \u00a0 sistema\t\r \u00a0 sangu\u00edneo\t\r \u00a0 y\t\r \u00a0linf\u00e1tico,\t\r \u00a0 y\t\r \u00a0 al\t\r \u00a0 sistema\t\r \u00a0 respiratorio\t\r \u00a0 y\t\r \u00a0 tor\u00e1cico.\t\r \u00a0 El\t\r \u00a0perfil\t\r \u00a0 5.3\t\r \u00a0se\t\r \u00a0 desmarca\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0anteriores\t\r \u00a0 por\t\r \u00a0 presentar\t\r \u00a0 menos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos\t\r \u00a0 y\t\r \u00a0 ser\t\r \u00a0 predominante\t\r \u00a0 en\t\r \u00a0mujeres.\t\r \u00a0 En\t\r \u00a0 este\t\r \u00a0 \u00faltimo\t\r \u00a0 perfil\t\r \u00a0 se\t\r \u00a0 registran\t\r \u00a0 RAs\t\r \u00a0 graves\t\r \u00a0 no\t\r \u00a0 mortales\t\r \u00a0 debidas\t\r \u00a0 a\t\r \u00a0trastornos\t\r \u00a0 del\t\r \u00a0 metabolismo\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 nutrici\u00f3n\t\r \u00a0 y\t\r \u00a0 trastornos\t\r \u00a0 gastrointestinales.\t\r \u00a0 A\t\r \u00a0continuaci\u00f3n\t\r \u00a0comentamos\t\r \u00a0las\t\r \u00a0relaciones\t\r \u00a0m\u00e1s\t\r \u00a0relevantes\t\r \u00a0observadas\t\r \u00a0en\t\r \u00a0este\t\r \u00a0perfil\t\r \u00a05:\t\r \u00a0\t\r \u00a0Antihipertensivos\t\r \u00a0 y\t\r \u00a0 metformina.\t\r \u00a0Dentro\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 tratamientos\t\r \u00a0antihipertensores\t\r \u00a0que\t\r \u00a0aparecen\t\r \u00a0m\u00e1s\t\r \u00a0relacionados\t\r \u00a0con\t\r \u00a0metformina,\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0enalapril\t\r \u00a0(IECA)\t\r \u00a0y\t\r \u00a0valsart\u00e1n\t\r \u00a0(ARA-\u00ad\u2010II)\t\r \u00a0pertenecientes\t\r \u00a0ambos\t\r \u00a0al\t\r \u00a0tratamiento\t\r \u00a0cardiovascular.\t\r \u00a0Son\t\r \u00a0agentes\t\r \u00a0que\t\r \u00a0ejercen\t\r \u00a0su\t\r \u00a0acci\u00f3n\t\r \u00a0antihipertensora\t\r \u00a0actuando\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 sistema\t\r \u00a0 renina-\u00ad\u2010angiotensina.\t\r \u00a0 Debido\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 metformina\t\r \u00a0 presenta\t\r \u00a0eliminaci\u00f3n\t\r \u00a0por\t\r \u00a0v\u00eda\t\r \u00a0renal,\t\r \u00a0en\t\r \u00a0su\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0se\t\r \u00a0recomienda\t\r \u00a0tener\t\r \u00a0especial\t\r \u00a0cuidado\t\r \u00a0en\t\r \u00a0situaciones\t\r \u00a0en\t\r \u00a0las\t\r \u00a0que\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0renal\t\r \u00a0pueda\t\r \u00a0estar\t\r \u00a0afectada\t\r \u00a0como\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0al\t\r \u00a0iniciarse\t\r \u00a0 un\t\r \u00a0 tratamiento\t\r \u00a0 antihipertensor,\t\r \u00a0 diur\u00e9tico\t\r \u00a0 o\t\r \u00a0 con\t\r \u00a0 AINEs\t\r \u00a0(48).\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0llegar\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 situaci\u00f3n\t\r \u00a0 de\t\r \u00a0 insuficiencia\t\r \u00a0 renal\t\r \u00a0 podr\u00eda\t\r \u00a0 producirse\t\r \u00a0 una\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0plasm\u00e1tica\t\r \u00a0de\t\r \u00a0metformina,\t\r \u00a0dando\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0(47).\t\r \u00a0Es\t\r \u00a0por\t\r \u00a0ello\t\r \u00a0que\t\r \u00a0se\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n306\t\r \u00a0\t\r \u00a0recomienda\t\r \u00a0estimar\t\r \u00a0el\t\r \u00a0aclaramiento\t\r \u00a0de\t\r \u00a0creatinina\t\r \u00a0antes\t\r \u00a0de\t\r \u00a0iniciarse\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0 regularmente\t\r \u00a0 desde\t\r \u00a0 su\t\r \u00a0 inicio\t\r \u00a0 (1\t\r \u00a0 vez\t\r \u00a0 al\t\r \u00a0 a\u00f1o\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0funci\u00f3n\t\r \u00a0renal\t\r \u00a0normal,\t\r \u00a0de\t\r \u00a02\t\r \u00a0a\t\r \u00a04\t\r \u00a0veces\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0con\t\r \u00a0aclaramiento\t\r \u00a0de\t\r \u00a0creatinina\t\r \u00a0pr\u00f3ximo\t\r \u00a0al\t\r \u00a0l\u00edmite\t\r \u00a0inferior\t\r \u00a0del\t\r \u00a0valor\t\r \u00a0normal\t\r \u00a0y\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0avanzada)\t\r \u00a0(48).\t\r \u00a0Tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 recomienda\t\r \u00a0 no\t\r \u00a0administrar\t\r \u00a0 metformina\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0creatinina\t\r \u00a0s\u00e9rica\t\r \u00a0superiores\t\r \u00a0a\t\r \u00a01,5\t\r \u00a0mg/dl\t\r \u00a0en\t\r \u00a0hombres\t\r \u00a0o\t\r \u00a01,4\t\r \u00a0mg/dl\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0(47).\t\r \u00a0\t\r \u00a0Nuestros\t\r \u00a0resultados\t\r \u00a0demuestran\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0enalapril\t\r \u00a0y/o\t\r \u00a0valsart\u00e1n\t\r \u00a0 (entre\t\r \u00a0 otros\t\r \u00a0 principios\t\r \u00a0 activos\t\r \u00a0 notificados)\t\r \u00a0 en\t\r \u00a0 47\t\r \u00a0 casos.\t\r \u00a0 En\t\r \u00a05\t\r \u00a0 de\t\r \u00a0 ellos\t\r \u00a0aparecen\t\r \u00a0 ambos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 como\t\r \u00a0 sospechosos,\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 3\t\r \u00a0 se\t\r \u00a0 presenta\t\r \u00a0como\t\r \u00a0 RA\t\r \u00a0insuficiencia\t\r \u00a0 renal\t\r \u00a0 (IR)\t\r \u00a0-\u00ad\u20102\t\r \u00a0 con\t\r \u00a0 resultado\t\r \u00a0 de\t\r \u00a0 muerte\t\r \u00a0 por\t\r \u00a0 acidosis\t\r \u00a0 e\t\r \u00a0 insuficiencia\t\r \u00a0renal\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 concuerda\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 indicadas\t\r \u00a0 anteriormente-\u00ad\u2010.\t\r \u00a0Debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0el\t\r \u00a0porcentaje\t\r \u00a0de\t\r \u00a0aparici\u00f3n\t\r \u00a0de\t\r \u00a0IR\t\r \u00a0no\t\r \u00a0es\t\r \u00a0muy\t\r \u00a0elevado\t\r \u00a0(6%),\t\r \u00a0creemos\t\r \u00a0que\t\r \u00a0 las\t\r \u00a0 recomendaciones\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 uso\t\r \u00a0 combinado\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0antihipertensivos\t\r \u00a0 parecen\t\r \u00a0 aplicarse.\t\r \u00a0 A\t\r \u00a0 su\t\r \u00a0 vez,\t\r \u00a0 si\t\r \u00a0 la\t\r \u00a0 IR\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 notificado\t\r \u00a0 como\t\r \u00a0 RA\t\r \u00a0significa\t\r \u00a0que\t\r \u00a0no\t\r \u00a0era\t\r \u00a0una\t\r \u00a0condici\u00f3n\t\r \u00a0preexistente\t\r \u00a0en\t\r \u00a0el\t\r \u00a0paciente,\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0generar\u00eda\t\r \u00a0sospecha\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 farmacol\u00f3gico,\t\r \u00a0 y\t\r \u00a0 como\t\r \u00a0 tal\t\r \u00a0 deber\u00eda\t\r \u00a0 aparecer\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0bibliograf\u00eda.\t\r \u00a0 En\t\r \u00a0 los\t\r \u00a0 tres\t\r \u00a0 casos\t\r \u00a0 donde\t\r \u00a0 aparece\t\r \u00a0 IR\t\r \u00a0 el\t\r \u00a0 antihipertensivo\t\r \u00a0 implicado\t\r \u00a0 es\t\r \u00a0enalapril.\t\r \u00a0Teniendo\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0la\t\r \u00a0elevada\t\r \u00a0proporci\u00f3n\t\r \u00a0de\t\r \u00a0mortalidad\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0que\t\r \u00a0desarrollaron\t\r \u00a0 IR\t\r \u00a0 (preexistente\t\r \u00a0 o\t\r \u00a0 por\t\r \u00a0 RA),\t\r \u00a0ser\u00eda\t\r \u00a0oportuno\t\r \u00a0incluir\t\r \u00a0informaci\u00f3n\t\r \u00a0 al\t\r \u00a0respecto\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 apartado\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 formulaciones\t\r \u00a0 con\t\r \u00a0metformina\t\r \u00a0\u2013adem\u00e1s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 existente\t\r \u00a0 en\t\r \u00a0 advertencias\t\r \u00a0 y\t\r \u00a0 precauciones-\u00ad\u2010\t\r \u00a0(48),\t\r \u00a0a\t\r \u00a0semejanza\t\r \u00a0de\t\r \u00a0como\t\r \u00a0aparece\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Cat\u00e1logo\t\r \u00a0de\t\r \u00a0Especialidades\t\r \u00a0Farmac\u00e9uticas\t\r \u00a0(47);\t\r \u00a0y\t\r \u00a0que\t\r \u00a0 se\t\r \u00a0 valore\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 potencialidad\t\r \u00a0 de\t\r \u00a0 generar\t\r \u00a0 IR\t\r \u00a0 por\t\r \u00a0 tratamiento\t\r \u00a0 con\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0antihipertensivos\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0sin\t\r \u00a0IR\t\r \u00a0preexistente.\t\r \u00a0Rivastigmina\t\r \u00a0 y\t\r \u00a0 metformina.\t\r \u00a0Relaci\u00f3n\t\r \u00a0 relevante\t\r \u00a0es\t\r \u00a0 la\t\r \u00a0 observada\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0rivastigmina\t\r \u00a0(f\u00e1rmaco\t\r \u00a0antidemencia),\t\r \u00a0y\t\r \u00a0estos,\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0 con\t\r \u00a0 RAs\t\r \u00a0 de\t\r \u00a0 n\u00e1useas\t\r \u00a0 y\t\r \u00a0 pirexia.\t\r \u00a0 Esta\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 aparece\t\r \u00a0 en\t\r \u00a03\t\r \u00a0casos,\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 cuales\t\r \u00a0 2\t\r \u00a0 tienen\t\r \u00a0 desenlace\t\r \u00a0 mortal.\t\r \u00a0 En\t\r \u00a0 estos\t\r \u00a0 casos\t\r \u00a0 mortales\t\r \u00a0 ambos\t\r \u00a0principios\t\r \u00a0activos,\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0otros\t\r \u00a0notificados\t\r \u00a0secundariamente,\t\r \u00a0son\t\r \u00a0considerados\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos.\t\r \u00a0\t\r \u00a0No\t\r \u00a0 hemos\t\r \u00a0 encontrado\t\r \u00a0 ninguna\t\r \u00a0 referencia\t\r \u00a0 respecto\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 relaci\u00f3n\t\r \u00a0 entre\t\r \u00a0metformina\t\r \u00a0 y\t\r \u00a0 rivastigmina\t\r \u00a0(47).\t\r \u00a0 Debido\t\r \u00a0 a\t\r \u00a0la\t\r \u00a0 gravedad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0aparece,\t\r \u00a0 ser\u00eda\t\r \u00a0 interesante\t\r \u00a0 estudiar\t\r \u00a0 esta\t\r \u00a0 posible\t\r \u00a0 interacci\u00f3n\t\r \u00a0(o\t\r \u00a0 RA),\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0avanzada.\t\r \u00a0Este\t\r \u00a0hecho\t\r \u00a0puede\t\r \u00a0adquirir\t\r \u00a0a\u00fan\t\r \u00a0m\u00e1s\t\r \u00a0relevancia\t\r \u00a0con\t\r \u00a0el\t\r \u00a0tiempo,\t\r \u00a0debido\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 alcanzan\t\r \u00a0 cada\t\r \u00a0 vez\t\r \u00a0 edades\t\r \u00a0 m\u00e1s\t\r \u00a0avanzadas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0que,\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0existe\t\r \u00a0mayor\t\r \u00a0incidencia\t\r \u00a0de\t\r \u00a0Alzheimer\t\r \u00a0y\t\r \u00a0Parkinson\t\r \u00a0pudiendo\t\r \u00a0verse\t\r \u00a0afectados\t\r \u00a0por\t\r \u00a0estas\t\r \u00a0RAs\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0su\t\r \u00a0medicaci\u00f3n\t\r \u00a0con\t\r \u00a0rivastigmina.\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0307\t\r \u00a0\t\r \u00a0En\t\r \u00a0 los\t\r \u00a0 dos\t\r \u00a0 casos\t\r \u00a0 mortales\t\r \u00a0 con\t\r \u00a0 metformina-\u00ad\u2010rivastigmina,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0como\t\r \u00a0RAs\t\r \u00a0malestar\t\r \u00a0general,\t\r \u00a0n\u00e1useas\t\r \u00a0y\t\r \u00a0pirexia,\t\r \u00a0esta\t\r \u00a0triada\t\r \u00a0podr\u00eda\t\r \u00a0utilizarse\t\r \u00a0como\t\r \u00a0sintomatolog\u00eda\t\r \u00a0 que\t\r \u00a0 precisara\t\r \u00a0 sobreseguimiento.\t\r \u00a0 Estas\t\r \u00a0 tres\t\r \u00a0 RAs\t\r \u00a0 notificadas\t\r \u00a0aparecen\t\r \u00a0en\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0rivastigmina\t\r \u00a0(89);\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0s\u00f3lo\t\r \u00a0las\t\r \u00a0n\u00e1useas.\t\r \u00a0 Aun\t\r \u00a0 as\u00ed,\t\r \u00a0 las\t\r \u00a0 n\u00e1useas\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 v\u00f3mitos\t\r \u00a0 son\t\r \u00a0 RAs\t\r \u00a0 frecuentes\t\r \u00a0 observadas\t\r \u00a0 con\t\r \u00a0rivastigmina\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 metformina,\t\r \u00a0 especialmente\t\r \u00a0 durante\t\r \u00a0 la\t\r \u00a0 fase\t\r \u00a0 de\t\r \u00a0 adaptaci\u00f3n\t\r \u00a0 al\t\r \u00a0tratamiento.\t\r \u00a0Puede\t\r \u00a0darse\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0sin\u00e9rgico\t\r \u00a0por\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0ambos\t\r \u00a0f\u00e1rmacos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 RAs,\t\r \u00a0 las\t\r \u00a0 cuales\t\r \u00a0 desencadenar\u00edan\t\r \u00a0estados\t\r \u00a0 de\t\r \u00a0 deshidrataci\u00f3n\t\r \u00a0aguda,\t\r \u00a0situaci\u00f3n\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0aumentar,\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0el\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0sufrir\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0(44).\t\r \u00a0 Hay\t\r \u00a0 que\t\r \u00a0 indicar\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 ambos\t\r \u00a0 casos\t\r \u00a0 mortales\t\r \u00a0 tambi\u00e9n\t\r \u00a0 hubo\t\r \u00a0 uso\t\r \u00a0concomitante\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 derivados\t\r \u00a0 de\t\r \u00a0 dihidropiridina\t\r \u00a0 (bloqueantes\t\r \u00a0 de\t\r \u00a0 canales\t\r \u00a0de\t\r \u00a0 calcio\t\r \u00a0 con\t\r \u00a0 efectos\t\r \u00a0 cardiovasculares)\t\r \u00a0 y\t\r \u00a0 estatinas\t\r \u00a0 sin\t\r \u00a0 especificarse\t\r \u00a0 el\t\r \u00a0 principio\t\r \u00a0activo.\t\r \u00a0Acenocumarol\t\r \u00a0y\t\r \u00a0glibenclamida.\t\r \u00a0En\t\r \u00a0nuestros\t\r \u00a0resultados\t\r \u00a0obtenemos\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0glibenclamida\t\r \u00a0\u2013sulfonilurea-\u00ad\u2010\t\r \u00a0y\t\r \u00a0acenocumarol\t\r \u00a0-\u00ad\u2010antagonista\t\r \u00a0de\t\r \u00a0vitamina\t\r \u00a0K\t\r \u00a0con\t\r \u00a0acci\u00f3n\t\r \u00a0 antitromb\u00f3tica-\u00ad\u2010.\t\r \u00a0 La\t\r \u00a0 interacci\u00f3n\t\r \u00a0 con\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0 entre\t\r \u00a0sulfonilureas\t\r \u00a0 y\t\r \u00a0 anticoagulantes\t\r \u00a0 orales\t\r \u00a0 es\t\r \u00a0 conocida\t\r \u00a0(19,\t\r \u00a0 20,\t\r \u00a0 26),\t\r \u00a0 pudiendo\t\r \u00a0 llegar\t\r \u00a0eventualmente\t\r \u00a0 a\t\r \u00a0 coma\t\r \u00a0 hipogluc\u00e9mico,\t\r \u00a0 cuando\t\r \u00a0 se\t\r \u00a0 producen\t\r \u00a0 administraciones\t\r \u00a0concomitantes\t\r \u00a0de\t\r \u00a0algunos\t\r \u00a0antagonistas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vitamina\t\r \u00a0K\t\r \u00a0-\u00ad\u2010dicumarol,\t\r \u00a0acenocumarol,\t\r \u00a0warfarina-\u00ad\u2010\t\r \u00a0con\t\r \u00a0 determinadas\t\r \u00a0 sulfonilureas\t\r \u00a0-\u00ad\u2010tolbutamida/clorpropamida,\t\r \u00a0clorpropamida,\t\r \u00a0 y\t\r \u00a0 glibenclamida,\t\r \u00a0respectivamente-\u00ad\u2010\t\r \u00a0(85).\t\r \u00a0 En\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 tener\t\r \u00a0 que\t\r \u00a0usarlos\t\r \u00a0combinados\t\r \u00a0se\t\r \u00a0recomienda\t\r \u00a0vigilar\t\r \u00a0los\t\r \u00a0par\u00e1metros\t\r \u00a0de\t\r \u00a0coagulaci\u00f3n\t\r \u00a0(tiempo\t\r \u00a0de\t\r \u00a0protrombina\t\r \u00a0\u2013TP-\u00ad\u2010\t\r \u00a0e\t\r \u00a0International\t\r \u00a0Normalized\t\r \u00a0Ratio\t\r \u00a0\u2013INR-\u00ad\u2010).\t\r \u00a0En\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0acenocumarol\t\r \u00a0se\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0este\t\r \u00a0puede\t\r \u00a0potenciar\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0hipoglucemiante\t\r \u00a0de\t\r \u00a0los\t\r \u00a0 derivados\t\r \u00a0 sulfonilur\u00e9icos\t\r \u00a0 sin\t\r \u00a0 especificar\t\r \u00a0 ninguno;\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 que\t\r \u00a0algunas\t\r \u00a0sulfonilureas\t\r \u00a0-\u00ad\u2010como\t\r \u00a0tolbutamida\t\r \u00a0o\t\r \u00a0clorpropamida-\u00ad\u2010\t\r \u00a0pueden,\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0potenciar\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0 anticoagulante\t\r \u00a0 del\t\r \u00a0 acenocumarol\t\r \u00a0(90).\t\r \u00a0 Otros\t\r \u00a0 autores\t\r \u00a0 consideran\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0interacciones\t\r \u00a0 asociadas\t\r \u00a0 con\t\r \u00a0 anticoagulantes\t\r \u00a0 orales\t\r \u00a0 son\t\r \u00a0 generalizables\t\r \u00a0 a\t\r \u00a0las\t\r \u00a0indicadas\t\r \u00a0para\t\r \u00a0warfarina\t\r \u00a0(34).\t\r \u00a0\t\r \u00a0Entre\t\r \u00a0 nuestros\t\r \u00a0 datos\t\r \u00a0 hay\t\r \u00a0 13\t\r \u00a0 casos\t\r \u00a0 con\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 glibenclamida\t\r \u00a0 y\t\r \u00a0acenocumarol.\t\r \u00a0 S\u00f3lo\t\r \u00a0 hay\t\r \u00a0 hipoglucemia\t\r \u00a0 en\t\r \u00a0 dos\t\r \u00a0 casos\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 acenocumarol\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0considera\t\r \u00a0 sospechoso.\t\r \u00a0 En\t\r \u00a0 cambio,\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 3\t\r \u00a0 casos\t\r \u00a0 donde\t\r \u00a0 se\t\r \u00a0 identifican\t\r \u00a0 RAs\t\r \u00a0hemorr\u00e1gicas\t\r \u00a0 tanto\t\r \u00a0 acenocumarol\t\r \u00a0 como\t\r \u00a0 glibenclamida\t\r \u00a0 son\t\r \u00a0 considerados\t\r \u00a0sospechosos\t\r \u00a0por\t\r \u00a0interacci\u00f3n.\t\r \u00a0Dado\t\r \u00a0que\t\r \u00a0en\t\r \u00a0algunas\t\r \u00a0referencias\t\r \u00a0advierten\t\r \u00a0de\t\r \u00a0las\t\r \u00a0interacciones\t\r \u00a0cruzadas\t\r \u00a0de\t\r \u00a0determinadas\t\r \u00a0 sulfonilureas\t\r \u00a0 y\t\r \u00a0anticoagulantes,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 otras\t\r \u00a0 se\t\r \u00a0 hace\t\r \u00a0 la\t\r \u00a0advertencia\t\r \u00a0respecto\t\r \u00a0al\t\r \u00a0grupo\t\r \u00a0al\t\r \u00a0que\t\r \u00a0pertenecen\t\r \u00a0sin\t\r \u00a0especificar\t\r \u00a0principios\t\r \u00a0activos,\t\r \u00a0ser\u00eda\t\r \u00a0adecuado\t\r \u00a0que\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0presenten\t\r \u00a0sulfonilureas\t\r \u00a0y\t\r \u00a0acenocumarol\t\r \u00a0implicados\t\r \u00a0en\t\r \u00a0 casos\t\r \u00a0 con\t\r \u00a0 hipoglucemias,\t\r \u00a0se\t\r \u00a0 notificase\t\r \u00a0el\t\r \u00a0 acenocumarol\t\r \u00a0 como\t\r \u00a0 sospechoso\t\r \u00a0 por\t\r \u00a0interacci\u00f3n.\t\r \u00a0\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n308\t\r \u00a0\t\r \u00a0Antidiab\u00e9ticos\t\r \u00a0 y\t\r \u00a0 terapia\t\r \u00a0 preventiva\t\r \u00a0 cardiovascular.\t\r \u00a0Seg\u00fan\t\r \u00a0 las\t\r \u00a0recomendaciones\t\r \u00a0 internacionales,\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 que\t\r \u00a0 presentan\t\r \u00a0hipertensi\u00f3n,\t\r \u00a0 es\t\r \u00a0 necesaria\t\r \u00a0 la\t\r \u00a0 politerapia\t\r \u00a0 de\t\r \u00a0 2\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 agentes\t\r \u00a0 antihipertensivos\t\r \u00a0(IECA/ARAII,\t\r \u00a0 diur\u00e9ticos)\t\r \u00a0(91).\t\r \u00a0 A\t\r \u00a0 su\t\r \u00a0 vez,\t\r \u00a0 en\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0los\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0tengan\t\r \u00a0 m\u00e1s\t\r \u00a0 de\t\r \u00a0 cuarenta\t\r \u00a0 a\u00f1os\t\r \u00a0 o\t\r \u00a0 alg\u00fan\t\r \u00a0 factor\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 (hipertensi\u00f3n,\t\r \u00a0 dislipemia,\t\r \u00a0riesgo\t\r \u00a0 cardiovascular,\t\r \u00a0 historia\t\r \u00a0 familiar\t\r \u00a0 de\t\r \u00a0 enfermedad\t\r \u00a0 cardiovascular,\t\r \u00a0tabaquismo),\t\r \u00a0se\t\r \u00a0recomienda\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0estatinas\t\r \u00a0y\t\r \u00a0antiagregantes\t\r \u00a0plaquetarios\t\r \u00a0(91).\t\r \u00a0\t\r \u00a0En\t\r \u00a0 nuestros\t\r \u00a0 resultados\t\r \u00a0 hay\t\r \u00a0 258\t\r \u00a0 casos\t\r \u00a0 con\t\r \u00a0 tratamiento\t\r \u00a0 antihipertensivo\t\r \u00a0(IECA\t\r \u00a0o\t\r \u00a0ARAII),\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a013\t\r \u00a0presentan\t\r \u00a0trastornos\t\r \u00a0cardiovasculares\t\r \u00a0como\t\r \u00a0RA\t\r \u00a0(5,0\t\r \u00a0%).\t\r \u00a0 Entre\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0con\t\r \u00a0 tratamiento\t\r \u00a0 antihipertensivo,\t\r \u00a0 hay\t\r \u00a0 82\t\r \u00a0 con\t\r \u00a0tratamiento\t\r \u00a0 hipolipemiante\t\r \u00a0 (estatinas),\t\r \u00a0de\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 4\t\r \u00a0 presentan\t\r \u00a0 trastornos\t\r \u00a0cardiovasculares\t\r \u00a0 (4,8%).\t\r \u00a0 De\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0con\t\r \u00a0 tratamiento\t\r \u00a0antihipertensivo\t\r \u00a0e\t\r \u00a0hipolipemiante,\t\r \u00a033\t\r \u00a0tienen\t\r \u00a0tratamiento\t\r \u00a0antiagregante,\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a01\t\r \u00a0presenta\t\r \u00a0trastorno\t\r \u00a0no\t\r \u00a0cardiaco\t\r \u00a0(3,0%).\t\r \u00a0Si\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0antidiab\u00e9tico,\t\r \u00a0antihipertensivo,\t\r \u00a0 hipolipemiante\t\r \u00a0 y\t\r \u00a0 antiagregante\t\r \u00a0 tienen\t\r \u00a0 tratamiento\t\r \u00a0 adicional\t\r \u00a0 de\t\r \u00a0diur\u00e9ticos,\t\r \u00a0nos\t\r \u00a0 encontramos\t\r \u00a0 con\t\r \u00a0 9\t\r \u00a0 casos\t\r \u00a0 donde\t\r \u00a0ninguno\t\r \u00a0 presenta\t\r \u00a0 trastornos\t\r \u00a0cardiovasculares.\t\r \u00a0Tras\t\r \u00a0 este\t\r \u00a0 desglose\t\r \u00a0 podr\u00edamos\t\r \u00a0concluir\t\r \u00a0que,\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos,\t\r \u00a0 un\t\r \u00a0mayor\t\r \u00a0control\t\r \u00a0de\t\r \u00a0factores\t\r \u00a0de\t\r \u00a0riesgo\t\r \u00a0cardiovascular\t\r \u00a0parece\t\r \u00a0eficaz\t\r \u00a0en\t\r \u00a0la\t\r \u00a0reducci\u00f3n\t\r \u00a0de\t\r \u00a0aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 RAs\t\r \u00a0 cardiovasculares.\t\r \u00a0 A\t\r \u00a0 su\t\r \u00a0 vez,\t\r \u00a0 este\t\r \u00a0 enfoque\t\r \u00a0 preventivo\t\r \u00a0(antidiab\u00e9ticos\t\r \u00a0 +\t\r \u00a0 IECA/ARAII\t\r \u00a0 +\t\r \u00a0 estatinas\t\r \u00a0 +\t\r \u00a0 antiagregantes\t\r \u00a0 +\t\r \u00a0 diur\u00e9ticos)\t\r \u00a0 obliga\t\r \u00a0 a\t\r \u00a0una\t\r \u00a0politerapia\t\r \u00a0 m\u00ednima\t\r \u00a0 de\t\r \u00a0 4-\u00ad\u20105\t\r \u00a0f\u00e1rmacos,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 contra\t\r \u00a0 de\t\r \u00a0 lo\t\r \u00a0 esperable,\t\r \u00a0 genera\t\r \u00a0pocas\t\r \u00a0RAs\t\r \u00a0y,\t\r \u00a0en\t\r \u00a0general,\t\r \u00a0no\t\r \u00a0graves.\t\r \u00a0Simvastatina,\t\r \u00a0 hepatitis\t\r \u00a0 colest\u00e1sica\t\r \u00a0 y\t\r \u00a0 AHOs.\t\r \u00a0Observamos\t\r \u00a0 2\t\r \u00a0 casos\t\r \u00a0 donde\t\r \u00a0 se\t\r \u00a0relacionan\t\r \u00a0 simvastatina\t\r \u00a0 y\t\r \u00a0 hepatitis\t\r \u00a0 colest\u00e1sica\t\r \u00a0 en\t\r \u00a0 notificaciones\t\r \u00a0 de\t\r \u00a0 AHOs\t\r \u00a0en\t\r \u00a0politerapia.\t\r \u00a0Simvastatina\t\r \u00a0est\u00e1\t\r \u00a0contraindicada\t\r \u00a0en\t\r \u00a0hepatopat\u00eda\t\r \u00a0activa\t\r \u00a0o\t\r \u00a0elevaciones\t\r \u00a0persistentes\t\r \u00a0de\t\r \u00a0transaminasas\t\r \u00a0s\u00e9ricas\t\r \u00a0(85).\t\r \u00a0A\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0en\t\r \u00a0su\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0se\t\r \u00a0recoge\t\r \u00a0hepatitis\t\r \u00a0como\t\r \u00a0RA\t\r \u00a0rara\t\r \u00a0(92),\t\r \u00a0aunque\t\r \u00a0no\t\r \u00a0se\t\r \u00a0hace\t\r \u00a0referencia\t\r \u00a0expresa\t\r \u00a0a\t\r \u00a0la\t\r \u00a0tipolog\u00eda\t\r \u00a0colest\u00e1sica\t\r \u00a0que\t\r \u00a0aparece\t\r \u00a0en\t\r \u00a0nuestros\t\r \u00a0resultados,\t\r \u00a0ni\t\r \u00a0a\t\r \u00a0que\t\r \u00a0existan\t\r \u00a0interacciones\t\r \u00a0con\t\r \u00a0hipoglucemiantes\t\r \u00a0orales.\t\r \u00a0\t\r \u00a0A\t\r \u00a0 pesar\t\r \u00a0 de\t\r \u00a0 ello,\t\r \u00a0 consideramos\t\r \u00a0 que\t\r \u00a0 un\t\r \u00a0 tratamiento\t\r \u00a0 concomitante\t\r \u00a0antidiab\u00e9tico\t\r \u00a0 bien\t\r \u00a0 con\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hepatitis\t\r \u00a0 reversible\t\r \u00a0-\u00ad\u2010como\t\r \u00a0 acarbosa\t\r \u00a0(88)\t\r \u00a0o\t\r \u00a0metformina\t\r \u00a0(48)-\u00ad\u2010,\t\r \u00a0bien\t\r \u00a0con\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0hepatitis\t\r \u00a0y\t\r \u00a0colestasis\t\r \u00a0que\t\r \u00a0puedan\t\r \u00a0derivar\t\r \u00a0en\t\r \u00a0fallo\t\r \u00a0hep\u00e1tico\t\r \u00a0-\u00ad\u2010como\t\r \u00a0glibenclamida\t\r \u00a0(87)-\u00ad\u2010\t\r \u00a0puede\t\r \u00a0aumentar\t\r \u00a0el\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0aparici\u00f3n\t\r \u00a0o\t\r \u00a0la\t\r \u00a0gravedad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hepatitis\t\r \u00a0colest\u00e1sica\t\r \u00a0por\t\r \u00a0simvastatina.\t\r \u00a0De\t\r \u00a0hecho,\t\r \u00a0glibenclamida\t\r \u00a0tambi\u00e9n\t\r \u00a0aparece\t\r \u00a0relacionada\t\r \u00a0con\t\r \u00a0hepatitis\t\r \u00a0colest\u00e1sica\t\r \u00a0en\t\r \u00a0la\t\r \u00a0red\t\r \u00a0de\t\r \u00a0enlaces.\t\r \u00a0\t\r \u00a0F\u00e1rmacos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0y\t\r \u00a0RAs\t\r \u00a0en\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0AHOs.\t\r \u00a0Hemos\t\r \u00a0observado\t\r \u00a0correlaci\u00f3n\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0 con\t\r \u00a0 gemfibrozilo\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 levofloxacino,\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 erupci\u00f3n\t\r \u00a0eritematosa\t\r \u00a0con\t\r \u00a0irbesart\u00e1n.\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0309\t\r \u00a0\t\r \u00a0En\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0gemfibrozilo,\t\r \u00a0es\t\r \u00a0conocido\t\r \u00a0su\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0producir\t\r \u00a0hipoglucemia\t\r \u00a0si\t\r \u00a0 se\t\r \u00a0 combina\t\r \u00a0 con\t\r \u00a0 hipoglucemiantes\t\r \u00a0(85)\t\r \u00a0\u2013como\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 caso-\u00ad\u2010;\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 especial\t\r \u00a0 con\t\r \u00a0repaglinida\t\r \u00a0(93).\t\r \u00a0En\t\r \u00a0nuestros\t\r \u00a0resultados\t\r \u00a0no\t\r \u00a0llega\t\r \u00a0a\t\r \u00a0especificarse\t\r \u00a0si\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0por\t\r \u00a0combinaci\u00f3n\t\r \u00a0con\t\r \u00a0este\t\r \u00a0\u00faltimo\t\r \u00a0f\u00e1rmaco.\t\r \u00a0\t\r \u00a0Respecto\t\r \u00a0a\t\r \u00a0levofloxacino,\t\r \u00a0hay\t\r \u00a0advertencias\t\r \u00a0-\u00ad\u2010al\t\r \u00a0igual\t\r \u00a0que\t\r \u00a0ocurre\t\r \u00a0con\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0quinolonas-\u00ad\u2010,\t\r \u00a0 del\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 que\t\r \u00a0 reciben\t\r \u00a0 tratamiento\t\r \u00a0concomitante\t\r \u00a0 con\t\r \u00a0 agentes\t\r \u00a0 hipoglucemiantes\t\r \u00a0 orales\t\r \u00a0-\u00ad\u2010como\t\r \u00a0 glibenclamida-\u00ad\u2010\t\r \u00a0o\t\r \u00a0insulina\t\r \u00a0(85);\t\r \u00a0y\t\r \u00a0aparece\t\r \u00a0recogida\t\r \u00a0como\t\r \u00a0RA\t\r \u00a0en\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0levofloxacino\t\r \u00a0(94).\t\r \u00a0En\t\r \u00a0 nuestros\t\r \u00a0 resultados\t\r \u00a0parece\t\r \u00a0m\u00e1s\t\r \u00a0 relacionada\t\r \u00a0 con\t\r \u00a0 AHOs,\t\r \u00a0 sin\t\r \u00a0predominio\t\r \u00a0 de\t\r \u00a0ninguno.\t\r \u00a0\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 irbesart\u00e1n,\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 registran\t\r \u00a0 reacciones\t\r \u00a0 cut\u00e1neas\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0 del\t\r \u00a0 f\u00e1rmaco\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 2009\t\r \u00a0(85)\t\r \u00a0pero\t\r \u00a0 s\u00ed\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 2011\t\r \u00a0(95),\t\r \u00a0 aunque\t\r \u00a0 s\u00f3lo\t\r \u00a0 se\t\r \u00a0recoge\t\r \u00a0 como\t\r \u00a0 RA\t\r \u00a0 rara\t\r \u00a0 la\t\r \u00a0 erupci\u00f3n\t\r \u00a0 cut\u00e1nea,\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 indica\t\r \u00a0 eritematosa.\t\r \u00a0Ser\u00eda\t\r \u00a0interesante\t\r \u00a0observar\t\r \u00a0si\t\r \u00a0tratamientos\t\r \u00a0concomitantes\t\r \u00a0con\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0eritema\t\r \u00a0\u2013como\t\r \u00a0repaglinida\t\r \u00a0(96)-\u00ad\u2010\t\r \u00a0pueden\t\r \u00a0influir\t\r \u00a0en\t\r \u00a0su\t\r \u00a0aparici\u00f3n.\t\r \u00a0\t\r \u00a0COMBINACIONES\t\r \u00a0DE\t\r \u00a0INSULINAS\t\r \u00a0Y\t\r \u00a0AHOs\t\r \u00a0EN\t\r \u00a0POLITERAPIA\t\r \u00a0Las\t\r \u00a0 asociaciones\t\r \u00a0 obtenidas\t\r \u00a0 presentan\t\r \u00a0 frecuencias\t\r \u00a0 muy\t\r \u00a0 bajas\t\r \u00a0 comparadas\t\r \u00a0con\t\r \u00a0 los\t\r \u00a0 grupos\t\r \u00a0 analizados\t\r \u00a0 anteriormente,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 significa\t\r \u00a0 que\t\r \u00a0 hay\t\r \u00a0 una\t\r \u00a0 gran\t\r \u00a0variabilidad\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0casos.\t\r \u00a0La\t\r \u00a0\u00fanica\t\r \u00a0asociaci\u00f3n\t\r \u00a0de\t\r \u00a0f\u00e1rmacos\t\r \u00a0que\t\r \u00a0aparece\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0una\t\r \u00a0vez\t\r \u00a0es\t\r \u00a0metformina-\u00ad\u2010repaglinida,\t\r \u00a0quedando\t\r \u00a0notificada\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0en\t\r \u00a0posiciones\t\r \u00a0de\t\r \u00a0menor\t\r \u00a0relevancia.\t\r \u00a0\t\r \u00a0En\t\r \u00a0este\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0politerapia,\t\r \u00a0a\t\r \u00a0semejanza\t\r \u00a0de\t\r \u00a0los\t\r \u00a0anteriores\t\r \u00a0de\t\r \u00a0Insulinas\t\r \u00a0y\t\r \u00a0AHOs\t\r \u00a0considerados\t\r \u00a0por\t\r \u00a0separado,\t\r \u00a0se\t\r \u00a0repite\t\r \u00a0el\t\r \u00a0predominio\t\r \u00a0de\t\r \u00a0hipoglucemia\t\r \u00a0en\t\r \u00a0su\t\r \u00a0asociaci\u00f3n\t\r \u00a0 con\t\r \u00a0 glargina\t\r \u00a0 o\t\r \u00a0 con\t\r \u00a0 metformina,\t\r \u00a0 cuando,\t\r \u00a0 en\t\r \u00a0 monoterapia,\t\r \u00a0 glargina\t\r \u00a0 se\t\r \u00a0asocia\t\r \u00a0 con\t\r \u00a0 m\u00e1s\t\r \u00a0 frecuencia\t\r \u00a0 a\t\r \u00a0 hiperglucemia,\t\r \u00a0 y\t\r \u00a0 metformina\t\r \u00a0 por\t\r \u00a0 s\u00ed\t\r \u00a0 sola\t\r \u00a0 no\t\r \u00a0 causa\t\r \u00a0hipoglucemia.\t\r \u00a0Se\t\r \u00a0puede\t\r \u00a0deducir\t\r \u00a0que\t\r \u00a0la\t\r \u00a0influencia\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0f\u00e1rmacos\t\r \u00a0concomitantes\t\r \u00a0es\t\r \u00a0la\t\r \u00a0causa\t\r \u00a0de\t\r \u00a0dicha\t\r \u00a0hipoglucemia,\t\r \u00a0y\t\r \u00a0que\t\r \u00a0el\t\r \u00a0hecho\t\r \u00a0de\t\r \u00a0que\t\r \u00a0glargina\t\r \u00a0o\t\r \u00a0metformina\t\r \u00a0no\t\r \u00a0aparezcan\t\r \u00a0relacionadas\t\r \u00a0con\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0concretos\t\r \u00a0es\t\r \u00a0signo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0variedad\t\r \u00a0de\t\r \u00a0tratamientos\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0estar\t\r \u00a0implicados.\t\r \u00a0\t\r \u00a0En\t\r \u00a0cambio,\t\r \u00a0aparece\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0entre\t\r \u00a0pioglitazona\t\r \u00a0y\t\r \u00a0la\t\r \u00a0RA\t\r \u00a0v\u00e9rtigo,\t\r \u00a0que\t\r \u00a0aun\t\r \u00a0siendo\t\r \u00a0 poco\t\r \u00a0 frecuente\t\r \u00a0 seg\u00fan\t\r \u00a0 se\t\r \u00a0 registra\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0(97),\t\r \u00a0 es\t\r \u00a0 bastante\t\r \u00a0espec\u00edfica\t\r \u00a0de\t\r \u00a0este\t\r \u00a0principio\t\r \u00a0activo.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a06.1,\t\r \u00a0metformina\t\r \u00a0es\t\r \u00a0el\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso\t\r \u00a0aunque\t\r \u00a0se\t\r \u00a0presenta\t\r \u00a0combinado\t\r \u00a0 con\t\r \u00a0 todo\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos\t\r \u00a0\u2013insulinas,\t\r \u00a0 IECAs,\t\r \u00a0 antiagregantes-\u00ad\u2010\t\r \u00a0considerados\t\r \u00a0no\t\r \u00a0sospechosos,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0notificadas\t\r \u00a0no\t\r \u00a0son\t\r \u00a0espec\u00edficas\t\r \u00a0de\t\r \u00a0metformina.\t\r \u00a0\t\r \u00a0La\t\r \u00a0 situaci\u00f3n\t\r \u00a0 de\t\r \u00a0 variabilidad\t\r \u00a0 que\t\r \u00a0 coment\u00e1bamos\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0 observable\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0perfil\t\r \u00a06.2.\t\r \u00a0Los\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0o\t\r \u00a0metformina\t\r \u00a0o\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n310\t\r \u00a0\t\r \u00a0repaglinida,\t\r \u00a0siendo\t\r \u00a0as\u00ed\t\r \u00a0el\t\r \u00a0\u00fanico\t\r \u00a0perfil\t\r \u00a0de\t\r \u00a0todo\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0donde\t\r \u00a0las\t\r \u00a0notificaciones\t\r \u00a0agrupadas\t\r \u00a0no\t\r \u00a0presentan\t\r \u00a0elementos\t\r \u00a0comunes.\t\r \u00a0Esta\t\r \u00a0situaci\u00f3n,\t\r \u00a0en\t\r \u00a0contra\t\r \u00a0de\t\r \u00a0parecer\t\r \u00a0una\t\r \u00a0 limitaci\u00f3n\t\r \u00a0 del\t\r \u00a0 m\u00e9todo,\t\r \u00a0 permite\t\r \u00a0 conocer\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 modelo\t\r \u00a0 agrupa\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 perfil\t\r \u00a0todos\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 que\t\r \u00a0 considera\t\r \u00a0 at\u00edpicos,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 tanto\t\r \u00a0 son\t\r \u00a0 m\u00e1s\t\r \u00a0 f\u00e1cilmente\t\r \u00a0identificables\t\r \u00a0en\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0que\t\r \u00a0ese\t\r \u00a0fuese\t\r \u00a0nuestro\t\r \u00a0objetivo\t\r \u00a0de\t\r \u00a0estudio.\t\r \u00a0\t\r \u00a0El\t\r \u00a0perfil\t\r \u00a06.3,\t\r \u00a0es\t\r \u00a0el\t\r \u00a0\u00fanico\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0se\t\r \u00a0notifican\t\r \u00a0insulinas\t\r \u00a0y\t\r \u00a0AHOs,\t\r \u00a0y\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0considera\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0un\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso.\t\r \u00a0La\t\r \u00a0insulina\t\r \u00a0glargina\t\r \u00a0destaca\t\r \u00a0por\t\r \u00a0ser\t\r \u00a0el\t\r \u00a0principal\t\r \u00a0f\u00e1rmaco\t\r \u00a0sospechoso,\t\r \u00a0y\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0interacciones\t\r \u00a0entre\t\r \u00a0f\u00e1rmacos\t\r \u00a0es\t\r \u00a0elevada\t\r \u00a0 dada\t\r \u00a0 la\t\r \u00a0 variabilidad\t\r \u00a0 de\t\r \u00a0 combinaciones\t\r \u00a0 posibles\t\r \u00a0 entre\t\r \u00a0 antidiab\u00e9ticos,\t\r \u00a0analg\u00e9sicos\t\r \u00a0 y\t\r \u00a0 antiinflamatorios,\t\r \u00a0 sedantes\t\r \u00a0 y\t\r \u00a0 anticoagulantes.\t\r \u00a0 A\t\r \u00a0 pesar\t\r \u00a0de\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0casos\t\r \u00a0no\t\r \u00a0fueron\t\r \u00a0graves\t\r \u00a0en\t\r \u00a0su\t\r \u00a0mayor\u00eda,\t\r \u00a0consideramos\t\r \u00a0especialmente\t\r \u00a0la\t\r \u00a0afectaci\u00f3n\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0nervioso.\t\r \u00a0A\t\r \u00a0continuaci\u00f3n\t\r \u00a0comentamos\t\r \u00a0las\t\r \u00a0relaciones\t\r \u00a0m\u00e1s\t\r \u00a0relevantes\t\r \u00a0observadas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a06:\t\r \u00a0\t\r \u00a0Metformina,\t\r \u00a0sulfonilurea\t\r \u00a0e\t\r \u00a0insulina.\t\r \u00a0Resulta\t\r \u00a0interesante\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0casos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0insulina,\t\r \u00a0no\t\r \u00a0se\t\r \u00a0presenten\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0sulfonilureas\t\r \u00a0como\t\r \u00a0los\t\r \u00a0dos\t\r \u00a0primeros\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos\t\r \u00a0de\t\r \u00a0RAs.\t\r \u00a0Esto\t\r \u00a0puede\t\r \u00a0significar,\t\r \u00a0por\t\r \u00a0un\t\r \u00a0lado,\t\r \u00a0que\t\r \u00a0el\t\r \u00a0escal\u00f3n\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0basado\t\r \u00a0en\t\r \u00a0una\t\r \u00a0terapia\t\r \u00a0triple\t\r \u00a0parece\t\r \u00a0seguro;\t\r \u00a0y\t\r \u00a0contrasta\t\r \u00a0con\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0donde\t\r \u00a0la\t\r \u00a0asociaci\u00f3n\t\r \u00a0metformina+sulfonilureas\t\r \u00a0estaba\t\r \u00a0presente\t\r \u00a0 sin\t\r \u00a0 utilizarse\t\r \u00a0 insulina,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 ser\u00eda\t\r \u00a0 de\t\r \u00a0 esperar\t\r \u00a0 que\t\r \u00a0 hubiese\t\r \u00a0 m\u00e1s\t\r \u00a0notificaciones\t\r \u00a0al\t\r \u00a0a\u00f1adir\t\r \u00a0esta\t\r \u00a0\u00faltima\t\r \u00a0al\t\r \u00a0tratamiento.\t\r \u00a0\t\r \u00a0Por\t\r \u00a0 otro\t\r \u00a0 lado,\t\r \u00a0 esto\t\r \u00a0 puede\t\r \u00a0 significar\t\r \u00a0que\t\r \u00a0 este\t\r \u00a0 enfoque\t\r \u00a0 terap\u00e9utico\t\r \u00a0(metformina\t\r \u00a0 +\t\r \u00a0 sulfonilurea\t\r \u00a0 +\t\r \u00a0 insulina\t\r \u00a0 nocturna)\t\r \u00a0 no\t\r \u00a0 es\t\r \u00a0 muy\t\r \u00a0 utilizado,\t\r \u00a0 a\t\r \u00a0 pesar\t\r \u00a0 de\t\r \u00a0recogerse\t\r \u00a0en\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0algoritmos\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0recomendados,\t\r \u00a0tanto\t\r \u00a0nacionales\t\r \u00a0(19,\t\r \u00a022,\t\r \u00a025),\t\r \u00a0como\t\r \u00a0internacionales\t\r \u00a0(76-\u00ad\u201079,\t\r \u00a079,\t\r \u00a098).\t\r \u00a0\t\r \u00a0Si\t\r \u00a0tomamos\t\r \u00a0en\t\r \u00a0conjunto\t\r \u00a0las\t\r \u00a0observaciones\t\r \u00a0del\t\r \u00a0perfil\t\r \u00a06\t\r \u00a0-\u00ad\u2010ausencia\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0con\t\r \u00a0uso\t\r \u00a0 asociado\t\r \u00a0 de\t\r \u00a0 metformina+sulfonilureas+insulina-\u00ad\u2010,\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 del\t\r \u00a0 perfil\t\r \u00a0 4\t\r \u00a0-\u00ad\u2010donde\t\r \u00a0vemos\t\r \u00a0 m\u00e1s\t\r \u00a0 RAs\t\r \u00a0 asociadas\t\r \u00a0 a\t\r \u00a0 uso\t\r \u00a0 combinado\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0 sulfonilureas\t\r \u00a0 o\t\r \u00a0metformina\t\r \u00a0 y\t\r \u00a0 glitazonas,\t\r \u00a0 sin\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 insulina-\u00ad\u2010;\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 contrastamos\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0algoritmos\t\r \u00a0 de\t\r \u00a0 tratamiento\t\r \u00a0 indicados\t\r \u00a0 anteriormente,\t\r \u00a0 podemos\t\r \u00a0 deducir\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0Espa\u00f1a\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0tendido\t\r \u00a0m\u00e1s\t\r \u00a0hacia\t\r \u00a0una\t\r \u00a0triple\t\r \u00a0terapia\t\r \u00a0con\t\r \u00a0AHOs\t\r \u00a0que\t\r \u00a0a\t\r \u00a0complementar\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 o\t\r \u00a0 de\t\r \u00a0 metformina-\u00ad\u2010sulfonilurea\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 insulinizaci\u00f3n\t\r \u00a0temprana.\t\r \u00a0Este\t\r \u00a0hecho\t\r \u00a0se\t\r \u00a0contrapone\t\r \u00a0con\t\r \u00a0la\t\r \u00a0recomendaci\u00f3n\t\r \u00a0adicional\t\r \u00a0al\t\r \u00a0algoritmo\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0realizada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0consenso\t\r \u00a0ADA/EASD\t\r \u00a0-\u00ad\u2010y\t\r \u00a0que\t\r \u00a0se\t\r \u00a0mantiene\t\r \u00a0actualmente-\u00ad\u2010,\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0aunque\t\r \u00a0se\t\r \u00a0pueden\t\r \u00a0usar\t\r \u00a0tres\t\r \u00a0AHOs,\t\r \u00a0el\t\r \u00a0inicio\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 intensificaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 terapia\t\r \u00a0 con\t\r \u00a0 insulina\t\r \u00a0 es\t\r \u00a0 preferible\t\r \u00a0 en\t\r \u00a0 t\u00e9rminos\t\r \u00a0 de\t\r \u00a0efectividad\t\r \u00a0y\t\r \u00a0gasto\t\r \u00a0(76).\t\r \u00a0Esta\t\r \u00a0deducci\u00f3n\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0ausencia\t\r \u00a0de\t\r \u00a0insulinizaci\u00f3n\t\r \u00a0tard\u00eda,\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0apoya\t\r \u00a0en\t\r \u00a0los\t\r \u00a0pocos\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0observados\t\r \u00a0donde\t\r \u00a0los\t\r \u00a0f\u00e1rmacos\t\r \u00a0sospechosos\t\r \u00a0principales\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0311\t\r \u00a0\t\r \u00a0son\t\r \u00a0 metformina\t\r \u00a0 e\t\r \u00a0 insulina\t\r \u00a0 de\t\r \u00a0 acci\u00f3n\t\r \u00a0 prolongada\t\r \u00a0 glargina\t\r \u00a0 (1\t\r \u00a0 caso),\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0parece\t\r \u00a0 no\t\r \u00a0 haber\t\r \u00a0 sido\t\r \u00a0un\t\r \u00a0 tratamiento\t\r \u00a0 muy\t\r \u00a0 extendido.\t\r \u00a0 Lo\t\r \u00a0 mismo\t\r \u00a0 ocurrir\u00eda\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0tratamiento\t\r \u00a0 insul\u00ednico\t\r \u00a0 intensivo\t\r \u00a0 combinado\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 (1\t\r \u00a0 caso\t\r \u00a0de\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0glulisina\t\r \u00a0y\t\r \u00a0metformina).\t\r \u00a0Metformina,\t\r \u00a0repaglinida\t\r \u00a0e\t\r \u00a0insulina.\t\r \u00a0Observamos\t\r \u00a0notificaciones\t\r \u00a0en\t\r \u00a0las\t\r \u00a0que\t\r \u00a0se\t\r \u00a0asocia\t\r \u00a0 metformina\t\r \u00a0 +\t\r \u00a0 repaglinida\t\r \u00a0 +\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 6\t\r \u00a0 (insulinas+AHOs),\t\r \u00a0mientras\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 4\t\r \u00a0 (combinaciones\t\r \u00a0 de\t\r \u00a0 AHOs)\t\r \u00a0 no\t\r \u00a0 destacaba\t\r \u00a0 la\t\r \u00a0 asociaci\u00f3n\t\r \u00a0metfomina-\u00ad\u2010repaglinida.\t\r \u00a0\t\r \u00a0Seg\u00fan\t\r \u00a0 las\t\r \u00a0 gu\u00edas\t\r \u00a0 nacionales,\t\r \u00a0 en\t\r \u00a0 casos\t\r \u00a0 donde\t\r \u00a0 las\t\r \u00a0 sulfonilureas\t\r \u00a0 est\u00e9n\t\r \u00a0contraindicadas\t\r \u00a0 o\t\r \u00a0 si\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 realizan\t\r \u00a0 comidas\t\r \u00a0 irregulares\t\r \u00a0 puede\t\r \u00a0 sustituirse\t\r \u00a0las\t\r \u00a0sulfonilureas\t\r \u00a0por\t\r \u00a0glinidas\t\r \u00a0(22).\t\r \u00a0Estas\t\r \u00a0\u00faltimas\t\r \u00a0s\u00f3lo\t\r \u00a0son\t\r \u00a0consideradas\t\r \u00a0como\t\r \u00a0una\t\r \u00a0opci\u00f3n\t\r \u00a0terap\u00e9utica\t\r \u00a0seg\u00fan\t\r \u00a0el\t\r \u00a0consenso\t\r \u00a0ADA/EASD\t\r \u00a0en\t\r \u00a0casos\t\r \u00a0concretos\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0su\t\r \u00a0menor\t\r \u00a0efectividad\t\r \u00a0hipoglucemiante\t\r \u00a0y\t\r \u00a0su\t\r \u00a0coste\t\r \u00a0(76).\t\r \u00a0Es\t\r \u00a0probable\t\r \u00a0que\t\r \u00a0en\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0donde\t\r \u00a0las\t\r \u00a0 sulfonilureas\t\r \u00a0 se\t\r \u00a0 descartan,\t\r \u00a0la\t\r \u00a0 opci\u00f3n\t\r \u00a0 de\t\r \u00a0 insulinizaci\u00f3n\t\r \u00a0 se\t\r \u00a0 considere\t\r \u00a0antes,\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0un\t\r \u00a0control\t\r \u00a0gluc\u00e9mico\t\r \u00a0deficiente\t\r \u00a0con\t\r \u00a0las\t\r \u00a0glinidas.\t\r \u00a0\t\r \u00a0Insulinas\t\r \u00a0 y\t\r \u00a0 glitazonas.\t\r \u00a0Hemos\t\r \u00a0 observado\t\r \u00a0 tres\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 edema\t\r \u00a0 (dos\t\r \u00a0perif\u00e9ricos\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 angioedema)\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 est\u00e1n\t\r \u00a0 implicados\t\r \u00a0 como\t\r \u00a0 sospechosos\t\r \u00a0pioglitazona\t\r \u00a0e\t\r \u00a0insulina\t\r \u00a0(detemir,\t\r \u00a0glargina\t\r \u00a0o\t\r \u00a0lispro-\u00ad\u2010lispro\t\r \u00a0protamina).\t\r \u00a0La\t\r \u00a0insulina\t\r \u00a0detemir\t\r \u00a0es\t\r \u00a0la\t\r \u00a0\u00fanica\t\r \u00a0que\t\r \u00a0no\t\r \u00a0se\t\r \u00a0consideraba\t\r \u00a0sospechosa.\t\r \u00a0\t\r \u00a0Es\t\r \u00a0conocido\t\r \u00a0que\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0concomitante\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0pioglitazona,\t\r \u00a0ambas\t\r \u00a0 asociadas\t\r \u00a0 con\t\r \u00a0la\t\r \u00a0 retenci\u00f3n\t\r \u00a0 h\u00eddrica,\t\r \u00a0 puede\t\r \u00a0 aumentar\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 edema\t\r \u00a0 y\t\r \u00a0dicha\t\r \u00a0situaci\u00f3n\t\r \u00a0exacerbar\t\r \u00a0o\t\r \u00a0precipitar\t\r \u00a0la\t\r \u00a0insuficiencia\t\r \u00a0cardiaca\t\r \u00a0(41,\t\r \u00a097).\t\r \u00a0\t\r \u00a0Seg\u00fan\t\r \u00a0 la\t\r \u00a0ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0 de\t\r \u00a0 pioglitazona,\t\r \u00a0 su\t\r \u00a0 uso\t\r \u00a0 requiere\t\r \u00a0 un\t\r \u00a0 seguimiento\t\r \u00a0 de\t\r \u00a0signos\t\r \u00a0 y\t\r \u00a0 s\u00edntomas\t\r \u00a0 de\t\r \u00a0 insuficiencia\t\r \u00a0 cardiaca,\t\r \u00a0aumento\t\r \u00a0 de\t\r \u00a0 peso\t\r \u00a0 o\t\r \u00a0 edema;\t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0pacientes\t\r \u00a0 con\t\r \u00a0 al\t\r \u00a0 menos\t\r \u00a0 un\t\r \u00a0 factor\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 que\t\r \u00a0combinen\t\r \u00a0pioglitazona\t\r \u00a0 e\t\r \u00a0 insulina\t\r \u00a0(97).\t\r \u00a0 Las\t\r \u00a0 mismas\t\r \u00a0 advertencias\t\r \u00a0 respecto\t\r \u00a0 al\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0insuficiencia\t\r \u00a0 cardiaca\t\r \u00a0 por\t\r \u00a0 dicho\t\r \u00a0 tratamiento\t\r \u00a0 combinado\t\r \u00a0 se\t\r \u00a0 recogen\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0detemir\t\r \u00a0(41).\t\r \u00a0Algunos\t\r \u00a0 autores\t\r \u00a0 incluso\t\r \u00a0 consideran\t\r \u00a0 contraindicado\t\r \u00a0 el\t\r \u00a0 uso\t\r \u00a0 de\t\r \u00a0 pioglitazona\t\r \u00a0en\t\r \u00a0combinaci\u00f3n\t\r \u00a0con\t\r \u00a0insulina\t\r \u00a0en\t\r \u00a0cualquier\t\r \u00a0circunstancia\t\r \u00a0tras\t\r \u00a0ocurrir\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0fallo\t\r \u00a0cardiaco\t\r \u00a0en\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0combinaci\u00f3n\t\r \u00a0(85).\t\r \u00a0Tambi\u00e9n\t\r \u00a0observamos\t\r \u00a0dos\t\r \u00a0notificaciones\t\r \u00a0de\t\r \u00a0insuficiencia\t\r \u00a0cardiaca\t\r \u00a0en\t\r \u00a0las\t\r \u00a0que\t\r \u00a0aparecen\t\r \u00a0rosiglitazona\t\r \u00a0 e\t\r \u00a0 insulina\t\r \u00a0(aspart-\u00ad\u2010aspart\t\r \u00a0 protamina\t\r \u00a0 o\t\r \u00a0 glargina).\t\r \u00a0De\t\r \u00a0 las\t\r \u00a0dos\t\r \u00a0 insulinas,\t\r \u00a0 \u00fanicamente\t\r \u00a0 glargina\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 sospechosa\t\r \u00a0 por\t\r \u00a0 interacci\u00f3n\t\r \u00a0-\u00ad\u2010aunque\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0 s\u00f3lo\t\r \u00a0 se\t\r \u00a0 recoge\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 insuficiencia\t\r \u00a0 cardiaca\t\r \u00a0 con\t\r \u00a0pioglitazona,\t\r \u00a0 no\t\r \u00a0 con\t\r \u00a0 rosiglitazona\t\r \u00a0(69)-\u00ad\u2010;\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0aspart-\u00ad\u2010aspart\t\r \u00a0 protamina\t\r \u00a0-\u00ad\u2010con\t\r \u00a0 id\u00e9nticas\t\r \u00a0 indicaciones\t\r \u00a0(99)-\u00ad\u2010\t\r \u00a0no\t\r \u00a0 se\t\r \u00a0 considera\t\r \u00a0 sospechosa\t\r \u00a0 por\t\r \u00a0 interacci\u00f3n\t\r \u00a0 en\t\r \u00a0nuestros\t\r \u00a0datos.\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n312\t\r \u00a0\t\r \u00a0Debido\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0anterior,\t\r \u00a0en\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0notifica\t\r \u00a0edema\t\r \u00a0y\t\r \u00a0los\t\r \u00a0pacientes\t\r \u00a0est\u00e1n\t\r \u00a0tratados\t\r \u00a0con\t\r \u00a0glitazonas\t\r \u00a0e\t\r \u00a0insulina,\t\r \u00a0estas\t\r \u00a0\u00faltimas\t\r \u00a0deber\u00edan\t\r \u00a0registrarse\t\r \u00a0siempre\t\r \u00a0como\t\r \u00a0 sospechosas\t\r \u00a0 o\t\r \u00a0 sospechosas\t\r \u00a0 por\t\r \u00a0 interacci\u00f3n,\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0deber\u00edan\t\r \u00a0sobreseguirse\t\r \u00a0por\t\r \u00a0su\t\r \u00a0posible\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0insuficiencia\t\r \u00a0cardiaca.\t\r \u00a0\t\r \u00a0Glimepirida,\t\r \u00a0 acarbosa\t\r \u00a0 e\t\r \u00a0 insulina.\t\r \u00a0Hay\t\r \u00a0 dos\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 hipoglucemia\t\r \u00a0 y\t\r \u00a0asociaci\u00f3n\t\r \u00a0 de\t\r \u00a0 glimepirida\t\r \u00a0 y\t\r \u00a0acarbosa\t\r \u00a0 como\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 sospechosos,\t\r \u00a0 y\t\r \u00a0exclusivamente\t\r \u00a0en\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0aparece\t\r \u00a0tambi\u00e9n\t\r \u00a0insulina\t\r \u00a0como\t\r \u00a0sospechosa.\t\r \u00a0S\u00f3lo\t\r \u00a0se\t\r \u00a0advierte\t\r \u00a0 del\t\r \u00a0 riesgo\t\r \u00a0 hipoglucemiante\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0 de\t\r \u00a0acarbosa\t\r \u00a0(88)\t\r \u00a0pero\t\r \u00a0no\t\r \u00a0en\t\r \u00a0la\t\r \u00a0de\t\r \u00a0glimepirida\t\r \u00a0expl\u00edcitamente\t\r \u00a0(100),\t\r \u00a0a\t\r \u00a0semejanza\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0ya\t\r \u00a0indicamos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0glibenclamida\t\r \u00a0y\t\r \u00a0acarbosa.\t\r \u00a06.\t\r \u00a0LIMITACIONES\t\r \u00a0DEL\t\r \u00a0ESTUDIO\t\r \u00a0Respecto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0en\t\r \u00a0casos\t\r \u00a0de\t\r \u00a0politerapia,\t\r \u00a0al\t\r \u00a0ajustar\t\r \u00a0el\t\r \u00a0modelo\t\r \u00a0a\t\r \u00a0tres\t\r \u00a0perfiles\t\r \u00a0por\t\r \u00a0grupo,\t\r \u00a0cada\t\r \u00a0perfil\t\r \u00a0est\u00e1\t\r \u00a0constituido\t\r \u00a0por\t\r \u00a0un\t\r \u00a0n\u00famero\t\r \u00a0elevado\t\r \u00a0de\t\r \u00a0casos,\t\r \u00a0y\t\r \u00a0las\t\r \u00a0observaciones\t\r \u00a0que\t\r \u00a0se\t\r \u00a0derivan\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0son\t\r \u00a0m\u00e1s\t\r \u00a0inespec\u00edficas\t\r \u00a0que\t\r \u00a0en\t\r \u00a0los\t\r \u00a0perfiles\t\r \u00a0de\t\r \u00a0monoterapia.\t\r \u00a0Hemos\t\r \u00a0comprobado\t\r \u00a0que\t\r \u00a0si\t\r \u00a0se\t\r \u00a0permite\t\r \u00a0que\t\r \u00a0el\t\r \u00a0modelo\t\r \u00a0adapte\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0a\t\r \u00a0tantos\t\r \u00a0perfiles\t\r \u00a0como\t\r \u00a0fuesen\t\r \u00a0necesarios\t\r \u00a0se\t\r \u00a0obtienen\t\r \u00a0resultados\t\r \u00a0mucho\t\r \u00a0m\u00e1s\t\r \u00a0espec\u00edficos\t\r \u00a0aunque\t\r \u00a0desproporcionadamente\t\r \u00a0amplios\t\r \u00a0para\t\r \u00a0su\t\r \u00a0tratamiento\t\r \u00a0detallado\t\r \u00a0en\t\r \u00a0el\t\r \u00a0presente\t\r \u00a0trabajo.\t\r \u00a0\t\r \u00a07.\t\r \u00a0CONCLUSIONES\t\r \u00a0En\t\r \u00a0monoterapia:\t\r \u00a0-\u00ad\u2010\t\r \u00a0los\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 hiperglucemia\t\r \u00a0 asociada\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 an\u00e1logos\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0corresponder\u00edan\t\r \u00a0 a\t\r \u00a0disminuciones\t\r \u00a0del\t\r \u00a0 nivel\t\r \u00a0 de\t\r \u00a0 insulina,\t\r \u00a0no\t\r \u00a0a\t\r \u00a0 hiperglucemias\t\r \u00a0 de\t\r \u00a0rebote;\t\r \u00a0\t\r \u00a0-\u00ad\u2010\t\r \u00a0los\t\r \u00a0an\u00e1logos\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0prolongada\t\r \u00a0producir\u00edan\t\r \u00a0m\u00e1s\t\r \u00a0reacciones\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a0por\t\r \u00a0una\t\r \u00a0administraci\u00f3n\t\r \u00a0inadecuada;\t\r \u00a0-\u00ad\u2010\t\r \u00a0la\t\r \u00a0diarrea\t\r \u00a0 y\t\r \u00a0 acidosis\t\r \u00a0 l\u00e1ctica\t\r \u00a0 por\t\r \u00a0 metformina\t\r \u00a0 predominaron\t\r \u00a0 en\t\r \u00a0 Arag\u00f3n\t\r \u00a0 y\t\r \u00a0Catalu\u00f1a,\t\r \u00a0 respectivamente,\t\r \u00a0en\t\r \u00a0 mujeres\t\r \u00a0 mayores\t\r \u00a0 de\t\r \u00a0 65\t\r \u00a0 a\u00f1os;\t\r \u00a0 estas\t\r \u00a0 RAs\t\r \u00a0parecen\t\r \u00a0limitar\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0Espa\u00f1a;\t\r \u00a0-\u00ad\u2010\t\r \u00a0en\t\r \u00a0 Galicia\t\r \u00a0 existe\t\r \u00a0 una\t\r \u00a0 posible\t\r \u00a0 infrautilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0sulfonilureas;\t\r \u00a0los\t\r \u00a0 pacientes\t\r \u00a0\u2013mujeres\t\r \u00a0 entre\t\r \u00a0 65\t\r \u00a0 y\t\r \u00a074\t\r \u00a0 a\u00f1os-\u00ad\u2010\t\r \u00a0suelen\t\r \u00a0 presentar\t\r \u00a0hipoglucemias\t\r \u00a0no\t\r \u00a0graves;\t\r \u00a0-\u00ad\u2010\t\r \u00a0la\t\r \u00a0 detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 anemia\t\r \u00a0 en\t\r \u00a0 monoterapia\t\r \u00a0 con\t\r \u00a0 rosiglitazona\t\r \u00a0podr\u00eda\t\r \u00a0 haber\t\r \u00a0facilitado\t\r \u00a0la\t\r \u00a0 identificaci\u00f3n\t\r \u00a0 de\t\r \u00a0pacientes\t\r \u00a0 en\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 sufrir\t\r \u00a0 resultados\t\r \u00a0 cl\u00ednicos\t\r \u00a0adversos.\t\r \u00a0En\t\r \u00a0politerapia:\t\r \u00a0-\u00ad\u2010\t\r \u00a0existe\t\r \u00a0un\t\r \u00a0posible\t\r \u00a0uso\t\r \u00a0incorrecto\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0lispro\t\r \u00a0combinada\t\r \u00a0con\t\r \u00a0insulinas\t\r \u00a0intermedias\t\r \u00a0(isof\u00e1nica)\t\r \u00a0o\t\r \u00a0bif\u00e1sicas\t\r \u00a0(lispro+lispro\t\r \u00a0protamina);\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0313\t\r \u00a0\t\r \u00a0-\u00ad\u2010\t\r \u00a0la\t\r \u00a0administraci\u00f3n\t\r \u00a0por\t\r \u00a0separado\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0y\t\r \u00a0glitazonas\t\r \u00a0parece\t\r \u00a0ser\t\r \u00a0m\u00e1s\t\r \u00a0segura;\t\r \u00a0-\u00ad\u2010\t\r \u00a0existe\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0 insuficiencia\t\r \u00a0 renal\t\r \u00a0 con\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0antihipertensivos;\t\r \u00a0-\u00ad\u2010\t\r \u00a0puede\t\r \u00a0 producirse\t\r \u00a0 hepatitis\t\r \u00a0 colest\u00e1sica\t\r \u00a0 por\t\r \u00a0 simvastatina\t\r \u00a0 en\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0acarbosa,\t\r \u00a0metformina\t\r \u00a0o\t\r \u00a0glibenclamida;\t\r \u00a0-\u00ad\u2010\t\r \u00a0existe\t\r \u00a0 un\t\r \u00a0 posible\t\r \u00a0 efecto\t\r \u00a0 sin\u00e9rgico\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 y\t\r \u00a0 rivastigmina\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0n\u00e1useas\t\r \u00a0y\t\r \u00a0pirexia\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0avanzada;\t\r \u00a0-\u00ad\u2010\t\r \u00a0s\u00f3lo\t\r \u00a0 en\t\r \u00a0 politerapia\t\r \u00a0 se\t\r \u00a0 observaron\t\r \u00a0 asociaciones\t\r \u00a0 de\t\r \u00a0 glargina-\u00ad\u2010shock\t\r \u00a0hipogluc\u00e9mico,\t\r \u00a0metformina-\u00ad\u2010hipoglucemia\t\r \u00a0y\t\r \u00a0metformina-\u00ad\u2010acidosis\t\r \u00a0(no\t\r \u00a0l\u00e1ctica);\t\r \u00a0-\u00ad\u2010\t\r \u00a0fueron\t\r \u00a0m\u00e1s\t\r \u00a0frecuentes\t\r \u00a0las\t\r \u00a0RAs\t\r \u00a0a\t\r \u00a0rosiglitazona/metformina\t\r \u00a0en\t\r \u00a0mujeres\t\r \u00a0y\t\r \u00a0a\t\r \u00a0pioglitazona/metformina\t\r \u00a0en\t\r \u00a0hombres;\t\r \u00a0-\u00ad\u2010\t\r \u00a0la\t\r \u00a0 terapia\t\r \u00a0 cardiovascular\t\r \u00a0 parece\t\r \u00a0 segura\t\r \u00a0 y\t\r \u00a0 eficaz\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 reducci\u00f3n\t\r \u00a0 de\t\r \u00a0aparici\u00f3n\t\r \u00a0de\t\r \u00a0RAs\t\r \u00a0cardiovasculares\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos;\t\r \u00a0-\u00ad\u2010\t\r \u00a0en\t\r \u00a0Espa\u00f1a\t\r \u00a0se\t\r \u00a0tiende\t\r \u00a0hacia\t\r \u00a0una\t\r \u00a0triple\t\r \u00a0terapia\t\r \u00a0con\t\r \u00a0AHOs\t\r \u00a0con\t\r \u00a0m\u00e1s\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0producir\t\r \u00a0 RAs,\t\r \u00a0 en\t\r \u00a0 vez\t\r \u00a0 de\t\r \u00a0 complementar\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 metformina\t\r \u00a0 o\t\r \u00a0 de\t\r \u00a0metformina-\u00ad\u2010sulfonilurea\t\r \u00a0con\t\r \u00a0la\t\r \u00a0insulinizaci\u00f3n\t\r \u00a0temprana.\t\r \u00a0El\t\r \u00a0 modelo\t\r \u00a0 aplicado\t\r \u00a0 ha\t\r \u00a0 demostrado\t\r \u00a0 ser\t\r \u00a0 v\u00e1lido\t\r \u00a0 para\t\r \u00a0 detectar\t\r \u00a0 tanto\t\r \u00a0caracter\u00edsticas\t\r \u00a0 comunes\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 como\t\r \u00a0 casos\t\r \u00a0 at\u00edpicos.\t\r \u00a0 La\t\r \u00a0 obtenci\u00f3n\t\r \u00a0 de\t\r \u00a0perfiles\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0que\t\r \u00a0 sufren\t\r \u00a0 reacciones\t\r \u00a0 adversas\t\r \u00a0 a\t\r \u00a0 medicamentos\t\r \u00a0presenta\t\r \u00a0 aplicaciones\t\r \u00a0 para\t\r \u00a0 prever\t\r \u00a0 acontecimientos\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 seguimiento\t\r \u00a0 post-\u00ad\u2010comercializaci\u00f3n\t\r \u00a0de\t\r \u00a0f\u00e1rmacos\t\r \u00a0tanto\t\r \u00a0tradicionales\t\r \u00a0como\t\r \u00a0nuevos.\t\r \u00a08.\t\r \u00a0AGRADECIMIENTOS\t\r \u00a0Trabajo\t\r \u00a0financiado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0Junta\t\r \u00a0de\t\r \u00a0Castilla\t\r \u00a0y\t\r \u00a0Le\u00f3n\t\r \u00a0y\t\r \u00a0el\t\r \u00a0Fondo\t\r \u00a0Social\t\r \u00a0Europeo.\t\r \u00a09.\t\r \u00a0REFERENCIAS\t\r \u00a01.\t\r \u00a0\t\r \u00a0Carvajal\t\r \u00a0 A.:\t\r \u00a0 Introducci\u00f3n\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 Farmacoepidemiolog\u00eda:\t\r \u00a0 Concepto,\t\r \u00a0 Historia,\t\r \u00a0 M\u00e9todos\t\r \u00a0 y\t\r \u00a0Fuentes\t\r \u00a0 de\t\r \u00a0 Datos.\t\r \u00a0 En\t\r \u00a0Farmacoepidemiolog\u00eda;\t\r \u00a0 Carvajal\t\r \u00a0 A,\t\r \u00a0 ed.;\t\r \u00a0Secretariado\t\r \u00a0 de\t\r \u00a0Publicaciones,\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Valladolid;\t\r \u00a0Valladolid,\t\r \u00a01993;\t\r \u00a0p\t\r \u00a011-\u00ad\u201024.\t\r \u00a0\t\r \u00a02.\t\r \u00a0\t\r \u00a0S\u00e1nchez\t\r \u00a0 A,\t\r \u00a0 Garc\u00eda\t\r \u00a0 A,\t\r \u00a0 Carvajal\t\r \u00a0 A.:\t\r \u00a0 Notificaci\u00f3n\t\r \u00a0 voluntaria\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0 adversas\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0medicamentos.\t\r \u00a0En\t\r \u00a0Farmacoepidemiolog\u00eda;\t\r \u00a0Carvajal\t\r \u00a0A,\t\r \u00a0ed.;\t\r \u00a0Secretariado\t\r \u00a0de\t\r \u00a0Publicaciones,\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Valladolid;\t\r \u00a0Valladolid,\t\r \u00a01993;\t\r \u00a0p\t\r \u00a061-\u00ad\u201074.\t\r \u00a0\t\r \u00a03.\t\r \u00a0\t\r \u00a0Lindquist\t\r \u00a0M,\t\r \u00a0Edwards\t\r \u00a0IR,\t\r \u00a0Bate\t\r \u00a0A,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0From\t\r \u00a0association\t\r \u00a0to\t\r \u00a0alert-\u00ad\u2010-\u00ad\u2010a\t\r \u00a0revised\t\r \u00a0approach\t\r \u00a0to\t\r \u00a0international\t\r \u00a0signal\t\r \u00a0analysis.\t\r \u00a0Pharmacoepidemiol\t\r \u00a0Drug\t\r \u00a0Saf\t\r \u00a08\t\r \u00a0Suppl\t\r \u00a01,\t\r \u00a0S15-\u00ad\u2010S25\t\r \u00a0(1999).\t\r \u00a0\t\r \u00a04.\t\r \u00a0\t\r \u00a0Capell\u00e0\t\r \u00a0D,\t\r \u00a0Laporte\t\r \u00a0JR.:\t\r \u00a0La\t\r \u00a0notificaci\u00f3n\t\r \u00a0espont\u00e1nea\t\r \u00a0de\t\r \u00a0reacciones\t\r \u00a0adversas\t\r \u00a0a\t\r \u00a0medicamentos.\t\r \u00a0En\t\r \u00a0Principios\t\r \u00a0 de\t\r \u00a0 epidemiolog\u00eda\t\r \u00a0 del\t\r \u00a0 medicamento;\t\r \u00a0 Laporte\t\r \u00a0 JR,\t\r \u00a0 Tognoni\t\r \u00a0 G,\t\r \u00a0 eds.;\t\r \u00a0 Masson-\u00ad\u2010Salvat\t\r \u00a0Medicina;\t\r \u00a0Barcelona,\t\r \u00a01983;\t\r \u00a0p\t\r \u00a0147-\u00ad\u201070.\t\r \u00a0\t\r \u00a05.\t\r \u00a0\t\r \u00a0Manso\t\r \u00a0G,\t\r \u00a0Hidalgo\t\r \u00a0A,\t\r \u00a0Carvajal\t\r \u00a0A,\t\r \u00a0et\t\r \u00a0al.,\t\r \u00a0editores.\t\r \u00a0Los\t\r \u00a0primeros\t\r \u00a025\t\r \u00a0a\u00f1os\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0de\t\r \u00a0Uso\t\r \u00a0Humano.\t\r \u00a0Oviedo:\t\r \u00a0Servicio\t\r \u00a0de\t\r \u00a0Publicaciones\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Oviedo,\t\r \u00a02010.\t\r \u00a0\t\r \u00a06.\t\r \u00a0\t\r \u00a0Fornos\t\r \u00a0 JA,\t\r \u00a0 Fern\u00e1ndez\t\r \u00a0 M,\t\r \u00a0 Garc\u00eda\t\r \u00a0 P,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 An\u00e1lisis\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 medicamentos\t\r \u00a0 por\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0provincia\t\r \u00a0de\t\r \u00a0Pontevedra.\t\r \u00a0Av\t\r \u00a0Diabetol\t\r \u00a026,\t\r \u00a047-\u00ad\u201052\t\r \u00a0(2010).\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n314\t\r \u00a0\t\r \u00a0\t\r \u00a07.\t\r \u00a0\t\r \u00a0Sender\t\r \u00a0 Palacios\t\r \u00a0 MJ,\t\r \u00a0 Vernet\t\r \u00a0 VM,\t\r \u00a0 Larrosa\t\r \u00a0 SP,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Caracter\u00edsticas\t\r \u00a0 sociodemogr\u00e1ficas\t\r \u00a0 y\t\r \u00a0cl\u00ednicas\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 poblaci\u00f3n\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 diabetes\t\r \u00a0 mellitus.\t\r \u00a0 Aten\t\r \u00a0 Primaria\t\r \u00a0 29,\t\r \u00a0 474-\u00ad\u201080\t\r \u00a0(2002).\t\r \u00a0\t\r \u00a08.\t\r \u00a0\t\r \u00a0Madurga\t\r \u00a0M,\t\r \u00a0L\u00e1zaro\t\r \u00a0F,\t\r \u00a0Mart\u00edn-\u00ad\u2010Serrano\t\r \u00a0G,\t\r \u00a0et\t\r \u00a0al.:\t\r \u00a0El\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0de\t\r \u00a0Uso\t\r \u00a0Humano:\t\r \u00a0su\t\r \u00a0historia\t\r \u00a0en\t\r \u00a0cifras.\t\r \u00a0En\t\r \u00a0Los\t\r \u00a0primeros\t\r \u00a025\t\r \u00a0a\u00f1os\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0 de\t\r \u00a0 Farmacovigilancia\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 de\t\r \u00a0 Uso\t\r \u00a0 Humano;\t\r \u00a0 Manso\t\r \u00a0 G,\t\r \u00a0 Hidalgo\t\r \u00a0 A,\t\r \u00a0Carvajal\t\r \u00a0A\t\r \u00a0et\t\r \u00a0al.,\t\r \u00a0eds.;\t\r \u00a0Servicio\t\r \u00a0de\t\r \u00a0Publicaciones\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Oviedo;\t\r \u00a0Oviedo,\t\r \u00a02010;\t\r \u00a0p\t\r \u00a031-\u00ad\u201046.\t\r \u00a0\t\r \u00a09.\t\r \u00a0\t\r \u00a0Instituto\t\r \u00a0de\t\r \u00a0Informaci\u00f3n\t\r \u00a0Sanitaria.Ministerio\t\r \u00a0de\t\r \u00a0Sanidad\t\r \u00a0y\t\r \u00a0Pol\u00edtica\t\r \u00a0Social.\t\r \u00a0Notificaci\u00f3n\t\r \u00a0de\t\r \u00a0reacciones\t\r \u00a0 adversas\t\r \u00a0 a\t\r \u00a0 medicamentos\t\r \u00a0 por\t\r \u00a0 cada\t\r \u00a0 1.000\t\r \u00a0 habitantes.\t\r \u00a0 Base\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 de\t\r \u00a0Indicadores\t\r \u00a0 Clave\t\r \u00a0 del\t\r \u00a0 Sistema\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 Salud\t\r \u00a0 (INCLASNS-\u00ad\u2010BD).\t\r \u00a0 [acceso\t\r \u00a0 12.12.2011].\t\r \u00a0Disponible\t\r \u00a0 en:\t\r \u00a0http://www.msc.es/estadEstudios/estadisticas/sisInfSanSNS/inclasSNS_DB.htm\t\r \u00a0\t\r \u00a010.\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0Inc.:\t\r \u00a0Understanding\t\r \u00a0Data\t\r \u00a0Mining.\t\r \u00a0En\t\r \u00a0SPSS\t\r \u00a0Clementine\t\r \u00a0\u00ae\t\r \u00a012.0\t\r \u00a0User's\t\r \u00a0Guide;\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0Inc;\t\r \u00a0Chicago,\t\r \u00a0IL,\t\r \u00a02007;\t\r \u00a0p\t\r \u00a033-\u00ad\u201045.\t\r \u00a011.\t\r \u00a0\t\r \u00a0WHO\t\r \u00a0Collaborating\t\r \u00a0Centre\t\r \u00a0for\t\r \u00a0Drug\t\r \u00a0Statistics\t\r \u00a0Methodology,\t\r \u00a0Norwegian\t\r \u00a0Institute\t\r \u00a0of\t\r \u00a0Public\t\r \u00a0Health.\t\r \u00a0ATC.\t\r \u00a0 Structure\t\r \u00a0 and\t\r \u00a0 principles\t\r \u00a0 [acceso\t\r \u00a0 12.02.2010].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.whocc.no/atc/structure_and_principles/\t\r \u00a0\t\r \u00a012.\t\r \u00a0\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0de\t\r \u00a0Uso\t\r \u00a0Humano.\t\r \u00a0Base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0FEDRA\t\r \u00a0(Farmacovigilancia\t\r \u00a0Espa\u00f1ola,\t\r \u00a0Datos\t\r \u00a0de\t\r \u00a0Reacciones\t\r \u00a0Adversas)\t\r \u00a02000-\u00ad\u20102008.\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0del\t\r \u00a0Medicamento.\t\r \u00a013.\t\r \u00a0\t\r \u00a0Divisi\u00f3n\t\r \u00a0 de\t\r \u00a0 Farmacoepidemiolog\u00eda\t\r \u00a0 y\t\r \u00a0 Farmacovigilancia.\t\r \u00a0 Subdirecci\u00f3n\t\r \u00a0 General\t\r \u00a0 de\t\r \u00a0Seguridad\t\r \u00a0de\t\r \u00a0Medicamentos,\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0y\t\r \u00a0Productos\t\r \u00a0Sanitarios.\t\r \u00a0Aceptaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0Criterios\t\r \u00a0y\t\r \u00a0Normas\t\r \u00a0de\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0FEDRA\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia:\t\r \u00a0SEFV/1/CT\t\r \u00a0y\t\r \u00a0SEFV/2/CT.\t\r \u00a014.\t\r \u00a0\t\r \u00a0Divisi\u00f3n\t\r \u00a0 de\t\r \u00a0 Farmacoepidemiolog\u00eda\t\r \u00a0 y\t\r \u00a0 Farmacovigilancia.\t\r \u00a0 Subdirecci\u00f3n\t\r \u00a0 General\t\r \u00a0 de\t\r \u00a0Seguridad\t\r \u00a0de\t\r \u00a0Medicamentos,\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0y\t\r \u00a0Productos\t\r \u00a0Sanitarios.\t\r \u00a0Criterios\t\r \u00a0para\t\r \u00a0la\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0datos\t\r \u00a0FEDRA\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0(SEFV/1/CT).\t\r \u00a015.\t\r \u00a0\t\r \u00a0Divisi\u00f3n\t\r \u00a0 de\t\r \u00a0 Farmacoepidemiolog\u00eda\t\r \u00a0 y\t\r \u00a0 Farmacovigilancia.\t\r \u00a0 Subdirecci\u00f3n\t\r \u00a0 General\t\r \u00a0 de\t\r \u00a0Seguridad\t\r \u00a0de\t\r \u00a0Medicamentos,\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0y\t\r \u00a0Productos\t\r \u00a0Sanitarios.\t\r \u00a0Normas\t\r \u00a0para\t\r \u00a0la\t\r \u00a0correcta\t\r \u00a0interpretaci\u00f3n\t\r \u00a0y\t\r \u00a0utlizaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0del\t\r \u00a0Sistema\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Farmacovigilancia\t\r \u00a0(SEFV/2/CT).\t\r \u00a016.\t\r \u00a0\t\r \u00a0Instituto\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 Estad\u00edstica\t\r \u00a0 (INE).\t\r \u00a0 Encuesta\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 Salud\t\r \u00a0 2006\t\r \u00a0 [acceso\t\r \u00a003.02.2010].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ine.es/jaxi/menu.do?type=pcaxis&path=/t15/p419&file=inebase&L=0\t\r \u00a0\t\r \u00a017.\t\r \u00a0\t\r \u00a0International\t\r \u00a0Conference\t\r \u00a0on\t\r \u00a0Harmonisation\t\r \u00a0(ICH).\t\r \u00a0MedDRA\t\r \u00a0\u00ae\t\r \u00a0Term\t\r \u00a0Selection:\t\r \u00a0Points\t\r \u00a0to\t\r \u00a0consider.\t\r \u00a0 ICH-\u00ad\u2010Endorsed\t\r \u00a0 Guide\t\r \u00a0 for\t\r \u00a0 MedDRA\t\r \u00a0 Users\t\r \u00a0 [acceso\t\r \u00a0 03.04.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.meddramsso.com/files_acrobat/ptc/9491-\u00ad\u20101310_TermSelPTC_R4.0_sep2010.pdf\t\r \u00a0\t\r \u00a018.\t\r \u00a0\t\r \u00a0Carvajal\t\r \u00a0 A,\t\r \u00a0 Montero\t\r \u00a0 D.\t\r \u00a0 MedDRA:\t\r \u00a0 una\t\r \u00a0 terminolog\u00eda\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 armonizaci\u00f3n\t\r \u00a0 en\t\r \u00a0 materia\t\r \u00a0 de\t\r \u00a0medicamentos.\t\r \u00a0ICB\t\r \u00a0digital\t\r \u00a010,\t\r \u00a01-\u00ad\u20104\t\r \u00a0(2002).\t\r \u00a019.\t\r \u00a0\t\r \u00a0Consejo\t\r \u00a0General\t\r \u00a0de\t\r \u00a0Colegios\t\r \u00a0Oficiales\t\r \u00a0de\t\r \u00a0Farmac\u00e9uticos.,\t\r \u00a0editores.\t\r \u00a0Plan\t\r \u00a0Estrat\u00e9gico\t\r \u00a0para\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Atenci\u00f3n\t\r \u00a0 Farmac\u00e9utica\t\r \u00a0 '10.\t\r \u00a0 Gu\u00eda\t\r \u00a0 de\t\r \u00a0 Atenci\u00f3n\t\r \u00a0 Farmac\u00e9utica\t\r \u00a0 al\t\r \u00a0 paciente\t\r \u00a0diab\u00e9tico.\t\r \u00a0Madrid:\t\r \u00a0Consejo\t\r \u00a0General\t\r \u00a0de\t\r \u00a0Colegios\t\r \u00a0Oficiales\t\r \u00a0de\t\r \u00a0Farmac\u00e9uticos,\t\r \u00a02010.\t\r \u00a020.\t\r \u00a0\t\r \u00a0Murillo\t\r \u00a0 MD,\t\r \u00a0 Fern\u00e1ndez-\u00ad\u2010Llim\u00f3s\t\r \u00a0 F,\t\r \u00a0 Tuneu\t\r \u00a0 L,\t\r \u00a0 editores.\t\r \u00a0 Gu\u00eda\t\r \u00a0 de\t\r \u00a0 seguimiento\t\r \u00a0farmacoterap\u00e9utico\t\r \u00a0sobre\t\r \u00a0diabetes.\t\r \u00a0Granada:\t\r \u00a0Espai\t\r \u00a0Gr\u00e0fic\t\r \u00a0Anagrafic,\t\r \u00a0S.L,\t\r \u00a02004.\t\r \u00a021.\t\r \u00a0\t\r \u00a0Men\u00e9ndez\t\r \u00a0E,\t\r \u00a0Lafita\t\r \u00a0J,\t\r \u00a0Artola\t\r \u00a0S,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Recomendaciones\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0farmacol\u00f3gico\t\r \u00a0de\t\r \u00a0la\t\r \u00a0hiperglucemia\t\r \u00a0en\t\r \u00a0la\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02.\t\r \u00a0Documento\t\r \u00a0de\t\r \u00a0consenso.\t\r \u00a0Av\t\r \u00a0Diabetol\t\r \u00a026,\t\r \u00a0331-\u00ad\u20108\t\r \u00a0(2010).\t\r \u00a022.\t\r \u00a0\t\r \u00a0Grupo\t\r \u00a0de\t\r \u00a0Trabajo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Gu\u00eda\t\r \u00a0de\t\r \u00a0Pr\u00e1ctica\t\r \u00a0Cl\u00ednica\t\r \u00a0sobre\t\r \u00a0Diabetes\t\r \u00a0tipo\t\r \u00a02,\t\r \u00a0editores.\t\r \u00a0Gu\u00eda\t\r \u00a0de\t\r \u00a0Pr\u00e1ctica\t\r \u00a0Cl\u00ednica\t\r \u00a0sobre\t\r \u00a0Diabetes\t\r \u00a0tipo\t\r \u00a02.\t\r \u00a0Madrid:\t\r \u00a0Plan\t\r \u00a0Nacional\t\r \u00a0para\t\r \u00a0el\t\r \u00a0SNS\t\r \u00a0del\t\r \u00a0MSC.\t\r \u00a0Agencia\t\r \u00a0de\t\r \u00a0Evaluaci\u00f3n\t\r \u00a0de\t\r \u00a0Tecnolog\u00edas\t\r \u00a0Sanitarias\t\r \u00a0del\t\r \u00a0Pa\u00eds\t\r \u00a0Vasco:\t\r \u00a02008.\t\r \u00a023.\t\r \u00a0\t\r \u00a0Sociedad\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Diabetes.\t\r \u00a0 Gu\u00edas\t\r \u00a0 de\t\r \u00a0 pr\u00e1ctica\t\r \u00a0 cl\u00ednica:\t\r \u00a0 FMC\t\r \u00a0-\u00ad\u2010\t\r \u00a0Protocolo\t\r \u00a0 DM2\t\r \u00a0 en\t\r \u00a0 AP\t\r \u00a0(2000)\t\r \u00a0 [acceso\t\r \u00a0 12.08.2010].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.sediabetes.org/gestor/upload/file/00003582archivo.pdf\t\r \u00a0\t\r \u00a024.\t\r \u00a0\t\r \u00a0Franch\t\r \u00a0 J,\t\r \u00a0 Goday\t\r \u00a0 A,\t\r \u00a0 Mata\t\r \u00a0 M.\t\r \u00a0 Proyecto\t\r \u00a0 COMBO.\t\r \u00a0 Actualizaci\u00f3n\t\r \u00a0 2004.\t\r \u00a0 Criterios\t\r \u00a0 y\t\r \u00a0 pautas\t\r \u00a0 de\t\r \u00a0terapia\t\r \u00a0combinada\t\r \u00a0en\t\r \u00a0la\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02.\t\r \u00a0Av\t\r \u00a0Diabetol\t\r \u00a020,\t\r \u00a077-\u00ad\u2010112\t\r \u00a0(2004).\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0315\t\r \u00a0\t\r \u00a025.\t\r \u00a0\t\r \u00a0del\t\r \u00a0Olmo\t\r \u00a0Gonz\u00e1lez\t\r \u00a0E,\t\r \u00a0Carrillo\t\r \u00a0P\u00e9rez\t\r \u00a0M,\t\r \u00a0Aguilera\t\r \u00a0Gumpert\t\r \u00a0S.\t\r \u00a0Actualizaci\u00f3n\t\r \u00a0del\t\r \u00a0tratamiento\t\r \u00a0farmacol\u00f3gico\t\r \u00a0de\t\r \u00a0la\t\r \u00a0diabetes\t\r \u00a0mellitus\t\r \u00a0tipo\t\r \u00a02.\t\r \u00a0Inf\t\r \u00a0Ter\t\r \u00a0Sis\t\r \u00a0Nac\t\r \u00a0Salud\t\r \u00a032,\t\r \u00a03-\u00ad\u201016\t\r \u00a0(2008).\t\r \u00a026.\t\r \u00a0\t\r \u00a0Consejo\t\r \u00a0 General\t\r \u00a0 de\t\r \u00a0 Colegios\t\r \u00a0 Oficiales\t\r \u00a0 de\t\r \u00a0 Farmac\u00e9uticos.\t\r \u00a0 Cat\u00e1logo\t\r \u00a0 de\t\r \u00a0 Especialidades\t\r \u00a0Farmac\u00e9uticas.\t\r \u00a0Madrid:\t\r \u00a0Colegio\t\r \u00a0de\t\r \u00a0Farmac\u00e9uticos;\t\r \u00a01998-\u00ad\u20102009.\t\r \u00a027.\t\r \u00a0\t\r \u00a0L\u00e1zaro\t\r \u00a0Bengoa\t\r \u00a0E.\t\r \u00a0Manual\t\r \u00a0de\t\r \u00a0usuario\t\r \u00a0FEDRA\t\r \u00a0\u00ae\t\r \u00a02.0\t\r \u00a0(Alta\t\r \u00a0de\t\r \u00a0notificaciones).\t\r \u00a028.\t\r \u00a0\t\r \u00a0Matute\t\r \u00a0 P,\t\r \u00a0 Merello\t\r \u00a0 J,\t\r \u00a0 Lara\t\r \u00a0 R,\t\r \u00a0 editores.\t\r \u00a0 Curso\t\r \u00a0 de\t\r \u00a0 farmacovigilancia\t\r \u00a0 para\t\r \u00a0 profesionales\t\r \u00a0sanitarios.\t\r \u00a0\t\r \u00a0Medical\t\r \u00a0Dynamics,\t\r \u00a02003.\t\r \u00a029.\t\r \u00a0\t\r \u00a0Chang\t\r \u00a0M.:\t\r \u00a0Data\t\r \u00a0mining\t\r \u00a0and\t\r \u00a0Signal\t\r \u00a0Detection.\t\r \u00a0En\t\r \u00a0Modern\t\r \u00a0Issues\t\r \u00a0and\t\r \u00a0Methods\t\r \u00a0in\t\r \u00a0Biostatistics.\t\r \u00a0Statistics\t\r \u00a0for\t\r \u00a0Biology\t\r \u00a0and\t\r \u00a0Health.;\t\r \u00a0Gail\t\r \u00a0M,\t\r \u00a0Krickeberg\t\r \u00a0K,\t\r \u00a0Samet\t\r \u00a0J\t\r \u00a0et\t\r \u00a0al.,\t\r \u00a0eds.;\t\r \u00a0Springer;\t\r \u00a0New\t\r \u00a0York,\t\r \u00a02011;\t\r \u00a0p\t\r \u00a0205-\u00ad\u201032.\t\r \u00a030.\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0 Inc.:\t\r \u00a0 Graph\t\r \u00a0 Nodes.\t\r \u00a0 En\t\r \u00a0SPSS\t\r \u00a0 Clementine\t\r \u00a0 \u00ae\t\r \u00a0 12.0\t\r \u00a0 Source,\t\r \u00a0 Process,\t\r \u00a0 and\t\r \u00a0 Output\t\r \u00a0 Nodes;\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0Inc;\t\r \u00a0Chicago,\t\r \u00a0IL,\t\r \u00a02007;\t\r \u00a0p\t\r \u00a0173-\u00ad\u2010273.\t\r \u00a031.\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0 Inc.:\t\r \u00a0 Clustering\t\r \u00a0 Models.\t\r \u00a0 En\t\r \u00a0SPSS\t\r \u00a0 Clementine\t\r \u00a0 \u00ae\t\r \u00a0 12.0\t\r \u00a0 Modeling\t\r \u00a0 Nodes;\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0 Inc;\t\r \u00a0Chicago,\t\r \u00a0IL,\t\r \u00a02007;\t\r \u00a0p\t\r \u00a0254-\u00ad\u201083.\t\r \u00a032.\t\r \u00a0\t\r \u00a0SPSS\t\r \u00a0 Inc.:\t\r \u00a0 Kohonen\t\r \u00a0 Algorithms.\t\r \u00a0 En\t\r \u00a0SPSS\t\r \u00a0 Clementine\t\r \u00a0 \u00ae\t\r \u00a0 12.0\t\r \u00a0 Algorithms\t\r \u00a0 Guide;\t\r \u00a0 \t\r \u00a0 SPSS\t\r \u00a0 Inc;\t\r \u00a0Chicago,\t\r \u00a0IL,\t\r \u00a02007;\t\r \u00a0p\t\r \u00a067-\u00ad\u201071.\t\r \u00a033.\t\r \u00a0\t\r \u00a0Kohonen\t\r \u00a0T.\t\r \u00a0Self-\u00ad\u2010organizing\t\r \u00a0neural\t\r \u00a0projections.\t\r \u00a0Neural\t\r \u00a0Netw\t\r \u00a019,\t\r \u00a0723-\u00ad\u201033\t\r \u00a0(2006).\t\r \u00a034.\t\r \u00a0\t\r \u00a0\t\r \u00a0Martindale:\t\r \u00a0The\t\r \u00a0complete\t\r \u00a0drug\t\r \u00a0reference.\t\r \u00a0London:\t\r \u00a0Pharmaceutical\t\r \u00a0Press,\t\r \u00a02009.\t\r \u00a035.\t\r \u00a0\t\r \u00a0Massi\t\r \u00a0 BM,\t\r \u00a0 Humburg\t\r \u00a0 E,\t\r \u00a0 Dressler\t\r \u00a0 A,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 A\t\r \u00a0 one-\u00ad\u2010year,\t\r \u00a0 randomised,\t\r \u00a0 multicentre\t\r \u00a0 trial\t\r \u00a0comparing\t\r \u00a0insulin\t\r \u00a0glargine\t\r \u00a0with\t\r \u00a0NPH\t\r \u00a0insulin\t\r \u00a0in\t\r \u00a0combination\t\r \u00a0with\t\r \u00a0oral\t\r \u00a0agents\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes.\t\r \u00a0Horm\t\r \u00a0Metab\t\r \u00a0Res\t\r \u00a035,\t\r \u00a0189-\u00ad\u201096\t\r \u00a0(2003).\t\r \u00a036.\t\r \u00a0\t\r \u00a0Carroll\t\r \u00a0 MF,\t\r \u00a0 Schade\t\r \u00a0 DS.\t\r \u00a0 The\t\r \u00a0 dawn\t\r \u00a0 phenomenon\t\r \u00a0 revisited:\t\r \u00a0 implications\t\r \u00a0 for\t\r \u00a0 diabetes\t\r \u00a0therapy.\t\r \u00a0Endocr\t\r \u00a0Pract\t\r \u00a011,\t\r \u00a055-\u00ad\u201064\t\r \u00a0(2005).\t\r \u00a037.\t\r \u00a0\t\r \u00a0Rybicka\t\r \u00a0 M,\t\r \u00a0 Krysiak\t\r \u00a0 R,\t\r \u00a0 Okopien\t\r \u00a0 B.\t\r \u00a0 The\t\r \u00a0 dawn\t\r \u00a0 phenomenon\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 Somogyi\t\r \u00a0 effect\t\r \u00a0-\u00ad\u2010\t\r \u00a0two\t\r \u00a0phenomena\t\r \u00a0of\t\r \u00a0morning\t\r \u00a0hyperglycaemia.\t\r \u00a0Endokrynol\t\r \u00a0Pol\t\r \u00a062,\t\r \u00a0276-\u00ad\u201084\t\r \u00a0(2011).\t\r \u00a038.\t\r \u00a0\t\r \u00a0Ceruelo-\u00ad\u2010Bermejo\t\r \u00a0 J,\t\r \u00a0 Miranda-\u00ad\u2010Hidalgo\t\r \u00a0 R,\t\r \u00a0 Garc\u00eda-\u00ad\u2010Ortiz\t\r \u00a0 A,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Insulina\t\r \u00a0 detemir.\t\r \u00a0 Hoja\t\r \u00a0Informativa\t\r \u00a0de\t\r \u00a0Medicamentos-\u00ad\u2010Sacylime\t\r \u00a01,\t\r \u00a01-\u00ad\u20102\t\r \u00a0(2005).\t\r \u00a039.\t\r \u00a0\t\r \u00a0CADIME,\t\r \u00a0EASP.\t\r \u00a0Insulina\t\r \u00a0glargina\t\r \u00a0(DCI).\t\r \u00a0Ficha\t\r \u00a0de\t\r \u00a0novedad\t\r \u00a0terap\u00e9utica\t\r \u00a01-\u00ad\u20102\t\r \u00a0(2006).\t\r \u00a040.\t\r \u00a0\t\r \u00a0CADIME,\t\r \u00a0EASP.\t\r \u00a0Insulina\t\r \u00a0detemir\t\r \u00a0(DCI).\t\r \u00a0Ficha\t\r \u00a0de\t\r \u00a0novedad\t\r \u00a0terap\u00e9utica\t\r \u00a01-\u00ad\u20102\t\r \u00a0(2006).\t\r \u00a041.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Levemir\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000528/WC500036662.pdf\t\r \u00a0\t\r \u00a042.\t\r \u00a0\t\r \u00a0Torlone\t\r \u00a0E,\t\r \u00a0Di\t\r \u00a0CG,\t\r \u00a0Mannino\t\r \u00a0D,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Insulin\t\r \u00a0analogs\t\r \u00a0and\t\r \u00a0pregnancy:\t\r \u00a0an\t\r \u00a0update.\t\r \u00a0Acta\t\r \u00a0Diabetol\t\r \u00a046,\t\r \u00a0163-\u00ad\u201072\t\r \u00a0(2009).\t\r \u00a043.\t\r \u00a0\t\r \u00a0International\t\r \u00a0 Diabetes\t\r \u00a0 Federation,\t\r \u00a0 editores.\t\r \u00a0 IDF\t\r \u00a0 Diabetes\t\r \u00a0 Atlas.\t\r \u00a0 Brussels,\t\r \u00a0 Belgium:\t\r \u00a0International\t\r \u00a0Diabetes\t\r \u00a0Federation,\t\r \u00a02006.\t\r \u00a044.\t\r \u00a0\t\r \u00a0Spiller\t\r \u00a0HA,\t\r \u00a0Sawyer\t\r \u00a0TS.\t\r \u00a0Toxicology\t\r \u00a0of\t\r \u00a0oral\t\r \u00a0antidiabetic\t\r \u00a0medications.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Health\t\r \u00a0Syst\t\r \u00a0Pharm\t\r \u00a063,\t\r \u00a0929-\u00ad\u201038\t\r \u00a0(2006).\t\r \u00a045.\t\r \u00a0\t\r \u00a0Comisi\u00f3n\t\r \u00a0 de\t\r \u00a0 Farmacia\t\r \u00a0 y\t\r \u00a0 Terap\u00e9utica\t\r \u00a0 del\t\r \u00a0 Hospital\t\r \u00a0 Alarcos\t\r \u00a0 (Ciudad\t\r \u00a0 Real).\t\r \u00a0 Alerta\t\r \u00a0 sobre\t\r \u00a0seguridad\t\r \u00a0de\t\r \u00a0metformina:\t\r \u00a0riesgo\t\r \u00a0grave\t\r \u00a0de\t\r \u00a0acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0[acceso\t\r \u00a020.06.2007].\t\r \u00a0Disponible\t\r \u00a0en:\t\r \u00a0http://sescam.jccm.es/web1/profesionales/farmacia/usoRacional/documentos/VI_05_RiesgoGraveAcidosisLactica.pdf\t\r \u00a0\t\r \u00a046.\t\r \u00a0\t\r \u00a0UK\t\r \u00a0Prospective\t\r \u00a0Diabetes\t\r \u00a0Study\t\r \u00a0(UKPDS)\t\r \u00a0Group.\t\r \u00a0Effect\t\r \u00a0of\t\r \u00a0intensive\t\r \u00a0blood-\u00ad\u2010glucose\t\r \u00a0control\t\r \u00a0with\t\r \u00a0metformin\t\r \u00a0on\t\r \u00a0complications\t\r \u00a0in\t\r \u00a0overweight\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0(UKPDS\t\r \u00a034).\t\r \u00a0Lancet\t\r \u00a0352,\t\r \u00a0854-\u00ad\u201065\t\r \u00a0(1998).\t\r \u00a047.\t\r \u00a0\t\r \u00a0Consejo\t\r \u00a0 General\t\r \u00a0 de\t\r \u00a0 Colegios\t\r \u00a0 Oficiales\t\r \u00a0 de\t\r \u00a0 Farmac\u00e9uticos.\t\r \u00a0 Cat\u00e1logo\t\r \u00a0 de\t\r \u00a0 Especialidades\t\r \u00a0Farmac\u00e9uticas.\t\r \u00a0Madrid:\t\r \u00a0Colegio\t\r \u00a0de\t\r \u00a0Farmac\u00e9uticos;\t\r \u00a02009.\t\r \u00a048.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Dianben\t\r \u00a0 850mg\u00ae.\t\r \u00a0 Ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0 [acceso\t\r \u00a0 24.02.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=55211&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a049.\t\r \u00a0\t\r \u00a0Redondo\t\r \u00a0Capafons\t\r \u00a0S,\t\r \u00a0Garriga\t\r \u00a0Riosca\t\r \u00a0MR,\t\r \u00a0Pla\t\r \u00a0Poblador\t\r \u00a0R.\t\r \u00a0Seguimiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0metformina\t\r \u00a0en\t\r \u00a0la\t\r \u00a0poblaci\u00f3n\t\r \u00a0de\t\r \u00a0riesgo.\t\r \u00a0Farm\t\r \u00a0Hosp\t\r \u00a029,\t\r \u00a0364-\u00ad\u20106\t\r \u00a0(2005).\t\r \u00a050.\t\r \u00a0\t\r \u00a0Hirst\t\r \u00a0JA,\t\r \u00a0Farmer\t\r \u00a0AJ,\t\r \u00a0Ali\t\r \u00a0R,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Quantifying\t\r \u00a0the\t\r \u00a0effect\t\r \u00a0of\t\r \u00a0metformin\t\r \u00a0treatment\t\r \u00a0and\t\r \u00a0dose\t\r \u00a0on\t\r \u00a0glycemic\t\r \u00a0control.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a035,\t\r \u00a0446-\u00ad\u201054\t\r \u00a0(2012).\t\r \u00a051.\t\r \u00a0\t\r \u00a0El-\u00ad\u2010Hennawy\t\r \u00a0AS,\t\r \u00a0Jacob\t\r \u00a0S,\t\r \u00a0Mahmood\t\r \u00a0AK.\t\r \u00a0Metformin-\u00ad\u2010associated\t\r \u00a0lactic\t\r \u00a0acidosis\t\r \u00a0precipitated\t\r \u00a0by\t\r \u00a0diarrhea.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Ther\t\r \u00a014,\t\r \u00a0403-\u00ad\u20105\t\r \u00a0(2007).\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n316\t\r \u00a0\t\r \u00a052.\t\r \u00a0\t\r \u00a0Holstein\t\r \u00a0A,\t\r \u00a0Plaschke\t\r \u00a0A,\t\r \u00a0Egberts\t\r \u00a0EH.\t\r \u00a0Lower\t\r \u00a0incidence\t\r \u00a0of\t\r \u00a0severe\t\r \u00a0hypoglycaemia\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0treated\t\r \u00a0with\t\r \u00a0glimepiride\t\r \u00a0versus\t\r \u00a0glibenclamide.\t\r \u00a0Diabetes\t\r \u00a0Metab\t\r \u00a0Res\t\r \u00a0Rev\t\r \u00a017,\t\r \u00a0467-\u00ad\u201073\t\r \u00a0(2001).\t\r \u00a053.\t\r \u00a0\t\r \u00a0Consejo\t\r \u00a0General\t\r \u00a0de\t\r \u00a0Colegios\t\r \u00a0Oficiales\t\r \u00a0de\t\r \u00a0Farmac\u00e9uticos.\t\r \u00a0A10BB.\t\r \u00a0Sulfonilureas\t\r \u00a0y\t\r \u00a0productos\t\r \u00a0relacionados.\t\r \u00a0 Cat\u00e1logo\t\r \u00a0 de\t\r \u00a0 Especialidades\t\r \u00a0 Farmac\u00e9uticas.\t\r \u00a0 Madrid,\t\r \u00a0 Consejo\t\r \u00a0 de\t\r \u00a0Farmac\u00e9uticos;\t\r \u00a02008.\t\r \u00a0p.407.\t\r \u00a054.\t\r \u00a0\t\r \u00a0Elizondo-\u00ad\u2010L\u00f3pez-\u00ad\u2010de-\u00ad\u2010Landache\t\r \u00a0 I,\t\r \u00a0 Braceras-\u00ad\u2010Izaguirre\t\r \u00a0 L.\t\r \u00a0 Evoluci\u00f3n\t\r \u00a0 de\t\r \u00a0 datos\t\r \u00a0 de\t\r \u00a0 consumo\t\r \u00a0 de\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0 orales\t\r \u00a0 correspondientes\t\r \u00a0 al\t\r \u00a0 grupo\t\r \u00a0 terap\u00e9utico\t\r \u00a0 A10B\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 receta\t\r \u00a0m\u00e9dica\t\r \u00a0 oficial\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Comunidad\t\r \u00a0 Aut\u00f3noma\t\r \u00a0 del\t\r \u00a0 Pa\u00eds\t\r \u00a0 Vasco\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 periodo\t\r \u00a0 2000-\u00ad\u2010octubre\t\r \u00a02007.\t\r \u00a0Gac\t\r \u00a0Med\t\r \u00a0Bilbao\t\r \u00a0106,\t\r \u00a041-\u00ad\u20103\t\r \u00a0(2009).\t\r \u00a055.\t\r \u00a0\t\r \u00a0McIntosh\t\r \u00a0 A,\t\r \u00a0 Hutchinson\t\r \u00a0 A,\t\r \u00a0 Home\t\r \u00a0 PD,\t\r \u00a0 et\t\r \u00a0 al.,\t\r \u00a0 editores.\t\r \u00a0 Clinical\t\r \u00a0 guidelines\t\r \u00a0 and\t\r \u00a0 evidence\t\r \u00a0review\t\r \u00a0for\t\r \u00a0Type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0management\t\r \u00a0of\t\r \u00a0blood\t\r \u00a0glucose.\t\r \u00a0Sheffield:\t\r \u00a0ScHARR,\t\r \u00a0University\t\r \u00a0of\t\r \u00a0Sheffield.\t\r \u00a0\t\r \u00a02001.\t\r \u00a056.\t\r \u00a0\t\r \u00a0Cano\t\r \u00a0Blanquer\t\r \u00a0D,\t\r \u00a0San\t\r \u00a0Mart\u00edn\t\r \u00a0Ciges\t\r \u00a0MD.\t\r \u00a0Utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0en\t\r \u00a0un\t\r \u00a0\u00e1rea\t\r \u00a0de\t\r \u00a0salud\t\r \u00a0urbana\t\r \u00a0y\t\r \u00a0otra\t\r \u00a0rural\t\r \u00a0de\t\r \u00a0la\t\r \u00a0provincia\t\r \u00a0de\t\r \u00a0Valencia.\t\r \u00a0FAP\t\r \u00a03,\t\r \u00a0105-\u00ad\u201017\t\r \u00a0(2005).\t\r \u00a057.\t\r \u00a0\t\r \u00a0Reimundez\t\r \u00a0G\t\r \u00a0and\t\r \u00a0Real\t\r \u00a0M.\t\r \u00a0El\t\r \u00a0estudio\t\r \u00a0ADVANCE,\t\r \u00a0el\t\r \u00a0m\u00e1s\t\r \u00a0amplio\t\r \u00a0realizado\t\r \u00a0hasta\t\r \u00a0ahora\t\r \u00a0en\t\r \u00a0diab\u00e9ticos\t\r \u00a0 Tipo\t\r \u00a0 2,\t\r \u00a0 muestra\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 control\t\r \u00a0 intensivo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 glucosa\t\r \u00a0 reduce\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 10%\t\r \u00a0 las\t\r \u00a0complicaciones\t\r \u00a0 macro\t\r \u00a0 y\t\r \u00a0 microvasculares\t\r \u00a0 asociadas\t\r \u00a0 a\t\r \u00a0 esta\t\r \u00a0 patolog\u00eda.\t\r \u00a0 Nota\t\r \u00a0 de\t\r \u00a0 prensa.\t\r \u00a0\t\r \u00a0Disponible\t\r \u00a0en:\t\r \u00a0http://www.accesomedia.com/display_release.html?id=47178\t\r \u00a0\t\r \u00a058.\t\r \u00a0\t\r \u00a0Patel\t\r \u00a0 A,\t\r \u00a0 MacMahon\t\r \u00a0 S,\t\r \u00a0 Chalmers\t\r \u00a0 J,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Intensive\t\r \u00a0 blood\t\r \u00a0 glucose\t\r \u00a0 control\t\r \u00a0 and\t\r \u00a0 vascular\t\r \u00a0outcomes\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes.\t\r \u00a0N\t\r \u00a0Engl\t\r \u00a0J\t\r \u00a0Med\t\r \u00a0358,\t\r \u00a02560-\u00ad\u201072\t\r \u00a0(2008).\t\r \u00a059.\t\r \u00a0\t\r \u00a0Shvidel\t\r \u00a0L,\t\r \u00a0Arcavi\t\r \u00a0L,\t\r \u00a0Sigler\t\r \u00a0E.\t\r \u00a0Symptomatic\t\r \u00a0anemia\t\r \u00a0induced\t\r \u00a0by\t\r \u00a0rosiglitazone.\t\r \u00a0Eur\t\r \u00a0J\t\r \u00a0Intern\t\r \u00a0Med\t\r \u00a018,\t\r \u00a0348\t\r \u00a0(2007).\t\r \u00a060.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Avandia\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000268/WC500029108.pdf\t\r \u00a0\t\r \u00a061.\t\r \u00a0\t\r \u00a0Thomas\t\r \u00a0 MC,\t\r \u00a0 Cooper\t\r \u00a0 ME,\t\r \u00a0 Rossing\t\r \u00a0 K,\t\r \u00a0 et\t\r \u00a0al.\t\r \u00a0 Anaemia\t\r \u00a0 in\t\r \u00a0 diabetes:\t\r \u00a0 Is\t\r \u00a0 there\t\r \u00a0 a\t\r \u00a0 rationale\t\r \u00a0 to\t\r \u00a0TREAT?\t\r \u00a0Diabetologia\t\r \u00a049,\t\r \u00a01151-\u00ad\u20107\t\r \u00a0(2006).\t\r \u00a062.\t\r \u00a0\t\r \u00a0The\t\r \u00a0 Diabetes\t\r \u00a0 Control\t\r \u00a0 and\t\r \u00a0 Complications\t\r \u00a0 Trial\t\r \u00a0 Research\t\r \u00a0 Group.\t\r \u00a0 The\t\r \u00a0 effect\t\r \u00a0 of\t\r \u00a0 intensive\t\r \u00a0treatment\t\r \u00a0of\t\r \u00a0diabetes\t\r \u00a0on\t\r \u00a0the\t\r \u00a0development\t\r \u00a0and\t\r \u00a0progression\t\r \u00a0of\t\r \u00a0long-\u00ad\u2010term\t\r \u00a0complications\t\r \u00a0in\t\r \u00a0insulin-\u00ad\u2010dependent\t\r \u00a0diabetes\t\r \u00a0mellitus.\t\r \u00a0N\t\r \u00a0Engl\t\r \u00a0J\t\r \u00a0Med\t\r \u00a0329,\t\r \u00a0977-\u00ad\u201086\t\r \u00a0(1993).\t\r \u00a063.\t\r \u00a0\t\r \u00a0UK\t\r \u00a0 Prospective\t\r \u00a0 Diabetes\t\r \u00a0 Study\t\r \u00a0 (UKPDS)\t\r \u00a0 Group.\t\r \u00a0 Intensive\t\r \u00a0 blood-\u00ad\u2010glucose\t\r \u00a0 control\t\r \u00a0 with\t\r \u00a0sulphonylureas\t\r \u00a0 or\t\r \u00a0 insulin\t\r \u00a0 compared\t\r \u00a0 with\t\r \u00a0 conventional\t\r \u00a0 treatment\t\r \u00a0 and\t\r \u00a0 risk\t\r \u00a0 of\t\r \u00a0complications\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0(UKPDS\t\r \u00a033).\t\r \u00a0Lancet\t\r \u00a0352,\t\r \u00a0837-\u00ad\u201053\t\r \u00a0(1998).\t\r \u00a064.\t\r \u00a0\t\r \u00a0DeWitt\t\r \u00a0DE,\t\r \u00a0Hirsch\t\r \u00a0IB.\t\r \u00a0Outpatient\t\r \u00a0insulin\t\r \u00a0therapy\t\r \u00a0in\t\r \u00a0type\t\r \u00a01\t\r \u00a0and\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0mellitus:\t\r \u00a0scientific\t\r \u00a0review.\t\r \u00a0JAMA\t\r \u00a0289,\t\r \u00a02254-\u00ad\u201064\t\r \u00a0(2003).\t\r \u00a065.\t\r \u00a0\t\r \u00a0CADIME\t\r \u00a0-\u00ad\u2010\t\r \u00a0Escuela\t\r \u00a0 Andaluza\t\r \u00a0 de\t\r \u00a0 Salud\t\r \u00a0 P\u00fablica.\t\r \u00a0 Nuevas\t\r \u00a0 insulinas.\t\r \u00a0 Bolet\u00edn\t\r \u00a0 Terap\u00e9utico\t\r \u00a0Andaluz\t\r \u00a022,\t\r \u00a017-\u00ad\u20109\t\r \u00a0(2006).\t\r \u00a066.\t\r \u00a0\t\r \u00a0Martin\t\r \u00a0 CL,\t\r \u00a0 Albers\t\r \u00a0 J,\t\r \u00a0 Herman\t\r \u00a0 WH,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Neuropathy\t\r \u00a0 among\t\r \u00a0 the\t\r \u00a0 diabetes\t\r \u00a0 control\t\r \u00a0 and\t\r \u00a0complications\t\r \u00a0trial\t\r \u00a0cohort\t\r \u00a08\t\r \u00a0years\t\r \u00a0after\t\r \u00a0trial\t\r \u00a0completion.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a029,\t\r \u00a0340-\u00ad\u20104\t\r \u00a0(2006).\t\r \u00a067.\t\r \u00a0\t\r \u00a0American\t\r \u00a0 Diabetes\t\r \u00a0 Association.\t\r \u00a0 Standards\t\r \u00a0 of\t\r \u00a0 medical\t\r \u00a0 care\t\r \u00a0 in\t\r \u00a0 diabetes-\u00ad\u2010-\u00ad\u20102008.\t\r \u00a0 Diabetes\t\r \u00a0Care\t\r \u00a031\t\r \u00a0Suppl\t\r \u00a01,\t\r \u00a0S12-\u00ad\u2010S54\t\r \u00a0(2008).\t\r \u00a068.\t\r \u00a0\t\r \u00a0Cengiz\t\r \u00a0 E,\t\r \u00a0 Swan\t\r \u00a0 KL,\t\r \u00a0 Tamborlane\t\r \u00a0 WV,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 The\t\r \u00a0 Alteration\t\r \u00a0 of\t\r \u00a0 Aspart\t\r \u00a0 Insulin\t\r \u00a0Pharmacodynamics\t\r \u00a0When\t\r \u00a0Mixed\t\r \u00a0With\t\r \u00a0Detemir\t\r \u00a0Insulin.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a0\t\r \u00a0(2012).\t\r \u00a069.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Lantus\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a003.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000284/WC500036082.pdf\t\r \u00a0\t\r \u00a070.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Novorapid\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000258/WC500030372.pdf\t\r \u00a0\t\r \u00a071.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0Humalog\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.10.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000088/WC500050332.pdf\t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0317\t\r \u00a0\t\r \u00a072.\t\r \u00a0\t\r \u00a0WHO\t\r \u00a0Collaborating\t\r \u00a0Centre\t\r \u00a0for\t\r \u00a0Drug\t\r \u00a0Statistics\t\r \u00a0Methodology,\t\r \u00a0Norwegian\t\r \u00a0Institute\t\r \u00a0of\t\r \u00a0Public\t\r \u00a0Health.\t\r \u00a0ATC/DDD\t\r \u00a0 Index\t\r \u00a0 [acceso\t\r \u00a0 16.03.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.whocc.no/atc_ddd_index/\t\r \u00a0\t\r \u00a073.\t\r \u00a0\t\r \u00a0WHO\t\r \u00a0Collaborating\t\r \u00a0Centre\t\r \u00a0for\t\r \u00a0Drug\t\r \u00a0Statistics\t\r \u00a0Methodology,\t\r \u00a0Norwegian\t\r \u00a0Institute\t\r \u00a0of\t\r \u00a0Public\t\r \u00a0Health.\t\r \u00a0 List\t\r \u00a0 of\t\r \u00a0 DDDs\t\r \u00a0 combined\t\r \u00a0 products\t\r \u00a0 [acceso\t\r \u00a0 20.05.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.whocc.no/ddd/list_of_ddds_combined_products/\t\r \u00a0\t\r \u00a074.\t\r \u00a0\t\r \u00a0Monami\t\r \u00a0 M,\t\r \u00a0 Luzzi\t\r \u00a0 C,\t\r \u00a0 Lamanna\t\r \u00a0 C,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Three-\u00ad\u2010year\t\r \u00a0 mortality\t\r \u00a0 in\t\r \u00a0 diabetic\t\r \u00a0 patients\t\r \u00a0 treated\t\r \u00a0with\t\r \u00a0different\t\r \u00a0combinations\t\r \u00a0of\t\r \u00a0insulin\t\r \u00a0secretagogues\t\r \u00a0and\t\r \u00a0metformin.\t\r \u00a0Diabetes\t\r \u00a0Metab\t\r \u00a0Res\t\r \u00a0Rev\t\r \u00a022,\t\r \u00a0477-\u00ad\u201082\t\r \u00a0(2006).\t\r \u00a075.\t\r \u00a0\t\r \u00a0Gonzalez-\u00ad\u2010Ortiz\t\r \u00a0 M,\t\r \u00a0 Guerrero-\u00ad\u2010Romero\t\r \u00a0 JF,\t\r \u00a0 Violante-\u00ad\u2010Ortiz\t\r \u00a0 R,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Efficacy\t\r \u00a0 of\t\r \u00a0glimepiride/metformin\t\r \u00a0 combination\t\r \u00a0 versus\t\r \u00a0 glibenclamide/metformin\t\r \u00a0 in\t\r \u00a0 patients\t\r \u00a0 with\t\r \u00a0uncontrolled\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0mellitus.\t\r \u00a0J\t\r \u00a0Diabetes\t\r \u00a0Complications\t\r \u00a023,\t\r \u00a0376-\u00ad\u20109\t\r \u00a0(2009).\t\r \u00a076.\t\r \u00a0\t\r \u00a0Nathan\t\r \u00a0DM,\t\r \u00a0Buse\t\r \u00a0JB,\t\r \u00a0Davidson\t\r \u00a0MB,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Management\t\r \u00a0of\t\r \u00a0hyperglycemia\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0A\t\r \u00a0consensus\t\r \u00a0algorithm\t\r \u00a0for\t\r \u00a0the\t\r \u00a0initiation\t\r \u00a0and\t\r \u00a0adjustment\t\r \u00a0of\t\r \u00a0therapy:\t\r \u00a0a\t\r \u00a0consensus\t\r \u00a0statement\t\r \u00a0from\t\r \u00a0 the\t\r \u00a0 American\t\r \u00a0 Diabetes\t\r \u00a0 Association\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 European\t\r \u00a0 Association\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 Study\t\r \u00a0 of\t\r \u00a0Diabetes.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a029,\t\r \u00a01963-\u00ad\u201072\t\r \u00a0(2006).\t\r \u00a077.\t\r \u00a0\t\r \u00a0Nathan\t\r \u00a0DM,\t\r \u00a0Buse\t\r \u00a0JB,\t\r \u00a0Davidson\t\r \u00a0MB,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Management\t\r \u00a0of\t\r \u00a0hyperglycemia\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0a\t\r \u00a0 consensus\t\r \u00a0 algorithm\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 initiation\t\r \u00a0 and\t\r \u00a0 adjustment\t\r \u00a0 of\t\r \u00a0 therapy:\t\r \u00a0 update\t\r \u00a0 regarding\t\r \u00a0thiazolidinediones:\t\r \u00a0 a\t\r \u00a0 consensus\t\r \u00a0 statement\t\r \u00a0 from\t\r \u00a0 the\t\r \u00a0 American\t\r \u00a0 Diabetes\t\r \u00a0 Association\t\r \u00a0 and\t\r \u00a0the\t\r \u00a0European\t\r \u00a0Association\t\r \u00a0for\t\r \u00a0the\t\r \u00a0Study\t\r \u00a0of\t\r \u00a0Diabetes.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a031,\t\r \u00a0173-\u00ad\u20105\t\r \u00a0(2008).\t\r \u00a078.\t\r \u00a0\t\r \u00a0Nathan\t\r \u00a0DM,\t\r \u00a0Buse\t\r \u00a0JB,\t\r \u00a0Davidson\t\r \u00a0MB,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Medical\t\r \u00a0management\t\r \u00a0of\t\r \u00a0hyperglycemia\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0a\t\r \u00a0consensus\t\r \u00a0algorithm\t\r \u00a0for\t\r \u00a0the\t\r \u00a0initiation\t\r \u00a0and\t\r \u00a0adjustment\t\r \u00a0of\t\r \u00a0therapy:\t\r \u00a0a\t\r \u00a0consensus\t\r \u00a0statement\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 American\t\r \u00a0 Diabetes\t\r \u00a0 Association\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 European\t\r \u00a0 Association\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0Study\t\r \u00a0of\t\r \u00a0Diabetes.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a032,\t\r \u00a0193-\u00ad\u2010203\t\r \u00a0(2009).\t\r \u00a079.\t\r \u00a0\t\r \u00a0National\t\r \u00a0Collaborating\t\r \u00a0Centre\t\r \u00a0for\t\r \u00a0Chronic\t\r \u00a0Conditions,\t\r \u00a0editores.\t\r \u00a0Type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0national\t\r \u00a0clinical\t\r \u00a0guideline\t\r \u00a0for\t\r \u00a0management\t\r \u00a0in\t\r \u00a0primary\t\r \u00a0and\t\r \u00a0secondary\t\r \u00a0care\t\r \u00a0(update).\t\r \u00a0London:\t\r \u00a0Royal\t\r \u00a0College\t\r \u00a0of\t\r \u00a0Physicians,\t\r \u00a02008.\t\r \u00a080.\t\r \u00a0\t\r \u00a0Schier\t\r \u00a0JG,\t\r \u00a0Hoffman\t\r \u00a0RS,\t\r \u00a0Nelson\t\r \u00a0LS.\t\r \u00a0Metformin-\u00ad\u2010induced\t\r \u00a0acidosis\t\r \u00a0due\t\r \u00a0to\t\r \u00a0a\t\r \u00a0warfarin\t\r \u00a0adverse\t\r \u00a0drug\t\r \u00a0event.\t\r \u00a0Ann\t\r \u00a0Pharmacother\t\r \u00a037,\t\r \u00a01145\t\r \u00a0(2003).\t\r \u00a081.\t\r \u00a0\t\r \u00a0Gomes\t\r \u00a0 T,\t\r \u00a0 Juurlink\t\r \u00a0 DN,\t\r \u00a0 Lipscombe\t\r \u00a0 LL,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Clinical\t\r \u00a0 and\t\r \u00a0 demographic\t\r \u00a0 characteristics\t\r \u00a0 of\t\r \u00a0patients\t\r \u00a0 receiving\t\r \u00a0 different\t\r \u00a0 oral\t\r \u00a0 hypoglycemic\t\r \u00a0 agents.\t\r \u00a0Pharmacoepidemiol\t\r \u00a0 Drug\t\r \u00a0 Saf\t\r \u00a0 18,\t\r \u00a0756-\u00ad\u201060\t\r \u00a0(2009).\t\r \u00a082.\t\r \u00a0\t\r \u00a0Fornos\t\r \u00a0 JA,\t\r \u00a0 Patricia\t\r \u00a0 Garc\u00eda\t\r \u00a0 G,\t\r \u00a0 Fern\u00e1ndez\t\r \u00a0 M,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Evaluaci\u00f3n\t\r \u00a0 del\t\r \u00a0 conocimiento,\t\r \u00a0 el\t\r \u00a0cumplimiento\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 satisfacci\u00f3n\t\r \u00a0 del\t\r \u00a0 tratamiento\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 diab\u00e9ticos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 oficina\t\r \u00a0 de\t\r \u00a0farmacia.\t\r \u00a0Av\t\r \u00a0Diabetol\t\r \u00a024,\t\r \u00a0399-\u00ad\u2010406\t\r \u00a0(2008).\t\r \u00a083.\t\r \u00a0\t\r \u00a0Instituto\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Estad\u00edstica\t\r \u00a0(INE).\t\r \u00a0Mujeres\t\r \u00a0y\t\r \u00a0hombres\t\r \u00a0en\t\r \u00a0Espa\u00f1a\t\r \u00a02008-\u00ad\u20102010\t\r \u00a0[acceso\t\r \u00a003.10.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ine.es/ss/Satellite?L=es_ES&c=INEPublicacion_C&cid=1259924822888&p=1254735110672&pagename=ProductosYServicios%2FPYSLayout&tittema=Sociedad\t\r \u00a0\t\r \u00a084.\t\r \u00a0\t\r \u00a0Dilla\t\r \u00a0T,\t\r \u00a0Costi\t\r \u00a0M,\t\r \u00a0Boye\t\r \u00a0KS,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0El\t\r \u00a0impacto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0en\t\r \u00a0el\t\r \u00a0manejo\t\r \u00a0y\t\r \u00a0evoluci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0diabetes\t\r \u00a0mellitus.\t\r \u00a0Rev\t\r \u00a0Clin\t\r \u00a0Esp\t\r \u00a0208,\t\r \u00a0437-\u00ad\u201043\t\r \u00a0(2008).\t\r \u00a085.\t\r \u00a0\t\r \u00a0UBM\t\r \u00a0 Medica.\t\r \u00a0 Vademecum\t\r \u00a0 de\t\r \u00a0 medicamentos,\t\r \u00a0 sustancias,\t\r \u00a0 principios\t\r \u00a0 activos,\t\r \u00a0 dopaje,\t\r \u00a0interacciones,\t\r \u00a0 equivalencias\t\r \u00a0 internacionales\t\r \u00a0 y\t\r \u00a0 laboratorios\t\r \u00a0 farmac\u00e9uticos\t\r \u00a0 de\t\r \u00a0 Espa\u00f1a\t\r \u00a0[acceso\t\r \u00a014.12.2011].\t\r \u00a0Disponible\t\r \u00a0en:\t\r \u00a0http://www.vademecum.es/\t\r \u00a0\t\r \u00a086.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Acetensil\u00ae.\t\r \u00a0 Ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a0 24.12.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=58116&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a087.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0y\t\r \u00a0Productos\t\r \u00a0Sanitarios.\t\r \u00a0Daonil\u00ae.\t\r \u00a0Ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a024.12.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=48545&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a088.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Glucobay\u00ae.\t\r \u00a0 Ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a0 24.02.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=59420&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a089.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Exelon\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n318\t\r \u00a0\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000169/WC500032598.pdf\t\r \u00a0\t\r \u00a090.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Sintrom\u00ae.\t\r \u00a0 Ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a0 24.12.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=58994&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a091.\t\r \u00a0\t\r \u00a0American\t\r \u00a0 Diabetes\t\r \u00a0 Association.\t\r \u00a0 Standards\t\r \u00a0 of\t\r \u00a0 medical\t\r \u00a0 care\t\r \u00a0 in\t\r \u00a0 diabetes-\u00ad\u2010-\u00ad\u20102009.\t\r \u00a0Diabetes\t\r \u00a0Care\t\r \u00a032\t\r \u00a0Suppl\t\r \u00a01,\t\r \u00a0S13-\u00ad\u2010S61\t\r \u00a0(2009).\t\r \u00a092.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0Espa\u00f1ola\t\r \u00a0de\t\r \u00a0Medicamentos\t\r \u00a0y\t\r \u00a0Productos\t\r \u00a0Sanitarios.\t\r \u00a0Zocor\u00ae.\t\r \u00a0Ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a024.02.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=58846&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a093.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Nota\t\r \u00a0 informativa\t\r \u00a0 2003/07.\t\r \u00a0Contraindicaci\u00f3n\t\r \u00a0del\t\r \u00a0uso\t\r \u00a0concomitante\t\r \u00a0de\t\r \u00a0repaglinida\t\r \u00a0y\t\r \u00a0gemfibrozilo\t\r \u00a0[acceso\t\r \u00a005.06.2008].\t\r \u00a0Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2003/NI_2003-\u00ad\u201007_repaglinida-\u00ad\u2010gemfibrozilo.htm\t\r \u00a0\t\r \u00a094.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Tavanic\u00ae.\t\r \u00a0 Ficha\t\r \u00a0 t\u00e9cnica\t\r \u00a0[acceso\t\r \u00a0 24.02.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=62065&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0\t\r \u00a095.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Aprovel\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000141/WC500025752.pdf\t\r \u00a0\t\r \u00a096.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Novonorm\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000187/WC500029905.pdf\t\r \u00a0\t\r \u00a097.\t\r \u00a0\t\r \u00a0European\t\r \u00a0 Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Actos\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000285/WC500021386.pdf\t\r \u00a0\t\r \u00a098.\t\r \u00a0\t\r \u00a0Sibal\t\r \u00a0 L,\t\r \u00a0 Home\t\r \u00a0 PD.\t\r \u00a0 Management\t\r \u00a0 of\t\r \u00a0 type\t\r \u00a0 2\t\r \u00a0 diabetes:\t\r \u00a0 NICE\t\r \u00a0 guidelines.\t\r \u00a0 Clin\t\r \u00a0 Med\t\r \u00a0 9,\t\r \u00a0 353-\u00ad\u20107\t\r \u00a0(2009).\t\r \u00a099.\t\r \u00a0\t\r \u00a0European\t\r \u00a0Medicines\t\r \u00a0 Agency\t\r \u00a0 (EMEA).\t\r \u00a0 Novomix\u00ae:\t\r \u00a0 EPAR-\u00ad\u2010Product\t\r \u00a0 information\t\r \u00a0 [acceso\t\r \u00a010.01.2012].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-\u00ad\u2010_Product_Information/human/000308/WC500029441.pdf\t\r \u00a0\t\r \u00a0100.\t\r \u00a0\t\r \u00a0Agencia\t\r \u00a0 Espa\u00f1ola\t\r \u00a0 de\t\r \u00a0 Medicamentos\t\r \u00a0 y\t\r \u00a0 Productos\t\r \u00a0 Sanitarios.\t\r \u00a0 Amaryl\u00ae.\t\r \u00a0 Ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0 [acceso\t\r \u00a0 24.12.2011].\t\r \u00a0 Disponible\t\r \u00a0 en:\t\r \u00a0http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=61409&formato=pdf&formulario=FICHAS&file=ficha.pdf\t\r \u00a0 \t\r \u00a0\t\r \u00a0Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0319\t\r \u00a0\t\r \u00a0AP\u00c9NDICE\t\r \u00a01a.\t\r \u00a0An\u00e1lisis\t\r \u00a0de\t\r \u00a0red\t\r \u00a0de\t\r \u00a0enlaces.\t\r \u00a0Frecuencias\t\r \u00a0de\t\r \u00a0correlaci\u00f3n\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0GRUPO\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0t\u00e9rmino\t\r \u00a0preferente\t\r \u00a0RAM\t\r \u00a0n\u00ba\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0GRUPO\t\r \u00a01.\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0Insulina\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0A10AD05\t\r \u00a0Hiperglucemia\t\r \u00a07\t\r \u00a0A10AE05\t\r \u00a0Reacci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a05\t\r \u00a0A10AC01\t\r \u00a0Hipoglucemia\t\r \u00a05\t\r \u00a0A10AE04\t\r \u00a0Hiperglucemia\t\r \u00a05\t\r \u00a0A10AE05\t\r \u00a0Erupci\u00f3n\t\r \u00a0eritematosa\t\r \u00a03\t\r \u00a0A10AE04\t\r \u00a0Hipoglucemia\t\r \u00a03\t\r \u00a0A10AE04\t\r \u00a0Reacci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0inyecci\u00f3n\t\r \u00a03\t\r \u00a0A10AD05\t\r \u00a0Respuesta\t\r \u00a0terap\u00e9utica\t\r \u00a0disminuida\t\r \u00a03\t\r \u00a0A10AD01\t\r \u00a0Hiperglucemia\t\r \u00a02\t\r \u00a0A10AE04\t\r \u00a0Erupci\u00f3n\t\r \u00a0eritematosa\t\r \u00a02\t\r \u00a0A10AD05\t\r \u00a0Prurito\t\r \u00a02\t\r \u00a0A10AE04\t\r \u00a0Diabetes\t\r \u00a0mellitus\t\r \u00a02\t\r \u00a0A10AC01\t\r \u00a0Hiperglucemia\t\r \u00a02\t\r \u00a0GRUPO\t\r \u00a02.\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0monoterapia\t\r \u00a0A10BA02\t\r \u00a0Diarrea\t\r \u00a060\t\r \u00a0A10BA02\t\r \u00a0Acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a028\t\r \u00a0A10BB01\t\r \u00a0Hipoglucemia\t\r \u00a020\t\r \u00a0A10BA02\t\r \u00a0Dolor\t\r \u00a0abdominal\t\r \u00a011\t\r \u00a0A10BA02\t\r \u00a0Dispepsia\t\r \u00a010\t\r \u00a0A10BA02\t\r \u00a0N\u00e1useas\t\r \u00a010\t\r \u00a0A10BB12\t\r \u00a0Hipoglucemia\t\r \u00a09\t\r \u00a0A10BG02\t\r \u00a0Anemia\t\r \u00a06\t\r \u00a0A10BF01\t\r \u00a0Diarrea\t\r \u00a06\t\r \u00a0A10BA02\t\r \u00a0Mareo\t\r \u00a06\t\r \u00a0\t\r \u00a0\t\r \u00a01b.\t\r \u00a0An\u00e1lisis\t\r \u00a0de\t\r \u00a0red\t\r \u00a0de\t\r \u00a0enlaces.\t\r \u00a0Frecuencias\t\r \u00a0de\t\r \u00a0correlaci\u00f3n\t\r \u00a0en\t\r \u00a0politerapia\t\r \u00a0GRUPO\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0sospechoso\t\r \u00a0posici\u00f3n\t\r \u00a01\t\r \u00a0principio\t\r \u00a0activo\t\r \u00a0sospechoso\t\r \u00a0posici\u00f3n\t\r \u00a02\t\r \u00a0t\u00e9rmino\t\r \u00a0preferente\t\r \u00a0RAM\t\r \u00a0posici\u00f3n\t\r \u00a01\t\r \u00a0t\u00e9rmino\t\r \u00a0preferente\t\r \u00a0RAM\t\r \u00a0posici\u00f3n\t\r \u00a02\t\r \u00a0n\u00ba\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0GRUPO\t\r \u00a03.\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0Insulina/s\t\r \u00a0y\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos\t\r \u00a0A10AE05\t\r \u00a0A10AB05\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0A10AC01\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0A10AD04\t\r \u00a0A10AB04\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0A10AE04\t\r \u00a0-\u00ad\u2010\t\r \u00a0Shock\t\r \u00a0hipogluc\u00e9mico\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0A10AB04\t\r \u00a0A10AC01\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0C09CA04\t\r \u00a0C03AA03\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0GRUPO\t\r \u00a04.\t\r \u00a0\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0AHO/s\t\r \u00a0y\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0AHO\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n\t\r \u00a0A10BA02\t\r \u00a0A10BB01\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a011\t\r \u00a0A10BB01\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a011\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0Diarrea\t\r \u00a0-\u00ad\u2010\t\r \u00a011\t\r \u00a0A10BB01\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a09\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BA02\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a08\t\r \u00a0Mar\u00eda\t\r \u00a0Isabel\t\r \u00a0Jim\u00e9nez\t\r \u00a0Serran\u00eda,\t\r \u00a0Ramona\t\r \u00a0Mateos\t\r \u00a0\t\r \u00a0\n320\t\r \u00a0\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a08\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0Acidosis\t\r \u00a0l\u00e1ctica\t\r \u00a0-\u00ad\u2010\t\r \u00a07\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BB01\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a07\t\r \u00a0A10BA02\t\r \u00a0A10BB12\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a04\t\r \u00a0A10BG03\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0A10BG02\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0A10BB12\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BB12\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0A10BB01\t\r \u00a0C09AA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Acidosis\t\r \u00a03\t\r \u00a0GRUPO\t\r \u00a05.\t\r \u00a0\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0AHO/s\t\r \u00a0y\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0no\t\r \u00a0antidiab\u00e9ticos.\t\r \u00a0Principio\t\r \u00a0activo\t\r \u00a0no\t\r \u00a0antidiab\u00e9tico\t\r \u00a0en\t\r \u00a0primera\t\r \u00a0posici\u00f3n\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BB01\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a05\t\r \u00a0B01AA07\t\r \u00a0A10BB01\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a04\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0N\u00e1useas\t\r \u00a03\t\r \u00a0C09AA02\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0C10AB04\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a03\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BB01\t\r \u00a0Hepatitis\t\r \u00a0colest\u00e1sica\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0C09CA03\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0C09CA04\t\r \u00a0-\u00ad\u2010\t\r \u00a0Erupci\u00f3n\t\r \u00a0eritematosa\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0C10AA01\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hepatitis\t\r \u00a0colest\u00e1sica\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0J01MA12\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0N06DA03\t\r \u00a0A10BA02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0N06DA03\t\r \u00a0-\u00ad\u2010\t\r \u00a0Pirexia\t\r \u00a0\t\r \u00a02\t\r \u00a0N06DA03\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0N\u00e1useas\t\r \u00a02\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BA02\t\r \u00a0Pirexia\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a0Pirexia\t\r \u00a0N\u00e1useas\t\r \u00a02\t\r \u00a0GRUPO\t\r \u00a06:\t\r \u00a0Notificaciones\t\r \u00a0con\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0Insulina/s\t\r \u00a0y\t\r \u00a0AHO/s\t\r \u00a0A10BA02\t\r \u00a0A10BX02\t\r \u00a0-\u00ad\u2010\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0-\u00ad\u2010\t\r \u00a0A10BA02\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0A10AE04\t\r \u00a0-\u00ad\u2010\t\r \u00a0Hipoglucemia\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0A10BG03\t\r \u00a0-\u00ad\u2010\t\r \u00a0V\u00e9rtigo\t\r \u00a0-\u00ad\u2010\t\r \u00a02\t\r \u00a0   Perfiles\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0diab\u00e9ticos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0321\t\r \u00a0\t\r \u00a02.\t\r \u00a0Ejemplo\t\r \u00a0de\t\r \u00a0ficha-\u00ad\u2010resumen\t\r \u00a0estructurada.\t\r \u00a0Informaci\u00f3n\t\r \u00a0obtenida\t\r \u00a0para\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a01.1:\t\r \u00a0\t\r \u00a0\t\r \u00a0PERFIL\t\r \u00a01.1\t\r \u00a0DATOS\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0NOTIFICACI\u00d3N\t\r \u00a052\t\r \u00a0notificaciones\t\r \u00a0x=0,\t\r \u00a0y=0\t\r \u00a0G\u00e9nero:\t\r \u00a0mujer\t\r \u00a0-\u00ad\u2010>\t\r \u00a059,62%\t\r \u00a0Gravedad:\t\r \u00a0no\t\r \u00a0-\u00ad\u2010>\t\r \u00a0100%\t\r \u00a0Edad\t\r \u00a0(a\u00f1os):\t\r \u00a0\u2265\t\r \u00a075\t\r \u00a0-\u00ad\u2010>\t\r \u00a021,15%\t\r \u00a0Mortal:\t\r \u00a0-\u00ad\u2010\t\r \u00a0CCAA:\t\r \u00a0Catalu\u00f1a\t\r \u00a0-\u00ad\u2010>\t\r \u00a017,31%\t\r \u00a0A\u00f1o:\t\r \u00a0\t\r \u00a02006\t\r \u00a0-\u00ad\u2010>\t\r \u00a023,08%\t\r \u00a0PRINCIPIOS\t\r \u00a0ACTIVOS\t\r \u00a0(PAs)\t\r \u00a0PA1\t\r \u00a0ATC\t\r \u00a04:\t\r \u00a0\t\r \u00a0A10AE\t\r \u00a0-\u00ad\u2010>\t\r \u00a040,38%\t\r \u00a0ATC\t\r \u00a05:\t\r \u00a0\t\r \u00a0A10AE05\t\r \u00a0-\u00ad\u2010>\t\r \u00a026,92%\t\r \u00a0Sospecha:\t\r \u00a0sospechoso\t\r \u00a0-\u00ad\u2010>\t\r \u00a0100%\t\r \u00a0Indicaci\u00f3n\t\r \u00a0terap\u00e9utica:\t\r \u00a0Diabetes\t\r \u00a0mellitus\t\r \u00a0-\u00ad\u2010>\t\r \u00a067,31%\t\r \u00a0REACCIONES\t\r \u00a0ADVERSAS\t\r \u00a0(RAMs)\t\r \u00a0RAM1\t\r \u00a0\u00d3rgano\t\r \u00a0Trastornos\t\r \u00a0generales\t\r \u00a0y\t\r \u00a0alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0administraci\u00f3n\t\r \u00a0-\u00ad\u2010>\t\r \u00a036,54%\t\r \u00a0RAM2\t\r \u00a0\u00d3rgano\t\r \u00a0Trastornos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0piel\t\r \u00a0y\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0subcut\u00e1neo,\t\r \u00a0Trastornos\t\r \u00a0generales\t\r \u00a0y\t\r \u00a0alteraciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0administraci\u00f3n\t\r \u00a0-\u00ad\u2010>\t\r \u00a031,58%\t\r \u00a0HltRAM\t\r \u00a0Pruritus\t\r \u00a0NCOC\t\r \u00a0-\u00ad\u2010>\t\r \u00a015,79%\t\r \u00a0RAM3\t\r \u00a0\u00d3rgano\t\r \u00a0Trastornos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0piel\t\r \u00a0y\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0subcut\u00e1neo\t\r \u00a0-\u00ad\u2010>\t\r \u00a060%\t\r \u00a0HltRAM\t\r \u00a0Pruritus\t\r \u00a0NCOC\t\r \u00a0-\u00ad\u2010>\t\r \u00a040%\t\r \u00a0PtRAM\t\r \u00a0Prurito\t\r \u00a0-\u00ad\u2010>\t\r \u00a040%\t\r \u00a0RELACI\u00d3N\t\r \u00a0CAUSAL-\u00ad\u2010\t\r \u00a0Algoritmo\t\r \u00a0de\t\r \u00a0Karch\t\r \u00a0y\t\r \u00a0Lasagna:\t\r \u00a05-\u00ad\u20108\t\r \u00a0probable\t\r \u00a0-\u00ad\u2010>\t\r \u00a063,46%\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0322\t\r \u00a0\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco,\t\r \u00a0 marr\u00f3n\t\r \u00a0 y\t\r \u00a0 perivascular\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0complicaciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0Almudena\t\r \u00a0 G\u00f3mez-\u00ad\u2010Hern\u00e1ndez1,2,3,\t\r \u00a0 Liliana\t\r \u00a0 Perdomo1,2\t\r \u00a0,\t\r \u00a0 \u00d3scar\t\r \u00a0Escribano1,2,\t\r \u00a0Manuel\t\r \u00a0Benito1,2\t\r \u00a01Departamento\t\r \u00a0de\t\r \u00a0Bioqu\u00edmica\t\r \u00a0y\t\r \u00a0Biolog\u00eda\t\r \u00a0Molecular,\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Farmacia,\t\r \u00a0Universidad\t\r \u00a0Complutense\t\r \u00a0de\t\r \u00a0Madrid,\t\r \u00a0Instituto\t\r \u00a0de\t\r \u00a0Investigaci\u00f3n\t\r \u00a0Sanitaria\t\r \u00a0del\t\r \u00a0Hospital\t\r \u00a0Cl\u00ednico\t\r \u00a0San\t\r \u00a0Carlos\t\r \u00a0de\t\r \u00a0Madrid\t\r \u00a0(IdISSC),\t\r \u00a0Espa\u00f1a.\t\r \u00a02CIBER\t\r \u00a0de\t\r \u00a0Diabetes\t\r \u00a0Enfermedades\t\r \u00a0Metab\u00f3licas\t\r \u00a0relacionadas,\t\r \u00a0Espa\u00f1a\t\r \u00a03Corresponding\t\r \u00a0 author:\t\r \u00a0Almudena\t\r \u00a0 G\u00f3mez-\u00ad\u2010Hern\u00e1ndez,\t\r \u00a0Departamento\t\r \u00a0 de\t\r \u00a0 Bioqu\u00edmica\t\r \u00a0 y\t\r \u00a0 Biolog\u00eda\t\r \u00a0Molecular,\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia,\t\r \u00a0 Universidad\t\r \u00a0 Complutense\t\r \u00a0 de\t\r \u00a0 Madrid,\t\r \u00a0 Instituto\t\r \u00a0 de\t\r \u00a0 Investigaci\u00f3n\t\r \u00a0Sanitaria\t\r \u00a0del\t\r \u00a0Hospital\t\r \u00a0Cl\u00ednico\t\r \u00a0San\t\r \u00a0Carlos\t\r \u00a0de\t\r \u00a0Madrid\t\r \u00a0(IdISSC),\t\r \u00a0Espa\u00f1a,\t\r \u00a0Madrid-\u00ad\u201028040,\t\r \u00a0Spain.\t\r \u00a0Phone:\t\r \u00a034-\u00ad\u201091-\u00ad\u20103941853;\t\r \u00a0Fax:\t\r \u00a034-\u00ad\u201091-\u00ad\u20103941779\t\r \u00a0e-\u00ad\u2010mail:\t\r \u00a0almudenagomez@farm.ucm.es\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0322-\u00ad\u2010346\t\r \u00a0RESUMEN\t\r \u00a0En\t\r \u00a0 esta\t\r \u00a0 revisi\u00f3n\t\r \u00a0 se\t\r \u00a0 valora\t\r \u00a0 la\t\r \u00a0 contribuci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0 blanco,\t\r \u00a0 marr\u00f3n\t\r \u00a0 y\t\r \u00a0\t\r \u00a0perivascular\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 fisiopatolog\u00eda\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 complicaciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 y\t\r \u00a0 vasculares\t\r \u00a0asociadas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 obesidad.\t\r \u00a0 Para\t\r \u00a0 combatir\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 evitar\t\r \u00a0 las\t\r \u00a0 crecientes\t\r \u00a0complicaciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 y\t\r \u00a0 vasculares,\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 tratamientos\t\r \u00a0establecidos,\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0avanzar\t\r \u00a0en\t\r \u00a0el\t\r \u00a0conocimiento\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0su\t\r \u00a0prometedor\t\r \u00a0potencial\t\r \u00a0terap\u00e9utico.\t\r \u00a0Dada\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0 gasto\t\r \u00a0 energ\u00e9tico\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 metabolismo\t\r \u00a0 lip\u00eddico\t\r \u00a0 y\t\r \u00a0 gluc\u00eddico,\t\r \u00a0 as\u00ed\t\r \u00a0como\t\r \u00a0 su\t\r \u00a0 potencial\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 inflamaci\u00f3n\t\r \u00a0 junto\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0perivascular;\t\r \u00a0 las\t\r \u00a0 nuevas\t\r \u00a0 perspectivas\t\r \u00a0 del\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 podr\u00edan\t\r \u00a0centrarse\t\r \u00a0en\t\r \u00a0el\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0nuevos\t\r \u00a0f\u00e1rmacos\t\r \u00a0o\t\r \u00a0distintos\t\r \u00a0reg\u00edmenes\t\r \u00a0o\t\r \u00a0terapias\t\r \u00a0que\t\r \u00a0incrementen\t\r \u00a0la\t\r \u00a0cantidad\t\r \u00a0y\t\r \u00a0funci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0para\t\r \u00a0luchar\t\r \u00a0contra\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 sino\t\r \u00a0 tambi\u00e9n\t\r \u00a0 para\t\r \u00a0 prevenir\t\r \u00a0 la\t\r \u00a0 diabetes\t\r \u00a0 tipo\t\r \u00a0 2\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0des\u00f3rdenes\t\r \u00a0metab\u00f3licos\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0asociados\t\r \u00a0a\t\r \u00a0la\t\r \u00a0misma.\t\r \u00a0Palabras\t\r \u00a0 clave:\t\r \u00a0Obesidad;\t\r \u00a0 Tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n;\t\r \u00a0 Tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco;\t\r \u00a0Complicaciones\t\r \u00a0vasculares.\t\r \u00a0ABSTRACT\t\r \u00a0This\t\r \u00a0review\t\r \u00a0analyzes\t\r \u00a0the\t\r \u00a0contribution\t\r \u00a0of\t\r \u00a0white,\t\r \u00a0brown\t\r \u00a0and\t\r \u00a0perivascular\t\r \u00a0adipose\t\r \u00a0tissues\t\r \u00a0to\t\r \u00a0the\t\r \u00a0pathophysiology\t\r \u00a0of\t\r \u00a0metabolic\t\r \u00a0and\t\r \u00a0vascular\t\r \u00a0complications\t\r \u00a0associated\t\r \u00a0REVISI\u00d3N\t\r \u00a0\nPapel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0323\t\r \u00a0\t\r \u00a0to\t\r \u00a0 obesity.\t\r \u00a0 To\t\r \u00a0 combat\t\r \u00a0 obesity\t\r \u00a0 and\t\r \u00a0 prevent\t\r \u00a0 its\t\r \u00a0 metabolic\t\r \u00a0 and\t\r \u00a0 vascular\t\r \u00a0complications\t\r \u00a0 of\t\r \u00a0 high\t\r \u00a0 prevalence,\t\r \u00a0 in\t\r \u00a0 addition\t\r \u00a0 to\t\r \u00a0 conventional\t\r \u00a0 treatments\t\r \u00a0 a\t\r \u00a0 new\t\r \u00a0insight\t\r \u00a0 in\t\r \u00a0 our\t\r \u00a0 knowledge\t\r \u00a0 of\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 brown\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 thermogenic\t\r \u00a0 function\t\r \u00a0and\t\r \u00a0its\t\r \u00a0promising\t\r \u00a0therapeutic\t\r \u00a0potential\t\r \u00a0in\t\r \u00a0humans\t\r \u00a0is\t\r \u00a0much\t\r \u00a0needed.\t\r \u00a0Owing\t\r \u00a0to\t\r \u00a0the\t\r \u00a0impact\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0on\t\r \u00a0energy\t\r \u00a0expenditure\t\r \u00a0related\t\r \u00a0to\t\r \u00a0lipid\t\r \u00a0and\t\r \u00a0glucose\t\r \u00a0metabolisms,\t\r \u00a0as\t\r \u00a0well\t\r \u00a0as\t\r \u00a0its\t\r \u00a0potential\t\r \u00a0resistance\t\r \u00a0against\t\r \u00a0inflammation\t\r \u00a0together\t\r \u00a0to\t\r \u00a0perivascular\t\r \u00a0adipose\t\r \u00a0tissue,\t\r \u00a0new\t\r \u00a0perspectives\t\r \u00a0in\t\r \u00a0the\t\r \u00a0obesity\t\r \u00a0treatment\t\r \u00a0might\t\r \u00a0be\t\r \u00a0focused\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 design\t\r \u00a0 of\t\r \u00a0 new\t\r \u00a0 drugs,\t\r \u00a0 or\t\r \u00a0 different\t\r \u00a0 regimens\t\r \u00a0 or\t\r \u00a0 therapies,\t\r \u00a0 that\t\r \u00a0increase\t\r \u00a0the\t\r \u00a0amount\t\r \u00a0and\t\r \u00a0activity\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0These\t\r \u00a0new\t\r \u00a0treatments\t\r \u00a0not\t\r \u00a0only\t\r \u00a0may\t\r \u00a0contribute\t\r \u00a0to\t\r \u00a0combat\t\r \u00a0obesity,\t\r \u00a0but\t\r \u00a0also\t\r \u00a0prevent\t\r \u00a0complications\t\r \u00a0such\t\r \u00a0as\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0and\t\r \u00a0other\t\r \u00a0associated\t\r \u00a0metabolic\t\r \u00a0and\t\r \u00a0vascular\t\r \u00a0alterations.\t\r \u00a0Keywords:\t\r \u00a0Obesity;\t\r \u00a0 Brown\t\r \u00a0 adipose\t\r \u00a0 tissue;\t\r \u00a0 White\t\r \u00a0 adipose\t\r \u00a0 tissue;\t\r \u00a0 Vascular\t\r \u00a0complications.\t\r \u00a01.\t\r \u00a0INTRODUCCI\u00d3N\t\r \u00a0La\t\r \u00a0 obesidad\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 enfermedad\t\r \u00a0 cr\u00f3nica\t\r \u00a0 de\t\r \u00a0 origen\t\r \u00a0 multifactorial\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0aumentado\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 considerable\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 pa\u00edses\t\r \u00a0 desarrollados\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0\u00faltimas\t\r \u00a0d\u00e9cadas,\t\r \u00a0 siendo\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 actualidad\t\r \u00a0 una\t\r \u00a0 epidemia\t\r \u00a0 mundial\t\r \u00a0 (1).\t\r \u00a0 La\t\r \u00a0 Organizaci\u00f3n\t\r \u00a0Mundial\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Salud\t\r \u00a0 (OMS)\t\r \u00a0 considera\t\r \u00a0 obesos\t\r \u00a0 a\t\r \u00a0 aquellas\t\r \u00a0 personas\t\r \u00a0 que\t\r \u00a0 tengan\t\r \u00a0 un\t\r \u00a0\u00edndice\t\r \u00a0de\t\r \u00a0masa\t\r \u00a0corporal\t\r \u00a0(IMC)\t\r \u00a0superior\t\r \u00a0a\t\r \u00a030\t\r \u00a0kg/m2\t\r \u00a0y\t\r \u00a0ha\t\r \u00a0estimado\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a02015\t\r \u00a0habr\u00e1\t\r \u00a02300\t\r \u00a0millones\t\r \u00a0de\t\r \u00a0adultos\t\r \u00a0con\t\r \u00a0sobrepeso\t\r \u00a0y\t\r \u00a0700\t\r \u00a0millones\t\r \u00a0de\t\r \u00a0obesos.\t\r \u00a0Adem\u00e1s\t\r \u00a0est\u00e1\t\r \u00a0 aumentando\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 preocupante\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 infantil\t\r \u00a0 y\t\r \u00a0 as\u00ed\t\r \u00a0 en\t\r \u00a0 2010,\t\r \u00a0alrededor\t\r \u00a0de\t\r \u00a040\t\r \u00a0millones\t\r \u00a0de\t\r \u00a0ni\u00f1os\t\r \u00a0menores\t\r \u00a0de\t\r \u00a0cinco\t\r \u00a0a\u00f1os\t\r \u00a0ten\u00edan\t\r \u00a0sobrepeso\t\r \u00a0(2).\t\r \u00a0La\t\r \u00a0obesidad\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0convertido\t\r \u00a0en\t\r \u00a0un\t\r \u00a0problema\t\r \u00a0de\t\r \u00a0salud\t\r \u00a0p\u00fablica\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0por\t\r \u00a0el\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 estigmatizaci\u00f3n\t\r \u00a0 social,\t\r \u00a0 el\t\r \u00a0 problema\t\r \u00a0 econ\u00f3mico\t\r \u00a0 que\t\r \u00a0 supone\t\r \u00a0 o\t\r \u00a0 el\t\r \u00a0 fallo\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0calidad\t\r \u00a0 de\t\r \u00a0 vida,\t\r \u00a0 sino\t\r \u00a0 tambi\u00e9n\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 asociado\t\r \u00a0 que\t\r \u00a0 presentan\t\r \u00a0 dichos\t\r \u00a0pacientes\t\r \u00a0 a\t\r \u00a0 desarrollar\t\r \u00a0 otras\t\r \u00a0 patolog\u00edas\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 diabetes\t\r \u00a0 tipo\t\r \u00a02,\t\r \u00a0 dislipidemias,\t\r \u00a0h\u00edgado\t\r \u00a0 graso,\t\r \u00a0 aterosclerosis,\t\r \u00a0 enfermedad\t\r \u00a0 cardiovascular,\t\r \u00a0 enfermedad\t\r \u00a0 de\t\r \u00a0Alzheimer,\t\r \u00a0 enfermedades\t\r \u00a0 \u00f3seas\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 frecuencia\t\r \u00a0 algunos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 c\u00e1nceres\t\r \u00a0especialmente\t\r \u00a0 digestivos.\t\r \u00a0 Esto\t\r \u00a0 ocurre,\t\r \u00a0 al\t\r \u00a0 menos\t\r \u00a0 en\t\r \u00a0 parte,\t\r \u00a0 como\t\r \u00a0 resultado\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0resistencia\t\r \u00a0 a\t\r \u00a0la\t\r \u00a0 insulina\t\r \u00a0 inducida\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 hecho\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0sirve\t\r \u00a0como\t\r \u00a0reservorio\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0sino\t\r \u00a0como\t\r \u00a0un\t\r \u00a0\u00f3rgano\t\r \u00a0endocrino\t\r \u00a0secretor\t\r \u00a0de\t\r \u00a0hormonas,\t\r \u00a0citoquinas\t\r \u00a0y\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0afectan\t\r \u00a0a\t\r \u00a0la\t\r \u00a0funcionalidad\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0y\t\r \u00a0tejidos\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0todo\t\r \u00a0el\t\r \u00a0organismo\t\r \u00a0(3).\t\r \u00a0\t\r \u00a0La\t\r \u00a0 obesidad\t\r \u00a0 se\t\r \u00a0 acompa\u00f1a\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 riesgo\t\r \u00a0 cardiovascular\t\r \u00a0 elevado\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0coexistencia\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0factores\t\r \u00a0de\t\r \u00a0riesgo,\t\r \u00a0particularmente\t\r \u00a0dislipemia,\t\r \u00a0hipertensi\u00f3n,\t\r \u00a0insulinorresistencia\t\r \u00a0 y\t\r \u00a0 diabetes\t\r \u00a0 (4).\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 estos\t\r \u00a0 factores\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 est\u00e1n\t\r \u00a0\u00edntimamente\t\r \u00a0ligados\t\r \u00a0a\t\r \u00a0un\t\r \u00a0exceso\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo,\t\r \u00a0y\t\r \u00a0m\u00e1s\t\r \u00a0espec\u00edficamente\t\r \u00a0a\t\r \u00a0una\t\r \u00a0particular\t\r \u00a0distribuci\u00f3n\t\r \u00a0corporal\t\r \u00a0del\t\r \u00a0mismo.\t\r \u00a0Esta\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0distribuci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0grasa\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n324\t\r \u00a0\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 obeso\t\r \u00a0 s\u00ed\t\r \u00a0 est\u00e1\t\r \u00a0 claramente\t\r \u00a0 relacionada\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0 independiente\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0morbimortalidad\t\r \u00a0cardiovascular\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0un\t\r \u00a0s\u00edndrome\t\r \u00a0metab\u00f3lico\t\r \u00a0aterog\u00e9nico\t\r \u00a0(5).\t\r \u00a0\u00c9ste\t\r \u00a0es\t\r \u00a0el\t\r \u00a0motivo\t\r \u00a0por\t\r \u00a0el\t\r \u00a0que\t\r \u00a0adquiere\t\r \u00a0especial\t\r \u00a0trascendencia\t\r \u00a0cl\u00ednica\t\r \u00a0la\t\r \u00a0medida,\t\r \u00a0no\t\r \u00a0 s\u00f3lo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 cuant\u00eda\t\r \u00a0 total\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 grasa\t\r \u00a0 corporal,\t\r \u00a0 sino\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0 distribuci\u00f3n,\t\r \u00a0 habida\t\r \u00a0cuenta\t\r \u00a0 que\t\r \u00a0 tal\t\r \u00a0 distribuci\u00f3n\t\r \u00a0 tiene\t\r \u00a0 m\u00e1s\t\r \u00a0 impacto\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 cardiovascular\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0obesidad\t\r \u00a0por\t\r \u00a0s\u00ed\t\r \u00a0misma.\t\r \u00a0Una\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 alteraciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 m\u00e1s\t\r \u00a0 delet\u00e9reas\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0dislipemia\t\r \u00a0que\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0la\t\r \u00a0acompa\u00f1a\t\r \u00a0y\t\r \u00a0resulta\t\r \u00a0altamente\t\r \u00a0aterog\u00e9nica\t\r \u00a0(6).\t\r \u00a0Su\t\r \u00a0patr\u00f3n\t\r \u00a0fenot\u00edpico\t\r \u00a0habitual\t\r \u00a0es\t\r \u00a0la\t\r \u00a0hipertrigliceridemia\t\r \u00a0preprandial,\t\r \u00a0la\t\r \u00a0hiperlipidemia\t\r \u00a0no\t\r \u00a0 HDL\t\r \u00a0 postprandial,\t\r \u00a0 el\t\r \u00a0 aumento\t\r \u00a0 real\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 part\u00edculas\t\r \u00a0 densas\t\r \u00a0 y\t\r \u00a0peque\u00f1as\t\r \u00a0de\t\r \u00a0LDL,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0la\t\r \u00a0baja\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0colesterol\t\r \u00a0HDL.\t\r \u00a0En\t\r \u00a0mam\u00edferos\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0est\u00e1\t\r \u00a0compuesto\t\r \u00a0al\t\r \u00a0menos\t\r \u00a0por\t\r \u00a0dos\t\r \u00a0tipos\t\r \u00a0muy\t\r \u00a0distintas\t\r \u00a0 de\t\r \u00a0 grasas\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 (WAT)\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0 o\t\r \u00a0 pardo\t\r \u00a0 (BAT)\t\r \u00a0 que\t\r \u00a0 presentan\t\r \u00a0 diferencias\t\r \u00a0 en\t\r \u00a0 cuanto\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 morfolog\u00eda,\t\r \u00a0distribuci\u00f3n,\t\r \u00a0genes\t\r \u00a0y\t\r \u00a0funci\u00f3n.\t\r \u00a0El\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0es\t\r \u00a0el\t\r \u00a0principal\t\r \u00a0reservorio\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0 y\t\r \u00a0 libera\t\r \u00a0 un\t\r \u00a0 gran\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 hormonas\t\r \u00a0 y\t\r \u00a0 citoquinas\t\r \u00a0 que\t\r \u00a0 modulan\t\r \u00a0 el\t\r \u00a0metabolismo\t\r \u00a0del\t\r \u00a0organismo\t\r \u00a0y\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0(7-\u00ad\u201010).\t\r \u00a0El\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0depende\t\r \u00a0del\t\r \u00a0balance\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0ingesta\t\r \u00a0y\t\r \u00a0el\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0 del\t\r \u00a0 balance\t\r \u00a0entre\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco,\t\r \u00a0 como\t\r \u00a0 principal\t\r \u00a0 reservorio\t\r \u00a0energ\u00e9tico,\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n,\t\r \u00a0 especializado\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 gasto\t\r \u00a0 energ\u00e9tico\t\r \u00a0 en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0termog\u00e9nesis\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0mitocondrial\t\r \u00a0desacoplante\t\r \u00a01\t\r \u00a0(UCP-\u00ad\u20101).\t\r \u00a0 Adem\u00e1s\t\r \u00a0 el\t\r \u00a0 BAT\t\r \u00a0 podr\u00eda\t\r \u00a0 afectar\t\r \u00a0 al\t\r \u00a0 metabolismo\t\r \u00a0 del\t\r \u00a0 organismo\t\r \u00a0 y\t\r \u00a0 alterar\t\r \u00a0 la\t\r \u00a0sensibilidad\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 (11,\t\r \u00a0 12)\t\r \u00a0 al\t\r \u00a0 igual\t\r \u00a0 que\t\r \u00a0 modificar\t\r \u00a0 la\t\r \u00a0 susceptibilidad\t\r \u00a0 a\t\r \u00a0desarrollar\t\r \u00a0obesidad\t\r \u00a0(13).\t\r \u00a0\t\r \u00a02.\t\r \u00a0PAPEL\t\r \u00a0 DEL\t\r \u00a0 TEJIDO\t\r \u00a0 ADIPOSO\t\r \u00a0 BLANCO\t\r \u00a0 EN\t\r \u00a0 LA\t\r \u00a0 OBESIDAD\t\r \u00a0 Y\t\r \u00a0 SUS\t\r \u00a0COMPLICACIONES\t\r \u00a0METAB\u00d3LICAS\t\r \u00a0Y\t\r \u00a0VASCULARES\t\r \u00a0ASOCIADAS\t\r \u00a02.1.\t\r \u00a0Morfolog\u00eda\t\r \u00a0y\t\r \u00a0distribuci\u00f3n\t\r \u00a0del\t\r \u00a0WAT.\t\r \u00a0Implicaci\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0riesgo\t\r \u00a0cardiovascular\t\r \u00a0El\t\r \u00a0 adipocito\t\r \u00a0 del\t\r \u00a0 WAT\t\r \u00a0 tiene\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0 variable,\t\r \u00a0 aunque\t\r \u00a0 cl\u00e1sicamente\t\r \u00a0 es\t\r \u00a0esf\u00e9rica\t\r \u00a0de\t\r \u00a0tama\u00f1o\t\r \u00a0entre\t\r \u00a025-\u00ad\u2010200\t\r \u00a0\u03bcm.\t\r \u00a0Adem\u00e1s,\t\r \u00a0tiene\t\r \u00a0un\t\r \u00a0n\u00facleo\t\r \u00a0perif\u00e9rico\t\r \u00a0y\t\r \u00a0plano\t\r \u00a0y\t\r \u00a0un\t\r \u00a0 citoplasma\t\r \u00a0 delgado\t\r \u00a0 que\t\r \u00a0 contiene\t\r \u00a0 una\t\r \u00a0 \u00fanica\t\r \u00a0 gota\t\r \u00a0 lip\u00eddica\t\r \u00a0 grande\t\r \u00a0 que\t\r \u00a0 ocupa\t\r \u00a0 el\t\r \u00a090%\t\r \u00a0 del\t\r \u00a0 volumen.\t\r \u00a0 Presenta\t\r \u00a0 escasas\t\r \u00a0 mitocondrias\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 peque\u00f1o\t\r \u00a0 ret\u00edculo\t\r \u00a0endoplasm\u00e1tico\t\r \u00a0liso\t\r \u00a0y\t\r \u00a0rugoso.\t\r \u00a0WAT\t\r \u00a0se\t\r \u00a0compone\t\r \u00a0de\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0que\t\r \u00a0se\t\r \u00a0mantienen\t\r \u00a0unidos\t\r \u00a0 por\t\r \u00a0 un\t\r \u00a0 tejido\t\r \u00a0 conectivo\t\r \u00a0 laxo\t\r \u00a0 que\t\r \u00a0 est\u00e1\t\r \u00a0 adecuadamente\t\r \u00a0vascularizado\t\r \u00a0 e\t\r \u00a0inervado\t\r \u00a0 (14).\t\r \u00a0 Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 adipocitos,\t\r \u00a0 WAT\t\r \u00a0 contiene\t\r \u00a0 macr\u00f3fagos,\t\r \u00a0 leucocitos,\t\r \u00a0fibroblastos,\t\r \u00a0 adipocitos,\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 progenitoras\t\r \u00a0 y\t\r \u00a0 c\u00e9lulas\t\r \u00a0 endoteliales.\t\r \u00a0 La\t\r \u00a0presencia\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 fibroblastos,\t\r \u00a0 los\t\r \u00a0 macr\u00f3fagos,\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 leucocitos,\t\r \u00a0 junto\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0adipocitos,\t\r \u00a0da\t\r \u00a0cuenta\t\r \u00a0de\t\r \u00a0la\t\r \u00a0gran\t\r \u00a0variedad\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0son\t\r \u00a0secretadas\t\r \u00a0por\t\r \u00a0WAT\t\r \u00a0bajo\t\r \u00a0condiciones\t\r \u00a0variables.\t\r \u00a0El\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0est\u00e1\t\r \u00a0distribuido\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0325\t\r \u00a0\t\r \u00a0todo\t\r \u00a0 el\t\r \u00a0 organismo\t\r \u00a0 y\t\r \u00a0 tiene\t\r \u00a0 diferentes\t\r \u00a0 compartimentos\t\r \u00a0 que\t\r \u00a0 var\u00edan\t\r \u00a0 en\t\r \u00a0 cuanto\t\r \u00a0 al\t\r \u00a0tama\u00f1o\t\r \u00a0 celular\t\r \u00a0 del\t\r \u00a0 adipocito\t\r \u00a0 (15,\t\r \u00a0 16)\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 actividad\t\r \u00a0 metab\u00f3lica\t\r \u00a0 y\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 papel\t\r \u00a0potencial\t\r \u00a0en\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0otras\t\r \u00a0complicaciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 (17,\t\r \u00a0 18).\t\r \u00a0 En\t\r \u00a0 humanos,\t\r \u00a0 se\t\r \u00a0 diferencian\t\r \u00a0 dos\t\r \u00a0 dep\u00f3sitos\t\r \u00a0 principales\t\r \u00a0 de\t\r \u00a0tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco:\t\r \u00a0 el\t\r \u00a0 dep\u00f3sito\t\r \u00a0 subcut\u00e1neo\t\r \u00a0 correspondiente\t\r \u00a0 al\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0que\t\r \u00a0se\t\r \u00a0localiza\t\r \u00a0bajo\t\r \u00a0la\t\r \u00a0piel,\t\r \u00a0y\t\r \u00a0el\t\r \u00a0dep\u00f3sito\t\r \u00a0visceral.\t\r \u00a0Hay\t\r \u00a0dos\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0visceral:\t\r \u00a0el\t\r \u00a0mesent\u00e9rico\t\r \u00a0y\t\r \u00a0el\t\r \u00a0omental\t\r \u00a0(19).\t\r \u00a0El\t\r \u00a0primero\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0envolviendo\t\r \u00a0al\t\r \u00a0intestino,\t\r \u00a0el\t\r \u00a0segundo\t\r \u00a0se\t\r \u00a0extiende\t\r \u00a0desde\t\r \u00a0la\t\r \u00a0parte\t\r \u00a0inferior\t\r \u00a0del\t\r \u00a0est\u00f3mago,\t\r \u00a0recubriendo\t\r \u00a0el\t\r \u00a0abdomen\t\r \u00a0y\t\r \u00a0es\t\r \u00a0el\t\r \u00a0que\t\r \u00a0normalmente\t\r \u00a0se\t\r \u00a0emplea\t\r \u00a0en\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0grasa\t\r \u00a0visceral.\t\r \u00a0Hace\t\r \u00a0tiempo\t\r \u00a0que\t\r \u00a0se\t\r \u00a0sabe\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0visceral\t\r \u00a0y\t\r \u00a0el\t\r \u00a0subcut\u00e1neo\t\r \u00a0presentan\t\r \u00a0numerosas\t\r \u00a0diferencias\t\r \u00a0anat\u00f3micas,\t\r \u00a0celulares\t\r \u00a0y\t\r \u00a0moleculares\t\r \u00a0(20,\t\r \u00a021);\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0la\t\r \u00a0 irrigaci\u00f3n\t\r \u00a0 de\t\r \u00a0 ambos\t\r \u00a0 tejidos\t\r \u00a0 es\t\r \u00a0 diferente\t\r \u00a0 (22),\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 RNA\t\r \u00a0 mensajero\t\r \u00a0(mRNA)\t\r \u00a0de\t\r \u00a0leptina\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0subcut\u00e1neo\t\r \u00a0est\u00e1n\t\r \u00a0incrementados\t\r \u00a0respecto\t\r \u00a0del\t\r \u00a0visceral\t\r \u00a0(20).\t\r \u00a0Estos\t\r \u00a0tejidos\t\r \u00a0tambi\u00e9n\t\r \u00a0son\t\r \u00a0diferentes\t\r \u00a0en\t\r \u00a0cuanto\t\r \u00a0a\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0de\t\r \u00a0movilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos,\t\r \u00a0 la\t\r \u00a0 grasa\t\r \u00a0 omental\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0 sensible\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0lipol\u00edticos\t\r \u00a0de\t\r \u00a0las\t\r \u00a0catecolaminas\t\r \u00a0y\t\r \u00a0menos\t\r \u00a0sensible\t\r \u00a0a\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0antilipol\u00edticos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0insulina;\t\r \u00a0 por\t\r \u00a0 tanto,\t\r \u00a0 este\t\r \u00a0 tejido\t\r \u00a0 tiene\t\r \u00a0 una\t\r \u00a0 mayor\t\r \u00a0 capacidad\t\r \u00a0 de\t\r \u00a0 movilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0que\t\r \u00a0el\t\r \u00a0dep\u00f3sito\t\r \u00a0subcut\u00e1neo\t\r \u00a0(22,\t\r \u00a023).\t\r \u00a0Adicionalmente\t\r \u00a0hay\t\r \u00a0descritas\t\r \u00a0numerosas\t\r \u00a0diferencias\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0visceral\t\r \u00a0y\t\r \u00a0subcut\u00e1neo\t\r \u00a0referentes\t\r \u00a0a\t\r \u00a0la\t\r \u00a0secreci\u00f3n\t\r \u00a0 de\t\r \u00a0 adipoquinas\t\r \u00a0 (24).\t\r \u00a0 En\t\r \u00a0 este\t\r \u00a0 sentido,\t\r \u00a0 una\t\r \u00a0 obesidad\t\r \u00a0 perif\u00e9rica\t\r \u00a0 se\t\r \u00a0caracteriza\t\r \u00a0por\t\r \u00a0una\t\r \u00a0acumulaci\u00f3n\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0subcut\u00e1neo\t\r \u00a0y\t\r \u00a0es\t\r \u00a0m\u00e1s\t\r \u00a0frecuente\t\r \u00a0en\t\r \u00a0mujeres.\t\r \u00a0Este\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0no\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0sufrir\t\r \u00a0patolog\u00edas\t\r \u00a0 asociadas\t\r \u00a0 (25).\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 central\t\r \u00a0 o\t\r \u00a0 abdominal\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0frecuente\t\r \u00a0 en\t\r \u00a0 hombres\t\r \u00a0 y\t\r \u00a0 consiste\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 visceral.\t\r \u00a0Este\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0asociado,\t\r \u00a0mediante\t\r \u00a0estudios\t\r \u00a0epidemiol\u00f3gicos,\t\r \u00a0con\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0sufrir\t\r \u00a0enfermedades\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina,\t\r \u00a0diabetes\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0II\t\r \u00a0e\t\r \u00a0hipertensi\u00f3n,\t\r \u00a0aumentando\t\r \u00a0considerablemente\t\r \u00a0el\t\r \u00a0riesgo\t\r \u00a0cardiovascular\t\r \u00a0(26).\t\r \u00a02.2.\t\r \u00a0El\t\r \u00a0WAT\t\r \u00a0\t\r \u00a0como\t\r \u00a0reservorio\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0En\t\r \u00a0 primer\t\r \u00a0 lugar,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 \u00f3rgano\t\r \u00a0 que\t\r \u00a0 constituye\t\r \u00a0 el\t\r \u00a0mayor\t\r \u00a0 reservorio\t\r \u00a0 energ\u00e9tico\t\r \u00a0 del\t\r \u00a0 organismo.\t\r \u00a0 La\t\r \u00a0 energ\u00eda\t\r \u00a0 es\t\r \u00a0 almacenada\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0adipocitos\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0triglic\u00e9ridos.\t\r \u00a0La\t\r \u00a0principal\t\r \u00a0fuente\t\r \u00a0de\t\r \u00a0triglic\u00e9ridos\t\r \u00a0procede\t\r \u00a0de\t\r \u00a0los\t\r \u00a0quilomicrones\t\r \u00a0y\t\r \u00a0las\t\r \u00a0prote\u00ednas\t\r \u00a0de\t\r \u00a0muy\t\r \u00a0baja\t\r \u00a0densidad\t\r \u00a0(VLDL)\t\r \u00a0circulantes.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0humanos,\t\r \u00a0 el\t\r \u00a0 almacenamiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 depende\t\r \u00a0pr\u00e1cticamente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0mismos\t\r \u00a0desde\t\r \u00a0las\t\r \u00a0lipoprote\u00ednas\t\r \u00a0por\t\r \u00a0acci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0 lipoprote\u00edna\t\r \u00a0 lipasa\t\r \u00a0 (LPL)\t\r \u00a0 (27).\t\r \u00a0 Tal\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 protagonismo\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 enzima\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0metabolismo\t\r \u00a0 lip\u00eddico,\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 describe\t\r \u00a0 una\t\r \u00a0 acci\u00f3n\t\r \u00a0 proaterog\u00e9nica\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 LPL,\t\r \u00a0expresada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0macr\u00f3fago,\t\r \u00a0y\t\r \u00a0una\t\r \u00a0acci\u00f3n\t\r \u00a0antiaterog\u00e9nica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0LPL,\t\r \u00a0expresada\t\r \u00a0en\t\r \u00a0el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 y\t\r \u00a0 m\u00fasculo.\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 esta\t\r \u00a0 enzima\t\r \u00a0 estar\u00eda\t\r \u00a0 implicada\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0alteraciones\t\r \u00a0 lip\u00eddicas\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 (28).\t\r \u00a0 Su\t\r \u00a0 actividad\t\r \u00a0 aumenta\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 per\u00edodo\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n326\t\r \u00a0\t\r \u00a0pospandrial\t\r \u00a0y\t\r \u00a0se\t\r \u00a0inhibe\t\r \u00a0en\t\r \u00a0el\t\r \u00a0ayuno\t\r \u00a0y\t\r \u00a0est\u00e1\t\r \u00a0incrementada\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0tanto\t\r \u00a0de\t\r \u00a0humanos\t\r \u00a0como\t\r \u00a0de\t\r \u00a0animales\t\r \u00a0de\t\r \u00a0experimentaci\u00f3n\t\r \u00a0obesos\t\r \u00a0\t\r \u00a0(29-\u00ad\u201034).\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0de\t\r \u00a0la\t\r \u00a0LPL\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0a\t\r \u00a0la\t\r \u00a0alimentaci\u00f3n\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0obesos\t\r \u00a0est\u00e1\t\r \u00a0disminuida\t\r \u00a0(32,\t\r \u00a035).\t\r \u00a0\t\r \u00a0Otro\t\r \u00a0de\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0metab\u00f3licos\t\r \u00a0que\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0es\t\r \u00a0la\t\r \u00a0lip\u00f3lisis,\t\r \u00a0donde\t\r \u00a0los\t\r \u00a0triglic\u00e9ridos\t\r \u00a0almacenados\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0son\t\r \u00a0hidrolizados\t\r \u00a0a\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos\t\r \u00a0 y\t\r \u00a0 glicerol.\t\r \u00a0 El\t\r \u00a0 paso\t\r \u00a0 limitante\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 lip\u00f3lisis\t\r \u00a0 est\u00e1\t\r \u00a0 controlado\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0lipasa\t\r \u00a0sensible\t\r \u00a0a\t\r \u00a0hormonas\t\r \u00a0(HSL).\t\r \u00a0Dicha\t\r \u00a0hormona\t\r \u00a0presenta\t\r \u00a0una\t\r \u00a0intensa\t\r \u00a0regulaci\u00f3n.\t\r \u00a0As\u00ed,\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 receptores\t\r \u00a0 \u03b2\t\r \u00a0 adren\u00e9rgicos\t\r \u00a0 produce\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0niveles\t\r \u00a0intracelulares\t\r \u00a0de\t\r \u00a0AMPc\t\r \u00a0y\t\r \u00a0estimula\t\r \u00a0la\t\r \u00a0fosforilaci\u00f3n\t\r \u00a0activadora\t\r \u00a0(P-\u00ad\u2010Ser\t\r \u00a0552),\t\r \u00a0catalizada\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0 quinasa\t\r \u00a0 activada\t\r \u00a0 por\t\r \u00a0 AMPc\t\r \u00a0 (PKA)\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 HSL\t\r \u00a0 (36).\t\r \u00a0 Sin\t\r \u00a0embargo,\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0receptores\t\r \u00a0\u03b12\t\r \u00a0adren\u00e9rgicos,\t\r \u00a0favorece\t\r \u00a0la\t\r \u00a0reducci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0 niveles\t\r \u00a0 intracelulares\t\r \u00a0 de\t\r \u00a0 AMPc,\t\r \u00a0 produciendo\t\r \u00a0 una\t\r \u00a0 menor\t\r \u00a0 activaci\u00f3n\t\r \u00a0 de\t\r \u00a0 PKA\t\r \u00a0 y\t\r \u00a0por\t\r \u00a0tanto,\t\r \u00a0de\t\r \u00a0HSL.\t\r \u00a0As\u00ed,\t\r \u00a0las\t\r \u00a0catecolaminas\t\r \u00a0tienen\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0dual\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0lip\u00f3lisis,\t\r \u00a0y\t\r \u00a0su\t\r \u00a0efecto\t\r \u00a0neto\t\r \u00a0depende\t\r \u00a0del\t\r \u00a0balance\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0receptores\t\r \u00a0\u03b12\t\r \u00a0y\t\r \u00a0\u03b2\t\r \u00a0adren\u00e9rgicos.\t\r \u00a0Otra\t\r \u00a0de\t\r \u00a0las\t\r \u00a0hormonas\t\r \u00a0inhibidoras\t\r \u00a0de\t\r \u00a0la\t\r \u00a0lip\u00f3lisis,\t\r \u00a0es\t\r \u00a0la\t\r \u00a0insulina,\t\r \u00a0que\t\r \u00a0induce\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0PI3K\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0fosfodiesterasa\t\r \u00a0III,\t\r \u00a0que\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez\t\r \u00a0produce\t\r \u00a0la\t\r \u00a0inactivaci\u00f3n\t\r \u00a0de\t\r \u00a0AMPc.\t\r \u00a0En\t\r \u00a0adipocitos\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0obesos,\t\r \u00a0la\t\r \u00a0lip\u00f3lisis\t\r \u00a0basal\t\r \u00a0est\u00e1\t\r \u00a0aumentada\t\r \u00a0y\t\r \u00a0falla\t\r \u00a0la\t\r \u00a0lip\u00f3lisis\t\r \u00a0estimulada\t\r \u00a0por\t\r \u00a0catecolamina\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0existir\t\r \u00a0un\t\r \u00a0descenso\t\r \u00a0en\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0HSL\t\r \u00a0(37).\t\r \u00a0 Se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 que\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 lip\u00f3lisis\t\r \u00a0 inducidas\t\r \u00a0 por\t\r \u00a0 catecolaminas\t\r \u00a0puede\t\r \u00a0tener\t\r \u00a0un\t\r \u00a0papel\t\r \u00a0importante\t\r \u00a0en\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0en\t\r \u00a0humanos,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0 sus\t\r \u00a0 complicaciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 y\t\r \u00a0 vasculares\t\r \u00a0 asociadas.\t\r \u00a0 La\t\r \u00a0 capacidad\t\r \u00a0lipol\u00edtica\t\r \u00a0 parece\t\r \u00a0 tener\t\r \u00a0 un\t\r \u00a0 componente\t\r \u00a0 hereditario,\t\r \u00a0 aunque\t\r \u00a0 tambi\u00e9n\t\r \u00a0 puede\t\r \u00a0 verse\t\r \u00a0afectada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0propio\t\r \u00a0sobrepeso\t\r \u00a0y\t\r \u00a0por\t\r \u00a0el\t\r \u00a0grado\t\r \u00a0de\t\r \u00a0actividad\t\r \u00a0f\u00edsica\t\r \u00a0(38).\t\r \u00a0Asimismo,\t\r \u00a0se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 defectos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 HSL\t\r \u00a0 en\t\r \u00a0 familias\t\r \u00a0 de\t\r \u00a0 obesos\t\r \u00a0 y\t\r \u00a0 polimorfismos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0genes\t\r \u00a0 para\t\r \u00a0 HSL\t\r \u00a0 y\t\r \u00a0 para\t\r \u00a0 los\t\r \u00a0 receptores\t\r \u00a0 adren\u00e9rgicos\t\r \u00a0 \u03b22\t\r \u00a0 y\t\r \u00a0 \u03b23\t\r \u00a0 en\t\r \u00a0 asociaci\u00f3n\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0obesidad\t\r \u00a0 humana.\t\r \u00a0 Los\t\r \u00a0 adipocitos\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 obesos\t\r \u00a0se\t\r \u00a0 caracterizan\t\r \u00a0 por\t\r \u00a0presentar\t\r \u00a0 niveles\t\r \u00a0 altos\t\r \u00a0 de\t\r \u00a0 receptores\t\r \u00a0 adren\u00e9rgicos\t\r \u00a0 \u03b12\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 ratio\t\r \u00a0 elevado\t\r \u00a0 de\t\r \u00a0receptores\t\r \u00a0 adren\u00e9rgicos\t\r \u00a0 \u03b12/\u03b2\t\r \u00a0 (39).\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 en\t\r \u00a0 modelos\t\r \u00a0 animales\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0demostrado\t\r \u00a0 una\t\r \u00a0 correlaci\u00f3n\t\r \u00a0 positiva\t\r \u00a0 entre\t\r \u00a0 el\t\r \u00a0 grado\t\r \u00a0 de\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 ratio\t\r \u00a0 de\t\r \u00a0receptores\t\r \u00a0adren\u00e9rgicos\t\r \u00a0\u03b12/\u03b2\t\r \u00a0(40).\t\r \u00a02.3.\t\r \u00a0El\t\r \u00a0WAT\t\r \u00a0como\t\r \u00a0\u00f3rgano\t\r \u00a0endocrino\t\r \u00a0El\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0es\t\r \u00a0un\t\r \u00a0\u00f3rgano\t\r \u00a0de\t\r \u00a0reservorio\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0un\t\r \u00a0\u00f3rgano\t\r \u00a0secretor\t\r \u00a0de\t\r \u00a0ciertas\t\r \u00a0mol\u00e9culas\t\r \u00a0que\t\r \u00a0tienen\t\r \u00a0una\t\r \u00a0acci\u00f3n\t\r \u00a0endocrina,\t\r \u00a0paracrina\t\r \u00a0 y\t\r \u00a0 autocrina\t\r \u00a0 (41).\t\r \u00a0 Algunas\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 mol\u00e9culas\t\r \u00a0 secretadas\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0adipocitos\t\r \u00a0 est\u00e1n\t\r \u00a0 implicadas\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 del\t\r \u00a0 peso\t\r \u00a0 corporal\t\r \u00a0 (leptina,\t\r \u00a0adiponectina),\t\r \u00a0en\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0inflamatoria\t\r \u00a0generada\t\r \u00a0localmente\t\r \u00a0en\t\r \u00a0una\t\r \u00a0situaci\u00f3n\t\r \u00a0de\t\r \u00a0 obesidad\t\r \u00a0 (TNF-\u00ad\u2010\u03b1,\t\r \u00a0 IL-\u00ad\u20106\t\r \u00a0 e\t\r \u00a0 IL-\u00ad\u20101\u03b2),\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 vascular\t\r \u00a0 (Ang\t\r \u00a0 II\t\r \u00a0 y\t\r \u00a0 PAI-\u00ad\u20101)\t\r \u00a0 o\t\r \u00a0reproductora\t\r \u00a0(estr\u00f3genos,\t\r \u00a0entre\t\r \u00a0otras).\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0327\t\r \u00a0\t\r \u00a0La\t\r \u00a0 leptina\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 hormona\t\r \u00a0 secretada\t\r \u00a0 principalmente\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 adipocitos\t\r \u00a0teniendo\t\r \u00a0 un\t\r \u00a0 papel\t\r \u00a0 relevante\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 del\t\r \u00a0 peso\t\r \u00a0 corporal\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 sus\t\r \u00a0efectos\t\r \u00a0\t\r \u00a0centrales,\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0apetito\t\r \u00a0y\t\r \u00a0perif\u00e9ricos,\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0(42).\t\r \u00a0La\t\r \u00a0concentraci\u00f3n\t\r \u00a0 de\t\r \u00a0 leptina\t\r \u00a0 circulante\t\r \u00a0 disminuye\t\r \u00a0 en\t\r \u00a0 condiciones\t\r \u00a0 de\t\r \u00a0 ayuno\t\r \u00a0 o\t\r \u00a0restricci\u00f3n\t\r \u00a0 cal\u00f3rica\t\r \u00a0 y\t\r \u00a0 aumenta\t\r \u00a0 en\t\r \u00a0 respuesta\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 ingesta,\t\r \u00a0 principalmente\t\r \u00a0 en\t\r \u00a0respuesta\t\r \u00a0 a\t\r \u00a0 glucosa\t\r \u00a0 (43,\t\r \u00a0 44).\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 la\t\r \u00a0 gran\t\r \u00a0 mayor\u00eda\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 obesos\t\r \u00a0presentan\t\r \u00a0concentraciones\t\r \u00a0elevadas\t\r \u00a0de\t\r \u00a0leptina\t\r \u00a0y\t\r \u00a0est\u00e1n\t\r \u00a0aumentados\t\r \u00a0en\t\r \u00a0relaci\u00f3n\t\r \u00a0al\t\r \u00a0grado\t\r \u00a0 de\t\r \u00a0 adiposidad\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 hiperinsulinemia,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0 llevado\t\r \u00a0 al\t\r \u00a0 concepto\t\r \u00a0 de\t\r \u00a0leptinorresistencia\t\r \u00a0 (45).\t\r \u00a0 Esta\t\r \u00a0 hiperleptinemia\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 involucrada\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0insulinorresistencia\t\r \u00a0 del\t\r \u00a0 obeso\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 alteraciones\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 fosforilaci\u00f3n\t\r \u00a0 del\t\r \u00a0receptor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 (46).\t\r \u00a0 Otra\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 hormonas\t\r \u00a0 secretadas\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 adipocitos\t\r \u00a0que\t\r \u00a0 participa\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 control\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 ingesta\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 adiponectina\t\r \u00a0 (Acrp30/AdipoQ).\t\r \u00a0 Es\t\r \u00a0una\t\r \u00a0 adipocitoquina\t\r \u00a0 implicada\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 del\t\r \u00a0 metabolismo\t\r \u00a0 energ\u00e9tico\t\r \u00a0 del\t\r \u00a0organismo,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0estimula\t\r \u00a0la\t\r \u00a0oxidaci\u00f3n\t\r \u00a0de\t\r \u00a0\u00e1cidos\t\r \u00a0grasos,\t\r \u00a0reduce\t\r \u00a0los\t\r \u00a0triglic\u00e9ridos\t\r \u00a0plasm\u00e1ticos\t\r \u00a0 y\t\r \u00a0 mejora\t\r \u00a0 el\t\r \u00a0 metabolismo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 glucosa\t\r \u00a0 mediante\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0sensibilidad\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 (47).\t\r \u00a0 En\t\r \u00a0 diversos\t\r \u00a0 estudios,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0hipoadiponectinemia\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 con\t\r \u00a0 obesidad,\t\r \u00a0 diabetes\t\r \u00a0 mellitus\t\r \u00a0 y\t\r \u00a0 arteriopat\u00eda\t\r \u00a0coronaria\t\r \u00a0(48,\t\r \u00a049).\t\r \u00a0Adem\u00e1s\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0propiedades\t\r \u00a0antidiabetog\u00e9nicas,\t\r \u00a0la\t\r \u00a0adiponectina\t\r \u00a0posee\t\r \u00a0 un\t\r \u00a0 efecto\t\r \u00a0 antiaterog\u00e9nico\t\r \u00a0 y\t\r \u00a0 tambi\u00e9n\t\r \u00a0 tiene\t\r \u00a0 una\t\r \u00a0 relaci\u00f3n\t\r \u00a0 inversa\t\r \u00a0 con\t\r \u00a0 otros\t\r \u00a0factores\t\r \u00a0de\t\r \u00a0riesgo\t\r \u00a0como\t\r \u00a0la\t\r \u00a0presi\u00f3n\t\r \u00a0arterial,\t\r \u00a0el\t\r \u00a0colesterol\t\r \u00a0total\t\r \u00a0y\t\r \u00a0las\t\r \u00a0lipoprote\u00ednas\t\r \u00a0de\t\r \u00a0baja\t\r \u00a0 densidad\t\r \u00a0 (LDL)\t\r \u00a0 (50-\u00ad\u201053).\t\r \u00a0 Los\t\r \u00a0 estudios\t\r \u00a0 transversales\t\r \u00a0 de\t\r \u00a0 poblaci\u00f3n\t\r \u00a0 muestran\t\r \u00a0que\t\r \u00a0concentraciones\t\r \u00a0bajas\t\r \u00a0de\t\r \u00a0adiponectina\t\r \u00a0est\u00e1n\t\r \u00a0relacionadas\t\r \u00a0con\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0del\t\r \u00a0perfil\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0metab\u00f3lico\t\r \u00a0 y\t\r \u00a0 cardiovascular\t\r \u00a0 (54,\t\r \u00a0 55).\t\r \u00a0 Recientemente,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0identificado\t\r \u00a0una\t\r \u00a0nueva\t\r \u00a0mol\u00e9cula,\t\r \u00a0la\t\r \u00a0resistina,\t\r \u00a0secretada\t\r \u00a0por\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0maduros\t\r \u00a0y\t\r \u00a0que\t\r \u00a0podr\u00eda\t\r \u00a0ser\t\r \u00a0el\t\r \u00a0nexo\t\r \u00a0de\t\r \u00a0uni\u00f3n\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0(56).\t\r \u00a0En\t\r \u00a0roedores\t\r \u00a0parece\t\r \u00a0estar\t\r \u00a0clara\t\r \u00a0su\t\r \u00a0implicaci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina.\t\r \u00a0 Sus\t\r \u00a0 niveles\t\r \u00a0 circulantes\t\r \u00a0 se\t\r \u00a0 incrementan\t\r \u00a0 durante\t\r \u00a0 la\t\r \u00a0 obesidad,\t\r \u00a0 su\t\r \u00a0 bloqueo\t\r \u00a0mejora\t\r \u00a0la\t\r \u00a0homeostasis\t\r \u00a0de\t\r \u00a0la\t\r \u00a0glucosa\t\r \u00a0y\t\r \u00a0su\t\r \u00a0administraci\u00f3n\t\r \u00a0ejerce\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0negativo\t\r \u00a0sobre\t\r \u00a0 los\t\r \u00a0 tejidos\t\r \u00a0 diana\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 insulina.\t\r \u00a0 En\t\r \u00a0 humanos,\t\r \u00a0 sin\t\r \u00a0 embargo,\t\r \u00a0 el\t\r \u00a0 papel\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0resistina\t\r \u00a0 no\t\r \u00a0 est\u00e1\t\r \u00a0 ni\t\r \u00a0 mucho\t\r \u00a0 menos\t\r \u00a0 esclarecido,\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 trabajos\t\r \u00a0 publicados\t\r \u00a0 son\t\r \u00a0bastante\t\r \u00a0contradictorios.\t\r \u00a0Parece\t\r \u00a0que\t\r \u00a0esta\t\r \u00a0hormona\t\r \u00a0podr\u00eda\t\r \u00a0ejercer\t\r \u00a0alg\u00fan\t\r \u00a0papel\t\r \u00a0en\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0 inflamatoria\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 mayoritaria\t\r \u00a0 expresi\u00f3n\t\r \u00a0 en\t\r \u00a0 c\u00e9lulas\t\r \u00a0mononucleares\t\r \u00a0(57).\t\r \u00a0Se\t\r \u00a0requieren,\t\r \u00a0por\t\r \u00a0tanto,\t\r \u00a0nuevos\t\r \u00a0estudios\t\r \u00a0para\t\r \u00a0determinar\t\r \u00a0el\t\r \u00a0papel\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0mol\u00e9cula\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0como\t\r \u00a0en\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina.\t\r \u00a0\t\r \u00a0Diversas\t\r \u00a0 citoquinas\t\r \u00a0 proinflamatorias\t\r \u00a0 son\t\r \u00a0 secretadas\t\r \u00a0 por\t\r \u00a0 distintos\t\r \u00a0 tipos\t\r \u00a0celulares\t\r \u00a0 incluidos\t\r \u00a0 los\t\r \u00a0 adipocitos.\t\r \u00a0 Tienen\t\r \u00a0 una\t\r \u00a0 acci\u00f3n\t\r \u00a0 paracrina\t\r \u00a0 o\t\r \u00a0 autocrina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0propio\t\r \u00a0tejido\t\r \u00a0y\t\r \u00a0participan\t\r \u00a0en\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0inflamatoria\t\r \u00a0local\t\r \u00a0que\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0en\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0 obesos.\t\r \u00a0 Se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0adipocito\t\r \u00a0 est\u00e1n\t\r \u00a0correlacionados\t\r \u00a0 positivamente\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 tama\u00f1o\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 dep\u00f3sitos\t\r \u00a0adiposos.\t\r \u00a0Adem\u00e1s,\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0del\t\r \u00a0RNA\t\r \u00a0mensajero\t\r \u00a0del\t\r \u00a0TNF-\u00ad\u2010\u03b1\t\r \u00a0est\u00e1\t\r \u00a0aumentada\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0de\t\r \u00a0distintos\t\r \u00a0modelos\t\r \u00a0murinos\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0diabetes\t\r \u00a0y\t\r \u00a0de\t\r \u00a0pacientes\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n328\t\r \u00a0\t\r \u00a0obesos,\t\r \u00a0relacion\u00e1ndose\t\r \u00a0dicho\t\r \u00a0aumento\t\r \u00a0con\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0(58,\t\r \u00a0 59).\t\r \u00a0 Por\t\r \u00a0 un\t\r \u00a0 lado,\t\r \u00a0 el\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0activa\t\r \u00a0 la\t\r \u00a0 lip\u00f3lisis\t\r \u00a0 e\t\r \u00a0 inhibe\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 \t\r \u00a0 LPL\t\r \u00a0 y\t\r \u00a0GLUT-\u00ad\u20104\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 mecanismo\t\r \u00a0 que\t\r \u00a0 trata\t\r \u00a0 de\t\r \u00a0 reducir\t\r \u00a0 el\t\r \u00a0 tama\u00f1o\t\r \u00a0 excesivo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0dep\u00f3sitos\t\r \u00a0 grasos.\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 altos\t\r \u00a0 de\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0podr\u00eda\t\r \u00a0 deberse\t\r \u00a0 a\t\r \u00a0 alguna\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 alteraciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 asociadas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0como\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina.\t\r \u00a0 As\u00ed,\t\r \u00a0 el\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0aumenta\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 \u00e1cidos\t\r \u00a0grasos\t\r \u00a0 libres,\t\r \u00a0 reduciendo\t\r \u00a0 la\t\r \u00a0 sensibilidad\t\r \u00a0 a\t\r \u00a0 insulina,\t\r \u00a0 y\t\r \u00a0 tiene\t\r \u00a0 un\t\r \u00a0efecto\t\r \u00a0 inhibidor\t\r \u00a0directo\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 acci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 h\u00edgado,\t\r \u00a0 incrementando\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0glucosa\t\r \u00a0 hep\u00e1tica\t\r \u00a0 (60,\t\r \u00a0 61).\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 las\t\r \u00a0 acciones\t\r \u00a0 biol\u00f3gicas\t\r \u00a0 del\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0 podr\u00eda\t\r \u00a0estar\t\r \u00a0influenciadas\t\r \u00a0por\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0dos\t\r \u00a0receptores:\t\r \u00a0p60\t\r \u00a0TNFR\t\r \u00a0(TNF-\u00ad\u2010R1)\t\r \u00a0y\t\r \u00a0p80\t\r \u00a0TNFR\t\r \u00a0(TNF-\u00ad\u2010R2).\t\r \u00a0La\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0TNF-\u00ad\u2010R1\t\r \u00a0est\u00e1\t\r \u00a0positivamente\t\r \u00a0correlacionada\t\r \u00a0con\t\r \u00a0el\t\r \u00a0\u00edndice\t\r \u00a0de\t\r \u00a0masa\t\r \u00a0corporal\t\r \u00a0y\t\r \u00a0el\t\r \u00a0tama\u00f1o\t\r \u00a0de\t\r \u00a0los\t\r \u00a0adipocitos,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0 TNF-\u00ad\u2010R2\t\r \u00a0 muestra\t\r \u00a0 asociaciones\t\r \u00a0 positivas\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 concentraci\u00f3n\t\r \u00a0 circulante\t\r \u00a0 de\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0triglic\u00e9ridos\t\r \u00a0(62).\t\r \u00a0As\u00ed,\t\r \u00a0interfiriendo\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0de\t\r \u00a0se\u00f1alizaci\u00f3n\t\r \u00a0del\t\r \u00a0TNF-\u00ad\u2010\u03b1\t\r \u00a0se\t\r \u00a0protege\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0obesidad\t\r \u00a0(63).\t\r \u00a0\t\r \u00a0La\t\r \u00a0neutralizaci\u00f3n\t\r \u00a0del\t\r \u00a0 TNF-\u00ad\u2010\u03b1\t\r \u00a0usando\t\r \u00a0 un\t\r \u00a0 anticuerpo\t\r \u00a0 monoclonal\t\r \u00a0 reduce\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 glucosa\t\r \u00a0 del\t\r \u00a0modelo\t\r \u00a0murino\t\r \u00a0diab\u00e9tico\t\r \u00a0KKAy\t\r \u00a0(64)\t\r \u00a0y\t\r \u00a0mejora\t\r \u00a0el\t\r \u00a0control\t\r \u00a0glic\u00e9mico\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0con\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0(65).\t\r \u00a0Del\t\r \u00a0mismo\t\r \u00a0modo,\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0un\t\r \u00a0anticuerpo\t\r \u00a0anti-\u00ad\u2010TNF-\u00ad\u2010\u03b1\t\r \u00a0durante\t\r \u00a0 seis\t\r \u00a0 semanas\t\r \u00a0 redujo\t\r \u00a0 la\t\r \u00a0 hiperglucemia\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 ayuno,\t\r \u00a0 la\t\r \u00a0 intolerancia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0glucosa\t\r \u00a0y\t\r \u00a0mejor\u00f3\t\r \u00a0la\t\r \u00a0sensibilidad\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0visceral,\t\r \u00a0principalmente\t\r \u00a0en\t\r \u00a0el\t\r \u00a0compartimento\t\r \u00a0gonadal,\t\r \u00a0del\t\r \u00a0rat\u00f3n\t\r \u00a0BATIRKO\t\r \u00a0de\t\r \u00a052\t\r \u00a0semanas,\t\r \u00a0que\t\r \u00a0 presenta\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 adiposidad\t\r \u00a0asociado\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 lipoatrofia\t\r \u00a0 marr\u00f3n\t\r \u00a0severa.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0modelo,\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0anti-\u00ad\u2010TNF-\u00ad\u2010\u03b1\t\r \u00a0redujo\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0NF-\u00ad\u2010\u03baB\t\r \u00a0en\t\r \u00a0ambos\t\r \u00a0tejidos\t\r \u00a0adiposos,\t\r \u00a0y\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0mol\u00e9culas\t\r \u00a0controladas\t\r \u00a0por\t\r \u00a0dicho\t\r \u00a0factor\t\r \u00a0 de\t\r \u00a0 transcripci\u00f3n\t\r \u00a0 \t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 gonadal,\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0en\t\r \u00a0la\t\r \u00a0aorta.\t\r \u00a0Adem\u00e1s,\t\r \u00a0las\t\r \u00a0alteraciones\t\r \u00a0vasculares,\t\r \u00a0como\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 vascular,\t\r \u00a0 y\t\r \u00a0 disfunci\u00f3n\t\r \u00a0 vascular\t\r \u00a0 fueron\t\r \u00a0 revertidas\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0tratamiento\t\r \u00a0con\t\r \u00a0anti-\u00ad\u2010TNF-\u00ad\u2010\u03b1\t\r \u00a0(66).\t\r \u00a0El\t\r \u00a0angiotensin\u00f3geno\t\r \u00a0y\t\r \u00a0el\t\r \u00a0inhibidor\t\r \u00a0del\t\r \u00a0activador\t\r \u00a0del\t\r \u00a0plasmin\u00f3geno\t\r \u00a0(PAI-\u00ad\u20101)\t\r \u00a0son\t\r \u00a0mol\u00e9culas\t\r \u00a0secretadas\t\r \u00a0tambi\u00e9n\t\r \u00a0por\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0y\t\r \u00a0cuya\t\r \u00a0expresi\u00f3n\t\r \u00a0g\u00e9nica\t\r \u00a0est\u00e1\t\r \u00a0aumentada\t\r \u00a0en\t\r \u00a0situaciones\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0(67,\t\r \u00a068),\t\r \u00a0teniendo\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0delet\u00e9reo\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0vascular.\t\r \u00a0Adem\u00e1s,\t\r \u00a0otro\t\r \u00a0componente\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0renina-\u00ad\u2010angiotensina\t\r \u00a0que\t\r \u00a0tambi\u00e9n\t\r \u00a0tiene\t\r \u00a0el\t\r \u00a0adipocito\t\r \u00a0es\t\r \u00a0la\t\r \u00a0angiotensina\t\r \u00a0II,\t\r \u00a0que\t\r \u00a0posee\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0estimulante\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0diferenciaci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0y\t\r \u00a0tiene\t\r \u00a0su\t\r \u00a0implicaci\u00f3n\t\r \u00a0en\t\r \u00a0la\t\r \u00a0regulaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0sus\t\r \u00a0acciones\t\r \u00a0lipog\u00e9nicas\t\r \u00a0(69).\t\r \u00a0En\t\r \u00a0relaci\u00f3n\t\r \u00a0a\t\r \u00a0la\t\r \u00a0secreci\u00f3n\t\r \u00a0de\t\r \u00a0PAI-\u00ad\u20101\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 observado\t\r \u00a0 una\t\r \u00a0 mayor\t\r \u00a0 producci\u00f3n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 grasa\t\r \u00a0visceral\t\r \u00a0que\t\r \u00a0en\t\r \u00a0la\t\r \u00a0grasa\t\r \u00a0subcut\u00e1nea.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0sentido,\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0PAI-\u00ad\u20101\t\r \u00a0estaban\t\r \u00a0aumentados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0central\t\r \u00a0relacion\u00e1ndose\t\r \u00a0con\t\r \u00a0las\t\r \u00a0alteraciones\t\r \u00a0vasculares\t\r \u00a0asociados\t\r \u00a0a\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0(68).\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0329\t\r \u00a0\t\r \u00a02.4.\t\r \u00a0Papel\t\r \u00a0 del\t\r \u00a0 WAT\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 inflamaci\u00f3n\t\r \u00a0 generada\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0alteraciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0En\t\r \u00a0una\t\r \u00a0situaci\u00f3n\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0asociada\t\r \u00a0a\t\r \u00a0una\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina,\t\r \u00a0tanto\t\r \u00a0el\t\r \u00a0exceso\t\r \u00a0de\t\r \u00a0dieta\t\r \u00a0como\t\r \u00a0la\t\r \u00a0propia\t\r \u00a0obesidad\t\r \u00a0producen\t\r \u00a0una\t\r \u00a0acumulaci\u00f3n\t\r \u00a0de\t\r \u00a0l\u00edpidos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0adipocitos,\t\r \u00a0inici\u00e1ndose\t\r \u00a0un\t\r \u00a0estr\u00e9s\t\r \u00a0en\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0y\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0de\t\r \u00a0las\t\r \u00a0JNK\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 factor\t\r \u00a0 nuclear\t\r \u00a0 de\t\r \u00a0 transcripci\u00f3n\t\r \u00a0\u03baB\t\r \u00a0 \t\r \u00a0 (NF-\u00ad\u2010\u03baB)\t\r \u00a0 (70,\t\r \u00a0 71).\t\r \u00a0 Estas\t\r \u00a0 v\u00edas\t\r \u00a0 de\t\r \u00a0se\u00f1alizaci\u00f3n\t\r \u00a0inflamatorias\t\r \u00a0regulan\t\r \u00a0la\t\r \u00a0fosforilaci\u00f3n\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0y\t\r \u00a0distintos\t\r \u00a0eventos\t\r \u00a0celulares\t\r \u00a0transcripcionales\t\r \u00a0que\t\r \u00a0conducen\t\r \u00a0a\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0por\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0adipocito\t\r \u00a0en\t\r \u00a0la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas\t\r \u00a0 proinflamatorias,\t\r \u00a0 incluidas\t\r \u00a0 el\t\r \u00a0 TNF-\u00ad\u2010\u03b1,\t\r \u00a0 IL-\u00ad\u20106,\t\r \u00a0 leptina\t\r \u00a0 y\t\r \u00a0resistina,\t\r \u00a0de\t\r \u00a0quimioquinas\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0quimioatractante\t\r \u00a0de\t\r \u00a0monocitos\t\r \u00a0(MCP-\u00ad\u20101),\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 otros\t\r \u00a0 mediadores\t\r \u00a0 proaterog\u00e9nicos,\t\r \u00a0 como\t\r \u00a0 por\t\r \u00a0 ejemplo\t\r \u00a0 PAI-\u00ad\u20101.\t\r \u00a0Mol\u00e9culas\t\r \u00a0 de\t\r \u00a0 adhesi\u00f3n\t\r \u00a0 endotelial\t\r \u00a0 (ej.:\t\r \u00a0 ICAM-\u00ad\u20101\t\r \u00a0 y\t\r \u00a0 VCAM-\u00ad\u20101),\t\r \u00a0 y\t\r \u00a0 mol\u00e9culas\t\r \u00a0quimioatractantes\t\r \u00a0 (ej.:\t\r \u00a0 CCX)\t\r \u00a0 se\t\r \u00a0 unen\t\r \u00a0 a\t\r \u00a0 integrinas\t\r \u00a0 y\t\r \u00a0 receptores\t\r \u00a0 de\t\r \u00a0 quimioquinas\t\r \u00a0(CCR),\t\r \u00a0respectivamente,\t\r \u00a0y\t\r \u00a0favorecen\t\r \u00a0el\t\r \u00a0reclutamiento\t\r \u00a0de\t\r \u00a0monocitos\t\r \u00a0y\t\r \u00a0otras\t\r \u00a0c\u00e9lulas\t\r \u00a0inflamatorias\t\r \u00a0al\t\r \u00a0tejido\t\r \u00a0adiposo.\t\r \u00a0Los\t\r \u00a0monocitos\t\r \u00a0una\t\r \u00a0vez\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0se\t\r \u00a0diferencian\t\r \u00a0a\t\r \u00a0 macr\u00f3fagos\t\r \u00a0 y\t\r \u00a0 amplifican\t\r \u00a0 la\t\r \u00a0 respuesta\t\r \u00a0 inflamatoria\t\r \u00a0 produciendo\t\r \u00a0 muchas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0mismas\t\r \u00a0 citoquinas\t\r \u00a0 y\t\r \u00a0 quimioquinas\t\r \u00a0 inflamatorias\t\r \u00a0 mencionadas\t\r \u00a0 previamente\t\r \u00a0 (72)\t\r \u00a0(Figura\t\r \u00a01).\t\r \u00a0Un\t\r \u00a0n\u00famero\t\r \u00a0reciente\t\r \u00a0de\t\r \u00a0art\u00edculos\t\r \u00a0han\t\r \u00a0sugerido\t\r \u00a0tambi\u00e9n\t\r \u00a0que\t\r \u00a0los\t\r \u00a0linfocitos\t\r \u00a0T\t\r \u00a0 podr\u00edan\t\r \u00a0 desempe\u00f1ar\t\r \u00a0 un\t\r \u00a0 papel\t\r \u00a0 importante\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 citoquinas\t\r \u00a0proinflamatorias\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0reclutamiento\t\r \u00a0de\t\r \u00a0macr\u00f3fagos\t\r \u00a0al\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0en\t\r \u00a0obesos.\t\r \u00a0Al\t\r \u00a0 igual\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 monocitos,\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 T\t\r \u00a0 que\t\r \u00a0 circulan\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 del\t\r \u00a0 organismo,\t\r \u00a0infiltran\t\r \u00a0 los\t\r \u00a0 tejidos\t\r \u00a0 perif\u00e9ricos\t\r \u00a0 en\t\r \u00a0 respuesta\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 se\u00f1ales\t\r \u00a0 de\t\r \u00a0 quimioquinas\t\r \u00a0 y\t\r \u00a0citoquinas.\t\r \u00a0 El\t\r \u00a0 infiltrado\t\r \u00a0 de\t\r \u00a0 linfocitos\t\r \u00a0 precede\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 poblaci\u00f3n\t\r \u00a0 de\t\r \u00a0 monocitos\t\r \u00a0 en\t\r \u00a0respuesta\t\r \u00a0 a\t\r \u00a0 dieta\t\r \u00a0 grasa\t\r \u00a0 y\t\r \u00a0 podr\u00eda\t\r \u00a0 proporcionar\t\r \u00a0 mediadores\t\r \u00a0 proinflamatorios\t\r \u00a0 que\t\r \u00a0promueven\t\r \u00a0 el\t\r \u00a0 reclutamiento\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 de\t\r \u00a0 macr\u00f3fagos\t\r \u00a0 (Figura\t\r \u00a0 1).\t\r \u00a0 Los\t\r \u00a0linfocitos\t\r \u00a0T\t\r \u00a0citot\u00f3xicos\t\r \u00a0del\t\r \u00a0linaje\t\r \u00a0CD8\t\r \u00a0est\u00e1n\t\r \u00a0muy\t\r \u00a0enriquecidos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0de\t\r \u00a0 ratones\t\r \u00a0sometidos\t\r \u00a0 a\t\r \u00a0 dieta\t\r \u00a0 grasa,\t\r \u00a0 resultando\t\r \u00a0 consistente\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 aumento\t\r \u00a0significativo\t\r \u00a0 de\t\r \u00a0 c\u00e9lulas\t\r \u00a0 CD8\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 obesos\t\r \u00a0 (73).\t\r \u00a0 As\u00ed,\t\r \u00a0 ratones\t\r \u00a0 deficientes\t\r \u00a0 en\t\r \u00a0CD8\t\r \u00a0fueron\t\r \u00a0parcialmente\t\r \u00a0resistentes\t\r \u00a0a\t\r \u00a0desarrollar\t\r \u00a0obesidad\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0dieta\t\r \u00a0rica\t\r \u00a0en\t\r \u00a0grasas,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0transferencia\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0CD8\t\r \u00a0agravaba\t\r \u00a0la\t\r \u00a0inflamaci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0(73).\t\r \u00a0\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n330\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a0 1.-\u00ad\u2010\t\r \u00a0Contribuci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 complicaciones\t\r \u00a0metab\u00f3licas\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0asociadas.\t\r \u00a0En\t\r \u00a0una\t\r \u00a0situaci\u00f3n\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0una\t\r \u00a0acumulaci\u00f3n\t\r \u00a0de\t\r \u00a0l\u00edpidos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0adipocitos,\t\r \u00a0inici\u00e1ndose\t\r \u00a0un\t\r \u00a0estr\u00e9s\t\r \u00a0en\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0y\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0de\t\r \u00a0las\t\r \u00a0JNK\t\r \u00a0y\t\r \u00a0del\t\r \u00a0 NF-\u00ad\u2010\u03baB,\t\r \u00a0 gener\u00e1ndose\t\r \u00a0 una\t\r \u00a0 inflamaci\u00f3n\t\r \u00a0 local\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 adipocito\t\r \u00a0 blanco.\t\r \u00a0 \u00c9sta\t\r \u00a0 puede\t\r \u00a0 exportarse\t\r \u00a0 a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0portal\t\r \u00a0al\t\r \u00a0h\u00edgado\t\r \u00a0y\t\r \u00a0finalmente,\t\r \u00a0a\t\r \u00a0otros\t\r \u00a0tejidos\t\r \u00a0perif\u00e9ricos,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0territorio\t\r \u00a0vascular\t\r \u00a0donde\t\r \u00a0podr\u00eda\t\r \u00a0producir\t\r \u00a0aterosclerosis,\t\r \u00a0hipertensi\u00f3n\t\r \u00a0y\t\r \u00a0resistencia\t\r \u00a0vascular\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina.\t\r \u00a0Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 propios\t\r \u00a0 adipocitos\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 inflamatorias,\t\r \u00a0 otros\t\r \u00a0 tipos\t\r \u00a0celulares\t\r \u00a0podr\u00eda\t\r \u00a0participar\t\r \u00a0en\t\r \u00a0dicha\t\r \u00a0respuesta\t\r \u00a0inflamatoria.\t\r \u00a0As\u00ed,\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0est\u00e1\t\r \u00a0vascularizado,\t\r \u00a0con\t\r \u00a0m\u00faltiples\t\r \u00a0capilares\t\r \u00a0en\t\r \u00a0contacto\t\r \u00a0con\t\r \u00a0cada\t\r \u00a0adipocito\t\r \u00a0(74).\t\r \u00a0\t\r \u00a0En\t\r \u00a0este\t\r \u00a0sentido,\t\r \u00a0para\t\r \u00a0la\t\r \u00a0expansi\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0grasa,\t\r \u00a0la\t\r \u00a0microcirculaci\u00f3n\t\r \u00a0podr\u00eda\t\r \u00a0desempe\u00f1ar\t\r \u00a0un\t\r \u00a0papel\t\r \u00a0clave\t\r \u00a0en\t\r \u00a0la\t\r \u00a0inflamaci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo.\t\r \u00a0As\u00ed,\t\r \u00a0en\t\r \u00a0un\t\r \u00a0endotelio\t\r \u00a0normal\t\r \u00a0que\t\r \u00a0es\t\r \u00a0 antiadherente,\t\r \u00a0 los\t\r \u00a0 leucocitos\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 adhieren,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 despu\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0administraci\u00f3n\t\r \u00a0 de\t\r \u00a0 dieta\t\r \u00a0 rica\t\r \u00a0 en\t\r \u00a0 grasas\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 demostrado\t\r \u00a0 que\t\r \u00a0 dicho\t\r \u00a0 endotelio\t\r \u00a0expresa\t\r \u00a0mol\u00e9culas\t\r \u00a0de\t\r \u00a0adhesi\u00f3n\t\r \u00a0y\t\r \u00a0une\t\r \u00a0leucocitos\t\r \u00a0(75).\t\r \u00a0Las\t\r \u00a0c\u00e9lulas\t\r \u00a0endoteliales\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0 adiposo\t\r \u00a0 podr\u00edan\t\r \u00a0 aumentar\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 prote\u00ednas\t\r \u00a0 de\t\r \u00a0 adhesi\u00f3n,\t\r \u00a0 como\t\r \u00a0ICAM-\u00ad\u20101,\t\r \u00a0 VCAM-\u00ad\u20101,\t\r \u00a0 E-\u00ad\u2010selectina\t\r \u00a0 o\t\r \u00a0 P-\u00ad\u2010selectina\t\r \u00a0 en\t\r \u00a0 respuesta\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0adiposidad\t\r \u00a0y\t\r \u00a0favorecer\t\r \u00a0as\u00ed\t\r \u00a0la\t\r \u00a0adhesi\u00f3n\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0inflamatorias\t\r \u00a0como\t\r \u00a0linfocitos\t\r \u00a0T\t\r \u00a0y\t\r \u00a0monocitos\t\r \u00a0(76).\t\r \u00a0\t\r \u00a0El\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0activa\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0inflamatoria\t\r \u00a0en\t\r \u00a0el\t\r \u00a0adipocito\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0portal\t\r \u00a0en\t\r \u00a0el\t\r \u00a0h\u00edgado\t\r \u00a0(77)\t\r \u00a0(Figura\t\r \u00a01).\t\r \u00a0Esto\t\r \u00a0sugiere\t\r \u00a0que\t\r \u00a0la\t\r \u00a0acumulaci\u00f3n\t\r \u00a0lip\u00eddica\t\r \u00a0en\t\r \u00a0los\t\r \u00a0hepatocitos\t\r \u00a0o\t\r \u00a0esteatosis\t\r \u00a0podr\u00eda\t\r \u00a0inducir\t\r \u00a0una\t\r \u00a0respuesta\t\r \u00a0inflamatoria\t\r \u00a0subaguda\t\r \u00a0en\t\r \u00a0el\t\r \u00a0h\u00edgado,\t\r \u00a0que\t\r \u00a0es\t\r \u00a0similar\t\r \u00a0a\t\r \u00a0la\t\r \u00a0inflamaci\u00f3n\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 que\t\r \u00a0 sigue\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 lip\u00eddica\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 adipocito.\t\r \u00a0 Las\t\r \u00a0mol\u00e9culas\t\r \u00a0 proinflamatorias\t\r \u00a0 producidas\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 grasa\t\r \u00a0 abdominal\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0\nPapel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0331\t\r \u00a0\t\r \u00a0circulaci\u00f3n\t\r \u00a0 portal\t\r \u00a0 podr\u00edan\t\r \u00a0 ser\t\r \u00a0 las\t\r \u00a0 responsables\t\r \u00a0 del\t\r \u00a0 inicio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 inflamaci\u00f3n\t\r \u00a0hep\u00e1tica.\t\r \u00a0Adem\u00e1s\t\r \u00a0en\t\r \u00a0el\t\r \u00a0propio\t\r \u00a0hepatocito\t\r \u00a0graso\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0NF-\u00ad\u2010\u03baB\t\r \u00a0y\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0citoquinas,\t\r \u00a0incluidas\t\r \u00a0el\t\r \u00a0TNF-\u00ad\u2010\u03b1,\t\r \u00a0IL-\u00ad\u20106\t\r \u00a0e\t\r \u00a0IL-\u00ad\u20101\u03b2\t\r \u00a0(77).\t\r \u00a0Las\t\r \u00a0 citoquinas\t\r \u00a0 proinflamatorias\t\r \u00a0participan\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0insulina\t\r \u00a0y\t\r \u00a0activan\t\r \u00a0a\t\r \u00a0los\t\r \u00a0macr\u00f3fagos\t\r \u00a0hep\u00e1ticos\t\r \u00a0residentes\t\r \u00a0llamadas\t\r \u00a0c\u00e9lulas\t\r \u00a0Kupffer.\t\r \u00a0El\t\r \u00a0 h\u00edgado\t\r \u00a0 est\u00e1\t\r \u00a0 densamente\t\r \u00a0 poblado\t\r \u00a0 por\t\r \u00a0 c\u00e9lulas\t\r \u00a0 Kupffer\t\r \u00a0 que\t\r \u00a0 representan\t\r \u00a0aproximadamente\t\r \u00a0el\t\r \u00a05%\t\r \u00a0del\t\r \u00a0total\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0con\t\r \u00a0el\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0no\t\r \u00a0aumenta\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0Kupffer\t\r \u00a0sino\t\r \u00a0su\t\r \u00a0activaci\u00f3n\t\r \u00a0(77).\t\r \u00a0En\t\r \u00a0el\t\r \u00a0 h\u00edgado,\t\r \u00a0 al\t\r \u00a0 igual\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 hay\t\r \u00a0 distintos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 c\u00e9lulas\t\r \u00a0 que\t\r \u00a0participan\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 inflamaci\u00f3n\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 a\t\r \u00a0nivel\t\r \u00a0 local\t\r \u00a0 del\t\r \u00a0hepatocito\t\r \u00a0como\t\r \u00a0son\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0inmunes\t\r \u00a0y\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0endoteliales\t\r \u00a0(78).\t\r \u00a0Por\t\r \u00a0tanto,\t\r \u00a0los\t\r \u00a0 mediadores\t\r \u00a0 proinflamatorios\t\r \u00a0 y\t\r \u00a0 proaterog\u00e9nicos\t\r \u00a0 que\t\r \u00a0 son\t\r \u00a0 producidos\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0tejido\t\r \u00a0 adiposo\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 h\u00edgado\t\r \u00a0 y\t\r \u00a0 asociados\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 inmunes\t\r \u00a0 generan\t\r \u00a0 una\t\r \u00a0inflamaci\u00f3n\t\r \u00a0 sist\u00e9mica\t\r \u00a0 que\t\r \u00a0 produce\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 m\u00fasculo\t\r \u00a0esquel\u00e9tico\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 tejidos\t\r \u00a0 perif\u00e9ricos.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 vascular,\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 producir\t\r \u00a0resistencia\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 vascular,\t\r \u00a0 podr\u00edan\t\r \u00a0 contribuir\t\r \u00a0 a\t\r \u00a0 iniciar\t\r \u00a0 el\t\r \u00a0 proceso\t\r \u00a0aterog\u00e9nico\t\r \u00a0(79)\t\r \u00a0(Figura\t\r \u00a01).\t\r \u00a03.\t\r \u00a0PAPEL\t\r \u00a0 DEL\t\r \u00a0 TEJIDO\t\r \u00a0 ADIPOSO\t\r \u00a0 MARR\u00d3N\t\r \u00a0 EN\t\r \u00a0 LA\t\r \u00a0 OBESIDAD\t\r \u00a0 Y\t\r \u00a0 SUS\t\r \u00a0COMPLICACIONES\t\r \u00a0METAB\u00d3LICAS\t\r \u00a0Y\t\r \u00a0VASCULARES\t\r \u00a0ASOCIADAS\t\r \u00a03.1.\t\r \u00a0Morfolog\u00eda\t\r \u00a0y\t\r \u00a0distribuci\u00f3n\t\r \u00a0del\t\r \u00a0BAT\t\r \u00a0\t\r \u00a0El\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 est\u00e1\t\r \u00a0 formado\t\r \u00a0 por\t\r \u00a0 adipocitos\t\r \u00a0 marrones\t\r \u00a0 y\t\r \u00a0 c\u00e9lulas\t\r \u00a0progenitoras\t\r \u00a0de\t\r \u00a0adipocitos.\t\r \u00a0As\u00ed,\t\r \u00a0el\t\r \u00a0adipocito\t\r \u00a0marr\u00f3n\t\r \u00a0tiene\t\r \u00a0una\t\r \u00a0forma\t\r \u00a0poligonal\t\r \u00a0con\t\r \u00a0un\t\r \u00a0 n\u00facleo\t\r \u00a0 oval\t\r \u00a0 y\t\r \u00a0 centrado\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 citoplasma\t\r \u00a0 grande\t\r \u00a0 que\t\r \u00a0 contiene\t\r \u00a0 m\u00faltiples\t\r \u00a0 y\t\r \u00a0peque\u00f1as\t\r \u00a0 gotas\t\r \u00a0 lip\u00eddicas.\t\r \u00a0Posee\t\r \u00a0 un\t\r \u00a0 gran\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 mitocondrias\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 ret\u00edculo\t\r \u00a0endoplasm\u00e1tico\t\r \u00a0poco\t\r \u00a0desarrollado.\t\r \u00a0Adem\u00e1s,\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0altamente\t\r \u00a0vascularizado\t\r \u00a0e\t\r \u00a0inervado\t\r \u00a0(80).\t\r \u00a0Originalmente,\t\r \u00a0se\t\r \u00a0pens\u00f3\t\r \u00a0que\t\r \u00a0el\t\r \u00a0BAT\t\r \u00a0estaba\t\r \u00a0presente\t\r \u00a0en\t\r \u00a0los\t\r \u00a0seres\t\r \u00a0humanos\t\r \u00a0 s\u00f3lo\t\r \u00a0 durante\t\r \u00a0 el\t\r \u00a0 per\u00edodo\t\r \u00a0 neonatal.\t\r \u00a0 Sin\t\r \u00a0embargo,\t\r \u00a0 datos\t\r \u00a0 recientes\t\r \u00a0 han\t\r \u00a0demostrado\t\r \u00a0que\t\r \u00a0los\t\r \u00a0adultos\t\r \u00a0conservan\t\r \u00a0algunos\t\r \u00a0dep\u00f3sitos\t\r \u00a0metab\u00f3licamente\t\r \u00a0activos\t\r \u00a0de\t\r \u00a0 BAT\t\r \u00a0 que\t\r \u00a0 responden\t\r \u00a0 al\t\r \u00a0 fr\u00edo\t\r \u00a0 y\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 simp\u00e1tica\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 nervioso.\t\r \u00a0Dichos\t\r \u00a0dep\u00f3sitos\t\r \u00a0son\t\r \u00a0UCP-\u00ad\u20101\t\r \u00a0positivos\t\r \u00a0y\t\r \u00a0son\t\r \u00a0detectados\t\r \u00a0por\t\r \u00a0tomograf\u00eda\t\r \u00a0por\t\r \u00a0emisi\u00f3n\t\r \u00a0de\t\r \u00a0 positrones\t\r \u00a0 (PET).\t\r \u00a0 Actualmente,\t\r \u00a0 en\t\r \u00a0 humanos,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0descrito\t\r \u00a0 que\t\r \u00a0 est\u00e1\t\r \u00a0 localizado\t\r \u00a0 en\t\r \u00a0 dep\u00f3sitos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 regi\u00f3n\t\r \u00a0 cervical,\t\r \u00a0 supraclavicular,\t\r \u00a0paravertebral,\t\r \u00a0 mediastinal,\t\r \u00a0 para-\u00ad\u2010a\u00f3rtica\t\r \u00a0 y\t\r \u00a0 suprarrenal\t\r \u00a0 (81).\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 tambi\u00e9n\t\r \u00a0 se\t\r \u00a0han\t\r \u00a0localizado\t\r \u00a0peque\u00f1os\t\r \u00a0grupos\t\r \u00a0de\t\r \u00a0adipocitos\t\r \u00a0marrones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0del\t\r \u00a0m\u00fasculo\t\r \u00a0esquel\u00e9tico\t\r \u00a0en\t\r \u00a0adultos\t\r \u00a0humanos\t\r \u00a0(13).\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0recientes\t\r \u00a0datos\t\r \u00a0han\t\r \u00a0mostrado\t\r \u00a0que\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0marrones\t\r \u00a0encontrados\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0dep\u00f3sitos\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0no\t\r \u00a0son\t\r \u00a0derivados\t\r \u00a0del\t\r \u00a0linaje\t\r \u00a0myf5,\t\r \u00a0como\t\r \u00a0son\t\r \u00a0los\t\r \u00a0cl\u00e1sicos\t\r \u00a0adipocitos\t\r \u00a0marrones\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0interescapular\t\r \u00a0de\t\r \u00a0los\t\r \u00a0roedores,\t\r \u00a0y\t\r \u00a0se\t\r \u00a0denominan\t\r \u00a0c\u00e9lulas\t\r \u00a0beige\t\r \u00a0(82).\t\r \u00a0Dichas\t\r \u00a0c\u00e9lulas\t\r \u00a0son\t\r \u00a0positivas\t\r \u00a0para\t\r \u00a0UCP-\u00ad\u20101,\t\r \u00a0con\t\r \u00a0alta\t\r \u00a0capacidad\t\r \u00a0respiratoria,\t\r \u00a0con\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n332\t\r \u00a0\t\r \u00a0caracter\u00edsticas\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0y\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0con\t\r \u00a0una\t\r \u00a0alta\t\r \u00a0sensibilidad\t\r \u00a0a\t\r \u00a0la\t\r \u00a0hormona\t\r \u00a0 polipept\u00eddica\t\r \u00a0 irisina\t\r \u00a0 (83).\t\r \u00a0 En\t\r \u00a0 este\t\r \u00a0 sentido,\t\r \u00a0 se\t\r \u00a0 habr\u00eda\t\r \u00a0 mostrado\t\r \u00a0previamente\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 irisina\t\r \u00a0 secretada\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 m\u00fasculo\t\r \u00a0 esquel\u00e9tico\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0incrementa\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 ejercicio,\t\r \u00a0 induce\t\r \u00a0 la\t\r \u00a0 \u201cmarronizaci\u00f3n\u201d\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0subcut\u00e1neo.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0esta\t\r \u00a0prote\u00edna\t\r \u00a0tiene\t\r \u00a0poco\t\r \u00a0efecto\t\r \u00a0en\t\r \u00a0los\t\r \u00a0cl\u00e1sicos\t\r \u00a0adipocitos\t\r \u00a0marrones\t\r \u00a0 aislados\t\r \u00a0 del\t\r \u00a0 dep\u00f3sito\t\r \u00a0 interescapular\t\r \u00a0 (84).\t\r \u00a0 Todo\t\r \u00a0 ello,\t\r \u00a0 sugiere\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0respuesta\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 irisina\t\r \u00a0 podr\u00eda\t\r \u00a0 ser\t\r \u00a0 una\t\r \u00a0 caracter\u00edstica\t\r \u00a0 selectiva\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 beige\t\r \u00a0localizadas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dep\u00f3sitos\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0subcut\u00e1neo.\t\r \u00a0\t\r \u00a0El\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 estar\t\r \u00a0 implicado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 termog\u00e9nesis,\t\r \u00a0recientes\t\r \u00a0estudios\t\r \u00a0han\t\r \u00a0demostrado\t\r \u00a0que\t\r \u00a0pudiera\t\r \u00a0estar\t\r \u00a0implicado\t\r \u00a0en\t\r \u00a0la\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0triglic\u00e9ridos\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 glucosa,\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 servir\t\r \u00a0 como\t\r \u00a0 fuente\t\r \u00a0 de\t\r \u00a0adipoquinas\t\r \u00a0 y\t\r \u00a0 poseer\t\r \u00a0 distinta\t\r \u00a0 funci\u00f3n\t\r \u00a0 inflamatoria\t\r \u00a0 comparada\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0blanco.\t\r \u00a03.2.\t\r \u00a0La\t\r \u00a0 relaci\u00f3n\t\r \u00a0 de\t\r \u00a0 BAT\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 sus\t\r \u00a0 complicaciones\t\r \u00a0 vasculares\t\r \u00a0 y\t\r \u00a0metab\u00f3licas\t\r \u00a0La\t\r \u00a0activaci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0reduce\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0y\t\r \u00a0protege\t\r \u00a0al\t\r \u00a0rat\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0la\t\r \u00a0dieta\t\r \u00a0rica\t\r \u00a0en\t\r \u00a0grasas\t\r \u00a0(85,\t\r \u00a086).\t\r \u00a0As\u00ed,\t\r \u00a0la\t\r \u00a0p\u00e9rdida\t\r \u00a0de\t\r \u00a0la\t\r \u00a0 masa\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 (87),\t\r \u00a0 como\t\r \u00a0 puede\t\r \u00a0 ser\t\r \u00a0 una\t\r \u00a0 lipoatrofia\t\r \u00a0 marr\u00f3n\t\r \u00a0severa\t\r \u00a0 por\t\r \u00a0 una\t\r \u00a0 deleci\u00f3n\t\r \u00a0 del\t\r \u00a0 receptor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 ese\t\r \u00a0 tejido\t\r \u00a0 (66,\t\r \u00a0 88),\t\r \u00a0 o\t\r \u00a0 la\t\r \u00a0p\u00e9rdida\t\r \u00a0de\t\r \u00a0UCP-\u00ad\u20101\t\r \u00a0(89)\t\r \u00a0confiere\t\r \u00a0susceptibilidad\t\r \u00a0a\t\r \u00a0desarrollar\t\r \u00a0obesidad\t\r \u00a0en\t\r \u00a0ratones.\t\r \u00a0En\t\r \u00a0 los\t\r \u00a0 \u00faltimos\t\r \u00a0 a\u00f1os,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 cantidad\t\r \u00a0 de\t\r \u00a0 BAT\t\r \u00a0 estaba\t\r \u00a0 inversamente\t\r \u00a0correlacionada\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 \u00edndice\t\r \u00a0 de\t\r \u00a0 masa\t\r \u00a0 corporal\t\r \u00a0 en\t\r \u00a0 humanos,\t\r \u00a0 especialmente\t\r \u00a0 en\t\r \u00a0personas\t\r \u00a0de\t\r \u00a0avanzada\t\r \u00a0edad\t\r \u00a0(90).\t\r \u00a0Adem\u00e1s,\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0demostrado\t\r \u00a0recientemente\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 podr\u00eda\t\r \u00a0 proteger\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0 m\u00faltiples\t\r \u00a0 enfermedades\t\r \u00a0relacionadas\t\r \u00a0con\t\r \u00a0el\t\r \u00a0envejecimiento\t\r \u00a0(14).\t\r \u00a0As\u00ed,\t\r \u00a0individuos\t\r \u00a0con\t\r \u00a0dep\u00f3sitos\t\r \u00a0de\t\r \u00a0BAT\t\r \u00a0m\u00e1s\t\r \u00a0peque\u00f1os\t\r \u00a0 son\t\r \u00a0 m\u00e1s\t\r \u00a0 susceptibles\t\r \u00a0 a\t\r \u00a0 acumular\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 y\t\r \u00a0 aumentar\t\r \u00a0 su\t\r \u00a0peso\t\r \u00a0corporal\t\r \u00a0y\t\r \u00a0tener\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0riesgo\t\r \u00a0de\t\r \u00a0desarrollar\t\r \u00a0enfermedades\t\r \u00a0metab\u00f3licas\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0dicha\t\r \u00a0obesidad\t\r \u00a0(85,\t\r \u00a091).\t\r \u00a03.3.\t\r \u00a0El\t\r \u00a0BAT\t\r \u00a0y\t\r \u00a0la\t\r \u00a0termog\u00e9nesis\t\r \u00a0Una\t\r \u00a0de\t\r \u00a0la\t\r \u00a0principales\t\r \u00a0funciones\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0es\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0 termog\u00e9nesis\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0 desacoplante\t\r \u00a0 1\t\r \u00a0 (UCP-\u00ad\u20101),\t\r \u00a0generando\t\r \u00a0 calor\t\r \u00a0 a\t\r \u00a0 partir\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos\t\r \u00a0 (92).\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 termog\u00e9nesis,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 utiliza,\t\r \u00a0 en\t\r \u00a0 primer\t\r \u00a0 lugar,\t\r \u00a0 los\t\r \u00a0 l\u00edpidos\t\r \u00a0 almacenados\t\r \u00a0 como\t\r \u00a0 sustrato\t\r \u00a0para\t\r \u00a0 generar\t\r \u00a0 calor.\t\r \u00a0 Esta\t\r \u00a0 fase\t\r \u00a0 temprana\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 termog\u00e9nesis\t\r \u00a0 corresponde\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0norepinefrina\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0nervioso\t\r \u00a0simp\u00e1tico\t\r \u00a0activando\t\r \u00a0la\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 gotas\t\r \u00a0 de\t\r \u00a0 triglic\u00e9ridos.\t\r \u00a0 Algunos\t\r \u00a0 de\t\r \u00a0 estos\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos\t\r \u00a0activan\t\r \u00a0a\t\r \u00a0UCP-\u00ad\u20101.\t\r \u00a0Los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0remanentes\t\r \u00a0son\t\r \u00a0importados\t\r \u00a0a\t\r \u00a0la\t\r \u00a0mitocondria\t\r \u00a0y\t\r \u00a0all\u00ed\t\r \u00a0se\t\r \u00a0realiza\t\r \u00a0la\t\r \u00a0termog\u00e9nesis\t\r \u00a0con\t\r \u00a0la\t\r \u00a0disipaci\u00f3n\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0calor\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0acci\u00f3n\t\r \u00a0de\t\r \u00a0UCP-\u00ad\u20101.\t\r \u00a0Como\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0es\t\r \u00a0un\t\r \u00a0peque\u00f1o\t\r \u00a0porcentaje\t\r \u00a0del\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0333\t\r \u00a0\t\r \u00a0total\t\r \u00a0 del\t\r \u00a0 peso\t\r \u00a0 corporal,\t\r \u00a0 para\t\r \u00a0 mantener\t\r \u00a0 una\t\r \u00a0 termog\u00e9nesis\t\r \u00a0 sostenida\t\r \u00a0 es\t\r \u00a0 necesario\t\r \u00a0importar\t\r \u00a0y\t\r \u00a0quemar\t\r \u00a0triglic\u00e9ridos\t\r \u00a0circulantes\t\r \u00a0(93).\t\r \u00a03.4.\t\r \u00a0El\t\r \u00a0BAT\t\r \u00a0y\t\r \u00a0el\t\r \u00a0metabolismo\t\r \u00a0lip\u00eddico\t\r \u00a0y\t\r \u00a0gluc\u00eddico\t\r \u00a0El\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 estar\t\r \u00a0implicado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 termog\u00e9nesis,\t\r \u00a0recientes\t\r \u00a0 trabajos\t\r \u00a0 han\t\r \u00a0 demostrado\t\r \u00a0 que\t\r \u00a0 podr\u00eda\t\r \u00a0 tener\t\r \u00a0 un\t\r \u00a0 papel\t\r \u00a0 destacado\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0metabolismo\t\r \u00a0 lip\u00eddico\t\r \u00a0 y\t\r \u00a0 gluc\u00eddico\t\r \u00a0 (Figura\t\r \u00a0 2).\t\r \u00a0 En\t\r \u00a0 primer\t\r \u00a0 lugar,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0 podr\u00eda\t\r \u00a0 estar\t\r \u00a0 implicado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 eliminaci\u00f3n\t\r \u00a0 de\t\r \u00a0 triglic\u00e9ridos.\t\r \u00a0 As\u00ed,\t\r \u00a0las\t\r \u00a0lipoprote\u00ednas\t\r \u00a0 ricas\t\r \u00a0 en\t\r \u00a0 triglic\u00e9ridos\t\r \u00a0 (TRLs)\t\r \u00a0 transportan\t\r \u00a0 l\u00edpidos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 circulaci\u00f3n,\t\r \u00a0donde\t\r \u00a0una\t\r \u00a0porci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0liberada\t\r \u00a0por\t\r \u00a0la\t\r \u00a0LPL\t\r \u00a0(94).\t\r \u00a0Otros\t\r \u00a0\u00f3rganos\t\r \u00a0perif\u00e9ricos,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0y\t\r \u00a0el\t\r \u00a0m\u00fasculo\t\r \u00a0esquel\u00e9tico\t\r \u00a0captan\t\r \u00a0\u00e1cidos\t\r \u00a0 grasos,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 part\u00edculas\t\r \u00a0 remanentes\t\r \u00a0 ricas\t\r \u00a0 en\t\r \u00a0 colesterol\t\r \u00a0 son\t\r \u00a0eliminadas\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 h\u00edgado\t\r \u00a0 (94).\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 niveles\t\r \u00a0 elevados\t\r \u00a0 de\t\r \u00a0 triglic\u00e9ridos\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0part\u00edculas\t\r \u00a0remanentes\t\r \u00a0ricas\t\r \u00a0en\t\r \u00a0colesterol,\t\r \u00a0como\t\r \u00a0ocurre\t\r \u00a0en\t\r \u00a0la\t\r \u00a0dislipidemia\t\r \u00a0diab\u00e9tica,\t\r \u00a0representan\t\r \u00a0 factores\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 para\t\r \u00a0 desarrollar\t\r \u00a0 enfermedades\t\r \u00a0 cardiovasculares\t\r \u00a0(95-\u00ad\u201097).\t\r \u00a0Se\t\r \u00a0ha\t\r \u00a0descrito\t\r \u00a0que\t\r \u00a0el\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0por\t\r \u00a0 exposiciones\t\r \u00a0 cortas\t\r \u00a0 al\t\r \u00a0 fr\u00edo\t\r \u00a0 podr\u00eda\t\r \u00a0 controlar\t\r \u00a0 el\t\r \u00a0 metabolismo\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 TRLs\t\r \u00a0 en\t\r \u00a0rat\u00f3n,\t\r \u00a0 regulando\t\r \u00a0 la\t\r \u00a0 eliminaci\u00f3n\t\r \u00a0 de\t\r \u00a0 dichas\t\r \u00a0 lipoprote\u00ednas\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 exceso\t\r \u00a0 de\t\r \u00a0 l\u00edpidos\t\r \u00a0circulantes\t\r \u00a0 (93)\t\r \u00a0 y\t\r \u00a0 as\u00ed\t\r \u00a0 disminuyendo\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 triglic\u00e9ridos\t\r \u00a0 y\t\r \u00a0 aumentado\t\r \u00a0ligeramente\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0HDL\t\r \u00a0(Figura\t\r \u00a02).\t\r \u00a0As\u00ed,\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0son\t\r \u00a0eficientemente\t\r \u00a0introducidos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0propio\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0un\t\r \u00a0programa\t\r \u00a0metab\u00f3lico\t\r \u00a0que\t\r \u00a0 empuja\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 TRLs\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 captaci\u00f3n\t\r \u00a0 muy\t\r \u00a0 eficiente\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1cidos\t\r \u00a0 grasos.\t\r \u00a0 Este\t\r \u00a0proceso\t\r \u00a0 asociado\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 VEGF\t\r \u00a0 (98),\t\r \u00a0 conduce\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0incremento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 permeabilidad\t\r \u00a0 para\t\r \u00a0 las\t\r \u00a0 lipoprote\u00ednas,\t\r \u00a0 permitiendo\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0triglic\u00e9ridos\t\r \u00a0 salgan\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 capilares.\t\r \u00a0 La\t\r \u00a0 activaci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 por\t\r \u00a0norepinefrina\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0activa\t\r \u00a0la\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0triglic\u00e9ridos\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0propio\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0VEGF,\t\r \u00a0tambi\u00e9n\t\r \u00a0aumenta\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 LPL\t\r \u00a0 (93,\t\r \u00a0 99).\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 LPL\t\r \u00a0 degrada\t\r \u00a0 los\t\r \u00a0triglic\u00e9ridos\t\r \u00a0y\t\r \u00a0permite\t\r \u00a0que\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0puedan\t\r \u00a0estar\t\r \u00a0disponibles\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0transportadores\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 plasm\u00e1tica\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 CD36.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0demostrado\t\r \u00a0 en\t\r \u00a0 humanos\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 de\t\r \u00a0 BAT\t\r \u00a0 por\t\r \u00a0 exposici\u00f3n\t\r \u00a0 al\t\r \u00a0 fr\u00edo,\t\r \u00a0incrementa\t\r \u00a0 su\t\r \u00a0 metabolismo\t\r \u00a0 oxidativo,\t\r \u00a0 reduciendo\t\r \u00a0 el\t\r \u00a0 contenido\t\r \u00a0 de\t\r \u00a0 triglic\u00e9ridos\t\r \u00a0 y\t\r \u00a0contribuyendo\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0decisiva\t\r \u00a0al\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0(100).\t\r \u00a0Por\t\r \u00a0tanto,\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0BAT\t\r \u00a0ser\u00eda\t\r \u00a0capaz\t\r \u00a0de\t\r \u00a0corregir\t\r \u00a0las\t\r \u00a0hiperlipidemias\t\r \u00a0y\t\r \u00a0mejorar\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0delet\u00e9reos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0la\t\r \u00a0dislipidemia\t\r \u00a0como\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0la\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0o\t\r \u00a0el\t\r \u00a0proceso\t\r \u00a0 aterog\u00e9nico.\t\r \u00a0 Recientemente,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0epic\u00e1rdico\t\r \u00a0 (EAT)\t\r \u00a0 podr\u00eda\t\r \u00a0 ser\t\r \u00a0 un\t\r \u00a0 dep\u00f3sito\t\r \u00a0 de\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 activo\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0capaz\t\r \u00a0de\t\r \u00a0modificar\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0l\u00edpidos\t\r \u00a0circulantes\t\r \u00a0alterados,\t\r \u00a0as\u00ed\t\r \u00a0aumentado\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0HDL\t\r \u00a0y\t\r \u00a0disminuyendo\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0triglic\u00e9ridos\t\r \u00a0(101).\t\r \u00a0\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n334\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a0 2.-\u00ad\u2010\t\r \u00a0Contribuci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 complicaciones\t\r \u00a0metab\u00f3licas\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0asociadas.\t\r \u00a0Una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0posibles\t\r \u00a0causas\t\r \u00a0que\t\r \u00a0inducen\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0podr\u00eda\t\r \u00a0ser\t\r \u00a0una\t\r \u00a0disminuci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0cantidad\t\r \u00a0y\t\r \u00a0actividad\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n.\t\r \u00a0En\t\r \u00a0esta\t\r \u00a0situaci\u00f3n\t\r \u00a0 se\t\r \u00a0 producir\u00eda\t\r \u00a0 una\t\r \u00a0 alteraci\u00f3n\t\r \u00a0 de\t\r \u00a0 funciones\t\r \u00a0 que\t\r \u00a0 realiza\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0metabolismo\t\r \u00a0 lip\u00eddico,\t\r \u00a0 gluc\u00eddico\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 citoquinas\t\r \u00a0 y\t\r \u00a0 adipoquinas,\t\r \u00a0favoreci\u00e9ndose\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0las\t\r \u00a0complicaciones\t\r \u00a0metab\u00f3licas\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0misma.\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0tambi\u00e9n\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0descrito\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n,\t\r \u00a0podr\u00eda\t\r \u00a0tambi\u00e9n\t\r \u00a0estar\t\r \u00a0regulando\t\r \u00a0el\t\r \u00a0metabolismo\t\r \u00a0gluc\u00eddico\t\r \u00a0(93).\t\r \u00a0Dicho\t\r \u00a0tejido\t\r \u00a0tiene\t\r \u00a0una\t\r \u00a0alta\t\r \u00a0captaci\u00f3n\t\r \u00a0de\t\r \u00a0glucosa\t\r \u00a0debido\t\r \u00a0probablemente\t\r \u00a0a\t\r \u00a0una\t\r \u00a0intensa\t\r \u00a0combusti\u00f3n\t\r \u00a0de\t\r \u00a0glucosa\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 mitocondria,\t\r \u00a0 m\u00e1s\t\r \u00a0 que\t\r \u00a0 por\t\r \u00a0 acci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 insulina.\t\r \u00a0 La\t\r \u00a0 mitocondria\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0marr\u00f3n\t\r \u00a0utiliza\t\r \u00a0el\t\r \u00a0piruvato\t\r \u00a0para\t\r \u00a0la\t\r \u00a0combusti\u00f3n\t\r \u00a0siempre\t\r \u00a0que\t\r \u00a0UCP-\u00ad\u20101\t\r \u00a0est\u00e9\t\r \u00a0activo\t\r \u00a0por\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0(102).\t\r \u00a0Asimismo,\t\r \u00a0los\t\r \u00a0transportadores\t\r \u00a0de\t\r \u00a0glucosa,\t\r \u00a0GLUT-\u00ad\u20101\t\r \u00a0y\t\r \u00a0GLUT-\u00ad\u20104,\t\r \u00a0podr\u00edan\t\r \u00a0estar\t\r \u00a0implicados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0captaci\u00f3n\t\r \u00a0de\t\r \u00a0glucosa\t\r \u00a0por\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0BAT\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0 y\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 ambos\t\r \u00a0 transportadores\t\r \u00a0 est\u00e1\t\r \u00a0 aumentada\t\r \u00a0 tanto\t\r \u00a0 por\t\r \u00a0 fr\u00edo\t\r \u00a0como\t\r \u00a0por\t\r \u00a0norepinefrina\t\r \u00a0(93,\t\r \u00a0103,\t\r \u00a0104).\t\r \u00a03.5.\t\r \u00a0El\t\r \u00a0BAT\t\r \u00a0como\t\r \u00a0\u00f3rgano\t\r \u00a0endocrino\t\r \u00a0El\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 \u00f3rgano\t\r \u00a0 endocrino\t\r \u00a0 al\t\r \u00a0 igual\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0blanco.\t\r \u00a0Secreta\t\r \u00a0distintas\t\r \u00a0citoquinas,\t\r \u00a0hormonas\t\r \u00a0y\t\r \u00a0otros\t\r \u00a0factores,\t\r \u00a0como\t\r \u00a0TNF-\u00ad\u2010\u03b1,\t\r \u00a0adiponectina\t\r \u00a0y\t\r \u00a0leptina\t\r \u00a0al\t\r \u00a0igual\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0hay\t\r \u00a0un\t\r \u00a0gran\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas\t\r \u00a0 que\t\r \u00a0 son\t\r \u00a0 exclusivamente\t\r \u00a0 secretadas\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0 marr\u00f3n,\t\r \u00a0 las\t\r \u00a0 llamadas\t\r \u00a0 BAToquinas\t\r \u00a0 (adipoquinas\t\r \u00a0 derivadas\t\r \u00a0 de\t\r \u00a0 BAT).\t\r \u00a0Muchas\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 BAToquinas,\t\r \u00a0 incluida\t\r \u00a0 el\t\r \u00a0 factor\t\r \u00a0 de\t\r \u00a0 crecimiento\t\r \u00a0 fibrobl\u00e1stico\t\r \u00a0(FGF21),\t\r \u00a0son\t\r \u00a0requeridas\t\r \u00a0en\t\r \u00a0la\t\r \u00a0adaptaci\u00f3n\t\r \u00a0al\t\r \u00a0fr\u00edo\t\r \u00a0y\t\r \u00a0en\t\r \u00a0la\t\r \u00a0estimulaci\u00f3n\t\r \u00a0adren\u00e9rgica\t\r \u00a0(105-\u00ad\u2010107).\t\r \u00a0Adem\u00e1s,\t\r \u00a0FGF21\t\r \u00a0puede\t\r \u00a0actuar\t\r \u00a0tambi\u00e9n\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0directa\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0 marr\u00f3n,\t\r \u00a0 independientemente\t\r \u00a0 del\t\r \u00a0 control\t\r \u00a0 adren\u00e9rgico,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 permitir\u00e1\t\r \u00a0abrir\t\r \u00a0nuevas\t\r \u00a0v\u00edas\t\r \u00a0para\t\r \u00a0explorar\t\r \u00a0mecanismos\t\r \u00a0de\t\r \u00a0control\t\r \u00a0de\t\r \u00a0la\t\r \u00a0grasa\t\r \u00a0corporal\t\r \u00a0(107).\t\r \u00a0\nPapel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0335\t\r \u00a0\t\r \u00a0Otras\t\r \u00a0 prote\u00ednas\t\r \u00a0 secretadas\t\r \u00a0 tambi\u00e9n\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 BAT,\t\r \u00a0 como\t\r \u00a0 adipsina,\t\r \u00a0 FGF2,\t\r \u00a0 IGF-\u00ad\u20101,\t\r \u00a0prostaglandinas\t\r \u00a0y\t\r \u00a0la\t\r \u00a0adenosina,\t\r \u00a0desempe\u00f1an\t\r \u00a0tambi\u00e9n\t\r \u00a0funciones\t\r \u00a0autocrinas.\t\r \u00a0\t\r \u00a0\t\r \u00a0Adem\u00e1s,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 secreta\t\r \u00a0 otros\t\r \u00a0 factores\t\r \u00a0 como\t\r \u00a0 IL-\u00ad\u20106\t\r \u00a0 y\t\r \u00a0factores\t\r \u00a0neurotr\u00f3ficos,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0BDNF\t\r \u00a0y\t\r \u00a0el\t\r \u00a0factor\t\r \u00a0de\t\r \u00a0crecimiento\t\r \u00a0nervioso\t\r \u00a0(NGF),\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0podr\u00edan\t\r \u00a0tener\t\r \u00a0papeles\t\r \u00a0\u00fanicos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0BAT\t\r \u00a0con\t\r \u00a0respecto\t\r \u00a0al\t\r \u00a0WAT\t\r \u00a0(108-\u00ad\u2010111).\t\r \u00a0La\t\r \u00a0secreci\u00f3n\t\r \u00a0de\t\r \u00a0NGF\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0principalmente\t\r \u00a0por\t\r \u00a0la\t\r \u00a0proliferaci\u00f3n\t\r \u00a0de\t\r \u00a0preadipocitos\t\r \u00a0marrones,\t\r \u00a0que\t\r \u00a0promueve\t\r \u00a0la\t\r \u00a0inervaci\u00f3n\t\r \u00a0simp\u00e1tica\t\r \u00a0del\t\r \u00a0tejido,\t\r \u00a0y\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez\t\r \u00a0permite\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0estimulaci\u00f3n\t\r \u00a0por\t\r \u00a0norepinefrina\t\r \u00a0en\t\r \u00a0los\t\r \u00a0adipocitos\t\r \u00a0marrones.\t\r \u00a0Otros\t\r \u00a0factores\t\r \u00a0paracrinos,\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0los\t\r \u00a0neurotr\u00f3ficos,\t\r \u00a0sintetizados\t\r \u00a0por\t\r \u00a0el\t\r \u00a0BAT\t\r \u00a0son\t\r \u00a0el\t\r \u00a0factor\t\r \u00a0de\t\r \u00a0crecimiento\t\r \u00a0endotelial\t\r \u00a0vascular\t\r \u00a0(VEGF),\t\r \u00a0el\t\r \u00a0angiotensin\u00f3geno\t\r \u00a0y\t\r \u00a0el\t\r \u00a0\u00f3xido\t\r \u00a0n\u00edtrico.\t\r \u00a0La\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0VEGF\t\r \u00a0con\t\r \u00a0sus\t\r \u00a0receptores,\t\r \u00a0FLK-\u00ad\u20101\t\r \u00a0y\t\r \u00a0FLK-\u00ad\u20104,\t\r \u00a0es\t\r \u00a0alta\t\r \u00a0en\t\r \u00a0la\t\r \u00a0proliferaci\u00f3n\t\r \u00a0y\t\r \u00a0madurez\t\r \u00a0de\t\r \u00a0adipocitos\t\r \u00a0marrones,\t\r \u00a0manteniendo\t\r \u00a0alto\t\r \u00a0el\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0vascularizaci\u00f3n\t\r \u00a0de\t\r \u00a0este\t\r \u00a0tejido.\t\r \u00a0Tanto\t\r \u00a0la\t\r \u00a0noradrenalina\t\r \u00a0como\t\r \u00a0la\t\r \u00a0exposici\u00f3n\t\r \u00a0al\t\r \u00a0fr\u00edo\t\r \u00a0inducen\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 VEGF\t\r \u00a0 en\t\r \u00a0 BAT\t\r \u00a0 (112).\t\r \u00a0 Por\t\r \u00a0 otro\t\r \u00a0 lado,\t\r \u00a0 tanto\t\r \u00a0 la\t\r \u00a0 \u00f3xido\t\r \u00a0 n\u00edtrico\t\r \u00a0inducible\t\r \u00a0 (iNOS)\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 endotelial\t\r \u00a0 (eNOS)\t\r \u00a0 se\t\r \u00a0 expresan\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 BAT\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0noradrenalina\t\r \u00a0 induce\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 \u00f3xido\t\r \u00a0 n\u00edtrico\t\r \u00a0 (NO)\t\r \u00a0 que\t\r \u00a0inhibe\t\r \u00a0 la\t\r \u00a0 oxidaci\u00f3n\t\r \u00a0 mitocondrial\t\r \u00a0 y\t\r \u00a0 promueve\t\r \u00a0 un\t\r \u00a0 r\u00e1pido\t\r \u00a0 aumento\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 flujo\t\r \u00a0sangu\u00edneo\t\r \u00a0(113).\t\r \u00a0A\t\r \u00a0 diferencia\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 que\t\r \u00a0 r\u00e1pidamente\t\r \u00a0 es\t\r \u00a0 infiltrado\t\r \u00a0 por\t\r \u00a0c\u00e9lulas\t\r \u00a0inflamatorias\t\r \u00a0en\t\r \u00a0respuesta\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0dieta\t\r \u00a0grasa,\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0no\t\r \u00a0parece\t\r \u00a0acumular\t\r \u00a0tanto\t\r \u00a0infiltrado\t\r \u00a0de\t\r \u00a0macr\u00f3fagos\t\r \u00a0(114)\t\r \u00a0(Figura\t\r \u00a02).\t\r \u00a0Esto\t\r \u00a0puede\t\r \u00a0deberse,\t\r \u00a0a\t\r \u00a0que\t\r \u00a0el\t\r \u00a0BAT\t\r \u00a0tiene\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0mitocondrias\t\r \u00a0que\t\r \u00a0le\t\r \u00a0permite\t\r \u00a0metabolizar\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0grasos\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0\u03b2-\u00ad\u2010oxidaci\u00f3n.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 WAT,\t\r \u00a0 la\t\r \u00a0 capacidad\t\r \u00a0 para\t\r \u00a0 metabolizar\t\r \u00a0 los\t\r \u00a0 l\u00edpidos\t\r \u00a0 estar\u00eda\t\r \u00a0 superada,\t\r \u00a0 teniendo\t\r \u00a0efectos\t\r \u00a0 lipot\u00f3xicos\t\r \u00a0 y\t\r \u00a0 desencadenando\t\r \u00a0 la\t\r \u00a0 respuesta\t\r \u00a0 inflamatoria\t\r \u00a0 y\t\r \u00a0 facilitando\t\r \u00a0 el\t\r \u00a0infiltrado\t\r \u00a0de\t\r \u00a0macr\u00f3fagos\t\r \u00a0y\t\r \u00a0c\u00e9lulas\t\r \u00a0inmunes.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0sentido,\t\r \u00a0otro\t\r \u00a0grupo\t\r \u00a0reciente\t\r \u00a0ha\t\r \u00a0demostrado\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 macr\u00f3fagos\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 no\t\r \u00a0 tienen\t\r \u00a0el\t\r \u00a0 mismo\t\r \u00a0perfil\t\r \u00a0 de\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 citoquinas\t\r \u00a0 y\t\r \u00a0 quimioquinas\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 macr\u00f3fagos\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0(115).\t\r \u00a04.\t\r \u00a0PAPEL\t\r \u00a0 DEL\t\r \u00a0 TEJIDO\t\r \u00a0 ADIPOSO\t\r \u00a0 PERIVASCULAR\t\r \u00a0 EN\t\r \u00a0LA\t\r \u00a0 OBESIDAD\t\r \u00a0 Y\t\r \u00a0 SUS\t\r \u00a0COMPLICACIONES\t\r \u00a0METAB\u00d3LICAS\t\r \u00a0Y\t\r \u00a0VASCULARES\t\r \u00a0ASOCIADAS\t\r \u00a04.1.\t\r \u00a0Morfolog\u00eda\t\r \u00a0y\t\r \u00a0distribuci\u00f3n\t\r \u00a0del\t\r \u00a0PVAT\t\r \u00a0El\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 perivascular\t\r \u00a0 (PVAT)\t\r \u00a0 se\t\r \u00a0 encuentra\t\r \u00a0 rodeando\t\r \u00a0 la\t\r \u00a0 arteria\t\r \u00a0coronaria\t\r \u00a0 (o\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 epic\u00e1rdico),\t\r \u00a0 la\t\r \u00a0 aorta\t\r \u00a0 (tejido\t\r \u00a0 adiposo\t\r \u00a0 peria\u00f3rtico)\t\r \u00a0 y\t\r \u00a0otros\t\r \u00a0 vasos\t\r \u00a0 sist\u00e9micos\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 lecho\t\r \u00a0 microcirculatorio\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 mesent\u00e9ricas,\t\r \u00a0m\u00fasculo,\t\r \u00a0ri\u00f1\u00f3n\t\r \u00a0y\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0a\t\r \u00a0excepci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0circulaci\u00f3n\t\r \u00a0cerebral\t\r \u00a0(116).\t\r \u00a0Se\t\r \u00a0une\t\r \u00a0al\t\r \u00a0 exterior\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 capa\t\r \u00a0 adventicia\t\r \u00a0 sin\t\r \u00a0 ninguna\t\r \u00a0 estructura\t\r \u00a0 laminar\t\r \u00a0 o\t\r \u00a0 barrera\t\r \u00a0organizada\t\r \u00a0 que\t\r \u00a0 separe\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 dos.\t\r \u00a0 Dependiendo\t\r \u00a0 del\t\r \u00a0 lecho\t\r \u00a0 vascular,\t\r \u00a0 PVAT\t\r \u00a0 puede\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n336\t\r \u00a0\t\r \u00a0tener\t\r \u00a0 m\u00e1s\t\r \u00a0 o\t\r \u00a0 menos\t\r \u00a0 caracter\u00edsticas\t\r \u00a0 de\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 blanco\t\r \u00a0 o\t\r \u00a0 marr\u00f3n.\t\r \u00a0 As\u00ed,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0descrito\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 PVAT\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 arteria\t\r \u00a0 abdominal\t\r \u00a0 ser\u00eda\t\r \u00a0 pr\u00e1cticamente\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0blanco,\t\r \u00a0el\t\r \u00a0PVAT\t\r \u00a0de\t\r \u00a0las\t\r \u00a0arterias\t\r \u00a0coronarias\t\r \u00a0humanas\t\r \u00a0tendr\u00eda\t\r \u00a0un\t\r \u00a0fenotipo\t\r \u00a0intermedio\t\r \u00a0entre\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0y\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0el\t\r \u00a0PVAT\t\r \u00a0de\t\r \u00a0la\t\r \u00a0arteria\t\r \u00a0a\u00f3rtica\t\r \u00a0tor\u00e1cica\t\r \u00a0ser\u00eda\t\r \u00a0muy\t\r \u00a0similar\t\r \u00a0al\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0(92,\t\r \u00a0117).\t\r \u00a0La\t\r \u00a0vascularizaci\u00f3n\t\r \u00a0y\t\r \u00a0la\t\r \u00a0inervaci\u00f3n\t\r \u00a0del\t\r \u00a0PVAT\t\r \u00a0tambi\u00e9n\t\r \u00a0var\u00edan\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0considerable\t\r \u00a0con\t\r \u00a0la\t\r \u00a0localizaci\u00f3n\t\r \u00a0y\t\r \u00a0podr\u00eda\t\r \u00a0ayudar\t\r \u00a0a\t\r \u00a0explicar\t\r \u00a0las\t\r \u00a0distintas\t\r \u00a0caracter\u00edsticas\t\r \u00a0funcionales\t\r \u00a0de\t\r \u00a0PVAT.\t\r \u00a04.2.\t\r \u00a0Papel\t\r \u00a0de\t\r \u00a0PVAT\t\r \u00a0en\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0en\t\r \u00a0las\t\r \u00a0complicaciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0PVAT\t\r \u00a0 est\u00e1\t\r \u00a0 constituido\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 adipocitos,\t\r \u00a0 fibroblastos,\t\r \u00a0 c\u00e9lulas\t\r \u00a0 madre,\t\r \u00a0c\u00e9lulas\t\r \u00a0 que\t\r \u00a0 penetran\t\r \u00a0 el\t\r \u00a0 vaso\t\r \u00a0 vasorum\t\r \u00a0 y\t\r \u00a0 c\u00e9lulas\t\r \u00a0 inflamatorias\t\r \u00a0 infiltradas\t\r \u00a0 como\t\r \u00a0macr\u00f3fagos\t\r \u00a0y\t\r \u00a0linfocitos\t\r \u00a0T,\t\r \u00a0pudiendo\t\r \u00a0ser\t\r \u00a0estas\t\r \u00a0\u00faltimas\t\r \u00a0relevantes\t\r \u00a0en\t\r \u00a0determinadas\t\r \u00a0situaciones\t\r \u00a0patol\u00f3gicas\t\r \u00a0(116).\t\r \u00a0\t\r \u00a0El\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0perivascular\t\r \u00a0que\t\r \u00a0se\t\r \u00a0extiende\t\r \u00a0desde\t\r \u00a0la\t\r \u00a0capa\t\r \u00a0adventicia\t\r \u00a0es\t\r \u00a0un\t\r \u00a0 modulador\t\r \u00a0 clave\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 vascular\t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0 sujetos\t\r \u00a0 delgados\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0animales\t\r \u00a0delgados\t\r \u00a0de\t\r \u00a0experimentaci\u00f3n.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0en\t\r \u00a0una\t\r \u00a0situaci\u00f3n\t\r \u00a0de\t\r \u00a0obesidad,\t\r \u00a0el\t\r \u00a0 tejido\t\r \u00a0 perivascular\t\r \u00a0 aumenta\t\r \u00a0 su\t\r \u00a0 tama\u00f1o,\t\r \u00a0 creando\t\r \u00a0 un\t\r \u00a0 entorno\t\r \u00a0 de\t\r \u00a0 hipoxia\t\r \u00a0 que\t\r \u00a0podr\u00eda\t\r \u00a0 disminuir\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 adiponectina\t\r \u00a0 que\t\r \u00a0 tiene\t\r \u00a0 efectos\t\r \u00a0 protectores\t\r \u00a0frente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 aterog\u00e9nesis\t\r \u00a0 y\t\r \u00a0 otras\t\r \u00a0 complicaciones\t\r \u00a0 vasculares\t\r \u00a0 (117)\t\r \u00a0 (Figura\t\r \u00a0 3).\t\r \u00a0Adem\u00e1s,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 s\u00edndrome\t\r \u00a0 metab\u00f3lico\t\r \u00a0 PVAT\t\r \u00a0 pierde\t\r \u00a0 su\t\r \u00a0capacidad\t\r \u00a0 vasorreguladora\t\r \u00a0 porque\t\r \u00a0 hay\t\r \u00a0 una\t\r \u00a0 menor\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 de\t\r \u00a0 adipoquinas\t\r \u00a0vasodilatoras\t\r \u00a0 y\t\r \u00a0 simult\u00e1neamente\t\r \u00a0 se\t\r \u00a0 liberan\t\r \u00a0 m\u00e1s\t\r \u00a0 factores\t\r \u00a0 que\t\r \u00a0 promueven\t\r \u00a0 la\t\r \u00a0vasoconstricci\u00f3n\t\r \u00a0 (118).\t\r \u00a0 As\u00ed,\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 perivascular\t\r \u00a0 tiene\t\r \u00a0 propiedades\t\r \u00a0anticontr\u00e1ctiles\t\r \u00a0y\t\r \u00a0algunos\t\r \u00a0estudios\t\r \u00a0encuentran\t\r \u00a0que\t\r \u00a0\u00e9stas\t\r \u00a0se\t\r \u00a0pierden\t\r \u00a0en\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0(116)\t\r \u00a0 (Figura\t\r \u00a0 3).\t\r \u00a0 Tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 descrito,\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 PVAT\t\r \u00a0 podr\u00eda\t\r \u00a0 estar\t\r \u00a0correlacionado\t\r \u00a0 positivamente\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 cantidad\t\r \u00a0 de\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 intra-\u00ad\u2010abdominal\t\r \u00a0(119).\t\r \u00a0Por\t\r \u00a0tanto,\t\r \u00a0en\t\r \u00a0una\t\r \u00a0situaci\u00f3n\t\r \u00a0de\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0aterosclerosis,\t\r \u00a0el\t\r \u00a0PVAT\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0expandirse\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0infiltrado\t\r \u00a0por\t\r \u00a0c\u00e9lulas\t\r \u00a0inmunes,\t\r \u00a0como\t\r \u00a0macr\u00f3fagos\t\r \u00a0y\t\r \u00a0linfocitos\t\r \u00a0T\t\r \u00a0 (114,\t\r \u00a0 121).\t\r \u00a0 La\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 linfocitos\t\r \u00a0 T\t\r \u00a0 favorecer\u00eda\t\r \u00a0 la\t\r \u00a0 expansi\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0estimulaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adipog\u00e9nesis\t\r \u00a0por\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a015d-\u00ad\u2010PGJ2\t\r \u00a0y\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0PPAR-\u00ad\u2010\u03b3\t\r \u00a0(121).\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0los\t\r \u00a0macr\u00f3fagos\t\r \u00a0no\t\r \u00a0afectan\t\r \u00a0a\t\r \u00a0la\t\r \u00a0expansi\u00f3n\t\r \u00a0del\t\r \u00a0 PVAT,\t\r \u00a0 pero\t\r \u00a0 producen\t\r \u00a0 citoquinas\t\r \u00a0 que\t\r \u00a0 alteran\t\r \u00a0 la\t\r \u00a0 secreci\u00f3n\t\r \u00a0 de\t\r \u00a0 adipoquinas\t\r \u00a0 de\t\r \u00a0dicho\t\r \u00a0tejido.\t\r \u00a0As\u00ed,\t\r \u00a0la\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0leptina\t\r \u00a0(123,\t\r \u00a0124),\t\r \u00a0de\t\r \u00a0citoquinas\t\r \u00a0y\t\r \u00a0quimioquinas\t\r \u00a0proinflamatorias\t\r \u00a0 (125,\t\r \u00a0 126)\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 especies\t\r \u00a0 libres\t\r \u00a0 de\t\r \u00a0 ox\u00edgeno\t\r \u00a0 (116,\t\r \u00a0 127)\t\r \u00a0 y\t\r \u00a0\u00e1cidos\t\r \u00a0 grasos\t\r \u00a0 no\t\r \u00a0 esterificados\t\r \u00a0 (128)\t\r \u00a0 est\u00e1\t\r \u00a0 aumentada\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 PVAT\t\r \u00a0 de\t\r \u00a0 pacientes\t\r \u00a0obesos\t\r \u00a0y\t\r \u00a0de\t\r \u00a0animales\t\r \u00a0de\t\r \u00a0experimentaci\u00f3n\t\r \u00a0obesos\t\r \u00a0(Figura\t\r \u00a03).\t\r \u00a0\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0337\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a0 3.-\u00ad\u2010\t\r \u00a0Contribuci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 perivascular\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 complicaciones\t\r \u00a0 vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad.\t\r \u00a0El\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0perivascular\t\r \u00a0interacciona\t\r \u00a0con\t\r \u00a0el\t\r \u00a0endotelio,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0m\u00fasculo\t\r \u00a0 liso\t\r \u00a0 vascular\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 inmunes.\t\r \u00a0 Igualmente,\t\r \u00a0 \t\r \u00a0 se\t\r \u00a0 producen\t\r \u00a0 ciertos\t\r \u00a0 mediadores\t\r \u00a0 que\t\r \u00a0estar\u00edan\t\r \u00a0implicados\t\r \u00a0en\t\r \u00a0las\t\r \u00a0posibles\t\r \u00a0alteraciones\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad,\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0la\t\r \u00a0hipertensi\u00f3n\t\r \u00a0y\t\r \u00a0la\t\r \u00a0aterog\u00e9nesis.\t\r \u00a0Sin\t\r \u00a0 embargo,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 descrito\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 propiedades\t\r \u00a0 inflamatorias\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0 epic\u00e1rdico\t\r \u00a0 son\t\r \u00a0independientes\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 (129).\t\r \u00a0 En\t\r \u00a0 este\t\r \u00a0 sentido,\t\r \u00a0estudios\t\r \u00a0recientes\t\r \u00a0tambi\u00e9n\t\r \u00a0han\t\r \u00a0demostrado\t\r \u00a0que\t\r \u00a0el\t\r \u00a0PVAT\t\r \u00a0que\t\r \u00a0est\u00e1\t\r \u00a0alrededor\t\r \u00a0de\t\r \u00a0la\t\r \u00a0arteria\t\r \u00a0aorta\t\r \u00a0tor\u00e1cica\t\r \u00a0es\t\r \u00a0muy\t\r \u00a0similar\t\r \u00a0a\t\r \u00a0BAT\t\r \u00a0en\t\r \u00a0cuanto\t\r \u00a0a\t\r \u00a0su\t\r \u00a0morfolog\u00eda\t\r \u00a0y\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a0de\t\r \u00a0expresi\u00f3n\t\r \u00a0gen\u00e9tico\t\r \u00a0en\t\r \u00a0ratones\t\r \u00a0(114).\t\r \u00a0Adem\u00e1s,\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0perivascular\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aorta\t\r \u00a0tor\u00e1cica\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0el\t\r \u00a0BAT\t\r \u00a0son\t\r \u00a0m\u00e1s\t\r \u00a0resistentes\t\r \u00a0a\t\r \u00a0la\t\r \u00a0inflamaci\u00f3n\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0un\t\r \u00a0dieta\t\r \u00a0rica\t\r \u00a0en\t\r \u00a0grasas\t\r \u00a0en\t\r \u00a0un\t\r \u00a0modelo\t\r \u00a0murino\t\r \u00a0(114)\t\r \u00a0(Figura\t\r \u00a03).\t\r \u00a0Ser\u00eda\t\r \u00a0interesante,\t\r \u00a0comprobar\t\r \u00a0 si\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 perivascular\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 obesos\t\r \u00a0 con\t\r \u00a0 y\t\r \u00a0 sin\t\r \u00a0enfermedad\t\r \u00a0 cardiovascular\t\r \u00a0 tiene\t\r \u00a0 una\t\r \u00a0 morfolog\u00eda\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 perfil\t\r \u00a0 gen\u00e9tico\t\r \u00a0 parecido\t\r \u00a0tambi\u00e9n\t\r \u00a0 al\t\r \u00a0 BAT\t\r \u00a0 como\t\r \u00a0 ocurre\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 modelos\t\r \u00a0 murinos\t\r \u00a0 estudiados.\t\r \u00a0 As\u00ed,\t\r \u00a0 podr\u00eda\t\r \u00a0resultar\t\r \u00a0 beneficiosa\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 del\t\r \u00a0 fenotipo\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tejido\t\r \u00a0adiposo\t\r \u00a0perivascular\t\r \u00a0con\t\r \u00a0el\t\r \u00a0fin\t\r \u00a0de\t\r \u00a0prevenir\t\r \u00a0enfermedades\t\r \u00a0vasculares\t\r \u00a0asociadas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad,\t\r \u00a0como\t\r \u00a0hipertensi\u00f3n\t\r \u00a0y\t\r \u00a0la\t\r \u00a0aterog\u00e9nesis.\t\r \u00a0\t\r \u00a0\t\r \u00a0\nAlmudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n338\t\r \u00a0\t\r \u00a05.\t\r \u00a0NUEVAS\t\r \u00a0PERSPECTIVAS\t\r \u00a0EN\t\r \u00a0EL\t\r \u00a0TRATAMIENTO\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0OBESIDAD\t\r \u00a0Las\t\r \u00a0primeras\t\r \u00a0indicaciones\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0la\t\r \u00a0restricci\u00f3n\t\r \u00a0 cal\u00f3rica\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 ejercicio\t\r \u00a0 f\u00edsico\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0 dosificada\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 cargas\t\r \u00a0adecuadas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 condici\u00f3n\t\r \u00a0 f\u00edsica\t\r \u00a0 de\t\r \u00a0 cada\t\r \u00a0 paciente\t\r \u00a0 obeso.\t\r \u00a0 Existen\t\r \u00a0 considerables\t\r \u00a0evidencias\t\r \u00a0que\t\r \u00a0la\t\r \u00a0restricci\u00f3n\t\r \u00a0cal\u00f3rica\t\r \u00a0aumenta\t\r \u00a0la\t\r \u00a0esperanza\t\r \u00a0de\t\r \u00a0vida\t\r \u00a0(130)\t\r \u00a0y\t\r \u00a0reduce\t\r \u00a0el\t\r \u00a0 riesgo\t\r \u00a0 de\t\r \u00a0 desarrollar\t\r \u00a0 diabetes,\t\r \u00a0 enfermedad\t\r \u00a0 cardiovascular,\t\r \u00a0 des\u00f3rdenes\t\r \u00a0degenerativos\t\r \u00a0 y\t\r \u00a0 algunos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 c\u00e1ncer\t\r \u00a0 (130,\t\r \u00a0 131).\t\r \u00a0 Los\t\r \u00a0 dos\t\r \u00a0 mecanismos\t\r \u00a0principales\t\r \u00a0 que\t\r \u00a0 estar\u00edan\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 \u201canti-\u00ad\u2010envejecimiento\u201d\t\r \u00a0 y\t\r \u00a0 \u201canti-\u00ad\u2010obesidad\u201d\t\r \u00a0de\t\r \u00a0la\t\r \u00a0restricci\u00f3n\t\r \u00a0cal\u00f3rica,\t\r \u00a0ser\u00edan:\t\r \u00a0(1)\t\r \u00a0una\t\r \u00a0menor\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0radicales\t\r \u00a0libres\t\r \u00a0 mitocondriales\t\r \u00a0 (132),\t\r \u00a0 y\t\r \u00a0 (2)\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 prote\u00ednas\t\r \u00a0resistentes\t\r \u00a0 al\t\r \u00a0 estr\u00e9s\t\r \u00a0 celular\t\r \u00a0 (133).\t\r \u00a0 Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 restricci\u00f3n\t\r \u00a0 cal\u00f3rica,\t\r \u00a0 hay\t\r \u00a0evidencias\t\r \u00a0 que\t\r \u00a0 muestran\t\r \u00a0 que\t\r \u00a0 un\t\r \u00a0 balance\t\r \u00a0 energ\u00e9tico\t\r \u00a0 mantenido\t\r \u00a0 durante\t\r \u00a0 varios\t\r \u00a0meses,\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0incluye\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0del\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0suele\t\r \u00a0resultar\t\r \u00a0efectivo\t\r \u00a0en\t\r \u00a0la\t\r \u00a0disminuci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adiposidad.\t\r \u00a0Esta\t\r \u00a0reducci\u00f3n\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0principalmente\t\r \u00a0en\t\r \u00a0la\t\r \u00a0grasa\t\r \u00a0visceral,\t\r \u00a0que\t\r \u00a0es\t\r \u00a0la\t\r \u00a0que\t\r \u00a0posee\t\r \u00a0receptores\t\r \u00a0y\t\r \u00a0actividad\t\r \u00a0lipol\u00edtica\t\r \u00a0mayor\t\r \u00a0que\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0de\t\r \u00a0otras\t\r \u00a0regiones\t\r \u00a0(134).\t\r \u00a0Adem\u00e1s,\t\r \u00a0personas\t\r \u00a0con\t\r \u00a0un\t\r \u00a0buen\t\r \u00a0estado\t\r \u00a0f\u00edsico\t\r \u00a0tienen\t\r \u00a0 la\t\r \u00a0 lip\u00f3lisis\t\r \u00a0 en\t\r \u00a0 reposo\t\r \u00a0 mayor\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 inactivos\t\r \u00a0 (135).\t\r \u00a0 Otro\t\r \u00a0 aspecto\t\r \u00a0 que\t\r \u00a0mejora\t\r \u00a0el\t\r \u00a0ejercicio\t\r \u00a0f\u00edsico\t\r \u00a0en\t\r \u00a0pacientes\t\r \u00a0obesos\t\r \u00a0es\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a0lip\u00eddico.\t\r \u00a0En\t\r \u00a0primer\t\r \u00a0lugar,\t\r \u00a0eleva\t\r \u00a0 las\t\r \u00a0 HDL\t\r \u00a0 y\t\r \u00a0 por\t\r \u00a0 tanto\t\r \u00a0 disminuye\t\r \u00a0 el\t\r \u00a0 cociente\t\r \u00a0 LDL/HDL\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0cardiovascular\t\r \u00a0(136).\t\r \u00a0Adem\u00e1s,\t\r \u00a0el\t\r \u00a0ejercicio\t\r \u00a0aumenta\t\r \u00a0el\t\r \u00a0tama\u00f1o\t\r \u00a0de\t\r \u00a0las\t\r \u00a0part\u00edculas\t\r \u00a0de\t\r \u00a0LDL\t\r \u00a0 y\t\r \u00a0 HDL\t\r \u00a0 resultando\t\r \u00a0 un\t\r \u00a0 perfil\t\r \u00a0 lip\u00eddico\t\r \u00a0 menos\t\r \u00a0 aterog\u00e9nico\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 part\u00edculas\t\r \u00a0peque\u00f1as\t\r \u00a0 de\t\r \u00a0 LDL\t\r \u00a0 y\t\r \u00a0 HDL,\t\r \u00a0 propias\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 pacientes\t\r \u00a0 obesos\t\r \u00a0 (136).\t\r \u00a0 Asimismo,\t\r \u00a0 un\t\r \u00a0ejercicio\t\r \u00a0f\u00edsico\t\r \u00a0regular\t\r \u00a0tambi\u00e9n\t\r \u00a0disminuye\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0triglic\u00e9ridos\t\r \u00a0en\t\r \u00a0aquellos\t\r \u00a0individuos\t\r \u00a0con\t\r \u00a0valores\t\r \u00a0inicialmente\t\r \u00a0altos,\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0una\t\r \u00a0mejora\t\r \u00a0en\t\r \u00a0la\t\r \u00a0sensibilidad\t\r \u00a0a\t\r \u00a0la\t\r \u00a0insulina\t\r \u00a0(137,\t\r \u00a0138).\t\r \u00a0Tambi\u00e9n\t\r \u00a0el\t\r \u00a0ejercicio\t\r \u00a0f\u00edsico\t\r \u00a0produce\t\r \u00a0distintas\t\r \u00a0adaptaciones\t\r \u00a0metab\u00f3licas\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0resultar\t\r \u00a0beneficiosas\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad.\t\r \u00a0Se\t\r \u00a0 produce\t\r \u00a0 un\t\r \u00a0 aumento\t\r \u00a0 del\t\r \u00a0 potencial\t\r \u00a0 oxidativo\t\r \u00a0 y\t\r \u00a0 as\u00ed,\t\r \u00a0 se\t\r \u00a0 favorece\t\r \u00a0 que\t\r \u00a0se\t\r \u00a0metabolicen\t\r \u00a0 m\u00e1s\t\r \u00a0 l\u00edpidos\t\r \u00a0 e\t\r \u00a0 hidratos\t\r \u00a0 de\t\r \u00a0 carbono\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 aer\u00f3bica,\t\r \u00a0 produciendo\t\r \u00a0adaptaciones\t\r \u00a0perif\u00e9ricas\t\r \u00a0muy\t\r \u00a0deseables.\t\r \u00a0Por\t\r \u00a0tanto,\t\r \u00a0el\t\r \u00a0ejercicio\t\r \u00a0f\u00edsico\t\r \u00a0normaliza\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a0metab\u00f3lico\t\r \u00a0y\t\r \u00a0permite\t\r \u00a0la\t\r \u00a0disminuci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0morbimortalidad\t\r \u00a0por\t\r \u00a0estas\t\r \u00a0causas\t\r \u00a0(139,\t\r \u00a0140).\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0339\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a04.-\u00ad\u2010\t\r \u00a0Nuevas\t\r \u00a0perspectivas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad.\t\r \u00a0Basado\t\r \u00a0en\t\r \u00a0los\t\r \u00a0conocimientos\t\r \u00a0actuales\t\r \u00a0como\t\r \u00a0futuras\t\r \u00a0aproximaciones\t\r \u00a0tanto\t\r \u00a0in\t\r \u00a0vivo\t\r \u00a0como\t\r \u00a0ex\t\r \u00a0vivo\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0obesidad.\t\r \u00a0Todas\t\r \u00a0ellas\t\r \u00a0est\u00e1n\t\r \u00a0destinadas\t\r \u00a0a\t\r \u00a0producir\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0o\t\r \u00a0la\t\r \u00a0diferenciaci\u00f3n\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0progenitoras\t\r \u00a0o\t\r \u00a0beiges\t\r \u00a0en\t\r \u00a0adipocitos\t\r \u00a0marrones\t\r \u00a0o\t\r \u00a0promover\t\r \u00a0la\t\r \u00a0termog\u00e9nesis\t\r \u00a0en\t\r \u00a0el\t\r \u00a0m\u00fasculo\t\r \u00a0con\t\r \u00a0el\t\r \u00a0fin\t\r \u00a0de\t\r \u00a0favorecer\t\r \u00a0la\t\r \u00a0termog\u00e9nesis,\t\r \u00a0el\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico,\t\r \u00a0la\t\r \u00a0reducci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0visceral\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0un\t\r \u00a0mejor\t\r \u00a0control\t\r \u00a0de\t\r \u00a0la\t\r \u00a0glucosa\t\r \u00a0y\t\r \u00a0el\t\r \u00a0perfil\t\r \u00a0lip\u00eddico,\t\r \u00a0todo\t\r \u00a0ello\t\r \u00a0reduciendo\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0las\t\r \u00a0complicaciones\t\r \u00a0vasculares\t\r \u00a0asociadas.\t\r \u00a0Para\t\r \u00a0poder\t\r \u00a0combatir\t\r \u00a0esta\t\r \u00a0epidemia\t\r \u00a0mundial\t\r \u00a0que\t\r \u00a0es\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0evitar\t\r \u00a0as\u00ed\t\r \u00a0las\t\r \u00a0 complicaciones\t\r \u00a0 metab\u00f3licas\t\r \u00a0 y\t\r \u00a0 vasculares\t\r \u00a0 que\t\r \u00a0 est\u00e1\t\r \u00a0 continuamente\t\r \u00a0 creciendo,\t\r \u00a0adem\u00e1s\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tratamientos\t\r \u00a0establecidos,\t\r \u00a0tanto\t\r \u00a0la\t\r \u00a0restricci\u00f3n\t\r \u00a0cal\u00f3rica,\t\r \u00a0el\t\r \u00a0ejercicio,\t\r \u00a0los\t\r \u00a0 distintos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 o\t\r \u00a0 la\t\r \u00a0 cirug\u00eda,\t\r \u00a0 hay\t\r \u00a0 que\t\r \u00a0 aunar\t\r \u00a0 esfuerzos\t\r \u00a0 para\t\r \u00a0 avanzar\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0conocimiento\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0 prometedor\t\r \u00a0 potencial\t\r \u00a0 terap\u00e9utico\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0la\t\r \u00a0obesidad\t\r \u00a0y\t\r \u00a0las\t\r \u00a0complicaciones\t\r \u00a0asociadas\t\r \u00a0(141-\u00ad\u2010143).\t\r \u00a0Se\t\r \u00a0ha\t\r \u00a0descrito\t\r \u00a0que\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0 adaptativa\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 moderado\t\r \u00a0 e\t\r \u00a0 intermitente\t\r \u00a0estr\u00e9s\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 activaci\u00f3n\t\r \u00a0 simp\u00e1tica,\t\r \u00a0 podr\u00eda\t\r \u00a0 aumentar\t\r \u00a0 la\t\r \u00a0 proliferaci\u00f3n\t\r \u00a0 y\t\r \u00a0diferenciaci\u00f3n\t\r \u00a0 de\t\r \u00a0 c\u00e9lulas\t\r \u00a0 progenitoras\t\r \u00a0 de\t\r \u00a0 adipocitos\t\r \u00a0 marrones,\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0incrementar\t\r \u00a0 la\t\r \u00a0 masa\t\r \u00a0 mitocondrial\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 UCP-\u00ad\u20101\t\r \u00a0 en\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0 (144).\t\r \u00a0 Todos\t\r \u00a0 estos\t\r \u00a0 efectos,\t\r \u00a0 junto\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 estimulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 BAT\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0dep\u00f3sitos\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco\t\r \u00a0o\t\r \u00a0en\t\r \u00a0el\t\r \u00a0m\u00fasculo\t\r \u00a0esquel\u00e9tico\t\r \u00a0(145,\t\r \u00a0146),\t\r \u00a0podr\u00edan\t\r \u00a0aumentar\t\r \u00a0el\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0y\t\r \u00a0reducir\t\r \u00a0el\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0y\t\r \u00a0la\t\r \u00a0adiposidad\t\r \u00a0visceral\t\r \u00a0y\t\r \u00a0en\t\r \u00a0 consecuencia,\t\r \u00a0 una\t\r \u00a0 mayor\t\r \u00a0 resistencia\t\r \u00a0 a\t\r \u00a0 desarrollar\t\r \u00a0 obesidad\t\r \u00a0 y\t\r \u00a0 enfermedades\t\r \u00a0metab\u00f3licas\t\r \u00a0 y\t\r \u00a0 vasculares\t\r \u00a0 asociadas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 misma.\t\r \u00a0Curiosamente,\t\r \u00a0 el\t\r \u00a0 trasplante\t\r \u00a0 de\t\r \u00a0tejido\t\r \u00a0 adiposo\t\r \u00a0 marr\u00f3n\t\r \u00a0 (0.1-\u00ad\u20100.4\t\r \u00a0 g)\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 cavidad\t\r \u00a0 visceral\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 rat\u00f3n\t\r \u00a0 es\t\r \u00a0 capaz\t\r \u00a0 de\t\r \u00a0prevenir\t\r \u00a0la\t\r \u00a0ganancia\t\r \u00a0de\t\r \u00a0peso\t\r \u00a0y\t\r \u00a0mejorar\t\r \u00a0la\t\r \u00a0homeostasis\t\r \u00a0gluc\u00eddica\t\r \u00a0en\t\r \u00a0el\t\r \u00a0rat\u00f3n\t\r \u00a0obeso\t\r \u00a0\nAlmudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n340\t\r \u00a0\t\r \u00a0sometido\t\r \u00a0 a\t\r \u00a0 dieta\t\r \u00a0 grasa\t\r \u00a0 (147).\t\r \u00a0 Por\t\r \u00a0 otro\t\r \u00a0 lado,\t\r \u00a0 como\t\r \u00a0 se\t\r \u00a0 han\t\r \u00a0 identificado\t\r \u00a0que\t\r \u00a0 los\t\r \u00a0dep\u00f3sitos\t\r \u00a0de\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0en\t\r \u00a0humanos\t\r \u00a0est\u00e1n\t\r \u00a0compuestos\t\r \u00a0por\t\r \u00a0adipocitos\t\r \u00a0beige\t\r \u00a0 (83);\t\r \u00a0 estos\t\r \u00a0 resultados\t\r \u00a0 podr\u00edan\t\r \u00a0 abrir\t\r \u00a0 nuevas\t\r \u00a0 v\u00edas\t\r \u00a0 de\t\r \u00a0 investigaci\u00f3n\t\r \u00a0 para\t\r \u00a0determinar\t\r \u00a0si\t\r \u00a0este\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0podr\u00edan\t\r \u00a0tener\t\r \u00a0cierto\t\r \u00a0potencial\t\r \u00a0terap\u00e9utico.\t\r \u00a0As\u00ed,\t\r \u00a0la\t\r \u00a0irisina\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 mol\u00e9cula\t\r \u00a0 circulante\t\r \u00a0 end\u00f3gena\t\r \u00a0 y\t\r \u00a0 media\t\r \u00a0 algunos\t\r \u00a0 beneficios\t\r \u00a0 que\t\r \u00a0produce\t\r \u00a0 el\t\r \u00a0 ejercicio\t\r \u00a0 y\t\r \u00a0 adem\u00e1s\t\r \u00a0 activa\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 adipocitos\t\r \u00a0 beige\t\r \u00a0 en\t\r \u00a0 roedores,\t\r \u00a0 podr\u00eda\t\r \u00a0representar\t\r \u00a0 uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 caminos\t\r \u00a0 aplicables\t\r \u00a0 a\t\r \u00a0 humanos.\t\r \u00a0 Finalmente,\t\r \u00a0 dada\t\r \u00a0 la\t\r \u00a0capacidad\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0gasto\t\r \u00a0energ\u00e9tico\t\r \u00a0y\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0metabolismo\t\r \u00a0lip\u00eddico\t\r \u00a0y\t\r \u00a0gluc\u00eddico,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0su\t\r \u00a0potencial\t\r \u00a0resistencia\t\r \u00a0a\t\r \u00a0la\t\r \u00a0inflamaci\u00f3n\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0el\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0perivascular;\t\r \u00a0las\t\r \u00a0nuevas\t\r \u00a0perspectivas\t\r \u00a0del\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 podr\u00edan\t\r \u00a0 centrarse\t\r \u00a0 en\t\r \u00a0el\t\r \u00a0 dise\u00f1o\t\r \u00a0 de\t\r \u00a0 nuevos\t\r \u00a0 f\u00e1rmacos\t\r \u00a0 o\t\r \u00a0 distintos\t\r \u00a0reg\u00edmenes\t\r \u00a0 o\t\r \u00a0 terapias\t\r \u00a0 que\t\r \u00a0 incrementen\t\r \u00a0 la\t\r \u00a0 cantidad\t\r \u00a0 y\t\r \u00a0 funci\u00f3n\t\r \u00a0 del\t\r \u00a0 tejido\t\r \u00a0 adiposo\t\r \u00a0marr\u00f3n\t\r \u00a0 no\t\r \u00a0 s\u00f3lo\t\r \u00a0 para\t\r \u00a0 luchar\t\r \u00a0 contra\t\r \u00a0 la\t\r \u00a0 obesidad\t\r \u00a0 sino\t\r \u00a0 tambi\u00e9n\t\r \u00a0 para\t\r \u00a0 prevenir\t\r \u00a0 la\t\r \u00a0diabetes\t\r \u00a0tipo\t\r \u00a02\t\r \u00a0y\t\r \u00a0otros\t\r \u00a0des\u00f3rdenes\t\r \u00a0metab\u00f3licos\t\r \u00a0y\t\r \u00a0vasculares\t\r \u00a0(Figura\t\r \u00a04).\t\r \u00a0\t\r \u00a06.\t\r \u00a0BIBLIOGRAF\u00cdA\t\r \u00a01. Caballero\t\r \u00a0B.\t\r \u00a0The\t\r \u00a0global\t\r \u00a0epidemic\t\r \u00a0of\t\r \u00a0obesity:\t\r \u00a0an\t\r \u00a0overview.\t\r \u00a0Epidemiol\t\r \u00a0Rev.\t\r \u00a02007;29:1-\u00ad\u20105.\t\r \u00a02. Obesidad\t\r \u00a0y\t\r \u00a0sobrepeso.\t\r \u00a0Nota\t\r \u00a0descriptiva\t\r \u00a0N\u00b0311.\t\r \u00a0Oreganizaci\u00f3n\t\r \u00a0Mundial\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Salud.\t\r \u00a0Marzo\t\r \u00a0de\t\r \u00a02011\t\r \u00a03. Gesta\t\r \u00a0 S,\t\r \u00a0 Tseng\t\r \u00a0 YH,\t\r \u00a0 Kahn\t\r \u00a0 CR.\t\r \u00a0 Developmental\t\r \u00a0origin\t\r \u00a0 of\t\r \u00a0 fat:\t\r \u00a0 tracking\t\r \u00a0 obesity\t\r \u00a0 to\t\r \u00a0 its\t\r \u00a0 source.\t\r \u00a0Cell.\t\r \u00a02007;\t\r \u00a0131(2):242-\u00ad\u201056.\t\r \u00a04. Cascio\t\r \u00a0G,\t\r \u00a0Schiera\t\r \u00a0G,\t\r \u00a0Di\t\r \u00a0Liegro\t\r \u00a0I.\t\r \u00a0Dietary\t\r \u00a0fatty\t\r \u00a0acids\t\r \u00a0in\t\r \u00a0metabolic\t\r \u00a0syndrome,\t\r \u00a0diabetes\t\r \u00a0and\t\r \u00a0cardiovascular\t\r \u00a0diseases.\t\r \u00a0Curr\t\r \u00a0Diabetes\t\r \u00a0Rev.\t\r \u00a02012;\t\r \u00a08(1):2-\u00ad\u201017.\t\r \u00a05. Mathieu\t\r \u00a0 P,\t\r \u00a0 Lemieux\t\r \u00a0 I,\t\r \u00a0 Despr\u00e9s\t\r \u00a0 JP.\t\r \u00a0 Obesity,\t\r \u00a0 inflammation,\t\r \u00a0 and\t\r \u00a0 cardiovascular\t\r \u00a0 risk.\t\r \u00a0 Clin\t\r \u00a0Pharmacol\t\r \u00a0Ther.\t\r \u00a02010;\t\r \u00a087(4):407-\u00ad\u201016.\t\r \u00a0\t\r \u00a06. Grundy\t\r \u00a0SM.\t\r \u00a0Metabolic\t\r \u00a0complications\t\r \u00a0of\t\r \u00a0obesity.\t\r \u00a0Endocrine.\t\r \u00a02000;13(2):155-\u00ad\u201065.\t\r \u00a07. Aldhahi\t\r \u00a0 W,\t\r \u00a0 Hamdy\t\r \u00a0 O.\t\r \u00a0 Adipokines,\t\r \u00a0 inflammation,\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 endothelium\t\r \u00a0 in\t\r \u00a0 diabetes.\t\r \u00a0 Curr\t\r \u00a0Diab\t\r \u00a0Rep.\t\r \u00a02003;\t\r \u00a03(4):293\u20138.\t\r \u00a08. Ronti\t\r \u00a0T,\t\r \u00a0Lupattelli\t\r \u00a0G,\t\r \u00a0Mannarino\t\r \u00a0E.\t\r \u00a0The\t\r \u00a0endocrine\t\r \u00a0function\t\r \u00a0of\t\r \u00a0adipose\t\r \u00a0tissue:\t\r \u00a0an\t\r \u00a0update.\t\r \u00a0Clin\t\r \u00a0Endocrinol\t\r \u00a0(Oxf)\t\r \u00a02006;\t\r \u00a064(4):355\u201365.\t\r \u00a09. Farmer\t\r \u00a0SR.\t\r \u00a0Transcriptional\t\r \u00a0control\t\r \u00a0of\t\r \u00a0adipocyte\t\r \u00a0formation.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02006;\t\r \u00a04(4):263\u201373.\t\r \u00a0\t\r \u00a010. Rosen\t\r \u00a0 ED,\t\r \u00a0 Spiegelman\t\r \u00a0 BM.\t\r \u00a0 Adipocytes\t\r \u00a0 as\t\r \u00a0 regulators\t\r \u00a0 of\t\r \u00a0 energy\t\r \u00a0 balance\t\r \u00a0 and\t\r \u00a0 glucose\t\r \u00a0homeostasis.\t\r \u00a0Nature.\t\r \u00a02006;\t\r \u00a0444\t\r \u00a0(7121):847\u201353.\t\r \u00a011. Lowell\t\r \u00a0 BB,\t\r \u00a0 S-\u00ad\u2010Susulic\t\r \u00a0 V,\t\r \u00a0 Hamann\t\r \u00a0 A,\t\r \u00a0 Lawitts\t\r \u00a0 JA,\t\r \u00a0 Himms-\u00ad\u2010Hagen\t\r \u00a0 J,\t\r \u00a0 Boyer\t\r \u00a0 BB,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0obesity\t\r \u00a0in\t\r \u00a0transgenic\t\r \u00a0mice\t\r \u00a0after\t\r \u00a0genetic\t\r \u00a0ablation\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Nature.\t\r \u00a01993;\t\r \u00a0366(6457):740\u20132.\t\r \u00a012. Yang\t\r \u00a0X,\t\r \u00a0Enerb\u00e4ck\t\r \u00a0S,\t\r \u00a0Smith\t\r \u00a0U.\t\r \u00a0Reduced\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0FOXC2\t\r \u00a0and\t\r \u00a0brown\t\r \u00a0adipogenic\t\r \u00a0genes\t\r \u00a0in\t\r \u00a0human\t\r \u00a0subjects\t\r \u00a0with\t\r \u00a0insulin\t\r \u00a0resistance.\t\r \u00a0Obes\t\r \u00a0Res.\t\r \u00a02003;\t\r \u00a011\t\r \u00a0(10):1182\u201391.\t\r \u00a013. Almind\t\r \u00a0K,\t\r \u00a0Manieri\t\r \u00a0M,\t\r \u00a0Sivitz\t\r \u00a0WI,\t\r \u00a0Cinti\t\r \u00a0S,\t\r \u00a0Kahn\t\r \u00a0CR.\t\r \u00a0Ectopic\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0in\t\r \u00a0muscle\t\r \u00a0provides\t\r \u00a0 a\t\r \u00a0 mechanism\t\r \u00a0 for\t\r \u00a0 differences\t\r \u00a0 in\t\r \u00a0 risk\t\r \u00a0 of\t\r \u00a0 metabolic\t\r \u00a0 syndrome\t\r \u00a0 in\t\r \u00a0 mice.\t\r \u00a0 Proc\t\r \u00a0 Natl\t\r \u00a0Acad\t\r \u00a0Sci\t\r \u00a0U\t\r \u00a0S\t\r \u00a0A.\t\r \u00a02007;\t\r \u00a0104(7):2366\u201371.\t\r \u00a014. Mattson\t\r \u00a0 MP.\t\r \u00a0 Perspective:\t\r \u00a0 Does\t\r \u00a0 brown\t\r \u00a0 fat\t\r \u00a0 protect\t\r \u00a0 against\t\r \u00a0 diseases\t\r \u00a0 of\t\r \u00a0 aging?\t\r \u00a0Ageing\t\r \u00a0 Res\t\r \u00a0Rev.\t\r \u00a02010;\t\r \u00a09(1):69-\u00ad\u201076.\t\r \u00a0\t\r \u00a015. Johnson\t\r \u00a0PR,\t\r \u00a0Zucker\t\r \u00a0LM,\t\r \u00a0Cruce\t\r \u00a0JA,\t\r \u00a0Hirsch\t\r \u00a0J.\t\r \u00a0Cellularity\t\r \u00a0of\t\r \u00a0adipose\t\r \u00a0depots\t\r \u00a0in\t\r \u00a0the\t\r \u00a0genetically\t\r \u00a0obese\t\r \u00a0Zucker\t\r \u00a0rat.\t\r \u00a0J\t\r \u00a0Lipid\t\r \u00a0Res.\t\r \u00a01971;\t\r \u00a012(6):706-\u00ad\u201014.\t\r \u00a016. Krotkiewski\t\r \u00a0M,\t\r \u00a0Bj\u00f6rntorp\t\r \u00a0P,\t\r \u00a0Sj\u00f6str\u00f6m\t\r \u00a0L,\t\r \u00a0Smith\t\r \u00a0U.\t\r \u00a0Impact\t\r \u00a0of\t\r \u00a0obesity\t\r \u00a0on\t\r \u00a0metabolism\t\r \u00a0in\t\r \u00a0men\t\r \u00a0and\t\r \u00a0 women.\t\r \u00a0 Importance\t\r \u00a0 of\t\r \u00a0 regional\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 distribution.\t\r \u00a0 J\t\r \u00a0 Clin\t\r \u00a0 Invest.\t\r \u00a0 1983;\t\r \u00a072(3):1150-\u00ad\u201062.\t\r \u00a017. Coon\t\r \u00a0PJ,\t\r \u00a0Rogus\t\r \u00a0EM,\t\r \u00a0Drinkwater\t\r \u00a0D,\t\r \u00a0Muller\t\r \u00a0DC,\t\r \u00a0Goldberg\t\r \u00a0AP.\t\r \u00a0Role\t\r \u00a0of\t\r \u00a0body\t\r \u00a0fat\t\r \u00a0distribution\t\r \u00a0in\t\r \u00a0the\t\r \u00a0decline\t\r \u00a0in\t\r \u00a0insulin\t\r \u00a0sensitivity\t\r \u00a0and\t\r \u00a0glucose\t\r \u00a0tolerance\t\r \u00a0with\t\r \u00a0age.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a01992;\t\r \u00a075(4):1125-\u00ad\u201032.\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0341\t\r \u00a0\t\r \u00a018. Gastaldelli\t\r \u00a0 A,\t\r \u00a0 Miyazaki\t\r \u00a0 Y,\t\r \u00a0 Pettiti\t\r \u00a0 M,\t\r \u00a0 Matsuda\t\r \u00a0 M,\t\r \u00a0 Mahankali\t\r \u00a0 S,\t\r \u00a0 Santini\t\r \u00a0 E,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Metabolic\t\r \u00a0effects\t\r \u00a0 of\t\r \u00a0 visceral\t\r \u00a0 fat\t\r \u00a0 accumulation\t\r \u00a0 in\t\r \u00a0 type\t\r \u00a0 2\t\r \u00a0 diabetes.\t\r \u00a0 J\t\r \u00a0 Clin\t\r \u00a0 Endocrinol\t\r \u00a0 Metab.\t\r \u00a02002;\t\r \u00a087(11):5098-\u00ad\u2010103.\t\r \u00a019. Marin\t\r \u00a0P,\t\r \u00a0Andersson\t\r \u00a0B,\t\r \u00a0Ottosson\t\r \u00a0M,\t\r \u00a0Olbe\t\r \u00a0L,\t\r \u00a0Chowdhury\t\r \u00a0B,\t\r \u00a0Kvist\t\r \u00a0H,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0The\t\r \u00a0morphology\t\r \u00a0and\t\r \u00a0metabolism\t\r \u00a0of\t\r \u00a0intraabdominal\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0in\t\r \u00a0men.\t\r \u00a0Metabolism.1992;\t\r \u00a041(11):1242-\u00ad\u20101248.\t\r \u00a020. Montague\t\r \u00a0CT,\t\r \u00a0Prins\t\r \u00a0JB,\t\r \u00a0Sanders\t\r \u00a0L,\t\r \u00a0Digby\t\r \u00a0JE,\t\r \u00a0O'Rahilly\t\r \u00a0S.\t\r \u00a0Depot-\u00ad\u2010\t\r \u00a0and\t\r \u00a0sex-\u00ad\u2010specific\t\r \u00a0differences\t\r \u00a0in\t\r \u00a0human\t\r \u00a0leptin\t\r \u00a0mRNA\t\r \u00a0expression:\t\r \u00a0implications\t\r \u00a0for\t\r \u00a0the\t\r \u00a0control\t\r \u00a0of\t\r \u00a0regional\t\r \u00a0fat\t\r \u00a0distribution.\t\r \u00a0Diabetes\t\r \u00a01997;\t\r \u00a046(3):342-\u00ad\u2010347.\t\r \u00a021. Wajchenberg\t\r \u00a0BL.\t\r \u00a0Subcutaneous\t\r \u00a0and\t\r \u00a0visceral\t\r \u00a0adipose\t\r \u00a0tissue:\t\r \u00a0their\t\r \u00a0relation\t\r \u00a0to\t\r \u00a0the\t\r \u00a0metabolic\t\r \u00a0syndrome.\t\r \u00a0Endocr\t\r \u00a0Rev\t\r \u00a02000;\t\r \u00a021(6):697-\u00ad\u2010738.\t\r \u00a022. Bjorntorp\t\r \u00a0 P.\t\r \u00a0 Metabolic\t\r \u00a0 implications\t\r \u00a0 of\t\r \u00a0 body\t\r \u00a0 fat\t\r \u00a0 distribution.\t\r \u00a0 Diabetes\t\r \u00a0 Care\t\r \u00a0 1991;14\t\r \u00a0(12):1132-\u00ad\u20101143.\t\r \u00a023. Hellmer\t\r \u00a0 J,\t\r \u00a0 Marcus\t\r \u00a0 C,\t\r \u00a0 Sonnenfeld\t\r \u00a0 T,\t\r \u00a0 Arner\t\r \u00a0 P.\t\r \u00a0 Mechanisms\t\r \u00a0 for\t\r \u00a0 differences\t\r \u00a0 in\t\r \u00a0 lipolysis\t\r \u00a0between\t\r \u00a0 human\t\r \u00a0 subcutaneous\t\r \u00a0 and\t\r \u00a0 omental\t\r \u00a0 fat\t\r \u00a0 cells.\t\r \u00a0 J\t\r \u00a0 Clin\t\r \u00a0Endocrinol\t\r \u00a0 Metab.\t\r \u00a0 1992;\t\r \u00a075(1):15-\u00ad\u201020.\t\r \u00a024. Fain\t\r \u00a0 JN,\t\r \u00a0 Madan\t\r \u00a0 AK,\t\r \u00a0 Hiler\t\r \u00a0 ML,\t\r \u00a0 Cheema\t\r \u00a0 P,\t\r \u00a0 Bahouth\t\r \u00a0 SW.\t\r \u00a0 Comparison\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 release\t\r \u00a0 of\t\r \u00a0adipokines\t\r \u00a0 by\t\r \u00a0 adipose\t\r \u00a0 tissue,\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 matrix,\t\r \u00a0 and\t\r \u00a0 adipocytes\t\r \u00a0 from\t\r \u00a0 visceral\t\r \u00a0 and\t\r \u00a0subcutaneous\t\r \u00a0 abdominal\t\r \u00a0 adipose\t\r \u00a0 tissues\t\r \u00a0 of\t\r \u00a0 obese\t\r \u00a0 humans.\t\r \u00a0 Endocrinology\t\r \u00a0 2004;\t\r \u00a0145(5):2273-\u00ad\u20102282.\t\r \u00a025. Snijder\t\r \u00a0MB,\t\r \u00a0Dekker\t\r \u00a0JM,\t\r \u00a0Visser\t\r \u00a0M,\t\r \u00a0Bouter\t\r \u00a0LM,\t\r \u00a0Stehouwer\t\r \u00a0CD,\t\r \u00a0Kostense\t\r \u00a0PJ\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Associations\t\r \u00a0of\t\r \u00a0hip\t\r \u00a0and\t\r \u00a0thigh\t\r \u00a0circumferences\t\r \u00a0independent\t\r \u00a0of\t\r \u00a0waist\t\r \u00a0circumference\t\r \u00a0with\t\r \u00a0the\t\r \u00a0incidence\t\r \u00a0of\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes:\t\r \u00a0the\t\r \u00a0Hoorn\t\r \u00a0Study.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Nutr\t\r \u00a02003;\t\r \u00a077(5):1192-\u00ad\u20101197.\t\r \u00a026. Fox\t\r \u00a0CS,\t\r \u00a0Massaro\t\r \u00a0JM,\t\r \u00a0Hoffmann\t\r \u00a0U,\t\r \u00a0Pou\t\r \u00a0KM,\t\r \u00a0Maurovich-\u00ad\u2010Horvat\t\r \u00a0P,\t\r \u00a0Liu\t\r \u00a0CY\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Abdominal\t\r \u00a0visceral\t\r \u00a0and\t\r \u00a0subcutaneous\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0compartments:\t\r \u00a0association\t\r \u00a0with\t\r \u00a0metabolic\t\r \u00a0risk\t\r \u00a0factors\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Framingham\t\r \u00a0Heart\t\r \u00a0Study.\t\r \u00a0Circulation\t\r \u00a02007;\t\r \u00a0116(1):39-\u00ad\u201048.\t\r \u00a027. Arner\t\r \u00a0P,\t\r \u00a0Eckel\t\r \u00a0RH.\t\r \u00a0Adipose\t\r \u00a0tissue\t\r \u00a0as\t\r \u00a0storage\t\r \u00a0organ.\t\r \u00a0En:\t\r \u00a0George\t\r \u00a0A.\t\r \u00a0Bray,\t\r \u00a0Claude\t\r \u00a0Bouchard,\t\r \u00a0WPT.\t\r \u00a0James,\t\r \u00a0editors.\t\r \u00a0Handbook\t\r \u00a0of\t\r \u00a0Obesity.\t\r \u00a01998:379-\u00ad\u2010395.\t\r \u00a028. Wang\t\r \u00a0 H,\t\r \u00a0 Eckel\t\r \u00a0 RH.\t\r \u00a0 Lipoprotein\t\r \u00a0 lipase:\t\r \u00a0 from\t\r \u00a0 gene\t\r \u00a0 to\t\r \u00a0 obesity.\t\r \u00a0 Am\t\r \u00a0 J\t\r \u00a0 Physiol\t\r \u00a0 Endocrinol\t\r \u00a0Metab.\t\r \u00a02009;\t\r \u00a0297(2):E271-\u00ad\u201088.\t\r \u00a0\t\r \u00a029. Bessesen\t\r \u00a0DH,\t\r \u00a0Robertson\t\r \u00a0AD,\t\r \u00a0Eckel\t\r \u00a0RH.\t\r \u00a0Weight\t\r \u00a0reduction\t\r \u00a0increases\t\r \u00a0adipose\t\r \u00a0but\t\r \u00a0decreases\t\r \u00a0cardiac\t\r \u00a0LPL\t\r \u00a0in\t\r \u00a0reduced-\u00ad\u2010obese\t\r \u00a0Zucker\t\r \u00a0rats.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a01991;\t\r \u00a0261(2\t\r \u00a0Pt\t\r \u00a01):\t\r \u00a0E246\u2013E251.\t\r \u00a030. Eckel\t\r \u00a0 RH,\t\r \u00a0 Yost\t\r \u00a0 TJ.\t\r \u00a0 Weight\t\r \u00a0 reduction\t\r \u00a0 increases\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 lipoprotein\t\r \u00a0 lipase\t\r \u00a0responsiveness\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0women.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest.1987;\t\r \u00a080(4):992\u2013997.\t\r \u00a031. Pollare\t\r \u00a0T,\t\r \u00a0Vessby\t\r \u00a0B,\t\r \u00a0Lithell\t\r \u00a0H.\t\r \u00a0Lipoprotein\t\r \u00a0lipase\t\r \u00a0activity\t\r \u00a0in\t\r \u00a0skeletal\t\r \u00a0muscle\t\r \u00a0is\t\r \u00a0related\t\r \u00a0to\t\r \u00a0insulin\t\r \u00a0sensitivity.\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a01991;\t\r \u00a011(5):1192\u20131203.\t\r \u00a032. Sadur\t\r \u00a0CN,\t\r \u00a0Yost\t\r \u00a0TJ,\t\r \u00a0Eckel\t\r \u00a0RH.\t\r \u00a0Insulin\t\r \u00a0responsiveness\t\r \u00a0of\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0lipoprotein\t\r \u00a0lipase\t\r \u00a0is\t\r \u00a0delayed\t\r \u00a0but\t\r \u00a0preserved\t\r \u00a0in\t\r \u00a0obesity.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Endocrinol\t\r \u00a0Metab\t\r \u00a01984;\t\r \u00a059(6):1176\u20131182.\t\r \u00a0\t\r \u00a033. Hartman\t\r \u00a0 AD.\t\r \u00a0 Lipoprotein\t\r \u00a0 lipase\t\r \u00a0 activities\t\r \u00a0 in\t\r \u00a0 adipose\t\r \u00a0 tissues\t\r \u00a0 and\t\r \u00a0 muscle\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 obese\t\r \u00a0Zucker\t\r \u00a0rat.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Endocrinol\t\r \u00a0Metab\t\r \u00a01981;\t\r \u00a0241(2):E108\u2013E115.\t\r \u00a034. Terrettaz\t\r \u00a0 J,\t\r \u00a0 Cusin\t\r \u00a0 I,\t\r \u00a0 Etienne\t\r \u00a0 J,\t\r \u00a0 Jeanrenaud\t\r \u00a0 B.\t\r \u00a0 In\t\r \u00a0 vivo\t\r \u00a0 regulation\t\r \u00a0 of\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0lipoprotein\t\r \u00a0 lipase\t\r \u00a0 in\t\r \u00a0 normal\t\r \u00a0 rats\t\r \u00a0 made\t\r \u00a0 hyperinsulinemic\t\r \u00a0 and\t\r \u00a0 in\t\r \u00a0 hyperinsulinemic\t\r \u00a0genetically-\u00ad\u2010obese\t\r \u00a0(fa/fa)\t\r \u00a0rats.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Obes\t\r \u00a0Relat\t\r \u00a0Metab\t\r \u00a0Disord\t\r \u00a01994;\t\r \u00a018(1):\t\r \u00a09\u201315.\t\r \u00a0\t\r \u00a035. Schwartz\t\r \u00a0RS,\t\r \u00a0Brunzell\t\r \u00a0JD.\t\r \u00a0Increase\t\r \u00a0of\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0lipoprotein\t\r \u00a0lipase\t\r \u00a0activity\t\r \u00a0with\t\r \u00a0weight\t\r \u00a0loss.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest\t\r \u00a01981;\t\r \u00a067(5):1425\u20131430.\t\r \u00a0\t\r \u00a036. Llorente-\u00ad\u2010Cebri\u00e1n\t\r \u00a0S,\t\r \u00a0Kulyt\u00e9\t\r \u00a0A,\t\r \u00a0Hed\u00e9n\t\r \u00a0P,\t\r \u00a0N\u00e4slund\t\r \u00a0E,\t\r \u00a0Arner\t\r \u00a0P,\t\r \u00a0Ryd\u00e9n\t\r \u00a0M.\t\r \u00a0Relationship\t\r \u00a0between\t\r \u00a0site-\u00ad\u2010specific\t\r \u00a0 HSL\t\r \u00a0 phosphorylation\t\r \u00a0 and\t\r \u00a0 adipocyte\t\r \u00a0 lipolysis\t\r \u00a0 in\t\r \u00a0 obese\t\r \u00a0 women.\t\r \u00a0 Obes\t\r \u00a0 Facts.\t\r \u00a02011;\t\r \u00a04(5):365-\u00ad\u201071.\t\r \u00a0\t\r \u00a037. Langin\t\r \u00a0D,\t\r \u00a0Dicker\t\r \u00a0A,\t\r \u00a0Tavernier\t\r \u00a0G,\t\r \u00a0Hoffstedt\t\r \u00a0J,\t\r \u00a0Mairal\t\r \u00a0A,\t\r \u00a0Ryd\u00e9n\t\r \u00a0M,\t\r \u00a0Arner\t\r \u00a0E,\t\r \u00a0Sicard\t\r \u00a0A,\t\r \u00a0Jenkins\t\r \u00a0CM,\t\r \u00a0Viguerie\t\r \u00a0N,\t\r \u00a0van\t\r \u00a0Harmelen\t\r \u00a0V,\t\r \u00a0Gross\t\r \u00a0RW,\t\r \u00a0Holm\t\r \u00a0C,\t\r \u00a0Arner\t\r \u00a0P.\t\r \u00a0Adipocyte\t\r \u00a0lipases\t\r \u00a0and\t\r \u00a0defect\t\r \u00a0of\t\r \u00a0lipolysis\t\r \u00a0in\t\r \u00a0human\t\r \u00a0obesity.\t\r \u00a0Diabetes.\t\r \u00a02005;\t\r \u00a054(11):3190-\u00ad\u20107.\t\r \u00a038. Arner\t\r \u00a0 P.\t\r \u00a0 Hunting\t\r \u00a0 for\t\r \u00a0 human\t\r \u00a0 obesity\t\r \u00a0 genes?\t\r \u00a0 Look\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 adipose\t\r \u00a0 tissue!\t\r \u00a0 Int\t\r \u00a0 J\t\r \u00a0 Obes\t\r \u00a0 Relat\t\r \u00a0Metab\t\r \u00a0Disord.\t\r \u00a02000;\t\r \u00a024\t\r \u00a0Suppl\t\r \u00a04:S57-\u00ad\u201062.\t\r \u00a039. Valet\t\r \u00a0P,\t\r \u00a0Grujic\t\r \u00a0D,\t\r \u00a0Wade\t\r \u00a0J,\t\r \u00a0Ito\t\r \u00a0M,\t\r \u00a0Zingaretti\t\r \u00a0MC,\t\r \u00a0Soloveva\t\r \u00a0V\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Expression\t\r \u00a0of\t\r \u00a0human\t\r \u00a0alpha\t\r \u00a02-\u00ad\u2010adrenergic\t\r \u00a0 receptors\t\r \u00a0 in\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 of\t\r \u00a0 beta\t\r \u00a0 3-\u00ad\u2010adrenergic\t\r \u00a0 receptor-\u00ad\u2010deficient\t\r \u00a0 mice\t\r \u00a0promotes\t\r \u00a0diet-\u00ad\u2010induced\t\r \u00a0obesity.\t\r \u00a0J\t\r \u00a0Biol\t\r \u00a0Chem.\t\r \u00a02000;\t\r \u00a0275(44):34797-\u00ad\u2010802.\t\r \u00a0\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n342\t\r \u00a0\t\r \u00a040. Boucher\t\r \u00a0 J,\t\r \u00a0Castan-\u00ad\u2010Laurell\t\r \u00a0 I,\t\r \u00a0 Le\t\r \u00a0 Lay\t\r \u00a0 S,\t\r \u00a0 Grujic\t\r \u00a0 D,\t\r \u00a0 Sibrac\t\r \u00a0 D,\t\r \u00a0 Krief\t\r \u00a0 S\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Human\t\r \u00a0 alpha\t\r \u00a0 2A-\u00ad\u2010adrenergic\t\r \u00a0receptor\t\r \u00a0gene\t\r \u00a0expressed\t\r \u00a0in\t\r \u00a0transgenic\t\r \u00a0mouse\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0under\t\r \u00a0the\t\r \u00a0control\t\r \u00a0of\t\r \u00a0its\t\r \u00a0regulatory\t\r \u00a0elements.\t\r \u00a0J\t\r \u00a0Mol\t\r \u00a0Endocrinol.\t\r \u00a02002;\t\r \u00a029(2):251-\u00ad\u201064.\t\r \u00a041. Fr\u00fchbeck\t\r \u00a0 G,\t\r \u00a0 G\u00f3mez-\u00ad\u2010Ambrosi\t\r \u00a0 J,\t\r \u00a0 Muruz\u00e1bal\t\r \u00a0 FJ,\t\r \u00a0 Burrell\t\r \u00a0 MA.\t\r \u00a0 The\t\r \u00a0 adipocyte:\t\r \u00a0 a\t\r \u00a0 model\t\r \u00a0 for\t\r \u00a0integration\t\r \u00a0 of\t\r \u00a0 endocrine\t\r \u00a0 and\t\r \u00a0 metabolic\t\r \u00a0 signaling\t\r \u00a0 in\t\r \u00a0 energy\t\r \u00a0 metabolism\t\r \u00a0 regulation.\t\r \u00a0 Am\t\r \u00a0 J\t\r \u00a0Physiol\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a02001;\t\r \u00a0280(6):E827-\u00ad\u201047.\t\r \u00a042. Mart\u00ed\t\r \u00a0A,\t\r \u00a0Berraondo\t\r \u00a0B,\t\r \u00a0Mart\u00ednez\t\r \u00a0JA.\t\r \u00a0Leptin:\t\r \u00a0physiological\t\r \u00a0actions.\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Biochem.\t\r \u00a01999;\t\r \u00a055(1):43-\u00ad\u20109.\t\r \u00a043. Mueller\t\r \u00a0WM,\t\r \u00a0Gregoire\t\r \u00a0FM,\t\r \u00a0Stanhope\t\r \u00a0KL,\t\r \u00a0Mobbs\t\r \u00a0CV,\t\r \u00a0Mizuno\t\r \u00a0TM,\t\r \u00a0Warden\t\r \u00a0CH\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Evidence\t\r \u00a0that\t\r \u00a0 glucose\t\r \u00a0 metabolism\t\r \u00a0 regulates\t\r \u00a0 leptin\t\r \u00a0 secretion\t\r \u00a0 from\t\r \u00a0 cultured\t\r \u00a0 rat\t\r \u00a0 adipocytes.\t\r \u00a0Endocrinology.\t\r \u00a01998;\t\r \u00a0139(2):551-\u00ad\u20108.\t\r \u00a044. Wellhoener\t\r \u00a0 P,\t\r \u00a0 Fruehwald-\u00ad\u2010Schultes\t\r \u00a0 B,\t\r \u00a0 Kern\t\r \u00a0 W,\t\r \u00a0 Dantz\t\r \u00a0 D,\t\r \u00a0 Kerner\t\r \u00a0 W,\t\r \u00a0 Born\t\r \u00a0 J\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Glucose\t\r \u00a0metabolism\t\r \u00a0rather\t\r \u00a0than\t\r \u00a0insulin\t\r \u00a0is\t\r \u00a0a\t\r \u00a0main\t\r \u00a0determinant\t\r \u00a0of\t\r \u00a0leptin\t\r \u00a0secretion\t\r \u00a0in\t\r \u00a0humans.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a02000;\t\r \u00a085(3):1267-\u00ad\u201071.\t\r \u00a045. Nakata\t\r \u00a0M,\t\r \u00a0Yada\t\r \u00a0T,\t\r \u00a0Soejima\t\r \u00a0N,\t\r \u00a0Maruyama\t\r \u00a0I.\t\r \u00a0Leptin\t\r \u00a0promotes\t\r \u00a0aggregation\t\r \u00a0of\t\r \u00a0human\t\r \u00a0platelets\t\r \u00a0via\t\r \u00a0the\t\r \u00a0long\t\r \u00a0form\t\r \u00a0of\t\r \u00a0its\t\r \u00a0receptor.\t\r \u00a0Diabetes.\t\r \u00a01999;\t\r \u00a048(2):426-\u00ad\u2010429.\t\r \u00a046. Mcgill,\t\r \u00a0JB,\t\r \u00a0 Schneider,\t\r \u00a0 DJ,\t\r \u00a0 Arfken,\t\r \u00a0 CL,\t\r \u00a0 Lucore,\t\r \u00a0 CL.\t\r \u00a0 Factors\t\r \u00a0 responsable\t\r \u00a0 for\t\r \u00a0 impaired\t\r \u00a0fibrinolysis\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0subject\t\r \u00a0and\t\r \u00a0NIDDM\t\r \u00a0patiens.\t\r \u00a0Diabetes\t\r \u00a01994;\t\r \u00a043(1):\t\r \u00a0104-\u00ad\u2010109.\t\r \u00a047. Palomer\t\r \u00a0 X,\t\r \u00a0 P\u00e9rez\t\r \u00a0 A,\t\r \u00a0 Blanco-\u00ad\u2010Vaca\t\r \u00a0 F.\t\r \u00a0 Adiponectin:\t\r \u00a0 a\t\r \u00a0 new\t\r \u00a0 link\t\r \u00a0 between\t\r \u00a0 obesity,\t\r \u00a0 insulin\t\r \u00a0resistance\t\r \u00a0and\t\r \u00a0cardiovascular\t\r \u00a0disease.\t\r \u00a0Med\t\r \u00a0Clin\t\r \u00a0(Barc)\t\r \u00a02005;\t\r \u00a0124(10):388-\u00ad\u201095.\t\r \u00a048. Arita\t\r \u00a0Y,\t\r \u00a0Kihara\t\r \u00a0S,\t\r \u00a0Ouchi\t\r \u00a0N,\t\r \u00a0Takahashi\t\r \u00a0M,\t\r \u00a0Maeda\t\r \u00a0K,\t\r \u00a0Miyagawa\t\r \u00a0J\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Paradoxical\t\r \u00a0decrease\t\r \u00a0of\t\r \u00a0an\t\r \u00a0adipose-\u00ad\u2010specific\t\r \u00a0protein,\t\r \u00a0adiponectin,\t\r \u00a0in\t\r \u00a0obesity.\t\r \u00a0Biochem\t\r \u00a0Biophys\t\r \u00a0Res\t\r \u00a0Commun.\t\r \u00a01999;\t\r \u00a0257(1):79-\u00ad\u201083.\t\r \u00a049. Hotta\t\r \u00a0 K,\t\r \u00a0 Funahashi\t\r \u00a0 T,\t\r \u00a0 Arita\t\r \u00a0 Y,\t\r \u00a0 Takahashi\t\r \u00a0 M,\t\r \u00a0 Matsuda\t\r \u00a0 M,\t\r \u00a0 Okamoto\t\r \u00a0 Y\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Plasma\t\r \u00a0concentrations\t\r \u00a0of\t\r \u00a0a\t\r \u00a0novel,\t\r \u00a0adipose-\u00ad\u2010specific\t\r \u00a0protein,\t\r \u00a0adiponectin,\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetic\t\r \u00a0patients.\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02000;\t\r \u00a020(6):1595-\u00ad\u20109.\t\r \u00a050. Pischon\t\r \u00a0T,\t\r \u00a0Girman\t\r \u00a0CJ,\t\r \u00a0Hotamisligil\t\r \u00a0GS,\t\r \u00a0Rifai\t\r \u00a0N,\t\r \u00a0Hu\t\r \u00a0FB,\t\r \u00a0Rimm\t\r \u00a0EB.\t\r \u00a0Plasma\t\r \u00a0adiponectin\t\r \u00a0levels\t\r \u00a0and\t\r \u00a0risk\t\r \u00a0of\t\r \u00a0myocardial\t\r \u00a0infarction\t\r \u00a0in\t\r \u00a0men.\t\r \u00a0JAMA.\t\r \u00a02004;\t\r \u00a0291(14):1730-\u00ad\u20107.\t\r \u00a051. Kazumi\t\r \u00a0T,\t\r \u00a0Kawaguchi\t\r \u00a0A,\t\r \u00a0Sakai\t\r \u00a0K,\t\r \u00a0Hirano\t\r \u00a0T,\t\r \u00a0Yoshino\t\r \u00a0G.\t\r \u00a0Young\t\r \u00a0men\t\r \u00a0with\t\r \u00a0high-\u00ad\u2010normal\t\r \u00a0blood\t\r \u00a0pressure\t\r \u00a0have\t\r \u00a0lower\t\r \u00a0serum\t\r \u00a0adiponectin,\t\r \u00a0smaller\t\r \u00a0LDL\t\r \u00a0size,\t\r \u00a0and\t\r \u00a0higher\t\r \u00a0elevated\t\r \u00a0heart\t\r \u00a0rate\t\r \u00a0than\t\r \u00a0those\t\r \u00a0with\t\r \u00a0optimal\t\r \u00a0blood\t\r \u00a0pressure.\t\r \u00a0Diabetes\t\r \u00a0Care.\t\r \u00a02002;\t\r \u00a025(6):971-\u00ad\u20106.\t\r \u00a052. Kubota\t\r \u00a0 N,\t\r \u00a0 Terauchi\t\r \u00a0 Y,\t\r \u00a0 Yamauchi\t\r \u00a0 T,\t\r \u00a0 Kubota\t\r \u00a0 T,\t\r \u00a0 Moroi\t\r \u00a0 M,\t\r \u00a0 Matsui\t\r \u00a0 J\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Disruption\t\r \u00a0 of\t\r \u00a0adiponectin\t\r \u00a0 causes\t\r \u00a0 insulin\t\r \u00a0 resistance\t\r \u00a0 and\t\r \u00a0 neointimal\t\r \u00a0formation.\t\r \u00a0 J\t\r \u00a0 Biol\t\r \u00a0 Chem.\t\r \u00a0 2002;\t\r \u00a0277(29):25863-\u00ad\u20106.\t\r \u00a053. Ouchi\t\r \u00a0N,\t\r \u00a0Kihara\t\r \u00a0S,\t\r \u00a0Arita\t\r \u00a0Y,\t\r \u00a0Nishida\t\r \u00a0M,\t\r \u00a0Matsuyama\t\r \u00a0A,\t\r \u00a0Okamoto\t\r \u00a0Y\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Adipocyte-\u00ad\u2010derived\t\r \u00a0plasma\t\r \u00a0 protein,\t\r \u00a0 adiponectin,\t\r \u00a0 suppresses\t\r \u00a0 lipid\t\r \u00a0 accumulation\t\r \u00a0 and\t\r \u00a0 class\t\r \u00a0 A\t\r \u00a0 scavenger\t\r \u00a0receptor\t\r \u00a0 expression\t\r \u00a0 in\t\r \u00a0 human\t\r \u00a0 monocyte-\u00ad\u2010derived\t\r \u00a0 macrophages.\t\r \u00a0 Circulation.\t\r \u00a0 2001;\t\r \u00a0103(8):1057-\u00ad\u201063.\t\r \u00a0\t\r \u00a054. Ryo\t\r \u00a0M,\t\r \u00a0Nakamura\t\r \u00a0T,\t\r \u00a0Kihara\t\r \u00a0S,\t\r \u00a0Kumada\t\r \u00a0M,\t\r \u00a0Shibazaki\t\r \u00a0S,\t\r \u00a0Takahashi\t\r \u00a0M\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Adiponectin\t\r \u00a0as\t\r \u00a0a\t\r \u00a0biomarker\t\r \u00a0of\t\r \u00a0the\t\r \u00a0metabolic\t\r \u00a0syndrome.\t\r \u00a0Circ\t\r \u00a0J.\t\r \u00a02004;\t\r \u00a068(11):975-\u00ad\u201081.\t\r \u00a055. Kumada\t\r \u00a0 M,\t\r \u00a0 Kihara\t\r \u00a0 S,\t\r \u00a0 Sumitsuji\t\r \u00a0 S,\t\r \u00a0 Kawamoto\t\r \u00a0 T,\t\r \u00a0 Matsumoto\t\r \u00a0 S,\t\r \u00a0 Ouchi\t\r \u00a0 N\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Osaka\t\r \u00a0 CAD\t\r \u00a0Study\t\r \u00a0Group.\t\r \u00a0Coronary\t\r \u00a0artery\t\r \u00a0disease.\t\r \u00a0Association\t\r \u00a0of\t\r \u00a0hypoadiponectinemia\t\r \u00a0with\t\r \u00a0coronary\t\r \u00a0artery\t\r \u00a0disease\t\r \u00a0in\t\r \u00a0men.\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02003;\t\r \u00a023(1):85-\u00ad\u20109.\t\r \u00a056. Steppan\t\r \u00a0 CM,\t\r \u00a0 Bailey\t\r \u00a0 ST,\t\r \u00a0 Bhat\t\r \u00a0 S,\t\r \u00a0 Brown\t\r \u00a0 EJ,\t\r \u00a0 Banerjee\t\r \u00a0 RR,\t\r \u00a0 Wright\t\r \u00a0CM,\t\r \u00a0 Patel\t\r \u00a0 HR,\t\r \u00a0 Ahima\t\r \u00a0 RS,\t\r \u00a0Lazar\t\r \u00a0 MA.\t\r \u00a0 The\t\r \u00a0 hormone\t\r \u00a0 resistin\t\r \u00a0 links\t\r \u00a0 obesity\t\r \u00a0 to\t\r \u00a0 diabetes.\t\r \u00a0 Nature.\t\r \u00a0 2001\t\r \u00a0 Jan\t\r \u00a018;409(6818):307-\u00ad\u201012.\t\r \u00a057. Patel\t\r \u00a0L,\t\r \u00a0Buckels\t\r \u00a0AC,\t\r \u00a0Kinghorn\t\r \u00a0IJ,\t\r \u00a0Murdock\t\r \u00a0PR,\t\r \u00a0Holbrook\t\r \u00a0JD,\t\r \u00a0Plumpton\t\r \u00a0C\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0\t\r \u00a0Resistin\t\r \u00a0is\t\r \u00a0expressed\t\r \u00a0 in\t\r \u00a0 human\t\r \u00a0 macrophages\t\r \u00a0 and\t\r \u00a0 directly\t\r \u00a0 regulated\t\r \u00a0 by\t\r \u00a0 PPAR\t\r \u00a0 gamma\t\r \u00a0 activators.\t\r \u00a0Biochem\t\r \u00a0Biophys\t\r \u00a0Res\t\r \u00a0Commun\t\r \u00a02003;\t\r \u00a0300(2):472-\u00ad\u20106.\t\r \u00a058. Hotamisligil\t\r \u00a0GS,\t\r \u00a0Arner\t\r \u00a0P,\t\r \u00a0Caro\t\r \u00a0JF,\t\r \u00a0Atkinson\t\r \u00a0RL,\t\r \u00a0Spiegelman\t\r \u00a0BM.\t\r \u00a0Increased\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0tumor\t\r \u00a0necrosis\t\r \u00a0factor-\u00ad\u2010alpha\t\r \u00a0in\t\r \u00a0human\t\r \u00a0obesity\t\r \u00a0and\t\r \u00a0insulin\t\r \u00a0resistance.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest\t\r \u00a01995;\t\r \u00a095(5):2409\u20132415.\t\r \u00a059. Hotamisligil\t\r \u00a0GS.\t\r \u00a0Inflammation\t\r \u00a0and\t\r \u00a0metabolic\t\r \u00a0disorders.\t\r \u00a0Nature.\t\r \u00a02006;\t\r \u00a0444(7121):860\u2013867\t\r \u00a060. Duncan\t\r \u00a0 ER,\t\r \u00a0 Walker\t\r \u00a0 SJ,\t\r \u00a0 Ezzat\t\r \u00a0 VA,\t\r \u00a0 Wheatcroft\t\r \u00a0 SB,\t\r \u00a0 Li\t\r \u00a0 JM,\t\r \u00a0 Shah\t\r \u00a0 AM,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Accelerated\t\r \u00a0endothelial\t\r \u00a0 dysfunction\t\r \u00a0 in\t\r \u00a0 mild\t\r \u00a0 prediabetic\t\r \u00a0 insulin\t\r \u00a0 resistance:\t\r \u00a0 the\t\r \u00a0 early\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 reactive\t\r \u00a0oxygen\t\r \u00a0species.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a02007;\t\r \u00a0293(5):E1311\u2013E1319.\t\r \u00a061. Hotamisligil\t\r \u00a0GS,\t\r \u00a0Budavari\t\r \u00a0A,\t\r \u00a0Murray\t\r \u00a0D,\t\r \u00a0Spiegelman\t\r \u00a0BM.\t\r \u00a0Reduced\t\r \u00a0tyrosine\t\r \u00a0kinase\t\r \u00a0activity\t\r \u00a0of\t\r \u00a0the\t\r \u00a0insulin\t\r \u00a0receptor\t\r \u00a0in\t\r \u00a0obesitydiabetes.\t\r \u00a0Central\t\r \u00a0role\t\r \u00a0of\t\r \u00a0tumor\t\r \u00a0necrosis\t\r \u00a0factor.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest\t\r \u00a01994;\t\r \u00a094(4):1543\u20131549\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0343\t\r \u00a0\t\r \u00a062. Hube\t\r \u00a0 F,\t\r \u00a0 Birgel\t\r \u00a0 M,\t\r \u00a0 Lee\t\r \u00a0 YM,\t\r \u00a0 Hauner\t\r \u00a0 H.\t\r \u00a0 Expression\t\r \u00a0 pattern\t\r \u00a0 of\t\r \u00a0 tumour\t\r \u00a0 necrosis\t\r \u00a0 factor\t\r \u00a0receptors\t\r \u00a0 in\t\r \u00a0 subcutaneous\t\r \u00a0 and\t\r \u00a0 omental\t\r \u00a0 human\t\r \u00a0 adipose\t\r \u00a0 tissue:\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 obesity\t\r \u00a0 and\t\r \u00a0noninsulin-\u00ad\u2010dependent\t\r \u00a0diabetes\t\r \u00a0mellitus.\t\r \u00a0Eur\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest\t\r \u00a01999;\t\r \u00a029(8):672\u2013678.\t\r \u00a063. Ruan\t\r \u00a0H,\t\r \u00a0Lodish\t\r \u00a0HF.\t\r \u00a0Insulin\t\r \u00a0resistance\t\r \u00a0in\t\r \u00a0adipose\t\r \u00a0tissue:\t\r \u00a0direct\t\r \u00a0and\t\r \u00a0indirect\t\r \u00a0effects\t\r \u00a0of\t\r \u00a0tumor\t\r \u00a0necrosis\t\r \u00a0factor-\u00ad\u2010alpha.\t\r \u00a0Cytokine\t\r \u00a0Growth\t\r \u00a0Factor\t\r \u00a0Rev.\t\r \u00a02003;\t\r \u00a014(5):447\u2013455\t\r \u00a064. Uysal\t\r \u00a0 KT,\t\r \u00a0 Wiesbrock\t\r \u00a0 SM,\t\r \u00a0 MarinoMW,\t\r \u00a0 Hotamisligil\t\r \u00a0GS.\t\r \u00a0 Protection\t\r \u00a0 from\t\r \u00a0 obesity-\u00ad\u2010induced\t\r \u00a0insulin\t\r \u00a0resistance\t\r \u00a0in\t\r \u00a0mice\t\r \u00a0lacking\t\r \u00a0TNF-\u00ad\u2010alpha\t\r \u00a0function.\t\r \u00a0Nature\t\r \u00a01997;\t\r \u00a0389:610\u2013614\t\r \u00a065. Takano\t\r \u00a0M,\t\r \u00a0Nishihara\t\r \u00a0R,\t\r \u00a0Sugano\t\r \u00a0N,\t\r \u00a0Matsumoto\t\r \u00a0K,\t\r \u00a0Yamada\t\r \u00a0Y,\t\r \u00a0Takane\t\r \u00a0M,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0The\t\r \u00a0effect\t\r \u00a0of\t\r \u00a0systemic\t\r \u00a0 anti-\u00ad\u2010tumor\t\r \u00a0 necrosis\t\r \u00a0 factor-\u00ad\u2010alpha\t\r \u00a0 treatment\t\r \u00a0 on\t\r \u00a0 Porphyromonas\t\r \u00a0 gingivalis\t\r \u00a0infection\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetic\t\r \u00a0mice.\t\r \u00a0Arch\t\r \u00a0Oral\t\r \u00a0Biol.\t\r \u00a02010;\t\r \u00a055(5):379\u2013384\t\r \u00a066. G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0A,\t\r \u00a0Otero\t\r \u00a0YF,\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Heras\t\r \u00a0N,\t\r \u00a0Escribano\t\r \u00a0O,\t\r \u00a0Cachofeiro\t\r \u00a0V,\t\r \u00a0Lahera\t\r \u00a0V,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Brown\t\r \u00a0 fat\t\r \u00a0 lipoatrophy\t\r \u00a0 and\t\r \u00a0 increased\t\r \u00a0 visceral\t\r \u00a0 adiposity\t\r \u00a0 through\t\r \u00a0 a\t\r \u00a0 concerted\t\r \u00a0adipocytokines\t\r \u00a0 overexpression\t\r \u00a0 induces\t\r \u00a0 vascular\t\r \u00a0 insulin\t\r \u00a0 resistance\t\r \u00a0 and\t\r \u00a0 dysfunction.\t\r \u00a0Endocrinology.\t\r \u00a02012;\t\r \u00a0153(3):1242-\u00ad\u201055.\t\r \u00a067. Van\t\r \u00a0 Harmelen\t\r \u00a0 V,\t\r \u00a0 Ariapart\t\r \u00a0 P,\t\r \u00a0 Hoffstedt\t\r \u00a0 J,\t\r \u00a0 Lundkvist\t\r \u00a0 I,\t\r \u00a0 Bringman\t\r \u00a0 S,\t\r \u00a0 Arner\t\r \u00a0 P.\t\r \u00a0 Increased\t\r \u00a0adipose\t\r \u00a0angiotensinogen\t\r \u00a0gene\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0human\t\r \u00a0obesity.\t\r \u00a0Obes\t\r \u00a0Res.\t\r \u00a02000;\t\r \u00a08(4):337-\u00ad\u201041.\t\r \u00a068. Shimomura\t\r \u00a0I,\t\r \u00a0Funahashi\t\r \u00a0T,\t\r \u00a0Takahashi\t\r \u00a0M,\t\r \u00a0Maeda\t\r \u00a0K,\t\r \u00a0Kotani\t\r \u00a0K,\t\r \u00a0Nakamura\t\r \u00a0T\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Enhanced\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0PAI-\u00ad\u20101\t\r \u00a0in\t\r \u00a0visceral\t\r \u00a0fat:\t\r \u00a0possible\t\r \u00a0contributor\t\r \u00a0to\t\r \u00a0vascular\t\r \u00a0disease\t\r \u00a0in\t\r \u00a0obesity.\t\r \u00a0Nat\t\r \u00a0Med.\t\r \u00a01996;\t\r \u00a02(7):800-\u00ad\u20103.\t\r \u00a069. Jones\t\r \u00a0BH,\t\r \u00a0Standridge\t\r \u00a0MK,\t\r \u00a0Moustaid\t\r \u00a0N.\t\r \u00a0Angiotensin\t\r \u00a0II\t\r \u00a0increases\t\r \u00a0lipogenesis\t\r \u00a0in\t\r \u00a03T3-\u00ad\u2010L1\t\r \u00a0and\t\r \u00a0human\t\r \u00a0adipose\t\r \u00a0cells.\t\r \u00a0Endocrinology.\t\r \u00a01997;\t\r \u00a0138(4):1512-\u00ad\u20109.\t\r \u00a070. Gil\t\r \u00a0A,\t\r \u00a0Mar\u00eda\t\r \u00a0Aguilera\t\r \u00a0C,\t\r \u00a0Gil-\u00ad\u2010Campos\t\r \u00a0M,\t\r \u00a0Ca\u00f1ete\t\r \u00a0R.\t\r \u00a0Altered\t\r \u00a0signalling\t\r \u00a0and\t\r \u00a0gene\t\r \u00a0expression\t\r \u00a0associated\t\r \u00a0with\t\r \u00a0the\t\r \u00a0immune\t\r \u00a0system\t\r \u00a0and\t\r \u00a0the\t\r \u00a0inflammatory\t\r \u00a0response\t\r \u00a0in\t\r \u00a0obesity.\t\r \u00a0Br\t\r \u00a0J\t\r \u00a0Nutr.\t\r \u00a02007;\t\r \u00a098\t\r \u00a0Suppl\t\r \u00a01:S121-\u00ad\u20106.\t\r \u00a071. Baker\t\r \u00a0RG,\t\r \u00a0Hayden\t\r \u00a0MS,\t\r \u00a0Ghosh\t\r \u00a0S.\t\r \u00a0NF-\u00ad\u2010\u03baB,\t\r \u00a0inflammation,\t\r \u00a0and\t\r \u00a0metabolic\t\r \u00a0disease.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02011;\t\r \u00a013(1):11-\u00ad\u201022.\t\r \u00a072. Chawla\t\r \u00a0A,\t\r \u00a0Nguyen\t\r \u00a0KD,\t\r \u00a0Goh\t\r \u00a0YP.\t\r \u00a0Macrophage-\u00ad\u2010mediated\t\r \u00a0inflammation\t\r \u00a0in\t\r \u00a0metabolic\t\r \u00a0disease.\t\r \u00a0Nat\t\r \u00a0Rev\t\r \u00a0Immunol.\t\r \u00a02011;\t\r \u00a011(11):738-\u00ad\u201049.\t\r \u00a0\t\r \u00a073. Nishimura\t\r \u00a0S,\t\r \u00a0Manabe\t\r \u00a0I,\t\r \u00a0Nagasaki\t\r \u00a0M,\t\r \u00a0Eto\t\r \u00a0K,\t\r \u00a0Yamashita\t\r \u00a0H,\t\r \u00a0Ohsugi\t\r \u00a0M\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0CD8+\t\r \u00a0effector\t\r \u00a0T\t\r \u00a0cells\t\r \u00a0 contribute\t\r \u00a0 to\t\r \u00a0 macrophage\t\r \u00a0 recruitment\t\r \u00a0 and\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 inflammation\t\r \u00a0 in\t\r \u00a0 obesity.\t\r \u00a0Nat\t\r \u00a0Med\t\r \u00a02009;\t\r \u00a015(8):914\u2013920.\t\r \u00a074. Crandall\t\r \u00a0 DL,\t\r \u00a0 Hausman\t\r \u00a0 GJ,\t\r \u00a0 Kral\t\r \u00a0 JG.\t\r \u00a0 A\t\r \u00a0 review\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 microcirculation\t\r \u00a0 of\t\r \u00a0 adipose\t\r \u00a0 tissue:\t\r \u00a0anatomic,\t\r \u00a0metabolic,\t\r \u00a0and\t\r \u00a0angiogenic\t\r \u00a0perspectives.\t\r \u00a0Microcirculation.\t\r \u00a01997;\t\r \u00a04(2):211-\u00ad\u201032.\t\r \u00a075. Blake\t\r \u00a0 GJ,\t\r \u00a0 Ridker\t\r \u00a0 PM.\t\r \u00a0 Inflammatory\t\r \u00a0 bio-\u00ad\u2010markers\t\r \u00a0 and\t\r \u00a0 cardiovascular\t\r \u00a0 risk\t\r \u00a0 prediction.\t\r \u00a0 J\t\r \u00a0Intern\t\r \u00a0Med.\t\r \u00a02002;\t\r \u00a0252(4):283-\u00ad\u201094.\t\r \u00a076. Sengen\u00e8s\t\r \u00a0C,\t\r \u00a0Miranville\t\r \u00a0A,\t\r \u00a0Lolm\u00e8de\t\r \u00a0K,\t\r \u00a0Curat\t\r \u00a0CA,\t\r \u00a0Bouloumi\u00e9\t\r \u00a0A.\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0endothelial\t\r \u00a0cells\t\r \u00a0in\t\r \u00a0inflamed\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0J\t\r \u00a0Intern\t\r \u00a0Med.\t\r \u00a02007;\t\r \u00a0262(4):415-\u00ad\u201021\t\r \u00a077. Cai\t\r \u00a0D,\t\r \u00a0Yuan\t\r \u00a0M,\t\r \u00a0Frantz\t\r \u00a0DF,\t\r \u00a0Melendez\t\r \u00a0PA,\t\r \u00a0Hansen\t\r \u00a0L,\t\r \u00a0Lee\t\r \u00a0J,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Local\t\r \u00a0and\t\r \u00a0systemic\t\r \u00a0insulin\t\r \u00a0resistance\t\r \u00a0resulting\t\r \u00a0from\t\r \u00a0hepatic\t\r \u00a0activation\t\r \u00a0of\t\r \u00a0IKK-\u00ad\u2010beta\t\r \u00a0and\t\r \u00a0NF-\u00ad\u2010kappaB.\t\r \u00a0Nat\t\r \u00a0Med.\t\r \u00a02005;\t\r \u00a011(2):183-\u00ad\u201090.\t\r \u00a078. Racanelli\t\r \u00a0V,\t\r \u00a0Rehermann\t\r \u00a0B.\t\r \u00a0The\t\r \u00a0liver\t\r \u00a0as\t\r \u00a0an\t\r \u00a0immunological\t\r \u00a0organ.\t\r \u00a0Hepatology.\t\r \u00a02006;\t\r \u00a043(2\t\r \u00a0Suppl\t\r \u00a01):S54-\u00ad\u201062.\t\r \u00a079. Shoelson\t\r \u00a0SE,\t\r \u00a0Lee\t\r \u00a0J,\t\r \u00a0Goldfine\t\r \u00a0AB.\t\r \u00a0Inflammation\t\r \u00a0and\t\r \u00a0insulin\t\r \u00a0resistance.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest.\t\r \u00a02006;\t\r \u00a0116(7):1793-\u00ad\u2010801.\t\r \u00a080. Mattson\t\r \u00a0 MP.\t\r \u00a0 Perspective:\t\r \u00a0 Does\t\r \u00a0 brown\t\r \u00a0 fat\t\r \u00a0 protect\t\r \u00a0 against\t\r \u00a0 diseases\t\r \u00a0 of\t\r \u00a0 aging?\t\r \u00a0 Ageing\t\r \u00a0 Res\t\r \u00a0Rev.\t\r \u00a02010;\t\r \u00a09(1):69-\u00ad\u201076.\t\r \u00a0\t\r \u00a081. Farmer\t\r \u00a0SR.\t\r \u00a0Transcriptional\t\r \u00a0control\t\r \u00a0of\t\r \u00a0adipocyte\t\r \u00a0formation.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02006;\t\r \u00a04\t\r \u00a0(4):263\u201373.\t\r \u00a0\t\r \u00a082. Ishibashi\t\r \u00a0J,\t\r \u00a0Seale\t\r \u00a0P.\t\r \u00a0Medicine.\t\r \u00a0Beige\t\r \u00a0can\t\r \u00a0be\t\r \u00a0slimming.\t\r \u00a0Science.\t\r \u00a02010;\t\r \u00a0328(5982):1113-\u00ad\u20104.\t\r \u00a0\t\r \u00a083. Wu\t\r \u00a0J,\t\r \u00a0Bostr\u00f6m\t\r \u00a0P,\t\r \u00a0Sparks\t\r \u00a0LM,\t\r \u00a0Ye\t\r \u00a0L,\t\r \u00a0Choi\t\r \u00a0JH,\t\r \u00a0Giang\t\r \u00a0AH,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Beige\t\r \u00a0adipocytes\t\r \u00a0are\t\r \u00a0a\t\r \u00a0distinct\t\r \u00a0type\t\r \u00a0of\t\r \u00a0thermogenic\t\r \u00a0fat\t\r \u00a0cell\t\r \u00a0in\t\r \u00a0mouse\t\r \u00a0and\t\r \u00a0human.\t\r \u00a0Cell.\t\r \u00a02012;\t\r \u00a0150(2):366-\u00ad\u201076.\t\r \u00a084. Bostr\u00f6m\t\r \u00a0 P,\t\r \u00a0 Wu\t\r \u00a0 J,\t\r \u00a0 Jedrychowski\t\r \u00a0 MP,\t\r \u00a0 Korde\t\r \u00a0 A,\t\r \u00a0 Ye\t\r \u00a0 L,\t\r \u00a0 Lo\t\r \u00a0 JC,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 A\t\r \u00a0 PGC1-\u00ad\u2010\u03b1-\u00ad\u2010dependent\t\r \u00a0myokine\t\r \u00a0that\t\r \u00a0drives\t\r \u00a0brown-\u00ad\u2010fat-\u00ad\u2010like\t\r \u00a0development\t\r \u00a0of\t\r \u00a0white\t\r \u00a0fat\t\r \u00a0and\t\r \u00a0thermogenesis.\t\r \u00a0Nature.\t\r \u00a02012;\t\r \u00a0481(7382):463-\u00ad\u20108.\t\r \u00a0\t\r \u00a085. Ghorbani\t\r \u00a0M,\t\r \u00a0Claus\t\r \u00a0TH,\t\r \u00a0Himms-\u00ad\u2010Hagen\t\r \u00a0J.\t\r \u00a0Hypertrophy\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipocytes\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0and\t\r \u00a0white\t\r \u00a0 adipose\t\r \u00a0 tissues\t\r \u00a0 and\t\r \u00a0 reversal\t\r \u00a0 of\t\r \u00a0 diet-\u00ad\u2010induced\t\r \u00a0 obesity\t\r \u00a0 in\t\r \u00a0 rats\t\r \u00a0 treated\t\r \u00a0 with\t\r \u00a0 a\t\r \u00a0 beta3-\u00ad\u2010adrenoceptor\t\r \u00a0agonist.\t\r \u00a0Biochem\t\r \u00a0Pharmacol.\t\r \u00a01997;\t\r \u00a054(1):121-\u00ad\u201031.\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n344\t\r \u00a0\t\r \u00a086. Guerra\t\r \u00a0C,\t\r \u00a0Koza\t\r \u00a0RA,\t\r \u00a0Yamashita\t\r \u00a0H,\t\r \u00a0Walsh\t\r \u00a0K,\t\r \u00a0Kozak\t\r \u00a0LP.\t\r \u00a0Emergence\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipocytes\t\r \u00a0in\t\r \u00a0white\t\r \u00a0 fat\t\r \u00a0 in\t\r \u00a0 mice\t\r \u00a0 is\t\r \u00a0 under\t\r \u00a0 genetic\t\r \u00a0 control.\t\r \u00a0 Effects\t\r \u00a0 on\t\r \u00a0 body\t\r \u00a0 weight\t\r \u00a0 and\t\r \u00a0 adiposity.\t\r \u00a0 J\t\r \u00a0 Clin\t\r \u00a0Invest.\t\r \u00a01998;\t\r \u00a0102(2):412-\u00ad\u201020.\t\r \u00a087. Lowell\t\r \u00a0 BB,\t\r \u00a0 S-\u00ad\u2010Susulic\t\r \u00a0 V,\t\r \u00a0 Hamann\t\r \u00a0 A,\t\r \u00a0 Lawitts\t\r \u00a0 JA,\t\r \u00a0 Himms-\u00ad\u2010Hagen\t\r \u00a0 J,\t\r \u00a0 Boyer\t\r \u00a0 BB,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0obesity\t\r \u00a0in\t\r \u00a0transgenic\t\r \u00a0mice\t\r \u00a0after\t\r \u00a0genetic\t\r \u00a0ablation\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Nature.\t\r \u00a01993;\t\r \u00a0366:740\u20132.\t\r \u00a088. Guerra\t\r \u00a0C,\t\r \u00a0Navarro\t\r \u00a0P,\t\r \u00a0Valverde\t\r \u00a0AM,\t\r \u00a0Arribas\t\r \u00a0M,\t\r \u00a0Br\u00fcning\t\r \u00a0J,\t\r \u00a0Kozak\t\r \u00a0LP,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Brown\t\r \u00a0adipose\t\r \u00a0tissue-\u00ad\u2010specific\t\r \u00a0 insulin\t\r \u00a0 receptor\t\r \u00a0 knockout\t\r \u00a0 shows\t\r \u00a0 diabetic\t\r \u00a0 phenotype\t\r \u00a0 without\t\r \u00a0 insulin\t\r \u00a0resistance.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest.\t\r \u00a02001;\t\r \u00a0108(8):1205-\u00ad\u201013.\t\r \u00a089. Kontani\t\r \u00a0Y,\t\r \u00a0Wang\t\r \u00a0Y,\t\r \u00a0Kimura\t\r \u00a0K,\t\r \u00a0Inokuma\t\r \u00a0KI,\t\r \u00a0Saito\t\r \u00a0M,\t\r \u00a0Suzuki-\u00ad\u2010Miura\t\r \u00a0T,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0UCP1\t\r \u00a0deficiency\t\r \u00a0increases\t\r \u00a0susceptibility\t\r \u00a0to\t\r \u00a0diet-\u00ad\u2010induced\t\r \u00a0obesity\t\r \u00a0with\t\r \u00a0age.\t\r \u00a0Aging\t\r \u00a0Cell.\t\r \u00a02005;\t\r \u00a04(3):147-\u00ad\u201055.\t\r \u00a090. Cypess\t\r \u00a0AM,\t\r \u00a0Lehman\t\r \u00a0S,\t\r \u00a0Williams\t\r \u00a0G,\t\r \u00a0Tal\t\r \u00a0I,\t\r \u00a0Rodman\t\r \u00a0D,\t\r \u00a0Goldfine\t\r \u00a0AB,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Identification\t\r \u00a0and\t\r \u00a0importance\t\r \u00a0of\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0in\t\r \u00a0adult\t\r \u00a0humans.\t\r \u00a0N\t\r \u00a0Engl\t\r \u00a0J\t\r \u00a0Med.\t\r \u00a02009;\t\r \u00a0360(15):1509-\u00ad\u201017.\t\r \u00a091. Hansen\t\r \u00a0 JB,\t\r \u00a0 Kristiansen\t\r \u00a0 K.\t\r \u00a0 Regulatory\t\r \u00a0 circuits\t\r \u00a0 controlling\t\r \u00a0 white\t\r \u00a0 versus\t\r \u00a0 brown\t\r \u00a0 adipocyte\t\r \u00a0differentiation.\t\r \u00a0Biochem\t\r \u00a0J.\t\r \u00a02006;\t\r \u00a0398(2):153-\u00ad\u201068\t\r \u00a092. Cannon\t\r \u00a0 B,\t\r \u00a0 Nedergaard\t\r \u00a0 J.\t\r \u00a0 Brown\t\r \u00a0 adipose\t\r \u00a0 tissue:\t\r \u00a0 function\t\r \u00a0 and\t\r \u00a0 physiological\t\r \u00a0 significance.\t\r \u00a0Physiol\t\r \u00a0Rev.\t\r \u00a02004;\t\r \u00a084(1):277-\u00ad\u2010359.\t\r \u00a093. Bartelt\t\r \u00a0A,\t\r \u00a0Bruns\t\r \u00a0OT,\t\r \u00a0Reimer\t\r \u00a0R,\t\r \u00a0Hohenberg\t\r \u00a0H,\t\r \u00a0Ittrich\t\r \u00a0H,\t\r \u00a0Peldschus\t\r \u00a0K,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0activity\t\r \u00a0controls\t\r \u00a0triglyceride\t\r \u00a0clearance.\t\r \u00a0Nat\t\r \u00a0Med.\t\r \u00a02011;\t\r \u00a017(2):200-\u00ad\u20105.\t\r \u00a094. Williams\t\r \u00a0 KJ.\t\r \u00a0 Molecular\t\r \u00a0 processes\t\r \u00a0 that\t\r \u00a0 handle\t\r \u00a0-\u00ad\u2010-\u00ad\u2010\t\r \u00a0and\t\r \u00a0 mishandle\t\r \u00a0-\u00ad\u2010-\u00ad\u2010\t\r \u00a0dietary\t\r \u00a0 lipids.\t\r \u00a0 J\t\r \u00a0 Clin\t\r \u00a0Invest.\t\r \u00a02008;\t\r \u00a0118(10):3247-\u00ad\u201059.\t\r \u00a095. Hokanson\t\r \u00a0 JE,\t\r \u00a0 Austin\t\r \u00a0 MA.\t\r \u00a0 Plasma\t\r \u00a0 triglyceride\t\r \u00a0 level\t\r \u00a0 is\t\r \u00a0 a\t\r \u00a0 risk\t\r \u00a0 factor\t\r \u00a0 for\t\r \u00a0 cardiovascular\t\r \u00a0disease\t\r \u00a0 independent\t\r \u00a0 of\t\r \u00a0 high-\u00ad\u2010density\t\r \u00a0 lipoprotein\t\r \u00a0 cholesterol\t\r \u00a0 level:\t\r \u00a0 a\t\r \u00a0 meta-\u00ad\u2010analysis\t\r \u00a0 of\t\r \u00a0population-\u00ad\u2010based\t\r \u00a0prospective\t\r \u00a0studies.\t\r \u00a0J\t\r \u00a0Cardiovasc\t\r \u00a0Risk.\t\r \u00a01996;\t\r \u00a03(2):213-\u00ad\u20109.\t\r \u00a096. Austin\t\r \u00a0 MA,\t\r \u00a0 McKnight\t\r \u00a0 B,\t\r \u00a0 Edwards\t\r \u00a0 KL,\t\r \u00a0 Bradley\t\r \u00a0 CM,\t\r \u00a0 McNeely\t\r \u00a0 MJ,\t\r \u00a0 Psaty\t\r \u00a0 BM,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Cardiovascular\t\r \u00a0 disease\t\r \u00a0 mortality\t\r \u00a0 in\t\r \u00a0 familial\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0 hypertriglyceridemia:\t\r \u00a0 A\t\r \u00a0 20-\u00ad\u2010year\t\r \u00a0prospective\t\r \u00a0study.\t\r \u00a0Circulation.\t\r \u00a02000;\t\r \u00a0101(24):2777-\u00ad\u201082.\t\r \u00a097. Mooradian\t\r \u00a0AD.\t\r \u00a0Dyslipidemia\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0mellitus.\t\r \u00a0Nat\t\r \u00a0Clin\t\r \u00a0Pract\t\r \u00a0Endocrinol\t\r \u00a0Metab.\t\r \u00a02009;\t\r \u00a05(3):150-\u00ad\u20109.\t\r \u00a098. Fredriksson\t\r \u00a0 JM,\t\r \u00a0 Nikami\t\r \u00a0 H,\t\r \u00a0 Nedergaard\t\r \u00a0 J.\t\r \u00a0 Cold-\u00ad\u2010induced\t\r \u00a0 expression\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 VEGF\t\r \u00a0 gene\t\r \u00a0 in\t\r \u00a0brown\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 is\t\r \u00a0 independent\t\r \u00a0 of\t\r \u00a0 thermogenic\t\r \u00a0 oxygen\t\r \u00a0 consumption.\t\r \u00a0 FEBS\t\r \u00a0 Lett.\t\r \u00a02005;\t\r \u00a0579(25):5680-\u00ad\u20104.\t\r \u00a099. Mitchell\t\r \u00a0JR,\t\r \u00a0Jacobsson\t\r \u00a0A,\t\r \u00a0Kirchgessner\t\r \u00a0TG,\t\r \u00a0Schotz\t\r \u00a0MC,\t\r \u00a0Cannon\t\r \u00a0B,\t\r \u00a0Nedergaard\t\r \u00a0J.\t\r \u00a0Regulation\t\r \u00a0of\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0the\t\r \u00a0lipoprotein\t\r \u00a0lipase\t\r \u00a0gene\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol.\t\r \u00a01992;\t\r \u00a0263(3\t\r \u00a0Pt\t\r \u00a01):E500-\u00ad\u20106.\t\r \u00a0100. Ouellet\t\r \u00a0 V,\t\r \u00a0 Labb\u00e9\t\r \u00a0 SM,\t\r \u00a0 Blondin\t\r \u00a0 DP,\t\r \u00a0 Phoenix\t\r \u00a0 S,\t\r \u00a0 Gu\u00e9rin\t\r \u00a0 B,\t\r \u00a0 Haman\t\r \u00a0 F,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0oxidative\t\r \u00a0metabolism\t\r \u00a0contributes\t\r \u00a0to\t\r \u00a0energy\t\r \u00a0expenditure\t\r \u00a0during\t\r \u00a0acute\t\r \u00a0cold\t\r \u00a0exposure\t\r \u00a0in\t\r \u00a0humans.\t\r \u00a0J\t\r \u00a0Clin\t\r \u00a0Invest.\t\r \u00a02012;\t\r \u00a0122(2):545-\u00ad\u201052.\t\r \u00a0\t\r \u00a0101. Chechi\t\r \u00a0 K,\t\r \u00a0 Blanchard\t\r \u00a0 PG,\t\r \u00a0 Mathieu\t\r \u00a0 P,\t\r \u00a0 Deshaies\t\r \u00a0 Y,\t\r \u00a0 Richard\t\r \u00a0 D.\t\r \u00a0 Brown\t\r \u00a0 fat\t\r \u00a0 like\t\r \u00a0 gene\t\r \u00a0expression\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 epicardial\t\r \u00a0 fat\t\r \u00a0 depot\t\r \u00a0 correlates\t\r \u00a0 with\t\r \u00a0 circulating\t\r \u00a0 HDL-\u00ad\u2010cholesterol\t\r \u00a0 and\t\r \u00a0triglycerides\t\r \u00a0in\t\r \u00a0patients\t\r \u00a0with\t\r \u00a0coronary\t\r \u00a0artery\t\r \u00a0disease.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Cardiol.\t\r \u00a02012\t\r \u00a0Jun\t\r \u00a022.\t\r \u00a0102. Shabalina\t\r \u00a0IG,\t\r \u00a0Jacobsson\t\r \u00a0A,\t\r \u00a0Cannon\t\r \u00a0B,\t\r \u00a0Nedergaard\t\r \u00a0J.\t\r \u00a0Native\t\r \u00a0UCP1\t\r \u00a0displays\t\r \u00a0simple\t\r \u00a0competitive\t\r \u00a0 kinetics\t\r \u00a0 between\t\r \u00a0 the\t\r \u00a0 regulators\t\r \u00a0 purine\t\r \u00a0 nucleotides\t\r \u00a0 and\t\r \u00a0 fatty\t\r \u00a0 acids.\t\r \u00a0 J\t\r \u00a0 Biol\t\r \u00a0Chem.\t\r \u00a02004;\t\r \u00a0279(37):38236-\u00ad\u201048.\t\r \u00a0\t\r \u00a0103. Nikami\t\r \u00a0H,\t\r \u00a0Shimizu\t\r \u00a0Y,\t\r \u00a0Endoh\t\r \u00a0D,\t\r \u00a0Yano\t\r \u00a0H,\t\r \u00a0Saito\t\r \u00a0M.\t\r \u00a0Cold\t\r \u00a0exposure\t\r \u00a0increases\t\r \u00a0glucose\t\r \u00a0utilization\t\r \u00a0and\t\r \u00a0glucose\t\r \u00a0transporter\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Biochem\t\r \u00a0Biophys\t\r \u00a0Res\t\r \u00a0Commun.\t\r \u00a01992;\t\r \u00a0185(3):1078-\u00ad\u201082\t\r \u00a0104. Dallner\t\r \u00a0 OS,\t\r \u00a0 Chernogubova\t\r \u00a0 E,\t\r \u00a0 Brolinson\t\r \u00a0 KA,\t\r \u00a0 Bengtsson\t\r \u00a0 T.\t\r \u00a0 Beta3-\u00ad\u2010adrenergic\t\r \u00a0receptors\t\r \u00a0 stimulate\t\r \u00a0 glucose\t\r \u00a0 uptake\t\r \u00a0 in\t\r \u00a0 brown\t\r \u00a0 adipocytes\t\r \u00a0 by\t\r \u00a0 two\t\r \u00a0 mechanisms\t\r \u00a0independently\t\r \u00a0 of\t\r \u00a0 glucose\t\r \u00a0 transporter\t\r \u00a0 4\t\r \u00a0 translocation.\t\r \u00a0 Endocrinology.\t\r \u00a0 2006;\t\r \u00a0147(12):5730-\u00ad\u20109.\t\r \u00a0105. Chartoumpekis\t\r \u00a0 DV,\t\r \u00a0 Habeos\t\r \u00a0 IG,\t\r \u00a0 Ziros\t\r \u00a0 PG,\t\r \u00a0 Psyrogiannis\t\r \u00a0 AI,\t\r \u00a0 Kyriazopoulou\t\r \u00a0 VE,\t\r \u00a0Papavassiliou\t\r \u00a0AG.\t\r \u00a0Brown\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0responds\t\r \u00a0to\t\r \u00a0cold\t\r \u00a0and\t\r \u00a0adrenergic\t\r \u00a0stimulation\t\r \u00a0by\t\r \u00a0induction\t\r \u00a0of\t\r \u00a0FGF21.\t\r \u00a0Mol\t\r \u00a0Med.\t\r \u00a02011;\t\r \u00a017(7-\u00ad\u20108):736-\u00ad\u201040.\t\r \u00a0\t\r \u00a0106. Hondares\t\r \u00a0 E,\t\r \u00a0 Iglesias\t\r \u00a0 R,\t\r \u00a0 Giralt\t\r \u00a0 A,\t\r \u00a0 Gonzalez\t\r \u00a0 FJ,\t\r \u00a0 Giralt\t\r \u00a0 M,\t\r \u00a0 Mampel\t\r \u00a0 T,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Thermogenic\t\r \u00a0activation\t\r \u00a0induces\t\r \u00a0FGF21\t\r \u00a0expression\t\r \u00a0and\t\r \u00a0release\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0J\t\r \u00a0Biol\t\r \u00a0Chem.\t\r \u00a02011;\t\r \u00a0286(15):12983-\u00ad\u201090.\t\r \u00a0\t\r \u00a0Papel\t\r \u00a0del\t\r \u00a0tejido\t\r \u00a0adiposo\t\r \u00a0blanco,\t\r \u00a0marr\u00f3n\t\r \u00a0y\t\r \u00a0perivascular\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0345\t\r \u00a0\t\r \u00a0107. Hondares\t\r \u00a0E,\t\r \u00a0Rosell\t\r \u00a0M,\t\r \u00a0Gonzalez\t\r \u00a0FJ,\t\r \u00a0Giralt\t\r \u00a0M,\t\r \u00a0Iglesias\t\r \u00a0R,\t\r \u00a0Villarroya\t\r \u00a0F.\t\r \u00a0Hepatic\t\r \u00a0FGF21\t\r \u00a0expression\t\r \u00a0is\t\r \u00a0induced\t\r \u00a0at\t\r \u00a0birth\t\r \u00a0via\t\r \u00a0PPARalpha\t\r \u00a0in\t\r \u00a0response\t\r \u00a0to\t\r \u00a0milk\t\r \u00a0intake\t\r \u00a0and\t\r \u00a0contributes\t\r \u00a0to\t\r \u00a0thermogenic\t\r \u00a0activation\t\r \u00a0of\t\r \u00a0neonatal\t\r \u00a0brown\t\r \u00a0fat.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02010;\t\r \u00a011(3):206-\u00ad\u201012.\t\r \u00a0108. Nisoli\t\r \u00a0 E,\t\r \u00a0 Tonello\t\r \u00a0 C,\t\r \u00a0 Carruba\t\r \u00a0 MO.\t\r \u00a0Nerve\t\r \u00a0 growth\t\r \u00a0 factor,\t\r \u00a0 beta3-\u00ad\u2010adrenoceptor\t\r \u00a0 and\t\r \u00a0uncoupling\t\r \u00a0protein\t\r \u00a01\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0rat\t\r \u00a0brown\t\r \u00a0fat\t\r \u00a0during\t\r \u00a0postnatal\t\r \u00a0development.Neurosci\t\r \u00a0Lett.\t\r \u00a01998;\t\r \u00a0246(1):5-\u00ad\u20108.\t\r \u00a0109. Nisoli\t\r \u00a0 E,\t\r \u00a0 Tonello\t\r \u00a0 C,\t\r \u00a0 Benarese\t\r \u00a0 M,\t\r \u00a0 Liberini\t\r \u00a0 P,\t\r \u00a0 Carruba\t\r \u00a0 MO.\t\r \u00a0Expression\t\r \u00a0 of\t\r \u00a0 nerve\t\r \u00a0growth\t\r \u00a0 factor\t\r \u00a0 in\t\r \u00a0 brown\t\r \u00a0 adipose\t\r \u00a0 tissue:\t\r \u00a0 implications\t\r \u00a0 for\t\r \u00a0 thermogenesis\t\r \u00a0 and\t\r \u00a0 obesity.\t\r \u00a0Endocrinology\t\r \u00a01996;\t\r \u00a0137(2):495-\u00ad\u2010503.\t\r \u00a0\t\r \u00a0110. N\u00e9chad\t\r \u00a0M,\t\r \u00a0Ruka\t\r \u00a0E,\t\r \u00a0Thibault\t\r \u00a0J.\t\r \u00a0Production\t\r \u00a0of\t\r \u00a0nerve\t\r \u00a0growth\t\r \u00a0factor\t\r \u00a0by\t\r \u00a0brown\t\r \u00a0fat\t\r \u00a0in\t\r \u00a0culture:\t\r \u00a0relation\t\r \u00a0with\t\r \u00a0the\t\r \u00a0in\t\r \u00a0vivo\t\r \u00a0developmental\t\r \u00a0stage\t\r \u00a0of\t\r \u00a0the\t\r \u00a0tissue.\t\r \u00a0Comp\t\r \u00a0Biochem\t\r \u00a0Physiol\t\r \u00a0Comp\t\r \u00a0Physiol.\t\r \u00a01994;\t\r \u00a0107(2):381-\u00ad\u20108.\t\r \u00a0111. Sornelli\t\r \u00a0 F,\t\r \u00a0 Fiore\t\r \u00a0 M,\t\r \u00a0 Chaldakov\t\r \u00a0 GN,\t\r \u00a0 Aloe\t\r \u00a0 L.\t\r \u00a0 Adipose\t\r \u00a0 tissue-\u00ad\u2010derived\t\r \u00a0 nerve\t\r \u00a0 growth\t\r \u00a0factor\t\r \u00a0 and\t\r \u00a0 brain-\u00ad\u2010derived\t\r \u00a0 neurotrophic\t\r \u00a0 factor:\t\r \u00a0 results\t\r \u00a0 from\t\r \u00a0 experimental\t\r \u00a0 stress\t\r \u00a0 and\t\r \u00a0diabetes.\t\r \u00a0Gen\t\r \u00a0Physiol\t\r \u00a0Biophys\t\r \u00a02009;\t\r \u00a028\t\r \u00a0Spec\t\r \u00a0No:179-\u00ad\u201083.\t\r \u00a0112. Tonello\t\r \u00a0 C,\t\r \u00a0 Giordano\t\r \u00a0 A,\t\r \u00a0 Cozzi\t\r \u00a0 V,\t\r \u00a0 Cinti\t\r \u00a0 S,\t\r \u00a0 Stock\t\r \u00a0 MJ,\t\r \u00a0 Carruba\t\r \u00a0 MO,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Role\t\r \u00a0 of\t\r \u00a0sympathetic\t\r \u00a0activity\t\r \u00a0in\t\r \u00a0controlling\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0vascular\t\r \u00a0endothelial\t\r \u00a0growth\t\r \u00a0factor\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0fat\t\r \u00a0cells\t\r \u00a0of\t\r \u00a0lean\t\r \u00a0and\t\r \u00a0genetically\t\r \u00a0obese\t\r \u00a0rats.\t\r \u00a0FEBS\t\r \u00a0Lett.\t\r \u00a01999;\t\r \u00a0442(2-\u00ad\u20103):167-\u00ad\u201072.\t\r \u00a0113. Kikuchi-\u00ad\u2010Utsumi\t\r \u00a0 K,\t\r \u00a0 Gao\t\r \u00a0 B,\t\r \u00a0 Ohinata\t\r \u00a0 H,\t\r \u00a0 Hashimoto\t\r \u00a0 M,\t\r \u00a0 Yamamoto\t\r \u00a0 N,\t\r \u00a0 Kuroshima\t\r \u00a0 A.\t\r \u00a0Enhanced\t\r \u00a0 gene\t\r \u00a0 expression\t\r \u00a0 of\t\r \u00a0 endothelial\t\r \u00a0 nitric\t\r \u00a0 oxide\t\r \u00a0 synthase\t\r \u00a0 in\t\r \u00a0brown\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0during\t\r \u00a0cold\t\r \u00a0exposure.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Regul\t\r \u00a0Integr\t\r \u00a0Comp\t\r \u00a0Physiol.\t\r \u00a02002;\t\r \u00a0282(2):R623-\u00ad\u20106.\t\r \u00a0114. Fitzgibbons\t\r \u00a0 TP,\t\r \u00a0 Kogan\t\r \u00a0 S,\t\r \u00a0 Aouadi\t\r \u00a0 M,\t\r \u00a0 Hendricks\t\r \u00a0 GM,\t\r \u00a0 Straubhaar\t\r \u00a0 J,\t\r \u00a0 Czech\t\r \u00a0 MP.\t\r \u00a0Similarity\t\r \u00a0of\t\r \u00a0mouse\t\r \u00a0perivascular\t\r \u00a0and\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissues\t\r \u00a0and\t\r \u00a0their\t\r \u00a0resistance\t\r \u00a0to\t\r \u00a0diet-\u00ad\u2010induced\t\r \u00a0inflammation.\t\r \u00a0Am\t\r \u00a0J\t\r \u00a0Physiol\t\r \u00a0Heart\t\r \u00a0Circ\t\r \u00a0Physiol\t\r \u00a02011;\t\r \u00a0301(4):H1425-\u00ad\u201037.\t\r \u00a0115. Ortega\t\r \u00a0MT,\t\r \u00a0Xie\t\r \u00a0L,\t\r \u00a0Mora\t\r \u00a0S,\t\r \u00a0Chapes\t\r \u00a0SK.\t\r \u00a0Evaluation\t\r \u00a0of\t\r \u00a0macrophage\t\r \u00a0plasticity\t\r \u00a0in\t\r \u00a0brown\t\r \u00a0and\t\r \u00a0white\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Cell\t\r \u00a0Immunol\t\r \u00a02011;\t\r \u00a0271(1):124-\u00ad\u201033.\t\r \u00a0116. Meijer\t\r \u00a0 RI,\t\r \u00a0 Serne\t\r \u00a0 EH,\t\r \u00a0 Smulders\t\r \u00a0 YM,\t\r \u00a0 van\t\r \u00a0 Hinsbergh\t\r \u00a0 VW,\t\r \u00a0 Yudkin\t\r \u00a0 JS,\t\r \u00a0 Eringa\t\r \u00a0 EC.\t\r \u00a0Perivascular\t\r \u00a0adipose\t\r \u00a0tissue\t\r \u00a0and\t\r \u00a0its\t\r \u00a0role\t\r \u00a0in\t\r \u00a0type\t\r \u00a02\t\r \u00a0diabetes\t\r \u00a0and\t\r \u00a0cardiovascular\t\r \u00a0disease.\t\r \u00a0Curr\t\r \u00a0Diab\t\r \u00a0Rep.\t\r \u00a02011;\t\r \u00a011(3):211-\u00ad\u20107.\t\r \u00a0117. Police\t\r \u00a0 SB,\t\r \u00a0 Thatcher\t\r \u00a0 SE,\t\r \u00a0 Charnigo\t\r \u00a0 R,\t\r \u00a0 Daugherty\t\r \u00a0 A,\t\r \u00a0 Cassis\t\r \u00a0 LA.\t\r \u00a0 Obesity\t\r \u00a0 promotes\t\r \u00a0inflammation\t\r \u00a0 in\t\r \u00a0 periaortic\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 and\t\r \u00a0 angiotensin\t\r \u00a0 II-\u00ad\u2010induced\t\r \u00a0 abdominal\t\r \u00a0 aortic\t\r \u00a0aneurysm\t\r \u00a0formation.\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02009;\t\r \u00a029(10):1458-\u00ad\u201064.\t\r \u00a0118. Greenstein\t\r \u00a0AS,\t\r \u00a0Khavandi\t\r \u00a0K,\t\r \u00a0Withers\t\r \u00a0SB,\t\r \u00a0Sonoyama\t\r \u00a0K,\t\r \u00a0Clancy\t\r \u00a0O,\t\r \u00a0Jeziorska\t\r \u00a0M,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Local\t\r \u00a0 inflammation\t\r \u00a0 and\t\r \u00a0 hypoxia\t\r \u00a0 abolish\t\r \u00a0 the\t\r \u00a0 protective\t\r \u00a0 anticontractile\t\r \u00a0 properties\t\r \u00a0 of\t\r \u00a0perivascular\t\r \u00a0fat\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0patients.\t\r \u00a0Circulation.\t\r \u00a02009;\t\r \u00a0119(12):1661-\u00ad\u201070.\t\r \u00a0119. Eringa\t\r \u00a0 EC,\t\r \u00a0 Bakker\t\r \u00a0 W,\t\r \u00a0 van\t\r \u00a0 Hinsbergh\t\r \u00a0 VW.\t\r \u00a0 Paracrine\t\r \u00a0 regulation\t\r \u00a0 of\t\r \u00a0 vascular\t\r \u00a0 tone,\t\r \u00a0inflammation\t\r \u00a0 and\t\r \u00a0 insulin\t\r \u00a0 sensitivity\t\r \u00a0 by\t\r \u00a0 perivascular\t\r \u00a0 adipose\t\r \u00a0 tissue.\t\r \u00a0 Vascul\t\r \u00a0 Pharmacol.\t\r \u00a02012\t\r \u00a0May-\u00ad\u2010Jun;\t\r \u00a056(5-\u00ad\u20106):204-\u00ad\u20109.\t\r \u00a0\t\r \u00a0120. Rittig\t\r \u00a0K,\t\r \u00a0Staib\t\r \u00a0K,\t\r \u00a0Machann\t\r \u00a0J,\t\r \u00a0B\u00f6ttcher\t\r \u00a0M,\t\r \u00a0Peter\t\r \u00a0A,\t\r \u00a0Schick\t\r \u00a0F\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Perivascular\t\r \u00a0fatty\t\r \u00a0tissue\t\r \u00a0 at\t\r \u00a0 the\t\r \u00a0 brachial\t\r \u00a0 artery\t\r \u00a0 is\t\r \u00a0 linked\t\r \u00a0 to\t\r \u00a0 insulin\t\r \u00a0 resistance\t\r \u00a0 but\t\r \u00a0 not\t\r \u00a0 to\t\r \u00a0 local\t\r \u00a0 endothelial\t\r \u00a0dysfunction.\t\r \u00a0Diabetologia.\t\r \u00a02008;\t\r \u00a051(11):2093-\u00ad\u20109.\t\r \u00a0\t\r \u00a0121. Feldon\t\r \u00a0SE,\t\r \u00a0O'loughlin\t\r \u00a0CW,\t\r \u00a0Ray\t\r \u00a0DM,\t\r \u00a0Landskroner-\u00ad\u2010Eiger\t\r \u00a0S,\t\r \u00a0Seweryniak\t\r \u00a0KE,\t\r \u00a0Phipps\t\r \u00a0RP.\t\r \u00a0Activated\t\r \u00a0human\t\r \u00a0T\t\r \u00a0lymphocytes\t\r \u00a0express\t\r \u00a0cyclooxygenase-\u00ad\u20102\t\r \u00a0and\t\r \u00a0produce\t\r \u00a0proadipogenic\t\r \u00a0prostaglandins\t\r \u00a0 that\t\r \u00a0 drive\t\r \u00a0 human\t\r \u00a0 orbital\t\r \u00a0 fibroblast\t\r \u00a0 differentiation\t\r \u00a0 to\t\r \u00a0 adipocytes.\t\r \u00a0 Am\t\r \u00a0 J\t\r \u00a0Pathol.\t\r \u00a02006;\t\r \u00a0169(4):1183-\u00ad\u201093.\t\r \u00a0122. Chatterjee\t\r \u00a0TK,\t\r \u00a0Stoll\t\r \u00a0LL,\t\r \u00a0Denning\t\r \u00a0GM,\t\r \u00a0Harrelson\t\r \u00a0A,\t\r \u00a0Blomkalns\t\r \u00a0AL,\t\r \u00a0Idelman\t\r \u00a0G,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Proinflammatory\t\r \u00a0phenotype\t\r \u00a0of\t\r \u00a0perivascular\t\r \u00a0adipocytes:\t\r \u00a0influence\t\r \u00a0of\t\r \u00a0high-\u00ad\u2010fat\t\r \u00a0feeding.\t\r \u00a0Circ\t\r \u00a0Res\t\r \u00a02009;\t\r \u00a0104(4):541.\t\r \u00a0123. Payne\t\r \u00a0 GA,\t\r \u00a0 Borbouse\t\r \u00a0 L,\t\r \u00a0 Kumar\t\r \u00a0 S,\t\r \u00a0 Neeb\t\r \u00a0 Z,\t\r \u00a0 Alloosh\t\r \u00a0 M,\t\r \u00a0 Sturek\t\r \u00a0 M,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Epicardial\t\r \u00a0perivascular\t\r \u00a0 adipose-\u00ad\u2010derived\t\r \u00a0 leptin\t\r \u00a0 exacerbates\t\r \u00a0 coronary\t\r \u00a0 endothelial\t\r \u00a0 dysfunction\t\r \u00a0 in\t\r \u00a0metabolic\t\r \u00a0syndrome\t\r \u00a0via\t\r \u00a0a\t\r \u00a0protein\t\r \u00a0kinase\t\r \u00a0C-\u00ad\u2010beta\t\r \u00a0pathway.\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02010;\t\r \u00a030(9):1711-\u00ad\u20107.\t\r \u00a0\t\r \u00a0124. Takaoka\t\r \u00a0M,\t\r \u00a0Suzuki\t\r \u00a0H,\t\r \u00a0Shioda\t\r \u00a0S,\t\r \u00a0Sekikawa\t\r \u00a0K,\t\r \u00a0Saito\t\r \u00a0Y,\t\r \u00a0Nagai\t\r \u00a0R,\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Endovascular\t\r \u00a0injury\t\r \u00a0 induces\t\r \u00a0 rapid\t\r \u00a0 phenotypic\t\r \u00a0 changes\t\r \u00a0 in\t\r \u00a0 perivascular\t\r \u00a0 adipose\t\r \u00a0 tissue.\t\r \u00a0 Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02010;\t\r \u00a030(8):1576\u201382.\t\r \u00a0125. Henrichot\t\r \u00a0 E,\t\r \u00a0 Juge-\u00ad\u2010Aubry\t\r \u00a0 CE,\t\r \u00a0Pernin\t\r \u00a0 A,\t\r \u00a0 Pache\t\r \u00a0 JC,\t\r \u00a0 Velebit\t\r \u00a0 V,\t\r \u00a0 Dayer\t\r \u00a0 JM,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Production\t\r \u00a0 of\t\r \u00a0 chemokines\t\r \u00a0 by\t\r \u00a0 perivascular\t\r \u00a0 adipose\t\r \u00a0 tissue:\t\r \u00a0 a\t\r \u00a0 role\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 pathogenesis\t\r \u00a0 of\t\r \u00a0atherosclerosis?\t\r \u00a0Arterioscler\t\r \u00a0Thromb\t\r \u00a0Vasc\t\r \u00a0Biol.\t\r \u00a02005;\t\r \u00a025(12):2594\u20139.\t\r \u00a0Almudena\t\r \u00a0G\u00f3mez-\u00ad\u2010Hern\u00e1ndez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n346\t\r \u00a0\t\r \u00a0126. Marchesi\t\r \u00a0 C,\t\r \u00a0 Ebrahimian\t\r \u00a0 T,\t\r \u00a0 Angulo\t\r \u00a0 O,\t\r \u00a0 Paradis\t\r \u00a0 P,\t\r \u00a0 Schiffrin\t\r \u00a0 EL.\t\r \u00a0Endothelial\t\r \u00a0 nitric\t\r \u00a0oxide\t\r \u00a0 synthase\t\r \u00a0 uncoupling\t\r \u00a0 and\t\r \u00a0 perivascular\t\r \u00a0 adipose\t\r \u00a0 oxidative\t\r \u00a0 stress\t\r \u00a0 and\t\r \u00a0 inflammation\t\r \u00a0contribute\t\r \u00a0 to\t\r \u00a0 vascular\t\r \u00a0 dysfunction\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0 rodent\t\r \u00a0 model\t\r \u00a0 of\t\r \u00a0 metabolic\t\r \u00a0 syndrome.\t\r \u00a0Hypertension.\t\r \u00a02009;\t\r \u00a054(6):1384\u201392.\t\r \u00a0127. Sacks\t\r \u00a0HS,\t\r \u00a0Fain\t\r \u00a0JN.\t\r \u00a0Human\t\r \u00a0epicardial\t\r \u00a0fat:\t\r \u00a0what\t\r \u00a0is\t\r \u00a0new\t\r \u00a0and\t\r \u00a0what\t\r \u00a0is\t\r \u00a0missing?\t\r \u00a0Clin.\t\r \u00a0Exp.\t\r \u00a0Pharmacol.\t\r \u00a0Physiol.\t\r \u00a02011;\t\r \u00a038(12):879\u2013887.\t\r \u00a0128. Mazurek\t\r \u00a0 T,\t\r \u00a0 Zhang\t\r \u00a0 L,\t\r \u00a0 Zalewski\t\r \u00a0 A,\t\r \u00a0 Mannion\t\r \u00a0 JD,\t\r \u00a0 Diehl\t\r \u00a0 JT,\t\r \u00a0 Arafat\t\r \u00a0 H,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Human\t\r \u00a0epicardial\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 is\t\r \u00a0 a\t\r \u00a0 source\t\r \u00a0 of\t\r \u00a0 inflammatory\t\r \u00a0 mediators.\t\r \u00a0 Circulation.\t\r \u00a0 2003;\t\r \u00a0108(20):2460\u20136.\t\r \u00a0129. Redman\t\r \u00a0LM,\t\r \u00a0Ravussin\t\r \u00a0E.\t\r \u00a0Endocrine\t\r \u00a0alterations\t\r \u00a0in\t\r \u00a0response\t\r \u00a0to\t\r \u00a0calorie\t\r \u00a0restriction\t\r \u00a0in\t\r \u00a0humans.\t\r \u00a0Mol\t\r \u00a0Cell\t\r \u00a0Endocrinol.\t\r \u00a02009;\t\r \u00a0299(1):129-\u00ad\u201036.\t\r \u00a0130. Howell\t\r \u00a0A,\t\r \u00a0Chapman\t\r \u00a0M,\t\r \u00a0Harvie\t\r \u00a0M.\t\r \u00a0Energy\t\r \u00a0restriction\t\r \u00a0for\t\r \u00a0breast\t\r \u00a0cancer\t\r \u00a0prevention.\t\r \u00a0Recent\t\r \u00a0Results\t\r \u00a0Cancer\t\r \u00a0Res.\t\r \u00a02009;\t\r \u00a0181:97-\u00ad\u2010111.\t\r \u00a0131. L\u00f3pez-\u00ad\u2010Lluch\t\r \u00a0 G,\t\r \u00a0 Hunt\t\r \u00a0 N,\t\r \u00a0 Jones\t\r \u00a0 B,\t\r \u00a0 Zhu\t\r \u00a0 M,\t\r \u00a0 Jamieson\t\r \u00a0 H,\t\r \u00a0 Hilmer\t\r \u00a0 S,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Calorie\t\r \u00a0restriction\t\r \u00a0 induces\t\r \u00a0 mitochondrial\t\r \u00a0 biogenesis\t\r \u00a0 and\t\r \u00a0 bioenergetic\t\r \u00a0 efficiency.\t\r \u00a0 Proc\t\r \u00a0 Natl\t\r \u00a0 Acad\t\r \u00a0Sci\t\r \u00a0U\t\r \u00a0S\t\r \u00a0A.\t\r \u00a02006;\t\r \u00a0103(6):1768-\u00ad\u201073.\t\r \u00a0\t\r \u00a0132. Liu\t\r \u00a0D,\t\r \u00a0Pitta\t\r \u00a0M,\t\r \u00a0Mattson\t\r \u00a0MP.\t\r \u00a0Preventing\t\r \u00a0NAD(+)\t\r \u00a0depletion\t\r \u00a0protects\t\r \u00a0neurons\t\r \u00a0against\t\r \u00a0excitotoxicity:\t\r \u00a0 bioenergetic\t\r \u00a0 effects\t\r \u00a0 of\t\r \u00a0 mild\t\r \u00a0 mitochondrial\t\r \u00a0 uncoupling\t\r \u00a0 and\t\r \u00a0 caloric\t\r \u00a0restriction.\t\r \u00a0Ann\t\r \u00a0N\t\r \u00a0Y\t\r \u00a0Acad\t\r \u00a0Sci.\t\r \u00a02008;\t\r \u00a01147:275-\u00ad\u201082.\t\r \u00a0\t\r \u00a0133. Kamel\t\r \u00a0 EG,\t\r \u00a0 McNeill\t\r \u00a0 G,\t\r \u00a0 Van\t\r \u00a0 Wijk\t\r \u00a0 MC.\t\r \u00a0 Change\t\r \u00a0 in\t\r \u00a0 intra-\u00ad\u2010abdominal\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0volume\t\r \u00a0 during\t\r \u00a0 weight\t\r \u00a0 loss\t\r \u00a0 in\t\r \u00a0 obese\t\r \u00a0 men\t\r \u00a0 and\t\r \u00a0 women:\t\r \u00a0 correlation\t\r \u00a0 between\t\r \u00a0 magnetic\t\r \u00a0resonance\t\r \u00a0 imaging\t\r \u00a0 and\t\r \u00a0 anthropometric\t\r \u00a0 measurements.\t\r \u00a0 Int\t\r \u00a0 J\t\r \u00a0 Obes\t\r \u00a0 Relat\t\r \u00a0 Metab\t\r \u00a0 Disord.\t\r \u00a02000;\t\r \u00a024(5):607-\u00ad\u201013.\t\r \u00a0134. Seidell\t\r \u00a0JC.Environmental\t\r \u00a0influences\t\r \u00a0on\t\r \u00a0regional\t\r \u00a0fat\t\r \u00a0distribution.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Obes.\t\r \u00a01991;\t\r \u00a015\t\r \u00a0Suppl\t\r \u00a02:31-\u00ad\u20105.\t\r \u00a0135. Varady\t\r \u00a0 KA,\t\r \u00a0 Bhutani\t\r \u00a0 S,\t\r \u00a0 Klempel\t\r \u00a0 MC,\t\r \u00a0 Kroeger\t\r \u00a0 CM.\t\r \u00a0 Comparison\t\r \u00a0 of\t\r \u00a0 effects\t\r \u00a0 of\t\r \u00a0 diet\t\r \u00a0versus\t\r \u00a0exercise\t\r \u00a0weight\t\r \u00a0loss\t\r \u00a0regimens\t\r \u00a0on\t\r \u00a0LDL\t\r \u00a0and\t\r \u00a0HDL\t\r \u00a0particle\t\r \u00a0size\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0adults.\t\r \u00a0Lipids\t\r \u00a0Health\t\r \u00a0Dis.\t\r \u00a02011;\t\r \u00a010:119.\t\r \u00a0136. Saris\t\r \u00a0WH.\t\r \u00a0Effects\t\r \u00a0of\t\r \u00a0energy\t\r \u00a0restriction\t\r \u00a0and\t\r \u00a0exercise\t\r \u00a0on\t\r \u00a0the\t\r \u00a0sympathetic\t\r \u00a0nervous\t\r \u00a0system.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Obes\t\r \u00a0Relat\t\r \u00a0Metab\t\r \u00a0Disord.\t\r \u00a01995;\t\r \u00a019\t\r \u00a0Suppl\t\r \u00a07:S17-\u00ad\u2010S23.\t\r \u00a0137. Zorba\t\r \u00a0 E,\t\r \u00a0 Cengiz\t\r \u00a0 T,\t\r \u00a0 Karacabey\t\r \u00a0 K.\t\r \u00a0 Exercise\t\r \u00a0 training\t\r \u00a0 improves\t\r \u00a0 body\t\r \u00a0 composition,\t\r \u00a0blood\t\r \u00a0lipid\t\r \u00a0profile\t\r \u00a0and\t\r \u00a0serum\t\r \u00a0insulin\t\r \u00a0levels\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0children.\t\r \u00a0J\t\r \u00a0Sports\t\r \u00a0Med\t\r \u00a0Phys\t\r \u00a0Fitness.\t\r \u00a02011;\t\r \u00a051(4):664-\u00ad\u20109.\t\r \u00a0138. Lamarche\t\r \u00a0 B,\t\r \u00a0 Despr\u00e9s\t\r \u00a0 JP,\t\r \u00a0 Moorjani\t\r \u00a0 S,\t\r \u00a0 Nadeau\t\r \u00a0 A,\t\r \u00a0 Lupien\t\r \u00a0 PJ,\t\r \u00a0 Tremblay\t\r \u00a0 A,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Evidence\t\r \u00a0 for\t\r \u00a0 a\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 insulin\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 regulation\t\r \u00a0 of\t\r \u00a0 abdominal\t\r \u00a0 adipose\t\r \u00a0 tissue\t\r \u00a0 lipoprotein\t\r \u00a0lipase\t\r \u00a0response\t\r \u00a0to\t\r \u00a0exercise\t\r \u00a0training\t\r \u00a0in\t\r \u00a0obese\t\r \u00a0women.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Obes\t\r \u00a0Relat\t\r \u00a0Metab\t\r \u00a0Disord.\t\r \u00a01993;\t\r \u00a017(5):255-\u00ad\u201061.\t\r \u00a0139. Tremblay\t\r \u00a0A,\t\r \u00a0Nadeau\t\r \u00a0A,\t\r \u00a0Despr\u00e9s\t\r \u00a0JP,\t\r \u00a0St-\u00ad\u2010Jean\t\r \u00a0L,\t\r \u00a0Th\u00e9riault\t\r \u00a0G,\t\r \u00a0Bouchard\t\r \u00a0C.\t\r \u00a0Long-\u00ad\u2010term\t\r \u00a0exercise\t\r \u00a0training\t\r \u00a0with\t\r \u00a0constant\t\r \u00a0energy\t\r \u00a0intake.\t\r \u00a02:\t\r \u00a0Effect\t\r \u00a0on\t\r \u00a0glucose\t\r \u00a0metabolism\t\r \u00a0and\t\r \u00a0resting\t\r \u00a0energy\t\r \u00a0expenditure.\t\r \u00a0Int\t\r \u00a0J\t\r \u00a0Obes.\t\r \u00a01990;\t\r \u00a014(1):75.\t\r \u00a0140. Langin\t\r \u00a0 D.\t\r \u00a0 Adipose\t\r \u00a0 tissue\t\r \u00a0 lipolysis\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0 metabolic\t\r \u00a0 pathway\t\r \u00a0 to\t\r \u00a0 define\t\r \u00a0pharmacological\t\r \u00a0strategies\t\r \u00a0against\t\r \u00a0obesity\t\r \u00a0and\t\r \u00a0the\t\r \u00a0metabolic\t\r \u00a0syndrome.\t\r \u00a0Pharmacol\t\r \u00a0Res.\t\r \u00a02006;\t\r \u00a053(6):482-\u00ad\u201091.\t\r \u00a0\t\r \u00a0141. Enerb\u00e4ck\t\r \u00a0S.\t\r \u00a0Human\t\r \u00a0brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02010;\t\r \u00a011(4):248-\u00ad\u201052.\t\r \u00a0142. Nedergaard\t\r \u00a0 J,\t\r \u00a0 Bengtsson\t\r \u00a0 T,\t\r \u00a0 Cannon\t\r \u00a0 B.\t\r \u00a0 New\t\r \u00a0 powers\t\r \u00a0 of\t\r \u00a0 brown\t\r \u00a0 fat:\t\r \u00a0 fighting\t\r \u00a0 the\t\r \u00a0metabolic\t\r \u00a0syndrome.\t\r \u00a0Cell\t\r \u00a0Metab.\t\r \u00a02011;\t\r \u00a013(3):238-\u00ad\u201040\t\r \u00a0143. Langin\t\r \u00a0 D.\t\r \u00a0 Recruitment\t\r \u00a0 of\t\r \u00a0 brown\t\r \u00a0 fat\t\r \u00a0 and\t\r \u00a0 conversion\t\r \u00a0 of\t\r \u00a0 white\t\r \u00a0 into\t\r \u00a0 brown\t\r \u00a0adipocytes:\t\r \u00a0 strategies\t\r \u00a0 to\t\r \u00a0 fight\t\r \u00a0 the\t\r \u00a0 metabolic\t\r \u00a0 complications\t\r \u00a0of\t\r \u00a0 obesity?\t\r \u00a0 Biochim\t\r \u00a0 Biophys\t\r \u00a0Acta.\t\r \u00a02010;\t\r \u00a01801(3):372-\u00ad\u20106.\t\r \u00a0\t\r \u00a0144. Farmer\t\r \u00a0 SR.\t\r \u00a0 Brown\t\r \u00a0 fat\t\r \u00a0 and\t\r \u00a0 skeletal\t\r \u00a0 muscle:\t\r \u00a0 unlikely\t\r \u00a0 cousins?\t\r \u00a0 Cell.\t\r \u00a02008;134(5):726-\u00ad\u20107.\t\r \u00a0145. Schulz\t\r \u00a0 TJ,\t\r \u00a0 Huang\t\r \u00a0 TL,\t\r \u00a0 Tran\t\r \u00a0 TT,\t\r \u00a0 Zhang\t\r \u00a0 H,\t\r \u00a0 Townsend\t\r \u00a0 KL,\t\r \u00a0 Shadrach\t\r \u00a0 JL,\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0Identification\t\r \u00a0 of\t\r \u00a0 inducible\t\r \u00a0 brown\t\r \u00a0 adipocyte\t\r \u00a0progenitors\t\r \u00a0 residing\t\r \u00a0 in\t\r \u00a0 skeletal\t\r \u00a0 muscle\t\r \u00a0 and\t\r \u00a0white\t\r \u00a0fat.\t\r \u00a0Proc\t\r \u00a0Natl\t\r \u00a0Acad\t\r \u00a0Sci\t\r \u00a0U\t\r \u00a0S\t\r \u00a0A.\t\r \u00a02011;\t\r \u00a0108(1):143-\u00ad\u20108.\t\r \u00a0146. Townsend\t\r \u00a0KL,\t\r \u00a0Tseng\t\r \u00a0YH.\t\r \u00a0Brown\t\r \u00a0adipose\t\r \u00a0tissue.\t\r \u00a0Recent\t\r \u00a0insights\t\r \u00a0into\t\r \u00a0development,\t\r \u00a0metabolic\t\r \u00a0function\t\r \u00a0and\t\r \u00a0therapeutic\t\r \u00a0potential.\t\r \u00a0Adipocyte\t\r \u00a02012;\t\r \u00a01(1):13-\u00ad\u201024.\t\r \u00a0347\t\r \u00a0\t\r \u00a0\t\r \u00a0The\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 catecholaminergic\t\r \u00a0 pathway\t\r \u00a0 in\t\r \u00a0 heart\t\r \u00a0development:\t\r \u00a0beyond\t\r \u00a0neuromodulatory\t\r \u00a0actions\t\r \u00a0Catalina\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0Patricia\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo*\t\r \u00a03D\t\r \u00a0Lab\t\r \u00a0(Development,\t\r \u00a0Differentiation,\t\r \u00a0Degeneration).\t\r \u00a0Centro\t\r \u00a0de\t\r \u00a0Investigaciones\t\r \u00a0Biol\u00f3gicas,\t\r \u00a0Ramiro\t\r \u00a0de\t\r \u00a0Maeztu\t\r \u00a09,\t\r \u00a0Madrid\t\r \u00a028040.\t\r \u00a0Spain\t\r \u00a0*e-\u00ad\u2010mail:\t\r \u00a0fdepablo@cib.csic.es\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0347-\u00ad\u2010361.\t\r \u00a0ABSTRACT\t\r \u00a0Hormones\t\r \u00a0are\t\r \u00a0expressed\t\r \u00a0during\t\r \u00a0development\t\r \u00a0in\t\r \u00a0unexpected\t\r \u00a0locations\t\r \u00a0and\t\r \u00a0stages,\t\r \u00a0and\t\r \u00a0 this\t\r \u00a0 fact\t\r \u00a0 relates\t\r \u00a0 to\t\r \u00a0 their\t\r \u00a0 distinct\t\r \u00a0 functional\t\r \u00a0 roles\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 embryo.\t\r \u00a0In\t\r \u00a0 recent\t\r \u00a0work,\t\r \u00a0we\t\r \u00a0found\t\r \u00a0that\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0Tyrosine\t\r \u00a0Hydroxylase\t\r \u00a0(TH,\t\r \u00a0first\t\r \u00a0enzyme\t\r \u00a0of\t\r \u00a0the\t\r \u00a0 catecholamine\t\r \u00a0 synthetic\t\r \u00a0 pathway)\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 presence\t\r \u00a0 of\t\r \u00a0 catecholamines,\t\r \u00a0antecede\t\r \u00a0 neural\t\r \u00a0 innervation\t\r \u00a0 in\t\r \u00a0 some\t\r \u00a0 tissues.\t\r \u00a0 We\t\r \u00a0 focus\t\r \u00a0 this\t\r \u00a0 overview\t\r \u00a0 on\t\r \u00a0 the\t\r \u00a0vertebrate\t\r \u00a0developing\t\r \u00a0heart.\t\r \u00a0TH\t\r \u00a0transcripts\t\r \u00a0were\t\r \u00a0present\t\r \u00a0in\t\r \u00a0early\t\r \u00a0cardiogenesis,\t\r \u00a0and\t\r \u00a0 adrenergic\t\r \u00a0 as\t\r \u00a0 well\t\r \u00a0 as\t\r \u00a0 dopaminergic\t\r \u00a0 receptors\t\r \u00a0 were\t\r \u00a0 found\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 cardiac\t\r \u00a0region\t\r \u00a0 of\t\r \u00a0 chick\t\r \u00a0 embryos.\t\r \u00a0 We\t\r \u00a0 found\t\r \u00a0 direct\t\r \u00a0 effects\t\r \u00a0 of\t\r \u00a0 dopamine\t\r \u00a0 on\t\r \u00a0 cardiac\t\r \u00a0 gene\t\r \u00a0expression\t\r \u00a0and\t\r \u00a0we\t\r \u00a0have\t\r \u00a0advanced\t\r \u00a0in\t\r \u00a0revealing\t\r \u00a0the\t\r \u00a0function\t\r \u00a0of\t\r \u00a0catecholamines\t\r \u00a0on\t\r \u00a0cardiac\t\r \u00a0patterning.\t\r \u00a0Keywords:\t\r \u00a0tyroxine\t\r \u00a0hydroxylase;\t\r \u00a0catecholamines;\t\r \u00a0dopamine;\t\r \u00a0cardiogenesis.\t\r \u00a0RESUMEN\t\r \u00a0El\t\r \u00a0papel\t\r \u00a0de\t\r \u00a0las\t\r \u00a0catecolaminas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0del\t\r \u00a0coraz\u00f3n:\t\r \u00a0m\u00e1s\t\r \u00a0all\u00e1\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0acciones\t\r \u00a0neuromoduladoras\t\r \u00a0Las\t\r \u00a0hormonas\t\r \u00a0est\u00e1n\t\r \u00a0expresadas\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0en\t\r \u00a0etapas\t\r \u00a0y\t\r \u00a0localizaciones\t\r \u00a0\t\r \u00a0inesperadas\t\r \u00a0y\t\r \u00a0este\t\r \u00a0hecho\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0con\t\r \u00a0sus\t\r \u00a0distintas\t\r \u00a0funciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0embri\u00f3n.\t\r \u00a0Recientemente,\t\r \u00a0 hemos\t\r \u00a0 encontrado\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Tirosina\t\r \u00a0 Hidroxilasa\t\r \u00a0(TH,\t\r \u00a0el\t\r \u00a0primer\t\r \u00a0enzima\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ruta\t\r \u00a0de\t\r \u00a0s\u00edntesis\t\r \u00a0de\t\r \u00a0catecolaminas)\t\r \u00a0y\t\r \u00a0la\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0catecolaminas,\t\r \u00a0anteceden\t\r \u00a0a\t\r \u00a0la\t\r \u00a0inervaci\u00f3n\t\r \u00a0neural\t\r \u00a0en\t\r \u00a0algunos\t\r \u00a0tejidos.\t\r \u00a0Este\t\r \u00a0art\u00edculo\t\r \u00a0est\u00e1\t\r \u00a0centrado\t\r \u00a0en\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0del\t\r \u00a0coraz\u00f3n\t\r \u00a0de\t\r \u00a0vertebrados.\t\r \u00a0Los\t\r \u00a0transcritos\t\r \u00a0de\t\r \u00a0TH\t\r \u00a0se\t\r \u00a0 expresan\t\r \u00a0 durante\t\r \u00a0 la\t\r \u00a0 cardiog\u00e9nesis\t\r \u00a0 temprana\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 encontraron\t\r \u00a0 receptores\t\r \u00a0dopamin\u00e9rgicos\t\r \u00a0y\t\r \u00a0adren\u00e9rgicos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0cardiaca\t\r \u00a0del\t\r \u00a0embri\u00f3n\t\r \u00a0de\t\r \u00a0pollo.\t\r \u00a0Hemos\t\r \u00a0REVISI\u00d3N\t\r \u00a0\nC.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n348\t\r \u00a0\t\r \u00a0demostrado\t\r \u00a0 efectos\t\r \u00a0 directos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 dopamina\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 genes\t\r \u00a0cardiacos\t\r \u00a0 y\t\r \u00a0 hemos\t\r \u00a0 avanzado\t\r \u00a0 en\t\r \u00a0 caracterizar\t\r \u00a0 una\t\r \u00a0 funci\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 catecolaminas\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0del\t\r \u00a0patr\u00f3n\t\r \u00a0del\t\r \u00a0coraz\u00f3n.\t\r \u00a0Palabras\t\r \u00a0clave:\t\r \u00a0tirosina\t\r \u00a0hidroxilasa;\t\r \u00a0catecolaminas;\t\r \u00a0dopamina;\t\r \u00a0cardiog\u00e9nesis.\t\r \u00a01.\t\r \u00a0INTRODUCTION\t\r \u00a0Hormones\t\r \u00a0 and\t\r \u00a0 neurotransmitters\t\r \u00a0 synthesis\t\r \u00a0 localized,\t\r \u00a0 under\t\r \u00a0 traditional\t\r \u00a0views,\t\r \u00a0within\t\r \u00a0the\t\r \u00a0endocrine\t\r \u00a0and\t\r \u00a0nervous\t\r \u00a0systems,\t\r \u00a0respectively.\t\r \u00a0In\t\r \u00a0contrast,\t\r \u00a0others\t\r \u00a0and\t\r \u00a0we\t\r \u00a0have\t\r \u00a0found\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0hormones\t\r \u00a0much\t\r \u00a0earlier\t\r \u00a0in\t\r \u00a0development\t\r \u00a0than\t\r \u00a0the\t\r \u00a0emergence\t\r \u00a0of\t\r \u00a0the\t\r \u00a0endocrine\t\r \u00a0gland\t\r \u00a0especialized\t\r \u00a0in\t\r \u00a0their\t\r \u00a0secretion\t\r \u00a0takes\t\r \u00a0place.\t\r \u00a0For\t\r \u00a0example,\t\r \u00a0growth\t\r \u00a0hormone,\t\r \u00a0secreted\t\r \u00a0in\t\r \u00a0adult\t\r \u00a0organisms\t\r \u00a0by\t\r \u00a0the\t\r \u00a0pituitary\t\r \u00a0gland,\t\r \u00a0is\t\r \u00a0detected\t\r \u00a0in\t\r \u00a0the\t\r \u00a0blastocyst\t\r \u00a0and\t\r \u00a0many\t\r \u00a0extrapituitary\t\r \u00a0tissues\t\r \u00a0during\t\r \u00a0development\t\r \u00a0(1).\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figure\t\r \u00a0 1.\t\r \u00a0 The\t\r \u00a0 catecholamine\t\r \u00a0 biosynthesis\t\r \u00a0 pathway.\t\r \u00a0Note\t\r \u00a0 that\t\r \u00a0 TH\t\r \u00a0 is\t\r \u00a0 the\t\r \u00a0 rate-\u00ad\u2010limiting\t\r \u00a0 enzyme\t\r \u00a0and\t\r \u00a0 that\t\r \u00a0 in\t\r \u00a0 developing\t\r \u00a0tissues\t\r \u00a0 the\t\r \u00a0 pathway\t\r \u00a0 may\t\r \u00a0 not\t\r \u00a0 lead\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0 production\t\r \u00a0 of\t\r \u00a0 all\t\r \u00a0three\t\r \u00a0catecholamines.\t\r \u00a0\t\r \u00a0\nThe\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0349\t\r \u00a0\t\r \u00a0It\t\r \u00a0 appears\t\r \u00a0 that\t\r \u00a0 tissue\t\r \u00a0 GH\t\r \u00a0 may\t\r \u00a0 act\t\r \u00a0 in\t\r \u00a0 paracrine\t\r \u00a0 or\t\r \u00a0 autocrine\t\r \u00a0 fashion\t\r \u00a0 to\t\r \u00a0control\t\r \u00a0 proliferation\t\r \u00a0 and\t\r \u00a0 differentiation,\t\r \u00a0 although\t\r \u00a0 a\t\r \u00a0 full\t\r \u00a0 characterization\t\r \u00a0 is\t\r \u00a0 not\t\r \u00a0avalilable.\t\r \u00a0In\t\r \u00a0studies\t\r \u00a0carried\t\r \u00a0out\t\r \u00a0over\t\r \u00a0the\t\r \u00a0last\t\r \u00a0three\t\r \u00a0decades,\t\r \u00a0we\t\r \u00a0showed\t\r \u00a0that\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0 of\t\r \u00a0 proinsulin\t\r \u00a0 (molecular\t\r \u00a0 precursor\t\r \u00a0 form\t\r \u00a0 of\t\r \u00a0 insulin)\t\r \u00a0 antecedes\t\r \u00a0 the\t\r \u00a0development\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 pancreas\t\r \u00a0 (2,\t\r \u00a0 3)\t\r \u00a0 and\t\r \u00a0 it\t\r \u00a0 has\t\r \u00a0 a\t\r \u00a0 cell\t\r \u00a0 survival\t\r \u00a0 function\t\r \u00a0 in\t\r \u00a0the\t\r \u00a0developing\t\r \u00a0nervous\t\r \u00a0system\t\r \u00a0(4,\t\r \u00a05).\t\r \u00a0Proinsulin\t\r \u00a0expression\t\r \u00a0is\t\r \u00a0tightly\t\r \u00a0regulated\t\r \u00a0as\t\r \u00a0well\t\r \u00a0in\t\r \u00a0 the\t\r \u00a0 heart\t\r \u00a0 tube,\t\r \u00a0 and\t\r \u00a0 malformations\t\r \u00a0 are\t\r \u00a0 induced\t\r \u00a0 when\t\r \u00a0 proinsulin\t\r \u00a0 is\t\r \u00a0disproportionally\t\r \u00a0high\t\r \u00a0at\t\r \u00a0early\t\r \u00a0stages\t\r \u00a0(6).\t\r \u00a0Catecholamines\t\r \u00a0 are\t\r \u00a0 well\t\r \u00a0 known\t\r \u00a0 essential\t\r \u00a0 hormones/neurotransmitters\t\r \u00a0during\t\r \u00a0 postnatal\t\r \u00a0 life,\t\r \u00a0 when\t\r \u00a0 they\t\r \u00a0have\t\r \u00a0 cardiovascular,\t\r \u00a0 neuromuscular\t\r \u00a0 and\t\r \u00a0behavioral\t\r \u00a0 effects,\t\r \u00a0 but\t\r \u00a0 their\t\r \u00a0 function\t\r \u00a0 in\t\r \u00a0 specific\t\r \u00a0 organs\t\r \u00a0 during\t\r \u00a0 vertebrate\t\r \u00a0development\t\r \u00a0 is\t\r \u00a0 poorly\t\r \u00a0 characterized\t\r \u00a0 (7).\t\r \u00a0 The\t\r \u00a0 catecholamine\t\r \u00a0 synthetic\t\r \u00a0 pathway\t\r \u00a0(Figure\t\r \u00a01)\t\r \u00a0is\t\r \u00a0initiated\t\r \u00a0by\t\r \u00a0the\t\r \u00a0action\t\r \u00a0of\t\r \u00a0Tyrosine\t\r \u00a0Hydroxylase\t\r \u00a0(TH)\t\r \u00a0which\t\r \u00a0catalyses\t\r \u00a0the\t\r \u00a0 conversion\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 amino\t\r \u00a0 acid\t\r \u00a0 L-\u00ad\u2010tyrosine\t\r \u00a0 to\t\r \u00a0 L-\u00ad\u20103,4-\u00ad\u2010dihydroxyphenylalanine\t\r \u00a0 (L-\u00ad\u2010DOPA);\t\r \u00a0in\t\r \u00a0subsequent\t\r \u00a0reactions,\t\r \u00a0dopamine,\t\r \u00a0noradrenaline\t\r \u00a0and\t\r \u00a0adrenaline\t\r \u00a0may\t\r \u00a0be\t\r \u00a0produced.\t\r \u00a0 While\t\r \u00a0 we\t\r \u00a0 were\t\r \u00a0 studying\t\r \u00a0 proinsulin\t\r \u00a0 transcripts\t\r \u00a0 regulation\t\r \u00a0 in\t\r \u00a0development\t\r \u00a0we\t\r \u00a0found,\t\r \u00a0to\t\r \u00a0our\t\r \u00a0surprise,\t\r \u00a0non-\u00ad\u2010canonical\t\r \u00a0th-\u00ad\u2010insulin\t\r \u00a0chimeric\t\r \u00a0mRNA\t\r \u00a0transcripts\t\r \u00a0(8);\t\r \u00a0this\t\r \u00a0finding\t\r \u00a0motivated\t\r \u00a0further\t\r \u00a0work\t\r \u00a0on\t\r \u00a0the\t\r \u00a0presence\t\r \u00a0and\t\r \u00a0function\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0in\t\r \u00a0early\t\r \u00a0embryogenesis.\t\r \u00a02.\t\r \u00a0TYROXINE\t\r \u00a0 HYDROXYLASE,\t\r \u00a0 A\t\r \u00a0 GENE\t\r \u00a0 WITH\t\r \u00a0 COMPLEX\t\r \u00a0 TRANSCRIPTIONAL\t\r \u00a0REGULATION\t\r \u00a0As\t\r \u00a0commented\t\r \u00a0 above,\t\r \u00a0 genes/proteins\t\r \u00a0 have\t\r \u00a0 mechanisms\t\r \u00a0 of\t\r \u00a0 regulation\t\r \u00a0 and\t\r \u00a0functions\t\r \u00a0 at\t\r \u00a0 certain\t\r \u00a0 developmental\t\r \u00a0 stages\t\r \u00a0 of\t\r \u00a0 vertebrates\t\r \u00a0 distinct\t\r \u00a0 from\t\r \u00a0 their\t\r \u00a0canonical\t\r \u00a0roles\t\r \u00a0later\t\r \u00a0in\t\r \u00a0life.\t\r \u00a0In\t\r \u00a0this\t\r \u00a0context,\t\r \u00a0while\t\r \u00a0the\t\r \u00a0th\t\r \u00a0and\t\r \u00a0ins\t\r \u00a0genes\t\r \u00a0are\t\r \u00a0located\t\r \u00a0in\t\r \u00a0tandem\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 same\t\r \u00a0 orientation\t\r \u00a0 (and\t\r \u00a0 they\t\r \u00a0 are\t\r \u00a0 generally\t\r \u00a0 transcribed\t\r \u00a0independently),\t\r \u00a0 two\t\r \u00a0 chimeric\t\r \u00a0 transcripts\t\r \u00a0 containing\t\r \u00a0 exons\t\r \u00a0 from\t\r \u00a0 both\t\r \u00a0 of\t\r \u00a0 these\t\r \u00a0genes\t\r \u00a0 can\t\r \u00a0 also\t\r \u00a0 be\t\r \u00a0 produced\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0 regulated\t\r \u00a0 manner\t\r \u00a0 during\t\r \u00a0 the\t\r \u00a0 first\t\r \u00a0 few\t\r \u00a0 days\t\r \u00a0 of\t\r \u00a0development\t\r \u00a0in\t\r \u00a0the\t\r \u00a0chick\t\r \u00a0and\t\r \u00a0quail\t\r \u00a0embryos\t\r \u00a0(Figure\t\r \u00a02).\t\r \u00a0\t\r \u00a0It\t\r \u00a0 is\t\r \u00a0 estimated\t\r \u00a0 that\t\r \u00a0 between\t\r \u00a0 2\t\r \u00a0 and\t\r \u00a0 5%\t\r \u00a0 of\t\r \u00a0 tandem\t\r \u00a0 human\t\r \u00a0 genes\t\r \u00a0 may\t\r \u00a0 be\t\r \u00a0transcribed\t\r \u00a0 into\t\r \u00a0 chimeric\t\r \u00a0 mRNAs\t\r \u00a0 (9-\u00ad\u201011),\t\r \u00a0 although\t\r \u00a0 the\t\r \u00a0 function\t\r \u00a0 of\t\r \u00a0 these\t\r \u00a0 unusual\t\r \u00a0transcripts\t\r \u00a0is\t\r \u00a0in\t\r \u00a0general\t\r \u00a0unknown.\t\r \u00a0\t\r \u00a0C.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n350\t\r \u00a0\t\r \u00a0\t\r \u00a0Figure\t\r \u00a0 2.\t\r \u00a0 Novel\t\r \u00a0 forms\t\r \u00a0 of\t\r \u00a0 gene\t\r \u00a0 regulation\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0th-\u00ad\u2010ins\t\r \u00a0locus.\t\r \u00a0A)\t\r \u00a0The\t\r \u00a0schematic\t\r \u00a0genomic\t\r \u00a0organization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 chicken\t\r \u00a0th-\u00ad\u2010ins\t\r \u00a0locus\t\r \u00a0 (there\t\r \u00a0 is\t\r \u00a0 a\t\r \u00a0 similar\t\r \u00a0 cluster\t\r \u00a0 in\t\r \u00a0 mammals\t\r \u00a0 although\t\r \u00a0 the\t\r \u00a0transcriptional\t\r \u00a0regulation\t\r \u00a0may\t\r \u00a0be\t\r \u00a0different)\t\r \u00a0and\t\r \u00a0diagram\t\r \u00a0of\t\r \u00a0the\t\r \u00a0transcripts\t\r \u00a0generated\t\r \u00a0by\t\r \u00a0the\t\r \u00a0out-\u00ad\u2010of-\u00ad\u2010frame\t\r \u00a0splicing\t\r \u00a0between\t\r \u00a0th\t\r \u00a0exon\t\r \u00a013\t\r \u00a0and\t\r \u00a0exon\t\r \u00a02\t\r \u00a0or\t\r \u00a03\t\r \u00a0of\t\r \u00a0the\t\r \u00a0insulin\t\r \u00a0gene.\t\r \u00a0B)\t\r \u00a0TH\t\r \u00a0isoforms\t\r \u00a0generated\t\r \u00a0and\t\r \u00a0 their\t\r \u00a0 enzymatic\t\r \u00a0 activity\t\r \u00a0 was\t\r \u00a0 analyzed\t\r \u00a0 by\t\r \u00a0 HPLC\t\r \u00a0 for\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 production.\t\r \u00a0The\t\r \u00a0 extracts\t\r \u00a0 of\t\r \u00a0transfected\t\r \u00a0 HEK293T\t\r \u00a0 cells\t\r \u00a0 with\t\r \u00a0 these\t\r \u00a0 TH\t\r \u00a0 isoforms\t\r \u00a0 show\t\r \u00a0 a\t\r \u00a0 lower\t\r \u00a0 enzymatic\t\r \u00a0 activity\t\r \u00a0 than\t\r \u00a0 the\t\r \u00a0canonical\t\r \u00a0TH.\t\r \u00a0(Modified\t\r \u00a0from\t\r \u00a0[8])\t\r \u00a0\t\r \u00a0\nB\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0351\t\r \u00a0\t\r \u00a0\t\r \u00a0Figure\t\r \u00a0 3.\t\r \u00a0 The\t\r \u00a0 chick\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 human\t\r \u00a0 embryos\t\r \u00a0 at\t\r \u00a0 early\t\r \u00a0 stages\t\r \u00a0 of\t\r \u00a0 cardiogenesis.\t\r \u00a0The\t\r \u00a0 chick\t\r \u00a0embryo\t\r \u00a0reaches\t\r \u00a0the\t\r \u00a0stage\t\r \u00a015\t\r \u00a0([16])\t\r \u00a0at\t\r \u00a0~2.5\t\r \u00a0days\t\r \u00a0of\t\r \u00a0incubation.\t\r \u00a0The\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0is\t\r \u00a0already\t\r \u00a0turned\t\r \u00a0and\t\r \u00a0specified\t\r \u00a0in\t\r \u00a0auricular\t\r \u00a0and\t\r \u00a0ventricular\t\r \u00a0regions.\t\r \u00a0The\t\r \u00a0human\t\r \u00a0embryo\t\r \u00a0reaches\t\r \u00a0the\t\r \u00a0stage\t\r \u00a012\t\r \u00a0(Carnigie\t\r \u00a0classification,\t\r \u00a0http://php.med.unsw.edu.au/embryology/index.php?title=Carnegie_Stages)\t\r \u00a0at\t\r \u00a026-\u00ad\u201030\t\r \u00a0days\t\r \u00a0 of\t\r \u00a0 pregnancy.\t\r \u00a0 The\t\r \u00a0 heart\t\r \u00a0 prominence\t\r \u00a0 is\t\r \u00a0 indicated\t\r \u00a0 by\t\r \u00a0the\t\r \u00a0 arrow.\t\r \u00a0 Note\t\r \u00a0 the\t\r \u00a0 great\t\r \u00a0 similarity\t\r \u00a0 of\t\r \u00a0both\t\r \u00a0embryos\t\r \u00a0at\t\r \u00a0these\t\r \u00a0stages.\t\r \u00a0\t\r \u00a0The\t\r \u00a0chimeric\t\r \u00a0transcripts\t\r \u00a0containing\t\r \u00a0exons\t\r \u00a0from\t\r \u00a0th\t\r \u00a0and\t\r \u00a0ins\t\r \u00a0genes\t\r \u00a0give\t\r \u00a0rise\t\r \u00a0to\t\r \u00a0two\t\r \u00a0 novel\t\r \u00a0 isoforms\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 TH\t\r \u00a0 protein\t\r \u00a0 (TH-\u00ad\u2010INS1\t\r \u00a0 and\t\r \u00a0 2)\t\r \u00a0 with\t\r \u00a0 markedly\t\r \u00a0 reduced\t\r \u00a0functionality,\t\r \u00a0 when\t\r \u00a0 compared\t\r \u00a0 to\t\r \u00a0the\t\r \u00a0 canonical\t\r \u00a0 TH.\t\r \u00a0 The\t\r \u00a0 levels\t\r \u00a0 of\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 in\t\r \u00a0 cells\t\r \u00a0expressing\t\r \u00a0 TH-\u00ad\u2010INS1\t\r \u00a0 are\t\r \u00a0 approximately\t\r \u00a0 5-\u00ad\u2010fold\t\r \u00a0 lower\t\r \u00a0 than\t\r \u00a0 those\t\r \u00a0 found\t\r \u00a0 in\t\r \u00a0 cells\t\r \u00a0expressing\t\r \u00a0similar\t\r \u00a0or\t\r \u00a0lower\t\r \u00a0amounts\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0protein\t\r \u00a0(Figure\t\r \u00a02).\t\r \u00a0\t\r \u00a0In\t\r \u00a0addition,\t\r \u00a0the\t\r \u00a0TH-\u00ad\u2010\nC.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n352\t\r \u00a0\t\r \u00a0INS1\t\r \u00a0 chimeric\t\r \u00a0 mRNA\t\r \u00a0 also\t\r \u00a0 generates\t\r \u00a0 a\t\r \u00a0 small\t\r \u00a0 amount\t\r \u00a0of\t\r \u00a0 insulin\t\r \u00a0 (8).\t\r \u00a0 Besides\t\r \u00a0 this\t\r \u00a0unusual\t\r \u00a0 post-\u00ad\u2010transcriptional\t\r \u00a0 regulation,\t\r \u00a0 the\t\r \u00a0 th\t\r \u00a0 gene\t\r \u00a0 displays\t\r \u00a0 an\t\r \u00a0 unexpected\t\r \u00a0expression\t\r \u00a0pattern.\t\r \u00a0We\t\r \u00a0 found\t\r \u00a0 that\t\r \u00a0 the\t\r \u00a0 expression\t\r \u00a0 of\t\r \u00a0 th\t\r \u00a0 mRNA\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 chick\t\r \u00a0 embryo\t\r \u00a0 antecedes\t\r \u00a0development\t\r \u00a0of\t\r \u00a0the\t\r \u00a0nervous\t\r \u00a0system.\t\r \u00a0th\t\r \u00a0transcripts\t\r \u00a0were\t\r \u00a0detected\t\r \u00a0from\t\r \u00a0gastrulation\t\r \u00a0onwards,\t\r \u00a0 and\t\r \u00a0 they\t\r \u00a0 were\t\r \u00a0 enriched\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 cardiogenic\t\r \u00a0 region.\t\r \u00a0 Before\t\r \u00a0 focusing\t\r \u00a0 this\t\r \u00a0overview\t\r \u00a0in\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0TH\t\r \u00a0during\t\r \u00a0cardiogenesis,\t\r \u00a0it\t\r \u00a0is\t\r \u00a0worth\t\r \u00a0however\t\r \u00a0to\t\r \u00a0emphasize\t\r \u00a0the\t\r \u00a0 remarkably\t\r \u00a0 similar\t\r \u00a0 features\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 human\t\r \u00a0 embryo\t\r \u00a0 and\t\r \u00a0 a\t\r \u00a0 chick\t\r \u00a0 embryo\t\r \u00a0 during\t\r \u00a0that\t\r \u00a0period\t\r \u00a0(Figure\t\r \u00a03).\t\r \u00a0In\t\r \u00a0vertebrates,\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0is\t\r \u00a0initially\t\r \u00a0formed\t\r \u00a0by\t\r \u00a0the\t\r \u00a0fusion\t\r \u00a0of\t\r \u00a0the\t\r \u00a0 two\t\r \u00a0 bilateral\t\r \u00a0 endocardial\t\r \u00a0 tubes\t\r \u00a0 arising\t\r \u00a0 from\t\r \u00a0 the\t\r \u00a0 splanchnic\t\r \u00a0 lateral\t\r \u00a0 plate\t\r \u00a0mesoderm.\t\r \u00a0The\t\r \u00a0resultant\t\r \u00a0primitive\t\r \u00a0heart\t\r \u00a0tube,\t\r \u00a0located\t\r \u00a0at\t\r \u00a0the\t\r \u00a0ventral\t\r \u00a0midline\t\r \u00a0of\t\r \u00a0the\t\r \u00a0organism,\t\r \u00a0undergoes\t\r \u00a0a\t\r \u00a0complex\t\r \u00a0series\t\r \u00a0of\t\r \u00a0movements\t\r \u00a0and\t\r \u00a0tissue\t\r \u00a0remodeling\t\r \u00a0events\t\r \u00a0that\t\r \u00a0leads\t\r \u00a0to\t\r \u00a0the\t\r \u00a0formation\t\r \u00a0of\t\r \u00a0the\t\r \u00a0mature\t\r \u00a0chambered\t\r \u00a0organ\t\r \u00a0(12).\t\r \u00a0\t\r \u00a03.\t\r \u00a0USE\t\r \u00a0OF\t\r \u00a0THE\t\r \u00a0CHICK\t\r \u00a0EMBRYO\t\r \u00a0AS\t\r \u00a0A\t\r \u00a0MODEL\t\r \u00a0FOR\t\r \u00a0STUDYING\t\r \u00a0THE\t\r \u00a0ROLE\t\r \u00a0OF\t\r \u00a0TH\t\r \u00a0IN\t\r \u00a0CARDIOGENESIS\t\r \u00a0As\t\r \u00a0very\t\r \u00a0clearly\t\r \u00a0stated\t\r \u00a0by\t\r \u00a0Brand\t\r \u00a0(in\t\r \u00a0a\t\r \u00a0kind\t\r \u00a0editorial\t\r \u00a0comment\t\r \u00a0of\t\r \u00a0our\t\r \u00a0work,\t\r \u00a013),\t\r \u00a0\u201cdespite\t\r \u00a0its\t\r \u00a0evolutionary\t\r \u00a0distance\t\r \u00a0to\t\r \u00a0mammals,\t\r \u00a0the\t\r \u00a0chick\t\r \u00a0embryo\t\r \u00a0is\t\r \u00a0a\t\r \u00a0valuable\t\r \u00a0model\t\r \u00a0to\t\r \u00a0work\t\r \u00a0out\t\r \u00a0the\t\r \u00a0mechanism\t\r \u00a0of\t\r \u00a0cardiac\t\r \u00a0specification.\t\r \u00a0The\t\r \u00a0embryo\t\r \u00a0is\t\r \u00a0large\t\r \u00a0and\t\r \u00a0accessible\t\r \u00a0 and,\t\r \u00a0 therefore,\t\r \u00a0 manipulations\t\r \u00a0 at\t\r \u00a0 the\t\r \u00a0 time\t\r \u00a0of\t\r \u00a0 cardiac\t\r \u00a0 specification\t\r \u00a0 and\t\r \u00a0early\t\r \u00a0 heart\t\r \u00a0 formation\t\r \u00a0 are\t\r \u00a0 easily\t\r \u00a0 performed\u201d.\t\r \u00a0 Research\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 last\t\r \u00a0 two\t\r \u00a0 decades\t\r \u00a0utilizing\t\r \u00a0 this\t\r \u00a0 model\t\r \u00a0 organism\t\r \u00a0 has\t\r \u00a0 identified\t\r \u00a0 several\t\r \u00a0 signaling\t\r \u00a0 molecules\t\r \u00a0 that\t\r \u00a0 are\t\r \u00a0important\t\r \u00a0for\t\r \u00a0cardiac\t\r \u00a0induction\t\r \u00a0(14).\t\r \u00a0\t\r \u00a0The\t\r \u00a0 fact\t\r \u00a0 that\t\r \u00a0 the\t\r \u00a0 chick\t\r \u00a0 embryo\t\r \u00a0 can\t\r \u00a0 be\t\r \u00a0 accessed\t\r \u00a0 and\t\r \u00a0 manipulated\t\r \u00a0 without\t\r \u00a0disrupting\t\r \u00a0early\t\r \u00a0development,\t\r \u00a0allows\t\r \u00a0to\t\r \u00a0perform\t\r \u00a0experiments\t\r \u00a0of\t\r \u00a0gain\t\r \u00a0of\t\r \u00a0function\t\r \u00a0and\t\r \u00a0 loss\t\r \u00a0 of\t\r \u00a0 function\t\r \u00a0 starting\t\r \u00a0 during\t\r \u00a0 gastrulation,\t\r \u00a0 and\t\r \u00a0 to\t\r \u00a0 analyze\t\r \u00a0 the\t\r \u00a0 effects\t\r \u00a0 on\t\r \u00a0embryonic\t\r \u00a0 organogenesis\t\r \u00a0 (Figure\t\r \u00a0 4).\t\r \u00a0 Factors\t\r \u00a0 or\t\r \u00a0 antibodies\t\r \u00a0 may\t\r \u00a0 be\t\r \u00a0 added\t\r \u00a0 and,\t\r \u00a0 if\t\r \u00a0the\t\r \u00a0aim\t\r \u00a0is\t\r \u00a0to\t\r \u00a0look\t\r \u00a0for\t\r \u00a0effects\t\r \u00a0over\t\r \u00a0the\t\r \u00a0next\t\r \u00a0several\t\r \u00a0days,\t\r \u00a0the\t\r \u00a0embryo\t\r \u00a0can\t\r \u00a0be\t\r \u00a0reached\t\r \u00a0through\t\r \u00a0a\t\r \u00a0window\t\r \u00a0in\t\r \u00a0the\t\r \u00a0shell\t\r \u00a0and\t\r \u00a0incubation\t\r \u00a0can\t\r \u00a0continue.\t\r \u00a0To\t\r \u00a0look\t\r \u00a0for\t\r \u00a0short-\u00ad\u2010term\t\r \u00a0effects,\t\r \u00a0 as\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 series\t\r \u00a0 of\t\r \u00a0 studies\t\r \u00a0 reviewed\t\r \u00a0 here,\t\r \u00a0 the\t\r \u00a0 addition\t\r \u00a0 of\t\r \u00a0 molecules\t\r \u00a0 or\t\r \u00a0plasmid\t\r \u00a0 DNA\t\r \u00a0 was\t\r \u00a0 carried\t\r \u00a0 out\t\r \u00a0 maintaining\t\r \u00a0 the\t\r \u00a0 embryo\t\r \u00a0 in\t\r \u00a0 culture\t\r \u00a0 under\t\r \u00a0 specific\t\r \u00a0tension\t\r \u00a0 conditions\t\r \u00a0 (15).\t\r \u00a0 \t\r \u00a0The\t\r \u00a0 chick\t\r \u00a0 embryos\t\r \u00a0 were\t\r \u00a0 treated\t\r \u00a0 at\t\r \u00a0 stages\t\r \u00a0 3-\u00ad\u20105\t\r \u00a0 (12-\u00ad\u201022\t\r \u00a0hours\t\r \u00a0 of\t\r \u00a0 development,\t\r \u00a0 according\t\r \u00a0 to\t\r \u00a0 Hamburger\t\r \u00a0 and\t\r \u00a0 Hamilton\t\r \u00a0 (16)\t\r \u00a0 and\t\r \u00a0 were\t\r \u00a0studied\t\r \u00a0at\t\r \u00a0 stages\t\r \u00a0 11-\u00ad\u201012\t\r \u00a0 (less\t\r \u00a0 than\t\r \u00a0 50\t\r \u00a0 hours\t\r \u00a0 of\t\r \u00a0 development).\t\r \u00a0 The\t\r \u00a0 addition\t\r \u00a0 of\t\r \u00a0dopamine\t\r \u00a0or\t\r \u00a0enzymatic\t\r \u00a0inhibitors\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0activity\t\r \u00a0could\t\r \u00a0be\t\r \u00a0carried\t\r \u00a0out\t\r \u00a0using\t\r \u00a0heparin\t\r \u00a0or\t\r \u00a0resin\t\r \u00a0microbeads,\t\r \u00a0implanted\t\r \u00a0in\t\r \u00a0the\t\r \u00a0embryo\t\r \u00a0underneath\t\r \u00a0the\t\r \u00a0epiblast\t\r \u00a0(Figure\t\r \u00a04B).\t\r \u00a0The\t\r \u00a0 uptake\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 embryo\t\r \u00a0 tissues\t\r \u00a0 of\t\r \u00a0 plasmid\t\r \u00a0 DNA\t\r \u00a0 containing\t\r \u00a0 TH,\t\r \u00a0 GFP\t\r \u00a0 (Green\t\r \u00a0Fluorescence\t\r \u00a0 Protein)\t\r \u00a0 or\t\r \u00a0 TH\t\r \u00a0 antisense-\u00ad\u2010morpholino\t\r \u00a0 DNA\t\r \u00a0 was\t\r \u00a0 facilitated\t\r \u00a0 by\t\r \u00a0electroporation\t\r \u00a0(Figure\t\r \u00a04C).\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0353\t\r \u00a0\t\r \u00a0\t\r \u00a0Figure\t\r \u00a0 4.\t\r \u00a0 \t\r \u00a0 Techniques\t\r \u00a0 to\t\r \u00a0 manipulate\t\r \u00a0 gene\t\r \u00a0 expression\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 chick\t\r \u00a0 embryo:\t\r \u00a0 implanted\t\r \u00a0microbeads\t\r \u00a0and\t\r \u00a0electroporation.\t\r \u00a0A)\t\r \u00a0The\t\r \u00a0stage\t\r \u00a03-\u00ad\u20105\t\r \u00a0blastoderm\t\r \u00a0can\t\r \u00a0be\t\r \u00a0accessed\t\r \u00a0in\t\r \u00a0ovo\t\r \u00a0and\t\r \u00a0B)\t\r \u00a0a\t\r \u00a0factor-\u00ad\u2010coated\t\r \u00a0microbead\t\r \u00a0(yellow\t\r \u00a0circle)\t\r \u00a0can\t\r \u00a0be\t\r \u00a0implanted\t\r \u00a0at\t\r \u00a0the\t\r \u00a0desired\t\r \u00a0location\t\r \u00a0lateral\t\r \u00a0to\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0field\t\r \u00a0of\t\r \u00a0one\t\r \u00a0side\t\r \u00a0(blue\t\r \u00a0square).\t\r \u00a0After\t\r \u00a06-\u00ad\u201018\t\r \u00a0h\t\r \u00a0of\t\r \u00a0further\t\r \u00a0incubation\t\r \u00a0the\t\r \u00a0embryo\t\r \u00a0can\t\r \u00a0be\t\r \u00a0retrieved\t\r \u00a0and\t\r \u00a0processed\t\r \u00a0 for\t\r \u00a0 RNA\t\r \u00a0 or\t\r \u00a0 protein\t\r \u00a0 detection.\t\r \u00a0C)\t\r \u00a0 The\t\r \u00a0 blastoderm\t\r \u00a0 can\t\r \u00a0 also\t\r \u00a0 be\t\r \u00a0 placed\t\r \u00a0 in\t\r \u00a0 culture\t\r \u00a0 and\t\r \u00a0injected\t\r \u00a0and\t\r \u00a0electroporated\t\r \u00a0with\t\r \u00a0DNA\t\r \u00a0constructs,\t\r \u00a0such\t\r \u00a0as\t\r \u00a0that\t\r \u00a0shown\t\r \u00a0in\t\r \u00a0schematic\t\r \u00a0form,\t\r \u00a0in\t\r \u00a0which\t\r \u00a0the\t\r \u00a0 sequences\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 green\t\r \u00a0 fluorescence\t\r \u00a0protein\t\r \u00a0 (GFP)\t\r \u00a0 are\t\r \u00a0 linked\t\r \u00a0 by\t\r \u00a0 an\t\r \u00a0 IRES\t\r \u00a0 (Internal\t\r \u00a0Ribosome\t\r \u00a0 Entry\t\r \u00a0 Site).\t\r \u00a0 After\t\r \u00a0 18-\u00ad\u201036\t\r \u00a0 h\t\r \u00a0 of\t\r \u00a0 additional\t\r \u00a0 incubation,\t\r \u00a0 embryos\t\r \u00a0 can\t\r \u00a0 be\t\r \u00a0 collected\t\r \u00a0 and\t\r \u00a0processed.\t\r \u00a0\t\r \u00a0\nC.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n354\t\r \u00a0\t\r \u00a0TH\t\r \u00a0as\t\r \u00a0well\t\r \u00a0as\t\r \u00a0adrenergic\t\r \u00a0and\t\r \u00a0dopaminergic\t\r \u00a0receptors\t\r \u00a0are\t\r \u00a0expressed\t\r \u00a0in\t\r \u00a0the\t\r \u00a0chick\t\r \u00a0embryo\t\r \u00a0developing\t\r \u00a0heart.\t\r \u00a0\t\r \u00a0We\t\r \u00a0have\t\r \u00a0found\t\r \u00a0that\t\r \u00a0th\t\r \u00a0mRNA\t\r \u00a0expression\t\r \u00a0is\t\r \u00a0enriched\t\r \u00a0in\t\r \u00a0the\t\r \u00a0cardiac\t\r \u00a0field\t\r \u00a0of\t\r \u00a0gastrulating\t\r \u00a0 chick\t\r \u00a0 embryos.\t\r \u00a0 By\t\r \u00a0 stages\t\r \u00a0 8-\u00ad\u201010,\t\r \u00a0 it\t\r \u00a0 was\t\r \u00a0 restricted\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0 splanchnic\t\r \u00a0mesoderm\t\r \u00a0 of\t\r \u00a0 both\t\r \u00a0 endocardial\t\r \u00a0 tubes\t\r \u00a0 and\t\r \u00a0 was\t\r \u00a0 subsequently\t\r \u00a0 (stages\t\r \u00a0 11-\u00ad\u201012)\t\r \u00a0expressed\t\r \u00a0predominantly\t\r \u00a0in\t\r \u00a0the\t\r \u00a0myocardial\t\r \u00a0layer\t\r \u00a0of\t\r \u00a0the\t\r \u00a0atrial\t\r \u00a0segment\t\r \u00a0(Figure\t\r \u00a05,\t\r \u00a0(13)).\t\r \u00a0The\t\r \u00a0levels\t\r \u00a0of\t\r \u00a0th\t\r \u00a0mRNA\t\r \u00a0in\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0increased\t\r \u00a0several\t\r \u00a0fold\t\r \u00a0between\t\r \u00a0stage\t\r \u00a08\t\r \u00a0and\t\r \u00a0stage\t\r \u00a012\t\r \u00a0(Figure\t\r \u00a05).\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figure\t\r \u00a05.\t\r \u00a0Tyrosine\t\r \u00a0hydroxylase\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0the\t\r \u00a0chick\t\r \u00a0embryonic\t\r \u00a0heart.\t\r \u00a0In\t\r \u00a0the\t\r \u00a0upper\t\r \u00a0panel,\t\r \u00a0whole\t\r \u00a0mount\t\r \u00a0in\t\r \u00a0situ\t\r \u00a0hybridization\t\r \u00a0for\t\r \u00a0stages\t\r \u00a010\t\r \u00a0to\t\r \u00a012\t\r \u00a0are\t\r \u00a0shown.\t\r \u00a0Note\t\r \u00a0the\t\r \u00a0restricted\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0tube.\t\r \u00a0 In\t\r \u00a0 the\t\r \u00a0 lower\t\r \u00a0 panel\t\r \u00a0 RT-\u00ad\u2010PCR\t\r \u00a0 of\t\r \u00a0th\t\r \u00a0mRNA\t\r \u00a0 expression\t\r \u00a0 is\t\r \u00a0 shown\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 developing\t\r \u00a0endocardial\t\r \u00a0tube\t\r \u00a0(stage\t\r \u00a08)\t\r \u00a0and\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0(stages\t\r \u00a010\t\r \u00a0and\t\r \u00a012)\t\r \u00a0and\t\r \u00a0postnatal\t\r \u00a0day\t\r \u00a010\t\r \u00a0(P10)\t\r \u00a0heart.\t\r \u00a0An\t\r \u00a0internal\t\r \u00a0control\t\r \u00a0with\t\r \u00a0GAPDH\t\r \u00a0is\t\r \u00a0shown\t\r \u00a0below.\t\r \u00a0(Modified\t\r \u00a0from\t\r \u00a0[13]).\t\r \u00a0\nThe\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0355\t\r \u00a0\t\r \u00a0\t\r \u00a0Figure\t\r \u00a0 6.\t\r \u00a0 Expression\t\r \u00a0 of\t\r \u00a0 receptors\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 chick\t\r \u00a0 embryonic\t\r \u00a0 heart\t\r \u00a0regions.\t\r \u00a0A)\t\r \u00a0 Analysis\t\r \u00a0 of\t\r \u00a0adrenergic\t\r \u00a0receptors\t\r \u00a0(\u03b1-\u00ad\u20101b,\t\r \u00a0\u03b1-\u00ad\u20101d\t\r \u00a0and\t\r \u00a0\u03b1-\u00ad\u20102c\t\r \u00a0;\t\r \u00a0\u03b2-\u00ad\u20101\t\r \u00a0and\t\r \u00a0\u03b2-\u00ad\u20102)\t\r \u00a0expression\t\r \u00a0by\t\r \u00a0RT-\u00ad\u2010PCR\t\r \u00a0of\t\r \u00a0mRNA\t\r \u00a0from\t\r \u00a0the\t\r \u00a0precardiogenic\t\r \u00a0 area\t\r \u00a0 (stage\t\r \u00a05),\t\r \u00a0 endocardial\t\r \u00a0 tubes\t\r \u00a0 (stage\t\r \u00a08)\t\r \u00a0 or\t\r \u00a0 heart\t\r \u00a0 tube\t\r \u00a0 (stage\t\r \u00a010).\t\r \u00a0An\t\r \u00a0internal\t\r \u00a0control\t\r \u00a0 with\t\r \u00a0GAPDH\t\r \u00a0is\t\r \u00a0 shown\t\r \u00a0 below.\t\r \u00a0B)\t\r \u00a0 Analysis\t\r \u00a0 of\t\r \u00a0 dopaminergic\t\r \u00a0 receptors\t\r \u00a0 (D1,\t\r \u00a0 D3\t\r \u00a0 and\t\r \u00a0 D5)\t\r \u00a0expression\t\r \u00a0by\t\r \u00a0quantitative\t\r \u00a0PCR\t\r \u00a0of\t\r \u00a0mRNA\t\r \u00a0from\t\r \u00a0stage\t\r \u00a010\t\r \u00a0and\t\r \u00a012\t\r \u00a0heart\t\r \u00a0tubes.\t\r \u00a0The\t\r \u00a0levels\t\r \u00a0of\t\r \u00a0dopamine\t\r \u00a0receptor\t\r \u00a0transcripts\t\r \u00a0were\t\r \u00a0normalized\t\r \u00a0relative\t\r \u00a0to\t\r \u00a0GAPDH\t\r \u00a0mRNA\t\r \u00a0levels.\t\r \u00a0Primers\t\r \u00a0are\t\r \u00a0shown\t\r \u00a0in\t\r \u00a0Tables\t\r \u00a01\t\r \u00a0and\t\r \u00a02.\t\r \u00a0\nC.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n356\t\r \u00a0\t\r \u00a0We\t\r \u00a0 set\t\r \u00a0 out,\t\r \u00a0 then,\t\r \u00a0 to\t\r \u00a0 demonstrate\t\r \u00a0 the\t\r \u00a0 presence\t\r \u00a0 of\t\r \u00a0 receptors\t\r \u00a0 which\t\r \u00a0 may\t\r \u00a0mediate\t\r \u00a0the\t\r \u00a0action\t\r \u00a0of\t\r \u00a0catecholamines,\t\r \u00a0likely\t\r \u00a0produced\t\r \u00a0by\t\r \u00a0the\t\r \u00a0cardiomyocytes\t\r \u00a0of\t\r \u00a0the\t\r \u00a0primitive\t\r \u00a0 heart\t\r \u00a0 tube.\t\r \u00a0 Adrenergic\t\r \u00a0 and\t\r \u00a0 dopaminergic\t\r \u00a0 receptors\t\r \u00a0 are\t\r \u00a0 7-\u00ad\u2010transmembrane\t\r \u00a0 domain\t\r \u00a0 G\t\r \u00a0 protein-\u00ad\u2010coupled\t\r \u00a0 receptors.\t\r \u00a0 The\t\r \u00a0 family\t\r \u00a0 of\t\r \u00a0 adrenergic\t\r \u00a0receptors\t\r \u00a0are\t\r \u00a0composed\t\r \u00a0by\t\r \u00a0\u03b1-\u00ad\u2010\t\r \u00a0and\t\r \u00a0\u03b2-\u00ad\u2010receptors.\t\r \u00a0There\t\r \u00a0are\t\r \u00a0two\t\r \u00a0types\t\r \u00a0of\t\r \u00a0\u03b1-\u00ad\u2010receptors:\t\r \u00a0The\t\r \u00a0stimulation\t\r \u00a0of\t\r \u00a0\t\r \u00a0\u03b1-\u00ad\u20101-\u00ad\u2010receptors\t\r \u00a0\t\r \u00a0(\u03b1-\u00ad\u20101a,\t\r \u00a0\u03b1-\u00ad\u20101b\t\r \u00a0and\t\r \u00a0\u03b1-\u00ad\u20101d\t\r \u00a0subtypes)\t\r \u00a0activates\t\r \u00a0the\t\r \u00a0G\u03b1q\t\r \u00a0subunit\t\r \u00a0of\t\r \u00a0G\t\r \u00a0proteins\t\r \u00a0and,\t\r \u00a0therefore,\t\r \u00a0Phospholipase\t\r \u00a0C\t\r \u00a0is\t\r \u00a0activated.\t\r \u00a0In\t\r \u00a0contrast,\t\r \u00a0the\t\r \u00a0\u03b1-\u00ad\u20102-\u00ad\u2010receptors\t\r \u00a0 (\u03b1-\u00ad\u20102a,\t\r \u00a0\u03b1-\u00ad\u20102b,\t\r \u00a0 and\t\r \u00a0 \u03b1-\u00ad\u20102c\t\r \u00a0 subtypes)\t\r \u00a0 are\t\r \u00a0 coupled\t\r \u00a0 to\t\r \u00a0 G\u03b1i/o\t\r \u00a0 subunit\t\r \u00a0 and,\t\r \u00a0therefore,\t\r \u00a0 inactivate\t\r \u00a0 adenyl\t\r \u00a0 cyclase\t\r \u00a0 (AC).\t\r \u00a0 In\t\r \u00a0 contrast,\t\r \u00a0 the\t\r \u00a0 \u03b2-\u00ad\u2010adrenergic-\u00ad\u2010receptors\t\r \u00a0family\t\r \u00a0includes\t\r \u00a0three\t\r \u00a0subtypes:\t\r \u00a0\u03b2-\u00ad\u20101,\t\r \u00a0\u03b2-\u00ad\u20102,\t\r \u00a0\u03b2-\u00ad\u20103,\t\r \u00a0which\t\r \u00a0activate\t\r \u00a0the\t\r \u00a0subunit\t\r \u00a0G\u03b1s\t\r \u00a0and\t\r \u00a0subsequently\t\r \u00a0increase\t\r \u00a0the\t\r \u00a0intracellular\t\r \u00a0cAMP\t\r \u00a0levels.\t\r \u00a0However,\t\r \u00a0the\t\r \u00a0\u03b2-\u00ad\u20102\t\r \u00a0adrenergic\t\r \u00a0receptors\t\r \u00a0may\t\r \u00a0activate\t\r \u00a0the\t\r \u00a0G\u03b1i\t\r \u00a0and\t\r \u00a0G\u03b2\u03b3\t\r \u00a0subunits\t\r \u00a0of\t\r \u00a0G\t\r \u00a0protein\t\r \u00a0in\t\r \u00a0some\t\r \u00a0cases.\t\r \u00a0The\t\r \u00a0 dopaminergic\t\r \u00a0 receptors\t\r \u00a0 are\t\r \u00a0 clasified\t\r \u00a0 into\t\r \u00a0 two\t\r \u00a0 subfamilies.\t\r \u00a0 The\t\r \u00a0 D1-\u00ad\u2010receptors\t\r \u00a0 (D1,\t\r \u00a0 D5)\t\r \u00a0 are\t\r \u00a0 coupled\t\r \u00a0 to\t\r \u00a0 G\u03b1s\t\r \u00a0 proteins\t\r \u00a0 and\t\r \u00a0 their\t\r \u00a0 activation\t\r \u00a0 leads\t\r \u00a0 to\t\r \u00a0estimulation\t\r \u00a0of\t\r \u00a0AC\t\r \u00a0and\t\r \u00a0subsequent\t\r \u00a0increase\t\r \u00a0in\t\r \u00a0cAMP\t\r \u00a0levels.\t\r \u00a0On\t\r \u00a0the\t\r \u00a0contrary,\t\r \u00a0the\t\r \u00a0D2-\u00ad\u2010receptors\t\r \u00a0(D2,\t\r \u00a0D3,\t\r \u00a0D4)\t\r \u00a0are\t\r \u00a0coupled\t\r \u00a0to\t\r \u00a0G\u03b1i\t\r \u00a0proteins\t\r \u00a0and\t\r \u00a0their\t\r \u00a0activation\t\r \u00a0leads\t\r \u00a0to\t\r \u00a0inhibition\t\r \u00a0of\t\r \u00a0AC\t\r \u00a0and\t\r \u00a0decrease\t\r \u00a0of\t\r \u00a0cAMP\t\r \u00a0levels.\t\r \u00a0Members\t\r \u00a0of\t\r \u00a0the\t\r \u00a0D1\t\r \u00a0and\t\r \u00a0D2\t\r \u00a0receptors\t\r \u00a0can\t\r \u00a0form\t\r \u00a0heterodimers\t\r \u00a0that\t\r \u00a0are\t\r \u00a0coupled\t\r \u00a0to\t\r \u00a0G\u03b1q\t\r \u00a0proteins\t\r \u00a0and\t\r \u00a0their\t\r \u00a0activation\t\r \u00a0leads\t\r \u00a0to\t\r \u00a0stimulation\t\r \u00a0of\t\r \u00a0phospholipase\t\r \u00a0C\t\r \u00a0and\t\r \u00a0intracellular\t\r \u00a0calcium\t\r \u00a0release.\t\r \u00a0\t\r \u00a0Our\t\r \u00a0preliminary\t\r \u00a0studies\t\r \u00a0showed\t\r \u00a0the\t\r \u00a0presence\t\r \u00a0of\t\r \u00a0adrenergic\t\r \u00a0(both\t\r \u00a0\u03b1\t\r \u00a0and\t\r \u00a0\u03b2\t\r \u00a0types)\t\r \u00a0 and\t\r \u00a0 dopaminergic\t\r \u00a0 receptors\t\r \u00a0 (D1\t\r \u00a0 and\t\r \u00a0 D2\t\r \u00a0 subfamilies)\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 heart\t\r \u00a0 tube\t\r \u00a0(Figure\t\r \u00a0 6)\t\r \u00a0 suggesting\t\r \u00a0 that\t\r \u00a0 catecholamines\t\r \u00a0 \t\r \u00a0 have\t\r \u00a0 the\t\r \u00a0 possibility\t\r \u00a0 to\t\r \u00a0 act\t\r \u00a0 through\t\r \u00a0them.\t\r \u00a0 Further\t\r \u00a0 studies\t\r \u00a0 are\t\r \u00a0 needed\t\r \u00a0 to\t\r \u00a0 confirm\t\r \u00a0 the\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 specific\t\r \u00a0 receptor\t\r \u00a0subtypes\t\r \u00a0and\t\r \u00a0signaling\t\r \u00a0pathways\t\r \u00a0in\t\r \u00a0cardiogenesis.\t\r \u00a04.\t\r \u00a0L-\u00ad\u2010DOPA\t\r \u00a0AND\t\r \u00a0DOPAMINE\t\r \u00a0INDUCE\t\r \u00a0CARDIAC\t\r \u00a0DIFFERENTIATION\t\r \u00a0Differentiation\t\r \u00a0 of\t\r \u00a0 contracting\t\r \u00a0 cardiomyocyte\t\r \u00a0 requires\t\r \u00a0 the\t\r \u00a0 action\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0combination\t\r \u00a0of\t\r \u00a0transcription\t\r \u00a0factors,\t\r \u00a0including\t\r \u00a0Nkx2.5\t\r \u00a0and\t\r \u00a0Tbx5\t\r \u00a0(17).\t\r \u00a0The\t\r \u00a0pattern\t\r \u00a0of\t\r \u00a0 th\t\r \u00a0 expression\t\r \u00a0 suggested\t\r \u00a0 that\t\r \u00a0 catecholamines\t\r \u00a0 may\t\r \u00a0 play\t\r \u00a0 a\t\r \u00a0 role\t\r \u00a0 in\t\r \u00a0 cardiac\t\r \u00a0development.\t\r \u00a0Implanting\t\r \u00a0microbeads\t\r \u00a0soaked\t\r \u00a0in\t\r \u00a0L-\u00ad\u2010DOPA\t\r \u00a0and\t\r \u00a0dopamine,\t\r \u00a0laterally\t\r \u00a0to\t\r \u00a0one\t\r \u00a0of\t\r \u00a0the\t\r \u00a0bilateral\t\r \u00a0heart\t\r \u00a0fields\t\r \u00a0in\t\r \u00a0cultured\t\r \u00a0chick\t\r \u00a0embryos,\t\r \u00a0we\t\r \u00a0could\t\r \u00a0show\t\r \u00a0that\t\r \u00a0both\t\r \u00a0L-\u00ad\u2010DOPA\t\r \u00a0and\t\r \u00a0dopamine\t\r \u00a0induce\t\r \u00a0cardiac\t\r \u00a0muscle\t\r \u00a0differentiation.\t\r \u00a0Cardiac\t\r \u00a0transcription\t\r \u00a0factors\t\r \u00a0Nkx2.5\t\r \u00a0and\t\r \u00a0Tbx5\t\r \u00a0were\t\r \u00a0expressed\t\r \u00a0in\t\r \u00a0the\t\r \u00a0ectopic\t\r \u00a0tissue\t\r \u00a0generated\t\r \u00a0near\t\r \u00a0the\t\r \u00a0microbead\t\r \u00a0(Figure\t\r \u00a07A).\t\r \u00a0Additionally,\t\r \u00a0the\t\r \u00a0sarcomeric\t\r \u00a0protein\t\r \u00a0AMHC1\t\r \u00a0(atrial\t\r \u00a0myosin\t\r \u00a0heavy\t\r \u00a0 chain),\t\r \u00a0 marker\t\r \u00a0 of\t\r \u00a0 terminal\t\r \u00a0 cardiac\t\r \u00a0 differentiation,\t\r \u00a0 was\t\r \u00a0 also\t\r \u00a0 induced,\t\r \u00a0 as\t\r \u00a0reflected\t\r \u00a0by\t\r \u00a0in\t\r \u00a0situ\t\r \u00a0hybridization\t\r \u00a0and\t\r \u00a0immunostaining\t\r \u00a0with\t\r \u00a0MF20\t\r \u00a0antibody\t\r \u00a0(Figure\t\r \u00a07A).\t\r \u00a0 Moreover,\t\r \u00a0 the\t\r \u00a0 cells\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 induced\t\r \u00a0 ectopic\t\r \u00a0 tissue\t\r \u00a0 developed\t\r \u00a0 myofibrils\t\r \u00a0organized\t\r \u00a0 into\t\r \u00a0 sarcomeres,\t\r \u00a0 similar\t\r \u00a0 to\t\r \u00a0 those\t\r \u00a0 found\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 cardiomyocytes\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0primitive\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0(Figure\t\r \u00a07B).\t\r \u00a0The\t\r \u00a0link\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0to\t\r \u00a0cardiac\t\r \u00a0differentiation\t\r \u00a0programs\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0357\t\r \u00a0\t\r \u00a0was\t\r \u00a0 further\t\r \u00a0 confirmed\t\r \u00a0 by\t\r \u00a0 blocking\t\r \u00a0 the\t\r \u00a0 endogenous\t\r \u00a0 synthesis\t\r \u00a0 of\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 and\t\r \u00a0dopamine,\t\r \u00a0which\t\r \u00a0led\t\r \u00a0to\t\r \u00a0a\t\r \u00a0decrease\t\r \u00a0in\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0AMHC1\t\r \u00a0(13).\t\r \u00a0Table\t\r \u00a01.\t\r \u00a0Sequence\t\r \u00a0of\t\r \u00a0the\t\r \u00a0primers\t\r \u00a0used\t\r \u00a0in\t\r \u00a0semiquantitative\t\r \u00a0PCR.\t\r \u00a0\nInterestingly,\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0 parallel\t\r \u00a0 study,\t\r \u00a0 carried\t\r \u00a0 out\t\r \u00a0 with\t\r \u00a0 mouse\t\r \u00a0 embryonic\t\r \u00a0 stem\t\r \u00a0cells,\t\r \u00a0 the\t\r \u00a0 addition\t\r \u00a0 of\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 and\t\r \u00a0 dopamine\t\r \u00a0 enhanced\t\r \u00a0 cardiac\t\r \u00a0 myocyte\t\r \u00a0differentiation\t\r \u00a0(international\t\r \u00a0patent\t\r \u00a0presented\t\r \u00a0by\t\r \u00a0Hern\u00e1ndez\t\r \u00a0S\u00e1nchez,\t\r \u00a0C.,\t\r \u00a0B\u00e1rtulos\t\r \u00a0Encinas,\t\r \u00a0O.,\t\r \u00a0De\t\r \u00a0Pablo\t\r \u00a0D\u00e1vila,\t\r \u00a0F.,\t\r \u00a0Ar\u00e1nega\t\r \u00a0Jim\u00e9nez,\t\r \u00a0A.\t\r \u00a0on\t\r \u00a0\u201cThe\t\r \u00a0use\t\r \u00a0of\t\r \u00a0catecholamine\t\r \u00a0for\t\r \u00a0the\t\r \u00a0differentiation\t\r \u00a0of\t\r \u00a0stem\t\r \u00a0cells\t\r \u00a0to\t\r \u00a0cardiomyocytes\u201d.\t\r \u00a0PCT/ES09/070339).\t\r \u00a0Overexpression\t\r \u00a0 and\t\r \u00a0 knock-\u00ad\u2010down\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 disrupts\t\r \u00a0 cardiac\t\r \u00a0 markers\t\r \u00a0 gene\t\r \u00a0expression\t\r \u00a0and\t\r \u00a0affects\t\r \u00a0chamber\t\r \u00a0formation\t\r \u00a0\t\r \u00a0We\t\r \u00a0 set\t\r \u00a0 out\t\r \u00a0 gain-\u00ad\u2010of-\u00ad\u2010function\t\r \u00a0 experiments\t\r \u00a0 using\t\r \u00a0 constructs\t\r \u00a0 that\t\r \u00a0 led\t\r \u00a0 to\t\r \u00a0overexpression\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 together\t\r \u00a0 with\t\r \u00a0 GFP\t\r \u00a0 (Figure\t\r \u00a0 4),\t\r \u00a0 or\t\r \u00a0 just\t\r \u00a0 GFP\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0 control,\t\r \u00a0 in\t\r \u00a0electroporated\t\r \u00a0 chick\t\r \u00a0 embryos.\t\r \u00a0 \t\r \u00a0 One\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 first\t\r \u00a0 features\t\r \u00a0 of\t\r \u00a0 anterior-\u00ad\u2010posterior\t\r \u00a0patterning\t\r \u00a0 is\t\r \u00a0 the\t\r \u00a0 restriction\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 ventricular\t\r \u00a0 (VMHC-\u00ad\u20101)\t\r \u00a0 and\t\r \u00a0 atrial\t\r \u00a0 (AMHC-\u00ad\u20101)\t\r \u00a0myosin\t\r \u00a0 heavy\t\r \u00a0 chain\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0 anterior\t\r \u00a0 and\t\r \u00a0 posterior\t\r \u00a0 pole,\t\r \u00a0 respectively,\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0primitive\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0(18-\u00ad\u201020).\t\r \u00a0We\t\r \u00a0showed\t\r \u00a0that\t\r \u00a0TH\t\r \u00a0overexpression\t\r \u00a0increased\t\r \u00a0and\t\r \u00a0expanded\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0the\t\r \u00a0posteriorly\t\r \u00a0restricted\t\r \u00a0genes\t\r \u00a0AMHC-\u00ad\u20101\t\r \u00a0and\t\r \u00a0Tbx5\t\r \u00a0toward\t\r \u00a0more\t\r \u00a0rostral\t\r \u00a0regions\t\r \u00a0(Figure\t\r \u00a08).\t\r \u00a0These\t\r \u00a0results\t\r \u00a0suggested\t\r \u00a0that\t\r \u00a0TH\t\r \u00a0is\t\r \u00a0involved\t\r \u00a0in\t\r \u00a0the\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0patterning\t\r \u00a0by\t\r \u00a0 specifying\t\r \u00a0 the\t\r \u00a0 atrial\t\r \u00a0 region.\t\r \u00a0 In\t\r \u00a0 addition,\t\r \u00a0 TH\t\r \u00a0 also\t\r \u00a0 had\t\r \u00a0 major\t\r \u00a0 functional\t\r \u00a0Gene\t\r \u00a0Primer\t\r \u00a0Forward\t\r \u00a0Primer\t\r \u00a0Reverse\t\r \u00a0Th\t\r \u00a0CACGAGTGAAGATGCCAAC\t\r \u00a0CACGAGTGAAGATGCCAAC\t\r \u00a0\u03b1-1b\t\r \u00a0\t\r \u00a0AAAGAAGGCAGCCAAGACA\t\r \u00a0GAAAGAGCTGGGGTTTTTCC\t\r \u00a0\u03b1-1d\t\r \u00a0CTTCTTCGTCCTGCCTTTTG\t\r \u00a0AGGAGCTGTTCAGGGTGCTA\t\r \u00a0\u03b1-2c\t\r \u00a0\t\r \u00a0AGAGCAGCACCTCAGAGAGC\t\r \u00a0GGCTACTGGAGTGCTTGGAG\t\r \u00a0\u03b2-1\t\r \u00a0CCAAGGAGCAGATCAGGAAG\t\r \u00a0GCCCAACCAGTTGAAGAAAA\t\r \u00a0\u03b2-2\t\r \u00a0CGAGTTCTGGACCTCTCTGG\t\r \u00a0GGGTCTTCAGAGCTTTGTGC\t\r \u00a0gapdh\t\r \u00a0GCAATGCATCGTGCACCACC\t\r \u00a0TGTGATGGCATGGACAGTGG\t\r \u00a0\nGene\t\r \u00a0Primer\t\r \u00a0Forward\t\r \u00a0Primer\t\r \u00a0Reverse\t\r \u00a0Roche\t\r \u00a0probe\t\r \u00a0D1\t\r \u00a0TGTCATTAGTGTGGACAGATACTGG\t\r \u00a0GGGTCATTTTCCTCTCGTACC\t\r \u00a019\t\r \u00a0D3\t\r \u00a0GATAAGCTCTTTAGGAAGGATAGGC\t\r \u00a0CCTAATACAGAGAGCCACTCCAC\t\r \u00a012\t\r \u00a0D5\t\r \u00a0GTCTGCTGCACTGGAGGTC\t\r \u00a0GAATCGTTCGTCTCCGTAGG\t\r \u00a027\t\r \u00a0gapdh\t\r \u00a0GTCCTCTCTGGCAAAGTCCA\t\r \u00a0ACCATGTAGTTCAGATCGATGAA\t\r \u00a049\t\r \u00a0\t\r \u00a0\nTable\t\r \u00a02.\t\r \u00a0Sequence\t\r \u00a0of\t\r \u00a0the\t\r \u00a0primers\t\r \u00a0used\t\r \u00a0in\t\r \u00a0quantitative\t\r \u00a0PCR\t\r \u00a0with\t\r \u00a0Roche\t\r \u00a0probes.\t\r \u00a0C.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n358\t\r \u00a0\t\r \u00a0consequences,\t\r \u00a0 since\t\r \u00a0 the\t\r \u00a0 electroporated\t\r \u00a0 chick\t\r \u00a0 embryos\t\r \u00a0 displayed\t\r \u00a0 slower\t\r \u00a0 (53\t\r \u00a0 vs.\t\r \u00a0100\t\r \u00a0beats\t\r \u00a0per\t\r \u00a0minute)\t\r \u00a0and\t\r \u00a0arrhythmic\t\r \u00a0heart\t\r \u00a0beats\t\r \u00a0compared\t\r \u00a0to\t\r \u00a0controls\t\r \u00a0(13).\t\r \u00a0The\t\r \u00a0use\t\r \u00a0of\t\r \u00a0morpholino-\u00ad\u2010oligonucleotides\t\r \u00a0against\t\r \u00a0th\t\r \u00a0mRNA\t\r \u00a0allowed\t\r \u00a0the\t\r \u00a0knock-\u00ad\u2010down\t\r \u00a0of\t\r \u00a0its\t\r \u00a0 expression\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 chick\t\r \u00a0 embryo,\t\r \u00a0 leading\t\r \u00a0 to\t\r \u00a0 a\t\r \u00a0 decrease\t\r \u00a0 in\t\r \u00a0 AMHC1\t\r \u00a0 and\t\r \u00a0 Tbx5\t\r \u00a0expression\t\r \u00a0 together\t\r \u00a0 with\t\r \u00a0 an\t\r \u00a0 atrophic\t\r \u00a0 sinoatrial\t\r \u00a0 region\t\r \u00a0 and\t\r \u00a0 oversized\t\r \u00a0 ventricular\t\r \u00a0region\t\r \u00a0(13).\t\r \u00a0Thus,\t\r \u00a0TH\t\r \u00a0action\t\r \u00a0not\t\r \u00a0only\t\r \u00a0induces\t\r \u00a0cardiac\t\r \u00a0differentiation\t\r \u00a0in\t\r \u00a0vivo\t\r \u00a0but\t\r \u00a0the\t\r \u00a0catecholamine\t\r \u00a0pathway\t\r \u00a0regulates\t\r \u00a0heart\t\r \u00a0patterning,\t\r \u00a0conferring\t\r \u00a0atriogenic\t\r \u00a0identity.\t\r \u00a0\n\t\r \u00a0Figure\t\r \u00a0 7.\t\r \u00a0 Induction\t\r \u00a0 of\t\r \u00a0 cardiac\t\r \u00a0 genes\t\r \u00a0 and\t\r \u00a0 cardiomyocytes\t\r \u00a0 differentiation\t\r \u00a0 by\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 and\t\r \u00a0Dopamine.\t\r \u00a0A)\t\r \u00a0 Drawing\t\r \u00a0 corresponds\t\r \u00a0 to\t\r \u00a0 a\t\r \u00a0 stage\t\r \u00a0 5\t\r \u00a0 embryo\t\r \u00a0 scheme\t\r \u00a0 with\t\r \u00a0a\t\r \u00a0 microbead\t\r \u00a0 implanted.\t\r \u00a0Beads\t\r \u00a0 were\t\r \u00a0 soaked\t\r \u00a0 with\t\r \u00a0either\t\r \u00a0PBS\t\r \u00a0(vehicle),\t\r \u00a0 or\t\r \u00a0 a\t\r \u00a0 solution\t\r \u00a0 of\t\r \u00a0 10\t\r \u00a0 \u00b5mol/L\t\r \u00a0 L-\u00ad\u2010DOPA\t\r \u00a0 or\t\r \u00a0 dopamine.\t\r \u00a0Stage\t\r \u00a0 10-\u00ad\u201012\t\r \u00a0 chick\t\r \u00a0 embryos\t\r \u00a0 were\t\r \u00a0 subjected\t\r \u00a0 to\t\r \u00a0 whole-\u00ad\u2010mount\t\r \u00a0 in\t\r \u00a0 situ\t\r \u00a0 hybridization\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 genes\t\r \u00a0indicated\t\r \u00a0 (Nkx2.5,\t\r \u00a0 Tbx5,\t\r \u00a0 AMHC1)\t\r \u00a0 or\t\r \u00a0 immunohistochemistry\t\r \u00a0 for\t\r \u00a0 MF20.\t\r \u00a0 Ectopic\t\r \u00a0 tissue\t\r \u00a0 adjacent\t\r \u00a0 to\t\r \u00a0the\t\r \u00a0bead\t\r \u00a0coated\t\r \u00a0with\t\r \u00a0L-\u00ad\u2010DOPA\t\r \u00a0or\t\r \u00a0dopamine\t\r \u00a0(arrow)\t\r \u00a0expressed\t\r \u00a0all\t\r \u00a0markers.\t\r \u00a0PBS\t\r \u00a0did\t\r \u00a0not\t\r \u00a0induce\t\r \u00a0any\t\r \u00a0signal\t\r \u00a0(not\t\r \u00a0shown).\t\r \u00a0B)\t\r \u00a0Ultrastructure\t\r \u00a0of\t\r \u00a0the\t\r \u00a0ectopic\t\r \u00a0tissue\t\r \u00a0induced.\t\r \u00a0The\t\r \u00a0white\t\r \u00a0arrowheads\t\r \u00a0indicate\t\r \u00a0the\t\r \u00a0Z\t\r \u00a0bands\t\r \u00a0and\t\r \u00a0the\t\r \u00a0purple\t\r \u00a0and\t\r \u00a0yellow\t\r \u00a0lines\t\r \u00a0delineate\t\r \u00a0I\t\r \u00a0and\t\r \u00a0A\t\r \u00a0bands\t\r \u00a0of\t\r \u00a0the\t\r \u00a0cardiomyocytes\t\r \u00a0adjacent\t\r \u00a0to\t\r \u00a0the\t\r \u00a0bead.\t\r \u00a0(Modified\t\r \u00a0from\t\r \u00a0[13]).\t\r \u00a0\nThe\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0359\t\r \u00a0\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figure\t\r \u00a0 8.\t\r \u00a0 Effect\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 on\t\r \u00a0 anterior-\u00ad\u2010posterior\t\r \u00a0 heart\t\r \u00a0 tube\t\r \u00a0 patterning\t\r \u00a0 and\t\r \u00a0 specification\t\r \u00a0 of\t\r \u00a0chambers.\t\r \u00a0Effect\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0gain-\u00ad\u2010of-\u00ad\u2010function\t\r \u00a0on\t\r \u00a0sino-\u00ad\u2010atrial\t\r \u00a0gene\t\r \u00a0expression.\t\r \u00a0Embryos\t\r \u00a0from\t\r \u00a0stages\t\r \u00a010\t\r \u00a0or\t\r \u00a012\t\r \u00a0underwent\t\r \u00a0in\t\r \u00a0situ\t\r \u00a0hybridization\t\r \u00a0for\t\r \u00a0the\t\r \u00a0indicated\t\r \u00a0gene\t\r \u00a0markers,\t\r \u00a0AMHC1\t\r \u00a0and\t\r \u00a0Tbx5.\t\r \u00a0The\t\r \u00a0control\t\r \u00a0non-\u00ad\u2010electroporated\t\r \u00a0 embryos\t\r \u00a0 are\t\r \u00a0 compared\t\r \u00a0 with\t\r \u00a0 embryos\t\r \u00a0 electroporated\t\r \u00a0 with\t\r \u00a0 either\t\r \u00a0 the\t\r \u00a0 control\t\r \u00a0construct\t\r \u00a0 (pCAGs-\u00ad\u2010I-\u00ad\u2010GFP)\t\r \u00a0 or\t\r \u00a0 with\t\r \u00a0 the\t\r \u00a0th\t\r \u00a0expressing\t\r \u00a0 construct\t\r \u00a0 (pCAGs-\u00ad\u2010TH-\u00ad\u2010I-\u00ad\u2010GFP).\t\r \u00a0 The\t\r \u00a0 anterior\t\r \u00a0expanded\t\r \u00a0 expression\t\r \u00a0 of\t\r \u00a0AMHC1\t\r \u00a0and\t\r \u00a0Tbx5\t\r \u00a0in\t\r \u00a0 the\t\r \u00a0 heart\t\r \u00a0 tube\t\r \u00a0 is\t\r \u00a0 indicated\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 black\t\r \u00a0 arrows.\t\r \u00a0Visualization\t\r \u00a0of\t\r \u00a0GFP\t\r \u00a0expression\t\r \u00a0for\t\r \u00a0the\t\r \u00a0embryos\t\r \u00a0electroporated\t\r \u00a0is\t\r \u00a0shown\t\r \u00a0in\t\r \u00a0the\t\r \u00a0corresponding\t\r \u00a0left\t\r \u00a0panels.\t\r \u00a0(Modified\t\r \u00a0from\t\r \u00a0[13]).\t\r \u00a0\t\r \u00a0It\t\r \u00a0is\t\r \u00a0worth\t\r \u00a0mentioning\t\r \u00a0that\t\r \u00a0the\t\r \u00a0th\t\r \u00a0global\t\r \u00a0knockout\t\r \u00a0mice,\t\r \u00a0generated\t\r \u00a0in\t\r \u00a01995\t\r \u00a0by\t\r \u00a0the\t\r \u00a0group\t\r \u00a0of\t\r \u00a0Dr.\t\r \u00a0Palmiter\t\r \u00a0(21),\t\r \u00a0is\t\r \u00a0embryonic\t\r \u00a0lethal\t\r \u00a0starting\t\r \u00a0at\t\r \u00a0day\t\r \u00a0E11.5-\u00ad\u201012.5.\t\r \u00a0Although,\t\r \u00a0the\t\r \u00a0null\t\r \u00a0mice\t\r \u00a0die\t\r \u00a0from\t\r \u00a0apparent\t\r \u00a0heart\t\r \u00a0failure,\t\r \u00a0a\t\r \u00a0detailed\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0 the\t\r \u00a0 mouse\t\r \u00a0 embryo\t\r \u00a0 phenotype\t\r \u00a0 in\t\r \u00a0 organogenesis\t\r \u00a0 has\t\r \u00a0 not\t\r \u00a0 been\t\r \u00a0 carried\t\r \u00a0 out\t\r \u00a0 yet.\t\r \u00a0This\t\r \u00a0 type\t\r \u00a0 of\t\r \u00a0 study\t\r \u00a0 would\t\r \u00a0 be\t\r \u00a0 required\t\r \u00a0 to\t\r \u00a0 unravel\t\r \u00a0 the\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 catecholamines\t\r \u00a0 in\t\r \u00a0mouse\t\r \u00a0cardiogenesis.\t\r \u00a0\t\r \u00a0\t\r \u00a0\nC.\t\r \u00a0Hern\u00e1ndez-\u00ad\u2010S\u00e1nchez,\t\r \u00a0P.\t\r \u00a0V\u00e1zquez,\t\r \u00a0Flora\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0\t\r \u00a0\n360\t\r \u00a0\t\r \u00a05.\t\r \u00a0CONCLUSIONS\t\r \u00a0AND\t\r \u00a0FUTURE\t\r \u00a0DIRECTIONS\t\r \u00a0The\t\r \u00a0morfological\t\r \u00a0and\t\r \u00a0functional\t\r \u00a0diversity\t\r \u00a0of\t\r \u00a0animal\t\r \u00a0organisms\t\r \u00a0depends\t\r \u00a0on\t\r \u00a0multiple\t\r \u00a0mechanisms\t\r \u00a0of\t\r \u00a0gene\t\r \u00a0regulation,\t\r \u00a0especific\t\r \u00a0in\t\r \u00a0time\t\r \u00a0and\t\r \u00a0space,\t\r \u00a0which\t\r \u00a0permit\t\r \u00a0the\t\r \u00a0 functional\t\r \u00a0 utilization\t\r \u00a0 of\t\r \u00a0 related\t\r \u00a0 transcripts\t\r \u00a0 (and\t\r \u00a0 their\t\r \u00a0 protein\t\r \u00a0 products)\t\r \u00a0 \t\r \u00a0 in\t\r \u00a0distinct\t\r \u00a0 contexts\t\r \u00a0 along\t\r \u00a0 the\t\r \u00a0 life\t\r \u00a0 cycle.\t\r \u00a0 \t\r \u00a0 We\t\r \u00a0 have\t\r \u00a0 characterized\t\r \u00a0 the\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 in\t\r \u00a0cardiac\t\r \u00a0development,\t\r \u00a0focusing\t\r \u00a0in\t\r \u00a0the\t\r \u00a0primitive\t\r \u00a0heart\t\r \u00a0tube\t\r \u00a0formation.\t\r \u00a0In\t\r \u00a0the\t\r \u00a0future\t\r \u00a0we\t\r \u00a0will\t\r \u00a0try\t\r \u00a0to\t\r \u00a0define\t\r \u00a0the\t\r \u00a0mechanism\t\r \u00a0of\t\r \u00a0dopamine\t\r \u00a0action\t\r \u00a0and\t\r \u00a0the\t\r \u00a0receptors\t\r \u00a0involved\t\r \u00a0in\t\r \u00a0cardiomyocyte\t\r \u00a0differentiation.\t\r \u00a0\t\r \u00a0It\t\r \u00a0 is\t\r \u00a0 intriguing\t\r \u00a0 as\t\r \u00a0 well\t\r \u00a0 the\t\r \u00a0 possible\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 TH\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 proepicardium,\t\r \u00a0 a\t\r \u00a0transient\t\r \u00a0 structure\t\r \u00a0 in\t\r \u00a0 which\t\r \u00a0 we\t\r \u00a0 have\t\r \u00a0 found\t\r \u00a0 expression\t\r \u00a0 in\t\r \u00a0 later\t\r \u00a0 stages\t\r \u00a0 of\t\r \u00a0 cardiac\t\r \u00a0organogenesis.\t\r \u00a0In\t\r \u00a0addition,\t\r \u00a0TH\t\r \u00a0is\t\r \u00a0expressed\t\r \u00a0in\t\r \u00a0the\t\r \u00a0mouse\t\r \u00a0pancreatic\t\r \u00a0primordium\t\r \u00a0since\t\r \u00a0its\t\r \u00a0formation.\t\r \u00a0We\t\r \u00a0are\t\r \u00a0now\t\r \u00a0characterizing\t\r \u00a0the\t\r \u00a0expression\t\r \u00a0pattern\t\r \u00a0of\t\r \u00a0TH\t\r \u00a0during\t\r \u00a0pancreas\t\r \u00a0 development,\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 likely\t\r \u00a0 participation\t\r \u00a0 of\t\r \u00a0 catecholamines\t\r \u00a0 in\t\r \u00a0differentiation\t\r \u00a0 programs\t\r \u00a0 leading\t\r \u00a0 to\t\r \u00a0 pancreatic\t\r \u00a0 endocrine\t\r \u00a0 cells.\t\r \u00a0 The\t\r \u00a0 field\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0action\t\r \u00a0of\t\r \u00a0catecholamines\t\r \u00a0in\t\r \u00a0non-\u00ad\u2010neural\t\r \u00a0tissues\t\r \u00a0development\t\r \u00a0has\t\r \u00a0turned\t\r \u00a0out\t\r \u00a0to\t\r \u00a0be\t\r \u00a0much\t\r \u00a0broader\t\r \u00a0than\t\r \u00a0anticipated.\t\r \u00a0ACKNOWLEDGEMENTS\t\r \u00a0We\t\r \u00a0thank\t\r \u00a0present\t\r \u00a0and\t\r \u00a0past\t\r \u00a0members\t\r \u00a0of\t\r \u00a0the\t\r \u00a0laboratory,\t\r \u00a0especially\t\r \u00a0Enrique\t\r \u00a0J.\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Rosa\t\r \u00a0 and\t\r \u00a0 Teresa\t\r \u00a0 Su\u00e1rez,\t\r \u00a0 for\t\r \u00a0 their\t\r \u00a0 contribution\t\r \u00a0 to\t\r \u00a0 scientific\t\r \u00a0 discussions,\t\r \u00a0 the\t\r \u00a0background\t\r \u00a0 data\t\r \u00a0 and\t\r \u00a0 specific\t\r \u00a0 figures\t\r \u00a0 modified\t\r \u00a0 for\t\r \u00a0 this\t\r \u00a0 article.\t\r \u00a0 This\t\r \u00a0 research\t\r \u00a0 was\t\r \u00a0funded\t\r \u00a0by\t\r \u00a0grants\t\r \u00a0BFU\t\r \u00a02007-\u00ad\u201061055\t\r \u00a0and\t\r \u00a0BFU\t\r \u00a02010-\u00ad\u201015868\t\r \u00a0(MINECO)\t\r \u00a0to\t\r \u00a0F.\t\r \u00a0de\t\r \u00a0Pablo.\t\r \u00a0PV\t\r \u00a0is\t\r \u00a0supported\t\r \u00a0by\t\r \u00a0a\t\r \u00a0JAE-\u00ad\u2010DOC\t\r \u00a0contract\t\r \u00a0from\t\r \u00a0the\t\r \u00a0CSIC.\t\r \u00a0REFERENCES\t\r \u00a0(1)\t\r \u00a0Harvey\t\r \u00a0S.\t\r \u00a0Extrapituitary\t\r \u00a0growth\t\r \u00a0hormone.\t\r \u00a0Endocrine\t\r \u00a038:\t\r \u00a0335-\u00ad\u2010359\t\r \u00a0(2010).\t\r \u00a0(2)\t\r \u00a0Hernandez-\u00ad\u2010Sanchez\t\r \u00a0 C;\t\r \u00a0 Lopez-\u00ad\u2010Carranza\t\r \u00a0 A;\t\r \u00a0 Alarcon\t\r \u00a0 C;\t\r \u00a0 de\t\r \u00a0 La\t\r \u00a0 Rosa\t\r \u00a0 EJ,\t\r \u00a0 de\t\r \u00a0 Pablo\t\r \u00a0 F.\t\r \u00a0Autocrine/paracrine\t\r \u00a0 role\t\r \u00a0 of\t\r \u00a0 insulin-\u00ad\u2010related\t\r \u00a0 growth\t\r \u00a0 factors\t\r \u00a0 in\t\r \u00a0 neurogenesis:\t\r \u00a0 local\t\r \u00a0expression\t\r \u00a0and\t\r \u00a0effects\t\r \u00a0on\t\r \u00a0cell\t\r \u00a0proliferation\t\r \u00a0and\t\r \u00a0differentiation\t\r \u00a0in\t\r \u00a0retina.\t\r \u00a0Proceedings\t\r \u00a0of\t\r \u00a0the\t\r \u00a0National\t\r \u00a0Academy\t\r \u00a0of\t\r \u00a0Sciences\t\r \u00a0of\t\r \u00a0the\t\r \u00a0United\t\r \u00a0States\t\r \u00a0of\t\r \u00a0America\t\r \u00a092:\t\r \u00a09834-\u00ad\u20109838\t\r \u00a0(1995).\t\r \u00a0(3)\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0F;\t\r \u00a0Roth\t\r \u00a0J.\t\r \u00a0Endocrinization\t\r \u00a0of\t\r \u00a0the\t\r \u00a0early\t\r \u00a0embryo:\t\r \u00a0an\t\r \u00a0emerging\t\r \u00a0role\t\r \u00a0for\t\r \u00a0hormones\t\r \u00a0and\t\r \u00a0hormone-\u00ad\u2010like\t\r \u00a0factors.\t\r \u00a0Trends\t\r \u00a0in\t\r \u00a0biochemical\t\r \u00a0sciences\t\r \u00a015:\t\r \u00a0339-\u00ad\u2010342\t\r \u00a0(1990).\t\r \u00a0(4)\t\r \u00a0Hernandez-\u00ad\u2010Sanchez\t\r \u00a0C;\t\r \u00a0Mansilla\t\r \u00a0A;\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Rosa\t\r \u00a0EJ;\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0F.\t\r \u00a0\t\r \u00a0Proinsulin\t\r \u00a0in\t\r \u00a0development:\t\r \u00a0New\t\r \u00a0roles\t\r \u00a0for\t\r \u00a0an\t\r \u00a0ancient\t\r \u00a0prohormone.\t\r \u00a0Diabetologia\t\r \u00a049:\t\r \u00a01142-\u00ad\u20101150\t\r \u00a0(2006).\t\r \u00a0(5)\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Rosa\t\r \u00a0EJ;\t\r \u00a0de\t\r \u00a0Pablo\t\r \u00a0F.\t\r \u00a0Proinsulin:\t\r \u00a0from\t\r \u00a0hormonal\t\r \u00a0precursor\t\r \u00a0to\t\r \u00a0neuroprotective\t\r \u00a0factor.\t\r \u00a0Frontiers\t\r \u00a0in\t\r \u00a0molecular\t\r \u00a0neuroscience\t\r \u00a04:\t\r \u00a020\t\r \u00a0(2011).\t\r \u00a0(6)\t\r \u00a0Martinez-\u00ad\u2010Campos\t\r \u00a0 E;\t\r \u00a0 Hernandez-\u00ad\u2010SanMiguel\t\r \u00a0 E;\t\r \u00a0 Lopez-\u00ad\u2010Sanchez\t\r \u00a0 C;\t\r \u00a0 De\t\r \u00a0 Pablo\t\r \u00a0 F,\t\r \u00a0 Hernandez-\u00ad\u2010Sanchez\t\r \u00a0 C.\t\r \u00a0 Alternative\t\r \u00a0 splicing\t\r \u00a0 variants\t\r \u00a0 of\t\r \u00a0 proinsulin\t\r \u00a0 mRNA\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 effects\t\r \u00a0 of\t\r \u00a0 excess\t\r \u00a0proinsulin\t\r \u00a0on\t\r \u00a0cardiac\t\r \u00a0morphogenesis.\t\r \u00a0FEBS\t\r \u00a0letters\t\r \u00a0587:\t\r \u00a02272-\u00ad\u20102277\t\r \u00a0(2013).\t\r \u00a0(7)\t\r \u00a0Pendleton\t\r \u00a0 RG;\t\r \u00a0 Rasheed\t\r \u00a0 A;\t\r \u00a0 Roychowdhury\t\r \u00a0 R;\t\r \u00a0 Hillman\t\r \u00a0 R.\t\r \u00a0 A\t\r \u00a0 new\t\r \u00a0 role\t\r \u00a0 for\t\r \u00a0 catecholamines:\t\r \u00a0ontogenesis.\t\r \u00a0Trends\t\r \u00a0in\t\r \u00a0pharmacological\t\r \u00a0sciences\t\r \u00a019:\t\r \u00a0248-\u00ad\u2010251\t\r \u00a0(1998).\t\r \u00a0(8)\t\r \u00a0Hernandez-\u00ad\u2010Sanchez\t\r \u00a0 C;\t\r \u00a0 Bartulos\t\r \u00a0 O;\t\r \u00a0 Valenciano\t\r \u00a0 AI;\t\r \u00a0 Mansilla\t\r \u00a0 A;\t\r \u00a0 de\t\r \u00a0 Pablo\t\r \u00a0 F.\t\r \u00a0 The\t\r \u00a0 regulated\t\r \u00a0expression\t\r \u00a0of\t\r \u00a0chimeric\t\r \u00a0tyrosine\t\r \u00a0hydroxylase-\u00ad\u2010insulin\t\r \u00a0transcripts\t\r \u00a0during\t\r \u00a0early\t\r \u00a0development.\t\r \u00a0Nucleic\t\r \u00a0acids\t\r \u00a0research\t\r \u00a034:\t\r \u00a03455-\u00ad\u20103464\t\r \u00a0(2006).\t\r \u00a0The\t\r \u00a0role\t\r \u00a0of\t\r \u00a0the\t\r \u00a0catecholaminergic\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0361\t\r \u00a0\t\r \u00a0(9)\t\r \u00a0Akiva\t\r \u00a0P;\t\r \u00a0Toporik\t\r \u00a0A;\t\r \u00a0Edelheit\t\r \u00a0S;\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0Transcription-\u00ad\u2010mediated\t\r \u00a0gene\t\r \u00a0fusion\t\r \u00a0in\t\r \u00a0the\t\r \u00a0human\t\r \u00a0genome.\t\r \u00a0Genome\t\r \u00a0research\t\r \u00a016:\t\r \u00a030-\u00ad\u201036\t\r \u00a0(2006).\t\r \u00a0(10)\t\r \u00a0Kim\t\r \u00a0N;\t\r \u00a0Kim\t\r \u00a0P;\t\r \u00a0Nam\t\r \u00a0S;\t\r \u00a0Shin\t\r \u00a0S;\t\r \u00a0Lee\t\r \u00a0S.\t\r \u00a0\t\r \u00a0ChimerDB-\u00ad\u2010-\u00ad\u2010a\t\r \u00a0knowledgebase\t\r \u00a0for\t\r \u00a0fusion\t\r \u00a0sequences.\t\r \u00a0Nucleic\t\r \u00a0acids\t\r \u00a0research\t\r \u00a034:\t\r \u00a0D21-\u00ad\u201024\t\r \u00a0(2006).\t\r \u00a0(11)\t\r \u00a0Parra\t\r \u00a0 G;\t\r \u00a0 Reymond\t\r \u00a0 A;\t\r \u00a0 Dabbouseh\t\r \u00a0 N;\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Tandem\t\r \u00a0 chimerism\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0 means\t\r \u00a0 to\t\r \u00a0 increase\t\r \u00a0protein\t\r \u00a0complexity\t\r \u00a0in\t\r \u00a0the\t\r \u00a0human\t\r \u00a0genome.\t\r \u00a0Genome\t\r \u00a0research\t\r \u00a016:\t\r \u00a037-\u00ad\u201044\t\r \u00a0(2006).\t\r \u00a0(12)\t\r \u00a0Buckingham\t\r \u00a0M;\t\r \u00a0Meilhac\t\r \u00a0S;\t\r \u00a0Zaffran\t\r \u00a0S.\t\r \u00a0\t\r \u00a0Building\t\r \u00a0the\t\r \u00a0mammalian\t\r \u00a0heart\t\r \u00a0from\t\r \u00a0two\t\r \u00a0sources\t\r \u00a0of\t\r \u00a0myocardial\t\r \u00a0cells.\t\r \u00a0Nature\t\r \u00a0reviews\t\r \u00a06:\t\r \u00a0826-\u00ad\u2010835\t\r \u00a0(2005).\t\r \u00a0(13)\t\r \u00a0Lopez-\u00ad\u2010Sanchez\t\r \u00a0 C;\t\r \u00a0 Bartulos\t\r \u00a0 O;\t\r \u00a0 Martinez-\u00ad\u2010Campos\t\r \u00a0 E;\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Tyrosine\t\r \u00a0 hydroxylase\t\r \u00a0 is\t\r \u00a0expressed\t\r \u00a0 during\t\r \u00a0 early\t\r \u00a0 heart\t\r \u00a0 development\t\r \u00a0 and\t\r \u00a0 is\t\r \u00a0 required\t\r \u00a0 for\t\r \u00a0 cardiac\t\r \u00a0 chamber\t\r \u00a0formation.\t\r \u00a0Cardiovascular\t\r \u00a0research\t\r \u00a088:\t\r \u00a0111-\u00ad\u2010120\t\r \u00a0(2010).\t\r \u00a0(14)\t\r \u00a0Brand\t\r \u00a0 T.\t\r \u00a0 \t\r \u00a0 Heart\t\r \u00a0 development:\t\r \u00a0 molecular\t\r \u00a0 insights\t\r \u00a0 into\t\r \u00a0 cardiac\t\r \u00a0 specification\t\r \u00a0 and\t\r \u00a0 early\t\r \u00a0morphogenesis.\t\r \u00a0Developmental\t\r \u00a0biology\t\r \u00a0258:\t\r \u00a01-\u00ad\u201019\t\r \u00a0(2003).\t\r \u00a0\t\r \u00a0(15)\t\r \u00a0Chapman\t\r \u00a0SC;\t\r \u00a0Schubert\t\r \u00a0FR;\t\r \u00a0Schoenwolf\t\r \u00a0GC;\t\r \u00a0Lumsden\t\r \u00a0A.\t\r \u00a0\t\r \u00a0Anterior\t\r \u00a0identity\t\r \u00a0is\t\r \u00a0established\t\r \u00a0in\t\r \u00a0 chick\t\r \u00a0 epiblast\t\r \u00a0 by\t\r \u00a0 hypoblast\t\r \u00a0 and\t\r \u00a0 anterior\t\r \u00a0 definitive\t\r \u00a0 endoderm.\t\r \u00a0 Development\t\r \u00a0(Cambridge,\t\r \u00a0England)\t\r \u00a0130:\t\r \u00a05091-\u00ad\u20105101\t\r \u00a0(2003).\t\r \u00a0(16)\t\r \u00a0Hamburger\t\r \u00a0V;\t\r \u00a0Hamilton\t\r \u00a0HL.\t\r \u00a0A\t\r \u00a0series\t\r \u00a0of\t\r \u00a0normal\t\r \u00a0stages\t\r \u00a0in\t\r \u00a0the\t\r \u00a0development\t\r \u00a0of\t\r \u00a0the\t\r \u00a0chick\t\r \u00a0embryo.\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Morphology\t\r \u00a088:\t\r \u00a043\t\r \u00a0(1951).\t\r \u00a0(17)\t\r \u00a0Takeuchi\t\r \u00a0 JK,;Bruneau\t\r \u00a0 BG.\t\r \u00a0 \t\r \u00a0 Directed\t\r \u00a0 transdifferentiation\t\r \u00a0 of\t\r \u00a0 mouse\t\r \u00a0 mesoderm\t\r \u00a0 to\t\r \u00a0 heart\t\r \u00a0tissue\t\r \u00a0by\t\r \u00a0defined\t\r \u00a0factors.\t\r \u00a0Nature\t\r \u00a0459:\t\r \u00a0708-\u00ad\u2010711\t\r \u00a0(2009).\t\r \u00a0(18)\t\r \u00a0Oana\t\r \u00a0S;\t\r \u00a0Machida\t\r \u00a0S;\t\r \u00a0Hiratsuka\t\r \u00a0E;\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0The\t\r \u00a0complete\t\r \u00a0sequence\t\r \u00a0and\t\r \u00a0expression\t\r \u00a0patterns\t\r \u00a0of\t\r \u00a0the\t\r \u00a0 atrial\t\r \u00a0 myosin\t\r \u00a0 heavy\t\r \u00a0 chain\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 developing\t\r \u00a0 chick.\t\r \u00a0 Biology\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 cell\t\r \u00a0 /\t\r \u00a0 under\t\r \u00a0 the\t\r \u00a0auspices\t\r \u00a0of\t\r \u00a0the\t\r \u00a0European\t\r \u00a0Cell\t\r \u00a0Biology\t\r \u00a0Organization\t\r \u00a090:\t\r \u00a0605-\u00ad\u2010613\t\r \u00a0(1998).\t\r \u00a0(19)\t\r \u00a0Somi\t\r \u00a0 S;\t\r \u00a0 Klein\t\r \u00a0 AT;\t\r \u00a0 Houweling\t\r \u00a0 AC;\t\r \u00a0 et\t\r \u00a0 al.\t\r \u00a0 Atrial\t\r \u00a0 and\t\r \u00a0 ventricular\t\r \u00a0 myosin\t\r \u00a0 heavy-\u00ad\u2010chain\t\r \u00a0expression\t\r \u00a0in\t\r \u00a0the\t\r \u00a0developing\t\r \u00a0chicken\t\r \u00a0heart:\t\r \u00a0strengths\t\r \u00a0and\t\r \u00a0limitations\t\r \u00a0of\t\r \u00a0non-\u00ad\u2010radioactive\t\r \u00a0in\t\r \u00a0situ\t\r \u00a0hybridization.\t\r \u00a0J\t\r \u00a0Histochem\t\r \u00a0Cytochem\t\r \u00a054:\t\r \u00a0649-\u00ad\u2010664(2006).\t\r \u00a0\t\r \u00a0(20)\t\r \u00a0Yutzey\t\r \u00a0 KE;\t\r \u00a0 Rhee\t\r \u00a0 JT;\t\r \u00a0 Bader\t\r \u00a0 D.\t\r \u00a0 \t\r \u00a0 Expression\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 atrial-\u00ad\u2010specific\t\r \u00a0 myosin\t\r \u00a0 heavy\t\r \u00a0 chain\t\r \u00a0AMHC1\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 establishment\t\r \u00a0 of\t\r \u00a0 anteroposterior\t\r \u00a0 polarity\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 developing\t\r \u00a0 chicken\t\r \u00a0heart.\t\r \u00a0Development\t\r \u00a0(Cambridge,\t\r \u00a0England)\t\r \u00a0120:\t\r \u00a0871-\u00ad\u2010883\t\r \u00a0(1994).\t\r \u00a0(21)\t\r \u00a0Zhou\t\r \u00a0QY;\t\r \u00a0Quaife\t\r \u00a0CJ;\t\r \u00a0Palmiter\t\r \u00a0RD.\t\r \u00a0Targeted\t\r \u00a0disruption\t\r \u00a0of\t\r \u00a0the\t\r \u00a0tyrosine\t\r \u00a0hydroxylase\t\r \u00a0gene\t\r \u00a0reveals\t\r \u00a0that\t\r \u00a0catecholamines\t\r \u00a0are\t\r \u00a0required\t\r \u00a0for\t\r \u00a0mouse\t\r \u00a0fetal\t\r \u00a0development.\t\r \u00a0Nature\t\r \u00a0374:\t\r \u00a0640-\u00ad\u2010643\t\r \u00a0(1995).\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0362\t\r \u00a0\t\r \u00a0\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\t\r \u00a0aislados\t\r \u00a0del\t\r \u00a0g\u00e9nero\t\r \u00a0Sideritis\t\r \u00a0Elena\t\r \u00a0 M\u00aa\t\r \u00a0 Gonz\u00e1lez\t\r \u00a0 Burgos,\t\r \u00a0 M\u00aa\t\r \u00a0 Emilia\t\r \u00a0 Carretero\t\r \u00a0 Accame,\t\r \u00a0 M\u00aa\t\r \u00a0 Pilar\t\r \u00a0 G\u00f3mez-\u00ad\u2010Serranillos\t\r \u00a0Cuadrado*\t\r \u00a0Departamento\t\r \u00a0 de\t\r \u00a0 Farmacolog\u00eda,\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia,\t\r \u00a0 Universidad\t\r \u00a0 Complutense\t\r \u00a0 de\t\r \u00a0 Madrid,\t\r \u00a0 Ciudad\t\r \u00a0Universitaria\t\r \u00a028040\u2013\t\r \u00a0Madrid,\t\r \u00a0Espa\u00f1a\t\r \u00a0*e-\u00ad\u2010mail:\t\r \u00a0egonzalezburgos@hotmail.com\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0362-\u00ad\u2010376.\t\r \u00a0Resumen\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Tesis\t\r \u00a0 Doctoral\t\r \u00a0premiada\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 premio\t\r \u00a0 \u201cAntonio\t\r \u00a0 Doadrio\t\r \u00a0 L\u00f3pez\u201d\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Concurso\t\r \u00a0Cient\u00edfico\t\r \u00a02013\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia.\t\r \u00a0RESUMEN\t\r \u00a0El\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo,\t\r \u00a0 definido\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 desequilibrio\t\r \u00a0 entre\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0especies\t\r \u00a0 reactivas\t\r \u00a0 de\t\r \u00a0 ox\u00edgeno\t\r \u00a0 (ROS)\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 capacidad\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 defensivo\t\r \u00a0 del\t\r \u00a0organismo\t\r \u00a0 (enzim\u00e1tico\t\r \u00a0 y\t\r \u00a0 no\t\r \u00a0 enzim\u00e1tico)\t\r \u00a0 para\t\r \u00a0 hacer\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 mismas,\t\r \u00a0 est\u00e1\t\r \u00a0implicado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 fisiopatolog\u00eda\t\r \u00a0 de\t\r \u00a0 varias\t\r \u00a0 enfermedades\t\r \u00a0 neurodegenerativas\t\r \u00a0incluidas\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Alzheimer,\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Parkinson,\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Huntington\t\r \u00a0y\t\r \u00a0la\t\r \u00a0Esclerosis\t\r \u00a0Lateral\t\r \u00a0Amiotr\u00f3fica.\t\r \u00a0En\t\r \u00a0este\t\r \u00a0contexto,\t\r \u00a0la\t\r \u00a0b\u00fasqueda\t\r \u00a0de\t\r \u00a0 compuestos\t\r \u00a0 antioxidantes\t\r \u00a0 que\t\r \u00a0 permitan\t\r \u00a0 disminuir\t\r \u00a0 o\t\r \u00a0 neutralizar\t\r \u00a0 el\t\r \u00a0 da\u00f1o\t\r \u00a0oxidativo\t\r \u00a0 constituye\t\r \u00a0 un\t\r \u00a0 importante\t\r \u00a0 campo\t\r \u00a0 de\t\r \u00a0investigaci\u00f3n.\t\r \u00a0 En\t\r \u00a0este\t\r \u00a0 trabajo\t\r \u00a0 de\t\r \u00a0Tesis\t\r \u00a0 Doctoral\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 evaluado\t\r \u00a0 la\t\r \u00a0 actividad\t\r \u00a0 neuroprotectora\t\r \u00a0frente\t\r \u00a0 a\t\r \u00a0 estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0andalusol,\t\r \u00a0 conchitriol,\t\r \u00a0 foliol,\t\r \u00a0 lagascatriol,\t\r \u00a0 linearol\t\r \u00a0 y\t\r \u00a0sidol\t\r \u00a0aislados\t\r \u00a0de\t\r \u00a0especies\t\r \u00a0del\t\r \u00a0g\u00e9nero\t\r \u00a0Sideritis.\t\r \u00a0Palabras\t\r \u00a0clave:\t\r \u00a0diterpenos;\t\r \u00a0Sideritis;\t\r \u00a0neuroprotecci\u00f3n.\t\r \u00a0ABSTRACT\t\r \u00a0Oxidative\t\r \u00a0 stress,\t\r \u00a0 defined\t\r \u00a0 as\t\r \u00a0 a\t\r \u00a0 disturbance\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 equilibrium\t\r \u00a0 between\t\r \u00a0 reactive\t\r \u00a0oxygen\t\r \u00a0 species\t\r \u00a0 (ROS)\t\r \u00a0 production\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 capacity\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 defense\t\r \u00a0 system\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0organism\t\r \u00a0(enzymatic\t\r \u00a0and\t\r \u00a0non-\u00ad\u2010enzymatic)\t\r \u00a0to\t\r \u00a0protect\t\r \u00a0against\t\r \u00a0them,\t\r \u00a0is\t\r \u00a0involved\t\r \u00a0in\t\r \u00a0the\t\r \u00a0physiopathology\t\r \u00a0of\t\r \u00a0several\t\r \u00a0neurodegenerative\t\r \u00a0diseases\t\r \u00a0including\t\r \u00a0Alzheimer's\t\r \u00a0disease,\t\r \u00a0 Parkinson's\t\r \u00a0 disease,\t\r \u00a0 Huntington's\t\r \u00a0 disease\t\r \u00a0 and\t\r \u00a0 Amyotrophic\t\r \u00a0 Lateral\t\r \u00a0Sclerosis.\t\r \u00a0 In\t\r \u00a0this\t\r \u00a0 context,\t\r \u00a0 the\t\r \u00a0 search\t\r \u00a0 of\t\r \u00a0 antioxidant\t\r \u00a0 compounds\t\r \u00a0 is\t\r \u00a0 an\t\r \u00a0 interesting\t\r \u00a0ART\u00cdCULO\t\r \u00a0\nEstudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0363\t\r \u00a0\t\r \u00a0research\t\r \u00a0field.\t\r \u00a0In\t\r \u00a0this\t\r \u00a0Doctoral\t\r \u00a0Thesis,\t\r \u00a0it\t\r \u00a0has\t\r \u00a0been\t\r \u00a0evaluated\t\r \u00a0the\t\r \u00a0neuroprotective\t\r \u00a0activity\t\r \u00a0 against\t\r \u00a0 oxidative\t\r \u00a0 stress\t\r \u00a0of\t\r \u00a0 the\t\r \u00a0 diterpenes\t\r \u00a0andalusol,\t\r \u00a0 conchitriol,\t\r \u00a0 foliol,\t\r \u00a0lagascatriol,\t\r \u00a0linearol\t\r \u00a0and\t\r \u00a0sidol\t\r \u00a0isolated\t\r \u00a0from\t\r \u00a0Sideritis\t\r \u00a0spp.\t\r \u00a0Keywords:\t\r \u00a0diterpenes;\t\r \u00a0Sideritis;\t\r \u00a0neuroprotection.\t\r \u00a01.\t\r \u00a0INTRODUCCI\u00d3N\t\r \u00a0Las\t\r \u00a0 enfermedades\t\r \u00a0 neurodegenerativas\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 enfermedad\t\r \u00a0 de\t\r \u00a0 Alzheimer,\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Parkinson,\t\r \u00a0la\t\r \u00a0Esclerosis\t\r \u00a0Lateral\t\r \u00a0Amiotr\u00f3fica\t\r \u00a0y\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Huntington\t\r \u00a0son\t\r \u00a0procesos\t\r \u00a0cr\u00f3nicos\t\r \u00a0caracterizados\t\r \u00a0por\t\r \u00a0la\t\r \u00a0p\u00e9rdida\t\r \u00a0progresiva\t\r \u00a0de\t\r \u00a0las\t\r \u00a0neuronas\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 consiguiente\t\r \u00a0 alteraci\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 funciones\t\r \u00a0 motora,\t\r \u00a0 sensorial\t\r \u00a0 y\t\r \u00a0cognitiva.\t\r \u00a0 Estas\t\r \u00a0 enfermedades\t\r \u00a0 constituyen\t\r \u00a0 un\t\r \u00a0 problema\t\r \u00a0 de\t\r \u00a0 salud\t\r \u00a0 p\u00fablica\t\r \u00a0 a\t\r \u00a0 nivel\t\r \u00a0mundial,\t\r \u00a0que\t\r \u00a0crece\t\r \u00a0d\u00eda\t\r \u00a0a\t\r \u00a0d\u00eda\t\r \u00a0debido\t\r \u00a0al\t\r \u00a0vertiginoso\t\r \u00a0envejecimiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0poblaci\u00f3n.\t\r \u00a0La\t\r \u00a0 investigaci\u00f3n\t\r \u00a0 b\u00e1sica\t\r \u00a0 y\t\r \u00a0 cl\u00ednica\t\r \u00a0 a\u00fana\t\r \u00a0 esfuerzos\t\r \u00a0 para\t\r \u00a0 conocer\t\r \u00a0 mejor\t\r \u00a0 la\t\r \u00a0fisiopatolog\u00eda\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0enfermedades\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0para\t\r \u00a0desarrollar\t\r \u00a0nuevas\t\r \u00a0estrategias\t\r \u00a0terap\u00e9uticas\t\r \u00a0tanto\t\r \u00a0para\t\r \u00a0paliar\t\r \u00a0como\t\r \u00a0para\t\r \u00a0frenar\t\r \u00a0la\t\r \u00a0progresi\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0mismas\t\r \u00a0(1,\t\r \u00a02).\t\r \u00a0Durante\t\r \u00a0las\t\r \u00a0\u00faltimas\t\r \u00a0d\u00e9cadas,\t\r \u00a0numerosos\t\r \u00a0estudios\t\r \u00a0experimentales\t\r \u00a0in\t\r \u00a0vitro\t\r \u00a0e\t\r \u00a0in\t\r \u00a0vivo,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0estudios\t\r \u00a0post\t\r \u00a0 mortem\t\r \u00a0en\t\r \u00a0tejidos\t\r \u00a0cerebrales\t\r \u00a0humanos,\t\r \u00a0apoyan\t\r \u00a0la\t\r \u00a0implicaci\u00f3n\t\r \u00a0 del\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 patogenia\t\r \u00a0 de\t\r \u00a0 diversas\t\r \u00a0 enfermedades\t\r \u00a0neurodegenerativas,\t\r \u00a0 incluidas\t\r \u00a0 las\t\r \u00a0 anteriormente\t\r \u00a0 mencionadas\t\r \u00a0 (3,\t\r \u00a0 4).\t\r \u00a0 El\t\r \u00a0 estr\u00e9s\t\r \u00a0oxidativo,\t\r \u00a0 definido\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 alteraci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 homeostasis\t\r \u00a0 \u00f3xido-\u00ad\u2010reducci\u00f3n\t\r \u00a0intracelular\t\r \u00a0 consecuencia\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 excesiva\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 ROS\t\r \u00a0 y/o\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0deficiencia\t\r \u00a0en\t\r \u00a0los\t\r \u00a0mecanismos\t\r \u00a0antioxidantes\t\r \u00a0end\u00f3genos\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0enzim\u00e1tico\t\r \u00a0y/o\t\r \u00a0no\t\r \u00a0enzim\u00e1tico,\t\r \u00a0 puede\t\r \u00a0 conllevar\t\r \u00a0 un\t\r \u00a0 da\u00f1o\t\r \u00a0 celular\t\r \u00a0 irreversible\t\r \u00a0 e\t\r \u00a0 irreparable\t\r \u00a0 por\t\r \u00a0mecanismos\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0la\t\r \u00a0 peroxidaci\u00f3n\t\r \u00a0 lip\u00eddica\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 membranas\t\r \u00a0 celulares,\t\r \u00a0 la\t\r \u00a0modificaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0bases\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1cidos\t\r \u00a0nucleicos,\t\r \u00a0la\t\r \u00a0inactivaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas\t\r \u00a0y\t\r \u00a0la\t\r \u00a0oxidaci\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 prote\u00ednas;\t\r \u00a0 incluso\t\r \u00a0 conducir\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 muerte\t\r \u00a0 celular,\t\r \u00a0 principalmente\t\r \u00a0por\t\r \u00a0apoptosis\t\r \u00a0(5,\t\r \u00a06).\t\r \u00a0\t\r \u00a0El\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0antioxidantes\t\r \u00a0ex\u00f3genos\t\r \u00a0se\t\r \u00a0presenta\t\r \u00a0como\t\r \u00a0una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0estrategias\t\r \u00a0terap\u00e9uticas\t\r \u00a0 m\u00e1s\t\r \u00a0 prometedoras\t\r \u00a0 para\t\r \u00a0 disminuir\t\r \u00a0 o\t\r \u00a0 neutralizar\t\r \u00a0 el\t\r \u00a0 da\u00f1o\t\r \u00a0 oxidativo\t\r \u00a0ocasionado\t\r \u00a0 por\t\r \u00a0 las\t\r \u00a0 especies\t\r \u00a0 reactivas\t\r \u00a0 de\t\r \u00a0 ox\u00edgeno\t\r \u00a0 (ROS)\t\r \u00a0 (7).\t\r \u00a0 Los\t\r \u00a0 mecanismos\t\r \u00a0 de\t\r \u00a0acci\u00f3n\t\r \u00a0 descritos\t\r \u00a0 que\t\r \u00a0 definen\t\r \u00a0 la\t\r \u00a0 capacidad\t\r \u00a0 antioxidante\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 compuesto\t\r \u00a0 son\t\r \u00a0diversos:\t\r \u00a0a)\t\r \u00a0interacci\u00f3n\t\r \u00a0directa\t\r \u00a0con\t\r \u00a0especies\t\r \u00a0reactivas\t\r \u00a0o\t\r \u00a0actividad\t\r \u00a0\"scavenger\"\t\r \u00a0de\t\r \u00a0radicales\t\r \u00a0libres,\t\r \u00a0v\u00eda\t\r \u00a0\"transferencia\t\r \u00a0de\t\r \u00a0un\t\r \u00a0solo\t\r \u00a0electr\u00f3n\"\t\r \u00a0(SET)\t\r \u00a0o\t\r \u00a0v\u00eda\t\r \u00a0\"transferencia\t\r \u00a0de\t\r \u00a0un\t\r \u00a0\u00e1tomo\t\r \u00a0de\t\r \u00a0hidr\u00f3geno\"\t\r \u00a0(HAT),\t\r \u00a0b)\t\r \u00a0quelaci\u00f3n\t\r \u00a0de\t\r \u00a0metales\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0(hierro,\t\r \u00a0cobre)\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0iniciar\t\r \u00a0reacciones\t\r \u00a0de\t\r \u00a0oxidaci\u00f3n,\t\r \u00a0c)\t\r \u00a0inducci\u00f3n\t\r \u00a0o\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas\t\r \u00a0 antioxidantes\t\r \u00a0 (catalasa,\t\r \u00a0 super\u00f3xido\t\r \u00a0dismutasa,\t\r \u00a0 glutation\t\r \u00a0peroxidasa,\t\r \u00a0glutation\t\r \u00a0reductasa,\t\r \u00a0hemooxigenasa-\u00ad\u20101,\t\r \u00a0entre\t\r \u00a0otras),\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0se\t\r \u00a0traduce\t\r \u00a0en\t\r \u00a0un\t\r \u00a0mayor\t\r \u00a0equilibrio\t\r \u00a0 redox\t\r \u00a0 celular\t\r \u00a0 y\t\r \u00a0 d)\t\r \u00a0 inhibici\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 actividad,\t\r \u00a0 expresi\u00f3n\t\r \u00a0 o\t\r \u00a0 s\u00edntesis\t\r \u00a0 de\t\r \u00a0enzimas\t\r \u00a0 prooxidantes\t\r \u00a0 como\t\r \u00a0 NADPH-\u00ad\u2010oxidasa,\t\r \u00a0 mieloperoxidasa,\t\r \u00a0 \u00f3xido\t\r \u00a0 n\u00edtrico\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n364\t\r \u00a0\t\r \u00a0sintasa\t\r \u00a0y\t\r \u00a0xantina-\u00ad\u2010oxidasa,\t\r \u00a0implicadas\t\r \u00a0en\t\r \u00a0la\t\r \u00a0generaci\u00f3n\t\r \u00a0de\t\r \u00a0especies\t\r \u00a0reactivas\t\r \u00a0(8).\t\r \u00a0En\t\r \u00a0este\t\r \u00a0 contexto,\t\r \u00a0 los\t\r \u00a0 productos\t\r \u00a0 naturales\t\r \u00a0 constituyen\t\r \u00a0 una\t\r \u00a0 fuente\t\r \u00a0 inagotable\t\r \u00a0 de\t\r \u00a0principios\t\r \u00a0activos\t\r \u00a0con\t\r \u00a0potencial\t\r \u00a0antioxidante.\t\r \u00a0De\t\r \u00a0hecho,\t\r \u00a0recientes\t\r \u00a0investigaciones\t\r \u00a0han\t\r \u00a0 demostrado\t\r \u00a0 la\t\r \u00a0capacidad\t\r \u00a0 antioxidante\t\r \u00a0de\t\r \u00a0 diversos\t\r \u00a0 compuestos\t\r \u00a0 de\t\r \u00a0 origen\t\r \u00a0natural,\t\r \u00a0siendo\t\r \u00a0entre\t\r \u00a0ellos\t\r \u00a0relevantes\t\r \u00a0el\t\r \u00a0grupo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0diterpenos\t\r \u00a0(9).\t\r \u00a0\t\r \u00a0El\t\r \u00a0g\u00e9nero\t\r \u00a0Sideritis,\t\r \u00a0perteneciente\t\r \u00a0a\t\r \u00a0la\t\r \u00a0familia\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Lamiaceae,\t\r \u00a0comprende\t\r \u00a0aproximadamente\t\r \u00a0 150\t\r \u00a0 especies\t\r \u00a0 distribuidas\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 vertiente\t\r \u00a0 mediterr\u00e1nea\t\r \u00a0europea,\t\r \u00a0 africana\t\r \u00a0 y\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 asi\u00e1tica,\t\r \u00a0 extendi\u00e9ndose\t\r \u00a0 desde\t\r \u00a0 las\t\r \u00a0 islas\t\r \u00a0 Canarias\t\r \u00a0 y\t\r \u00a0Madeira\t\r \u00a0 hasta\t\r \u00a0 el\t\r \u00a0 C\u00e1ucaso\t\r \u00a0 (10).\t\r \u00a0Distintas\t\r \u00a0 especies\t\r \u00a0de\t\r \u00a0Sideritis\t\r \u00a0se\t\r \u00a0 han\t\r \u00a0 usado\t\r \u00a0tradicionalmente\t\r \u00a0 para\t\r \u00a0 preparar\t\r \u00a0 infusiones,\t\r \u00a0 como\t\r \u00a0 agentes\t\r \u00a0 saborizantes\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0con\t\r \u00a0 fines\t\r \u00a0terap\u00e9uticos\t\r \u00a0 por\t\r \u00a0sus\t\r \u00a0 propiedades\t\r \u00a0 antiinflamatorias,\t\r \u00a0 antioxidantes,\t\r \u00a0antiulcerosas,\t\r \u00a0digestivas,\t\r \u00a0antimicrobianas,\t\r \u00a0vulnerarias,\t\r \u00a0analg\u00e9sicas\t\r \u00a0y\t\r \u00a0carminativas\t\r \u00a0(11).\t\r \u00a0 M\u00e1s\t\r \u00a0 de\t\r \u00a0 160\t\r \u00a0 diterpenos,\t\r \u00a0 incluidos\t\r \u00a0 en\t\r \u00a0 al\t\r \u00a0 menos\t\r \u00a0 9\t\r \u00a0 grupos\t\r \u00a0 de\t\r \u00a0 estructuras\t\r \u00a0diferentes,\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0identificados\t\r \u00a0y\t\r \u00a0aislados\t\r \u00a0de\t\r \u00a0las\t\r \u00a0partes\t\r \u00a0a\u00e9reas\t\r \u00a0de\t\r \u00a0Sideritis\t\r \u00a0spp.\t\r \u00a0(12).\t\r \u00a0Los\t\r \u00a0compuestos\t\r \u00a0sideridiol\t\r \u00a0y\t\r \u00a0siderol\t\r \u00a0fueron\t\r \u00a0los\t\r \u00a0primeros\t\r \u00a0diterpenos\t\r \u00a0aislados\t\r \u00a0y\t\r \u00a0su\t\r \u00a0estructura\t\r \u00a0se\t\r \u00a0elucid\u00f3\t\r \u00a0durante\t\r \u00a0la\t\r \u00a0segunda\t\r \u00a0mitad\t\r \u00a0del\t\r \u00a0siglo\t\r \u00a0XX\t\r \u00a0(13,\t\r \u00a014).\t\r \u00a0Este\t\r \u00a0 trabajo\t\r \u00a0 de\t\r \u00a0 Tesis\t\r \u00a0 Doctoral\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 planteado\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0actividad\t\r \u00a0neuroprotectora,\t\r \u00a0frente\t\r \u00a0al\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo,\t\r \u00a0de\t\r \u00a0los\t\r \u00a0diterpenos\t\r \u00a0andalusol,\t\r \u00a0conchitriol,\t\r \u00a0 lagascatriol,\t\r \u00a0 foliol,\t\r \u00a0 linearol\t\r \u00a0 y\t\r \u00a0 sidol\t\r \u00a0 aislados\t\r \u00a0 de\t\r \u00a0 especies\t\r \u00a0 del\t\r \u00a0 g\u00e9nero\t\r \u00a0Sideritis\t\r \u00a0y\t\r \u00a0 su\t\r \u00a0 posible\t\r \u00a0 aplicaci\u00f3n\t\r \u00a0 en\t\r \u00a0 aquellos\t\r \u00a0 procesos\t\r \u00a0 neurodegenerativos\t\r \u00a0 que\t\r \u00a0cursen\t\r \u00a0con\t\r \u00a0da\u00f1o\t\r \u00a0celular.\t\r \u00a02.\t\r \u00a0MATERIAL\t\r \u00a0Y\t\r \u00a0M\u00c9TODOS\t\r \u00a02.1.\t\r \u00a0Diterpenos\t\r \u00a0El\t\r \u00a0 diterpeno\t\r \u00a0 de\t\r \u00a0 tipo\t\r \u00a0 labdanoandalusol\t\r \u00a0 se\t\r \u00a0 aisl\u00f3\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 especie\t\r \u00a0Sideritis\t\r \u00a0arborescens\t\r \u00a0Salzm.\t\r \u00a0(15).\t\r \u00a0Tanto\t\r \u00a0el\t\r \u00a0diterpeno\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0beyerano,\t\r \u00a0conchitriol,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0de\t\r \u00a0 tipo\t\r \u00a0 rosano,\t\r \u00a0 lagascatriol,\t\r \u00a0 se\t\r \u00a0 aislaron\t\r \u00a0 de\t\r \u00a0Sideritis\t\r \u00a0 angustifolia\t\r \u00a0Lag.\t\r \u00a0 (16-\u00ad\u201018).\t\r \u00a0 Los\t\r \u00a0diterpenos\t\r \u00a0derivados\t\r \u00a0del\t\r \u00a0kaurano,\t\r \u00a0foliol,\t\r \u00a0linearol\t\r \u00a0y\t\r \u00a0sidol\t\r \u00a0se\t\r \u00a0obtuvieron\t\r \u00a0de\t\r \u00a0Sideritis\t\r \u00a0linearifolia\t\r \u00a0Lam.\t\r \u00a0(18).\t\r \u00a0\t\r \u00a0\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0365\t\r \u00a0\t\r \u00a02.2.\t\r \u00a0L\u00edneas\t\r \u00a0celulares\t\r \u00a02.2.1.\t\r \u00a0 L\u00edneas\t\r \u00a0 celulares\t\r \u00a0 utilizadas\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 estudios\t\r \u00a0 de\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo\t\r \u00a0 y\t\r \u00a0disfunci\u00f3n\t\r \u00a0mitocondrial.\t\r \u00a0Tratamiento\t\r \u00a0celular.\t\r \u00a0L\u00ednea\t\r \u00a0celular\t\r \u00a0PC12\t\r \u00a0(Neuronas)\t\r \u00a0\t\r \u00a0La\t\r \u00a0 l\u00ednea\t\r \u00a0 celular\t\r \u00a0 PC12\t\r \u00a0 se\t\r \u00a0 adquiri\u00f3\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 colecci\u00f3n\t\r \u00a0 de\t\r \u00a0 cepas\t\r \u00a0 American\t\r \u00a0 Type\t\r \u00a0Culture\t\r \u00a0 Collection\t\r \u00a0 (ATCC).\t\r \u00a0El\t\r \u00a0 medio\t\r \u00a0 de\t\r \u00a0 cultivo\t\r \u00a0 utilizado\t\r \u00a0 es\t\r \u00a0 Dulbecco\u2019s\t\r \u00a0Modified\t\r \u00a0Eagle\u2019s\t\r \u00a0Medium\t\r \u00a0(DMEM)\t\r \u00a0(Gibco,\t\r \u00a0Invitrogen\t\r \u00a0Corporation)\t\r \u00a0suplementado\t\r \u00a0con\t\r \u00a00,5%\t\r \u00a0de\t\r \u00a0 gentamicina\t\r \u00a0 (Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0 Corporation)\t\r \u00a0 y\t\r \u00a0 0,2%\t\r \u00a0 de\t\r \u00a0 piruvato\t\r \u00a0 (Sigma-\u00ad\u2010Aldrich).\t\r \u00a0Las\t\r \u00a0c\u00e9lulas\t\r \u00a0se\t\r \u00a0mantienen\t\r \u00a0a\t\r \u00a037\u00baC\t\r \u00a0en\t\r \u00a0atm\u00f3sfera\t\r \u00a0de\t\r \u00a0aire\t\r \u00a0al\t\r \u00a095%\t\r \u00a0y\t\r \u00a0de\t\r \u00a0CO2\t\r \u00a0al\t\r \u00a05%.\t\r \u00a0L\u00ednea\t\r \u00a0celular\t\r \u00a0U373-\u00ad\u2010MG\t\r \u00a0(Astrocitos)\t\r \u00a0\t\r \u00a0La\t\r \u00a0l\u00ednea\t\r \u00a0celular\t\r \u00a0U373-\u00ad\u2010MG\t\r \u00a0se\t\r \u00a0adquiri\u00f3\t\r \u00a0desde\t\r \u00a0Sigma-\u00ad\u2010Aldrich\t\r \u00a0procedente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Colecci\u00f3n\t\r \u00a0 Europea\t\r \u00a0 de\t\r \u00a0 Cultivos\t\r \u00a0 Celulares\t\r \u00a0 Animales\t\r \u00a0 (ECACC).\t\r \u00a0 El\t\r \u00a0 medio\t\r \u00a0 de\t\r \u00a0 cultivo\t\r \u00a0empleado\t\r \u00a0 es\t\r \u00a0 Dulbecco\u2019sModifiedEagle\u2019s\t\r \u00a0 Medium\t\r \u00a0 (DMEM)\t\r \u00a0 (Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0Corporation)\t\r \u00a0 suplementado\t\r \u00a0 con\t\r \u00a0 0,5%\t\r \u00a0 de\t\r \u00a0 gentamicina\t\r \u00a0 (Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0Corporation)\t\r \u00a0y\t\r \u00a0suero\t\r \u00a0fetal\t\r \u00a0bovino\t\r \u00a0(FBS)\t\r \u00a0(Gibco,\t\r \u00a0Invitrogen\t\r \u00a0Corporation).Las\t\r \u00a0c\u00e9lulas\t\r \u00a0se\t\r \u00a0mantienen\t\r \u00a0en\t\r \u00a0condiciones\t\r \u00a0de\t\r \u00a0temperatura\t\r \u00a0y\t\r \u00a0atm\u00f3sfera\t\r \u00a0h\u00fameda\t\r \u00a0de\t\r \u00a037\u00baC,\t\r \u00a095%\t\r \u00a0de\t\r \u00a0aire\t\r \u00a0y\t\r \u00a05%\t\r \u00a0de\t\r \u00a0CO2.\t\r \u00a0Tratamiento\t\r \u00a0celular\t\r \u00a0Las\t\r \u00a0c\u00e9lulas\t\r \u00a0U373-\u00ad\u2010MG\t\r \u00a0y\t\r \u00a0PC12\t\r \u00a0se\t\r \u00a0tratan\t\r \u00a0con\t\r \u00a0los\t\r \u00a0diterpenos\t\r \u00a0objeto\t\r \u00a0de\t\r \u00a0estudio\t\r \u00a0(diferentes\t\r \u00a0concentraciones\t\r \u00a0seg\u00fan\t\r \u00a0el\t\r \u00a0propio\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Tesis)\t\r \u00a0durante\t\r \u00a024\t\r \u00a0h,\t\r \u00a0y\t\r \u00a0posteriormente\t\r \u00a0 con\t\r \u00a0 H2O2\t\r \u00a0(1\t\r \u00a0 mM\t\r \u00a0 para\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 U373-\u00ad\u2010MG\t\r \u00a0 y\t\r \u00a0 0,1\t\r \u00a0 mM\t\r \u00a0 para\t\r \u00a0 las\t\r \u00a0c\u00e9lulas\t\r \u00a0PC12)\t\r \u00a0durante\t\r \u00a030\t\r \u00a0minutos.\t\r \u00a02.2.2.\t\r \u00a0L\u00edneas\t\r \u00a0celulares\t\r \u00a0utilizadas\t\r \u00a0en\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0de\t\r \u00a0paso\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0Barrera\t\r \u00a0Hemato\t\r \u00a0Encef\u00e1lica\t\r \u00a0(BHE)\t\r \u00a0L\u00ednea\t\r \u00a0celular\t\r \u00a0RBE4\t\r \u00a0\t\r \u00a0Las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 RBE4\t\r \u00a0 fueron\t\r \u00a0 cedidas\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 Dr.\t\r \u00a0 Pierre\t\r \u00a0 Olivier\t\r \u00a0 Couraud\t\r \u00a0 del\t\r \u00a0Instituto\t\r \u00a0 Cochin\t\r \u00a0 del\t\r \u00a0 Instituto\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Salud\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Investigaci\u00f3n\t\r \u00a0 M\u00e9dica\t\r \u00a0(INSERM)\t\r \u00a0 de\t\r \u00a0 Par\u00eds\t\r \u00a0 (Francia).Las\t\r \u00a0c\u00e9lulas\t\r \u00a0 RBE4\t\r \u00a0 crecen\t\r \u00a0 en\t\r \u00a0 frascos\t\r \u00a0 de\t\r \u00a0 cultivo\t\r \u00a0tapizados\t\r \u00a0 durante\t\r \u00a0 al\t\r \u00a0 menos\t\r \u00a0 3\t\r \u00a0 horas\t\r \u00a0 con\t\r \u00a0 3\t\r \u00a0 mL\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 soluci\u00f3n\t\r \u00a0 de\t\r \u00a0 col\u00e1geno\t\r \u00a0obtenida\t\r \u00a0 a\t\r \u00a0 partir\t\r \u00a0 del\t\r \u00a0 tend\u00f3n\t\r \u00a0 de\t\r \u00a0 cola\t\r \u00a0 de\t\r \u00a0 rata.\t\r \u00a0 Las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 se\t\r \u00a0 mantienen\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0atm\u00f3sfera\t\r \u00a0de\t\r \u00a095%\t\r \u00a0de\t\r \u00a0aire\t\r \u00a0y\t\r \u00a05%\t\r \u00a0de\t\r \u00a0CO2,\t\r \u00a0saturada\t\r \u00a0de\t\r \u00a0humedad\t\r \u00a0a\t\r \u00a037\u00baC.\t\r \u00a0El\t\r \u00a0medio\t\r \u00a0de\t\r \u00a0cultivo\t\r \u00a0 empleado\t\r \u00a0 es\t\r \u00a0 Hams\t\r \u00a0 F-\u00ad\u201010/\u03b1-\u00ad\u2010Minimum\t\r \u00a0Essential\t\r \u00a0 Medium\t\r \u00a0 (\u03b1-\u00ad\u2010MEM)\t\r \u00a0 (1:1)\t\r \u00a0(Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0Corporation),\t\r \u00a0 suplementado\t\r \u00a0 con\t\r \u00a0 Glutamax\t\r \u00a0 (Sigma-\u00ad\u2010Aldrich),\t\r \u00a010%\t\r \u00a0 de\t\r \u00a0 suero\t\r \u00a0 fetal\t\r \u00a0 de\t\r \u00a0 ternero\t\r \u00a0 (Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0 Corporation),\t\r \u00a0 geneticina\t\r \u00a0 (300\t\r \u00a0\u03bcg/mL)\t\r \u00a0 (Sigma-\u00ad\u2010Aldrich)\t\r \u00a0 y\t\r \u00a0 factor\t\r \u00a0 b\u00e1sico\t\r \u00a0 de\t\r \u00a0 crecimiento\t\r \u00a0 de\t\r \u00a0 fibroblastos\t\r \u00a0 (bFGF,\t\r \u00a0 1\t\r \u00a0ng/mL)\t\r \u00a0(Boehringer).\t\r \u00a0\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n366\t\r \u00a0\t\r \u00a0L\u00ednea\t\r \u00a0celular\t\r \u00a0ECV304/C6\t\r \u00a0\t\r \u00a0La\t\r \u00a0 l\u00ednea\t\r \u00a0 celular\t\r \u00a0 ECV304\t\r \u00a0 corresponde\t\r \u00a0 a\t\r \u00a0 c\u00e9lulas\t\r \u00a0 endoteliales\t\r \u00a0 de\t\r \u00a0 cord\u00f3n\t\r \u00a0umbilical\t\r \u00a0humano.\t\r \u00a0Esta\t\r \u00a0l\u00ednea\t\r \u00a0celular\t\r \u00a0se\t\r \u00a0obtuvo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Colecci\u00f3n\t\r \u00a0Europea\t\r \u00a0de\t\r \u00a0Cultivos\t\r \u00a0Celulares\t\r \u00a0Animales\t\r \u00a0(ECACC).\t\r \u00a0La\t\r \u00a0l\u00ednea\t\r \u00a0celular\t\r \u00a0C6,\t\r \u00a0procedente\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0glioma\t\r \u00a0de\t\r \u00a0rata,\t\r \u00a0se\t\r \u00a0adquiri\u00f3\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Colecci\u00f3n\t\r \u00a0Europea\t\r \u00a0de\t\r \u00a0Cultivos\t\r \u00a0Celulares\t\r \u00a0Animales\t\r \u00a0(ECACC).\t\r \u00a0\t\r \u00a0En\t\r \u00a0 este\t\r \u00a0 trabajo,\t\r \u00a0 se\t\r \u00a0 emplearon\t\r \u00a0 sistemas\t\r \u00a0 de\t\r \u00a0 cocultivos\t\r \u00a0 entre\t\r \u00a0 las\t\r \u00a0 l\u00edneas\t\r \u00a0celulares\t\r \u00a0ECV304\t\r \u00a0y\t\r \u00a0C6.Estas\t\r \u00a0c\u00e9lulas\t\r \u00a0crecen\t\r \u00a0en\t\r \u00a0medio\t\r \u00a0M199\t\r \u00a0(Sigma)\t\r \u00a0suplementado\t\r \u00a0con\t\r \u00a0 Glutamax\t\r \u00a0 (Sigma-\u00ad\u2010Aldrich),\t\r \u00a0 10%\t\r \u00a0 de\t\r \u00a0 suero\t\r \u00a0 fetal\t\r \u00a0 de\t\r \u00a0 ternero\t\r \u00a0 (Gibco,\t\r \u00a0 Invitrogen\t\r \u00a0Corporation)\t\r \u00a0 y\t\r \u00a0 penicilina/estreptomicina\t\r \u00a0 (100\t\r \u00a0 U/mL;\t\r \u00a0 100\t\r \u00a0 \u03bcg/mL)\t\r \u00a0 (Gibco,\t\r \u00a0Invitrogen\t\r \u00a0 Corporation).\t\r \u00a0 Las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 se\t\r \u00a0 mantienen\t\r \u00a0 en\t\r \u00a0 atm\u00f3sfera\t\r \u00a0 h\u00fameda\t\r \u00a0 de\t\r \u00a0 5%\t\r \u00a0CO2/95%\t\r \u00a0aire\t\r \u00a0a\t\r \u00a037\u00baC.\t\r \u00a02.3.\t\r \u00a0M\u00e9todos\t\r \u00a0para\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0y\t\r \u00a0disfunci\u00f3n\t\r \u00a0mitocondrial\t\r \u00a0En\t\r \u00a0el\t\r \u00a0presente\t\r \u00a0resumen\t\r \u00a0de\t\r \u00a0Tesis\t\r \u00a0Doctoral\t\r \u00a0se\t\r \u00a0muestra\t\r \u00a0una\t\r \u00a0peque\u00f1a\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0empleados\t\r \u00a0en\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0y\t\r \u00a0disfunci\u00f3n\t\r \u00a0mitocondrial.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Medida\t\r \u00a0de\t\r \u00a0la\t\r \u00a0generaci\u00f3n\t\r \u00a0intracelular\t\r \u00a0de\t\r \u00a0radicales\t\r \u00a0libres:\t\r \u00a0 T\u00e9cnica\t\r \u00a0 de\t\r \u00a0diclorofluoresce\u00edna\t\r \u00a0 (DCFH-\u00ad\u2010DA)\t\r \u00a0 (19).\t\r \u00a0Tras\t\r \u00a0 los\t\r \u00a0 tratamientos,\t\r \u00a0 se\t\r \u00a0 a\u00f1aden\t\r \u00a0 200\t\r \u00a0\u03bcL/pocillo\t\r \u00a0de\t\r \u00a0una\t\r \u00a0mezcla\t\r \u00a0de\t\r \u00a0una\t\r \u00a0soluci\u00f3n\t\r \u00a0de\t\r \u00a00,01\t\r \u00a0mM\t\r \u00a0DCFH-\u00ad\u2010DA\t\r \u00a0con\t\r \u00a0PBS\t\r \u00a0glucosado\t\r \u00a0(180\t\r \u00a0mg\t\r \u00a0glucosa/100\t\r \u00a0mL\t\r \u00a0PBS\t\r \u00a0est\u00e9ril)\t\r \u00a0y\t\r \u00a0se\t\r \u00a0mantiene\t\r \u00a0la\t\r \u00a0placa\t\r \u00a0en\t\r \u00a0incubaci\u00f3n\t\r \u00a0durante\t\r \u00a030\t\r \u00a0minutos\t\r \u00a0a\t\r \u00a037\u00baC.\t\r \u00a0Despu\u00e9s\t\r \u00a0de\t\r \u00a0este\t\r \u00a0tiempo,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0se\t\r \u00a0lavan\t\r \u00a0con\t\r \u00a0200\t\r \u00a0\u03bcL/pocillo\t\r \u00a0de\t\r \u00a0 PBS\t\r \u00a0 glucosado\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 procede\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 lectura\t\r \u00a0 utilizando\t\r \u00a0 un\t\r \u00a0 Fluor\u00edmetro\t\r \u00a0 Lector\t\r \u00a0 de\t\r \u00a0microplacas\t\r \u00a0 FLx800,\t\r \u00a0 BioTek,\t\r \u00a0 Instruments,\t\r \u00a0 Inc.,\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 condiciones\t\r \u00a0 de\t\r \u00a0 lectura\t\r \u00a0 de\t\r \u00a0excitaci\u00f3n\t\r \u00a0480\t\r \u00a0nm\t\r \u00a0y\t\r \u00a0de\t\r \u00a0emisi\u00f3n\t\r \u00a0510\t\r \u00a0nm.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Determinaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0peroxidaci\u00f3n\t\r \u00a0lip\u00eddica\t\r \u00a0(20).\t\r \u00a0Para\t\r \u00a0la\t\r \u00a0cuantificaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0peroxidaci\u00f3n\t\r \u00a0lip\u00eddica\t\r \u00a0se\t\r \u00a0miden\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0MDA\t\r \u00a0presentes\t\r \u00a0en\t\r \u00a0cada\t\r \u00a0muestra\t\r \u00a0mediante\t\r \u00a0 cromatograf\u00eda\t\r \u00a0 l\u00edquida\t\r \u00a0 de\t\r \u00a0 alta\t\r \u00a0 eficacia\t\r \u00a0 (HPLC),\t\r \u00a0 siguiendo\t\r \u00a0 un\t\r \u00a0 protocolo\t\r \u00a0modificado\t\r \u00a0de\t\r \u00a0Grotto\t\r \u00a0et\t\r \u00a0al.\t\r \u00a0(2007).\t\r \u00a0-\u00ad\u2010\t\r \u00a0Determinaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0enzimas\t\r \u00a0antioxidantes.\t\r \u00a0Las\t\r \u00a0enzimas\t\r \u00a0estudiadas\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0aquellas\t\r \u00a0implicadas\t\r \u00a0en\t\r \u00a0los\t\r \u00a0principales\t\r \u00a0procesos\t\r \u00a0de\t\r \u00a0 detoxificaci\u00f3n\t\r \u00a0 de\t\r \u00a0ROS:\t\r \u00a0 catalasa\t\r \u00a0(21),\t\r \u00a0 super\u00f3xido\t\r \u00a0dismutasa\t\r \u00a0 (22),\t\r \u00a0 glutati\u00f3n\t\r \u00a0reductasa\t\r \u00a0(23)\t\r \u00a0y\t\r \u00a0glutati\u00f3n\t\r \u00a0peroxidasa\t\r \u00a0(24).\t\r \u00a0Se\t\r \u00a0ha\t\r \u00a0determinado\t\r \u00a0tanto\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0por\t\r \u00a0 t\u00e9cnicas\t\r \u00a0 espectofotom\u00e9tricas\t\r \u00a0as\u00ed\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 proteica\t\r \u00a0 de\t\r \u00a0 cada\t\r \u00a0 una\t\r \u00a0 de\t\r \u00a0ellas\t\r \u00a0mediante\t\r \u00a0Western\t\r \u00a0blot.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Determinaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial.\t\r \u00a0La\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial\t\r \u00a0se\t\r \u00a0determina\t\r \u00a0midiendo\t\r \u00a0la\t\r \u00a0fluorescencia\t\r \u00a0de\t\r \u00a0Rhod-\u00ad\u20102.Despu\u00e9s\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tratamientos,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0se\t\r \u00a0lavan\t\r \u00a0con\t\r \u00a0medio\t\r \u00a0de\t\r \u00a0Krebs\t\r \u00a0con\t\r \u00a0calcio\t\r \u00a0y\t\r \u00a0sin\t\r \u00a0sonda\t\r \u00a0fluorescente,\t\r \u00a0y\t\r \u00a0a\t\r \u00a0continuaci\u00f3n\t\r \u00a0se\t\r \u00a0incuban\t\r \u00a0durante\t\r \u00a040\t\r \u00a0minutos\t\r \u00a0a\t\r \u00a037\u00baC\t\r \u00a0en\t\r \u00a0oscuridad\t\r \u00a0con\t\r \u00a0 medio\t\r \u00a0 de\t\r \u00a0 Krebs\t\r \u00a0 con\t\r \u00a0 calcio\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 fluorescente.\t\r \u00a0Despu\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0367\t\r \u00a0\t\r \u00a0incubaci\u00f3n,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0se\t\r \u00a0lavan\t\r \u00a02\t\r \u00a0veces\t\r \u00a0con\t\r \u00a0medio\t\r \u00a0de\t\r \u00a0Krebs\t\r \u00a0sin\t\r \u00a0calcio\t\r \u00a0y\t\r \u00a0sin\t\r \u00a0sonda\t\r \u00a0fluorescente\t\r \u00a0y\t\r \u00a0se\t\r \u00a0dejan\t\r \u00a0incubar\t\r \u00a0durante\t\r \u00a030\t\r \u00a0minutos\t\r \u00a0a\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0temperatura\t\r \u00a0para\t\r \u00a0permitir\t\r \u00a0la\t\r \u00a0hidr\u00f3lisis\t\r \u00a0completa\t\r \u00a0del\t\r \u00a0\u00e9ster.\t\r \u00a0La\t\r \u00a0fluorescencia\t\r \u00a0se\t\r \u00a0mide\t\r \u00a0a\t\r \u00a037\u00baC\t\r \u00a0durante\t\r \u00a05\t\r \u00a0minutos\t\r \u00a0a\t\r \u00a0una\t\r \u00a0\u03bbexcitaci\u00f3n\t\r \u00a0de\t\r \u00a0552\t\r \u00a0nm\t\r \u00a0y\t\r \u00a0a\t\r \u00a0una\t\r \u00a0\u03bbemisi\u00f3n\t\r \u00a0de\t\r \u00a0581\t\r \u00a0nm\t\r \u00a0a\t\r \u00a037\u00baC\t\r \u00a0en\t\r \u00a0un\t\r \u00a0fluor\u00edmetro\t\r \u00a0Spectramax\t\r \u00a0Gemini\t\r \u00a0 EM\t\r \u00a0 (Molecular\t\r \u00a0 Devices).\t\r \u00a0 A\t\r \u00a0 continuaci\u00f3n,\t\r \u00a0 se\t\r \u00a0adiciona\t\r \u00a0el\t\r \u00a0ion\u00f3foro\t\r \u00a0A23187\t\r \u00a0(5\t\r \u00a0\u03bcM)\t\r \u00a0y\t\r \u00a0se\t\r \u00a0mide\t\r \u00a0la\t\r \u00a0fluorescencia\t\r \u00a0durante\t\r \u00a015\t\r \u00a0minutos\t\r \u00a0en\t\r \u00a0las\t\r \u00a0mismas\t\r \u00a0condiciones\t\r \u00a0descritas\t\r \u00a0anteriormente\t\r \u00a0(25).\t\r \u00a02.4.\t\r \u00a0M\u00e9todos\t\r \u00a0para\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0paso\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0BHE\t\r \u00a0-\u00ad\u2010\t\r \u00a0Estudios\t\r \u00a0de\t\r \u00a0permeabilidad.\t\r \u00a0El\t\r \u00a0experimento\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0se\t\r \u00a0inicia\t\r \u00a0con\t\r \u00a0la\t\r \u00a0adici\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 volumen\t\r \u00a0 de\t\r \u00a0 0,5\t\r \u00a0 mL\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 compartimento\t\r \u00a0 apical\t\r \u00a0(para\t\r \u00a0el\t\r \u00a0transporte\t\r \u00a0apical\t\r \u00a0a\t\r \u00a0basal)\t\r \u00a0y\t\r \u00a0en\t\r \u00a0un\t\r \u00a0volumen\t\r \u00a0de\t\r \u00a01,5\t\r \u00a0mL\t\r \u00a0en\t\r \u00a0el\t\r \u00a0compartimento\t\r \u00a0basal\t\r \u00a0(para\t\r \u00a0el\t\r \u00a0transporte\t\r \u00a0basal\t\r \u00a0a\t\r \u00a0apical).\t\r \u00a0Las\t\r \u00a0placas\t\r \u00a0se\t\r \u00a0incuban\t\r \u00a0a\t\r \u00a037\u00baC\t\r \u00a0en\t\r \u00a0agitaci\u00f3n\t\r \u00a0durante\t\r \u00a06\t\r \u00a0h.\t\r \u00a0Una\t\r \u00a0vez\t\r \u00a0finalizado\t\r \u00a0el\t\r \u00a0transporte,\t\r \u00a0se\t\r \u00a0toman\t\r \u00a0al\u00edcuotas\t\r \u00a0de\t\r \u00a0los\t\r \u00a0lados\t\r \u00a0apical\t\r \u00a0y\t\r \u00a0basal,\t\r \u00a0para\t\r \u00a0su\t\r \u00a0posterior\t\r \u00a0an\u00e1lisis\t\r \u00a0y\t\r \u00a0cuantificaci\u00f3n\t\r \u00a0por\t\r \u00a0HPLC\t\r \u00a0(26).\t\r \u00a03.\t\r \u00a0RESULTADOS\t\r \u00a0Y\t\r \u00a0DISCUSI\u00d3N\t\r \u00a0En\t\r \u00a0el\t\r \u00a0presente\t\r \u00a0trabajo\t\r \u00a0de\t\r \u00a0Tesis,\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0evaluado\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0 seis\t\r \u00a0 diterpenos\t\r \u00a0andalusol,\t\r \u00a0 conchitriol,\t\r \u00a0 lagascatriol,\t\r \u00a0 foliol,\t\r \u00a0 linearol\t\r \u00a0 y\t\r \u00a0 sidol\t\r \u00a0aislados\t\r \u00a0 del\t\r \u00a0 g\u00e9nero\t\r \u00a0Sideritis\t\r \u00a0frente\t\r \u00a0 al\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo\t\r \u00a0 inducido\t\r \u00a0por\t\r \u00a0 exposici\u00f3n\t\r \u00a0 a\t\r \u00a0H2O2\t\r \u00a0en\t\r \u00a0 los\t\r \u00a0 modelos\t\r \u00a0 celulares\t\r \u00a0 PC12\t\r \u00a0 (modelo\t\r \u00a0 neuronal)\t\r \u00a0 y\t\r \u00a0 U373-\u00ad\u2010MG\t\r \u00a0 (modelo\t\r \u00a0 de\t\r \u00a0astrocitoma).\t\r \u00a0Para\t\r \u00a0llevarlo\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0hemos\t\r \u00a0establecido,\t\r \u00a0en\t\r \u00a0primer\t\r \u00a0lugar,\t\r \u00a0las\t\r \u00a0condiciones\t\r \u00a0de\t\r \u00a0da\u00f1o\t\r \u00a0oxidativo\t\r \u00a0para\t\r \u00a0pasar\t\r \u00a0posteriormente\t\r \u00a0a\t\r \u00a0determinar\t\r \u00a0si\t\r \u00a0las\t\r \u00a0mol\u00e9culas\t\r \u00a0en\t\r \u00a0estudio\t\r \u00a0protegen\t\r \u00a0frente\t\r \u00a0al\t\r \u00a0mismo.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0sobre\t\r \u00a0protecci\u00f3n\t\r \u00a0celular\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0evaluado\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0viabilidad\t\r \u00a0celular,\t\r \u00a0los\t\r \u00a0cambios\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0morfolog\u00eda\t\r \u00a0celular,\t\r \u00a0el\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0 ROS\t\r \u00a0 intracelular,\t\r \u00a0 los\t\r \u00a0 cambios\t\r \u00a0 sobre\t\r \u00a0 los\t\r \u00a0 marcadores\t\r \u00a0 de\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo\t\r \u00a0(peroxidaci\u00f3n\t\r \u00a0 lip\u00eddica\t\r \u00a0 y\t\r \u00a0 ratio\t\r \u00a0 GSH/GSSG)\t\r \u00a0 y\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 actividad\t\r \u00a0 y\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0prote\u00ednas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 principales\t\r \u00a0 enzimas\t\r \u00a0 antioxidantes\t\r \u00a0 implicadas\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 sistema\t\r \u00a0 de\t\r \u00a0defensa.\t\r \u00a0 El\t\r \u00a0 efecto\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 sobre\t\r \u00a0 diferentes\t\r \u00a0 marcadores\t\r \u00a0 de\t\r \u00a0 disfunci\u00f3n\t\r \u00a0mitocondrial\t\r \u00a0como\t\r \u00a0son\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0citos\u00f3lico\t\r \u00a0y\t\r \u00a0mitocondrial,\t\r \u00a0el\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0mitocondrial\t\r \u00a0y\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0ATP\t\r \u00a0tambi\u00e9n\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0evaluados.\t\r \u00a0Los\t\r \u00a0posibles\t\r \u00a0 mecanismos\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 protecci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 en\t\r \u00a0 estudio\t\r \u00a0frente\t\r \u00a0 al\t\r \u00a0 da\u00f1o\t\r \u00a0 celular\t\r \u00a0 inducido\t\r \u00a0 por\t\r \u00a0 H2O2\t\r \u00a0han\t\r \u00a0 sido\t\r \u00a0 asimismo\t\r \u00a0 elucidados.\t\r \u00a0Finalmente,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 realizado\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 y\t\r \u00a0 posible\t\r \u00a0 mecanismo\t\r \u00a0 de\t\r \u00a0 paso\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0diterpenos\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0BHE.\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 presente\t\r \u00a0 resumen\t\r \u00a0 de\t\r \u00a0 Tesis\t\r \u00a0 Doctoral\t\r \u00a0 se\t\r \u00a0 muestra\t\r \u00a0 s\u00f3lo\t\r \u00a0 una\t\r \u00a0 peque\u00f1a\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0obtenidos.\t\r \u00a0El\t\r \u00a0 H2O2\t\r \u00a0ha\t\r \u00a0 sido\t\r \u00a0la\t\r \u00a0 mol\u00e9cula\t\r \u00a0 utilizada\t\r \u00a0 como\t\r \u00a0 agente\t\r \u00a0 generador\t\r \u00a0 de\t\r \u00a0 estr\u00e9s\t\r \u00a0oxidativo.\t\r \u00a0La\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0elevadas\t\r \u00a0concentraciones\t\r \u00a0de\t\r \u00a0H2O2\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0descrito\t\r \u00a0en\t\r \u00a0las\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n368\t\r \u00a0\t\r \u00a0fibrillas\t\r \u00a0de\t\r \u00a0amiloide\t\r \u00a0formadas\t\r \u00a0por\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0beta-\u00ad\u2010amiloide\t\r \u00a0en\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Alzheimer\t\r \u00a0 y,\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0 alfa-\u00ad\u2010sinucle\u00edna\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 enfermedad\t\r \u00a0 de\t\r \u00a0 Parkinson,\t\r \u00a0implic\u00e1ndose\t\r \u00a0a\t\r \u00a0esta\t\r \u00a0especie\t\r \u00a0reactiva\t\r \u00a0de\t\r \u00a0ox\u00edgeno\t\r \u00a0como\t\r \u00a0posible\t\r \u00a0mecanismo\t\r \u00a0causal\t\r \u00a0en\t\r \u00a0la\t\r \u00a0 muerte\t\r \u00a0 celular\t\r \u00a0 que\t\r \u00a0 ocurre\t\r \u00a0 en\t\r \u00a0 ambas\t\r \u00a0 enfermedades\t\r \u00a0 neurodegenerativas\t\r \u00a0 (27,\t\r \u00a028).Teniendo\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0que\t\r \u00a0el\t\r \u00a0principal\t\r \u00a0mecanismo\t\r \u00a0de\t\r \u00a0da\u00f1o\t\r \u00a0celular\t\r \u00a0inducido\t\r \u00a0por\t\r \u00a0H2O2\t\r \u00a0implica\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0del\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0(29),\t\r \u00a0procedimos\t\r \u00a0a\t\r \u00a0estudiar\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0exposici\u00f3n\t\r \u00a0 a\t\r \u00a0 H2O2\t\r \u00a0sobre\t\r \u00a0 el\t\r \u00a0 nivel\t\r \u00a0 de\t\r \u00a0 ROS\t\r \u00a0 intracelular\t\r \u00a0 mediante\t\r \u00a0 el\t\r \u00a0 ensayo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0diclorofluoresce\u00edna.\t\r \u00a0Como\t\r \u00a0 se\t\r \u00a0 muestra\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Figura\t\r \u00a0 1,\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0intracelulares\t\r \u00a0 de\t\r \u00a0 ROS\t\r \u00a0 se\t\r \u00a0 ven\t\r \u00a0aumentados\t\r \u00a0de\t\r \u00a0manera\t\r \u00a0significativa\t\r \u00a0en\t\r \u00a0comparaci\u00f3n\t\r \u00a0con\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0control,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0confirma\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 H2O2,\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 condiciones\t\r \u00a0 experimentales\t\r \u00a0 establecidas,\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0inductor\t\r \u00a0de\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo.\t\r \u00a0El\t\r \u00a0pretratamiento\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0PC12\t\r \u00a0y\t\r \u00a0U373-\u00ad\u2010MG\t\r \u00a0con\t\r \u00a0los\t\r \u00a0 diterpenos\t\r \u00a0 ocasiona\t\r \u00a0 una\t\r \u00a0 inhibici\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 producci\u00f3n\t\r \u00a0 de\t\r \u00a0 ROS\t\r \u00a0 intracelular,\t\r \u00a0 de\t\r \u00a0manera\t\r \u00a0significativa\t\r \u00a0para\t\r \u00a0andalusol,\t\r \u00a0lagascatriol,\t\r \u00a0linearol\t\r \u00a0y\t\r \u00a0sidol\t\r \u00a0en\t\r \u00a0los\t\r \u00a0astrocitos\t\r \u00a0y\t\r \u00a0adem\u00e1s\t\r \u00a0para\t\r \u00a0conchitriol,\t\r \u00a0en\t\r \u00a0las\t\r \u00a0neuronas\t\r \u00a0a\t\r \u00a0las\t\r \u00a0concentraciones\t\r \u00a0de\t\r \u00a05\t\r \u00a0y\t\r \u00a010\t\r \u00a0\u03bcM.\t\r \u00a0A)\t\r \u00a0Producci\u00f3n ROS intracelulares (%)\n0501001502005 \u00b5M 10 \u00b5M\nAndalusolControlH2O2H2O2 (0,1 mM)H2O2 (0,1 mM)H2O2 (0,1 mM)\nConchitriolFoliolLinearolLagascatriolSidol**# ## ### ## ## ## # ###H2O2 (0,1 mM)H2O2 (0,1 mM)H2O2 (0,1 mM)\n\t\r \u00a0\t\r \u00a0\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0369\t\r \u00a0\t\r \u00a0B)\t\r \u00a0Producci\u00f3n de ROS intracelulares ( % )\n050100150200250300\n5 \u00b5M10 \u00b5M\nAndalusolControlH2O2H2O2 (1 mM)H2O2 (1 mM)H2O2 (1 mM)H2O2 (1 mM)H2O2 (1 mM)H2O2 (1 mM)\nConchitriolFoliolLinearolLagascatriolSidol***# ## ## ## ## ## ## ## #\n Figura\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Efecto\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0ROS\t\r \u00a0intracelular.\t\r \u00a0A)\t\r \u00a0C\u00e9lulas\t\r \u00a0PC12.\t\r \u00a0B)\t\r \u00a0C\u00e9lulas\t\r \u00a0U373-\u00ad\u2010MG.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0%\t\r \u00a0de\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0ROS\t\r \u00a0intracelulares\t\r \u00a0respecto\t\r \u00a0al\t\r \u00a0control.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0 se\t\r \u00a0 expresan\t\r \u00a0 como\t\r \u00a0 media\t\r \u00a0 \u00b1\t\r \u00a0 Desviaci\u00f3n\t\r \u00a0 Est\u00e1ndar\t\r \u00a0 (n=9)\t\r \u00a0 de\t\r \u00a0 tres\t\r \u00a0 experimentos\t\r \u00a0independientes.\t\r \u00a0**\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0control;\t\r \u00a0#\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0##\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0H2O2.\t\r \u00a0Una\t\r \u00a0 vez\t\r \u00a0 demostrada\t\r \u00a0 la\t\r \u00a0 capacidad\t\r \u00a0 de\t\r \u00a0 inducci\u00f3n\t\r \u00a0 de\t\r \u00a0 ROS\t\r \u00a0 por\t\r \u00a0 H2O2,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0evaluado\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0protector\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0l\u00edpidos,\t\r \u00a0componentes\t\r \u00a0fundamentales\t\r \u00a0de\t\r \u00a0las\t\r \u00a0membranas\t\r \u00a0 y\t\r \u00a0 una,\t\r \u00a0 y\t\r \u00a0 quiz\u00e1s\t\r \u00a0 la\t\r \u00a0 primera,\t\r \u00a0 diana\t\r \u00a0 biol\u00f3gica\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 radicales\t\r \u00a0 libres.\t\r \u00a0 El\t\r \u00a0da\u00f1o\t\r \u00a0en\t\r \u00a0la\t\r \u00a0membrana\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0determinado\t\r \u00a0midiendo\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0del\t\r \u00a0producto\t\r \u00a0final\t\r \u00a0de\t\r \u00a0la\t\r \u00a0 peroxidaci\u00f3n\t\r \u00a0 lip\u00eddica\t\r \u00a0 malonildialdehido\t\r \u00a0 (MDA),\t\r \u00a0 ampliamente\t\r \u00a0 utilizado\t\r \u00a0 como\t\r \u00a0biomarcador\t\r \u00a0de\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0en\t\r \u00a0varias\t\r \u00a0enfermedades\t\r \u00a0neurodegenerativas\t\r \u00a0(30,\t\r \u00a031).\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0de\t\r \u00a0este\t\r \u00a0estudio\t\r \u00a0(Figura\t\r \u00a02)\t\r \u00a0indican\t\r \u00a0que\t\r \u00a0la\t\r \u00a0exposici\u00f3n\t\r \u00a0a\t\r \u00a0H2O2\t\r \u00a0en\t\r \u00a0c\u00e9lulas\t\r \u00a0 PC12\t\r \u00a0 y\t\r \u00a0 U373-\u00ad\u2010MG\t\r \u00a0 produce\t\r \u00a0 una\t\r \u00a0 peroxidaci\u00f3n\t\r \u00a0 lip\u00eddica\t\r \u00a0 significativa\t\r \u00a0comparado\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 control.\t\r \u00a0 El\t\r \u00a0 pretratamiento\t\r \u00a0 celular\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0objeto\t\r \u00a0de\t\r \u00a0estudio,\t\r \u00a0en\t\r \u00a0concreto\t\r \u00a0andalusol\t\r \u00a0y\t\r \u00a0linearol\t\r \u00a0(en\t\r \u00a0c\u00e9lulas\t\r \u00a0PC12)\t\r \u00a0y,\t\r \u00a0andalusol\t\r \u00a0y\t\r \u00a0lagascatriol\t\r \u00a0 (en\t\r \u00a0 c\u00e9lulas\t\r \u00a0 U373-\u00ad\u2010MG)\t\r \u00a0 protege\t\r \u00a0frente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 peroxidaci\u00f3n\t\r \u00a0 de\t\r \u00a0 l\u00edpidos\t\r \u00a0 de\t\r \u00a0membrana\t\r \u00a0inducida\t\r \u00a0por\t\r \u00a0H2O2,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0por\t\r \u00a0un\t\r \u00a0lado\t\r \u00a0confirma\t\r \u00a0que\t\r \u00a0estos\t\r \u00a0compuestos\t\r \u00a0son\t\r \u00a0capaces\t\r \u00a0de\t\r \u00a0inhibir\t\r \u00a0el\t\r \u00a0da\u00f1o\t\r \u00a0oxidativo\t\r \u00a0inducido\t\r \u00a0por\t\r \u00a0especies\t\r \u00a0reactivas\t\r \u00a0como\t\r \u00a0ROS\t\r \u00a0y\t\r \u00a0por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0se\t\r \u00a0demuestra\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0compuestos\t\r \u00a0para\t\r \u00a0interaccionar\t\r \u00a0y\t\r \u00a0 penetrar\t\r \u00a0 las\t\r \u00a0 bicapas\t\r \u00a0 lip\u00eddicas,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 le\t\r \u00a0 confiere\t\r \u00a0 valor\t\r \u00a0 a\u00f1adido\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 actividad\t\r \u00a0protectora.\t\r \u00a0\t\r \u00a0\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n370\t\r \u00a0\t\r \u00a0A)\t\r \u00a0\t\r \u00a0MDA (nmoles / mg prote\u00edna)0,00,20,40,60,81,01,21,45 \u00b5M10 \u00b5M \nH2O2AndalusolControlH2O2 (0,1 mM)**# # # #MDA (nmoles / mg prote\u00edna)0,00,20,40,60,81,01,21,45 \u00b5M 10 \u00b5M \nH2O2LinearolControlH2O2 (0,1 mM)**# # # #\t\r \u00a0\t\r \u00a0B)\t\r \u00a0MDA (nmol / mg prote\u00edna)0,00,20,40,60,81,0\n5 \u00b5M 10 \u00b5M \nH2O2AndalusolControlH2O2 (1 mM)*#   #   MDA (nmol / mg prote\u00edna)0,00,20,40,60,81,0\n5 \u00b5M 10 \u00b5M \nH2O2LagascatriolControlH2O2 (1 mM)*#   #   \t\r \u00a0Figura\t\r \u00a02.-\u00ad\u2010\t\r \u00a0Efecto\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0peroxidaci\u00f3n\t\r \u00a0lip\u00eddica.\t\r \u00a0El\t\r \u00a0grado\t\r \u00a0de\t\r \u00a0peroxidaci\u00f3n\t\r \u00a0lip\u00eddica\t\r \u00a0se\t\r \u00a0cuantifica\t\r \u00a0midiendo\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 MDA\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 extractos\t\r \u00a0 celulares\t\r \u00a0 totales\t\r \u00a0 por\t\r \u00a0 HPLC.\t\r \u00a0 Los\t\r \u00a0 resultados\t\r \u00a0 se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0nmoles/mg\t\r \u00a0prote\u00edna.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0media\t\r \u00a0\u00b1\t\r \u00a0Desviaci\u00f3n\t\r \u00a0Est\u00e1ndar\t\r \u00a0de\t\r \u00a0tres\t\r \u00a0experimentos\t\r \u00a0independientes.\t\r \u00a0*\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0**\t\r \u00a0p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0control;\t\r \u00a0#p<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0##p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0H2O2.\t\r \u00a0\t\r \u00a0La\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas\t\r \u00a0antioxidantes\t\r \u00a0es\t\r \u00a0otro\t\r \u00a0de\t\r \u00a0los\t\r \u00a0mecanismos\t\r \u00a0que\t\r \u00a0explica\t\r \u00a0 la\t\r \u00a0 acci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 compuestos\t\r \u00a0 antioxidantes.\t\r \u00a0 Cambios\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 patrones\t\r \u00a0enzim\u00e1ticos\t\r \u00a0de\t\r \u00a0catalasa\t\r \u00a0(CAT),\t\r \u00a0super\u00f3xido\t\r \u00a0dismutasa\t\r \u00a0(SOD),\t\r \u00a0glutation\t\r \u00a0peroxidada\t\r \u00a0(GPx),\t\r \u00a0 glutation\t\r \u00a0reductasa\t\r \u00a0 (GR)\t\r \u00a0 y\t\r \u00a0 hemooxigenasa-\u00ad\u20101\t\r \u00a0 (HO-\u00ad\u20101),\t\r \u00a0 entre\t\r \u00a0 otras,\t\r \u00a0 se\t\r \u00a0traducen\t\r \u00a0 en\t\r \u00a0 variaciones\t\r \u00a0 del\t\r \u00a0 balance\t\r \u00a0 redox\t\r \u00a0 celular,\t\r \u00a0 constituyendo,\t\r \u00a0 por\t\r \u00a0 tanto,\t\r \u00a0 un\t\r \u00a0biomarcador\t\r \u00a0esencial\t\r \u00a0del\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0(32,\t\r \u00a033).\t\r \u00a0As\u00ed,\t\r \u00a0con\t\r \u00a0objeto\t\r \u00a0de\t\r \u00a0profundizar\t\r \u00a0en\t\r \u00a0el/los\t\r \u00a0mecanismos\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0diterpenos\t\r \u00a0del\t\r \u00a0presente\t\r \u00a0trabajo,\t\r \u00a0procedimos\t\r \u00a0a\t\r \u00a0estudiar\t\r \u00a0el\t\r \u00a0papel\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0compuestos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas\t\r \u00a0antioxidantes,\t\r \u00a0 mediante\t\r \u00a0 t\u00e9cnicas\t\r \u00a0 espectrofotom\u00e9tricas\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 Western-\u00ad\u2010blot,\t\r \u00a0respectivamente.\t\r \u00a0 En\t\r \u00a0 nuestro\t\r \u00a0 trabajo,\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 con\t\r \u00a0 H2O2\t\r \u00a0produce\t\r \u00a0una\t\r \u00a0significativa\t\r \u00a0disminuci\u00f3n\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0como\t\r \u00a0en\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0 las\t\r \u00a0 enzimas\t\r \u00a0 anteriormente\t\r \u00a0 mencionadas.\t\r \u00a0 El\t\r \u00a0 pretratamiento\t\r \u00a0 celular\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0diterpenos\t\r \u00a0de\t\r \u00a0Sideritis\t\r \u00a0produce\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas\t\r \u00a0 antioxidantes\t\r \u00a0 end\u00f3genas\t\r \u00a0 evaluadas\t\r \u00a0 (excepto\t\r \u00a0 foliol\t\r \u00a0 en\t\r \u00a0 c\u00e9lulas\t\r \u00a0 PC12\t\r \u00a0 y\t\r \u00a0conchitriol\t\r \u00a0 y\t\r \u00a0 foliol\t\r \u00a0 en\t\r \u00a0 c\u00e9lulas\t\r \u00a0 U373-\u00ad\u2010MG),\t\r \u00a0 comparado\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 expuestas\t\r \u00a0 a\t\r \u00a0H2O2\t\r \u00a0como\t\r \u00a0\u00fanico\t\r \u00a0tratamiento.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0Figura\t\r \u00a03,\t\r \u00a0se\t\r \u00a0muestra\t\r \u00a0como\t\r \u00a0ejemplo\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0 la\t\r \u00a0 expresi\u00f3n\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 enzima\t\r \u00a0 catalasa\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 compuestos\t\r \u00a0 andalusol,\t\r \u00a0 conchitriol\t\r \u00a0 y\t\r \u00a0lagascatriol.\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0371\t\r \u00a0\t\r \u00a0Modelos\t\r \u00a0in\t\r \u00a0vitro\t\r \u00a0e\t\r \u00a0in\t\r \u00a0vivo\t\r \u00a0han\t\r \u00a0demostrado\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0evidente\t\r \u00a0una\t\r \u00a0asociaci\u00f3n\t\r \u00a0entre\t\r \u00a0 estr\u00e9s\t\r \u00a0 oxidativo\t\r \u00a0 y\t\r \u00a0 disfunci\u00f3n\t\r \u00a0 mitocondrial.\t\r \u00a0 El\t\r \u00a0 aumento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0calcio\t\r \u00a0 mitocondrial\t\r \u00a0 puede\t\r \u00a0 llevar\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 desacoplamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0fosforilaci\u00f3n\t\r \u00a0oxidativa,\t\r \u00a0y\t\r \u00a0la\t\r \u00a0consecuente\t\r \u00a0disfunci\u00f3n\t\r \u00a0mitocondrial.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0Figura\t\r \u00a04,\t\r \u00a0se\t\r \u00a0muestra\t\r \u00a0 que\t\r \u00a0 ninguno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos,\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 concentraciones\t\r \u00a0 y\t\r \u00a0 tiempo\t\r \u00a0 de\t\r \u00a0tratamiento\t\r \u00a0ensayados,\t\r \u00a0aumentan\t\r \u00a0la\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial.\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0 el\t\r \u00a0 H2O2\t\r \u00a0produce\t\r \u00a0 una\t\r \u00a0 significativa\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 calcio\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 mitocondria.\t\r \u00a0Cuando\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 se\t\r \u00a0 tratan\t\r \u00a0 durante\t\r \u00a0 24\t\r \u00a0 h\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 objeto\t\r \u00a0 de\t\r \u00a0 estudio,\t\r \u00a0previo\t\r \u00a0a\t\r \u00a0la\t\r \u00a0exposici\u00f3n\t\r \u00a0a\t\r \u00a0H2O2,\t\r \u00a0se\t\r \u00a0observa\t\r \u00a0una\t\r \u00a0disminuci\u00f3n\t\r \u00a0en\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial;\t\r \u00a0 concretamente,\t\r \u00a0 este\t\r \u00a0 efecto\t\r \u00a0 es\t\r \u00a0 significativamente\t\r \u00a0 marcado\t\r \u00a0 para\t\r \u00a0linearol,\t\r \u00a0andalusol\t\r \u00a0(5\t\r \u00a0y\t\r \u00a010\t\r \u00a0\u00b5M)\t\r \u00a0y\t\r \u00a0conchitriol\t\r \u00a0(10\t\r \u00a0\u00b5M)\t\r \u00a0en\t\r \u00a0c\u00e9lulas\t\r \u00a0PC12\t\r \u00a0y\t\r \u00a0andalusol,\t\r \u00a0lagascatriol\t\r \u00a0y\t\r \u00a0linearol\t\r \u00a0(5\t\r \u00a0y\t\r \u00a010\t\r \u00a0\u00b5M)\t\r \u00a0y\t\r \u00a0sidol\t\r \u00a0(5\t\r \u00a0\u00b5M)\t\r \u00a0en\t\r \u00a0c\u00e9lulas\t\r \u00a0U373-\u00ad\u2010MG.\t\r \u00a0Una\t\r \u00a0 vez\t\r \u00a0 demostrado\t\r \u00a0 el\t\r \u00a0 potencial\t\r \u00a0 neuroprotector\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 en\t\r \u00a0estudio,\t\r \u00a0 procedimos\t\r \u00a0 a\t\r \u00a0 evaluar\t\r \u00a0 si\t\r \u00a0 estos\t\r \u00a0 compuestos\t\r \u00a0 son\t\r \u00a0 capaces\t\r \u00a0 de\t\r \u00a0 atravesar\t\r \u00a0 la\t\r \u00a0BHE.\t\r \u00a0El\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 permeabilidad\t\r \u00a0 (Tabla\t\r \u00a0 1)\t\r \u00a0 revela\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 valores\t\r \u00a0 de\t\r \u00a0permeabilidad\t\r \u00a0 aparente\t\r \u00a0 de\t\r \u00a0 todos\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 son\t\r \u00a0 menores\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 del\t\r \u00a0compuesto\t\r \u00a0de\t\r \u00a0referencia\t\r \u00a0positivo,\t\r \u00a0propranolol,\t\r \u00a0y\t\r \u00a0mayores\t\r \u00a0que\t\r \u00a0los\t\r \u00a0del\t\r \u00a0compuesto\t\r \u00a0de\t\r \u00a0referencia\t\r \u00a0negativo,\t\r \u00a0atenolol.\t\r \u00a0Estudios\t\r \u00a0previos\t\r \u00a0han\t\r \u00a0establecido\t\r \u00a0que\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0permeabilidad\t\r \u00a0 (Papp)\t\r \u00a0 mayores\t\r \u00a0 de\t\r \u00a0 3\t\r \u00a0 x\t\r \u00a0 10-\u00ad\u20106\t\r \u00a0 cm/s\t\r \u00a0 indican\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 compuestos\t\r \u00a0pueden\t\r \u00a0 penetrar\t\r \u00a0 eficientemente\t\r \u00a0 la\t\r \u00a0 BHE\t\r \u00a0 (34).\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 el\t\r \u00a0 valor\t\r \u00a0 de\t\r \u00a0 Papp\t\r \u00a0de\t\r \u00a0 los\t\r \u00a0diferentes\t\r \u00a0diterpenos\t\r \u00a0sugiere\t\r \u00a0que\t\r \u00a0\u00e9stos\t\r \u00a0pueden\t\r \u00a0atravesar\t\r \u00a0la\t\r \u00a0BHE\t\r \u00a0v\u00eda\t\r \u00a0transcelular\t\r \u00a0por\t\r \u00a0mecanismos\t\r \u00a0de\t\r \u00a0difusi\u00f3n\t\r \u00a0pasiva.\t\r \u00a0Andalusol\t\r \u00a0y\t\r \u00a0lagascatriol\t\r \u00a0presentan\t\r \u00a0los\t\r \u00a0valores\t\r \u00a0m\u00e1s\t\r \u00a0altos\t\r \u00a0de\t\r \u00a0Papp,\t\r \u00a0linearol\t\r \u00a0y\t\r \u00a0sidol\t\r \u00a0tienen\t\r \u00a0valores\t\r \u00a0moderados\t\r \u00a0y\t\r \u00a0foliol\t\r \u00a0y\t\r \u00a0conchitriol,\t\r \u00a0los\t\r \u00a0m\u00e1s\t\r \u00a0bajos. \t\r \u00a0A)\t\r \u00a0Actividad CAT(UI / mg prote\u00edna)024681012145 \u00b5M10 \u00b5M\nH2O2AndalusolControlH2O2 (0,1 mM)ConchitriolLagascatriol*# # # # # # \n E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n372\t\r \u00a0\t\r \u00a0 B)\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Intensidad banda CAT (%)\n0204060801005 \u00b5M10 \u00b5M \nH2O2AndalusolControlH2O2 (0,1 mM)ConchitriolLagascatriol*# # # # \n\t\r \u00a0Figura\t\r \u00a03.-\u00ad\u2010\t\r \u00a0Efecto\t\r \u00a0en\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0enzima\t\r \u00a0CAT\t\r \u00a0en\t\r \u00a0c\u00e9lulas\t\r \u00a0PC12.\t\r \u00a0A)\t\r \u00a0La\t\r \u00a0actividad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0enzima\t\r \u00a0CAT\t\r \u00a0se\t\r \u00a0cuantifica\t\r \u00a0por\t\r \u00a0m\u00e9todos\t\r \u00a0espectrofotom\u00e9tricos\t\r \u00a0en\t\r \u00a0extractos\t\r \u00a0celulares\t\r \u00a0totales.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 actividad\t\r \u00a0 enzim\u00e1tica\t\r \u00a0 se\t\r \u00a0 expresan\t\r \u00a0 como\t\r \u00a0 UI/mg\t\r \u00a0 prote\u00edna.\t\r \u00a0B)\t\r \u00a0La\t\r \u00a0 expresi\u00f3n\t\r \u00a0 de\t\r \u00a0prote\u00ednas\t\r \u00a0se\t\r \u00a0determina\t\r \u00a0mediante\t\r \u00a0Western\t\r \u00a0blot\t\r \u00a0en\t\r \u00a0extractos\t\r \u00a0celulares\t\r \u00a0totales.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0de\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0%\t\r \u00a0de\t\r \u00a0intensidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0banda,\t\r \u00a0consider\u00e1ndose\t\r \u00a0como\t\r \u00a0100%\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0control.\t\r \u00a0La\t\r \u00a0\u00df-\u00ad\u2010actina\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0como\t\r \u00a0normalizador\t\r \u00a0de\t\r \u00a0carga.\t\r \u00a0Se\t\r \u00a0muestra\t\r \u00a0una\t\r \u00a0membrana\t\r \u00a0representativa\t\r \u00a0de\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0CAT\t\r \u00a0(n=3).\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0media\t\r \u00a0\u00b1\t\r \u00a0Desviaci\u00f3n\t\r \u00a0Est\u00e1ndar\t\r \u00a0de\t\r \u00a0tres\t\r \u00a0experimentos\t\r \u00a0independientes.\t\r \u00a0*\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0**\t\r \u00a0p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0control;\t\r \u00a0#p<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0##p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0H2O2.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\u00df-ACTINA\t\r \u00a0\n10\t\r \u00a010\t\r \u00a0(\u00b5M)\t\r \u00a05\t\r \u00a0Control\t\r \u00a0H2O2\t\r \u00a05\t\r \u00a0Andalusol\t\r \u00a0Conchitriol\t\r \u00a0Lagascatriol\t\r \u00a0H2O2\t\r \u00a05\t\r \u00a010\t\r \u00a0CAT\t\r \u00a0\u0392-\u00ad\u2010Actina\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0373\t\r \u00a0\t\r \u00a0Nivel Ca2+mitocondrial (relativo al control)1,01,21,41,61,8Control H2O2 (0,1 mM)5 \u00b5M10 \u00b5M5 \u00b5M + H2O2 (0,1 mM)10 \u00b5M + H2O2 (0,1 mM) \nAndalusolConchitriolLagascatriolFoliolLinearolSidol**#  #  #  #  #  \n \t\r \u00a0Nivel Ca2+mitocondrial (relativo al control)1,01,21,41,61,8Control H2O2 (1 mM)5 \u00b5M10 \u00b5M5 \u00b5M + H2O2 (1 mM)10 \u00b5M + H2O2 (1 mM) \nAndalusolConchitriolLagascatriolFoliolLinearolSidol**#  #  #  #  \n Figura\t\r \u00a04.-\u00ad\u2010\t\r \u00a0Efecto\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial.\t\r \u00a0Los\t\r \u00a0cambios\t\r \u00a0en\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0mitocondrial\t\r \u00a0se\t\r \u00a0determinan\t\r \u00a0por\t\r \u00a0fluorescencia\t\r \u00a0empleando\t\r \u00a0el\t\r \u00a0cati\u00f3n\t\r \u00a0lipof\u00edlico\t\r \u00a0fluorescente\t\r \u00a0Rhod-\u00ad\u20102.\t\r \u00a0Los\t\r \u00a0 resultados\t\r \u00a0 se\t\r \u00a0 expresan\t\r \u00a0 como\t\r \u00a0 media\t\r \u00a0 \u00b1\t\r \u00a0 Desviaci\u00f3n\t\r \u00a0 Est\u00e1ndar\t\r \u00a0 (n=9)\t\r \u00a0 de\t\r \u00a0 tres\t\r \u00a0 experimentos\t\r \u00a0independientes.\t\r \u00a0*\t\r \u00a0p\t\r \u00a0<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0**\t\r \u00a0p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0control;\t\r \u00a0#p<\t\r \u00a00,05\t\r \u00a0y\t\r \u00a0##p<\t\r \u00a00,01\t\r \u00a0versus\t\r \u00a0H2O2.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0A)\t\r \u00a0\nB)\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n374\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Estudios\t\r \u00a0de\t\r \u00a0permeabilidad.\t\r \u00a0El\t\r \u00a0transporte\t\r \u00a0de\t\r \u00a0los\t\r \u00a0diferentes\t\r \u00a0diterpenos\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0evaluado\t\r \u00a0durante\t\r \u00a06\t\r \u00a0horas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0direcciones\t\r \u00a0absortiva(A-\u00ad\u2010B)\t\r \u00a0y\t\r \u00a0secretora\t\r \u00a0(B-\u00ad\u2010A).\t\r \u00a0Los\t\r \u00a0compuestos\t\r \u00a0de\t\r \u00a0referencia\t\r \u00a0propranolol\t\r \u00a0 y\t\r \u00a0 atenolol\t\r \u00a0 se\t\r \u00a0 utilizan\t\r \u00a0 como\t\r \u00a0 control\t\r \u00a0 positivo\t\r \u00a0 y\t\r \u00a0 negativo,\t\r \u00a0 respectivamente.\t\r \u00a0 El\t\r \u00a0 ratio\t\r \u00a0 se\t\r \u00a0determina\t\r \u00a0como\t\r \u00a0Papp(B-\u00ad\u2010A)/Papp(A-\u00ad\u2010B).\t\r \u00a0El\t\r \u00a0porcentaje\t\r \u00a0de\t\r \u00a0recuperaci\u00f3n\t\r \u00a0se\t\r \u00a0calcula\t\r \u00a0como\t\r \u00a0100\t\r \u00a0\u2013\t\r \u00a0Mc\u00e9lulas,\t\r \u00a0siendo\t\r \u00a0Mc\u00e9lulas\t\r \u00a0la\t\r \u00a0cantidad\t\r \u00a0de\t\r \u00a0compuesto\t\r \u00a0retenido\t\r \u00a0en\t\r \u00a0las\t\r \u00a0membranas.\t\r \u00a0)\t\r \u00a0[Mc\u00e9lulas\t\r \u00a0=\t\r \u00a0MD0\t\r \u00a0\u2013\t\r \u00a0(MDt\t\r \u00a0+\t\r \u00a0\u03a3MR)]\t\r \u00a0(ver\t\r \u00a0material\t\r \u00a0y\t\r \u00a0m\u00e9todos\t\r \u00a02.3.2.4.).\t\r \u00a0Los\t\r \u00a0datos\t\r \u00a0se\t\r \u00a0expresan\t\r \u00a0como\t\r \u00a0media\t\r \u00a0\u00b1\t\r \u00a0Desviaci\u00f3n\t\r \u00a0Est\u00e1ndar.\t\r \u00a0Compuesto\t\r \u00a0\t\r \u00a0Papp(x\t\r \u00a010-\u00ad\u20106\t\r \u00a0cm/s)\t\r \u00a0\t\r \u00a0\t\r \u00a0Pappcorregido(x\t\r \u00a010-\u00ad\u20106\t\r \u00a0cm/s)\t\r \u00a0\t\r \u00a0\t\r \u00a0Ratio\t\r \u00a0\t\r \u00a0\t\r \u00a0Ratiocorregido\t\r \u00a0\t\r \u00a0%\t\r \u00a0Recuperaci\u00f3n\t\r \u00a0\t\r \u00a0A-\u00ad\u2010B\t\r \u00a0B-\u00ad\u2010A\t\r \u00a0A-\u00ad\u2010B\t\r \u00a0B-\u00ad\u2010A\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Andalusol\t\r \u00a09,1\t\r \u00a0\u00b1\t\r \u00a01,1\t\r \u00a09,5\t\r \u00a0\u00b1\t\r \u00a02,8\t\r \u00a011,4\t\r \u00a0\u00b1\t\r \u00a02,1\t\r \u00a011,6\t\r \u00a0\u00b1\t\r \u00a02,6\t\r \u00a00,9\t\r \u00a01,0\t\r \u00a078,8\t\r \u00a0\u00b1\t\r \u00a03,1\t\r \u00a0Conchitriol\t\r \u00a04,6\t\r \u00a0\u00b1\t\r \u00a00,9\t\r \u00a04,8\t\r \u00a0\u00b1\t\r \u00a01,4\t\r \u00a04,8\t\r \u00a0\u00b1\t\r \u00a01,1\t\r \u00a04,9\t\r \u00a0\u00b1\t\r \u00a01,6\t\r \u00a00,9\t\r \u00a01,0\t\r \u00a088,1\t\r \u00a0\u00b1\t\r \u00a02,2\t\r \u00a0Foliol\t\r \u00a03,8\t\r \u00a0\u00b1\t\r \u00a01,3\t\r \u00a03,7\t\r \u00a0\u00b1\t\r \u00a01,9\t\r \u00a04,0\t\r \u00a0\u00b1\t\r \u00a01,2\t\r \u00a04,2\t\r \u00a0\u00b1\t\r \u00a01,5\t\r \u00a00,9\t\r \u00a00,9\t\r \u00a090,5\t\r \u00a0\u00b1\t\r \u00a02,3\t\r \u00a0Lagascatriol\t\r \u00a08,8\t\r \u00a0\u00b1\t\r \u00a00,3\t\r \u00a08,9\t\r \u00a0\u00b1\t\r \u00a00,5\t\r \u00a010,7\t\r \u00a0\u00b1\t\r \u00a01,8\t\r \u00a010,8\t\r \u00a0\u00b1\t\r \u00a01,5\t\r \u00a01,0\t\r \u00a01,0\t\r \u00a081,5\t\r \u00a0\u00b1\t\r \u00a02,9\t\r \u00a0Linearol\t\r \u00a06,3\t\r \u00a0\u00b1\t\r \u00a00,5\t\r \u00a06,6\t\r \u00a0\u00b1\t\r \u00a01,1\t\r \u00a08,2\t\r \u00a0\u00b1\t\r \u00a01,1\t\r \u00a08,3\t\r \u00a0\u00b1\t\r \u00a00,9\t\r \u00a00,9\t\r \u00a01,0\t\r \u00a083,6\t\r \u00a0\u00b1\t\r \u00a03,3\t\r \u00a0Sidol\t\r \u00a06,9\t\r \u00a0\u00b1\t\r \u00a01,4\t\r \u00a07,\t\r \u00a02\u00b1\t\r \u00a00,5\t\r \u00a08,5\t\r \u00a0\u00b1\t\r \u00a01,7\t\r \u00a08,6\t\r \u00a0\u00b1\t\r \u00a00,9\t\r \u00a00,9\t\r \u00a01,0\t\r \u00a084,5\t\r \u00a0\u00b1\t\r \u00a02,8\t\r \u00a0Propranolol\t\r \u00a014,3\t\r \u00a0\u00b1\t\r \u00a01,1\t\r \u00a014,8\t\r \u00a0\u00b1\t\r \u00a00,7\t\r \u00a015,1\t\r \u00a0\u00b1\t\r \u00a01,3\t\r \u00a015,6\t\r \u00a0\u00b1\t\r \u00a01,5\t\r \u00a00,9\t\r \u00a01,0\t\r \u00a095,6\t\r \u00a0\u00b1\t\r \u00a01,9\t\r \u00a0Atenolol\t\r \u00a00,7\t\r \u00a0\u00b1\t\r \u00a00,4\t\r \u00a00,8\t\r \u00a0\u00b1\t\r \u00a00,3\t\r \u00a00,7\t\r \u00a0\u00b1\t\r \u00a00,6\t\r \u00a00,8\t\r \u00a0\u00b1\t\r \u00a00,5\t\r \u00a00,9\t\r \u00a00,9\t\r \u00a098,4\t\r \u00a0\u00b1\t\r \u00a02,1\t\r \u00a04.\t\r \u00a0CONCLUSIONES\t\r \u00a0Los\t\r \u00a0diterpenos\t\r \u00a0estudiados\t\r \u00a0ejercen\t\r \u00a0un\t\r \u00a0efecto\t\r \u00a0neuroprotector\t\r \u00a0frente\t\r \u00a0al\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0inducido\t\r \u00a0por\t\r \u00a0per\u00f3xido\t\r \u00a0de\t\r \u00a0hidr\u00f3geno,\t\r \u00a0inhibiendo\t\r \u00a0la\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0ROS,\t\r \u00a0aumentando\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0y\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0enzimas\t\r \u00a0antioxidantes\t\r \u00a0y\t\r \u00a0atenuando\t\r \u00a0los\t\r \u00a0cambios\t\r \u00a0derivados\t\r \u00a0del\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0a\t\r \u00a0nivel\t\r \u00a0mitocondrial.\t\r \u00a0\t\r \u00a0De\t\r \u00a0forma\t\r \u00a0global,\t\r \u00a0al\t\r \u00a0comparar\t\r \u00a0la\t\r \u00a0eficiencia\t\r \u00a0protectora\t\r \u00a0de\t\r \u00a0los\t\r \u00a06\t\r \u00a0diterpenos\t\r \u00a0de\t\r \u00a0Sideritis\t\r \u00a0spp.\t\r \u00a0frente\t\r \u00a0al\t\r \u00a0estr\u00e9s\t\r \u00a0oxidativo\t\r \u00a0inducido\t\r \u00a0por\t\r \u00a0H2O2,\t\r \u00a0se\t\r \u00a0observa\t\r \u00a0un\t\r \u00a0patr\u00f3n\t\r \u00a0de\t\r \u00a0actividad\t\r \u00a0similar\t\r \u00a0pero\t\r \u00a0no\t\r \u00a0id\u00e9ntico\t\r \u00a0para\t\r \u00a0todos\t\r \u00a0estos\t\r \u00a0compuestos\t\r \u00a0en\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0l\u00edneas\t\r \u00a0celulares\t\r \u00a0 estudiadas.\t\r \u00a0 As\u00ed,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 l\u00ednea\t\r \u00a0 celular\t\r \u00a0 PC12,\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0andalusol\t\r \u00a0 y\t\r \u00a0linearol\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0los\t\r \u00a0m\u00e1s\t\r \u00a0activos,\t\r \u00a0seguidos\t\r \u00a0de\t\r \u00a0sidol,\t\r \u00a0lagascatriol\t\r \u00a0y\t\r \u00a0conchitriol,\t\r \u00a0y\t\r \u00a0por\t\r \u00a0\u00faltimo,\t\r \u00a0el\t\r \u00a0compuesto\t\r \u00a0menos\t\r \u00a0activo\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0foliol.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0realizados\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0 l\u00ednea\t\r \u00a0 celular\t\r \u00a0 U373-\u00ad\u2010MG,\t\r \u00a0 los\t\r \u00a0 diterpenos\t\r \u00a0 que\t\r \u00a0 han\t\r \u00a0 ejercido\t\r \u00a0 el\t\r \u00a0 mayor\t\r \u00a0 efecto\t\r \u00a0citoprotector\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0andalusol\t\r \u00a0y\t\r \u00a0lagascatriol,\t\r \u00a0seguidos\t\r \u00a0de\t\r \u00a0linearol\t\r \u00a0y\t\r \u00a0sidol,\t\r \u00a0y\t\r \u00a0por\t\r \u00a0\u00faltimo,\t\r \u00a0de\t\r \u00a0conchitriol\t\r \u00a0y\t\r \u00a0foliol.\t\r \u00a05.\t\r \u00a0AGRADECIMIENTOS\t\r \u00a0Este\t\r \u00a0 trabajo\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 realizado\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Departamento\t\r \u00a0 de\t\r \u00a0 Farmacolog\u00eda\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0Complutense\t\r \u00a0de\t\r \u00a0Madrid\t\r \u00a0gracias\t\r \u00a0a\t\r \u00a0una\t\r \u00a0beca\t\r \u00a0predoctoral\t\r \u00a0 de\t\r \u00a0 Formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 Profesorado\t\r \u00a0 Universitario\t\r \u00a0 (FPU)\t\r \u00a0 del\t\r \u00a0 Ministerio\t\r \u00a0 de\t\r \u00a0Ciencia\t\r \u00a0e\t\r \u00a0Innovaci\u00f3n.\t\r \u00a0\t\r \u00a0Estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0neuroprotectora\t\r \u00a0de\t\r \u00a0diterpenos\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0375\t\r \u00a0\t\r \u00a06.\t\r \u00a0REFERENCIAS\t\r \u00a01. Ehrnhoefer,\t\r \u00a0 D.E.;\t\r \u00a0 Wong,\t\r \u00a0 B.K.;\t\r \u00a0 Hayden,\t\r \u00a0 M.R.\t\r \u00a0 Convergent\t\r \u00a0 pathogenic\t\r \u00a0 pathways\t\r \u00a0 in\t\r \u00a0Alzheimer's\t\r \u00a0 and\t\r \u00a0 Huntington's\t\r \u00a0 diseases:\t\r \u00a0 shared\t\r \u00a0 targets\t\r \u00a0 for\t\r \u00a0 drug\t\r \u00a0 development.\t\r \u00a0NatureReviewsDrug\t\r \u00a0Discovery10,\t\r \u00a0853-\u00ad\u2010867\t\r \u00a0(2011).\t\r \u00a02. Katsuno,\t\r \u00a0M.,\t\r \u00a0Tanaka,\t\r \u00a0F.,\t\r \u00a0Sobue,\t\r \u00a0G.\t\r \u00a0Perspectives\t\r \u00a0on\t\r \u00a0molecular\t\r \u00a0targeted\t\r \u00a0therapies\t\r \u00a0and\t\r \u00a0clinical\t\r \u00a0trials\t\r \u00a0 for\t\r \u00a0 neurodegenerative\t\r \u00a0 diseases.\t\r \u00a0 Journal\t\r \u00a0of\t\r \u00a0Neurology,\t\r \u00a0Neurosurgery,\t\r \u00a0 and\t\r \u00a0Psychiatry83,\t\r \u00a0329-\u00ad\u2010335\t\r \u00a0(2012).\t\r \u00a03. Barnham,\t\r \u00a0 K.J.,\t\r \u00a0 Masters,\t\r \u00a0 C.L.,\t\r \u00a0 Bush\t\r \u00a0 A.I.\t\r \u00a0 Neurodegenerative\t\r \u00a0 diseases\t\r \u00a0 and\t\r \u00a0 oxidative\t\r \u00a0 stress\t\r \u00a0Nature\t\r \u00a0Reviews\t\r \u00a0Drug\t\r \u00a0Discovery3,\t\r \u00a0205\u2013214\t\r \u00a0(2004).\t\r \u00a04. Hayashi,\t\r \u00a0 M.,\t\r \u00a0 Miyata,\t\r \u00a0 R.,\t\r \u00a0 Tanuma,\t\r \u00a0 N.\t\r \u00a0 Oxidative\t\r \u00a0 stress\t\r \u00a0 in\t\r \u00a0 developmental\t\r \u00a0 brain\t\r \u00a0disorders.Advances\t\r \u00a0in\t\r \u00a0Experimental\t\r \u00a0Medicine\t\r \u00a0and\t\r \u00a0Biology724,\t\r \u00a0278-\u00ad\u2010290\t\r \u00a0(2012).\t\r \u00a05. Valko,\t\r \u00a0M.,\t\r \u00a0Morris,\t\r \u00a0H.,\t\r \u00a0Cronin,\t\r \u00a0M.T.\t\r \u00a0Metals,\t\r \u00a0toxicity\t\r \u00a0and\t\r \u00a0oxidative\t\r \u00a0stress.\t\r \u00a0Current\t\r \u00a0Medicinal\t\r \u00a0Chemistry12,\t\r \u00a01161\u20131208\t\r \u00a0(2005).\t\r \u00a06. Avery,\t\r \u00a0S.V.\t\r \u00a0Molecular\t\r \u00a0targets\t\r \u00a0of\t\r \u00a0oxidative\t\r \u00a0stress.\t\r \u00a0Biochemical\t\r \u00a0Journal434,\t\r \u00a0201\u2013210\t\r \u00a0(2011).\t\r \u00a07. Floyd,\t\r \u00a0 R.A.\t\r \u00a0 Antioxidants,\t\r \u00a0 oxidative\t\r \u00a0 stress,\t\r \u00a0 and\t\r \u00a0 degenerative\t\r \u00a0 neurological\t\r \u00a0 disorders.\t\r \u00a0Proceedings\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Society\t\r \u00a0for\t\r \u00a0Experimental\t\r \u00a0Biology\t\r \u00a0and\t\r \u00a0Medicine222,\t\r \u00a0236\u2013245\t\r \u00a0(1999).\t\r \u00a08. Ndhlala,\t\r \u00a0 A.R.,\t\r \u00a0 Moyo,\t\r \u00a0 M.,\t\r \u00a0 Van\t\r \u00a0 Staden,\t\r \u00a0 J.\t\r \u00a0Natural\t\r \u00a0 antioxidants:\t\r \u00a0 fascinating\t\r \u00a0 or\t\r \u00a0 mythical\t\r \u00a0biomolecules?\t\r \u00a0Molecules\t\r \u00a015,\t\r \u00a06905-\u00ad\u20106930\t\r \u00a0(2010).\t\r \u00a09. Gonz\u00e1lez-\u00ad\u2010Burgos,\t\r \u00a0E.,\t\r \u00a0G\u00f3mez-\u00ad\u2010Serranillos,\t\r \u00a0M.P.\t\r \u00a0Terpene\t\r \u00a0compounds\t\r \u00a0in\t\r \u00a0nature:\t\r \u00a0A\t\r \u00a0review\t\r \u00a0of\t\r \u00a0their\t\r \u00a0potential\t\r \u00a0antioxidant\t\r \u00a0activity.\t\r \u00a0Current\t\r \u00a0Medicinal\t\r \u00a0Chemistry19,\t\r \u00a05319-\u00ad\u20105341\t\r \u00a0(2012).\t\r \u00a010. Lo\u011fo\u011flu,\t\r \u00a0 E.,\t\r \u00a0 Arslan,\t\r \u00a0 S.,\t\r \u00a0 \u00d6ktemer,\t\r \u00a0 A.,\t\r \u00a0 \u015eakiyan,\t\r \u00a0 \u0130.\t\r \u00a0 Biological\t\r \u00a0 activities\t\r \u00a0 of\t\r \u00a0 some\t\r \u00a0 natural\t\r \u00a0compounds\t\r \u00a0from\t\r \u00a0SideritissipyleaBoiss.\t\r \u00a0Phytotherapy\t\r \u00a0Research20,\t\r \u00a0294-\u00ad\u2010297\t\r \u00a0(2006).\t\r \u00a011. Gonz\u00e1lez-\u00ad\u2010Burgos,\t\r \u00a0E.,\t\r \u00a0Carretero,\t\r \u00a0M.E.,\t\r \u00a0G\u00f3mez-\u00ad\u2010Serranillos,\t\r \u00a0M.P.\t\r \u00a0Sideritis\t\r \u00a0spp.:\t\r \u00a0Uses,\t\r \u00a0chemical\t\r \u00a0composition\t\r \u00a0and\t\r \u00a0pharmacological\t\r \u00a0activities-\u00ad\u2010\t\r \u00a0A\t\r \u00a0review.\t\r \u00a0Journal\t\r \u00a0ofEthnopharmacology135,\t\r \u00a0209-\u00ad\u2010225\t\r \u00a0(2011).\t\r \u00a012. Piozzi,\t\r \u00a0F.,\t\r \u00a0Bruno,\t\r \u00a0M.,\t\r \u00a0Rosselli,\t\r \u00a0S.,\t\r \u00a0Maggio,\t\r \u00a0A.\t\r \u00a0The\t\r \u00a0diterpenoids\t\r \u00a0from\t\r \u00a0the\t\r \u00a0genus\t\r \u00a0Sideritis.\t\r \u00a0En:\t\r \u00a0Atta-\u00ad\u2010ur-\u00ad\u2010Rahman\t\r \u00a0(Ed)\t\r \u00a0Studies\t\r \u00a0in\t\r \u00a0natural\t\r \u00a0products\t\r \u00a0chemistry\t\r \u00a033,\t\r \u00a0493-\u00ad\u2010540\t\r \u00a0(2006).\t\r \u00a0Bioactive\t\r \u00a0Natural\t\r \u00a0Products.\t\r \u00a0Elservier.\t\r \u00a013. Venturella,\t\r \u00a0 P.,\t\r \u00a0 Bellino,\t\r \u00a0 A.\t\r \u00a0 Constituents\t\r \u00a0 of\t\r \u00a0Stachysitalica.\t\r \u00a0 Atti\t\r \u00a0 de\t\r \u00a0 ll\u2019AccademiaNazionale\t\r \u00a0 di\t\r \u00a0ScienzeArti\t\r \u00a0Palermo\t\r \u00a0IV\t\r \u00a024,\t\r \u00a095-\u00ad\u201099\t\r \u00a0(1965).\t\r \u00a014. Piozzi,\t\r \u00a0 F.,\t\r \u00a0 Venturella,\t\r \u00a0 P.,\t\r \u00a0 Bellino,\t\r \u00a0 A.,\t\r \u00a0 Mondelli,\t\r \u00a0 R.\t\r \u00a0 DiterpenesfromSideritissiculaUcria.\t\r \u00a0Tetrahedron24,\t\r \u00a04073-\u00ad\u20104081\t\r \u00a0(1968).\t\r \u00a015. vonCarstenn-\u00ad\u2010Lichterfelde,\t\r \u00a0C.,\t\r \u00a0Valverde,\t\r \u00a0S.,\t\r \u00a0Rodriguez,\t\r \u00a0B.\t\r \u00a0Studies\t\r \u00a0on\t\r \u00a0diterpenes\t\r \u00a0from\t\r \u00a0genus\t\r \u00a0Sideritis.\t\r \u00a0 XIII\t\r \u00a0 two\t\r \u00a0 new\t\r \u00a0 stachene\t\r \u00a0 derivatives\t\r \u00a0 from\t\r \u00a0Sideritisangustifolia\t\r \u00a0(Labiatae).\t\r \u00a0AustralianJournal\t\r \u00a0of\t\r \u00a0Chemistry27,\t\r \u00a0517\u2013529\t\r \u00a0(1974).\t\r \u00a016. Mart\u00edn\t\r \u00a0Panizo,\t\r \u00a0F.,\t\r \u00a0Rodriguez,\t\r \u00a0B.,\t\r \u00a0Valverde,\t\r \u00a0S.\t\r \u00a0Lagascatriol,\t\r \u00a0a\t\r \u00a0new\t\r \u00a0diterpenoidfromSideritis\t\r \u00a0angustifoliaLag.\t\r \u00a0(Labiateae).\t\r \u00a0Anales\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a068,\t\r \u00a01463-\u00ad\u20101465\t\r \u00a0(1972).\t\r \u00a017. Mart\u00edn\t\r \u00a0 Panizo,\t\r \u00a0 F.,\t\r \u00a0 Rodr\u00edguez,\t\r \u00a0 B.,\t\r \u00a0 Valverde,\t\r \u00a0 S.\t\r \u00a0 Estructura\t\r \u00a0 total\t\r \u00a0 revisada\t\r \u00a0 del\t\r \u00a0 lagascatriol,\t\r \u00a0nuevo\t\r \u00a0diterpeno\t\r \u00a0de\t\r \u00a0\u201cSideritis\t\r \u00a0angustifolia\u201d\t\r \u00a0Lag.\t\r \u00a0Anales\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a070,\t\r \u00a0164-\u00ad\u2010171\t\r \u00a0(1974).\t\r \u00a018. Garc\u00eda\t\r \u00a0 de\t\r \u00a0 Quesada,\t\r \u00a0 T.,\t\r \u00a0 Rodr\u00edguez,\t\r \u00a0 B.,\t\r \u00a0 Valverde,\t\r \u00a0 S.\t\r \u00a0 Six\t\r \u00a0 new\t\r \u00a0diterpenesfromSideritisleucanthaCav.\t\r \u00a0 and\t\r \u00a0Sideritislinearifolia\t\r \u00a0Lam.\t\r \u00a0 TetrahedronLetter22,\t\r \u00a02187-\u00ad\u20102190\t\r \u00a0(1972).\t\r \u00a019. LeBel,\t\r \u00a0C.P.,\t\r \u00a0Ischiropoulos\t\r \u00a0H.,\t\r \u00a0Bondy\t\r \u00a0S.C.\t\r \u00a0Evaluation\t\r \u00a0of\t\r \u00a0the\t\r \u00a0probe\t\r \u00a02',7'-\u00ad\u2010dichlorofluorescin\t\r \u00a0as\t\r \u00a0an\t\r \u00a0indicator\t\r \u00a0of\t\r \u00a0reactive\t\r \u00a0oxygen\t\r \u00a0species\t\r \u00a0formation\t\r \u00a0and\t\r \u00a0oxidative\t\r \u00a0stress.\t\r \u00a0Chemical\t\r \u00a0Research\t\r \u00a0in\t\r \u00a0Toxicology5,\t\r \u00a0227-\u00ad\u2010231\t\r \u00a0(1992).\t\r \u00a020. Grotto,\t\r \u00a0D.,\t\r \u00a0Santa\t\r \u00a0Maria,\t\r \u00a0L.D.,\t\r \u00a0Boeira,\t\r \u00a0S.,\t\r \u00a0Valentini,\t\r \u00a0J.,\t\r \u00a0Char\u00e3o,\t\r \u00a0M.F.,\t\r \u00a0Moro,\t\r \u00a0A.M.,\t\r \u00a0Nascimiento,\t\r \u00a0P.C.,\t\r \u00a0Pomblum,\t\r \u00a0V.J.,\t\r \u00a0Garcia,\t\r \u00a0S.C.\t\r \u00a0Rapid\t\r \u00a0quantification\t\r \u00a0of\t\r \u00a0malondialdehyde\t\r \u00a0in\t\r \u00a0plasma\t\r \u00a0by\t\r \u00a0high\t\r \u00a0performance\t\r \u00a0 liquid\t\r \u00a0 chromatography-\u00ad\u2010visible\t\r \u00a0 detetion.\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0Pharmaceutical\t\r \u00a0and\t\r \u00a0Biomedical\t\r \u00a0Analysis\t\r \u00a043,\t\r \u00a0619-\u00ad\u2010624\t\r \u00a0(2007).\t\r \u00a021. Aebi,\t\r \u00a0H.\t\r \u00a0Catalasein\t\r \u00a0vitro.\t\r \u00a0Methods\t\r \u00a0in\t\r \u00a0Enzymology105,\t\r \u00a0121-\u00ad\u2010125\t\r \u00a0(1984).\t\r \u00a022. Marklund,\t\r \u00a0S.,\t\r \u00a0Marklund,\t\r \u00a0G.\t\r \u00a0Involvement\t\r \u00a0of\t\r \u00a0the\t\r \u00a0superoxide\t\r \u00a0anion\t\r \u00a0radical\t\r \u00a0in\t\r \u00a0the\t\r \u00a0autoxidation\t\r \u00a0of\t\r \u00a0 pyrogallol\t\r \u00a0 and\t\r \u00a0 a\t\r \u00a0 convenient\t\r \u00a0 assay\t\r \u00a0 for\t\r \u00a0 superoxide\t\r \u00a0 dismutase.\t\r \u00a0European\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0Biochemistry47,\t\r \u00a0469-\u00ad\u2010474\t\r \u00a0(1974).\t\r \u00a023. Barja\t\r \u00a0 de\t\r \u00a0 Quiroga,\t\r \u00a0 G.,\t\r \u00a0 Perez-\u00ad\u2010Campo,\t\r \u00a0 R.\t\r \u00a0 L\u00f3pez-\u00ad\u2010Torres,\t\r \u00a0 M.\t\r \u00a0 Anti-\u00ad\u2010oxidant\t\r \u00a0 defences\t\r \u00a0 and\t\r \u00a0peroxidation\t\r \u00a0in\t\r \u00a0liver\t\r \u00a0and\t\r \u00a0brain\t\r \u00a0of\t\r \u00a0aged\t\r \u00a0rats.\t\r \u00a0Biochemical\t\r \u00a0Journal\t\r \u00a0272,\t\r \u00a0247-\u00ad\u2010250\t\r \u00a0(1990).\t\r \u00a024. Paglia,\t\r \u00a0D.E.,\t\r \u00a0Valentine,\t\r \u00a0W.N.\t\r \u00a0Studies\t\r \u00a0on\t\r \u00a0the\t\r \u00a0quantitative\t\r \u00a0and\t\r \u00a0qualitative\t\r \u00a0characterization\t\r \u00a0of\t\r \u00a0erythrocyte\t\r \u00a0 glutathione\t\r \u00a0 peroxidase.\t\r \u00a0 Journal\t\r \u00a0 of\t\r \u00a0Laboratory\t\r \u00a0and\t\r \u00a0Clinical\t\r \u00a0Medicine\t\r \u00a070,\t\r \u00a0 158-\u00ad\u2010\t\r \u00a0169\t\r \u00a0(1967).\t\r \u00a0E.\t\r \u00a0M.\t\r \u00a0Gonz\u00e1lez-\u00ad\u2010Burgos\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n376\t\r \u00a0\t\r \u00a025. Deniaud,\t\r \u00a0A.,\t\r \u00a0Sharaf\t\r \u00a0el\t\r \u00a0dein,\t\r \u00a0O.,\t\r \u00a0Maillier,\t\r \u00a0E.,\t\r \u00a0Poncet,\t\r \u00a0D.,\t\r \u00a0Kroemer,\t\r \u00a0G.,\t\r \u00a0Lemaire,\t\r \u00a0C.,\t\r \u00a0Brenner,\t\r \u00a0C.\t\r \u00a0Endoplasmic\t\r \u00a0 reticulum\t\r \u00a0 stress\t\r \u00a0 induces\t\r \u00a0 calcium-\u00ad\u2010dependent\t\r \u00a0 permeability\t\r \u00a0 transition,\t\r \u00a0mitochondrial\t\r \u00a0 outer\t\r \u00a0 membrane\t\r \u00a0 permeabilization\t\r \u00a0 and\t\r \u00a0 apoptosis.\t\r \u00a0 Oncogene\t\r \u00a027,\t\r \u00a0 285\u2013299\t\r \u00a0(2008).\t\r \u00a026. G\u00f3mez-\u00ad\u2010Serranillos,\t\r \u00a0P.,\t\r \u00a0Carretero,\t\r \u00a0E.,\t\r \u00a0Slowing,\t\r \u00a0K.,\t\r \u00a0Palomino,\t\r \u00a0O.\t\r \u00a0M.,\t\r \u00a0Villarrubia,\t\r \u00a0A.\t\r \u00a0I.,\t\r \u00a0Villar,\t\r \u00a0A.\t\r \u00a0HPLC\t\r \u00a0 Quantitative\t\r \u00a0 analysis\t\r \u00a0 of\t\r \u00a0 diterpenoids\t\r \u00a0 in\t\r \u00a0Sideritis\t\r \u00a0(Labiatae)\t\r \u00a0 species.\t\r \u00a0Phytotherapy\t\r \u00a0Research.\t\r \u00a072,\t\r \u00a0S101-\u00ad\u2010S103\t\r \u00a0(1998).\t\r \u00a027. Tabner,\t\r \u00a0B.J.,\t\r \u00a0Turnbull,\t\r \u00a0S.,\t\r \u00a0El-\u00ad\u2010Agnaf,\t\r \u00a0O.,\t\r \u00a0Allsop,\t\r \u00a0D.\t\r \u00a0Production\t\r \u00a0of\t\r \u00a0reactive\t\r \u00a0oxygen\t\r \u00a0species\t\r \u00a0from\t\r \u00a0aggregating\t\r \u00a0 proteins\t\r \u00a0 implicated\t\r \u00a0 in\t\r \u00a0 Alzheimer's\t\r \u00a0 disease,\t\r \u00a0 Parkinson's\t\r \u00a0 disease\t\r \u00a0 and\t\r \u00a0 other\t\r \u00a0neurodegenerative\t\r \u00a0diseases.\t\r \u00a0Current\t\r \u00a0Topics\t\r \u00a0in\t\r \u00a0Medicinal\t\r \u00a0Chemistry1,\t\r \u00a0507-\u00ad\u2010517\t\r \u00a0(2001).\t\r \u00a028. Tabner,\t\r \u00a0 B.J.,\t\r \u00a0 Turnbull,\t\r \u00a0 S.,\t\r \u00a0 El-\u00ad\u2010Agnaf,\t\r \u00a0 O.M.,\t\r \u00a0 Allsop,\t\r \u00a0 D.\t\r \u00a0 Formation\t\r \u00a0 of\t\r \u00a0 hydrogen\t\r \u00a0 peroxide\t\r \u00a0 and\t\r \u00a0hydroxyl\t\r \u00a0radicals\t\r \u00a0from\t\r \u00a0A(beta)\t\r \u00a0and\t\r \u00a0alpha-\u00ad\u2010synuclein\t\r \u00a0as\t\r \u00a0a\t\r \u00a0possible\t\r \u00a0mechanism\t\r \u00a0of\t\r \u00a0cell\t\r \u00a0death\t\r \u00a0in\t\r \u00a0 Alzheimer's\t\r \u00a0 disease\t\r \u00a0 and\t\r \u00a0 Parkinson's\t\r \u00a0 disease.\t\r \u00a0Free\t\r \u00a0 Radical\t\r \u00a0 Biology\t\r \u00a0and\t\r \u00a0Medicine.\t\r \u00a032,\t\r \u00a01076-\u00ad\u20101083\t\r \u00a0(2002).\t\r \u00a029. Halliwell,\t\r \u00a0 B.\t\r \u00a0 Reactive\t\r \u00a0 oxygen\t\r \u00a0 species\t\r \u00a0 and\t\r \u00a0 the\t\r \u00a0 central\t\r \u00a0 nervous\t\r \u00a0 system.\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Neurochemistry\t\r \u00a059,\t\r \u00a01609-\u00ad\u20101623\t\r \u00a0(1992).\t\r \u00a030. Reed,\t\r \u00a0 T.T.\t\r \u00a0 Lipid\t\r \u00a0 peroxidation\t\r \u00a0 and\t\r \u00a0 neurodegenerative\t\r \u00a0 disease.\t\r \u00a0 Free\t\r \u00a0 Radical\t\r \u00a0Biology\t\r \u00a0and\t\r \u00a0Medicine\t\r \u00a051,\t\r \u00a01302-\u00ad\u20101319\t\r \u00a0(2011).\t\r \u00a031. Hayashi,\t\r \u00a0 M.,\t\r \u00a0 Miyata,\t\r \u00a0 R.,\t\r \u00a0 Tanuma,\t\r \u00a0 N.\t\r \u00a0 Oxidative\t\r \u00a0 stress\t\r \u00a0 in\t\r \u00a0 developmental\t\r \u00a0 brain\t\r \u00a0 disorders.\t\r \u00a0Advances\t\r \u00a0in\t\r \u00a0Experimental\t\r \u00a0Medicine\t\r \u00a0and\t\r \u00a0Biology\t\r \u00a0724,\t\r \u00a0278-\u00ad\u2010290\t\r \u00a0(2012).\t\r \u00a032. Wang,\t\r \u00a0 J.Y.,\t\r \u00a0 Wen,\t\r \u00a0 L.L.,\t\r \u00a0 Huang,\t\r \u00a0 Y.N.,\t\r \u00a0 Chen,\t\r \u00a0 Y.T.,\t\r \u00a0 Ku,\t\r \u00a0 M.C.\t\r \u00a0 Dual\t\r \u00a0 effects\t\r \u00a0 of\t\r \u00a0 antioxidants\t\r \u00a0 in\t\r \u00a0neurodegeneration:\t\r \u00a0 direct\t\r \u00a0 neuroprotection\t\r \u00a0 against\t\r \u00a0 oxidative\t\r \u00a0 stress\t\r \u00a0 and\t\r \u00a0 indirect\t\r \u00a0protection\t\r \u00a0via\t\r \u00a0suppression\t\r \u00a0of\t\r \u00a0glia-\u00ad\u2010mediated\t\r \u00a0inflammation.\t\r \u00a0Current\t\r \u00a0Pharmaceutical\t\r \u00a0Design\t\r \u00a012,\t\r \u00a03521-\u00ad\u2010333\t\r \u00a0(2006).\t\r \u00a033. Jazwa,\t\r \u00a0 A.,\t\r \u00a0 Cuadrado,\t\r \u00a0 A.\t\r \u00a0 Targeting\t\r \u00a0 heme\t\r \u00a0 oxygenase-\u00ad\u20101\t\r \u00a0 for\t\r \u00a0 neuroprotection\t\r \u00a0 and\t\r \u00a0neuroinflammation\t\r \u00a0in\t\r \u00a0neurodegenerative\t\r \u00a0diseases.\t\r \u00a0Current\t\r \u00a0Drug\t\r \u00a0Targets\t\r \u00a011,\t\r \u00a01517-\u00ad\u20101531\t\r \u00a0(2010).\t\r \u00a034. Madgula,\t\r \u00a0V.L.,\t\r \u00a0Avula,\t\r \u00a0B.,\t\r \u00a0Yu,\t\r \u00a0Y.B.,\t\r \u00a0Wang,\t\r \u00a0Y.H.,\t\r \u00a0Tchantchou,\t\r \u00a0F.,\t\r \u00a0Fisher,\t\r \u00a0S.,\t\r \u00a0Luo,\t\r \u00a0Y.,\t\r \u00a0Khan,\t\r \u00a0I.A.,\t\r \u00a0Khan,\t\r \u00a0S.I.\t\r \u00a0Intestinal\t\r \u00a0and\t\r \u00a0blood-\u00ad\u2010brain\t\r \u00a0barrier\t\r \u00a0permeability\t\r \u00a0of\t\r \u00a0ginkgolides\t\r \u00a0and\t\r \u00a0bilobalide:\t\r \u00a0in\t\r \u00a0vitro\t\r \u00a0and\t\r \u00a0in\t\r \u00a0vivo\t\r \u00a0approaches.\t\r \u00a0PlantaMedica76,\t\r \u00a0599-\u00ad\u2010606\t\r \u00a0(2010).\t\r \u00a0377\t\r \u00a0\t\r \u00a0\t\r \u00a0Detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 al\u00e9rgenos\t\r \u00a0 de\t\r \u00a0 cacahuete\t\r \u00a0 mediante\t\r \u00a0 un\t\r \u00a0 sensor\t\r \u00a0 de\t\r \u00a0ADN\t\r \u00a0Marta\t\r \u00a0 S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0 L\u00f3pez1,\t\r \u00a0 Gloria\t\r \u00a0 Frutos\t\r \u00a0 Cabanillas2,\t\r \u00a0 M.\t\r \u00a0 Jes\u00fas\t\r \u00a0 Lobo\t\r \u00a0Casta\u00f1\u00f3n3,\t\r \u00a0Beatriz\t\r \u00a0L\u00f3pez-\u00ad\u2010Ruiz1*\t\r \u00a01Sec.\t\r \u00a0Dptal.\t\r \u00a0 Qu\u00edmica\t\r \u00a0 Anal\u00edtica,\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia,\t\r \u00a0 Universidad\t\r \u00a0 Complutense\t\r \u00a0 de\t\r \u00a0 Madrid,\t\r \u00a0 28040,\t\r \u00a0Madrid,\t\r \u00a0 Espa\u00f1a.\t\r \u00a02Dpto.\t\r \u00a0 Estad\u00edstica\t\r \u00a0 e\t\r \u00a0 Investigaci\u00f3n\t\r \u00a0 Operativa,\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0 Farmacia,\t\r \u00a0 Universidad\t\r \u00a0Complutense\t\r \u00a0de\t\r \u00a0Madrid,\t\r \u00a028040,\t\r \u00a0Madrid,\t\r \u00a0Espa\u00f1a.\t\r \u00a03Dpto.\t\r \u00a0Qu\u00edmica\t\r \u00a0F\u00edsica\t\r \u00a0y\t\r \u00a0Anal\u00edtica,\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Qu\u00edmica,\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Oviedo,\t\r \u00a033006,\t\r \u00a0Oviedo,\t\r \u00a0Espa\u00f1a\t\r \u00a0*e-\u00ad\u2010mail:\t\r \u00a0bealopru@ucm.es\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol.\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0377-\u00ad\u2010392.\t\r \u00a0RESUMEN\t\r \u00a0En\t\r \u00a0el\t\r \u00a0presente\t\r \u00a0trabajo\t\r \u00a0se\t\r \u00a0propone\t\r \u00a0un\t\r \u00a0genosensor\t\r \u00a0electroqu\u00edmico\t\r \u00a0para\t\r \u00a0la\t\r \u00a0detecci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0segmento\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0que\t\r \u00a0codifica\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0alerg\u00e9nica\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a02\t\r \u00a0del\t\r \u00a0cacahuete.\t\r \u00a0El\t\r \u00a0genosensor\t\r \u00a0se\t\r \u00a0basa\t\r \u00a0en\t\r \u00a0un\t\r \u00a0ensayo\t\r \u00a0tipo\t\r \u00a0s\u00e1ndwich,\t\r \u00a0el\t\r \u00a0analito\t\r \u00a0hibrida\t\r \u00a0con\t\r \u00a0dos\t\r \u00a0secuencias\t\r \u00a0de\t\r \u00a0bases,\t\r \u00a0una\t\r \u00a0de\t\r \u00a0ellas\t\r \u00a0inmovilizada\t\r \u00a0sobre\t\r \u00a0un\t\r \u00a0electrodo\t\r \u00a0de\t\r \u00a0oro\t\r \u00a0serigrafiado,\t\r \u00a0 formando\t\r \u00a0 una\t\r \u00a0 monocapa\t\r \u00a0 autoensamblada.\t\r \u00a0 La\t\r \u00a0 optimizaci\u00f3n\t\r \u00a0 del\t\r \u00a0dispositivo\t\r \u00a0 se\t\r \u00a0realiz\u00f3\t\r \u00a0 utilizando\t\r \u00a0 la\t\r \u00a0 metodolog\u00eda\t\r \u00a0 de\t\r \u00a0Superficies\t\r \u00a0 de\t\r \u00a0 Respuesta.\t\r \u00a0La\t\r \u00a0m\u00e1xima\t\r \u00a0respuesta\t\r \u00a0se\t\r \u00a0encontr\u00f3\t\r \u00a0para\t\r \u00a0concentraciones\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0agente\t\r \u00a0bloqueante,\t\r \u00a01\t\r \u00a0\u00b5M\t\r \u00a0y\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0respectivamente.\t\r \u00a0Palabras\t\r \u00a0 clave:\t\r \u00a0cacahuete;\t\r \u00a0sensor\t\r \u00a0 de\t\r \u00a0 ADN\t\r \u00a0electroqu\u00edmico;\t\r \u00a0Superficies\t\r \u00a0 de\t\r \u00a0respuesta.\t\r \u00a0ABSTRACT\t\r \u00a0Detection\t\r \u00a0of\t\r \u00a0peanut\t\r \u00a0allergens\t\r \u00a0by\t\r \u00a0a\t\r \u00a0DNA\t\r \u00a0sensor\t\r \u00a0In\t\r \u00a0the\t\r \u00a0present\t\r \u00a0work\t\r \u00a0an\t\r \u00a0electrochemical\t\r \u00a0genosensor\t\r \u00a0for\t\r \u00a0detecting\t\r \u00a0a\t\r \u00a0DNA\t\r \u00a0segment\t\r \u00a0encoding\t\r \u00a0part\t\r \u00a0of\t\r \u00a0the\t\r \u00a0allergenic\t\r \u00a0protein\t\r \u00a0peanut\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a02\t\r \u00a0is\t\r \u00a0proposed.\t\r \u00a0Genosensors\t\r \u00a0is\t\r \u00a0based\t\r \u00a0 on\t\r \u00a0 a\t\r \u00a0 sandwich\t\r \u00a0 assay\t\r \u00a0 format,\t\r \u00a0 the\t\r \u00a0 analyte\t\r \u00a0 hybridized\t\r \u00a0 with\t\r \u00a0 two\t\r \u00a0 base\t\r \u00a0sequences,\t\r \u00a0one\t\r \u00a0immobilized\t\r \u00a0onto\t\r \u00a0a\t\r \u00a0screen\t\r \u00a0printed\t\r \u00a0gold\t\r \u00a0electrode,\t\r \u00a0forming\t\r \u00a0a\t\r \u00a0self-\u00ad\u2010assembled\t\r \u00a0 monolayer.\t\r \u00a0 The\t\r \u00a0 optimization\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 device\t\r \u00a0 was\t\r \u00a0 performed\t\r \u00a0 using\t\r \u00a0Response\t\r \u00a0Surface\t\r \u00a0Methodology.\t\r \u00a0The\t\r \u00a0maximum\t\r \u00a0response\t\r \u00a0was\t\r \u00a0found\t\r \u00a0to\t\r \u00a0be\t\r \u00a01\t\r \u00a0\u00b5M\t\r \u00a0of\t\r \u00a0capture\t\r \u00a0probe\t\r \u00a0concentration\t\r \u00a0and\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0of\t\r \u00a0blocking\t\r \u00a0agent\t\r \u00a0concentration.\t\r \u00a0ART\u00cdCULO\t\r \u00a0\n\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n378\t\r \u00a0\t\r \u00a0Keywords:\t\r \u00a0peanut;\t\r \u00a0electrochemical\t\r \u00a0DNA\t\r \u00a0sensor;\t\r \u00a0response\t\r \u00a0surface\t\r \u00a0metodology.\t\r \u00a01.\t\r \u00a0INTRODUCCI\u00d3N\t\r \u00a0La\t\r \u00a0incidencia\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 alergias\t\r \u00a0 alimentarias\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 gravedad\t\r \u00a0 de\t\r \u00a0 sus\t\r \u00a0consecuencias\t\r \u00a0han\t\r \u00a0incrementado\t\r \u00a0el\t\r \u00a0inter\u00e9s\t\r \u00a0de\t\r \u00a0los\t\r \u00a0consumidores\t\r \u00a0y\t\r \u00a0ha\t\r \u00a0pasado\t\r \u00a0a\t\r \u00a0ser\t\r \u00a0una\t\r \u00a0cuesti\u00f3n\t\r \u00a0de\t\r \u00a0seguridad\t\r \u00a0alimentaria\t\r \u00a0y\t\r \u00a0salud\t\r \u00a0p\u00fablica.\t\r \u00a0Se\t\r \u00a0estima\t\r \u00a0que\t\r \u00a0en\t\r \u00a0Europa\t\r \u00a0las\t\r \u00a0alergias\t\r \u00a0alimentarias\t\r \u00a0afectan\t\r \u00a0aproximadamente\t\r \u00a0al\t\r \u00a01-\u00ad\u20102\t\r \u00a0%\t\r \u00a0de\t\r \u00a0la\t\r \u00a0poblaci\u00f3n\t\r \u00a0adulta\t\r \u00a0y\t\r \u00a0al\t\r \u00a05-\u00ad\u20107\t\r \u00a0%\t\r \u00a0de\t\r \u00a0la\t\r \u00a0poblaci\u00f3n\t\r \u00a0infantil,\t\r \u00a0aumentando\t\r \u00a0su\t\r \u00a0incidencia\t\r \u00a0en\t\r \u00a0los\t\r \u00a0\u00faltimos\t\r \u00a0a\u00f1os.\t\r \u00a0Se\t\r \u00a0hace\t\r \u00a0 indispensable\t\r \u00a0tomar\t\r \u00a0 medidas\t\r \u00a0 para\t\r \u00a0 proteger\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 poblaci\u00f3n\t\r \u00a0 sensible,\t\r \u00a0informando\t\r \u00a0adecuadamente\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0ingredientes\t\r \u00a0alerg\u00e9nicos\t\r \u00a0que\t\r \u00a0contienen\t\r \u00a0los\t\r \u00a0alimentos\t\r \u00a0e\t\r \u00a0identificando\t\r \u00a0 posibles\t\r \u00a0 contaminaciones\t\r \u00a0 cruzadas.\t\r \u00a0Por\t\r \u00a0 ello,\t\r \u00a0 se\t\r \u00a0 han\t\r \u00a0establecido\t\r \u00a0normas\t\r \u00a0de\t\r \u00a0etiquetado\t\r \u00a0que\t\r \u00a0obligan\t\r \u00a0a\t\r \u00a0indicar\t\r \u00a0su\t\r \u00a0presencia.\t\r \u00a0La\t\r \u00a0legislaci\u00f3n\t\r \u00a0alimentaria\t\r \u00a0espa\u00f1ola,\t\r \u00a0en\t\r \u00a0sentido\t\r \u00a0estricto,\t\r \u00a0no\t\r \u00a0regula\t\r \u00a0los\t\r \u00a0al\u00e9rgenos,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0hace\t\r \u00a0es\t\r \u00a0fijar\t\r \u00a0 obligaciones\t\r \u00a0 en\t\r \u00a0 cuanto\t\r \u00a0a\t\r \u00a0la\t\r \u00a0 informaci\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 etiquetado\t\r \u00a0 sobre\t\r \u00a0 estos\t\r \u00a0ingredientes\t\r \u00a0al\u00e9rgenos.\t\r \u00a0Existe\t\r \u00a0una\t\r \u00a0lista\t\r \u00a0de\t\r \u00a014\t\r \u00a0grupos\t\r \u00a0de\t\r \u00a0ingredientes\t\r \u00a0alerg\u00e9nicos,\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0el\t\r \u00a0cacahuete\t\r \u00a0y\t\r \u00a0los\t\r \u00a0productos\t\r \u00a0a\t\r \u00a0base\t\r \u00a0de\t\r \u00a0cacahuetes,\t\r \u00a0que\t\r \u00a0es\t\r \u00a0 obligado\t\r \u00a0 declarar\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 etiquetado\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 productos\t\r \u00a0 alimenticios\t\r \u00a0con\t\r \u00a0independencia\t\r \u00a0del\t\r \u00a0porcentaje\t\r \u00a0en\t\r \u00a0peso\t\r \u00a0que\t\r \u00a0representen\t\r \u00a0en\t\r \u00a0el\t\r \u00a0producto\t\r \u00a0final.\t\r \u00a0Real\t\r \u00a0Decreto\t\r \u00a0 1334/1999,\t\r \u00a0 de\t\r \u00a0 31\t\r \u00a0 de\t\r \u00a0 julio,\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 aprueba\t\r \u00a0 la\t\r \u00a0 Norma\t\r \u00a0 general\t\r \u00a0 de\t\r \u00a0etiquetado,\t\r \u00a0 presentaci\u00f3n\t\r \u00a0 y\t\r \u00a0 publicidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 productos\t\r \u00a0 alimenticios\t\r \u00a0 en\t\r \u00a0 Espa\u00f1a\t\r \u00a0 y\t\r \u00a0Reglamento\t\r \u00a0 N\u00ba\t\r \u00a0 1169/2011\t\r \u00a0 del\t\r \u00a0 Parlamento\t\r \u00a0 Europeo\t\r \u00a0 y\t\r \u00a0 del\t\r \u00a0 Consejo\t\r \u00a0 de\t\r \u00a0 25\t\r \u00a0 de\t\r \u00a0Octubre\t\r \u00a0de\t\r \u00a02011\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0informaci\u00f3n\t\r \u00a0alimentaria\t\r \u00a0facilitada\t\r \u00a0al\t\r \u00a0consumidor.\t\r \u00a0Entre\t\r \u00a0esos\t\r \u00a0 14\t\r \u00a0 grupos\t\r \u00a0 se\t\r \u00a0 encuentra\t\r \u00a0 el\t\r \u00a0 cacahuete\t\r \u00a0 y\t\r \u00a0 productos\t\r \u00a0a\t\r \u00a0 base\t\r \u00a0 de\t\r \u00a0 cacahuetes.\t\r \u00a0El\t\r \u00a0cacahuete\t\r \u00a0Arachis\t\r \u00a0 hypogaea,\t\r \u00a0 conocido\t\r \u00a0 tambi\u00e9n\t\r \u00a0 como\t\r \u00a0 man\u00ed\t\r \u00a0 y\t\r \u00a0 perteneciente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0familia\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Papilion\u00e1ceas\t\r \u00a0(leguminosas),\t\r \u00a0es\t\r \u00a0un\t\r \u00a0alimento\t\r \u00a0muy\t\r \u00a0alerg\u00e9nico\t\r \u00a0de\t\r \u00a0gran\t\r \u00a0importancia\t\r \u00a0 sanitaria\t\r \u00a0por\t\r \u00a0 la\t\r \u00a0incidencia\t\r \u00a0 y\t\r \u00a0severidad\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0al\u00e9rgica\t\r \u00a0 que\t\r \u00a0produce.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0pa\u00edses\t\r \u00a0desarrollados\t\r \u00a0afecta\t\r \u00a0a\t\r \u00a0un\t\r \u00a00,4%-\u00ad\u20100,6%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0ni\u00f1os\t\r \u00a0y\t\r \u00a0un\t\r \u00a00,3%-\u00ad\u20100,7%\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 adultos.\t\r \u00a0 En\t\r \u00a0 Espa\u00f1a,\t\r \u00a0 la\t\r \u00a0 prevalencia\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 alergia\t\r \u00a0 est\u00e1\t\r \u00a0 aumentando,\t\r \u00a0probablemente\t\r \u00a0 debido\t\r \u00a0a\t\r \u00a0 la\t\r \u00a0 mayor\t\r \u00a0popularidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 productos\t\r \u00a0 derivados\t\r \u00a0 del\t\r \u00a0cacahuete\t\r \u00a0y\t\r \u00a0a\t\r \u00a0su\t\r \u00a0inclusi\u00f3n\t\r \u00a0en\t\r \u00a0las\t\r \u00a0dietas\t\r \u00a0infantiles.\t\r \u00a0\t\r \u00a0Algunas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 prote\u00ednas\t\r \u00a0 de\t\r \u00a0 almacenamiento\t\r \u00a0 del\t\r \u00a0 cacahuete\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0responsables\t\r \u00a0de\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0al\u00e9rgica.\t\r \u00a0Aproximadamente,\t\r \u00a0el\t\r \u00a020%\t\r \u00a0del\t\r \u00a0contenido\t\r \u00a0total\t\r \u00a0proteico\t\r \u00a0del\t\r \u00a0cacahuete\t\r \u00a0se\t\r \u00a0puede\t\r \u00a0atribuir\t\r \u00a0al\t\r \u00a0al\u00e9rgeno\t\r \u00a0principal\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a01\t\r \u00a0y\t\r \u00a0el\t\r \u00a010%\t\r \u00a0al\t\r \u00a0al\u00e9rgeno\t\r \u00a0 Ara\t\r \u00a0 h\t\r \u00a0 2.\t\r \u00a0 Estos\t\r \u00a0 dos\t\r \u00a0 al\u00e9rgenos\t\r \u00a0 son\t\r \u00a0 la\t\r \u00a0 causa\t\r \u00a0 del\t\r \u00a0 95%\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 reacciones\t\r \u00a0al\u00e9rgicas\t\r \u00a0de\t\r \u00a0 esta\t\r \u00a0 legumbre\t\r \u00a0 (1).\t\r \u00a0 La\t\r \u00a0 sensibilizaci\u00f3n\t\r \u00a0 al\t\r \u00a0 cacahuete\t\r \u00a0 ocurre\t\r \u00a0generalmente\t\r \u00a0durante\t\r \u00a0la\t\r \u00a0infancia\t\r \u00a0y\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0persiste\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vida;\t\r \u00a0en\t\r \u00a0este\t\r \u00a0sentido,\t\r \u00a0difiere\t\r \u00a0de\t\r \u00a0otras\t\r \u00a0alergias\t\r \u00a0alimentarias\t\r \u00a0frecuentes\t\r \u00a0(como\t\r \u00a0la\t\r \u00a0alergia\t\r \u00a0a\t\r \u00a0las\t\r \u00a0prote\u00ednas\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 leche\t\r \u00a0 o\t\r \u00a0 del\t\r \u00a0 huevo),\t\r \u00a0 que\t\r \u00a0surgen\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 infancia\t\r \u00a0 pero\t\r \u00a0 generalmente\t\r \u00a0desaparecen\t\r \u00a0en\t\r \u00a0la\t\r \u00a0vida\t\r \u00a0adulta.\t\r \u00a0Detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0379\t\r \u00a0\t\r \u00a0Aunque\t\r \u00a0no\t\r \u00a0se\t\r \u00a0conoce\t\r \u00a0con\t\r \u00a0certeza\t\r \u00a0el\t\r \u00a0nivel\t\r \u00a0umbral\t\r \u00a0necesario\t\r \u00a0para\t\r \u00a0causar\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0 al\u00e9rgica,\t\r \u00a0hay\t\r \u00a0estudios\t\r \u00a0que\t\r \u00a0demuestran\t\r \u00a0que\t\r \u00a0 cantidades\t\r \u00a0 de\t\r \u00a0 prote\u00edna\t\r \u00a0 del\t\r \u00a0orden\t\r \u00a0 de\t\r \u00a0microgramos\t\r \u00a0 son\t\r \u00a0 suficientes\t\r \u00a0 para\t\r \u00a0originar\t\r \u00a0reacciones\t\r \u00a0 objetivas\t\r \u00a0 en\t\r \u00a0sujetos\t\r \u00a0hipersensibles\t\r \u00a0(2).\t\r \u00a0Por\t\r \u00a0 lo\t\r \u00a0 tanto,\t\r \u00a0 la\t\r \u00a0 presencia,\t\r \u00a0 no\t\r \u00a0 declarada,\t\r \u00a0 de\t\r \u00a0 trazas\t\r \u00a0 de\t\r \u00a0cacahuete\t\r \u00a0en\t\r \u00a0los\t\r \u00a0alimentos\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0muy\t\r \u00a0peligrosa\t\r \u00a0para\t\r \u00a0estos\t\r \u00a0individuos.\t\r \u00a0Bock\t\r \u00a0y\t\r \u00a0col.\t\r \u00a0 realizaron\t\r \u00a0 un\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 32\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 muerte\t\r \u00a0 por\t\r \u00a0 anafilaxia\t\r \u00a0 debidas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0ingesti\u00f3n\t\r \u00a0 de\t\r \u00a0 alimentos\t\r \u00a0 alerg\u00e9nicos.\t\r \u00a0 Encontraron\t\r \u00a0 que\t\r \u00a0m\u00e1s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 mitad\t\r \u00a0de\t\r \u00a0 los\t\r \u00a0accidentes\t\r \u00a0mortales\t\r \u00a0(55-\u00ad\u201067%)\t\r \u00a0se\t\r \u00a0debieron\t\r \u00a0a\t\r \u00a0la\t\r \u00a0ingesti\u00f3n\t\r \u00a0de\t\r \u00a0cacahuete\t\r \u00a0y\t\r \u00a0que\t\r \u00a0en\t\r \u00a0el\t\r \u00a090%\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos,\t\r \u00a0los\t\r \u00a0al\u00e9rgenos\t\r \u00a0responsables\t\r \u00a0fueron\t\r \u00a0los\t\r \u00a0cacahuetes\t\r \u00a0y\t\r \u00a0las\t\r \u00a0nueces\t\r \u00a0(3).\t\r \u00a0Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 numerosos\t\r \u00a0 productos\t\r \u00a0 alimenticios\t\r \u00a0 industriales\t\r \u00a0que\t\r \u00a0 incluyen\t\r \u00a0cacahuetes\t\r \u00a0 como\t\r \u00a0 galletas,\t\r \u00a0 chocolate,\t\r \u00a0aperitivos,\t\r \u00a0cereales,\t\r \u00a0 es\t\r \u00a0 habitual\t\r \u00a0 encontrarse\t\r \u00a0con\t\r \u00a0 alimentos\t\r \u00a0 que\t\r \u00a0 contienen\t\r \u00a0 este\t\r \u00a0 al\u00e9rgeno\t\r \u00a0 cuyo\t\r \u00a0 origen\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0contaminaci\u00f3n\t\r \u00a0cruzada\t\r \u00a0producida\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0procesamiento.\t\r \u00a0Por\t\r \u00a0ello,\t\r \u00a0resulta\t\r \u00a0necesario\t\r \u00a0disponer\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0adecuados\t\r \u00a0de\t\r \u00a0an\u00e1lisis\t\r \u00a0para\t\r \u00a0la\t\r \u00a0detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\t\r \u00a0en\t\r \u00a0productos\t\r \u00a0alimenticios.\t\r \u00a0Se\t\r \u00a0han\t\r \u00a0desarrollado\t\r \u00a0m\u00faltiples\t\r \u00a0m\u00e9todos\t\r \u00a0anal\u00edticos\t\r \u00a0basados\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 dos\t\r \u00a0 tipos\t\r \u00a0 de\t\r \u00a0 macromol\u00e9culas,\t\r \u00a0 prote\u00ednas\t\r \u00a0y\t\r \u00a0 ADN:\t\r \u00a0los\t\r \u00a0 primeros\t\r \u00a0detectan\t\r \u00a0 alguna\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 prote\u00ednas\t\r \u00a0 alerg\u00e9nicas\t\r \u00a0del\t\r \u00a0 cacahuete,\t\r \u00a0mientras\t\r \u00a0 que\t\r \u00a0los\t\r \u00a0segundos\t\r \u00a0se\t\r \u00a0basan\t\r \u00a0en\t\r \u00a0la\t\r \u00a0detecci\u00f3n\t\r \u00a0de\t\r \u00a0secuencias\t\r \u00a0de\t\r \u00a0oligonucle\u00f3tidos\t\r \u00a0que\t\r \u00a0codifican\t\r \u00a0alguna\t\r \u00a0 de\t\r \u00a0 dichas\t\r \u00a0 prote\u00ednas\t\r \u00a0 alerg\u00e9nicas.\t\r \u00a0Los\t\r \u00a0 m\u00e9todos\t\r \u00a0 m\u00e1s\t\r \u00a0 utilizados\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 prote\u00ednas\t\r \u00a0 son\t\r \u00a0 los\t\r \u00a0enzimoinmunoensayos\t\r \u00a0 y,\t\r \u00a0en\t\r \u00a0 especial,\t\r \u00a0el\t\r \u00a0 m\u00e9todo\t\r \u00a0ELISA\t\r \u00a0(4-\u00ad\u20106).\t\r \u00a0Aunque\t\r \u00a0este\t\r \u00a0ensayo\t\r \u00a0ha\t\r \u00a0demostrado\t\r \u00a0ser\t\r \u00a0sensible\t\r \u00a0y\t\r \u00a0vers\u00e1til,\t\r \u00a0consume\t\r \u00a0tiempo\t\r \u00a0y\t\r \u00a0es\t\r \u00a0relativamente\t\r \u00a0caro,\t\r \u00a0adem\u00e1s,\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0de\t\r \u00a0producci\u00f3n\t\r \u00a0implican\t\r \u00a0un\t\r \u00a0tratamiento\t\r \u00a0t\u00e9rmico\t\r \u00a0que,\t\r \u00a0a\t\r \u00a0menudo,\t\r \u00a0desnaturaliza\t\r \u00a0las\t\r \u00a0prote\u00ednas\t\r \u00a0de\t\r \u00a0los\t\r \u00a0alimentos,\t\r \u00a0alterando\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 modo\t\r \u00a0su\t\r \u00a0estructura\t\r \u00a0 terciaria\t\r \u00a0e\t\r \u00a0 impidiendo\t\r \u00a0 su\t\r \u00a0 detecci\u00f3n.\t\r \u00a0Teniendo\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0que\t\r \u00a0el\t\r \u00a0ADN\t\r \u00a0no\t\r \u00a0se\t\r \u00a0altera\t\r \u00a0tras\t\r \u00a0someterse\t\r \u00a0a\t\r \u00a0altas\t\r \u00a0temperaturas,\t\r \u00a0los\t\r \u00a0 m\u00e9todos\t\r \u00a0 basados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 ADN\t\r \u00a0 surgen\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 interesante\t\r \u00a0alternativa.\t\r \u00a0Dentro\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0m\u00e9todos,\t\r \u00a0el\t\r \u00a0primero\t\r \u00a0en\t\r \u00a0aparecer\t\r \u00a0y\t\r \u00a0m\u00e1s\t\r \u00a0utilizado\t\r \u00a0hasta\t\r \u00a0el\t\r \u00a0 momento\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0reacci\u00f3n\t\r \u00a0 en\t\r \u00a0 cadena\t\r \u00a0 de\t\r \u00a0la\t\r \u00a0 polimerasa,\t\r \u00a0 PCR,\t\r \u00a0 cuantitativa\t\r \u00a0(7-\u00ad\u20109),\t\r \u00a0m\u00e9todo\t\r \u00a0 muy\t\r \u00a0 sensible\t\r \u00a0 que\t\r \u00a0requiere\t\r \u00a0 equipos\t\r \u00a0caros\t\r \u00a0y\t\r \u00a0personal\t\r \u00a0 cualificado.\t\r \u00a0 Estos\t\r \u00a0inconvenientes\t\r \u00a0han\t\r \u00a0impulsado\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0otros\t\r \u00a0m\u00e9todos\t\r \u00a0anal\u00edticos\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0los\t\r \u00a0biosensores\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0o\t\r \u00a0genosensores,\t\r \u00a0que\t\r \u00a0presentan\t\r \u00a0ventajas\t\r \u00a0como\t\r \u00a0su\t\r \u00a0menor\t\r \u00a0coste,\t\r \u00a0facilidad\t\r \u00a0de\t\r \u00a0manejo,\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0automatizaci\u00f3n,\t\r \u00a0etc.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0revisi\u00f3n\t\r \u00a0 bibliogr\u00e1fica\t\r \u00a0 realizada\t\r \u00a0 solo\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 encontrado\t\r \u00a0 un\t\r \u00a0 genosensor\t\r \u00a0electroqu\u00edmico\t\r \u00a0 aplicado\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 detecci\u00f3n\t\r \u00a0 de\t\r \u00a0 al\u00e9rgenos\t\r \u00a0 de\t\r \u00a0 cacahuete,\t\r \u00a0 basado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0detecci\u00f3n\t\r \u00a0del\t\r \u00a0ADN\t\r \u00a0que\t\r \u00a0codifica\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0al\u00e9rgeno\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a01\t\r \u00a0(10).\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 presente\t\r \u00a0 trabajo\t\r \u00a0se\t\r \u00a0propone\t\r \u00a0 un\t\r \u00a0 genosensor\t\r \u00a0electroqu\u00edmico\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0detecci\u00f3n\t\r \u00a0del\t\r \u00a0ADN\t\r \u00a0que\t\r \u00a0codifica\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0alerg\u00e9nica\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a02.\t\r \u00a0Se\t\r \u00a0opt\u00f3\t\r \u00a0por\t\r \u00a0un\t\r \u00a0 formato\t\r \u00a0 tipo\t\r \u00a0 s\u00e1ndwich\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 todo\t\r \u00a0 el\t\r \u00a0 analito\t\r \u00a0 hidrida\t\r \u00a0 con\t\r \u00a0 dos\t\r \u00a0 secuencias\t\r \u00a0complementarias,\t\r \u00a0 una\t\r \u00a0 inmovilizada\t\r \u00a0 sobre\t\r \u00a0 un\t\r \u00a0 electrodo\t\r \u00a0 de\t\r \u00a0 oro\t\r \u00a0 serigrafiado\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0segunda\t\r \u00a0funcionalizada\t\r \u00a0con\t\r \u00a0biotina.\t\r \u00a0La\t\r \u00a0optimizaci\u00f3n\t\r \u00a0del\t\r \u00a0dispositivo\t\r \u00a0se\t\r \u00a0llev\u00f3\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0mediante\t\r \u00a0dise\u00f1os\t\r \u00a0de\t\r \u00a0experimentos\t\r \u00a0(DoE),\t\r \u00a0metodolog\u00eda\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0demostrado\t\r \u00a0ser\t\r \u00a0una\t\r \u00a0\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n380\t\r \u00a0\t\r \u00a0potente\t\r \u00a0herramienta\t\r \u00a0en\t\r \u00a0qu\u00edmica\t\r \u00a0anal\u00edtica\t\r \u00a0y,\t\r \u00a0especialmente,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0optimizaci\u00f3n\t\r \u00a0de\t\r \u00a0dispositivos\t\r \u00a0anal\u00edticos,\t\r \u00a0aunque\t\r \u00a0su\t\r \u00a0uso\t\r \u00a0no\t\r \u00a0est\u00e1\t\r \u00a0muy\t\r \u00a0extendido\t\r \u00a0en\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0biosensores\t\r \u00a0(11-\u00ad\u201013).\t\r \u00a0\t\r \u00a0La\t\r \u00a0metodolog\u00eda\t\r \u00a0de\t\r \u00a0dise\u00f1os\t\r \u00a0de\t\r \u00a0experimentos\t\r \u00a0es\t\r \u00a0una\t\r \u00a0herramienta\t\r \u00a0matem\u00e1tica\t\r \u00a0y\t\r \u00a0estad\u00edstica\t\r \u00a0cuyos\t\r \u00a0objetivos\t\r \u00a0son\t\r \u00a0seleccionar\t\r \u00a0la\t\r \u00a0estrategia\t\r \u00a0experimental\t\r \u00a0\u00f3ptima\t\r \u00a0que\t\r \u00a0permita\t\r \u00a0 obtener\t\r \u00a0 la\t\r \u00a0 m\u00e1xima\t\r \u00a0 informaci\u00f3n\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 m\u00ednimo\t\r \u00a0 coste\t\r \u00a0 y\t\r \u00a0 evaluar\t\r \u00a0 los\t\r \u00a0resultados\t\r \u00a0experimentales\t\r \u00a0obtenidos,\t\r \u00a0garantizando\t\r \u00a0la\t\r \u00a0m\u00e1xima\t\r \u00a0fiabilidad.\t\r \u00a0Los\t\r \u00a0DoE\t\r \u00a0ofrecen\t\r \u00a0ventajas\t\r \u00a0incuestionables\t\r \u00a0frente\t\r \u00a0a\t\r \u00a0la\t\r \u00a0metodolog\u00eda\t\r \u00a0cl\u00e1sica,\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0que\t\r \u00a0cabe\t\r \u00a0destacar:\t\r \u00a0i)\t\r \u00a0estima\t\r \u00a0el\t\r \u00a0error\t\r \u00a0experimental,\t\r \u00a0ii)\t\r \u00a0calcula\t\r \u00a0la\t\r \u00a0influencia\t\r \u00a0simult\u00e1nea\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores,\t\r \u00a0iii)\t\r \u00a0 calcula\t\r \u00a0 el\t\r \u00a0 efecto\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 interacciones,\t\r \u00a0iv)\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 mismo\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0experimentos\t\r \u00a0proporciona\t\r \u00a0mayor\t\r \u00a0informaci\u00f3n,\t\r \u00a0y\t\r \u00a0v)\t\r \u00a0supone\t\r \u00a0un\t\r \u00a0ahorro\t\r \u00a0de\t\r \u00a0tiempo\t\r \u00a0y\t\r \u00a0esfuerzo\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0un\t\r \u00a0menor\t\r \u00a0coste\t\r \u00a0econ\u00f3mico\t\r \u00a0(14).\t\r \u00a0\t\r \u00a0Existen\t\r \u00a0 gran\t\r \u00a0 variedad\t\r \u00a0 de\t\r \u00a0 dise\u00f1os\t\r \u00a0de\t\r \u00a0 experimentos\t\r \u00a0(15).\t\r \u00a0 Una\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0clasificarlos\t\r \u00a0es\t\r \u00a0en\t\r \u00a0funci\u00f3n\t\r \u00a0del\t\r \u00a0objetivo\t\r \u00a0anal\u00edtico\t\r \u00a0propuesto,\t\r \u00a0diferenci\u00e1ndose\t\r \u00a0entre\t\r \u00a0dise\u00f1os\t\r \u00a0de\t\r \u00a0cribado\t\r \u00a0o\t\r \u00a0\u201cscreening\u201d\t\r \u00a0y\t\r \u00a0dise\u00f1os\t\r \u00a0de\t\r \u00a0optimizaci\u00f3n.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0dise\u00f1os\t\r \u00a0screening\t\r \u00a0el\t\r \u00a0objetivo\t\r \u00a0es\t\r \u00a0reducir\t\r \u00a0el\t\r \u00a0posible\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0factores\t\r \u00a0experimentales\t\r \u00a0que\t\r \u00a0afectan\t\r \u00a0a\t\r \u00a0la\t\r \u00a0respuesta,\t\r \u00a0 descartando\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 tienen\t\r \u00a0 menor\t\r \u00a0 o\t\r \u00a0 ninguna\t\r \u00a0 influencia\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 misma.\t\r \u00a0Estos\t\r \u00a0dise\u00f1os\t\r \u00a0son\t\r \u00a0adecuados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0fase\t\r \u00a0inicial\t\r \u00a0de\t\r \u00a0experimentaci\u00f3n\t\r \u00a0y\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0m\u00e1s\t\r \u00a0utilizados\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0los\t\r \u00a0Dise\u00f1os\t\r \u00a0Plackett-\u00ad\u2010Burman\t\r \u00a0y\t\r \u00a0Dise\u00f1os\t\r \u00a0Factoriales\t\r \u00a0a\t\r \u00a0dos\t\r \u00a0niveles.\t\r \u00a0Existen\t\r \u00a0dos\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0dise\u00f1os\t\r \u00a0factoriales,\t\r \u00a0completos\t\r \u00a0y\t\r \u00a0fraccionados.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0dise\u00f1os\t\r \u00a0factoriales\t\r \u00a0completos\t\r \u00a0se\t\r \u00a0utilizan\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0combinaciones\t\r \u00a0posibles\t\r \u00a0de\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0 factores\t\r \u00a0 a\t\r \u00a0 todos\t\r \u00a0 los\t\r \u00a0 niveles\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 experimento,\t\r \u00a0 habr\u00e1\t\r \u00a0Lk\t\r \u00a0combinaciones\t\r \u00a0de\t\r \u00a0L\t\r \u00a0niveles\t\r \u00a0 de\t\r \u00a0k\t\r \u00a0factores.\t\r \u00a0Los\t\r \u00a0 dise\u00f1os\t\r \u00a0 factoriales\t\r \u00a0 fraccionados\t\r \u00a0est\u00e1n\t\r \u00a0formados\t\r \u00a0por\t\r \u00a0una\t\r \u00a0fracci\u00f3n\t\r \u00a0del\t\r \u00a0correspondiente\t\r \u00a0dise\u00f1o\t\r \u00a0factorial\t\r \u00a0completo\t\r \u00a0y\t\r \u00a0contemplan\t\r \u00a0un\t\r \u00a0n\u00famero\t\r \u00a0menor\t\r \u00a0de\t\r \u00a0experimentos.\t\r \u00a0Una\t\r \u00a0vez\t\r \u00a0realizado\t\r \u00a0el\t\r \u00a0cribado\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables,\t\r \u00a0se\t\r \u00a0procede\t\r \u00a0a\t\r \u00a0la\t\r \u00a0optimizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0respuesta,\t\r \u00a0para\t\r \u00a0lo\t\r \u00a0cual\t\r \u00a0se\t\r \u00a0utilizan\t\r \u00a0dise\u00f1os\t\r \u00a0 factoriales\t\r \u00a0a\t\r \u00a0 tres\t\r \u00a0 o\t\r \u00a0 m\u00e1s\t\r \u00a0 niveles,\t\r \u00a0Dise\u00f1os\t\r \u00a0Centrales\t\r \u00a0 compuestos,\t\r \u00a0Dise\u00f1os\t\r \u00a0Box-\u00ad\u2010Behnken,\t\r \u00a0 Dise\u00f1os\t\r \u00a0 Doehlert\t\r \u00a0 y\t\r \u00a0Dise\u00f1os\t\r \u00a0 D-\u00ad\u2010\u00f3ptimos\t\r \u00a0entre\t\r \u00a0 otros,\t\r \u00a0que\t\r \u00a0 aportan\t\r \u00a0informaci\u00f3n\t\r \u00a0 relacionada\t\r \u00a0 con\t\r \u00a0el\t\r \u00a0 efecto\t\r \u00a0 cuantitativo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 factores\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 sus\t\r \u00a0interacciones\t\r \u00a0 y\t\r \u00a0 permiten\t\r \u00a0 obtener\t\r \u00a0la\t\r \u00a0 Superficie\t\r \u00a0de\t\r \u00a0 Respuesta\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 variable\t\r \u00a0dependiente\t\r \u00a0en\t\r \u00a0el\t\r \u00a0espacio\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables\t\r \u00a0independientes.\t\r \u00a02.\t\r \u00a0MATERIAL\t\r \u00a0Y\t\r \u00a0M\u00c9TODOS\t\r \u00a02.1.\t\r \u00a0Reactivos\t\r \u00a0El\t\r \u00a0 6-\u00ad\u2010mercapto-\u00ad\u20101-\u00ad\u2010hexanol\t\r \u00a0 (MCH),\t\r \u00a0 ditiotreitol\t\r \u00a0 (DTT),\t\r \u00a0fosfatasa\t\r \u00a0 alcalina-\u00ad\u2010estreptavidina\t\r \u00a0 (ALP-\u00ad\u2010Strp),\t\r \u00a0 1-\u00ad\u2010naftilfosfato,\t\r \u00a0 alb\u00famina\t\r \u00a0 humana\t\r \u00a0 (BSA),\t\r \u00a0 tween\t\r \u00a0 20,\t\r \u00a0 las\t\r \u00a0sales\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 preparaci\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 disoluciones\t\r \u00a0 tamp\u00f3n\t\r \u00a0 (Tris,\t\r \u00a0 KCl,\t\r \u00a0 MgCl2)\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0disoluci\u00f3n\t\r \u00a020\u00d7\t\r \u00a0de\t\r \u00a0fosfato\t\r \u00a0de\t\r \u00a0sodio\t\r \u00a0salino\t\r \u00a0con\t\r \u00a0EDTA\t\r \u00a0pH\t\r \u00a07.4\t\r \u00a0(200\t\r \u00a0mM\t\r \u00a0fosfato\t\r \u00a0s\u00f3dico,\t\r \u00a03\t\r \u00a0M\t\r \u00a0 NaCl,\t\r \u00a0 20\t\r \u00a0mM\t\r \u00a0 EDTA)\t\r \u00a0 fueron\t\r \u00a0 suministrados\t\r \u00a0 por\t\r \u00a0 Sigma-\u00ad\u2010Aldrich\t\r \u00a0 (Espa\u00f1a)\t\r \u00a0 y\t\r \u00a0Detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0381\t\r \u00a0\t\r \u00a0utilizados\t\r \u00a0sin\t\r \u00a0purificaci\u00f3n\t\r \u00a0previa.\t\r \u00a0El\t\r \u00a0etanol\t\r \u00a0y\t\r \u00a0el\t\r \u00a0\u00e1cido\t\r \u00a0sulf\u00farico\t\r \u00a0fueron\t\r \u00a0adquiridos\t\r \u00a0en\t\r \u00a0Panreac\t\r \u00a0(Espa\u00f1a).\t\r \u00a0Las\t\r \u00a0disoluciones\t\r \u00a0tamp\u00f3n\t\r \u00a0utilizadas\t\r \u00a0en\t\r \u00a0la\t\r \u00a0preparaci\u00f3n\t\r \u00a0del\t\r \u00a0sensor\t\r \u00a0fueron:\t\r \u00a0i)\t\r \u00a0disoluci\u00f3n\t\r \u00a0tamp\u00f3n\t\r \u00a0de\t\r \u00a0inmovilizaci\u00f3n\t\r \u00a0e\t\r \u00a0hibridaci\u00f3n\t\r \u00a0formada\t\r \u00a0por\t\r \u00a02\u00d7SSPE\t\r \u00a0pH\t\r \u00a07,4;\t\r \u00a0ii)\t\r \u00a0disoluci\u00f3n\t\r \u00a0tamp\u00f3n\t\r \u00a0 de\t\r \u00a0 bloqueo\t\r \u00a0consistente\t\r \u00a0 en\t\r \u00a0 5\u00d7SSPE\t\r \u00a0 pH\t\r \u00a0 7,4\t\r \u00a0 +\t\r \u00a0 5%\t\r \u00a0 BSA\t\r \u00a0 +\t\r \u00a0 0,1%\t\r \u00a0Tween\t\r \u00a020;\t\r \u00a0y\t\r \u00a0iii)\t\r \u00a0disoluci\u00f3n\t\r \u00a0tamp\u00f3n\t\r \u00a0de\t\r \u00a0medida\t\r \u00a0compuesta\t\r \u00a0por\t\r \u00a00,5\t\r \u00a0M\t\r \u00a0Tris-\u00ad\u2010HCl\t\r \u00a0pH\t\r \u00a09,8\t\r \u00a0+\t\r \u00a01\t\r \u00a0mM\t\r \u00a0de\t\r \u00a0MgCl2\t\r \u00a0+\t\r \u00a00,1\t\r \u00a0M\t\r \u00a0de\t\r \u00a0KCl.\t\r \u00a0Las\t\r \u00a0 secuencias\t\r \u00a0 de\t\r \u00a0 oligonucle\u00f3tidos\t\r \u00a0 utilizadas\t\r \u00a0 fueron\t\r \u00a0 suministradas\t\r \u00a0 por\t\r \u00a0Sigma-\u00ad\u2010Life\t\r \u00a0Science\t\r \u00a0(Reino\t\r \u00a0Unido).\t\r \u00a0Dichas\t\r \u00a0disoluciones\t\r \u00a0se\t\r \u00a0reconstituyeron\t\r \u00a0en\t\r \u00a0agua\t\r \u00a0Milli-\u00ad\u2010Q\t\r \u00a0y\t\r \u00a0se\t\r \u00a0almacenaron\t\r \u00a0a\t\r \u00a0-\u00ad\u201020\u00baC\t\r \u00a0hasta\t\r \u00a0su\t\r \u00a0uso.\t\r \u00a02.2.\t\r \u00a0Instrumentaci\u00f3n\t\r \u00a0Las\t\r \u00a0 medidas\t\r \u00a0 electroqu\u00edmicas\t\r \u00a0se\t\r \u00a0 realizaron\t\r \u00a0en\t\r \u00a0 un\t\r \u00a0potenciostato\t\r \u00a0Autolab\t\r \u00a0PGSTAT\t\r \u00a012,\t\r \u00a0controlado\t\r \u00a0por\t\r \u00a0el\t\r \u00a0software\t\r \u00a0GPES\t\r \u00a04.9005\t\r \u00a0(EcoChemie\t\r \u00a0B.V,\t\r \u00a0Holanda).\t\r \u00a0Se\t\r \u00a0utilizaron\t\r \u00a0electrodos\t\r \u00a0 serigrafiados\t\r \u00a0 de\t\r \u00a0 oro\t\r \u00a0 (referencia\t\r \u00a0 220BT;\t\r \u00a0 DropSens,\t\r \u00a0 Espa\u00f1a)\t\r \u00a0que\t\r \u00a0constan\t\r \u00a0de\t\r \u00a0una\t\r \u00a0 configuraci\u00f3n\t\r \u00a0 de\t\r \u00a0 tres\t\r \u00a0 electrodos\t\r \u00a0impresos\t\r \u00a0 en\t\r \u00a0 una\t\r \u00a0 l\u00e1mina\t\r \u00a0de\t\r \u00a0al\u00famina,\t\r \u00a0un\t\r \u00a0electrodo\t\r \u00a0de\t\r \u00a0trabajo\t\r \u00a0(di\u00e1metro\t\r \u00a04\t\r \u00a0mm)\t\r \u00a0y\t\r \u00a0un\t\r \u00a0electrodo\t\r \u00a0auxiliar,\t\r \u00a0ambos\t\r \u00a0de\t\r \u00a0oro,\t\r \u00a0y\t\r \u00a0un\t\r \u00a0electrodo\t\r \u00a0de\t\r \u00a0pseudo-\u00ad\u2010referencia\t\r \u00a0de\t\r \u00a0plata.\t\r \u00a0La\t\r \u00a0celda\t\r \u00a0electroqu\u00edmica\t\r \u00a0est\u00e1\t\r \u00a0limitada\t\r \u00a0 por\t\r \u00a0 un\t\r \u00a0 anillo\t\r \u00a0 formado\t\r \u00a0 por\t\r \u00a0 un\t\r \u00a0 pol\u00edmero\t\r \u00a0 aislante\t\r \u00a0 que\t\r \u00a0 rodea\t\r \u00a0a\t\r \u00a0 los\t\r \u00a0 tres\t\r \u00a0electrodos\t\r \u00a0 y\t\r \u00a0 tiene\t\r \u00a0 un\t\r \u00a0 volumen\t\r \u00a0 m\u00e1ximo\t\r \u00a0 de\t\r \u00a0 50\t\r \u00a0\u00b5L.\t\r \u00a0Todos\t\r \u00a0 los\t\r \u00a0 experimentos\t\r \u00a0 se\t\r \u00a0llevaron\t\r \u00a0 a\t\r \u00a0 cabo\t\r \u00a0 a\t\r \u00a0 temperatura\t\r \u00a0 ambiente\t\r \u00a0utiliz\u00e1ndose\t\r \u00a0un\t\r \u00a0 electrodo\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0medida.\t\r \u00a0Las\t\r \u00a0 medidas\t\r \u00a0 de\t\r \u00a0 pH\t\r \u00a0 se\t\r \u00a0 realizaron\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 pH-\u00ad\u2010metro\t\r \u00a0 Crison\t\r \u00a0 micropH\t\r \u00a0 2001\t\r \u00a0(Espa\u00f1a).\t\r \u00a0Para\t\r \u00a0la\t\r \u00a0cuantificaci\u00f3n\t\r \u00a0del\t\r \u00a0ADN\t\r \u00a0se\t\r \u00a0utiliz\u00f3\t\r \u00a0un\t\r \u00a0espectrofot\u00f3metro\t\r \u00a0UV-\u00ad\u2010visible\t\r \u00a0Cary\t\r \u00a0300\t\r \u00a0Bio\t\r \u00a0(Agilent\t\r \u00a0Tehcnologies,\t\r \u00a0Estados\t\r \u00a0Unidos).\t\r \u00a02.3.\t\r \u00a0Procedimiento\t\r \u00a0experimental\t\r \u00a02.3.1.\t\r \u00a0Dise\u00f1o\t\r \u00a0del\t\r \u00a0sensor\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0\t\r \u00a0Como\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0biosensores,\t\r \u00a0los\t\r \u00a0genosensores\t\r \u00a0o\t\r \u00a0sensores\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0combinan\t\r \u00a0un\t\r \u00a0 elemento\t\r \u00a0 de\t\r \u00a0 reconocimiento\t\r \u00a0 biol\u00f3gico,\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 caso\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 secuencia\t\r \u00a0 de\t\r \u00a0oligonucle\u00f3tidos\t\r \u00a0denominada\t\r \u00a0sonda,\t\r \u00a0con\t\r \u00a0un\t\r \u00a0transductor\t\r \u00a0encargado\t\r \u00a0de\t\r \u00a0la\t\r \u00a0medida\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 de\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0 entre\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 analito.\t\r \u00a0 La\t\r \u00a0 sonda\t\r \u00a0 utilizada\t\r \u00a0 ser\u00e1\t\r \u00a0complementaria\t\r \u00a0a\t\r \u00a0la\t\r \u00a0secuencia\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0de\t\r \u00a0inter\u00e9s\t\r \u00a0(analito)\t\r \u00a0y\t\r \u00a0formar\u00e1n\t\r \u00a0un\t\r \u00a0h\u00edbrido\t\r \u00a0de\t\r \u00a0 Watson-\u00ad\u2010Crick\t\r \u00a0 con\t\r \u00a0 extrema\t\r \u00a0 selectividad\t\r \u00a0 incluso\t\r \u00a0 en\t\r \u00a0 presencia\t\r \u00a0 de\t\r \u00a0 sondas\t\r \u00a0 de\t\r \u00a0oligonucle\u00f3tidos\t\r \u00a0no\t\r \u00a0complementarias.\t\r \u00a0La\t\r \u00a0 preparaci\u00f3n\t\r \u00a0 del\t\r \u00a0 sensor\t\r \u00a0 comienza\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 monocapa\t\r \u00a0autoensamblada\t\r \u00a0(SAM)\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 superficie\t\r \u00a0 del\t\r \u00a0 electrodo\t\r \u00a0 de\t\r \u00a0 oro.\t\r \u00a0 Antes\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0utilizaci\u00f3n,\t\r \u00a0 los\t\r \u00a0 electrodos\t\r \u00a0 serigrafiados\t\r \u00a0 de\t\r \u00a0 oro\t\r \u00a0 se\t\r \u00a0 sometieron\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 proceso\t\r \u00a0 de\t\r \u00a0limpieza\t\r \u00a0 que\t\r \u00a0 consisti\u00f3\t\r \u00a0 en\t\r \u00a0 lavado\t\r \u00a0 con\t\r \u00a0etanol\t\r \u00a0 y\t\r \u00a0 agua\t\r \u00a0 Milli-\u00ad\u2010Q\t\r \u00a0seguido\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0pretratamiento\t\r \u00a0electroqu\u00edmico\t\r \u00a0de\t\r \u00a025\t\r \u00a0barridos\t\r \u00a0c\u00edclicos\t\r \u00a0entre\t\r \u00a00\t\r \u00a0y\t\r \u00a0+1,6V,\t\r \u00a0a\t\r \u00a0100\t\r \u00a0mV/s,\t\r \u00a0en\t\r \u00a0H2SO4\t\r \u00a00,1\t\r \u00a0M,\t\r \u00a0para\t\r \u00a0eliminar\t\r \u00a0los\t\r \u00a0residuos\t\r \u00a0del\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0fabricaci\u00f3n,\t\r \u00a0y\t\r \u00a0as\u00ed\t\r \u00a0mejorar\t\r \u00a0la\t\r \u00a0sensibilidad\t\r \u00a0y\t\r \u00a0reproducibilidad\t\r \u00a0de\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0(16).\t\r \u00a0\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n382\t\r \u00a0\t\r \u00a0La\t\r \u00a0 monocapa\t\r \u00a0 mixta\t\r \u00a0 (SAM),\t\r \u00a0 consta\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 ADN\t\r \u00a0 tiolada\t\r \u00a0 y\t\r \u00a0 como\t\r \u00a0agente\t\r \u00a0bloqueante,\t\r \u00a0mercaptohexanol\t\r \u00a0(MCH).\t\r \u00a0La\t\r \u00a0inmovilizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0se\t\r \u00a0llev\u00f3\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0mediante\t\r \u00a0un\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0quimisorci\u00f3n,\t\r \u00a0uni\u00f3n\t\r \u00a0colavente\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0grupos\t\r \u00a0SH\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Au\t\r \u00a0del\t\r \u00a0electrodo.\t\r \u00a0El\t\r \u00a0MCH\t\r \u00a0se\t\r \u00a0intercala\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0hebras\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0quimisorbidas,\t\r \u00a0 controlando\t\r \u00a0 su\t\r \u00a0 disposici\u00f3n\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 electrodo\t\r \u00a0 e\t\r \u00a0 impidiendo\t\r \u00a0 las\t\r \u00a0adsorciones\t\r \u00a0 inespec\u00edficas\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sonda.\t\r \u00a0 Las\t\r \u00a0 cadenas\t\r \u00a0 de\t\r \u00a0 ADN\t\r \u00a0 se\t\r \u00a0 orientan\t\r \u00a0paralelas\t\r \u00a0entre\t\r \u00a0s\u00ed\t\r \u00a0y\t\r \u00a0perpendiculares\t\r \u00a0a\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0electr\u00f3dica\t\r \u00a0(Figura\t\r \u00a01),\t\r \u00a0y\t\r \u00a0as\u00ed,\t\r \u00a0favorecen\t\r \u00a0el\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n\t\r \u00a0(17,\t\r \u00a018).\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Formaci\u00f3n\t\r \u00a0de\t\r \u00a0una\t\r \u00a0monocapa\t\r \u00a0autoensamblada\t\r \u00a0mixta\t\r \u00a0organizada\t\r \u00a0sobre\t\r \u00a0electrodos\t\r \u00a0de\t\r \u00a0oro\t\r \u00a0serigrafiado.\t\r \u00a0Para\t\r \u00a0la\t\r \u00a0inmovilizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0se\t\r \u00a0depositaron\t\r \u00a015\t\r \u00a0\u00b5L\t\r \u00a0de\t\r \u00a0una\t\r \u00a0disoluci\u00f3n\t\r \u00a0 de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 tamp\u00f3n\t\r \u00a0 de\t\r \u00a0 inmovilizaci\u00f3n,\t\r \u00a0manteni\u00e9ndose\t\r \u00a0en\t\r \u00a0atm\u00f3sfera\t\r \u00a0cerrada\t\r \u00a0y\t\r \u00a0saturada\t\r \u00a0con\t\r \u00a0agua\t\r \u00a0durante\t\r \u00a019\t\r \u00a0horas.\t\r \u00a0La\t\r \u00a0monocapa\t\r \u00a0mixta\t\r \u00a0se\t\r \u00a0complet\u00f3\t\r \u00a0adicionando\t\r \u00a0 10\t\r \u00a0 \u00b5L\t\r \u00a0 de\t\r \u00a0 MCH\t\r \u00a0 en\t\r \u00a0 disoluci\u00f3n\t\r \u00a0 tamp\u00f3n\t\r \u00a0 de\t\r \u00a0 inmovilizaci\u00f3n;\t\r \u00a0dej\u00e1ndose\t\r \u00a015\t\r \u00a0min.\t\r \u00a0Las\t\r \u00a0concentraciones\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0MCH\t\r \u00a0cambian\t\r \u00a0y\t\r \u00a0se\t\r \u00a0especifican\t\r \u00a0en\t\r \u00a0cada\t\r \u00a0una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0experiencias.\t\r \u00a0\t\r \u00a0El\t\r \u00a0genosensor\t\r \u00a0propuesto\t\r \u00a0se\t\r \u00a0basa\t\r \u00a0en\t\r \u00a0un\t\r \u00a0formato\t\r \u00a0tipo\t\r \u00a0s\u00e1ndwich\t\r \u00a0que\t\r \u00a0requiere\t\r \u00a0la\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0 completa\t\r \u00a0 del\t\r \u00a0analito\t\r \u00a0 con\t\r \u00a0 dos\t\r \u00a0 sondas\t\r \u00a0 diferentes.\t\r \u00a0 Una\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0secuencia\t\r \u00a0 del\t\r \u00a0 analito\t\r \u00a0hibrida\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0 sonda\t\r \u00a0 indicadora\t\r \u00a0 biotinilada\t\r \u00a0 (hibridaci\u00f3n\t\r \u00a0homog\u00e9nea,\t\r \u00a0 Figura\t\r \u00a0 2.A)\t\r \u00a0y\t\r \u00a0 el\t\r \u00a0 resto\t\r \u00a0 de\t\r \u00a0 analito\t\r \u00a0 hibrida\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0inmovilizada\t\r \u00a0(hibridaci\u00f3n\t\r \u00a0heterog\u00e9nea,\t\r \u00a0Figura\t\r \u00a02.B).\t\r \u00a0La\t\r \u00a0hibridaci\u00f3n\t\r \u00a0homog\u00e9nea\t\r \u00a0se\t\r \u00a0llev\u00f3\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0mezclando\t\r \u00a0el\t\r \u00a0analito\t\r \u00a0y\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0indicadora\t\r \u00a0en\t\r \u00a0la\t\r \u00a0disoluci\u00f3n\t\r \u00a0tamp\u00f3n\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n,\t\r \u00a0con\t\r \u00a0una\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0indicadora\t\r \u00a0final\t\r \u00a0de\t\r \u00a02\t\r \u00a0\u00b5M.\t\r \u00a0La\t\r \u00a0mezcla\t\r \u00a0se\t\r \u00a0calent\u00f3\t\r \u00a0 a\t\r \u00a0 98\u00baC\t\r \u00a0 para\t\r \u00a0 romper\t\r \u00a0 las\t\r \u00a0 estructuras\t\r \u00a0 secundarias\t\r \u00a0 de\t\r \u00a0ambas\t\r \u00a0 sondas,\t\r \u00a0 se\t\r \u00a0sumergi\u00f3\t\r \u00a0 en\t\r \u00a0 hielo\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 dej\u00f3\t\r \u00a0 reposar\t\r \u00a0 a\t\r \u00a0 temperatura\t\r \u00a0 ambiente\t\r \u00a0 para\t\r \u00a0 favorecer\t\r \u00a0 la\t\r \u00a0hibridaci\u00f3n.\t\r \u00a0 Posteriormente,\t\r \u00a0 se\t\r \u00a0 depositaron\t\r \u00a015\t\r \u00a0 \u00b5L\t\r \u00a0 de\t\r \u00a0esta\t\r \u00a0disoluci\u00f3n\t\r \u00a0 sobre\t\r \u00a0el\t\r \u00a0electrodo\t\r \u00a0 modificado,\t\r \u00a0 dejando\t\r \u00a0 que\t\r \u00a0 transcurriese\t\r \u00a0 la\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0 heterog\u00e9nea\t\r \u00a0durante\t\r \u00a02\t\r \u00a0horas\t\r \u00a0a\t\r \u00a0temperatura\t\r \u00a0ambiente.\t\r \u00a0\t\r \u00a0\nDetecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0383\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a0 2.-\u00ad\u2010\t\r \u00a0Etapa\t\r \u00a0 de\t\r \u00a0 hibridaci\u00f3n.\t\r \u00a0(A)\t\r \u00a0 Hibridaci\u00f3n\t\r \u00a0 homog\u00e9nea\t\r \u00a0 o\t\r \u00a0 en\t\r \u00a0 disoluci\u00f3n\t\r \u00a0 e\t\r \u00a0 (B)\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0heterog\u00e9nea\t\r \u00a0o\t\r \u00a0en\t\r \u00a0superficie\t\r \u00a0\t\r \u00a0Concluida\t\r \u00a0 la\t\r \u00a0etapa\t\r \u00a0 de\t\r \u00a0hibridaci\u00f3n,\t\r \u00a0se\t\r \u00a0 procedi\u00f3\t\r \u00a0 al\t\r \u00a0 marcaje\t\r \u00a0 enzim\u00e1tico,\t\r \u00a0a\u00f1adiendo\t\r \u00a015\t\r \u00a0\u00b5L\t\r \u00a0de\t\r \u00a0una\t\r \u00a0disoluci\u00f3n\t\r \u00a0del\t\r \u00a0conjugado\t\r \u00a0fosfatasa\t\r \u00a0alcalina-\u00ad\u2010estreptavidina\t\r \u00a0(1,075\u22c510-\u00ad\u20103\t\r \u00a0g/L)\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0monocapa.\t\r \u00a0 La\t\r \u00a0 sonda\t\r \u00a0 indicadora\t\r \u00a0 biotinilada\t\r \u00a0 se\t\r \u00a0 uni\u00f3\t\r \u00a0 al\t\r \u00a0conjugado\t\r \u00a0 enzim\u00e1tico\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 enlace\t\r \u00a0 de\t\r \u00a0 alta\t\r \u00a0 afinidad\t\r \u00a0 estreptavidina-\u00ad\u2010biotina.\t\r \u00a0Finalmente,\t\r \u00a0se\t\r \u00a0llev\u00f3\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0la\t\r \u00a0detecci\u00f3n\t\r \u00a0electroqu\u00edmica\t\r \u00a0para\t\r \u00a0lo\t\r \u00a0cual\t\r \u00a0se\t\r \u00a0a\u00f1adi\u00f3,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0 electr\u00f3dica,\t\r \u00a040\t\r \u00a0 \u00b5L\t\r \u00a0 de\t\r \u00a0una\t\r \u00a0 disoluci\u00f3n\t\r \u00a0 de\t\r \u00a01-\u00ad\u2010naftilfosfato\t\r \u00a0 4\t\r \u00a0 mM\t\r \u00a0 en\t\r \u00a0disoluci\u00f3n\t\r \u00a0 tamp\u00f3n\t\r \u00a0 de\t\r \u00a0 medida.\t\r \u00a0 El\t\r \u00a0 enzima\t\r \u00a0 ALP\t\r \u00a0 cataliza\t\r \u00a0 la\t\r \u00a0 conversi\u00f3n\t\r \u00a0 de\t\r \u00a0 1-\u00ad\u2010naftilfosfato\t\r \u00a0 a\t\r \u00a0 1-\u00ad\u2010naftol,\t\r \u00a0 producto\t\r \u00a0 electroactivo\t\r \u00a0 de\t\r \u00a0estructura\t\r \u00a0 plana\t\r \u00a0 heteroc\u00edclica,\t\r \u00a0cuya\t\r \u00a0 oxidaci\u00f3n\t\r \u00a0se\t\r \u00a0midi\u00f3\t\r \u00a0mediante\t\r \u00a0voltamperometr\u00eda\t\r \u00a0 de\t\r \u00a0 pulso\t\r \u00a0 diferencial\t\r \u00a0 (DPV),\t\r \u00a0realizando\t\r \u00a0un\t\r \u00a0barrido\t\r \u00a0de\t\r \u00a00\t\r \u00a0a\t\r \u00a0+0,6\t\r \u00a0V.\t\r \u00a02.3.2.\t\r \u00a0Dise\u00f1o\t\r \u00a0de\t\r \u00a0experimentos\t\r \u00a0Se\t\r \u00a0realiz\u00f3\t\r \u00a0un\t\r \u00a0dise\u00f1o\t\r \u00a0factorial\t\r \u00a0completo\t\r \u00a032,\t\r \u00a0con\t\r \u00a02\t\r \u00a0variables\t\r \u00a0(concentraciones\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0MCH)\t\r \u00a0medidas\t\r \u00a0a\t\r \u00a03\t\r \u00a0niveles.\t\r \u00a0Los\t\r \u00a0resultados\t\r \u00a0se\t\r \u00a0analizaron\t\r \u00a0con\t\r \u00a0el\t\r \u00a0software\t\r \u00a0estad\u00edstico\t\r \u00a0Statgraphics\u00ae\t\r \u00a0Centurion,\t\r \u00a0versi\u00f3n\t\r \u00a0XVI\t\r \u00a0(19).\t\r \u00a0El\t\r \u00a0modelo\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0soportar\t\r \u00a0el\t\r \u00a0dise\u00f1o\t\r \u00a0utilizado\t\r \u00a0es\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0polin\u00f3mica\t\r \u00a0de\t\r \u00a0segundo\t\r \u00a0grado:\t\r \u00a021122222211122110XXXXXXY\u03b2+\u03b2+\u03b2+\u03b2+\u03b2+\u03b2=\t\r \u00a0donde\t\r \u00a0los\t\r \u00a0coeficientes\t\r \u00a0\u03b2\t\r \u00a0representan\t\r \u00a0los\t\r \u00a0efectos\t\r \u00a0lineales\t\r \u00a0y\t\r \u00a0cuadr\u00e1ticos\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables\t\r \u00a0X1\t\r \u00a0(concentraci\u00f3n\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura,\t\r \u00a0M)\t\r \u00a0y\t\r \u00a0X2\t\r \u00a0(concentraci\u00f3n\t\r \u00a0de\t\r \u00a0MCH,\t\r \u00a0M)\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 su\t\r \u00a0 interacci\u00f3n.\t\r \u00a0La\t\r \u00a0 variable\t\r \u00a0 dependiente\t\r \u00a0 o\t\r \u00a0 variable\t\r \u00a0 respuesta\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0respuesta\t\r \u00a0electroqu\u00edmica\t\r \u00a0medida\t\r \u00a0por\t\r \u00a0el\t\r \u00a0genosensor\t\r \u00a0(intensidad\t\r \u00a0de\t\r \u00a0corriente,\t\r \u00a0A).\t\r \u00a0\n\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n384\t\r \u00a0\t\r \u00a0En\t\r \u00a0 general,\t\r \u00a0 los\t\r \u00a0 dise\u00f1os\t\r \u00a0 de\t\r \u00a0 experimentos\t\r \u00a0 se\t\r \u00a0 escriben\t\r \u00a0 en\t\r \u00a0 t\u00e9rminos\t\r \u00a0 de\t\r \u00a0variables\t\r \u00a0codificadas.\t\r \u00a0En\t\r \u00a0un\t\r \u00a0dise\u00f1o\t\r \u00a0a\t\r \u00a0tres\t\r \u00a0niveles,\t\r \u00a0como\t\r \u00a0es\t\r \u00a0este\t\r \u00a0caso,\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores\t\r \u00a0codificados\t\r \u00a0son\t\r \u00a0+1,\t\r \u00a00\t\r \u00a0y\t\r \u00a0-\u00ad\u20101,\t\r \u00a0donde\t\r \u00a0+1\t\r \u00a0es\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0m\u00e1ximo\t\r \u00a0considerado,\t\r \u00a0-\u00ad\u20101\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0m\u00ednimo\t\r \u00a0y\t\r \u00a00\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0central.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0Tabla\t\r \u00a01\t\r \u00a0se\t\r \u00a0muestra\t\r \u00a0la\t\r \u00a0matriz\t\r \u00a0codificada\t\r \u00a0y\t\r \u00a0la\t\r \u00a0matriz\t\r \u00a0experimental\t\r \u00a0y\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0experimentales\t\r \u00a0fijados\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores\t\r \u00a0estudiados.\t\r \u00a0\t\r \u00a0Tabla\t\r \u00a01.\t\r \u00a0-\u00ad\u2010\t\r \u00a0Matriz\t\r \u00a0codificada\t\r \u00a0y\t\r \u00a0matriz\t\r \u00a0experimental\t\r \u00a0del\t\r \u00a0Dise\u00f1o\t\r \u00a0Factorial\t\r \u00a032\t\r \u00a0\t\r \u00a0Matriz\t\r \u00a0codificada\t\r \u00a0Matriz\t\r \u00a0experimental\t\r \u00a0Niveles\t\r \u00a0del\t\r \u00a0factor\t\r \u00a01\t\r \u00a0Niveles\t\r \u00a0del\t\r \u00a0factor\t\r \u00a02\t\r \u00a0Concentraci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0(\u00b5M)\t\r \u00a0Concentraci\u00f3n\t\r \u00a0 de\t\r \u00a0MCH\t\r \u00a0(mM)\t\r \u00a00\t\r \u00a0-\u00ad\u20101\t\r \u00a01,05\t\r \u00a00,5\t\r \u00a00\t\r \u00a00\t\r \u00a01,05\t\r \u00a02,5\t\r \u00a0+1\t\r \u00a0+1\t\r \u00a02\t\r \u00a04,5\t\r \u00a00\t\r \u00a00\t\r \u00a01,05\t\r \u00a02,5\t\r \u00a00\t\r \u00a0+1\t\r \u00a01,05\t\r \u00a04,5\t\r \u00a0-\u00ad\u20101\t\r \u00a0+1\t\r \u00a00,1\t\r \u00a04,5\t\r \u00a0-\u00ad\u20101\t\r \u00a0-\u00ad\u20101\t\r \u00a00,1\t\r \u00a00,5\t\r \u00a0+1\t\r \u00a0-\u00ad\u20101\t\r \u00a02\t\r \u00a00,5\t\r \u00a00\t\r \u00a00\t\r \u00a01,05\t\r \u00a02,5\t\r \u00a00\t\r \u00a00\t\r \u00a01,05\t\r \u00a02,5\t\r \u00a0\t\r \u00a0El\t\r \u00a0dise\u00f1o\t\r \u00a0propuesto\t\r \u00a0se\t\r \u00a0realiz\u00f3,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0mismo\t\r \u00a0instrumento,\t\r \u00a0el\t\r \u00a0mismo\t\r \u00a0d\u00eda\t\r \u00a0y\t\r \u00a0por\t\r \u00a0el\t\r \u00a0mismo\t\r \u00a0operador,\t\r \u00a0es\t\r \u00a0decir,\t\r \u00a0en\t\r \u00a0condiciones\t\r \u00a0de\t\r \u00a0repetibilidad.\t\r \u00a0La\t\r \u00a0aleatoriedad\t\r \u00a0en\t\r \u00a0el\t\r \u00a0orden\t\r \u00a0de\t\r \u00a0realizaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0experimentos\t\r \u00a0asegura,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0medida\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0posible,\t\r \u00a0que\t\r \u00a0factores\t\r \u00a0incontrolados\t\r \u00a0no\t\r \u00a0afecten\t\r \u00a0de\t\r \u00a0forman\t\r \u00a0sistem\u00e1tica\t\r \u00a0a\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0obtenidos\t\r \u00a0y\t\r \u00a0se\t\r \u00a0asegura\t\r \u00a0que\t\r \u00a0las\t\r \u00a0estimaciones\t\r \u00a0de\t\r \u00a0la\t\r \u00a0varianza\t\r \u00a0en\t\r \u00a0la\t\r \u00a0repetibilidad\t\r \u00a0reflejen\t\r \u00a0de\t\r \u00a0manera\t\r \u00a0adecuada\t\r \u00a0los\t\r \u00a0aspectos\t\r \u00a0aleatorios\t\r \u00a0del\t\r \u00a0proceso.\t\r \u00a03.\t\r \u00a0RESULTADOS\t\r \u00a0Y\t\r \u00a0DISCUSI\u00d3N\t\r \u00a03.1.\t\r \u00a0Selecci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0sondas\t\r \u00a0de\t\r \u00a0oligonucle\u00f3tidos\t\r \u00a0Para\t\r \u00a0obtener\t\r \u00a0un\t\r \u00a0sensor\t\r \u00a0\u00fatil\t\r \u00a0desde\t\r \u00a0el\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0vista\t\r \u00a0anal\u00edtico,\t\r \u00a0el\t\r \u00a0fragmento\t\r \u00a0de\t\r \u00a0 oligonucle\u00f3tidos\t\r \u00a0 elegido\t\r \u00a0 como\t\r \u00a0 analito\t\r \u00a0 tiene\t\r \u00a0 que\t\r \u00a0 cumplir\t\r \u00a0 como\t\r \u00a0 m\u00ednimo\t\r \u00a0 las\t\r \u00a0siguientes\t\r \u00a0 caracter\u00edsticas:\t\r \u00a0i)\t\r \u00a0 ser\t\r \u00a0 espec\u00edfico\t\r \u00a0 del\t\r \u00a0 cacahuete\t\r \u00a0 y\t\r \u00a0ii)\t\r \u00a0 no\t\r \u00a0 tratarse\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0secuencia\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0muy\t\r \u00a0larga\t\r \u00a0(no\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0100\t\r \u00a0nucle\u00f3tidos)\t\r \u00a0para\t\r \u00a0evitar\t\r \u00a0la\t\r \u00a0aparici\u00f3n\t\r \u00a0de\t\r \u00a0 estructuras\t\r \u00a0secundarias\t\r \u00a0 y\t\r \u00a0 apareamientos\t\r \u00a0 de\t\r \u00a0 bases\t\r \u00a0 que\t\r \u00a0 dificultar\u00edan\t\r \u00a0 la\t\r \u00a0hibridaci\u00f3n\t\r \u00a0(20).\t\r \u00a0Detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0385\t\r \u00a0\t\r \u00a0Como\t\r \u00a0analito\t\r \u00a0se\t\r \u00a0seleccion\u00f3\t\r \u00a0una\t\r \u00a0secuencia\t\r \u00a0de\t\r \u00a086-\u00ad\u2010mer\t\r \u00a0que\t\r \u00a0codifica\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0 Ara\t\r \u00a0 h\t\r \u00a0 2,\t\r \u00a0caracter\u00edstica\t\r \u00a0del\t\r \u00a0 cacahuete\t\r \u00a0 y\t\r \u00a0 cuya\t\r \u00a0 especificidad\t\r \u00a0 se\t\r \u00a0 comprob\u00f3\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0programa\t\r \u00a0BLAST\t\r \u00a0(21).\t\r \u00a0\t\r \u00a0Se\t\r \u00a0 seleccion\u00f3\t\r \u00a0 una\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 de\t\r \u00a0 32\t\r \u00a0 bases\t\r \u00a0 tiolada\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 extremo\t\r \u00a0 5\u00b4,\t\r \u00a0complementaria\t\r \u00a0en\t\r \u00a0su\t\r \u00a0totalidad\t\r \u00a0con\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0analito\t\r \u00a0y\t\r \u00a0una\t\r \u00a0sonda\t\r \u00a0indicadora\t\r \u00a0de\t\r \u00a054\t\r \u00a0nucle\u00f3tidos\t\r \u00a0 funcionalizada\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 extremo\t\r \u00a0 3\u2019\t\r \u00a0 con\t\r \u00a0 biotina.\t\r \u00a0 La\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 se\t\r \u00a0dise\u00f1\u00f3\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 que\t\r \u00a0 hibride\t\r \u00a0con\t\r \u00a0 la\t\r \u00a0 parte\t\r \u00a0 del\t\r \u00a0 analito\t\r \u00a0 que\t\r \u00a0 queda\t\r \u00a0 libre\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0hibridaci\u00f3n\t\r \u00a0con\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0indicadora,\t\r \u00a0formando\t\r \u00a0las\t\r \u00a0tres\t\r \u00a0hebras\t\r \u00a0un\t\r \u00a0d\u00faplex\t\r \u00a0perfecto.\t\r \u00a0De\t\r \u00a0esta\t\r \u00a0forma,\t\r \u00a0se\t\r \u00a0evita\t\r \u00a0que\t\r \u00a0alguna\t\r \u00a0base\t\r \u00a0quede\t\r \u00a0sin\t\r \u00a0hibridar\t\r \u00a0y\t\r \u00a0d\u00e9\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0adsorciones\t\r \u00a0inespec\u00edficas\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0electrodo\t\r \u00a0y\t\r \u00a0por\t\r \u00a0tanto\t\r \u00a0a\t\r \u00a0errores\t\r \u00a0en\t\r \u00a0la\t\r \u00a0medida.\t\r \u00a0Para\t\r \u00a0predecir\t\r \u00a0las\t\r \u00a0posibles\t\r \u00a0estructuras\t\r \u00a0secundarias\t\r \u00a0de\t\r \u00a0las\t\r \u00a0sondas\t\r \u00a0y\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0 del\t\r \u00a0 analito\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 e\t\r \u00a0 indicadora\t\r \u00a0 se\t\r \u00a0 utiliz\u00f3\t\r \u00a0 el\t\r \u00a0programa\t\r \u00a0inform\u00e1tico\t\r \u00a0Mfold\t\r \u00a0web\t\r \u00a0Server\t\r \u00a0(22).\t\r \u00a0La\t\r \u00a0estructura\t\r \u00a0secundaria\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0presenta\t\r \u00a0una\t\r \u00a0energ\u00eda\t\r \u00a0libre\t\r \u00a0\u0394G=\t\r \u00a0-\u00ad\u20102,9\t\r \u00a0kcal/mol,\t\r \u00a0la\t\r \u00a0del\t\r \u00a0analito\t\r \u00a0\u0394G\t\r \u00a0=\t\r \u00a0-\u00ad\u201016,71\t\r \u00a0kcal/mol,\t\r \u00a0la\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0indicadora\t\r \u00a0\u0394G\t\r \u00a0=\t\r \u00a0-\u00ad\u20104,39\t\r \u00a0kcal/mol,\t\r \u00a0el\t\r \u00a0h\u00edbrido\t\r \u00a0analito-\u00ad\u2010sonda\t\r \u00a0de\t\r \u00a0 captura\t\r \u00a0 presenta\t\r \u00a0una\t\r \u00a0 energ\u00eda\t\r \u00a0 libre\t\r \u00a0\u2206G\t\r \u00a0 =\t\r \u00a0-\u00ad\u201049,8\t\r \u00a0kcal/mol\t\r \u00a0y\t\r \u00a0 el\t\r \u00a0 h\u00edbrido\t\r \u00a0 analito-\u00ad\u2010sonda\t\r \u00a0 indicadora\t\r \u00a0\u2206G\t\r \u00a0 =\t\r \u00a0-\u00ad\u201085,5\t\r \u00a0kal/mol.\t\r \u00a0 Estos\t\r \u00a0 datos\t\r \u00a0 demuestran\t\r \u00a0 la\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0espont\u00e1nea\t\r \u00a0del\t\r \u00a0analito\t\r \u00a0con\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0sondas.\t\r \u00a03.2.\t\r \u00a0Selecci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0caracter\u00edsticas\t\r \u00a0del\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0experimentos\t\r \u00a0En\t\r \u00a0la\t\r \u00a0ejecuci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0experimentos\t\r \u00a0resulta\t\r \u00a0de\t\r \u00a0gran\t\r \u00a0importancia\t\r \u00a0identificar\t\r \u00a0 adecuadamente\t\r \u00a0 los\t\r \u00a0 factores\t\r \u00a0 o\t\r \u00a0 variables\t\r \u00a0 independientes\t\r \u00a0 que\t\r \u00a0 pueden\t\r \u00a0afectar\t\r \u00a0a\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0(variable\t\r \u00a0dependiente)\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0sus\t\r \u00a0niveles\t\r \u00a0experimentales.\t\r \u00a0Una\t\r \u00a0selecci\u00f3n\t\r \u00a0err\u00f3nea\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0niveles\t\r \u00a0podr\u00eda\t\r \u00a0dar\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0respuestas\t\r \u00a0muy\t\r \u00a0similares\t\r \u00a0que\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 deber\u00edan\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 no\t\r \u00a0 influencia\t\r \u00a0 del\t\r \u00a0 factor\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 respuesta\t\r \u00a0 sino\t\r \u00a0simplemente\t\r \u00a0a\t\r \u00a0que\t\r \u00a0el\t\r \u00a0factor\t\r \u00a0no\t\r \u00a0afecta\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0trabajo,\t\r \u00a0pero\t\r \u00a0puede\t\r \u00a0hacerlo\t\r \u00a0si\t\r \u00a0se\t\r \u00a0ampl\u00eda\t\r \u00a0dicha\t\r \u00a0zona.\t\r \u00a0Se\t\r \u00a0comenz\u00f3\t\r \u00a0 por\t\r \u00a0 optimizar\t\r \u00a0 la\t\r \u00a0 composici\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 monocapa,\t\r \u00a0 considerando\t\r \u00a0como\t\r \u00a0factores\t\r \u00a0las\t\r \u00a0concentraciones\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0de\t\r \u00a0mercaptohexanol.\t\r \u00a0Al\t\r \u00a0seleccionar\t\r \u00a0 los\t\r \u00a0 niveles,\t\r \u00a0 hay\t\r \u00a0 que\t\r \u00a0 intentar\t\r \u00a0 conseguir\t\r \u00a0 una\t\r \u00a0 SAM\t\r \u00a0 homog\u00e9nea\t\r \u00a0 y\t\r \u00a0 no\t\r \u00a0demasiado\t\r \u00a0 compacta\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 permita\t\r \u00a0 el\t\r \u00a0 contacto\t\r \u00a0 entre\t\r \u00a0 las\t\r \u00a0 hebras\t\r \u00a0complementarias\t\r \u00a0(23).\t\r \u00a0Experiencias\t\r \u00a0 previas\t\r \u00a0 demostraron\t\r \u00a0 que\t\r \u00a0 una\t\r \u00a0 concentraci\u00f3n\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0captura\t\r \u00a0 inferior\t\r \u00a0 a\t\r \u00a0 0,1\t\r \u00a0 \u00b5M\t\r \u00a0 produc\u00eda\t\r \u00a0 defectos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 monocapa\t\r \u00a0 quedando\t\r \u00a0 zonas\t\r \u00a0 de\t\r \u00a0oro\t\r \u00a0 no\t\r \u00a0 cubiertas.\t\r \u00a0 Por\t\r \u00a0 otra\t\r \u00a0 parte,\t\r \u00a0 se\t\r \u00a0 requiere\t\r \u00a0 un\t\r \u00a0 exceso\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 en\t\r \u00a0relaci\u00f3n\t\r \u00a0 al\t\r \u00a0 h\u00edbrido\t\r \u00a0 analito-\u00ad\u2010sonda\t\r \u00a0 indicadora\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 fin\t\r \u00a0 de\t\r \u00a0 asegurar\t\r \u00a0 que\t\r \u00a0 todo\t\r \u00a0 el\t\r \u00a0analito\t\r \u00a0incorporado\t\r \u00a0va\t\r \u00a0a\t\r \u00a0poder\t\r \u00a0reaccionar\t\r \u00a0con\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0para\t\r \u00a0formar\t\r \u00a0el\t\r \u00a0h\u00edbrido\t\r \u00a0 final.\t\r \u00a0 Teniendo\t\r \u00a0 esto\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 se\t\r \u00a0 consideraron\t\r \u00a0 como\t\r \u00a0 l\u00edmites\t\r \u00a0experimentales\t\r \u00a00,1\t\r \u00a0y\t\r \u00a02\t\r \u00a0\u00b5M.\t\r \u00a0\t\r \u00a0\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n386\t\r \u00a0\t\r \u00a0Estudios\t\r \u00a0previos\t\r \u00a0aportan\t\r \u00a0evidencias\t\r \u00a0de\t\r \u00a0que\t\r \u00a0aunque\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0posterior\t\r \u00a0con\t\r \u00a0MCH\t\r \u00a0no\t\r \u00a0permite\t\r \u00a0eliminar\t\r \u00a0completamente\t\r \u00a0el\t\r \u00a0ADN\t\r \u00a0adsorbido\t\r \u00a0inespec\u00edficamente,\t\r \u00a0se\t\r \u00a0 logra\t\r \u00a0 una\t\r \u00a0 disminuci\u00f3n\t\r \u00a0 considerable\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 interacciones\t\r \u00a0 inespec\u00edficas\t\r \u00a0 y\t\r \u00a0 una\t\r \u00a0eficiencia\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n\t\r \u00a0superior\t\r \u00a0a\t\r \u00a0la\t\r \u00a0de\t\r \u00a0una\t\r \u00a0SAM\t\r \u00a0pura\t\r \u00a0de\t\r \u00a0\u00e1cido\t\r \u00a0nucleico\t\r \u00a0tiolado\t\r \u00a0(24).\t\r \u00a0 Con\t\r \u00a0 el\t\r \u00a0 objetivo\t\r \u00a0 de\t\r \u00a0 minimizar\t\r \u00a0 las\t\r \u00a0 absorciones\t\r \u00a0 inespec\u00edficas\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0captura\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 superficie\t\r \u00a0 electr\u00f3dica,\t\r \u00a0 en\t\r \u00a0 todos\t\r \u00a0 los\t\r \u00a0 casos\t\r \u00a0 se\t\r \u00a0 a\u00f1adi\u00f3\t\r \u00a0 mayor\t\r \u00a0cantidad\t\r \u00a0 de\t\r \u00a0 MCH\t\r \u00a0que\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura.\t\r \u00a0 Valores\t\r \u00a0 de\t\r \u00a0 MCH\t\r \u00a0 inferiores\t\r \u00a0 a\t\r \u00a0 0,5\t\r \u00a0 mM\t\r \u00a0produc\u00edan\t\r \u00a0 descensos\t\r \u00a0 dr\u00e1sticos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 se\u00f1al\t\r \u00a0 voltamperom\u00e9trica\t\r \u00a0 del\t\r \u00a0 1-\u00ad\u2010naftol,\t\r \u00a0gener\u00e1ndose\t\r \u00a0 probablemente\t\r \u00a0 una\t\r \u00a0 monocapa\t\r \u00a0 irregular.\t\r \u00a0 Se\t\r \u00a0 comprob\u00f3\t\r \u00a0 que\t\r \u00a0concentraciones\t\r \u00a0superiores\t\r \u00a0a\t\r \u00a04,5\t\r \u00a0mM\t\r \u00a0provocaban\t\r \u00a0el\t\r \u00a0desplazamiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura.\t\r \u00a0Como\t\r \u00a0consecuencia\t\r \u00a0se\t\r \u00a0seleccionaron\t\r \u00a0como\t\r \u00a0valores\t\r \u00a0l\u00edmites\t\r \u00a00,5\t\r \u00a0y\t\r \u00a04,5\t\r \u00a0mM.\t\r \u00a03.3.\t\r \u00a0Ensayo\t\r \u00a0preliminar\t\r \u00a0Antes\t\r \u00a0 de\t\r \u00a0 realizar\t\r \u00a0 los\t\r \u00a0 dise\u00f1os\t\r \u00a0 de\t\r \u00a0 experimentos\t\r \u00a0 se\t\r \u00a0 llev\u00f3\t\r \u00a0 a\t\r \u00a0 cabo\t\r \u00a0 un\t\r \u00a0 estudio\t\r \u00a0previo\t\r \u00a0con\t\r \u00a0el\t\r \u00a0fin\t\r \u00a0de\t\r \u00a0comprobar\t\r \u00a0que\t\r \u00a0las\t\r \u00a0sondas\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0e\t\r \u00a0indicadora\t\r \u00a0hibridan,\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0selectiva,\t\r \u00a0con\t\r \u00a0el\t\r \u00a0analito\t\r \u00a0y\t\r \u00a0que\t\r \u00a0ese\t\r \u00a0evento\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n\t\r \u00a0se\t\r \u00a0traduce\t\r \u00a0en\t\r \u00a0una\t\r \u00a0se\u00f1al\t\r \u00a0electroqu\u00edmica.\t\r \u00a0Se\t\r \u00a0opt\u00f3\t\r \u00a0por\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0MCH\t\r \u00a0 utilizados\t\r \u00a0 con\t\r \u00a0 \u00e9xito\t\r \u00a0 en\t\r \u00a0 trabajos\t\r \u00a0 anteriores\t\r \u00a0 (16),\t\r \u00a02\t\r \u00a0 \u00b5M\t\r \u00a0 y\t\r \u00a0 4,5\t\r \u00a0 mM\t\r \u00a0respectivamente.\t\r \u00a0El\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0condiciones\t\r \u00a0experimentales\t\r \u00a0fueron\t\r \u00a0las\t\r \u00a0descritas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Procedimiento\t\r \u00a0 Experimental.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 Figura\t\r \u00a0 3\t\r \u00a0se\t\r \u00a0 muestra\t\r \u00a0 el\t\r \u00a0 voltamperograma\t\r \u00a0obtenido\t\r \u00a0con\t\r \u00a0el\t\r \u00a0analito\t\r \u00a0y\t\r \u00a0con\t\r \u00a0una\t\r \u00a0secuencia\t\r \u00a0no\t\r \u00a0complementaria\t\r \u00a0(nC),\t\r \u00a0ambas\t\r \u00a0a\t\r \u00a0un\t\r \u00a0nivel\t\r \u00a0 de\t\r \u00a0 concentraci\u00f3n\t\r \u00a0 1\t\r \u00a0 nM.\t\r \u00a0 El\t\r \u00a0 analito\t\r \u00a0 dio\t\r \u00a0 una\t\r \u00a0 se\u00f1al\t\r \u00a0 muy\t\r \u00a0 superior\t\r \u00a0 al\t\r \u00a0 blanco\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0se\u00f1al\t\r \u00a0generada\t\r \u00a0por\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0no\t\r \u00a0complementaria\t\r \u00a0fue\t\r \u00a0semejante\t\r \u00a0a\t\r \u00a0la\t\r \u00a0generada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0blanco,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0demuestra\t\r \u00a0la\t\r \u00a0complementariedad\t\r \u00a0de\t\r \u00a0las\t\r \u00a0sondas\t\r \u00a0con\t\r \u00a0el\t\r \u00a0analito\t\r \u00a0y\t\r \u00a0la\t\r \u00a0especificidad\t\r \u00a0del\t\r \u00a0dispositivo.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a03.-\u00ad\u2010\t\r \u00a0Voltamperogramas\t\r \u00a0obtenidos\t\r \u00a0con\t\r \u00a0la\t\r \u00a0secuencia\t\r \u00a0analito,\t\r \u00a0una\t\r \u00a0secuencia\t\r \u00a0no\t\r \u00a0complementaria\t\r \u00a0y\t\r \u00a0un\t\r \u00a0blanco.\t\r \u00a0Condiciones\t\r \u00a0experimentales:\t\r \u00a0Voltametr\u00eda\t\r \u00a0diferencial\t\r \u00a0de\t\r \u00a0impulsos,\t\r \u00a0amplitud\t\r \u00a0de\t\r \u00a0pulso\t\r \u00a020\t\r \u00a0mV,\t\r \u00a0velocidad\t\r \u00a0de\t\r \u00a0barrido\t\r \u00a010\t\r \u00a0mV/s.\t\r \u00a0\t\r \u00a0E (V)I(\u00b5A)01234567\n00,20,40,6blanconC 1 nManalito 1 nMDetecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0387\t\r \u00a0\t\r \u00a03.4.\t\r \u00a0Optimizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0monocapa\t\r \u00a0\t\r \u00a0Con\t\r \u00a0el\t\r \u00a0objetivo\t\r \u00a0de\t\r \u00a0optimizar\t\r \u00a0la\t\r \u00a0composici\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0monocapa\t\r \u00a0se\t\r \u00a0realizaron\t\r \u00a0dos\t\r \u00a0 dise\u00f1os\t\r \u00a0 factoriales\t\r \u00a0 completos\t\r \u00a032,\t\r \u00a0ya\t\r \u00a0descritos\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 apartado\t\r \u00a0 Dise\u00f1o\t\r \u00a0estad\u00edstico,\t\r \u00a0 siendo\t\r \u00a0 las\t\r \u00a0 variables\t\r \u00a0 independientes\t\r \u00a0las\t\r \u00a0concentraciones\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a0de\t\r \u00a0MCH.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0primero\t\r \u00a0de\t\r \u00a0ellos\t\r \u00a0se\t\r \u00a0utiliz\u00f3\t\r \u00a0una\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0analito\t\r \u00a0de\t\r \u00a010\t\r \u00a0nM.\t\r \u00a0El\t\r \u00a0diagrama\t\r \u00a0de\t\r \u00a0Pareto\t\r \u00a0(Figura\t\r \u00a04.A)\t\r \u00a0muestra\t\r \u00a0la\t\r \u00a0influencia\t\r \u00a0de\t\r \u00a0las\t\r \u00a0variables\t\r \u00a0y\t\r \u00a0sus\t\r \u00a0interacciones\t\r \u00a0en\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0del\t\r \u00a0sensor,\t\r \u00a0siendo\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0cuadr\u00e1tico\t\r \u00a0de\t\r \u00a0ambas\t\r \u00a0variables\t\r \u00a0 el\t\r \u00a0 de\t\r \u00a0 mayor\t\r \u00a0 influencia\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 respuesta.\t\r \u00a0 El\t\r \u00a0 efecto\t\r \u00a0 individual\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0variables\t\r \u00a0 muestra\t\r \u00a0 una\t\r \u00a0 influencia\t\r \u00a0 menor,\t\r \u00a0 siendo\t\r \u00a0 positivo\t\r \u00a0 el\t\r \u00a0 efecto\t\r \u00a0 del\t\r \u00a0 MCH\t\r \u00a0 y\t\r \u00a0negativo\t\r \u00a0 el\t\r \u00a0 efecto\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura.\t\r \u00a0 El\t\r \u00a0modelo\t\r \u00a0 matem\u00e1tico\t\r \u00a0 obtenido\t\r \u00a0corresponde\t\r \u00a0a\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0Sanalito\t\r \u00a0(A)\t\r \u00a0 =\t\r \u00a0 5,22737\u00d710-\u00ad\u20106\t\r \u00a0+\t\r \u00a0 4,98504\u00d710-\u00ad\u20106[sonda\t\r \u00a0 captura]\t\r \u00a0+\t\r \u00a0 5,97693\u00d710-\u00ad\u20106[MCH]\t\r \u00a0-\u00ad\u2010\t\r \u00a04,50416\u00d710-\u00ad\u20106[sonda\t\r \u00a0captura]2\t\r \u00a0+\t\r \u00a01,54737\u00d710-\u00ad\u20106[sonda\t\r \u00a0captura][MCH]\t\r \u00a0-\u00ad\u2010\t\r \u00a01,4\u00d710-\u00ad\u20106[MCH]2\t\r \u00a0\t\r \u00a0La\t\r \u00a0 Figura\t\r \u00a0 4.B\t\r \u00a0 muestra\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 principales\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 intensidad\t\r \u00a0 de\t\r \u00a0corriente\t\r \u00a0producidos\t\r \u00a0por\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0variables.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0Figura\t\r \u00a04.C\t\r \u00a0se\t\r \u00a0muestra\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0y\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Figura\t\r \u00a04.D\t\r \u00a0las\t\r \u00a0correspondientes\t\r \u00a0curvas\t\r \u00a0de\t\r \u00a0nivel\t\r \u00a0proyectadas\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 plano\t\r \u00a0 formado\t\r \u00a0por\t\r \u00a0 los\t\r \u00a0 dos\t\r \u00a0 factores.\t\r \u00a0 Estas\t\r \u00a0 curvas\t\r \u00a0 de\t\r \u00a0 nivel\t\r \u00a0 muestran\t\r \u00a0 las\t\r \u00a0condiciones\t\r \u00a0experimentales\t\r \u00a0para\t\r \u00a0las\t\r \u00a0que\t\r \u00a0se\t\r \u00a0obtiene\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0m\u00e1ximo\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0as\u00ed\t\r \u00a0 como\t\r \u00a0 un\t\r \u00a0 espacio\t\r \u00a0 pr\u00f3ximo\t\r \u00a0 al\t\r \u00a0 \u00f3ptimo\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 misma\t\r \u00a0 respuesta\t\r \u00a0 para\t\r \u00a0 distintas\t\r \u00a0condiciones\t\r \u00a0 experimentales,\t\r \u00a0 pudiendo\t\r \u00a0 elegir\t\r \u00a0de\t\r \u00a0 toda\t\r \u00a0 la\t\r \u00a0 zona\t\r \u00a0 los\t\r \u00a0 valores\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0factores\t\r \u00a0m\u00e1s\t\r \u00a0convenientes\t\r \u00a0seg\u00fan\t\r \u00a0otros\t\r \u00a0criterios\t\r \u00a0econ\u00f3micos\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0coste,\t\r \u00a0tiempo,\t\r \u00a0etc.\t\r \u00a0Este\t\r \u00a0m\u00e1ximo\t\r \u00a0viene\t\r \u00a0definido\t\r \u00a0por\t\r \u00a0los\t\r \u00a0valores\t\r \u00a0\u00f3ptimos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores\t\r \u00a0implicados\t\r \u00a0que\t\r \u00a0resultaron\t\r \u00a0ser\t\r \u00a01\u03bcM\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0de\t\r \u00a0MCH.\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a0 4.-\u00ad\u2010\t\r \u00a0Resultados\t\r \u00a0 del\t\r \u00a0 dise\u00f1o\t\r \u00a0 factorial\t\r \u00a0 32\t\r \u00a0con\t\r \u00a0 analito\t\r \u00a0 10\t\r \u00a0 nM,\t\r \u00a0(A)\t\r \u00a0diagrama\t\r \u00a0 de\t\r \u00a0 Pareto\t\r \u00a0estandarizado\t\r \u00a0para\t\r \u00a0intensidad\t\r \u00a0de\t\r \u00a0corriente,\t\r \u00a0(B)\t\r \u00a0gr\u00e1fica\t\r \u00a0de\t\r \u00a0efectos\t\r \u00a0principales\t\r \u00a0para\t\r \u00a0la\t\r \u00a0intensidad,\t\r \u00a0(C)\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0y\t\r \u00a0(D)\t\r \u00a0curvas\t\r \u00a0de\t\r \u00a0nivel.\t\r \u00a05\nIntensidad (A)[MCH]*[MCH][sonda captura]*[sonda captura][sonda captura]*[MCH][sonda captura][MCH]\nIntensidad (A)\n[Sonda captura][MCH]Efecto estandarizado(A)(B)\n(C)(x 10-6)(x 10-6)\n4 1.6 0.8 3.2 5.6 8 10.4 12.8 15.2 17.6 20 Intensidad (\u00b5A)\n[sonda captura][MCH](D)\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n388\t\r \u00a0\t\r \u00a0\t\r \u00a0Debido\t\r \u00a0 a\t\r \u00a0la\t\r \u00a0 complejidad\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 monocapa\t\r \u00a0 es\t\r \u00a0 habitual\t\r \u00a0 la\t\r \u00a0 aparici\u00f3n\t\r \u00a0 de\t\r \u00a0adsorciones\t\r \u00a0 inespec\u00edficas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 sondas\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 agentes\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 componen\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0traduce\t\r \u00a0 en\t\r \u00a0 se\u00f1ales\t\r \u00a0 indeseables.\t\r \u00a0 Para\t\r \u00a0 averiguar\t\r \u00a0 la\t\r \u00a0 posible\t\r \u00a0 existencia\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0adsorciones\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0 efecto\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 se\u00f1al,\t\r \u00a0 se\t\r \u00a0 realiz\u00f3\t\r \u00a0 un\t\r \u00a0 segundo\t\r \u00a0 dise\u00f1o\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0disoluci\u00f3n\t\r \u00a0blanco.\t\r \u00a0La\t\r \u00a0matriz\t\r \u00a0experimental\t\r \u00a0y\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0de\t\r \u00a0los\t\r \u00a0factores\t\r \u00a0del\t\r \u00a0dise\u00f1o\t\r \u00a0factorial\t\r \u00a0 32\t\r \u00a0fueron\t\r \u00a0 los\t\r \u00a0 mismos\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 dise\u00f1o\t\r \u00a0 anterior.\t\r \u00a0 Seg\u00fan\t\r \u00a0 el\t\r \u00a0 diagrama\t\r \u00a0 de\t\r \u00a0Pareto\t\r \u00a0(Figura\t\r \u00a05.A),\t\r \u00a0el\t\r \u00a0MCH\t\r \u00a0fue\t\r \u00a0el\t\r \u00a0factor\t\r \u00a0de\t\r \u00a0mayor\t\r \u00a0influencia,\t\r \u00a0siendo\t\r \u00a0\u00e9sta\t\r \u00a0negativa\t\r \u00a0al\t\r \u00a0igual\t\r \u00a0que\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura,\t\r \u00a0es\t\r \u00a0decir,\t\r \u00a0el\t\r \u00a0blanco\t\r \u00a0dio\t\r \u00a0menor\t\r \u00a0se\u00f1al\t\r \u00a0al\t\r \u00a0aumentar\t\r \u00a0el\t\r \u00a0contenido\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 y\t\r \u00a0 agente\t\r \u00a0 bloqueante.\t\r \u00a0 Este\t\r \u00a0 hecho\t\r \u00a0 se\t\r \u00a0 atribuye\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n,\t\r \u00a0bajo\t\r \u00a0estas\t\r \u00a0condiciones,\t\r \u00a0de\t\r \u00a0una\t\r \u00a0monocapa\t\r \u00a0compacta\t\r \u00a0y\t\r \u00a0sin\t\r \u00a0huecos\t\r \u00a0que\t\r \u00a0dificultan\t\r \u00a0las\t\r \u00a0adsorciones\t\r \u00a0inespec\u00edficas.\t\r \u00a0El\t\r \u00a0modelo\t\r \u00a0matem\u00e1tico\t\r \u00a0ajustado\t\r \u00a0corresponde\t\r \u00a0a\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0Sblanco\t\r \u00a0(A)\t\r \u00a0 =\t\r \u00a0 8,43393\u00d710-\u00ad\u20107\t\r \u00a0-\u00ad\u2010\t\r \u00a01,48473\u00d710-\u00ad\u20107[sonda\t\r \u00a0 captura]\t\r \u00a0-\u00ad\u2010\t\r \u00a02,19162\u00d710-\u00ad\u20107[MCH]\t\r \u00a0-\u00ad\u2010\t\r \u00a01,19114\u00d710-\u00ad\u20108\t\r \u00a0[sonda\t\r \u00a0captura]2\t\r \u00a0+\t\r \u00a03,32895\u00d710-\u00ad\u20108\t\r \u00a0[sonda\t\r \u00a0captura][MCH]+\t\r \u00a02,3625\u00d710-\u00ad\u20108[MCH]2\t\r \u00a0La\t\r \u00a0 Figura\t\r \u00a0 5.B\t\r \u00a0 muestra\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 principales\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 intensidad\t\r \u00a0 de\t\r \u00a0corriente\t\r \u00a0producidos\t\r \u00a0por\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0variables,\t\r \u00a0no\t\r \u00a0estableci\u00e9ndose\t\r \u00a0un\t\r \u00a0valor\t\r \u00a0m\u00ednimo\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0para\t\r \u00a0la\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0en\t\r \u00a0la\t\r \u00a0zona\t\r \u00a0de\t\r \u00a0experimentaci\u00f3n.\t\r \u00a0As\u00ed\t\r \u00a0mismo,\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0(Figura\t\r \u00a05.C)\t\r \u00a0no\t\r \u00a0presenta\t\r \u00a0un\t\r \u00a0\u00f3ptimo\t\r \u00a0y\t\r \u00a0las\t\r \u00a0curvas\t\r \u00a0de\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0este\t\r \u00a0ensayo\t\r \u00a0(Figura\t\r \u00a05.D)\t\r \u00a0muestran\t\r \u00a0una\t\r \u00a0tendencia\t\r \u00a0que\t\r \u00a0apunta\t\r \u00a0hacia\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0modificar\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0experimental\t\r \u00a0hacia\t\r \u00a0valores\t\r \u00a0mayores\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura,\t\r \u00a0sin\t\r \u00a0 embargo,\t\r \u00a0 mayores\t\r \u00a0 concentraciones\t\r \u00a0 de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 dificultar\u00edan\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n\t\r \u00a0por\t\r \u00a0impedimento\t\r \u00a0est\u00e9rico.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a05.-\u00ad\u2010\t\r \u00a0Resultados\t\r \u00a0del\t\r \u00a0dise\u00f1o\t\r \u00a0factorial\t\r \u00a032\t\r \u00a0con\t\r \u00a0un\t\r \u00a0blanco\t\r \u00a0(A)\t\r \u00a0diagrama\t\r \u00a0de\t\r \u00a0Pareto\t\r \u00a0estandarizado\t\r \u00a0para\t\r \u00a0intensidad\t\r \u00a0de\t\r \u00a0corriente,\t\r \u00a0(B)\t\r \u00a0gr\u00e1fica\t\r \u00a0de\t\r \u00a0efectos\t\r \u00a0principales\t\r \u00a0para\t\r \u00a0la\t\r \u00a0intensidad,\t\r \u00a0(C)\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0y\t\r \u00a0(D)\t\r \u00a0curvas\t\r \u00a0de\t\r \u00a0nivel.\t\r \u00a0\t\r \u00a0\t\r \u00a0\nIntensidad  (A)(C)(x 10-8)\nIntensidad  (A)\n[sonda captura][MCH](B)(x 10-8)\n[MCH]*[MCH][sonda captura]*[sonda captura][sonda captura]*[MCH][sonda captura[MCH]\nEfecto estandarizado(A)\n0,25 0,31 0,37 0,43 0,55 0,61 0,67 0,73 0,79 Intensidad (\u00b5A)\n0,85 0,49 \n[sonda captura][MCH](D)Detecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0389\t\r \u00a0\t\r \u00a0Con\t\r \u00a0 el\t\r \u00a0 objetivo\t\r \u00a0 de\t\r \u00a0 conocer\t\r \u00a0 la\t\r \u00a0 se\u00f1al\t\r \u00a0 debida\t\r \u00a0 exclusivamente\t\r \u00a0 al\t\r \u00a0 analito,\t\r \u00a0 se\t\r \u00a0gener\u00f3\t\r \u00a0 una\t\r \u00a0 nueva\t\r \u00a0 variable\t\r \u00a0diferencia\t\r \u00a0(se\u00f1al\t\r \u00a0 del\t\r \u00a0 analito\t\r \u00a0\u2013\t\r \u00a0se\u00f1al\t\r \u00a0 del\t\r \u00a0 blanco).\t\r \u00a0El\t\r \u00a0modelo\t\r \u00a0matem\u00e1tico\t\r \u00a0obtenido\t\r \u00a0corresponde\t\r \u00a0a\t\r \u00a0la\t\r \u00a0ecuaci\u00f3n\t\r \u00a0Sanalito-\u00ad\u2010Sblanco\t\r \u00a0(A)\t\r \u00a0 =4,39816\u00d710-\u00ad\u20106\t\r \u00a0+\t\r \u00a0 5,13019\u00d710-\u00ad\u20106\t\r \u00a0[sonda\t\r \u00a0 captura]\t\r \u00a0+\t\r \u00a0 6,17592\u00d710-\u00ad\u20106\t\r \u00a0[MCH]\t\r \u00a0-\u00ad\u2010\t\r \u00a04,49307\u00d710-\u00ad\u20106\t\r \u00a0[sonda\t\r \u00a0captura]2\t\r \u00a0+\t\r \u00a01,51579\u00d710-\u00ad\u20106\t\r \u00a0[sonda\t\r \u00a0captura][MCH]\t\r \u00a0-\u00ad\u2010\t\r \u00a01,42\u00d710-\u00ad\u20106\t\r \u00a0[MCH]2\t\r \u00a0En\t\r \u00a0 la\t\r \u00a0 Figura\t\r \u00a0 6\t\r \u00a0 se\t\r \u00a0 muestran\t\r \u00a0 la\t\r \u00a0 superficie\t\r \u00a0 de\t\r \u00a0 respuesta\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 analito,\t\r \u00a0 el\t\r \u00a0blanco\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0diferencia\t\r \u00a0y\t\r \u00a0 la\t\r \u00a0 curva\t\r \u00a0 de\t\r \u00a0 nivel\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 diferencia\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Figura\t\r \u00a0 6.D.\t\r \u00a0 Los\t\r \u00a0valores\t\r \u00a0\u00f3ptimos\t\r \u00a0pr\u00e1cticamente\t\r \u00a0coincidieron\t\r \u00a0con\t\r \u00a0los\t\r \u00a0obtenidos\t\r \u00a0previamente,\t\r \u00a01\u03bcM\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0de\t\r \u00a0MCH,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0la\t\r \u00a0se\u00f1al\t\r \u00a0obtenida\t\r \u00a0por\t\r \u00a0el\t\r \u00a0blanco,\t\r \u00a0en\t\r \u00a0estas\t\r \u00a0 condiciones,\t\r \u00a0 es\t\r \u00a0 pr\u00e1cticamente\t\r \u00a0 despreciable\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 obtenida\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0analito.\t\r \u00a0Reducir\t\r \u00a0los\t\r \u00a0valores\t\r \u00a0del\t\r \u00a0blanco\t\r \u00a0es\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0principales\t\r \u00a0objetivos\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0dispositivos\t\r \u00a0 anal\u00edticos,\t\r \u00a0 para\t\r \u00a0 as\u00ed\t\r \u00a0aumentar\t\r \u00a0 la\t\r \u00a0 relaci\u00f3n\t\r \u00a0 se\u00f1al/blanco\t\r \u00a0 y,\t\r \u00a0 como\t\r \u00a0consiguiente,\t\r \u00a0 el\t\r \u00a0 l\u00edmite\t\r \u00a0 de\t\r \u00a0 detecci\u00f3n.\t\r \u00a0 Los\t\r \u00a0 blancos\t\r \u00a0 obtenidos\t\r \u00a0 en\t\r \u00a0 estas\t\r \u00a0 condiciones\t\r \u00a0experimentales\t\r \u00a0hacen\t\r \u00a0que\t\r \u00a0la\t\r \u00a0relaci\u00f3n\t\r \u00a0S/B\t\r \u00a0aumente\t\r \u00a0de\t\r \u00a0manera\t\r \u00a0apreciable.\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a06.-\u00ad\u2010\t\r \u00a0Curvas\t\r \u00a0de\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0respuesta:\t\r \u00a0(A)\t\r \u00a010\t\r \u00a0nM\t\r \u00a0de\t\r \u00a0analito,\t\r \u00a0(B)\t\r \u00a0blanco\t\r \u00a0y\t\r \u00a0(C)\t\r \u00a0diferencia\t\r \u00a010\t\r \u00a0nM\t\r \u00a0analito-\u00ad\u2010blanco.\t\r \u00a0(D)\t\r \u00a0Curva\t\r \u00a0de\t\r \u00a0nivel\t\r \u00a0para\t\r \u00a0la\t\r \u00a0variable\t\r \u00a0diferencia.\t\r \u00a03.5.\t\r \u00a0Curva\t\r \u00a0de\t\r \u00a0calibrado\t\r \u00a0y\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0reproducibilidad\t\r \u00a0Se\t\r \u00a0 realiz\u00f3\t\r \u00a0 una\t\r \u00a0 curva\t\r \u00a0 de\t\r \u00a0 calibrado,\t\r \u00a0 bajo\t\r \u00a0 las\t\r \u00a0 condiciones\t\r \u00a0 experimentales\t\r \u00a0\u00f3ptimas\t\r \u00a0obtenidas\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dise\u00f1os\t\r \u00a0de\t\r \u00a0experimentos,\t\r \u00a01\u00b5M\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura\t\r \u00a0y\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0de\t\r \u00a0MCH.\t\r \u00a0Se\t\r \u00a0observ\u00f3\t\r \u00a0una\t\r \u00a0relaci\u00f3n\t\r \u00a0lineal\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0intensidad\t\r \u00a0de\t\r \u00a0corriente\t\r \u00a0y\t\r \u00a0la\t\r \u00a0concentraci\u00f3n\t\r \u00a0 de\t\r \u00a0 analito,\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 intervalo\t\r \u00a0 lineal\t\r \u00a0 de\t\r \u00a01\u22c510-\u00ad\u201010\t\r \u00a0a\t\r \u00a01\t\r \u00a0 10-\u00ad\u20107\t\r \u00a0M\t\r \u00a0(Figura7),\t\r \u00a0una\t\r \u00a0ecuaci\u00f3n\t\r \u00a0I\t\r \u00a0(A)\t\r \u00a0=\t\r \u00a02\u22c510-\u00ad\u20106\t\r \u00a0C\t\r \u00a0(nM)\t\r \u00a0+\t\r \u00a04\u22c510-\u00ad\u20106,\t\r \u00a0y\t\r \u00a0un\t\r \u00a0coeficiente\t\r \u00a0de\t\r \u00a0regresi\u00f3n:\t\r \u00a0r=0,998.\t\r \u00a0El\t\r \u00a0 l\u00edmite\t\r \u00a0 de\t\r \u00a0 detecci\u00f3n\t\r \u00a0result\u00f3\t\r \u00a0 ser\t\r \u00a050\t\r \u00a0 pM.\t\r \u00a0 Para\t\r \u00a0 la\t\r \u00a0 reproducibilidad\t\r \u00a0 se\t\r \u00a0 midi\u00f3\t\r \u00a0 la\t\r \u00a0respuesta\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 disoluci\u00f3n\t\r \u00a0 de\t\r \u00a0 analito\t\r \u00a0 10\t\r \u00a0 nM\t\r \u00a0 en\t\r \u00a0 ocho\t\r \u00a0 electrodos\t\r \u00a0 diferentes,\t\r \u00a0 el\t\r \u00a0coeficiente\t\r \u00a0de\t\r \u00a0variaci\u00f3n\t\r \u00a0obtenido\t\r \u00a0fue\t\r \u00a07,56\t\r \u00a0%\t\r \u00a0(n\t\r \u00a0=\t\r \u00a08).\t\r \u00a012\nItensidad(A)(A)(x 10-6)\n(B)(x 10-6)\nItensidad(A)(C)(x 10-6)\nItensidad(A)\nItensidad(A)\n4 1.6 0.8 3.2 5.6 8 10.4 12.8 15.2 17.6 20 Intensidad (\u00b5A)\n(D)[sonda captura][MCH]\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n390\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a07.-\u00ad\u2010\t\r \u00a0Curva\t\r \u00a0de\t\r \u00a0calibrado\t\r \u00a0obtenida\t\r \u00a0bajo\t\r \u00a0las\t\r \u00a0condiciones\t\r \u00a0\u00f3ptimas:\t\r \u00a01\u00b5M\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0captura,\t\r \u00a02,5\t\r \u00a0mM\t\r \u00a0de\t\r \u00a0MCH,\t\r \u00a02\t\r \u00a0\u00b5M\t\r \u00a0de\t\r \u00a0sonda\t\r \u00a0de\t\r \u00a0indicadora,\t\r \u00a01,075\u22c510-\u00ad\u20103\t\r \u00a0g/L\t\r \u00a0conjugado\t\r \u00a0ALP-\u00ad\u2010Strp\t\r \u00a0y\t\r \u00a04\t\r \u00a0mM\t\r \u00a0naftilfosfato.\t\r \u00a0Inlet:\t\r \u00a0Intervalo\t\r \u00a0lineal.\t\r \u00a04.\t\r \u00a0CONCLUSIONES\t\r \u00a0Las\t\r \u00a0 sondas\t\r \u00a0indicadora\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0 seleccionadas\t\r \u00a0 hibridan\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0selectiva\t\r \u00a0con\t\r \u00a0el\t\r \u00a0analito,\t\r \u00a0y\t\r \u00a0el\t\r \u00a0sensor\t\r \u00a0de\t\r \u00a0ADN\t\r \u00a0electroqu\u00edmico\t\r \u00a0resultante\t\r \u00a0permiti\u00f3\t\r \u00a0la\t\r \u00a0determinaci\u00f3n\t\r \u00a0selectiva\t\r \u00a0de\t\r \u00a0una\t\r \u00a0secuencia\t\r \u00a0espec\u00edfica\t\r \u00a0de\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a02,\t\r \u00a0prote\u00edna\t\r \u00a0alerg\u00e9nica\t\r \u00a0del\t\r \u00a0 cacahuete.\t\r \u00a0 Mediante\t\r \u00a0 el\t\r \u00a0 uso\t\r \u00a0 de\t\r \u00a0 dise\u00f1os\t\r \u00a0 experimentales\t\r \u00a0 factoriales\t\r \u00a0 32\t\r \u00a0se\t\r \u00a0obtuvieron\t\r \u00a0superficies\t\r \u00a0de\t\r \u00a0respuesta\t\r \u00a0a\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0las\t\r \u00a0cuales\t\r \u00a0se\t\r \u00a0calcularon\t\r \u00a0los\t\r \u00a0valores\t\r \u00a0\u00f3ptimos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 factores\t\r \u00a0 considerados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 optimizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 monocapa\t\r \u00a0autoensamblada,\t\r \u00a01\u00b5M\t\r \u00a0de\t\r \u00a0 sonda\t\r \u00a0 de\t\r \u00a0 captura\t\r \u00a0y\t\r \u00a02,5\t\r \u00a0 mM\t\r \u00a0de\t\r \u00a0 mercaptohexanol.\t\r \u00a0El\t\r \u00a0genosensor\t\r \u00a0propuesto\t\r \u00a0presenta\t\r \u00a0una\t\r \u00a0relaci\u00f3n\t\r \u00a0lineal\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0anal\u00edtica\t\r \u00a0y\t\r \u00a0la\t\r \u00a0concentraci\u00f3n\t\r \u00a0de\t\r \u00a0analito\t\r \u00a0en\t\r \u00a0un\t\r \u00a0amplio\t\r \u00a0intervalo\t\r \u00a0concentraciones,\t\r \u00a0entre\t\r \u00a00,1\t\r \u00a0nM\t\r \u00a0y\t\r \u00a00,1\t\r \u00a0\u03bcM,\t\r \u00a0con\t\r \u00a0un\t\r \u00a0l\u00edmite\t\r \u00a0de\t\r \u00a0detecci\u00f3n\t\r \u00a0del\t\r \u00a0orden\t\r \u00a0de\t\r \u00a0picomolar\t\r \u00a0y\t\r \u00a0una\t\r \u00a0reproducibilidad\t\r \u00a0satisfactoria,\t\r \u00a0que\t\r \u00a0lo\t\r \u00a0hace\t\r \u00a0id\u00f3neo\t\r \u00a0para\t\r \u00a0su\t\r \u00a0utilizaci\u00f3n\t\r \u00a0como\t\r \u00a0detector\t\r \u00a0del\t\r \u00a0al\u00e9rgeno\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a02.\t\r \u00a05.\t\r \u00a0AGRADECIMIENTOS\t\r \u00a0Los\t\r \u00a0 autores\t\r \u00a0 agradecen\t\r \u00a0 el\t\r \u00a0 apoyo\t\r \u00a0financiero\t\r \u00a0 obtenido\t\r \u00a0a\t\r \u00a0 trav\u00e9s\t\r \u00a0 del\t\r \u00a0 Proyecto\t\r \u00a0Nacional\t\r \u00a0financiado\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0Ministerio\t\r \u00a0 de\t\r \u00a0 Econom\u00eda\t\r \u00a0 y\t\r \u00a0 Competitividad.\t\r \u00a0 C\u00f3digo:\t\r \u00a0MINECO-\u00ad\u201013-\u00ad\u2010CTQ2012-\u00ad\u201031157\t\r \u00a0y\t\r \u00a0 del\t\r \u00a0Grupo\t\r \u00a0 de\t\r \u00a0 Investigaci\u00f3n\t\r \u00a0 Universidad\t\r \u00a0Complutense\t\r \u00a0(Ref.\t\r \u00a0Grupo:\t\r \u00a0950247).\t\r \u00a0\t\r \u00a0\nDetecci\u00f3n\t\r \u00a0de\t\r \u00a0al\u00e9rgenos\t\r \u00a0de\t\r \u00a0cacahuete\u2026\t\r \u00a0\t\r \u00a0\n\t\r \u00a0391\t\r \u00a0\t\r \u00a06.\t\r \u00a0REFERENCIAS\t\r \u00a01. Hefle,\t\r \u00a0S.\t\r \u00a0Methods\t\r \u00a0for\t\r \u00a0detecting\t\r \u00a0peanuts\t\r \u00a0in\t\r \u00a0food.\t\r \u00a0Detecting\t\r \u00a0allergens\t\r \u00a0in\t\r \u00a0food;\t\r \u00a0Koppelman,\t\r \u00a0S.J.,\t\r \u00a0Hefle,\t\r \u00a0S.L.\t\r \u00a0Ed.;\t\r \u00a0Woodhead\t\r \u00a0Publising;\t\r \u00a02006;\t\r \u00a0p\t\r \u00a0185-\u00ad\u2010186.\t\r \u00a02. Morisset,\t\r \u00a0 M.;\t\r \u00a0 Moneret-\u00ad\u2010Vautrin,\t\r \u00a0 D\t\r \u00a0 A.;\t\r \u00a0 Kanny,\t\r \u00a0 G.;\t\r \u00a0 Guenard,\t\r \u00a0 L.;\t\r \u00a0 Beaudouin,\t\r \u00a0 E.;\t\r \u00a0 Flabbee,\t\r \u00a0 J.;\t\r \u00a0Hatahet,\t\r \u00a0 R.\t\r \u00a0 Thresholds\t\r \u00a0 of\t\r \u00a0 clinical\t\r \u00a0 reactivity\t\r \u00a0 to\t\r \u00a0 milk,\t\r \u00a0 peanut,\t\r \u00a0 and\t\r \u00a0 sesame\t\r \u00a0 in\t\r \u00a0immunoglobulin\t\r \u00a0 E-\u00ad\u2010dependent\t\r \u00a0 allergies:\t\r \u00a0 evaluation\t\r \u00a0 by\t\r \u00a0 double-\u00ad\u2010blind\t\r \u00a0 or\t\r \u00a0 single-\u00ad\u2010blind\t\r \u00a0placebo-\u00ad\u2010controlled\t\r \u00a0oral\t\r \u00a0challenges.\t\r \u00a0Clin.\t\r \u00a0Exp.\t\r \u00a0Allergy\t\r \u00a033,\t\r \u00a01046\u20131051\t\r \u00a0(2003).\t\r \u00a03. Bock,\t\r \u00a0 SA.;\t\r \u00a0 Mu\u00f1oz-\u00ad\u2010Furlong,\t\r \u00a0 A.;\t\r \u00a0 Sampson,\t\r \u00a0 HA.\t\r \u00a0 Fatalities\t\r \u00a0 due\t\r \u00a0 to\t\r \u00a0 anaphylactic\t\r \u00a0 reactions\t\r \u00a0 to\t\r \u00a0foods.\t\r \u00a0J.\t\r \u00a0Allergy\t\r \u00a0Clin.\t\r \u00a0Immun.\t\r \u00a0107,\t\r \u00a0191-\u00ad\u2010193\t\r \u00a0(2001).\t\r \u00a04. Pom\u00e9s,\t\r \u00a0 A.;\t\r \u00a0 Helm,\t\r \u00a0 RM.\t\r \u00a0;\t\r \u00a0 Bannon,\t\r \u00a0 GA.\t\r \u00a0;\t\r \u00a0 Burks,\t\r \u00a0 AW.\t\r \u00a0;\t\r \u00a0 Tsay,\t\r \u00a0 A.;\t\r \u00a0 Chapman,\t\r \u00a0 MD.\t\r \u00a0Monitoring\t\r \u00a0peanut\t\r \u00a0allergen\t\r \u00a0in\t\r \u00a0food\t\r \u00a0products\t\r \u00a0by\t\r \u00a0measuring\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a01.\t\r \u00a0J.\t\r \u00a0Allergy\t\r \u00a0Clin.\t\r \u00a0Immun.\t\r \u00a0111,\t\r \u00a0640-\u00ad\u2010645\t\r \u00a0(2003).\t\r \u00a05. Stephan,\t\r \u00a0 O.;\t\r \u00a0 Vieths,\t\r \u00a0 S.\t\r \u00a0Development\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 Real-\u00ad\u2010Time\t\r \u00a0 PCR\t\r \u00a0 and\t\r \u00a0 a\t\r \u00a0 Sandwich\t\r \u00a0 ELISA\t\r \u00a0 for\t\r \u00a0Detection\t\r \u00a0 of\t\r \u00a0 Potentially\t\r \u00a0 Allergenic\t\r \u00a0 Trace\t\r \u00a0 Amounts\t\r \u00a0 of\t\r \u00a0 Peanut\t\r \u00a0 (Arachis\t\r \u00a0 hypogaea)\t\r \u00a0 in\t\r \u00a0Processed\t\r \u00a0Foods.\t\r \u00a0J.\t\r \u00a0Agr.\t\r \u00a0Food\t\r \u00a0Chem.\t\r \u00a052,\t\r \u00a03754\u20133760\t\r \u00a0(2004).\t\r \u00a06. Zeleny,\t\r \u00a0 R.;\t\r \u00a0 Schimmel,\t\r \u00a0 H.\t\r \u00a0Towards\t\r \u00a0 comparability\t\r \u00a0 of\t\r \u00a0 ELISA\t\r \u00a0 results\t\r \u00a0 for\t\r \u00a0 peanut\t\r \u00a0 proteins\t\r \u00a0 in\t\r \u00a0food:\t\r \u00a0A\t\r \u00a0feasibility\t\r \u00a0study.\t\r \u00a0Food\t\r \u00a0Chem.\t\r \u00a0123,\t\r \u00a01343-\u00ad\u20101351\t\r \u00a0(2010).\t\r \u00a07. Hird,\t\r \u00a0 H.;\t\r \u00a0 Lloyd,\t\r \u00a0 J.;\t\r \u00a0 Goodier,\t\r \u00a0 R.;\t\r \u00a0 Brown,\t\r \u00a0 J.;\t\r \u00a0 Reece,\t\r \u00a0 P.\t\r \u00a0 Detection\t\r \u00a0 of\t\r \u00a0 peanut\t\r \u00a0 using\t\r \u00a0 real-\u00ad\u2010time\t\r \u00a0polymerase\t\r \u00a0chain\t\r \u00a0reaction.\t\r \u00a0Eur.\t\r \u00a0Food\t\r \u00a0Res.\t\r \u00a0Technol.\t\r \u00a0217,\t\r \u00a0265-\u00ad\u2010268\t\r \u00a0(2003).\t\r \u00a08. Watanabe,\t\r \u00a0 T.;\t\r \u00a0 Akiyama,\t\r \u00a0 H.;\t\r \u00a0 Maleki,\t\r \u00a0 S.;\t\r \u00a0 Yamakawa,\t\r \u00a0 H.;\t\r \u00a0 Iijima,\t\r \u00a0 K.;\t\r \u00a0 Yamazaki,\t\r \u00a0 F.\t\r \u00a0 A\t\r \u00a0 specific\t\r \u00a0qualitative\t\r \u00a0 detection\t\r \u00a0 method\t\r \u00a0for\t\r \u00a0 peanut\t\r \u00a0 (Arachis\t\r \u00a0 Hypogaea)\t\r \u00a0 in\t\r \u00a0 foods\t\r \u00a0 using\t\r \u00a0 polymerase\t\r \u00a0chain\t\r \u00a0reaction.\t\r \u00a0J.\t\r \u00a0Food\t\r \u00a0Biochem.\t\r \u00a030,\t\r \u00a0215-\u00ad\u2010233\t\r \u00a0(2006).\t\r \u00a09. Lopez-\u00ad\u2010Calleja,\t\r \u00a0IM.;\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Cruz,\t\r \u00a0S.;\t\r \u00a0Pegels,\t\r \u00a0N.;\t\r \u00a0Gonzalez,\t\r \u00a0I.;\t\r \u00a0Garcia,\t\r \u00a0T.;\t\r \u00a0Martin,\t\r \u00a0R.\t\r \u00a0Development\t\r \u00a0of\t\r \u00a0 a\t\r \u00a0 real\t\r \u00a0 time\t\r \u00a0 PCR\t\r \u00a0 assay\t\r \u00a0 for\t\r \u00a0 detection\t\r \u00a0 of\t\r \u00a0 allergenic\t\r \u00a0 trace\t\r \u00a0 amounts\t\r \u00a0 of\t\r \u00a0 peanut\t\r \u00a0 (Arachis\t\r \u00a0hypogaea)\t\r \u00a0in\t\r \u00a0processed\t\r \u00a0foods.\t\r \u00a0Food\t\r \u00a0Control\t\r \u00a030,\t\r \u00a0480-\u00ad\u2010490\t\r \u00a0(2012).\t\r \u00a010. Sun,\t\r \u00a0X.;\t\r \u00a0Guan,\t\r \u00a0L.;\t\r \u00a0Shan,\t\r \u00a0X.;\t\r \u00a0Zhang,\t\r \u00a0Y.;\t\r \u00a0Li,\t\r \u00a0Z.\t\r \u00a0Electrochemical\t\r \u00a0detection\t\r \u00a0of\t\r \u00a0peanut\t\r \u00a0allergen\t\r \u00a0Ara\t\r \u00a0h\t\r \u00a0 1\t\r \u00a0 using\t\r \u00a0 a\t\r \u00a0 sensitive\t\r \u00a0 ADN\t\r \u00a0 biosensor\t\r \u00a0 based\t\r \u00a0 on\t\r \u00a0 stem-\u00ad\u2010loop\t\r \u00a0 probe.\t\r \u00a0 J.\t\r \u00a0 Agr.\t\r \u00a0 Food\t\r \u00a0 Chem.\t\r \u00a060,\t\r \u00a010979-\u00ad\u201010984\t\r \u00a0(2012).\t\r \u00a011. Rubio\t\r \u00a0 Retama,\t\r \u00a0 J.;\t\r \u00a0 Sanchez-\u00ad\u2010Paniagua,\t\r \u00a0 M.;\t\r \u00a0 Hervas\t\r \u00a0 Perez,\t\r \u00a0 JP.;\t\r \u00a0 Frutos\t\r \u00a0 Cabanillas,\t\r \u00a0 G.;\t\r \u00a0 Lopez-\u00ad\u2010Cabarcos,\t\r \u00a0E.;\t\r \u00a0Lopez-\u00ad\u2010Ruiz,\t\r \u00a0B.\t\r \u00a0Biosensors\t\r \u00a0based\t\r \u00a0on\t\r \u00a0acrylic\t\r \u00a0microgels.\t\r \u00a0A\t\r \u00a0comparative\t\r \u00a0study\t\r \u00a0of\t\r \u00a0immobilized\t\r \u00a0glucose\t\r \u00a0oxidase\t\r \u00a0and\t\r \u00a0tyrosinase.\t\r \u00a0Biosens.\t\r \u00a0Bioelectron.\t\r \u00a020,\t\r \u00a02268-\u00ad\u20102275\t\r \u00a0(2005).\t\r \u00a012. Alonso-\u00ad\u2010Lomillo,\t\r \u00a0M.A.;\t\r \u00a0Dominguez-\u00ad\u2010Renedo,\t\r \u00a0O.;\t\r \u00a0Ferreira-\u00ad\u2010Goncalves,\t\r \u00a0L.;\t\r \u00a0Arcos-\u00ad\u2010Martinez,\t\r \u00a0M.J.\t\r \u00a0Sensitive\t\r \u00a0enzyme-\u00ad\u2010biosensor\t\r \u00a0based\t\r \u00a0on\t\r \u00a0screen-\u00ad\u2010printed\t\r \u00a0electrodes\t\r \u00a0for\t\r \u00a0Ochratoxin\t\r \u00a0A.\t\r \u00a0Biosens.\t\r \u00a0Bioelectron.\t\r \u00a025,\t\r \u00a01333-\u00ad\u20101337\t\r \u00a0(2010)\t\r \u00a013. Venturini\t\r \u00a0 Uliana,\t\r \u00a0 C.;\t\r \u00a0 Olimpio\t\r \u00a0 Tognolli,\t\r \u00a0 J.;\t\r \u00a0 Yamanaka,\t\r \u00a0 H.\t\r \u00a0 Application\t\r \u00a0 of\t\r \u00a0 Factorial\t\r \u00a0 Design\t\r \u00a0Experiments\t\r \u00a0 to\t\r \u00a0 the\t\r \u00a0 Development\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 Disposable\t\r \u00a0 Amperometric\t\r \u00a0 ADN\t\r \u00a0 Biosensor.\t\r \u00a0Electroanal.\t\r \u00a023,\t\r \u00a02607\u20132615\t\r \u00a0(2011).\t\r \u00a0\t\r \u00a014. Montgomery,\t\r \u00a0D.C;\t\r \u00a0Design\t\r \u00a0and\t\r \u00a0Analysis\t\r \u00a0of\t\r \u00a0Experiments;\t\r \u00a0John\t\r \u00a0Wiley\t\r \u00a0&\t\r \u00a0Sons,\t\r \u00a0United\t\r \u00a0States,\t\r \u00a02009.\t\r \u00a015. Hibbert,\t\r \u00a0DB.\t\r \u00a0Experimental\t\r \u00a0design\t\r \u00a0in\t\r \u00a0chromatography:\t\r \u00a0a\t\r \u00a0tutorial\t\r \u00a0review.\t\r \u00a0J.\t\r \u00a0Chromatogr.\t\r \u00a0B\t\r \u00a0910,\t\r \u00a02-\u00ad\u201013\t\r \u00a0(2012).\t\r \u00a016. Miranda-\u00ad\u2010Castro,\t\r \u00a0 R.;\t\r \u00a0 Lobo-\u00ad\u2010Casta\u00f1\u00f3n.,\t\r \u00a0 MJ.;\t\r \u00a0 Miranda-\u00ad\u2010Ordieres,\t\r \u00a0 AJ.;\t\r \u00a0 Tu\u00f1\u00f3n-\u00ad\u2010Blanco,\t\r \u00a0 P.\t\r \u00a0 Stem-\u00ad\u2010Loop\t\r \u00a0 ADN\t\r \u00a0 probes\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 voltammetric\t\r \u00a0 determination\t\r \u00a0of\t\r \u00a0 Legionella\t\r \u00a0 pneumophila\t\r \u00a0on\t\r \u00a0disposable\t\r \u00a0screen-\u00ad\u2010printed\t\r \u00a0gold\t\r \u00a0electrodes.\t\r \u00a0Electroanal.\t\r \u00a021,\t\r \u00a0267-\u00ad\u2010273\t\r \u00a0(2009).\t\r \u00a017. Herne,\t\r \u00a0TM.;\t\r \u00a0Tarlov.\t\r \u00a0MJ.\t\r \u00a0Characterization\t\r \u00a0of\t\r \u00a0ADN\t\r \u00a0probes\t\r \u00a0immobilized\t\r \u00a0on\t\r \u00a0gold\t\r \u00a0surfaces.\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a0119,\t\r \u00a08916-\u00ad\u20108920\t\r \u00a0(1997)\t\r \u00a018. Pividori,\t\r \u00a0MI.;\t\r \u00a0Merkoci,\t\r \u00a0A.;\t\r \u00a0Alegret,\t\r \u00a0S.\t\r \u00a0Electrochemical\t\r \u00a0genosensor\t\r \u00a0design:\t\r \u00a0immobiliation\t\r \u00a0of\t\r \u00a0oligonucleotides\t\r \u00a0 onto\t\r \u00a0 transducer\t\r \u00a0 surfaces\t\r \u00a0 and\t\r \u00a0 detection\t\r \u00a0 methods.\t\r \u00a0 Biosens.\t\r \u00a0 Bioelectron.\t\r \u00a015,\t\r \u00a0291-\u00ad\u2010303\t\r \u00a0(2000).\t\r \u00a019. Statgraphics\t\r \u00a0 Centurion.\t\r \u00a0 STATGRAPHICS\u00ae.\t\r \u00a0 Version\t\r \u00a0 XVI.\t\r \u00a0 2012.\t\r \u00a0StatPoint\t\r \u00a0 Technologies,\t\r \u00a0Inc.\t\r \u00a0www.STATGRAPHICS.com\t\r \u00a020. Del\t\r \u00a0 Giallo,\t\r \u00a0 M.L.;\t\r \u00a0 Lucarelli,\t\r \u00a0 F.;\t\r \u00a0 Cosulich,\t\r \u00a0 E.;\t\r \u00a0Pistarino,\t\r \u00a0 E.;\t\r \u00a0 Santamaria,\t\r \u00a0 B.;\t\r \u00a0 Marrazza,\t\r \u00a0 G.;\t\r \u00a0Mascini,\t\r \u00a0 M.\t\r \u00a0 Steric\t\r \u00a0 Factors\t\r \u00a0 Controlling\t\r \u00a0 the\t\r \u00a0 Surface\t\r \u00a0 Hybridization\t\r \u00a0 of\t\r \u00a0 PCR\t\r \u00a0 Amplified\t\r \u00a0Sequences.\t\r \u00a0Anal.\t\r \u00a0Chem.\t\r \u00a077,\t\r \u00a06324-\u00ad\u20106330\t\r \u00a0(2005).\t\r \u00a021. Basic\t\r \u00a0Local\t\r \u00a0Alignment\t\r \u00a0Search\t\r \u00a0Tool;\t\r \u00a0www.ncbi.nlm.nih.gov/BLAST\t\r \u00a022. Zuker,\t\r \u00a0M.\t\r \u00a0Mfold\t\r \u00a0web\t\r \u00a0server\t\r \u00a0for\t\r \u00a0nucleic\t\r \u00a0acid\t\r \u00a0folding\t\r \u00a0and\t\r \u00a0hybridization\t\r \u00a0prediction.\t\r \u00a0Nucleic\t\r \u00a0Acids\t\r \u00a0Res.\t\r \u00a031,\t\r \u00a03406-\u00ad\u20103415\t\r \u00a0(2003).\t\r \u00a0\t\r \u00a0M.\t\r \u00a0S\u00e1nchez-\u00ad\u2010Paniagua\t\r \u00a0L\u00f3pez\t\r \u00a0&\t\r \u00a0al.\t\r \u00a0\t\r \u00a0\n392\t\r \u00a0\t\r \u00a023. Levicky,\t\r \u00a0R;\t\r \u00a0Herne,\t\r \u00a0T.M.;\t\r \u00a0Tarlov,\t\r \u00a0M.;\t\r \u00a0Satija,\t\r \u00a0S.K.\t\r \u00a0Using\t\r \u00a0Self-\u00ad\u2010assembly\t\r \u00a0to\t\r \u00a0control\t\r \u00a0the\t\r \u00a0structure\t\r \u00a0of\t\r \u00a0ADN\t\r \u00a0monolayers\t\r \u00a0on\t\r \u00a0gold:\t\r \u00a0a\t\r \u00a0neutron\t\r \u00a0reflectivity\t\r \u00a0study.\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a0120,\t\r \u00a09787-\u00ad\u20109792\t\r \u00a0(1998).\t\r \u00a024. Lao,\t\r \u00a0R.;\t\r \u00a0Song,\t\r \u00a0S.;\t\r \u00a0Wu,\t\r \u00a0H.;\t\r \u00a0Wang,\t\r \u00a0L.;\t\r \u00a0Zhang,\t\r \u00a0Z.;\t\r \u00a0He,\t\r \u00a0L.;\t\r \u00a0Fan,\t\r \u00a0C.\t\r \u00a0Electrochemical\t\r \u00a0interrogation\t\r \u00a0of\t\r \u00a0DNA\t\r \u00a0monolayers\t\r \u00a0on\t\r \u00a0gold\t\r \u00a0surfaces.\t\r \u00a0Anal.\t\r \u00a0Chem.\t\r \u00a077,\t\r \u00a06475-\u00ad\u20106480\t\r \u00a0(2005).\t\r \u00a0393\t\r \u00a0\t\r \u00a0\t\r \u00a0Sesi\u00f3n\t\r \u00a0 cient\u00edfica\t\r \u00a0 conmemorativa\t\r \u00a0 del\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0y\t\r \u00a0en\t\r \u00a0Qu\u00edmica\t\r \u00a0Juan\t\r \u00a0Ram\u00f3n\t\r \u00a0Lacadena\t\r \u00a0Calero\t\r \u00a0Coordinador\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sesi\u00f3n.\t\r \u00a0Sesi\u00f3n\t\r \u00a0celebrada\t\r \u00a0el\t\r \u00a012\t\r \u00a0de\t\r \u00a0diciembre\t\r \u00a0de\t\r \u00a02013.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0ORDEN\t\r \u00a0DEL\t\r \u00a0D\u00cdA\t\r \u00a0Presentaci\u00f3n:\t\r \u00a0\u201cEl\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina:\t\r \u00a0control\t\r \u00a0gen\u00e9tico\t\r \u00a0del\t\r \u00a0tr\u00e1fico\t\r \u00a0celular\u201d\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Juan-\u00ad\u2010Ram\u00f3n\t\r \u00a0Lacadena\t\r \u00a0Calero\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0Ponentes:\t\r \u00a0\u201cDel\t\r \u00a0 tr\u00e1fico\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 comunicaci\u00f3n\t\r \u00a0 neuronal\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0 enfermedades\t\r \u00a0mentales\u201d\t\r \u00a0Dr.\t\r \u00a0Jos\u00e9\t\r \u00a0Antonio\t\r \u00a0Esteban\t\r \u00a0Garc\u00eda\t\r \u00a0Centro\t\r \u00a0de\t\r \u00a0Biolog\u00eda\t\r \u00a0Molecular\t\r \u00a0\u201cSevero\t\r \u00a0Ochoa\u201d\t\r \u00a0(CSIC/UAM)\t\r \u00a0\t\r \u00a0\u201cNobel\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a02013:\t\r \u00a0Combinaci\u00f3n\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0de\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0y\t\r \u00a0mec\u00e1nica\t\r \u00a0cu\u00e1ntica\t\r \u00a0para\t\r \u00a0entender\t\r \u00a0y\t\r \u00a0predecir\t\r \u00a0procesos\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos\u201d\t\r \u00a0Dra.\t\r \u00a0Beatriz\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0Teresa\t\r \u00a0\t\r \u00a0\t\r \u00a0SESIONES\t\r \u00a0CIENT\u00cdFICAS\t\r \u00a0\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n394\t\r \u00a0\t\r \u00a0El\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina:\t\r \u00a0control\t\r \u00a0gen\u00e9tico\t\r \u00a0del\t\r \u00a0tr\u00e1fico\t\r \u00a0celular\t\r \u00a0Juan-\u00ad\u2010Ram\u00f3n\t\r \u00a0Lacadena\t\r \u00a0Ladero\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0394-\u00ad\u2010397.\t\r \u00a0EL\t\r \u00a0PREMIO\t\r \u00a0NOBEL\t\r \u00a0EN\t\r \u00a0FISIOLOG\u00cdA\t\r \u00a0O\t\r \u00a0MEDICINA\t\r \u00a0El\t\r \u00a0 7\t\r \u00a0 de\t\r \u00a0 octubre\t\r \u00a0 de\t\r \u00a0 2013,\t\r \u00a0 la\t\r \u00a0 Asamblea\t\r \u00a0 Nobel\t\r \u00a0 del\t\r \u00a0 Instituto\t\r \u00a0 Karolinska\t\r \u00a0de\t\r \u00a0Estocolmo\t\r \u00a0otorg\u00f3\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0conjuntamente\t\r \u00a0a\t\r \u00a0James\t\r \u00a0E.\t\r \u00a0 Rothman\t\r \u00a0 (1950,\t\r \u00a0 USA,\t\r \u00a0 Yale\t\r \u00a0 University),\t\r \u00a0 Randy\t\r \u00a0 W.\t\r \u00a0 Schekman\t\r \u00a0 (1948,\t\r \u00a0 USA,\t\r \u00a0University\t\r \u00a0of\t\r \u00a0California,\t\r \u00a0Berkeley)\t\r \u00a0y\t\r \u00a0Thomas\t\r \u00a0C.\t\r \u00a0S\u00fcdhof\t\r \u00a0(1955,\t\r \u00a0Alemania,\t\r \u00a0Stanford\t\r \u00a0University)\t\r \u00a0 \u201cpor\t\r \u00a0 sus\t\r \u00a0descubrimientos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 maquinaria\t\r \u00a0 que\t\r \u00a0 regula\t\r \u00a0 el\t\r \u00a0 tr\u00e1fico\t\r \u00a0 de\t\r \u00a0ves\u00edculas,\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0principal\t\r \u00a0en\t\r \u00a0nuestras\t\r \u00a0c\u00e9lulas\u201d.\t\r \u00a0Como\t\r \u00a0 se\u00f1alaba\t\r \u00a0 el\t\r \u00a0 comunicado\t\r \u00a0 de\t\r \u00a0 prensa\t\r \u00a0 del\t\r \u00a0 Instituto\t\r \u00a0 Karolinska,\t\r \u00a0 el\t\r \u00a0 buen\t\r \u00a0funcionamiento\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 depende\t\r \u00a0 de\t\r \u00a0 conseguir\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 correctas\t\r \u00a0est\u00e9n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 adecuado\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 momento\t\r \u00a0 apropiado,\t\r \u00a0 teniendo\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 que\t\r \u00a0algunas\t\r \u00a0de\t\r \u00a0tales\t\r \u00a0mol\u00e9culas\t\r \u00a0son\t\r \u00a0exportadas\t\r \u00a0fuera\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0otras\t\r \u00a0tienen\t\r \u00a0que\t\r \u00a0estar\t\r \u00a0en\t\r \u00a0lugares\t\r \u00a0espec\u00edficos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0propia\t\r \u00a0c\u00e9lula.\t\r \u00a0Si\t\r \u00a0 fu\u00e9ramos\t\r \u00a0 capaces\t\r \u00a0 de\t\r \u00a0 introducirnos\t\r \u00a0 f\u00edsicamente\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 interior\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0c\u00e9lula\t\r \u00a0nos\t\r \u00a0quedar\u00edamos\t\r \u00a0maravillados\t\r \u00a0al\t\r \u00a0visualizar\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0moleculares\t\r \u00a0que\t\r \u00a0ocurren\t\r \u00a0en\t\r \u00a0ella\t\r \u00a0a\t\r \u00a0gran\t\r \u00a0velocidad\t\r \u00a0y\t\r \u00a0con\t\r \u00a0total\t\r \u00a0precisi\u00f3n.\t\r \u00a0Pensemos,\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0replicaci\u00f3n\t\r \u00a0del\t\r \u00a0ADN,\t\r \u00a0la\t\r \u00a0transcripci\u00f3n\t\r \u00a0y\t\r \u00a0s\u00edntesis\t\r \u00a0del\t\r \u00a0ARN\t\r \u00a0mensajero,\t\r \u00a0la\t\r \u00a0s\u00edntesis\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0en\t\r \u00a0la\t\r \u00a0maquinaria\t\r \u00a0ribos\u00f3mica.\t\r \u00a0Tambi\u00e9n\t\r \u00a0nos\t\r \u00a0asombrar\u00eda\t\r \u00a0ver\t\r \u00a0c\u00f3mo\t\r \u00a0las\t\r \u00a0mol\u00e9culas\t\r \u00a0 sintetizadas\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 c\u00e9lula\t\r \u00a0 (enzimas,\t\r \u00a0 hormonas,\t\r \u00a0 neurotransmisores,\t\r \u00a0citokinas,\t\r \u00a0etc.)\t\r \u00a0son\t\r \u00a0transportadas\t\r \u00a0en\t\r \u00a0ves\u00edculas\t\r \u00a0a\t\r \u00a0lugares\t\r \u00a0espec\u00edficos\t\r \u00a0(org\u00e1nulos)\t\r \u00a0de\t\r \u00a0la\t\r \u00a0propia\t\r \u00a0c\u00e9lula\t\r \u00a0o\t\r \u00a0liberadas\t\r \u00a0al\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0misma\t\r \u00a0en\t\r \u00a0el\t\r \u00a0momento\t\r \u00a0justo.\t\r \u00a0\t\r \u00a0En\t\r \u00a0 los\t\r \u00a0 comentarios\t\r \u00a0 escritos\t\r \u00a0 para\t\r \u00a0 explicar\t\r \u00a0 en\t\r \u00a0 qu\u00e9\t\r \u00a0 han\t\r \u00a0 consistido\t\r \u00a0 las\t\r \u00a0investigaciones\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tres\t\r \u00a0cient\u00edficos\t\r \u00a0galardonados\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0repetido\t\r \u00a0el\t\r \u00a0ejemplo\t\r \u00a0de\t\r \u00a0un\t\r \u00a0gran\t\r \u00a0puerto\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0distribuir\t\r \u00a0ingentes\t\r \u00a0cantidades\t\r \u00a0de\t\r \u00a0mercanc\u00edas\t\r \u00a0para\t\r \u00a0que\t\r \u00a0lleguen\t\r \u00a0al\t\r \u00a0destino\t\r \u00a0correcto\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tiempo\t\r \u00a0preciso,\t\r \u00a0para\t\r \u00a0lo\t\r \u00a0cual\t\r \u00a0se\t\r \u00a0requiere\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0 de\t\r \u00a0 reparto\t\r \u00a0 adecuado\t\r \u00a0 que\t\r \u00a0 genera\t\r \u00a0 un\t\r \u00a0 denso\t\r \u00a0 tr\u00e1fico\t\r \u00a0 interior\t\r \u00a0 que\t\r \u00a0 tiene\t\r \u00a0 que\t\r \u00a0estar\t\r \u00a0 perfectamente\t\r \u00a0 regulado.\t\r \u00a0 Pues\t\r \u00a0 bien,\t\r \u00a0 volviendo\t\r \u00a0 al\t\r \u00a0 terreno\t\r \u00a0 biol\u00f3gico,\t\r \u00a0 las\t\r \u00a0mol\u00e9culas\t\r \u00a0son\t\r \u00a0empaquetadas\t\r \u00a0en\t\r \u00a0ves\u00edculas\t\r \u00a0min\u00fasculas\t\r \u00a0recubiertas\t\r \u00a0con\t\r \u00a0membranas\t\r \u00a0para\t\r \u00a0 su\t\r \u00a0 transporte\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 diferentes\t\r \u00a0 lugares\t\r \u00a0 espec\u00edficos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 c\u00e9lula\t\r \u00a0 o\t\r \u00a0 para\t\r \u00a0 ser\t\r \u00a0exportadas\t\r \u00a0al\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0misma.\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n395\t\r \u00a0\t\r \u00a0Las\t\r \u00a0investigaciones\t\r \u00a0premiadas\t\r \u00a0se\t\r \u00a0refieren\t\r \u00a0a\t\r \u00a0tres\t\r \u00a0aspectos\t\r \u00a0diferentes,\t\r \u00a0pero\t\r \u00a0a\t\r \u00a0la\t\r \u00a0vez\t\r \u00a0complementarios,\t\r \u00a0de\t\r \u00a0la\t\r \u00a0cuesti\u00f3n\t\r \u00a0global:\t\r \u00a01)\t\r \u00a0la\t\r \u00a0existencia\t\r \u00a0de\t\r \u00a0una\t\r \u00a0regulaci\u00f3n\t\r \u00a0gen\u00e9tica\t\r \u00a0 que\t\r \u00a0 controla\t\r \u00a0 el\t\r \u00a0 tr\u00e1fico\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 ves\u00edculas\t\r \u00a0 (Schekman):\t\r \u00a0 2)\t\r \u00a0 la\t\r \u00a0 existencia\t\r \u00a0 de\t\r \u00a0complejos\t\r \u00a0 proteicos\t\r \u00a0 que\t\r \u00a0 permiten\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 ves\u00edculas\t\r \u00a0 anclarse\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 preciso\t\r \u00a0 y\t\r \u00a0fusionarse\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 membranas\t\r \u00a0 celulares\t\r \u00a0 o\t\r \u00a0 intracelulares\t\r \u00a0 (Rothman);\t\r \u00a0 y\t\r \u00a0 3)\t\r \u00a0 la\t\r \u00a0existencia\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 mecanismo\t\r \u00a0 molecular\t\r \u00a0 dependiente\t\r \u00a0 del\t\r \u00a0 calcio\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 transmisi\u00f3n\t\r \u00a0entre\t\r \u00a0c\u00e9lulas\t\r \u00a0nerviosas\t\r \u00a0(S\u00fcdhof).\t\r \u00a0De\t\r \u00a0las\t\r \u00a0 tres\t\r \u00a0 investigaciones\t\r \u00a0 premiadas\t\r \u00a0 yo\t\r \u00a0 solamente\t\r \u00a0 me\t\r \u00a0 siento\t\r \u00a0 legitimado\t\r \u00a0para\t\r \u00a0hacer\t\r \u00a0un\t\r \u00a0breve\t\r \u00a0comentario\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0aportaci\u00f3n\t\r \u00a0de\t\r \u00a0Randy\t\r \u00a0W.\t\r \u00a0Schekman\t\r \u00a0quien\t\r \u00a0descubri\u00f3\t\r \u00a0los\t\r \u00a0genes\t\r \u00a0que\t\r \u00a0codifican\t\r \u00a0para\t\r \u00a0las\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0son\t\r \u00a0los\t\r \u00a0reguladores\t\r \u00a0clave\t\r \u00a0del\t\r \u00a0 tr\u00e1fico\t\r \u00a0 de\t\r \u00a0 ves\u00edculas\t\r \u00a0en\t\r \u00a0 levaduras,\t\r \u00a0 controlando\t\r \u00a0 el\t\r \u00a0 transporte\t\r \u00a0 tanto\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0diferentes\t\r \u00a0 compartimentos\t\r \u00a0 internos\t\r \u00a0 celulares\t\r \u00a0 (del\t\r \u00a0 ret\u00edculo\t\r \u00a0 endopl\u00e1smico\t\r \u00a0 al\t\r \u00a0aparato\t\r \u00a0 de\t\r \u00a0 Golgi)\t\r \u00a0 como\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 superficie\t\r \u00a0 celular.\t\r \u00a0 Interesado\t\r \u00a0 por\t\r \u00a0 c\u00f3mo\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0organizan\t\r \u00a0su\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte,\t\r \u00a0Scheckman\t\r \u00a0decidi\u00f3\t\r \u00a0iniciar\t\r \u00a0en\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a0setenta\t\r \u00a0un\t\r \u00a0 estudio\t\r \u00a0 gen\u00e9tico\t\r \u00a0 utilizando\t\r \u00a0 como\t\r \u00a0 sistema\t\r \u00a0 modelo\t\r \u00a0 mutantes\t\r \u00a0 de\t\r \u00a0 levadura\t\r \u00a0sensibles\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 temperatura\t\r \u00a0 (1).\t\r \u00a0 Posteriormente\t\r \u00a0 identific\u00f3\t\r \u00a0 23\t\r \u00a0 grupos\t\r \u00a0 de\t\r \u00a0complementaci\u00f3n\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 sucesos\t\r \u00a0 post-\u00ad\u2010traduccionales\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 ruta\t\r \u00a0secretora\t\r \u00a0de\t\r \u00a0la\t\r \u00a0levadura\t\r \u00a0(2)\t\r \u00a0y\t\r \u00a0estableci\u00f3\t\r \u00a0el\t\r \u00a0orden\t\r \u00a0de\t\r \u00a0los\t\r \u00a0sucesos\t\r \u00a0que\t\r \u00a0ocurr\u00edan\t\r \u00a0en\t\r \u00a0el\t\r \u00a0patr\u00f3n\t\r \u00a0secretor\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0levadura\t\r \u00a0(3).\t\r \u00a0En\t\r \u00a0un\t\r \u00a0estudio\t\r \u00a0posterior,\t\r \u00a0Scheckman\t\r \u00a0y\t\r \u00a0colaboradores\t\r \u00a0caracterizaron\t\r \u00a0morfol\u00f3gicamente\t\r \u00a0y\t\r \u00a0gen\u00e9ticamente\t\r \u00a0las\t\r \u00a0mutaciones\t\r \u00a0en\t\r \u00a0siete\t\r \u00a0genes\t\r \u00a0SEC\t\r \u00a0demostrando\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0jugar\t\r \u00a0un\t\r \u00a0papel\t\r \u00a0en\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0o\t\r \u00a0en\t\r \u00a0la\t\r \u00a0fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 ves\u00edculas\t\r \u00a0 intermedias\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0 prote\u00ednas\t\r \u00a0 desde\t\r \u00a0 el\t\r \u00a0 ret\u00edculo\t\r \u00a0endopl\u00e1smico\t\r \u00a0al\t\r \u00a0aparato\t\r \u00a0de\t\r \u00a0Golgi\t\r \u00a0(4).\t\r \u00a0Es\t\r \u00a0interesante\t\r \u00a0hacer\t\r \u00a0constar\t\r \u00a0que\t\r \u00a0las\t\r \u00a0investigaciones\t\r \u00a0realizadas\t\r \u00a0en\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0mam\u00edferos\t\r \u00a0por\t\r \u00a0Rothman\t\r \u00a0(5,6),\t\r \u00a0con\t\r \u00a0quien\t\r \u00a0ha\t\r \u00a0compartido\t\r \u00a0el\t\r \u00a0galard\u00f3n\t\r \u00a0Nobel,\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0complejos\t\r \u00a0proteicos\t\r \u00a0que\t\r \u00a0permiten\t\r \u00a0a\t\r \u00a0las\t\r \u00a0ves\u00edculas\t\r \u00a0fusionarse\t\r \u00a0con\t\r \u00a0sus\t\r \u00a0dianas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0 membranas\t\r \u00a0 asegurando\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 ves\u00edculas\t\r \u00a0 transportan\t\r \u00a0(mol\u00e9culas-\u00ad\u2010cargo,\t\r \u00a0mol\u00e9culas-\u00ad\u2010mercanc\u00eda)\t\r \u00a0 sean\t\r \u00a0 liberadas\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 lugar\t\r \u00a0 preciso\t\r \u00a0 han\t\r \u00a0demostrado\t\r \u00a0 \t\r \u00a0 que\t\r \u00a0 incluyen\t\r \u00a0 prote\u00ednas\t\r \u00a0 semejantes\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 descritas\t\r \u00a0 por\t\r \u00a0 Scheckman\t\r \u00a0codificadas\t\r \u00a0 por\t\r \u00a0 genes\t\r \u00a0 hom\u00f3logos.\t\r \u00a0 Es\t\r \u00a0 decir,\t\r \u00a0 se\t\r \u00a0 trata\t\r \u00a0 de\t\r \u00a0 procesos\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 de\t\r \u00a0transporte\t\r \u00a0celular\t\r \u00a0conservados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0evoluci\u00f3n.\t\r \u00a0Aunque\t\r \u00a0la\t\r \u00a0investigaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0pertenece\t\r \u00a0al\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Biolog\u00eda\t\r \u00a0y\t\r \u00a0la\t\r \u00a0Fisiolog\u00eda\t\r \u00a0Celular\t\r \u00a0\u2013de\t\r \u00a0hecho,\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 tercera\t\r \u00a0 vez\t\r \u00a0 desde\t\r \u00a0 que\t\r \u00a0 George\t\r \u00a0 Palade,\t\r \u00a0 Albert\t\r \u00a0 Claude\t\r \u00a0 y\t\r \u00a0 Christian\t\r \u00a0 de\t\r \u00a0Duve\t\r \u00a0 obtuvieron\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 en\t\r \u00a0 1974\t\r \u00a0 y\t\r \u00a0 G\u00fcnterBlobel\t\r \u00a0 en\t\r \u00a0 1999\t\r \u00a0 en\t\r \u00a0 que\t\r \u00a0 este\t\r \u00a0campo\t\r \u00a0cient\u00edfico\t\r \u00a0es\t\r \u00a0galardonado\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\u2013\t\r \u00a0sin\t\r \u00a0embargo\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 del\t\r \u00a0 Dr.\t\r \u00a0 Scheckman\t\r \u00a0 me\t\r \u00a0 he\t\r \u00a0 permitido\t\r \u00a0 incluirlo\t\r \u00a0 tambi\u00e9n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0campo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Gen\u00e9tica\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 metodolog\u00eda\t\r \u00a0 gen\u00e9tica\t\r \u00a0 cl\u00e1sica\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0 utilizado\t\r \u00a0 para\t\r \u00a0seleccionar\t\r \u00a0 los\t\r \u00a0 mutantes\t\r \u00a0 de\t\r \u00a0 levadura\t\r \u00a0 que\t\r \u00a0 han\t\r \u00a0 constituido\t\r \u00a0 su\t\r \u00a0 material\t\r \u00a0 de\t\r \u00a0 trabajo\t\r \u00a0imprescindible\t\r \u00a0 para\t\r \u00a0 llevar\t\r \u00a0 a\t\r \u00a0 cabo\t\r \u00a0 sus\t\r \u00a0 estudios\t\r \u00a0 citol\u00f3gicos.\t\r \u00a0 Confirma\t\r \u00a0 criterio\t\r \u00a0 el\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n396\t\r \u00a0\t\r \u00a0mismo\t\r \u00a0 hecho\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 Dr.\t\r \u00a0 Schekman\t\r \u00a0 eligiera\t\r \u00a0 como\t\r \u00a0 t\u00edtulo\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0 Nobel\t\r \u00a0 Lecture\t\r \u00a0\u201cGenes\t\r \u00a0and\t\r \u00a0proteins\t\r \u00a0that\t\r \u00a0organize\t\r \u00a0the\t\r \u00a0secretory\t\r \u00a0pathway\u201d\t\r \u00a0(7\t\r \u00a0diciembre\t\r \u00a02013).\t\r \u00a0\t\r \u00a0Termino\t\r \u00a0este\t\r \u00a0breve\t\r \u00a0comentario\t\r \u00a0actualizando\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0num\u00e9ricos\t\r \u00a0que\t\r \u00a0a\u00f1o\t\r \u00a0tras\t\r \u00a0a\u00f1o\t\r \u00a0vengo\t\r \u00a0ofreciendo:\t\r \u00a0hoy,\t\r \u00a0en\t\r \u00a02013,\t\r \u00a0podemos\t\r \u00a0estar\t\r \u00a0orgullosos\t\r \u00a0los\t\r \u00a0amantes\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Gen\u00e9tica\t\r \u00a0porque\t\r \u00a0ya\t\r \u00a0son\t\r \u00a041\t\r \u00a0las\t\r \u00a0veces\t\r \u00a0en\t\r \u00a0que\t\r \u00a0el\t\r \u00a0galard\u00f3n\t\r \u00a0Nobel\t\r \u00a0ha\t\r \u00a0correspondido\t\r \u00a0a\t\r \u00a090\t\r \u00a0cient\u00edficos\t\r \u00a0 del\t\r \u00a0 campo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Gen\u00e9tica\t\r \u00a0 o\t\r \u00a0 ciencias\t\r \u00a0 afines.\t\r \u00a0 De\t\r \u00a0los\t\r \u00a0 41premios\t\r \u00a0considerados,\t\r \u00a032\t\r \u00a0pertenecen\t\r \u00a0al\t\r \u00a0\u00e1mbito\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina,\t\r \u00a08\t\r \u00a0a\t\r \u00a0la\t\r \u00a0Qu\u00edmica\t\r \u00a0y\t\r \u00a01\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Paz\t\r \u00a0 y,\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 vez,\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 90cient\u00edficos\t\r \u00a0 galardonados,\t\r \u00a0 71\t\r \u00a0corresponden\t\r \u00a0 a\t\r \u00a0premios\t\r \u00a0 de\t\r \u00a0 Fisiolog\u00eda\t\r \u00a0 o\t\r \u00a0 Medicina,\t\r \u00a0 18\t\r \u00a0 de\t\r \u00a0 Qu\u00edmica\t\r \u00a0 y\t\r \u00a0 1\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Paz.\t\r \u00a0Finalmente,\t\r \u00a0 me\t\r \u00a0gustar\u00eda\t\r \u00a0 destacar\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 va\t\r \u00a0 de\t\r \u00a0 siglo\t\r \u00a0 XXI\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 premiado\t\r \u00a0 la\t\r \u00a0 investigaci\u00f3n\t\r \u00a0gen\u00e9tica\t\r \u00a0 en\t\r \u00a0 trece\t\r \u00a0 ocasiones:\t\r \u00a0 en\t\r \u00a0 2001\t\r \u00a0 (Hartwell,\t\r \u00a0 Hunt\t\r \u00a0 y\t\r \u00a0 Nurse,\t\r \u00a0 \u201cpor\t\r \u00a0 sus\t\r \u00a0descubrimientos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 reguladores\t\r \u00a0 clave\t\r \u00a0 del\t\r \u00a0 ciclo\t\r \u00a0 celular\u201d),\t\r \u00a0 2002\t\r \u00a0 (Brenner,\t\r \u00a0Horvitz\t\r \u00a0 y\t\r \u00a0 Sulston,\t\r \u00a0 \u201cpor\t\r \u00a0 sus\t\r \u00a0 descubrimientos\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 gen\u00e9tica\t\r \u00a0 del\t\r \u00a0desarrollo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00f3rganos\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 muerte\t\r \u00a0 celular\t\r \u00a0 programada\u201d),\t\r \u00a0 2004\t\r \u00a0 (Axel\t\r \u00a0 y\t\r \u00a0 Buck,\t\r \u00a0\u201cpor\t\r \u00a0 sus\t\r \u00a0 descubrimientos\t\r \u00a0 de\t\r \u00a0 receptores\t\r \u00a0 olorosos\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 organizaci\u00f3n\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0olfativo\u201d),\t\r \u00a02006\t\r \u00a0(Fire\t\r \u00a0y\t\r \u00a0Mello,\t\r \u00a0\u201cpor\t\r \u00a0su\t\r \u00a0descubrimiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0interferencia\t\r \u00a0por\t\r \u00a0ARN:\t\r \u00a0silenciamiento\t\r \u00a0 de\t\r \u00a0 genes\t\r \u00a0 por\t\r \u00a0 ARN\t\r \u00a0 de\t\r \u00a0 doble\t\r \u00a0 cadena\u201d),\t\r \u00a0 2006\t\r \u00a0 (Kornberg,\t\r \u00a0 \u201cpor\t\r \u00a0 sus\t\r \u00a0estudios\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 molecular\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 trancripci\u00f3neucari\u00f3tica\u201d),\t\r \u00a0 2007\t\r \u00a0 (Capecchi,\t\r \u00a0Evans\t\r \u00a0 y\t\r \u00a0 Smithies,\t\r \u00a0 \u201cpor\t\r \u00a0 sus\t\r \u00a0 descubrimientos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 principios\t\r \u00a0 para\t\r \u00a0 introducir\t\r \u00a0modificaciones\t\r \u00a0g\u00e9nicas\t\r \u00a0espec\u00edficas\t\r \u00a0en\t\r \u00a0ratones\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0troncales\t\r \u00a0embrionarias\u201d),\t\r \u00a0 2008\t\r \u00a0 (zurHausen,\t\r \u00a0 \u201cpor\t\r \u00a0 su\t\r \u00a0 descubrimiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 virus\t\r \u00a0 del\t\r \u00a0papiloma\t\r \u00a0 humano\t\r \u00a0 causantes\t\r \u00a0 del\t\r \u00a0 c\u00e1ncer\t\r \u00a0 cervical\u201d;\t\r \u00a0 Barr\u00e9-\u00ad\u2010Sinoussi\t\r \u00a0 y\t\r \u00a0 Montagnier,\t\r \u00a0\u201cpor\t\r \u00a0 su\t\r \u00a0 descubrimiento\t\r \u00a0 del\t\r \u00a0 virus\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 inmunodeficiencia\t\r \u00a0 humana\u201d),\t\r \u00a0 2008\t\r \u00a0 (\t\r \u00a0Shimomura,\t\r \u00a0 Chalfie\t\r \u00a0 y\t\r \u00a0 Tsien,\t\r \u00a0 \u201cpor\t\r \u00a0 el\t\r \u00a0 descubrimiento\t\r \u00a0 y\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0fluorescente\t\r \u00a0 verde,\t\r \u00a0 GFP\u201d),\t\r \u00a0 2009\t\r \u00a0 (Blackburn,\t\r \u00a0 Greider\t\r \u00a0 y\t\r \u00a0 Szostack,\t\r \u00a0 \u201cpor\t\r \u00a0 el\t\r \u00a0descubrimiento\t\r \u00a0 de\t\r \u00a0 c\u00f3mo\t\r \u00a0 los\t\r \u00a0 cromosomas\t\r \u00a0 son\t\r \u00a0 protegidos\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 tel\u00f3meros\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0enzima\t\r \u00a0telomerasa\u201d),\t\r \u00a02009\t\r \u00a0(Ramakrishnan,\t\r \u00a0Steitz\t\r \u00a0y\t\r \u00a0Yonath,\t\r \u00a0\u201cpor\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0de\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0 y\t\r \u00a0 funci\u00f3n\t\r \u00a0 del\t\r \u00a0 ribosoma\u201d),\t\r \u00a0 2011\t\r \u00a0 (Bruce\t\r \u00a0 A.\t\r \u00a0 Beutler\t\r \u00a0 y\t\r \u00a0 Jules\t\r \u00a0 A.\t\r \u00a0 Hoffmann\t\r \u00a0\u201cpor\t\r \u00a0sus\t\r \u00a0descubrimientos\t\r \u00a0en\t\r \u00a0relaci\u00f3n\t\r \u00a0con\t\r \u00a0la\t\r \u00a0activaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0inmunidad\t\r \u00a0innata\u201d;\t\r \u00a0y\t\r \u00a0a\t\r \u00a0Ralph\t\r \u00a0M.\t\r \u00a0Steinman\t\r \u00a0\u201cpor\t\r \u00a0su\t\r \u00a0descubrimiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0dendr\u00edtica\t\r \u00a0y\t\r \u00a0su\t\r \u00a0papel\t\r \u00a0en\t\r \u00a0la\t\r \u00a0inmunidad\t\r \u00a0 adaptativa\u201d,\t\r \u00a0 2012\t\r \u00a0 a\t\r \u00a0 John\t\r \u00a0 B.\t\r \u00a0 Gurdon\t\r \u00a0 y\t\r \u00a0 ShinyaYamanaka\t\r \u00a0 \u201cpor\t\r \u00a0 el\t\r \u00a0descubrimiento\t\r \u00a0de\t\r \u00a0que\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0diferenciadas\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0reprogramadas\t\r \u00a0para\t\r \u00a0convertirse\t\r \u00a0en\t\r \u00a0pluripotentes\u201d\t\r \u00a0y\t\r \u00a0en\t\r \u00a02013\t\r \u00a0a\t\r \u00a0Randy\t\r \u00a0W.\t\r \u00a0Schekman\t\r \u00a0que\t\r \u00a0comparti\u00f3\t\r \u00a0el\t\r \u00a0premio\t\r \u00a0con\t\r \u00a0James\t\r \u00a0E.\t\r \u00a0Rothman\t\r \u00a0y\t\r \u00a0Thomas\t\r \u00a0C.\t\r \u00a0S\u00fcdhof\t\r \u00a0\u201cpor\t\r \u00a0sus\t\r \u00a0descubrimientos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0maquinaria\t\r \u00a0que\t\r \u00a0regula\t\r \u00a0el\t\r \u00a0tr\u00e1fico\t\r \u00a0de\t\r \u00a0ves\u00edculas,\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0principal\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0en\t\r \u00a0nuestras\t\r \u00a0c\u00e9lulas\u201d,\t\r \u00a0demostrando\t\r \u00a0que\t\r \u00a0existe\t\r \u00a0un\t\r \u00a0control\t\r \u00a0gen\u00e9tico\t\r \u00a0de\t\r \u00a0la\t\r \u00a0maquinaria\t\r \u00a0que\t\r \u00a0controla\t\r \u00a0el\t\r \u00a0tr\u00e1fico\t\r \u00a0de\t\r \u00a0ves\u00edculas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0y\t\r \u00a0al\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas.\t\r \u00a0Con\t\r \u00a0mucho\t\r \u00a0mayor\t\r \u00a0conocimiento\t\r \u00a0que\t\r \u00a0yo,\t\r \u00a0el\t\r \u00a0Dr.\t\r \u00a0Jos\u00e9\t\r \u00a0Antonio\t\r \u00a0Esteban\t\r \u00a0Garc\u00eda\t\r \u00a0glosar\u00e1\t\r \u00a0los\t\r \u00a0trabajos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tres\t\r \u00a0cient\u00edficos\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina.\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n397\t\r \u00a0\t\r \u00a0EL\t\r \u00a0PREMIO\t\r \u00a0NOBEL\t\r \u00a0EN\t\r \u00a0QU\u00cdMICA\t\r \u00a02013\t\r \u00a0El\t\r \u00a0 9\t\r \u00a0 de\t\r \u00a0 octubre\t\r \u00a0 de\t\r \u00a0 2013,\t\r \u00a0 la\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 de\t\r \u00a0 Ciencias\t\r \u00a0 de\t\r \u00a0 Suecia\t\r \u00a0 en\t\r \u00a0Estocolmo\t\r \u00a0 acord\u00f3\t\r \u00a0 conceder\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 2013\t\r \u00a0 en\t\r \u00a0 Qu\u00edmica\t\r \u00a0 conjuntamente\t\r \u00a0 a\t\r \u00a0Martin\t\r \u00a0 Karplus,\t\r \u00a0 Michael\t\r \u00a0 Levitt\t\r \u00a0 y\t\r \u00a0 Arieh\t\r \u00a0Warshel\t\r \u00a0 \u201cpor\t\r \u00a0 el\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 modelos\t\r \u00a0computacionales\t\r \u00a0para\t\r \u00a0sistemas\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos\u201d.\t\r \u00a0Como\t\r \u00a0 dec\u00eda\t\r \u00a0 la\t\r \u00a0 nota\t\r \u00a0 de\t\r \u00a0 prensa\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 Sueca\t\r \u00a0 de\t\r \u00a0 Ciencias,\t\r \u00a0 los\t\r \u00a0qu\u00edmicos\t\r \u00a0 usaban\t\r \u00a0 bolas\t\r \u00a0 y\t\r \u00a0 bastones\t\r \u00a0 de\t\r \u00a0 pl\u00e1stico\t\r \u00a0 para\t\r \u00a0 crear\t\r \u00a0 modelos\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas.\t\r \u00a0Hoy,\t\r \u00a0el\t\r \u00a0modelado\t\r \u00a0se\t\r \u00a0realiza\t\r \u00a0en\t\r \u00a0computadores.\t\r \u00a0En\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a0setenta,\t\r \u00a0Martin\t\r \u00a0Karplus,\t\r \u00a0Michael\t\r \u00a0 Levitt\t\r \u00a0 y\t\r \u00a0 AriehWarshel\t\r \u00a0 pusieron\t\r \u00a0 los\t\r \u00a0 fundamentos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 poderosos\t\r \u00a0programas\t\r \u00a0de\t\r \u00a0computaci\u00f3n\t\r \u00a0que\t\r \u00a0se\t\r \u00a0usan\t\r \u00a0actualmente\t\r \u00a0para\t\r \u00a0comprender\t\r \u00a0y\t\r \u00a0predecir\t\r \u00a0procesos\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos.\t\r \u00a0El\t\r \u00a0acierto\t\r \u00a0de\t\r \u00a0los\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0ha\t\r \u00a0 sido\t\r \u00a0 poner\t\r \u00a0 a\t\r \u00a0 trabajar\t\r \u00a0 juntas\t\r \u00a0 la\t\r \u00a0 f\u00edsica\t\r \u00a0 newtoniana\t\r \u00a0 cl\u00e1sica\t\r \u00a0y\t\r \u00a0 la\t\r \u00a0 f\u00edsica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0cuando\t\r \u00a0 antes\t\r \u00a0 hab\u00eda\t\r \u00a0 que\t\r \u00a0 decidirse\t\r \u00a0 por\t\r \u00a0 una\t\r \u00a0 u\t\r \u00a0 otra,\t\r \u00a0 cada\t\r \u00a0 una\t\r \u00a0 con\t\r \u00a0 sus\t\r \u00a0 fortalezas\t\r \u00a0 y\t\r \u00a0debilidades.\t\r \u00a0As\u00ed\t\r \u00a0como\t\r \u00a0en\t\r \u00a0la\t\r \u00a0presentaci\u00f3n\t\r \u00a0del\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0en\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0me\t\r \u00a0he\t\r \u00a0sentido\t\r \u00a0m\u00ednimamente\t\r \u00a0legitimado\t\r \u00a0para\t\r \u00a0hacer\t\r \u00a0un\t\r \u00a0brev\u00edsimo\t\r \u00a0comentario\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0investigaci\u00f3n\t\r \u00a0de\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0galardonados,\t\r \u00a0no\t\r \u00a0es\t\r \u00a0este\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0las\t\r \u00a0investigaciones\t\r \u00a0premiadas\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 en\t\r \u00a0 Qu\u00edmica,\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 cedo\t\r \u00a0 el\t\r \u00a0 testigo\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0Profesora\t\r \u00a0Beatriz\t\r \u00a0de\t\r \u00a0Pascual-\u00ad\u2010Teresa\t\r \u00a0Fern\u00e1ndez\t\r \u00a0que\t\r \u00a0glosar\u00e1\t\r \u00a0las\t\r \u00a0investigaciones\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tres\t\r \u00a0cient\u00edficos\t\r \u00a0galardonados.\t\r \u00a0REFERENCIAS\t\r \u00a0(1)\t\r \u00a0 Novick,\t\r \u00a0 P.;\t\r \u00a0 Scheckman,\t\r \u00a0 R.W.\t\r \u00a0 1979.\t\r \u00a0 Secretion\t\r \u00a0 and\t\r \u00a0 cell-\u00ad\u2010surface\t\r \u00a0 growth\t\r \u00a0 are\t\r \u00a0 blocked\t\r \u00a0 in\t\r \u00a0 a\t\r \u00a0temperature-\u00ad\u2010sensitive\t\r \u00a0 mutant\t\r \u00a0 of\t\r \u00a0Saccharomyces\t\r \u00a0 cerevisiae.\t\r \u00a0 ProcNacAcadSci,\t\r \u00a0 76:1858-\u00ad\u20101862.\t\r \u00a0(2)\t\r \u00a0Novick,\t\r \u00a0P.;\t\r \u00a0Field,\t\r \u00a0C.;\t\r \u00a0Scheckman,\t\r \u00a0R.W.\t\r \u00a01980.\t\r \u00a0Identification\t\r \u00a0of\t\r \u00a023\t\r \u00a0complementation\t\r \u00a0groups\t\r \u00a0required\t\r \u00a0for\t\r \u00a0post-\u00ad\u2010translational\t\r \u00a0events\t\r \u00a0in\t\r \u00a0the\t\r \u00a0yeast\t\r \u00a0secretory\t\r \u00a0pathway.\t\r \u00a0Cell,\t\r \u00a021:205-\u00ad\u2010215.\t\r \u00a0(3)\t\r \u00a0 Novick,\t\r \u00a0 P.;\t\r \u00a0 Ferro,\t\r \u00a0 S.;\t\r \u00a0 Scheckman,\t\r \u00a0 R.W.\t\r \u00a0 1981.\t\r \u00a0 Order\t\r \u00a0 of\t\r \u00a0 events\t\r \u00a0 in\t\r \u00a0 the\t\r \u00a0 yeast\t\r \u00a0 secretory\t\r \u00a0pathways.Cell,\t\r \u00a025:461-\u00ad\u2010469.\t\r \u00a0(4)\t\r \u00a0 Kaiser,\t\r \u00a0 C.A.;\t\r \u00a0 Scheckman,\t\r \u00a0 R.\t\r \u00a0 1990.\t\r \u00a0 Distinct\t\r \u00a0 sets\t\r \u00a0 of\t\r \u00a0SEC\t\r \u00a0genes\t\r \u00a0 govern\t\r \u00a0 transport\t\r \u00a0 vesicle\t\r \u00a0formation\t\r \u00a0and\t\r \u00a0fusion\t\r \u00a0early\t\r \u00a0in\t\r \u00a0the\t\r \u00a0secretory\t\r \u00a0pathway.\t\r \u00a0Cell,\t\r \u00a061:723-\u00ad\u2010733.\t\r \u00a0(5)\t\r \u00a0Balch,\t\r \u00a0W.E.;\t\r \u00a0Dunphy,\t\r \u00a0W.G.;\t\r \u00a0Braell,\t\r \u00a0W.A.;\t\r \u00a0Rothman,\t\r \u00a0J.E.\t\r \u00a01984.\t\r \u00a0Reconstitution\t\r \u00a0of\t\r \u00a0the\t\r \u00a0transport\t\r \u00a0of\t\r \u00a0 protein\t\r \u00a0 between\t\r \u00a0 successive\t\r \u00a0 compartments\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 Golgi\t\r \u00a0 measured\t\r \u00a0 by\t\r \u00a0 the\t\r \u00a0 coupled\t\r \u00a0incorporation\t\r \u00a0of\t\r \u00a0N-\u00ad\u2010acetylglucosamine.\t\r \u00a0Cell,\t\r \u00a039:405-\u00ad\u2010416.\t\r \u00a0(6)\t\r \u00a0Sollner,\t\r \u00a0T.;\t\r \u00a0Whiteheart,\t\r \u00a0W.;\t\r \u00a0Brunner,\t\r \u00a0M.;\t\r \u00a0Erdjument-\u00ad\u2010Bromage,\t\r \u00a0H.;\t\r \u00a0Geromanos,\t\r \u00a0S.;\t\r \u00a0Tempst,\t\r \u00a0P.;\t\r \u00a0 Rothman,\t\r \u00a0 J.E.\t\r \u00a0 1993.\t\r \u00a0SNAP\t\r \u00a0 receptor\t\r \u00a0 implicated\t\r \u00a0 in\t\r \u00a0 vesicletargeting\t\r \u00a0 and\t\r \u00a0 fusi\u00f3n.\t\r \u00a0Nature,\t\r \u00a0362:318-\u00ad\u2010324.\t\r \u00a0\t\r \u00a0\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n398\t\r \u00a0\t\r \u00a0Del\t\r \u00a0 tr\u00e1fico\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 comunicaci\u00f3n\t\r \u00a0 neuronal\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0enfermedades\t\r \u00a0mentales\t\r \u00a0Jos\u00e9\t\r \u00a0Antonio\t\r \u00a0Esteban\t\r \u00a0Garc\u00eda\t\r \u00a0Centro\t\r \u00a0de\t\r \u00a0Biolog\u00eda\t\r \u00a0Molecular\t\r \u00a0\u201cSevero\t\r \u00a0Ochoa\u201d.\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0398-\u00ad\u2010407.\t\r \u00a0\t\r \u00a0El\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina\t\r \u00a0del\t\r \u00a0a\u00f1o\t\r \u00a02013\t\r \u00a0ha\t\r \u00a0estado\t\r \u00a0dedicado\t\r \u00a0a\t\r \u00a0un\t\r \u00a0 problema\t\r \u00a0 biol\u00f3gico\t\r \u00a0 fundamental:\t\r \u00a0 \u00bfc\u00f3mo\t\r \u00a0 se\t\r \u00a0 transportan\t\r \u00a0 y\t\r \u00a0 distribuyen\t\r \u00a0 las\t\r \u00a0distintas\t\r \u00a0sustancias\t\r \u00a0y\t\r \u00a0cargamentos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula?\t\r \u00a0\u00bfy\t\r \u00a0c\u00f3mo\t\r \u00a0se\t\r \u00a0dirigen\t\r \u00a0las\t\r \u00a0sustancias\t\r \u00a0destinadas\t\r \u00a0a\t\r \u00a0ser\t\r \u00a0liberadas\t\r \u00a0al\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula?\t\r \u00a0Todas\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0contienen\t\r \u00a0un\t\r \u00a0complejo\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0interno,\t\r \u00a0con\t\r \u00a0carreteras\t\r \u00a0primarias\t\r \u00a0y\t\r \u00a0secundarias,\t\r \u00a0 con\t\r \u00a0 se\u00f1ales\t\r \u00a0 de\t\r \u00a0 parada\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 avance,\t\r \u00a0 con\t\r \u00a0 estaciones\t\r \u00a0 de\t\r \u00a0 servicio\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0reparaci\u00f3n.\t\r \u00a0La\t\r \u00a0existencia\t\r \u00a0de\t\r \u00a0este\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0es\t\r \u00a0conocida\t\r \u00a0ya\t\r \u00a0desde\t\r \u00a0los\t\r \u00a0trabajos\t\r \u00a0 pioneros\t\r \u00a0 de\t\r \u00a0 George\t\r \u00a0 Palade\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 1960\t\r \u00a0 (Premio\t\r \u00a0 Nobel\t\r \u00a0 en\t\r \u00a0 1974),\t\r \u00a0pero\t\r \u00a0 s\u00f3lo\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 \u00faltimos\t\r \u00a0 20\t\r \u00a0 a\u00f1os\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 conseguido\t\r \u00a0 un\t\r \u00a0 conocimiento\t\r \u00a0razonablemente\t\r \u00a0completo\t\r \u00a0de\t\r \u00a0su\t\r \u00a0organizaci\u00f3n\t\r \u00a0y\t\r \u00a0regulaci\u00f3n\t\r \u00a0interna,\t\r \u00a0en\t\r \u00a0gran\t\r \u00a0medida\t\r \u00a0gracias\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 investigaciones\t\r \u00a0 de\t\r \u00a0 Randy\t\r \u00a0 Sheckman,\t\r \u00a0 James\t\r \u00a0 Rothman\t\r \u00a0 y\t\r \u00a0 Thomas\t\r \u00a0S\u00fcdhof,\t\r \u00a0galardonados\t\r \u00a0este\t\r \u00a0a\u00f1o\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Fisiolog\u00eda\t\r \u00a0o\t\r \u00a0Medicina.\t\r \u00a0Antes\t\r \u00a0 de\t\r \u00a0 entrar\t\r \u00a0 en\t\r \u00a0 m\u00e1s\t\r \u00a0 detalle\t\r \u00a0 sobre\t\r \u00a0 estas\t\r \u00a0 investigaciones,\t\r \u00a0 incluyo\t\r \u00a0 aqu\u00ed\t\r \u00a0unas\t\r \u00a0peque\u00f1as\t\r \u00a0notas\t\r \u00a0biogr\u00e1ficas.\t\r \u00a0Randy\t\r \u00a0Sheckman\t\r \u00a0naci\u00f3\t\r \u00a0en\t\r \u00a01948,\t\r \u00a0en\t\r \u00a0Minnesota,\t\r \u00a0EEUU,\t\r \u00a0y\t\r \u00a0realiz\u00f3\t\r \u00a0casi\t\r \u00a0todo\t\r \u00a0su\t\r \u00a0trabajo\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0California,\t\r \u00a0en\t\r \u00a0Berkeley,\t\r \u00a0donde\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 actualidad\t\r \u00a0 es\t\r \u00a0 Profesor\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Departamento\t\r \u00a0 de\t\r \u00a0 Biolog\u00eda\t\r \u00a0 Molecular\t\r \u00a0 y\t\r \u00a0Celular.\t\r \u00a0 Curiosamente,\t\r \u00a0 Randy\t\r \u00a0 Scheckman\t\r \u00a0 tiene\t\r \u00a0 una\t\r \u00a0 relaci\u00f3n\t\r \u00a0 de\t\r \u00a0 parentesco\t\r \u00a0cient\u00edfico\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 espa\u00f1ol\t\r \u00a0 Severo\t\r \u00a0 Ochoa,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 realiz\u00f3\t\r \u00a0 su\t\r \u00a0 tesis\t\r \u00a0doctoral\t\r \u00a0 bajo\t\r \u00a0 la\t\r \u00a0 supervisi\u00f3n\t\r \u00a0 de\t\r \u00a0 Arthur\t\r \u00a0 Kornberg,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0 Stanford\t\r \u00a0(EEUU),\t\r \u00a0quien\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez\t\r \u00a0trabaj\u00f3\t\r \u00a0con\t\r \u00a0Severo\t\r \u00a0Ochoa\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Nueva\t\r \u00a0York\t\r \u00a0(Arthur\t\r \u00a0 Kornberg\t\r \u00a0 y\t\r \u00a0 Severo\t\r \u00a0 Ochoa\t\r \u00a0 recibieron\t\r \u00a0 conjuntamente\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 de\t\r \u00a0Medicina\t\r \u00a0 o\t\r \u00a0 Fisiolog\u00eda\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 1959).\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 Randy\t\r \u00a0 Scheckman\t\r \u00a0 puede\t\r \u00a0considerarse\t\r \u00a0el\t\r \u00a0\u201cnieto\t\r \u00a0cient\u00edfico\u201d\t\r \u00a0de\t\r \u00a0Severo\t\r \u00a0Ochoa.\t\r \u00a0James\t\r \u00a0Rothman\t\r \u00a0naci\u00f3\t\r \u00a0en\t\r \u00a01950,\t\r \u00a0en\t\r \u00a0Massachusetts,\t\r \u00a0EEUU,\t\r \u00a0e\t\r \u00a0inici\u00f3\t\r \u00a0sus\t\r \u00a0investigaciones\t\r \u00a0relacionadas\t\r \u00a0con\t\r \u00a0este\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Stanford,\t\r \u00a0precisamente\t\r \u00a0en\t\r \u00a0el\t\r \u00a0departamento\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0unos\t\r \u00a0 a\u00f1os\t\r \u00a0 antes\t\r \u00a0 Randy\t\r \u00a0 Scheckman\t\r \u00a0 realizaba\t\r \u00a0 su\t\r \u00a0 tesis\t\r \u00a0 doctoral.\t\r \u00a0 James\t\r \u00a0 Rothman\t\r \u00a0tambi\u00e9n\t\r \u00a0 ha\t\r \u00a0 trabajado\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0de\t\r \u00a0 Princeton,\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Instituto\t\r \u00a0 de\t\r \u00a0 C\u00e1ncer\t\r \u00a0Memorial\t\r \u00a0 Sloan-\u00ad\u2010Kettering\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0 Columbia.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 actualidad,\t\r \u00a0 es\t\r \u00a0Profesor\t\r \u00a0y\t\r \u00a0Catedr\u00e1tico\t\r \u00a0del\t\r \u00a0departamento\t\r \u00a0de\t\r \u00a0Biolog\u00eda\t\r \u00a0Celular\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Yale.\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0naci\u00f3\t\r \u00a0en\t\r \u00a0G\u00f6ttingen,\t\r \u00a0Alemania\t\r \u00a0en\t\r \u00a01955.\t\r \u00a0Es\t\r \u00a0por\t\r \u00a0tanto\t\r \u00a0el\t\r \u00a0\u00fanico\t\r \u00a0investigador\t\r \u00a0no\t\r \u00a0estadounidense\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tres\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0este\t\r \u00a0premio.\t\r \u00a0Realiz\u00f3\t\r \u00a0su\t\r \u00a0 tesis\t\r \u00a0 doctoral\t\r \u00a0 y\t\r \u00a0 obtuvo\t\r \u00a0 el\t\r \u00a0 t\u00edtulo\t\r \u00a0 de\t\r \u00a0 doctor\t\r \u00a0 en\t\r \u00a0 medicina\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n399\t\r \u00a0\t\r \u00a0G\u00f6ttingen.\t\r \u00a0A\t\r \u00a0continuaci\u00f3n\t\r \u00a0se\t\r \u00a0traslad\u00f3\t\r \u00a0a\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Texas\t\r \u00a0Southwestern,\t\r \u00a0en\t\r \u00a0EEUU,\t\r \u00a0donde\t\r \u00a0realiz\u00f3\t\r \u00a0la\t\r \u00a0mayor\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0su\t\r \u00a0trabajo\t\r \u00a0de\t\r \u00a0investigaci\u00f3n.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0actualidad\t\r \u00a0es\t\r \u00a0Profesor\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Departamento\t\r \u00a0de\t\r \u00a0Fisiolog\u00eda\t\r \u00a0Molecular\t\r \u00a0y\t\r \u00a0Celular\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0de\t\r \u00a0Stanford.\t\r \u00a0Desde\t\r \u00a0 un\t\r \u00a0 punto\t\r \u00a0 de\t\r \u00a0 vista\t\r \u00a0 m\u00e1s\t\r \u00a0 anecd\u00f3tico,\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 ha\t\r \u00a0 tenido\t\r \u00a0una\t\r \u00a0conexi\u00f3n\t\r \u00a0muy\t\r \u00a0reciente\t\r \u00a0y\t\r \u00a0directa\t\r \u00a0con\t\r \u00a0la\t\r \u00a0universidad\t\r \u00a0espa\u00f1ola,\t\r \u00a0y\t\r \u00a0en\t\r \u00a0concreto,\t\r \u00a0con\t\r \u00a0el\t\r \u00a0autor\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0l\u00edneas.\t\r \u00a0Ello\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0a\t\r \u00a0la\t\r \u00a0celebraci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0congreso\t\r \u00a0sobre\t\r \u00a0transporte\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0en\t\r \u00a0las\t\r \u00a0neuronas,\t\r \u00a0que\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0del\t\r \u00a07\t\r \u00a0al\t\r \u00a09\t\r \u00a0de\t\r \u00a0octubre\t\r \u00a0del\t\r \u00a02013\t\r \u00a0en\t\r \u00a0Baeza\t\r \u00a0(Ja\u00e9n),\t\r \u00a0auspiciado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0Internacional\t\r \u00a0de\t\r \u00a0Andaluc\u00eda\t\r \u00a0(UNIA)\t\r \u00a0y\t\r \u00a0organizado\t\r \u00a0 por\t\r \u00a0 Juan\t\r \u00a0 Lerma\t\r \u00a0 (Instituto\t\r \u00a0 de\t\r \u00a0 Neurociencia\t\r \u00a0 de\t\r \u00a0 Alicante),\t\r \u00a0 Thomas\t\r \u00a0Schwarz\t\r \u00a0(Harvard\t\r \u00a0Medical\t\r \u00a0School)\t\r \u00a0y\t\r \u00a0yo\t\r \u00a0mismo.\t\r \u00a0Este\t\r \u00a0congreso\t\r \u00a0se\t\r \u00a0hab\u00eda\t\r \u00a0organizado\t\r \u00a0casi\t\r \u00a0con\t\r \u00a0un\t\r \u00a0a\u00f1o\t\r \u00a0de\t\r \u00a0antelaci\u00f3n,\t\r \u00a0y\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0era\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0ponentes\t\r \u00a0invitados.\t\r \u00a0La\t\r \u00a0feliz\t\r \u00a0coincidencia\t\r \u00a0fue\t\r \u00a0que\t\r \u00a0el\t\r \u00a0d\u00eda\t\r \u00a0que\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0llegaba\t\r \u00a0a\t\r \u00a0Espa\u00f1a\t\r \u00a0(desde\t\r \u00a0los\t\r \u00a0Estados\t\r \u00a0Unidos)\t\r \u00a0para\t\r \u00a0participar\t\r \u00a0en\t\r \u00a0este\t\r \u00a0congreso,\t\r \u00a0se\t\r \u00a0le\t\r \u00a0comunicaba\t\r \u00a0la\t\r \u00a0concesi\u00f3n\t\r \u00a0del\t\r \u00a0 Premio\t\r \u00a0 Nobel.\t\r \u00a0 El\t\r \u00a0 Instituto\t\r \u00a0 Karolinska\t\r \u00a0 tiene\t\r \u00a0 por\t\r \u00a0 costumbre\t\r \u00a0 anunciar\t\r \u00a0 el\t\r \u00a0resultado\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 galardonados\t\r \u00a0 por\t\r \u00a0 tel\u00e9fono.\t\r \u00a0 En\t\r \u00a0 este\t\r \u00a0 caso\t\r \u00a0 la\t\r \u00a0 llamada\t\r \u00a0 tuvo\t\r \u00a0 lugar\t\r \u00a0mientras\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0conduc\u00eda,\t\r \u00a0en\t\r \u00a0un\t\r \u00a0coche\t\r \u00a0alquilado,\t\r \u00a0desde\t\r \u00a0el\t\r \u00a0aeropuerto\t\r \u00a0de\t\r \u00a0Barajas\t\r \u00a0en\t\r \u00a0Madrid\t\r \u00a0a\t\r \u00a0la\t\r \u00a0sede\t\r \u00a0del\t\r \u00a0congreso\t\r \u00a0en\t\r \u00a0Baeza.\t\r \u00a0Cuando\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0atendi\u00f3\t\r \u00a0la\t\r \u00a0llamada,\t\r \u00a0despu\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0incredulidad\t\r \u00a0inicial,\t\r \u00a0tuvo\t\r \u00a0que\t\r \u00a0pedir\t\r \u00a0a\t\r \u00a0su\t\r \u00a0interlocutor\t\r \u00a0que\t\r \u00a0esperara\t\r \u00a0 un\t\r \u00a0 momento\t\r \u00a0 mientras\t\r \u00a0 deten\u00eda\t\r \u00a0 el\t\r \u00a0 coche,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 encontraba\t\r \u00a0\u201cconduciendo\t\r \u00a0 por\t\r \u00a0 alg\u00fan\t\r \u00a0 lugar\t\r \u00a0 en\t\r \u00a0 medio\t\r \u00a0 de\t\r \u00a0 Espa\u00f1a\u201d.\t\r \u00a0 La\t\r \u00a0 conversaci\u00f3n\t\r \u00a0 telef\u00f3nica\t\r \u00a0completa,\t\r \u00a0 junto\t\r \u00a0 con\t\r \u00a0 su\t\r \u00a0 transcripci\u00f3n\t\r \u00a0 al\t\r \u00a0 espa\u00f1ol,\t\r \u00a0 puede\t\r \u00a0 seguirse\t\r \u00a0 en\t\r \u00a0http://www.youtube.com/watch?v=8cZnznOAZMY.\t\r \u00a0Es\t\r \u00a0realmente\t\r \u00a0un\t\r \u00a0testimonio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0naturalidad\t\r \u00a0y\t\r \u00a0sorpresa\t\r \u00a0con\t\r \u00a0que\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0recibi\u00f3\t\r \u00a0la\t\r \u00a0noticia.\t\r \u00a0\t\r \u00a0Unas\t\r \u00a0 pocas\t\r \u00a0 horas\t\r \u00a0 m\u00e1s\t\r \u00a0 tarde,\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 llegaba\t\r \u00a0 a\t\r \u00a0 Baeza.\t\r \u00a0 Para\t\r \u00a0 aquel\t\r \u00a0momento\t\r \u00a0nosotros\t\r \u00a0ya\t\r \u00a0sab\u00edamos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0concesi\u00f3n\t\r \u00a0del\t\r \u00a0Premio\t\r \u00a0Nobel,\t\r \u00a0y\t\r \u00a0esper\u00e1bamos\t\r \u00a0con\t\r \u00a0 impaciencia\t\r \u00a0 su\t\r \u00a0 llegada,\t\r \u00a0 junto\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 primeros\t\r \u00a0 periodistas\t\r \u00a0 que\t\r \u00a0 empezaban\t\r \u00a0 a\t\r \u00a0\nagruparse\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 sede\t\r \u00a0 del\t\r \u00a0 congreso.\t\r \u00a0 Despu\u00e9s\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 r\u00e1pida\t\r \u00a0 ducha\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 hotel,\t\r \u00a0\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n400\t\r \u00a0\t\r \u00a0Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 se\t\r \u00a0 reuni\u00f3\t\r \u00a0 con\t\r \u00a0 nosotros\t\r \u00a0 y\t\r \u00a0 atendi\u00f3\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 periodistas,\t\r \u00a0 tanto\t\r \u00a0 locales\t\r \u00a0como\t\r \u00a0 nacionales,\t\r \u00a0 que\t\r \u00a0 a\t\r \u00a0 duras\t\r \u00a0 penas\t\r \u00a0 hab\u00edan\t\r \u00a0 tenido\t\r \u00a0 tiempo\t\r \u00a0 para\t\r \u00a0 enterarse\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0noticia\t\r \u00a0 y\t\r \u00a0 preparar\t\r \u00a0 la\t\r \u00a0 entrevista.\t\r \u00a0 A\t\r \u00a0 pesar\t\r \u00a0 de\t\r \u00a0 lo\t\r \u00a0 improvisado\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 situaci\u00f3n,\t\r \u00a0 todo\t\r \u00a0transcurri\u00f3\t\r \u00a0en\t\r \u00a0un\t\r \u00a0ambiente\t\r \u00a0relajado\t\r \u00a0y\t\r \u00a0cordial.\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0se\t\r \u00a0prest\u00f3\t\r \u00a0siempre\t\r \u00a0de\t\r \u00a0buen\t\r \u00a0\u00e1nimo\t\r \u00a0y\t\r \u00a0con\t\r \u00a0una\t\r \u00a0sonrisa\t\r \u00a0a\t\r \u00a0las\t\r \u00a0sucesivas\t\r \u00a0entrevistas\t\r \u00a0y\t\r \u00a0sesiones\t\r \u00a0fotogr\u00e1ficas\t\r \u00a0que\t\r \u00a0 le\t\r \u00a0 fueron\t\r \u00a0 pidiendo\t\r \u00a0 (conviene\t\r \u00a0 recordar\t\r \u00a0 que\t\r \u00a0 hab\u00eda\t\r \u00a0 pasado\t\r \u00a0 la\t\r \u00a0 noche\t\r \u00a0 anterior\t\r \u00a0volando\t\r \u00a0desde\t\r \u00a0California\t\r \u00a0a\t\r \u00a0Madrid,\t\r \u00a0para\t\r \u00a0luego\t\r \u00a0conducir\t\r \u00a0durante\t\r \u00a0tres\t\r \u00a0horas\t\r \u00a0por\t\r \u00a0su\t\r \u00a0cuenta\t\r \u00a0hasta\t\r \u00a0Baeza).\t\r \u00a0Quiz\u00e1\t\r \u00a0un\t\r \u00a0ejemplo\t\r \u00a0m\u00e1s\t\r \u00a0del\t\r \u00a0buen\t\r \u00a0talante\t\r \u00a0y\t\r \u00a0profesionalidad\t\r \u00a0de\t\r \u00a0Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 fue\t\r \u00a0 que,\t\r \u00a0 concluidas\t\r \u00a0 la\t\r \u00a0 ronda\t\r \u00a0 de\t\r \u00a0 entrevistas;\t\r \u00a0 nos\t\r \u00a0 dispusimos\t\r \u00a0 a\t\r \u00a0continuar\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 programa\t\r \u00a0 cient\u00edfico\t\r \u00a0 del\t\r \u00a0 congreso\u2026\t\r \u00a0 \u00a1en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 \u00e9l\t\r \u00a0 era\t\r \u00a0 el\t\r \u00a0 pr\u00f3ximo\t\r \u00a0ponente!\t\r \u00a0 En\t\r \u00a0 efecto,\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 entr\u00f3\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 sala\t\r \u00a0 de\t\r \u00a0 conferencias,\t\r \u00a0 donde\t\r \u00a0 fue\t\r \u00a0recibido\t\r \u00a0con\t\r \u00a0aplausos\t\r \u00a0y\t\r \u00a0el\t\r \u00a0p\u00fablico\t\r \u00a0en\t\r \u00a0pie.\t\r \u00a0Tras\t\r \u00a0los\t\r \u00a0agradecimientos\t\r \u00a0de\t\r \u00a0rigor,\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0 su\t\r \u00a0 conferencia,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 nos\t\r \u00a0 present\u00f3\t\r \u00a0 los\t\r \u00a0 \u00faltimos\t\r \u00a0 trabajos\t\r \u00a0 que\t\r \u00a0 est\u00e1n\t\r \u00a0realizando\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 laboratorio,\t\r \u00a0 sobre\t\r \u00a0 los\t\r \u00a0 cuales\t\r \u00a0 hablar\u00e9\t\r \u00a0 un\t\r \u00a0 poco\t\r \u00a0 m\u00e1s\t\r \u00a0 adelante.\t\r \u00a0 En\t\r \u00a0conclusi\u00f3n,\t\r \u00a0 esta\t\r \u00a0 feliz\t\r \u00a0 coincidencia,\t\r \u00a0 adem\u00e1s\t\r \u00a0 de\t\r \u00a0 crear\t\r \u00a0 un\t\r \u00a0 poco\t\r \u00a0 de\t\r \u00a0 revuelo\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0tranquila\t\r \u00a0 ciudad\t\r \u00a0 de\t\r \u00a0 Baeza,\t\r \u00a0 sirvi\u00f3\t\r \u00a0 para\t\r \u00a0resaltar\t\r \u00a0 la\t\r \u00a0 importancia\t\r \u00a0 del\t\r \u00a0 tema\t\r \u00a0 de\t\r \u00a0investigaci\u00f3n\t\r \u00a0que\t\r \u00a0nos\t\r \u00a0ocupa,\t\r \u00a0y\t\r \u00a0para\t\r \u00a0que\t\r \u00a0los\t\r \u00a0estudiantes\t\r \u00a0(y\t\r \u00a0profesores)\t\r \u00a0tuvieran\t\r \u00a0la\t\r \u00a0oportunidad\t\r \u00a0de\t\r \u00a0conocer\t\r \u00a0y\t\r \u00a0charlar\t\r \u00a0con\t\r \u00a0un\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0\u201cde\t\r \u00a0carne\t\r \u00a0y\t\r \u00a0hueso\u201d.\t\r \u00a0Como\t\r \u00a0 mencionaba\t\r \u00a0 al\t\r \u00a0 comienzo,\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 a\u00f1o\t\r \u00a0 reconoce\t\r \u00a0 las\t\r \u00a0investigaciones\t\r \u00a0 de\t\r \u00a0 Randy\t\r \u00a0 Sheckman,\t\r \u00a0 James\t\r \u00a0 Rothman\t\r \u00a0 y\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula.\t\r \u00a0Cada\t\r \u00a0c\u00e9lula\t\r \u00a0es\t\r \u00a0una\t\r \u00a0peque\u00f1a\t\r \u00a0f\u00e1brica\t\r \u00a0que\t\r \u00a0produce\t\r \u00a0y\t\r \u00a0exporta\t\r \u00a0mol\u00e9culas,\t\r \u00a0ya\t\r \u00a0sean\t\r \u00a0se\u00f1ales\t\r \u00a0qu\u00edmicas\t\r \u00a0para\t\r \u00a0la\t\r \u00a0comunicaci\u00f3n\t\r \u00a0nerviosa,\t\r \u00a0o\t\r \u00a0enzimas\t\r \u00a0degradativas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0que\t\r \u00a0rodean\t\r \u00a0el\t\r \u00a0tubo\t\r \u00a0digestivo.\t\r \u00a0Estas\t\r \u00a0mol\u00e9culas\t\r \u00a0 (o\t\r \u00a0 cargamentos)\t\r \u00a0 se\t\r \u00a0 empaquetan\t\r \u00a0 en\t\r \u00a0 peque\u00f1os\t\r \u00a0 compartimentos\t\r \u00a0 de\t\r \u00a0membrana\t\r \u00a0 llamados\t\r \u00a0 ves\u00edculas,\t\r \u00a0 que\t\r \u00a0 son\t\r \u00a0 luego\t\r \u00a0 transportados\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 interior\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0c\u00e9lula\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 manera\t\r \u00a0 exquisitamente\t\r \u00a0 dirigida\t\r \u00a0 para\t\r \u00a0 llegar\t\r \u00a0 al\t\r \u00a0 lugar\t\r \u00a0 correcto\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0momento\t\r \u00a0 adecuado.\t\r \u00a0 El\t\r \u00a0 trabajo\t\r \u00a0 de\t\r \u00a0 estos\t\r \u00a0 tres\t\r \u00a0 investigadores\t\r \u00a0 ha\t\r \u00a0 contribuido\t\r \u00a0 a\t\r \u00a0elucidar\t\r \u00a0en\t\r \u00a0gran\t\r \u00a0medida\t\r \u00a0c\u00f3mo\t\r \u00a0este\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0se\t\r \u00a0organiza\t\r \u00a0y\t\r \u00a0regula\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula.\t\r \u00a0Un\t\r \u00a0aspecto\t\r \u00a0interesante\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0investigaciones\t\r \u00a0es\t\r \u00a0que\t\r \u00a0fueron\t\r \u00a0fundamentalmente\t\r \u00a0 de\t\r \u00a0 \u00edndole\t\r \u00a0 b\u00e1sica,\t\r \u00a0 es\t\r \u00a0 decir,\t\r \u00a0 no\t\r \u00a0 estaban\t\r \u00a0 necesariamente\t\r \u00a0encaminadas\t\r \u00a0u\t\r \u00a0orientadas\t\r \u00a0a\t\r \u00a0resolver\t\r \u00a0o\t\r \u00a0tratar\t\r \u00a0una\t\r \u00a0enfermedad\t\r \u00a0o\t\r \u00a0problema\t\r \u00a0social\t\r \u00a0determinado.\t\r \u00a0Por\t\r \u00a0supuesto,\t\r \u00a0como\t\r \u00a0comentar\u00e9\t\r \u00a0al\t\r \u00a0final,\t\r \u00a0sus\t\r \u00a0resultados\t\r \u00a0han\t\r \u00a0resultado\t\r \u00a0de\t\r \u00a0gran\t\r \u00a0utilidad\t\r \u00a0para\t\r \u00a0comprender,\t\r \u00a0y\t\r \u00a0en\t\r \u00a0parte\t\r \u00a0aliviar,\t\r \u00a0m\u00faltiples\t\r \u00a0enfermedades.\t\r \u00a0Pero\t\r \u00a0es\t\r \u00a0 importante\t\r \u00a0 resaltar,\t\r \u00a0 en\t\r \u00a0 estos\t\r \u00a0 tiempos\t\r \u00a0 de\t\r \u00a0 recortes\t\r \u00a0 presupuestarios,\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0investigaci\u00f3n\t\r \u00a0 b\u00e1sica\t\r \u00a0 siempre\t\r \u00a0 encuentra\t\r \u00a0 aplicaciones\t\r \u00a0 pr\u00e1cticas,\t\r \u00a0 muchas\t\r \u00a0 veces\t\r \u00a0inesperadas,\t\r \u00a0 aunque\t\r \u00a0 generalmente\t\r \u00a0 a\t\r \u00a0 largo\t\r \u00a0 plazo.\t\r \u00a0 A\t\r \u00a0 continuaci\u00f3n\t\r \u00a0 paso\t\r \u00a0 a\t\r \u00a0 rese\u00f1ar\t\r \u00a0brevemente\t\r \u00a0 algunos\t\r \u00a0 aspectos\t\r \u00a0 destacados\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 investigaci\u00f3n\t\r \u00a0 llevada\t\r \u00a0 a\t\r \u00a0 cabo\t\r \u00a0 por\t\r \u00a0estos\t\r \u00a0investigadores.\t\r \u00a0La\t\r \u00a0 aproximaci\u00f3n\t\r \u00a0 de\t\r \u00a0 Randy\t\r \u00a0 Sheckman\t\r \u00a0 fue\t\r \u00a0 fundamentalmente\t\r \u00a0 gen\u00e9tica.\t\r \u00a0 La\t\r \u00a0hip\u00f3tesis\t\r \u00a0 b\u00e1sica\t\r \u00a0 es\t\r \u00a0 que\t\r \u00a0si\t\r \u00a0 queremos\t\r \u00a0 entender\t\r \u00a0 el\t\r \u00a0 sistema\t\r \u00a0 de\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n401\t\r \u00a0\t\r \u00a0membrana\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 c\u00e9lula,\t\r \u00a0 necesitamos\t\r \u00a0 conocer\t\r \u00a0 los\t\r \u00a0 genes\t\r \u00a0 que\t\r \u00a0 lo\t\r \u00a0 gobiernan.\t\r \u00a0 Y\t\r \u00a0 para\t\r \u00a0abordar\t\r \u00a0 este\t\r \u00a0 problema,\t\r \u00a0 utiliz\u00f3\t\r \u00a0 un\t\r \u00a0 organismo\t\r \u00a0 cuya\t\r \u00a0 manipulaci\u00f3n\t\r \u00a0 gen\u00e9tica\t\r \u00a0 es\t\r \u00a0relativamente\t\r \u00a0 sencilla,\t\r \u00a0 como\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 levadura\t\r \u00a0 cervecera\t\r \u00a0 o\t\r \u00a0Saccharomycescerevisiae.\t\r \u00a0Randy\t\r \u00a0Sheckman\t\r \u00a0estudi\u00f3\t\r \u00a0multitud\t\r \u00a0de\t\r \u00a0mutantes\t\r \u00a0de\t\r \u00a0levadura\t\r \u00a0en\t\r \u00a0los\t\r \u00a0que\t\r \u00a0el\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0 transporte\t\r \u00a0 era\t\r \u00a0 defectuoso.\t\r \u00a0 Utilizando\t\r \u00a0 t\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 bioqu\u00edmica\t\r \u00a0 y\t\r \u00a0 microscop\u00eda,\t\r \u00a0observ\u00f3\t\r \u00a0 c\u00f3mo\t\r \u00a0 en\t\r \u00a0 algunas\t\r \u00a0 cepas\t\r \u00a0 de\t\r \u00a0 levadura\t\r \u00a0 se\t\r \u00a0 produc\u00edan\t\r \u00a0 \u201catascos\u201d\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tr\u00e1fico\t\r \u00a0intracelular,\t\r \u00a0con\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0determinados\t\r \u00a0cargamentos\t\r \u00a0no\t\r \u00a0llegaba\t\r \u00a0al\t\r \u00a0lugar\t\r \u00a0adecuado.\t\r \u00a0A\t\r \u00a0continuaci\u00f3n,\t\r \u00a0 empleando\t\r \u00a0 estrategias\t\r \u00a0 de\t\r \u00a0 gen\u00e9tica\t\r \u00a0 cl\u00e1sica,\t\r \u00a0 clasific\u00f3\t\r \u00a0 las\t\r \u00a0 cepas\t\r \u00a0mutantes\t\r \u00a0y\t\r \u00a0aisl\u00f3\t\r \u00a0los\t\r \u00a0genes\t\r \u00a0cuya\t\r \u00a0mutaci\u00f3n\t\r \u00a0produc\u00eda\t\r \u00a0los\t\r \u00a0defectos\t\r \u00a0de\t\r \u00a0transporte.\t\r \u00a0De\t\r \u00a0esta\t\r \u00a0forma\t\r \u00a0fue\t\r \u00a0capaz\t\r \u00a0de\t\r \u00a0generar\t\r \u00a0un\t\r \u00a0mapa\t\r \u00a0anat\u00f3mico\t\r \u00a0y\t\r \u00a0funcional,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0distintos\t\r \u00a0genes\t\r \u00a0 controlan\t\r \u00a0 pasos\t\r \u00a0 espec\u00edficos\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 entre\t\r \u00a0 distintos\t\r \u00a0compartimentos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula.\t\r \u00a0Esta\t\r \u00a0cartograf\u00eda\t\r \u00a0dise\u00f1ada\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0de\t\r \u00a0 levadura\t\r \u00a0 es\t\r \u00a0 esencialmente\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 utiliza\t\r \u00a0 hoy\t\r \u00a0 en\t\r \u00a0 d\u00eda\t\r \u00a0 para\t\r \u00a0 entender\t\r \u00a0 el\t\r \u00a0funcionamiento\t\r \u00a0 interno\t\r \u00a0 de\t\r \u00a0 c\u00e9lulas\t\r \u00a0 tan\t\r \u00a0 dispares\t\r \u00a0 como\t\r \u00a0 las\t\r \u00a0 neuronas\t\r \u00a0 o\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0secretoras\t\r \u00a0de\t\r \u00a0insulina\t\r \u00a0en\t\r \u00a0el\t\r \u00a0p\u00e1ncreas.\t\r \u00a0El\t\r \u00a0 trabajo\t\r \u00a0 de\t\r \u00a0 James\t\r \u00a0 Rothman\t\r \u00a0 consisti\u00f3\t\r \u00a0 fundamentalmente\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 disecci\u00f3n\t\r \u00a0bioqu\u00edmica\t\r \u00a0del\t\r \u00a0 proceso\t\r \u00a0 de\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 membrana.\t\r \u00a0 La\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas\t\r \u00a0 al\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0(como\t\r \u00a0es\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0los\t\r \u00a0neurotransmisores\t\r \u00a0en\t\r \u00a0las\t\r \u00a0neuronas\t\r \u00a0o\t\r \u00a0las\t\r \u00a0hormonas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0las\t\r \u00a0gl\u00e1ndulas\t\r \u00a0endocrinas)\t\r \u00a0requiere\t\r \u00a0que\t\r \u00a0las\t\r \u00a0ves\u00edculas\t\r \u00a0que\t\r \u00a0las\t\r \u00a0contienen\t\r \u00a0se\t\r \u00a0fusionen\t\r \u00a0con\t\r \u00a0la\t\r \u00a0membrana\t\r \u00a0exterior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula,\t\r \u00a0produciendo\t\r \u00a0el\t\r \u00a0 volcado\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0 contenido.\t\r \u00a0 Tambi\u00e9n\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 transporte\t\r \u00a0 intracelular,\t\r \u00a0 distintas\t\r \u00a0ves\u00edculas\t\r \u00a0tienen\t\r \u00a0que\t\r \u00a0fusionarse\t\r \u00a0con\t\r \u00a0otras\t\r \u00a0membranas\t\r \u00a0internas,\t\r \u00a0para\t\r \u00a0transferir\t\r \u00a0su\t\r \u00a0contenido\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 compartimento\t\r \u00a0 a\t\r \u00a0 otro.\t\r \u00a0 Este\t\r \u00a0 transporte\t\r \u00a0 es\t\r \u00a0 extremadamente\t\r \u00a0espec\u00edfico,\t\r \u00a0 para\t\r \u00a0 evitar\t\r \u00a0 la\t\r \u00a0 mezcla\t\r \u00a0 de\t\r \u00a0 cargamentos\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 compartimentos\t\r \u00a0incorrectos\t\r \u00a0y\t\r \u00a0el\t\r \u00a0caos\t\r \u00a0intracelular.\t\r \u00a0James\t\r \u00a0Rothman\t\r \u00a0descubri\u00f3\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0se\t\r \u00a0anclan\t\r \u00a0espec\u00edficamente\t\r \u00a0en\t\r \u00a0distintas\t\r \u00a0ves\u00edculas\t\r \u00a0o\t\r \u00a0en\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula,\t\r \u00a0y\t\r \u00a0 fuerzan\t\r \u00a0 la\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 membranas\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 sitios\t\r \u00a0 adecuados.\t\r \u00a0 Para\t\r \u00a0 ello\t\r \u00a0 utiliz\u00f3\t\r \u00a0c\u00e9lulas\t\r \u00a0 de\t\r \u00a0 mam\u00edfero,\t\r \u00a0 sobre\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 emple\u00f3\t\r \u00a0 t\u00e9cnicas\t\r \u00a0 de\t\r \u00a0 fraccionamiento\t\r \u00a0 y\t\r \u00a0purificaci\u00f3n\t\r \u00a0 de\t\r \u00a0 distintos\t\r \u00a0 compartimentos\t\r \u00a0 de\t\r \u00a0 membrana.\t\r \u00a0 De\t\r \u00a0 esta\t\r \u00a0 forma,\t\r \u00a0 por\t\r \u00a0primera\t\r \u00a0vez,\t\r \u00a0se\t\r \u00a0identificaron\t\r \u00a0componentes\t\r \u00a0de\t\r \u00a0la\t\r \u00a0maquinaria\t\r \u00a0molecular\t\r \u00a0que\t\r \u00a0ejecuta\t\r \u00a0el\t\r \u00a0 transporte\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 membranas.\t\r \u00a0 Quiz\u00e1\t\r \u00a0 uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 resultados\t\r \u00a0 m\u00e1s\t\r \u00a0interesantes\t\r \u00a0 fue\t\r \u00a0 comprobar\t\r \u00a0 que\t\r \u00a0 algunas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 prote\u00ednas\t\r \u00a0 encontradas\t\r \u00a0 con\t\r \u00a0 estos\t\r \u00a0estudios\t\r \u00a0bioqu\u00edmicos\t\r \u00a0con\t\r \u00a0c\u00e9lulas\t\r \u00a0de\t\r \u00a0mam\u00edfero\t\r \u00a0eran\t\r \u00a0las\t\r \u00a0mismas\t\r \u00a0que\t\r \u00a0se\t\r \u00a0codificaban\t\r \u00a0por\t\r \u00a0los\t\r \u00a0genes\t\r \u00a0que\t\r \u00a0hab\u00eda\t\r \u00a0encontrado\t\r \u00a0Randy\t\r \u00a0Sheckman\t\r \u00a0con\t\r \u00a0sus\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0levadura.\t\r \u00a0Esta\t\r \u00a0coincidencia\t\r \u00a0revela\t\r \u00a0y\t\r \u00a0refuerza\t\r \u00a0la\t\r \u00a0conservaci\u00f3n\t\r \u00a0evolutiva\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0mecanismos\t\r \u00a0como\t\r \u00a0 procesos\t\r \u00a0 fundamentales\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 funcionamiento\t\r \u00a0de\t\r \u00a0 todas\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0eucariotas.\t\r \u00a0Precisamente\t\r \u00a0 el\t\r \u00a0 trabajo\t\r \u00a0 de\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof\t\r \u00a0 est\u00e1\t\r \u00a0 encaminado\t\r \u00a0 a\t\r \u00a0 entender\t\r \u00a0estos\t\r \u00a0mecanismos\t\r \u00a0en\t\r \u00a0una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0m\u00e1s\t\r \u00a0evolucionadas\t\r \u00a0y\t\r \u00a0especializadas\t\r \u00a0que\t\r \u00a0se\t\r \u00a0conocen,\t\r \u00a0como\t\r \u00a0son\t\r \u00a0las\t\r \u00a0neuronas\t\r \u00a0en\t\r \u00a0el\t\r \u00a0cerebro.\t\r \u00a0Aqu\u00ed\t\r \u00a0el\t\r \u00a0proceso\t\r \u00a0que\t\r \u00a0se\t\r \u00a0estudi\u00f3\t\r \u00a0fue\t\r \u00a0la\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n402\t\r \u00a0\t\r \u00a0liberaci\u00f3n\t\r \u00a0 de\t\r \u00a0 neurotransmisor,\t\r \u00a0 que\t\r \u00a0 permite\t\r \u00a0 la\t\r \u00a0 comunicaci\u00f3n\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 neurona\t\r \u00a0 a\t\r \u00a0otra.\t\r \u00a0 Todos\t\r \u00a0 los\t\r \u00a0 requerimientos\t\r \u00a0 de\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 y\t\r \u00a0 especificidad\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0membranas,\t\r \u00a0est\u00e1n\t\r \u00a0llevados\t\r \u00a0al\t\r \u00a0m\u00e1ximo\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0la\t\r \u00a0comunicaci\u00f3n\t\r \u00a0neuronal.\t\r \u00a0As\u00ed,\t\r \u00a0las\t\r \u00a0ves\u00edculas\t\r \u00a0que\t\r \u00a0contienen\t\r \u00a0los\t\r \u00a0neurotransmisores\t\r \u00a0pueden\t\r \u00a0permanecer\t\r \u00a0inm\u00f3viles,\t\r \u00a0ancladas\t\r \u00a0 durante\t\r \u00a0 horas\t\r \u00a0 o\t\r \u00a0 d\u00edas\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 terminales\t\r \u00a0 nerviosas,\t\r \u00a0 conocidas\t\r \u00a0 como\t\r \u00a0sinapsis.\t\r \u00a0Luego,\t\r \u00a0cuando\t\r \u00a0llega\t\r \u00a0el\t\r \u00a0est\u00edmulo\t\r \u00a0nervioso\t\r \u00a0(potencial\t\r \u00a0de\t\r \u00a0acci\u00f3n),\t\r \u00a0la\t\r \u00a0fusi\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ves\u00edcula\t\r \u00a0con\t\r \u00a0la\t\r \u00a0membrana\t\r \u00a0sin\u00e1ptica\t\r \u00a0se\t\r \u00a0dispara\t\r \u00a0a\t\r \u00a0gran\t\r \u00a0velocidad,\t\r \u00a0en\t\r \u00a0tiempos\t\r \u00a0inferiores\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 milisegundo.\t\r \u00a0 Esta\t\r \u00a0 precisi\u00f3n\t\r \u00a0 y\t\r \u00a0 rapidez\t\r \u00a0 son\t\r \u00a0 fundamentales\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0comunicaci\u00f3n\t\r \u00a0 nerviosa,\t\r \u00a0 y\t\r \u00a0 son\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 del\t\r \u00a0 funcionamiento\t\r \u00a0 cerebral,\t\r \u00a0 desde\t\r \u00a0 la\t\r \u00a0percepci\u00f3n\t\r \u00a0 de\t\r \u00a0 est\u00edmulos\t\r \u00a0 del\t\r \u00a0 exterior,\t\r \u00a0 hasta\t\r \u00a0 la\t\r \u00a0 ejecuci\u00f3n\t\r \u00a0 de\t\r \u00a0 complicados\t\r \u00a0movimientos\t\r \u00a0 o\t\r \u00a0 los\t\r \u00a0 procesos\t\r \u00a0 cognitivos\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 aprendizaje\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 memoria.\t\r \u00a0Curiosamente,\t\r \u00a0cuando\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0comenz\u00f3\t\r \u00a0estos\t\r \u00a0estudios,\t\r \u00a0en\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a01990,\t\r \u00a0se\t\r \u00a0 desconoc\u00eda\t\r \u00a0 pr\u00e1cticamente\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 totalidad\t\r \u00a0 la\t\r \u00a0 maquinaria\t\r \u00a0 molecular\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0ves\u00edculas\t\r \u00a0 de\t\r \u00a0 neurotransmisor.\t\r \u00a0 Y\t\r \u00a0 aunque\t\r \u00a0 era\t\r \u00a0 de\t\r \u00a0 esperar\t\r \u00a0 que\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0maquinaria\t\r \u00a0 fuera\t\r \u00a0 com\u00fan\t\r \u00a0 y\t\r \u00a0 compartida\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 opera\t\r \u00a0 en\t\r \u00a0 otros\t\r \u00a0 tipos\t\r \u00a0 celulares\t\r \u00a0para\t\r \u00a0 la\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 membranas,\t\r \u00a0 parec\u00eda\t\r \u00a0 obvio\t\r \u00a0 que\t\r \u00a0 ten\u00eda\t\r \u00a0 que\t\r \u00a0 haber\t\r \u00a0 adaptaciones\t\r \u00a0 y\t\r \u00a0especializaciones\t\r \u00a0que\t\r \u00a0\u201cacoplaran\u201d\t\r \u00a0esta\t\r \u00a0maquinaria\t\r \u00a0a\t\r \u00a0los\t\r \u00a0est\u00edmulos\t\r \u00a0nerviosos.\t\r \u00a0Antes\t\r \u00a0del\t\r \u00a0comienzo\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0investigaciones\t\r \u00a0ya\t\r \u00a0se\t\r \u00a0conoc\u00eda\t\r \u00a0que\t\r \u00a0un\t\r \u00a0factor\t\r \u00a0fundamental\t\r \u00a0en\t\r \u00a0este\t\r \u00a0acoplamiento\t\r \u00a0son\t\r \u00a0los\t\r \u00a0iones\t\r \u00a0de\t\r \u00a0calcio\t\r \u00a0(Ca2+).\t\r \u00a0La\t\r \u00a0llegada\t\r \u00a0del\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0a\t\r \u00a0la\t\r \u00a0terminal\t\r \u00a0sin\u00e1ptica\t\r \u00a0provoca\t\r \u00a0la\t\r \u00a0entrada\t\r \u00a0de\t\r \u00a0Ca2+\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0unos\t\r \u00a0canales\t\r \u00a0i\u00f3nicos\t\r \u00a0espec\u00edficos,\t\r \u00a0 y\t\r \u00a0 esta\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 Ca2+\t\r \u00a0es\t\r \u00a0 necesaria\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 del\t\r \u00a0neurotransmisor.\t\r \u00a0 Una\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 contribuciones\t\r \u00a0 fundamentales\t\r \u00a0 del\t\r \u00a0 laboratorio\t\r \u00a0 de\t\r \u00a0Thomas\t\r \u00a0S\u00fcdhof\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0la\t\r \u00a0identificaci\u00f3n\t\r \u00a0de\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0ves\u00edculas\t\r \u00a0de\t\r \u00a0neurotransmisor\t\r \u00a0que\t\r \u00a0unen\t\r \u00a0Ca2+\t\r \u00a0y\t\r \u00a0act\u00faan\t\r \u00a0como\t\r \u00a0sensores\t\r \u00a0que\t\r \u00a0detectan\t\r \u00a0la\t\r \u00a0llegada\t\r \u00a0del\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0acci\u00f3n\t\r \u00a0y\t\r \u00a0disparan\t\r \u00a0con\t\r \u00a0gran\t\r \u00a0rapidez\t\r \u00a0la\t\r \u00a0fusi\u00f3n\t\r \u00a0de\t\r \u00a0membrana.\t\r \u00a0De\t\r \u00a0esta\t\r \u00a0forma\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0posible\t\r \u00a0entender\t\r \u00a0la\t\r \u00a0exquisita\t\r \u00a0precisi\u00f3n\t\r \u00a0temporal\t\r \u00a0de\t\r \u00a0la\t\r \u00a0comunicaci\u00f3n\t\r \u00a0nerviosa.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 estas\t\r \u00a0 investigaciones\t\r \u00a0 supusieron\t\r \u00a0 un\t\r \u00a0 cambio\t\r \u00a0 conceptual,\t\r \u00a0 al\t\r \u00a0descubrir\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 fusi\u00f3n\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 pod\u00eda\t\r \u00a0 ocurrir\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 regulada,\t\r \u00a0 en\t\r \u00a0respuesta\t\r \u00a0a\t\r \u00a0est\u00edmulos\t\r \u00a0determinados.\t\r \u00a0Ahora\t\r \u00a0se\t\r \u00a0sabe\t\r \u00a0que\t\r \u00a0este\t\r \u00a0no\t\r \u00a0es\t\r \u00a0s\u00f3lo\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0las\t\r \u00a0 neuronas,\t\r \u00a0 sino\t\r \u00a0 tambi\u00e9n\t\r \u00a0 el\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 mayor\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 endocrinas,\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0inmune\t\r \u00a0y\t\r \u00a0otros\t\r \u00a0tipos\t\r \u00a0celulares.\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n403\t\r \u00a0\t\r \u00a0En\t\r \u00a0conclusi\u00f3n,\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0distinguidos\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Medicina\t\r \u00a0de\t\r \u00a0este\t\r \u00a0a\u00f1o\t\r \u00a0nos\t\r \u00a0han\t\r \u00a0llevado\t\r \u00a0en\t\r \u00a0dos\t\r \u00a0direcciones\t\r \u00a0complementarias.\t\r \u00a0Por\t\r \u00a0un\t\r \u00a0lado,\t\r \u00a0nos\t\r \u00a0han\t\r \u00a0permitido\t\r \u00a0 entender\t\r \u00a0 los\t\r \u00a0 mecanismos\t\r \u00a0 b\u00e1sicos\t\r \u00a0 del\t\r \u00a0 transporte\t\r \u00a0 intracelular\t\r \u00a0 de\t\r \u00a0membrana,\t\r \u00a0que\t\r \u00a0operan\t\r \u00a0en\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0eucariotas\t\r \u00a0y\t\r \u00a0son\t\r \u00a0fundamentales\t\r \u00a0para\t\r \u00a0su\t\r \u00a0organizaci\u00f3n\t\r \u00a0interna\t\r \u00a0y\t\r \u00a0correcto\t\r \u00a0funcionamiento.\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0nos\t\r \u00a0han\t\r \u00a0ofrecido\t\r \u00a0un\t\r \u00a0ejemplo\t\r \u00a0 de\t\r \u00a0 c\u00f3mo\t\r \u00a0 estos\t\r \u00a0 mecanismos\t\r \u00a0 pueden\t\r \u00a0adaptarse\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 requerimientos\t\r \u00a0espec\u00edficos\t\r \u00a0 de\t\r \u00a0 distintos\t\r \u00a0 tipos\t\r \u00a0 celulares,\t\r \u00a0 como\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 liberaci\u00f3n\t\r \u00a0 de\t\r \u00a0neurotransmisor\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 neuronas.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 la\t\r \u00a0 mayor\u00eda\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 investigaciones\t\r \u00a0actuales\t\r \u00a0en\t\r \u00a0este\t\r \u00a0campo\t\r \u00a0se\t\r \u00a0concentra\t\r \u00a0en\t\r \u00a0entender\t\r \u00a0las\t\r \u00a0distintas\t\r \u00a0especializaciones\t\r \u00a0y\t\r \u00a0mecanismos\t\r \u00a0de\t\r \u00a0regulaci\u00f3n\t\r \u00a0del\t\r \u00a0transporte\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0en\t\r \u00a0distintos\t\r \u00a0tejidos\t\r \u00a0y\t\r \u00a0tipos\t\r \u00a0celulares.\t\r \u00a0Algunas\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0adaptaciones\t\r \u00a0son\t\r \u00a0realmente\t\r \u00a0notables.\t\r \u00a0Por\t\r \u00a0ejemplo,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0fotorreceptoras\t\r \u00a0en\t\r \u00a0la\t\r \u00a0retina,\t\r \u00a0conos\t\r \u00a0y\t\r \u00a0bastones\t\r \u00a0(arriba\t\r \u00a0a\t\r \u00a0la\t\r \u00a0izquierda),\t\r \u00a0est\u00e1n\t\r \u00a0tremendamente\t\r \u00a0 polarizadas.\t\r \u00a0 En\t\r \u00a0 su\t\r \u00a0 segmento\t\r \u00a0 externo\t\r \u00a0 forman\t\r \u00a0 unos\t\r \u00a0 discos\t\r \u00a0 de\t\r \u00a0membrana\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0concentra\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0sensible\t\r \u00a0a\t\r \u00a0la\t\r \u00a0luz,\t\r \u00a0la\t\r \u00a0rodopsina.\t\r \u00a0La\t\r \u00a0mayor\t\r \u00a0parte\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 energ\u00eda\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 c\u00e9lula\t\r \u00a0 se\t\r \u00a0 destina\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 estos\t\r \u00a0 discos\t\r \u00a0 de\t\r \u00a0membrana\t\r \u00a0 y\t\r \u00a0 al\t\r \u00a0 empaquetamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 rodopsina,\t\r \u00a0 en\t\r \u00a0 concentraciones\t\r \u00a0 casi\t\r \u00a0cristalinas,\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 interior.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 esta\t\r \u00a0 especializaci\u00f3n\t\r \u00a0 est\u00e1\t\r \u00a0 sometida\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0continua\t\r \u00a0renovaci\u00f3n,\t\r \u00a0al\t\r \u00a0irse\t\r \u00a0perdiendo\t\r \u00a0los\t\r \u00a0discos\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0m\u00e1s\t\r \u00a0externos\t\r \u00a0y\t\r \u00a0ser\t\r \u00a0sustituidos\t\r \u00a0por\t\r \u00a0discos\t\r \u00a0m\u00e1s\t\r \u00a0internos\t\r \u00a0que\t\r \u00a0se\t\r \u00a0van\t\r \u00a0desplazando\t\r \u00a0hacia\t\r \u00a0el\t\r \u00a0exterior.\t\r \u00a0Otro\t\r \u00a0ejemplo\t\r \u00a0 notable\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0 c\u00e9lulas\t\r \u00a0 productoras\t\r \u00a0 de\t\r \u00a0 insulina\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 p\u00e1ncreas\t\r \u00a0 (c\u00e9lulas\t\r \u00a0beta).\t\r \u00a0 Estas\t\r \u00a0 c\u00e9lulas\t\r \u00a0 son\t\r \u00a0 aut\u00e9nticas\t\r \u00a0 factor\u00edas,\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 casi\t\r \u00a0 la\t\r \u00a0 totalidad\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0\nbastonesen\t\r \u00a0la\t\r \u00a0retinac\u00e9lula\t\r \u00a0betadel\t\r \u00a0p\u00e1ncreas\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n404\t\r \u00a0\t\r \u00a0sistema\t\r \u00a0 de\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 est\u00e1\t\r \u00a0 destinado\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 s\u00edntesis,\t\r \u00a0empaquetamiento,\t\r \u00a0procesamiento\t\r \u00a0y\t\r \u00a0liberaci\u00f3n\t\r \u00a0de\t\r \u00a0insulina.\t\r \u00a0De\t\r \u00a0hecho,\t\r \u00a0gran\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0su\t\r \u00a0 contenido\t\r \u00a0 celular\t\r \u00a0 est\u00e1\t\r \u00a0 ocupado\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 gr\u00e1nulos\t\r \u00a0 de\t\r \u00a0 secreci\u00f3n\t\r \u00a0 (arriba\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0derecha).\t\r \u00a0Dada\t\r \u00a0 la\t\r \u00a0 importancia\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 de\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 para\t\r \u00a0 los\t\r \u00a0distintos\t\r \u00a0tipos\t\r \u00a0celulares,\t\r \u00a0no\t\r \u00a0es\t\r \u00a0sorprendente\t\r \u00a0que\t\r \u00a0su\t\r \u00a0alteraci\u00f3n\t\r \u00a0d\u00e9\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0una\t\r \u00a0gran\t\r \u00a0variedad\t\r \u00a0 de\t\r \u00a0 enfermedades.\t\r \u00a0 De\t\r \u00a0 hecho,\t\r \u00a0 es\t\r \u00a0 gracias\t\r \u00a0 al\t\r \u00a0 conocimiento\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 sistema\t\r \u00a0que\t\r \u00a0 hemos\t\r \u00a0 podido\t\r \u00a0 entender\t\r \u00a0 la\t\r \u00a0 base\t\r \u00a0 gen\u00e9tica\t\r \u00a0 y\t\r \u00a0 molecular\t\r \u00a0 de\t\r \u00a0 m\u00faltiples\t\r \u00a0enfermedades\t\r \u00a0 en\t\r \u00a0 humanos.\t\r \u00a0 A\t\r \u00a0 continuaci\u00f3n\t\r \u00a0 menciono\t\r \u00a0 s\u00f3lo\t\r \u00a0 unos\t\r \u00a0 pocos\t\r \u00a0 ejemplos\t\r \u00a0para\t\r \u00a0poner\t\r \u00a0de\t\r \u00a0relieve\t\r \u00a0la\t\r \u00a0variedad\t\r \u00a0de\t\r \u00a0patolog\u00edas\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0producirse.\t\r \u00a0Tejidos\t\r \u00a0 estructurales\t\r \u00a0 como\t\r \u00a0 los\t\r \u00a0 huesos\t\r \u00a0 o\t\r \u00a0 cart\u00edlagos\t\r \u00a0 est\u00e1n\t\r \u00a0 basados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0producci\u00f3n\t\r \u00a0de\t\r \u00a0una\t\r \u00a0compleja\t\r \u00a0matriz\t\r \u00a0extracelular,\t\r \u00a0que\t\r \u00a0es\t\r \u00a0la\t\r \u00a0que\t\r \u00a0da\t\r \u00a0consistencia\t\r \u00a0al\t\r \u00a0tejido.\t\r \u00a0 En\t\r \u00a0 su\t\r \u00a0 mayor\t\r \u00a0 parte,\t\r \u00a0 esta\t\r \u00a0 matriz\t\r \u00a0 est\u00e1\t\r \u00a0 compuesta\t\r \u00a0 por\t\r \u00a0 prote\u00ednas\t\r \u00a0 altamente\t\r \u00a0modificadas\t\r \u00a0 que\t\r \u00a0 son\t\r \u00a0 producidas\t\r \u00a0 por\t\r \u00a0 osteoblastos\t\r \u00a0 y\t\r \u00a0 condrocitos\t\r \u00a0 (c\u00e9lulas\t\r \u00a0generadoras\t\r \u00a0de\t\r \u00a0hueso\t\r \u00a0y\t\r \u00a0cart\u00edlago,\t\r \u00a0respectivamente).\t\r \u00a0Estas\t\r \u00a0prote\u00ednas\t\r \u00a0tienen\t\r \u00a0que\t\r \u00a0ser\t\r \u00a0empaquetadas\t\r \u00a0y\t\r \u00a0secretadas\t\r \u00a0al\t\r \u00a0medio\t\r \u00a0exterior\t\r \u00a0utilizando\t\r \u00a0esencialmente\t\r \u00a0los\t\r \u00a0mismos\t\r \u00a0mecanismos\t\r \u00a0 de\t\r \u00a0 transporte\t\r \u00a0 descritos\t\r \u00a0 anteriormente.\t\r \u00a0 Cuando\t\r \u00a0 estos\t\r \u00a0 mecanismos\t\r \u00a0fallan,\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0huesos\t\r \u00a0y\t\r \u00a0cart\u00edlagos\t\r \u00a0es\t\r \u00a0defectuosa,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0da\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0graves\t\r \u00a0malformaciones\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0desarrollo.\t\r \u00a0Es\t\r \u00a0el\t\r \u00a0caso,\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0de\t\r \u00a0mutaciones\t\r \u00a0en\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0GMAP-\u00ad\u2010210,\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encarga\t\r \u00a0de\t\r \u00a0organizar\t\r \u00a0el\t\r \u00a0aparato\t\r \u00a0secretor\t\r \u00a0y\t\r \u00a0anclarlo\t\r \u00a0al\t\r \u00a0citoesqueleto\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 condrocitos.\t\r \u00a0 Al\t\r \u00a0 fallar\t\r \u00a0 el\t\r \u00a0 aparato\t\r \u00a0 secretor,\t\r \u00a0 se\t\r \u00a0 produce\t\r \u00a0 la\t\r \u00a0acumulaci\u00f3n\t\r \u00a0intracelular\t\r \u00a0de\t\r \u00a0una\t\r \u00a0prote\u00edna\t\r \u00a0de\t\r \u00a0la\t\r \u00a0matriz\t\r \u00a0del\t\r \u00a0cart\u00edlago,\t\r \u00a0el\t\r \u00a0perlecan,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0impide\t\r \u00a0la\t\r \u00a0correcta\t\r \u00a0formaci\u00f3n\t\r \u00a0del\t\r \u00a0cart\u00edlago\t\r \u00a0(acondrog\u00e9nesis\t\r \u00a0tipo\t\r \u00a0IA).\t\r \u00a0Otro\t\r \u00a0 \u00f3rgano\t\r \u00a0 que\t\r \u00a0 depende\t\r \u00a0 en\t\r \u00a0 gran\t\r \u00a0 medida\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 sistemas\t\r \u00a0 de\t\r \u00a0 tr\u00e1fico\t\r \u00a0intracelular\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 ri\u00f1\u00f3n.\t\r \u00a0 Aqu\u00ed\t\r \u00a0 se\t\r \u00a0 produce\t\r \u00a0 una\t\r \u00a0 intensa\t\r \u00a0 actividad\t\r \u00a0 de\t\r \u00a0 filtraci\u00f3n\t\r \u00a0 e\t\r \u00a0intercambio\t\r \u00a0de\t\r \u00a0sustancias,\t\r \u00a0que\t\r \u00a0depende\t\r \u00a0de\t\r \u00a0la\t\r \u00a0correcta\t\r \u00a0localizaci\u00f3n\t\r \u00a0de\t\r \u00a0multitud\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0act\u00faan\t\r \u00a0como\t\r \u00a0transportadores\t\r \u00a0moleculares.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0del\t\r \u00a0s\u00edndrome\t\r \u00a0de\t\r \u00a0 Lowe,\t\r \u00a0 se\t\r \u00a0 encuentra\t\r \u00a0 mutada\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0OCRL1.\t\r \u00a0 Esta\t\r \u00a0 prote\u00edna\t\r \u00a0 se\t\r \u00a0 encarga\t\r \u00a0 del\t\r \u00a0metabolismo\t\r \u00a0 de\t\r \u00a0 unos\t\r \u00a0 l\u00edpidos\t\r \u00a0 de\t\r \u00a0 membrana\t\r \u00a0 espec\u00edficos,\t\r \u00a0 los\t\r \u00a0 fosfoinos\u00edtidos,\t\r \u00a0 cuya\t\r \u00a0correcta\t\r \u00a0 localizaci\u00f3n\t\r \u00a0 es\t\r \u00a0 fundamental\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 organizaci\u00f3n\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 de\t\r \u00a0transporte\t\r \u00a0intracelular.\t\r \u00a0La\t\r \u00a0falta\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0prote\u00edna\t\r \u00a0da\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0alteraciones\t\r \u00a0oculares,\t\r \u00a0cerebrales\t\r \u00a0y\t\r \u00a0renales,\t\r \u00a0que\t\r \u00a0constituyen\t\r \u00a0el\t\r \u00a0s\u00edndrome\t\r \u00a0de\t\r \u00a0Lowe\t\r \u00a0(de\t\r \u00a0ah\u00ed\t\r \u00a0el\t\r \u00a0nombre\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna,\t\r \u00a0OCRL).\t\r \u00a0Finalmente,\t\r \u00a0 un\t\r \u00a0 \u00f3rgano\t\r \u00a0 que\t\r \u00a0 depende\t\r \u00a0 cr\u00edticamente\t\r \u00a0 del\t\r \u00a0 transporte\t\r \u00a0 de\t\r \u00a0membranas,\t\r \u00a0 como\t\r \u00a0 mencionaba\t\r \u00a0 anteriormente,\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 cerebro,\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0requerimientos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 comunicaci\u00f3n\t\r \u00a0 neuronal.\t\r \u00a0 Hay\t\r \u00a0 multitud\t\r \u00a0 de\t\r \u00a0 enfermedades\t\r \u00a0mentales\t\r \u00a0 debidas,\t\r \u00a0 directamente\t\r \u00a0 o\t\r \u00a0 indirectamente,\t\r \u00a0 a\t\r \u00a0 defectos\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 proceso\t\r \u00a0 de\t\r \u00a0transporte\t\r \u00a0 intracelular\t\r \u00a0 de\t\r \u00a0 membrana.\t\r \u00a0 Por\t\r \u00a0 ejemplo,\t\r \u00a0 mutaciones\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0Rab39b\t\r \u00a0da\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0una\t\r \u00a0acumulaci\u00f3n\t\r \u00a0defectuosa\t\r \u00a0de\t\r \u00a0ves\u00edculas\t\r \u00a0de\t\r \u00a0neurotransmisor\t\r \u00a0en\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n405\t\r \u00a0\t\r \u00a0la\t\r \u00a0 terminal\t\r \u00a0 sin\u00e1ptica,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 conduce\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 retraso\t\r \u00a0 mental\t\r \u00a0 asociada\t\r \u00a0 al\t\r \u00a0cromosoma\t\r \u00a0 X.\t\r \u00a0 Las\t\r \u00a0 disfunciones\t\r \u00a0 pueden\t\r \u00a0 ser\t\r \u00a0 m\u00e1s\t\r \u00a0 sutiles.\t\r \u00a0 Por\t\r \u00a0 ejemplo,\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0Rab7a\t\r \u00a0se\t\r \u00a0encarga\t\r \u00a0de\t\r \u00a0dirigir\t\r \u00a0cargamentos\t\r \u00a0para\t\r \u00a0su\t\r \u00a0degradaci\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula,\t\r \u00a0en\t\r \u00a0un\t\r \u00a0org\u00e1nulo\t\r \u00a0especializado\t\r \u00a0llamado\t\r \u00a0lisosoma.\t\r \u00a0Cuando\t\r \u00a0esta\t\r \u00a0prote\u00edna\t\r \u00a0est\u00e1\t\r \u00a0mutada\t\r \u00a0 se\t\r \u00a0 produce\t\r \u00a0 una\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 \u201cbasura\t\r \u00a0 intracelular\u201d\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 puede\t\r \u00a0eliminarse,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0acaba\t\r \u00a0desencadenando\t\r \u00a0la\t\r \u00a0degeneraci\u00f3n\t\r \u00a0neuronal.\t\r \u00a0Es\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0la\t\r \u00a0neuropat\u00eda\t\r \u00a0Charcot-\u00ad\u2010Marie-\u00ad\u2010Tooth\t\r \u00a0tipo\t\r \u00a02B\t\r \u00a0(la\t\r \u00a0neuropat\u00eda\t\r \u00a0Charcot-\u00ad\u2010Marie-\u00ad\u2010Tooth\t\r \u00a0es\t\r \u00a0muy\t\r \u00a0 compleja,\t\r \u00a0 con\t\r \u00a0 m\u00e1s\t\r \u00a0 de\t\r \u00a0 60\t\r \u00a0 genes\t\r \u00a0 asociados).\t\r \u00a0 Pero\t\r \u00a0 no\t\r \u00a0 todas\t\r \u00a0 las\t\r \u00a0 alteraciones\t\r \u00a0cerebrales\t\r \u00a0se\t\r \u00a0deben\t\r \u00a0a\t\r \u00a0defectos\t\r \u00a0en\t\r \u00a0el\t\r \u00a0funcionamiento\t\r \u00a0de\t\r \u00a0las\t\r \u00a0neuronas.\t\r \u00a0Por\t\r \u00a0ejemplo,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0transmisi\u00f3n\t\r \u00a0nerviosa,\t\r \u00a0el\t\r \u00a0neurotransmisor\t\r \u00a0es\t\r \u00a0liberado\t\r \u00a0y\t\r \u00a0se\t\r \u00a0une\t\r \u00a0a\t\r \u00a0receptores\t\r \u00a0espec\u00edficos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 neurona\t\r \u00a0 adyacente.\t\r \u00a0 A\t\r \u00a0 continuaci\u00f3n,\t\r \u00a0 es\t\r \u00a0 importante\t\r \u00a0 eliminar\t\r \u00a0 el\t\r \u00a0exceso\t\r \u00a0 de\t\r \u00a0 neurotransmisor\t\r \u00a0 con\t\r \u00a0 gran\t\r \u00a0 rapidez,\t\r \u00a0 para\t\r \u00a0 terminar\t\r \u00a0 la\t\r \u00a0 transmisi\u00f3n\t\r \u00a0 y\t\r \u00a0permitir\t\r \u00a0que\t\r \u00a0la\t\r \u00a0neurona\t\r \u00a0se\t\r \u00a0prepare\t\r \u00a0para\t\r \u00a0el\t\r \u00a0siguiente\t\r \u00a0est\u00edmulo.\t\r \u00a0Adem\u00e1s,\t\r \u00a0un\t\r \u00a0exceso\t\r \u00a0de\t\r \u00a0 neurotransmisor\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 medio\t\r \u00a0 extracelular\t\r \u00a0 puede\t\r \u00a0 dar\t\r \u00a0 lugar\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 excitaci\u00f3n\t\r \u00a0excesiva\t\r \u00a0de\t\r \u00a0la\t\r \u00a0neurona,\t\r \u00a0en\t\r \u00a0un\t\r \u00a0proceso\t\r \u00a0conocido\t\r \u00a0como\t\r \u00a0excitotoxicidad.\t\r \u00a0Pues\t\r \u00a0bien,\t\r \u00a0la\t\r \u00a0eliminaci\u00f3n\t\r \u00a0del\t\r \u00a0exceso\t\r \u00a0de\t\r \u00a0neurotransmisor\t\r \u00a0se\t\r \u00a0lleva\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0por\t\r \u00a0otro\t\r \u00a0tipo\t\r \u00a0celular,\t\r \u00a0los\t\r \u00a0astrocitos,\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 encuentran\t\r \u00a0 en\t\r \u00a0 gran\t\r \u00a0 proximidad\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 terminal\t\r \u00a0 sin\u00e1ptica.\t\r \u00a0 Estas\t\r \u00a0c\u00e9lulas\t\r \u00a0 presentan\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 membrana\t\r \u00a0 unos\t\r \u00a0 transportadores\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 encargan\t\r \u00a0 de\t\r \u00a0captar\t\r \u00a0el\t\r \u00a0neurotransmisor\t\r \u00a0y\t\r \u00a0transportarlo\t\r \u00a0al\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula.\t\r \u00a0Es\t\r \u00a0por\t\r \u00a0tanto\t\r \u00a0muy\t\r \u00a0importante\t\r \u00a0 que\t\r \u00a0estos\t\r \u00a0 transportadores\t\r \u00a0 espec\u00edficos\t\r \u00a0 se\t\r \u00a0 encuentre\t\r \u00a0 localizados\t\r \u00a0correctamente\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 membrana\t\r \u00a0 del\t\r \u00a0 astrocito.\t\r \u00a0 Cuando\t\r \u00a0 esto\t\r \u00a0 no\t\r \u00a0 ocurre,\t\r \u00a0 puede\t\r \u00a0 dar\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0distintas\t\r \u00a0formas\t\r \u00a0de\t\r \u00a0epilepsia,\t\r \u00a0y\t\r \u00a0finalmente,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0muerte\t\r \u00a0neuronal.\t\r \u00a0Este\t\r \u00a0 es\t\r \u00a0 s\u00f3lo\t\r \u00a0 un\t\r \u00a0 peque\u00f1o\t\r \u00a0 \u201cmuestrario\u201d\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0enfermedades\t\r \u00a0 humanas\t\r \u00a0 que\t\r \u00a0pueden\t\r \u00a0producirse\t\r \u00a0cuando\t\r \u00a0el\t\r \u00a0sofisticado\t\r \u00a0tr\u00e1fico\t\r \u00a0intracelular\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0alterado.\t\r \u00a0Como\t\r \u00a0 dec\u00eda,\t\r \u00a0 esta\t\r \u00a0 informaci\u00f3n\t\r \u00a0 nos\t\r \u00a0 ha\t\r \u00a0 ayudado\t\r \u00a0 notablemente\t\r \u00a0 a\t\r \u00a0 entender\t\r \u00a0 mejor\t\r \u00a0estas\t\r \u00a0enfermedades.\t\r \u00a0Pero\t\r \u00a0\u00bfha\t\r \u00a0sido\t\r \u00a0esto\t\r \u00a0\u00fatil\t\r \u00a0para\t\r \u00a0el\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0nuevos\t\r \u00a0tratamientos\t\r \u00a0para\t\r \u00a0estas\t\r \u00a0enfermedades?\t\r \u00a0S\u00ed,\t\r \u00a0sin\t\r \u00a0duda\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0\u00fatil,\t\r \u00a0pero\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0reconocer\t\r \u00a0que\t\r \u00a0lo\t\r \u00a0ha\t\r \u00a0 sido\t\r \u00a0 fundamentalmente\t\r \u00a0 para\t\r \u00a0 aliviar\t\r \u00a0 o\t\r \u00a0 paliar\t\r \u00a0 los\t\r \u00a0 s\u00edntomas\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0enfermedades,\t\r \u00a0 m\u00e1s\t\r \u00a0 que\t\r \u00a0 para\t\r \u00a0 corregir\t\r \u00a0 sus\t\r \u00a0 causas.\t\r \u00a0 Esto\t\r \u00a0 es\t\r \u00a0 as\u00ed\t\r \u00a0 porque\t\r \u00a0 en\t\r \u00a0 gran\t\r \u00a0manera\t\r \u00a0 nuestro\t\r \u00a0 conocimiento\t\r \u00a0 es\t\r \u00a0 todav\u00eda\t\r \u00a0 demasiado\t\r \u00a0 incompleto,\t\r \u00a0 y\t\r \u00a0 sobre\t\r \u00a0 todo,\t\r \u00a0porque\t\r \u00a0 carecemos\t\r \u00a0 de\t\r \u00a0 herramientas\t\r \u00a0 lo\t\r \u00a0 bastante\t\r \u00a0 finas\t\r \u00a0 como\t\r \u00a0 revertir\t\r \u00a0 los\t\r \u00a0 procesos\t\r \u00a0moleculares\t\r \u00a0defectuosos\t\r \u00a0que\t\r \u00a0originan\t\r \u00a0estas\t\r \u00a0enfermedades.\t\r \u00a0Aun\t\r \u00a0as\u00ed,\t\r \u00a0el\t\r \u00a0progreso\t\r \u00a0es\t\r \u00a0continuo,\t\r \u00a0 y\t\r \u00a0 hay\t\r \u00a0 m\u00faltiples\t\r \u00a0 terapias\t\r \u00a0 en\t\r \u00a0 fase\t\r \u00a0experimental\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0alguna\t\r \u00a0 de\t\r \u00a0 estas\t\r \u00a0 enfermedades.\t\r \u00a0 Por\t\r \u00a0 ejemplo,\t\r \u00a0 la\t\r \u00a0 enfermedad\t\r \u00a0 de\t\r \u00a0 Niemann-\u00ad\u2010Pick\t\r \u00a0 se\t\r \u00a0debe\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 intracelular\t\r \u00a0 de\t\r \u00a0 distintos\t\r \u00a0 l\u00edpidos\t\r \u00a0 de\t\r \u00a0 membrana,\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0esfingomielina,\t\r \u00a0fundamentalmente\t\r \u00a0en\t\r \u00a0los\t\r \u00a0lisosomas.\t\r \u00a0Esto\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0a\t\r \u00a0deficiencias\t\r \u00a0en\t\r \u00a0la\t\r \u00a0 enzima\t\r \u00a0 que\t\r \u00a0 degrada\t\r \u00a0 la\t\r \u00a0 esfingomielina,\t\r \u00a0 la\t\r \u00a0 esfingomielinasa.\t\r \u00a0 Basado\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0conocimiento,\t\r \u00a0se\t\r \u00a0est\u00e1n\t\r \u00a0ensayando\t\r \u00a0dos\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0terapias\t\r \u00a0moleculares.\t\r \u00a0Por\t\r \u00a0un\t\r \u00a0lado,\t\r \u00a0se\t\r \u00a0 intenta\t\r \u00a0 prevenir\t\r \u00a0 la\t\r \u00a0 acumulaci\u00f3n\t\r \u00a0 excesiva\t\r \u00a0 de\t\r \u00a0 esfingomielina\t\r \u00a0 reduciendo\t\r \u00a0 su\t\r \u00a0producci\u00f3n.\t\r \u00a0 Para\t\r \u00a0 ello\t\r \u00a0 se\t\r \u00a0 est\u00e1n\t\r \u00a0 utilizando\t\r \u00a0 inhibidores\t\r \u00a0 espec\u00edficos\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 enzimas\t\r \u00a0que\t\r \u00a0regulan\t\r \u00a0su\t\r \u00a0s\u00edntesis.\t\r \u00a0Por\t\r \u00a0otro\t\r \u00a0lado,\t\r \u00a0se\t\r \u00a0est\u00e1\t\r \u00a0intentado\t\r \u00a0recuperar\t\r \u00a0la\t\r \u00a0capacidad\t\r \u00a0de\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n406\t\r \u00a0\t\r \u00a0degradar\t\r \u00a0 esfingomielina\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 c\u00e9lula,\t\r \u00a0 utilizando\t\r \u00a0 activadores\t\r \u00a0 de\t\r \u00a0 enzimas\t\r \u00a0alternativas.\t\r \u00a0Otro\t\r \u00a0 ejemplo\t\r \u00a0 importante\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 fibrosis\t\r \u00a0 qu\u00edstica.\t\r \u00a0 Esta\t\r \u00a0 enfermedad\t\r \u00a0 se\t\r \u00a0debe\t\r \u00a0a\t\r \u00a0mutaciones\t\r \u00a0en\t\r \u00a0un\t\r \u00a0canal\t\r \u00a0de\t\r \u00a0cloruro\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentra\t\r \u00a0en\t\r \u00a0la\t\r \u00a0membrana\t\r \u00a0de\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0que\t\r \u00a0recubren\t\r \u00a0los\t\r \u00a0alveolos\t\r \u00a0pulmonares.\t\r \u00a0Cuando\t\r \u00a0este\t\r \u00a0canal\t\r \u00a0no\t\r \u00a0est\u00e1\t\r \u00a0presente,\t\r \u00a0se\t\r \u00a0producen\t\r \u00a0alteraciones\t\r \u00a0osm\u00f3ticas\t\r \u00a0en\t\r \u00a0estas\t\r \u00a0c\u00e9lulas\t\r \u00a0que\t\r \u00a0dan\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0una\t\r \u00a0secreci\u00f3n\t\r \u00a0excesiva\t\r \u00a0 de\t\r \u00a0 mucosidad.\t\r \u00a0 Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 problemas\t\r \u00a0 respiratorios\t\r \u00a0 cr\u00f3nicos,\t\r \u00a0 esta\t\r \u00a0condici\u00f3n\t\r \u00a0produce\t\r \u00a0graves\t\r \u00a0peligros\t\r \u00a0de\t\r \u00a0infecci\u00f3n\t\r \u00a0pulmonar,\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0llegar\t\r \u00a0a\t\r \u00a0ser\t\r \u00a0mortales.\t\r \u00a0 En\t\r \u00a0 m\u00faltiples\t\r \u00a0 casos\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 enfermedad,\t\r \u00a0 las\t\r \u00a0mutaciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 canal\t\r \u00a0 de\t\r \u00a0cloruro\t\r \u00a0no\t\r \u00a0eliminan\t\r \u00a0completamente\t\r \u00a0la\t\r \u00a0prote\u00edna,\t\r \u00a0sino\t\r \u00a0que\t\r \u00a0producen\t\r \u00a0defectos\t\r \u00a0en\t\r \u00a0su\t\r \u00a0plegamiento\t\r \u00a0 molecular,\t\r \u00a0 lo\t\r \u00a0 cual\t\r \u00a0 provoca\t\r \u00a0 su\t\r \u00a0 retenci\u00f3n\t\r \u00a0 en\t\r \u00a0 compartimentos\t\r \u00a0intracelulares.\t\r \u00a0El\t\r \u00a0plegamiento\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0en\t\r \u00a0el\t\r \u00a0interior\t\r \u00a0de\t\r \u00a0la\t\r \u00a0c\u00e9lula\t\r \u00a0es\t\r \u00a0un\t\r \u00a0proceso\t\r \u00a0muy\t\r \u00a0complejo,\t\r \u00a0que\t\r \u00a0viene\t\r \u00a0asistido\t\r \u00a0por\t\r \u00a0m\u00faltiples\t\r \u00a0prote\u00ednas\t\r \u00a0conocidas\t\r \u00a0como\t\r \u00a0 \u201cchaperonas\t\r \u00a0 moleculares\u201d.\t\r \u00a0 Por\t\r \u00a0 tanto,\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 tratamiento\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0enfermedad,\t\r \u00a0 se\t\r \u00a0 est\u00e1n\t\r \u00a0 ensayando\t\r \u00a0 distintas\t\r \u00a0 aproximaciones\t\r \u00a0 farmacol\u00f3gicas\t\r \u00a0 que\t\r \u00a0mejoren\t\r \u00a0en\t\r \u00a0cierta\t\r \u00a0medida\t\r \u00a0el\t\r \u00a0plegamiento\t\r \u00a0molecular,\t\r \u00a0y\t\r \u00a0por\t\r \u00a0tanto,\t\r \u00a0conseguir\t\r \u00a0que\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0proporci\u00f3n\t\r \u00a0de\t\r \u00a0canales\t\r \u00a0mutados\t\r \u00a0lleguen\t\r \u00a0a\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0celular\t\r \u00a0y\t\r \u00a0lleven\t\r \u00a0all\u00ed\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0sus\t\r \u00a0labores\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0i\u00f3nico.\t\r \u00a0Otros\t\r \u00a0 casos\t\r \u00a0 notables\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0 enfermedades\t\r \u00a0 debidas\t\r \u00a0 a\t\r \u00a0 acumulaciones\t\r \u00a0 o\t\r \u00a0agregados\t\r \u00a0 proteicos,\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0 la\t\r \u00a0 enfermedad\t\r \u00a0 de\t\r \u00a0 Alzheimer,\t\r \u00a0 Huntington\t\r \u00a0 o\t\r \u00a0Parkinson,\t\r \u00a0 que\t\r \u00a0 acaban\t\r \u00a0 produciendo\t\r \u00a0 la\t\r \u00a0 muerte\t\r \u00a0 neuronal.\t\r \u00a0 En\t\r \u00a0 estos\t\r \u00a0 casos\t\r \u00a0 se\t\r \u00a0 est\u00e1n\t\r \u00a0ensayando\t\r \u00a0 distintas\t\r \u00a0 aproximaciones\t\r \u00a0 para\t\r \u00a0 \u201cdisolver\u201d\t\r \u00a0 estos\t\r \u00a0 agregados,\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0esperanza\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 as\u00ed\t\r \u00a0 se\t\r \u00a0 recupere\t\r \u00a0 el\t\r \u00a0 normal\t\r \u00a0 funcionamiento\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 neuronas\t\r \u00a0afectadas.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0estas\t\r \u00a0estrategias\t\r \u00a0no\t\r \u00a0carecen\t\r \u00a0de\t\r \u00a0riesgos.\t\r \u00a0Por\t\r \u00a0ejemplo,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0la\t\r \u00a0enfermedad\t\r \u00a0de\t\r \u00a0Alzheimer,\t\r \u00a0los\t\r \u00a0agregados\t\r \u00a0son\t\r \u00a0conocidos\t\r \u00a0como\t\r \u00a0placas\t\r \u00a0de\t\r \u00a0amiloide,\t\r \u00a0y\t\r \u00a0est\u00e1n\t\r \u00a0producidas\t\r \u00a0por\t\r \u00a0la\t\r \u00a0agregaci\u00f3n\t\r \u00a0extracelular\t\r \u00a0de\t\r \u00a0un\t\r \u00a0peque\u00f1o\t\r \u00a0p\u00e9ptido\t\r \u00a0(p\u00e9ptido\t\r \u00a0beta-\u00ad\u2010amiloide)\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0excesiva\t\r \u00a0secreci\u00f3n\t\r \u00a0por\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0las\t\r \u00a0neuronas.\t\r \u00a0En\t\r \u00a0un\t\r \u00a0principio\t\r \u00a0se\t\r \u00a0consider\u00f3\t\r \u00a0que\t\r \u00a0el\t\r \u00a0principal\t\r \u00a0agente\t\r \u00a0patol\u00f3gico\t\r \u00a0eran\t\r \u00a0las\t\r \u00a0placas\t\r \u00a0de\t\r \u00a0amiloide,\t\r \u00a0y\t\r \u00a0por\t\r \u00a0tanto,\t\r \u00a0la\t\r \u00a0estrategia\t\r \u00a0consist\u00eda\t\r \u00a0en\t\r \u00a0su\t\r \u00a0disgregaci\u00f3n.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0ahora\t\r \u00a0sabemos\t\r \u00a0que\t\r \u00a0el\t\r \u00a0agente\t\r \u00a0t\u00f3xico\t\r \u00a0fundamental\t\r \u00a0es\t\r \u00a0el\t\r \u00a0propio\t\r \u00a0p\u00e9ptido,\t\r \u00a0antes\t\r \u00a0de\t\r \u00a0formar\t\r \u00a0agregados.\t\r \u00a0 Este\t\r \u00a0 p\u00e9ptido\t\r \u00a0 altera\t\r \u00a0 el\t\r \u00a0 correcto\t\r \u00a0 funcionamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 sinapsis,\t\r \u00a0 dando\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0problemas\t\r \u00a0de\t\r \u00a0memoria\t\r \u00a0mucho\t\r \u00a0antes\t\r \u00a0del\t\r \u00a0comienzo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0muerte\t\r \u00a0neuronal.\t\r \u00a0De\t\r \u00a0hecho,\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0comprobado\t\r \u00a0en\t\r \u00a0modelos\t\r \u00a0animales\t\r \u00a0que\t\r \u00a0la\t\r \u00a0disoluci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0placas\t\r \u00a0de\t\r \u00a0amiloide\t\r \u00a0produce\t\r \u00a0la\t\r \u00a0movilizaci\u00f3n\t\r \u00a0de\t\r \u00a0grandes\t\r \u00a0cantidades\t\r \u00a0del\t\r \u00a0p\u00e9ptido\t\r \u00a0amiloide,\t\r \u00a0con\t\r \u00a0 el\t\r \u00a0 consiguiente\t\r \u00a0 empeoramiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 cognitiva.\t\r \u00a0 Sirva\t\r \u00a0 esto\t\r \u00a0 como\t\r \u00a0ejemplo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 importancia\t\r \u00a0 del\t\r \u00a0 conocimiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 mecanismos\t\r \u00a0 b\u00e1sicos\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0enfermedad\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 correcto\t\r \u00a0 dise\u00f1o\t\r \u00a0 correcto\t\r \u00a0 de\t\r \u00a0 posibles\t\r \u00a0 intervenciones\t\r \u00a0terap\u00e9uticas.\t\r \u00a0Por\t\r \u00a0tanto,\t\r \u00a0como\t\r \u00a0dec\u00eda,\t\r \u00a0el\t\r \u00a0conocimiento\t\r \u00a0de\t\r \u00a0los\t\r \u00a0mecanismos\t\r \u00a0de\t\r \u00a0transporte\t\r \u00a0de\t\r \u00a0membrana\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 c\u00e9lula\t\r \u00a0 ha\t\r \u00a0 abierto\t\r \u00a0 m\u00faltiples\t\r \u00a0 avenidas\t\r \u00a0 terap\u00e9uticas\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n407\t\r \u00a0\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0enfermedades.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0reconocer\t\r \u00a0que\t\r \u00a0la\t\r \u00a0mayor\u00eda\t\r \u00a0se\t\r \u00a0encuentran\t\r \u00a0 todav\u00eda\t\r \u00a0 en\t\r \u00a0 fases\t\r \u00a0 tempranas\t\r \u00a0 de\t\r \u00a0 desarrollo.\t\r \u00a0 No\t\r \u00a0 por\t\r \u00a0 ello\t\r \u00a0 hemos\t\r \u00a0 de\t\r \u00a0minimizar\t\r \u00a0las\t\r \u00a0aplicaciones\t\r \u00a0pr\u00e1cticas\t\r \u00a0de\t\r \u00a0este\t\r \u00a0conocimiento.\t\r \u00a0En\t\r \u00a0la\t\r \u00a0mayor\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0los\t\r \u00a0casos\t\r \u00a0 estamos\t\r \u00a0 hablando\t\r \u00a0 de\t\r \u00a0 resultados\t\r \u00a0 cient\u00edficos\t\r \u00a0 generados\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 \u00faltimos\t\r \u00a0 10\t\r \u00a0a\u00f1os,\t\r \u00a0 y\t\r \u00a0 por\t\r \u00a0 tanto\t\r \u00a0 creo\t\r \u00a0 que\t\r \u00a0 podemos\t\r \u00a0 ser\t\r \u00a0 optimistas\t\r \u00a0 acerca\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 aplicaciones\t\r \u00a0cl\u00ednicas\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 futuro\t\r \u00a0 pr\u00f3ximo\t\r \u00a0 estar\u00e1n\t\r \u00a0 basadas\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 conocimiento.\t\r \u00a0 Estoy\t\r \u00a0seguro\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 esto\t\r \u00a0 servir\u00e1\t\r \u00a0 de\t\r \u00a0 gran\t\r \u00a0 regocijo\t\r \u00a0 para\t\r \u00a0 investigadores\t\r \u00a0 b\u00e1sicos\t\r \u00a0 como\t\r \u00a0Randy\t\r \u00a0 Schekman,\t\r \u00a0 James\t\r \u00a0 Rothman\t\r \u00a0 y\t\r \u00a0 Thomas\t\r \u00a0 S\u00fcdhof,\t\r \u00a0 que\t\r \u00a0 dif\u00edcilmente\t\r \u00a0 podr\u00edan\t\r \u00a0haber\t\r \u00a0 imaginado,\t\r \u00a0 al\t\r \u00a0 comienzo\t\r \u00a0 de\t\r \u00a0 sus\t\r \u00a0 investigaciones,\t\r \u00a0 la\t\r \u00a0 gran\t\r \u00a0 relevancia\t\r \u00a0 que\t\r \u00a0acabar\u00eda\t\r \u00a0teniendo\t\r \u00a0su\t\r \u00a0trabajo\t\r \u00a0para\t\r \u00a0la\t\r \u00a0salud\t\r \u00a0humana.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n408\t\r \u00a0\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a02013:\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0de\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0 y\t\r \u00a0 mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 para\t\r \u00a0 entender\t\r \u00a0 y\t\r \u00a0 predecir\t\r \u00a0procesos\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos\t\r \u00a0Beatriz\t\r \u00a0de\t\r \u00a0Pascual-\u00ad\u2010Teresa\t\r \u00a0Departamento\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a0y\t\r \u00a0Bioqu\u00edmica,\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Farmacia,\t\r \u00a0Universidad\t\r \u00a0San\t\r \u00a0Pablo\t\r \u00a0CEU.\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.\t\r \u00a0408-\u00ad\u2010432.\t\r \u00a0RESUMEN\t\r \u00a0La\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 Sueca\t\r \u00a0 de\t\r \u00a0 Ciencias\t\r \u00a0 ha\t\r \u00a0 decidido\t\r \u00a0 otorgar\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 de\t\r \u00a0Qu\u00edmica\t\r \u00a0 2013\t\r \u00a0 al\t\r \u00a0 investigador\t\r \u00a0 austr\u00edaco\t\r \u00a0 Martin\t\r \u00a0 Karplus,\t\r \u00a0 Profesor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Universidad\t\r \u00a0 de\t\r \u00a0 Strasbourg,\t\r \u00a0 Francia\t\r \u00a0 y\t\r \u00a0 Profesor\t\r \u00a0 Em\u00e9rito\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0Harvard,\t\r \u00a0 USA,\t\r \u00a0 al\t\r \u00a0 sudafricano\t\r \u00a0 Michael\t\r \u00a0 Levitt,\t\r \u00a0 Profesor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0Stanford,\t\r \u00a0 USA,\t\r \u00a0 y\t\r \u00a0 al\t\r \u00a0 israel\u00ed\t\r \u00a0 AriehWarshel,\t\r \u00a0 Profesor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 del\t\r \u00a0 Sur\t\r \u00a0 de\t\r \u00a0California,\t\r \u00a0USA,\t\r \u00a0por\t\r \u00a0\u201cel\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0modelos\t\r \u00a0multiescala\t\r \u00a0para\t\r \u00a0sistemas\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos\u201d.\t\r \u00a0 Los\t\r \u00a0 trabajos\t\r \u00a0 galardonados\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 Premio\t\r \u00a0 Nobel\t\r \u00a0 de\t\r \u00a0 Qu\u00edmica\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0a\u00f1o\t\r \u00a0 se\t\r \u00a0 centran\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 m\u00e9todos\t\r \u00a0 que\t\r \u00a0 utilizan\t\r \u00a0 tanto\t\r \u00a0 la\t\r \u00a0 mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 mec\u00e1nica\t\r \u00a0 cu\u00e1ntica.\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 a\t\r \u00a0 pesar\t\r \u00a0 del\t\r \u00a0 impresionante\t\r \u00a0avance\t\r \u00a0en\t\r \u00a0software\t\r \u00a0y\t\r \u00a0hardware,\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0sistemas\t\r \u00a0complejos,\t\r \u00a0con\t\r \u00a0un\t\r \u00a0elevado\t\r \u00a0n\u00famero\t\r \u00a0 de\t\r \u00a0 \u00e1tomos,\t\r \u00a0 como\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 biomol\u00e9culas,\t\r \u00a0 presenta\t\r \u00a0 bastantes\t\r \u00a0dificultades.\t\r \u00a0Para\t\r \u00a0poder\t\r \u00a0llevar\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0el\t\r \u00a0modelado\t\r \u00a0de\t\r \u00a0las\t\r \u00a0reacciones\t\r \u00a0enzim\u00e1ticas\t\r \u00a0y\t\r \u00a0otras\t\r \u00a0procesos\t\r \u00a0biomoleculares\t\r \u00a0que\t\r \u00a0implican\t\r \u00a0cambios\t\r \u00a0en\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0electr\u00f3nica,\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0formaci\u00f3n\t\r \u00a0y\t\r \u00a0ruptura\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0covalentes\t\r \u00a0o\t\r \u00a0transferencia\t\r \u00a0de\t\r \u00a0carga,\t\r \u00a0la\t\r \u00a0utilizaci\u00f3n\t\r \u00a0 combinada\t\r \u00a0 de\t\r \u00a0 mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 y\t\r \u00a0 mec\u00e1nica\t\r \u00a0 molecular\t\r \u00a0 (QM/MM)\t\r \u00a0 se\t\r \u00a0ha\t\r \u00a0 convertido\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 m\u00e9todo\t\r \u00a0 de\t\r \u00a0 elecci\u00f3n,\t\r \u00a0 siguiendo\t\r \u00a0 una\t\r \u00a0 idea\t\r \u00a0 inicialmente\t\r \u00a0formulada\t\r \u00a0por\t\r \u00a0los\t\r \u00a0investigadores\t\r \u00a0premiados\t\r \u00a0este\t\r \u00a0a\u00f1o.\t\r \u00a0Palabras\t\r \u00a0 clave:Mec\u00e1nica\t\r \u00a0 Molecular;\t\r \u00a0Din\u00e1mica\t\r \u00a0 Molecular;\t\r \u00a0Mec\u00e1nica\t\r \u00a0 Cu\u00e1ntica;\t\r \u00a0QM/MM;\t\r \u00a0Reactividad\t\r \u00a0Qu\u00edmica\t\r \u00a0ABSTRACT\t\r \u00a0Nobel\t\r \u00a0 Prize\t\r \u00a0 in\t\r \u00a0 Chemistry\t\r \u00a0 2013:\t\r \u00a0 combination\t\r \u00a0 of\t\r \u00a0 molecular\t\r \u00a0 mechanics\t\r \u00a0 and\t\r \u00a0 quantum\t\r \u00a0mechanics\t\r \u00a0for\t\r \u00a0understanding\t\r \u00a0and\t\r \u00a0predicting\t\r \u00a0complex\t\r \u00a0chemical\t\r \u00a0processes\t\r \u00a0The\t\r \u00a0Royal\t\r \u00a0Swedish\t\r \u00a0Academy\t\r \u00a0of\t\r \u00a0Sciences\t\r \u00a0has\t\r \u00a0decided\t\r \u00a0to\t\r \u00a0award\t\r \u00a0the\t\r \u00a0Nobel\t\r \u00a0Prize\t\r \u00a0in\t\r \u00a0Chemistry\t\r \u00a0 for\t\r \u00a0 2013\t\r \u00a0 to\t\r \u00a0 Austrian\t\r \u00a0 researcher\t\r \u00a0 Martin\t\r \u00a0 Karplus,\t\r \u00a0 Professor\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0Universit\u00e9\t\r \u00a0 de\t\r \u00a0 Strasbourg,\t\r \u00a0 France\t\r \u00a0 and\t\r \u00a0 Emeritus\t\r \u00a0 Professor\t\r \u00a0 at\t\r \u00a0 Harvard\t\r \u00a0 University,\t\r \u00a0USA,\t\r \u00a0 to\t\r \u00a0 Southafrican\t\r \u00a0 Michael\t\r \u00a0 Levitt,\t\r \u00a0 Professor\t\r \u00a0 at\t\r \u00a0 Stanford\t\r \u00a0 University,\t\r \u00a0 USA,\t\r \u00a0 and\t\r \u00a0Israeli\t\r \u00a0AriehWarshel,\t\r \u00a0Professor\t\r \u00a0at\t\r \u00a0University\t\r \u00a0of\t\r \u00a0Southern\t\r \u00a0California,\t\r \u00a0USA\t\r \u00a0\u201cfor\t\r \u00a0the\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n409\t\r \u00a0\t\r \u00a0development\t\r \u00a0 of\t\r \u00a0 multiscale\t\r \u00a0 models\t\r \u00a0 for\t\r \u00a0 complex\t\r \u00a0 chemical\t\r \u00a0 systems\u201d.\t\r \u00a0 \t\r \u00a0 The\t\r \u00a0 work\t\r \u00a0awarded\t\r \u00a0with\t\r \u00a0the\t\r \u00a0Nobel\t\r \u00a0Prize\t\r \u00a0in\t\r \u00a0Chemistry\t\r \u00a0this\t\r \u00a0year\t\r \u00a0focuses\t\r \u00a0on\t\r \u00a0the\t\r \u00a0development\t\r \u00a0of\t\r \u00a0methods\t\r \u00a0that\t\r \u00a0use\t\r \u00a0both\t\r \u00a0molecular\t\r \u00a0mechanics\t\r \u00a0and\t\r \u00a0quantum\t\r \u00a0mechanics.\t\r \u00a0However,\t\r \u00a0despite\t\r \u00a0the\t\r \u00a0impressive\t\r \u00a0advances\t\r \u00a0in\t\r \u00a0software\t\r \u00a0and\t\r \u00a0hardware,\t\r \u00a0the\t\r \u00a0study\t\r \u00a0of\t\r \u00a0complex\t\r \u00a0systems\t\r \u00a0with\t\r \u00a0a\t\r \u00a0large\t\r \u00a0number\t\r \u00a0of\t\r \u00a0atoms,\t\r \u00a0such\t\r \u00a0as\t\r \u00a0biomolecules,\t\r \u00a0is\t\r \u00a0quite\t\r \u00a0challenging.\t\r \u00a0To\t\r \u00a0carry\t\r \u00a0out\t\r \u00a0modeling\t\r \u00a0of\t\r \u00a0enzymatic\t\r \u00a0reactions\t\r \u00a0and\t\r \u00a0other\t\r \u00a0biomolecular\t\r \u00a0processes\t\r \u00a0involving\t\r \u00a0 changes\t\r \u00a0 in\t\r \u00a0 electronic\t\r \u00a0 structure,\t\r \u00a0 such\t\r \u00a0 as\t\r \u00a0 formation\t\r \u00a0 and\t\r \u00a0 breaking\t\r \u00a0 of\t\r \u00a0covalent\t\r \u00a0 bonds\t\r \u00a0 or\t\r \u00a0 charge-\u00ad\u2010transfer\t\r \u00a0 processes,\t\r \u00a0 the\t\r \u00a0 combined\t\r \u00a0 use\t\r \u00a0 of\t\r \u00a0 quantum\t\r \u00a0mechanics\t\r \u00a0and\t\r \u00a0molecular\t\r \u00a0mechanics\t\r \u00a0(QM/MM)\t\r \u00a0has\t\r \u00a0become\t\r \u00a0the\t\r \u00a0method\t\r \u00a0of\t\r \u00a0choice\t\r \u00a0,\t\r \u00a0following\t\r \u00a0an\t\r \u00a0idea\t\r \u00a0originally\t\r \u00a0formulated\t\r \u00a0by\t\r \u00a0this\t\r \u00a0year\u2019s\t\r \u00a0awarded\t\r \u00a0researchers.\t\r \u00a0Keywords:Molecular\t\r \u00a0 Mechanics;\t\r \u00a0Molecular\t\r \u00a0 Dynamics;\t\r \u00a0Quantum\t\r \u00a0 Mechanics;\t\r \u00a0QM/MM;\t\r \u00a0Chemical\t\r \u00a0Reactivity.\t\r \u00a01.\t\r \u00a0INTRODUCCI\u00d3N\t\r \u00a0La\t\r \u00a0 qu\u00edmica\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 bioqu\u00edmica\t\r \u00a0 se\t\r \u00a0 han\t\r \u00a0 desarrollado\t\r \u00a0 muy\t\r \u00a0 r\u00e1pidamente\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0\u00faltimos\t\r \u00a0 50\t\r \u00a0 a\u00f1os.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 primera\t\r \u00a0 mitad\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 periodo\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 especialmente\t\r \u00a0llamativo\t\r \u00a0 el\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 determinaci\u00f3n\t\r \u00a0 estructural\t\r \u00a0 de\t\r \u00a0 macromol\u00e9culas,\t\r \u00a0primero\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0cristalograf\u00eda\t\r \u00a0de\t\r \u00a0rayos\t\r \u00a0X\t\r \u00a0y\t\r \u00a0despu\u00e9s\t\r \u00a0con\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0 de\t\r \u00a0 resonancia\t\r \u00a0 magn\u00e9tica\t\r \u00a0 nuclear.\t\r \u00a0 Ambas\t\r \u00a0 metodolog\u00edas\t\r \u00a0 han\t\r \u00a0 sido\t\r \u00a0galardonadas\t\r \u00a0 con\t\r \u00a0 premios\t\r \u00a0 nobel\t\r \u00a0 en\t\r \u00a0 qu\u00edmica.\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 la\t\r \u00a0 estrategia\t\r \u00a0 menos\t\r \u00a0conocida\t\r \u00a0es\t\r \u00a0la\t\r \u00a0aplicaci\u00f3n\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0computacionales\t\r \u00a0para\t\r \u00a0analizar\t\r \u00a0el\t\r \u00a0patr\u00f3n\t\r \u00a0de\t\r \u00a0difracci\u00f3n\t\r \u00a0 de\t\r \u00a0 rayos\t\r \u00a0 X,\t\r \u00a0 los\t\r \u00a0 acoplamientos\t\r \u00a0 spin-\u00ad\u2010spin\t\r \u00a0 obtenidos\t\r \u00a0 a\t\r \u00a0 partir\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0experimento\t\r \u00a0de\t\r \u00a0RMN,\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0un\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0transici\u00f3n,\t\r \u00a0la\t\r \u00a0reactividad\t\r \u00a0de\t\r \u00a0una\t\r \u00a0enzima,\t\r \u00a0etc.\t\r \u00a0En\t\r \u00a0estas\t\r \u00a0situaciones\t\r \u00a0no\t\r \u00a0existe\t\r \u00a0suficiente\t\r \u00a0informaci\u00f3n\t\r \u00a0experimental\t\r \u00a0que\t\r \u00a0permite\t\r \u00a0 determinar\t\r \u00a0 la\t\r \u00a0 estructura\t\r \u00a0 del\t\r \u00a0 sistema.\t\r \u00a0 La\t\r \u00a0 teor\u00eda\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 complemento\t\r \u00a0necesario\t\r \u00a0para\t\r \u00a0experimentar.\t\r \u00a0Los\t\r \u00a0ordenadores\t\r \u00a0y\t\r \u00a0los\t\r \u00a0modelos\t\r \u00a0te\u00f3ricos\t\r \u00a0se\t\r \u00a0han\t\r \u00a0convertido\t\r \u00a0en\t\r \u00a0herramientas\t\r \u00a0esenciales\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 qu\u00edmico\t\r \u00a0 experimental.\t\r \u00a0 Como\t\r \u00a0 resalta\t\r \u00a0 la\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 de\t\r \u00a0Ciencias\t\r \u00a0 de\t\r \u00a0 Suecia,\t\r \u00a0 \u201choy\t\r \u00a0 en\t\r \u00a0 d\u00eda\t\r \u00a0 el\t\r \u00a0 ordenador\t\r \u00a0 es\t\r \u00a0 tan\t\r \u00a0 importante\t\r \u00a0 para\t\r \u00a0 un\t\r \u00a0 qu\u00edmico\t\r \u00a0como\t\r \u00a0un\t\r \u00a0tubo\t\r \u00a0de\t\r \u00a0ensayo\u201d.\t\r \u00a0Estos\t\r \u00a0modelos\t\r \u00a0inform\u00e1ticos\t\r \u00a0se\t\r \u00a0han\t\r \u00a0convertido\t\r \u00a0en\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0avances\t\r \u00a0m\u00e1s\t\r \u00a0cruciales\t\r \u00a0para\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0del\t\r \u00a0siglo\t\r \u00a0XXI.\t\r \u00a0Los\t\r \u00a0trabajos\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a0de\t\r \u00a0este\t\r \u00a0a\u00f1o\t\r \u00a0se\t\r \u00a0centran\t\r \u00a0en\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0que\t\r \u00a0utilizan\t\r \u00a0tanto\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0como\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0cu\u00e1ntica.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0a\t\r \u00a0pesar\t\r \u00a0del\t\r \u00a0impresionante\t\r \u00a0avance\t\r \u00a0en\t\r \u00a0software\t\r \u00a0y\t\r \u00a0hardware,\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 sistemas\t\r \u00a0 complejos,\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 elevado\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 \u00e1tomos,\t\r \u00a0como\t\r \u00a0es\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0las\t\r \u00a0enzimas,\t\r \u00a0presenta\t\r \u00a0bastantes\t\r \u00a0dificultades.\t\r \u00a0Para\t\r \u00a0poder\t\r \u00a0llevar\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0el\t\r \u00a0modelado\t\r \u00a0de\t\r \u00a0las\t\r \u00a0reacciones\t\r \u00a0enzim\u00e1ticas\t\r \u00a0y\t\r \u00a0otras\t\r \u00a0procesos\t\r \u00a0biomoleculares\t\r \u00a0que\t\r \u00a0implican\t\r \u00a0cambios\t\r \u00a0en\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0electr\u00f3nica,\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0formaci\u00f3n\t\r \u00a0y\t\r \u00a0ruptura\t\r \u00a0de\t\r \u00a0 enlaces\t\r \u00a0 covalentes\t\r \u00a0 o\t\r \u00a0 transferencia\t\r \u00a0 de\t\r \u00a0 carga,\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 combinada\t\r \u00a0 de\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n410\t\r \u00a0\t\r \u00a0mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 y\t\r \u00a0 mec\u00e1nica\t\r \u00a0 molecular\t\r \u00a0 (QM\t\r \u00a0 /\t\r \u00a0 MM)\t\r \u00a0 se\t\r \u00a0 han\t\r \u00a0 convertido\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0m\u00e9todo\t\r \u00a0 de\t\r \u00a0 elecci\u00f3n,\t\r \u00a0 siguiendo\t\r \u00a0 una\t\r \u00a0 idea\t\r \u00a0 fue\t\r \u00a0 inicialmente\t\r \u00a0 formulada\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0investigadores\t\r \u00a0premiados\t\r \u00a0este\t\r \u00a0a\u00f1o.\t\r \u00a0El\t\r \u00a0elemento\t\r \u00a0b\u00e1sico\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0idea\t\r \u00a0consiste\t\r \u00a0en\t\r \u00a0la\t\r \u00a0siguiente\t\r \u00a0 aproximaci\u00f3n:\t\r \u00a0 el\t\r \u00a0 sistema\t\r \u00a0 en\t\r \u00a0 estudio\t\r \u00a0 se\t\r \u00a0 divide\t\r \u00a0 en\t\r \u00a0 dos\t\r \u00a0 partes,\t\r \u00a0 la\t\r \u00a0 parte\t\r \u00a0reactiva\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 entorno.\t\r \u00a0 La\t\r \u00a0 parte\t\r \u00a0 reactiva,\t\r \u00a0 asociada\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 procesos\t\r \u00a0 de\t\r \u00a0 formaci\u00f3n\t\r \u00a0 y\t\r \u00a0ruptura\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0qu\u00edmicos,\t\r \u00a0se\t\r \u00a0trata\t\r \u00a0mediante\t\r \u00a0m\u00e9todos\t\r \u00a0mec\u00e1nico\t\r \u00a0cu\u00e1nticos,\t\r \u00a0QM,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0para\t\r \u00a0el\t\r \u00a0entorno\t\r \u00a0(disolvente\t\r \u00a0o\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna),\t\r \u00a0que\t\r \u00a0constituye\t\r \u00a0la\t\r \u00a0parte\t\r \u00a0 que\t\r \u00a0 consumir\u00eda\t\r \u00a0 mayores\t\r \u00a0 recursos\t\r \u00a0 computacionales,\t\r \u00a0 se\t\r \u00a0 aprovecha\t\r \u00a0 la\t\r \u00a0eficiencia\t\r \u00a0computacional\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0cl\u00e1sica.\t\r \u00a0Debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0regiones\t\r \u00a0en\t\r \u00a0general\t\r \u00a0interaccionan\t\r \u00a0fuertemente,\t\r \u00a0no\t\r \u00a0es\t\r \u00a0posible\t\r \u00a0escribir\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0total\t\r \u00a0de\t\r \u00a0todo\t\r \u00a0el\t\r \u00a0sistema\t\r \u00a0 simplemente\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 suma\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 energ\u00edas\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 subsistemas.\t\r \u00a0 Los\t\r \u00a0t\u00e9rminos\t\r \u00a0 de\t\r \u00a0 acoplamiento\t\r \u00a0 tienen\t\r \u00a0 que\t\r \u00a0 ser\t\r \u00a0 considerados,\t\r \u00a0 y\t\r \u00a0 es\t\r \u00a0 necesario\t\r \u00a0 tomar\t\r \u00a0precauciones\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 l\u00edmite\t\r \u00a0 entre\t\r \u00a0 los\t\r \u00a0 subsistemas,\t\r \u00a0 especialmente\t\r \u00a0 si\t\r \u00a0 la\t\r \u00a0 frontera\t\r \u00a0 de\t\r \u00a0separaci\u00f3n\t\r \u00a0corta\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0enlaces\t\r \u00a0covalentes.\t\r \u00a0\t\r \u00a0La\t\r \u00a0qu\u00edmica\t\r \u00a0computacional\t\r \u00a0naci\u00f3\t\r \u00a0con\t\r \u00a0los\t\r \u00a0primeros\t\r \u00a0ordenadores,\t\r \u00a0a\t\r \u00a0mediados\t\r \u00a0del\t\r \u00a0 siglo\t\r \u00a0 XX,\t\r \u00a0 aplicando\t\r \u00a0 los\t\r \u00a0 conceptos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 para\t\r \u00a0 caracterizar\t\r \u00a0mol\u00e9culas\t\r \u00a0sencillas.\t\r \u00a0Los\t\r \u00a0c\u00e1lculos\t\r \u00a0de\t\r \u00a0este\t\r \u00a0tipo\t\r \u00a0requieren\t\r \u00a0mucho\t\r \u00a0tiempo\t\r \u00a0de\t\r \u00a0c\u00e1lculo\t\r \u00a0y\t\r \u00a0ordenadores\t\r \u00a0 potentes,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 hace\t\r \u00a0 que\t\r \u00a0 aun\t\r \u00a0 hoy\t\r \u00a0 su\t\r \u00a0 \u00e1mbito\t\r \u00a0 de\t\r \u00a0 aplicaci\u00f3n\t\r \u00a0 sea\t\r \u00a0generalmente\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 detallado\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas\t\r \u00a0 peque\u00f1as\t\r \u00a0 (el\t\r \u00a0 sustrato\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0enzima,\t\r \u00a0 un\t\r \u00a0 f\u00e1rmaco,\t\r \u00a0 etc.).\t\r \u00a0 Esta\t\r \u00a0 limitaci\u00f3n\t\r \u00a0 se\t\r \u00a0 debe\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 elevada\t\r \u00a0 precisi\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0m\u00e9todos\t\r \u00a0cu\u00e1nticos,\t\r \u00a0que\t\r \u00a0consideran\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0presentes\t\r \u00a0en\t\r \u00a0las\t\r \u00a0mol\u00e9culas,\t\r \u00a0pero\t\r \u00a0 que\t\r \u00a0 adem\u00e1s\t\r \u00a0 describen\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 expl\u00edcita\t\r \u00a0 el\t\r \u00a0 comportamiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0electrones.\t\r \u00a0\t\r \u00a0El\t\r \u00a0primer\t\r \u00a0paso\t\r \u00a0para\t\r \u00a0poder\t\r \u00a0aplicar\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0computacional\t\r \u00a0al\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0procesos\t\r \u00a0 biol\u00f3gicos\t\r \u00a0 vino\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 simplificaci\u00f3n:\t\r \u00a0 describir\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0\u00fanicamente\t\r \u00a0 a\t\r \u00a0 nivel\t\r \u00a0 at\u00f3mico,\t\r \u00a0 sin\t\r \u00a0 tener\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 los\t\r \u00a0 electrones.\t\r \u00a0 Nac\u00eda\t\r \u00a0 as\u00ed\t\r \u00a0 la\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0a\t\r \u00a0finales\t\r \u00a0de\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a0sesenta,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0grupo\t\r \u00a0del\t\r \u00a0fallecido\t\r \u00a0Lifson,\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 WeizmannInstitute\t\r \u00a0 de\t\r \u00a0 Israel,\t\r \u00a0 donde\t\r \u00a0 AriehWarshel\t\r \u00a0 estaba\t\r \u00a0 haciendo\t\r \u00a0 su\t\r \u00a0 tesis\t\r \u00a0doctoral\t\r \u00a0 y\t\r \u00a0 adonde\t\r \u00a0 Michael\t\r \u00a0 Levitt\t\r \u00a0 lleg\u00f3\t\r \u00a0 como\t\r \u00a0 estudiante\t\r \u00a0 predoctoral.\t\r \u00a0 Dos\t\r \u00a0jovenc\u00edsimos\t\r \u00a0 investigadores\t\r \u00a0 que\t\r \u00a0 escribieron\t\r \u00a0 el\t\r \u00a0 primer\t\r \u00a0 programa\t\r \u00a0 de\t\r \u00a0 mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0 al\t\r \u00a0 inicio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 d\u00e9cada\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 setenta,\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 pocos\t\r \u00a0 a\u00f1os\t\r \u00a0 despu\u00e9s\t\r \u00a0realizar\u00edan\t\r \u00a0 la\t\r \u00a0 primera\t\r \u00a0 simulaci\u00f3n\t\r \u00a0 computacional\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 prote\u00edna.\t\r \u00a0 Finalmente\t\r \u00a0pod\u00edan\t\r \u00a0describirse\t\r \u00a0algunas\t\r \u00a0propiedades\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0o\t\r \u00a0\u00e1cidos\t\r \u00a0nucleicos,\t\r \u00a0como\t\r \u00a0su\t\r \u00a0movilidad\t\r \u00a0en\t\r \u00a0condiciones\t\r \u00a0fisiol\u00f3gicas,\t\r \u00a0la\t\r \u00a0din\u00e1mica\t\r \u00a0molecular.\t\r \u00a0\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0quedaba\t\r \u00a0por\t\r \u00a0resolver\t\r \u00a0el\t\r \u00a0problema\t\r \u00a0de\t\r \u00a0los\t\r \u00a0sistemas\t\r \u00a0complejos,\t\r \u00a0como\t\r \u00a0la\t\r \u00a0reactividad\t\r \u00a0o\t\r \u00a0la\t\r \u00a0asociaci\u00f3n\t\r \u00a0entre\t\r \u00a0mol\u00e9culas\t\r \u00a0(reconocimiento\t\r \u00a0molecular)\t\r \u00a0y\t\r \u00a0aqu\u00ed\t\r \u00a0vino\t\r \u00a0la\t\r \u00a0principal\t\r \u00a0contribuci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0galardonados.\t\r \u00a0Cuando\t\r \u00a0AriehWarshel\t\r \u00a0hizo\t\r \u00a0su\t\r \u00a0 estancia\t\r \u00a0 posdoctoral\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 de\t\r \u00a0 Harvard\t\r \u00a0 con\t\r \u00a0 Martin\t\r \u00a0 Karplus\t\r \u00a0 a\t\r \u00a0principios\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 70,\t\r \u00a0 \t\r \u00a0 utilizaron\t\r \u00a0 un\t\r \u00a0 nivel\t\r \u00a0 de\t\r \u00a0 detalle\t\r \u00a0 mayor\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 centro\t\r \u00a0reactivo,\t\r \u00a0mientras\t\r \u00a0el\t\r \u00a0entorno\t\r \u00a0donde\t\r \u00a0sucede\t\r \u00a0la\t\r \u00a0reacci\u00f3n,\t\r \u00a0t\u00edpicamente\t\r \u00a0una\t\r \u00a0prote\u00edna\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n411\t\r \u00a0\t\r \u00a0catal\u00edtica\t\r \u00a0o\t\r \u00a0enzima,\t\r \u00a0era\t\r \u00a0descrito\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0m\u00e1s\t\r \u00a0aproximada.\t\r \u00a0Nac\u00eda\t\r \u00a0as\u00ed\t\r \u00a0la\t\r \u00a0simulaci\u00f3n\t\r \u00a0multiescala,\t\r \u00a0o\t\r \u00a0hermanamiento\t\r \u00a0de\t\r \u00a0las\t\r \u00a0diferentes\t\r \u00a0escalas\t\r \u00a0de\t\r \u00a0descripci\u00f3n\t\r \u00a0molecular\t\r \u00a0como\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0cu\u00e1ntica\t\r \u00a0y\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular.\t\r \u00a0A\t\r \u00a0 mitad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 70,\t\r \u00a0 Warshel\t\r \u00a0 y\t\r \u00a0 Levitt\t\r \u00a0 extendieron\t\r \u00a0 esta\t\r \u00a0 aproximaci\u00f3n\t\r \u00a0 a\t\r \u00a0sistemas\t\r \u00a0moleculares\t\r \u00a0m\u00e1s\t\r \u00a0grandes,\t\r \u00a0como\t\r \u00a0la\t\r \u00a0acci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0inhibidor\t\r \u00a0de\t\r \u00a0la\t\r \u00a0tripsina\t\r \u00a0pancre\u00e1tica\t\r \u00a0y\t\r \u00a0a\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0del\t\r \u00a0i\u00f3n\t\r \u00a0carbonio\t\r \u00a0en\t\r \u00a0el\t\r \u00a0sitio\t\r \u00a0activo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0lisozima.\t\r \u00a0(1)\t\r \u00a0Esta\t\r \u00a0metodolog\u00eda\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0posteriormente\t\r \u00a0utilizada\t\r \u00a0con\t\r \u00a0\u00e9xito\t\r \u00a0para\t\r \u00a0estudiar\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0complejos\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0en\t\r \u00a0qu\u00edmica\t\r \u00a0org\u00e1nica\t\r \u00a0y\t\r \u00a0bioqu\u00edmica,\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0en\t\r \u00a0cat\u00e1lisis\t\r \u00a0heterog\u00e9nea,\t\r \u00a0c\u00e1lculos\t\r \u00a0de\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0pKa,\t\r \u00a0propiedades\t\r \u00a0redox,\t\r \u00a0predicci\u00f3n\t\r \u00a0de\t\r \u00a0propiedades\t\r \u00a0 espectrosc\u00f3picas.\t\r \u00a0 Pero\t\r \u00a0 lo\t\r \u00a0 m\u00e1s\t\r \u00a0 importante\t\r \u00a0 es\t\r \u00a0 que\t\r \u00a0 ha\t\r \u00a0 abierto\t\r \u00a0 una\t\r \u00a0cooperaci\u00f3n\t\r \u00a0fruct\u00edfera\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0qu\u00edmicos\t\r \u00a0experimentales\t\r \u00a0y\t\r \u00a0te\u00f3ricos,\t\r \u00a0permitiendo\t\r \u00a0solucionar\t\r \u00a0problemas\t\r \u00a0que\t\r \u00a0hace\t\r \u00a0unos\t\r \u00a0a\u00f1os\t\r \u00a0no\t\r \u00a0podr\u00edan\t\r \u00a0ser\t\r \u00a0abordados\t\r \u00a0con\t\r \u00a0detalle\t\r \u00a0y\t\r \u00a0han\t\r \u00a0 contribuido\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 especialmente\t\r \u00a0 importante\t\r \u00a0 en\t\r \u00a0 muchos\t\r \u00a0 campos,\t\r \u00a0 entre\t\r \u00a0otros\t\r \u00a0el\t\r \u00a0del\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0f\u00e1rmacos.\t\r \u00a02.\t\r \u00a0MECANICA\t\r \u00a0CUANTICA\t\r \u00a0La\t\r \u00a0qu\u00edmica\t\r \u00a0cu\u00e1ntica\t\r \u00a0aborda\t\r \u00a0la\t\r \u00a0din\u00e1mica\t\r \u00a0y\t\r \u00a0distribuci\u00f3n\t\r \u00a0de\t\r \u00a0electrones\t\r \u00a0en\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0molecular,\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0onda\t\r \u00a0molecular,Y.\t\r \u00a0Esta,\t\r \u00a0se\t\r \u00a0relaciona\t\r \u00a0con\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0mediante\t\r \u00a0la\t\r \u00a0ecuaci\u00f3n\t\r \u00a0de\t\r \u00a0Schr\u00f6dinger,\t\r \u00a0que\t\r \u00a0si\t\r \u00a0consideramos\t\r \u00a0su\t\r \u00a0formulaci\u00f3n\t\r \u00a0independiente\t\r \u00a0del\t\r \u00a0tiempo,\t\r \u00a0toma\t\r \u00a0la\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0la\t\r \u00a0siguiente\t\r \u00a0ecuaci\u00f3n\t\r \u00a0diferencial:\t\r \u00a0)()(rrEH\u03c8\u03c8=\t\r \u00a0(1)\t\r \u00a0H\t\r \u00a0es\t\r \u00a0un\t\r \u00a0operador\t\r \u00a0(llamado\t\r \u00a0Hamiltoniano)\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0cin\u00e9tica\t\r \u00a0y\t\r \u00a0potencial\t\r \u00a0 de\t\r \u00a0 n\u00facleos\t\r \u00a0 y\t\r \u00a0 electrones.\t\r \u00a0 Esta\t\r \u00a0 ecuaci\u00f3n\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 \u201cecuaci\u00f3n\t\r \u00a0 de\t\r \u00a0 valores\t\r \u00a0propios\u201d\t\r \u00a0 (eigenvalue),\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 operador\t\r \u00a0H,\t\r \u00a0 actuando\t\r \u00a0 sobre\t\r \u00a0 la\t\r \u00a0 funci\u00f3nY,\t\r \u00a0produce\t\r \u00a0 un\t\r \u00a0 m\u00faltiplo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 funci\u00f3n,\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 caso,\t\r \u00a0 multiplicada\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 valor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0energ\u00eda,\t\r \u00a0E,\t\r \u00a0correspondiente\t\r \u00a0al\t\r \u00a0estado\t\r \u00a0descrito\t\r \u00a0por\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0onda.\t\r \u00a0La\t\r \u00a0resoluci\u00f3n\t\r \u00a0de\t\r \u00a0 esta\t\r \u00a0 ecuaci\u00f3n\t\r \u00a0 nos\t\r \u00a0 llevar\u00e1\t\r \u00a0 a\t\r \u00a0 varias\t\r \u00a0 soluciones\t\r \u00a0 posibles,\t\r \u00a0 correspondientes\t\r \u00a0 a\t\r \u00a0estados\t\r \u00a0estacionarios\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mol\u00e9cula,\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0caracterizado\t\r \u00a0por\t\r \u00a0una\t\r \u00a0determinada\t\r \u00a0funci\u00f3n\t\r \u00a0 de\t\r \u00a0 onda\t\r \u00a0 Y\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 valor\t\r \u00a0 de\t\r \u00a0 E\t\r \u00a0 asociado\t\r \u00a0 a\t\r \u00a0 ella.\t\r \u00a0 La\t\r \u00a0 soluci\u00f3n\t\r \u00a0 que\t\r \u00a0 obtiene\t\r \u00a0 el\t\r \u00a0menor\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0corresponde\t\r \u00a0al\t\r \u00a0estado\t\r \u00a0basal\t\r \u00a0(groundstate).\t\r \u00a0La\t\r \u00a0obtenci\u00f3n\t\r \u00a0de\t\r \u00a0soluciones\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0ecuaci\u00f3n,\t\r \u00a0salvo\t\r \u00a0para\t\r \u00a0casos\t\r \u00a0muy\t\r \u00a0sencillos,\t\r \u00a0es\t\r \u00a0compleja,\t\r \u00a0y\t\r \u00a0requiere\t\r \u00a0la\t\r \u00a0introducci\u00f3n\t\r \u00a0de\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0aproximaciones:\t\r \u00a0\u2022 Aproximaci\u00f3n\t\r \u00a0de\t\r \u00a0Born-\u00ad\u2010Openheimer:\t\r \u00a0asume\t\r \u00a0que\t\r \u00a0el\t\r \u00a0movimiento\t\r \u00a0de\t\r \u00a0los\t\r \u00a0n\u00facleos\t\r \u00a0 se\t\r \u00a0 puede\t\r \u00a0 desacoplar\t\r \u00a0 del\t\r \u00a0 movimiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 electrones,\t\r \u00a0 debido\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0peque\u00f1a\t\r \u00a0masa\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0respecto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0n\u00facleos.\t\r \u00a0\u2022 Descripci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0orbitales\t\r \u00a0at\u00f3micos\t\r \u00a0mediante\t\r \u00a0un\t\r \u00a0determinante\t\r \u00a0de\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n412\t\r \u00a0\t\r \u00a0Slater\t\r \u00a0(para\t\r \u00a0cumplir\t\r \u00a0el\t\r \u00a0principio\t\r \u00a0de\t\r \u00a0exclusi\u00f3n\t\r \u00a0de\t\r \u00a0Pauli).\t\r \u00a0\u2022 Aproximaci\u00f3n\t\r \u00a0 de\t\r \u00a0 Roothaan,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 cada\t\r \u00a0 orbital\t\r \u00a0 molecular\t\r \u00a0monoelectr\u00f3nicof\t\r \u00a0se\t\r \u00a0 construye\t\r \u00a0 de\t\r \u00a0 acuerdo\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 aproximaci\u00f3n\t\r \u00a0 LCAO\t\r \u00a0 (Linear\t\r \u00a0Combination\t\r \u00a0 of\t\r \u00a0 AtomicOrbitals),\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 lineal\t\r \u00a0 de\t\r \u00a0 N\t\r \u00a0 orbitales\t\r \u00a0at\u00f3micos\t\r \u00a0(c),\t\r \u00a0tambi\u00e9n\t\r \u00a0llamados\t\r \u00a0funciones\t\r \u00a0de\t\r \u00a0base:\t\r \u00a0)().....()(2211)(nnrrrr\u03c6\u03c6\u03c6\u03c8=\t\r \u00a0(2)\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0cada\t\r \u00a0orbital\t\r \u00a0molecular\t\r \u00a0monoelectr\u00f3nicof\t\r \u00a0se\t\r \u00a0expresa,\t\r \u00a0de\t\r \u00a0acuerdo\t\r \u00a0con\t\r \u00a0 la\t\r \u00a0 aproximaci\u00f3n\t\r \u00a0 LCAO\t\r \u00a0 (Linear\t\r \u00a0 Combination\t\r \u00a0 of\t\r \u00a0 AtomicOrbitals),\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0combinaci\u00f3n\t\r \u00a0 lineal\t\r \u00a0 de\t\r \u00a0 N\t\r \u00a0 orbitales\t\r \u00a0 at\u00f3micos\t\r \u00a0 (c),\t\r \u00a0 tambi\u00e9n\t\r \u00a0 llamados\t\r \u00a0 funciones\t\r \u00a0 de\t\r \u00a0base:\t\r \u00a0\u2211==Niic1\u00b5\u00b5\u00b5\u03c7\u03c6\t\r \u00a0(3)\t\r \u00a0A\t\r \u00a0su\t\r \u00a0vez,\t\r \u00a0cada\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0base\t\r \u00a0se\t\r \u00a0puede\t\r \u00a0expresar\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0an\u00e1loga\t\r \u00a0como\t\r \u00a0una\t\r \u00a0combinaci\u00f3n\t\r \u00a0lineal\t\r \u00a0de\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0funciones\t\r \u00a0matem\u00e1ticas\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0gaussiano.\t\r \u00a0La\t\r \u00a0calidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aproximaci\u00f3n\t\r \u00a0depender\u00e1\t\r \u00a0del\t\r \u00a0conjunto\t\r \u00a0de\t\r \u00a0funciones\t\r \u00a0utilizado\t\r \u00a0para\t\r \u00a0dichas\t\r \u00a0 combinaciones\t\r \u00a0 lineales\t\r \u00a0 (basis\t\r \u00a0 set).\t\r \u00a0 Actualmente\t\r \u00a0 es\t\r \u00a0 frecuente\t\r \u00a0 utilizar\t\r \u00a0 una\t\r \u00a0funci\u00f3n\t\r \u00a0 de\t\r \u00a0 base\t\r \u00a0 6-\u00ad\u201031G*\t\r \u00a0 para\t\r \u00a0 calcular\t\r \u00a0 propiedades\t\r \u00a0 de\t\r \u00a0 mol\u00e9culas\t\r \u00a0 org\u00e1nicas\t\r \u00a0peque\u00f1as\t\r \u00a0(tipo\t\r \u00a0f\u00e1rmaco).\t\r \u00a06-\u00ad\u201031G*\t\r \u00a0indica\t\r \u00a0que\t\r \u00a0se\t\r \u00a0utilizan\t\r \u00a0seis\t\r \u00a0funciones\t\r \u00a0gaussianas\t\r \u00a0para\t\r \u00a0representar\t\r \u00a0los\t\r \u00a0orbitales\t\r \u00a0at\u00f3micos\t\r \u00a0internos,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0los\t\r \u00a0externos\t\r \u00a0-\u00ad\u2010capa\t\r \u00a0de\t\r \u00a0 valencia-\u00ad\u2010\t\r \u00a0se\t\r \u00a0 representan\t\r \u00a0 mediante\t\r \u00a0 tres\t\r \u00a0 funciones\t\r \u00a0 para\t\r \u00a0 la\t\r \u00a0 parte\t\r \u00a0 \u201ccontra\u00edda\u201d\t\r \u00a0 y\t\r \u00a0una\t\r \u00a0para\t\r \u00a0la\t\r \u00a0parte\t\r \u00a0\u201cdifusa\u201d,\t\r \u00a0m\u00e1s\t\r \u00a0una\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0polarizaci\u00f3n\t\r \u00a0para\t\r \u00a0\u00e1tomos\t\r \u00a0pesados\t\r \u00a0(indicada\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0asterisco\t\r \u00a0*),\t\r \u00a0que\t\r \u00a0representa\t\r \u00a0el\t\r \u00a0efecto\t\r \u00a0de\t\r \u00a0los\t\r \u00a0orbitales\t\r \u00a0tipo\t\r \u00a0d.\t\r \u00a0Existen,\t\r \u00a0 no\t\r \u00a0 obstante,\t\r \u00a0 otras\t\r \u00a0 funciones\t\r \u00a0 de\t\r \u00a0 base\t\r \u00a0 menos\t\r \u00a0 costosas,\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 pueden\t\r \u00a0utilizar\t\r \u00a0para\t\r \u00a0la\t\r \u00a0b\u00fasqueda\t\r \u00a0de\t\r \u00a0la\t\r \u00a0geometr\u00eda\t\r \u00a0\u00f3ptima,\t\r \u00a0como\t\r \u00a0son\t\r \u00a0las\t\r \u00a0bases\t\r \u00a0STO-\u00ad\u20103G\t\r \u00a0\u00f3\t\r \u00a03-\u00ad\u201021G.\t\r \u00a0\t\r \u00a0Debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0cada\t\r \u00a0electr\u00f3n\t\r \u00a0se\t\r \u00a0halla\t\r \u00a0bajo\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0el\u00e9ctrico\t\r \u00a0del\t\r \u00a0resto,\t\r \u00a0cada\t\r \u00a0orbital\t\r \u00a0 molecular\t\r \u00a0 monoelectr\u00f3nico\t\r \u00a0 depender\u00e1\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 dem\u00e1s,\t\r \u00a0 con\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0b\u00fasqueda\t\r \u00a0 del\t\r \u00a0 mejor\t\r \u00a0 conjunto\t\r \u00a0 de\t\r \u00a0 coeficientes\t\r \u00a0 se\t\r \u00a0 har\u00e1\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 iterativa.\t\r \u00a0 Esta\t\r \u00a0aproximaci\u00f3n\t\r \u00a0 recibe\t\r \u00a0 el\t\r \u00a0 nombre\t\r \u00a0 de\t\r \u00a0 campo\t\r \u00a0 autocoherente\t\r \u00a0 (Self-\u00ad\u2010Consistent\t\r \u00a0 Field,\t\r \u00a0SCF).\t\r \u00a0 Dentro\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 m\u00e9todos\t\r \u00a0 que\t\r \u00a0 utilizan\t\r \u00a0 c\u00e1lculos\t\r \u00a0 SCF\t\r \u00a0 cabe\t\r \u00a0 destacar\t\r \u00a0 el\t\r \u00a0 m\u00e9todo\t\r \u00a0Hartree-\u00ad\u2010Fock\t\r \u00a0 (HF),\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 de\t\r \u00a0 mayor\t\r \u00a0 difusi\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 dise\u00f1o\t\r \u00a0 de\t\r \u00a0 f\u00e1rmacos.\t\r \u00a0 Las\t\r \u00a0ecuaciones\t\r \u00a0de\t\r \u00a0Hartree-\u00ad\u2010Fock\t\r \u00a0buscan\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0onda\t\r \u00a0que\t\r \u00a0produzca\t\r \u00a0el\t\r \u00a0m\u00ednimo\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0molecular,\t\r \u00a0es\t\r \u00a0decir,\t\r \u00a0imponen\t\r \u00a0la\t\r \u00a0condici\u00f3n\t\r \u00a0de\t\r \u00a0que\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0sea\t\r \u00a0cero\t\r \u00a0(\u00b6E=0)\t\r \u00a0sujeta\t\r \u00a0a\t\r \u00a0su\t\r \u00a0vez\t\r \u00a0a\t\r \u00a0la\t\r \u00a0condici\u00f3n\t\r \u00a0de\t\r \u00a0que\t\r \u00a0los\t\r \u00a0orbitales\t\r \u00a0moleculares\t\r \u00a0sean\t\r \u00a0ortonormales\t\r \u00a0(teorema\t\r \u00a0variacional).\t\r \u00a0\t\r \u00a0Todos\t\r \u00a0estos\t\r \u00a0m\u00e9todos,\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0consideran\t\r \u00a0toda\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0at\u00f3mica\t\r \u00a0y\t\r \u00a0no\t\r \u00a0 introducen\t\r \u00a0 par\u00e1metros\t\r \u00a0 emp\u00edricos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 resoluci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 ecuaci\u00f3n\t\r \u00a0 de\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n413\t\r \u00a0\t\r \u00a0Schr\u00f6dinger,\t\r \u00a0se\t\r \u00a0denominan\t\r \u00a0m\u00e9todos\t\r \u00a0ab\t\r \u00a0initio.\t\r \u00a0En\t\r \u00a0cuanto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0programas\t\r \u00a0con\t\r \u00a0los\t\r \u00a0que\t\r \u00a0se\t\r \u00a0realizan\t\r \u00a0c\u00e1lculos\t\r \u00a0qu\u00edmico-\u00ad\u2010cu\u00e1nticos\t\r \u00a0ab\t\r \u00a0initio,\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0m\u00e1s\t\r \u00a0comunes\t\r \u00a0est\u00e1n\t\r \u00a0el\t\r \u00a0paquete\t\r \u00a0GAUSSIAN(2)\t\r \u00a0y\t\r \u00a0GAMESS.(3)\t\r \u00a0Cuando\t\r \u00a0se\t\r \u00a0introducen\t\r \u00a0par\u00e1metros\t\r \u00a0ajustados\t\r \u00a0emp\u00edricamente\t\r \u00a0que\t\r \u00a0sustituyen\t\r \u00a0alguna\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 integrales\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 m\u00e9todos\t\r \u00a0 ab\t\r \u00a0 initio,\t\r \u00a0 pero\t\r \u00a0 a\u00fan\t\r \u00a0 consideramos\t\r \u00a0 la\t\r \u00a0estructura\t\r \u00a0electr\u00f3nica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mol\u00e9cula,\t\r \u00a0nos\t\r \u00a0hallamos\t\r \u00a0ante\t\r \u00a0los\t\r \u00a0denominados\t\r \u00a0m\u00e9todos\t\r \u00a0semiemp\u00edricos.\t\r \u00a0 Estos\t\r \u00a0 m\u00e9todos\t\r \u00a0 omiten\t\r \u00a0 los\t\r \u00a0 c\u00e1lculos\t\r \u00a0 relativos\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 electrones\t\r \u00a0 de\t\r \u00a0capa\t\r \u00a0interna\t\r \u00a0(core)\t\r \u00a0que\t\r \u00a0se\t\r \u00a0tratan\t\r \u00a0como\t\r \u00a0si\t\r \u00a0formasen\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0n\u00facleo,\t\r \u00a0y\t\r \u00a0se\t\r \u00a0centran\t\r \u00a0\u00fanicamente\t\r \u00a0en\t\r \u00a0los\t\r \u00a0electrones\t\r \u00a0de\t\r \u00a0capas\t\r \u00a0de\t\r \u00a0valencia,\t\r \u00a0partiendo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0base\t\r \u00a0de\t\r \u00a0que\t\r \u00a0son\t\r \u00a0estos\t\r \u00a0electrones\t\r \u00a0 los\t\r \u00a0 responsables\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 reactividad\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 mayor\u00eda\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0propiedades\t\r \u00a0moleculares.\t\r \u00a0No\t\r \u00a0obstante,\t\r \u00a0no\t\r \u00a0existen\t\r \u00a0par\u00e1metros\t\r \u00a0v\u00e1lidos\t\r \u00a0para\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0sistemas\t\r \u00a0moleculares,\t\r \u00a0lo\t\r \u00a0cual\t\r \u00a0hace\t\r \u00a0aconsejar\t\r \u00a0prudencia\t\r \u00a0en\t\r \u00a0su\t\r \u00a0utilizaci\u00f3n.\t\r \u00a0Se\t\r \u00a0han\t\r \u00a0desarrollado\t\r \u00a0multitud\t\r \u00a0de\t\r \u00a0m\u00e9todos\t\r \u00a0semiemp\u00edricos,\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0destacan,\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0com\u00fan\t\r \u00a0de\t\r \u00a0su\t\r \u00a0utilizaci\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0del\t\r \u00a0dise\u00f1o\t\r \u00a0de\t\r \u00a0f\u00e1rmacos,\t\r \u00a0MNDO(4)\t\r \u00a0o\t\r \u00a0AM1.(5)\t\r \u00a0De\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 de\t\r \u00a0 onda\t\r \u00a0 se\t\r \u00a0 pueden\t\r \u00a0 derivar\t\r \u00a0 multitud\t\r \u00a0 de\t\r \u00a0 descriptores\t\r \u00a0moleculares,\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0utilizados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0caracterizaci\u00f3n\t\r \u00a0de\t\r \u00a0mol\u00e9culas.\t\r \u00a0Entre\t\r \u00a0estos\t\r \u00a0cabe\t\r \u00a0citar:\t\r \u00a0\t\r \u00a0\u2022 Potencial\t\r \u00a0electrost\u00e1tico\t\r \u00a0molecular\t\r \u00a0(MEP):\t\r \u00a0Esta\t\r \u00a0propiedad\t\r \u00a0es\t\r \u00a0de\t\r \u00a0gran\t\r \u00a0inter\u00e9s\t\r \u00a0en\t\r \u00a0el\t\r \u00a0modelado\t\r \u00a0molecular\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0describe\t\r \u00a0las\t\r \u00a0caracter\u00edsticas\t\r \u00a0electr\u00f3nicas\t\r \u00a0de\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 puede\t\r \u00a0 utilizar\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 an\u00e1lisis\t\r \u00a0 y\t\r \u00a0 predicci\u00f3n\t\r \u00a0 de\t\r \u00a0 interacciones\t\r \u00a0moleculares.\t\r \u00a0\u2022 Entalp\u00eda\t\r \u00a0 de\t\r \u00a0 formaci\u00f3n\t\r \u00a0 (DHf):\t\r \u00a0 derivada\t\r \u00a0 del\t\r \u00a0 c\u00e1lculo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 energ\u00eda,\t\r \u00a0 da\t\r \u00a0cuenta\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 estabilidad\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 compuesto.\t\r \u00a0 Puede\t\r \u00a0 ser\t\r \u00a0 calculada\t\r \u00a0 en\t\r \u00a0 distintos\t\r \u00a0entornos\t\r \u00a0(agua,\t\r \u00a0solventes\t\r \u00a0org\u00e1nicos,\t\r \u00a0etc...)\t\r \u00a0en\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0que\t\r \u00a0consideran\t\r \u00a0medios\t\r \u00a0distintos\t\r \u00a0del\t\r \u00a0vac\u00edo.\t\r \u00a0\t\r \u00a0\u2022 Momento\t\r \u00a0dipolar\t\r \u00a0(m):\t\r \u00a0es\t\r \u00a0una\t\r \u00a0magnitud\t\r \u00a0vectorial\t\r \u00a0relacionada\t\r \u00a0con\t\r \u00a0la\t\r \u00a0asimetr\u00eda\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 distribuci\u00f3n\t\r \u00a0 de\t\r \u00a0 carga\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 compuesto;\t\r \u00a0 da\t\r \u00a0 una\t\r \u00a0 idea\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0polaridad.\t\r \u00a0\t\r \u00a0\u2022 Energ\u00eda\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 orbitales\t\r \u00a0 moleculares:\t\r \u00a0 tienen\t\r \u00a0 especial\t\r \u00a0 inter\u00e9s\t\r \u00a0 la\t\r \u00a0 del\t\r \u00a0orbital\t\r \u00a0ocupado\t\r \u00a0de\t\r \u00a0mayor\t\r \u00a0energ\u00eda\t\r \u00a0(HOMO,\t\r \u00a0highestoccupied\t\r \u00a0molecular\t\r \u00a0orbital)\t\r \u00a0y\t\r \u00a0la\t\r \u00a0del\t\r \u00a0 desocupado\t\r \u00a0 de\t\r \u00a0 menor\t\r \u00a0 energ\u00eda\t\r \u00a0 (LUMO,\t\r \u00a0lowestunnoccupied\t\r \u00a0 molecular\t\r \u00a0 orbital).\t\r \u00a0Ambos\t\r \u00a0 est\u00e1n\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 interacciones\t\r \u00a0 intermoleculares\t\r \u00a0 de\t\r \u00a0 transferencia\t\r \u00a0 de\t\r \u00a0carga.\t\r \u00a0\t\r \u00a0\u2022 Cargas\t\r \u00a0 puntuales:\t\r \u00a0 Los\t\r \u00a0 electrones\t\r \u00a0 de\t\r \u00a0 valencia\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 no\t\r \u00a0est\u00e1n\t\r \u00a0fijados\t\r \u00a0a\t\r \u00a0un\t\r \u00a0\u00e1tomo\t\r \u00a0en\t\r \u00a0particular\t\r \u00a0y\t\r \u00a0se\t\r \u00a0pueden\t\r \u00a0mover\t\r \u00a0alrededor\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mol\u00e9cula\t\r \u00a0como\t\r \u00a0 un\t\r \u00a0 conjunto.\t\r \u00a0 Debido\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 electrones\t\r \u00a0 suelen\t\r \u00a0 estar\t\r \u00a0 m\u00e1s\t\r \u00a0 tiempo\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0proximidades\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0electronegativos\t\r \u00a0que\t\r \u00a0en\t\r \u00a0la\t\r \u00a0de\t\r \u00a0los\t\r \u00a0electropositivos,\t\r \u00a0esta\t\r \u00a0distribuci\u00f3n\t\r \u00a0electr\u00f3nica\t\r \u00a0no\t\r \u00a0es\t\r \u00a0uniforme\t\r \u00a0y\t\r \u00a0tiene\t\r \u00a0como\t\r \u00a0resultado\t\r \u00a0que\t\r \u00a0unas\t\r \u00a0regiones\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n414\t\r \u00a0\t\r \u00a0de\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 posean\t\r \u00a0 una\t\r \u00a0 densidad\t\r \u00a0 de\t\r \u00a0 carga\t\r \u00a0 positiva\t\r \u00a0 y\t\r \u00a0 otras\t\r \u00a0 partes\t\r \u00a0 una\t\r \u00a0densidad\t\r \u00a0de\t\r \u00a0carga\t\r \u00a0negativa.\t\r \u00a0La\t\r \u00a0carga\t\r \u00a0puntual\t\r \u00a0es\t\r \u00a0una\t\r \u00a0estimaci\u00f3n\t\r \u00a0del\t\r \u00a0promedio\t\r \u00a0de\t\r \u00a0carga\t\r \u00a0 de\t\r \u00a0 cada\t\r \u00a0 \u00e1tomo\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 deriva\t\r \u00a0 del\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 electrones\t\r \u00a0 presentes\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0alrededor.\t\r \u00a0\t\r \u00a0Haciendo\t\r \u00a0referencia\t\r \u00a0a\t\r \u00a0los\t\r \u00a0avances\t\r \u00a0en\t\r \u00a0el\t\r \u00a0\u00e1rea\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0computacional,\t\r \u00a0Martin\t\r \u00a0Karplus,\t\r \u00a0en\t\r \u00a0un\t\r \u00a0art\u00edculo\t\r \u00a0autobiogr\u00e1fico\t\r \u00a0publicado\t\r \u00a0en\t\r \u00a02006(6),\t\r \u00a0menciona:\t\r \u00a0\t\r \u00a0\t\r \u00a0\u201cAhora,\t\r \u00a0pueden\t\r \u00a0ser\t\r \u00a0calculadas\t\r \u00a0apretando\t\r \u00a0un\t\r \u00a0bot\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0programa,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0ampliamente\t\r \u00a0utilizado\t\r \u00a0Gaussian.\t\r \u00a0El\t\r \u00a0alto\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0c\u00e1lculos\t\r \u00a0ab\t\r \u00a0initio\t\r \u00a0que\t\r \u00a0se\t\r \u00a0utilizan\t\r \u00a0hoy\t\r \u00a0en\t\r \u00a0d\u00eda\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0rutinaria\t\r \u00a0posee\t\r \u00a0el\t\r \u00a0inconveniente\t\r \u00a0de\t\r \u00a0que\t\r \u00a0aunque\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0sean\t\r \u00a0 exactos,\t\r \u00a0 la\t\r \u00a0 visi\u00f3n\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 ten\u00eda\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 aproximaciones\t\r \u00a0 anteriores\t\r \u00a0simplificadas,\t\r \u00a0se\t\r \u00a0pierden\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0en\t\r \u00a0la\t\r \u00a0complejidad\t\r \u00a0del\t\r \u00a0c\u00e1lculo\u201d\t\r \u00a0\t\r \u00a02.1.\t\r \u00a0Aplicaciones\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0cu\u00e1ntica:\t\r \u00a0\t\r \u00a02.1.1.\t\r \u00a0Reacci\u00f3n\t\r \u00a0de\t\r \u00a0fotoisomerizaci\u00f3n\t\r \u00a0del\t\r \u00a0retinal\t\r \u00a0para\t\r \u00a0la\t\r \u00a0excitaci\u00f3n\t\r \u00a0visual.\t\r \u00a0\t\r \u00a0Un\t\r \u00a0ejemplo\t\r \u00a0de\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0metodolog\u00eda\t\r \u00a0para\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0sistemas\t\r \u00a0biol\u00f3gicos,\t\r \u00a0fue\t\r \u00a0el\t\r \u00a0realizado\t\r \u00a0por\t\r \u00a0Barry\t\r \u00a0Honig,\t\r \u00a0bajo\t\r \u00a0la\t\r \u00a0direcci\u00f3n\t\r \u00a0de\t\r \u00a0Martin\t\r \u00a0Karplus,\t\r \u00a0el\t\r \u00a0cual\t\r \u00a0 consider\u00f3\t\r \u00a0 que\t\r \u00a0 era\t\r \u00a0 un\t\r \u00a0 sistema\t\r \u00a0 biol\u00f3gico\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 efectos\t\r \u00a0 cu\u00e1nticos\t\r \u00a0 eran\t\r \u00a0suficientemente\t\r \u00a0interesantes\t\r \u00a0y\t\r \u00a0que\t\r \u00a0podr\u00eda\t\r \u00a0ser\t\r \u00a0tratado\t\r \u00a0con\t\r \u00a0los\t\r \u00a0medios\t\r \u00a0disponibles\t\r \u00a0en\t\r \u00a0 ese\t\r \u00a0 momento.\t\r \u00a0 Adem\u00e1s,\t\r \u00a0 contaba\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 grupo\t\r \u00a0 de\t\r \u00a0 investigaci\u00f3n\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 persona\t\r \u00a0preparada\t\r \u00a0para\t\r \u00a0realizar\t\r \u00a0ese\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0c\u00e1lculos.\t\r \u00a0\t\r \u00a0Mediante\t\r \u00a0este\t\r \u00a0estudio,\t\r \u00a0fueron\t\r \u00a0capaces\t\r \u00a0de\t\r \u00a0predecir\t\r \u00a0que\t\r \u00a0la\t\r \u00a0conformaci\u00f3n\t\r \u00a0m\u00e1s\t\r \u00a0estable\t\r \u00a0era\t\r \u00a012-\u00ad\u2010s-\u00ad\u2010cis.\t\r \u00a0Este\t\r \u00a0trabajo,\t\r \u00a0a\t\r \u00a0pesar\t\r \u00a0de\t\r \u00a0ser\t\r \u00a0un\t\r \u00a0trabajo\t\r \u00a0te\u00f3rico\t\r \u00a0y\t\r \u00a0no\t\r \u00a0sin\t\r \u00a0ciertas\t\r \u00a0dificultades,\t\r \u00a0fue\t\r \u00a0finalmente\t\r \u00a0publicado\t\r \u00a0en\t\r \u00a0la\t\r \u00a0revista\t\r \u00a0Nature(7).\t\r \u00a0Unos\t\r \u00a0meses\t\r \u00a0m\u00e1s\t\r \u00a0tarde,\t\r \u00a0se\t\r \u00a0resolvi\u00f3\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0de\t\r \u00a0rayos-\u00ad\u2010x,\t\r \u00a0pr\u00e1cticamente\t\r \u00a0coincidente\t\r \u00a0con\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0te\u00f3ricos(8).\t\r \u00a02.1.2.\t\r \u00a0Desarrollo\t\r \u00a0de\t\r \u00a0anticuerpos\t\r \u00a0catal\u00edticos\t\r \u00a0Existen\t\r \u00a0miles\t\r \u00a0de\t\r \u00a0ejemplos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0m\u00e9todos,\t\r \u00a0sin\t\r \u00a0embargo\t\r \u00a0he\t\r \u00a0 seleccionado\t\r \u00a0 una\t\r \u00a0 estrategia\t\r \u00a0 que\t\r \u00a0 supuso,\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 90,\t\r \u00a0 una\t\r \u00a0 nueva\t\r \u00a0aproximaci\u00f3n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 b\u00fasqueda\t\r \u00a0 de\t\r \u00a0 anticuerpos\t\r \u00a0 catal\u00edticos\t\r \u00a0 para\t\r \u00a0 catalizar\t\r \u00a0 diferentes\t\r \u00a0reacciones\t\r \u00a0org\u00e1nicas.\t\r \u00a0\t\r \u00a0Los\t\r \u00a0 anticuerpos\t\r \u00a0 catal\u00edticos\t\r \u00a0 se\t\r \u00a0 presentan\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 herramienta\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0futuro\t\r \u00a0prometedor\t\r \u00a0en\t\r \u00a0campos\t\r \u00a0como\t\r \u00a0la\t\r \u00a0s\u00edntesis\t\r \u00a0qu\u00edmica,\t\r \u00a0la\t\r \u00a0farmacolog\u00eda\t\r \u00a0e\t\r \u00a0incluso\t\r \u00a0la\t\r \u00a0medicina,\t\r \u00a0gracias,\t\r \u00a0entre\t\r \u00a0otras\t\r \u00a0cosas\t\r \u00a0al\t\r \u00a0gran\t\r \u00a0progreso\t\r \u00a0de\t\r \u00a0las\t\r \u00a0t\u00e9cnicas\t\r \u00a0de\t\r \u00a0generaci\u00f3n\t\r \u00a0de\t\r \u00a0 anticuerpos\t\r \u00a0 monoclonales.\t\r \u00a0 En\t\r \u00a0 ellos\t\r \u00a0 se\t\r \u00a0 combina\t\r \u00a0 la\t\r \u00a0 excepcional\t\r \u00a0 capacidad\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0inmune\t\r \u00a0para\t\r \u00a0generar\t\r \u00a0grandes\t\r \u00a0colecciones\t\r \u00a0de\t\r \u00a0mol\u00e9culas\t\r \u00a0con\t\r \u00a0gran\t\r \u00a0afinidad\t\r \u00a0por\t\r \u00a0 las\t\r \u00a0 mol\u00e9culas\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 inducen\t\r \u00a0-\u00ad\u2010ant\u00edgenos-\u00ad\u2010,\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 poder\t\r \u00a0 catal\u00edtico\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0enzimas.\t\r \u00a0La\t\r \u00a0principal\t\r \u00a0complejidad\t\r \u00a0que\t\r \u00a0presenta\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0t\u00e9cnica\t\r \u00a0est\u00e1\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 dise\u00f1o\t\r \u00a0 de\t\r \u00a0 haptenos\t\r \u00a0-\u00ad\u2010peque\u00f1as\t\r \u00a0 mol\u00e9culas\t\r \u00a0 inmunog\u00e9nicas-\u00ad\u2010\t\r \u00a0que\t\r \u00a0 han\t\r \u00a0 de\t\r \u00a0 ser\t\r \u00a0an\u00e1logos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 estados\t\r \u00a0 de\t\r \u00a0 transici\u00f3n\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 reacciones\t\r \u00a0 qu\u00edmicas\t\r \u00a0 que\t\r \u00a0 deseamos\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n415\t\r \u00a0\t\r \u00a0catalizar.\t\r \u00a0 Los\t\r \u00a0 estudios\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 campo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 elucidaci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0complejos\t\r \u00a0 enzima-\u00ad\u2010sustrato\t\r \u00a0en\t\r \u00a0los\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0aportan,\t\r \u00a0sin\t\r \u00a0embargo,\t\r \u00a0datos\t\r \u00a0esenciales\t\r \u00a0para\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0este\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0investigaci\u00f3n(9).\t\r \u00a0Una\t\r \u00a0de\t\r \u00a0las\t\r \u00a0reacciones\t\r \u00a0que\t\r \u00a0ofrece\t\r \u00a0un\t\r \u00a0especial\t\r \u00a0atractivo\t\r \u00a0para\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0 estrategia\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 de\t\r \u00a0 Diels-\u00ad\u2010Alder.\t\r \u00a0 Los\t\r \u00a0 anticuerpos,\t\r \u00a0 con\t\r \u00a0 sus\t\r \u00a0 sitios\t\r \u00a0 de\t\r \u00a0uni\u00f3n\t\r \u00a0espec\u00edficos\t\r \u00a0y\t\r \u00a0quirales,\t\r \u00a0deber\u00edan\t\r \u00a0de\t\r \u00a0ser\t\r \u00a0catalizadores\t\r \u00a0ideales\t\r \u00a0para\t\r \u00a0controlar\t\r \u00a0por\t\r \u00a0completo\t\r \u00a0esta\t\r \u00a0reacci\u00f3n\t\r \u00a0de\t\r \u00a0\t\r \u00a0cicloadici\u00f3n.\t\r \u00a0La\t\r \u00a0reacci\u00f3n\t\r \u00a0de\t\r \u00a0Diels-\u00ad\u2010Alder\t\r \u00a0seleccionada\t\r \u00a0para\t\r \u00a0este\t\r \u00a0trabajo,\t\r \u00a0es\t\r \u00a0aquella\t\r \u00a0en\t\r \u00a0la\t\r \u00a0que\t\r \u00a0 se\t\r \u00a0 hace\t\r \u00a0 reaccionar\t\r \u00a0 el\t\r \u00a0trans-\u00ad\u20101-\u00ad\u2010N-\u00ad\u2010acilamino-\u00ad\u20101,3-\u00ad\u2010butadieno\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0N,N-\u00ad\u2010dimetilacrilamida.\t\r \u00a0 Los\t\r \u00a0 productos\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 reacci\u00f3n\t\r \u00a0 pertenecen\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 familia\t\r \u00a0 de\t\r \u00a0compuestos\t\r \u00a0\u00fatiles\t\r \u00a0en\t\r \u00a0la\t\r \u00a0s\u00edntesis\t\r \u00a0de\t\r \u00a0alcaloides.\t\r \u00a0\t\r \u00a0En\t\r \u00a0 ausencia\t\r \u00a0 de\t\r \u00a0 catalizador\t\r \u00a0 se\t\r \u00a0 obtiene\t\r \u00a0 a\t\r \u00a0 110\u00ba\t\r \u00a0 en\t\r \u00a0 tolueno\t\r \u00a0 una\t\r \u00a0 mezcla\t\r \u00a0endo/exo\t\r \u00a066:34.\t\r \u00a0En\t\r \u00a0presencia\t\r \u00a0de\t\r \u00a0catalizador\t\r \u00a0se\t\r \u00a0obtiene\t\r \u00a0una\t\r \u00a0mezcla\t\r \u00a085:15.\t\r \u00a0Ambas\t\r \u00a0reacciones\t\r \u00a0 son\t\r \u00a0 totalmente\t\r \u00a0regioselectivas\t\r \u00a0obteni\u00e9ndose\t\r \u00a0 \u00fanicamente\t\r \u00a0 los\t\r \u00a0regiois\u00f3merosorto.\t\r \u00a0\t\r \u00a0ONHO\nRCONMe2ONHORCONMe2ONHORCONMe2+\nENDOEXO\t\r \u00a0Figura\t\r \u00a01.-\u00ad\u2010\t\r \u00a0Reacci\u00f3n\t\r \u00a0Diels-\u00ad\u2010Alder\t\r \u00a0seleccionada.\t\r \u00a0La\t\r \u00a0 idea\t\r \u00a0 era\t\r \u00a0obtener\t\r \u00a0 dos\t\r \u00a0 \u201cdiles-\u00ad\u2010alderasas\u201d\t\r \u00a0 capaces\t\r \u00a0 de\t\r \u00a0 catalizar\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0para\t\r \u00a0obtener\t\r \u00a0tanto\t\r \u00a0el\t\r \u00a0producto\t\r \u00a0de\t\r \u00a0cicloadici\u00f3n\t\r \u00a0favorecido\t\r \u00a0endo\t\r \u00a0o,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0era\t\r \u00a0m\u00e1s\t\r \u00a0complicado\t\r \u00a0 el\t\r \u00a0 cicloaducto\t\r \u00a0 desfavorecido\t\r \u00a0 exo.\t\r \u00a0 Para\t\r \u00a0 ello\t\r \u00a0 era\t\r \u00a0 necesario\t\r \u00a0 dise\u00f1ar\t\r \u00a0 un\t\r \u00a0hapteno,\t\r \u00a0an\u00e1logo\t\r \u00a0estable\t\r \u00a0del\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0transici\u00f3n,\t\r \u00a0\t\r \u00a0que\t\r \u00a0permitiese\t\r \u00a0la\t\r \u00a0obtenci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dos\t\r \u00a0anticuerpos\t\r \u00a0(Figura\t\r \u00a02).\t\r \u00a0\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n416\t\r \u00a0\t\r \u00a0R1R2\nR1R2R1R2R1R2R1R2R1R2R1R2R1R1ENDOEXO\t\r \u00a0Figura\t\r \u00a02.-\u00ad\u2010Haptenos\t\r \u00a0dise\u00f1ados\t\r \u00a0para\t\r \u00a0obtener\t\r \u00a0el\t\r \u00a0producto\t\r \u00a0\"endo\"\t\r \u00a0y\t\r \u00a0\"exo\"\t\r \u00a0de\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0Diels-\u00ad\u2010Alder\t\r \u00a0por\t\r \u00a0similitud\t\r \u00a0con\t\r \u00a0el\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0transici\u00f3n.\t\r \u00a0Con\t\r \u00a0el\t\r \u00a0fin\t\r \u00a0de\t\r \u00a0llevar\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0el\t\r \u00a0dise\u00f1o\t\r \u00a0racional\t\r \u00a0de\t\r \u00a0los\t\r \u00a0haptenos,\t\r \u00a0se\t\r \u00a0localizaron\t\r \u00a0los\t\r \u00a0 correspondientes\t\r \u00a0 estados\t\r \u00a0 de\t\r \u00a0 transici\u00f3n,\t\r \u00a0 para\t\r \u00a0 poder\t\r \u00a0 obtener\t\r \u00a0 datos\t\r \u00a0estereoelectr\u00f3nicos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0que\t\r \u00a0se\t\r \u00a0deseaba\t\r \u00a0catalizar.\t\r \u00a0Se\t\r \u00a0utiliz\u00f3\t\r \u00a0el\t\r \u00a0m\u00e9todo\t\r \u00a0ab\t\r \u00a0initio\t\r \u00a0y\t\r \u00a0el\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0c\u00e1lculo\t\r \u00a0RHF/3-\u00ad\u201021G\t\r \u00a0para\t\r \u00a0localizar\t\r \u00a0los\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0en\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0modelo\t\r \u00a0constituido\t\r \u00a0por\t\r \u00a0acrilamida\t\r \u00a0y\t\r \u00a0el\t\r \u00a0\u00e1cido\t\r \u00a0N-\u00ad\u2010(1-\u00ad\u2010butadienil)\t\r \u00a0carb\u00e1mico.\t\r \u00a0Previamente\t\r \u00a0se\t\r \u00a0realiz\u00f3\t\r \u00a0un\t\r \u00a0estudio\t\r \u00a0conformacional\t\r \u00a0de\t\r \u00a0los\t\r \u00a0reactivos.\t\r \u00a0Se\t\r \u00a0localizaron\t\r \u00a0los\t\r \u00a0cuatro\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0correspondientes\t\r \u00a0a\t\r \u00a0los\t\r \u00a0cuatro\t\r \u00a0estereo\t\r \u00a0(endo/exo)-\u00ad\u2010\t\r \u00a0y\t\r \u00a0regiois\u00f3meros\t\r \u00a0(orto/meta)\t\r \u00a0(orto\t\r \u00a0endo,\t\r \u00a0orto\t\r \u00a0exo,\t\r \u00a0meta\t\r \u00a0endo\t\r \u00a0y\t\r \u00a0meta\t\r \u00a0exo)\t\r \u00a0y\t\r \u00a0como\t\r \u00a0era\t\r \u00a0de\t\r \u00a0esperar\t\r \u00a0predicen\t\r \u00a0una\t\r \u00a0mayor\t\r \u00a0estabilidad\t\r \u00a0para\t\r \u00a0los\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0endo.\t\r \u00a0\t\r \u00a0A\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0estudios\t\r \u00a0se\t\r \u00a0dise\u00f1\u00f3\t\r \u00a0el\t\r \u00a0correspondiente\t\r \u00a0hapteno\t\r \u00a0teniendo\t\r \u00a0en\t\r \u00a0cuenta\t\r \u00a0que\t\r \u00a0este\t\r \u00a0deber\u00eda\t\r \u00a0mimetizar\t\r \u00a0algunas\t\r \u00a0de\t\r \u00a0las\t\r \u00a0caracter\u00edsticas\t\r \u00a0importantes\t\r \u00a0del\t\r \u00a0estado\t\r \u00a0 de\t\r \u00a0 transici\u00f3n.\t\r \u00a0 El\t\r \u00a0 anticuerpo\t\r \u00a0 generado\t\r \u00a0 mediante\t\r \u00a0 la\t\r \u00a0 administraci\u00f3n\t\r \u00a0 del\t\r \u00a0hapteno\t\r \u00a0dise\u00f1ado\t\r \u00a0ha\t\r \u00a0de\t\r \u00a0ser\t\r \u00a0capaz\t\r \u00a0de\t\r \u00a0reconocer\t\r \u00a0y\t\r \u00a0estabilizar\t\r \u00a0s\u00f3lo\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0cuatro\t\r \u00a0posibles\t\r \u00a0estados\t\r \u00a0de\t\r \u00a0transici\u00f3n.\t\r \u00a0Los\t\r \u00a0haptenos\t\r \u00a0fueron\t\r \u00a0sintetizados\t\r \u00a0y\t\r \u00a0cristalizados\t\r \u00a0y\t\r \u00a0su\t\r \u00a0 estructura\t\r \u00a0 cristalina\t\r \u00a0 fue\t\r \u00a0 comparada\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 estructura\t\r \u00a0 calculada\t\r \u00a0 del\t\r \u00a0 estado\t\r \u00a0 de\t\r \u00a0transici\u00f3n\t\r \u00a0 correspondiente,\t\r \u00a0 observ\u00e1ndose\t\r \u00a0 una\t\r \u00a0 similitud\t\r \u00a0 estructural\t\r \u00a0 apreciable.\t\r \u00a0(Figura\t\r \u00a03)\t\r \u00a0\t\r \u00a0La\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0haptenos\t\r \u00a0as\u00ed\t\r \u00a0dise\u00f1ados\t\r \u00a0permiti\u00f3\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0anticuerpos\t\r \u00a0capaces\t\r \u00a0de\t\r \u00a0catalizar\t\r \u00a0esta\t\r \u00a0reacci\u00f3n\t\r \u00a0y\t\r \u00a0obtener\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0selectiva\t\r \u00a0no\t\r \u00a0solo\t\r \u00a0el\t\r \u00a0 producto\t\r \u00a0 de\t\r \u00a0 adici\u00f3n\t\r \u00a0 favorecida,\t\r \u00a0 producto\t\r \u00a0 endo,\t\r \u00a0 sino\t\r \u00a0 tambi\u00e9n\t\r \u00a0 el\t\r \u00a0 producto\t\r \u00a0desfavorecida,\t\r \u00a0producto\t\r \u00a0exo(10).\t\r \u00a0\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n417\t\r \u00a0\t\r \u00a0\t\r \u00a0C3-\u00ad\u2010C4-\u00ad\u2010C5-\u00ad\u2010C6:\t\r \u00a01.1\u00ba\t\r \u00a0\t\r \u00a0C3-\u00ad\u2010C4-\u00ad\u2010C5-\u00ad\u2010C6:\t\r \u00a00.7\u00ba\t\r \u00a0C2-\u00ad\u2010C3:\t\r \u00a02.35\t\r \u00a0\u00c5\t\r \u00a0\t\r \u00a0C2-\u00ad\u2010C3:\t\r \u00a01.55\t\r \u00a0\u00c5\t\r \u00a0C6-\u00ad\u2010C1:\t\r \u00a02.05\t\r \u00a0\u00c5\t\r \u00a0\t\r \u00a0C6-\u00ad\u2010C1:\t\r \u00a01.55\t\r \u00a0\u00c5\t\r \u00a0Figura\t\r \u00a03.-\u00ad\u2010\t\r \u00a0Comparaci\u00f3n\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0geometr\u00edas\t\r \u00a0del\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0transici\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0orto-\u00ad\u2010endo\t\r \u00a0(izquierda)\t\r \u00a0con\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0cristalina\t\r \u00a0del\t\r \u00a0hapteno\t\r \u00a0dise\u00f1ado\t\r \u00a0para\t\r \u00a0mimetizarlo\t\r \u00a0(derecha).\t\r \u00a0A\u00f1os\t\r \u00a0m\u00e1s\t\r \u00a0tarde\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0Xu(11)\t\r \u00a0de\t\r \u00a01999\t\r \u00a0constituy\u00f3\t\r \u00a0un\t\r \u00a0nuevo\t\r \u00a0avance\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 ampliaci\u00f3n\t\r \u00a0 del\t\r \u00a0 campo\t\r \u00a0 de\t\r \u00a0 utilidad\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 anticuerpos\t\r \u00a0 catal\u00edticos.\t\r \u00a0 Utilizando\t\r \u00a0t\u00e9cnicas\t\r \u00a0de\t\r \u00a0rayos\t\r \u00a0X\t\r \u00a0y\t\r \u00a0computacionales\t\r \u00a0avanzadas\t\r \u00a0pudieron\t\r \u00a0estudiar\t\r \u00a0la\t\r \u00a0evoluci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0complementariedad\t\r \u00a0\u2013ya\t\r \u00a0que\t\r \u00a0la\t\r \u00a0uni\u00f3n\t\r \u00a0ant\u00edgeno-\u00ad\u2010anticuerpo\t\r \u00a0no\t\r \u00a0es\t\r \u00a0algo\t\r \u00a0est\u00e1tico,\t\r \u00a0sino\t\r \u00a0din\u00e1mico-\u00ad\u2010\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0mol\u00e9culas,\t\r \u00a0y\t\r \u00a0extraer\t\r \u00a0conclusiones\t\r \u00a0acerca\t\r \u00a0de\t\r \u00a0c\u00f3mo\t\r \u00a0debe\t\r \u00a0ser\t\r \u00a0el\t\r \u00a0hapteno\t\r \u00a0que\t\r \u00a0genere\t\r \u00a0el\t\r \u00a0anticuerpo\t\r \u00a0que\t\r \u00a0catalice,\t\r \u00a0por\t\r \u00a0ejemplo,\t\r \u00a0cicloadiciones\t\r \u00a0tipo\t\r \u00a0Diels-\u00ad\u2010Alder.\t\r \u00a0(Figura\t\r \u00a04,\t\r \u00a0c\u00f3digo\t\r \u00a0pdb=1c1e)\t\r \u00a0\n\t\r \u00a0Figura4.-\u00ad\u2010\t\r \u00a0Estructura\t\r \u00a0cristalina\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Diels-\u00ad\u2010Alderasa\t\r \u00a0en\t\r \u00a0complejo\t\r \u00a0con\t\r \u00a0un\t\r \u00a0hapteno.\t\r \u00a0Quiz\u00e1\t\r \u00a0 aquello\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 afirmaba\t\r \u00a0 en\t\r \u00a0 1996\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 dise\u00f1o\t\r \u00a0 de\t\r \u00a0 haptenos\t\r \u00a0 \u201ces\t\r \u00a0todav\u00eda\t\r \u00a0 m\u00e1s\t\r \u00a0 un\t\r \u00a0 arte\t\r \u00a0 que\t\r \u00a0 una\t\r \u00a0 ciencia\u201d(12)\t\r \u00a0se\t\r \u00a0 ha\t\r \u00a0 quedado\t\r \u00a0 ya\t\r \u00a0 obsoleto,\t\r \u00a0 derivando\t\r \u00a0hacia\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0ser\t\r \u00a0el\t\r \u00a0empuj\u00f3n\t\r \u00a0definitivo\t\r \u00a0al\t\r \u00a0avance\t\r \u00a0decidido\t\r \u00a0en\t\r \u00a0este\t\r \u00a0campo\t\r \u00a0del\t\r \u00a0conocimiento.\t\r \u00a0Adem\u00e1s,\t\r \u00a0 estos\t\r \u00a0 estudios\t\r \u00a0 iniciales,\t\r \u00a0 sobre\t\r \u00a0 los\t\r \u00a0 anticuerpos\t\r \u00a0 catal\u00edticos\t\r \u00a0 han\t\r \u00a0derivado\t\r \u00a0 hacia\t\r \u00a0 un\t\r \u00a0 campo\t\r \u00a0 apasionante\t\r \u00a0 como\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0 theozymes\t\r \u00a0(theoreticalenzymes),\t\r \u00a0 permitiendo\t\r \u00a0 dise\u00f1ar\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 te\u00f3rica\t\r \u00a0 la\t\r \u00a0 enzima\t\r \u00a0 necesaria\t\r \u00a0para\t\r \u00a0catalizar\t\r \u00a0un\t\r \u00a0determinado\t\r \u00a0proceso(13).\t\r \u00a03.\t\r \u00a0MEC\u00c1NICA\t\r \u00a0MOLECULAR\t\r \u00a0Las\t\r \u00a0t\u00e9cnicas\t\r \u00a0de\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0se\t\r \u00a0basan\t\r \u00a0en\t\r \u00a0un\t\r \u00a0modelo\t\r \u00a0simplificado\t\r \u00a0de\t\r \u00a0las\t\r \u00a0mol\u00e9culas,\t\r \u00a0entendidas\t\r \u00a0como\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0cl\u00e1sico\t\r \u00a0de\t\r \u00a0masas\t\r \u00a0(los\t\r \u00a0n\u00facleos\t\r \u00a0at\u00f3micos)\t\r \u00a0\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n418\t\r \u00a0\t\r \u00a0conectadas\t\r \u00a0 por\t\r \u00a0 unos\t\r \u00a0 resortes\t\r \u00a0 (los\t\r \u00a0 enlaces\t\r \u00a0 formados\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 electrones)\t\r \u00a0 que\t\r \u00a0verifican\t\r \u00a0 la\t\r \u00a0 ley\t\r \u00a0 de\t\r \u00a0 elasticidad\t\r \u00a0 de\t\r \u00a0 Hooke.\t\r \u00a0 Frecuentemente\t\r \u00a0 esta\t\r \u00a0simplificaci\u00f3n\t\r \u00a0 es\t\r \u00a0 a\t\r \u00a0menudo\t\r \u00a0comparada\t\r \u00a0como\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0bolas\t\r \u00a0y\t\r \u00a0muelles.\t\r \u00a0Esta\t\r \u00a0analog\u00eda\t\r \u00a0responde\t\r \u00a0a\t\r \u00a0las\t\r \u00a0 siguientes\t\r \u00a0 caracter\u00edsticas:\t\r \u00a0 cada\t\r \u00a0 bola\t\r \u00a0 encierra\t\r \u00a0 las\t\r \u00a0 propiedades\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 \u00e1tomo,\t\r \u00a0propiedades\t\r \u00a0 que\t\r \u00a0 dependen\t\r \u00a0 en\t\r \u00a0 realidad\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0distribuci\u00f3n\t\r \u00a0 electr\u00f3nica.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0mec\u00e1nica\t\r \u00a0 molecular,\t\r \u00a0 en\t\r \u00a0 lugar\t\r \u00a0 de\t\r \u00a0 calcular\t\r \u00a0 la\t\r \u00a0 funci\u00f3n\t\r \u00a0 de\t\r \u00a0 onda\t\r \u00a0 en\t\r \u00a0 cada\t\r \u00a0 sistema,\t\r \u00a0 se\t\r \u00a0estima\t\r \u00a0 el\t\r \u00a0 valor\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 propiedades\t\r \u00a0 derivadas\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 serie\t\r \u00a0 de\t\r \u00a0par\u00e1metros.\t\r \u00a0La\t\r \u00a0primera\t\r \u00a0consideraci\u00f3n\t\r \u00a0es\t\r \u00a0definir\t\r \u00a0un\t\r \u00a0conjunto\t\r \u00a0de\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0\u00e1tomos,\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0viene\t\r \u00a0determinado\t\r \u00a0no\t\r \u00a0s\u00f3lo\t\r \u00a0por\t\r \u00a0el\t\r \u00a0elemento\t\r \u00a0a\t\r \u00a0que\t\r \u00a0se\t\r \u00a0refiere\t\r \u00a0(ox\u00edgeno,\t\r \u00a0carbono...)\t\r \u00a0sino\t\r \u00a0por\t\r \u00a0los\t\r \u00a0diferentes\t\r \u00a0estados\t\r \u00a0en\t\r \u00a0que\t\r \u00a0este\t\r \u00a0se\t\r \u00a0puede\t\r \u00a0encontrar\t\r \u00a0en\t\r \u00a0 un\t\r \u00a0 sistema\t\r \u00a0 molecular\t\r \u00a0 (carbono\t\r \u00a0 con\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0 sp2,\t\r \u00a0 carbono\t\r \u00a0 con\t\r \u00a0 hibridaci\u00f3n\t\r \u00a0sp3...).\t\r \u00a0\t\r \u00a0Una\t\r \u00a0 vez\t\r \u00a0 definido\t\r \u00a0 el\t\r \u00a0 conjunto\t\r \u00a0 de\t\r \u00a0 \u00e1tomos,\t\r \u00a0 el\t\r \u00a0 efecto\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 distribuci\u00f3n\t\r \u00a0electr\u00f3nica\t\r \u00a0 se\t\r \u00a0 puede\t\r \u00a0 aproximar\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 inclusi\u00f3n\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 serie\t\r \u00a0 de\t\r \u00a0 cargas\t\r \u00a0parciales\t\r \u00a0(partialcharges)\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0\u00e1tomo.\t\r \u00a0Estas\t\r \u00a0cargas\t\r \u00a0se\t\r \u00a0habr\u00e1n\t\r \u00a0de\t\r \u00a0definir\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0 mol\u00e9cula\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 trabaja,\t\r \u00a0 puesto\t\r \u00a0 que\t\r \u00a0 dependen\t\r \u00a0 no\t\r \u00a0 solo\t\r \u00a0 del\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0\u00e1tomo\t\r \u00a0 sino\t\r \u00a0 del\t\r \u00a0 entorno\t\r \u00a0 molecular.\t\r \u00a0 El\t\r \u00a0 m\u00e9todo\t\r \u00a0 de\t\r \u00a0 c\u00e1lculo\t\r \u00a0 de\t\r \u00a0 carga\t\r \u00a0 parcial\t\r \u00a0 var\u00eda\t\r \u00a0desde\t\r \u00a0 aproximaciones\t\r \u00a0 topol\u00f3gicas,\t\r \u00a0 como\t\r \u00a0 las\t\r \u00a0 cargas\t\r \u00a0 de\t\r \u00a0 Gasteiger-\u00ad\u2010Marsili,(14)\t\r \u00a0a\t\r \u00a0m\u00e9todos\t\r \u00a0te\u00f3ricamente\t\r \u00a0m\u00e1s\t\r \u00a0exactos,\t\r \u00a0como\t\r \u00a0el\t\r \u00a0restrainedelectrostaticpotentialfitting\t\r \u00a0(RESP)(15)\t\r \u00a0empleado\t\r \u00a0 para\t\r \u00a0 definir\t\r \u00a0 las\t\r \u00a0 cargas\t\r \u00a0 parciales\t\r \u00a0 mediante\t\r \u00a0 un\t\r \u00a0 ajuste\t\r \u00a0 que\t\r \u00a0pretende\t\r \u00a0 reproducir\t\r \u00a0 lo\t\r \u00a0 mejor\t\r \u00a0 posible\t\r \u00a0 la\t\r \u00a0 distribuci\u00f3n\t\r \u00a0 del\t\r \u00a0 potencial\t\r \u00a0 electrost\u00e1tico\t\r \u00a0molecular,\t\r \u00a0 calculada\t\r \u00a0 ab\t\r \u00a0 initio\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0 base\t\r \u00a0 6-\u00ad\u201031G*.\t\r \u00a0 Existen\t\r \u00a0 otros\t\r \u00a0 m\u00e9todos\t\r \u00a0intermedios,\t\r \u00a0 como\t\r \u00a0 por\t\r \u00a0 ejemplo\t\r \u00a0 los\t\r \u00a0 basados\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 an\u00e1lisis\t\r \u00a0 de\t\r \u00a0 Mulliken\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0distribuci\u00f3n\t\r \u00a0 electr\u00f3nica\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 hamiltoniano\t\r \u00a0 AM1.\t\r \u00a0 Es\t\r \u00a0 com\u00fan\t\r \u00a0 el\t\r \u00a0 empleo\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0m\u00e9todos\t\r \u00a0de\t\r \u00a0c\u00e1lculo\t\r \u00a0de\t\r \u00a0cargas\t\r \u00a0r\u00e1pidos\t\r \u00a0(Gasteiger,\t\r \u00a0AM1)\t\r \u00a0en\t\r \u00a0los\t\r \u00a0estudios\t\r \u00a0de\t\r \u00a0docking,\t\r \u00a0mientras\t\r \u00a0 que\t\r \u00a0 procedimientos\t\r \u00a0 m\u00e1s\t\r \u00a0 elaborados\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 RESP\t\r \u00a0 se\t\r \u00a0 reservan\t\r \u00a0 para\t\r \u00a0estudios\t\r \u00a0 de\t\r \u00a0 din\u00e1mica\t\r \u00a0 molecular\t\r \u00a0 o\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 c\u00e1lculo\t\r \u00a0 de\t\r \u00a0 energ\u00eda\t\r \u00a0 libre\t\r \u00a0 de\t\r \u00a0 uni\u00f3n.\t\r \u00a0 Las\t\r \u00a0cargas\t\r \u00a0 parciales\t\r \u00a0 son\t\r \u00a0 necesarias\t\r \u00a0 para\t\r \u00a0 calcular\t\r \u00a0 interacciones\t\r \u00a0 de\t\r \u00a0 tipo\t\r \u00a0 electrost\u00e1tico\t\r \u00a0que\t\r \u00a0se\t\r \u00a0dan\t\r \u00a0entre\t\r \u00a0dos\t\r \u00a0\u00e1tomos\t\r \u00a0i\t\r \u00a0y\t\r \u00a0j\t\r \u00a0que\t\r \u00a0no\t\r \u00a0est\u00e1n\t\r \u00a0enlazados,\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0del\t\r \u00a0t\u00e9rmino\t\r \u00a0de\t\r \u00a0interacci\u00f3n\t\r \u00a0cul\u00f3mbica:\t\r \u00a0\t\r \u00a0ijjijielrqqV\u03c0\u03b541),(\u2212= (4) siendo\t\r \u00a0q\t\r \u00a0la\t\r \u00a0carga\t\r \u00a0parcial\t\r \u00a0de\t\r \u00a0cada\t\r \u00a0\u00e1tomo,\t\r \u00a0r\t\r \u00a0la\t\r \u00a0distancia\t\r \u00a0que\t\r \u00a0los\t\r \u00a0separa\t\r \u00a0y\t\r \u00a0e\t\r \u00a0la\t\r \u00a0constante\t\r \u00a0diel\u00e9ctrica\t\r \u00a0del\t\r \u00a0medio,\t\r \u00a0que\t\r \u00a0representa\t\r \u00a0la\t\r \u00a0oposici\u00f3n\t\r \u00a0del\t\r \u00a0entorno\t\r \u00a0(agua\t\r \u00a0y\t\r \u00a0prote\u00edna)\t\r \u00a0a\t\r \u00a0la\t\r \u00a0interacci\u00f3n\t\r \u00a0entre\t\r \u00a0ambas\t\r \u00a0cargas.\t\r \u00a0El\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0constante\t\r \u00a0es\t\r \u00a0de\t\r \u00a0e\t\r \u00a0=\t\r \u00a080\t\r \u00a0para\t\r \u00a0el\t\r \u00a0agua,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0los\t\r \u00a0valores\t\r \u00a0t\u00edpicos\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0son\t\r \u00a0mucho\t\r \u00a0menores\t\r \u00a0(entre\t\r \u00a0 2\t\r \u00a0 y\t\r \u00a0 5).\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 pueden\t\r \u00a0 existir\t\r \u00a0 microentornos\t\r \u00a0 proteicos\t\r \u00a0 m\u00e1s\t\r \u00a0 polares\t\r \u00a0donde\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0e\t\r \u00a0se\t\r \u00a0incremente.\t\r \u00a0Se\t\r \u00a0puede\t\r \u00a0afirmar\t\r \u00a0que\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0constante\t\r \u00a0pretende\t\r \u00a0 incorporar\t\r \u00a0 todos\t\r \u00a0 aquellos\t\r \u00a0 efectos\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 han\t\r \u00a0 sido\t\r \u00a0 expl\u00edcitamente\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n419\t\r \u00a0\t\r \u00a0considerados\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 modelo\t\r \u00a0 (como\t\r \u00a0 el\t\r \u00a0 solvente\t\r \u00a0 acuoso\t\r \u00a0 o\t\r \u00a0 la\t\r \u00a0 membrana\t\r \u00a0 celular),\t\r \u00a0tomando\t\r \u00a0 valor\t\r \u00a0 unidad\t\r \u00a0 cuando\t\r \u00a0 todos\t\r \u00a0 estos\t\r \u00a0 efectos\t\r \u00a0 se\t\r \u00a0 consideran\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0expl\u00edcita.\t\r \u00a0La\t\r \u00a0optimizaci\u00f3n\t\r \u00a0de\t\r \u00a0su\t\r \u00a0valor\t\r \u00a0en\t\r \u00a0c\u00e1lculos\t\r \u00a0referidos\t\r \u00a0a\t\r \u00a0prote\u00ednas\t\r \u00a0es\t\r \u00a0motivo\t\r \u00a0de\t\r \u00a0 continuas\t\r \u00a0 revisiones.\t\r \u00a0 Una\t\r \u00a0 aproximaci\u00f3n\t\r \u00a0 generalizada\t\r \u00a0 es\t\r \u00a0 asignar\t\r \u00a0 valores\t\r \u00a0 de\t\r \u00a0 e\t\r \u00a0dependientes\t\r \u00a0de\t\r \u00a0la\t\r \u00a0distancia\t\r \u00a0rij.\t\r \u00a0\t\r \u00a0Es\t\r \u00a0 necesario\t\r \u00a0 tener\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 los\t\r \u00a0 t\u00e9rminos\t\r \u00a0 de\t\r \u00a0 repulsi\u00f3n\t\r \u00a0 y\t\r \u00a0 atracci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0van\t\r \u00a0der\t\r \u00a0Waals,\t\r \u00a0la\t\r \u00a0cual\t\r \u00a0eval\u00faa\t\r \u00a0la\t\r \u00a0interacci\u00f3n\t\r \u00a0no\t\r \u00a0electrost\u00e1tica\t\r \u00a0entre\t\r \u00a0pares\t\r \u00a0de\t\r \u00a0\u00e1tomos\t\r \u00a0no\t\r \u00a0enlazados.\t\r \u00a0Estos\t\r \u00a0t\u00e9rminos\t\r \u00a0vienen\t\r \u00a0representados\t\r \u00a0por\t\r \u00a0las\t\r \u00a0constantes\t\r \u00a0A\t\r \u00a0y\t\r \u00a0B.\t\r \u00a0612),(ijijijijjivdWrBrAV= (5) Estos\t\r \u00a0 valores\t\r \u00a0 se\t\r \u00a0 obtienen\t\r \u00a0 emp\u00edricamente\t\r \u00a0 para\t\r \u00a0 cada\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 \u00e1tomo\t\r \u00a0interaccionando\t\r \u00a0consigo\t\r \u00a0mismo\t\r \u00a0(Aij\t\r \u00a0y\t\r \u00a0Bij).\t\r \u00a0Los\t\r \u00a0valores\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0par\t\r \u00a0ij\t\r \u00a0se\t\r \u00a0obtienen\t\r \u00a0mediante\t\r \u00a0 la\t\r \u00a0 media\t\r \u00a0 geom\u00e9trica\t\r \u00a0jjijijAAA\u00b7=\t\r \u00a0\t\r \u00a0(y\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0 an\u00e1loga\t\r \u00a0 para\t\r \u00a0 B).\t\r \u00a0 La\t\r \u00a0formulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 ecuaci\u00f3n\t\r \u00a0 5\t\r \u00a0 recibe\t\r \u00a0 el\t\r \u00a0 nombre\t\r \u00a0 de\t\r \u00a0 potencial\t\r \u00a0 de\t\r \u00a0 Lennard-\u00ad\u2010Jones\t\r \u00a0aunque\t\r \u00a0existen\t\r \u00a0otras\t\r \u00a0formas\t\r \u00a0alternativas\t\r \u00a0de\t\r \u00a0formular\t\r \u00a0la\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0van\t\r \u00a0der\t\r \u00a0Waals,\t\r \u00a0bas\u00e1ndose\t\r \u00a0en\t\r \u00a0variaciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0los\t\r \u00a0exponentes\t\r \u00a0de\t\r \u00a0los\t\r \u00a0t\u00e9rminos\t\r \u00a0rij.\t\r \u00a0\t\r \u00a0Los\t\r \u00a0t\u00e9rminos\t\r \u00a0electrost\u00e1tico\t\r \u00a0(Vel)\t\r \u00a0y\t\r \u00a0de\t\r \u00a0van\t\r \u00a0der\t\r \u00a0Waals\t\r \u00a0(VvdW)\t\r \u00a0se\t\r \u00a0calculan\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0par\t\r \u00a0de\t\r \u00a0\u00e1tomos\t\r \u00a0no\t\r \u00a0enlazados\t\r \u00a0que\t\r \u00a0se\t\r \u00a0encuentren\t\r \u00a0a\t\r \u00a0una\t\r \u00a0distancia\t\r \u00a0r\t\r \u00a0menor\t\r \u00a0que\t\r \u00a0una\t\r \u00a0distancia\t\r \u00a0de\t\r \u00a0corte\t\r \u00a0rcut-\u00ad\u2010off.\t\r \u00a0Esta\t\r \u00a0aproximaci\u00f3n\t\r \u00a0se\t\r \u00a0utiliza\t\r \u00a0para\t\r \u00a0ahorrar\t\r \u00a0tiempo\t\r \u00a0de\t\r \u00a0c\u00e1lculo,\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0si\t\r \u00a0no,\t\r \u00a0habr\u00eda\t\r \u00a0que\t\r \u00a0evaluar\t\r \u00a0N2\t\r \u00a0interacciones\t\r \u00a0(siendo\t\r \u00a0N\t\r \u00a0el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0sistema).\t\r \u00a0Es\t\r \u00a0posible\t\r \u00a0evaluar\t\r \u00a0la\t\r \u00a0interacci\u00f3n\t\r \u00a0electrost\u00e1tica\t\r \u00a0cuando\t\r \u00a0r\t\r \u00a0>rcut-\u00ad\u2010offen\t\r \u00a0un\t\r \u00a0tiempo\t\r \u00a0razonable\t\r \u00a0de\t\r \u00a0tiempo,\t\r \u00a0como\t\r \u00a0por\t\r \u00a0ejemplo\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0m\u00e9todo\t\r \u00a0local\t\r \u00a0reactionfield.(16)\t\r \u00a0Se\t\r \u00a0 asume\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 enlaces\t\r \u00a0 entre\t\r \u00a0 \u00e1tomos\t\r \u00a0 son\t\r \u00a0 flexibles\t\r \u00a0 alrededor\t\r \u00a0 de\t\r \u00a0 unas\t\r \u00a0distancias\t\r \u00a0de\t\r \u00a0equilibrio\t\r \u00a0(r0),\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0vibrar\t\r \u00a0como\t\r \u00a0lo\t\r \u00a0hace\t\r \u00a0un\t\r \u00a0muelle.\t\r \u00a0Esta\t\r \u00a0vibraci\u00f3n\t\r \u00a0se\t\r \u00a0representa\t\r \u00a0mediante\t\r \u00a0un\t\r \u00a0potencial\t\r \u00a0harm\u00f3nico\t\r \u00a0cuadr\u00e1tico\t\r \u00a0del\t\r \u00a0tipo:\t\r \u00a02)(orenlacerrkV\u2212= (6) Este\t\r \u00a0potencial\t\r \u00a0cumple\t\r \u00a0estrictamente\t\r \u00a0la\t\r \u00a0ley\t\r \u00a0de\t\r \u00a0Hooke.\t\r \u00a0kr\t\r \u00a0es\t\r \u00a0una\t\r \u00a0constante\t\r \u00a0de\t\r \u00a0fuerza\t\r \u00a0definida\t\r \u00a0para\t\r \u00a0cada\t\r \u00a0par\t\r \u00a0de\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0\u00e1tomo\t\r \u00a0(ij)\t\r \u00a0que\t\r \u00a0puedan\t\r \u00a0estar\t\r \u00a0enlazados,\t\r \u00a0y\t\r \u00a0r0\t\r \u00a0la\t\r \u00a0distancia\t\r \u00a0de\t\r \u00a0equilibrio\t\r \u00a0del\t\r \u00a0enlace\t\r \u00a0ij.\t\r \u00a0De\t\r \u00a0 forma\t\r \u00a0 an\u00e1loga,\t\r \u00a0 el\t\r \u00a0 \u00e1ngulo\t\r \u00a0 q\t\r \u00a0 que\t\r \u00a0 forma\t\r \u00a0 cada\t\r \u00a0 par\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 contiguo\t\r \u00a0tambi\u00e9n\t\r \u00a0puede\t\r \u00a0variar\t\r \u00a0alrededor\t\r \u00a0de\t\r \u00a0un\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0equilibrio\t\r \u00a0q0,\t\r \u00a0siendo\t\r \u00a0la\t\r \u00a0constante\t\r \u00a0de\t\r \u00a0fuerza\t\r \u00a0kq:\t\r \u00a0\t\r \u00a020)(\u03b8\u03b8\u03b8\u2212=kV\u00e1ngulo (J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n420\t\r \u00a0\t\r \u00a07) Los\t\r \u00a0\u00e1ngulos\t\r \u00a0torsionales\t\r \u00a0f\t\r \u00a0(que\t\r \u00a0definen\t\r \u00a0la\t\r \u00a0rotaci\u00f3n\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0enlaces)\t\r \u00a0var\u00edan\t\r \u00a0de\t\r \u00a0 forma\t\r \u00a0 distinta,\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 dicha\t\r \u00a0 rotaci\u00f3n\t\r \u00a0 ha\t\r \u00a0 de\t\r \u00a0 pasar\t\r \u00a0 una\t\r \u00a0 barrera\t\r \u00a0 peri\u00f3dica.\t\r \u00a0 Por\t\r \u00a0tanto,\t\r \u00a0su\t\r \u00a0variaci\u00f3n\t\r \u00a0se\t\r \u00a0modela\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0una\t\r \u00a0funci\u00f3n\t\r \u00a0peri\u00f3dica\t\r \u00a0del\t\r \u00a0tipo:\t\r \u00a0\t\r \u00a0))co s(1(21\u03b3\u03c6\u2212+=nkVntorsi\u00f3n (8) siendo\t\r \u00a0kn\t\r \u00a0la\t\r \u00a0 barrera\t\r \u00a0 de\t\r \u00a0rotaci\u00f3n,\t\r \u00a0n\t\r \u00a0la\t\r \u00a0 periodicidad\t\r \u00a0 (n\u00famero\t\r \u00a0 de\t\r \u00a0 veces\t\r \u00a0 que\t\r \u00a0aparece\t\r \u00a0la\t\r \u00a0barrera\t\r \u00a0en\t\r \u00a0un\t\r \u00a0giro\t\r \u00a0completo)\t\r \u00a0y\t\r \u00a0g\t\r \u00a0la\t\r \u00a0fase\t\r \u00a0(la\t\r \u00a0localizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0primera\t\r \u00a0barrera).\t\r \u00a0\t\r \u00a0Adicionalmente\t\r \u00a0 se\t\r \u00a0 pueden\t\r \u00a0 modelar\t\r \u00a0 los\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0 hidr\u00f3geno\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0espec\u00edfica,\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 potencial\t\r \u00a0 an\u00e1logo\t\r \u00a0 al\t\r \u00a0 de\t\r \u00a0 Lennard-\u00ad\u2010Jones\t\r \u00a0 con\t\r \u00a0modificaciones\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 par\u00e1metros.\t\r \u00a0 Esta\t\r \u00a0 consideraci\u00f3n\t\r \u00a0 expl\u00edcita\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 enlaces\t\r \u00a0 de\t\r \u00a0hidr\u00f3geno\t\r \u00a0 aparec\u00eda\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 primera\t\r \u00a0 versi\u00f3n\t\r \u00a0 del\t\r \u00a0 campo\t\r \u00a0 de\t\r \u00a0 fuerzas\t\r \u00a0 del\t\r \u00a0 programa\t\r \u00a0AMBER,(17),\t\r \u00a0 por\t\r \u00a0 ejemplo.\t\r \u00a0 En\t\r \u00a0 otros\t\r \u00a0 programas,\t\r \u00a0 su\t\r \u00a0 efecto\t\r \u00a0 ya\t\r \u00a0 est\u00e1\t\r \u00a0 incluido\t\r \u00a0indirectamente\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 t\u00e9rminos\t\r \u00a0 electrost\u00e1tico\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 van\t\r \u00a0 der\t\r \u00a0 Waals.\t\r \u00a0 Tambi\u00e9n\t\r \u00a0 hay\t\r \u00a0que\t\r \u00a0 considerar\t\r \u00a0 los\t\r \u00a0 llamados\t\r \u00a0 \u00e1ngulos\t\r \u00a0 torsionales\t\r \u00a0 impropios,\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 refieren\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0planaridad\t\r \u00a0de\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0de\t\r \u00a0cuatro\t\r \u00a0\u00e1tomos\t\r \u00a0en\t\r \u00a0los\t\r \u00a0cuales\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0ellos,\t\r \u00a0en\t\r \u00a0posici\u00f3n\t\r \u00a0central,\t\r \u00a0est\u00e1\t\r \u00a0enlazado\t\r \u00a0a\t\r \u00a0los\t\r \u00a0otros\t\r \u00a0tres\t\r \u00a0(por\t\r \u00a0ejemplo\t\r \u00a0en\t\r \u00a0anillos\t\r \u00a0tipo\t\r \u00a0naftaleno).\t\r \u00a0Estos\t\r \u00a0pueden\t\r \u00a0 ser\t\r \u00a0 modelados\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 an\u00e1loga\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 \u00e1ngulos\t\r \u00a0 torsionales\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0potenciales\t\r \u00a0peri\u00f3dicos,\t\r \u00a0como\t\r \u00a0sucede\t\r \u00a0en\t\r \u00a0CHARMM,(18)\t\r \u00a0GROMOS(19)\t\r \u00a0y\t\r \u00a0AMBER(17)\t\r \u00a0o\t\r \u00a0 bien\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 potenciales\t\r \u00a0 harm\u00f3nicos.\t\r \u00a0 Por\t\r \u00a0 \u00faltimo,\t\r \u00a0 existe\t\r \u00a0 la\t\r \u00a0 posibilidad\t\r \u00a0 de\t\r \u00a0simplificar\t\r \u00a0la\t\r \u00a0representaci\u00f3n\t\r \u00a0molecular\t\r \u00a0mediante\t\r \u00a0los\t\r \u00a0modelos\t\r \u00a0unitedatom,\t\r \u00a0que\t\r \u00a0no\t\r \u00a0consideran\t\r \u00a0 expl\u00edcitamente\t\r \u00a0 los\t\r \u00a0 hidr\u00f3genos\t\r \u00a0 no\t\r \u00a0 polares,\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 que\t\r \u00a0 sus\t\r \u00a0caracter\u00edsticas\t\r \u00a0 (masa,\t\r \u00a0 carga)\t\r \u00a0 se\t\r \u00a0 a\u00f1aden\t\r \u00a0 al\t\r \u00a0 \u00e1tomo\t\r \u00a0 al\t\r \u00a0 que\t\r \u00a0 est\u00e9n\t\r \u00a0 unidos(20).\t\r \u00a0Esta\t\r \u00a0aproximaci\u00f3n\t\r \u00a0se\t\r \u00a0usa\t\r \u00a0en\t\r \u00a0los\t\r \u00a0programas\t\r \u00a0GROMOS,\t\r \u00a0GRID\t\r \u00a0y\t\r \u00a0AutoDock.\t\r \u00a0\t\r \u00a0El\t\r \u00a0 sumatorio\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 t\u00e9rminos\t\r \u00a0 formulados\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 ecuaciones\t\r \u00a0 anteriores\t\r \u00a0 da\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0la\t\r \u00a0expresi\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0molecular:\t\r \u00a0\t\r \u00a0\u2211\u2211\u2211\u2211\u2212<++++=en l ac e\u00e1n gul ossto rsion al errvd Welto rsionan gul oen l ac epo toffcutVVVVVV)( (9) \t\r \u00a0El\t\r \u00a0modo\t\r \u00a0de\t\r \u00a0formular\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0t\u00e9rminos\t\r \u00a0comentados\t\r \u00a0anteriormente,\t\r \u00a0el\t\r \u00a0 m\u00e9todo\t\r \u00a0de\t\r \u00a0 obtenci\u00f3n\t\r \u00a0 de\t\r \u00a0 cargas\t\r \u00a0 parciales\t\r \u00a0 y\t\r \u00a0 par\u00e1metros\t\r \u00a0 Lennard-\u00ad\u2010Jones,\t\r \u00a0 el\t\r \u00a0n\u00famero\t\r \u00a0de\t\r \u00a0tipos\t\r \u00a0de\t\r \u00a0\u00e1tomos\t\r \u00a0(atomtypes)\t\r \u00a0y\t\r \u00a0el\t\r \u00a0conjunto\t\r \u00a0de\t\r \u00a0par\u00e1metros\t\r \u00a0(constantes\t\r \u00a0k\t\r \u00a0y\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0equilibrio\t\r \u00a0en\t\r \u00a0cada\t\r \u00a0ecuaci\u00f3n)\t\r \u00a0constituye\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0se\t\r \u00a0denomina\t\r \u00a0un\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0fuerzas\t\r \u00a0de\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0(force-\u00ad\u2010field).\t\r \u00a0\t\r \u00a0Existen\t\r \u00a0 numerosos\t\r \u00a0campos\t\r \u00a0 de\t\r \u00a0 fuerza\t\r \u00a0como\t\r \u00a0 MM2,\t\r \u00a0 Amber,\t\r \u00a0 POLS,\t\r \u00a0 CVFF,\t\r \u00a0GROMOS\t\r \u00a0o\t\r \u00a0CHARMM,\t\r \u00a0entre\t\r \u00a0otros.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0mencionaremos\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0especial\t\r \u00a0CHARMM\t\r \u00a0 porque\t\r \u00a0 la\t\r \u00a0 contribuci\u00f3n\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 galardonados\t\r \u00a0 al\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n421\t\r \u00a0\t\r \u00a0programa\t\r \u00a0 ha\t\r \u00a0 sido\t\r \u00a0 fundamental.\t\r \u00a0 Los\t\r \u00a0 trabajos\t\r \u00a0 conducentes\t\r \u00a0 al\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0campo\t\r \u00a0 de\t\r \u00a0 fuerzas,\t\r \u00a0est\u00e1n\t\r \u00a0 basados\t\r \u00a0 en\t\r \u00a0 uno\t\r \u00a0 inicialmente\t\r \u00a0 desarrollado\t\r \u00a0 por\t\r \u00a0 Lifson\t\r \u00a0 y\t\r \u00a0AriehWarhsel,\t\r \u00a0 denominado\t\r \u00a0 ConsistentForceFielc\t\r \u00a0 (CFF),\t\r \u00a0 que\t\r \u00a0 inclu\u00eda\t\r \u00a0 interacciones\t\r \u00a0no\t\r \u00a0 enlazantes.(21)\t\r \u00a0Tambi\u00e9n\t\r \u00a0 fueron\t\r \u00a0 fundamentales\t\r \u00a0 los\t\r \u00a0 trabajos\t\r \u00a0 pioneros\t\r \u00a0 de\t\r \u00a0Michael\t\r \u00a0Levitt\t\r \u00a0en\t\r \u00a0el\t\r \u00a0c\u00e1lculo\t\r \u00a0de\t\r \u00a0energ\u00edas\t\r \u00a0de\t\r \u00a0prote\u00ednas,\t\r \u00a0(22)\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0los\t\r \u00a0trabajos\t\r \u00a0de\t\r \u00a0Harold\t\r \u00a0Scheraga.(23)\t\r \u00a0Inicialmente\t\r \u00a0 se\t\r \u00a0 le\t\r \u00a0 dio\t\r \u00a0 el\t\r \u00a0 nombre\t\r \u00a0 de\t\r \u00a0HARMM\t\r \u00a0(HARvardMacromolecular\t\r \u00a0Mechanics),\t\r \u00a0sin\t\r \u00a0embargo,\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0que\t\r \u00a0su\t\r \u00a0significado\t\r \u00a0en\t\r \u00a0ingl\u00e9s\t\r \u00a0no\t\r \u00a0resultaba\t\r \u00a0muy\t\r \u00a0atractivo,\t\r \u00a0se\t\r \u00a0introdujo\t\r \u00a0el\t\r \u00a0t\u00e9rmino\t\r \u00a0Chemistry,\t\r \u00a0resultando\t\r \u00a0con\t\r \u00a0el\t\r \u00a0nombre\t\r \u00a0con\t\r \u00a0el\t\r \u00a0que\t\r \u00a0actualmente\t\r \u00a0 se\t\r \u00a0 conoce\t\r \u00a0CHARMM\t\r \u00a0(ChemistryHARvardMacromolecular\t\r \u00a0Mechanics)(18).\t\r \u00a03.1.\t\r \u00a0Din\u00e1mica\t\r \u00a0Molecular\t\r \u00a0En\t\r \u00a0 la\t\r \u00a0 din\u00e1mica\t\r \u00a0 molecular\t\r \u00a0 (Molecular\t\r \u00a0 Dynamics,\t\r \u00a0 MD)\t\r \u00a0 se\t\r \u00a0 generan\t\r \u00a0 las\t\r \u00a0conformaciones\t\r \u00a0 sucesivas\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 integrando\t\r \u00a0 las\t\r \u00a0 leyes\t\r \u00a0 de\t\r \u00a0 Newton\t\r \u00a0 del\t\r \u00a0movimiento.\t\r \u00a0 El\t\r \u00a0 resultado\t\r \u00a0 es\t\r \u00a0 una\t\r \u00a0 trayectoria\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 posiciones\t\r \u00a0 y\t\r \u00a0 las\t\r \u00a0velocidades\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0var\u00edan\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0del\t\r \u00a0tiempo\t\r \u00a0de\t\r \u00a0simulaci\u00f3n.\t\r \u00a0La\t\r \u00a0 trayectoria\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 se\t\r \u00a0 obtiene\t\r \u00a0 resolviendo\t\r \u00a0 la\t\r \u00a0 segunda\t\r \u00a0 derivada\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Segunda\t\r \u00a0Ley\t\r \u00a0de\t\r \u00a0Newton.\t\r \u00a0F=ma:\t\r \u00a0\t\r \u00a0iximFdtxid=22\t\r \u00a0(10)\t\r \u00a0Esta\t\r \u00a0 describe\t\r \u00a0 el\t\r \u00a0 movimiento\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 \u00e1tomo\t\r \u00a0 de\t\r \u00a0 masa\t\r \u00a0mi\t\r \u00a0a\t\r \u00a0 lo\t\r \u00a0 largo\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0coordenadas\t\r \u00a0(xi)\t\r \u00a0con\t\r \u00a0una\t\r \u00a0fuerza\t\r \u00a0determinada\t\r \u00a0(Fi)\t\r \u00a0que\t\r \u00a0viene\t\r \u00a0dada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0fuerzas,\t\r \u00a0 y\t\r \u00a0 un\t\r \u00a0 tiempo\t\r \u00a0t.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 punto\t\r \u00a0 inicial\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 din\u00e1mica,\t\r \u00a0 la\t\r \u00a0 energ\u00eda\t\r \u00a0 total\t\r \u00a0 del\t\r \u00a0sistema\t\r \u00a0es\t\r \u00a0la\t\r \u00a0suma\t\r \u00a0de\t\r \u00a0las\t\r \u00a0energ\u00edas\t\r \u00a0cin\u00e9tica\t\r \u00a0y\t\r \u00a0potencial\t\r \u00a0para\t\r \u00a0las\t\r \u00a0coordenadas\t\r \u00a0(x0)\t\r \u00a0y\t\r \u00a0velocidades\t\r \u00a0(v0)\t\r \u00a0iniciales:\t\r \u00a0\t\r \u00a0)()(00vExEEkpottot+=\t\r \u00a0(11)\t\r \u00a0\t\r \u00a0Este\t\r \u00a0es\t\r \u00a0un\t\r \u00a0m\u00e9todo\t\r \u00a0determinista\t\r \u00a0ya\t\r \u00a0que\t\r \u00a0el\t\r \u00a0resultado\t\r \u00a0final\t\r \u00a0es\t\r \u00a0dependiente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0posici\u00f3n\t\r \u00a0inicial\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0(de\t\r \u00a0ah\u00ed\t\r \u00a0la\t\r \u00a0recomendaci\u00f3n\t\r \u00a0de\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0varias\t\r \u00a0conformaciones\t\r \u00a0iniciales\t\r \u00a0para\t\r \u00a0comprobar\t\r \u00a0que\t\r \u00a0los\t\r \u00a0resultados\t\r \u00a0convergen,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0 la\t\r \u00a0 necesidad\t\r \u00a0 de\t\r \u00a0 realizar\t\r \u00a0 una\t\r \u00a0 minimizaci\u00f3n\t\r \u00a0 previa\t\r \u00a0 para\t\r \u00a0 evitar\t\r \u00a0 que\t\r \u00a0 haya\t\r \u00a0gradientes\t\r \u00a0 de\t\r \u00a0 energ\u00eda\t\r \u00a0 muy\t\r \u00a0 grandes\t\r \u00a0 que\t\r \u00a0 distorsionen\t\r \u00a0 el\t\r \u00a0 comportamiento\t\r \u00a0 del\t\r \u00a0sistema).\t\r \u00a0La\t\r \u00a0 evoluci\u00f3n\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 a\t\r \u00a0 lo\t\r \u00a0 largo\t\r \u00a0 del\t\r \u00a0 tiempo\t\r \u00a0 se\t\r \u00a0 obtendr\u00e1\t\r \u00a0 mediante\t\r \u00a0integraci\u00f3n\t\r \u00a0 num\u00e9rica.\t\r \u00a0 Esta\t\r \u00a0 integraci\u00f3n\t\r \u00a0 se\t\r \u00a0 realizar\u00e1\t\r \u00a0 en\t\r \u00a0 fracciones\t\r \u00a0 de\t\r \u00a0 tiempo\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n422\t\r \u00a0\t\r \u00a0separadas\t\r \u00a0por\t\r \u00a0el\t\r \u00a0valor\t\r \u00a0de\t\r \u00a0dt.\t\r \u00a0La\t\r \u00a0fuerza\t\r \u00a0total\t\r \u00a0de\t\r \u00a0cada\t\r \u00a0part\u00edcula\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tiempo\t\r \u00a0t\t\r \u00a0(que\t\r \u00a0se\t\r \u00a0asume\t\r \u00a0que\t\r \u00a0es\t\r \u00a0constante)\t\r \u00a0se\t\r \u00a0calcula\t\r \u00a0como\t\r \u00a0la\t\r \u00a0suma\t\r \u00a0vectorial\t\r \u00a0de\t\r \u00a0las\t\r \u00a0interacciones\t\r \u00a0con\t\r \u00a0los\t\r \u00a0dem\u00e1s\t\r \u00a0\u00e1tomos\t\r \u00a0y\t\r \u00a0se\t\r \u00a0determina\t\r \u00a0mediante\t\r \u00a0la\t\r \u00a0derivada\t\r \u00a0de\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0potencial\t\r \u00a0con\t\r \u00a0respecto\t\r \u00a0a\t\r \u00a0las\t\r \u00a0coordenadas:\t\r \u00a0\t\r \u00a0\t\r \u00a0(10)\t\r \u00a0\t\r \u00a0A\t\r \u00a0partir\t\r \u00a0de\t\r \u00a0las\t\r \u00a0fuerzas\t\r \u00a0se\t\r \u00a0puede\t\r \u00a0determinar\t\r \u00a0la\t\r \u00a0aceleraci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0de\t\r \u00a0modo\t\r \u00a0que,\t\r \u00a0conociendo\t\r \u00a0sus\t\r \u00a0posiciones\t\r \u00a0y\t\r \u00a0velocidades\t\r \u00a0a\t\r \u00a0tiempo\t\r \u00a0t,\t\r \u00a0podemos\t\r \u00a0calcular\t\r \u00a0sus\t\r \u00a0posiciones\t\r \u00a0y\t\r \u00a0velocidades\t\r \u00a0en\t\r \u00a0la\t\r \u00a0siguiente\t\r \u00a0fracci\u00f3n\t\r \u00a0de\t\r \u00a0tiempo,\t\r \u00a0t+dt.\t\r \u00a0Este\t\r \u00a0proceso\t\r \u00a0se\t\r \u00a0repite\t\r \u00a0sucesivamente\t\r \u00a0para\t\r \u00a0generar\t\r \u00a0la\t\r \u00a0trayectoria\t\r \u00a0completa\t\r \u00a0para\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0sistema.\t\r \u00a0Los\t\r \u00a0algoritmos\t\r \u00a0empleados\t\r \u00a0en\t\r \u00a0MD\t\r \u00a0para\t\r \u00a0generar\t\r \u00a0las\t\r \u00a0trayectorias\t\r \u00a0asumen\t\r \u00a0que\t\r \u00a0las\t\r \u00a0propiedades\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0se\t\r \u00a0pueden\t\r \u00a0aproximar\t\r \u00a0mediante\t\r \u00a0series\t\r \u00a0de\t\r \u00a0Taylor:\t\r \u00a0\t\r \u00a0\t\r \u00a0(11)\t\r \u00a0\t\r \u00a0\t\r \u00a0donde\t\r \u00a0v\t\r \u00a0es\t\r \u00a0la\t\r \u00a0velocidad\t\r \u00a0(primera\t\r \u00a0derivada\t\r \u00a0de\t\r \u00a0las\t\r \u00a0posiciones\t\r \u00a0con\t\r \u00a0respecto\t\r \u00a0al\t\r \u00a0tiempo),\t\r \u00a0a\t\r \u00a0es\t\r \u00a0la\t\r \u00a0aceleraci\u00f3n\t\r \u00a0(segunda\t\r \u00a0derivada),\t\r \u00a0c\t\r \u00a0es\t\r \u00a0la\t\r \u00a0tercera\t\r \u00a0derivada,\t\r \u00a0etc.\t\r \u00a0Estas\t\r \u00a0ecuaciones\t\r \u00a0se\t\r \u00a0integran\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0algoritmo\t\r \u00a0de\t\r \u00a0Verlet(24),\t\r \u00a0que\t\r \u00a0usa\t\r \u00a0las\t\r \u00a0posiciones\t\r \u00a0y\t\r \u00a0aceleraciones\t\r \u00a0a\t\r \u00a0tiempo\t\r \u00a0t\t\r \u00a0y\t\r \u00a0las\t\r \u00a0posiciones\t\r \u00a0en\t\r \u00a0la\t\r \u00a0etapa\t\r \u00a0previa,\t\r \u00a0x(t-\u00ad\u2010dt),\t\r \u00a0para\t\r \u00a0calcular\t\r \u00a0las\t\r \u00a0nuevas\t\r \u00a0posiciones\t\r \u00a0a\t\r \u00a0t+dt,\t\r \u00a0x(t+d).\t\r \u00a0El\t\r \u00a0 tiempo\t\r \u00a0 de\t\r \u00a0 integraci\u00f3n\t\r \u00a0dt\t\r \u00a0 elegido\t\r \u00a0 es\t\r \u00a0 de\t\r \u00a0 vital\t\r \u00a0 importancia\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 si\t\r \u00a0 es\t\r \u00a0demasiado\t\r \u00a0 peque\u00f1o\t\r \u00a0 la\t\r \u00a0 trayectoria\t\r \u00a0 apenas\t\r \u00a0 cubrir\u00e1\t\r \u00a0 una\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 todo\t\r \u00a0 el\t\r \u00a0 espacio\t\r \u00a0conformacional,\t\r \u00a0 mientras\t\r \u00a0 que\t\r \u00a0 si\t\r \u00a0 es\t\r \u00a0 demasiado\t\r \u00a0 grande\t\r \u00a0 puede\t\r \u00a0 provocar\t\r \u00a0inestabilidades\t\r \u00a0 debidas\t\r \u00a0 a\t\r \u00a0 solapamientos\t\r \u00a0 energ\u00e9ticos\t\r \u00a0 entre\t\r \u00a0 \u00e1tomos.\t\r \u00a0 Los\t\r \u00a0movimientos\t\r \u00a0de\t\r \u00a0mayor\t\r \u00a0frecuencia\t\r \u00a0son\t\r \u00a0aquellos\t\r \u00a0que\t\r \u00a0corresponden\t\r \u00a0a\t\r \u00a0la\t\r \u00a0vibraci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0enlaces\t\r \u00a0con\t\r \u00a0hidr\u00f3genos.\t\r \u00a0Se\t\r \u00a0sabe\t\r \u00a0que\t\r \u00a0estas\t\r \u00a0vibraciones\t\r \u00a0ocurren\t\r \u00a0en\t\r \u00a0la\t\r \u00a0escala\t\r \u00a0del\t\r \u00a0femtosegundo\t\r \u00a0(fs)\t\r \u00a0y\t\r \u00a0su\t\r \u00a0inclusi\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0c\u00e1lculo\t\r \u00a0no\t\r \u00a0har\u00eda\t\r \u00a0m\u00e1s\t\r \u00a0que\t\r \u00a0a\u00f1adir\t\r \u00a0una\t\r \u00a0carga\t\r \u00a0computacional\t\r \u00a0 extra\t\r \u00a0 innecesaria\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 influyen\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 movimiento\t\r \u00a0 global\t\r \u00a0 del\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n423\t\r \u00a0\t\r \u00a0sistema.\t\r \u00a0Es\t\r \u00a0por\t\r \u00a0ello\t\r \u00a0que\t\r \u00a0se\t\r \u00a0suele\t\r \u00a0fijar\t\r \u00a0la\t\r \u00a0longitud\t\r \u00a0de\t\r \u00a0los\t\r \u00a0enlaces\t\r \u00a0covalentes\t\r \u00a0a\t\r \u00a0sus\t\r \u00a0valores\t\r \u00a0de\t\r \u00a0equilibrio\t\r \u00a0mediante\t\r \u00a0el\t\r \u00a0algoritmo\t\r \u00a0SHAKE(25).\t\r \u00a0De\t\r \u00a0esta\t\r \u00a0forma\t\r \u00a0se\t\r \u00a0aumenta\t\r \u00a0el\t\r \u00a0tiempo\t\r \u00a0de\t\r \u00a0integraci\u00f3n\t\r \u00a0a\t\r \u00a02\t\r \u00a0fs\t\r \u00a0y\t\r \u00a0se\t\r \u00a0acelera\t\r \u00a0la\t\r \u00a0velocidad\t\r \u00a0del\t\r \u00a0c\u00e1lculo.\t\r \u00a0La\t\r \u00a0din\u00e1mica\t\r \u00a0molecular\t\r \u00a0permite,\t\r \u00a0entre\t\r \u00a0otras\t\r \u00a0aplicaciones\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica:\t\r \u00a0\u2022 Predecir\t\r \u00a0estructuras\t\r \u00a0y\t\r \u00a0propiedades\t\r \u00a0de\t\r \u00a0prote\u00ednas\t\r \u00a0que\t\r \u00a0se\t\r \u00a0diferencian\t\r \u00a0s\u00f3lo\t\r \u00a0en\t\r \u00a0unos\t\r \u00a0pocos\t\r \u00a0amino\u00e1cidos.\t\r \u00a0\t\r \u00a0\u2022 Refinar\t\r \u00a0un\t\r \u00a0modelo\t\r \u00a0resuelto\t\r \u00a0por\t\r \u00a0homolog\u00eda.\t\r \u00a0\t\r \u00a0\t\r \u00a0\u2022 Estudiar\t\r \u00a0 la\t\r \u00a0 estabilidad\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 prote\u00edna\t\r \u00a0 frente\t\r \u00a0 a\t\r \u00a0 variaciones\t\r \u00a0 de\t\r \u00a0 pH,\t\r \u00a0temperatura\t\r \u00a0o\t\r \u00a0disolvente.\t\r \u00a0\u2022 Estudiar\t\r \u00a0 cambios\t\r \u00a0 conformacionales\t\r \u00a0 asociados\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 propiedades\t\r \u00a0catal\u00edticas\t\r \u00a0de\t\r \u00a0una\t\r \u00a0enzima\t\r \u00a0(estabilizaci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0transici\u00f3n).\t\r \u00a0\u2022 Estudiar\t\r \u00a0las\t\r \u00a0aperturas\t\r \u00a0y\t\r \u00a0cierres\t\r \u00a0de\t\r \u00a0sitios\t\r \u00a0activos\t\r \u00a0de\t\r \u00a0biomol\u00e9culas.\t\r \u00a0\u2022 Estudiar\t\r \u00a0 la\t\r \u00a0 estabilidad\t\r \u00a0 del\t\r \u00a0 modo\t\r \u00a0 de\t\r \u00a0 uni\u00f3n\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 ligando\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0prote\u00edna.\t\r \u00a0\u2022 Estudiar\t\r \u00a0selectividad\t\r \u00a0y\t\r \u00a0afinidad\t\r \u00a0de\t\r \u00a0un\t\r \u00a0ligando\t\r \u00a0por\t\r \u00a0una\t\r \u00a0prote\u00edna.\t\r \u00a03.2.\t\r \u00a0La\t\r \u00a0primera\t\r \u00a0din\u00e1mica\t\r \u00a0molecular\t\r \u00a0de\t\r \u00a0una\t\r \u00a0biomol\u00e9cula\t\r \u00a0Si\t\r \u00a0las\t\r \u00a0aplicaciones\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0cu\u00e1ntica\t\r \u00a0son\t\r \u00a0numeros\u00edsimas,\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0es\t\r \u00a0quiz\u00e1s\t\r \u00a0a\u00fan\t\r \u00a0mayor\t\r \u00a0en\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0campos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0qu\u00edmica.\t\r \u00a0\t\r \u00a0Una\t\r \u00a0 vez\t\r \u00a0 m\u00e1s\t\r \u00a0 los\t\r \u00a0 galardonados\t\r \u00a0 fueron\t\r \u00a0 pioneros\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0metodolog\u00eda\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 sistemas\t\r \u00a0 biol\u00f3gicos.\t\r \u00a0 As\u00ed,\t\r \u00a0 seleccionaron\t\r \u00a0 la\t\r \u00a0 BPTI\t\r \u00a0(Inhibidor\t\r \u00a0de\t\r \u00a0la\t\r \u00a0tripsina\t\r \u00a0pancr\u00e1tica\t\r \u00a0bovina)\t\r \u00a0para\t\r \u00a0llevar\t\r \u00a0a\t\r \u00a0cabo\t\r \u00a0la\t\r \u00a0que\t\r \u00a0se\t\r \u00a0considera\t\r \u00a0la\t\r \u00a0primera\t\r \u00a0simulaci\u00f3n\t\r \u00a0de\t\r \u00a0din\u00e1mica\t\r \u00a0molecular\t\r \u00a0de\t\r \u00a0una\t\r \u00a0biomol\u00e9cula.\t\r \u00a0Seleccionaron\t\r \u00a0 esta\t\r \u00a0 prote\u00edna\t\r \u00a0 por\t\r \u00a0 ser\t\r \u00a0 de\t\r \u00a0 peque\u00f1o\t\r \u00a0 tama\u00f1o,\t\r \u00a0 poseer\t\r \u00a0 una\t\r \u00a0estabilidad\t\r \u00a0relativa\t\r \u00a0bastante\t\r \u00a0razonable\t\r \u00a0y\t\r \u00a0porque\t\r \u00a0se\t\r \u00a0dispon\u00eda\t\r \u00a0en\t\r \u00a0ese\t\r \u00a0momento\t\r \u00a0de\t\r \u00a0una\t\r \u00a0estructura\t\r \u00a0cristalina\t\r \u00a0con\t\r \u00a0buena\t\r \u00a0resoluci\u00f3n\t\r \u00a0(1.5\t\r \u00a0A),\t\r \u00a0disponible(26).\t\r \u00a0Esta\t\r \u00a0 din\u00e1mica\t\r \u00a0 dur\u00f3\t\r \u00a0 tan\t\r \u00a0 s\u00f3lo\t\r \u00a0 9.2\t\r \u00a0 ps,\t\r \u00a0 sin\t\r \u00a0 embargo\t\r \u00a0 fue\t\r \u00a0 fundamental\t\r \u00a0 para\t\r \u00a0reemplazar\t\r \u00a0la\t\r \u00a0visi\u00f3n\t\r \u00a0generalizada\t\r \u00a0de\t\r \u00a0las\t\r \u00a0prote\u00ednas\t\r \u00a0como\t\r \u00a0estructuras\t\r \u00a0r\u00edgidas(27).\t\r \u00a04.\t\r \u00a0QM/MM\t\r \u00a0Para\t\r \u00a0 el\t\r \u00a0 modelado\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0 enzim\u00e1ticas\t\r \u00a0 y\t\r \u00a0 otros\t\r \u00a0 procesos\t\r \u00a0biomoleculares\t\r \u00a0que\t\r \u00a0involucran\t\r \u00a0cambios\t\r \u00a0en\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0electr\u00f3nica,\t\r \u00a0como\t\r \u00a0ruptura\t\r \u00a0y\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 enlaces,\t\r \u00a0 \t\r \u00a0 transferencia\t\r \u00a0 de\t\r \u00a0 carga\t\r \u00a0 o\t\r \u00a0 excitaci\u00f3n\t\r \u00a0 electr\u00f3nica,\t\r \u00a0 la\t\r \u00a0metodolog\u00eda\t\r \u00a0mixta\t\r \u00a0QM/MM\t\r \u00a0se\t\r \u00a0ha\t\r \u00a0convertido\t\r \u00a0en\t\r \u00a0el\t\r \u00a0m\u00e9todo\t\r \u00a0de\t\r \u00a0elecci\u00f3n.\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n424\t\r \u00a0\t\r \u00a0El\t\r \u00a0 trabajo\t\r \u00a0 pionero\t\r \u00a0 en\t\r \u00a0 esta\t\r \u00a0 \u00e1rea\t\r \u00a0 se\t\r \u00a0 debe\t\r \u00a0 a\t\r \u00a0 Warshel\t\r \u00a0 y\t\r \u00a0 Levitt.(1)\t\r \u00a0En\t\r \u00a0 este\t\r \u00a0trabajo,\t\r \u00a0los\t\r \u00a0investigadores\t\r \u00a0presentaban\t\r \u00a0por\t\r \u00a0primera\t\r \u00a0vez\t\r \u00a0la\t\r \u00a0combinaci\u00f3n\t\r \u00a0de\t\r \u00a0ambos\t\r \u00a0m\u00e9todos\t\r \u00a0para\t\r \u00a0describir\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0intermedio\t\r \u00a0de\t\r \u00a0tipo\t\r \u00a0i\u00f3n\t\r \u00a0carbonio\t\r \u00a0en\t\r \u00a0el\t\r \u00a0sitio\t\r \u00a0activo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0lisozima.\t\r \u00a0\t\r \u00a0Esta\t\r \u00a0t\u00e9cnica\t\r \u00a0permite\t\r \u00a0combinar\t\r \u00a0potenciales\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0cu\u00e1ntica\t\r \u00a0(QM)\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0(MM)\t\r \u00a0en\t\r \u00a0un\t\r \u00a0potencial\t\r \u00a0h\u00edbrido\t\r \u00a0QM/MM.\t\r \u00a0Permite\t\r \u00a0 combinar\t\r \u00a0 la\t\r \u00a0 simplicidad\t\r \u00a0 y\t\r \u00a0 velocidad\t\r \u00a0 del\t\r \u00a0 tratamiento\t\r \u00a0 MM\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0la\t\r \u00a0QM\t\r \u00a0que\t\r \u00a0permite\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0y\t\r \u00a0ruptura\t\r \u00a0de\t\r \u00a0enlaces,\t\r \u00a0as\u00ed\t\r \u00a0como\t\r \u00a0 la\t\r \u00a0 inclusi\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 polarizaci\u00f3n\t\r \u00a0 electr\u00f3nica\t\r \u00a0 debida\t\r \u00a0 al\t\r \u00a0 medio.\t\r \u00a0 Este\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0aproximaci\u00f3n\t\r \u00a0 nos\t\r \u00a0 va\t\r \u00a0 a\t\r \u00a0 permitir\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 reacciones\t\r \u00a0 qu\u00edmicas\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 seno\t\r \u00a0 de\t\r \u00a0grandes\t\r \u00a0 sistemas\t\r \u00a0 ya\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 regiones\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 se\t\r \u00a0analizan\t\r \u00a0mediante\t\r \u00a0una\t\r \u00a0funci\u00f3n\t\r \u00a0QM\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0el\t\r \u00a0potencial\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dem\u00e1s\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0 sistema\t\r \u00a0 se\t\r \u00a0 examina\t\r \u00a0 por\t\r \u00a0 c\u00e1lculos\t\r \u00a0 cl\u00e1sicos\t\r \u00a0 de\t\r \u00a0 MM\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 interacciones\t\r \u00a0at\u00f3micas\t\r \u00a0est\u00e1n\t\r \u00a0regidas\t\r \u00a0por\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0fuerzas.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a05.\t\r \u00a0Representaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0divisi\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0molecular\t\r \u00a0en\t\r \u00a0zona\t\r \u00a0QM\t\r \u00a0y\t\r \u00a0zona\t\r \u00a0MM.\t\r \u00a0La\t\r \u00a0 energ\u00eda\t\r \u00a0 total\t\r \u00a0 (Etot)\t\r \u00a0 para\t\r \u00a0 este\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 sistemas\t\r \u00a0 se\t\r \u00a0 puede\t\r \u00a0 escribir\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0siguiente\t\r \u00a0forma:\t\r \u00a0Etot\t\r \u00a0=\t\r \u00a0EQM\t\r \u00a0+\t\r \u00a0EMM\t\r \u00a0+\t\r \u00a0EQM\t\r \u00a0/\t\r \u00a0MM\t\r \u00a0\t\r \u00a0donde\t\r \u00a0EQM\t\r \u00a0y\t\r \u00a0EMM\t\r \u00a0corresponden\t\r \u00a0a\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0aquellas\t\r \u00a0partes\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0tratadas\t\r \u00a0 exclusivamente\t\r \u00a0 con\t\r \u00a0 mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 y\t\r \u00a0 mec\u00e1nica\t\r \u00a0 molecular,\t\r \u00a0respectivamente.\t\r \u00a0Mientras\t\r \u00a0que\t\r \u00a0EQM/MM\t\r \u00a0es\t\r \u00a0la\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0interacci\u00f3n\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0partes\t\r \u00a0mec\u00e1nicocu\u00e1nticas\t\r \u00a0y\t\r \u00a0mec\u00e1nico-\u00ad\u2010moleculares.\t\r \u00a0Los\t\r \u00a0\u00e1tomos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0QM\t\r \u00a0se\t\r \u00a0representan\t\r \u00a0como\t\r \u00a0electrones\t\r \u00a0y\t\r \u00a0n\u00facleos.\t\r \u00a0El\t\r \u00a0Hamiltoniano\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0esta\t\r \u00a0regi\u00f3n,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0aproximaci\u00f3n\t\r \u00a0de\t\r \u00a0Born-\u00ad\u2010Oppenheimer.\t\r \u00a0\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n425\t\r \u00a0\t\r \u00a0donde\t\r \u00a0i\t\r \u00a0y\t\r \u00a0j\t\r \u00a0representan\t\r \u00a0las\t\r \u00a0coordenadas\t\r \u00a0electr\u00f3nicas,\t\r \u00a0\u03b1\t\r \u00a0y\t\r \u00a0\u03b2\t\r \u00a0las\t\r \u00a0coordenadas\t\r \u00a0nucleares,\t\r \u00a0r\t\r \u00a0la\t\r \u00a0distancia\t\r \u00a0electr\u00f3n-\u00ad\u2010electr\u00f3n\t\r \u00a0o\t\r \u00a0electr\u00f3n-\u00ad\u2010n\u00facleo,\t\r \u00a0R\t\r \u00a0las\t\r \u00a0distancia\t\r \u00a0n\u00facleo-\u00ad\u2010n\u00facleo,\t\r \u00a0\u2207\t\r \u00a0es\t\r \u00a0el\t\r \u00a0operador\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0cin\u00e9tica\t\r \u00a0electr\u00f3nica\t\r \u00a0y\t\r \u00a0Z\t\r \u00a0es\t\r \u00a0la\t\r \u00a0carga\t\r \u00a0nuclear.\t\r \u00a0La\t\r \u00a0zona\t\r \u00a0MM\t\r \u00a0contiene\t\r \u00a0el\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0del\t\r \u00a0sistema.\t\r \u00a0Estos\t\r \u00a0se\t\r \u00a0describen\t\r \u00a0cl\u00e1sicamente,\t\r \u00a0 y\t\r \u00a0 sus\t\r \u00a0 interacciones\t\r \u00a0 se\t\r \u00a0 determinan\t\r \u00a0 mediante\t\r \u00a0 funciones\t\r \u00a0 de\t\r \u00a0 energ\u00eda\t\r \u00a0potencial\t\r \u00a0 emp\u00edricas,\t\r \u00a0 de\t\r \u00a0 modo\t\r \u00a0 que\t\r \u00a0 dichos\t\r \u00a0 \u00e1tomos\t\r \u00a0 no\t\r \u00a0 pueden\t\r \u00a0 estar\t\r \u00a0 implicados\t\r \u00a0 en\t\r \u00a0procesos\t\r \u00a0 de\t\r \u00a0 formaci\u00f3n\t\r \u00a0 o\t\r \u00a0 ruptura\t\r \u00a0 de\t\r \u00a0 enlaces,\t\r \u00a0 ni\t\r \u00a0 de\t\r \u00a0 transferencia\t\r \u00a0 de\t\r \u00a0 carga.\t\r \u00a0 La\t\r \u00a0energ\u00eda\t\r \u00a0de\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0MM\t\r \u00a0depende\t\r \u00a0inicialmente\t\r \u00a0de\t\r \u00a0las\t\r \u00a0posiciones\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0o\t\r \u00a0centros\t\r \u00a0 tratados\t\r \u00a0 mediante\t\r \u00a0 mec\u00e1nica\t\r \u00a0 molecular,\t\r \u00a0 si\t\r \u00a0 ignoramos\t\r \u00a0 la\t\r \u00a0 polarizaci\u00f3n\t\r \u00a0 de\t\r \u00a0este\t\r \u00a0subsistema:\t\r \u00a0EMM=Eenlace\t\r \u00a0+\t\r \u00a0Eno\t\r \u00a0enlace\t\r \u00a0Eenlace=\t\r \u00a0Eenlaces\t\r \u00a0+\t\r \u00a0E\u00e1ngulos\t\r \u00a0+\t\r \u00a0Ediedros\t\r \u00a0Eno\t\r \u00a0enlace=\t\r \u00a0Eelectrost\u00e1tica\t\r \u00a0+\t\r \u00a0Evan\t\r \u00a0del\t\r \u00a0Waals\t\r \u00a0Por\t\r \u00a0\u00faltimo,\t\r \u00a0el\t\r \u00a0t\u00e9rmino\t\r \u00a0EQM/MM\t\r \u00a0describe\t\r \u00a0c\u00f3mo\t\r \u00a0interaccionan\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0QM\t\r \u00a0con\t\r \u00a0 los\t\r \u00a0 centros\t\r \u00a0 MM.\t\r \u00a0 El\t\r \u00a0 Hamiltoniano,\t\r \u00a0 en\t\r \u00a0 unidades\t\r \u00a0 at\u00f3micas,\t\r \u00a0 viene\t\r \u00a0 dado\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0siguiente\t\r \u00a0ecuaci\u00f3n\t\r \u00a0\t\r \u00a0donde\t\r \u00a0los\t\r \u00a0sub\u00edndices\t\r \u00a0i,j\t\r \u00a0hacen\t\r \u00a0referencia\t\r \u00a0a\t\r \u00a0los\t\r \u00a0electrones\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0QM,\t\r \u00a0los\t\r \u00a0sub\u00edndices\t\r \u00a0\u03b1\t\r \u00a0a\t\r \u00a0los\t\r \u00a0n\u00facleos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0QM\t\r \u00a0y\t\r \u00a0los\t\r \u00a0sub\u00edndices\t\r \u00a0M\t\r \u00a0a\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0MM.\t\r \u00a0El\t\r \u00a0primer\t\r \u00a0t\u00e9rmino\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ecuaci\u00f3n\t\r \u00a0representa\t\r \u00a0las\t\r \u00a0interacciones\t\r \u00a0electrost\u00e1ticas\t\r \u00a0entre\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 MM\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 electrones\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 QM.\t\r \u00a0 El\t\r \u00a0 segundo\t\r \u00a0 t\u00e9rmino\t\r \u00a0representa\t\r \u00a0las\t\r \u00a0interacciones\t\r \u00a0electrost\u00e1ticas\t\r \u00a0entre\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0MM\t\r \u00a0y\t\r \u00a0los\t\r \u00a0n\u00facleos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0QM,\t\r \u00a0y\t\r \u00a0el\t\r \u00a0tercer\t\r \u00a0t\u00e9rmino\t\r \u00a0describe\t\r \u00a0interacciones\t\r \u00a0de\t\r \u00a0van\t\r \u00a0der\t\r \u00a0Waals\t\r \u00a0entre\t\r \u00a0centros\t\r \u00a0 QM\t\r \u00a0 y\t\r \u00a0 MM.\t\r \u00a0 Los\t\r \u00a0 dos\t\r \u00a0 \u00faltimos\t\r \u00a0 t\u00e9rminos\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 ecuaci\u00f3n\t\r \u00a0 no\t\r \u00a0 incluyen\t\r \u00a0coordenadas\t\r \u00a0 electr\u00f3nicas,\t\r \u00a0 de\t\r \u00a0 modo\t\r \u00a0 que\t\r \u00a0 pueden\t\r \u00a0 ser\t\r \u00a0 calculados\t\r \u00a0 y\t\r \u00a0 sumados\t\r \u00a0directamente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 energ\u00eda\t\r \u00a0 total.\t\r \u00a0 Sin\t\r \u00a0 embargo,\t\r \u00a0 el\t\r \u00a0 primer\t\r \u00a0 t\u00e9rmino\t\r \u00a0 s\u00ed\t\r \u00a0 que\t\r \u00a0 incluye\t\r \u00a0coordenadas\t\r \u00a0 electr\u00f3nicas\t\r \u00a0 por\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 debe\t\r \u00a0 tratarse\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 procedimiento\t\r \u00a0autoconsistente.\t\r \u00a0Se\t\r \u00a0 han\t\r \u00a0 implementado\t\r \u00a0 distintos\t\r \u00a0 m\u00e9todos\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 fin\t\r \u00a0 de\t\r \u00a0 estudiar\t\r \u00a0 un\t\r \u00a0 sistema\t\r \u00a0mediante\t\r \u00a0QM/MM.\t\r \u00a0Estos\t\r \u00a0difieren\t\r \u00a0entre\t\r \u00a0s\u00ed\t\r \u00a0(i)\t\r \u00a0por\t\r \u00a0el\t\r \u00a0nivel\t\r \u00a0de\t\r \u00a0teor\u00eda\t\r \u00a0utilizado\t\r \u00a0para\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0 cu\u00e1ntica\t\r \u00a0 (semiemp\u00edrico,\t\r \u00a0ab\t\r \u00a0 initio,\t\r \u00a0 enlace\t\r \u00a0 de\t\r \u00a0 valencia\t\r \u00a0 o\t\r \u00a0 funcional\t\r \u00a0 de\t\r \u00a0densidad),\t\r \u00a0(ii)\t\r \u00a0por\t\r \u00a0el\t\r \u00a0modelo\t\r \u00a0de\t\r \u00a0mec\u00e1nica\t\r \u00a0molecular\t\r \u00a0empleado\t\r \u00a0o\t\r \u00a0(iii)\t\r \u00a0por\t\r \u00a0el\t\r \u00a0modo\t\r \u00a0de\t\r \u00a0representar\t\r \u00a0el\t\r \u00a0disolvente\t\r \u00a0(disolvente\t\r \u00a0expl\u00edcito\t\r \u00a0o\t\r \u00a0modelo\t\r \u00a0simplificado).\t\r \u00a0Un\t\r \u00a0 punto\t\r \u00a0 importante,\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 tambi\u00e9n\t\r \u00a0 constituye\t\r \u00a0 una\t\r \u00a0 diferencia\t\r \u00a0 entre\t\r \u00a0m\u00e9todos\t\r \u00a0QM/MM,\t\r \u00a0es\t\r \u00a0el\t\r \u00a0modo\t\r \u00a0de\t\r \u00a0tratar\t\r \u00a0la\t\r \u00a0uni\u00f3n\t\r \u00a0entre\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0regiones.\t\r \u00a0En\t\r \u00a0general,\t\r \u00a0\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n426\t\r \u00a0\t\r \u00a0es\t\r \u00a0 preferible\t\r \u00a0 cortar\t\r \u00a0 enlaces\t\r \u00a0 no\t\r \u00a0 polares\t\r \u00a0 (como\t\r \u00a0 enlaces\t\r \u00a0 sencillos\t\r \u00a0 C\u2013C)\t\r \u00a0 que\t\r \u00a0cortar\t\r \u00a0enlaces\t\r \u00a0insaturados\t\r \u00a0o\t\r \u00a0polares.\t\r \u00a0\t\r \u00a0La\t\r \u00a0 partici\u00f3n\t\r \u00a0 del\t\r \u00a0 sistema\t\r \u00a0 en\t\r \u00a0 subsistemas\t\r \u00a0 QM\t\r \u00a0 y\t\r \u00a0 MM\t\r \u00a0 resulta\t\r \u00a0 especialmente\t\r \u00a0problem\u00e1tica\t\r \u00a0cuando\t\r \u00a0la\t\r \u00a0divisi\u00f3n\t\r \u00a0tiene\t\r \u00a0lugar,\t\r \u00a0necesariamente,\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ruptura\t\r \u00a0de\t\r \u00a0un\t\r \u00a0enlace\t\r \u00a0covalente\t\r \u00a0entre\t\r \u00a0ambos\t\r \u00a0subsistemas\t\r \u00a0(Figura\t\r \u00a06).\t\r \u00a0En\t\r \u00a0estos\t\r \u00a0casos\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0recurrir\t\r \u00a0a\t\r \u00a0alg\u00fan\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0aproximaci\u00f3n\t\r \u00a0que\t\r \u00a0permita\t\r \u00a0satisfacer\t\r \u00a0las\t\r \u00a0valencias\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0cu\u00e1nticos\t\r \u00a0que\t\r \u00a0definen\t\r \u00a0el\t\r \u00a0enlace\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0cu\u00e1ntica\t\r \u00a0y\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0cl\u00e1sica\t\r \u00a0por\t\r \u00a0donde\t\r \u00a0se\t\r \u00a0producir\u00e1\t\r \u00a0la\t\r \u00a0divisi\u00f3n.\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a06.\t\r \u00a0Representaci\u00f3n\t\r \u00a0esquem\u00e1tica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0divisi\u00f3n\t\r \u00a0de\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0molecular\t\r \u00a0en\t\r \u00a0subsistemas\t\r \u00a0en\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0QM/MM\t\r \u00a0cuando\t\r \u00a0la\t\r \u00a0frontera\t\r \u00a0corta\t\r \u00a0necesariamente\t\r \u00a0un\t\r \u00a0enlace\t\r \u00a0covalente.\t\r \u00a0Actualmente\t\r \u00a0existen\t\r \u00a0varias\t\r \u00a0aproximaciones\t\r \u00a0para\t\r \u00a0resolver\t\r \u00a0este\t\r \u00a0problema.\t\r \u00a0En\t\r \u00a0una\t\r \u00a0 primera\t\r \u00a0 aproximaci\u00f3n,\t\r \u00a0 se\t\r \u00a0 establece\t\r \u00a0 un\t\r \u00a0orbital\t\r \u00a0 h\u00edbrido\t\r \u00a0 sp2\t\r \u00a0que\t\r \u00a0 contiene\t\r \u00a0 un\t\r \u00a0electr\u00f3n\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0QM/MM(1).\t\r \u00a0La\t\r \u00a0opci\u00f3n\t\r \u00a0m\u00e1s\t\r \u00a0popular\t\r \u00a0es,\t\r \u00a0probablemente,\t\r \u00a0el\t\r \u00a0uso\t\r \u00a0de\t\r \u00a0\u00e1tomos\t\r \u00a0de\t\r \u00a0uni\u00f3n\t\r \u00a0\u201clink\t\r \u00a0atoms\u201d:\t\r \u00a0en\t\r \u00a0este\t\r \u00a0m\u00e9todos\t\r \u00a0se\t\r \u00a0saturan\t\r \u00a0las\t\r \u00a0valencias\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0QM\t\r \u00a0pertenecientes\t\r \u00a0al\t\r \u00a0 enlace\t\r \u00a0 fluctuante\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0 \u00e1tomo\t\r \u00a0 QM\t\r \u00a0 m\u00e1s,\t\r \u00a0 normalmente\t\r \u00a0 hidr\u00f3geno,\t\r \u00a0convenientemente\t\r \u00a0parametrizado,\t\r \u00a0que\t\r \u00a0asegura\t\r \u00a0la\t\r \u00a0conservaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0valencia.\t\r \u00a0Este\t\r \u00a0\u00e1tomo\t\r \u00a0 se\t\r \u00a0 describe\t\r \u00a0 a\t\r \u00a0 nivel\t\r \u00a0 QM\t\r \u00a0 y\t\r \u00a0 es\t\r \u00a0 invisible\t\r \u00a0 para\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 MM,\t\r \u00a0 porque\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0tienen\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 las\t\r \u00a0 interacciones\t\r \u00a0 entre\t\r \u00a0 el\t\r \u00a0 \u00e1tomo\t\r \u00a0 de\t\r \u00a0 uni\u00f3n\t\r \u00a0 y\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 del\t\r \u00a0subsistema\t\r \u00a0cl\u00e1sico(28).\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a07.-\u00ad\u2010\t\r \u00a0Representacion\t\r \u00a0esquem\u00e1tica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aproximaci\u00f3n\t\r \u00a0del\t\r \u00a0\u201clink\t\r \u00a0atom\u201d\t\r \u00a0para\t\r \u00a0el\t\r \u00a0tratamiento\t\r \u00a0de\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0frontera\t\r \u00a0en\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0QM/MM.\t\r \u00a0\nSesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n427\t\r \u00a0\t\r \u00a0Otro\t\r \u00a0m\u00e9todo\t\r \u00a0es\t\r \u00a0el\t\r \u00a0denominado\t\r \u00a0LSCF\t\r \u00a0(Local\t\r \u00a0Self\t\r \u00a0consisten\t\r \u00a0Field),\t\r \u00a0basado\t\r \u00a0en\t\r \u00a0el\t\r \u00a0 formalismo\t\r \u00a0 del\t\r \u00a0 campo\t\r \u00a0 local\t\r \u00a0 auto-\u00ad\u2010consistente,\t\r \u00a0 donde\t\r \u00a0 los\t\r \u00a0 enlaces\t\r \u00a0 QM/MM\t\r \u00a0frontera\t\r \u00a0 son\t\r \u00a0 descritos\t\r \u00a0 mediantes\t\r \u00a0 orbitales\t\r \u00a0 de\t\r \u00a0 enlace\t\r \u00a0 localizados.\t\r \u00a0 Estos\t\r \u00a0 orbitales,\t\r \u00a0llamados\t\r \u00a0 orbitales\t\r \u00a0 congelados,\t\r \u00a0 son\t\r \u00a0 excluidos\t\r \u00a0 del\t\r \u00a0 c\u00e1lculo\t\r \u00a0 SCF\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 encuentran\t\r \u00a0definidos\t\r \u00a0por\t\r \u00a0sus\t\r \u00a0coeficientes\t\r \u00a0de\t\r \u00a0hibridaci\u00f3n\t\r \u00a0y\t\r \u00a0por\t\r \u00a0su\t\r \u00a0poblaci\u00f3n\t\r \u00a0electr\u00f3nica.\t\r \u00a0Estos\t\r \u00a0dos\t\r \u00a0par\u00e1metros\t\r \u00a0son\t\r \u00a0determinados\t\r \u00a0mediante\t\r \u00a0c\u00e1lculos\t\r \u00a0QM\t\r \u00a0sobre\t\r \u00a0sistemas\t\r \u00a0peque\u00f1os\t\r \u00a0y\t\r \u00a0se\t\r \u00a0supone\t\r \u00a0que\t\r \u00a0estos\t\r \u00a0resultados\t\r \u00a0son\t\r \u00a0transferibles\t\r \u00a0a\t\r \u00a0los\t\r \u00a0sistemas\t\r \u00a0de\t\r \u00a0inter\u00e9s.\t\r \u00a0Este\t\r \u00a0m\u00e9todo\t\r \u00a0 es\t\r \u00a0 m\u00e1s\t\r \u00a0 ajustado\t\r \u00a0 desde\t\r \u00a0 el\t\r \u00a0 punto\t\r \u00a0 de\t\r \u00a0 vista\t\r \u00a0 te\u00f3rico,\t\r \u00a0 pero\t\r \u00a0 m\u00e1s\t\r \u00a0 complejo\t\r \u00a0 de\t\r \u00a0implementar.\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a0 8.-\u00ad\u2010\t\r \u00a0Representaci\u00f3n\t\r \u00a0esquem\u00e1tica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aproximaci\u00f3n\t\r \u00a0LSCF\t\r \u00a0para\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0frontera\t\r \u00a0en\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0QM/MM.\t\r \u00a0El\t\r \u00a0 m\u00e9todo\t\r \u00a0 GHO\t\r \u00a0(GeneralizedHybrid\t\r \u00a0 Orbital),\t\r \u00a0 hace\t\r \u00a0 uso\t\r \u00a0 del\t\r \u00a0 orbital\t\r \u00a0 at\u00f3mico\t\r \u00a0h\u00edbrido,\t\r \u00a0 similar\t\r \u00a0 al\t\r \u00a0 m\u00e9todo\t\r \u00a0 anterior\t\r \u00a0 LSCF,\t\r \u00a0 pero\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 caso\t\r \u00a0 los\t\r \u00a0 orbitales\t\r \u00a0 pueden\t\r \u00a0dividirse\t\r \u00a0 en\t\r \u00a0 orbitales\t\r \u00a0 auxiliares\t\r \u00a0 y\t\r \u00a0 orbitales\t\r \u00a0 activos.\t\r \u00a0 Estos\t\r \u00a0 \u00faltimos\t\r \u00a0 se\t\r \u00a0 optimizan\t\r \u00a0junto\t\r \u00a0con\t\r \u00a0el\t\r \u00a0resto\t\r \u00a0de\t\r \u00a0orbitales\t\r \u00a0de\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0QM\t\r \u00a0en\t\r \u00a0el\t\r \u00a0c\u00e1lculo\t\r \u00a0SCF,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0uni\u00f3n\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0\u00e1tomo\t\r \u00a0frontera\t\r \u00a0y\t\r \u00a0la\t\r \u00a0regi\u00f3n\t\r \u00a0MM\t\r \u00a0se\t\r \u00a0define\t\r \u00a0mediante\t\r \u00a0los\t\r \u00a0campos\t\r \u00a0de\t\r \u00a0fuerza\t\r \u00a0 MM.\t\r \u00a0 A\t\r \u00a0 diferencia\t\r \u00a0 del\t\r \u00a0 m\u00e9todo\t\r \u00a0 LSCF,\t\r \u00a0 el\t\r \u00a0 m\u00e9todo\t\r \u00a0 GHO\t\r \u00a0 no\t\r \u00a0 necesita\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0parametrizaci\u00f3n\t\r \u00a0cada\t\r \u00a0vez\t\r \u00a0que\t\r \u00a0se\t\r \u00a0estudia\t\r \u00a0un\t\r \u00a0nuevo\t\r \u00a0sistema.\t\r \u00a0\t\r \u00a0\n\t\r \u00a0Figura\t\r \u00a09.-\u00ad\u2010\t\r \u00a0Representaci\u00f3n\t\r \u00a0esquem\u00e1tica\t\r \u00a0de\t\r \u00a0la\t\r \u00a0aproximaci\u00f3n\t\r \u00a0GHO\t\r \u00a0para\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0frontera.\t\r \u00a0\t\r \u00a0En\t\r \u00a0general\t\r \u00a0se\t\r \u00a0recomienda\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0caso\t\r \u00a0de\t\r \u00a0ser\t\r \u00a0necesario,\t\r \u00a0la\t\r \u00a0partici\u00f3n\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0 sistema\t\r \u00a0 QM\t\r \u00a0 y\t\r \u00a0 MM\t\r \u00a0 est\u00e9\t\r \u00a0 lo\t\r \u00a0 m\u00e1s\t\r \u00a0 alejada\t\r \u00a0 posible\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 implicados\t\r \u00a0directamente\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0reacci\u00f3n.\t\r \u00a0 De\t\r \u00a0 esta\t\r \u00a0 manera\t\r \u00a0 se\t\r \u00a0 evita\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0 aproximaciones\t\r \u00a0utilizadas\t\r \u00a0en\t\r \u00a0las\t\r \u00a0metodolog\u00edas\t\r \u00a0influyan\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0resultado\t\r \u00a0final.\t\r \u00a0\t\r \u00a0\nJ.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n428\t\r \u00a0\t\r \u00a0Existen\t\r \u00a0numerosos\t\r \u00a0programas\t\r \u00a0que\t\r \u00a0permiten\t\r \u00a0realizar\t\r \u00a0este\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0c\u00e1lculos,\t\r \u00a0uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 m\u00e1s\t\r \u00a0 utilizados\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 programa\t\r \u00a0ONIOM\t\r \u00a0(OurownN-\u00ad\u2010LayeredIntegrated\t\r \u00a0molecular\t\r \u00a0Orbital\t\r \u00a0 and\t\r \u00a0 molecular\t\r \u00a0Mechanics),\t\r \u00a0 que\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 nombre\t\r \u00a0 hace\t\r \u00a0 alusi\u00f3n\t\r \u00a0precisamente\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 construcci\u00f3n\t\r \u00a0 en\t\r \u00a0 capas,\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 cebolla.\t\r \u00a0 El\t\r \u00a0 desarrollo\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0primeras\t\r \u00a0versiones\t\r \u00a0de\t\r \u00a0este\t\r \u00a0programa\t\r \u00a0se\t\r \u00a0debe\t\r \u00a0a\t\r \u00a0un\t\r \u00a0Espa\u00f1ol,\t\r \u00a0Feliu\t\r \u00a0Masera,\t\r \u00a0que\t\r \u00a0la\t\r \u00a0Academia\t\r \u00a0Sueca\t\r \u00a0 de\t\r \u00a0 Ciencias\t\r \u00a0 menciona\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 comunicado\t\r \u00a0 tras\t\r \u00a0 la\t\r \u00a0 concesi\u00f3n\t\r \u00a0 del\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0este\t\r \u00a0a\u00f1o(29).\t\r \u00a04.1.\t\r \u00a0La\t\r \u00a0primera\t\r \u00a0simulaci\u00f3n\t\r \u00a0QM/MM\t\r \u00a0aplicada\t\r \u00a0a\t\r \u00a0una\t\r \u00a0enzima\t\r \u00a0Una\t\r \u00a0 vez\t\r \u00a0 m\u00e1s\t\r \u00a0 los\t\r \u00a0 galardonados\t\r \u00a0 fueron\t\r \u00a0 pioneros\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 utilizaci\u00f3n\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0metodolog\u00eda\t\r \u00a0 para\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 de\t\r \u00a0 sistemas\t\r \u00a0 biol\u00f3gicos.\t\r \u00a0 Consideraron\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0detallado\t\r \u00a0del\t\r \u00a0mecanismo\t\r \u00a0de\t\r \u00a0una\t\r \u00a0reacci\u00f3n\t\r \u00a0enzim\u00e1tica\t\r \u00a0era\t\r \u00a0un\t\r \u00a0problema\t\r \u00a0importante.\t\r \u00a0\t\r \u00a0Seleccionaron\t\r \u00a0 para\t\r \u00a0 este\t\r \u00a0 primer\t\r \u00a0 estudio\t\r \u00a0 la\t\r \u00a0 lisozima,\t\r \u00a0 una\t\r \u00a0 conocida\t\r \u00a0 enzima,\t\r \u00a0sobre\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 hab\u00edan\t\r \u00a0 realizado\t\r \u00a0 ya\t\r \u00a0 numerosos\t\r \u00a0 estudios\t\r \u00a0 sobre\t\r \u00a0 su\t\r \u00a0 posible\t\r \u00a0mecanismo\t\r \u00a0 de\t\r \u00a0 reacci\u00f3n(30)\t\r \u00a0y\t\r \u00a0 hab\u00eda\t\r \u00a0 diversas\t\r \u00a0 estructuras\t\r \u00a0 tridimensionales\t\r \u00a0 del\t\r \u00a0complejo\t\r \u00a0entre\t\r \u00a0la\t\r \u00a0lisozima\t\r \u00a0y\t\r \u00a0un\t\r \u00a0inhibidor\t\r \u00a0tri-\u00ad\u2010N-\u00ad\u2010acetyl\t\r \u00a0glucosamina\t\r \u00a0(tri-\u00ad\u2010NAG)\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0modelo\t\r \u00a0de\t\r \u00a0hexa-\u00ad\u2010NAG,\t\r \u00a0sustrato\t\r \u00a0natural\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0sitio\t\r \u00a0activo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0enzima(31).\t\r \u00a0En\t\r \u00a0concreto\t\r \u00a0estudiaron\t\r \u00a0la\t\r \u00a0estabilidad\t\r \u00a0del\t\r \u00a0ion\t\r \u00a0carbonio\t\r \u00a0intermedio\t\r \u00a0formado\t\r \u00a0en\t\r \u00a0 la\t\r \u00a0 ruptura\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 lisozima\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 enlace\t\r \u00a0 glucos\u00eddico.\t\r \u00a0 Se\t\r \u00a0 encontr\u00f3\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0estabilizaci\u00f3n\t\r \u00a0electrost\u00e1tica\t\r \u00a0constitu\u00eda\t\r \u00a0un\t\r \u00a0factor\t\r \u00a0importante\t\r \u00a0que\t\r \u00a0podr\u00eda\t\r \u00a0justificar\t\r \u00a0el\t\r \u00a0incremento\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 velocidad\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 que\t\r \u00a0 conduce\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0intermedio.\t\r \u00a0Los\t\r \u00a0factores\t\r \u00a0est\u00e9ricos,\t\r \u00a0tales\t\r \u00a0como\t\r \u00a0la\t\r \u00a0tensi\u00f3n\t\r \u00a0del\t\r \u00a0sustrato\t\r \u00a0al\t\r \u00a0unirse\t\r \u00a0a\t\r \u00a0la\t\r \u00a0lisozima,\t\r \u00a0no\t\r \u00a0parecen\t\r \u00a0contribuir\t\r \u00a0significativamente.\t\r \u00a0El\t\r \u00a0 m\u00e9todo\t\r \u00a0 descrito\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 trabajo\t\r \u00a0 considera\t\r \u00a0 todo\t\r \u00a0 el\t\r \u00a0 sistema\t\r \u00a0 enzima-\u00ad\u2010sustrato.\t\r \u00a0 La\t\r \u00a0 energ\u00eda\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 distribuci\u00f3n\t\r \u00a0 de\t\r \u00a0 carga\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \u00e1tomos\t\r \u00a0 directamente\t\r \u00a0involucrados\t\r \u00a0en\t\r \u00a0la\t\r \u00a0reacci\u00f3n\t\r \u00a0se\t\r \u00a0evaluaron\t\r \u00a0mediante\t\r \u00a0qu\u00edmica\t\r \u00a0cu\u00e1ntica,\t\r \u00a0mientras\t\r \u00a0que\t\r \u00a0la\t\r \u00a0superficie\t\r \u00a0de\t\r \u00a0energ\u00eda\t\r \u00a0potencial\t\r \u00a0del\t\r \u00a0resto\t\r \u00a0del\t\r \u00a0sistema,\t\r \u00a0incluyendo\t\r \u00a0el\t\r \u00a0disolvente\t\r \u00a0se\t\r \u00a0evalu\u00f3\t\r \u00a0 con\t\r \u00a0 m\u00e9todos\t\r \u00a0 cl\u00e1sicos.\t\r \u00a0 Un\t\r \u00a0 detalle\t\r \u00a0 importante\t\r \u00a0 del\t\r \u00a0 m\u00e9todo\t\r \u00a0 es\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0tratamiento\t\r \u00a0del\t\r \u00a0efecto\t\r \u00a0diel\u00e9ctrico\t\r \u00a0debido\t\r \u00a0tanto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna,\t\r \u00a0como\t\r \u00a0al\t\r \u00a0disolvente\t\r \u00a0(agua).\t\r \u00a0Su\t\r \u00a0modelo\t\r \u00a0diel\u00e9ctrico\t\r \u00a0se\t\r \u00a0bas\u00f3\t\r \u00a0en\t\r \u00a0un\t\r \u00a0c\u00e1lculo\t\r \u00a0directo\t\r \u00a0del\t\r \u00a0campo\t\r \u00a0electrost\u00e1tico\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0los\t\r \u00a0dipolos\t\r \u00a0inducidos\t\r \u00a0al\t\r \u00a0polarizar\t\r \u00a0los\t\r \u00a0\u00e1tomos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0prote\u00edna\t\r \u00a0y\t\r \u00a0los\t\r \u00a0dipolos\t\r \u00a0inducidos\t\r \u00a0al\t\r \u00a0orientar\t\r \u00a0las\t\r \u00a0mol\u00e9culas\t\r \u00a0de\t\r \u00a0agua\t\r \u00a0del\t\r \u00a0entorno(1).\t\r \u00a04.2.\t\r \u00a0Otras\t\r \u00a0aplicaciones\t\r \u00a0de\t\r \u00a0QM/MM\t\r \u00a0Durante\t\r \u00a0 mucho\t\r \u00a0 tiempo\t\r \u00a0 los\t\r \u00a0 c\u00e1lculos\t\r \u00a0 QM/MM\t\r \u00a0 estuvieron\t\r \u00a0 dominados\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0reactividad\t\r \u00a0enzim\u00e1tica.\t\r \u00a0Sin\t\r \u00a0lugar\t\r \u00a0a\t\r \u00a0duda\t\r \u00a0este\t\r \u00a0es\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0principales\t\r \u00a0campos\t\r \u00a0 de\t\r \u00a0 aplicaci\u00f3n,\t\r \u00a0 pero\t\r \u00a0 no\t\r \u00a0 s\u00f3lo\t\r \u00a0la\t\r \u00a0 formaci\u00f3n\t\r \u00a0 y\t\r \u00a0 ruptura\t\r \u00a0 de\t\r \u00a0 enlaces\t\r \u00a0 requiere\t\r \u00a0QM/MM,\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0otros\t\r \u00a0procesos\t\r \u00a0asociados\t\r \u00a0a\t\r \u00a0reorganizaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0estructura\t\r \u00a0electr\u00f3nica.\t\r \u00a0Por\t\r \u00a0ejemplo\t\r \u00a0las\t\r \u00a0propiedades\t\r \u00a0espectrosc\u00f3picas.\t\r \u00a0\t\r \u00a0\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n429\t\r \u00a0\t\r \u00a0Refinamiento\t\r \u00a0de\t\r \u00a0estructuras.\t\r \u00a0Una\t\r \u00a0 aplicaci\u00f3n\t\r \u00a0 especialmente\t\r \u00a0 interesante\t\r \u00a0 es\t\r \u00a0 su\t\r \u00a0 combinaci\u00f3n\t\r \u00a0 con\t\r \u00a0 datos\t\r \u00a0experimentales\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 refinamiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 estructura.\t\r \u00a0 Una\t\r \u00a0 t\u00e9cnica\t\r \u00a0 prometedora\t\r \u00a0utilizada\t\r \u00a0por\t\r \u00a0primera\t\r \u00a0vez\t\r \u00a0por\t\r \u00a0Ryde\t\r \u00a0y\t\r \u00a0colaboradores(32)\t\r \u00a0aplica\t\r \u00a0el\t\r \u00a0m\u00e9todo\t\r \u00a0QM/MM\t\r \u00a0para\t\r \u00a0 refinar\t\r \u00a0 los\t\r \u00a0 datos\t\r \u00a0 estructurales\t\r \u00a0 a\t\r \u00a0 partir\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 solo\t\r \u00a0 cristal\t\r \u00a0 de\t\r \u00a0 difracci\u00f3n\t\r \u00a0 de\t\r \u00a0rayos\t\r \u00a0X(33)\t\r \u00a0,\t\r \u00a0RMN(34)\t\r \u00a0o\t\r \u00a0EXAFS(35).\t\r \u00a0La\t\r \u00a0idea\t\r \u00a0b\u00e1sica\t\r \u00a0es\t\r \u00a0usar\t\r \u00a0un\t\r \u00a0QM/MM,\t\r \u00a0en\t\r \u00a0lugar\t\r \u00a0de\t\r \u00a0s\u00f3lo\t\r \u00a0 MM,\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 modelo\t\r \u00a0 obtenido\t\r \u00a0 se\t\r \u00a0 refina\t\r \u00a0 teniendo\t\r \u00a0 en\t\r \u00a0 cuenta\t\r \u00a0 los\t\r \u00a0 datos\t\r \u00a0experimentales.\t\r \u00a0Esta\t\r \u00a0aplicaci\u00f3n\t\r \u00a0alivia\t\r \u00a0el\t\r \u00a0problema\t\r \u00a0que\t\r \u00a0surge\t\r \u00a0con\t\r \u00a0la\t\r \u00a0fiabilidad\t\r \u00a0de\t\r \u00a0los\t\r \u00a0datos\t\r \u00a0experimentales\t\r \u00a0alrededor\t\r \u00a0del\t\r \u00a0sitio\t\r \u00a0activo,\t\r \u00a0porque\t\r \u00a0los\t\r \u00a0m\u00e9todos\t\r \u00a0MM\t\r \u00a0han\t\r \u00a0sido\t\r \u00a0cuidadosamente\t\r \u00a0desarrollados\t\r \u00a0para\t\r \u00a0describir\t\r \u00a0las\t\r \u00a0prote\u00ednas,\t\r \u00a0pero\t\r \u00a0son\t\r \u00a0menos\t\r \u00a0fiables\t\r \u00a0para\t\r \u00a0los\t\r \u00a0sustratos\t\r \u00a0o\t\r \u00a0cofactores.\t\r \u00a0\t\r \u00a0Reactividad\t\r \u00a0Las\t\r \u00a0 reacciones\t\r \u00a0 enzim\u00e1ticas\t\r \u00a0 han\t\r \u00a0 sido\t\r \u00a0 el\t\r \u00a0 objetivo\t\r \u00a0 principal\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 \t\r \u00a0 m\u00e9todos\t\r \u00a0QM/MM.\t\r \u00a0\t\r \u00a0Dentro\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 gran\t\r \u00a0 variedad\t\r \u00a0 de\t\r \u00a0 sistemas\t\r \u00a0 estudiados\t\r \u00a0 uno\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 m\u00e1s\t\r \u00a0representativos\t\r \u00a0es\t\r \u00a0el\t\r \u00a0de\t\r \u00a0la\t\r \u00a0corismatomutasa.\t\r \u00a0\t\r \u00a0La\t\r \u00a0corismatomutasa\t\r \u00a0es\t\r \u00a0una\t\r \u00a0enzima\t\r \u00a0que\t\r \u00a0cataliza\t\r \u00a0la\t\r \u00a0transposici\u00f3n\t\r \u00a0de\t\r \u00a0Claisen\t\r \u00a0de\t\r \u00a0corismato\t\r \u00a0a\t\r \u00a0prefenato\t\r \u00a0(Figura\t\r \u00a010),\t\r \u00a0un\t\r \u00a0paso\t\r \u00a0clave\t\r \u00a0en\t\r \u00a0la\t\r \u00a0v\u00eda\t\r \u00a0del\t\r \u00a0\u00e1cido\t\r \u00a0siqu\u00edmico\t\r \u00a0que\t\r \u00a0 da\t\r \u00a0 lugar\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 s\u00edntesis\t\r \u00a0 de\t\r \u00a0 amino\u00e1cidos\t\r \u00a0 arom\u00e1ticos\t\r \u00a0 en\t\r \u00a0 plantas,\t\r \u00a0 hongos\t\r \u00a0 y\t\r \u00a0bacterias.\t\r \u00a0Esta\t\r \u00a0reacci\u00f3n\t\r \u00a0constituye\t\r \u00a0un\t\r \u00a0raro\t\r \u00a0ejemplo\t\r \u00a0de\t\r \u00a0una\t\r \u00a0reacci\u00f3n\t\r \u00a0peric\u00edclica\t\r \u00a0en\t\r \u00a0un\t\r \u00a0sistema\t\r \u00a0biol\u00f3gico\t\r \u00a0y\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0el\t\r \u00a0objeto\t\r \u00a0de\t\r \u00a0numerosos\t\r \u00a0estudios\t\r \u00a0te\u00f3ricos.\t\r \u00a0\t\r \u00a0\t\r \u00a0Figura\t\r \u00a0 10.-\u00ad\u2010Reordenamiento\t\r \u00a0 de\t\r \u00a0 claisen\t\r \u00a0 de\t\r \u00a0 \u00e1cido\t\r \u00a0 cor\u00edsmico\t\r \u00a0 a\t\r \u00a0 pref\u00e9nico\t\r \u00a0 por\t\r \u00a0 medio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0corismatomutasa.\t\r \u00a0Lyne,\t\r \u00a0Mulholland\t\r \u00a0y\t\r \u00a0Richards\t\r \u00a0publicaron\t\r \u00a0en\t\r \u00a01995\t\r \u00a0el\t\r \u00a0primer\t\r \u00a0estudio\t\r \u00a0QM/MM\t\r \u00a0(AM1/CHARMM)\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 corismatomutasa(36).\t\r \u00a0Optimizaron\t\r \u00a0 la\t\r \u00a0 estructura\t\r \u00a0 del\t\r \u00a0reactivo\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 perfil\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 reacci\u00f3n\t\r \u00a0 e\t\r \u00a0 identificaron\t\r \u00a0 residuos\t\r \u00a0 esenciales\t\r \u00a0 dentro\t\r \u00a0 del\t\r \u00a0sitio\t\r \u00a0 activo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 enzima.\t\r \u00a0 Observaron\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 complejo\t\r \u00a0 enzima\t\r \u00a0 sustrato\t\r \u00a0 est\u00e1\t\r \u00a0distorsionado\t\r \u00a0 comparado\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0 c\u00e1lculos\t\r \u00a0 previos\t\r \u00a0 en\t\r \u00a0 fase\t\r \u00a0 gaseosa,\t\r \u00a0 pareci\u00e9ndose\t\r \u00a0m\u00e1s\t\r \u00a0 al\t\r \u00a0 estado\t\r \u00a0 de\t\r \u00a0 transici\u00f3n,\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 que\t\r \u00a0 un\t\r \u00a0 residuo\t\r \u00a0 de\t\r \u00a0 arginina\t\r \u00a0y\t\r \u00a0 otro\t\r \u00a0 de\t\r \u00a0glut\u00e1mico\t\r \u00a0 estabilizan\t\r \u00a0 esta\t\r \u00a0 disposici\u00f3n.\t\r \u00a0 Llegaron\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 conclusi\u00f3n\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0estabilizaci\u00f3n\t\r \u00a0 electrost\u00e1tica\t\r \u00a0 del\t\r \u00a0 estado\t\r \u00a0 de\t\r \u00a0 transici\u00f3n\t\r \u00a0 es\t\r \u00a0 la\t\r \u00a0 contribuci\u00f3n\t\r \u00a0 m\u00e1s\t\r \u00a0importante\t\r \u00a0al\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0cat\u00e1lisis,\t\r \u00a0en\t\r \u00a0este\t\r \u00a0caso.\t\r \u00a0\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n430\t\r \u00a0\t\r \u00a0Un\t\r \u00a0 gran\t\r \u00a0 n\u00famero\t\r \u00a0 de\t\r \u00a0 estudios\t\r \u00a0 posteriores,(37)\t\r \u00a0incluyendo\t\r \u00a0 trabajos\t\r \u00a0 de\t\r \u00a0Warshel,(38)\t\r \u00a0utilizando\t\r \u00a0 diferentes\t\r \u00a0 m\u00e9todos\t\r \u00a0 y\t\r \u00a0 aproximaciones\t\r \u00a0 de\t\r \u00a0 c\u00e1lculo\t\r \u00a0 han\t\r \u00a0permitido\t\r \u00a0confirmar\t\r \u00a0esta\t\r \u00a0primera\t\r \u00a0hip\u00f3tesis.\t\r \u00a05.\t\r \u00a0CONCLUSI\u00d3N\t\r \u00a0En\t\r \u00a0 este\t\r \u00a0 trabajo\t\r \u00a0 he\t\r \u00a0 pretendido\t\r \u00a0 resumir\t\r \u00a0 los\t\r \u00a0 hallazgos\t\r \u00a0 m\u00e1s\t\r \u00a0 importantes\t\r \u00a0 que\t\r \u00a0han\t\r \u00a0conducido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0concesi\u00f3n\t\r \u00a0del\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0Qu\u00edmica\t\r \u00a0en\t\r \u00a02013,\t\r \u00a0al\t\r \u00a0haber\t\r \u00a0sido\t\r \u00a0pioneros\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0y\t\r \u00a0\t\r \u00a0utilizaci\u00f3n\t\r \u00a0de\t\r \u00a0diversos\t\r \u00a0m\u00e9todos\t\r \u00a0computacionales\t\r \u00a0basados\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0cu\u00e1ntica,\t\r \u00a0como\t\r \u00a0en\t\r \u00a0la\t\r \u00a0mec\u00e1nica\t\r \u00a0cl\u00e1sica\t\r \u00a0con\t\r \u00a0el\t\r \u00a0fin\t\r \u00a0de\t\r \u00a0desvelar,\t\r \u00a0al\t\r \u00a0nivel\t\r \u00a0 de\t\r \u00a0 detalle\t\r \u00a0 at\u00f3mico,\t\r \u00a0 numerosos\t\r \u00a0 misterios\t\r \u00a0 acerca\t\r \u00a0 de\t\r \u00a0 c\u00f3mo\t\r \u00a0 funcionan\t\r \u00a0 las\t\r \u00a0biomol\u00e9culas\t\r \u00a0 y\t\r \u00a0 sobre\t\r \u00a0 todo\t\r \u00a0 por\t\r \u00a0 haber\t\r \u00a0 sido\t\r \u00a0 los\t\r \u00a0 primeros\t\r \u00a0 en\t\r \u00a0 combinar\t\r \u00a0 ambos\t\r \u00a0m\u00e9todos\t\r \u00a0 permitiendo\t\r \u00a0 un\t\r \u00a0 estudio\t\r \u00a0 m\u00e1s\t\r \u00a0 detallado\t\r \u00a0 y\t\r \u00a0 preciso\t\r \u00a0 de\t\r \u00a0 estos\t\r \u00a0 procesos\t\r \u00a0qu\u00edmicos\t\r \u00a0complejos.\t\r \u00a0\t\r \u00a0Recomiendo\t\r \u00a0al\t\r \u00a0lector\t\r \u00a0la\t\r \u00a0lectura\t\r \u00a0detallada\t\r \u00a0del\t\r \u00a0art\u00edculo\t\r \u00a0autobiogr\u00e1fico\t\r \u00a0escrito\t\r \u00a0por\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0los\t\r \u00a0galardonados,\t\r \u00a0Martin\t\r \u00a0Karplus\t\r \u00a0(6),\t\r \u00a0titulado\t\r \u00a0\u201cSpinach\t\r \u00a0on\t\r \u00a0the\t\r \u00a0Ceiling:\t\r \u00a0A\t\r \u00a0 theoreticalChemist\u2019sReturntoBiology\u201d,\t\r \u00a0 donde\t\r \u00a0 describe\t\r \u00a0 las\t\r \u00a0 experiencias\t\r \u00a0 que\t\r \u00a0 le\t\r \u00a0condujeron\t\r \u00a0desde\t\r \u00a0la\t\r \u00a0qu\u00edmica\t\r \u00a0y\t\r \u00a0la\t\r \u00a0f\u00edsica\t\r \u00a0de\t\r \u00a0nuevo\t\r \u00a0a\t\r \u00a0su\t\r \u00a0\u201cprimer\t\r \u00a0amor\u201d,\t\r \u00a0la\t\r \u00a0biolog\u00eda\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0describe\t\r \u00a0algunas\t\r \u00a0de\t\r \u00a0las\t\r \u00a0contribuciones\t\r \u00a0realizadas\t\r \u00a0durante\t\r \u00a0su\t\r \u00a0trayectoria\t\r \u00a0investigadora.\t\r \u00a0En\t\r \u00a0esta\t\r \u00a0trayectoria\t\r \u00a0sus\t\r \u00a0trabajos\t\r \u00a0se\t\r \u00a0cruzan\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0con\t\r \u00a0los\t\r \u00a0de\t\r \u00a0los\t\r \u00a0otros\t\r \u00a0investigadores\t\r \u00a0galardonados\t\r \u00a0con\t\r \u00a0el\t\r \u00a0Premio\t\r \u00a0Nobel\t\r \u00a0de\t\r \u00a0este\t\r \u00a0a\u00f1o.\t\r \u00a0\t\r \u00a06.\t\r \u00a0BIBLIOGRAF\u00cdA\t\r \u00a01.\t\r \u00a0Warshel,\t\r \u00a0 A.,\t\r \u00a0 and\t\r \u00a0 Levitt,\t\r \u00a0 M.\t\r \u00a0 (1976)\t\r \u00a0 Theoretical\t\r \u00a0 Studies\t\r \u00a0 of\t\r \u00a0 Enzymic\t\r \u00a0 Reactions:\t\r \u00a0 Dielectric,\t\r \u00a0Electrostatic\t\r \u00a0and\t\r \u00a0Steric\t\r \u00a0Stabilization\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Carbonium\t\r \u00a0ion\t\r \u00a0in\t\r \u00a0the\t\r \u00a0Reaction\t\r \u00a0of\t\r \u00a0Lysozyme.\t\r \u00a0J.\t\r \u00a0Mol.\t\r \u00a0Biol.\t\r \u00a0103:\t\r \u00a0227-\u00ad\u2010249.\t\r \u00a02.\t\r \u00a0Gaussian\t\r \u00a098\t\r \u00a0(Revision\t\r \u00a0A.7),\t\r \u00a0M.\t\r \u00a0J.\t\r \u00a0F.,\t\r \u00a0G.\t\r \u00a0W.\t\r \u00a0Trucks,\t\r \u00a0H.\t\r \u00a0B.\t\r \u00a0Schlegel,\t\r \u00a0G.\t\r \u00a0E.\t\r \u00a0Scuseria,\t\r \u00a0M.\t\r \u00a0A.\t\r \u00a0Robb,\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0 Cheeseman,\t\r \u00a0 V.\t\r \u00a0 G.\t\r \u00a0 Zakrzewski,\t\r \u00a0 J.\t\r \u00a0 A.\t\r \u00a0 Montgomery,\t\r \u00a0 R.\t\r \u00a0 E.\t\r \u00a0 Stratmann,\t\r \u00a0 J.\t\r \u00a0 C.\t\r \u00a0 Burant,\t\r \u00a0 S.\t\r \u00a0Dapprich,\t\r \u00a0 J.\t\r \u00a0 M.\t\r \u00a0 Millam,\t\r \u00a0 A.\t\r \u00a0 D.\t\r \u00a0 Daniels,\t\r \u00a0 K.\t\r \u00a0 N.\t\r \u00a0 Kudin,\t\r \u00a0 M.\t\r \u00a0 C.\t\r \u00a0 Strain,\t\r \u00a0 O.\t\r \u00a0 Farkas,\t\r \u00a0 J.\t\r \u00a0Tomasi,\t\r \u00a0 V.\t\r \u00a0Barone,\t\r \u00a0M.\t\r \u00a0Cossi,\t\r \u00a0R.\t\r \u00a0Cammi,\t\r \u00a0B.\t\r \u00a0Mennucci,\t\r \u00a0C.\t\r \u00a0Pomelli,\t\r \u00a0C.\t\r \u00a0Adamo,\t\r \u00a0S.\t\r \u00a0Clifford,\t\r \u00a0J.\t\r \u00a0Ochterski,\t\r \u00a0G.\t\r \u00a0A.\t\r \u00a0Petersson,\t\r \u00a0P.\t\r \u00a0Y.\t\r \u00a0Ayala,\t\r \u00a0Q.\t\r \u00a0Cui,\t\r \u00a0K.\t\r \u00a0Morokuma,\t\r \u00a0D.\t\r \u00a0K.\t\r \u00a0Malick,\t\r \u00a0A.\t\r \u00a0D.\t\r \u00a0Rabuck,\t\r \u00a0K.\t\r \u00a0Raghavachari,\t\r \u00a0J.\t\r \u00a0B.\t\r \u00a0Foresman,\t\r \u00a0 J.\t\r \u00a0 Cioslowski,\t\r \u00a0 J.\t\r \u00a0 V.\t\r \u00a0 Ortiz,\t\r \u00a0 B.\t\r \u00a0 B.\t\r \u00a0 Stefanov,\t\r \u00a0 G.\t\r \u00a0 Liu,\t\r \u00a0 A.\t\r \u00a0 Liashenko,\t\r \u00a0 P.\t\r \u00a0 Piskorz,\t\r \u00a0 I.\t\r \u00a0Komaromi,\t\r \u00a0 R.\t\r \u00a0 Gomperts,\t\r \u00a0 R.\t\r \u00a0 L.\t\r \u00a0 Martin,\t\r \u00a0 D.\t\r \u00a0 J.\t\r \u00a0 Fox,\t\r \u00a0 ,\t\r \u00a0 T.\t\r \u00a0 Keith,\t\r \u00a0 M.\t\r \u00a0 A.\t\r \u00a0 Al-\u00ad\u2010Laham,\t\r \u00a0 C.\t\r \u00a0 Y.\t\r \u00a0 Peng,\t\r \u00a0 A.\t\r \u00a0Nanayakkara,\t\r \u00a0 C.\t\r \u00a0 Gonzalez,\t\r \u00a0 M.\t\r \u00a0 Challacombe,\t\r \u00a0 P.\t\r \u00a0 M.\t\r \u00a0 W.\t\r \u00a0 Gill,\t\r \u00a0 B.\t\r \u00a0 G.\t\r \u00a0 Johnson,\t\r \u00a0 W.\t\r \u00a0 Chen,\t\r \u00a0 M.\t\r \u00a0 W.\t\r \u00a0Wong,\t\r \u00a0 J.\t\r \u00a0 L.\t\r \u00a0 Andres,\t\r \u00a0 M.\t\r \u00a0 Head-\u00ad\u2010Gordon,\t\r \u00a0 E.\t\r \u00a0S.\t\r \u00a0 Replogle,\t\r \u00a0 and\t\r \u00a0 J.\t\r \u00a0 A.\t\r \u00a0 Pople,\t\r \u00a0 Gaussian,\t\r \u00a0 Inc.,\t\r \u00a0Pittsburgh,\t\r \u00a0PA,\t\r \u00a01998.\t\r \u00a0\t\r \u00a03.\t\r \u00a0Schmidt,\t\r \u00a0M.\t\r \u00a0W.,\t\r \u00a0Baldridge,\t\r \u00a0K.\t\r \u00a0K.,\t\r \u00a0Boatz,\t\r \u00a0J.\t\r \u00a0A.,\t\r \u00a0Elbert,\t\r \u00a0S.\t\r \u00a0T.,\t\r \u00a0Gordon,\t\r \u00a0M.\t\r \u00a0S.,\t\r \u00a0Jensen,\t\r \u00a0J.\t\r \u00a0H.,\t\r \u00a0Koseki,\t\r \u00a0S.,\t\r \u00a0Matsunaga,\t\r \u00a0N.,\t\r \u00a0Nguyen,\t\r \u00a0K.\t\r \u00a0A.,\t\r \u00a0Su,\t\r \u00a0S.,\t\r \u00a0Windus,\t\r \u00a0T.\t\r \u00a0L.,\t\r \u00a0Dupuis,\t\r \u00a0M.,\t\r \u00a0and\t\r \u00a0Montgomery\t\r \u00a0Jr,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0(1993)\t\r \u00a0 General\t\r \u00a0 atomic\t\r \u00a0 and\t\r \u00a0 molecular\t\r \u00a0 electronic\t\r \u00a0 structure\t\r \u00a0 system.\t\r \u00a0J.\t\r \u00a0 Comp.\t\r \u00a0 Chem.\t\r \u00a014:\t\r \u00a01347-\u00ad\u20101363.\t\r \u00a04.\t\r \u00a0Dewar,\t\r \u00a0 M.\t\r \u00a0 J.\t\r \u00a0 S.,\t\r \u00a0 and\t\r \u00a0 Thiel,\t\r \u00a0 W.\t\r \u00a0 (1977)\t\r \u00a0 Ground\t\r \u00a0 states\t\r \u00a0 of\t\r \u00a0 molecules.\t\r \u00a0 39.\t\r \u00a0 MNDO\t\r \u00a0 results\t\r \u00a0 for\t\r \u00a0molecules\t\r \u00a0containing\t\r \u00a0hydrogen,\t\r \u00a0carbon,\t\r \u00a0nitrogen,\t\r \u00a0and\t\r \u00a0oxygen.\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a099:\t\r \u00a04907-\u00ad\u20104917.\t\r \u00a05.\t\r \u00a0Dewar,\t\r \u00a0M.\t\r \u00a0J.\t\r \u00a0S.,\t\r \u00a0Zoebisch,\t\r \u00a0E.\t\r \u00a0G.,\t\r \u00a0Healy,\t\r \u00a0E.\t\r \u00a0F.,\t\r \u00a0and\t\r \u00a0Stewart,\t\r \u00a0J.\t\r \u00a0J.\t\r \u00a0P.\t\r \u00a0(1985)\t\r \u00a0Development\t\r \u00a0and\t\r \u00a0use\t\r \u00a0of\t\r \u00a0 quantum\t\r \u00a0 mechanical\t\r \u00a0 molecular\t\r \u00a0 models.\t\r \u00a0 76.\t\r \u00a0 AM1:\t\r \u00a0 a\t\r \u00a0 new\t\r \u00a0 general\t\r \u00a0 purpose\t\r \u00a0 quantum\t\r \u00a0mechanical\t\r \u00a0molecular\t\r \u00a0model.\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a0107:\t\r \u00a03902-\u00ad\u20103909.\t\r \u00a06.\t\r \u00a0Karplus,\t\r \u00a0M.\t\r \u00a0(2006)\t\r \u00a0Spinach\t\r \u00a0on\t\r \u00a0the\t\r \u00a0Ceiling:\t\r \u00a0A\t\r \u00a0theoretical\t\r \u00a0Chemist's\t\r \u00a0Return\t\r \u00a0to\t\r \u00a0Biology.\t\r \u00a0Annu.\t\r \u00a0Rev.\t\r \u00a0Biophys.\t\r \u00a0Biomol.\t\r \u00a0Struct.\t\r \u00a035:\t\r \u00a01-\u00ad\u201047.\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0Premios\t\r \u00a0Nobel\t\r \u00a02013\t\r \u00a0\t\r \u00a0\n431\t\r \u00a0\t\r \u00a07.\t\r \u00a0Honig,\t\r \u00a0B.,\t\r \u00a0and\t\r \u00a0Karplus,\t\r \u00a0M.\t\r \u00a0(1971)\t\r \u00a0Implications\t\r \u00a0of\t\r \u00a0torsional\t\r \u00a0potential\t\r \u00a0of\t\r \u00a0retinal\t\r \u00a0isomers\t\r \u00a0for\t\r \u00a0visual\t\r \u00a0excitation.\t\r \u00a0Nature.\t\r \u00a0229:\t\r \u00a0558-\u00ad\u2010560.\t\r \u00a08.\t\r \u00a0Gilardi,\t\r \u00a0 R.,\t\r \u00a0 Karle,\t\r \u00a0 I.,\t\r \u00a0 Karle,\t\r \u00a0 J.,\t\r \u00a0 and\t\r \u00a0 Sperling,\t\r \u00a0 W.\t\r \u00a0 (1971)\t\r \u00a0 Crystal\t\r \u00a0 structure\t\r \u00a0 of\t\r \u00a0 visual\t\r \u00a0chromophores,\t\r \u00a011-\u00ad\u2010cis\t\r \u00a0and\t\r \u00a0all-\u00ad\u2010trans\t\r \u00a0retinal.\t\r \u00a0Nature.\t\r \u00a0232:\t\r \u00a0187.\t\r \u00a09.\t\r \u00a0Gonz\u00e1lez,\t\r \u00a0 D.,\t\r \u00a0 Garc\u00eda,\t\r \u00a0 M.\t\r \u00a0 A.,\t\r \u00a0 and\t\r \u00a0 de\t\r \u00a0 Pascual-\u00ad\u2010Teresa,\t\r \u00a0 B.\t\r \u00a0 (2000)\t\r \u00a0 Anticuerpos\t\r \u00a0 Catal\u00edticos:\t\r \u00a0Aplicaciones\t\r \u00a0Qu\u00edmicas\t\r \u00a0y\t\r \u00a0Farmacol\u00f3gicas.\t\r \u00a0.\t\r \u00a0Industria\t\r \u00a0Farmac\u00e9utica.\t\r \u00a0Noviembre-\u00ad\u2010Diciembre:\t\r \u00a0111-\u00ad\u2010120.\t\r \u00a010.\t\r \u00a0Gouverneur,\t\r \u00a0V.\t\r \u00a0E.,\t\r \u00a0Houk,\t\r \u00a0K.\t\r \u00a0N.,\t\r \u00a0de\t\r \u00a0Pascual-\u00ad\u2010Teresa,\t\r \u00a0B.,\t\r \u00a0Beno,\t\r \u00a0B.,\t\r \u00a0Janda,\t\r \u00a0K.\t\r \u00a0D.,\t\r \u00a0and\t\r \u00a0Lerner,\t\r \u00a0R.\t\r \u00a0A.\t\r \u00a0(1993)\t\r \u00a0 Control\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 Exo-\u00ad\u2010pathway\t\r \u00a0 and\t\r \u00a0 Endo-\u00ad\u2010pathway\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 Diels-\u00ad\u2010Alder\t\r \u00a0 Reaction\t\r \u00a0 by\t\r \u00a0Antibody\t\r \u00a0Catalysis.\t\r \u00a0Science.\t\r \u00a0262:\t\r \u00a0204-\u00ad\u2010208.\t\r \u00a011.\t\r \u00a0Xu,\t\r \u00a0J.,\t\r \u00a0Deng,\t\r \u00a0Q.,\t\r \u00a0Chen,\t\r \u00a0J.,\t\r \u00a0Houk,\t\r \u00a0K.\t\r \u00a0N.,\t\r \u00a0Bartek,\t\r \u00a0J.,\t\r \u00a0Hilvert,\t\r \u00a0D.,\t\r \u00a0and\t\r \u00a0Wilson,\t\r \u00a0I.\t\r \u00a0(1999)\t\r \u00a0Evolution\t\r \u00a0of\t\r \u00a0shape\t\r \u00a0 complementarity\t\r \u00a0 and\t\r \u00a0 catalytic\t\r \u00a0 efficiency\t\r \u00a0 from\t\r \u00a0 a\t\r \u00a0 primordial\t\r \u00a0 antibody\t\r \u00a0 template.\t\r \u00a0Science.\t\r \u00a0286:\t\r \u00a02345\t\r \u00a0-\u00ad\u2010\t\r \u00a02348.\t\r \u00a012.\t\r \u00a0Kirby,\t\r \u00a0A.\t\r \u00a0J.\t\r \u00a0(1996)\t\r \u00a0The\t\r \u00a0potential\t\r \u00a0of\t\r \u00a0catalytic\t\r \u00a0antibodies.\t\r \u00a0Acta\t\r \u00a0Chem.\t\r \u00a0Scand.\t\r \u00a050:\t\r \u00a0203-\u00ad\u2010210.\t\r \u00a013.\t\r \u00a0Kiss,\t\r \u00a0 G.,\t\r \u00a0 Olcum,\t\r \u00a0 N.,\t\r \u00a0 Moretti,\t\r \u00a0 R.,\t\r \u00a0 Baker,\t\r \u00a0 D.,\t\r \u00a0 and\t\r \u00a0 Houk,\t\r \u00a0 K.\t\r \u00a0 (2013)\t\r \u00a0 Computational\t\r \u00a0 Enzyme\t\r \u00a0Design.\t\r \u00a0Angew.\t\r \u00a0Chem.\t\r \u00a0Int.\t\r \u00a0Ed.\t\r \u00a0Engl.\t\r \u00a052:\t\r \u00a05700-\u00ad\u20105725.\t\r \u00a014.\t\r \u00a0Gasteiger,\t\r \u00a0 J.,\t\r \u00a0 and\t\r \u00a0 Marsili,\t\r \u00a0 M.\t\r \u00a0 (1978)\t\r \u00a0 A\t\r \u00a0 new\t\r \u00a0 model\t\r \u00a0 for\t\r \u00a0 calculating\t\r \u00a0 atomic\t\r \u00a0 charges\t\r \u00a0 in\t\r \u00a0molecules.\t\r \u00a0Tetrahedron\t\r \u00a0Lett.\t\r \u00a019:\t\r \u00a03181-\u00ad\u20103184.\t\r \u00a015.\t\r \u00a0Bayly,\t\r \u00a0C.\t\r \u00a0I.,\t\r \u00a0Cieplak,\t\r \u00a0P.,\t\r \u00a0Cornell,\t\r \u00a0W.,\t\r \u00a0and\t\r \u00a0Kollman,\t\r \u00a0P.\t\r \u00a0A.\t\r \u00a0(1993)\t\r \u00a0A\t\r \u00a0well-\u00ad\u2010behaved\t\r \u00a0electrostatic\t\r \u00a0potential\t\r \u00a0 based\t\r \u00a0 method\t\r \u00a0 using\t\r \u00a0 charge\t\r \u00a0 restraints\t\r \u00a0 for\t\r \u00a0 deriving\t\r \u00a0 atomic\t\r \u00a0 charges:\t\r \u00a0 the\t\r \u00a0 RESP\t\r \u00a0model.\t\r \u00a0J.\t\r \u00a0Phys.\t\r \u00a0Chem.\t\r \u00a097:\t\r \u00a010269-\u00ad\u201010280.\t\r \u00a016.\t\r \u00a0Lee,\t\r \u00a0F.\t\r \u00a0S.,\t\r \u00a0and\t\r \u00a0Warshel,\t\r \u00a0A.\t\r \u00a0(1992)\t\r \u00a0A\t\r \u00a0local\t\r \u00a0reaction\t\r \u00a0field\t\r \u00a0method\t\r \u00a0for\t\r \u00a0fast\t\r \u00a0evaluation\t\r \u00a0of\t\r \u00a0long-\u00ad\u2010range\t\r \u00a0electrostatic\t\r \u00a0interactions\t\r \u00a0in\t\r \u00a0molecular\t\r \u00a0simulations.\t\r \u00a0J.\t\r \u00a0Phys.\t\r \u00a0Chem.\t\r \u00a097:\t\r \u00a03100-\u00ad\u20103107.\t\r \u00a017.\t\r \u00a0Case,\t\r \u00a0D.\t\r \u00a0A.,\t\r \u00a0Cheatham,\t\r \u00a0T.\t\r \u00a0E.,\t\r \u00a03rd,\t\r \u00a0Darden,\t\r \u00a0T.,\t\r \u00a0Gohlke,\t\r \u00a0H.,\t\r \u00a0Luo,\t\r \u00a0R.,\t\r \u00a0Merz,\t\r \u00a0K.\t\r \u00a0M.,\t\r \u00a0Jr.,\t\r \u00a0Onufriev,\t\r \u00a0A.,\t\r \u00a0Simmerling,\t\r \u00a0 C.,\t\r \u00a0 Wang,\t\r \u00a0 B.,\t\r \u00a0 and\t\r \u00a0 Woods,\t\r \u00a0 R.\t\r \u00a0 J.\t\r \u00a0 (2005)\t\r \u00a0 The\t\r \u00a0 Amber\t\r \u00a0 biomolecular\t\r \u00a0 simulation\t\r \u00a0programs.\t\r \u00a0J.\t\r \u00a0Comp.\t\r \u00a0Chem.\t\r \u00a026:\t\r \u00a01668-\u00ad\u20101688.\t\r \u00a018.\t\r \u00a0Brooks,\t\r \u00a0B.\t\r \u00a0R.,\t\r \u00a0Bruccoleri,\t\r \u00a0R.\t\r \u00a0E.,\t\r \u00a0Olafson,\t\r \u00a0B.\t\r \u00a0D.,\t\r \u00a0States,\t\r \u00a0D.\t\r \u00a0J.,\t\r \u00a0Swaminathan,\t\r \u00a0S.,\t\r \u00a0and\t\r \u00a0Karplus,\t\r \u00a0M.\t\r \u00a0(1983)\t\r \u00a0 CHARMM:\t\r \u00a0 A\t\r \u00a0 Program\t\r \u00a0 for\t\r \u00a0 Macromolecular\t\r \u00a0 Energy,\t\r \u00a0 Minimization,\t\r \u00a0 and\t\r \u00a0 Dynamics\t\r \u00a0Calculations.\t\r \u00a0J.\t\r \u00a0Comp.\t\r \u00a0Chem.\t\r \u00a04:\t\r \u00a0187-\u00ad\u2010217.\t\r \u00a019.\t\r \u00a0Hermans,\t\r \u00a0 J.,\t\r \u00a0 Berendsen,\t\r \u00a0 H.\t\r \u00a0 J.\t\r \u00a0 C.,\t\r \u00a0 van\t\r \u00a0 Gusteren,\t\r \u00a0 W.\t\r \u00a0 F.,\t\r \u00a0 and\t\r \u00a0 Postma,\t\r \u00a0 J.\t\r \u00a0 P.\t\r \u00a0 M.\t\r \u00a0 (1984)\t\r \u00a0 A\t\r \u00a0consistent\t\r \u00a0empirical\t\r \u00a0potential\t\r \u00a0for\t\r \u00a0water-\u00ad\u2010protein\t\r \u00a0interactions.\t\r \u00a0Biopolymers.\t\r \u00a023:\t\r \u00a01513-\u00ad\u20101518.\t\r \u00a020.\t\r \u00a0Kini,\t\r \u00a0R.\t\r \u00a0M.,\t\r \u00a0and\t\r \u00a0Evans,\t\r \u00a0H.\t\r \u00a0J.\t\r \u00a0(1992)\t\r \u00a0Comparison\t\r \u00a0of\t\r \u00a0protein\t\r \u00a0models\t\r \u00a0minimized\t\r \u00a0by\t\r \u00a0the\t\r \u00a0all-\u00ad\u2010atom\t\r \u00a0and\t\r \u00a0united-\u00ad\u2010atom\t\r \u00a0models\t\r \u00a0in\t\r \u00a0the\t\r \u00a0AMBER\t\r \u00a0force\t\r \u00a0field:\t\r \u00a0correlation\t\r \u00a0of\t\r \u00a0RMS\t\r \u00a0deviation\t\r \u00a0with\t\r \u00a0the\t\r \u00a0crystallographic\t\r \u00a0R\t\r \u00a0factor\t\r \u00a0and\t\r \u00a0size.\t\r \u00a0J.\t\r \u00a0Biomol.\t\r \u00a0Struct.\t\r \u00a0Dyn.\t\r \u00a010:\t\r \u00a0265-\u00ad\u2010279.\t\r \u00a021.\t\r \u00a0Lifson,\t\r \u00a0S.,\t\r \u00a0and\t\r \u00a0Warshel,\t\r \u00a0A.\t\r \u00a0(1969)\t\r \u00a0Consistent\t\r \u00a0force\t\r \u00a0field\t\r \u00a0for\t\r \u00a0calculations\t\r \u00a0of\t\r \u00a0conformations\t\r \u00a0vibrational\t\r \u00a0spectra\t\r \u00a0and\t\r \u00a0enthalpies\t\r \u00a0of\t\r \u00a0cycloalkanes\t\r \u00a0and\t\r \u00a0n-\u00ad\u2010alkane\t\r \u00a0molecules.\t\r \u00a0J.\t\r \u00a0Chem.\t\r \u00a0Phys.\t\r \u00a049:\t\r \u00a0116-\u00ad\u2010129.\t\r \u00a022.\t\r \u00a0Levitt,\t\r \u00a0 M.,\t\r \u00a0 and\t\r \u00a0 Lifson,\t\r \u00a0 S.\t\r \u00a0 (1969)\t\r \u00a0 Refinemento\t\r \u00a0 fo\t\r \u00a0 Protein\t\r \u00a0 Conformations\t\r \u00a0 Using\t\r \u00a0 a\t\r \u00a0Macromolecular\t\r \u00a0Energy\t\r \u00a0Minimization\t\r \u00a0Procedure.\t\r \u00a0J.\t\r \u00a0Mol.\t\r \u00a0Biol.\t\r \u00a046:\t\r \u00a0269-\u00ad\u2010&.\t\r \u00a023.\t\r \u00a0Scheraga,\t\r \u00a0H.\t\r \u00a0(1968)\t\r \u00a0Calculations\t\r \u00a0of\t\r \u00a0the\t\r \u00a0conformations\t\r \u00a0of\t\r \u00a0small\t\r \u00a0molecules.\t\r \u00a0Adv.\t\r \u00a0Phys.\t\r \u00a0Org.\t\r \u00a0Chem.:\t\r \u00a0103-\u00ad\u2010184.\t\r \u00a024.\t\r \u00a0Schiff,\t\r \u00a0 D.,\t\r \u00a0 and\t\r \u00a0 Verlet,\t\r \u00a0 L.\t\r \u00a0 (1967)\t\r \u00a0 Gound\t\r \u00a0 State\t\r \u00a0 of\t\r \u00a0 Liquid\t\r \u00a0 Helium-\u00ad\u20104\t\r \u00a0 and\t\r \u00a0 Helium-\u00ad\u20103.\t\r \u00a0Physical\t\r \u00a0Review.\t\r \u00a0160:\t\r \u00a0208-\u00ad\u2010&.\t\r \u00a025.\t\r \u00a0Ryckaert,\t\r \u00a0 J.\t\r \u00a0P.,\t\r \u00a0 Ciccotti,\t\r \u00a0 G.,\t\r \u00a0 and\t\r \u00a0 Berendsen,\t\r \u00a0 H.\t\r \u00a0 J.\t\r \u00a0 C.\t\r \u00a0 (1977)\t\r \u00a0 Numerical-\u00ad\u2010Integration\t\r \u00a0 of\t\r \u00a0Cartesian\t\r \u00a0 Equations\t\r \u00a0 of\t\r \u00a0 Motion\t\r \u00a0 of\t\r \u00a0 a\t\r \u00a0 system\t\r \u00a0 with\t\r \u00a0 Constraints-\u00ad\u2010Molecular-\u00ad\u2010Dynamics\t\r \u00a0 of\t\r \u00a0 n-\u00ad\u2010Alkanes.\t\r \u00a0J.\t\r \u00a0Comput.\t\r \u00a0Phys.\t\r \u00a023:\t\r \u00a0327-\u00ad\u2010341.\t\r \u00a026.\t\r \u00a0Buscar.\t\r \u00a0(1975).\t\r \u00a0Acta\t\r \u00a0crystallographica\t\r \u00a0B.\t\r \u00a031:\t\r \u00a0238-\u00ad\u2010250.\t\r \u00a027.\t\r \u00a0McCammon,\t\r \u00a0J.,\t\r \u00a0Gelin,\t\r \u00a0B.,\t\r \u00a0and\t\r \u00a0Karplus,\t\r \u00a0M.\t\r \u00a0(1977)\t\r \u00a0Dynamics\t\r \u00a0of\t\r \u00a0folded\t\r \u00a0proteins.\t\r \u00a0Nature.\t\r \u00a0267:\t\r \u00a0585-\u00ad\u2010590.\t\r \u00a028.\t\r \u00a0Senn,\t\r \u00a0 H.\t\r \u00a0 M.,\t\r \u00a0 and\t\r \u00a0 Thiel,\t\r \u00a0 W.\t\r \u00a0 (2009)\t\r \u00a0 QM/MM\t\r \u00a0 Methods\t\r \u00a0 for\t\r \u00a0 Biomolecular\t\r \u00a0 Systems.\t\r \u00a0Angew.\t\r \u00a0Chem.\t\r \u00a0Int.\t\r \u00a0Ed.\t\r \u00a0Engl.\t\r \u00a048:\t\r \u00a01198-\u00ad\u20101229.\t\r \u00a029.\t\r \u00a0Maseras,\t\r \u00a0F.,\t\r \u00a0and\t\r \u00a0Morokuma,\t\r \u00a0K.\t\r \u00a0 (1995)\t\r \u00a0 IMOMM\t\r \u00a0-\u00ad\u2010\t\r \u00a0A\t\r \u00a0new\t\r \u00a0integrated\t\r \u00a0ab\t\r \u00a0initio\t\r \u00a0+\t\r \u00a0molecular\t\r \u00a0mechanics\t\r \u00a0geometry\t\r \u00a0optimization\t\r \u00a0scheme\t\r \u00a0of\t\r \u00a0equilibrium\t\r \u00a0structures\t\r \u00a0and\t\r \u00a0transition\t\r \u00a0states.\t\r \u00a0\t\r \u00a0.\t\r \u00a0J.\t\r \u00a0Comp.\t\r \u00a0Chem.\t\r \u00a016:\t\r \u00a01170-\u00ad\u20101179.\t\r \u00a030.\t\r \u00a0Levitt,\t\r \u00a0M.\t\r \u00a0(1974)\t\r \u00a0energy\t\r \u00a0Refinement\t\r \u00a0of\t\r \u00a0Hen\t\r \u00a0Egg-\u00ad\u2010White\t\r \u00a0Lysozyme.\t\r \u00a0J.\t\r \u00a0Mol.\t\r \u00a0Biol.\t\r \u00a082:\t\r \u00a0393-\u00ad\u2010420.\t\r \u00a031.\t\r \u00a0Blake,\t\r \u00a0 C.\t\r \u00a0 C.\t\r \u00a0 F.,\t\r \u00a0 Johnson,\t\r \u00a0 L.\t\r \u00a0 N.,\t\r \u00a0 Mair,\t\r \u00a0 G.\t\r \u00a0 A.,\t\r \u00a0 North,\t\r \u00a0 A.\t\r \u00a0 C.\t\r \u00a0 T.,\t\r \u00a0 Phillips,\t\r \u00a0 D.\t\r \u00a0 C.,\t\r \u00a0 and\t\r \u00a0 Sarma,\t\r \u00a0 V.\t\r \u00a0 R.\t\r \u00a0(1967)\t\r \u00a0Crystallographic\t\r \u00a0Studies\t\r \u00a0of\t\r \u00a0Activity\t\r \u00a0of\t\r \u00a0Hen\t\r \u00a0Ege-\u00ad\u2010White\t\r \u00a0Lysozyme.\t\r \u00a0Proceedings\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Royal\t\r \u00a0Society\t\r \u00a0Series\t\r \u00a0B-\u00ad\u2010Biological\t\r \u00a0Sciences.\t\r \u00a0167:\t\r \u00a0378-\u00ad\u2010+.\t\r \u00a0J.\t\r \u00a0R.\t\r \u00a0Lacadena,\t\r \u00a0J.\t\r \u00a0A.\t\r \u00a0Esteban,\t\r \u00a0B.\t\r \u00a0de\t\r \u00a0Pascual\t\r \u00a0\t\r \u00a0\n432\t\r \u00a0\t\r \u00a032.\t\r \u00a0Ryde,\t\r \u00a0 U.,\t\r \u00a0 Olsen,\t\r \u00a0 L.,\t\r \u00a0 and\t\r \u00a0 Nilsson,\t\r \u00a0 K.\t\r \u00a0 (2002)\t\r \u00a0 Quantum\t\r \u00a0 chemical\t\r \u00a0 geometry\t\r \u00a0 optimizations\t\r \u00a0 in\t\r \u00a0proteins\t\r \u00a0using\t\r \u00a0crystallographic\t\r \u00a0raw\t\r \u00a0data.\t\r \u00a0J.\t\r \u00a0Comp.\t\r \u00a0Chem.\t\r \u00a023:\t\r \u00a01058-\u00ad\u20101070.\t\r \u00a033.\t\r \u00a0Rul\u0131sek,\t\r \u00a0L.,\t\r \u00a0and\t\r \u00a0Ryde,\t\r \u00a0U.\t\r \u00a0(2006)\t\r \u00a0Structure\t\r \u00a0of\t\r \u00a0reduced\t\r \u00a0and\t\r \u00a0oxidized\t\r \u00a0manganese\t\r \u00a0superoxide\t\r \u00a0dismutase:\t\r \u00a0 a\t\r \u00a0 combined\t\r \u00a0 computational\t\r \u00a0 and\t\r \u00a0 experimental\t\r \u00a0 approach.\t\r \u00a0Journal\t\r \u00a0 of\t\r \u00a0 Physical\t\r \u00a0Chemistry\t\r \u00a0B.\t\r \u00a0110:\t\r \u00a011511-\u00ad\u201011518.\t\r \u00a034.\t\r \u00a0Hsiao,\t\r \u00a0Y.-\u00ad\u2010W.,\t\r \u00a0Drakenberg,\t\r \u00a0T.,\t\r \u00a0and\t\r \u00a0Ryde,\t\r \u00a0U.\t\r \u00a0(2005)\t\r \u00a0NMR\t\r \u00a0structure\t\r \u00a0determination\t\r \u00a0of\t\r \u00a0proteins\t\r \u00a0supplemented\t\r \u00a0 by\t\r \u00a0 quantum\t\r \u00a0 chemical\t\r \u00a0 calculations:\t\r \u00a0detailed\t\r \u00a0structure\t\r \u00a0of\t\r \u00a0the\t\r \u00a0Ca2+\t\r \u00a0sites\t\r \u00a0in\t\r \u00a0the\t\r \u00a0EGF34\t\r \u00a0fragment\t\r \u00a0of\t\r \u00a0protein\t\r \u00a0S.\t\r \u00a0.\t\r \u00a0J.\t\r \u00a0Biomol.\t\r \u00a0NMR.\t\r \u00a031:\t\r \u00a097-\u00ad\u2010114.\t\r \u00a035.\t\r \u00a0Hsiao,\t\r \u00a0 Y.-\u00ad\u2010W.,\t\r \u00a0 and\t\r \u00a0 Ryde,\t\r \u00a0 U.\t\r \u00a0 (2006)\t\r \u00a0 Interpretation\t\r \u00a0 of\t\r \u00a0 EXAFS\t\r \u00a0 spectra\t\r \u00a0 for\t\r \u00a0 sitting-\u00ad\u2010atop\t\r \u00a0complexes\t\r \u00a0with\t\r \u00a0the\t\r \u00a0help\t\r \u00a0of\t\r \u00a0computational\t\r \u00a0methods.\t\r \u00a0Inorganica\t\r \u00a0Chimica\t\r \u00a0Acta.\t\r \u00a0359:\t\r \u00a01081-\u00ad\u20101092.\t\r \u00a036.\t\r \u00a0Lyne,\t\r \u00a0P.\t\r \u00a0D.,\t\r \u00a0Mulholland,\t\r \u00a0A.\t\r \u00a0J.,\t\r \u00a0and\t\r \u00a0Richards,\t\r \u00a0W.\t\r \u00a0G.\t\r \u00a0(1995)\t\r \u00a0Insights\t\r \u00a0into\t\r \u00a0Chorismate\t\r \u00a0Mutase\t\r \u00a0Catalysis\t\r \u00a0 from\t\r \u00a0 Combined\t\r \u00a0 QM/MM\t\r \u00a0 Simulations\t\r \u00a0 of\t\r \u00a0 the\t\r \u00a0 Enzyme\t\r \u00a0 Reaction\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a0117\t\r \u00a037.\t\r \u00a0Claeyssens,\t\r \u00a0 F.,\t\r \u00a0 Ranaghan,\t\r \u00a0 K.\t\r \u00a0 E.,\t\r \u00a0 Manby,\t\r \u00a0 F.\t\r \u00a0 R.,\t\r \u00a0 Harvey,\t\r \u00a0 J.\t\r \u00a0 N.,\t\r \u00a0 and\t\r \u00a0 Mulholland,\t\r \u00a0 A.\t\r \u00a0 J.\t\r \u00a0 (2005)\t\r \u00a0Multiple\t\r \u00a0 high-\u00ad\u2010level\t\r \u00a0 QM/MM\t\r \u00a0 reaction\t\r \u00a0 paths\t\r \u00a0 demonstrate\t\r \u00a0 transition-\u00ad\u2010state\t\r \u00a0 stabilization\t\r \u00a0 in\t\r \u00a0chorismate\t\r \u00a0mutase:\t\r \u00a0correlation\t\r \u00a0of\t\r \u00a0barrier\t\r \u00a0height\t\r \u00a0with\t\r \u00a0transition-\u00ad\u2010state\t\r \u00a0stabilization.\t\r \u00a0Chem.\t\r \u00a0Commun.:\t\r \u00a05068-\u00ad\u20105070.\t\r \u00a038.\t\r \u00a0Strajbl,\t\r \u00a0M.,\t\r \u00a0Shurki,\t\r \u00a0A.,\t\r \u00a0Kato,\t\r \u00a0M.,\t\r \u00a0and\t\r \u00a0Warshel,\t\r \u00a0A.\t\r \u00a0(2003)\t\r \u00a0Apparent\t\r \u00a0NAC\t\r \u00a0effect\t\r \u00a0in\t\r \u00a0chorismate\t\r \u00a0mutase\t\r \u00a0 reflects\t\r \u00a0 electrostatic\t\r \u00a0 transition\t\r \u00a0 state\t\r \u00a0 stabilization.\t\r \u00a0J.\t\r \u00a0Am.\t\r \u00a0Chem.\t\r \u00a0Soc.\t\r \u00a0125:\t\r \u00a0 10228-\u00ad\u201010237.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0433\t\r \u00a0\t\r \u00a0\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0Jos\u00e9\t\r \u00a0Manuel\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0Catedr\u00e1tico\t\r \u00a0Em\u00e9rito\t\r \u00a0de\t\r \u00a0Geriatr\u00eda.\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Medicina.\t\r \u00a0U.\t\r \u00a0Complutense.\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Medicina.\t\r \u00a0Conferencia\t\r \u00a0pronunciada\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0(7.V.2014).\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0An.\t\r \u00a0Real\t\r \u00a0Acad.\t\r \u00a0Farm.\t\r \u00a0Vol\t\r \u00a080,\t\r \u00a0N\u00ba\t\r \u00a02\t\r \u00a0(2014),\t\r \u00a0pag.433-\u00ad\u2010443.\t\r \u00a0\u201cLa\t\r \u00a0dignidad\t\r \u00a0est\u00e1\t\r \u00a0por\t\r \u00a0encima\t\r \u00a0de\t\r \u00a0cualquier\t\r \u00a0precio\t\r \u00a0y,\t\r \u00a0\t\r \u00a0por\t\r \u00a0lo\t\r \u00a0tanto,\t\r \u00a0no\t\r \u00a0tiene\t\r \u00a0equivalente\u201d\t\r \u00a0(E.\t\r \u00a0Kant)\t\r \u00a0\u00bfDe\t\r \u00a0qu\u00e9\t\r \u00a0estamos\t\r \u00a0hablando?\t\r \u00a0Lo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0parece\t\r \u00a0bastante\t\r \u00a0claro.\t\r \u00a0No\t\r \u00a0tanto\t\r \u00a0lo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0dignidad.\t\r \u00a0Como\t\r \u00a0ocurre\t\r \u00a0casi\t\r \u00a0siempre\t\r \u00a0que\t\r \u00a0nos\t\r \u00a0referimos\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0llamamos\t\r \u00a0\u201cvalores\u201d\t\r \u00a0resulta\t\r \u00a0muy\t\r \u00a0dif\u00edcil\t\r \u00a0establecer\t\r \u00a0una\t\r \u00a0buena\t\r \u00a0definici\u00f3n\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0entendemos\t\r \u00a0por\t\r \u00a0dignidad.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0diccionario\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0y\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Espasa\t\r \u00a0se\t\r \u00a0le\t\r \u00a0 asignan\t\r \u00a0 entre\t\r \u00a0 otras\t\r \u00a0 acepciones\t\r \u00a0 las\t\r \u00a0 de\t\r \u00a0 excelencia,\t\r \u00a0 realce\t\r \u00a0 o,\t\r \u00a0 aplicado\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0individuo\t\r \u00a0 o\t\r \u00a0 a\t\r \u00a0 un\t\r \u00a0 colectivo,\t\r \u00a0 se\t\r \u00a0 habla\t\r \u00a0 de\t\r \u00a0 poseer\t\r \u00a0 la\t\r \u00a0 calidad\t\r \u00a0 de\t\r \u00a0 digno,\t\r \u00a0 entendiendo\t\r \u00a0como\t\r \u00a0 tal\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 persona\t\r \u00a0 o\t\r \u00a0 grupo\t\r \u00a0 que\t\r \u00a0 es\t\r \u00a0 merecedora\t\r \u00a0 de\t\r \u00a0 ello.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 diccionario\t\r \u00a0 de\t\r \u00a0filosof\u00eda\t\r \u00a0 de\t\r \u00a0 Ferrater\t\r \u00a0 Mora\t\r \u00a0 simplemente\t\r \u00a0 no\t\r \u00a0 aparece\t\r \u00a0 el\t\r \u00a0 t\u00e9rmino.\t\r \u00a0 Donde\t\r \u00a0 m\u00e1s\t\r \u00a0detenidamente\t\r \u00a0 se\t\r \u00a0 interpreta\t\r \u00a0 la\t\r \u00a0 palabra\t\r \u00a0 \u201cdigno\u201d\t\r \u00a0 es\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Diccionario\t\r \u00a0 del\t\r \u00a0 Uso\t\r \u00a0 del\t\r \u00a0Espa\u00f1ol\t\r \u00a0de\t\r \u00a0Mar\u00eda\t\r \u00a0Moliner.\t\r \u00a0Lo\t\r \u00a0hace\t\r \u00a0asociado\t\r \u00a0a\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0una\t\r \u00a0decena\t\r \u00a0de\t\r \u00a0sin\u00f3nimos\t\r \u00a0y\t\r \u00a0a\t\r \u00a0varias\t\r \u00a0acepciones.\t\r \u00a0Entre\t\r \u00a0ellas\t\r \u00a0una\t\r \u00a0que\t\r \u00a0considero\t\r \u00a0muy\t\r \u00a0adecuada:\t\r \u00a0\u201cse\t\r \u00a0aplica\t\r \u00a0al\t\r \u00a0que\t\r \u00a0obra,\t\r \u00a0habla,\t\r \u00a0se\t\r \u00a0comporta,\t\r \u00a0etc.\t\r \u00a0de\t\r \u00a0manera\t\r \u00a0que\t\r \u00a0merece\t\r \u00a0el\t\r \u00a0respeto\t\r \u00a0y\t\r \u00a0la\t\r \u00a0estimaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0dem\u00e1s\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 s\u00ed\t\r \u00a0 mismo\u201d.\t\r \u00a0 El\t\r \u00a0 t\u00e9rmino\t\r \u00a0 respeto\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 muy\t\r \u00a0 pr\u00f3ximo\t\r \u00a0 de\t\r \u00a0 autoestima\t\r \u00a0considero\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 ajustan\t\r \u00a0 bien\t\r \u00a0 a\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 entendemos\t\r \u00a0 por\t\r \u00a0 dignidad\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 persona\t\r \u00a0mayor.\t\r \u00a0\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 lenguaje\t\r \u00a0 diario\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 sentir\t\r \u00a0 general\t\r \u00a0 asociamos\t\r \u00a0 el\t\r \u00a0 ser\t\r \u00a0 humano\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0idea\t\r \u00a0de\t\r \u00a0dignidad.\t\r \u00a0Esto\t\r \u00a0no\t\r \u00a0siempre\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0as\u00ed.\t\r \u00a0Como\t\r \u00a0bien\t\r \u00a0se\u00f1ala\t\r \u00a0el\t\r \u00a0fil\u00f3sofo\t\r \u00a0Ram\u00f3n\t\r \u00a0Valls\t\r \u00a0 (1)\t\r \u00a0 en\t\r \u00a0origen\t\r \u00a0 era\t\r \u00a0 un\t\r \u00a0 concepto\t\r \u00a0 que\t\r \u00a0 distingu\u00eda\t\r \u00a0 y\t\r \u00a0 jerarquizaba.\t\r \u00a0 Afectaba\t\r \u00a0 a\t\r \u00a0quienes\t\r \u00a0por\t\r \u00a0su\t\r \u00a0excelencia\t\r \u00a0sobresal\u00edan\t\r \u00a0por\t\r \u00a0encima\t\r \u00a0de\t\r \u00a0otros.\t\r \u00a0Era\t\r \u00a0cosa\t\r \u00a0de\t\r \u00a0algunos.\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0moderna\t\r \u00a0es\t\r \u00a0de\t\r \u00a0todos.\t\r \u00a0Es\t\r \u00a0universal\t\r \u00a0porque\t\r \u00a0no\t\r \u00a0se\t\r \u00a0considera\t\r \u00a0consecuencia\t\r \u00a0de\t\r \u00a0 un\t\r \u00a0 buen\t\r \u00a0 comportamiento\t\r \u00a0 sino\t\r \u00a0 como\t\r \u00a0 principio\t\r \u00a0 de\t\r \u00a0 \u00e9l.\t\r \u00a0 Todos\t\r \u00a0 somos\t\r \u00a0dignos,\t\r \u00a0 al\t\r \u00a0menos\t\r \u00a0 desde\t\r \u00a0 Kant\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0Ilustraci\u00f3n.\t\r \u00a0 De\t\r \u00a0 forma\t\r \u00a0 espec\u00edfica\t\r \u00a0 desde\t\r \u00a0que\t\r \u00a0 en\t\r \u00a0 1948\t\r \u00a0 el\t\r \u00a0art\u00edculo\t\r \u00a01\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Declaraci\u00f3n\t\r \u00a0Universal\t\r \u00a0de\t\r \u00a0Derechos\t\r \u00a0Humanos\t\r \u00a0se\u00f1alase\t\r \u00a0que\t\r \u00a0\u201ctodos\t\r \u00a0los\t\r \u00a0 seres\t\r \u00a0 humanos\t\r \u00a0 nacen\t\r \u00a0 libres\t\r \u00a0 e\t\r \u00a0 iguales\t\r \u00a0 en\t\r \u00a0 dignidad\t\r \u00a0 y\t\r \u00a0derechos\u201d.\t\r \u00a0 Todos\t\r \u00a0 somos\t\r \u00a0SESIONES\t\r \u00a0CIENT\u00cdFICAS\t\r \u00a0\nJ.M.\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0\t\r \u00a0\n434\t\r \u00a0\t\r \u00a0dignos,\t\r \u00a0con\t\r \u00a0independencia\t\r \u00a0de\t\r \u00a0nuestras\t\r \u00a0caracter\u00edsticas\t\r \u00a0personales,\t\r \u00a0como\t\r \u00a0raza,\t\r \u00a0edad,\t\r \u00a0salud\t\r \u00a0o\t\r \u00a0cualquier\t\r \u00a0otro\t\r \u00a0elemento\t\r \u00a0diferenciador.\t\r \u00a0El\t\r \u00a0art\u00edculo\t\r \u00a010.1\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Constituci\u00f3n\t\r \u00a0Espa\u00f1ola\t\r \u00a0 insiste\t\r \u00a0 en\t\r \u00a0 lo\t\r \u00a0 mismo\t\r \u00a0 al\t\r \u00a0 remarcar\t\r \u00a0 que\t\r \u00a0 \u201cla\t\r \u00a0 dignidad\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 persona,\t\r \u00a0 los\t\r \u00a0derechos\t\r \u00a0inviolables\t\r \u00a0que\t\r \u00a0le\t\r \u00a0son\t\r \u00a0inherentes\t\r \u00a0\u2026\t\r \u00a0son\t\r \u00a0fundamento\t\r \u00a0del\t\r \u00a0orden\t\r \u00a0pol\u00edtico\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0paz\t\r \u00a0social\u201d.\t\r \u00a0Equipara\t\r \u00a0dignidad\t\r \u00a0e\t\r \u00a0igualdad,\t\r \u00a0la\t\r \u00a0considera\t\r \u00a0un\t\r \u00a0derecho\t\r \u00a0y\t\r \u00a0excluye\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0expl\u00edcita\t\r \u00a0cualquier\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0discriminaci\u00f3n.\t\r \u00a0Hasta\t\r \u00a0aqu\u00ed\t\r \u00a0un\t\r \u00a0resumen\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0podemos\t\r \u00a0considerar\t\r \u00a0la\t\r \u00a0teor\u00eda.\t\r \u00a0\t\r \u00a0Entiendo\t\r \u00a0que\t\r \u00a0el\t\r \u00a0planteamiento\t\r \u00a0que\t\r \u00a0se\t\r \u00a0hace\t\r \u00a0al\t\r \u00a0proponerme\t\r \u00a0este\t\r \u00a0t\u00edtulo\t\r \u00a0tiene\t\r \u00a0que\t\r \u00a0ver\t\r \u00a0con\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0\u2013y\t\r \u00a0el\t\r \u00a0riesgo-\u00ad\u2010\t\r \u00a0de\t\r \u00a0que\t\r \u00a0los\t\r \u00a0cambios\t\r \u00a0que\t\r \u00a0tienen\t\r \u00a0lugar\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tiempo\t\r \u00a0vinculados\t\r \u00a0al\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0envejecer\t\r \u00a0determinen\t\r \u00a0por\t\r \u00a0s\u00ed\t\r \u00a0mismos\t\r \u00a0alg\u00fan\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0metamorfosis\t\r \u00a0que\t\r \u00a0pudiera\t\r \u00a0comprometer\t\r \u00a0o\t\r \u00a0menoscabar\t\r \u00a0esta\t\r \u00a0condici\u00f3n\t\r \u00a0de\t\r \u00a0digno.\t\r \u00a0O\t\r \u00a0bien\t\r \u00a0que\t\r \u00a0la\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0valorar\t\r \u00a0este\t\r \u00a0concepto\t\r \u00a0haya\t\r \u00a0sufrido\t\r \u00a0cambios\t\r \u00a0importantes\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0a\u00f1os.\t\r \u00a0Norberto\t\r \u00a0Bobbio\t\r \u00a0(2)\t\r \u00a0expresa\t\r \u00a0de\t\r \u00a0forma\t\r \u00a0adecuada\t\r \u00a0un\t\r \u00a0sentimiento\t\r \u00a0social\t\r \u00a0muy\t\r \u00a0extendido\t\r \u00a0cuando\t\r \u00a0afirma\t\r \u00a0que\t\r \u00a0\u201cquienes\t\r \u00a0en\t\r \u00a0tiempos\t\r \u00a0habr\u00edan\t\r \u00a0sido\t\r \u00a0calificados\t\r \u00a0de\t\r \u00a0ancianos\t\r \u00a0venerables\t\r \u00a0\u2026\u2026\t\r \u00a0pasaron\t\r \u00a0a\t\r \u00a0ser\t\r \u00a0llamados\t\r \u00a0sin\t\r \u00a0grandes\t\r \u00a0contemplaciones\t\r \u00a0esos\t\r \u00a0vejestorios\u201d,\t\r \u00a0unos\t\r \u00a0viejos\t\r \u00a0decr\u00e9pitos\t\r \u00a0de\t\r \u00a0quienes\t\r \u00a0no\t\r \u00a0merece\t\r \u00a0la\t\r \u00a0pena\t\r \u00a0ocuparse.\t\r \u00a0Lo\t\r \u00a0 primero\t\r \u00a0 que\t\r \u00a0 me\t\r \u00a0 viene\t\r \u00a0a\t\r \u00a0 la\t\r \u00a0 cabeza\t\r \u00a0 siempre\t\r \u00a0 que\t\r \u00a0 escucho\t\r \u00a0 la\t\r \u00a0 palabra\t\r \u00a0dignidad\t\r \u00a0 asociada\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0persona\t\r \u00a0 mayor\t\r \u00a0 es\t\r \u00a0 el\t\r \u00a0 recuerdo\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 art\u00edculo\t\r \u00a0 editorial\t\r \u00a0publicado\t\r \u00a0en\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a0setenta\t\r \u00a0en\t\r \u00a0la\t\r \u00a0revista\t\r \u00a0New\t\r \u00a0England\t\r \u00a0Journal\t\r \u00a0of\t\r \u00a0Medicine\t\r \u00a0bajo\t\r \u00a0la\t\r \u00a0firma\t\r \u00a0 de\t\r \u00a0 quien\t\r \u00a0 era\t\r \u00a0 su\t\r \u00a0 director,\t\r \u00a0 el\t\r \u00a0Prof.\t\r \u00a0Franz\t\r \u00a0 Ingelfinger\t\r \u00a0 (3).\t\r \u00a0 Sus\t\r \u00a0 comentarios\t\r \u00a0versaban\t\r \u00a0sobre\t\r \u00a0la\t\r \u00a0\u201cmuerte\t\r \u00a0digna\u201d,\t\r \u00a0un\t\r \u00a0tema\t\r \u00a0muy\t\r \u00a0de\t\r \u00a0actualidad\t\r \u00a0por\t\r \u00a0aquellos\t\r \u00a0a\u00f1os.\t\r \u00a0Se\u00f1alaba\t\r \u00a0Ingelfinger\t\r \u00a0que,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0vista\t\r \u00a0de\t\r \u00a0las\t\r \u00a0posibilidades\t\r \u00a0tecnol\u00f3gicas\t\r \u00a0que\t\r \u00a0ofrec\u00eda\t\r \u00a0la\t\r \u00a0medicina\t\r \u00a0parec\u00eda\t\r \u00a0un\t\r \u00a0sarcasmo\t\r \u00a0asociar\t\r \u00a0la\t\r \u00a0palabra\t\r \u00a0dignidad\t\r \u00a0al\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0morir.\t\r \u00a0A\t\r \u00a0su\t\r \u00a0 juicio,\t\r \u00a0 a\t\r \u00a0 lo\t\r \u00a0 m\u00e1s\t\r \u00a0 que\t\r \u00a0 podr\u00edamos\t\r \u00a0 aspirar\t\r \u00a0 era\t\r \u00a0 a\t\r \u00a0 no\t\r \u00a0 a\u00f1adir\t\r \u00a0 indignidades\t\r \u00a0 en\t\r \u00a0 esas\t\r \u00a0circunstancias.\t\r \u00a0 Salvando\t\r \u00a0 las\t\r \u00a0 distancias,\t\r \u00a0 creo\t\r \u00a0 que\t\r \u00a0 algo\t\r \u00a0 de\t\r \u00a0 eso\t\r \u00a0 cabe\t\r \u00a0 intuir\t\r \u00a0 cuando\t\r \u00a0asociamos\t\r \u00a0los\t\r \u00a0t\u00e9rminos\t\r \u00a0dignidad\t\r \u00a0y\t\r \u00a0envejecimiento.\t\r \u00a0\t\r \u00a0En\t\r \u00a0la\t\r \u00a0l\u00ednea\t\r \u00a0de\t\r \u00a0Ingelfinger\t\r \u00a0luchar\t\r \u00a0por\t\r \u00a0evitar\t\r \u00a0las\t\r \u00a0indignidades\t\r \u00a0constituye\t\r \u00a0otra\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0ver\t\r \u00a0el\t\r \u00a0tema.\t\r \u00a0Supone\t\r \u00a0tomar\t\r \u00a0en\t\r \u00a0consideraci\u00f3n\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0caras\t\r \u00a0de\t\r \u00a0una\t\r \u00a0misma\t\r \u00a0situaci\u00f3n.\t\r \u00a0 Por\t\r \u00a0 ello\t\r \u00a0 a\t\r \u00a0 efectos\t\r \u00a0 expositivos\t\r \u00a0 mis\t\r \u00a0 reflexiones\t\r \u00a0 van\t\r \u00a0 a\t\r \u00a0 ir\t\r \u00a0 en\t\r \u00a0 uno\t\r \u00a0 u\t\r \u00a0 otro\t\r \u00a0sentido,\t\r \u00a0 asumiendo\t\r \u00a0como\t\r \u00a0 hilo\t\r \u00a0 conductor\t\r \u00a0 el\t\r \u00a0 riesgo\t\r \u00a0 que\t\r \u00a0 representa\t\r \u00a0 poder\t\r \u00a0 ser\t\r \u00a0v\u00edctima\t\r \u00a0 de\t\r \u00a0 indignidades.\t\r \u00a0 Me\t\r \u00a0 centrar\u00e9\t\r \u00a0 en\t\r \u00a0 tres\t\r \u00a0 puntos:\t\r \u00a0 las\t\r \u00a0 p\u00e9rdidas\t\r \u00a0 de\t\r \u00a0 nuestra\t\r \u00a0reserva\t\r \u00a0 org\u00e1nica\t\r \u00a0 como\t\r \u00a0 factor\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 muy\t\r \u00a0 com\u00fan\t\r \u00a0 dentro\t\r \u00a0 de\t\r \u00a0 este\t\r \u00a0 campo,\t\r \u00a0 la\t\r \u00a0discriminaci\u00f3n\t\r \u00a0por\t\r \u00a0edad\t\r \u00a0como\t\r \u00a0forma\t\r \u00a0sutil\t\r \u00a0y\t\r \u00a0poco\t\r \u00a0valorada\t\r \u00a0de\t\r \u00a0generar\t\r \u00a0indignidad\t\r \u00a0y\t\r \u00a0la\t\r \u00a0 necesidad\t\r \u00a0 de\t\r \u00a0 asumir\t\r \u00a0 el\t\r \u00a0 mandato\t\r \u00a0 de\t\r \u00a0 Naciones\t\r \u00a0 Unidas\t\r \u00a0 (NU)\t\r \u00a0 en\t\r \u00a0 relaci\u00f3n\t\r \u00a0 con\t\r \u00a0 un\t\r \u00a0envejecimiento\t\r \u00a0 activo\t\r \u00a0 como\t\r \u00a0 actitud\t\r \u00a0 m\u00e1s\t\r \u00a0 positiva\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 intento\t\r \u00a0 de\t\r \u00a0 mantener\t\r \u00a0 una\t\r \u00a0vejez\t\r \u00a0digna.\t\r \u00a0Antes\t\r \u00a0de\t\r \u00a0entrar\t\r \u00a0en\t\r \u00a0materia\t\r \u00a0insistir\u00e9\t\r \u00a0todav\u00eda\t\r \u00a0en\t\r \u00a0un\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0partida\t\r \u00a0que\t\r \u00a0no.\t\r \u00a0Se\t\r \u00a0 trata\t\r \u00a0 de\t\r \u00a0 destacar\t\r \u00a0 y\t\r \u00a0 aceptar\t\r \u00a0 como\t\r \u00a0 no\t\r \u00a0 discutible\t\r \u00a0 el\t\r \u00a0 hecho\t\r \u00a0 de\t\r \u00a0 que\t\r \u00a0 los\t\r \u00a0 viejos\t\r \u00a0constituimos\t\r \u00a0 hoy\t\r \u00a0 un\t\r \u00a0 problema\t\r \u00a0 social\t\r \u00a0 importante.\t\r \u00a0 No\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 fen\u00f3meno\t\r \u00a0 nuevo,\t\r \u00a0 ya\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0\t\r \u00a0\n435\t\r \u00a0\t\r \u00a0que,\t\r \u00a0m\u00e1s\t\r \u00a0o\t\r \u00a0menos\t\r \u00a0atemperado,\t\r \u00a0siempre\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0as\u00ed.\t\r \u00a0Pero\t\r \u00a0hoy\t\r \u00a0somos\t\r \u00a0muchos,\t\r \u00a0m\u00e1s\t\r \u00a0que\t\r \u00a0en\t\r \u00a0ninguna\t\r \u00a0otra\t\r \u00a0\u00e9poca,\t\r \u00a0tanto\t\r \u00a0en\t\r \u00a0t\u00e9rminos\t\r \u00a0absolutos\t\r \u00a0como\t\r \u00a0relativos.\t\r \u00a0Adem\u00e1s,\t\r \u00a0duramos\t\r \u00a0una\t\r \u00a0barbaridad\t\r \u00a0como\t\r \u00a0nunca\t\r \u00a0antes\t\r \u00a0se\t\r \u00a0hab\u00eda\t\r \u00a0pensado\t\r \u00a0que\t\r \u00a0pudiera\t\r \u00a0ocurrir.\t\r \u00a0Hemos\t\r \u00a0aumentado\t\r \u00a0nuestra\t\r \u00a0esperanza\t\r \u00a0de\t\r \u00a0vida\t\r \u00a0de\t\r \u00a0tal\t\r \u00a0manera\t\r \u00a0que\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0inicios\t\r \u00a0del\t\r \u00a0siglo\t\r \u00a0XXI\t\r \u00a0la\t\r \u00a0mayor\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0la\t\r \u00a0poblaci\u00f3n\t\r \u00a0en\t\r \u00a0los\t\r \u00a0pa\u00edses\t\r \u00a0desarrollados\t\r \u00a0vamos\t\r \u00a0a\t\r \u00a0pasar\t\r \u00a0entre\t\r \u00a0un\t\r \u00a0cuarto\t\r \u00a0y\t\r \u00a0un\t\r \u00a0tercio\t\r \u00a0de\t\r \u00a0nuestra\t\r \u00a0vida\t\r \u00a0en\t\r \u00a0calidad\t\r \u00a0de\t\r \u00a0jubilados,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0traducido\t\r \u00a0a\t\r \u00a0efectos\t\r \u00a0administrativos\t\r \u00a0equivale\t\r \u00a0a\t\r \u00a0ser\t\r \u00a0oficialmente\t\r \u00a0viejos.\t\r \u00a0Un\t\r \u00a0reciente\t\r \u00a0art\u00edculo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0revista\t\r \u00a0Lancet\t\r \u00a0(4)\t\r \u00a0afirmaba\t\r \u00a0que\t\r \u00a0los\t\r \u00a0nacidos\t\r \u00a0en\t\r \u00a0estos\t\r \u00a0primeros\t\r \u00a0a\u00f1os\t\r \u00a0del\t\r \u00a0 siglo\t\r \u00a0 XXI\t\r \u00a0 en\t\r \u00a0 pa\u00edses\t\r \u00a0 desarrollados\t\r \u00a0 tienen\t\r \u00a0 grandes\t\r \u00a0 posibilidades\t\r \u00a0 de\t\r \u00a0 llegar\t\r \u00a0 a\t\r \u00a0centenarios.\t\r \u00a0\t\r \u00a0Constituimos\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 alg\u00fan\t\r \u00a0 profesor\t\r \u00a0 de\t\r \u00a0 sociolog\u00eda\t\r \u00a0 (David\t\r \u00a0 Reher)\t\r \u00a0 ha\t\r \u00a0calificado\t\r \u00a0como\t\r \u00a0\u201cun\t\r \u00a0maremoto\u201d\t\r \u00a0del\t\r \u00a0que,\t\r \u00a0adem\u00e1s,\t\r \u00a0la\t\r \u00a0sociedad\t\r \u00a0en\t\r \u00a0su\t\r \u00a0conjunto\t\r \u00a0apenas\t\r \u00a0si\t\r \u00a0 ha\t\r \u00a0 tomado\t\r \u00a0 conciencia\t\r \u00a0 Un\t\r \u00a0 maremoto\t\r \u00a0 cuyas\t\r \u00a0 consecuencias\t\r \u00a0 alcanzan\t\r \u00a0 a\t\r \u00a0 todas\t\r \u00a0 las\t\r \u00a0esferas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vida.\t\r \u00a0Comprometen\t\r \u00a0a\t\r \u00a0los\t\r \u00a0sistemas\t\r \u00a0sanitarios,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0econom\u00eda,\t\r \u00a0al\t\r \u00a0mundo\t\r \u00a0laboral,\t\r \u00a0o\t\r \u00a0a\t\r \u00a0las\t\r \u00a0formas\t\r \u00a0de\t\r \u00a0organizaci\u00f3n\t\r \u00a0social\t\r \u00a0y\t\r \u00a0de\t\r \u00a0convivencia,\t\r \u00a0y\t\r \u00a0lo\t\r \u00a0hacen\t\r \u00a0con\t\r \u00a0unas\t\r \u00a0repercusiones\t\r \u00a0enormes\t\r \u00a0que\t\r \u00a0no\t\r \u00a0escapan\t\r \u00a0a\t\r \u00a0ning\u00fan\t\r \u00a0observador.\t\r \u00a0Lo\t\r \u00a0que\t\r \u00a0parece\t\r \u00a0menos\t\r \u00a0comprensible\t\r \u00a0 es\t\r \u00a0 que\t\r \u00a0 este\t\r \u00a0 fen\u00f3meno\t\r \u00a0 que\t\r \u00a0 debiera\t\r \u00a0 ser\t\r \u00a0 un\t\r \u00a0 motivo\t\r \u00a0 de\t\r \u00a0 satisfacci\u00f3n\t\r \u00a0individual\t\r \u00a0y\t\r \u00a0colectiva\t\r \u00a0se\t\r \u00a0traduzca\t\r \u00a0para\t\r \u00a0muchos\t\r \u00a0en\t\r \u00a0una\t\r \u00a0especia\t\r \u00a0de\t\r \u00a0carga\t\r \u00a0negativa\t\r \u00a0y\t\r \u00a0de\t\r \u00a0invitaci\u00f3n\t\r \u00a0al\t\r \u00a0pesimismo.\t\r \u00a0Siguiendo\t\r \u00a0con\t\r \u00a0Bobbio,\t\r \u00a0siempre\t\r \u00a0dispuesto\t\r \u00a0a\t\r \u00a0asumir\t\r \u00a0los\t\r \u00a0aspectos\t\r \u00a0m\u00e1s\t\r \u00a0negros\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vejez,\t\r \u00a0cabr\u00eda\t\r \u00a0considerar\t\r \u00a0que\t\r \u00a0los\t\r \u00a0avances\t\r \u00a0de\t\r \u00a0la\t\r \u00a0medicina\t\r \u00a0a\t\r \u00a0menudo\t\r \u00a0 \u201cno\t\r \u00a0 tanto\t\r \u00a0 te\t\r \u00a0 hacen\t\r \u00a0 vivir\t\r \u00a0 cuanto\t\r \u00a0 te\t\r \u00a0 impiden\t\r \u00a0 morir\u201d.\t\r \u00a0 En\t\r \u00a0 su\t\r \u00a0 caso\t\r \u00a0 esto\t\r \u00a0 se\t\r \u00a0manifiesta\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 \u00e9l\t\r \u00a0 llama\t\r \u00a0 \u201cuna\t\r \u00a0vejez\t\r \u00a0 melanc\u00f3lica,\t\r \u00a0 entendiendo\t\r \u00a0 la\t\r \u00a0melancol\u00eda\t\r \u00a0como\t\r \u00a0la\t\r \u00a0consciencia\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0no\t\r \u00a0alcanzado\t\r \u00a0y\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0ya\t\r \u00a0no\t\r \u00a0es\t\r \u00a0alcanzable\u201d.\t\r \u00a01.\t\r \u00a0UN\t\r \u00a0 FACTOR\t\r \u00a0 DE\t\r \u00a0 RIESGO\t\r \u00a0NO\t\r \u00a0 DISCUTIBLE:\t\r \u00a0 LAS\t\r \u00a0 P\u00c9RDIDAS\t\r \u00a0 ASOCIADAS\t\r \u00a0 AL\t\r \u00a0HECHO\t\r \u00a0DE\t\r \u00a0ENVEJECER\t\r \u00a0Una\t\r \u00a0definici\u00f3n\t\r \u00a0de\t\r \u00a0envejecimiento\t\r \u00a0bastante\t\r \u00a0ajustada\t\r \u00a0a\t\r \u00a0la\t\r \u00a0realidad\t\r \u00a0cient\u00edfica\t\r \u00a0es\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 toma\t\r \u00a0 como\t\r \u00a0 base\t\r \u00a0 referencial\t\r \u00a0 las\t\r \u00a0 p\u00e9rdidas\t\r \u00a0 en\t\r \u00a0 nuestros\t\r \u00a0 mecanismos\t\r \u00a0 de\t\r \u00a0reserva\t\r \u00a0 y,\t\r \u00a0 ligado\t\r \u00a0 a\t\r \u00a0 ellas,\t\r \u00a0 el\t\r \u00a0 incremento\t\r \u00a0 progresivo\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 vulnerabilidad\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0consiguiente\t\r \u00a0 claudicaci\u00f3n\t\r \u00a0 ante\t\r \u00a0 cualquier\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 agresi\u00f3n\t\r \u00a0 externa.\t\r \u00a0 Es\t\r \u00a0 cierto\t\r \u00a0que\t\r \u00a0nacemos\t\r \u00a0con\t\r \u00a0un\t\r \u00a0margen\t\r \u00a0de\t\r \u00a0reserva\t\r \u00a0enorme\t\r \u00a0en\t\r \u00a0todos\t\r \u00a0nuestros\t\r \u00a0\u00f3rganos\t\r \u00a0y\t\r \u00a0sistemas.\t\r \u00a0Son\t\r \u00a0reservas\t\r \u00a0funcionales\t\r \u00a0que\t\r \u00a0vamos\t\r \u00a0perdiendo\t\r \u00a0\u2013o\t\r \u00a0consumiendo-\u00ad\u2010\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vida.\t\r \u00a0P\u00e9rdidas\t\r \u00a0universales\t\r \u00a0que\t\r \u00a0desde\t\r \u00a0el\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0vista\t\r \u00a0org\u00e1nico\t\r \u00a0afectan\t\r \u00a0a\t\r \u00a0todos\t\r \u00a0y\t\r \u00a0cada\t\r \u00a0 uno\t\r \u00a0 de\t\r \u00a0 nuestros\t\r \u00a0 aparatos.\t\r \u00a0 Al\t\r \u00a0 m\u00fasculo,\t\r \u00a0 al\t\r \u00a0 hueso,\t\r \u00a0 a\t\r \u00a0 las\t\r \u00a0 articulaciones,\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0sistemas\t\r \u00a0 cardiocirculatorio,\t\r \u00a0 digestivo,\t\r \u00a0 respiratorio,\t\r \u00a0 nervioso,\t\r \u00a0 endocrino,\t\r \u00a0nefrourol\u00f3gico,\t\r \u00a0 inmunol\u00f3gico\t\r \u00a0 o\t\r \u00a0 sexual.\t\r \u00a0 A\t\r \u00a0 los\t\r \u00a0 sistemas\t\r \u00a0 de\t\r \u00a0 regulaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0homeostasis.\t\r \u00a0 A\t\r \u00a0 la\t\r \u00a0 piel,\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 boca\t\r \u00a0 y\t\r \u00a0 a\t\r \u00a0 los\t\r \u00a0 \u00f3rganos\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 sentidos.\t\r \u00a0 Nada\t\r \u00a0 ni\t\r \u00a0 nadie\t\r \u00a0escapa\t\r \u00a0 a\t\r \u00a0 ello,\t\r \u00a0 aunque\t\r \u00a0 la\t\r \u00a0 realidad\t\r \u00a0 nos\t\r \u00a0 muestra\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 cadencia\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 estas\t\r \u00a0p\u00e9rdidas\t\r \u00a0se\t\r \u00a0van\t\r \u00a0manifestando\t\r \u00a0var\u00eda\t\r \u00a0enormemente\t\r \u00a0de\t\r \u00a0unos\t\r \u00a0individuos\t\r \u00a0a\t\r \u00a0otros.\t\r \u00a0M\u00e1s\t\r \u00a0a\u00fan,\t\r \u00a0que\t\r \u00a0incluso\t\r \u00a0existe\t\r \u00a0tambi\u00e9n\t\r \u00a0una\t\r \u00a0gran\t\r \u00a0variabilidad\t\r \u00a0dentro\t\r \u00a0de\t\r \u00a0la\t\r \u00a0propia\t\r \u00a0persona,\t\r \u00a0J.M.\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0\t\r \u00a0\n436\t\r \u00a0\t\r \u00a0dependiendo\t\r \u00a0 de\t\r \u00a0 factores\t\r \u00a0 que\t\r \u00a0 van\t\r \u00a0 desde\t\r \u00a0 la\t\r \u00a0 carga\t\r \u00a0 gen\u00e9tica\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 hemos\t\r \u00a0aterrizado\t\r \u00a0en\t\r \u00a0este\t\r \u00a0mundo\t\r \u00a0hasta\t\r \u00a0el\t\r \u00a0tipo\t\r \u00a0de\t\r \u00a0vida\t\r \u00a0que\t\r \u00a0lleva\t\r \u00a0o\t\r \u00a0ha\t\r \u00a0llevado\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0de\t\r \u00a0nosotros.\t\r \u00a0\t\r \u00a0Son\t\r \u00a0 p\u00e9rdidas\t\r \u00a0 que\t\r \u00a0 nos\t\r \u00a0 convierten\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0 progresiva\t\r \u00a0 en\t\r \u00a0 sujetos\t\r \u00a0mucho\t\r \u00a0m\u00e1s\t\r \u00a0vulnerables.\t\r \u00a0Facilitan\t\r \u00a0la\t\r \u00a0posibilidad\t\r \u00a0de\t\r \u00a0claudicar\t\r \u00a0en\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0enfermedad\t\r \u00a0o\t\r \u00a0de\t\r \u00a0limitaci\u00f3n\t\r \u00a0funcional.\t\r \u00a0Empeoran\t\r \u00a0los\t\r \u00a0pron\u00f3sticos\t\r \u00a0y\t\r \u00a0las\t\r \u00a0posibilidades\t\r \u00a0de\t\r \u00a0superar\t\r \u00a0con\t\r \u00a0\u00e9xito\t\r \u00a0las\t\r \u00a0enfermedades\t\r \u00a0agudas.\t\r \u00a0Dan\t\r \u00a0pi\u00e9\t\r \u00a0a\t\r \u00a0un\t\r \u00a0aumento\t\r \u00a0en\t\r \u00a0los\t\r \u00a0procesos\t\r \u00a0cr\u00f3nicos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0 que\t\r \u00a0 surgen\t\r \u00a0 situaciones\t\r \u00a0 de\t\r \u00a0 dependencia.\t\r \u00a0 Tambi\u00e9n\t\r \u00a0 a\t\r \u00a0 muertes\t\r \u00a0 prematuras\t\r \u00a0 ante\t\r \u00a0provocaciones\t\r \u00a0 cada\t\r \u00a0 vez\t\r \u00a0 menos\t\r \u00a0 intensas.\t\r \u00a0 Unas\t\r \u00a0 p\u00e9rdidas\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 son\t\r \u00a0 s\u00f3lo\t\r \u00a0 f\u00edsicas.\t\r \u00a0Tienen\t\r \u00a0su\t\r \u00a0correlato\t\r \u00a0en\t\r \u00a0la\t\r \u00a0esfera\t\r \u00a0psicol\u00f3gica\t\r \u00a0y\t\r \u00a0del\t\r \u00a0comportamiento.\t\r \u00a0Se\t\r \u00a0traducen\t\r \u00a0en\t\r \u00a0un\t\r \u00a0enlentecimiento\t\r \u00a0generalizado\t\r \u00a0f\u00edsico,\t\r \u00a0del\t\r \u00a0pensamiento\t\r \u00a0y\t\r \u00a0del\t\r \u00a0\u00e1nimo.\t\r \u00a0Afectan\t\r \u00a0a\t\r \u00a0la\t\r \u00a0esfera\t\r \u00a0 social,\t\r \u00a0 a\t\r \u00a0 nuestra\t\r \u00a0 situaci\u00f3n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 entorno\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 nos\t\r \u00a0 movemos.\t\r \u00a0 Sin\t\r \u00a0embargo,\t\r \u00a0son\t\r \u00a0p\u00e9rdidas\t\r \u00a0modulables\t\r \u00a0por\t\r \u00a0diferentes\t\r \u00a0v\u00edas\t\r \u00a0y\t\r \u00a0que,\t\r \u00a0especialmente\t\r \u00a0en\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0respecta\t\r \u00a0a\t\r \u00a0estos\t\r \u00a0\u00faltimos\t\r \u00a0apartados,\t\r \u00a0admiten\t\r \u00a0numerosos\t\r \u00a0factores\t\r \u00a0correctores\t\r \u00a0m\u00e1s\t\r \u00a0o\t\r \u00a0menos\t\r \u00a0eficaces.\t\r \u00a0La\t\r \u00a0 pregunta\t\r \u00a0 clave\t\r \u00a0 en\t\r \u00a0 relaci\u00f3n\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 tema\t\r \u00a0 es\t\r \u00a0 si\t\r \u00a0 esta\t\r \u00a0 realidad\t\r \u00a0 que\t\r \u00a0 asocia\t\r \u00a0p\u00e9rdidas\t\r \u00a0 y\t\r \u00a0 envejecimiento\t\r \u00a0 puede\t\r \u00a0 resultar\t\r \u00a0 por\t\r \u00a0 s\u00ed\t\r \u00a0 misma\t\r \u00a0 lesiva\t\r \u00a0 para\t\r \u00a0 nuestra\t\r \u00a0dignidad\t\r \u00a0 a\t\r \u00a0 ojos\t\r \u00a0 propios\t\r \u00a0 o\t\r \u00a0 ajenos.\t\r \u00a0 Si\t\r \u00a0 representa\t\r \u00a0 que\t\r \u00a0 nos\t\r \u00a0 convertimos\t\r \u00a0 en\t\r \u00a0 menos\t\r \u00a0dignos\t\r \u00a0ante\t\r \u00a0los\t\r \u00a0dem\u00e1s\t\r \u00a0o\t\r \u00a0ante\t\r \u00a0nosotros\t\r \u00a0mismos.\t\r \u00a0La\t\r \u00a0respuesta\t\r \u00a0te\u00f3rica\t\r \u00a0y\t\r \u00a0contundente\t\r \u00a0es\t\r \u00a0no.\t\r \u00a0No\t\r \u00a0tiene\t\r \u00a0por\t\r \u00a0qu\u00e9\t\r \u00a0ser\t\r \u00a0as\u00ed.\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0no\t\r \u00a0es\t\r \u00a0un\t\r \u00a0valor\t\r \u00a0intercambiable\t\r \u00a0con\t\r \u00a0la\t\r \u00a0belleza,\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0 capacidad\t\r \u00a0 funcional\t\r \u00a0 \u00f3ptima,\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 salud\t\r \u00a0 o\t\r \u00a0 con\t\r \u00a0 cualquier\t\r \u00a0 otro\t\r \u00a0par\u00e1metro\t\r \u00a0 positivo\t\r \u00a0 vinculado\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 juventud.\t\r \u00a0 Podemos\t\r \u00a0 encontrar\t\r \u00a0 dignidad\t\r \u00a0 ante\t\r \u00a0adversidades\t\r \u00a0de\t\r \u00a0cualquier\t\r \u00a0naturaleza,\t\r \u00a0incluidas\t\r \u00a0las\t\r \u00a0econ\u00f3micas\t\r \u00a0o\t\r \u00a0las\t\r \u00a0situaciones\t\r \u00a0de\t\r \u00a0terminalidad.\t\r \u00a0Por\t\r \u00a0qu\u00e9\t\r \u00a0vamos\t\r \u00a0a\t\r \u00a0cuestionar\t\r \u00a0su\t\r \u00a0existencia\t\r \u00a0en\t\r \u00a0funci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0p\u00e9rdidas\t\r \u00a0derivadas\t\r \u00a0de\t\r \u00a0haber\t\r \u00a0alcanzado\t\r \u00a0una\t\r \u00a0edad\t\r \u00a0a\t\r \u00a0la\t\r \u00a0que,\t\r \u00a0por\t\r \u00a0otra\t\r \u00a0parte,\t\r \u00a0todos\t\r \u00a0aspiramos\t\r \u00a0y\t\r \u00a0que,\t\r \u00a0en\t\r \u00a0ning\u00fan\t\r \u00a0caso,\t\r \u00a0debe\t\r \u00a0modificar\t\r \u00a0los\t\r \u00a0condicionantes\t\r \u00a0m\u00e1s\t\r \u00a0\u00edntimos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona.\t\r \u00a0Las\t\r \u00a0posibles\t\r \u00a0indignidades\t\r \u00a0vendr\u00edan\t\r \u00a0por\t\r \u00a0otros\t\r \u00a0caminos.\t\r \u00a0Por\t\r \u00a0v\u00edas,\t\r \u00a0comportamientos\t\r \u00a0y\t\r \u00a0 actitudes\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 est\u00e1n\t\r \u00a0 marcadas\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 edad\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 pueden\t\r \u00a0 encontrarse\t\r \u00a0 en\t\r \u00a0cualquier\t\r \u00a0individuo,\t\r \u00a0joven\t\r \u00a0o\t\r \u00a0no.\t\r \u00a0Sin\t\r \u00a0 embargo,\t\r \u00a0 seg\u00fan\t\r \u00a0 envejecemos\t\r \u00a0 es\t\r \u00a0 frecuente\t\r \u00a0 dejarse\t\r \u00a0 ir,\t\r \u00a0 renunciar\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0exigencia\t\r \u00a0de\t\r \u00a0mantenerse\t\r \u00a0digno\t\r \u00a0en\t\r \u00a0cualquier\t\r \u00a0momento\t\r \u00a0y\t\r \u00a0circunstancia.\t\r \u00a0Se\t\r \u00a0trata\t\r \u00a0de\t\r \u00a0una\t\r \u00a0tendencia\t\r \u00a0social,\t\r \u00a0vivida\t\r \u00a0tambi\u00e9n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0mundo\t\r \u00a0sanitario\t\r \u00a0y\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0arrastrar\t\r \u00a0al\t\r \u00a0propio\t\r \u00a0individuo.\t\r \u00a0Una\t\r \u00a0geriatra\t\r \u00a0escocesa\t\r \u00a0muy\t\r \u00a0conocida\t\r \u00a0afirma\t\r \u00a0que\t\r \u00a0la\t\r \u00a0entrada\t\r \u00a0en\t\r \u00a0la\t\r \u00a0categor\u00eda\t\r \u00a0de\t\r \u00a0paciente\t\r \u00a0geri\u00e1trico\t\r \u00a0viene\t\r \u00a0dada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0\u201cmomento\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0el\t\r \u00a0m\u00e9dico\t\r \u00a0pierde\t\r \u00a0inter\u00e9s\t\r \u00a0por\t\r \u00a0el\t\r \u00a0estado\t\r \u00a0de\t\r \u00a0salud\t\r \u00a0de\t\r \u00a0su\t\r \u00a0paciente\u201d.\t\r \u00a0En\t\r \u00a0el\t\r \u00a0nacimiento\t\r \u00a0de\t\r \u00a0la\t\r \u00a0especialidad\t\r \u00a0de\t\r \u00a0Geriatr\u00eda\t\r \u00a0subyacen\t\r \u00a0muchos\t\r \u00a0de\t\r \u00a0estos\t\r \u00a0conceptos.\t\r \u00a0Quienes\t\r \u00a0concibieron,\t\r \u00a0elaboraron\t\r \u00a0y\t\r \u00a0pusieron\t\r \u00a0en\t\r \u00a0pr\u00e1ctica\t\r \u00a0los\t\r \u00a0principios\t\r \u00a0b\u00e1sicos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0medicina\t\r \u00a0geri\u00e1trica\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Reino\t\r \u00a0Unido\t\r \u00a0durante\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a040\t\r \u00a0y\t\r \u00a050\t\r \u00a0del\t\r \u00a0siglo\t\r \u00a0 pasado\t\r \u00a0 lo\t\r \u00a0 hicieron\t\r \u00a0 como\t\r \u00a0 una\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 rebeli\u00f3n\t\r \u00a0 contra\t\r \u00a0 el\t\r \u00a0 abandono\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0\t\r \u00a0\n437\t\r \u00a0\t\r \u00a0resignaci\u00f3n.\t\r \u00a0 Intentaban\t\r \u00a0 afrontar\t\r \u00a0 los\t\r \u00a0 problemas\t\r \u00a0 de\t\r \u00a0 unos\t\r \u00a0pacientes\t\r \u00a0 cr\u00f3nicos,\t\r \u00a0\u201cpluripatol\u00f3gicos\u201d\t\r \u00a0los\t\r \u00a0llaman\t\r \u00a0ahora,\t\r \u00a0de\t\r \u00a0los\t\r \u00a0que\t\r \u00a0nadie\t\r \u00a0se\t\r \u00a0ocupaba.\t\r \u00a0Naci\u00f3\t\r \u00a0la\t\r \u00a0geriatr\u00eda\t\r \u00a0para\t\r \u00a0 luchar\t\r \u00a0 contra\t\r \u00a0 el\t\r \u00a0fatalismo\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 resignaci\u00f3n\t\r \u00a0 y\t\r \u00a0concentrar\t\r \u00a0 esfuerzos\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0recuperaci\u00f3n\t\r \u00a0 funcional.\t\r \u00a0 Para\t\r \u00a0encontrar\t\r \u00a0 y\t\r \u00a0 combatir\t\r \u00a0situaciones\t\r \u00a0 cl\u00ednicas,\t\r \u00a0enfermedades\t\r \u00a0y\t\r \u00a0limitaciones,\t\r \u00a0desconocidas\t\r \u00a0previamente.\t\r \u00a0Para\t\r \u00a0integrar\t\r \u00a0soluciones\t\r \u00a0globales\t\r \u00a0a\t\r \u00a0los\t\r \u00a0problemas\t\r \u00a0m\u00e9dicos\t\r \u00a0y\t\r \u00a0sociales.\t\r \u00a0Tambi\u00e9n\t\r \u00a0para\t\r \u00a0prevenir\t\r \u00a0en\t\r \u00a0lo\t\r \u00a0posible\t\r \u00a0problemas\t\r \u00a0 m\u00e9dicos\t\r \u00a0 de\t\r \u00a0 alta\t\r \u00a0 incidencia\t\r \u00a0 y\t\r \u00a0 prevalencia.\t\r \u00a0 En\t\r \u00a0 suma\t\r \u00a0 para\t\r \u00a0 luchar\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0aquellos\t\r \u00a0ancianos\t\r \u00a0m\u00e1s\t\r \u00a0desfavorecidos.\t\r \u00a0En\t\r \u00a0\u00faltimo\t\r \u00a0t\u00e9rmino,\t\r \u00a0todos\t\r \u00a0estos\t\r \u00a0objetivos\t\r \u00a0suponen\t\r \u00a0un\t\r \u00a0esfuerzo\t\r \u00a0por\t\r \u00a0combatir\t\r \u00a0la\t\r \u00a0 indignidad\t\r \u00a0 social\t\r \u00a0 que\t\r \u00a0 representaba\t\r \u00a0 asumir\t\r \u00a0 como\t\r \u00a0 normal\t\r \u00a0 la\t\r \u00a0 existencia\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0poblaci\u00f3n\t\r \u00a0mayor,\t\r \u00a0cargada\t\r \u00a0de\t\r \u00a0patolog\u00eda\t\r \u00a0cr\u00f3nica,\t\r \u00a0marginada,\t\r \u00a0desahuciada\t\r \u00a0desde\t\r \u00a0una\t\r \u00a0perspectiva\t\r \u00a0m\u00e9dica,\t\r \u00a0abandonada\t\r \u00a0por\t\r \u00a0familia\t\r \u00a0y\t\r \u00a0sociedad\t\r \u00a0en\t\r \u00a0asilos\t\r \u00a0y\t\r \u00a0hospitales.\t\r \u00a0Una\t\r \u00a0poblaci\u00f3n\t\r \u00a0v\u00edctima\t\r \u00a0de\t\r \u00a0la\t\r \u00a0\u201cindignidad\u201d\t\r \u00a0social,\t\r \u00a0no\t\r \u00a0respetada,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0que\t\r \u00a0se\t\r \u00a0hab\u00eda\t\r \u00a0privado\t\r \u00a0de\t\r \u00a0cualquier\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0autoestima,\t\r \u00a0e\t\r \u00a0individualmente\t\r \u00a0resignada\t\r \u00a0y\t\r \u00a0condenada\t\r \u00a0a\t\r \u00a0su\t\r \u00a0exclusi\u00f3n\t\r \u00a0 sanitaria\t\r \u00a0 y\t\r \u00a0 social.\t\r \u00a0 Esta\t\r \u00a0 actitud,\t\r \u00a0 presente\t\r \u00a0 ya\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 ra\u00edces\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0especialidad,\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 mantenido\t\r \u00a0 viva\t\r \u00a0 desde\t\r \u00a0 entonces\t\r \u00a0 en\t\r \u00a0 todos\t\r \u00a0 quienes\t\r \u00a0 la\t\r \u00a0 hemos\t\r \u00a0cultivado.\t\r \u00a02.\t\r \u00a0LA\t\r \u00a0 DISCRIMINACI\u00d3N\t\r \u00a0 POR\t\r \u00a0 EDAD\t\r \u00a0 COMO\t\r \u00a0 FORMA\t\r \u00a0 DE\t\r \u00a0AGRESI\u00d3N\t\r \u00a0 A\t\r \u00a0 LA\t\r \u00a0DIGNIDAD\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0PERSONA\t\r \u00a0MAYOR\t\r \u00a0El\t\r \u00a0eventual\t\r \u00a0cat\u00e1logo\t\r \u00a0de\t\r \u00a0indignidades\t\r \u00a0potenciales\t\r \u00a0con\t\r \u00a0las\t\r \u00a0que\t\r \u00a0el\t\r \u00a0conjunto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0sociedad\t\r \u00a0castiga\t\r \u00a0a\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0de\t\r \u00a0edad\t\r \u00a0avanzada\t\r \u00a0es\t\r \u00a0extraordinariamente\t\r \u00a0amplio\t\r \u00a0y\t\r \u00a0tiene\t\r \u00a0 como\t\r \u00a0 elemento\t\r \u00a0 com\u00fan\t\r \u00a0 la\t\r \u00a0 sorprendente\t\r \u00a0 evidencia\t\r \u00a0 de\t\r \u00a0 pasar\t\r \u00a0 inadvertido.\t\r \u00a0Abarca\t\r \u00a0desde\t\r \u00a0la\t\r \u00a0falta\t\r \u00a0de\t\r \u00a0respeto\t\r \u00a0al\t\r \u00a0principio\t\r \u00a0bio\u00e9tico\t\r \u00a0de\t\r \u00a0autonom\u00eda\t\r \u00a0en\t\r \u00a0cualquiera\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0manifestaciones\t\r \u00a0hasta\t\r \u00a0el\t\r \u00a0apartado\t\r \u00a0de\t\r \u00a0los\t\r \u00a0malos\t\r \u00a0tratos\t\r \u00a0al\t\r \u00a0mayor,\t\r \u00a0bien\t\r \u00a0lo\t\r \u00a0sean\t\r \u00a0en\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 agresi\u00f3n\t\r \u00a0 f\u00edsica\t\r \u00a0 directa,\t\r \u00a0 bien\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 vertiente\t\r \u00a0 de\t\r \u00a0 comportamientos\t\r \u00a0negligentes\t\r \u00a0y\t\r \u00a0de\t\r \u00a0abusos\t\r \u00a0psicol\u00f3gicos\t\r \u00a0o\t\r \u00a0econ\u00f3micos.\t\r \u00a0Me\t\r \u00a0centrar\u00e9\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tema\t\r \u00a0de\t\r \u00a0la\t\r \u00a0discriminaci\u00f3n\t\r \u00a0por\t\r \u00a0edad,\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0la\t\r \u00a0literatura\t\r \u00a0inglesa\t\r \u00a0conoce\t\r \u00a0como\t\r \u00a0\u201cageism\u201d\t\r \u00a0(Butler\t\r \u00a01969),\t\r \u00a0que\t\r \u00a0podr\u00edamos\t\r \u00a0traducir\t\r \u00a0por\t\r \u00a0eta\u00edsmo\t\r \u00a0o\t\r \u00a0age\u00edsmo,\t\r \u00a0otra\t\r \u00a0forma\t\r \u00a0de\t\r \u00a0agresi\u00f3n\t\r \u00a0a\t\r \u00a0la\t\r \u00a0dignidad\t\r \u00a0del\t\r \u00a0mayor,\t\r \u00a0ignorada\t\r \u00a0con\t\r \u00a0frecuencia\t\r \u00a0por\t\r \u00a0ciudadanos\t\r \u00a0y\t\r \u00a0administraciones.\t\r \u00a0El age\u00edsmo, la discriminaci\u00f3n por edad, constituye una forma de agresi\u00f3n a la dignidad del colectivo de m\u00e1s edad. Una forma de agresi\u00f3n que tiene m\u00faltiples manifestaciones en el plano social, pero que tambi\u00e9n aparece en los \u00e1mbitos vinculados a la salud.  Con car\u00e1cter general los ejemplos de discriminaci\u00f3n social al anciano son m\u00faltiples. Enumerar\u00e9 algunos. Se vulnera el principio de autonom\u00eda al decidir por el anciano tanto en el \u00e1mbito familiar como en otros. Se establecen limitaciones para la convivencia en el marco familiar y en el contexto social. Existen y no se toman en consideraci\u00f3n barreras ciudadanas evitables en materias como iluminaci\u00f3n, transportes, J.M.\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0\t\r \u00a0\n438\t\r \u00a0\t\r \u00a0arquitectura, regulaci\u00f3n del tr\u00e1fico, etc. Se legisla con frecuencia bordeando la frontera de algunos derechos; entre ellos los laborales, dentro de los cuales algunas formas de jubilaci\u00f3n forzosa centradas en la edad podr\u00edan ser un buen prototipo. No se potencian estudios espec\u00edficos. Se excluye o limita su participaci\u00f3n en la pol\u00edtica o en aspectos relativos a la gesti\u00f3n com\u00fan de la vida p\u00fablica. Se cortan o cuestionan los recursos sociales necesarios como pone en evidencia lo que est\u00e1 pasando con la Ley de Dependencia y con otras formas de limitaci\u00f3n de derechos sociales. Se aplica un lenguaje sectario cargado de connotaciones negativas para denominar al colectivo. No hay m\u00e1s que analizar la utilizaci\u00f3n como insulto de las palabras viejo o anciano. Una gerontofobia social de la que dan testimonio abundante los medios de comunicaci\u00f3n a la hora de tratar por la v\u00eda del rid\u00edculo o del chiste f\u00e1cil numerosas im\u00e1genes del viejo. En el plano sanitario la Ley General de Salud P\u00fablica (33/2011, 4 de octubre) sienta las bases para que la poblaci\u00f3n espa\u00f1ola \u201calcance y mantenga el mayor nivel de salud posible a trav\u00e9s de pol\u00edticas, programas, servicios y actuaciones desarrolladas por los poderes p\u00fablicos, empresas y organizaciones ciudadanas\u201d. En ella se habla de prevenci\u00f3n y de promover la salud de las personas en la esfera individual y colectiva. Quiero destacar que esta ley, como ocurre con la Ley General de Sanidad de 1986, pone \u00e9nfasis en el derecho a la igualdad. El art\u00edculo 6 establece que \u201ctodas las personas tienen derecho a que las actuaciones de salud p\u00fablica se realicen en condiciones de igualdad sin que pueda producirse discriminaci\u00f3n por raz\u00f3n de nacimiento, origen racial o \u00e9tnico, sexo, religi\u00f3n, convicci\u00f3n u opini\u00f3n, edad, discapacidad, orientaci\u00f3n o identidad sexual, enfermedad o cualquier otra condici\u00f3n o circunstancia personal o social\u201d.  Sin embargo, las evidencias de discriminaci\u00f3n son tambi\u00e9n abundantes en este campo e inundan las publicaciones cient\u00edficas de las m\u00e1s variadas especialidades m\u00e9dicas. Como ejemplo basta repasar algunas \u00e1reas espec\u00edficas como la cardiovascular o la oncol\u00f3gica. En ambas la evidencia demuestra que el grado de cumplimiento de protocolos y gu\u00edas de actuaci\u00f3n establecidos por las sociedades cient\u00edficas correspondientes ante determinadas enfermedades o s\u00edndromes se cumplen en tanta menor medida cuanto mayor es la edad del colectivo analizado. Esto afecta a la profundidad de los estudios llevados a cabo en el anciano enfermo para sentar las bases del diagn\u00f3stico en toda su complejidad, pero afecta, sobre todo, a los protocolos terap\u00e9uticos, ante los cuales es muy frecuente aplicar una manga extraordinariamente ancha que permite, con el argumento de la edad, excluir de manera discrecional o en base a criterios no m\u00e9dicos opciones que no se hubieran ni siquiera discutido en los m\u00e1s j\u00f3venes. Situaciones de este tipo es posible encontrarlas igualmente en cualquier otra especialidad m\u00e9dica o quir\u00fargica que incluya pacientes de edad avanzada y son denunciadas peri\u00f3dicamente en las revistas m\u00e1s serias de la especialidad de turno. La cardiolog\u00eda o la oncolog\u00eda no pasan de ser meros ejemplos que he tenido la oportunidad de estudiar m\u00e1s directamente. La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0\t\r \u00a0\n439\t\r \u00a0\t\r \u00a0La discriminaci\u00f3n sanitaria no se limita al cumplimiento negligente de unos protocolos diagn\u00f3sticos o terap\u00e9uticos cient\u00edficamente consensuados. Alcanza a otras muchas esferas, desde las limitaciones para acceder a las posibilidades que a d\u00eda de hoy ofrece la alta tecnolog\u00eda, hasta la exclusi\u00f3n de pacientes mayores en los ensayos cl\u00ednicos, pasando por la aplicaci\u00f3n de pol\u00edticas claramente discriminatorias en funci\u00f3n de la edad por parte de las administraciones, que establecen topes arbitrarios a la hora de poder acceder a determinadas campa\u00f1as de prevenci\u00f3n o de revisiones del estado de salud. Cabr\u00eda a\u00f1adir a\u00fan la discriminaci\u00f3n econ\u00f3mica vinculada al mundo de la salud que representan decisiones como el copago farmac\u00e9utico o la imposici\u00f3n de trabas administrativas para acceder a algunos f\u00e1rmacos, productos o servicios sanitarios. La falta de inter\u00e9s de las autoridades acad\u00e9micas por la ense\u00f1anza de la gerontogeriatr\u00eda o por potenciar recursos espec\u00edficos para la poblaci\u00f3n de m\u00e1s edad son otros ejemplos de lo mismo. Discriminan las administraciones cuando utilizan la edad como criterio para determinadas campa\u00f1as preventivas, por ejemplo para detecci\u00f3n precoz de c\u00e1ncer de mama, o al olvidarse de la persona mayor cuando se trata de establecer pol\u00edticas sanitarias. No hace muchos a\u00f1os la Asociaci\u00f3n M\u00e9dica Brit\u00e1nica se quejaba de que los ancianos fueran excluidos de las campa\u00f1as antitabaco en aquel pa\u00eds.  Todas estas actitudes age\u00edstas representan una agresi\u00f3n individual y colectiva contra la dignidad. En muchos casos atentan contra el derecho, pero, sobre todo lo hacen contra un principio b\u00e1sico en bio\u00e9tica, el principio de equidad. Van contra la tradici\u00f3n m\u00e9dica ejemplificada en el llamado juramento hipocr\u00e1tico. Con frecuencia atacan tambi\u00e9n a la evidencia cient\u00edfica al dar por supuestas contraindicaciones basadas en la edad que el tiempo se ocupa de desmentir. La pr\u00e1ctica de lo que se conoce como angioplastia coronaria o de las di\u00e1lisis cr\u00f3nicas son buenos ejemplos de procedimientos que entraron en medicina con el cartel de contraindicados en los mayores y sobre lo que hubo que dar marcha atr\u00e1s muy poco tiempo despu\u00e9s. Y, sobre todo, van tambi\u00e9n contra el propio sentido com\u00fan. \u00bfD\u00f3nde deber\u00edamos situar el punto de corte si tiramos de la edad como criterio para cualquier tipo de decisi\u00f3n? Dir\u00e9\t\r \u00a0para\t\r \u00a0cerrar\t\r \u00a0este\t\r \u00a0apartado\t\r \u00a0que\t\r \u00a0discriminamos,\t\r \u00a0ofendemos\t\r \u00a0y\t\r \u00a0agredimos\t\r \u00a0a\t\r \u00a0la\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0cada\t\r \u00a0vez\t\r \u00a0que\t\r \u00a0cualquiera\t\r \u00a0de\t\r \u00a0nosotros\t\r \u00a0damos\t\r \u00a0por\t\r \u00a0buenas\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 d\u00eda\t\r \u00a0 a\t\r \u00a0 d\u00eda\t\r \u00a0 frases\t\r \u00a0 tan\t\r \u00a0 habituales\t\r \u00a0 como\t\r \u00a0 las\t\r \u00a0 de:\t\r \u00a0 \u201cbastante\t\r \u00a0 bien\t\r \u00a0 est\u00e1\t\r \u00a0 Vd.\t\r \u00a0para\t\r \u00a0 los\t\r \u00a0 a\u00f1os\t\r \u00a0 que\t\r \u00a0tiene\u201d,\t\r \u00a0 \u00f3\t\r \u00a0 \u201ca\t\r \u00a0 su\t\r \u00a0 edad\t\r \u00a0 que\t\r \u00a0 querr\u00e1\u201d,\t\r \u00a0 o,\t\r \u00a0 peor\t\r \u00a0 a\u00fan,\t\r \u00a0 porque\t\r \u00a0 suele\t\r \u00a0traducir\t\r \u00a0ignorancia,\t\r \u00a0cuando\t\r \u00a0el\t\r \u00a0profesional\t\r \u00a0de\t\r \u00a0la\t\r \u00a0salud,\t\r \u00a0ya\t\r \u00a0sea\t\r \u00a0m\u00e9dico,\t\r \u00a0farmac\u00e9utico\t\r \u00a0o\t\r \u00a0enfermero,\t\r \u00a0interpreta\t\r \u00a0como\t\r \u00a0\u201ccosas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0edad\u201d\t\r \u00a0determinados\t\r \u00a0problemas\t\r \u00a0cl\u00ednicos\t\r \u00a0cuya\t\r \u00a0 causa\t\r \u00a0 desconoce,\t\r \u00a0 muchas\t\r \u00a0 veces\t\r \u00a0 incluso\t\r \u00a0 sin\t\r \u00a0 haberse\t\r \u00a0 tomado\t\r \u00a0 siquiera\t\r \u00a0 la\t\r \u00a0molestia\t\r \u00a0de\t\r \u00a0indagar\t\r \u00a0su\t\r \u00a0origen.\t\r \u00a0\t\r \u00a0J.M.\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0\t\r \u00a0\n440\t\r \u00a0\t\r \u00a03.\t\r \u00a0EL\t\r \u00a0 LLAMADO\t\r \u00a0 ENVEJECIMIENTO\t\r \u00a0 ACTIVO\t\r \u00a0 COMO\t\r \u00a0 SISTEMA\t\r \u00a0 DE\t\r \u00a0 DEFENSA\t\r \u00a0CONTRA\t\r \u00a0LA\t\r \u00a0INDIGNIDAD\t\r \u00a0Quiz\u00e1s\t\r \u00a0 una\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 formas\t\r \u00a0 m\u00e1s\t\r \u00a0 adecuadas\t\r \u00a0 para\t\r \u00a0 hacer\t\r \u00a0 realidad\t\r \u00a0 de\t\r \u00a0 manera\t\r \u00a0mantenida\t\r \u00a0 el\t\r \u00a0 concepto\t\r \u00a0 de\t\r \u00a0 dignidad\t\r \u00a0 aplicado\t\r \u00a0 al\t\r \u00a0 individuo\t\r \u00a0 de\t\r \u00a0 edad\t\r \u00a0 avanzada\t\r \u00a0 sea\t\r \u00a0cumplir\t\r \u00a0 algunas\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 recomendaciones\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 que,\t\r \u00a0 peri\u00f3dicamente,\t\r \u00a0 los\t\r \u00a0organismos\t\r \u00a0internacionales\t\r \u00a0y\t\r \u00a0a\t\r \u00a0su\t\r \u00a0cabeza\t\r \u00a0NU\t\r \u00a0intentan\t\r \u00a0incidir\t\r \u00a0en\t\r \u00a0el\t\r \u00a0tema.\t\r \u00a0Me\t\r \u00a0voy\t\r \u00a0a\t\r \u00a0referir\t\r \u00a0el\t\r \u00a0lema\t\r \u00a0del\t\r \u00a0\u201cenvejecimiento\t\r \u00a0activo\u201d\t\r \u00a0por\t\r \u00a0considerar\t\r \u00a0que\t\r \u00a0constituye\t\r \u00a0una\t\r \u00a0clave\t\r \u00a0paradigm\u00e1tica\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 terreno.\t\r \u00a0 La\t\r \u00a0 II\t\r \u00a0 Asamblea\t\r \u00a0 Mundial\t\r \u00a0 del\t\r \u00a0 Envejecimiento\t\r \u00a0(Madrid-\u00ad\u20102002)\t\r \u00a0lo\t\r \u00a0defin\u00eda\t\r \u00a0como\t\r \u00a0\u201cel\t\r \u00a0proceso\t\r \u00a0de\t\r \u00a0optimizaci\u00f3n\t\r \u00a0de\t\r \u00a0las\t\r \u00a0oportunidades\t\r \u00a0de\t\r \u00a0 salud,\t\r \u00a0 participaci\u00f3n\t\r \u00a0 y\t\r \u00a0 seguridad\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 fin\t\r \u00a0 de\t\r \u00a0 mejorar\t\r \u00a0 la\t\r \u00a0 calidad\t\r \u00a0 de\t\r \u00a0 vida\t\r \u00a0a\t\r \u00a0medida\t\r \u00a0que\t\r \u00a0las\t\r \u00a0personas\t\r \u00a0envejecen\u201d.\t\r \u00a0M\u00e1s\t\r \u00a0adelante\t\r \u00a0destacaba\t\r \u00a0que\t\r \u00a0hab\u00eda\t\r \u00a0\u201cllegado\t\r \u00a0el\t\r \u00a0momento\t\r \u00a0de\t\r \u00a0instaurar\t\r \u00a0un\t\r \u00a0nuevo\t\r \u00a0paradigma\t\r \u00a0que\t\r \u00a0considere\t\r \u00a0a\t\r \u00a0las\t\r \u00a0personas\t\r \u00a0ancianas\t\r \u00a0participantes\t\r \u00a0 activas\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 sociedad\t\r \u00a0 que\t\r \u00a0 integre\t\r \u00a0 el\t\r \u00a0 envejecimiento\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 las\t\r \u00a0considere\t\r \u00a0contribuyentes\t\r \u00a0activos\t\r \u00a0y\t\r \u00a0beneficiarios\t\r \u00a0del\t\r \u00a0desarrollo\u201d.\t\r \u00a0Es\t\r \u00a0decir,\t\r \u00a0apelaba\t\r \u00a0directamente\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 dignidad\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 v\u00eda\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 participaci\u00f3n\t\r \u00a0 social.\t\r \u00a0 Una\t\r \u00a0 d\u00e9cada\t\r \u00a0despu\u00e9s\t\r \u00a0 NU\t\r \u00a0 insist\u00eda\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 tema\t\r \u00a0 declarando\t\r \u00a0 oficialmente\t\r \u00a0 2012\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 a\u00f1o\t\r \u00a0 del\t\r \u00a0envejecimiento\t\r \u00a0activo.\t\r \u00a0El\t\r \u00a0objetivo\t\r \u00a0obvio\t\r \u00a0que\t\r \u00a0se\t\r \u00a0desprende\t\r \u00a0de\t\r \u00a0este\t\r \u00a0lema\t\r \u00a0estriba\t\r \u00a0en\t\r \u00a0que\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0que\t\r \u00a0 llega\t\r \u00a0 a\t\r \u00a0 una\t\r \u00a0 edad\t\r \u00a0 avanzada\t\r \u00a0 siga\t\r \u00a0 integrada\t\r \u00a0 y\t\r \u00a0 se\t\r \u00a0 mantenga\t\r \u00a0 viva\t\r \u00a0 y\t\r \u00a0 con\t\r \u00a0responsabilidades\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0engranaje\t\r \u00a0social.\t\r \u00a0Busca\t\r \u00a0la\t\r \u00a0dignificaci\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0articulando\t\r \u00a0su\t\r \u00a0encaje\t\r \u00a0en\t\r \u00a0la\t\r \u00a0sociedad,\t\r \u00a0facilitando\t\r \u00a0esa\t\r \u00a0\u201csociedad\t\r \u00a0para\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0edades\u201d\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0otro\t\r \u00a0de\t\r \u00a0los\t\r \u00a0lemas\t\r \u00a0de\t\r \u00a0NU.\t\r \u00a0Hacerlo\t\r \u00a0as\u00ed\t\r \u00a0supone\t\r \u00a0un\t\r \u00a0valor\t\r \u00a0a\u00f1adido\t\r \u00a0en\t\r \u00a0la\t\r \u00a0medida\t\r \u00a0en\t\r \u00a0la\t\r \u00a0que\t\r \u00a0representa\t\r \u00a0sumar\t\r \u00a0al\t\r \u00a0conjunto,\t\r \u00a0con\t\r \u00a0beneficios\t\r \u00a0dobles.\t\r \u00a0Para\t\r \u00a0la\t\r \u00a0sociedad\t\r \u00a0-\u00ad\u2010m\u00e1s\t\r \u00a0personas\t\r \u00a0arrimando\t\r \u00a0el\t\r \u00a0hombro-\u00ad\u2010\t\r \u00a0y\t\r \u00a0para\t\r \u00a0el\t\r \u00a0individuo,\t\r \u00a0que\t\r \u00a0tendr\u00e1\t\r \u00a0la\t\r \u00a0oportunidad\t\r \u00a0de\t\r \u00a0mantener\t\r \u00a0su\t\r \u00a0contribuci\u00f3n\t\r \u00a0al\t\r \u00a0bien\t\r \u00a0com\u00fan.\t\r \u00a0Debemos\t\r \u00a0ser\t\r \u00a0conscientes\t\r \u00a0de\t\r \u00a0que\t\r \u00a0la\t\r \u00a0responsabilidad\t\r \u00a0para\t\r \u00a0llevar\t\r \u00a0a\t\r \u00a0buen\t\r \u00a0puerto\t\r \u00a0este\t\r \u00a0objetivo\t\r \u00a0corresponde\t\r \u00a0a\t\r \u00a0las\t\r \u00a0dos\t\r \u00a0partes,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0a\t\r \u00a0la\t\r \u00a0que\t\r \u00a0se\t\r \u00a0pide\t\r \u00a0actividad,\t\r \u00a0y\t\r \u00a0a\t\r \u00a0quien\t\r \u00a0no\t\r \u00a0lo\t\r \u00a0es\t\r \u00a0pero\t\r \u00a0puede,\t\r \u00a0 con\t\r \u00a0 su\t\r \u00a0 forma\t\r \u00a0 de\t\r \u00a0 actuar\t\r \u00a0 a\t\r \u00a0 trav\u00e9s\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 instituciones\t\r \u00a0 o\t\r \u00a0 con\t\r \u00a0 su\t\r \u00a0comportamiento\t\r \u00a0individual,\t\r \u00a0facilitar\t\r \u00a0\u2013o\t\r \u00a0dificultar-\u00ad\u2010\t\r \u00a0dicha\t\r \u00a0actividad.\t\r \u00a0Con\t\r \u00a0 el\t\r \u00a0 \u201cenvejecimiento\t\r \u00a0 activo\u201d,\t\r \u00a0 evidentemente,\t\r \u00a0 se\t\r \u00a0 buscan\t\r \u00a0 objetivos\t\r \u00a0 en\t\r \u00a0salud,\t\r \u00a0pero\t\r \u00a0no\t\r \u00a0s\u00f3lo.\t\r \u00a0Tambi\u00e9n\t\r \u00a0objetivos\t\r \u00a0sociales\t\r \u00a0de\t\r \u00a0independencia,\t\r \u00a0de\t\r \u00a0movilidad\t\r \u00a0en\t\r \u00a0su\t\r \u00a0 sentido\t\r \u00a0 m\u00e1s\t\r \u00a0 amplio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 palabra,\t\r \u00a0 facilitar\t\r \u00a0 la\t\r \u00a0 posibilidad\t\r \u00a0 de\t\r \u00a0 desarrollar\t\r \u00a0programas\t\r \u00a0y\t\r \u00a0trabajos\t\r \u00a0que,\t\r \u00a0remunerados\t\r \u00a0o\t\r \u00a0no,\t\r \u00a0constituyan\t\r \u00a0una\t\r \u00a0continuidad\t\r \u00a0con\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0la\t\r \u00a0vida\t\r \u00a0previa\t\r \u00a0de\t\r \u00a0cada\t\r \u00a0uno\t\r \u00a0y\t\r \u00a0contribuyan\t\r \u00a0al\t\r \u00a0bien\t\r \u00a0com\u00fan.\t\r \u00a0El\t\r \u00a0individuo\t\r \u00a0mayor\t\r \u00a0 debe\t\r \u00a0 propon\u00e9rselo\t\r \u00a0 pero\t\r \u00a0 la\t\r \u00a0 sociedad\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0 conjunto,\t\r \u00a0 administraciones\t\r \u00a0 y\t\r \u00a0personas\t\r \u00a0m\u00e1s\t\r \u00a0j\u00f3venes,\t\r \u00a0contribuir\t\r \u00a0a\t\r \u00a0hacer\t\r \u00a0factible\t\r \u00a0su\t\r \u00a0realizaci\u00f3n.\t\r \u00a0Una\t\r \u00a0tarea\t\r \u00a0que\t\r \u00a0no\t\r \u00a0siempre\t\r \u00a0 es\t\r \u00a0 f\u00e1cil\t\r \u00a0 y\t\r \u00a0 que\t\r \u00a0 para\t\r \u00a0 poder\t\r \u00a0culminar\t\r \u00a0 con\t\r \u00a0 \u00e9xito\t\r \u00a0 precisa\t\r \u00a0superar\t\r \u00a0 diferentes\t\r \u00a0escollos.\t\r \u00a0 En\t\r \u00a0 esta\t\r \u00a0 \u00faltima\t\r \u00a0 parte\t\r \u00a0 de\t\r \u00a0 mi\t\r \u00a0 intervenci\u00f3n\t\r \u00a0 voy\t\r \u00a0 a\t\r \u00a0 enumerar\t\r \u00a0 aquellos\t\r \u00a0 que\t\r \u00a0considero\t\r \u00a0m\u00e1s\t\r \u00a0importantes.\t\r \u00a0Algunas\t\r \u00a0de\t\r \u00a0las\t\r \u00a0dificultades\t\r \u00a0son\t\r \u00a0intr\u00ednsecas,\t\r \u00a0dependen\t\r \u00a0del\t\r \u00a0 propio\t\r \u00a0 sujeto\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 sus\t\r \u00a0 circunstancias\t\r \u00a0 personales,\t\r \u00a0 pero\t\r \u00a0 en\t\r \u00a0 muchos\t\r \u00a0 casos\t\r \u00a0 hay\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0\t\r \u00a0\n441\t\r \u00a0\t\r \u00a0que\t\r \u00a0sumar\t\r \u00a0a\t\r \u00a0ellas\t\r \u00a0las\t\r \u00a0impuestas\t\r \u00a0desde\t\r \u00a0el\t\r \u00a0exterior,\t\r \u00a0obst\u00e1culos\t\r \u00a0a\u00f1adidos\t\r \u00a0a\t\r \u00a0la\t\r \u00a0ya\t\r \u00a0dif\u00edcil\t\r \u00a0tarea\t\r \u00a0de\t\r \u00a0no\t\r \u00a0tirar\t\r \u00a0la\t\r \u00a0toalla.\t\r \u00a0Me\t\r \u00a0centrar\u00e9\t\r \u00a0en\t\r \u00a0cinco\t\r \u00a0puntos.\t\r \u00a0La\t\r \u00a0primera\t\r \u00a0dificultad\t\r \u00a0viene\t\r \u00a0de\t\r \u00a0oficio.\t\r \u00a0Como\t\r \u00a0he\t\r \u00a0se\u00f1alado\t\r \u00a0el\t\r \u00a0envejecimiento\t\r \u00a0se\t\r \u00a0asocia\t\r \u00a0con\t\r \u00a0p\u00e9rdidas\t\r \u00a0org\u00e1nicas\t\r \u00a0a\t\r \u00a0todos\t\r \u00a0los\t\r \u00a0niveles\t\r \u00a0y\t\r \u00a0nos\t\r \u00a0hace\t\r \u00a0m\u00e1s\t\r \u00a0vulnerables.\t\r \u00a0La\t\r \u00a0consecuencia\t\r \u00a0es\t\r \u00a0la\t\r \u00a0acumulaci\u00f3n\t\r \u00a0de\t\r \u00a0enfermedades\t\r \u00a0agudas\t\r \u00a0y,\t\r \u00a0sobre\t\r \u00a0todo,\t\r \u00a0cr\u00f3nicas,\t\r \u00a0las\t\r \u00a0 limitaciones\t\r \u00a0 funcionales\t\r \u00a0 que,\t\r \u00a0 en\t\r \u00a0 algunos\t\r \u00a0 casos,\t\r \u00a0 acaban\t\r \u00a0 llev\u00e1ndonos\t\r \u00a0 a\t\r \u00a0situaciones\t\r \u00a0de\t\r \u00a0dependencia.\t\r \u00a0Se\t\r \u00a0consumen\t\r \u00a0m\u00e1s\t\r \u00a0f\u00e1rmacos,\t\r \u00a0los\t\r \u00a0controles\t\r \u00a0sanitarios\t\r \u00a0se\t\r \u00a0hacen\t\r \u00a0m\u00e1s\t\r \u00a0frecuentes,\t\r \u00a0crece\t\r \u00a0la\t\r \u00a0necesidad\t\r \u00a0de\t\r \u00a0contar\t\r \u00a0con\t\r \u00a0la\t\r \u00a0figura\t\r \u00a0del\t\r \u00a0cuidador,\t\r \u00a0etc.\t\r \u00a0Son\t\r \u00a0limitaciones\t\r \u00a0intr\u00ednsecas,\t\r \u00a0en\t\r \u00a0parte\t\r \u00a0inevitables,\t\r \u00a0que\t\r \u00a0pueden\t\r \u00a0desmotivar\t\r \u00a0e\t\r \u00a0invitan\t\r \u00a0poco\t\r \u00a0 a\t\r \u00a0 proseguir\t\r \u00a0 con\t\r \u00a0 una\t\r \u00a0 actividad\t\r \u00a0 mantenida.\t\r \u00a0 Primer\t\r \u00a0 obst\u00e1culo\t\r \u00a0 que\t\r \u00a0 hay\t\r \u00a0 que\t\r \u00a0superar.\t\r \u00a0Otro\t\r \u00a0cap\u00edtulo,\t\r \u00a0tambi\u00e9n\t\r \u00a0centrado\t\r \u00a0en\t\r \u00a0la\t\r \u00a0propia\t\r \u00a0persona\t\r \u00a0mayor,\t\r \u00a0es\t\r \u00a0el\t\r \u00a0que\t\r \u00a0tiene\t\r \u00a0que\t\r \u00a0ver\t\r \u00a0con\t\r \u00a0la\t\r \u00a0necesidad\t\r \u00a0de\t\r \u00a0vencer\t\r \u00a0muchas\t\r \u00a0de\t\r \u00a0las\t\r \u00a0inercias\t\r \u00a0que\t\r \u00a0act\u00faan\t\r \u00a0en\t\r \u00a0el\t\r \u00a0sentido\t\r \u00a0de\t\r \u00a0dejarse\t\r \u00a0ir\t\r \u00a0una\t\r \u00a0vez\t\r \u00a0que\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0ha\t\r \u00a0cumplido\t\r \u00a0los\t\r \u00a0principales\t\r \u00a0preceptos\t\r \u00a0de\t\r \u00a0su\t\r \u00a0rol\t\r \u00a0en\t\r \u00a0esta\t\r \u00a0 vida.\t\r \u00a0 Se\t\r \u00a0 manifiesta\t\r \u00a0 en\t\r \u00a0 frases\t\r \u00a0 o\t\r \u00a0 en\t\r \u00a0 sentimientos\t\r \u00a0 ligados\t\r \u00a0 al\t\r \u00a0 \u201cya\t\r \u00a0 he\t\r \u00a0 trabajado\t\r \u00a0bastante\u201d,\t\r \u00a0\u201cno\t\r \u00a0tengo\t\r \u00a0\u00e1nimos\u201d,\t\r \u00a0\u201ces\t\r \u00a0el\t\r \u00a0turno\t\r \u00a0de\t\r \u00a0otros\u201d,\t\r \u00a0\u201cque\t\r \u00a0me\t\r \u00a0dejen\t\r \u00a0tranquilo\u201d,\t\r \u00a0\u201cque\t\r \u00a0me\t\r \u00a0cuiden\u201d,\t\r \u00a0y\t\r \u00a0expresiones\t\r \u00a0similares.\t\r \u00a0Puede\t\r \u00a0ser\t\r \u00a0una\t\r \u00a0v\u00eda\t\r \u00a0para\t\r \u00a0el\t\r \u00a0abandono\t\r \u00a0y\t\r \u00a0una\t\r \u00a0puerta\t\r \u00a0de\t\r \u00a0entrada\t\r \u00a0en\t\r \u00a0\u201csituaciones\t\r \u00a0de\t\r \u00a0indignidad\u201d.\t\r \u00a0En\t\r \u00a0 el\t\r \u00a0 tercer\t\r \u00a0 apartado\t\r \u00a0 existen\t\r \u00a0 ya\t\r \u00a0 elementos\t\r \u00a0 externos.\t\r \u00a0 Tiene\t\r \u00a0 que\t\r \u00a0 ver\t\r \u00a0 con\t\r \u00a0 los\t\r \u00a0problemas\t\r \u00a0que\t\r \u00a0surgen\t\r \u00a0a\t\r \u00a0la\t\r \u00a0hora\t\r \u00a0de\t\r \u00a0asumir\t\r \u00a0situaciones\t\r \u00a0nuevas\t\r \u00a0y\t\r \u00a0est\u00e1\t\r \u00a0muy\t\r \u00a0vinculado\t\r \u00a0al\t\r \u00a0salto\t\r \u00a0cualitativo\t\r \u00a0que\t\r \u00a0representa\t\r \u00a0la\t\r \u00a0jubilaci\u00f3n.\t\r \u00a0Cambia\t\r \u00a0la\t\r \u00a0vida\t\r \u00a0y\t\r \u00a0hay\t\r \u00a0que\t\r \u00a0adaptarse\t\r \u00a0a\t\r \u00a0ello.\t\r \u00a0Es\t\r \u00a0habitual\t\r \u00a0que\t\r \u00a0coincidiendo\t\r \u00a0con\t\r \u00a0la\t\r \u00a0edad\t\r \u00a0jubilar\t\r \u00a0tengan\t\r \u00a0lugar\t\r \u00a0modificaciones\t\r \u00a0en\t\r \u00a0el\t\r \u00a0entorno\t\r \u00a0inmediato,\t\r \u00a0separaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0hijos,\t\r \u00a0p\u00e9rdidas\t\r \u00a0familiares\t\r \u00a0y\t\r \u00a0de\t\r \u00a0amigos,\t\r \u00a0asunci\u00f3n\t\r \u00a0 del\t\r \u00a0 papel\t\r \u00a0 de\t\r \u00a0 abuelos,\t\r \u00a0 etc.\t\r \u00a0 Son\t\r \u00a0 retos\t\r \u00a0 muy\t\r \u00a0serios,\t\r \u00a0 pero,\t\r \u00a0 para\t\r \u00a0 intentar\t\r \u00a0envejecer\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 activa,\t\r \u00a0 resulta\t\r \u00a0 obligado\t\r \u00a0 buscar\t\r \u00a0 un\t\r \u00a0 nuevo\t\r \u00a0 papel\t\r \u00a0 social\t\r \u00a0 que\t\r \u00a0permita\t\r \u00a0 superarlos,\t\r \u00a0 algo\t\r \u00a0 que\t\r \u00a0 afecta\t\r \u00a0 desde\t\r \u00a0 la\t\r \u00a0 ocupaci\u00f3n\t\r \u00a0 del\t\r \u00a0 tiempo\t\r \u00a0 hasta\t\r \u00a0 la\t\r \u00a0respuesta\t\r \u00a0al\t\r \u00a0\u00bfA\t\r \u00a0qu\u00e9\t\r \u00a0me\t\r \u00a0voy\t\r \u00a0a\t\r \u00a0dedicar\t\r \u00a0ahora?\t\r \u00a0Por\t\r \u00a0si\t\r \u00a0fuera\t\r \u00a0poco\t\r \u00a0\u2013cuarta\t\r \u00a0dificultad-\u00ad\u2010\t\r \u00a0no\t\r \u00a0es\t\r \u00a0raro\t\r \u00a0que\t\r \u00a0se\t\r \u00a0vuelva\t\r \u00a0hostil\t\r \u00a0buena\t\r \u00a0parte\t\r \u00a0del\t\r \u00a0entorno\t\r \u00a0m\u00e1s\t\r \u00a0pr\u00f3ximo,\t\r \u00a0sobre\t\r \u00a0todo\t\r \u00a0aquel\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0se\t\r \u00a0han\t\r \u00a0vivido\t\r \u00a0las\t\r \u00a0fases\t\r \u00a0inmediatas\t\r \u00a0a\t\r \u00a0la\t\r \u00a0jubilaci\u00f3n,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0marco\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0ha\t\r \u00a0sido\t\r \u00a0la\t\r \u00a0actividad\t\r \u00a0laboral\t\r \u00a0previa.\t\r \u00a0Hay\t\r \u00a0de\t\r \u00a0todo.\t\r \u00a0Las\t\r \u00a0situaciones\t\r \u00a0son\t\r \u00a0muy\t\r \u00a0plurales\t\r \u00a0pero\t\r \u00a0es\t\r \u00a0mucho\t\r \u00a0m\u00e1s\t\r \u00a0frecuente\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0 cabr\u00eda\t\r \u00a0 pensar\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 se\t\r \u00a0 faciliten\t\r \u00a0 unas\t\r \u00a0 m\u00ednimas\t\r \u00a0 condiciones\t\r \u00a0 que\t\r \u00a0 permitan\t\r \u00a0mantener\t\r \u00a0 cierta\t\r \u00a0 actividad\t\r \u00a0 en\t\r \u00a0 l\u00ednea\t\r \u00a0 con\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 han\t\r \u00a0 sido\t\r \u00a0 las\t\r \u00a0 competencias\t\r \u00a0 del\t\r \u00a0individuo\t\r \u00a0 durante\t\r \u00a0 toda\t\r \u00a0 su\t\r \u00a0 vida\t\r \u00a0 anterior.\t\r \u00a0 M\u00e1s\t\r \u00a0 bien\t\r \u00a0 la\t\r \u00a0 experiencia\t\r \u00a0 demuestra\t\r \u00a0 que\t\r \u00a0puede\t\r \u00a0 ocurrir\t\r \u00a0 lo\t\r \u00a0 contrario:\t\r \u00a0 puertas\t\r \u00a0 cerradas,\t\r \u00a0 malas\t\r \u00a0 caras,\t\r \u00a0 recelos\t\r \u00a0 vinculados\t\r \u00a0 a\t\r \u00a0frases\t\r \u00a0como\t\r \u00a0\u201clo\t\r \u00a0que\t\r \u00a0le\t\r \u00a0cuesta\t\r \u00a0a\t\r \u00a0este\t\r \u00a0dejar\t\r \u00a0la\t\r \u00a0silla\u201d,\t\r \u00a0zancadillas,\t\r \u00a0empujones,\t\r \u00a0etc.\t\r \u00a0No\t\r \u00a0es\t\r \u00a0excepcional\t\r \u00a0 escuchar\t\r \u00a0 recomendaciones\t\r \u00a0 del\t\r \u00a0 tipo\t\r \u00a0 de\t\r \u00a0 \u201csi\t\r \u00a0 quiere\t\r \u00a0 envejecer\t\r \u00a0activamente\t\r \u00a0 que\t\r \u00a0 aprenda\t\r \u00a0 a\t\r \u00a0 jugar\t\r \u00a0 al\t\r \u00a0 golf\t\r \u00a0 o\t\r \u00a0 que\t\r \u00a0 cuide\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 nietos\u201d.\t\r \u00a0 Estamos\t\r \u00a0 ya\t\r \u00a0J.M.\t\r \u00a0Ribera\t\r \u00a0Casado\t\r \u00a0\t\r \u00a0\n442\t\r \u00a0\t\r \u00a0plenamente\t\r \u00a0en\t\r \u00a0el\t\r \u00a0campo\t\r \u00a0de\t\r \u00a0los\t\r \u00a0obst\u00e1culos\t\r \u00a0extr\u00ednsecos,\t\r \u00a0unas\t\r \u00a0dificultades\t\r \u00a0impuestas\t\r \u00a0desde\t\r \u00a0fuera\t\r \u00a0y\t\r \u00a0que\t\r \u00a0se\t\r \u00a0suman\t\r \u00a0a\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0anteriores.\t\r \u00a0Pero\t\r \u00a0todav\u00eda\t\r \u00a0queda\t\r \u00a0algo\t\r \u00a0peor.\t\r \u00a0El\t\r \u00a0tan\t\r \u00a0manido\t\r \u00a0tema\t\r \u00a0de\t\r \u00a0la\t\r \u00a0crisis\t\r \u00a0ha\t\r \u00a0facilitado\t\r \u00a0la\t\r \u00a0implantaci\u00f3n\t\r \u00a0de\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0puede\t\r \u00a0calificarse\t\r \u00a0como\t\r \u00a0\u201ccastigo\t\r \u00a0gubernamental\u201d.\t\r \u00a0Castigos\t\r \u00a0a\u00f1adidos,\t\r \u00a0sobre\t\r \u00a0todo\t\r \u00a0de\t\r \u00a0\u00edndole\t\r \u00a0econ\u00f3mica.\t\r \u00a0En\t\r \u00a0parte\t\r \u00a0son\t\r \u00a0comunes\t\r \u00a0a\t\r \u00a0los\t\r \u00a0dise\u00f1ados\t\r \u00a0para\t\r \u00a0otros\t\r \u00a0grupos\t\r \u00a0etarios,\t\r \u00a0como\t\r \u00a0ocurre\t\r \u00a0con\t\r \u00a0las\t\r \u00a0p\u00e9rdidas\t\r \u00a0de\t\r \u00a0poder\t\r \u00a0adquisitivo,\t\r \u00a0algo\t\r \u00a0que,\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 caso\t\r \u00a0 del\t\r \u00a0 anciano,\t\r \u00a0 ya\t\r \u00a0 se\t\r \u00a0 ha\t\r \u00a0 visto\t\r \u00a0 muy\t\r \u00a0 mermado\t\r \u00a0 previamente\t\r \u00a0 desde\t\r \u00a0 el\t\r \u00a0momento\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0lo\t\r \u00a0que\t\r \u00a0era\t\r \u00a0un\t\r \u00a0sueldo\t\r \u00a0se\t\r \u00a0convierte\t\r \u00a0en\t\r \u00a0una\t\r \u00a0pensi\u00f3n.\t\r \u00a0Tambi\u00e9n\t\r \u00a0los\t\r \u00a0impuestos\t\r \u00a0municipales,\t\r \u00a0auton\u00f3micos\t\r \u00a0y\t\r \u00a0estatales\t\r \u00a0cada\t\r \u00a0vez\t\r \u00a0m\u00e1s\t\r \u00a0altos.\t\r \u00a0Otros\t\r \u00a0castigos\t\r \u00a0son\t\r \u00a0 espec\u00edficos,\t\r \u00a0 copago\t\r \u00a0 farmac\u00e9utico,\t\r \u00a0 euro\t\r \u00a0 por\t\r \u00a0 receta,\t\r \u00a0 limitaciones\t\r \u00a0 crecientes\t\r \u00a0 en\t\r \u00a0los\t\r \u00a0 recursos\t\r \u00a0 sociales\t\r \u00a0 o\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 aplicaci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 ley\t\r \u00a0 de\t\r \u00a0 dependencia,\t\r \u00a0 y\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 caiga.\t\r \u00a0\u00a1C\u00e1llese\t\r \u00a0 y\t\r \u00a0 ayude\t\r \u00a0 en\t\r \u00a0 casa\t\r \u00a0 si\t\r \u00a0 sus\t\r \u00a0 hijos\t\r \u00a0 o\t\r \u00a0 sus\t\r \u00a0 nietos\t\r \u00a0 est\u00e1n\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 paro!\t\r \u00a0 Las\t\r \u00a0administraciones\t\r \u00a0suelen\t\r \u00a0hacer\t\r \u00a0recaer\t\r \u00a0las\t\r \u00a0cargas\t\r \u00a0m\u00e1ximas\t\r \u00a0sobre\t\r \u00a0los\t\r \u00a0m\u00e1s\t\r \u00a0d\u00e9biles\t\r \u00a0y\t\r \u00a0el\t\r \u00a0anciano\t\r \u00a0est\u00e1\t\r \u00a0en\t\r \u00a0ese\t\r \u00a0grupo.\t\r \u00a0Hacerlo\t\r \u00a0as\u00ed\t\r \u00a0es\t\r \u00a0m\u00e1s\t\r \u00a0f\u00e1cil.\t\r \u00a0Genera\t\r \u00a0menos\t\r \u00a0contestaci\u00f3n\t\r \u00a0y\t\r \u00a0menos\t\r \u00a0problemas.\t\r \u00a0\t\r \u00a0Bien,\t\r \u00a0pues\t\r \u00a0en\t\r \u00a0ese\t\r \u00a0contexto\t\r \u00a0Naciones\t\r \u00a0Unidas\t\r \u00a0y\t\r \u00a0a\t\r \u00a0su\t\r \u00a0rebufo\t\r \u00a0todos\t\r \u00a0quienes\t\r \u00a0nos\t\r \u00a0ocupamos\t\r \u00a0de\t\r \u00a0estas\t\r \u00a0cuestiones,\t\r \u00a0intentamos\t\r \u00a0convencer\t\r \u00a0a\t\r \u00a0nuestros\t\r \u00a0mayores\t\r \u00a0para\t\r \u00a0que\t\r \u00a0mantengan\t\r \u00a0su\t\r \u00a0dignidad\t\r \u00a0a\t\r \u00a0trav\u00e9s\t\r \u00a0de\t\r \u00a0envejecer\t\r \u00a0activamente.\t\r \u00a0En\t\r \u00a0algunos\t\r \u00a0casos,\t\r \u00a0como\t\r \u00a0en\t\r \u00a0 el\t\r \u00a0 de\t\r \u00a0 quien\t\r \u00a0 esto\t\r \u00a0 suscribe,\t\r \u00a0 predicando\t\r \u00a0 con\t\r \u00a0 el\t\r \u00a0 ejemplo,\t\r \u00a0 toda\t\r \u00a0 vez\t\r \u00a0 que,\t\r \u00a0objetivamente,\t\r \u00a0 uno\t\r \u00a0 ya\t\r \u00a0 se\t\r \u00a0 siente\t\r \u00a0 inmerso\t\r \u00a0 con\t\r \u00a0todas\t\r \u00a0 las\t\r \u00a0 consecuencias\t\r \u00a0 dentro\t\r \u00a0 de\t\r \u00a0este\t\r \u00a0colectivo.\t\r \u00a04.\t\r \u00a0A\t\r \u00a0MODO\t\r \u00a0DE\t\r \u00a0COLOF\u00d3N\t\r \u00a0Vemos\t\r \u00a0que\t\r \u00a0la\t\r \u00a0dignidad\t\r \u00a0del\t\r \u00a0individuo\t\r \u00a0se\t\r \u00a0mantiene\t\r \u00a0durante\t\r \u00a0toda\t\r \u00a0la\t\r \u00a0vida.\t\r \u00a0Ni\t\r \u00a0las\t\r \u00a0limitaciones\t\r \u00a0 que\t\r \u00a0 acompa\u00f1an\t\r \u00a0 el\t\r \u00a0 proceso\t\r \u00a0 de\t\r \u00a0 envejecer,\t\r \u00a0 ni\t\r \u00a0 las\t\r \u00a0 diversas\t\r \u00a0 formas\t\r \u00a0 de\t\r \u00a0agresi\u00f3n\t\r \u00a0 a\t\r \u00a0 que\t\r \u00a0 puede\t\r \u00a0 verse\t\r \u00a0 sometido\t\r \u00a0 el\t\r \u00a0 colectivo\t\r \u00a0 de\t\r \u00a0 m\u00e1s\t\r \u00a0 edad,\t\r \u00a0 constituyen\t\r \u00a0argumentos\t\r \u00a0suficientes\t\r \u00a0para\t\r \u00a0una\t\r \u00a0p\u00e9rdida\t\r \u00a0de\t\r \u00a0dignidad.\t\r \u00a0La\t\r \u00a0sociedad\t\r \u00a0y\t\r \u00a0los\t\r \u00a0individuos\t\r \u00a0deberemos\t\r \u00a0 asumir\t\r \u00a0 actitudes\t\r \u00a0 positivas\t\r \u00a0 y,\t\r \u00a0 en\t\r \u00a0 este\t\r \u00a0 contexto,\t\r \u00a0 lemas\t\r \u00a0 como\t\r \u00a0 el\t\r \u00a0 del\t\r \u00a0envejecimiento\t\r \u00a0 activo,\t\r \u00a0 enunciados\t\r \u00a0 por\t\r \u00a0 organismos\t\r \u00a0 del\t\r \u00a0 prestigio\t\r \u00a0 de\t\r \u00a0 UN,\t\r \u00a0representan\t\r \u00a0una\t\r \u00a0ayuda\t\r \u00a0inestimable\t\r \u00a0para\t\r \u00a0mantener\t\r \u00a0e\t\r \u00a0incrementar\t\r \u00a0ese\t\r \u00a0elemento\t\r \u00a0de\t\r \u00a0excelencia\t\r \u00a0que\t\r \u00a0conocemos\t\r \u00a0con\t\r \u00a0el\t\r \u00a0nombre\t\r \u00a0de\t\r \u00a0\u201cdignidad\u201d\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0marco\t\r \u00a0com\u00fan.\t\r \u00a0Terminar\u00e9\t\r \u00a0 de\t\r \u00a0 nuevo\t\r \u00a0 con\t\r \u00a0 Bobbio\t\r \u00a0 quien,\t\r \u00a0 en\t\r \u00a0 un\t\r \u00a0 homenaje\t\r \u00a0 expreso\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 geriatr\u00eda,\t\r \u00a0habla\t\r \u00a0de\t\r \u00a0la\t\r \u00a0nobleza\t\r \u00a0de\t\r \u00a0su\t\r \u00a0fin\t\r \u00a0\u201cque\t\r \u00a0no\t\r \u00a0estriba\t\r \u00a0s\u00f3lo\t\r \u00a0en\t\r \u00a0aliviar\t\r \u00a0los\t\r \u00a0sufrimientos\t\r \u00a0f\u00edsicos,\t\r \u00a0sino\t\r \u00a0tambi\u00e9n\t\r \u00a0\u2026\t\r \u00a0en\t\r \u00a0exhortar\t\r \u00a0a\t\r \u00a0quien\t\r \u00a0est\u00e1\t\r \u00a0a\t\r \u00a0punto\t\r \u00a0de\t\r \u00a0entrar\t\r \u00a0en\t\r \u00a0la\t\r \u00a0\u00faltima\t\r \u00a0parte\t\r \u00a0de\t\r \u00a0su\t\r \u00a0vida\t\r \u00a0 a\t\r \u00a0 no\t\r \u00a0 dejarse\t\r \u00a0 dominar\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 temor,\t\r \u00a0 a\t\r \u00a0 veces\t\r \u00a0 obsesivo,\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 decadencia,\t\r \u00a0 a\t\r \u00a0sentirse\t\r \u00a0un\t\r \u00a0vencedor\t\r \u00a0con\t\r \u00a0respecto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0j\u00f3venes\t\r \u00a0muertos\t\r \u00a0que\t\r \u00a0son\t\r \u00a0los\t\r \u00a0vencidos\t\r \u00a0y\t\r \u00a0no\t\r \u00a0\u00e9l\u201d.\t\r \u00a0\t\r \u00a0\u201cA\t\r \u00a0tu\t\r \u00a0edad,\t\r \u00a0si\t\r \u00a0ves\t\r \u00a0que\t\r \u00a0se\t\r \u00a0te\t\r \u00a0escapa\t\r \u00a0el\t\r \u00a0autob\u00fas\t\r \u00a0no\t\r \u00a0corras.\t\r \u00a0\t\r \u00a0Perder\u00e1s\t\r \u00a0el\t\r \u00a0autob\u00fas\t\r \u00a0y\t\r \u00a0la\t\r \u00a0dignidad\u201d\t\r \u00a0(Mar\u00eda\t\r \u00a0Salas)\t\r \u00a0La\t\r \u00a0dignidad\t\r \u00a0de\t\r \u00a0la\t\r \u00a0persona\t\r \u00a0mayor\t\r \u00a0\t\r \u00a0\n443\t\r \u00a0\t\r \u00a05.\t\r \u00a0REFERENCIAS\t\r \u00a01.-\u00ad\u2010Valls\t\r \u00a0 R.\t\r \u00a0La\t\r \u00a0 dignidad\t\r \u00a0 humana.\t\r \u00a0 En\t\r \u00a0 DMD\t\r \u00a0 Jornadas\t\r \u00a0 de\t\r \u00a0 derecho\t\r \u00a0 a\t\r \u00a0 morir\t\r \u00a0 dignamente.\t\r \u00a0Ayuntamiento\t\r \u00a0de\t\r \u00a0Barcelona.\t\r \u00a0Barcelona.\t\r \u00a02000\t\r \u00a0pgs:89-\u00ad\u2010104.\t\r \u00a02.-\u00ad\u2010\t\r \u00a0Bobbio\t\r \u00a0N.\t\r \u00a0De\t\r \u00a0Senectute.\t\r \u00a0Ed\t\r \u00a0Taurus.\t\r \u00a0Madrid.\t\r \u00a01997.\t\r \u00a03.-\u00ad\u2010\t\r \u00a0Ingelfinger\t\r \u00a0FJ.\t\r \u00a0Empty\t\r \u00a0slogan\t\r \u00a0for\t\r \u00a0the\t\r \u00a0dying.\t\r \u00a0N\t\r \u00a0Engl\t\r \u00a0J\t\r \u00a0Med\t\r \u00a01974;\t\r \u00a0291:845-\u00ad\u201046.\t\r \u00a04.-\u00ad\u2010\t\r \u00a0Chistensen\t\r \u00a0K,\t\r \u00a0Doblhammer\t\r \u00a0G,\t\r \u00a0Vaupel\t\r \u00a0JW.\t\r \u00a0Aging\t\r \u00a0population:\t\r \u00a0the\t\r \u00a0challenges\t\r \u00a0ahead.\t\r \u00a0Lancet\t\r \u00a02009;\t\r \u00a0374:1196-\u00ad\u20101208.\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0444\t\r \u00a0\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0Ozonas\t\r \u00a0Acad\u00e9mico\t\r \u00a0Secretario\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0e-\u00ad\u2010mail:\t\r \u00a0secretaria@ranf.com\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Durante\t\r \u00a0 el\t\r \u00a0 segundo\t\r \u00a0 trimestre\t\r \u00a0 del\t\r \u00a0 a\u00f1o\t\r \u00a0 2014,\t\r \u00a0 hemos\t\r \u00a0 realizado\t\r \u00a0 un\t\r \u00a0 total\t\r \u00a0 de\t\r \u00a0diez\t\r \u00a0sesiones\t\r \u00a0cient\u00edficas,\t\r \u00a0de\t\r \u00a0la\t\r \u00a0cuales\t\r \u00a0dos\t\r \u00a0fueron\t\r \u00a0dedicadas\t\r \u00a0a\t\r \u00a0Sesiones\t\r \u00a0Necrol\u00f3gicas;\t\r \u00a0dos\t\r \u00a0mesas\t\r \u00a0redondas\t\r \u00a0y\t\r \u00a0seis\t\r \u00a0conferencias.\t\r \u00a0Tambi\u00e9n\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0en\t\r \u00a0nuestra\t\r \u00a0sede\t\r \u00a0un\t\r \u00a0Curso\t\r \u00a0Avanzado\t\r \u00a0sobre\t\r \u00a0Obesidad\t\r \u00a0y\t\r \u00a0una\t\r \u00a0serie\t\r \u00a0de\t\r \u00a0actos\t\r \u00a0organizados\t\r \u00a0en\t\r \u00a0colaboraci\u00f3n\t\r \u00a0con\t\r \u00a0diversas\t\r \u00a0instituciones\t\r \u00a0SESIONES\t\r \u00a0NECROL\u00d3GICAS:\t\r \u00a0\t\r \u00a0El\t\r \u00a0pasado\t\r \u00a08\t\r \u00a0de\t\r \u00a0mayo,\t\r \u00a0se\t\r \u00a0celebr\u00f3\t\r \u00a0en\t\r \u00a0nuestra\t\r \u00a0Sede\t\r \u00a0una\t\r \u00a0Sesi\u00f3n\t\r \u00a0Necrol\u00f3gica\t\r \u00a0en\t\r \u00a0memoria\t\r \u00a0 del\t\r \u00a0 Acad\u00e9mico\t\r \u00a0 Numerario,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Medalla\t\r \u00a0 36,\t\r \u00a0 Excmo.\t\r \u00a0 Sr.\t\r \u00a0 D.\t\r \u00a0 Gaspar\t\r \u00a0Gonz\u00e1lez\t\r \u00a0 Gonz\u00e1lez,\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 intervinieron\t\r \u00a0 los\t\r \u00a0 Excmos.\t\r \u00a0 Sres.\t\r \u00a0 Acad\u00e9micos\t\r \u00a0 de\t\r \u00a0N\u00famero\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RANF,\t\r \u00a0 D.\t\r \u00a0 Albino\t\r \u00a0 Garc\u00eda\t\r \u00a0 Sacrist\u00e1n,\t\r \u00a0 D.\t\r \u00a0 Bartolom\u00e9\t\r \u00a0 Ribas\t\r \u00a0 Ozonas\t\r \u00a0 y\t\r \u00a0 D.\t\r \u00a0Bernab\u00e9\t\r \u00a0Sanz\t\r \u00a0P\u00e9rez\t\r \u00a0que\t\r \u00a0disertaron\t\r \u00a0sobre\t\r \u00a0tres\t\r \u00a0diferentes\t\r \u00a0facetas\t\r \u00a0del\t\r \u00a0Prof.\t\r \u00a0Gonz\u00e1lez,\t\r \u00a0como\t\r \u00a0Profesor,\t\r \u00a0como\t\r \u00a0Acad\u00e9mico\t\r \u00a0y\t\r \u00a0como\t\r \u00a0Amigo,\t\r \u00a0respectivamente.\t\r \u00a0\t\r \u00a0\u201cGaspar\t\r \u00a0Gonz\u00e1lez\t\r \u00a0Gonz\u00e1lez:\t\r \u00a0El\t\r \u00a0Profesor\u201d\t\r \u00a0\t\r \u00a0El\t\r \u00a0Dr.\t\r \u00a0Gonz\u00e1lez\t\r \u00a0se\t\r \u00a0gradu\u00f3\t\r \u00a0en\t\r \u00a0Veterinaria\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Escuela\t\r \u00a0Superior\t\r \u00a0de\t\r \u00a0Le\u00f3n\t\r \u00a0en\t\r \u00a01943,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0edad\t\r \u00a0de\t\r \u00a020\t\r \u00a0a\u00f1os.\t\r \u00a0Revalid\u00f3\t\r \u00a0sus\t\r \u00a0estudios\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Escuela\t\r \u00a0Superior\t\r \u00a0de\t\r \u00a0Madrid\t\r \u00a0y\t\r \u00a0 posteriormente\t\r \u00a0 se\t\r \u00a0 doctor\u00f3\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 Central\t\r \u00a0-\u00ad\u2010hoy\t\r \u00a0 Complutense-\u00ad\u2010.\t\r \u00a0Complet\u00f3\t\r \u00a0su\t\r \u00a0formaci\u00f3n\t\r \u00a0en\t\r \u00a0el\t\r \u00a0CSIC,\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Instituto\t\r \u00a0Social\t\r \u00a0Le\u00f3n\t\r \u00a0XIII\t\r \u00a0y\t\r \u00a0con\t\r \u00a0diversas\t\r \u00a0estancias\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 extranjero,\t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0 Universidades\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 centros\t\r \u00a0 de\t\r \u00a0investigaci\u00f3n\t\r \u00a0 agron\u00f3mica.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0 Facultad\t\r \u00a0 de\t\r \u00a0Veterinaria\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0Complutense\t\r \u00a0de\t\r \u00a0Madrid,\t\r \u00a0pas\u00f3\t\r \u00a0por\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0categor\u00edas\t\r \u00a0docentes.\t\r \u00a0Fue\t\r \u00a0Ayudante\t\r \u00a0de\t\r \u00a0clases\t\r \u00a0pr\u00e1cticas,\t\r \u00a0Profesor\t\r \u00a0Adjunto\t\r \u00a0por\t\r \u00a0oposici\u00f3n,\t\r \u00a0Encargado\t\r \u00a0de\t\r \u00a0C\u00e1tedra\t\r \u00a0y\t\r \u00a0en\t\r \u00a01951\t\r \u00a0Catedr\u00e1tico\t\r \u00a0 numerario\t\r \u00a0 de\t\r \u00a0 Agricultura\t\r \u00a0 y\t\r \u00a0 Econom\u00eda\t\r \u00a0 agraria,\t\r \u00a0 y\t\r \u00a0 Em\u00e9rito\t\r \u00a0 desde\t\r \u00a0 su\t\r \u00a0jubilaci\u00f3n\t\r \u00a0 en\t\r \u00a0 1987.\t\r \u00a0 En\t\r \u00a0 el\t\r \u00a0 Consejo\t\r \u00a0 Superior\t\r \u00a0 de\t\r \u00a0 Investigaciones\t\r \u00a0 Cient\u00edficas,\t\r \u00a0 fue,\t\r \u00a0sucesivamente,\t\r \u00a0 Becario,\t\r \u00a0 Profesor\t\r \u00a0 Agregado,\t\r \u00a0 Director\t\r \u00a0 del\t\r \u00a0 Departamento\t\r \u00a0 de\t\r \u00a0Producci\u00f3n\t\r \u00a0Animal,\t\r \u00a0Director\t\r \u00a0Adjunto\t\r \u00a0de\t\r \u00a0Investigaci\u00f3n\t\r \u00a0y\t\r \u00a0Director\t\r \u00a0del\t\r \u00a0Instituto\t\r \u00a0de\t\r \u00a0Alimentaci\u00f3n\t\r \u00a0y\t\r \u00a0 Producci\u00f3n\t\r \u00a0 animal.\t\r \u00a0 As\u00ed\t\r \u00a0 como\t\r \u00a0 tambi\u00e9n,\t\r \u00a0 Consejero\t\r \u00a0 de\t\r \u00a0 N\u00famero\t\r \u00a0 y\t\r \u00a0Vocal\t\r \u00a0 del\t\r \u00a0 Consejo\t\r \u00a0 Ejecutivo,\t\r \u00a0 Vocal\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Junta\t\r \u00a0 de\t\r \u00a0 Gobierno\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Comisi\u00f3n\t\r \u00a0 de\t\r \u00a0Pol\u00edtica\t\r \u00a0 Cient\u00edfica\t\r \u00a0 del\t\r \u00a0 Patronato\t\r \u00a0 Alonso\t\r \u00a0 de\t\r \u00a0 Herrera\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Junta\t\r \u00a0 de\t\r \u00a0 Gobierno\t\r \u00a0 y\t\r \u00a0Comisi\u00f3n\t\r \u00a0 Permanente\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Divisi\u00f3n\t\r \u00a0de\t\r \u00a0 Ciencias\t\r \u00a0 Matem\u00e1ticas,\t\r \u00a0 F\u00edsicas\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0Naturaleza.\t\r \u00a0 Esta\t\r \u00a0 presencia,\t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 como\t\r \u00a0 en\t\r \u00a0 CSIC,\t\r \u00a0 le\t\r \u00a0 permiti\u00f3\t\r \u00a0INFORMACI\u00d3N\t\r \u00a0ACAD\u00c9MICA\t\r \u00a0\nInformaci\u00f3n\t\r \u00a0acad\u00e9mica\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0445\t\r \u00a0generar\t\r \u00a0 a\t\r \u00a0 Don\t\r \u00a0 Gaspar,\t\r \u00a0 una\t\r \u00a0 intensa\t\r \u00a0 actividad\t\r \u00a0 investigadora\t\r \u00a0 con\t\r \u00a0 numerosas\t\r \u00a0publicaciones\t\r \u00a0 de\t\r \u00a0 estudios\t\r \u00a0 experimentales,\t\r \u00a0 tanto\t\r \u00a0 en\t\r \u00a0 revistas\t\r \u00a0 extranjeras\t\r \u00a0 como\t\r \u00a0nacionales,\t\r \u00a0 la\t\r \u00a0 intervenci\u00f3n\t\r \u00a0 como\t\r \u00a0 ponente\t\r \u00a0 en\t\r \u00a0 54\t\r \u00a0 Congresos\t\r \u00a0 nacionales\t\r \u00a0 y\t\r \u00a0 29\t\r \u00a0internacionales,\t\r \u00a0 la\t\r \u00a0 direcci\u00f3n\t\r \u00a0 de\t\r \u00a0 34\t\r \u00a0 tesis\t\r \u00a0 doctorales,\t\r \u00a0 as\u00ed\t\r \u00a0 como\t\r \u00a0 la\t\r \u00a0 traducci\u00f3n\t\r \u00a0 de\t\r \u00a0textos\t\r \u00a0 del\t\r \u00a0 ingl\u00e9s,\t\r \u00a0 como\t\r \u00a0 los\t\r \u00a0 de\t\r \u00a0 Stiles,\t\r \u00a0 Russell,\t\r \u00a0 Blaxter,\t\r \u00a0 Heady\t\r \u00a0 y\t\r \u00a0 Sppedingg\t\r \u00a0 o\t\r \u00a0 del\t\r \u00a0italiano,\t\r \u00a0como\t\r \u00a0 los\t\r \u00a0 libros\t\r \u00a0 de\t\r \u00a0 Tassinari\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 Bonciarelli,\t\r \u00a0 todos\t\r \u00a0 ellos\t\r \u00a0 referentes\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0agronom\u00eda\t\r \u00a0 y\t\r \u00a0 econom\u00eda\t\r \u00a0 agraria.\t\r \u00a0 Adem\u00e1s\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 fruct\u00edfera\t\r \u00a0 actividad\t\r \u00a0 docente\t\r \u00a0 e\t\r \u00a0investigadora\t\r \u00a0 el\t\r \u00a0 Profesor\t\r \u00a0 Gonz\u00e1lez\t\r \u00a0 realiz\u00f3\t\r \u00a0 una\t\r \u00a0 intensa\t\r \u00a0 gesti\u00f3n\t\r \u00a0 acad\u00e9mica.\t\r \u00a0 En\t\r \u00a0 la\t\r \u00a0Facultad\t\r \u00a0 de\t\r \u00a0 Veterinaria\t\r \u00a0 fue\t\r \u00a0 Director\t\r \u00a0 de\t\r \u00a0 Departamento,\t\r \u00a0 Vicedecano,\t\r \u00a0 Decano\t\r \u00a0 y,\t\r \u00a0finalmente,\t\r \u00a0Vicerrector\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Universidad\t\r \u00a0Complutense.\t\r \u00a0\t\r \u00a0\"Gaspar\t\r \u00a0Gonz\u00e1lez\t\r \u00a0Gonz\u00e1lez:\t\r \u00a0El\t\r \u00a0Acad\u00e9mico\"\t\r \u00a0\t\r \u00a0La\t\r \u00a0 propuesta\t\r \u00a0 de\t\r \u00a0 Acad\u00e9mico\t\r \u00a0 del\t\r \u00a0 Profesor\t\r \u00a0 Gaspar\t\r \u00a0 Gonz\u00e1lez\t\r \u00a0 fue\t\r \u00a0cumplimentada\t\r \u00a0y\t\r \u00a0presentada\t\r \u00a0por\t\r \u00a0los\t\r \u00a0Acad\u00e9micos\t\r \u00a0Excmos.\t\r \u00a0Sres.\t\r \u00a0\u00c1ngel\t\r \u00a0Vian\t\r \u00a0Ortu\u00f1o;\t\r \u00a0Rom\u00e1n\t\r \u00a0de\t\r \u00a0Vicente\t\r \u00a0Jordana\t\r \u00a0y\t\r \u00a0Bernab\u00e9\t\r \u00a0Sanz\t\r \u00a0P\u00e9rez,\t\r \u00a0con\t\r \u00a0fecha\t\r \u00a0del\t\r \u00a014\t\r \u00a0de\t\r \u00a0enero\t\r \u00a01994\t\r \u00a0para\t\r \u00a0cubrir\t\r \u00a0la\t\r \u00a0vacante\t\r \u00a0del\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0Felipe\t\r \u00a0\u00c1ngel\t\r \u00a0Calvo\t\r \u00a0y\t\r \u00a0Calvo,\t\r \u00a0cuyo\t\r \u00a0fallecimiento\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0el\t\r \u00a026\t\r \u00a0noviembre\t\r \u00a0de\t\r \u00a01992.\t\r \u00a0\t\r \u00a0El\t\r \u00a0Acad\u00e9mico\t\r \u00a0\u00c1ngel\t\r \u00a0Vi\u00e1n\t\r \u00a0Ortu\u00f1o\t\r \u00a0manifiesta\t\r \u00a0en\t\r \u00a0sus\t\r \u00a0primeras\t\r \u00a0palabras\t\r \u00a0en\t\r \u00a0la\t\r \u00a0recepci\u00f3n\t\r \u00a0 de\t\r \u00a0 Gaspar\t\r \u00a0 como\t\r \u00a0 Acad\u00e9mico:\t\r \u00a0 \"Don\t\r \u00a0 Gaspar\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0 leon\u00e9s\t\r \u00a0 recto,\t\r \u00a0 grande,\t\r \u00a0talentudo,\t\r \u00a0 amable\t\r \u00a0 y\t\r \u00a0 bien\t\r \u00a0 intencionado,\t\r \u00a0 con\t\r \u00a0 tanta\t\r \u00a0 curiosidad\t\r \u00a0 intelectual\t\r \u00a0 y,\t\r \u00a0correlativamente,\t\r \u00a0tanta\t\r \u00a0vida\t\r \u00a0interior\t\r \u00a0que\t\r \u00a0su\t\r \u00a0atenci\u00f3n\t\r \u00a0salta\t\r \u00a0a\t\r \u00a0menudo\t\r \u00a0de\t\r \u00a0dentro\t\r \u00a0a\t\r \u00a0fuera\t\r \u00a0de\t\r \u00a0s\u00ed\".\t\r \u00a0\t\r \u00a0Fue\t\r \u00a0elegido\t\r \u00a0Acad\u00e9mico\t\r \u00a0el\t\r \u00a017\t\r \u00a0de\t\r \u00a0marzo\t\r \u00a0de\t\r \u00a01994\t\r \u00a0por\t\r \u00a0la\t\r \u00a0Junta\t\r \u00a0General\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Corporaci\u00f3n\t\r \u00a0para\t\r \u00a0ocupar\t\r \u00a0la\t\r \u00a0Medalla\t\r \u00a0N\u00ba\t\r \u00a036\t\r \u00a0de\t\r \u00a0Ciencias\t\r \u00a0Afines;\t\r \u00a0y\t\r \u00a0tom\u00f3\t\r \u00a0posesi\u00f3n\t\r \u00a0en\t\r \u00a0esta\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0el\t\r \u00a0jueves\t\r \u00a016\t\r \u00a0de\t\r \u00a0marzo\t\r \u00a0de\t\r \u00a01995.\t\r \u00a0Su\t\r \u00a0discurso\t\r \u00a0de\t\r \u00a0ingreso\t\r \u00a0tuvo\t\r \u00a0por\t\r \u00a0t\u00edtulo:\t\r \u00a0\"Animales\t\r \u00a0superiores\t\r \u00a0y\t\r \u00a0bienestar\t\r \u00a0humano:\t\r \u00a0\u00bfestamos\t\r \u00a0legitimados\t\r \u00a0para\t\r \u00a0seguir\t\r \u00a0us\u00e1ndolos?\".\t\r \u00a0Y\t\r \u00a0al\t\r \u00a0final\t\r \u00a0de\t\r \u00a0su\t\r \u00a0discurso,\t\r \u00a0Don\t\r \u00a0Gaspar\t\r \u00a0termin\u00f3\t\r \u00a0con\t\r \u00a0la\t\r \u00a0frase:\t\r \u00a0\"He\t\r \u00a0aqu\u00ed,\t\r \u00a0como\t\r \u00a0colof\u00f3n,\t\r \u00a0la\t\r \u00a0respuesta\t\r \u00a0que\t\r \u00a0me\t\r \u00a0atrevo\t\r \u00a0a\t\r \u00a0aventurar:\t\r \u00a0Sirv\u00e1monos\t\r \u00a0de\t\r \u00a0los\t\r \u00a0animales,\t\r \u00a0pero\t\r \u00a0con\t\r \u00a0la\t\r \u00a0dignidad\t\r \u00a0que\t\r \u00a0confiere\t\r \u00a0el\t\r \u00a0habernos\t\r \u00a0sido\t\r \u00a0creados\t\r \u00a0personas\".\t\r \u00a0\t\r \u00a0Nuestro\t\r \u00a0homenajeado\t\r \u00a0realiz\u00f3\t\r \u00a0sus\t\r \u00a0actividades\t\r \u00a0Acad\u00e9micas\t\r \u00a0desde\t\r \u00a0la\t\r \u00a0fecha\t\r \u00a0de\t\r \u00a0ingreso,\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Secci\u00f3n\t\r \u00a05\u00aa:\t\r \u00a0\"Salud\t\r \u00a0P\u00fablica,\t\r \u00a0Alimentaci\u00f3n\t\r \u00a0y\t\r \u00a0Medioambiente\".\t\r \u00a0Y\t\r \u00a0el\t\r \u00a021\t\r \u00a0de\t\r \u00a0 diciembre\t\r \u00a0 de\t\r \u00a0 1996\t\r \u00a0 la\t\r \u00a0 Junta\t\r \u00a0 de\t\r \u00a0 Gobierno\t\r \u00a0 acord\u00f3\t\r \u00a0 por\t\r \u00a0 unanimidad\t\r \u00a0 incluirle\t\r \u00a0tambi\u00e9n\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 Secci\u00f3n\t\r \u00a0 2\u00aa\t\r \u00a0 de\t\r \u00a0 esta\t\r \u00a0 Instituci\u00f3n:\t\r \u00a0 \"Biolog\u00eda,\t\r \u00a0 Biotecnolog\u00eda\t\r \u00a0 y\t\r \u00a0Farmacogen\u00f3mica\".\t\r \u00a0En\t\r \u00a0representaci\u00f3n\t\r \u00a0de\t\r \u00a0esta\t\r \u00a0Secci\u00f3n\t\r \u00a02\u00aa,\t\r \u00a0el\t\r \u00a014\t\r \u00a0de\t\r \u00a0octubre\t\r \u00a02005\t\r \u00a0fue\t\r \u00a0nombrado\t\r \u00a0vocal\t\r \u00a0de\t\r \u00a0la\t\r \u00a0\"Comisi\u00f3n\t\r \u00a0de\t\r \u00a0Admisiones\".\t\r \u00a0\t\r \u00a0Algunas\t\r \u00a0de\t\r \u00a0sus\t\r \u00a0frases\t\r \u00a0y\t\r \u00a0palabras\t\r \u00a0nos\t\r \u00a0permit\u00edan\t\r \u00a0conocer\t\r \u00a0m\u00e1s\t\r \u00a0sobre\t\r \u00a0sus\t\r \u00a0ideas\t\r \u00a0y\t\r \u00a0 su\t\r \u00a0 pensar,\t\r \u00a0 sab\u00eda\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 fin\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 econom\u00eda,\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 que\t\r \u00a0 le\t\r \u00a0 gustaba\t\r \u00a0 hablar,\t\r \u00a0 era\t\r \u00a0precisamente\t\r \u00a0 estar\t\r \u00a0 al\t\r \u00a0 servicio\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 dem\u00e1s,\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 hombres,\t\r \u00a0 del\t\r \u00a0 pa\u00eds\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0humanidad.\t\r \u00a0Y\t\r \u00a0en\t\r \u00a0consecuencia\t\r \u00a0intervino\t\r \u00a0en\t\r \u00a0la\t\r \u00a0Sesi\u00f3n\t\r \u00a0cient\u00edfica\t\r \u00a0del\t\r \u00a018\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0de\t\r \u00a01995\t\r \u00a0con\t\r \u00a0el\t\r \u00a0t\u00edtulo:\t\r \u00a0\"Algunas\t\r \u00a0consideraciones\t\r \u00a0\u00e9tico-\u00ad\u2010morales\t\r \u00a0y\t\r \u00a0t\u00e9cnico-\u00ad\u2010econ\u00f3micas,\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0446\t\r \u00a0en\t\r \u00a0 torno\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 interacci\u00f3n\t\r \u00a0 producci\u00f3n\t\r \u00a0 animal-\u00ad\u2010medio\t\r \u00a0 ambiente\".\t\r \u00a0 Sab\u00eda\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0persona\t\r \u00a0m\u00e1s\t\r \u00a0rica\t\r \u00a0no\t\r \u00a0es\t\r \u00a0la\t\r \u00a0que\t\r \u00a0m\u00e1s\t\r \u00a0tiene,\t\r \u00a0sino\t\r \u00a0la\t\r \u00a0que\t\r \u00a0menos\t\r \u00a0necesita.\t\r \u00a0\t\r \u00a0El\t\r \u00a0trabajo\t\r \u00a0bien\t\r \u00a0hecho\t\r \u00a0de\t\r \u00a0Don\t\r \u00a0Gaspar,\t\r \u00a0en\t\r \u00a0seguir\t\r \u00a0la\t\r \u00a0buena\t\r \u00a0direcci\u00f3n,\t\r \u00a0en\t\r \u00a0aunar\t\r \u00a0fuerza\t\r \u00a0 y\t\r \u00a0 conocimientos,\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 saber\t\r \u00a0 hacer\t\r \u00a0 equipo,\t\r \u00a0 el\t\r \u00a0 15\t\r \u00a0 de\t\r \u00a0 octubre\t\r \u00a0 2001\t\r \u00a0 se\t\r \u00a0 le\t\r \u00a0nombra\t\r \u00a0 coordinador\t\r \u00a0 del\t\r \u00a0 Foro\t\r \u00a0 sobre\t\r \u00a0 \"La\t\r \u00a0 salud,\t\r \u00a0 prioridad\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 Sexto\t\r \u00a0 Programa\t\r \u00a0Comunitario\t\r \u00a0 del\t\r \u00a0 Medio\t\r \u00a0 Ambiente\",\t\r \u00a0 que\t\r \u00a0 tendr\u00eda\t\r \u00a0 lugar\t\r \u00a0 en\t\r \u00a0 Madrid,\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 sede\t\r \u00a0 de\t\r \u00a0esta\t\r \u00a0Real\t\r \u00a0Academia,\t\r \u00a0del\t\r \u00a029\t\r \u00a0de\t\r \u00a0octubre\t\r \u00a0al\t\r \u00a08\t\r \u00a0de\t\r \u00a0noviembre\t\r \u00a0de\t\r \u00a02001.\t\r \u00a0El\t\r \u00a0tema\t\r \u00a0de\t\r \u00a0Don\t\r \u00a0Gaspar\t\r \u00a0tuvo\t\r \u00a0por\t\r \u00a0t\u00edtulo:\t\r \u00a0\"Perspectivas\t\r \u00a0de\t\r \u00a0la\t\r \u00a0demanda\t\r \u00a0mundial\t\r \u00a0de\t\r \u00a0alimentos\".\t\r \u00a0\t\r \u00a0A\t\r \u00a0Don\t\r \u00a0Gaspar\t\r \u00a0le\t\r \u00a0importaba\t\r \u00a0hablar\t\r \u00a0de\t\r \u00a0la\t\r \u00a0vida,\t\r \u00a0y\t\r \u00a0de\t\r \u00a0la\t\r \u00a0humanidad,\t\r \u00a0y\t\r \u00a0dec\u00eda\t\r \u00a0que\t\r \u00a0aquella\t\r \u00a0pende\t\r \u00a0y\t\r \u00a0vivimos\t\r \u00a0todos\t\r \u00a0del\t\r \u00a0campo;\t\r \u00a0y\t\r \u00a0es\t\r \u00a0as\u00ed\t\r \u00a0que\t\r \u00a0existimos\t\r \u00a0por\t\r \u00a0la\t\r \u00a0agricultura.\t\r \u00a0Y\t\r \u00a0Don\t\r \u00a0Gaspar\t\r \u00a0nos\t\r \u00a0dec\u00eda\t\r \u00a0en\t\r \u00a0cierta\t\r \u00a0ocasi\u00f3n,\t\r \u00a0que\t\r \u00a0la\t\r \u00a0agricultura\t\r \u00a0es\t\r \u00a0la\t\r \u00a0madre\t\r \u00a0fecunda\t\r \u00a0que\t\r \u00a0proporciona\t\r \u00a0todas\t\r \u00a0las\t\r \u00a0materias\t\r \u00a0primeras\t\r \u00a0que\t\r \u00a0dan\t\r \u00a0vida\t\r \u00a0a\t\r \u00a0los\t\r \u00a0vivientes.\t\r \u00a0\t\r \u00a0Seguimos\t\r \u00a0 enumerando\t\r \u00a0 el\t\r \u00a0 entusiasmo\t\r \u00a0 y\t\r \u00a0 cari\u00f1o\t\r \u00a0 que\t\r \u00a0 mostr\u00f3\t\r \u00a0 por\t\r \u00a0 esta\t\r \u00a0 Real\t\r \u00a0Academia\t\r \u00a0 y\t\r \u00a0 sus\t\r \u00a0 compa\u00f1eros\t\r \u00a0 Acad\u00e9micos,\t\r \u00a0 acudi\u00f3\t\r \u00a0 a\t\r \u00a0 todas\t\r \u00a0 sus\t\r \u00a0 Sesiones\t\r \u00a0 cient\u00edficas\t\r \u00a0hasta\t\r \u00a0que\t\r \u00a0su\t\r \u00a0actividad\t\r \u00a0f\u00edsica\t\r \u00a0se\t\r \u00a0lo\t\r \u00a0permiti\u00f3\t\r \u00a0y\t\r \u00a0que\t\r \u00a0mantuvo\t\r \u00a0hasta\t\r \u00a0su\t\r \u00a0fallecimiento.\t\r \u00a0Todos\t\r \u00a0los\t\r \u00a0Acad\u00e9micos\t\r \u00a0le\t\r \u00a0agradecemos\t\r \u00a0que,\t\r \u00a0nos\t\r \u00a0deleitara\t\r \u00a0con\t\r \u00a0su\t\r \u00a0amenidad,\t\r \u00a0y\t\r \u00a0nos\t\r \u00a0brindara\t\r \u00a0su\t\r \u00a0respeto,\t\r \u00a0amistad\t\r \u00a0y\t\r \u00a0cari\u00f1o.\t\r \u00a0\t\r \u00a0Se\t\r \u00a0 nos\t\r \u00a0 fue\t\r \u00a0 el\t\r \u00a0 querido\t\r \u00a0 y\t\r \u00a0 ejemplar\t\r \u00a0 Acad\u00e9mico.\t\r \u00a0 Nos\t\r \u00a0 queda\t\r \u00a0 su\t\r \u00a0 trabajo\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0recuerdo,\t\r \u00a0 que\t\r \u00a0 no\t\r \u00a0 es\t\r \u00a0 poco.\t\r \u00a0 Era\t\r \u00a0 un\t\r \u00a0 hombre\t\r \u00a0 completo\t\r \u00a0 un\t\r \u00a0admirable\t\r \u00a0 castellano\t\r \u00a0 y\t\r \u00a0ejemplar\t\r \u00a0espa\u00f1ol.\t\r \u00a0Esperaba\t\r \u00a0mucho\t\r \u00a0de\t\r \u00a0Espa\u00f1a\t\r \u00a0y\t\r \u00a0\u00e9l\t\r \u00a0nos\t\r \u00a0dio\t\r \u00a0el\t\r \u00a0ejemplo\t\r \u00a0de\t\r \u00a0darse\t\r \u00a0a\t\r \u00a0ella\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 trabajar\t\r \u00a0 de\t\r \u00a0 forma\t\r \u00a0 altruista\t\r \u00a0 por\t\r \u00a0 nuestro\t\r \u00a0 pa\u00eds.\t\r \u00a0 Sig\u00e1moslo.\t\r \u00a0 Sus\t\r \u00a0 amigos\t\r \u00a0intentamos\t\r \u00a0seguir\t\r \u00a0la\t\r \u00a0pauta\t\r \u00a0que\t\r \u00a0sigui\u00f3\t\r \u00a0Gaspar,\t\r \u00a0del\t\r \u00a0trabajo\t\r \u00a0bien\t\r \u00a0hecho,\t\r \u00a0y\t\r \u00a0en\t\r \u00a0equipo\t\r \u00a0en\t\r \u00a0bien\t\r \u00a0de\t\r \u00a0todos.\t\r \u00a0\t\r \u00a0\"Gaspar\t\r \u00a0Gonz\u00e1lez\t\r \u00a0Gonz\u00e1lez:\t\r \u00a0El\t\r \u00a0Amigo\"\t\r \u00a0\t\r \u00a0\t\r \u00a0El\t\r \u00a0 Prof.\t\r \u00a0 Bernab\u00e9\t\r \u00a0 Sanz\t\r \u00a0 se\t\r \u00a0 refiri\u00f3\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0 sentimiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 amistad\t\r \u00a0 y\t\r \u00a0 a\t\r \u00a0 su\t\r \u00a0cari\u00f1osa\t\r \u00a0preocupaci\u00f3n\t\r \u00a0por\t\r \u00a0sus\t\r \u00a0compa\u00f1eros,\t\r \u00a0alumnos\t\r \u00a0y\t\r \u00a0colaboradores.\t\r \u00a0Solo\t\r \u00a0mostr\u00f3\t\r \u00a0unas\t\r \u00a0pocas\t\r \u00a0pinceladas\t\r \u00a0del\t\r \u00a0atractivo\t\r \u00a0cuadro\t\r \u00a0que\t\r \u00a0constituy\u00f3\t\r \u00a0su\t\r \u00a0actividad\t\r \u00a0vital.\t\r \u00a0Especial\t\r \u00a0atenci\u00f3n\t\r \u00a0merecen\t\r \u00a0sus\t\r \u00a0relaciones\t\r \u00a0con\t\r \u00a0el\t\r \u00a0profesor\t\r \u00a0Albareda\t\r \u00a0Herrera\t\r \u00a0que\t\r \u00a0fue\t\r \u00a0primero\t\r \u00a0su\t\r \u00a0gu\u00eda\t\r \u00a0y\t\r \u00a0mentor,\t\r \u00a0despu\u00e9s\t\r \u00a0su\t\r \u00a0compa\u00f1ero\t\r \u00a0y\t\r \u00a0consejero\t\r \u00a0docente\t\r \u00a0y\t\r \u00a0siempre\t\r \u00a0el\t\r \u00a0amigo\t\r \u00a0en\t\r \u00a0quien\t\r \u00a0confiar.\t\r \u00a0Otro\t\r \u00a0 miembro\t\r \u00a0 del\t\r \u00a0 c\u00edrculo\t\r \u00a0 de\t\r \u00a0 amistades\t\r \u00a0 de\t\r \u00a0 Don\t\r \u00a0 Jos\u00e9\t\r \u00a0 Mar\u00eda\t\r \u00a0 Albareda,\t\r \u00a0 con\t\r \u00a0quien\t\r \u00a0 Gaspar\t\r \u00a0 mantuvo\t\r \u00a0 gran\t\r \u00a0 amistad\t\r \u00a0 e\t\r \u00a0 intereses\t\r \u00a0 docentes\t\r \u00a0 fue\t\r \u00a0 el\t\r \u00a0 profesor\t\r \u00a0 don\t\r \u00a0Lorenzo\t\r \u00a0Vilas\t\r \u00a0L\u00f3pez.\t\r \u00a0Ambos\t\r \u00a0colaboraron\t\r \u00a0en\t\r \u00a0la\t\r \u00a0creaci\u00f3n\t\r \u00a0de\t\r \u00a0los\t\r \u00a0Institutos\t\r \u00a0Laborales\t\r \u00a0de\t\r \u00a0Ense\u00f1anza\t\r \u00a0Media\t\r \u00a0y\t\r \u00a0participaron\t\r \u00a0en\t\r \u00a0el\t\r \u00a0desarrollo\t\r \u00a0curricular\t\r \u00a0de\t\r \u00a0los\t\r \u00a0de\t\r \u00a0modalidad\t\r \u00a0agr\u00edcola\t\r \u00a0y\t\r \u00a0ganadera.\t\r \u00a0Conoci\u00f3\t\r \u00a0 a\t\r \u00a0 don\t\r \u00a0 Gaspar\t\r \u00a0 en\t\r \u00a0 1952\t\r \u00a0 en\t\r \u00a0 Zaragoza.\t\r \u00a0 Le\t\r \u00a0 fue\t\r \u00a0 presentado\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 Dr.\t\r \u00a0Pascual\t\r \u00a0L\u00f3pez\t\r \u00a0Lorenzo,\t\r \u00a0Catedr\u00e1tico\t\r \u00a0de\t\r \u00a0Farmacolog\u00eda\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Veterinaria\t\r \u00a0y\t\r \u00a0compa\u00f1ero\t\r \u00a0y\t\r \u00a0amigo\t\r \u00a0de\t\r \u00a0Gaspar\t\r \u00a0desde\t\r \u00a0sus\t\r \u00a0a\u00f1os\t\r \u00a0de\t\r \u00a0colegiales\t\r \u00a0en\t\r \u00a0el\t\r \u00a0C.\t\r \u00a0Mayor\t\r \u00a0\"C\u00e9sar\t\r \u00a0Informaci\u00f3n\t\r \u00a0acad\u00e9mica\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0447\t\r \u00a0Carlos\"\t\r \u00a0 de\t\r \u00a0 Madrid.\t\r \u00a0 Entonces\t\r \u00a0 y\t\r \u00a0 siempre\t\r \u00a0 que\t\r \u00a0 nuestro\t\r \u00a0 acad\u00e9mico\t\r \u00a0 ven\u00eda\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0Facultad\t\r \u00a0de\t\r \u00a0Zaragoza,\t\r \u00a0no\t\r \u00a0dej\u00f3\t\r \u00a0de\t\r \u00a0interesarse\t\r \u00a0por\t\r \u00a0el\t\r \u00a0trabajo\t\r \u00a0de\t\r \u00a0quienes\t\r \u00a0est\u00e1bamos\t\r \u00a0dando\t\r \u00a0nuestros\t\r \u00a0primeros\t\r \u00a0pasos\t\r \u00a0en\t\r \u00a0la\t\r \u00a0carrera\t\r \u00a0docente.\t\r \u00a0Para\t\r \u00a0todos\t\r \u00a0ten\u00eda\t\r \u00a0siempre\t\r \u00a0a\t\r \u00a0punto\t\r \u00a0unas\t\r \u00a0palabras\t\r \u00a0de\t\r \u00a0\u00e1nimo\t\r \u00a0y\t\r \u00a0esperanza.\t\r \u00a0En\t\r \u00a0junio\t\r \u00a0de\t\r \u00a01955\t\r \u00a0visit\u00f3\t\r \u00a0el\t\r \u00a0Instituto\t\r \u00a0de\t\r \u00a0Alimentaci\u00f3n\t\r \u00a0y\t\r \u00a0Productividad\t\r \u00a0Animal\t\r \u00a0que\t\r \u00a0 dirig\u00eda\t\r \u00a0 Gaspar.\t\r \u00a0 Era\t\r \u00a0 una\t\r \u00a0 estaci\u00f3n\t\r \u00a0 agroganadera\t\r \u00a0 experimental\t\r \u00a0 en\t\r \u00a0 miniatura,\t\r \u00a0pero\t\r \u00a0con\t\r \u00a0un\t\r \u00a0par\t\r \u00a0de\t\r \u00a0laboratorios\t\r \u00a0bastante\t\r \u00a0bien\t\r \u00a0dotados\t\r \u00a0para\t\r \u00a0los\t\r \u00a0a\u00f1os\t\r \u00a050\t\r \u00a0del\t\r \u00a0siglo\t\r \u00a0pasado.\t\r \u00a0 Recuerda\t\r \u00a0 que\t\r \u00a0 12\t\r \u00a0 a\u00f1os\t\r \u00a0 despu\u00e9s\t\r \u00a0 le\t\r \u00a0 dec\u00eda,\t\r \u00a0 lleno\t\r \u00a0 de\t\r \u00a0 satisfacci\u00f3n\t\r \u00a0 y\t\r \u00a0 cari\u00f1o\t\r \u00a0refiri\u00e9ndose\t\r \u00a0a\t\r \u00a0sus\t\r \u00a0colaboradores,\t\r \u00a0gracias\t\r \u00a0a\t\r \u00a0ellos,\t\r \u00a0con\t\r \u00a0esa\t\r \u00a0estructura,\t\r \u00a0mucha\t\r \u00a0ilusi\u00f3n\t\r \u00a0y\t\r \u00a0 no\t\r \u00a0 poco\t\r \u00a0 trabajo\t\r \u00a0 hemos\t\r \u00a0 conseguido\t\r \u00a0 que\t\r \u00a0 se\t\r \u00a0 nos\t\r \u00a0 conozca\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 mundo\t\r \u00a0 cient\u00edfico\t\r \u00a0europeo\t\r \u00a0y\t\r \u00a0norteamericano.\t\r \u00a0Cuando\t\r \u00a0a\t\r \u00a0primeros\t\r \u00a0de\t\r \u00a0diciembre\t\r \u00a0de\t\r \u00a01962\t\r \u00a0expuse\t\r \u00a0mi\t\r \u00a0primer\t\r \u00a0ejercicio\t\r \u00a0de\t\r \u00a0las\t\r \u00a0oposiciones\t\r \u00a0a\t\r \u00a0c\u00e1tedra,\t\r \u00a0vio\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0p\u00fablico\t\r \u00a0asistente\t\r \u00a0al\t\r \u00a0profesor\t\r \u00a0Gaspar\t\r \u00a0Gonz\u00e1lez.\t\r \u00a0Aguant\u00f3\t\r \u00a0 toda\t\r \u00a0 su\t\r \u00a0 exposici\u00f3n\t\r \u00a0 y\t\r \u00a0 esper\u00f3\t\r \u00a0 hasta\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 tribunal\t\r \u00a0 hiciera\t\r \u00a0 p\u00fablicas\t\r \u00a0 sus\t\r \u00a0calificaciones.\t\r \u00a0Siempre\t\r \u00a0recordar\u00e1\t\r \u00a0esta\t\r \u00a0prueba\t\r \u00a0de\t\r \u00a0amistad\t\r \u00a0y\t\r \u00a0apoyo\t\r \u00a0moral.\t\r \u00a0Gaspar\t\r \u00a0 sab\u00eda\t\r \u00a0 callar\t\r \u00a0 y\t\r \u00a0 escuchar,\t\r \u00a0 dejaba\t\r \u00a0 que\t\r \u00a0 sus\t\r \u00a0 estudiantes\t\r \u00a0 y\t\r \u00a0 doctorandos\t\r \u00a0expusieran\t\r \u00a0 sus\t\r \u00a0 propias\t\r \u00a0 ideas\t\r \u00a0 y\t\r \u00a0 al\t\r \u00a0 final\t\r \u00a0 las\t\r \u00a0 correg\u00eda\t\r \u00a0 o\t\r \u00a0 admit\u00eda.\t\r \u00a0 Lo\t\r \u00a0 hac\u00eda\t\r \u00a0 con\t\r \u00a0sinceridad,\t\r \u00a0en\t\r \u00a0una\t\r \u00a0mezcla\t\r \u00a0delicada\t\r \u00a0de\t\r \u00a0prudencia\t\r \u00a0y\t\r \u00a0cortes\u00eda.\t\r \u00a0Otra\t\r \u00a0buena\t\r \u00a0cualidad\t\r \u00a0de\t\r \u00a0Gaspar\t\r \u00a0era\t\r \u00a0que\t\r \u00a0no\t\r \u00a0le\t\r \u00a0importaba\t\r \u00a0\u2013\t\r \u00a0y\t\r \u00a0cree\t\r \u00a0que\t\r \u00a0hasta\t\r \u00a0le\t\r \u00a0gustaba\t\r \u00a0\u2013\t\r \u00a0ceder\t\r \u00a0 protagonismo\t\r \u00a0 a\t\r \u00a0 sus\t\r \u00a0 colaboradores\t\r \u00a0 y\t\r \u00a0 doctorandos.\t\r \u00a0 En\t\r \u00a0 todo\t\r \u00a0momento\t\r \u00a0mantuvo\t\r \u00a0una\t\r \u00a0respetuosa\t\r \u00a0amistad\t\r \u00a0con\t\r \u00a0quienes\t\r \u00a0fueron\t\r \u00a0sus\t\r \u00a0maestros.\t\r \u00a0La\t\r \u00a0obra\t\r \u00a0de\t\r \u00a0Gaspar\t\r \u00a0contin\u00faa\t\r \u00a0y\t\r \u00a0continuar\u00e1\t\r \u00a0en\t\r \u00a0su\t\r \u00a0ausencia,\t\r \u00a0gracias\t\r \u00a0a\t\r \u00a0la\t\r \u00a0amistad\t\r \u00a0y\t\r \u00a0 bien\t\r \u00a0 hacer\t\r \u00a0 que\t\r \u00a0 sembr\u00f3\t\r \u00a0 en\t\r \u00a0 sus\t\r \u00a0 alumnos,\t\r \u00a0 diseminados\t\r \u00a0 por\t\r \u00a0 muchas\t\r \u00a0 c\u00e1tedras\t\r \u00a0universitarias,\t\r \u00a0 centros\t\r \u00a0 del\t\r \u00a0 CSIC,\t\r \u00a0 cuerpos\t\r \u00a0 especializados\t\r \u00a0 del\t\r \u00a0 Estado\t\r \u00a0 y\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 UE,\t\r \u00a0empresas\t\r \u00a0 agroganaderas,\t\r \u00a0 f\u00e1bricas\t\r \u00a0 de\t\r \u00a0 pienso\t\r \u00a0 y\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 cientos\t\r \u00a0 de\t\r \u00a0 alumnos\t\r \u00a0 que\t\r \u00a0sabr\u00e1n\t\r \u00a0\u2013\t\r \u00a0dec\u00eda\t\r \u00a0\u2013\t\r \u00a0batirse\t\r \u00a0 a\t\r \u00a0 diario\t\r \u00a0 el\t\r \u00a0 cobre\t\r \u00a0 en\t\r \u00a0 ayuntamientos,\t\r \u00a0 granjas\t\r \u00a0 y\t\r \u00a0 peque\u00f1as\t\r \u00a0explotaciones\t\r \u00a0ganaderas.\t\r \u00a0Persona\t\r \u00a0profundamente\t\r \u00a0religiosa\t\r \u00a0y\t\r \u00a0cat\u00f3lico\t\r \u00a0practicante,\t\r \u00a0hoy\t\r \u00a0reposa\t\r \u00a0junto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0justos\t\r \u00a0a\t\r \u00a0la\t\r \u00a0derecha\t\r \u00a0del\t\r \u00a0Padre.\t\r \u00a0Descanse\t\r \u00a0en\t\r \u00a0paz!.\t\r \u00a0\t\r \u00a0La\t\r \u00a0 Segunda\t\r \u00a0 Sesi\u00f3n\t\r \u00a0 Necrol\u00f3gica\t\r \u00a0 tuvo\t\r \u00a0 lugar\t\r \u00a0 el\t\r \u00a0 11\t\r \u00a0 de\t\r \u00a0 junio,\t\r \u00a0 en\t\r \u00a0 memoria\t\r \u00a0 del\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Mariano\t\r \u00a0Turiel\t\r \u00a0de\t\r \u00a0Castro,\t\r \u00a0Acad\u00e9mico\t\r \u00a0Correspondiente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF\t\r \u00a0y\t\r \u00a0Secretario\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Fundaci\u00f3n\t\r \u00a0Jos\u00e9\t\r \u00a0Casares\t\r \u00a0Gil,\t\r \u00a0de\t\r \u00a0Amigos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0Dicho\t\r \u00a0acto\t\r \u00a0fue\t\r \u00a0celebrado\t\r \u00a0por\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0en\t\r \u00a0colaboraci\u00f3n\t\r \u00a0con\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0de\t\r \u00a0Doctores\t\r \u00a0de\t\r \u00a0Espa\u00f1a,\t\r \u00a0a\t\r \u00a0la\t\r \u00a0cual\t\r \u00a0pertenec\u00eda\t\r \u00a0como\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero.\t\r \u00a0\t\r \u00a0Abri\u00f3\t\r \u00a0el\t\r \u00a0acto\t\r \u00a0el\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Mariano\t\r \u00a0Esteban\t\r \u00a0Rodr\u00edguez,\t\r \u00a0Presidente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF\t\r \u00a0y\t\r \u00a0actuaron\t\r \u00a0como\t\r \u00a0ponentes\t\r \u00a0los\t\r \u00a0Acad\u00e9micos\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF\t\r \u00a0y\t\r \u00a0la\t\r \u00a0RADE,\t\r \u00a0Excmos.\t\r \u00a0 Sres.\t\r \u00a0 D\u00f1a.\t\r \u00a0 Mar\u00eda\t\r \u00a0 Cascales\t\r \u00a0 Angosto,\t\r \u00a0 D.\t\r \u00a0 Julio\t\r \u00a0 Rodr\u00edguez\t\r \u00a0 Villanueva\t\r \u00a0 y\t\r \u00a0 D\u00f1a.\t\r \u00a0Rosa\t\r \u00a0Basante\t\r \u00a0Pol.\t\r \u00a0Cerr\u00f3\t\r \u00a0el\t\r \u00a0Acto\t\r \u00a0elExcmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Jes\u00fas\t\r \u00a0\u00c1lvarez-\u00ad\u2010Fern\u00e1ndez\t\r \u00a0Represa,\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0448\t\r \u00a0Presidente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RADE.\t\r \u00a0\t\r \u00a0El\t\r \u00a0 Excmo.\t\r \u00a0 Sr.\t\r \u00a0 D.\t\r \u00a0 Mariano\t\r \u00a0 Turiel\t\r \u00a0 de\t\r \u00a0Castro,\t\r \u00a0 naci\u00f3\t\r \u00a0 en\t\r \u00a0 Vigo.\t\r \u00a0 Era\t\r \u00a0 doctor\t\r \u00a0 en\t\r \u00a0Farmacia,\t\r \u00a0 periodista,\t\r \u00a0 Acad\u00e9mico,\t\r \u00a0 profesor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0 Complutense\t\r \u00a0 de\t\r \u00a0Madrid\t\r \u00a0 y\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 \u00faltimos\t\r \u00a0 a\u00f1os,\t\r \u00a0 presidente\t\r \u00a0 del\t\r \u00a0 Casino\t\r \u00a0 de\t\r \u00a0 Madrid,\t\r \u00a0 instituci\u00f3n\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0que\t\r \u00a0fue\t\r \u00a0su\t\r \u00a0secretario\t\r \u00a0durante\t\r \u00a0m\u00e1s\t\r \u00a0de\t\r \u00a0doce\t\r \u00a0a\u00f1os\t\r \u00a0y\t\r \u00a0presidente\t\r \u00a0durante\t\r \u00a0casi\t\r \u00a0siete\t\r \u00a0(fue\t\r \u00a0elegido\t\r \u00a0en\t\r \u00a0el\t\r \u00a02006\t\r \u00a0y\t\r \u00a0reelegido\t\r \u00a0en\t\r \u00a0el\t\r \u00a02010).\t\r \u00a0Autor\t\r \u00a0de\t\r \u00a0varios\t\r \u00a0ensayos\t\r \u00a0y\t\r \u00a0colaborador\t\r \u00a0de\t\r \u00a0 programas\t\r \u00a0 de\t\r \u00a0 televisi\u00f3n\t\r \u00a0 como\t\r \u00a0 \"La\t\r \u00a0 rebotica\",\t\r \u00a0 ten\u00eda\t\r \u00a0 numerosos\t\r \u00a0 premios\t\r \u00a0 y\t\r \u00a0distinciones.\t\r \u00a0MESAS\t\r \u00a0REDONDAS\t\r \u00a0\t\r \u00a0El\t\r \u00a0 3\t\r \u00a0 de\t\r \u00a0 abril\t\r \u00a0 tuvo\t\r \u00a0 lugar\t\r \u00a0 la\t\r \u00a0 Mesa\t\r \u00a0 Redonda\t\r \u00a0 organizada\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 Comisi\u00f3n\t\r \u00a0 de\t\r \u00a0Aguas\t\r \u00a0 Minerales\t\r \u00a0 y\t\r \u00a0 Mineromedicinales,\t\r \u00a0 en\t\r \u00a0 colaboraci\u00f3n\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0 Fundaci\u00f3n\t\r \u00a0 Jos\u00e9\t\r \u00a0Casares\t\r \u00a0 Gil,\t\r \u00a0 de\t\r \u00a0 Amigos\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RANF\t\r \u00a0 Sobre:\t\r \u00a0 \"El\t\r \u00a0 Balneario\t\r \u00a0 Villa\t\r \u00a0 de\t\r \u00a0 Olmedo\"\t\r \u00a0(Valladolid).\t\r \u00a0 Cont\u00f3\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 ponencias\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 Dres.\t\r \u00a0 D\u00f1a.\t\r \u00a0 Carmen\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Rosa\t\r \u00a0 Jorge,\t\r \u00a0que\t\r \u00a0habl\u00f3\t\r \u00a0sobre:\t\r \u00a0\t\r \u00a0\"Microbiolog\u00eda\t\r \u00a0 del\t\r \u00a0 manantial\t\r \u00a0 mineromedicinal\t\r \u00a0 del\t\r \u00a0 Balneario\";\t\r \u00a0 D.\t\r \u00a0 Miguel\t\r \u00a0 Ladero\t\r \u00a0Alvarez,\t\r \u00a0que\t\r \u00a0realiz\u00f3\t\r \u00a0el\t\r \u00a0estudio\t\r \u00a0de\t\r \u00a0\"El\t\r \u00a0Entorno\t\r \u00a0bot\u00e1nico\t\r \u00a0del\t\r \u00a0Balneario\";\t\r \u00a0D.\t\r \u00a0Juan\t\r \u00a0Antonio\t\r \u00a0L\u00f3pez\t\r \u00a0Lafuente,\t\r \u00a0sobre\t\r \u00a0\"Caracter\u00edsticas\t\r \u00a0generales\t\r \u00a0de\t\r \u00a0los\t\r \u00a0suelos\t\r \u00a0circundantes\t\r \u00a0al\t\r \u00a0Balneario\";\t\r \u00a0y\t\r \u00a0D\u00f1a.\t\r \u00a0Josefina\t\r \u00a0San\t\r \u00a0 Mart\u00edn\t\r \u00a0 Bacaicoa,\t\r \u00a0 con\t\r \u00a0 su\t\r \u00a0 \"Estudio\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 acci\u00f3n\t\r \u00a0 terap\u00e9utica\t\r \u00a0 de\t\r \u00a0 las\t\r \u00a0 aguas\t\r \u00a0 del\t\r \u00a0Balneario\".\t\r \u00a0\t\r \u00a0El\t\r \u00a0 10\t\r \u00a0 de\t\r \u00a0 abril\t\r \u00a0 la\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 Nacional\t\r \u00a0 de\t\r \u00a0 Farmacia\t\r \u00a0 celebr\u00f3\t\r \u00a0 la\t\r \u00a0 Mesa\t\r \u00a0Redonda\t\r \u00a0en\t\r \u00a0colaboraci\u00f3n\t\r \u00a0con\t\r \u00a0la\t\r \u00a0Fundaci\u00f3n\t\r \u00a0Jos\u00e9\t\r \u00a0Casares\t\r \u00a0Gil,\t\r \u00a0de\t\r \u00a0Amigos\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF\t\r \u00a0sobre:\t\r \u00a0\"Situaci\u00f3n\t\r \u00a0actual\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Atenci\u00f3n\t\r \u00a0Farmac\u00e9utica\t\r \u00a0Hospitalaria\",\t\r \u00a0coordinada\t\r \u00a0por\t\r \u00a0el\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero,\t\r \u00a0el\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Juan\t\r \u00a0Tamargo\t\r \u00a0Men\u00e9ndez.\t\r \u00a0Cont\u00f3\t\r \u00a0con\t\r \u00a0las\t\r \u00a0ponencias\t\r \u00a0 de\t\r \u00a0las\t\r \u00a0 Dras.\t\r \u00a0 D\u00f1a.\t\r \u00a0 Amalia\t\r \u00a0 Torralba,\t\r \u00a0Jefe\t\r \u00a0 del\t\r \u00a0 Servicio\t\r \u00a0 de\t\r \u00a0 Farmacia\t\r \u00a0 del\t\r \u00a0Hospital\t\r \u00a0 Universitario\t\r \u00a0 Puerta\t\r \u00a0 de\t\r \u00a0 Hierro,\t\r \u00a0 que\t\r \u00a0 habl\u00f3\t\r \u00a0 sobre\t\r \u00a0 \"Conciliaci\u00f3n\t\r \u00a0 del\t\r \u00a0tratamiento\t\r \u00a0terap\u00e9utico\t\r \u00a0al\t\r \u00a0ingreso\t\r \u00a0y\t\r \u00a0al\t\r \u00a0alta\t\r \u00a0hospitalaria\";\t\r \u00a0D\u00f1a.\t\r \u00a0Alicia\t\r \u00a0Herrero,\t\r \u00a0Jefe\t\r \u00a0del\t\r \u00a0Servicio\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0del\t\r \u00a0Hospital\t\r \u00a0Universitario\t\r \u00a0La\t\r \u00a0Paz,\t\r \u00a0sobre\t\r \u00a0\"Programas\t\r \u00a0para\t\r \u00a0asegurar\t\r \u00a0 la\t\r \u00a0 atenci\u00f3n\t\r \u00a0 Farmac\u00e9utica\t\r \u00a0 en\t\r \u00a0 pacientes\t\r \u00a0 hospitalizados\"\t\r \u00a0 y\t\r \u00a0 D\u00f1a.\t\r \u00a0 Teresa\t\r \u00a0Bermejo,\t\r \u00a0Jefe\t\r \u00a0 del\t\r \u00a0 Servicio\t\r \u00a0 de\t\r \u00a0 Farmacia\t\r \u00a0 del\t\r \u00a0 Hospital\t\r \u00a0 Universitario\t\r \u00a0 Ram\u00f3n\t\r \u00a0 y\t\r \u00a0 Cajal,\t\r \u00a0sobre\t\r \u00a0\"Las\t\r \u00a0nuevas\t\r \u00a0tecnolog\u00edas\t\r \u00a0aplicadas\t\r \u00a0al\t\r \u00a0uso\t\r \u00a0seguro\t\r \u00a0de\t\r \u00a0los\t\r \u00a0medicamentos\"\t\r \u00a0CONFERENCIAS,\t\r \u00a0CELEBRADAS\t\r \u00a0TODAS\t\r \u00a0EN\t\r \u00a0COLABORACI\u00d3N\t\r \u00a0CON\t\r \u00a0AL\t\r \u00a0FUNDACI\u00d3N\t\r \u00a0JOS\u00c9\t\r \u00a0CASARES\t\r \u00a0GIL\t\r \u00a0DE\t\r \u00a0AMIGOS\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0RANF.\t\r \u00a0\t\r \u00a0\t\r \u00a0El\t\r \u00a0 24\t\r \u00a0 de\t\r \u00a0 abril\t\r \u00a0 tuvo\t\r \u00a0 lugar\t\r \u00a0 la\t\r \u00a0 conferencia\t\r \u00a0 \"El\t\r \u00a0 Consejo\t\r \u00a0 Europeo\t\r \u00a0 de\t\r \u00a0Investigaci\u00f3n,\t\r \u00a0 cuatro\t\r \u00a0 mil\t\r \u00a0 ideas\t\r \u00a0 para\t\r \u00a0 mejorar\t\r \u00a0 el\t\r \u00a0 futuro\t\r \u00a0 de\t\r \u00a0 todos\"\t\r \u00a0 a\t\r \u00a0 cargo\t\r \u00a0 del\t\r \u00a0 Dr.\t\r \u00a0Pablo\t\r \u00a0Amor,\t\r \u00a0Director\t\r \u00a0del\t\r \u00a0European\t\r \u00a0Research\t\r \u00a0Council\t\r \u00a0Executive\t\r \u00a0Agency,\t\r \u00a0quien\t\r \u00a0fue\t\r \u00a0presentado\t\r \u00a0por\t\r \u00a0el\t\r \u00a0Presidente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF,\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Mariano\t\r \u00a0Esteban.\t\r \u00a0En\t\r \u00a0primer\t\r \u00a0Informaci\u00f3n\t\r \u00a0acad\u00e9mica\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0449\t\r \u00a0lugar\t\r \u00a0 habl\u00f3\t\r \u00a0 a\t\r \u00a0 modo\t\r \u00a0 de\t\r \u00a0 introducci\u00f3n\t\r \u00a0 la\t\r \u00a0 Dra.\t\r \u00a0 Cristina\t\r \u00a0 Gutierrez-\u00ad\u2010Cortines,Eurodiputada\t\r \u00a0 y\t\r \u00a0 Catedr\u00e1tica\t\r \u00a0 de\t\r \u00a0 Historia\t\r \u00a0 del\t\r \u00a0 Arte\t\r \u00a0 que\t\r \u00a0 trat\u00f3\t\r \u00a0 el\t\r \u00a0 tema\t\r \u00a0\"Una\t\r \u00a0visi\u00f3n\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Investigaci\u00f3n\t\r \u00a0en\t\r \u00a0Europa\".\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0Ese\t\r \u00a0 mismo\t\r \u00a0 d\u00eda\t\r \u00a0 tambi\u00e9n\t\r \u00a0 se\t\r \u00a0 celebr\u00f3\t\r \u00a0 la\t\r \u00a0 conferencia\t\r \u00a0 impartida\t\r \u00a0 por\t\r \u00a0 nuestro\t\r \u00a0Acad\u00e9mico\t\r \u00a0 Extranjero,\t\r \u00a0 Prof.\t\r \u00a0 Christoph\t\r \u00a0 Friedrich,\t\r \u00a0 Professor\t\r \u00a0 for\t\r \u00a0 the\t\r \u00a0 History\t\r \u00a0 of\t\r \u00a0Pharmacy,\t\r \u00a0Direktor\t\r \u00a0Institute\t\r \u00a0f\u00fcr\t\r \u00a0Geschichite\t\r \u00a0der\t\r \u00a0Pharmazie\t\r \u00a0titulada:\t\r \u00a0\"Pharmacists\t\r \u00a0in\t\r \u00a0 German\t\r \u00a0 Cultural\t\r \u00a0 History\".\t\r \u00a0 Fue\t\r \u00a0 presentado\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 Excma.\t\r \u00a0 Sra.\t\r \u00a0 D\u00f1a.\t\r \u00a0 M\u00aa\t\r \u00a0 del\t\r \u00a0Carmen\t\r \u00a0Franc\u00e9s\t\r \u00a0Causap\u00e9\t\r \u00a0Acad\u00e9mica\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0\t\r \u00a0El\t\r \u00a022\t\r \u00a0de\t\r \u00a0mayo\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0la\t\r \u00a0conferencia\t\r \u00a0titulada:\t\r \u00a0\"Competici\u00f3n\t\r \u00a0Celular\t\r \u00a0en\t\r \u00a0el\t\r \u00a0Embri\u00f3n\t\r \u00a0 y\t\r \u00a0 el\t\r \u00a0 Mantenimiento\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 Tejidos\",\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 que\t\r \u00a0 intervino\t\r \u00a0 el\t\r \u00a0 Dr.\t\r \u00a0 Miguel\t\r \u00a0Torres,\t\r \u00a0Director\t\r \u00a0del\t\r \u00a0Departamento\t\r \u00a0de\t\r \u00a0Desarrollo\t\r \u00a0y\t\r \u00a0Reparaci\u00f3n\t\r \u00a0Cardiovascular\t\r \u00a0del\t\r \u00a0CNIC.\t\r \u00a0Fue\t\r \u00a0presentado\t\r \u00a0por\t\r \u00a0el\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Mariano\t\r \u00a0Esteban\t\r \u00a0Rodr\u00edguez,\t\r \u00a0Presidente\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0\t\r \u00a0La\t\r \u00a0competici\u00f3n\t\r \u00a0celular\t\r \u00a0fue\t\r \u00a0descubierta\t\r \u00a0por\t\r \u00a0los\t\r \u00a0cient\u00edficos\t\r \u00a0espa\u00f1oles,\t\r \u00a0Gin\u00e9s\t\r \u00a0Morata\t\r \u00a0 y\t\r \u00a0 Pedro\t\r \u00a0 Ripoll\t\r \u00a0 en\t\r \u00a0 1975\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 mosca\t\r \u00a0 Drosophila\t\r \u00a0 melanogaster.\t\r \u00a0 Desde\t\r \u00a0entonces\t\r \u00a0 el\t\r \u00a0 fen\u00f3meno\t\r \u00a0 s\u00f3lo\t\r \u00a0 se\t\r \u00a0 hab\u00eda\t\r \u00a0 observado\t\r \u00a0 tras\t\r \u00a0 su\t\r \u00a0 inducci\u00f3n\t\r \u00a0 experimental.\t\r \u00a0Nuestros\t\r \u00a0 estudios\t\r \u00a0 recientes\t\r \u00a0 describen\t\r \u00a0 por\t\r \u00a0 primera\t\r \u00a0 vez\t\r \u00a0 su\t\r \u00a0 funci\u00f3n\t\r \u00a0 natural,\t\r \u00a0 y\t\r \u00a0 lo\t\r \u00a0hace\t\r \u00a0en\t\r \u00a0mam\u00edferos,\t\r \u00a0indicando\t\r \u00a0que\t\r \u00a0se\t\r \u00a0trata\t\r \u00a0de\t\r \u00a0un\t\r \u00a0proceso\t\r \u00a0natural\t\r \u00a0y\t\r \u00a0conservado\t\r \u00a0a\t\r \u00a0lo\t\r \u00a0largo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0evoluci\u00f3n.\t\r \u00a0\t\r \u00a0En\t\r \u00a0 los\t\r \u00a0 primeros\t\r \u00a0 estadios\t\r \u00a0 del\t\r \u00a0 desarrollo\t\r \u00a0 embrionario\t\r \u00a0 de\t\r \u00a0 los\t\r \u00a0 mam\u00edferos\t\r \u00a0 las\t\r \u00a0c\u00e9lulas\t\r \u00a0compiten\t\r \u00a0intensamente\t\r \u00a0por\t\r \u00a0la\t\r \u00a0supervivencia\t\r \u00a0y,\t\r \u00a0como\t\r \u00a0resultado,\t\r \u00a0las\t\r \u00a0menos\t\r \u00a0activas\t\r \u00a0metab\u00f3licamente\t\r \u00a0son\t\r \u00a0eliminadas\t\r \u00a0por\t\r \u00a0sus\t\r \u00a0hermanas.\t\r \u00a0Las\t\r \u00a0c\u00e9lulas\t\r \u00a0vencedoras\t\r \u00a0en\t\r \u00a0 este\t\r \u00a0 proceso\t\r \u00a0 son\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 presentan\t\r \u00a0 mayores\t\r \u00a0 niveles\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 prote\u00edna\t\r \u00a0 Myc,\t\r \u00a0 un\t\r \u00a0controlador\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 capacidad\t\r \u00a0 metab\u00f3lica\t\r \u00a0 celular.\t\r \u00a0 El\t\r \u00a0 embri\u00f3n\t\r \u00a0 temprano\t\r \u00a0 es\t\r \u00a0 un\t\r \u00a0mosaico\t\r \u00a0de\t\r \u00a0c\u00e9lulas\t\r \u00a0con\t\r \u00a0niveles\t\r \u00a0muy\t\r \u00a0diferentes\t\r \u00a0de\t\r \u00a0Myc\t\r \u00a0en\t\r \u00a0el\t\r \u00a0que\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0con\t\r \u00a0m\u00e1s\t\r \u00a0Myc,\t\r \u00a0m\u00e1s\t\r \u00a0activas\t\r \u00a0anab\u00f3licamente,\t\r \u00a0eliminan\t\r \u00a0a\t\r \u00a0las\t\r \u00a0de\t\r \u00a0niveles\t\r \u00a0m\u00e1s\t\r \u00a0bajos.\t\r \u00a0Sin\t\r \u00a0embargo,\t\r \u00a0es\t\r \u00a0importante\t\r \u00a0resaltar\t\r \u00a0que\t\r \u00a0las\t\r \u00a0que\t\r \u00a0mueren\t\r \u00a0son\t\r \u00a0c\u00e9lulas\t\r \u00a0viables;\t\r \u00a0su\t\r \u00a0eliminaci\u00f3n\t\r \u00a0se\t\r \u00a0produce\t\r \u00a0\u00fanicamente\t\r \u00a0porque\t\r \u00a0el\t\r \u00a0embri\u00f3n\t\r \u00a0cuenta\t\r \u00a0con\t\r \u00a0c\u00e9lulas\t\r \u00a0m\u00e1s\t\r \u00a0aptas\t\r \u00a0capaces\t\r \u00a0de\t\r \u00a0reemplazarlas\t\r \u00a0 y\t\r \u00a0 por\t\r \u00a0 tanto\t\r \u00a0 se\t\r \u00a0 trata\t\r \u00a0 de\t\r \u00a0 un\t\r \u00a0 mecanismo\t\r \u00a0 de\t\r \u00a0 optimizaci\u00f3n,\t\r \u00a0 no\t\r \u00a0 de\t\r \u00a0reparaci\u00f3n.\t\r \u00a0\t\r \u00a0Gracias\t\r \u00a0a\t\r \u00a0esta\t\r \u00a0competici\u00f3n\t\r \u00a0celular,\t\r \u00a0el\t\r \u00a0organismo\t\r \u00a0en\t\r \u00a0formaci\u00f3n\t\r \u00a0se\t\r \u00a0optimiza\t\r \u00a0durante\t\r \u00a0el\t\r \u00a0desarrollo,\t\r \u00a0seleccionando\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0con\t\r \u00a0mayor\t\r \u00a0capacidad\t\r \u00a0anab\u00f3lica\t\r \u00a0y\t\r \u00a0por\t\r \u00a0 tanto,\t\r \u00a0 previsiblemente,\t\r \u00a0 las\t\r \u00a0 mas\t\r \u00a0 aptas\t\r \u00a0 para\t\r \u00a0 soportar\t\r \u00a0 las\t\r \u00a0 funciones\t\r \u00a0 vitales\t\r \u00a0durante\t\r \u00a0toda\t\r \u00a0la\t\r \u00a0vida\t\r \u00a0del\t\r \u00a0nuevo\t\r \u00a0individuo.\t\r \u00a0Este\t\r \u00a0proceso\t\r \u00a0se\t\r \u00a0presume\t\r \u00a0especialmente\t\r \u00a0importante\t\r \u00a0 en\t\r \u00a0 organismos\t\r \u00a0 longevos,\t\r \u00a0 como\t\r \u00a0 los\t\r \u00a0 humanos,\t\r \u00a0 que\t\r \u00a0 deben\t\r \u00a0 mantener\t\r \u00a0 la\t\r \u00a0funcionalidad\t\r \u00a0 de\t\r \u00a0 sus\t\r \u00a0 tejidos\t\r \u00a0 durante\t\r \u00a0 toda\t\r \u00a0 una\t\r \u00a0 larga\t\r \u00a0 vida.\t\r \u00a0 Cuando\t\r \u00a0 la\t\r \u00a0 competici\u00f3n\t\r \u00a0celular\t\r \u00a0se\t\r \u00a0impide\t\r \u00a0experimentalmente,\t\r \u00a0las\t\r \u00a0c\u00e9lulas\t\r \u00a0con\t\r \u00a0menor\t\r \u00a0capacidad\t\r \u00a0metab\u00f3lica\t\r \u00a0\u2014que\t\r \u00a0 normalmente\t\r \u00a0 hubiesen\t\r \u00a0 sido\t\r \u00a0 eliminadas\u2014\t\r \u00a0pueden\t\r \u00a0 contribuir\t\r \u00a0 al\t\r \u00a0 nuevo\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0450\t\r \u00a0organismo\t\r \u00a0que,\t\r \u00a0predeciblemente,\t\r \u00a0tendr\u00e1\t\r \u00a0una\t\r \u00a0menor\t\r \u00a0aptitud\t\r \u00a0que\t\r \u00a0el\t\r \u00a0organismo\t\r \u00a0que\t\r \u00a0se\t\r \u00a0hubiera\t\r \u00a0formado\t\r \u00a0normalmente.\t\r \u00a0\t\r \u00a0Recientemente\t\r \u00a0 hemos\t\r \u00a0 extendido\t\r \u00a0 estas\t\r \u00a0 observaciones\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 fase\t\r \u00a0 de\t\r \u00a0organog\u00e9nesis\t\r \u00a0y\t\r \u00a0mantenimiento\t\r \u00a0de\t\r \u00a0los\t\r \u00a0tejidos\t\r \u00a0adultos.\t\r \u00a0Las\t\r \u00a0evidencias\t\r \u00a0acumuladas\t\r \u00a0indican\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 competici\u00f3n\t\r \u00a0 celular\t\r \u00a0 es\t\r \u00a0 esencial\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0 mantenimiento\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0homeostasis\t\r \u00a0 tisular,\t\r \u00a0 lo\t\r \u00a0 que\t\r \u00a0 abre\t\r \u00a0 las\t\r \u00a0 puertas\t\r \u00a0 a\t\r \u00a0 la\t\r \u00a0 investigaci\u00f3n\t\r \u00a0 de\t\r \u00a0 su\t\r \u00a0 papel\t\r \u00a0 en\t\r \u00a0procesos\t\r \u00a0 y\t\r \u00a0 enfermedades\t\r \u00a0 humanas\t\r \u00a0 en\t\r \u00a0 las\t\r \u00a0 que\t\r \u00a0 la\t\r \u00a0 homeostasis\t\r \u00a0 tisular\t\r \u00a0 es\t\r \u00a0 esencial,\t\r \u00a0como\t\r \u00a0la\t\r \u00a0regeneraci\u00f3n,\t\r \u00a0la\t\r \u00a0formaci\u00f3n\t\r \u00a0de\t\r \u00a0tumores\t\r \u00a0y\t\r \u00a0las\t\r \u00a0enfermedades\t\r \u00a0degenerativas.\t\r \u00a0\t\r \u00a0El\t\r \u00a029\t\r \u00a0de\t\r \u00a0mayo\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0celebr\u00f3\t\r \u00a0la\t\r \u00a0Sesi\u00f3n\t\r \u00a0en\t\r \u00a0Honor\t\r \u00a0al\t\r \u00a0Dr.\t\r \u00a0Michael\t\r \u00a0G.\t\r \u00a0Barbour\t\r \u00a0con\t\r \u00a0la\t\r \u00a0conferencia\t\r \u00a0impartida\t\r \u00a0por\t\r \u00a0el\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RANF,\t\r \u00a0 Excmo.\t\r \u00a0 Sr.\t\r \u00a0 D.\t\r \u00a0 Salvador\t\r \u00a0 Rivas\t\r \u00a0 Mart\u00ednez\t\r \u00a0 quien\t\r \u00a0 abord\u00f3\t\r \u00a0 el\t\r \u00a0\"Avances\t\r \u00a0 sobre\t\r \u00a0 el\t\r \u00a0 estudio\t\r \u00a0 geobot\u00e1nico\t\r \u00a0 del\t\r \u00a0 estado\t\r \u00a0 de\t\r \u00a0 California,\t\r \u00a0 EE.\t\r \u00a0 UU\".\t\r \u00a0 El\t\r \u00a0 Dr.\t\r \u00a0Rivas,\t\r \u00a0 ley\u00f3\t\r \u00a0 la\t\r \u00a0 laudatio\t\r \u00a0 en\t\r \u00a0 honor\t\r \u00a0 del\t\r \u00a0 Dr.\t\r \u00a0 Michael\t\r \u00a0 George\t\r \u00a0 Barbour\t\r \u00a0 y\t\r \u00a0 recibi\u00f3\t\r \u00a0 en\t\r \u00a0 su\t\r \u00a0nombre\t\r \u00a0el\t\r \u00a0Diploma\t\r \u00a0como\t\r \u00a0Acad\u00e9mico\t\r \u00a0Extranjero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0\t\r \u00a0El\t\r \u00a05\t\r \u00a0de\t\r \u00a0junio\t\r \u00a0la\t\r \u00a0Excma.\t\r \u00a0Sra.\t\r \u00a0D\u00f1a.\t\r \u00a0Ana\t\r \u00a0M\u00aa\t\r \u00a0Pascual-\u00ad\u2010Leone\t\r \u00a0Pascual,\t\r \u00a0Acad\u00e9mica\t\r \u00a0de\t\r \u00a0 N\u00famero\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RANF,\t\r \u00a0 pronunci\u00f3\t\r \u00a0 su\t\r \u00a0 conferencia\t\r \u00a0 titulada:\t\r \u00a0 \"El\t\r \u00a0 concepto\t\r \u00a0Darwiniano\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Allostasis.\t\r \u00a0Epig\u00e9nesis\".\t\r \u00a0\t\r \u00a0El\t\r \u00a0 12\t\r \u00a0 de\t\r \u00a0 junio\t\r \u00a0 se\t\r \u00a0 celebr\u00f3\t\r \u00a0 la\t\r \u00a0 conferencia\t\r \u00a0 titulada:\t\r \u00a0 \"Prescripci\u00f3n\t\r \u00a0 de\t\r \u00a0medicamentos\t\r \u00a0fuera\t\r \u00a0de\t\r \u00a0la\t\r \u00a0ficha\t\r \u00a0t\u00e9cnica\t\r \u00a0(off-\u00ad\u2010label)\",\t\r \u00a0en\t\r \u00a0la\t\r \u00a0que\t\r \u00a0intervino\t\r \u00a0el\t\r \u00a0Dr.\t\r \u00a0D.\t\r \u00a0Jos\u00e9\t\r \u00a0Ram\u00f3n\t\r \u00a0 Luis-\u00ad\u2010Yag\u00fce,\t\r \u00a0 Director\t\r \u00a0 del\t\r \u00a0 Departamento\t\r \u00a0 de\t\r \u00a0 Relaciones\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0 CCAA\t\r \u00a0 de\t\r \u00a0Farmaindustria,\t\r \u00a0 quien\t\r \u00a0 fue\t\r \u00a0 presentado\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 Excmo.\t\r \u00a0 Sr.\t\r \u00a0 D.\t\r \u00a0 Juan\t\r \u00a0 Tamargo\t\r \u00a0Men\u00e9ndez,\t\r \u00a0Acad\u00e9mico\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0CURSOS\t\r \u00a0\t\r \u00a0La\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0celebr\u00f3\t\r \u00a0entre\t\r \u00a0el\t\r \u00a0\t\r \u00a07\t\r \u00a0y\t\r \u00a0el\t\r \u00a010\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0de\t\r \u00a0 2014\t\r \u00a0 el\t\r \u00a0 \"I\t\r \u00a0 Curso\t\r \u00a0 Avanzado\t\r \u00a0 sobre\t\r \u00a0 Obesidad\".\t\r \u00a0 Coordinado\t\r \u00a0 por\t\r \u00a0 los\t\r \u00a0 Dres.\t\r \u00a0 Mar\u00eda\t\r \u00a0Cascales\t\r \u00a0Angosto,\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0Ozonas\t\r \u00a0y\t\r \u00a0Francisco\t\r \u00a0Jos\u00e9\t\r \u00a0S\u00e1nchez\t\r \u00a0Muniz.\t\r \u00a0Cont\u00f3\t\r \u00a0con\t\r \u00a0las\t\r \u00a0intervenciones\t\r \u00a0de\t\r \u00a0cient\u00edficos\t\r \u00a0y\t\r \u00a0docentes\t\r \u00a0del\t\r \u00a0m\u00e1s\t\r \u00a0alto\t\r \u00a0nivel\t\r \u00a0investigador.\t\r \u00a0\t\r \u00a0El\t\r \u00a0curso\t\r \u00a0result\u00f3\t\r \u00a0un\t\r \u00a0\u00e9xito\t\r \u00a0abrumador\t\r \u00a0debido\t\r \u00a0a\t\r \u00a0la\t\r \u00a0gran\t\r \u00a0cantidad\t\r \u00a0de\t\r \u00a0solicitudes\t\r \u00a0de\t\r \u00a0inscripci\u00f3n\t\r \u00a0recibidas.\t\r \u00a0Por\t\r \u00a0tal\t\r \u00a0motivo,\t\r \u00a0una\t\r \u00a0vez\t\r \u00a0completo\t\r \u00a0el\t\r \u00a0cupo\t\r \u00a0presencial\t\r \u00a0con\t\r \u00a0los\t\r \u00a0alumnos\t\r \u00a0matriculados,\t\r \u00a0se\t\r \u00a0ampli\u00f3\t\r \u00a0a\t\r \u00a0la\t\r \u00a0modalidad\t\r \u00a0on\t\r \u00a0line\t\r \u00a0para\t\r \u00a0profesionales.\t\r \u00a0\t\r \u00a0OTROS\t\r \u00a0ACTOS\t\r \u00a0EN\t\r \u00a0LA\t\r \u00a0RANF\t\r \u00a0\t\r \u00a0El\t\r \u00a08\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0los\t\r \u00a0Laboratorios\t\r \u00a0Merck\t\r \u00a0realizaron\t\r \u00a0en\t\r \u00a0nuestra\t\r \u00a0sede\t\r \u00a0una\t\r \u00a0Jornada\t\r \u00a0de\t\r \u00a0trabajo\t\r \u00a0sobre\t\r \u00a0Biosimilares,\t\r \u00a0con\t\r \u00a0los\t\r \u00a0miembros\t\r \u00a0de\t\r \u00a0las\t\r \u00a0Comisiones\t\r \u00a0de\t\r \u00a0Sanidad\t\r \u00a0del\t\r \u00a0Congreso\t\r \u00a0y\t\r \u00a0del\t\r \u00a0Senado.\t\r \u00a0Informaci\u00f3n\t\r \u00a0acad\u00e9mica\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0451\t\r \u00a0\t\r \u00a0Asimismo\t\r \u00a0han\t\r \u00a0tenido\t\r \u00a0lugar\t\r \u00a0varios\t\r \u00a0actos\t\r \u00a0de\t\r \u00a0COFARES\t\r \u00a0dentro\t\r \u00a0del\t\r \u00a0ciclo\t\r \u00a0sobre\t\r \u00a0Patolog\u00edas\t\r \u00a0prevalentes\t\r \u00a0tratando\t\r \u00a0diversos\t\r \u00a0temas\t\r \u00a0como\t\r \u00a0\u201cArtrosis\u201d,\t\r \u00a0\u201cArtritis-\u00ad\u2010Gota\u201d\t\r \u00a0y\t\r \u00a0\u201cOsteoporosis\u201d.\t\r \u00a0\t\r \u00a0El\t\r \u00a022\t\r \u00a0y\t\r \u00a029\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0tuvieron\t\r \u00a0lugar\t\r \u00a0dos\t\r \u00a0reuniones\t\r \u00a0de\t\r \u00a0ASEDEF,\t\r \u00a0con\t\r \u00a0motivo\t\r \u00a0de\t\r \u00a0la\t\r \u00a0 publicaci\u00f3n\t\r \u00a0 del\t\r \u00a0 Real\t\r \u00a0 Decreto\t\r \u00a0 de\t\r \u00a0 Precios\t\r \u00a0 recientemente\t\r \u00a0 publicado.\t\r \u00a0 Acudi\u00f3\t\r \u00a0 el\t\r \u00a0Director\t\r \u00a0del\t\r \u00a0Departamento\t\r \u00a0de\t\r \u00a0Precios\t\r \u00a0del\t\r \u00a0Ministerio\t\r \u00a0de\t\r \u00a0Sanidad.\t\r \u00a0\t\r \u00a0El\t\r \u00a0 23\t\r \u00a0 de\t\r \u00a0 abril\t\r \u00a0 se\t\r \u00a0 realiz\u00f3\t\r \u00a0 un\t\r \u00a0 Acto\t\r \u00a0 conjunto\t\r \u00a0 con\t\r \u00a0 PharmaMar\t\r \u00a0 sobre\t\r \u00a0\"Medicamentos\t\r \u00a0 con\t\r \u00a0 nuevos\t\r \u00a0 mecanismos\t\r \u00a0 de\t\r \u00a0 acci\u00f3n:\t\r \u00a0innovaci\u00f3n\t\r \u00a0 radical\",\t\r \u00a0 con\t\r \u00a0 la\t\r \u00a0bienvenida\t\r \u00a0del\t\r \u00a0\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Mariano\t\r \u00a0Esteban\t\r \u00a0Rodr\u00edguez\t\r \u00a0y\t\r \u00a0conferencia\t\r \u00a0inaugural\t\r \u00a0del\t\r \u00a0 Presidente\t\r \u00a0 Prof.\t\r \u00a0 Dr.\t\r \u00a0 Jos\u00e9\t\r \u00a0 Mar\u00eda\t\r \u00a0 Fern\u00e1ndez-\u00ad\u2010Sousa\t\r \u00a0 Faro.\t\r \u00a0 La\t\r \u00a0 jornada\t\r \u00a0 fue\t\r \u00a0moderada\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0 Ilmo.\t\r \u00a0 Prof.\t\r \u00a0 Dr.\t\r \u00a0 Honorio\t\r \u00a0 Carlos\t\r \u00a0 Bando\t\r \u00a0 Casado,\t\r \u00a0 con\t\r \u00a0 las\t\r \u00a0presentaciones\t\r \u00a0 del\t\r \u00a0 Ilmo.\t\r \u00a0 Prof.\t\r \u00a0 Dr.\t\r \u00a0 Alfonso\t\r \u00a0 Moreno\t\r \u00a0 Gonz\u00e1lez,\t\r \u00a0 Ilmo.\t\r \u00a0 Dr.\t\r \u00a0 D.\t\r \u00a0 Carlos\t\r \u00a0Lens\t\r \u00a0y\t\r \u00a0la\t\r \u00a0Ilma.\t\r \u00a0Dra.\t\r \u00a0D\u00f1a.\t\r \u00a0Olga\t\r \u00a0Delgado\t\r \u00a0S\u00e1nchez.\t\r \u00a0\t\r \u00a0Ese\t\r \u00a0 mismo\t\r \u00a0 d\u00eda\t\r \u00a0 tambi\u00e9n\t\r \u00a0 tuvo\t\r \u00a0 lugar\t\r \u00a0 en\t\r \u00a0 la\t\r \u00a0 RANF\t\r \u00a0 un\t\r \u00a0 acto\t\r \u00a0 de\t\r \u00a0 Euractiv,\t\r \u00a0 que\t\r \u00a0consisti\u00f3\t\r \u00a0en\t\r \u00a0un\t\r \u00a0Taller\t\r \u00a0Mesa\t\r \u00a0redonda\t\r \u00a0sobre\t\r \u00a0el\t\r \u00a0problema\t\r \u00a0del\t\r \u00a0exceso\t\r \u00a0de\t\r \u00a0colesterol\t\r \u00a0y\t\r \u00a0sus\t\r \u00a0implicaciones\t\r \u00a0para\t\r \u00a0la\t\r \u00a0salud\t\r \u00a0de\t\r \u00a0los\t\r \u00a0ciudadanos\t\r \u00a0y\t\r \u00a0del\t\r \u00a0sistema\t\r \u00a0sanitario\t\r \u00a0espa\u00f1ol.\t\r \u00a0\t\r \u00a0\t\r \u00a0El\t\r \u00a028\t\r \u00a0de\t\r \u00a0abril\t\r \u00a0hubo\t\r \u00a0un\t\r \u00a0Acto\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Fundaci\u00f3n\t\r \u00a0Ciencias\t\r \u00a0de\t\r \u00a0la\t\r \u00a0Salud.\t\r \u00a0\u201cLas\t\r \u00a0causas\t\r \u00a0de\t\r \u00a0 la\t\r \u00a0 guerra\t\r \u00a0 de\t\r \u00a0 sucesi\u00f3n\t\r \u00a0 o\t\r \u00a0 el\t\r \u00a0 valor\t\r \u00a0 de\t\r \u00a0 una\t\r \u00a0 Historia\t\r \u00a0 Cr\u00edtica\u201d;\t\r \u00a0 organizada\t\r \u00a0 por\t\r \u00a0 el\t\r \u00a0Acad\u00e9mico\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Javier\t\r \u00a0Puerto\t\r \u00a0Sarmiento.\t\r \u00a0\t\r \u00a0El\t\r \u00a022\t\r \u00a0de\t\r \u00a0mayo\t\r \u00a0de\t\r \u00a02014\t\r \u00a0la\t\r \u00a0Real\t\r \u00a0Academia\t\r \u00a0Nacional\t\r \u00a0de\t\r \u00a0Farmacia\t\r \u00a0recibi\u00f3\t\r \u00a0a\t\r \u00a0los\t\r \u00a0Acad\u00e9micos\t\r \u00a0 Extranjeros\t\r \u00a0 Dres.\t\r \u00a0 Tadashi\t\r \u00a0 Goino\t\r \u00a0 y\t\r \u00a0 Rafael\t\r \u00a0 Melik-\u00ad\u2010Ohanjanyan\t\r \u00a0 en\t\r \u00a0 el\t\r \u00a0Solemne\t\r \u00a0Acto\t\r \u00a0de\t\r \u00a0entrega\t\r \u00a0de\t\r \u00a0una\t\r \u00a0nueva\t\r \u00a0colecci\u00f3n\t\r \u00a0de\t\r \u00a0grabados\t\r \u00a0de\t\r \u00a0arte\t\r \u00a0Ukiyo-\u00ad\u2010e.\t\r \u00a0Se\t\r \u00a0condecor\u00f3\t\r \u00a0a\t\r \u00a0ambos\t\r \u00a0Acad\u00e9micos\t\r \u00a0con\t\r \u00a0la\t\r \u00a0Medalla\t\r \u00a0Carracido\t\r \u00a0de\t\r \u00a0plata\t\r \u00a0de\t\r \u00a0la\t\r \u00a0RANF\t\r \u00a0por\t\r \u00a0la\t\r \u00a0gran\t\r \u00a0contribuci\u00f3n\t\r \u00a0realizada\t\r \u00a0por\t\r \u00a0y\t\r \u00a0para\t\r \u00a0la\t\r \u00a0RANF.\t\r \u00a0\t\r \u00a0El\t\r \u00a026\t\r \u00a0de\t\r \u00a0mayo\t\r \u00a0tuvo\t\r \u00a0lugar\t\r \u00a0la\t\r \u00a0Presentaci\u00f3n\t\r \u00a0del\t\r \u00a0Libro:\t\r \u00a0\"Gesti\u00f3n\t\r \u00a0Hospitalaria\t\r \u00a0y\t\r \u00a0acuerdos\t\r \u00a0 de\t\r \u00a0 riesgo\t\r \u00a0 compartido\t\r \u00a0 en\t\r \u00a0 Espa\u00f1a\",\t\r \u00a0 organizada\t\r \u00a0 por\t\r \u00a0 la\t\r \u00a0 Universidad\t\r \u00a0Internacional\t\r \u00a0Men\u00e9ndez\t\r \u00a0Pelayo\t\r \u00a0y\t\r \u00a0UCB\t\r \u00a0Pharma.\t\r \u00a0\t\r \u00a0\t\r \u00a0En\t\r \u00a0cuanto\t\r \u00a0a\t\r \u00a0los\t\r \u00a0honores\t\r \u00a0que\t\r \u00a0han\t\r \u00a0recibido\t\r \u00a0nuestros\t\r \u00a0Acad\u00e9micos\t\r \u00a0durante\t\r \u00a0este\t\r \u00a0\u00faltimo\t\r \u00a0 trimestre,\t\r \u00a0 hay\t\r \u00a0 que\t\r \u00a0 destacar\t\r \u00a0 que\t\r \u00a0 el\t\r \u00a0 pasado\t\r \u00a0 19\t\r \u00a0 de\t\r \u00a0 mayo\t\r \u00a0 de\t\r \u00a0 2014\t\r \u00a0 nuestra\t\r \u00a0Acad\u00e9mica\t\r \u00a0de\t\r \u00a0 N\u00famero\t\r \u00a0 la\t\r \u00a0 Excma.\t\r \u00a0 Sra.\t\r \u00a0 D\u00f1a.\t\r \u00a0 Mar\u00eda\t\r \u00a0 Teresa\t\r \u00a0 Miras\t\r \u00a0 Portugal,\t\r \u00a0 tom\u00f3\t\r \u00a0posesi\u00f3n\t\r \u00a0 como\t\r \u00a0 Acad\u00e9mica\t\r \u00a0 Correspondiente\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Real\t\r \u00a0 Academia\t\r \u00a0 de\t\r \u00a0 Farmacia\t\r \u00a0 de\t\r \u00a0Catalu\u00f1a.\t\r \u00a0\t\r \u00a0La\t\r \u00a0 Dra.\t\r \u00a0 Miras\t\r \u00a0 ley\u00f3\t\r \u00a0 su\t\r \u00a0 discurso\t\r \u00a0 de\t\r \u00a0 ingreso\t\r \u00a0 titulado:\t\r \u00a0 \"Receptores\t\r \u00a0 de\t\r \u00a0nucle\u00f3tidos\t\r \u00a0 y\t\r \u00a0 su\t\r \u00a0 implicaci\u00f3n\t\r \u00a0 en\t\r \u00a0 los\t\r \u00a0 mecanismos\t\r \u00a0 del\t\r \u00a0 dolor\t\r \u00a0 y\t\r \u00a0 la\t\r \u00a0 analgesia\",\t\r \u00a0 y\t\r \u00a0 fue\t\r \u00a0presentada\t\r \u00a0 a\t\r \u00a0 cargo\t\r \u00a0 del\t\r \u00a0 tambi\u00e9n\t\r \u00a0 Acad\u00e9mico\t\r \u00a0 de\t\r \u00a0 N\u00famero\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 RANF\t\r \u00a0 y\t\r \u00a0 RAFC\t\r \u00a0 el\t\r \u00a0Excmo.\t\r \u00a0Sr.\t\r \u00a0D.\t\r \u00a0Joan\t\r \u00a0Guinovart\t\r \u00a0Cirera.\t\r \u00a0Bartolom\u00e9\t\r \u00a0Ribas\t\r \u00a0\t\r \u00a0\n\t\r \u00a0\t\r \u00a0452\t\r \u00a0\t\r \u00a0El\t\r \u00a0 12\t\r \u00a0 de\t\r \u00a0 mayo\t\r \u00a0 se\t\r \u00a0 produjo\t\r \u00a0 la\t\r \u00a0 entrega\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Cruz\t\r \u00a0 de\t\r \u00a0 Honor\t\r \u00a0 de\t\r \u00a0 la\t\r \u00a0 Sanidad\t\r \u00a0madrile\u00f1a,\t\r \u00a0en\t\r \u00a0su\t\r \u00a0categor\u00eda\t\r \u00a0de\t\r \u00a0oro\t\r \u00a0otorgada\t\r \u00a0por\t\r \u00a0la\t\r \u00a0Comunidad\t\r \u00a0de\t\r \u00a0Madrid\t\r \u00a0a\t\r \u00a0nuestra\t\r \u00a0compa\u00f1era\t\r \u00a0Acad\u00e9mica\t\r \u00a0de\t\r \u00a0N\u00famero\t\r \u00a0la\t\r \u00a0Excma.\t\r \u00a0Sra.\t\r \u00a0D\u00f1a.\t\r \u00a0Rosa\t\r \u00a0M.\t\r \u00a0Basante\t\r \u00a0Pol.\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0\t\r \u00a0PUBLICACIOES\t\r \u00a0ELECTR\u00d3NCAS\t\r \u00a0DE\t\r \u00a0LA\t\r \u00a0\t\r \u00a0REAL\t\r \u00a0ACADEMIA\t\r \u00a0\t\r \u00a0NACIONAL\t\r \u00a0DE\t\r \u00a0FARMACIA\t\r \u00a0\t\r \u00a0\n", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}